Citrus Sinensis ID: 043267

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610----
Protein Sequence
ANNAFFRKLAIMITVFNTDHQISPFQMSLFLSIFFALVSVLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKIFLAALLTAYL
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHccccccccccccHHHHHHHHHHcccccccccccccccccccccccccccHHHHHHHcccccHHHHHHHHccccccccccccHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccHHcccccccEEEEHHHHHHHHcccccccccccccccccEEEEcccccEEEEEEccccccHHHHHHHHHHHHHHHccccccccccEEEcccccccccEEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccEEccccccccHHHHcccccccccccccHHHHHHHHHHccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHcccccccccccccccHHEccccccccccccccccEEEEcccEEEEEEEEEccccEEEEEEEcccccEEEEEEEEEccccccEEEEEEcccccccccHcccccccEccccccccccHHHHcccccccccEEcccccccccccEEEEEcccccccccEEcccccHHHHHHHHHHcccEEEEEEEcccccccEEEEEcccHHHHHHcccccccEEEEHHHEEEHHccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccEcHHHHHHHHccccHccccccccccccEccccccccEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccEEEEEEEcccccHHHEHcccccccccHHHHHHHHHHHHHHHHHHHHccccEEccccccHHHEEEEHHHEEEEccccHHHEccccccccccEEEEEEcHccHHHHHHccccHHHHHHHHHHHHHHHEcccccccccccccccHHHHHHHHHHccccHHHccHHHcccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHccccccccccccccccccccc
Coil and Loop (DISEMBL)
ANNAFFRKLAIMITVFntdhqispfQMSLFLSIFFALVSVLHSVssssgnlsespcplnfDAVRRLVnegpkrpmltdmntQCQIVLQGIRLLRAEYLrtngyflppvnsscyeSCRNFVTEFVQgfdirtscgyypelISEACMNITSraqfeslipkSKLQEIKRHCSQslensyacdsctsKLSSLSEILrhgpgngngnvsdcsgypYLYAAAVVnqfgpidrATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERVVkvtdndepslvlesrssnlARFKIEEIKAATMNFsreniigkggygnvykgmlpngTEVAVKRFKNcskagdanfKHEVEIIASVKHVNLVALRGystatvpleghqrIIVCdllhngslydhlfgsgmkklsWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAfeakvgdfglakfnpegithLTTRVagtlgyvapeyalygkltpgsdvySFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIeenmpemelpeMMEQYVLTAAICahpilqarptMDQIVKILETDVPLSNIKIFLAALLTAYL
Flexible Loop (DISEMBL)
ANNAFFRKLAIMITVFNTDHQISPFQMSLFLSIFFALVSVLHSVSSSsgnlsespcplNFDAVRRLVNEGpkrpmltdmntqCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTrskkseervvkvtdndepslvlesrssnlarfKIEEIKaatmnfsreniIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILetdvplsnIKIFLAALLTAYL
Low Complexity Region (SEG)
ANNAFFRKLAIMITVFNTDHQISPFQMSLFLSIFFAlvsvlhsvssssgnlsesPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEiviyglvlgsvigilgAFTAFWFLFTRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIeenmpemelpemmeQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKIFLAALLTAYL
Disordered region (IsUnstruct)
***AFFRKLAIMITVFNTDHQISPFQMSLFLSIFFALVSVLHSV*************LNFDAVRRLVN******MLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIP*****************SYACDSCT********IL*******NGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTR***************************LARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKIFLAALLTAY*
Disordered Region (DISOPRED)
*****FR*LAIMITVFNTDHQISPFQMSLFLSIFFALVSVLHS*************PLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATA***********************YGLVLGSVIGILGAFTAFWFLFTR***************************LARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFK*C****DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI*QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSN**IF*A*****YL
Disordered Region (DISEMBL)
ANNAFFRKLAIMITVFNTDHQISPFQMSLFLSIFFALVSVLH************PCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKIFLAALLTAYL
Disordered Region (DISPRO)
*NNAFFRKLAIMITVFNTDHQISPFQMSLFLSIFFALVSVLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSE********************SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIK***********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
ANNAFFRKLAIMITVFNTDHQISPFQMSLFLSIFFALVSVLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKIFLAALLTAYL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	614	2.2.26 [Sep-21-2011]
P93050	617	Probable LRR receptor-lik	yes	no	0.900	0.896	0.550	1e-178
O04086	625	Probable receptor-like pr	no	no	0.884	0.868	0.388	4e-93
Q9LS95	700	Putative proline-rich rec	no	no	0.498	0.437	0.460	6e-69
Q9LV48	652	Proline-rich receptor-lik	no	no	0.485	0.457	0.473	9e-68
Q8GX23	670	Proline-rich receptor-lik	no	no	0.514	0.471	0.44	1e-67
Q9LK03	717	Proline-rich receptor-lik	no	no	0.470	0.403	0.461	3e-67
Q9XI96	699	Proline-rich receptor-lik	no	no	0.480	0.422	0.465	1e-66
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.534	0.639	0.423	4e-65
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.469	0.4	0.45	1e-64
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.478	0.414	0.447	2e-64

>sp|P93050|RKF3_ARATH Probable LRR receptor-like serine/threonine-protein kinase RKF3 OS=Arabidopsis thaliana GN=RKF3 PE=1 SV=1

 Score =  626 bits (1614), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 314/570 (55%), Positives = 400/570 (70%), Gaps = 17/570 (2%)

Query: 33  IFFALVSVLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRL 92
           +F   ++V+  V +S      S CPL+F  +       P R    D  T CQ +LQG+RL
Sbjct: 2   LFLRRIAVVFFVFTSFSAAQNSTCPLDFSVLE------PFRRPKPDGATTCQYLLQGLRL 55

Query: 93  LRAEYLRTNGYFLPPVNS--SCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSR 150
           L + +LR  G FLPP  S  SC+ + ++ V  F+  FD+R++CG+    IS+ CM+IT+R
Sbjct: 56  LYSHHLRQTGSFLPPPESAASCWAALQSSVAGFLPRFDVRSTCGFQTPWISQGCMDITTR 115

Query: 151 AQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGY 210
           +QFESLIP S L      C+ SLE++  C SCT  LS+    L    G   GNVSDC+ +
Sbjct: 116 SQFESLIPNSSLATTAMRCNTSLESNTPCASCTQSLSAFQPYLS---GPSLGNVSDCASF 172

Query: 211 PYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTA 270
           P +YAAA  N  GP D+ TA+CLF L  ++  SS   + ++++    +  V  +L   TA
Sbjct: 173 PSIYAAAFANSLGPTDKGTAKCLFQLDLASPTSSGANKVKVLVSSFSVLLVASVL-VITA 231

Query: 271 FWFLFTRSKKSE---ERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIG 327
            WF + R KKS+    R   +    +  L   S S+ L +F  +EIK AT NFSR NIIG
Sbjct: 232 -WFWYCRRKKSKLLKPRDTSLEAGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIG 290

Query: 328 KGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATV 387
           +GGYGNV+KG LP+GT+VA KRFKNCS  GDANF HEVE+IAS++HVNL+ALRGY TAT 
Sbjct: 291 RGGYGNVFKGALPDGTQVAFKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATT 350

Query: 388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIH 447
           P EGHQRIIVCDL+ NGSL+DHLFG    +L+WP+R RIALG ARGLAYLHYG QP+IIH
Sbjct: 351 PYEGHQRIIVCDLVSNGSLHDHLFGDLEAQLAWPLRQRIALGMARGLAYLHYGAQPSIIH 410

Query: 448 RDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSD 507
           RDIKASNILLDE FEAKV DFGLAKFNPEG+TH++TRVAGT+GYVAPEYALYG+LT  SD
Sbjct: 411 RDIKASNILLDERFEAKVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKSD 470

Query: 508 VYSFGVVLLELLSGKKACEII-QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMME 566
           VYSFGVVLLELLS +KA     +G+ V ++DWAW LV+EG+TLDV+E+ MPE   PE++E
Sbjct: 471 VYSFGVVLLELLSRRKAIVTDEEGQPVSVADWAWSLVREGQTLDVVEDGMPEKGPPEVLE 530

Query: 567 QYVLTAAICAHPILQARPTMDQIVKILETD 596
           +YVL A +C+HP L ARPTMDQ+VK+LE++
Sbjct: 531 KYVLIAVLCSHPQLHARPTMDQVVKMLESN 560

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|O04086|Y1105_ARATH Probable receptor-like protein kinase At1g11050 OS=Arabidopsis thaliana GN=At1g11050 PE=2 SV=1

 Score =  342 bits (878), Expect = 4e-93,   Method: Compositional matrix adjust.
 Identities = 225/579 (38%), Positives = 329/579 (56%), Gaps = 36/579 (6%)

Query: 51  LSESP---CPLNFDAVRRL---VNEGPKRPMLTD-MNTQCQIVLQGIRLLRAEYLR-TNG 102
           +++SP   CPL+F  V  +     +  K     D  N+ CQ +L  I +  A  L+ T+ 
Sbjct: 19  VAQSPSQTCPLDFSHVLTIPWNTTDCQKSDKSADSKNSCCQSLLTLIGIPLAHRLKQTSN 78

Query: 103 YFLPPVNSS--CYESCRNFVTEFVQGFDIRTSCGYYPELI--SEACMNI-TSRAQFESLI 157
           + LP + +S  C  + +  ++      ++ + C    + +  +E C  I T++     L 
Sbjct: 79  FRLPNLATSISCLNNLQTKLSSLSLSSNLTSLCFDPNQFVINNETCAGIQTTQDWVSRLG 138

Query: 158 PKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAA 217
           P + L      CS  L +   CD+C +    + + L    GN +  V  C  +   YAA 
Sbjct: 139 PSTALDSA---CSSGLTDLTRCDACVAAGFRVQKQLITLDGNSSHGVY-CYHFVVTYAAG 194

Query: 218 VVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIG--ILGAFTAFWFLF 275
           +VN+ GP       CLFSL   +  +S  KRH + +   + G++ G  ++      +F F
Sbjct: 195 IVNKKGPESDDALSCLFSLSLRSPLNSKKKRHTVALALGITGAIFGALVIAGLICLYFRF 254

Query: 276 TRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVY 335
            ++ K  E    V   D+ S      ++    FKIEE++ AT NFS++N IG+GG+G VY
Sbjct: 255 GKAVKGGE----VGWEDQGSRPKWRPNTGSIWFKIEELEKATNNFSQKNFIGRGGFGFVY 310

Query: 336 KGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI 395
           KG+LP+G+ +AVK+       GDA F++EVEII+++KH NLV LRG S      E  QR 
Sbjct: 311 KGVLPDGSVIAVKKVIESEFQGDAEFRNEVEIISNLKHRNLVPLRGCSMVDDDSES-QRY 369

Query: 396 IVCDLLHNGSLYDHLFGSGMKK---LSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA 452
           +V D + NG+L DHLF  G      LSWP R  I L  A+GLAYLHYGV+PAI HRDIK 
Sbjct: 370 LVYDYMSNGNLDDHLFPRGETTKMPLSWPQRKSIILDVAKGLAYLHYGVKPAIYHRDIKG 429

Query: 453 SNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFG 512
           +NILLD    A+V DFGLAK + EG +HLTTRVAGT GY+APEYALYG+LT  SDVYSFG
Sbjct: 430 TNILLDVDMRARVADFGLAKQSREGESHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFG 489

Query: 513 VVLLELLSGKKACEIIQGKS---VLLSDWAWELVKEGKTLDVIEENMPEME-----LPE- 563
           VV+LE++ G+KA ++    S    L++DWAW LVK GKT + +E+++   E      P+ 
Sbjct: 490 VVILEIMCGRKALDLSTSGSPNTFLITDWAWSLVKAGKTEEALEQSLLREEGSGLSNPKG 549

Query: 564 MMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNI 602
           +ME+++    +CAH ++  RPT+   +K+LE D+ +  I
Sbjct: 550 IMERFLQVGILCAHVLVALRPTILDALKMLEGDIEVPPI 588

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LS95|PERK6_ARATH Putative proline-rich receptor-like protein kinase PERK6 OS=Arabidopsis thaliana GN=PERK6 PE=2 SV=2

 Score =  262 bits (670), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 145/315 (46%), Positives = 199/315 (63%), Gaps = 9/315 (2%)

Query: 304 NLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKH 363
           N + F  +E+ AAT  FS+  ++G+GG+G V+KG+LPNG E+AVK  K  S  G+  F+ 
Sbjct: 321 NKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQA 380

Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
           EV+II+ V H  LV+L GY  A     G QR++V + L N +L  HL G   K L WP R
Sbjct: 381 EVDIISRVHHRFLVSLVGYCIA-----GGQRMLVYEFLPNDTLEFHLHGKSGKVLDWPTR 435

Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           L+IALG+A+GLAYLH    P IIHRDIKASNILLDE+FEAKV DFGLAK + + +TH++T
Sbjct: 436 LKIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVST 495

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL- 542
           R+ GT GY+APEYA  GKLT  SDV+SFGV+LLEL++G++  ++       L DWA  + 
Sbjct: 496 RIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMEDSLVDWARPIC 555

Query: 543 ---VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL 599
               ++G   ++++  +     P  M Q V  AA       + RP M QIV+ LE D  L
Sbjct: 556 LNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEGDATL 615

Query: 600 SNIKIFLAALLTAYL 614
            ++     A  +++L
Sbjct: 616 DDLSEGGKAGQSSFL 630

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  258 bits (659), Expect = 9e-68,   Method: Compositional matrix adjust.
 Identities = 150/317 (47%), Positives = 196/317 (61%), Gaps = 19/317 (5%)

Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
           P LVL    S    F  EE+  AT  FS  N++G+GG+G V+KG+LP+G EVAVK+ K  
Sbjct: 257 PGLVLGFSKST---FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAG 313

Query: 354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
           S  G+  F+ EVEII+ V H +LV+L GY  A V     QR++V + + N +L  HL G 
Sbjct: 314 SGQGEREFQAEVEIISRVHHRHLVSLIGYCMAGV-----QRLLVYEFVPNNNLEFHLHGK 368

Query: 414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
           G   + W  RL+IALG+A+GL+YLH    P IIHRDIKASNIL+D  FEAKV DFGLAK 
Sbjct: 369 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 428

Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
             +  TH++TRV GT GY+APEYA  GKLT  SDV+SFGVVLLEL++G++    +   +V
Sbjct: 429 ASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRP---VDANNV 485

Query: 534 L----LSDWAWELV----KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT 585
                L DWA  L+    +EG    + +  M      E M + V  AA C     + RP 
Sbjct: 486 YVDDSLVDWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPR 545

Query: 586 MDQIVKILETDVPLSNI 602
           M QIV+ LE +V LS++
Sbjct: 546 MSQIVRALEGNVSLSDL 562

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  258 bits (658), Expect = 1e-67,   Method: Compositional matrix adjust.
 Identities = 143/325 (44%), Positives = 200/325 (61%), Gaps = 9/325 (2%)

Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
           PS    +   N + F  +E+  AT  F++ N++G+GG+G V+KG+LP+G EVAVK  K  
Sbjct: 286 PSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLG 345

Query: 354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
           S  G+  F+ EV+II+ V H +LV+L GY      + G QR++V + + N +L  HL G 
Sbjct: 346 SGQGEREFQAEVDIISRVHHRHLVSLVGYC-----ISGGQRLLVYEFIPNNTLEFHLHGK 400

Query: 414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
           G   L WP R++IALG+ARGLAYLH    P IIHRDIKA+NILLD +FE KV DFGLAK 
Sbjct: 401 GRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKL 460

Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
           + +  TH++TRV GT GY+APEYA  GKL+  SDV+SFGV+LLEL++G+   ++      
Sbjct: 461 SQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMED 520

Query: 534 LLSDWAWEL-VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQA---RPTMDQI 589
            L DWA  L +K  +  D  +   P +EL    ++ V  A+  A  I  +   RP M QI
Sbjct: 521 SLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQI 580

Query: 590 VKILETDVPLSNIKIFLAALLTAYL 614
           V+ LE D+ + ++        + YL
Sbjct: 581 VRALEGDMSMDDLSEGTRPGQSTYL 605

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  256 bits (655), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 139/301 (46%), Positives = 190/301 (63%), Gaps = 12/301 (3%)

Query: 308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEI 367
           F  EE+  AT  FS  N++G+GG+G V+KGML NG EVAVK+ K  S  G+  F+ EV I
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           I+ V H +LVAL GY  A       QR++V + + N +L  HL G G   + W  RL+IA
Sbjct: 402 ISRVHHRHLVALVGYCIADA-----QRLLVYEFVPNNTLEFHLHGKGRPTMEWSSRLKIA 456

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           +G+A+GL+YLH    P IIHRDIKASNIL+D  FEAKV DFGLAK   +  TH++TRV G
Sbjct: 457 VGSAKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMG 516

Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI--IQGKSVLLSDWAWELVKE 545
           T GY+APEYA  GKLT  SDV+SFGVVLLEL++G++  ++  +   + L+ DWA  L+ +
Sbjct: 517 TFGYLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLV-DWARPLLNQ 575

Query: 546 GKTLD----VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSN 601
              L     V+++ +      E M + V  AA C       RP MDQ+ ++LE ++  S+
Sbjct: 576 VSELGNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEGNISPSD 635

Query: 602 I 602
           +
Sbjct: 636 L 636

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9XI96|PERK7_ARATH Proline-rich receptor-like protein kinase PERK7 OS=Arabidopsis thaliana GN=PERK7 PE=2 SV=1

 Score =  254 bits (650), Expect = 1e-66,   Method: Compositional matrix adjust.
 Identities = 141/303 (46%), Positives = 192/303 (63%), Gaps = 8/303 (2%)

Query: 304 NLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKH 363
           N + F  EE+ +AT  FS++ ++G+GG+G V+KG+LPNG E+AVK  K  S  G+  F+ 
Sbjct: 320 NNSTFTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQA 379

Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
           EVEII+ V H +LV+L GY +      G QR++V + L N +L  HL G     + WP R
Sbjct: 380 EVEIISRVHHRHLVSLVGYCSNA----GGQRLLVYEFLPNDTLEFHLHGKSGTVMDWPTR 435

Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           L+IALG+A+GLAYLH    P IIHRDIKASNILLD  FEAKV DFGLAK + +  TH++T
Sbjct: 436 LKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVST 495

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL- 542
           RV GT GY+APEYA  GKLT  SDV+SFGV+LLEL++G+   ++       L DWA  L 
Sbjct: 496 RVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDMEDSLVDWARPLC 555

Query: 543 ---VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL 599
               ++G+  ++++  +     P  M + V  AA       + RP M QIV+ LE D  L
Sbjct: 556 MRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEGDASL 615

Query: 600 SNI 602
            ++
Sbjct: 616 DDL 618

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  249 bits (637), Expect = 4e-65,   Method: Compositional matrix adjust.
 Identities = 154/364 (42%), Positives = 216/364 (59%), Gaps = 36/364 (9%)

Query: 256 LVLGSVIGIL---GAF--TAFWFLFTRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKI 310
           L  G+V+GI    G F  T  +FL  + +  +++ +         LVL    S    F  
Sbjct: 121 LSTGAVVGISIGGGVFVLTLIFFLCKKKRPRDDKALPAPI----GLVLGIHQST---FTY 173

Query: 311 EEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIAS 370
            E+  AT  FS  N++G+GG+G VYKG+L NG EVAVK+ K  S  G+  F+ EV II+ 
Sbjct: 174 GELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNIISQ 233

Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
           + H NLV+L GY  A     G QR++V + + N +L  HL G G   + W +RL+IA+ +
Sbjct: 234 IHHRNLVSLVGYCIA-----GAQRLLVYEFVPNNTLEFHLHGKGRPTMEWSLRLKIAVSS 288

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
           ++GL+YLH    P IIHRDIKA+NIL+D  FEAKV DFGLAK   +  TH++TRV GT G
Sbjct: 289 SKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFG 348

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK---ACEIIQGKSVLLSDWAWELVKEGK 547
           Y+APEYA  GKLT  SDVYSFGVVLLEL++G++   A  +    S  L DWA  L+    
Sbjct: 349 YLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDS--LVDWARPLL---- 402

Query: 548 TLDVIEEN----MPEMEL-----PEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP 598
            +  +EE+    + +++L      E M + V  AA C     + RP MDQ+V++LE ++ 
Sbjct: 403 -VQALEESNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEGNIS 461

Query: 599 LSNI 602
            S++
Sbjct: 462 PSDL 465

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  248 bits (632), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 135/300 (45%), Positives = 189/300 (63%), Gaps = 12/300 (4%)

Query: 303 SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFK 362
           S    F  EE+   T  F+R+NI+G+GG+G VYKG L +G  VAVK+ K  S  GD  FK
Sbjct: 354 SGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFK 413

Query: 363 HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
            EVEII+ V H +LV+L GY      +    R+++ + + N +L  HL G G+  L W  
Sbjct: 414 AEVEIISRVHHRHLVSLVGYC-----ISDQHRLLIYEYVSNQTLEHHLHGKGLPVLEWSK 468

Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
           R+RIA+G+A+GLAYLH    P IIHRDIK++NILLD+ +EA+V DFGLA+ N    TH++
Sbjct: 469 RVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS 528

Query: 483 TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ--GKSVLLSDWAW 540
           TRV GT GY+APEYA  GKLT  SDV+SFGVVLLEL++G+K  +  Q  G+  L+ +WA 
Sbjct: 529 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV-EWAR 587

Query: 541 EL----VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD 596
            L    ++ G   ++I+  + +  +   + + + TAA C       RP M Q+V+ L+ D
Sbjct: 588 PLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCD 647

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  247 bits (631), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 137/306 (44%), Positives = 192/306 (62%), Gaps = 12/306 (3%)

Query: 303 SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFK 362
           S    F  EE+   T  FS+ NI+G+GG+G VYKG L +G  VAVK+ K  S  GD  FK
Sbjct: 336 SGQTHFTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFK 395

Query: 363 HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
            EVEII+ V H +LV+L GY  A       +R+++ + + N +L  HL G G   L W  
Sbjct: 396 AEVEIISRVHHRHLVSLVGYCIADS-----ERLLIYEYVPNQTLEHHLHGKGRPVLEWAR 450

Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
           R+RIA+G+A+GLAYLH    P IIHRDIK++NILLD+ FEA+V DFGLAK N    TH++
Sbjct: 451 RVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVS 510

Query: 483 TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ--GKSVLLSDWAW 540
           TRV GT GY+APEYA  GKLT  SDV+SFGVVLLEL++G+K  +  Q  G+  L+ +WA 
Sbjct: 511 TRVMGTFGYLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLV-EWAR 569

Query: 541 EL----VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD 596
            L    ++ G   ++++  + +  +   + + + TAA C       RP M Q+V+ L+++
Sbjct: 570 PLLHKAIETGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSE 629

Query: 597 VPLSNI 602
             + +I
Sbjct: 630 GDMGDI 635

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	614
359487965	598	PREDICTED: probable LRR receptor-like se	0.944	0.969	0.617	0.0
255542510	633	BRASSINOSTEROID INSENSITIVE 1-associated	0.910	0.883	0.624	0.0
224128640	599	predicted protein [Populus trichocarpa]	0.884	0.906	0.577	0.0
224146838	681	predicted protein [Populus trichocarpa]	0.884	0.797	0.577	0.0
359479850	611	PREDICTED: probable LRR receptor-like se	0.876	0.880	0.570	1e-180
15227189	617	putative LRR receptor-like serine/threon	0.900	0.896	0.550	1e-176
297824913	613	hypothetical protein ARALYDRAFT_904279 [	0.899	0.900	0.552	1e-176
255567598	641	kinase, putative [Ricinus communis] gi|2	0.884	0.847	0.554	1e-174
356504888	643	PREDICTED: probable LRR receptor-like se	0.910	0.869	0.546	1e-174
296086670	635	unnamed protein product [Vitis vinifera]	0.856	0.828	0.554	1e-174

>gi|359487965|ref|XP_002263855.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RKF3-like [Vitis vinifera]

 Score =  715 bits (1846), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/601 (61%), Positives = 455/601 (75%), Gaps = 21/601 (3%)

Query: 27  MSLFLSIFFALVSVL------------HSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRP 74
           MS FLSI FAL  +L            + +S          CPLNFD  R++V EG  RP
Sbjct: 1   MSSFLSIVFALGLILGFSRVSFALENGYKISHRKLVEPGPSCPLNFDVFRKMVVEGIPRP 60

Query: 75  MLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSS--CYESCRNFVTEFVQGFDIRTS 132
              D+ TQC  VL+GIR++R+EYLRT+GYFLPP +++  C+ES R  V++ V GFDI  +
Sbjct: 61  SFRDVPTQCNYVLEGIRVIRSEYLRTDGYFLPPSSTTKVCWESYRLLVSDLVSGFDIELA 120

Query: 133 CGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEI 192
           CGY+PE +SE+CMNI+S ++FESLIP+SKLQE++ +C+QSL NS +C  C   L SL   
Sbjct: 121 CGYHPEWVSESCMNISSGSEFESLIPESKLQEVRCYCNQSLGNSTSCALCKENLGSLQA- 179

Query: 193 LRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIV 252
             +  G+G GN SDC+GY ++YAA  VN +GP D ATA+CLFSL FS      NKR++I+
Sbjct: 180 -SYLSGSGIGNASDCAGYSFMYAAGWVNPYGPTDVATAKCLFSLDFSPHHIR-NKRYKIL 237

Query: 253 IYGLVLGSVIGILGAFTAFWFLFTRSKKSE---ERVVKVTDNDEPSLVLESRSSNLARFK 309
           I G VLG VIG  GAF A WFL+TR +K E   E   K+  + +      + S  L +FK
Sbjct: 238 ISGAVLGCVIGFFGAFAAAWFLWTRHRKLEREMEVCAKMETSLDSGFGSMTGSDTLVKFK 297

Query: 310 IEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIA 369
            EEIK ATMNFSRENIIG+GGYGNVYKG+LP+G+EVA KRFKNCS +GDA F HEVE++A
Sbjct: 298 FEEIKRATMNFSRENIIGQGGYGNVYKGILPDGSEVAFKRFKNCSASGDAVFTHEVEVLA 357

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG 429
           SV+H+NLV LRGY TATVP+EGHQRIIVCDL+ NGSL+DHLFGS  KKLSWPIR  IALG
Sbjct: 358 SVRHMNLVVLRGYCTATVPMEGHQRIIVCDLMPNGSLHDHLFGSVGKKLSWPIRQNIALG 417

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
           TARGLAYLHYG QPAIIHRDIKASNILLDE FEAKV DFGLAK NPEGITHL+TRVAGTL
Sbjct: 418 TARGLAYLHYGAQPAIIHRDIKASNILLDETFEAKVADFGLAKVNPEGITHLSTRVAGTL 477

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG-KSVLLSDWAWELVKEGKT 548
           GYVAPEYAL+GKLT  SDVYSFGVVLLELLSGKKA     G +++LL++WAW LVKEG+ 
Sbjct: 478 GYVAPEYALFGKLTERSDVYSFGVVLLELLSGKKAFMAANGPQALLLTEWAWSLVKEGRP 537

Query: 549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKIFLAA 608
           +DV++E MPE+ L E+ME++VL A +C HP+L++RPTMD+IVK+LET++P+ +I I  AA
Sbjct: 538 IDVVDEEMPELGLTEVMERHVLIAVLCCHPVLESRPTMDKIVKMLETNLPIPSILIASAA 597

Query: 609 L 609
           L
Sbjct: 598 L 598

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542510|ref|XP_002512318.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis] gi|223548279|gb|EEF49770.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase 1 precursor, putative [Ricinus communis]

 Score =  709 bits (1831), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 356/570 (62%), Positives = 435/570 (76%), Gaps = 11/570 (1%)

Query: 47  SSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLP 106
           S+ +L+ES CPL ++ +R L  E P R  L D+ TQCQ + +GI L+R+EYLRT+GYF+P
Sbjct: 35  SNRSLAESSCPLKYNVLRDLAKEAPPRLALVDVPTQCQYMQKGILLVRSEYLRTHGYFVP 94

Query: 107 PVNS--SCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQE 164
           P ++   C+   R  V +++  FDI+T+CGY+PE I +   NIT+R QFES IP  ++QE
Sbjct: 95  PPDTVQPCWGLYRKLVGQYLHDFDIQTTCGYHPEWIWKTFNNITTRQQFESKIPFPEMQE 154

Query: 165 IKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGP 224
           ++  C+ SLENS  C SC  KL SL ++    P   N  VS+ S Y ++YAAA  ++ GP
Sbjct: 155 MRLACNHSLENSSVCQSCLQKLLSLEKLYLQNPKLNN--VSNASDYLFMYAAAFSSELGP 212

Query: 225 IDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEER 284
            D ATA CLF L FS R +S NK+H+ VI G+VLG VIG++GA  A W  +   KK E +
Sbjct: 213 SDPATANCLFRLEFSGRLTS-NKKHKSVISGVVLGCVIGVVGASVAVWLFWMLHKKFERK 271

Query: 285 VVKVTDNDEPSLV----LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP 340
                  DE SL     L  RS+NL +FKI+EI++ATMNFSR  IIGKGG+GNVYKG+LP
Sbjct: 272 KNISVTKDETSLDFGFGLHRRSTNLVKFKIDEIRSATMNFSRNYIIGKGGFGNVYKGILP 331

Query: 341 NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDL 400
           +G+EVA KRFKNCS +GDA F HEVEIIASV+HVNLVALRGY TATVPLE HQRIIVCDL
Sbjct: 332 DGSEVAFKRFKNCSASGDATFAHEVEIIASVRHVNLVALRGYCTATVPLECHQRIIVCDL 391

Query: 401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA 460
           + NGSL+DHLFGS MKKLSWPIR +IALGTARGLAYLH+GVQPAIIHRDIKASNILLDE 
Sbjct: 392 MQNGSLHDHLFGSEMKKLSWPIRQKIALGTARGLAYLHHGVQPAIIHRDIKASNILLDET 451

Query: 461 FEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FE KV DFGLAKFN +G+THL+TRVAGTLGYVAPEYALYGKL+  SDVYSFGVVLLELLS
Sbjct: 452 FEPKVADFGLAKFNSQGMTHLSTRVAGTLGYVAPEYALYGKLSERSDVYSFGVVLLELLS 511

Query: 521 GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPIL 580
           G+KA    +G+  LL+DWAW LVKEG+ LDVIE NMPEM+ P++MEQYV  AAICAHPIL
Sbjct: 512 GRKAYVNCEGEVSLLTDWAWSLVKEGRALDVIEHNMPEMDSPKIMEQYVHIAAICAHPIL 571

Query: 581 QARPTMDQIVKILETDVPL--SNIKIFLAA 608
            ARPTM QIVKILET++ L  S + +++++
Sbjct: 572 YARPTMYQIVKILETNLLLVPSTLGVYISS 601

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224128640|ref|XP_002320382.1| predicted protein [Populus trichocarpa] gi|222861155|gb|EEE98697.1| predicted protein [Populus trichocarpa]

 Score =  643 bits (1659), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/551 (57%), Positives = 424/551 (76%), Gaps = 8/551 (1%)

Query: 56  CPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNS--SCY 113
           CPL+F+ +R L +   KRP  +D+N QC+ +LQG+RL+++ YL+ N  FLPP++S  SC+
Sbjct: 10  CPLDFNVLRNLTSASSKRPPTSDINQQCRYILQGLRLVQSHYLQLNNSFLPPLDSAESCW 69

Query: 114 ESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSL 173
            + +  +  F+  FDIR+SCG+    IS+ CMNI++R+QFE+++P S L ++  +C+QSL
Sbjct: 70  STYQVLIDGFLPNFDIRSSCGFNTSWISQGCMNISTRSQFEAIVPVSALNDVASNCNQSL 129

Query: 174 ENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCL 233
           +N+  C +CT+ LS+L    R+  G   GNVSDC  YP +YAAA  N++GP D+ TA+CL
Sbjct: 130 QNNSPCAACTTSLSTLQA--RYLTGASIGNVSDCQAYPSIYAAAFTNRYGPTDKGTAKCL 187

Query: 234 FSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERVVKVTDNDE 293
           F L FS+ + S  KR  ++I G++LG  +G++      W +F + KK  ++  +V + + 
Sbjct: 188 FFLDFSS-KKSSKKRSIVLILGVLLGGGVGLVVLIGLCW-IFHKRKKRADKFGRVLETEL 245

Query: 294 PS-LVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKN 352
            S L   S+S++L ++  +EI+ AT NFSR+NIIG+GGYGNVYKG LP+G+ VA KRFKN
Sbjct: 246 GSGLESISQSTSLVKYTFDEIRKATRNFSRDNIIGRGGYGNVYKGELPDGSLVAFKRFKN 305

Query: 353 CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG 412
           CS AGD++F HEVE+IASV+HVNLVALRGY TAT P EGHQRIIVCDL+ NG+L+DHLFG
Sbjct: 306 CSAAGDSSFAHEVEVIASVRHVNLVALRGYCTATSPFEGHQRIIVCDLIKNGTLHDHLFG 365

Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
           S  +KLSWPIR +IALGTARGLAYLHYG QP+IIHRDIKASNILLDE+FE KV DFGLAK
Sbjct: 366 SCAEKLSWPIRQKIALGTARGLAYLHYGAQPSIIHRDIKASNILLDESFEPKVADFGLAK 425

Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII-QGK 531
           F PEG+THL+TRVAGT+GYVAPEYALYG+LT  SDV+SFGVVLLELLSGKKA  +  +G+
Sbjct: 426 FTPEGMTHLSTRVAGTMGYVAPEYALYGQLTERSDVFSFGVVLLELLSGKKALMVDHEGQ 485

Query: 532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
             +++DWAW LV+EG+TLDVIE+ MPE    E++E+YVL A +C+HP L ARPTMDQ+VK
Sbjct: 486 PSIVTDWAWSLVREGRTLDVIEDGMPESGSQEILEKYVLVAVLCSHPQLYARPTMDQVVK 545

Query: 592 ILETDVPLSNI 602
           +LETD+ + +I
Sbjct: 546 MLETDLSIPSI 556

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224146838|ref|XP_002336349.1| predicted protein [Populus trichocarpa] gi|222834774|gb|EEE73237.1| predicted protein [Populus trichocarpa]

 Score =  642 bits (1657), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 318/551 (57%), Positives = 424/551 (76%), Gaps = 8/551 (1%)

Query: 56  CPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNS--SCY 113
           CPL+FD ++ L++ G  R   +D+N QCQ + QG+RL+++ YL+ N  FLPP++S  SC+
Sbjct: 30  CPLDFDVLQNLISAGSNRIPTSDINQQCQYIRQGLRLVQSHYLQINNSFLPPLDSAESCW 89

Query: 114 ESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSL 173
            + +  +  F+  FDIR+SCG+    IS+ CMNI++R+QFE+++P S L ++  +C+QSL
Sbjct: 90  STYQVLIDGFLPNFDIRSSCGFNTSWISQGCMNISTRSQFEAIVPVSALNDVASNCNQSL 149

Query: 174 ENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCL 233
           +N+  C +CT+ LS+L    R+  G+  GNVSDC  YP +YAAA  N++GP D+ TA+CL
Sbjct: 150 QNNSPCAACTTSLSTLQA--RYLTGSSIGNVSDCQAYPSIYAAAFTNRYGPTDKGTAKCL 207

Query: 234 FSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERVVKVTDNDE 293
           F L FS+ + S  KR  ++I G++LG  +G++      W +F + KK  ++  +V + + 
Sbjct: 208 FFLDFSS-KKSSKKRSIVLILGVLLGGGVGLVVLIGLCW-IFHKRKKRADKFGRVLETEL 265

Query: 294 PS-LVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKN 352
            S L   S+S++L ++  +EI+ AT NFSR+NIIG+GGYGNVYKG LP+G+ VA KRFKN
Sbjct: 266 GSGLESISQSTSLVKYTFDEIRKATRNFSRDNIIGRGGYGNVYKGELPDGSLVAFKRFKN 325

Query: 353 CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG 412
           CS AGD++F HEVE+IASV+HVNLVALRGY TAT P EGHQRIIVCDL+ NG+L+DHLFG
Sbjct: 326 CSAAGDSSFAHEVEVIASVRHVNLVALRGYCTATSPFEGHQRIIVCDLIKNGTLHDHLFG 385

Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
           S  +KLSWPIR +IALGTARGLAYLHYG QP+IIHRDIKASNILLDE+FE KV DFGLAK
Sbjct: 386 SCAEKLSWPIRQKIALGTARGLAYLHYGAQPSIIHRDIKASNILLDESFEPKVADFGLAK 445

Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII-QGK 531
           F PEGITHL+TRVAGT+GYVAPEYALYG+LT  SDV+SFGVVLLELLSGKKA  +  +G+
Sbjct: 446 FTPEGITHLSTRVAGTMGYVAPEYALYGQLTERSDVFSFGVVLLELLSGKKALMVDHEGQ 505

Query: 532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
             +++DWAW LV+EG+TLDVIE+ MPE    E++E+YVL A +C+HP L ARPTMDQ+VK
Sbjct: 506 PSIVTDWAWSLVREGRTLDVIEDGMPESGSQEILEKYVLVAVLCSHPQLYARPTMDQVVK 565

Query: 592 ILETDVPLSNI 602
           +LETD+ + +I
Sbjct: 566 MLETDLSIPSI 576

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359479850|ref|XP_003632362.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RKF3-like [Vitis vinifera]

 Score =  636 bits (1641), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 315/552 (57%), Positives = 407/552 (73%), Gaps = 14/552 (2%)

Query: 54  SPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSS-- 111
           +PCPL+F+ +  +           + +TQCQ V+QG+RL+ A YL++ G FLPP+NSS  
Sbjct: 27  APCPLDFEPLLNVTT------FDVNASTQCQYVIQGLRLVLATYLQSTGSFLPPINSSES 80

Query: 112 CYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQ 171
           C++S ++ V  F   F+IR+ CG+    ISE CMNIT+R+QF++++ ++   +I   C+Q
Sbjct: 81  CWDSYQSVVNNFTSNFNIRSDCGFETTWISEGCMNITTRSQFDAVVSQATRADIVASCNQ 140

Query: 172 SLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATAR 231
           SLENS  C +CT+ LS+L  +  +  G+  GN++DC+ YP +YAA   N  GP D  TA+
Sbjct: 141 SLENSSPCATCTTSLSNLQAV--YLTGSSVGNLTDCTAYPSIYAAGFANYLGPTDPGTAK 198

Query: 232 CLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERVVKVTDN 291
           CLF+L F A   S NKR  +VI  +V+   +  L      W +F R ++    V +   N
Sbjct: 199 CLFNLNF-ASGGSGNKRRGVVIVVVVVVCSVVFLAVIGGVW-VFYRKRRESRSVKREIVN 256

Query: 292 DEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFK 351
            E  L   S S+ L +F I+EI+ AT NF+R+NIIG+GGYGNVYKG+L +G+EVA KRFK
Sbjct: 257 IEMGLESISGSTTLIKFTIDEIRQATRNFTRDNIIGRGGYGNVYKGVLKDGSEVAFKRFK 316

Query: 352 NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF 411
           NCS AGD NF HEVE+IASV+HVNLVALRGY TAT PLEGHQRIIVCDL+ NGSL+DHLF
Sbjct: 317 NCSAAGDTNFAHEVEVIASVRHVNLVALRGYCTATTPLEGHQRIIVCDLMKNGSLHDHLF 376

Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
           GS  +KLSWP+R +IALGTARGLAYLH G QP IIHRDIKASNILLDE FE KV DFGLA
Sbjct: 377 GS-TEKLSWPLRQKIALGTARGLAYLHSGAQPGIIHRDIKASNILLDEKFEPKVADFGLA 435

Query: 472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII-QG 530
           KF PEG+THL+TRVAGT+GYVAPEYALYG+LT  SDVYSFGVVLLELLSGKKA  +I + 
Sbjct: 436 KFTPEGMTHLSTRVAGTMGYVAPEYALYGQLTERSDVYSFGVVLLELLSGKKALMVIGEN 495

Query: 531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV 590
           +  L++DWAW LV++G+ +DV++ +MPE+  PE+ME+YVL A +C+HP L ARP MDQ+V
Sbjct: 496 QPSLVTDWAWSLVRKGRAIDVVDNSMPELGSPEVMEKYVLVAVLCSHPQLYARPAMDQVV 555

Query: 591 KILETDVPLSNI 602
           KILETD+P+ +I
Sbjct: 556 KILETDLPVPSI 567

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15227189|ref|NP_182322.1| putative LRR receptor-like serine/threonine-protein kinase RKF3 [Arabidopsis thaliana] gi|75319082|sp|P93050.1|RKF3_ARATH RecName: Full=Probable LRR receptor-like serine/threonine-protein kinase RKF3; AltName: Full=Receptor-like kinase in flowers 3; Flags: Precursor gi|1785621|emb|CAB06335.1| AtPK2324 [Arabidopsis thaliana] gi|2465927|gb|AAC50045.1| receptor-like serine/threonine kinase [Arabidopsis thaliana] gi|4249408|gb|AAD13705.1| putative protein kinase [Arabidopsis thaliana] gi|14335116|gb|AAK59837.1| At2g48010/T9J23.16 [Arabidopsis thaliana] gi|23308235|gb|AAN18087.1| At2g48010/T9J23.16 [Arabidopsis thaliana] gi|330255829|gb|AEC10923.1| putative LRR receptor-like serine/threonine-protein kinase RKF3 [Arabidopsis thaliana]

 Score =  626 bits (1614), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 314/570 (55%), Positives = 400/570 (70%), Gaps = 17/570 (2%)

Query: 33  IFFALVSVLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRL 92
           +F   ++V+  V +S      S CPL+F  +       P R    D  T CQ +LQG+RL
Sbjct: 2   LFLRRIAVVFFVFTSFSAAQNSTCPLDFSVLE------PFRRPKPDGATTCQYLLQGLRL 55

Query: 93  LRAEYLRTNGYFLPPVNS--SCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSR 150
           L + +LR  G FLPP  S  SC+ + ++ V  F+  FD+R++CG+    IS+ CM+IT+R
Sbjct: 56  LYSHHLRQTGSFLPPPESAASCWAALQSSVAGFLPRFDVRSTCGFQTPWISQGCMDITTR 115

Query: 151 AQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGY 210
           +QFESLIP S L      C+ SLE++  C SCT  LS+    L    G   GNVSDC+ +
Sbjct: 116 SQFESLIPNSSLATTAMRCNTSLESNTPCASCTQSLSAFQPYLS---GPSLGNVSDCASF 172

Query: 211 PYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTA 270
           P +YAAA  N  GP D+ TA+CLF L  ++  SS   + ++++    +  V  +L   TA
Sbjct: 173 PSIYAAAFANSLGPTDKGTAKCLFQLDLASPTSSGANKVKVLVSSFSVLLVASVL-VITA 231

Query: 271 FWFLFTRSKKSE---ERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIG 327
            WF + R KKS+    R   +    +  L   S S+ L +F  +EIK AT NFSR NIIG
Sbjct: 232 -WFWYCRRKKSKLLKPRDTSLEAGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIG 290

Query: 328 KGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATV 387
           +GGYGNV+KG LP+GT+VA KRFKNCS  GDANF HEVE+IAS++HVNL+ALRGY TAT 
Sbjct: 291 RGGYGNVFKGALPDGTQVAFKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATT 350

Query: 388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIH 447
           P EGHQRIIVCDL+ NGSL+DHLFG    +L+WP+R RIALG ARGLAYLHYG QP+IIH
Sbjct: 351 PYEGHQRIIVCDLVSNGSLHDHLFGDLEAQLAWPLRQRIALGMARGLAYLHYGAQPSIIH 410

Query: 448 RDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSD 507
           RDIKASNILLDE FEAKV DFGLAKFNPEG+TH++TRVAGT+GYVAPEYALYG+LT  SD
Sbjct: 411 RDIKASNILLDERFEAKVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKSD 470

Query: 508 VYSFGVVLLELLSGKKACEII-QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMME 566
           VYSFGVVLLELLS +KA     +G+ V ++DWAW LV+EG+TLDV+E+ MPE   PE++E
Sbjct: 471 VYSFGVVLLELLSRRKAIVTDEEGQPVSVADWAWSLVREGQTLDVVEDGMPEKGPPEVLE 530

Query: 567 QYVLTAAICAHPILQARPTMDQIVKILETD 596
           +YVL A +C+HP L ARPTMDQ+VK+LE++
Sbjct: 531 KYVLIAVLCSHPQLHARPTMDQVVKMLESN 560

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297824913|ref|XP_002880339.1| hypothetical protein ARALYDRAFT_904279 [Arabidopsis lyrata subsp. lyrata] gi|297326178|gb|EFH56598.1| hypothetical protein ARALYDRAFT_904279 [Arabidopsis lyrata subsp. lyrata]

 Score =  625 bits (1613), Expect = e-176,   Method: Compositional matrix adjust.
 Identities = 313/567 (55%), Positives = 398/567 (70%), Gaps = 15/567 (2%)

Query: 33  IFFALVSVLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRL 92
           +F   ++V+  + +S      S CPL+F  ++      P R    D  T CQ +LQG+RL
Sbjct: 2   LFLRGIAVVFILLTSFSAAQNSTCPLDFSVLQ------PFRRPKPDGATTCQYLLQGLRL 55

Query: 93  LRAEYLRTNGYFLPPVNS--SCYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSR 150
           L + +LR  G FLPP +S  SC+ + ++ +  F+  FD+R++CG+    IS+ CMNIT+R
Sbjct: 56  LYSHHLRQTGSFLPPPDSAPSCWAALQSSIAGFLPRFDVRSTCGFQTPWISQGCMNITTR 115

Query: 151 AQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGY 210
           +QFESLIP   L      C+ SLE++  C SCT  LS+    L    G   GNVSDC+ +
Sbjct: 116 SQFESLIPNPSLTTTAMRCNTSLESNTPCASCTQSLSAFQPFLT---GPSLGNVSDCASF 172

Query: 211 PYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTA 270
           P +YAAA  N FGP D+ TA+CLF L   A  SS N +   ++  L +  V   L     
Sbjct: 173 PSIYAAAFANSFGPTDQGTAKCLFQLDL-ASPSSGNGKLITILVSLSVLLVASALVTTAC 231

Query: 271 FWFLFTRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGG 330
           FW+   R KK++ R   +    +  L   S S+ L +F  +EIK AT NFSR NIIG+GG
Sbjct: 232 FWYC--RRKKNKPRDTSLEAGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIGRGG 289

Query: 331 YGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE 390
           YGNV+KG+LP+GT+VA KRFKNCS  GDANF HEVE+IAS++HVNL+ALRGY TAT P E
Sbjct: 290 YGNVFKGVLPDGTQVAFKRFKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATTPYE 349

Query: 391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDI 450
           GHQRIIVCDL+ NGSL+DHLFG    +L WP+R RIALG ARGLAYLHYG QP+IIHRDI
Sbjct: 350 GHQRIIVCDLVSNGSLHDHLFGDLEAQLPWPLRQRIALGMARGLAYLHYGAQPSIIHRDI 409

Query: 451 KASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYS 510
           KASNILLDE FEAKV DFGLAKFNPEG+TH++TRVAGT+GYVAPEYALYG+LT  SDVYS
Sbjct: 410 KASNILLDERFEAKVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKSDVYS 469

Query: 511 FGVVLLELLSGKKACEII-QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYV 569
           FGVVLLELLS +KA     +G+ V ++DWAW LV+EG+TLDV+E+ MPE   PE++E+YV
Sbjct: 470 FGVVLLELLSRRKAIVTDEEGQPVSVADWAWSLVREGQTLDVVEDGMPEKGPPEVLEKYV 529

Query: 570 LTAAICAHPILQARPTMDQIVKILETD 596
           L A +C+HP L ARPTMDQ+VK+LE++
Sbjct: 530 LIAVLCSHPQLHARPTMDQVVKMLESN 556

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255567598|ref|XP_002524778.1| kinase, putative [Ricinus communis] gi|223535962|gb|EEF37621.1| kinase, putative [Ricinus communis]

 Score =  619 bits (1597), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 307/554 (55%), Positives = 397/554 (71%), Gaps = 11/554 (1%)

Query: 56  CPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNS--SCY 113
           CPLNF  +  ++ +   +P     N +CQ +  G+R +++ YL+ +  FLPP++S  SC+
Sbjct: 32  CPLNFTILSNIIAD--SKPAGFGPNQECQYIKNGLRFVQSYYLQHSNSFLPPLSSAQSCW 89

Query: 114 ESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSL 173
              ++FV +F+  FDIR SCGY    ISE CMNIT+++QFE+LIP S   ++  +C+QSL
Sbjct: 90  RVYQDFVDKFISNFDIRASCGYNTSWISEGCMNITTKSQFEALIPISSFNDVAINCNQSL 149

Query: 174 ENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCL 233
           EN+  C +CT+ LS   +   +  G   GN+SDC  YP +YA A +N+FGP DR TA+CL
Sbjct: 150 ENNSPCAACTASLSR--QQASYLTGKSVGNLSDCQAYPAIYAGAFLNRFGPTDRGTAKCL 207

Query: 234 FSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSKKSEERV----VKVT 289
           F L F  +     K+  ++   +V+   + +    +  W+     KK+ ER      ++T
Sbjct: 208 FLLDFEPKNPRHKKKKTLIFVLVVVILGVVLSLIISGCWYFRRIKKKTRERSRNRGTEIT 267

Query: 290 DNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR 349
                 L   S S+  A+FK +EIK AT NFSR++IIG+GGYGNVYKG+LP+G++VA KR
Sbjct: 268 GGLSSGLEGISESTTFAKFKFDEIKEATRNFSRDHIIGRGGYGNVYKGILPDGSQVAFKR 327

Query: 350 FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDH 409
           FKN S AGDA+F HEVE+IASV+HVNLVALRGY TAT P EGHQRIIVCDL+ NGSL+DH
Sbjct: 328 FKNLSAAGDASFAHEVEVIASVRHVNLVALRGYCTATTPFEGHQRIIVCDLMKNGSLHDH 387

Query: 410 LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG 469
           LFG   +KLSWPIR  IALGTARGLAYLHYGVQP IIHRDIKASNILLD+ FE KV DFG
Sbjct: 388 LFGGVKEKLSWPIRQNIALGTARGLAYLHYGVQPGIIHRDIKASNILLDDRFEPKVADFG 447

Query: 470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII- 528
           LAKF  EG THL+TRVAGT+GYVAPEYALYG+LT  SDVYSFGVVLLELLSGKKA  +  
Sbjct: 448 LAKFTLEGATHLSTRVAGTMGYVAPEYALYGQLTERSDVYSFGVVLLELLSGKKALAMSG 507

Query: 529 QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQ 588
           + +  L++DWAW LV+EG+TLDVIE+ MPE+   +++E++VL A +C+HP L ARPTMDQ
Sbjct: 508 ESQPSLVTDWAWSLVREGRTLDVIEDGMPELGPNDVVEKHVLIALLCSHPQLYARPTMDQ 567

Query: 589 IVKILETDVPLSNI 602
           +VK+LETD  +  I
Sbjct: 568 VVKMLETDQAIPTI 581

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356504888|ref|XP_003521226.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase RKF3-like [Glycine max]

 Score =  619 bits (1596), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 315/576 (54%), Positives = 407/576 (70%), Gaps = 17/576 (2%)

Query: 29  LFLSIFFALVSVLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQ 88
           +F  +F   +++    S ++ N    PCPLN   +R  V  G +RP   D  T+C  +LQ
Sbjct: 10  IFYVVFLLTLNIFPPASLAANN--TLPCPLNITVLR--VVSGGRRPSF-DSGTKCHYILQ 64

Query: 89  GIRLLRAEYLRTNGYFLPPVNSS--CYESCRNFVTEFVQGF-DIRTSCGYYPELISEACM 145
            + LL+A+YLR +  F+PP+N+S  C+ + ++F+ E      DIR+SCG+  E IS+ CM
Sbjct: 65  ALHLLQADYLRRSSLFVPPLNTSESCWNTFQSFINEADPSISDIRSSCGFRTEWISQGCM 124

Query: 146 NITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVS 205
           NIT++ QFE ++P++ +Q ++  C+Q LEN+  C  CT+KLSS+   L +  G   GNV+
Sbjct: 125 NITTKQQFEDIVPRNAIQPVQDDCNQPLENNAPCALCTTKLSSM---LSYLTGTTQGNVT 181

Query: 206 DCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGIL 265
           DC  Y  +YAA++ +Q+G  D  T++CLF L FS+  S   +R  IVI  + +  V+  L
Sbjct: 182 DCRAYTQIYAASLSDQYGVTDPGTSKCLFGLDFSSSGSGGKRRRTIVIAVVSVFCVVS-L 240

Query: 266 GAFTAFWFLFTRSKKSEERVVKVTDNDEPSLV--LES--RSSNLARFKIEEIKAATMNFS 321
             F + W      K+ E    K     E  L   L+S  +S+ L RF  +EIK AT NFS
Sbjct: 241 SVFASLWAYLRFKKRLEVEKRKGAGISELGLGSGLDSINQSTTLIRFSFDEIKKATRNFS 300

Query: 322 RENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           R+NIIG GGYGNVYKGML +G++VA KRFKNCS AGDA+F HEVE+IASV+HVNLV LRG
Sbjct: 301 RDNIIGSGGYGNVYKGMLLDGSQVAFKRFKNCSVAGDASFTHEVEVIASVRHVNLVTLRG 360

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
           Y TAT  LEGHQRIIV DL+ NGSLYDHLFGS  K L+WPIR +IALGTARGLAYLHYG 
Sbjct: 361 YCTATTNLEGHQRIIVTDLMENGSLYDHLFGSAKKNLTWPIRQKIALGTARGLAYLHYGA 420

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           QP+IIHRDIKASNILLD  FEAKV DFGLAKFNPEG+TH++TRVAGT+GYVAPEYALYG+
Sbjct: 421 QPSIIHRDIKASNILLDHNFEAKVADFGLAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQ 480

Query: 502 LTPGSDVYSFGVVLLELLSGKKACEI-IQGKSVLLSDWAWELVKEGKTLDVIEENMPEME 560
           LT  SDV+SFGVVLLELLSG+KA +    G+   L+D+AW LV+ G  LDV+E+ +PE  
Sbjct: 481 LTERSDVFSFGVVLLELLSGRKALQTDDDGQPAALTDFAWSLVRNGSALDVVEDGIPEPG 540

Query: 561 LPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD 596
            PE++E+YVL A +C+HP L ARPTMDQ+VK+LETD
Sbjct: 541 PPEVLEKYVLVAVLCSHPQLYARPTMDQVVKMLETD 576

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296086670|emb|CBI32305.3| unnamed protein product [Vitis vinifera]

 Score =  619 bits (1595), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 314/566 (55%), Positives = 399/566 (70%), Gaps = 40/566 (7%)

Query: 40  VLHSVSSSSGNLSESPCPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLR 99
            L S S SS   + +PCPL+F+ +  +           + +TQCQ V+QG+RL+ A YL+
Sbjct: 57  TLTSFSFSSAQYNLAPCPLDFEPLLNVTT------FDVNASTQCQYVIQGLRLVLATYLQ 110

Query: 100 TNGYFLPPVNSS--CYESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLI 157
           + G FLPP+NSS  C++S ++ V  F   F+IR+ CG+    ISE CMNIT+R+QF++++
Sbjct: 111 STGSFLPPINSSESCWDSYQSVVNNFTSNFNIRSDCGFETTWISEGCMNITTRSQFDAVV 170

Query: 158 PKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAA 217
            ++   +I   C+QSLENS  C +CT+ LS+L  +  +  G+  GN++DC+ YP +YAA 
Sbjct: 171 SQATRADIVASCNQSLENSSPCATCTTSLSNLQAV--YLTGSSVGNLTDCTAYPSIYAAG 228

Query: 218 VVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGILGAFTAFWFLFTR 277
             N  GP D  TA+CLF+L F A   S NKR                             
Sbjct: 229 FANYLGPTDPGTAKCLFNLNF-ASGGSGNKRRG--------------------------- 260

Query: 278 SKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKG 337
                  VV    N E  L   S S+ L +F I+EI+ AT NF+R+NIIG+GGYGNVYKG
Sbjct: 261 VVIVVVVVVCSIVNIEMGLESISGSTTLIKFTIDEIRQATRNFTRDNIIGRGGYGNVYKG 320

Query: 338 MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV 397
           +L +G+EVA KRFKNCS AGD NF HEVE+IASV+HVNLVALRGY TAT PLEGHQRIIV
Sbjct: 321 VLKDGSEVAFKRFKNCSAAGDTNFAHEVEVIASVRHVNLVALRGYCTATTPLEGHQRIIV 380

Query: 398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL 457
           CDL+ NGSL+DHLFGS  +KLSWP+R +IALGTARGLAYLH G QP IIHRDIKASNILL
Sbjct: 381 CDLMKNGSLHDHLFGS-TEKLSWPLRQKIALGTARGLAYLHSGAQPGIIHRDIKASNILL 439

Query: 458 DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE 517
           DE FE KV DFGLAKF PEG+THL+TRVAGT+GYVAPEYALYG+LT  SDVYSFGVVLLE
Sbjct: 440 DEKFEPKVADFGLAKFTPEGMTHLSTRVAGTMGYVAPEYALYGQLTERSDVYSFGVVLLE 499

Query: 518 LLSGKKACEII-QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICA 576
           LLSGKKA  +I + +  L++DWAW LV++G+ +DV++ +MPE+  PE+ME+YVL A +C+
Sbjct: 500 LLSGKKALMVIGENQPSLVTDWAWSLVRKGRAIDVVDNSMPELGSPEVMEKYVLVAVLCS 559

Query: 577 HPILQARPTMDQIVKILETDVPLSNI 602
           HP L ARP MDQ+VKILETD+P+ +I
Sbjct: 560 HPQLYARPAMDQVVKILETDLPVPSI 585

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	614
TAIR|locus:2066390	617	RKF3 "receptor-like kinase in	0.861	0.857	0.554	4.7e-151
TAIR|locus:2197414	625	AT1G11050 [Arabidopsis thalian	0.872	0.857	0.382	1.5e-83
TAIR|locus:2093999	700	PERK6 "proline-rich extensin-l	0.490	0.43	0.460	2.9e-64
TAIR|locus:2010282	699	PERK7 "proline-rich extensin-l	0.491	0.432	0.453	4.8e-62
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.486	0.458	0.465	1.6e-61
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.486	0.462	0.458	1.5e-60
TAIR|locus:2139474	670	PERK5 "proline-rich extensin-l	0.495	0.453	0.440	1.5e-60
TAIR|locus:2019938	718	PERK11 "proline-rich extensin-	0.469	0.401	0.447	4.8e-60
TAIR|locus:2028911	720	PERK12 "proline-rich extensin-	0.469	0.4	0.453	3.5e-59
TAIR|locus:2125692	731	PERK14 "proline-rich extensin-	0.503	0.422	0.434	3.5e-59

TAIR|locus:2066390 RKF3 "receptor-like kinase in in flowers 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1474 (523.9 bits), Expect = 4.7e-151, P = 4.7e-151
 Identities = 304/548 (55%), Positives = 376/548 (68%)

Query:    56 CPLNFDAVRRLVNEGPKRPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNS--SCY 113
             CPL+F  +     E  +RP   D  T CQ +LQG+RLL + +LR  G FLPP  S  SC+
Sbjct:    25 CPLDFSVL-----EPFRRPK-PDGATTCQYLLQGLRLLYSHHLRQTGSFLPPPESAASCW 78

Query:   114 ESCRNFVTEFVQGFDIRTSCGYYPELISEACMNITSRAQFESLIPKSKLQEIKRHCSQSL 173
              + ++ V  F+  FD+R++CG+    IS+ CM+IT+R+QFESLIP S L      C+ SL
Sbjct:    79 AALQSSVAGFLPRFDVRSTCGFQTPWISQGCMDITTRSQFESLIPNSSLATTAMRCNTSL 138

Query:   174 ENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCL 233
             E++  C SCT  LS+    L  GP  GN  VSDC+ +P +YAAA  N  GP D+ TA+CL
Sbjct:   139 ESNTPCASCTQSLSAFQPYLS-GPSLGN--VSDCASFPSIYAAAFANSLGPTDKGTAKCL 195

Query:   234 FSLYFSARQSS-LNKRHEXXXXXXXXXXXXXXXXAFTAFWFLFTRSKKSE---ERVVKVT 289
             F L  ++  SS  NK                     TA WF + R KKS+    R   + 
Sbjct:   196 FQLDLASPTSSGANK--VKVLVSSFSVLLVASVLVITA-WFWYCRRKKSKLLKPRDTSLE 252

Query:   290 DNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR 349
                +  L   S S+ L +F  +EIK AT NFSR NIIG+GGYGNV+KG LP+GT+VA KR
Sbjct:   253 AGTQSRLDSMSESTTLVKFSFDEIKKATNNFSRHNIIGRGGYGNVFKGALPDGTQVAFKR 312

Query:   350 FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDH 409
             FKNCS  GDANF HEVE+IAS++HVNL+ALRGY TAT P EGHQRIIVCDL+ NGSL+DH
Sbjct:   313 FKNCSAGGDANFAHEVEVIASIRHVNLLALRGYCTATTPYEGHQRIIVCDLVSNGSLHDH 372

Query:   410 LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG 469
             LFG    +L+WP+R RIALG ARGLAYLHYG QP+IIHRDIKASNILLDE FEAKV DFG
Sbjct:   373 LFGDLEAQLAWPLRQRIALGMARGLAYLHYGAQPSIIHRDIKASNILLDERFEAKVADFG 432

Query:   470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
             LAKFNPEG+TH++TRVAGT+GYVAPEYALYG+LT  SDVYSFGVVLLELLS +KA    +
Sbjct:   433 LAKFNPEGMTHMSTRVAGTMGYVAPEYALYGQLTEKSDVYSFGVVLLELLSRRKAIVTDE 492

Query:   530 -GKSVLLSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQ 588
              G+ V ++DWAW LV+EG+TLDV+              +YVL A +C+HP L ARPTMDQ
Sbjct:   493 EGQPVSVADWAWSLVREGQTLDVVEDGMPEKGPPEVLEKYVLIAVLCSHPQLHARPTMDQ 552

Query:   589 IVKILETD 596
             +VK+LE++
Sbjct:   553 VVKMLESN 560

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0004702 "receptor signaling protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2197414 AT1G11050 [Arabidopsis thaliana (taxid:3702)]

 Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
 Identities = 219/573 (38%), Positives = 305/573 (53%)

Query:    56 CPLNFDAVRRL---VNEGPKRPMLTDM-NTQCQIVLQGIRLLRAEYLR-TNGYFLPPVNS 110
             CPL+F  V  +     +  K     D  N+ CQ +L  I +  A  L+ T+ + LP + +
Sbjct:    27 CPLDFSHVLTIPWNTTDCQKSDKSADSKNSCCQSLLTLIGIPLAHRLKQTSNFRLPNLAT 86

Query:   111 SCYESCRNFVTEFVQGFDIR---TSCGYYPE---LISEACMNITSRAQFESLI-PKSKLQ 163
             S   SC N +   +    +    TS  + P    + +E C  I +   + S + P + L 
Sbjct:    87 SI--SCLNNLQTKLSSLSLSSNLTSLCFDPNQFVINNETCAGIQTTQDWVSRLGPSTALD 144

Query:   164 EIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLYAAAVVNQFG 223
                  CS  L +   CD+C +    + + L    GN +  V  C  +   YAA +VN+ G
Sbjct:   145 SA---CSSGLTDLTRCDACVAAGFRVQKQLITLDGNSSHGVY-CYHFVVTYAAGIVNKKG 200

Query:   224 PIDRATARCLFSLYFSARQSSLNKRHEXXXXXXXXXXXXXXX--XAFTAFWFLFTRSKKS 281
             P       CLFSL   +  +S  KRH                        +F F ++ K 
Sbjct:   201 PESDDALSCLFSLSLRSPLNSKKKRHTVALALGITGAIFGALVIAGLICLYFRFGKAVKG 260

Query:   282 EERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN 341
              E    V   D+ S      ++    FKIEE++ AT NFS++N IG+GG+G VYKG+LP+
Sbjct:   261 GE----VGWEDQGSRPKWRPNTGSIWFKIEELEKATNNFSQKNFIGRGGFGFVYKGVLPD 316

Query:   342 GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL 401
             G+ +AVK+       GDA F++EVEII+++KH NLV LRG S      E  QR +V D +
Sbjct:   317 GSVIAVKKVIESEFQGDAEFRNEVEIISNLKHRNLVPLRGCSMVDDDSES-QRYLVYDYM 375

Query:   402 HNGSLYDHLFGSG---MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD 458
              NG+L DHLF  G      LSWP R  I L  A+GLAYLHYGV+PAI HRDIK +NILLD
Sbjct:   376 SNGNLDDHLFPRGETTKMPLSWPQRKSIILDVAKGLAYLHYGVKPAIYHRDIKGTNILLD 435

Query:   459 EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
                 A+V DFGLAK + EG +HLTTRVAGT GY+APEYALYG+LT  SDVYSFGVV+LE+
Sbjct:   436 VDMRARVADFGLAKQSREGESHLTTRVAGTHGYLAPEYALYGQLTEKSDVYSFGVVILEI 495

Query:   519 LSGKKACEIIQGKS---VLLSDWAWELVKEGKTLDVIXXXXXXXXXXXXXX------QYV 569
             + G+KA ++    S    L++DWAW LVK GKT + +                    +++
Sbjct:   496 MCGRKALDLSTSGSPNTFLITDWAWSLVKAGKTEEALEQSLLREEGSGLSNPKGIMERFL 555

Query:   570 LTAAICAHPILQARPTMDQIVKILETDVPLSNI 602
                 +CAH ++  RPT+   +K+LE D+ +  I
Sbjct:   556 QVGILCAHVLVALRPTILDALKMLEGDIEVPPI 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 655 (235.6 bits), Expect = 2.9e-64, P = 2.9e-64
 Identities = 144/313 (46%), Positives = 194/313 (61%)

Query:   294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
             PS+ L     N + F  +E+ AAT  FS+  ++G+GG+G V+KG+LPNG E+AVK  K  
Sbjct:   314 PSVAL---GFNKSTFTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAG 370

Query:   354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
             S  G+  F+ EV+II+ V H  LV+L GY  A     G QR++V + L N +L  HL G 
Sbjct:   371 SGQGEREFQAEVDIISRVHHRFLVSLVGYCIA-----GGQRMLVYEFLPNDTLEFHLHGK 425

Query:   414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
               K L WP RL+IALG+A+GLAYLH    P IIHRDIKASNILLDE+FEAKV DFGLAK 
Sbjct:   426 SGKVLDWPTRLKIALGSAKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKL 485

Query:   474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
             + + +TH++TR+ GT GY+APEYA  GKLT  SDV+SFGV+LLEL++G++  ++      
Sbjct:   486 SQDNVTHVSTRIMGTFGYLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVDLTGEMED 545

Query:   534 LLSDWAWEL----VKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQI 589
              L DWA  +     ++G   +++              Q V  AA       + RP M QI
Sbjct:   546 SLVDWARPICLNAAQDGDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQI 605

Query:   590 VKILETDVPLSNI 602
             V+ LE D  L ++
Sbjct:   606 VRALEGDATLDDL 618

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 634 (228.2 bits), Expect = 4.8e-62, P = 4.8e-62
 Identities = 142/313 (45%), Positives = 192/313 (61%)

Query:   294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
             PS+ L   +S    F  EE+ +AT  FS++ ++G+GG+G V+KG+LPNG E+AVK  K  
Sbjct:   313 PSVALGFNNST---FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAG 369

Query:   354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
             S  G+  F+ EVEII+ V H +LV+L GY +      G QR++V + L N +L  HL G 
Sbjct:   370 SGQGEREFQAEVEIISRVHHRHLVSLVGYCSNA----GGQRLLVYEFLPNDTLEFHLHGK 425

Query:   414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
                 + WP RL+IALG+A+GLAYLH    P IIHRDIKASNILLD  FEAKV DFGLAK 
Sbjct:   426 SGTVMDWPTRLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKL 485

Query:   474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
             + +  TH++TRV GT GY+APEYA  GKLT  SDV+SFGV+LLEL++G+   ++      
Sbjct:   486 SQDNNTHVSTRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVDLSGDMED 545

Query:   534 LLSDWAWEL----VKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQI 589
              L DWA  L     ++G+  +++              + V  AA       + RP M QI
Sbjct:   546 SLVDWARPLCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQI 605

Query:   590 VKILETDVPLSNI 602
             V+ LE D  L ++
Sbjct:   606 VRTLEGDASLDDL 618

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 629 (226.5 bits), Expect = 1.6e-61, P = 1.6e-61
 Identities = 147/316 (46%), Positives = 193/316 (61%)

Query:   294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
             P LVL    S    F  EE+  AT  FS  N++G+GG+G V+KG+LP+G EVAVK+ K  
Sbjct:   257 PGLVLGFSKST---FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAG 313

Query:   354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
             S  G+  F+ EVEII+ V H +LV+L GY  A     G QR++V + + N +L  HL G 
Sbjct:   314 SGQGEREFQAEVEIISRVHHRHLVSLIGYCMA-----GVQRLLVYEFVPNNNLEFHLHGK 368

Query:   414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
             G   + W  RL+IALG+A+GL+YLH    P IIHRDIKASNIL+D  FEAKV DFGLAK 
Sbjct:   369 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 428

Query:   474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK---ACEIIQG 530
               +  TH++TRV GT GY+APEYA  GKLT  SDV+SFGVVLLEL++G++   A  +   
Sbjct:   429 ASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVD 488

Query:   531 KSVLLSDWAWELV----KEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTM 586
              S++  DWA  L+    +EG    +               + V  AA C     + RP M
Sbjct:   489 DSLV--DWARPLLNRASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRM 546

Query:   587 DQIVKILETDVPLSNI 602
              QIV+ LE +V LS++
Sbjct:   547 SQIVRALEGNVSLSDL 562

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 145/316 (45%), Positives = 193/316 (61%)

Query:   294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
             P LVL    S    F  EE+  AT  FS  N++G+GG+G V+KG+LP+G EVAVK+ K  
Sbjct:   252 PGLVLGFSKST---FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVG 308

Query:   354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
             S  G+  F+ EVEII+ V H +LV+L GY  A     G +R++V + + N +L  HL G 
Sbjct:   309 SGQGEREFQAEVEIISRVHHRHLVSLVGYCIA-----GAKRLLVYEFVPNNNLELHLHGE 363

Query:   414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
             G   + W  RL+IALG+A+GL+YLH    P IIHRDIKASNIL+D  FEAKV DFGLAK 
Sbjct:   364 GRPTMEWSTRLKIALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKI 423

Query:   474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK---ACEIIQG 530
               +  TH++TRV GT GY+APEYA  GKLT  SDV+SFGVVLLEL++G++   A  +   
Sbjct:   424 ASDTNTHVSTRVMGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVD 483

Query:   531 KSVLLSDWAWELV----KEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTM 586
              S++  DWA  L+    ++G    +               + V  AA C     + RP M
Sbjct:   484 DSLV--DWARPLLNRASEQGDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRM 541

Query:   587 DQIVKILETDVPLSNI 602
              QIV+ LE +V LS++
Sbjct:   542 SQIVRALEGNVSLSDL 557

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 620 (223.3 bits), Expect = 1.5e-60, P = 1.5e-60
 Identities = 138/313 (44%), Positives = 191/313 (61%)

Query:   294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
             PS    +   N + F  +E+  AT  F++ N++G+GG+G V+KG+LP+G EVAVK  K  
Sbjct:   286 PSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVKSLKLG 345

Query:   354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
             S  G+  F+ EV+II+ V H +LV+L GY      + G QR++V + + N +L  HL G 
Sbjct:   346 SGQGEREFQAEVDIISRVHHRHLVSLVGYC-----ISGGQRLLVYEFIPNNTLEFHLHGK 400

Query:   414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
             G   L WP R++IALG+ARGLAYLH    P IIHRDIKA+NILLD +FE KV DFGLAK 
Sbjct:   401 GRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLAKL 460

Query:   474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
             + +  TH++TRV GT GY+APEYA  GKL+  SDV+SFGV+LLEL++G+   ++      
Sbjct:   461 SQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLDLTGEMED 520

Query:   534 LLSDWAWEL-VKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQA---RPTMDQI 589
              L DWA  L +K  +  D                + V  A+  A  I  +   RP M QI
Sbjct:   521 SLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKMSQI 580

Query:   590 VKILETDVPLSNI 602
             V+ LE D+ + ++
Sbjct:   581 VRALEGDMSMDDL 593

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2019938 PERK11 "proline-rich extensin-like receptor kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 594 (214.2 bits), Expect = 4.8e-60, Sum P(2) = 4.8e-60
 Identities = 135/302 (44%), Positives = 187/302 (61%)

Query:   308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEI 367
             F  EE+   T  F +  ++G+GG+G VYKG+L  G  VA+K+ K+ S  G   FK EVEI
Sbjct:   358 FTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEI 417

Query:   368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
             I+ V H +LV+L GY  +    E H R ++ + + N +L  HL G  +  L W  R+RIA
Sbjct:   418 ISRVHHRHLVSLVGYCIS----EQH-RFLIYEFVPNNTLDYHLHGKNLPVLEWSRRVRIA 472

Query:   428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
             +G A+GLAYLH    P IIHRDIK+SNILLD+ FEA+V DFGLA+ N    +H++TRV G
Sbjct:   473 IGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTAQSHISTRVMG 532

Query:   488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ--GKSVLLSDWAW----E 541
             T GY+APEYA  GKLT  SDV+SFGVVLLEL++G+K  +  Q  G+  L+ +WA     E
Sbjct:   533 TFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV-EWARPRLIE 591

Query:   542 LVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICA-HPILQARPTMDQIVKILETDVPLS 600
              +++G   +V+              + + TAA C  H  L+ RP M Q+V+ L+T   LS
Sbjct:   592 AIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALK-RPRMVQVVRALDTRDDLS 650

Query:   601 NI 602
             ++
Sbjct:   651 DL 652

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 607 (218.7 bits), Expect = 3.5e-59, P = 3.5e-59
 Identities = 136/300 (45%), Positives = 186/300 (62%)

Query:   303 SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFK 362
             S    F  EE+   T  F+R+NI+G+GG+G VYKG L +G  VAVK+ K  S  GD  FK
Sbjct:   354 SGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFK 413

Query:   363 HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
              EVEII+ V H +LV+L GY  +    + H R+++ + + N +L  HL G G+  L W  
Sbjct:   414 AEVEIISRVHHRHLVSLVGYCIS----DQH-RLLIYEYVSNQTLEHHLHGKGLPVLEWSK 468

Query:   423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
             R+RIA+G+A+GLAYLH    P IIHRDIK++NILLD+ +EA+V DFGLA+ N    TH++
Sbjct:   469 RVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLNDTTQTHVS 528

Query:   483 TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ--GKSVLLSDWAW 540
             TRV GT GY+APEYA  GKLT  SDV+SFGVVLLEL++G+K  +  Q  G+  L+ +WA 
Sbjct:   529 TRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLV-EWAR 587

Query:   541 EL----VKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILETD 596
              L    ++ G   ++I              + + TAA C       RP M Q+V+ L+ D
Sbjct:   588 PLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRALDCD 647

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0032502 "developmental process" evidence=IMP

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)]

 Score = 607 (218.7 bits), Expect = 3.5e-59, P = 3.5e-59
 Identities = 140/322 (43%), Positives = 190/322 (59%)

Query:   290 DNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR 349
             D  E + V ++ S     F  EE+  AT  FS EN++G+GG+G V+KG+L NGTEVAVK+
Sbjct:   359 DTKENNSVAKNISMPSGMFSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQ 418

Query:   350 FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDH 409
              K  S  G+  F+ EV+ I+ V H +LV+L GY      + G +R++V + +   +L  H
Sbjct:   419 LKIGSYQGEREFQAEVDTISRVHHKHLVSLVGYC-----VNGDKRLLVYEFVPKDTLEFH 473

Query:   410 LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG 469
             L  +    L W +RLRIA+G A+GLAYLH    P IIHRDIKA+NILLD  FEAKV DFG
Sbjct:   474 LHENRGSVLEWEMRLRIAVGAAKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFG 533

Query:   470 LAKFNPE---GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE 526
             LAKF  +     TH++TRV GT GY+APEYA  GK+T  SDVYSFGVVLLEL++G+ +  
Sbjct:   534 LAKFFSDTNSSFTHISTRVVGTFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIF 593

Query:   527 IIQGKS-VLLSDWAWELVKE---GKTLD-VIXXXXXXXXXXXXXXQYVLTAAICAHPILQ 581
                  +   L DWA  L+ +   G++ D ++                   AA C      
Sbjct:   594 AKDSSTNQSLVDWARPLLTKAISGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAW 653

Query:   582 ARPTMDQIVKILETDVPLSNIK 603
              RP M Q+V+ LE +V L  ++
Sbjct:   654 LRPRMSQVVRALEGEVALRKVE 675

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P93050	RKF3_ARATH	2, ., 7, ., 1, 1, ., 1	0.5508	0.9006	0.8962	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00006101001 SubName- Full=Chromosome chr14 scaffold_164, whole genome shotgun sequence; (661 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	614
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-45
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-45
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-43
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-42
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-41
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-35
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-30
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-29
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-28
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	6e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	9e-27
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-25
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-24
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-23
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-23
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-23
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-23
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-22
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-21
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-21
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-21
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-20
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-20
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-20
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-20
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	7e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-18
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-18
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-18
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-18
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-17
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-17
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-17
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-17
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	5e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	6e-17
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-17
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	8e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-16
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-16
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-16
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-16
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-16
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-16
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-15
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-15
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-15
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-15
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-15
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-15
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	7e-15
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-14
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-14
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-14
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	6e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	8e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-13
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-13
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-13
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	4e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-13
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-13
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-13
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-12
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-12
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-12
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-12
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-12
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-12
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	6e-12
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	8e-12
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-12
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-11
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	3e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-11
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-11
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-11
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-11
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	4e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	5e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-11
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-10
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-10
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-10
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-09
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-09
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-09
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-09
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-09
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	3e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-09
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-09
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-09
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	6e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	7e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	7e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	8e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	9e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-08
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-08
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-08
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-08
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	1e-07
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-07
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-07
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	7e-07
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	8e-07
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-07
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-07
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-06
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	3e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	7e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	8e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.002
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	0.002
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	0.003

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  160 bits (408), Expect = 3e-45
 Identities = 91/278 (32%), Positives = 130/278 (46%), Gaps = 30/278 (10%)

Query: 323 ENIIGKGGYGNVYKGML-----PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNL 376
              +G+G +G VYKG L         EVAVK  K   S+     F  E  I+  + H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           V L G  T   PL     +IV + +  G L D+L  +  K+LS    L  AL  ARG+ Y
Sbjct: 64  VKLLGVCTEEEPL-----MIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           L        IHRD+ A N L+ E    K+ DFGL++   +   +        + ++APE 
Sbjct: 119 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175

Query: 497 ALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN 555
              GK T  SDV+SFGV+L E+ + G++    +    VL      E +K+G  L     N
Sbjct: 176 LKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL------EYLKKGYRLP-KPPN 228

Query: 556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
            P  EL ++M Q       C     + RPT  ++V+IL
Sbjct: 229 CPP-ELYKLMLQ-------CWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  159 bits (405), Expect = 8e-45
 Identities = 89/278 (32%), Positives = 126/278 (45%), Gaps = 31/278 (11%)

Query: 323 ENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNL 376
              +G+G +G VYKG L         EVAVK  K  +       F  E  I+  + H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           V L G  T   PL      IV + +  G L  +L  +   KLS    L  AL  ARG+ Y
Sbjct: 64  VKLLGVCTEEEPL-----YIVMEYMEGGDLLSYLRKNR-PKLSLSDLLSFALQIARGMEY 117

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           L        IHRD+ A N L+ E    K+ DFGL++   +   +        + ++APE 
Sbjct: 118 LE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPES 174

Query: 497 ALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN 555
              GK T  SDV+SFGV+L E+ + G++    +  + VL      E +K G  L     N
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL------EYLKNGYRLP-QPPN 227

Query: 556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
            P  EL ++M Q       C     + RPT  ++V+IL
Sbjct: 228 CPP-ELYDLMLQ-------CWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  156 bits (396), Expect = 4e-44
 Identities = 74/208 (35%), Positives = 102/208 (49%), Gaps = 17/208 (8%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNLVALRGYS 383
           +G+GG+G VY       G +VA+K  K    +        E+EI+  + H N+V L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                 + +   +V +    GSL D L      KLS    LRI L    GL YLH     
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLK-ENEGKLSEDEILRILLQILEGLEYLH---SN 111

Query: 444 AIIHRDIKASNILLDEA-FEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-YGK 501
            IIHRD+K  NILLD    + K+ DFGL+K      + L T V GT  Y+APE  L  G 
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGY 170

Query: 502 LTPGSDVYSFGVVLLELLSGKKACEIIQ 529
            +  SD++S GV+L EL    +  ++I+
Sbjct: 171 YSEKSDIWSLGVILYEL---PELKDLIR 195

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  156 bits (398), Expect = 1e-43
 Identities = 83/295 (28%), Positives = 123/295 (41%), Gaps = 57/295 (19%)

Query: 324 NIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVA 378
             +G+G +G VYKG L       TEVAVK  K  +   +  +F  E  ++  + H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-------FGSGMKKLSWPIRLRIALGTA 431
           L G  T     E     +V + +  G L D+L              LS    L  A+  A
Sbjct: 61  LLGVCT-----EEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIA 115

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           +G+ YL        +HRD+ A N L+ E    K+ DFGL++     +         T G 
Sbjct: 116 KGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRD----VYDDDYYRKKTGGK 168

Query: 492 V-----APEYALYGKLTPGSDVYSFGVVLLELLS-------GKKACEIIQGKSVLLSDWA 539
           +     APE    G  T  SDV+SFGV+L E+ +       G    E++           
Sbjct: 169 LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL----------- 217

Query: 540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            E +++G  L    E  P+ EL E+M         C     + RPT  ++V+ LE
Sbjct: 218 -EYLRKGYRLP-KPEYCPD-ELYELMLS-------CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (393), Expect = 4e-43
 Identities = 81/203 (39%), Positives = 102/203 (50%), Gaps = 17/203 (8%)

Query: 325 IIGKGGYGNVYKGMLPN-GTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRG 381
            +G G +G VYK      G  VAVK  K  S     D   + E+ I+  + H N+V L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
                   E    + +V +    G L+D+L   G   LS     +IAL   RGL YLH  
Sbjct: 66  A------FEDKDHLYLVMEYCEGGDLFDYLSRGG--PLSEDEAKKIALQILRGLEYLH-- 115

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
               IIHRD+K  NILLDE    K+ DFGLAK   +  + LTT V GT  Y+APE  L G
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173

Query: 501 KL-TPGSDVYSFGVVLLELLSGK 522
               P  DV+S GV+L ELL+GK
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  152 bits (386), Expect = 5e-42
 Identities = 92/280 (32%), Positives = 132/280 (47%), Gaps = 40/280 (14%)

Query: 326 IGKGGYGNVYKGML-----PNGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +G+G +G VYKG L        T+VAVK  K   S+     F  E  I+  + H N+V L
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
            G  T   PL      IV + +  G L D L   G +KL+    L++AL  A+G+ YL  
Sbjct: 67  LGVCTQGEPL-----YIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLE- 119

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV-----AP 494
                 +HRD+ A N L+ E    K+ DFGL++     I           G +     AP
Sbjct: 120 --SKNFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAP 173

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE 553
           E    GK T  SDV+SFGV+L E+ + G++    +  + VL      EL+++G  L    
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL------ELLEDGYRLP-RP 226

Query: 554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
           EN P+ EL E+M Q       C     + RPT  ++V+ L
Sbjct: 227 ENCPD-ELYELMLQ-------CWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  151 bits (383), Expect = 1e-41
 Identities = 74/243 (30%), Positives = 103/243 (42%), Gaps = 26/243 (10%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLV 377
           +     +G+G +G VY       G  VA+K  K      D      E++I+  +KH N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 378 ALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
            L          E   ++ +V +    G L+D L      +LS              L Y
Sbjct: 61  RLYDV------FEDEDKLYLVMEYCEGGDLFDLL--KKRGRLSEDEARFYLRQILSALEY 112

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH      I+HRD+K  NILLDE    K+ DFGLA+    G   LTT V GT  Y+APE 
Sbjct: 113 LH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEV 167

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK----------KACEIIQGKSVLLSDWAWELVKEG 546
            L        D++S GV+L ELL+GK          +  + I           W++  E 
Sbjct: 168 LLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEA 227

Query: 547 KTL 549
           K L
Sbjct: 228 KDL 230

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  132 bits (335), Expect = 5e-35
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
            ++R  ++G+G +G+VY  +    G  +AVK       S+      + E+ I++S++H N
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--FGSGMKKLSWP-IRLRIALGTAR 432
           +V   G        E +   I  + +  GSL   L  FG    KL  P IR +       
Sbjct: 61  IVRYYGSERDE---EKNTLNIFLEYVSGGSLSSLLKKFG----KLPEPVIR-KYTRQILE 112

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGY 491
           GLAYLH      I+HRDIK +NIL+D     K+ DFG AK   +  T   T  V GT  +
Sbjct: 113 GLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYW 169

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           +APE     +    +D++S G  ++E+ +GK
Sbjct: 170 MAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  118 bits (298), Expect = 4e-30
 Identities = 70/209 (33%), Positives = 108/209 (51%), Gaps = 11/209 (5%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI   ++   R+  +G G +G V++G+  N T VAVK  K  +     +F  E +I+  +
Sbjct: 2   EIDRTSIQLLRK--LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKL 58

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +H  L+ L    T   P+      IV +L+  GSL ++L G   + L  P  + +A   A
Sbjct: 59  RHPKLIQLYAVCTLEEPI-----YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVA 113

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+AYL        IHRD+ A N+L+ E    KV DFGLA+   E I          + +
Sbjct: 114 SGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKW 170

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            APE ALY + +  SDV+SFG++L E+++
Sbjct: 171 TAPEAALYNRFSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (295), Expect = 1e-29
 Identities = 72/207 (34%), Positives = 99/207 (47%), Gaps = 18/207 (8%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           F     IGKGG+G VYK      G EVA+K  K  SK       +E++I+   KH N+V 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
             G Y      L+  +  IV +    GSL D L  S  + L+      +     +GL YL
Sbjct: 62  YYGSY------LKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIAYVCKELLKGLEYL 114

Query: 438 H-YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPE 495
           H  G    IIHRDIKA+NILL    E K+ DFGL+   +     +    + GT  ++APE
Sbjct: 115 HSNG----IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPE 167

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
                     +D++S G+  +EL  GK
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 2e-28
 Identities = 89/284 (31%), Positives = 131/284 (46%), Gaps = 38/284 (13%)

Query: 321 SRENI-----IGKGGYGNVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKH 373
            RE++     +G G +G V+ G     T+VAVK  K    S      F  E +I+  ++H
Sbjct: 4   PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKKLRH 60

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
             LV L    +   P+      IV + +  GSL D L     KKL  P  + +A   A G
Sbjct: 61  DKLVQLYAVCSEEEPI-----YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEG 115

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLGY 491
           +AYL        IHRD+ A NIL+ E    K+ DFGLA+   + E       +    + +
Sbjct: 116 MAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKW 170

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
            APE A YG+ T  SDV+SFG++L E+++ G+     +  + VL      E V+ G  + 
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL------EQVERGYRM- 223

Query: 551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
               N PE EL ++M Q       C     + RPT + +   LE
Sbjct: 224 PRPPNCPE-ELYDLMLQ-------CWDKDPEERPTFEYLQSFLE 259

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  113 bits (285), Expect = 3e-28
 Identities = 86/285 (30%), Positives = 134/285 (47%), Gaps = 39/285 (13%)

Query: 321 SRENIIGKGGYGNVYKGML--PNGTE--VAVKRFKNCSKAGD-ANFKHEVEIIASVKHVN 375
           + E +IG G +G V +G L  P   E  VA+K  K  S      +F  E  I+    H N
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           ++ L G  T + P+     +I+ + + NGSL   L  +   K +    + +  G A G+ 
Sbjct: 67  IIRLEGVVTKSRPV-----MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMK 120

Query: 436 YL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG--TLG 490
           YL   +Y      +HRD+ A NIL++     KV DFGL++   +     TT+  G   + 
Sbjct: 121 YLSEMNY------VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIR 173

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
           + APE   Y K T  SDV+SFG+V+ E++S G++    +  + V+ +      V++G  L
Sbjct: 174 WTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKA------VEDGYRL 227

Query: 550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
                  P M+ P  + Q +L    C       RPT  QIV  L+
Sbjct: 228 P------PPMDCPSALYQLMLD---CWQKDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 5e-28
 Identities = 69/195 (35%), Positives = 100/195 (51%), Gaps = 14/195 (7%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IGKG +G+V  G    G +VAVK  K+ S A  A F  E  ++ +++H NLV L G    
Sbjct: 14  IGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             PL      IV + +  GSL D+L   G   ++   +L  AL    G+ YL    +   
Sbjct: 72  GNPL-----YIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNF 123

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD+ A N+L+ E   AKV DFGLAK         + ++   + + APE     K +  
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTK 179

Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L E+ S
Sbjct: 180 SDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  113 bits (284), Expect = 6e-28
 Identities = 77/289 (26%), Positives = 129/289 (44%), Gaps = 33/289 (11%)

Query: 324 NIIGKGGYGNVYKGMLPN-----GTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
             +G+G +G V            G +VAVK    +  +   ++F+ E+EI+ ++ H N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
             +G      P     R+I+ + L +GSL D+L      +++    L  +    +G+ YL
Sbjct: 70  KYKGVCEK--PGGRSLRLIM-EYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYL 125

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG--YVAPE 495
                   IHRD+ A NIL++     K+ DFGLAK  PE   +   +  G     + APE
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182

Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAW--------ELVKEG 546
                K +  SDV+SFGV L EL + G  +         ++             EL+KEG
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG 242

Query: 547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           + L     + P+ E+ ++M+        C     Q RP+   ++ I++ 
Sbjct: 243 ERLPR-PPSCPD-EVYDLMKL-------CWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  109 bits (275), Expect = 6e-27
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 9/201 (4%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           F+ E  +G G +G V++G+  N   VA+K  K+       +F+ EV+ +  ++H +L++L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
               +   P+      I+ +L+  GSL   L     + L     + +A   A G+AYL  
Sbjct: 68  FAVCSVGEPV-----YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE- 121

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +   IHRD+ A NIL+ E    KV DFGLA+   E + +L++       + APE A +
Sbjct: 122 --EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASH 178

Query: 500 GKLTPGSDVYSFGVVLLELLS 520
           G  +  SDV+SFG++L E+ +
Sbjct: 179 GTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  109 bits (274), Expect = 9e-27
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVN 375
           N+   ++IG+G +G VYKG+ L  G  VA+K+        +A  +   E++++ ++KH N
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V   G     +       II+ +   NGSL   +   G       +         +GLA
Sbjct: 61  IVKYIGS----IETSDSLYIIL-EYAENGSLRQIIKKFG--PFPESLVAVYVYQVLQGLA 113

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAP 494
           YLH   +  +IHRDIKA+NIL  +    K+ DFG+A K N          V GT  ++AP
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAP 168

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G  ++ELL+G 
Sbjct: 169 EVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 3e-25
 Identities = 79/277 (28%), Positives = 109/277 (39%), Gaps = 67/277 (24%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANF----KHEVEIIASVKHV 374
           + +   IG+G YG VYK      G  VA+K+ +   +     F      E++++  ++H 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRM--ENEKEGFPITAIREIKLLQKLRHP 58

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY------DH----LFGSGMKKLSWPIRL 424
           N+V L+               IV      GS+Y      DH    L  S   K +     
Sbjct: 59  NIVRLKE--------------IVTSKG-KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIK 103

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTT 483
                   GL YLH      I+HRDIK SNIL++     K+ DFGLA  +        T 
Sbjct: 104 CYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTN 160

Query: 484 RVAGTLGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA 539
           RV  TL Y  PE  L    YG   P  D++S G +L EL  GK    I QG +       
Sbjct: 161 RVI-TLWYRPPELLLGATRYG---PEVDMWSVGCILAELFLGKP---IFQGST------- 206

Query: 540 WELVKEGKTLDVI--------EENMPEMELPEMMEQY 568
                E + L+ I        +EN P +      E  
Sbjct: 207 -----ELEQLEKIFELCGSPTDENWPGVSKLPWFENL 238

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 4e-25
 Identities = 70/202 (34%), Positives = 101/202 (50%), Gaps = 19/202 (9%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVALRGYST 384
           IGKG +G+VYKG+L   TEVAVK  ++         F  E EI+    H N+V L G   
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62

Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSG----MKKLSWPIRLRIALGTARGLAYLHYG 440
              P+      IV +L+  GSL   L        +KKL     L+++L  A G+ YL   
Sbjct: 63  QKQPI-----YIVMELVPGGSLLTFLRKKKNRLTVKKL-----LQMSLDAAAGMEYLE-- 110

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT-LGYVAPEYALY 499
                IHRD+ A N L+ E    K+ DFG+++    GI  ++  +    + + APE   Y
Sbjct: 111 -SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169

Query: 500 GKLTPGSDVYSFGVVLLELLSG 521
           G+ T  SDV+S+G++L E  S 
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (261), Expect = 7e-25
 Identities = 73/236 (30%), Positives = 110/236 (46%), Gaps = 42/236 (17%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPNG----TEVAVKRFK-NCSKAGDANFKHE 364
           EI  + + F  E  +G+G +G VYKG    PN     T VA+K  K N        F+ E
Sbjct: 1   EIPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQE 58

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF------------- 411
            E+++ ++H N+V L G  T   P       ++ + L +G L++ L              
Sbjct: 59  AELMSDLQHPNIVCLLGVCTKEQPT-----CMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113

Query: 412 -GSGMKKLSWPIRLRIALGTARGLAYL--HYGVQPAIIHRDIKASNILLDEAFEAKVGDF 468
             +    L     L IA+  A G+ YL  H+      +HRD+ A N L+ E    K+ DF
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDF 168

Query: 469 GLAKFNPEGITHLTTRVAGT----LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           GL++   +  +    RV       + ++ PE  LYGK T  SD++SFGVVL E+ S
Sbjct: 169 GLSR---DIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  102 bits (256), Expect = 2e-24
 Identities = 81/282 (28%), Positives = 136/282 (48%), Gaps = 34/282 (12%)

Query: 321 SRENI-----IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN 375
            RE+I     +G G +G V+ G   N T+VAVK  K  + +  A F  E  ++ +++H  
Sbjct: 4   PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDK 62

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           LV L    T   P+      I+ + +  GSL D L      K+  P  +  +   A G+A
Sbjct: 63  LVRLYAVVTKEEPI-----YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVA 493
           Y+    +   IHRD++A+N+L+ E+   K+ DFGLA+   +     T R      + + A
Sbjct: 118 YIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTA 172

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           PE   +G  T  SDV+SFG++L E+++ GK     +    V+ +      ++ G  +  +
Sbjct: 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA------LQRGYRMPRM 226

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            EN P+ EL ++M+        C     + RPT D +  +L+
Sbjct: 227 -ENCPD-ELYDIMKT-------CWKEKAEERPTFDYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  102 bits (255), Expect = 2e-24
 Identities = 71/201 (35%), Positives = 105/201 (52%), Gaps = 18/201 (8%)

Query: 325 IIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IIG+G +G V +G    G +VAVK  K C     A F  E  ++  + H NLV L G   
Sbjct: 13  IIGEGEFGAVLQGEY-TGQKVAVKNIK-CDVTAQA-FLEETAVMTKLHHKNLVRLLG--- 66

Query: 385 ATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
             V L  H  + IV +L+  G+L + L   G   +S    L+ +L  A G+ YL      
Sbjct: 67  --VIL--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SK 119

Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
            ++HRD+ A NIL+ E   AKV DFGLA+    G+    +++   + + APE   + K +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVD--NSKLP--VKWTAPEALKHKKFS 175

Query: 504 PGSDVYSFGVVLLELLSGKKA 524
             SDV+S+GV+L E+ S  +A
Sbjct: 176 SKSDVWSYGVLLWEVFSYGRA 196

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 71/242 (29%), Positives = 111/242 (45%), Gaps = 49/242 (20%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNG------TEVAVKRFKN-CSKAGDANFKHE 364
            ++  T+   RE  +G+G +G V+ G   +         VAVK  K   S     +F+ E
Sbjct: 1   HVQRDTIVLKRE--LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFERE 58

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL------------FG 412
            E++ + +H N+V   G     V  EG   I+V + + +G L   L              
Sbjct: 59  AELLTNFQHENIVKFYG-----VCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD 113

Query: 413 SGMKKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFG 469
           S M +L+    L+IA+  A G+ YL   H+      +HRD+   N L+      K+GDFG
Sbjct: 114 SPMGELTLSQLLQIAVQIASGMVYLASQHF------VHRDLATRNCLVGYDLVVKIGDFG 167

Query: 470 LAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-G 521
           +++       +   G T L  R      ++ PE  +Y K T  SDV+SFGVVL E+ + G
Sbjct: 168 MSRDVYTTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVVLWEIFTYG 221

Query: 522 KK 523
           K+
Sbjct: 222 KQ 223

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  100 bits (250), Expect = 1e-23
 Identities = 68/195 (34%), Positives = 103/195 (52%), Gaps = 14/195 (7%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 72

Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 73  E-PI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 123

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLT 503
           +HRD++A+NIL+ E    KV DFGLA+   +     T R      + + APE ALYG+ T
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 504 PGSDVYSFGVVLLEL 518
             SDV+SFG++L EL
Sbjct: 182 IKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  100 bits (250), Expect = 1e-23
 Identities = 65/197 (32%), Positives = 104/197 (52%), Gaps = 14/197 (7%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  + + ++ F  E +I+  ++H  LV L    + 
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES-FLEEAQIMKKLRHDKLVQLYAVVSE 72

Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L     + L  P  + +A   A G+AY+    +   
Sbjct: 73  E-PI-----YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNY 123

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLT 503
           IHRD++++NIL+ +    K+ DFGLA+   +     T R      + + APE ALYG+ T
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 504 PGSDVYSFGVVLLELLS 520
             SDV+SFG++L EL++
Sbjct: 182 IKSDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  100 bits (249), Expect = 1e-23
 Identities = 85/272 (31%), Positives = 131/272 (48%), Gaps = 30/272 (11%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T+VA+K  K  +   +A F  E +I+  ++H  LV L    + 
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA-FLQEAQIMKKLRHDKLVPLYAVVSE 72

Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L     K L  P  + +A   A G+AY+    +   
Sbjct: 73  E-PI-----YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNY 123

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLT 503
           IHRD++A+NIL+ +    K+ DFGLA+   +     T R      + + APE ALYG+ T
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIED--NEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 504 PGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELP 562
             SDV+SFG++L EL++ G+     +  + VL      E V+ G  +    +  PE  L 
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVL------EQVERGYRMPC-PQGCPE-SLH 233

Query: 563 EMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           E+M+        C       RPT + I   LE
Sbjct: 234 ELMKL-------CWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =   99 bits (249), Expect = 2e-23
 Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 14/197 (7%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VA+K  K  S + +A F  E  ++  ++H  LV L    T 
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA-FLAEANLMKQLQHPRLVRLYAVVTQ 72

Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    + +A   A G+A++    +   
Sbjct: 73  E-PI-----YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNY 123

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLT 503
           IHRD++A+NIL+ E    K+ DFGLA+   +     T R      + + APE   YG  T
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFT 181

Query: 504 PGSDVYSFGVVLLELLS 520
             SDV+SFG++L E+++
Sbjct: 182 IKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  100 bits (249), Expect = 7e-23
 Identities = 70/211 (33%), Positives = 94/211 (44%), Gaps = 24/211 (11%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKH-VNLVALRG 381
           +G+G +G VY         VA+K               F  E++I+AS+ H  N+V L  
Sbjct: 8   LGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-KLSWPIRLRIALGTARGLAYLHYG 440
           +       +     +V + +  GSL D L   G K  LS    L I       L YLH  
Sbjct: 66  FFQ-----DEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH-- 118

Query: 441 VQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNPEGITHLTTR-----VAGTLGYVAP 494
               IIHRDIK  NILLD      K+ DFGLAK  P+  +  +         GT GY+AP
Sbjct: 119 -SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 495 EYAL---YGKLTPGSDVYSFGVVLLELLSGK 522
           E  L       +  SD++S G+ L ELL+G 
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGL 208

Length = 384

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 82/302 (27%), Positives = 131/302 (43%), Gaps = 55/302 (18%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHEVEI 367
             RE I     +G+G +G VY+G+          T VA+K     +   +   F +E  +
Sbjct: 3   LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASV 62

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--------FGSGMKKLS 419
           +      ++V L G     V   G   ++V +L+  G L  +L           G+   +
Sbjct: 63  MKEFNCHHVVRLLG-----VVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPT 117

Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK------- 472
               +++A   A G+AYL        +HRD+ A N ++ E    K+GDFG+ +       
Sbjct: 118 LQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY 174

Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS 532
           +   G   L  R      ++APE    G  T  SDV+SFGVVL E+ +   A +  QG S
Sbjct: 175 YRKGGKGLLPVR------WMAPESLKDGVFTTKSDVWSFGVVLWEMAT--LAEQPYQGLS 226

Query: 533 VLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI 592
              ++   + V +G  LD + EN P+  L E+M        +C     + RPT  +IV  
Sbjct: 227 ---NEEVLKFVIDGGHLD-LPENCPDK-LLELMR-------MCWQYNPKMRPTFLEIVSS 274

Query: 593 LE 594
           L+
Sbjct: 275 LK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 61/222 (27%), Positives = 89/222 (40%), Gaps = 36/222 (16%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVN 375
            +     IGKG +G VY      +G    +K     N S+    +  +EV+I+  + H N
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60

Query: 376 LVALRGYSTATVPLEGHQRIIV--CDLLHNGSLYDHL--FGSGMKKLS----WPIRLRIA 427
           ++     S      +G   I++   D    G L   +       K           +++ 
Sbjct: 61  IIKYYE-SFEE---KGKLCIVMEYAD---GGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           L     L YLH      I+HRDIK  NI L      K+GDFG++K        L   V G
Sbjct: 114 LA----LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVVG 165

Query: 488 TLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKA 524
           T  Y++PE  L     Y      SD++S G VL EL + K  
Sbjct: 166 TPYYLSPE--LCQNKPYNY---KSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.1 bits (239), Expect = 3e-22
 Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 16/200 (8%)

Query: 323 ENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           ++ +G G YG VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV L G
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLG 69

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
             T   P       I+ + +  G+L D+L     ++++  + L +A   +  + YL    
Sbjct: 70  VCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 121

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT---LGYVAPEYAL 498
           +   IHRD+ A N L+ E    KV DFGL++          T  AG    + + APE   
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLA 178

Query: 499 YGKLTPGSDVYSFGVVLLEL 518
           Y K +  SDV++FGV+L E+
Sbjct: 179 YNKFSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 96.2 bits (239), Expect = 4e-22
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 20/209 (9%)

Query: 321 SRENIIGKGGYGNVYKGML--PNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKHVN 375
           +++ +IG G +G V++G+L  P   E  VA+K  K   ++    +F  E  I+    H N
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           ++ L G  T   P      +I+ + + NG+L D        + S   +L   +G  RG+A
Sbjct: 68  IIRLEGVVTKFKPA-----MIITEYMENGAL-DKYLRDHDGEFS-SYQL---VGMLRGIA 117

Query: 436 Y-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGTLGY 491
             + Y      +HRD+ A NIL++   E KV DFGL++    +PEG T+ T+     + +
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGKIPIRW 176

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            APE   Y K T  SDV+SFG+V+ E++S
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 6e-22
 Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 16/213 (7%)

Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  +G G +G V+ G      +VA+K  +  + + D +F  E +++  + 
Sbjct: 1   IDPSELTFLKE--LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED-DFIEEAKVMMKLS 57

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H NLV L G  T   P+      IV + + NG L ++L      KL     L +      
Sbjct: 58  HPNLVQLYGVCTKQRPI-----FIVTEYMANGCLLNYL-RERKGKLGTEWLLDMCSDVCE 111

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
            + YL        IHRD+ A N L+ E    KV DFGLA++  + +  +   T+    + 
Sbjct: 112 AMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP--VK 166

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +  PE   Y + +  SDV+SFGV++ E+ S  K
Sbjct: 167 WAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 95.3 bits (237), Expect = 8e-22
 Identities = 83/288 (28%), Positives = 136/288 (47%), Gaps = 46/288 (15%)

Query: 323 ENIIGKGGYGNVYKGML--PNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
           E +IG G +G V +G L  P   E  VA+K  K   ++    +F  E  I+    H N++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY- 436
            L G  T + P+     +I+ + + NG+L D        + +  I+L   +G  RG+A  
Sbjct: 69  HLEGVVTKSRPV-----MIITEFMENGAL-DSFLRQNDGQFT-VIQL---VGMLRGIAAG 118

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG------ 490
           + Y  +   +HRD+ A NIL++     KV DFGL++F  +  +  T     +LG      
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIR 176

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
           + APE   Y K T  SDV+S+G+V+ E++S G++                W++  +   +
Sbjct: 177 WTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP--------------YWDMSNQ-DVI 221

Query: 550 DVIEENM---PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           + IE++    P M+ P  + Q +L    C      ARP   QIV  L+
Sbjct: 222 NAIEQDYRLPPPMDCPTALHQLMLD---CWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 67/208 (32%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
            +IG G    VY  + LPN  +VA+KR   + C  + D   + EV+ ++   H N+V   
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVD-ELRKEVQAMSQCNHPNVV--- 62

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK--LSWPIRLRIALGTARGLAYLH 438
            Y T+ V   G +  +V   L  GSL D +  S   +  L   I   +     +GL YLH
Sbjct: 63  KYYTSFV--VGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGITHLT-TRVAGTLGYVAPE 495
              Q   IHRDIKA NILL E    K+ DFG++    +    T        GT  ++APE
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPE 176

Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
                      +D++SFG+  +EL +G 
Sbjct: 177 VMEQVHGYDFKADIWSFGITAIELATGA 204

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 61/211 (28%), Positives = 102/211 (48%), Gaps = 12/211 (5%)

Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + +   +E  IG G +G V+ G      +VA+K  +  + + + +F  E +++  + 
Sbjct: 1   IHPSELTLVQE--IGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLS 57

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G  T   P+      +V + + +G L D+L  +   K S    L + L    
Sbjct: 58  HPKLVQLYGVCTERSPI-----CLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCE 111

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+AYL       +IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + 
Sbjct: 112 GMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWS 168

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +PE   + K +  SDV+SFGV++ E+ S  K
Sbjct: 169 SPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 66/205 (32%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 326 IGKGGYGNVYKG--MLPNGT--EVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +G G +G V +G      G    VAVK  K    S   D +F  E  I+ S+ H NL+ L
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD-DFLKEAAIMHSLDHENLIRL 61

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
            G     V L  H  ++V +L   GSL D L    +           A+  A G+ YL  
Sbjct: 62  YG-----VVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE- 114

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT----RVAGTLGYVAPE 495
                 IHRD+ A NILL    + K+GDFGL +  P+   H       +V     + APE
Sbjct: 115 --SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVP--FAWCAPE 170

Query: 496 YALYGKLTPGSDVYSFGVVLLELLS 520
                  +  SDV+ FGV L E+ +
Sbjct: 171 SLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.8 bits (231), Expect = 5e-21
 Identities = 68/211 (32%), Positives = 96/211 (45%), Gaps = 19/211 (9%)

Query: 322 RENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           R N IG G +G VY  + L  G  +AVK  R ++           E++++  +KH NLV 
Sbjct: 4   RGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK 63

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
             G     V +   +  I  +    G+L + L    +      IR    L    GLAYLH
Sbjct: 64  YYG-----VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV-IR-VYTLQLLEGLAYLH 116

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG---YVAPE 495
                 I+HRDIK +NI LD     K+GDFG A       T +   V    G   Y+APE
Sbjct: 117 ---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPE 173

Query: 496 YALYGKLTP---GSDVYSFGVVLLELLSGKK 523
               GK       +D++S G V+LE+ +GK+
Sbjct: 174 VITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 92.7 bits (231), Expect = 6e-21
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 24/212 (11%)

Query: 319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKH----EVEIIASVKH 373
           +  R  ++G+G  G VYK    P G   A+K+       GD  F+     E++ + S + 
Sbjct: 2   DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRSCES 58

Query: 374 VNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
             +V   G  Y    +        IV + +  GSL D L    + K+  P+   IA    
Sbjct: 59  PYVVKCYGAFYKEGEIS-------IVLEYMDGGSLADLL--KKVGKIPEPVLAYIARQIL 109

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           +GL YLH      IIHRDIK SN+L++   E K+ DFG++K     +    T V GT+ Y
Sbjct: 110 KGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTY 166

Query: 492 VAPEYALYGKLTP-GSDVYSFGVVLLELLSGK 522
           ++PE  + G+     +D++S G+ LLE   GK
Sbjct: 167 MSPE-RIQGESYSYAADIWSLGLTLLECALGK 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 92.9 bits (231), Expect = 7e-21
 Identities = 66/241 (27%), Positives = 112/241 (46%), Gaps = 40/241 (16%)

Query: 325 IIGKGGYGNVYKGM-LPNG----TEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNLVA 378
           ++G G +G VYKG+ +P G      VA+K  +  +          E  ++ASV H ++V 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLRIALGTAR 432
           L G           Q  ++  L+  G L D++       GS    L+W +++      A+
Sbjct: 74  LLGICL------SSQVQLITQLMPLGCLLDYVRNHKDNIGS-QYLLNWCVQI------AK 120

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TL 489
           G++YL    +  ++HRD+ A N+L+      K+ DFGLAK              G    +
Sbjct: 121 GMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPI 175

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT 548
            ++A E  L+   T  SDV+S+GV + EL++ G K  E I    +       +L+++G+ 
Sbjct: 176 KWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP------DLLEKGER 229

Query: 549 L 549
           L
Sbjct: 230 L 230

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 92.3 bits (229), Expect = 7e-21
 Identities = 82/282 (29%), Positives = 132/282 (46%), Gaps = 36/282 (12%)

Query: 323 ENIIGKGGYGNVYKGML--PNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
           E +IG G +G V  G L  P   E  VA+K  K   ++    +F  E  I+    H N++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY- 436
            L G  T + P+     +IV + + NGSL      + ++K      +   +G  RG+A  
Sbjct: 69  HLEGVVTKSKPV-----MIVTEYMENGSL-----DAFLRKHDGQFTVIQLVGMLRGIASG 118

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGTLGYVA 493
           + Y      +HRD+ A NIL++     KV DFGL++    +PE   + T      + + A
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIPIRWTA 177

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           PE   Y K T  SDV+S+G+V+ E++S G++    +  + V+ +      ++EG  L   
Sbjct: 178 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA------IEEGYRLP-- 229

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
                 M+ P  + Q +L    C       RP  +QIV IL+
Sbjct: 230 ----APMDCPAALHQLMLD---CWQKDRNERPKFEQIVSILD 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 92.6 bits (231), Expect = 1e-20
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 40/222 (18%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA---NFK--HEVEIIASVK 372
            + +   +G+G Y  VYK      G  VA+K+ K   +       NF    E++++  +K
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60

Query: 373 HVNLVALRGYSTATVPLEGHQRII--VCDLLH--------NGSLYDHLFGSGMKKLSWPI 422
           H N++ L       + + GH+  I  V + +         + S+   +      K S+  
Sbjct: 61  HPNIIGL-------LDVFGHKSNINLVFEFMETDLEKVIKDKSI---VLTPADIK-SY-- 107

Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
                L T RGL YLH      I+HRD+K +N+L+      K+ DFGLA+        +T
Sbjct: 108 ----MLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMT 160

Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
            +V  T  Y APE  L+G      G D++S G +  ELL   
Sbjct: 161 HQVV-TRWYRAPEL-LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 82/281 (29%), Positives = 128/281 (45%), Gaps = 41/281 (14%)

Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ +     +F+ E+EI+ S++H N+V  +
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L      +V + L  GSL D+L     ++L     L  A    +G+ YL 
Sbjct: 72  GVCYSAGRRNLR-----LVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYLG 125

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
                  +HRD+   NIL++     K+GDFGL K  P+   +   R  G   + + APE 
Sbjct: 126 ---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182

Query: 497 ALYGKLTPGSDVYSFGVVLLELLS-GKKAC-----------EIIQGKSVLLSDWAWELVK 544
               K +  SDV+SFGVVL EL +   K+C              QG+ ++      EL+K
Sbjct: 183 LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH--LIELLK 240

Query: 545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT 585
               L       P  E+  +M++       C +     RP+
Sbjct: 241 NNGRLPA-PPGCP-AEIYAIMKE-------CWNNDPSQRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 64/197 (32%), Positives = 96/197 (48%), Gaps = 10/197 (5%)

Query: 325 IIGKGGYGNVYKGMLPNGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           ++GKG +G V+KG L + T VAVK  K +  +     F  E  I+    H N+V L G  
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
           T   P+      IV +L+  G     L      +L     ++ AL  A G+AYL      
Sbjct: 62  TQRQPI-----YIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE---SK 112

Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
             IHRD+ A N L+ E    K+ DFG+++   +GI   +      + + APE   YG+ +
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172

Query: 504 PGSDVYSFGVVLLELLS 520
             SDV+S+G++L E  S
Sbjct: 173 SESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 12/209 (5%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI   ++   ++  +G G +G V+       T+VAVK  K  S + +A F  E  ++ ++
Sbjct: 2   EIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTL 58

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +H  LV L    T   P+      I+ + +  GSL D L      K   P  +  +   A
Sbjct: 59  QHDKLVKLHAVVTKE-PI-----YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 112

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+A++    Q   IHRD++A+NIL+  +   K+ DFGLA+   +            + +
Sbjct: 113 EGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW 169

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            APE   +G  T  SDV+SFG++L+E+++
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 64/202 (31%), Positives = 89/202 (44%), Gaps = 17/202 (8%)

Query: 326 IGKGGYGNVYKGMLPN-GTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           +GKG +G V      + G   A+K   + K   +    +   E  I++ + H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA-LGTARGLAYLHYG 440
           Y+  T   E     +V +    G L+ HL   G        R   A +  A  L YLH  
Sbjct: 60  YAFQT---EEKL-YLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAEIVLA--LEYLH-- 110

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
               II+RD+K  NILLD     K+ DFGLAK      +   T   GT  Y+APE  L  
Sbjct: 111 -SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGK 168

Query: 501 KLTPGSDVYSFGVVLLELLSGK 522
                 D +S GV+L E+L+GK
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 25/218 (11%)

Query: 326 IGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G +G+V KG  ++ +G E  VAVK  K     AG   F  E  ++A + H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           G        +G   ++V +L   G L  +L       +S    L  A   A G+AYL   
Sbjct: 63  GVC------KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMGMAYLE-- 112

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYAL 498
                +HRD+ A N+LL    +AK+ DFG+++    G  +     AG   L + APE   
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 499 YGKLTPGSDVYSFGVVLLELLS-------GKKACEIIQ 529
           YGK +  SDV+S+GV L E  S         K  E+I 
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIA 209

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.2 bits (225), Expect = 5e-20
 Identities = 61/217 (28%), Positives = 94/217 (43%), Gaps = 35/217 (16%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK----HEVEIIASVKHV 374
           + +   +G+G YG VYK      G  VA+K+ +  ++  +         E+ ++  +KH 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE--EEGIPSTALREISLLKELKHP 58

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR----IALGT 430
           N+V L       V     +  +V +        D      + K   P+       I    
Sbjct: 59  NIVKLL-----DVIHTERKLYLVFEYC------DMDLKKYLDKRPGPLSPNLIKSIMYQL 107

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTL 489
            RGLAY H      I+HRD+K  NIL++     K+ DFGLA+ F     T+ T  V  TL
Sbjct: 108 LRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY-THEVV-TL 162

Query: 490 GYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGK 522
            Y APE  L    Y       D++S G +  E+++GK
Sbjct: 163 WYRAPEILLGSKHYS---TAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 89.6 bits (222), Expect = 8e-20
 Identities = 91/291 (31%), Positives = 133/291 (45%), Gaps = 43/291 (14%)

Query: 326 IGKGGYGNV--YKGMLPN---GTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +G+G +G V  Y     N   G  VAVK  K  C +   + +K E+ I+ ++ H N+V  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 380 RGYSTATVPLEGHQRII--VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
           +G  +     E   + +  + + +  GSL D+L      KL+    L  A     G+AYL
Sbjct: 72  KGCCS-----EQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYL 123

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA----GTLGYVA 493
           H       IHRD+ A N+LLD     K+GDFGLAK  PEG  H   RV       + + A
Sbjct: 124 H---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG--HEYYRVREDGDSPVFWYA 178

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSG--------KKACEIIQGKSVLLSDWAW-ELVK 544
            E     K +  SDV+SFGV L ELL+         KK  E+I  K   ++     EL++
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238

Query: 545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
            G  L    +N P  E+  +M+        C     + RPT   ++ IL+ 
Sbjct: 239 RGMRLPC-PKNCP-QEVYILMKN-------CWETEAKFRPTFRSLIPILKE 280

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 87/311 (27%), Positives = 137/311 (44%), Gaps = 66/311 (21%)

Query: 320 FSRENI-----IGKGGYGNVYKGM---LPNGTE---VAVKRFK-NCSKAGDANFKHEVEI 367
             R+ +     +G+G +G V K     L N  E   VAVK  K + ++   ++   E+E+
Sbjct: 9   LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEM 68

Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG-------------- 412
           +  + KH N++ L G  T   PL      +V +   +G+L D L                
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPL-----YVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
              + L+    +  A   ARG+ +L        IHRD+ A N+L+ E    K+ DFGLA+
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR 180

Query: 473 FNPEGITHL-----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACE 526
                I H+     TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ +      
Sbjct: 181 ----DIHHIDYYRKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT------ 229

Query: 527 IIQGKSVLLSDWAWELV---KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR 583
              G S        EL    KEG  ++   +N  + EL  +M         C H +   R
Sbjct: 230 --LGGSPYPGIPVEELFKLLKEGYRMEK-PQNCTQ-ELYHLMRD-------CWHEVPSQR 278

Query: 584 PTMDQIVKILE 594
           PT  Q+V+ L+
Sbjct: 279 PTFKQLVEDLD 289

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 67/198 (33%), Positives = 95/198 (47%), Gaps = 14/198 (7%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
              IGKG +G+V  G    G +VAVK  KN + A    F  E  ++  ++H NLV L G 
Sbjct: 11  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG- 66

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
               +  E     IV + +  GSL D+L   G   L     L+ +L     + YL     
Sbjct: 67  ---VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN-- 121

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL 502
              +HRD+ A N+L+ E   AKV DFGL K      T  T ++   + + APE     K 
Sbjct: 122 -NFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKLP--VKWTAPEALREKKF 176

Query: 503 TPGSDVYSFGVVLLELLS 520
           +  SDV+SFG++L E+ S
Sbjct: 177 STKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 89.5 bits (223), Expect = 2e-19
 Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 48/223 (21%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
             IG G YG V   +    G +VA+K+  N        F           E++++  ++H
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLRHLRH 58

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA-- 431
            N++ L        P + +   IV +L+           + + K+   I+    L     
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELME----------TDLHKV---IKSPQPLTDDHI 105

Query: 432 --------RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITH 480
                   RGL YLH      +IHRD+K SNIL++   + K+ DFGLA+    + +    
Sbjct: 106 QYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 481 LTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           LT  V  T  Y APE  L   + T   D++S G +  ELL+ K
Sbjct: 163 LTEYVV-TRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 30/208 (14%)

Query: 326 IGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKH----EVEIIASVKHVNLVALR 380
           IG+G +G V+K      G  VA+K+     +  +    +    E++ + + +H  +V L 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKV--ALRRLEGGIPNQALREIKALQACQHPYVVKLL 65

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR----GLAY 436
                 V   G   ++V + +    L + L     +    P+         R    G+AY
Sbjct: 66  -----DVFPHGSGFVLVMEYM-PSDLSEVL-----RDEERPLPEAQVKSYMRMLLKGVAY 114

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPE 495
           +H      I+HRD+K +N+L+      K+ DFGLA+ F+ E     + +VA T  Y APE
Sbjct: 115 MH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPE 170

Query: 496 YALYG--KLTPGSDVYSFGVVLLELLSG 521
             LYG  K  PG D+++ G +  ELL+G
Sbjct: 171 L-LYGARKYDPGVDLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 16/209 (7%)

Query: 319 NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVN 375
           +F     +GKG YG+VYK   L +    A+K     + S+    +  +E+ I+ASV H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL--RIALGTARG 433
           ++    Y  A   L+G++  IV +    G L   +     K+   P +   RI +   RG
Sbjct: 61  II---SYKEAF--LDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG 115

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L  LH   +  I+HRD+K++NILL      K+GD G++K   +    +     GT  Y+A
Sbjct: 116 LQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMA 169

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE       +  SD++S G +L E+ +  
Sbjct: 170 PEVWKGRPYSYKSDIWSLGCLLYEMATFA 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 86.6 bits (215), Expect = 6e-19
 Identities = 67/208 (32%), Positives = 96/208 (46%), Gaps = 36/208 (17%)

Query: 326 IGKGGYGNVYKG-MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG-YS 383
           IG G YG+VYK   +  G  VA+K  K          + E+ ++   +H N+VA  G Y 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY- 69

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-RLRIAL---GTARGLAYLHY 439
                L   +  IV +    GSL D       +    P+  L+IA     T +GLAYLH 
Sbjct: 70  -----LRRDKLWIVMEYCGGGSLQDI-----YQVTRGPLSELQIAYVCRETLKGLAYLH- 118

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA------GTLGYVA 493
             +   IHRDIK +NILL E  + K+ DFG++         LT  +A      GT  ++A
Sbjct: 119 --ETGKIHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMA 169

Query: 494 PEYA---LYGKLTPGSDVYSFGVVLLEL 518
           PE A     G      D+++ G+  +EL
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 86.2 bits (214), Expect = 7e-19
 Identities = 75/230 (32%), Positives = 97/230 (42%), Gaps = 31/230 (13%)

Query: 319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHV 374
           +F    +IGKG +G V            A+K   + K   K    N  +E  I+  + H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIALGTAR 432
            LV L  YS      +  + + +V DLL  G L  HL  S   K S   ++  I      
Sbjct: 61  FLVNLW-YS-----FQDEENMYLVVDLLLGGDLRYHL--SQKVKFSEEQVKFWIC-EIVL 111

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
            L YLH      IIHRDIK  NILLDE     + DF +A K  P+    LTT  +GT GY
Sbjct: 112 ALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD---TLTTSTSGTPGY 165

Query: 492 VAPE---YALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW 538
           +APE      Y       D +S GV   E L GK+        S  + D 
Sbjct: 166 MAPEVLCRQGYSVA---VDWWSLGVTAYECLRGKRPYRG---HSRTIRDQ 209

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 13/203 (6%)

Query: 324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVNLVALRG 381
           + +G+G  G+V K  L N   +   +        D   +   E+EI  S K   +V  + 
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV--KY 64

Query: 382 YSTATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           Y            I +  C+     S+Y  +   G +     +  +IA    +GL+YLH 
Sbjct: 65  YGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVLKGLSYLH- 122

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                IIHRDIK SNILL    + K+ DFG++    E +  L     GT  Y+APE    
Sbjct: 123 --SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTSFYMAPERIQG 177

Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
              +  SDV+S G+ LLE+   +
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 84.8 bits (210), Expect = 3e-18
 Identities = 85/321 (26%), Positives = 127/321 (39%), Gaps = 93/321 (28%)

Query: 321 SRENI-----IGKGGYGNVYKGML------PNGTEVAVK-RFKNCSKAGDANFKHEVEII 368
            R++I     +G G +G VY+G+           +VAVK   ++CS+  +++F  E  I+
Sbjct: 4   PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL----------FGSGMKKL 418
           +   H N+V L G S   +P     R I+ +L+  G L   L              MK L
Sbjct: 64  SKFNHQNIVRLIGVSFERLP-----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDL 118

Query: 419 SWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGLAK 472
                L  A   A+G  YL   H+      IHRDI A N LL        AK+ DFG+A+
Sbjct: 119 -----LFCARDVAKGCKYLEENHF------IHRDIAARNCLLTCKGPGRVAKIADFGMAR 167

Query: 473 -------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS----- 520
                  +   G   L  +      ++ PE  L G  T  +DV+SFGV+L E+ S     
Sbjct: 168 DIYRASYYRKGGRAMLPIK------WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Query: 521 --GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELP----EMMEQYVLTAAI 574
             G+   E++            E V  G  LD      P    P     +M         
Sbjct: 222 YPGRTNQEVM------------EFVTGGGRLD------PPKGCPGPVYRIMTD------- 256

Query: 575 CAHPILQARPTMDQIVKILET 595
           C     + RP    I++ ++ 
Sbjct: 257 CWQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 85.0 bits (210), Expect = 3e-18
 Identities = 71/248 (28%), Positives = 112/248 (45%), Gaps = 57/248 (22%)

Query: 326 IGKGGYGNVY----KGMLPNG--TEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +G+G +G V+      +LP      VAVK  K  S++   +F+ E E++  ++H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-------------MKKLSWPIRLRI 426
            G  T     EG   ++V + + +G L   L   G               +L+    L I
Sbjct: 73  YGVCT-----EGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 427 ALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------FNPE 476
           A   A G+ YL   H+      +HRD+   N L+ +    K+GDFG+++       +   
Sbjct: 128 ASQIASGMVYLASLHF------VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 181

Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL----------LSGKKACE 526
           G T L  R      ++ PE  LY K T  SD++SFGVVL E+          LS  +A E
Sbjct: 182 GRTMLPIR------WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE 235

Query: 527 -IIQGKSV 533
            I QG+ +
Sbjct: 236 CITQGREL 243

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 89/297 (29%), Positives = 138/297 (46%), Gaps = 55/297 (18%)

Query: 324 NIIGKGGYGNVYKG----MLPNGTE---VAVKRFKNCSKAGD-ANFKHEVEIIASVKHVN 375
           N +G G +G VY+G    +L  G+    VAVK  +  +   +   F  E  ++++  H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR-----LRIALGT 430
           +V L G     V L    + I+ +L+  G L  +L  + +++   P+      L I L  
Sbjct: 61  IVKLLG-----VCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDV 115

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA-----KVGDFGLAK-------FNPEGI 478
           A+G  YL    Q   IHRD+ A N L+ E         K+GDFGLA+       +  EG 
Sbjct: 116 AKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGE 172

Query: 479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
             L  R      ++APE  L GK T  SDV+SFGV++ E+L+ G++    +  + VL   
Sbjct: 173 GLLPVR------WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL--- 223

Query: 538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
              + V  G  L    EN P+ ++ ++M         C       RPT D+I +IL+
Sbjct: 224 ---QHVTAGGRLQK-PENCPD-KIYQLMTN-------CWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 84.1 bits (208), Expect = 4e-18
 Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 14/208 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVN 375
           +F   N IGKG +G V+K +   +    A+K+      ++        E  ++A +    
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           ++  R Y +    L+  +  IV +   NG L+  L     + L      R  +    GLA
Sbjct: 61  II--RYYESF---LDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAP 494
           +LH      I+HRDIK+ N+ LD     K+GD G+AK  +    T+    + GT  Y++P
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNFANTIVGTPYYLSP 170

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E          SDV++ GVVL E  +GK
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGK 198

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 84.7 bits (210), Expect = 5e-18
 Identities = 64/217 (29%), Positives = 95/217 (43%), Gaps = 48/217 (22%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK----HEVEIIASVKHVNLVALR 380
           +G+G YG V K      G  VA+K+FK      D + K     EV+++  ++H N+V L 
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFK--ESEDDEDVKKTALREVKVLRQLRHENIVNL- 65

Query: 381 GYSTATVPLEGHQR----IIVCDLLHNGSLYDHL--FGSGM-----KKLSWPIRLRIALG 429
                    E  +R     +V + +   +L + L     G+     +   W +       
Sbjct: 66  --------KEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQL------- 109

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGT 488
             + +AY H      IIHRDIK  NIL+ E+   K+ DFG A+         LT  VA T
Sbjct: 110 -LQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-T 164

Query: 489 LGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSG 521
             Y APE  +    YG      DV++ G ++ ELL G
Sbjct: 165 RWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDG 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 62/213 (29%), Positives = 90/213 (42%), Gaps = 31/213 (14%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           F     +G+G YG+VYK +    G  VA+K      +        E+ I+       +V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV--EEDLQEIIKEISILKQCDSPYIVK 62

Query: 379 LRG-YSTATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
             G Y            I++  C     GS+ D +     K L+      I   T +GL 
Sbjct: 63  YYGSYFK-----NTDLWIVMEYCGA---GSVSD-IMKITNKTLTEEEIAAILYQTLKGLE 113

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR------VAGTL 489
           YLH       IHRDIKA NILL+E  +AK+ DFG++         LT        V GT 
Sbjct: 114 YLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKRNTVIGTP 163

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            ++APE          +D++S G+  +E+  GK
Sbjct: 164 FWMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 31/208 (14%)

Query: 326 IGKGGYGNVYKGML--PNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALR 380
           +G G  G V K +L  P G  +AVK  +      +A  K    E++I+       +V   
Sbjct: 9   LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFY 65

Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  Y+   +        I  + +  GSL D +      ++   I  +IA+   +GL YLH
Sbjct: 66  GAFYNNGDI-------SICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLH 117

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA----GTLGYVAP 494
              +  IIHRD+K SNIL++   + K+ DFG++         L   +A    GT  Y+AP
Sbjct: 118 E--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-------GQLVNSLAKTFVGTSSYMAP 168

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G+ L+EL +G+
Sbjct: 169 ERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 326 IGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYS 383
           IG+G +G V+ G L  + T VAVK  +        A F  E  I+    H N+V L G  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSG----MKKLSWPIRLRIALGTARGLAYLHY 439
           T   P+      IV +L+  G     L   G    +K+L     +++    A G+ YL  
Sbjct: 63  TQKQPI-----YIVMELVQGGDFLTFLRTEGPRLKVKEL-----IQMVENAAAGMEYLE- 111

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT-LGYVAPEYAL 498
                 IHRD+ A N L+ E    K+ DFG+++   +G+   T  +    + + APE   
Sbjct: 112 --SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 499 YGKLTPGSDVYSFGVVLLELLS 520
           YG+ +  SDV+SFG++L E  S
Sbjct: 170 YGRYSSESDVWSFGILLWEAFS 191

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 82.2 bits (203), Expect = 2e-17
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 32/281 (11%)

Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++  + 
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMKLS 57

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G  T   P+      IV + + NG L ++L     K+      L +      
Sbjct: 58  HEKLVQLYGVCTKQRPI-----YIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCE 111

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+AYL        IHRD+ A N L+D+    KV DFGL+++  + E  + + ++    + 
Sbjct: 112 GMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP--VR 166

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           +  PE  LY K +  SDV++FGV++ E+ S              L    +E     +T++
Sbjct: 167 WSPPEVLLYSKFSSKSDVWAFGVLMWEVYS--------------LGKMPYERFNNSETVE 212

Query: 551 VIEENMPEMELPEMMEQYVLTAAI-CAHPILQARPTMDQIV 590
            + + +  +  P +  + V      C H   + RPT  Q++
Sbjct: 213 KVSQGL-RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 24/203 (11%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G VYK      G EVA+K+ +   +  +     E+ I+   KH N+V    Y +
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIIN-EILIMKDCKHPNIVDY--YDS 83

Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
               L G +  +V + +  GSL D +  +   +++ P    +     +GL YLH      
Sbjct: 84  Y---LVGDELWVVMEYMDGGSLTDIITQN-FVRMNEPQIAYVCREVLQGLEYLH---SQN 136

Query: 445 IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR------VAGTLGYVAPEYAL 498
           +IHRDIK+ NILL +    K+ DFG A         LT        V GT  ++APE   
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFA-------AQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
                P  D++S G++ +E+  G
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 78/283 (27%), Positives = 118/283 (41%), Gaps = 43/283 (15%)

Query: 325 IIGKGGYGNVYKG--MLPNGTE--VAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNLVAL 379
            IG+G +G+VY+G  M P   +  VAVK  KNC+       F  E  I+    H ++V L
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI--ALGTARGLAYL 437
            G  T   P+      IV +L   G L  +L    + K S  +   I  +   +  LAYL
Sbjct: 73  IGVITEN-PV-----WIVMELAPLGELRSYL---QVNKYSLDLASLILYSYQLSTALAYL 123

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
                   +HRDI A N+L+      K+GDFGL+++  +   +  ++    + ++APE  
Sbjct: 124 E---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESI 180

Query: 498 LYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN- 555
            + + T  SDV+ FGV + E+L  G K              +    VK    +  IE   
Sbjct: 181 NFRRFTSASDVWMFGVCMWEILMLGVKP-------------FQG--VKNNDVIGRIENGE 225

Query: 556 ---MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
              MP    P +   Y L    C       RP   ++   L  
Sbjct: 226 RLPMPPNCPPTL---YSLMTK-CWAYDPSKRPRFTELKAQLSD 264

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 81.4 bits (201), Expect = 4e-17
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK----------RFKNCSKAGDANFKHEVEI 367
            + +  +IGKG YG VY  + +  G  +AVK          R  +  K      + E+E 
Sbjct: 2   KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           +  + H+N+V   G+ T    L      I  + +  GS+   L   G  +    +     
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLS-----IFLEYVPGGSIGSCLRTYG--RFEEQLVRFFT 114

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL-TTRVA 486
                GLAYLH      I+HRD+KA N+L+D     K+ DFG++K + +   +     + 
Sbjct: 115 EQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 487 GTLGYVAPEY-ALYGKLTPGS-DVYSFGVVLLELLSGKK 523
           G++ ++APE    Y +      D++S G V+LE+ +G++
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 29/209 (13%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN-----FKHEVEIIASVKHVNLVAL 379
           +G G +G+VY+G+ L +G   AVK                  + E+ +++ ++H N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV-- 65

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTAR---GL 434
           +   T     E     I  +L+  GSL   L  +GS       P+   I L T +   GL
Sbjct: 66  QYLGTER---EEDNLYIFLELVPGGSLAKLLKKYGS----FPEPV---IRLYTRQILLGL 115

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH       +HRDIK +NIL+D     K+ DFG+AK   E          G+  ++AP
Sbjct: 116 EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--AKSFKGSPYWMAP 170

Query: 495 EYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           E     G     +D++S G  +LE+ +GK
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 48/239 (20%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCSKAGD-ANFKHEV 365
           E+  + + F  E  +G+  +G +YKG L      +   VA+K  K+ +       F+ E 
Sbjct: 1   ELPLSAVRFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEA 58

Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF-------------- 411
            ++A + H N+V L G  T   P+      ++ + L+ G L++ L               
Sbjct: 59  SLMAELHHPNIVCLLGVVTQEQPV-----CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDE 113

Query: 412 -GSGMKKLSWPIRLRIALGTARGLAYL--HYGVQPAIIHRDIKASNILLDEAFEAKVGDF 468
            G+    L     L IA+  A G+ YL  H+      +H+D+ A NIL+ E    K+ D 
Sbjct: 114 DGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF-----FVHKDLAARNILIGEQLHVKISDL 168

Query: 469 GLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           GL++       +  +  + L  R      ++ PE  +YGK +  SD++SFGVVL E+ S
Sbjct: 169 GLSREIYSADYYRVQPKSLLPIR------WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 80.7 bits (199), Expect = 6e-17
 Identities = 71/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)

Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  +G G +G V+ G      +VA+K     + + + +F  E +++  + 
Sbjct: 1   INPSELTFMKE--LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLS 57

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G  T   PL      IV + + NG L ++L      KLS  + L +      
Sbjct: 58  HPKLVQLYGVCTQQKPL-----YIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCE 111

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+ YL    + + IHRD+ A N L+      KV DFG+ ++  +     ++     + + 
Sbjct: 112 GMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWS 168

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK----- 547
            PE   + K +  SDV+SFGV++                        WE+  EGK     
Sbjct: 169 PPEVFNFSKYSSKSDVWSFGVLM------------------------WEVFTEGKMPFEK 204

Query: 548 --TLDVIEENMPEMEL--PEMMEQYVLTAAI-CAHPILQARPTMDQIVKIL 593
               +V+E       L  P++    V      C H   + RPT  ++++ +
Sbjct: 205 KSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 81.1 bits (201), Expect = 6e-17
 Identities = 61/240 (25%), Positives = 85/240 (35%), Gaps = 58/240 (24%)

Query: 319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +F    IIG+G +  V          E A+K      K      +     +   K V  V
Sbjct: 2   DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKI---LDK------RQ----LIKEKKVKYV 48

Query: 378 ALRGYSTATVPLEGHQRII--------------VCDLLHNGSLYDHL--FGSGMKKLSWP 421
            +         L GH  II              V +   NG L  ++  +GS    L   
Sbjct: 49  KIE--KEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS----LDEK 102

Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITH 480
                A      L YLH      IIHRD+K  NILLD+    K+ DFG AK  +P     
Sbjct: 103 CTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159

Query: 481 LTTRVA------------------GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
                A                  GT  YV+PE          SD+++ G ++ ++L+GK
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 81.3 bits (201), Expect = 8e-17
 Identities = 66/221 (29%), Positives = 103/221 (46%), Gaps = 39/221 (17%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK-NCSKAG-DANFKHEVEIIASVKHVN 375
            F + N IG+G YG VY+     +G  VA+K+ + +  + G   +   E+ ++ +++H N
Sbjct: 8   EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHN------------GSLYDHLFGSGMKKLSWPIR 423
           +V L+              ++V   L +             SL D++        S    
Sbjct: 68  IVELK-------------EVVVGKHLDSIFLVMEYCEQDLASLLDNM----PTPFSESQV 110

Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
             + L   RGL YLH   +  IIHRD+K SN+LL +    K+ DFGLA+        +T 
Sbjct: 111 KCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTP 167

Query: 484 RVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +V  TL Y APE  L G    T   D+++ G +L ELL+ K
Sbjct: 168 KVV-TLWYRAPEL-LLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 60/219 (27%), Positives = 85/219 (38%), Gaps = 37/219 (16%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
             IGKG +G V K     +G  +  K   + N ++        EV I+  +KH N+V   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV--- 62

Query: 381 GYSTATVPLEGHQRIIV------------C---DLLHNGSLYDHLFGSGMKKLSWPIRLR 425
            Y         + RII             C   DL     L         K +      R
Sbjct: 63  RY---------YDRIIDRSNQTLYIVMEYCEGGDL---AQLIQK-CKKERKYIEEEFIWR 109

Query: 426 IALGTARGLAYLHYGVQP--AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           I       L   H    P   ++HRD+K +NI LD     K+GDFGLAK      +   T
Sbjct: 110 ILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT 169

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            V GT  Y++PE   +      SD++S G ++ EL +  
Sbjct: 170 YV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 71/223 (31%), Positives = 108/223 (48%), Gaps = 36/223 (16%)

Query: 320 FSRENI-----IGKGGYGNVYKGML--PNGTEVAVKRFK-NCSKAGDANFKHEVE-IIAS 370
           F+ E++     IG+G +G V K ML  P+GT +AVKR +    +        +++ ++ S
Sbjct: 1   FTAEDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59

Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL---YDHLFGSGMKKLSWPIRLRIA 427
                +V   G   A    EG   I  C  L + SL   Y +++      +   I  +IA
Sbjct: 60  SDCPYIVKFYG---ALFR-EGDCWI--CMELMDISLDKFYKYVYEVLKSVIPEEILGKIA 113

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           + T + L YL   ++  IIHRD+K SNILLD     K+ DFG++    + I    TR AG
Sbjct: 114 VATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAG 169

Query: 488 TLGYVAPEYALYGKLTPG--------SDVYSFGVVLLELLSGK 522
              Y+APE     ++ P         SDV+S G+ L E+ +GK
Sbjct: 170 CRPYMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGK 207

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 68/217 (31%), Positives = 99/217 (45%), Gaps = 40/217 (18%)

Query: 324 NIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVA 378
            +IGKG +G VY G L          AVK     +   +   F  E  I+    H N+++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 379 LRGYSTATVPLEGHQRIIV-----CDLL-------HNGSLYDHLFGSGMKKLSWPIRLRI 426
           L G     +P EG   +++      DL        HN ++ D L G G            
Sbjct: 61  LLGIC---LPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKD-LIGFG------------ 104

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTT 483
            L  A+G+ YL        +HRD+ A N +LDE+F  KV DFGLA+  ++ E  + H  T
Sbjct: 105 -LQVAKGMEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHT 160

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 161 GAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 73/262 (27%), Positives = 117/262 (44%), Gaps = 47/262 (17%)

Query: 313 IKAATMNFSRENIIGKGGYGNVY----KGMLPNGTE--VAVKRFKNCSKAGDANFKHEVE 366
           IK   +   RE  +G+G +G V+      + P   +  VAVK  K+ S     +F  E E
Sbjct: 2   IKRHNIVLKRE--LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAE 59

Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM----------- 415
           ++ +++H ++V   G     V +EG   I+V + + +G L   L   G            
Sbjct: 60  LLTNLQHEHIVKFYG-----VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRP 114

Query: 416 KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--- 472
            +L+    L IA   A G+ YL        +HRD+   N L+ E    K+GDFG+++   
Sbjct: 115 AELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171

Query: 473 ----FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEI 527
               +   G T L  R      ++ PE  +Y K T  SDV+S GVVL E+ + GK+    
Sbjct: 172 STDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQ 225

Query: 528 IQGKSVLLSDWAWELVKEGKTL 549
           +    V+      E + +G+ L
Sbjct: 226 LSNNEVI------ECITQGRVL 241

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 17/202 (8%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFK-NCSKAGDANFK-HEVEIIASVKHVNLVALRGY 382
           IG+G YG VYK      G  VA+K+ K      G       E++++  + H N++ L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL-- 64

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                  +G    +V + +    LY  L     + L   +         +GLA+ H    
Sbjct: 65  --DVFRHKGDL-YLVFEFMDT-DLY-KLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I+HRD+K  N+L++     K+ DFGLA+ F        T  V  T  Y APE  L  K
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP-YTHYVV-TRWYRAPELLLGDK 174

Query: 502 L-TPGSDVYSFGVVLLELLSGK 522
             +   D++S G +  ELLS +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 78.8 bits (195), Expect = 3e-16
 Identities = 62/211 (29%), Positives = 83/211 (39%), Gaps = 29/211 (13%)

Query: 326 IGKGGYGNVY---KGMLPNGTEVAVKRFKNCSKAGDANF---KHEVEIIASVKHVNLVAL 379
           I KG YG V+   K     G   A+K  K               E +I++  +   +V L
Sbjct: 1   ISKGAYGRVFLAKKKST--GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYD--HLFGSGMKKLSWPIRLRIALGTARGLAYL 437
             YS            +V + L  G L       GS  + +    R+ IA      L YL
Sbjct: 59  Y-YSFQGK----KNLYLVMEYLPGGDLASLLENVGSLDEDV---ARIYIA-EIVLALEYL 109

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-------NPEGITHLTTRVAGTLG 490
           H      IIHRD+K  NIL+D     K+ DFGL+K        N         R+ GT  
Sbjct: 110 H---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPD 166

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           Y+APE  L    +   D +S G +L E L G
Sbjct: 167 YIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 77.9 bits (192), Expect = 6e-16
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 28/217 (12%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN-----FKHEVEIIASVK 372
           N+ R  ++G+G +G VY    +  G E+AVK+      + +        + E++++ +++
Sbjct: 3   NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62

Query: 373 HVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           H  +V   G       L   + + I  + +  GS+ D L   G   L+  +  +      
Sbjct: 63  HERIVQYYGC------LRDDETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQIL 114

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT---RVAGT 488
            G+ YLH      I+HRDIK +NIL D A   K+GDFG +K   + I    T    V GT
Sbjct: 115 EGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASK-RLQTICSSGTGMKSVTGT 170

Query: 489 LGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGK 522
             +++PE      YG+    +DV+S G  ++E+L+ K
Sbjct: 171 PYWMSPEVISGEGYGR---KADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 79.0 bits (195), Expect = 6e-16
 Identities = 66/237 (27%), Positives = 100/237 (42%), Gaps = 58/237 (24%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA------------NFK--HEVEII 368
             +G+G YG V K      G  VA+K+ K    + D             +F    E++I+
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKL-SWPIRLR-- 425
             +KH N++ L       V +EG    +V D++           S +KK+    IRL   
Sbjct: 75  NEIKHENIMGLV-----DVYVEGDFINLVMDIMA----------SDLKKVVDRKIRLTES 119

Query: 426 ----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--------- 472
               I L    GL  LH   +   +HRD+  +NI ++     K+ DFGLA+         
Sbjct: 120 QVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 473 -----FNPEGITHLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
                   +    +T++V  TL Y APE  L G  K     D++S G +  ELL+GK
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPEL-LMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 78.5 bits (194), Expect = 1e-15
 Identities = 64/234 (27%), Positives = 105/234 (44%), Gaps = 39/234 (16%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            +     IG G YG V   +   +G +VA+K+  +         K    E++I+   KH 
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDV-PTLAKRTLRELKILRHFKHD 64

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDL----LH-----NGSLYDHLFGSGMKKLSWPIRLR 425
           N++A+R         +     +V DL    LH     +  L +      + +L       
Sbjct: 65  NIIAIRDILRPPGA-DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQL------- 116

Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK----FNPEGITHL 481
                 RGL Y+H      +IHRD+K SN+L++E  E ++GDFG+A+       E    +
Sbjct: 117 -----LRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168

Query: 482 TTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
           T  VA T  Y APE  L   + T   D++S G +  E+L G++  ++  GK+ +
Sbjct: 169 TEYVA-TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR--QLFPGKNYV 218

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 17/204 (8%)

Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +G+G +G V    Y     N G +VAVK  K  S     A+ K E+EI+ ++ H N+V  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 380 RGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           +G  T     +G   I ++ + L +GSL ++L      K++   +L+ A+   +G+ YL 
Sbjct: 72  KGICTE----DGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR--VAGTLGYVAPEY 496
                  +HRD+ A N+L++   + K+GDFGL K       + T +  +   + + APE 
Sbjct: 127 ---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183

Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            +  K    SDV+SFGV L ELL+
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 75/301 (24%), Positives = 119/301 (39%), Gaps = 54/301 (17%)

Query: 320 FSREN-----IIGKGGYGNVYKGMLPN----GTE--VAVKRFKNCSKAGDAN----FKHE 364
           F R N      +G+G +G V+          G E  V VK      K  D N    F+ E
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKAL---QKTKDENLQSEFRRE 58

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRII-VCDLLHNGSLYDHLFGSGMKK------ 417
           +++   + H N+V L G      P   H  I+   DL   G L   L  +  K       
Sbjct: 59  LDMFRKLSHKNVVRLLGLCREAEP---HYMILEYTDL---GDLKQFLRATKSKDEKLKPP 112

Query: 418 -LSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FN 474
            LS   ++ +    A G+ +L        +HRD+ A N L+    E KV    L+K  +N
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN 169

Query: 475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
            E        +   L ++APE       +  SDV+SFGV++ E+ + G+     +  + V
Sbjct: 170 SEYYKLRNALIP--LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV 227

Query: 534 LLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
           L        ++ GK    + E  P   L ++M +       C     + RP+  ++V  L
Sbjct: 228 L------NRLQAGKLELPVPEGCPS-RLYKLMTR-------CWAVNPKDRPSFSELVSAL 273

Query: 594 E 594
            
Sbjct: 274 G 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 64/289 (22%), Positives = 122/289 (42%), Gaps = 53/289 (18%)

Query: 319 NFSRENIIGKGGYGN--VYKGMLPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHV 374
           ++    ++GKG +G   +Y+    + + V  K       S+    +  +E+ I++ ++H 
Sbjct: 1   HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--GTAR 432
           N++A   +      ++ +  +I  +  + G+LYD +     K   +   + +        
Sbjct: 60  NIIAYYNHF-----MDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVS 112

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            ++Y+H   +  I+HRDIK  NI L +A   K+GDFG++K      +   T V GT  Y+
Sbjct: 113 AVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYM 168

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKKACE----------IIQGKSVLLSDWAWEL 542
           +PE     K    SD+++ G VL ELL+ K+  +          I+QG         +  
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--------NYTP 220

Query: 543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
           V    +           EL  ++               + RPT D+++ 
Sbjct: 221 VVSVYSS----------ELISLVHS-------LLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 72/286 (25%), Positives = 126/286 (44%), Gaps = 37/286 (12%)

Query: 325 IIGKGGYGNVYKGML--PNGT--EVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVA 378
           I+G+G +G+V +G L   +G+  +VAVK  K    + +    F  E   +    H N++ 
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 379 LRGYSTATVPLEGHQRI----IVCDLLHNGSLYDHLFGS--GMKKLSWPIR--LRIALGT 430
           L G           Q+I    ++   + +G L+  L  S  G      P++  L+  +  
Sbjct: 66  LIGVC---FEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDI 122

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT-L 489
           A G+ YL        IHRD+ A N +L E     V DFGL+K    G  +   R+A   +
Sbjct: 123 ALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT 548
            ++A E       T  SDV++FGV + E+ + G+     ++   +      ++ ++ G  
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI------YDYLRHGNR 233

Query: 549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           L   E+ +   EL ++M         C     + RPT  ++ ++LE
Sbjct: 234 LKQPEDCLD--ELYDLMYS-------CWRADPKDRPTFTKLREVLE 270

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 18/208 (8%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHV--- 374
           + R  +IG+G YG VY+G  +P G  VA+K     +   D ++ + EV +++ ++     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N+    G       L+G +  I+ +    GS+   +    + +    + +R  L     L
Sbjct: 63  NITKYYGSY-----LKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVL---VAL 114

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y+H   +  +IHRDIKA+NIL+      K+ DFG+A    +  +  +T V GT  ++AP
Sbjct: 115 KYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAP 170

Query: 495 EYALYGKL-TPGSDVYSFGVVLLELLSG 521
           E    GK     +D++S G+ + E+ +G
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATG 198

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 76.9 bits (189), Expect = 2e-15
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 40/228 (17%)

Query: 308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTE----VAVKRFKNCSKAGDANFK 362
            K  E++       +  ++G G +G V+KG+ +P G      VA+K  ++  ++G   F 
Sbjct: 4   LKETELR-------KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD--RSGRQTF- 53

Query: 363 HEVE----IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG-----S 413
            E+      + S+ H  +V L G         G    +V  L   GSL DH+        
Sbjct: 54  QEITDHMLAMGSLDHAYIVRLLGICP------GASLQLVTQLSPLGSLLDHVRQHRDSLD 107

Query: 414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK- 472
             + L+W +++      A+G+ YL    +  ++HR++ A NILL      ++ DFG+A  
Sbjct: 108 PQRLLNWCVQI------AKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADL 158

Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             P+   +  +     + ++A E  L+G+ T  SDV+S+GV + E++S
Sbjct: 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 20/204 (9%)

Query: 326 IGKGGYGNVY------KGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +GKGG+G V        G +    ++  KR K   + G+    +E +I+  V    +V+L
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLK--KRKGEQMALNEKKILEKVSSRFIVSL 58

Query: 380 R-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
              + T           +V  L++ G L  H++  G         +  A     GL +LH
Sbjct: 59  AYAFETKD------DLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              Q  I++RD+K  N+LLD+    ++ D GLA     G        AGT GY+APE   
Sbjct: 113 ---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQ 167

Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
                   D ++ G  L E+++G+
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 66/214 (30%), Positives = 102/214 (47%), Gaps = 23/214 (10%)

Query: 323 ENIIGKGGYGNVYKGMLPNG---TEVAVKRFKN-CSKAGDANFKHEVEIIASV-KHVNLV 377
           +++IG+G +G V K  +       + A+KR K   SK    +F  E+E++  +  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 378 AL------RGYSTATVPLEGHQRIIVCDLLHNGSLY--DHLFG---SGMKKLSWPIRLRI 426
            L      RGY    +    H  ++  D L    +   D  F    S    LS    L  
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 129

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           A   ARG+ YL    Q   IHRD+ A NIL+ E + AK+ DFGL++     +     R+ 
Sbjct: 130 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 186

Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             + ++A E   Y   T  SDV+S+GV+L E++S
Sbjct: 187 --VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 68/230 (29%), Positives = 97/230 (42%), Gaps = 33/230 (14%)

Query: 320 FSRENI-----IGKGGYGNVYK----GMLPNG--TEVAVKRFKN-CSKAGDANFKHEVEI 367
           + R NI     IG+G +G V++    G+LP    T VAVK  K   S    A+F+ E  +
Sbjct: 2   YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61

Query: 368 IASVKHVNLVALRGYSTATVP----------------LEGHQRIIVCDLLHNGSLYDHLF 411
           +A   H N+V L G      P                L        C L H  +      
Sbjct: 62  MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH-STSSARKC 120

Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
           G     LS   +L IA   A G+AYL    +   +HRD+   N L+ E    K+ DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS 177

Query: 472 -KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                      +   A  + ++ PE   Y + T  SDV+++GVVL E+ S
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 69/234 (29%), Positives = 112/234 (47%), Gaps = 20/234 (8%)

Query: 320 FSRENIIGKGGYGNV------YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH 373
           F +  ++GKGG+G V        G +    ++  KR K   + G++   +E +I+  V  
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGESMALNEKQILEKVNS 59

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
             +V+L  Y+  T         +V  L++ G L  H++  G         +  A     G
Sbjct: 60  RFVVSL-AYAYET----KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCG 114

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L  LH   Q  I++RD+K  NILLD+    ++ D GLA   PEG T +  RV GT+GY+A
Sbjct: 115 LEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMA 169

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK 547
           PE     + T   D ++ G +L E+++G+   +  Q K  +  +    LVKE +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ--QRKKKIKREEVERLVKEVQ 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 48/234 (20%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK----HEVEIIASVKH 373
            + + N I +G YG VY+      G  VA+K+ K   +     F      E+ I+  ++H
Sbjct: 6   EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKE--KEGFPITSLREINILLKLQH 63

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF----------GSGMKKLSWPIR 423
            N+V ++              ++V      GS  D ++           S M+ +  P  
Sbjct: 64  PNIVTVK-------------EVVV------GSNLDKIYMVMEYVEHDLKSLMETMKQPFL 104

Query: 424 LR----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                 + L    G+A+LH      I+HRD+K SN+LL+     K+ DFGLA+     + 
Sbjct: 105 QSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161

Query: 480 HLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKS 532
             T  V  TL Y APE  L  K  +   D++S G +  ELL+ K    +  GKS
Sbjct: 162 PYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK---PLFPGKS 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 73/262 (27%), Positives = 104/262 (39%), Gaps = 65/262 (24%)

Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN 360
            S L  ++I   K           +G+G +G VYK   +  G  VA+K+          N
Sbjct: 4   CSKLRDYEILG-K-----------LGEGTFGEVYKARQIKTGRVVALKKILM------HN 45

Query: 361 FK--------HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV-----------CDLL 401
            K         E++I+  +KH N+V L   +         +R  V             LL
Sbjct: 46  EKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL 105

Query: 402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
            N S+   L  S +K           L    G+ YLH   +  I+HRDIKA+NIL+D   
Sbjct: 106 ENPSV--KLTESQIKC--------YMLQLLEGINYLH---ENHILHRDIKAANILIDNQG 152

Query: 462 EAKVGDFGLA----------KFNPEGITHLTTRVAGTLGYVAPEYALYGK-LTPGSDVYS 510
             K+ DFGLA          K    G T   T +  T  Y  PE  L  +  T   D++ 
Sbjct: 153 ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWG 212

Query: 511 FGVVLLELLSGKKACEIIQGKS 532
            G V  E+ + +    I+QGKS
Sbjct: 213 IGCVFAEMFTRRP---ILQGKS 231

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 76.0 bits (187), Expect = 4e-15
 Identities = 59/209 (28%), Positives = 91/209 (43%), Gaps = 33/209 (15%)

Query: 395 IIVC-DLLHNGSLYDHLFGSGMKKLSWPIRL----RIALGTARGLAYLHYGVQPAIIHRD 449
           I +C + +  GSL        + K   PI +    +IA+    GL YL+   +  I+HRD
Sbjct: 78  ICMCMEFMDCGSL------DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR--IMHRD 129

Query: 450 IKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           IK SNIL++   + K+ DFG++    E I  +     GT  Y++PE    GK T  SDV+
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSG---ELINSIADTFVGTSTYMSPERIQGGKYTVKSDVW 186

Query: 510 SFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE-------NMPEMELP 562
           S G+ ++EL  GK              D           LD++++        +P  + P
Sbjct: 187 SLGISIIELALGKFPFAFSNIDDDGQDDPM-------GILDLLQQIVQEPPPRLPSSDFP 239

Query: 563 EMMEQYVLTAAICAHPILQARPTMDQIVK 591
           E +  +V     C       RPT  Q+  
Sbjct: 240 EDLRDFV---DACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 67/219 (30%), Positives = 98/219 (44%), Gaps = 37/219 (16%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGY 382
           +IG+G YG VYK      G  VA+K   +  +  +   K E  I+     H N+    G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 383 STATVPL-EGHQRIIVCDLLHNGSLYD-----HLFGSGMKK--LSWPIRLRIALGTARGL 434
                P     Q  +V +L   GS+ D        G  +K+  +++ +R      T RGL
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR-----ETLRGL 126

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA------GT 488
           AYLH   +  +IHRDIK  NILL +  E K+ DFG++         L + +       GT
Sbjct: 127 AYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-------QLDSTLGRRNTFIGT 176

Query: 489 LGYVAPEY-ALYGKLTPG----SDVYSFGVVLLELLSGK 522
             ++APE  A   +        SDV+S G+  +EL  GK
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 75.4 bits (185), Expect = 6e-15
 Identities = 69/265 (26%), Positives = 115/265 (43%), Gaps = 48/265 (18%)

Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTE------VAVKRFKNCSKAGDANFKHEVE 366
           IK   +   RE  +G+G +G V+     N +       VAVK  K+ + A   +F+ E E
Sbjct: 2   IKRRDIVLKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAE 59

Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK---------- 416
           ++ +++H ++V   G     V  +G   I+V + + +G L   L   G            
Sbjct: 60  LLTNLQHEHIVKFYG-----VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 114

Query: 417 ----KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
               +L     L IA   A G+ YL        +HRD+   N L+      K+GDFG+++
Sbjct: 115 QAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 473 -------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC 525
                  +   G T L  R      ++ PE  +Y K T  SDV+SFGV+L E+ +  K  
Sbjct: 172 DVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Query: 526 EIIQGKSVLLSDWAWELVKEGKTLD 550
                 + ++     E + +G+ L+
Sbjct: 226 WFQLSNTEVI-----ECITQGRVLE 245

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 64/219 (29%), Positives = 107/219 (48%), Gaps = 31/219 (14%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA------NFKHEVEIIASVKH 373
           +++  ++GKG YG VY G+   G  +AVK+ +  +    A        + EV+++ S+KH
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTA 431
           VN+V   G       L+ +   I  + +  GS+   L  FG     L  P+  +      
Sbjct: 62  VNIVQYLGTC-----LDDNTISIFMEFVPGGSISSILNRFGP----LPEPVFCKYTKQIL 112

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITH--LTTRVA 486
            G+AYLH      ++HRDIK +N++L      K+ DFG A+   +     TH  +   + 
Sbjct: 113 DGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169

Query: 487 GTLGYVAPEY---ALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  ++APE    + YG+    SD++S G  + E+ +GK
Sbjct: 170 GTPYWMAPEVINESGYGR---KSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 74.9 bits (184), Expect = 7e-15
 Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 35/218 (16%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKHV 374
           +IG G +G+VY GM   +G  +AVK+ +  S +  +  +          E+ ++  ++H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 375 NLVALRGYSTA----TVPLEGHQRIIVCDLLHN-GSLYDHLFGSGMKKLSWPIRLRIALG 429
           N+V   G S       + LE      V  LL+N G+  + L  + +++            
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ------------ 114

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA--- 486
             +GL YLH      IIHRDIK +NIL+D     K+ DFG++K          T  A   
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 487 --GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
             G++ ++APE       T  +D++S G +++E+L+GK
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.0 bits (184), Expect = 8e-15
 Identities = 89/307 (28%), Positives = 147/307 (47%), Gaps = 59/307 (19%)

Query: 326 IGKGGYGNVYK----GM---LPNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V      G+    PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS---GM-----------KKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM           ++LS+ 
Sbjct: 86  IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 141 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 193

Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 194 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 251

Query: 535 LSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
                ++L+KEG  +D  + +    EL  MM         C H +   RPT  Q+V+ L+
Sbjct: 252 -----FKLLKEGHRMD--KPSNCTNELYMMMRD-------CWHAVPSQRPTFKQLVEDLD 297

Query: 595 TDVPLSN 601
             + L++
Sbjct: 298 RILALTS 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.4 bits (185), Expect = 9e-15
 Identities = 82/311 (26%), Positives = 143/311 (45%), Gaps = 64/311 (20%)

Query: 320 FSRENII-----GKGGYGNVYK----GMLPNGTE----VAVKRFKNCSKAGD-ANFKHEV 365
           F R+ ++     G+G +G V +    G+  +  +    VAVK  K+ +   D A+   E+
Sbjct: 9   FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68

Query: 366 EIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG------------ 412
           E++  + KH N++ L G  T   PL      ++ +    G+L + L              
Sbjct: 69  ELMKLIGKHKNIINLLGVCTQEGPL-----YVIVEYAAKGNLREFLRARRPPGPDYTFDI 123

Query: 413 --SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                ++LS+   +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGL
Sbjct: 124 TKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGL 180

Query: 471 AKFNPEGITHL-----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKK 523
           A+    G+  +     T+     + ++APE AL+ ++ T  SDV+SFG+++ E+ + G  
Sbjct: 181 AR----GVHDIDYYKKTSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFTLGGS 235

Query: 524 ACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR 583
               I  + +      ++L++EG  +D    N    EL  +M +       C H +   R
Sbjct: 236 PYPGIPVEEL------FKLLREGHRMDK-PSNCTH-ELYMLMRE-------CWHAVPTQR 280

Query: 584 PTMDQIVKILE 594
           PT  Q+V+ L+
Sbjct: 281 PTFKQLVEALD 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 67/216 (31%), Positives = 107/216 (49%), Gaps = 33/216 (15%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDAN--FKHEVEIIASVKH 373
             R  ++G G +G VYKG+ +P G  V +    +  N +    AN  F  E  I+AS+ H
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 374 VNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLRI 426
            +LV L G   + T+ L       V  L+ +G L D++       GS +  L+W +++  
Sbjct: 69  PHLVRLLGVCLSPTIQL-------VTQLMPHGCLLDYVHEHKDNIGSQLL-LNWCVQI-- 118

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
               A+G+ YL    +  ++HRD+ A N+L+      K+ DFGLA+   EG         
Sbjct: 119 ----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADG 170

Query: 487 GTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           G +   ++A E   Y K T  SDV+S+GV + EL++
Sbjct: 171 GKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 55/218 (25%), Positives = 106/218 (48%), Gaps = 27/218 (12%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDAN-----FKHEVEIIASV 371
            + +   +G G + + Y+   +  GT +AVK+     + + +        + E+ ++A +
Sbjct: 1   EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H +++ + G   AT   + H  + V + +  GS+   L   G  K +  + +       
Sbjct: 61  NHPHIIRMLG---ATCE-DSHFNLFV-EWMAGGSVSHLLSKYGAFKEA--VIINYTEQLL 113

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFE-AKVGDFGLA-KFNPE--GITHLTTRVAG 487
           RGL+YLH   +  IIHRD+K +N+L+D   +  ++ DFG A +   +  G      ++ G
Sbjct: 114 RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLG 170

Query: 488 TLGYVAPEY---ALYGKLTPGSDVYSFGVVLLELLSGK 522
           T+ ++APE      YG+     DV+S G V++E+ + K
Sbjct: 171 TIAFMAPEVLRGEQYGR---SCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 73.9 bits (181), Expect = 2e-14
 Identities = 78/281 (27%), Positives = 128/281 (45%), Gaps = 46/281 (16%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 2   EVAREKITMSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 59

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR- 423
             ++      ++V L G     V  +G   +++ +L+  G L  +L     +  + P++ 
Sbjct: 60  ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 424 -------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 171

Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 172 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 223

Query: 530 GKSVLLSDWAWELVKEGKTLDVIEENMPEM--ELPEMMEQY 568
           G S   ++     V EG  LD   +N P+M  EL  M  QY
Sbjct: 224 GMS---NEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQY 260

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 66/215 (30%), Positives = 101/215 (46%), Gaps = 38/215 (17%)

Query: 326 IGKGGYGNVYKGMLPNGTE--VAVKR-------FKNCSKAGDANFKH---EVEII-ASVK 372
           +G G +G VYK    N  +  +A+K        F    +  D +      EV II   ++
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK--------KLSWPIRL 424
           H N+V  R Y T    LE  +  IV DL+    L +H   + +K        +  W I +
Sbjct: 68  HPNIV--RYYKTF---LENDRLYIVMDLIEGAPLGEHF--NSLKEKKQRFTEERIWNIFV 120

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTT 483
           ++ L     L YLH   +  I+HRD+  +NI+L E  +  + DFGLAK   PE  + LT+
Sbjct: 121 QMVLA----LRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE--SKLTS 172

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
            V GT+ Y  PE          +DV++FG +L ++
Sbjct: 173 -VVGTILYSCPEIVKNEPYGEKADVWAFGCILYQM 206

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 86/310 (27%), Positives = 141/310 (45%), Gaps = 56/310 (18%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRF-KNCSKAGDANFKHE 364
           E+    +   RE  +G+G +G VY+G   +       T VAVK   ++ S      F +E
Sbjct: 2   EVSREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNE 59

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR- 423
             ++      ++V L G     V  +G   ++V +L+ +G L  +L     +  + P R 
Sbjct: 60  ASVMKGFTCHHVVRLLG-----VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114

Query: 424 -------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++   F  K+GDFG+ +    
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 171

Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      ++APE    G  T  SD++SFGVVL E+ S   A +  Q
Sbjct: 172 TDYYRKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITS--LAEQPYQ 223

Query: 530 GKSVLLSDWAWELVKEGKTLDVIEENMPE--MELPEMMEQYVLTAAICAHPILQARPTMD 587
           G S   ++   + V +G  LD   +N PE   +L  M  Q+        +P  + RPT  
Sbjct: 224 GLS---NEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQF--------NP--KMRPTFL 269

Query: 588 QIVKILETDV 597
           +IV +L+ D+
Sbjct: 270 EIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 43/218 (19%)

Query: 326 IGKGGYGNVYKGML--PNGTEVAVKRFK-NCSKAGDANFKHEVEI-IASVKHVNLVALRG 381
           +G+G YG V K M   P GT +AVKR +   +         +++I + SV     V   G
Sbjct: 9   LGRGAYGVVDK-MRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYG 67

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSL---YDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
                  L     + +C  + + SL   Y  ++  G+  +   I  +IA+   + L YLH
Sbjct: 68  ------ALFREGDVWICMEVMDTSLDKFYKKVYDKGLT-IPEDILGKIAVSIVKALEYLH 120

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG-----YVA 493
              + ++IHRD+K SN+L++   + K+ DFG++        +L   VA T+      Y+A
Sbjct: 121 --SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG-------YLVDSVAKTIDAGCKPYMA 171

Query: 494 PEYALYGKLTPG---------SDVYSFGVVLLELLSGK 522
           PE     ++ P          SDV+S G+ ++EL +G+
Sbjct: 172 PE-----RINPELNQKGYDVKSDVWSLGITMIELATGR 204

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 28/212 (13%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNL 376
           F+    IGKG +G VYK +       VA+K   +  +A D   + + E++ ++  +   +
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI-DLEEAEDEIEDIQQEIQFLSQCRSPYI 61

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
              + Y +    L+G +  I+ +    GS  D L    + +      LR  L    GL Y
Sbjct: 62  T--KYYGSF---LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVL---LGLEY 113

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV------AGTLG 490
           LH   +   IHRDIKA+NILL E  + K+ DFG++         LT+ +       GT  
Sbjct: 114 LH---EEGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPF 163

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           ++APE          +D++S G+  +EL  G+
Sbjct: 164 WMAPEVIKQSGYDEKADIWSLGITAIELAKGE 195

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 75.7 bits (186), Expect = 4e-14
 Identities = 77/288 (26%), Positives = 132/288 (45%), Gaps = 36/288 (12%)

Query: 261 VIGILGAF-----TAFWFLFTRSKKSEERVVKVTDNDEPSLVLESRSSNLAR-FKIEEIK 314
           +   LGAF      AF F+F R + + E  +K  +N++ +  L+   S +++   I +I 
Sbjct: 632 ITCTLGAFLVLALVAFGFVFIRGRNNLE--LKRVENEDGTWELQFFDSKVSKSITINDI- 688

Query: 315 AATMNFSRENIIGKGGYGNVYKG-MLPNGTEVAVKRFKNCSKAGDANFKHEVEI--IASV 371
               +   EN+I +G  G  YKG  + NG +  VK         D N     EI  +  +
Sbjct: 689 --LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIN------DVNSIPSSEIADMGKL 740

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +H N+V L G   +          ++ + +   +L + L       LSW  R +IA+G A
Sbjct: 741 QHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIA 790

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           + L +LH    PA++  ++    I++D   E  +      + +  G+    T+   +  Y
Sbjct: 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAY 844

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA 539
           VAPE      +T  SD+Y FG++L+ELL+GK   +   G    + +WA
Sbjct: 845 VAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWA 892

Length = 968

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 71.9 bits (176), Expect = 5e-14
 Identities = 70/243 (28%), Positives = 112/243 (46%), Gaps = 27/243 (11%)

Query: 326 IGKGGYGNVYKG---MLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNLVALRG 381
           +G G +G V KG   M     +VA+K  KN ++    +    E EI+  + +  +V + G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--GTARGLAYLHY 439
                   E    ++V ++   G L   L G   KK    +   + L    + G+ YL  
Sbjct: 63  VC------EAEALMLVMEMASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLE- 112

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYA 497
                 +HRD+ A N+LL     AK+ DFGL+K      ++   R AG   L + APE  
Sbjct: 113 --GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170

Query: 498 LYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM 556
            + K +  SDV+S+G+ + E  S G+K  + ++G  V+        +++GK LD   E  
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM------SFIEQGKRLDCPAECP 224

Query: 557 PEM 559
           PEM
Sbjct: 225 PEM 227

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 78/279 (27%), Positives = 113/279 (40%), Gaps = 36/279 (12%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEV-AVKRFKNCSKAGDANFK---HEVEIIASVKHVN 375
           F+    IG G +G VY        EV A+K+     K  +  ++    EV+ +  +KH N
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
            +  +G       L  H   +V +    GS  D L     K L       I  G  +GLA
Sbjct: 87  SIEYKG-----CYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLA 139

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH      +IHRDIKA NILL E  + K+ DFG A      I        GT  ++APE
Sbjct: 140 YLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSAS-----IASPANSFVGTPYWMAPE 191

Query: 496 YALY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
             L    G+     DV+S G+  +EL   K     +   S L                + 
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------------IA 237

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
           +   P ++  E  + +      C   I Q RPT ++++K
Sbjct: 238 QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLK 276

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 61/205 (29%), Positives = 98/205 (47%), Gaps = 14/205 (6%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLV 377
           F++   IGKG +G VYKG+     EV   +  +  +A D   + + E+ +++      + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
              G       L+G +  I+ + L  GS  D L    +++      LR  L   +GL YL
Sbjct: 66  RYYGSY-----LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYL 117

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H   +   IHRDIKA+N+LL E  + K+ DFG+A    +      T V GT  ++APE  
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 173

Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
                   +D++S G+  +EL  G+
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 71.9 bits (176), Expect = 6e-14
 Identities = 53/203 (26%), Positives = 90/203 (44%), Gaps = 14/203 (6%)

Query: 323 ENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
           E I+G G +G + +G   LP+  E  VA+   +  CS      F  E   +    H N+V
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T      G+  +IV + + NG+L D        +L     + +  G A G+ YL
Sbjct: 70  RLEGVIT-----RGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYL 123

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
               +   +H+ + A  +L++     K+  F   + +     + T      + + APE  
Sbjct: 124 ---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAI 180

Query: 498 LYGKLTPGSDVYSFGVVLLELLS 520
            Y   +  SDV+SFG+V+ E++S
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 8e-14
 Identities = 71/205 (34%), Positives = 102/205 (49%), Gaps = 21/205 (10%)

Query: 325 IIGKGGYGNVY---KGMLPN-GTEVAVKRFKNCS-KAGD-ANFKHEVEIIASVKHVNLVA 378
           ++G+G +G V+   K   P+ G   A+K  K  + K  D    K E +I+A V H  +V 
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVK 62

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L  Y+  T   EG   +I+ D L  G L+  L    M      ++  +A   A  L +LH
Sbjct: 63  LH-YAFQT---EGKLYLIL-DFLRGGDLFTRLSKEVMFTEE-DVKFYLA-ELALALDHLH 115

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL--TTRVAGTLGYVAPEY 496
                 II+RD+K  NILLDE    K+ DFGL+K   E I H        GT+ Y+APE 
Sbjct: 116 ---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEV 169

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSG 521
                 T  +D +SFGV++ E+L+G
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 36/226 (15%)

Query: 325 IIGKGGYGNVYKGM-LPNGTE----VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++G G +G VYKG+ +P+G      VA+K  + N S   +     E  ++A V    +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 379 LRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLRIALGTA 431
           L G   T+TV L       V  L+  G L D++       GS    L+W +++      A
Sbjct: 74  LLGICLTSTVQL-------VTQLMPYGCLLDYVRENKDRIGS-QDLLNWCVQI------A 119

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---T 488
           +G++YL    +  ++HRD+ A N+L+      K+ DFGLA+     I        G    
Sbjct: 120 KGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL--LDIDETEYHADGGKVP 174

Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + ++A E  L+ + T  SDV+S+GV + EL++ G K  + I  + +
Sbjct: 175 IKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 65/206 (31%), Positives = 94/206 (45%), Gaps = 22/206 (10%)

Query: 325 IIGKGGYGNVYKGMLPNGTEV-AVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           ++GKG +G V    L    E+ AVK  K            +VE   + K V  +AL G  
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKK----DVILQDDDVECTMTEKRV--LALAGKH 55

Query: 384 TATVPL----EGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
                L    +   R+  V + ++ G L  H+  SG  +   P     A     GL +LH
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLH 113

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEY 496
              +  II+RD+K  N+LLD     K+ DFG+ K   EGI     T+   GT  Y+APE 
Sbjct: 114 ---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEI 167

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
             Y    P  D ++ GV+L E+L+G+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 71/218 (32%), Positives = 95/218 (43%), Gaps = 34/218 (15%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
             IG+G YG VYK      G  VA+K  R  N  +        E++I+  + H N+V L+
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 381 GYSTATVPLEGHQRIIVCDLLHN-GSLY------DH----LFGSGMKKLSWPIRLRIALG 429
              T         +    D   + G+ Y      DH    L  SG+   S          
Sbjct: 73  EIVT--------DKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
              GL Y H   +   +HRDIK SNILL+   + K+ DFGLA+ +N E     T +V  T
Sbjct: 125 LLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVI-T 180

Query: 489 LGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGK 522
           L Y  PE  L    YG   P  DV+S G +L EL + K
Sbjct: 181 LWYRPPELLLGEERYG---PAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 70.9 bits (173), Expect = 2e-13
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 14/205 (6%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLV 377
           F++   IGKG +G V+KG+     +V   +  +  +A D   + + E+ +++      + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
              G       L+G +  I+ + L  GS  D L      +      L+  L   +GL YL
Sbjct: 66  KYYGSY-----LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYL 117

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H       IHRDIKA+N+LL E  + K+ DFG+A    +      T V GT  ++APE  
Sbjct: 118 H---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 173

Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
                   +D++S G+  +EL  G+
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 14/204 (6%)

Query: 326 IGKGGYGNVYKGMLPNGT---EVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G+G +G+V +G L       +VAVK  K   C+++   +F  E   +    H N++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 381 GYSTATVPLEGHQR-IIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGT--ARGLA 435
           G    TV  EG+   +++   + +G L+  L  S  G      P ++ +   T  A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT-LGYVAP 494
           YL      + IHRD+ A N +L+E     V DFGL+K    G  +   R+A   + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 495 EYALYGKLTPGSDVYSFGVVLLEL 518
           E       T  SDV+SFGV + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 17/207 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK----NCSKAGDANFKHEVEIIASVKH 373
           NF  E  IGKG +  VYK + L +G  VA+K+ +      +KA     K E++++  + H
Sbjct: 3   NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTA 431
            N++    Y  + +  E ++  IV +L   G L   +  F    + +      +  +   
Sbjct: 62  PNVIK---YLASFI--ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             L ++H      I+HRDIK +N+ +      K+GD GL +F     T   + V GT  Y
Sbjct: 117 SALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLEL 518
           ++PE          SD++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 23/214 (10%)

Query: 323 ENIIGKGGYGNVYKGMLP---NGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVNLV 377
           E++IG+G +G V + M+         A+K  K  +   D  +F  E+E++  +  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 378 AL------RGYSTATVPLEGHQRIIVCDLLHNGSLY--DHLFG---SGMKKLSWPIRLRI 426
            L      RGY    +    +  ++  D L    +   D  F         L+    L+ 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLL--DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           A   A G+ YL    +   IHRD+ A N+L+ E   +K+ DFGL++     +     R+ 
Sbjct: 125 ASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLP 181

Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             + ++A E   Y   T  SDV+SFGV+L E++S
Sbjct: 182 --VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 71.0 bits (174), Expect = 3e-13
 Identities = 69/208 (33%), Positives = 91/208 (43%), Gaps = 28/208 (13%)

Query: 325 IIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIA-------SVKHVNLV 377
           +IGKG +G V   +  +  +      K   K      K +  I+A       +VKH  LV
Sbjct: 2   VIGKGSFGKVL--LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRI-ALGTARGLA 435
            L  YS  T      +   V D ++ G L+ HL     ++ S+P  R R  A   A  L 
Sbjct: 60  GLH-YSFQT----ADKLYFVLDYVNGGELFFHL----QRERSFPEPRARFYAAEIASALG 110

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVA 493
           YLH      II+RD+K  NILLD      + DFGL K   EGI H   T+   GT  Y+A
Sbjct: 111 YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLA 164

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSG 521
           PE           D +  G VL E+L G
Sbjct: 165 PEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 75/273 (27%), Positives = 112/273 (41%), Gaps = 36/273 (13%)

Query: 326 IGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFK---HEVEIIASVKHVNLVALRG 381
           IG G +G VY     +  E VAVK+     K  +  ++    EV+ +  +KH N +  +G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  L+ H   +V +    GS  D L     K L       I  G  +GLAYLH   
Sbjct: 89  -----CYLKEHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLH--- 138

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-- 499
              +IHRDIKA NILL E  + K+ DFG A       +       GT  ++APE  L   
Sbjct: 139 SHNMIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPYWMAPEVILAMD 193

Query: 500 -GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
            G+     DV+S G+  +EL   K     +   S L                + + + P 
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------------IAQNDSPT 239

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
           ++  E  + +      C   I Q RP   ++++
Sbjct: 240 LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 69.9 bits (171), Expect = 4e-13
 Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  + +  G EVA+K+     +       +E+ ++   KH N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 81  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 131

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ NILL      K+ DFG  A+  PE     T  + GT  ++APE 
Sbjct: 132 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 186

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 66/223 (29%), Positives = 96/223 (43%), Gaps = 42/223 (18%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK----HEVEIIASVKHVNLVALR 380
           IG+G YG V+K      G  VA+K+F       D   K     E+ ++  +KH NLV L 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESED--DPVIKKIALREIRMLKQLKHPNLVNL- 65

Query: 381 GYSTATVPLEGHQR-------IIVCD--LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
                   +E  +R          CD  +L+           G+ +    I+ +I   T 
Sbjct: 66  --------IEVFRRKRKLHLVFEYCDHTVLNELEKNPR----GVPEHL--IK-KIIWQTL 110

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           + + + H   +   IHRD+K  NIL+ +  + K+ DFG A+         T  VA T  Y
Sbjct: 111 QAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWY 166

Query: 492 VAPEYALYGKLTPGS--DVYSFGVVLLELLSGKKACEIIQGKS 532
            APE  L G    G   DV++ G V  ELL+G     +  GKS
Sbjct: 167 RAPEL-LVGDTQYGPPVDVWAIGCVFAELLTG---QPLWPGKS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 85/314 (27%), Positives = 143/314 (45%), Gaps = 58/314 (18%)

Query: 320 FSRENI-----IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEV 365
           FSR+ +     +G+G +G V         K        VAVK  K+ +   D ++   E+
Sbjct: 12  FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71

Query: 366 EIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS---GMK----- 416
           E++  + KH N++ L G  T   PL      ++ +    G+L ++L      GM+     
Sbjct: 72  EMMKMIGKHKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDI 126

Query: 417 ------KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                 ++++   +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGL
Sbjct: 127 ARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 183

Query: 471 AKFNPEGITHLTTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACE 526
           A+ +   I +      G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G     
Sbjct: 184 AR-DVNNIDYYKKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241

Query: 527 IIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTM 586
            I  + +      ++L+KEG  +D       E+ +  MM         C H I   RPT 
Sbjct: 242 GIPVEEL------FKLLKEGHRMDKPANCTNELYM--MMRD-------CWHAIPSHRPTF 286

Query: 587 DQIVKILETDVPLS 600
            Q+V+ L+  + L+
Sbjct: 287 KQLVEDLDRILTLT 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 4e-13
 Identities = 64/222 (28%), Positives = 98/222 (44%), Gaps = 38/222 (17%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---------EVEII 368
            +   + IG+G YG V      P G +VA+K+         + F+H         E++I+
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI--------SPFEHQTFCQRTLREIKIL 57

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDL----LHNGSLYDHLFGSGMKKLSWPIRL 424
              KH N++ +            +   IV +L    L+      HL    ++   + I  
Sbjct: 58  RRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQI-- 115

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH---L 481
                  RGL Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H   L
Sbjct: 116 ------LRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFL 166

Query: 482 TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
           T  VA T  Y APE  L  K  T   D++S G +L E+LS +
Sbjct: 167 TEYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.6 bits (170), Expect = 6e-13
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTE----VAVKRFKNC-SKAGDANFKHEVEIIASVKH 373
           F +  ++G G +G VYKG+ +P G +    VA+K  +   S   +     E  ++ASV +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 374 VNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-----GMKKLSWPIRLRIA 427
            ++  L G   T+TV L       +  L+  G L D++            L+W +++   
Sbjct: 69  PHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI--- 118

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVA 486
              A+G+ YL    +  ++HRD+ A N+L+      K+ DFGLAK    +   +      
Sbjct: 119 ---AKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172

Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 69.4 bits (169), Expect = 6e-13
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 82  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 132

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ NILL      K+ DFG  A+  PE      + + GT  ++APE 
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEV 187

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.1 bits (169), Expect = 7e-13
 Identities = 68/271 (25%), Positives = 121/271 (44%), Gaps = 28/271 (10%)

Query: 323 ENIIGKGGYGNVYKGM-LPNGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALR 380
           + I+G G  G VYK   L     +AVK    + +         E+EI    K  +   + 
Sbjct: 6   QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEI--LYKCDSPYIIG 63

Query: 381 GYSTATVPLEGHQRIIVC-DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
            Y    V      RI +C + +  GSL         +K+   +  RIA+   +GL YL +
Sbjct: 64  FYGAFFV----ENRISICTEFMDGGSL------DVYRKIPEHVLGRIAVAVVKGLTYL-W 112

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
            ++  I+HRD+K SN+L++   + K+ DFG++    + +  +     GT  Y+APE    
Sbjct: 113 SLK--ILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISG 167

Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM 559
            +    SDV+S G+  +EL  G+     IQ     L     +L++      +++E+ P +
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM--PLQLLQ-----CIVDEDPPVL 220

Query: 560 ELPEMMEQYVLTAAICAHPILQARPTMDQIV 590
            + +  E++V     C     + RP  + ++
Sbjct: 221 PVGQFSEKFVHFITQCMRKQPKERPAPENLM 251

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 78/286 (27%), Positives = 114/286 (39%), Gaps = 38/286 (13%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK---HEVEIIASVKHVNLVALRG 381
           IG G +G VY    + N   VA+K+     K  +  ++    EV  +  ++H N +  RG
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  L  H   +V +    GS  D L     K L       +  G  +GLAYLH   
Sbjct: 83  -----CYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLH--- 132

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-- 499
              +IHRD+KA NILL E    K+GDFG A      I        GT  ++APE  L   
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS-----IMAPANXFVGTPYWMAPEVILAMD 187

Query: 500 -GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
            G+     DV+S G+  +EL   K     +   S L                + +   P 
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH--------------IAQNESPA 233

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNI 602
           ++     E +      C   I Q RPT + ++K   +  + P + I
Sbjct: 234 LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 279

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 69.9 bits (171), Expect = 8e-13
 Identities = 62/219 (28%), Positives = 101/219 (46%), Gaps = 27/219 (12%)

Query: 315 AATMNFS---RENIIGKGGYGNVYKGM-LPNGTEVAVKR-FKNCSKAGDANFKHEVEIIA 369
           +A  + S   R N IG G  G VYK +  P G   A+K  + N           E+EI+ 
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILR 127

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG 429
            V H N+V           ++     ++ + +  GSL         + L+      +A  
Sbjct: 128 DVNHPNVVKCHDMFDHNGEIQ-----VLLEFMDGGSLEGTHIAD-EQFLA-----DVARQ 176

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
              G+AYLH   +  I+HRDIK SN+L++ A   K+ DFG+++   + +    + V GT+
Sbjct: 177 ILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTI 232

Query: 490 GYVAPEYALYGKLTPGS------DVYSFGVVLLELLSGK 522
            Y++PE  +   L  G+      D++S GV +LE   G+
Sbjct: 233 AYMSPE-RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.0 bits (168), Expect = 9e-13
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  + +  G EVA+K+     +       +E+ ++   K+ N+V 
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 81  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALDFL 131

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ NILL      K+ DFG  A+  PE     T  + GT  ++APE 
Sbjct: 132 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 186

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 68.9 bits (168), Expect = 9e-13
 Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 63/279 (22%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGT------EVAVKRFKNCSKAG-DANFKHE 364
           EI  +T+ F  E  +G+  +G VYKG L           VA+K  K+ ++      FKHE
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF--------GSG-- 414
             + + ++H N+V L G  T   PL      ++     +  L++ L         GS   
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLS-----MIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113

Query: 415 ----MKKLSWPIRLRIALGTARGLAYL--HYGVQPAIIHRDIKASNILLDEAFEAKVGDF 468
                  L     + I    A G+ +L  H+     ++H+D+   N+L+ +    K+ D 
Sbjct: 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHH-----VVHKDLATRNVLVFDKLNVKISDL 168

Query: 469 GLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL-- 519
           GL +       +   G + L  R      +++PE  +YGK +  SD++S+GVVL E+   
Sbjct: 169 GLFREVYAADYYKLMGNSLLPIR------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSY 222

Query: 520 --------SGKKACEIIQGKSVLL-----SDWAWELVKE 545
                   S +   E+I+ + VL        W + L+ E
Sbjct: 223 GLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLE 261

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 69.1 bits (170), Expect = 1e-12
 Identities = 41/98 (41%), Positives = 54/98 (55%), Gaps = 12/98 (12%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITH----LTTRVA 486
           + L Y+H G    +IHRD+K SNILL+     K+ DFGLA+  +          LT  VA
Sbjct: 118 KALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 487 GTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
            T  Y APE  L G  + T G D++S G +L E+L GK
Sbjct: 175 -TRWYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 75/244 (30%), Positives = 118/244 (48%), Gaps = 36/244 (14%)

Query: 325 IIGKGGYGNVYKGMLPNGTE----VAVKRFKNC----SKAGDANFKHEVEIIASVKHVNL 376
           ++GKGGYG V++     G +     A+K  K      ++   A+ K E  I+ +VKH  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGL 434
           V L  Y+  T    G +  ++ + L  G L+ HL   G  M+  +      I+L     L
Sbjct: 63  VDLI-YAFQT----GGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLA----L 113

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            +LH   Q  II+RD+K  NILLD     K+ DFGL K +    T +T    GT+ Y+AP
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-VTHTFCGTIEYMAP 169

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG---------KKACE-IIQGKSVL---LSDWAWE 541
           E  +        D +S G ++ ++L+G         KK  + I++GK  L   L+  A +
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARD 229

Query: 542 LVKE 545
           L+K+
Sbjct: 230 LLKK 233

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 68.6 bits (167), Expect = 1e-12
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 17/206 (8%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G V+  + +  G EVA+K+     +       +E+ ++  +K+ N+V 
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  +      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 81  FLDSF------LVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL---QALEFL 131

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ N+LL      K+ DFG  A+  PE     T  + GT  ++APE 
Sbjct: 132 HAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 186

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 71/255 (27%), Positives = 107/255 (41%), Gaps = 68/255 (26%)

Query: 307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANF 361
           R+KI+E+            IGKG YG V   +    G +VA+K+    F++ S A     
Sbjct: 1   RYKIQEV------------IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDA--TRI 46

Query: 362 KHEVEIIASVKHVNLVAL---------RGYSTATVPLEG-----HQRIIVCDLL----HN 403
             E++++  ++H ++V +         R +    V  E      HQ I   D L    H 
Sbjct: 47  LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQ 106

Query: 404 GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA 463
             LY  L                     R L Y+H      + HRD+K  NIL +   + 
Sbjct: 107 FFLYQLL---------------------RALKYIH---TANVFHRDLKPKNILANADCKL 142

Query: 464 KVGDFGLAK--FNPEGITHLTTRVAGTLGYVAPEY--ALYGKLTPGSDVYSFGVVLLELL 519
           K+ DFGLA+  FN        T    T  Y APE   + + K TP  D++S G +  E+L
Sbjct: 143 KICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVL 202

Query: 520 SGKKACEIIQGKSVL 534
           +GK    +  GK+V+
Sbjct: 203 TGKP---LFPGKNVV 214

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAV------KRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +GKGG+G V    + N  ++        KR K   K+G+     E EI+  V    +V L
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKK--KSGEKMALLEKEILEKVNSPFIVNL 58

Query: 380 R-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
              + + T         +V  L++ G L  H++  G + L     +  +     G+ +LH
Sbjct: 59  AYAFESKT------HLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                 I++RD+K  N+LLD+    ++ D GLA    +G T   T+ AGT GY+APE   
Sbjct: 113 ---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILK 167

Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
               +   D ++ G  + E+++G+
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 34/213 (15%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           ++GKG YG VY    L     +A+K               E+ + + +KH N+V   G  
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG-- 72

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW-PIRLR---IALGTAR---GLAY 436
             +    G  +I + + +  GSL      S + +  W P++     I   T +   GL Y
Sbjct: 73  --SDSENGFFKIFM-EQVPGGSL------SALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123

Query: 437 LHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFG----LAKFNPEGITHLTTRVAGTLGY 491
           LH      I+HRDIK  N+L++  +   K+ DFG    LA  NP      T    GTL Y
Sbjct: 124 LH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTGTLQY 175

Query: 492 VAPEYALYGKLTPG--SDVYSFGVVLLELLSGK 522
           +APE    G    G  +D++S G  ++E+ +GK
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 18/203 (8%)

Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG V        G +VA+K+    F++   A       E+ ++  + H N++ L 
Sbjct: 23  VGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT--YRELRLLKHMDHENVIGLL 80

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
              T    LE  Q + +   L    L + +     +KLS      +     RGL Y+H  
Sbjct: 81  DVFTPASSLEDFQDVYLVTHLMGADLNNIV---KCQKLSDDHIQFLVYQILRGLKYIH-- 135

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-Y 499
               IIHRD+K SNI ++E  E K+ DFGLA+   +    +T  VA T  Y APE  L +
Sbjct: 136 -SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD---EMTGYVA-TRWYRAPEIMLNW 190

Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
                  D++S G ++ ELL+GK
Sbjct: 191 MHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 28/227 (12%)

Query: 319 NFSRENIIGKGGYGNVYKGM------LPNGTEVAVKRFK-NCSKAGDANFKHEVEIIASV 371
           N      +G+G +G V K            T VAVK  K N S +   +   E  ++  V
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 372 KHVNLVALRGYSTATVP------------LEGHQRI---IVCDLLHNGSLYD--HLFGSG 414
            H +++ L G  +   P            L    R    +    L +    +  +L    
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 415 MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN 474
            + L+    +  A   +RG+ YL    +  ++HRD+ A N+L+ E  + K+ DFGL++  
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 475 PEGITHLT-TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            E  +++  ++    + ++A E       T  SDV+SFGV+L E+++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.4 bits (165), Expect = 3e-12
 Identities = 35/96 (36%), Positives = 52/96 (54%), Gaps = 17/96 (17%)

Query: 437 LHY-GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           LHY   +  +IHRD+K SNILLD +   K+ DFG++    +      TR AG   Y+APE
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAGCAAYMAPE 184

Query: 496 YALYGKLTPG---------SDVYSFGVVLLELLSGK 522
                ++ P          +DV+S G+ L+EL +G+
Sbjct: 185 -----RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 3e-12
 Identities = 64/220 (29%), Positives = 96/220 (43%), Gaps = 41/220 (18%)

Query: 326 IGKGGYGNVYKGMLPN---GTEVAVKRFKNCSKAGD---ANFKHEVEIIASVKHVNLVAL 379
           IG+G YG VYK    N   G E A+K+FK   +       +   E+ ++  +KH N+V+L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 380 RGYSTATVPLEGHQRIIVC-------DLL-----HNGSLYDHLFGSGMKKLSWPIRLRIA 427
                  V LE   + +         DL      H  +    +  S +K L W I     
Sbjct: 68  VE-----VFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI----- 117

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLTT 483
                G+ YLH      ++HRD+K +NIL+     E    K+GD GLA+     +  L  
Sbjct: 118 ---LNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171

Query: 484 --RVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLS 520
              V  T+ Y APE  L  +  T   D+++ G +  ELL+
Sbjct: 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 3e-12
 Identities = 83/309 (26%), Positives = 143/309 (46%), Gaps = 53/309 (17%)

Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS---GM-----------KKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM           ++L++ 
Sbjct: 80  IINLLGACTQDGPL-----YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134

Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 135 DLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR-DVHNIDYY 190

Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV+L E+ + G      I  + +    
Sbjct: 191 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---- 245

Query: 538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV 597
             ++L+KEG  +D       E+ +  +M +       C H +   RPT  Q+V+ L+  +
Sbjct: 246 --FKLLKEGHRMDKPANCTHELYM--IMRE-------CWHAVPSQRPTFKQLVEDLDRVL 294

Query: 598 PLSNIKIFL 606
            +++   +L
Sbjct: 295 TVTSTDEYL 303

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLV 377
           F++   IGKG +G V+KG+     +V   +  +  +A D   + + E+ +++      + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
              G       L+  +  I+ + L  GS  D L    + +      LR  L   +GL YL
Sbjct: 66  KYYGSY-----LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYL 117

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEY 496
           H       IHRDIKA+N+LL E  E K+ DFG+A +     I        GT  ++APE 
Sbjct: 118 H---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEV 172

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                    +D++S G+  +EL  G+
Sbjct: 173 IKQSAYDSKADIWSLGITAIELAKGE 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 65/213 (30%), Positives = 101/213 (47%), Gaps = 23/213 (10%)

Query: 324 NIIGKGGYGNVYKGMLPNG---TEVAVKRFKNCSKAGD-ANFKHEVEIIASVKH----VN 375
           ++IG+G +G V K  +       + A+KR K  +   D  +F  E+E++  + H    +N
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 376 LVAL---RGYSTATVPLEGHQRIIVCDLLHNGSLY--DHLFG---SGMKKLSWPIRLRIA 427
           L+     RGY    +    H  ++  D L    +   D  F    S    LS    L  A
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
              ARG+ YL    Q   IHRD+ A NIL+ E + AK+ DFGL++     +     R+  
Sbjct: 119 ADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP- 174

Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E   Y   T  SDV+S+GV+L E++S
Sbjct: 175 -VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 65/244 (26%), Positives = 110/244 (45%), Gaps = 29/244 (11%)

Query: 326 IGKGGYGNVYKG---MLPNGTEVAVKRFKNCSKAGDANFKHEV----EIIASVKHVNLVA 378
           +G G +G V KG   M  +   VAVK  KN     D   K E+     ++  + +  +V 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKN--DNNDPALKDELLREANVMQQLDNPYIVR 60

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           + G        E    ++V +L   G L  + F    K ++      +    + G+ YL 
Sbjct: 61  MIGIC------EAESWMLVMELAELGPL--NKFLQKNKHVTEKNITELVHQVSMGMKYLE 112

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
              +   +HRD+ A N+LL     AK+ DFGL+K       +   +  G   + + APE 
Sbjct: 113 ---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169

Query: 497 ALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN 555
             Y K +  SDV+SFGV++ E  S G+K  + ++G  V       ++++ G+ ++  +  
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT------QMIESGERMECPQRC 223

Query: 556 MPEM 559
            PEM
Sbjct: 224 PPEM 227

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 30/219 (13%)

Query: 320 FSREN-----IIGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FKHEVEI 367
           F R N      +G G +G V +    G+  +    +VAVK  K  + + +      E++I
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           ++ +  H N+V L G  T   P+     +++ +    G L + L       L+    L  
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPI-----LVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           +   A+G+A+L        IHRD+ A N+LL      K+ DFGLA+     I + +  V 
Sbjct: 147 SYQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR----DIMNDSNYVV 199

Query: 487 G-----TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                  + ++APE       T  SDV+S+G++L E+ S
Sbjct: 200 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 64/225 (28%), Positives = 110/225 (48%), Gaps = 40/225 (17%)

Query: 318 MNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK------NCSKAGDANFKHEVEIIAS 370
           +N+ R  ++G+G +G VY    +  G E+A K+ +        SK   A  + E++++ +
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA-LECEIQLLKN 60

Query: 371 VKHVNLV----ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           ++H  +V     LR  +  T+        I  + +  GS+ D L   G   L+  +  + 
Sbjct: 61  LQHERIVQYYGCLRDRAEKTL-------TIFMEYMPGGSVKDQLKAYG--ALTESVTRKY 111

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK------FNPEGITH 480
                 G++YLH  +   I+HRDIK +NIL D A   K+GDFG +K       +  GI  
Sbjct: 112 TRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS 168

Query: 481 LTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGK 522
           +T    GT  +++PE      YG+    +DV+S G  ++E+L+ K
Sbjct: 169 VT----GTPYWMSPEVISGEGYGR---KADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 43/131 (32%), Positives = 62/131 (47%), Gaps = 13/131 (9%)

Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG-TARGLAYLHYGVQPAIIHRDIKASN 454
           ++ D ++ G L+ HL+       S    +R+ +      L +LH   Q  II+RDIK  N
Sbjct: 82  LILDYVNGGELFTHLYQREHFTES---EVRVYIAEIVLALDHLH---QLGIIYRDIKLEN 135

Query: 455 ILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGS----DVYS 510
           ILLD      + DFGL+K              GT+ Y+APE    G  + G     D +S
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWWS 193

Query: 511 FGVVLLELLSG 521
            GV+  ELL+G
Sbjct: 194 LGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 44/131 (33%), Positives = 66/131 (50%), Gaps = 16/131 (12%)

Query: 396 IVCDLL--HNGSLYDHLFGSGMKKLSWPIRLRIALGTAR----GLAYLHYGVQPAIIHRD 449
           I C +L  ++  LY +L      K S P+ +  AL   +    GL YLH      IIHRD
Sbjct: 131 ITCMVLPHYSSDLYTYL-----TKRSRPLPIDQALIIEKQILEGLRYLH---AQRIIHRD 182

Query: 450 IKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +K  NI +++  +  +GD G A+F       L   +AGT+   APE     K    +D++
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIW 240

Query: 510 SFGVVLLELLS 520
           S G+VL E+L+
Sbjct: 241 SAGIVLFEMLA 251

Length = 357

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 59/207 (28%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 320 FSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVN 375
           F +  ++GKGG+G V    +   G   A KR +      + G++   +E +I+  V    
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L  Y+  T         +V  +++ G L  H++  G         L  A     GL 
Sbjct: 62  VVNL-AYAYET----KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE 116

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
            LH   +   ++RD+K  NILLD+    ++ D GLA   PEG   +  RV GT+GY+APE
Sbjct: 117 DLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRV-GTVGYMAPE 171

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
                + T   D +  G ++ E++ G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.5 bits (162), Expect = 6e-12
 Identities = 54/195 (27%), Positives = 88/195 (45%), Gaps = 27/195 (13%)

Query: 345 VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN 403
           VAVK  + + +K    +F  EV+I++ +K  N++ L G      PL      ++ + + N
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPL-----CMITEYMEN 103

Query: 404 GSLYDHLFGSGMKK-----------------LSWPIRLRIALGTARGLAYLHYGVQPAII 446
           G L   L    +                   +S+   L +AL  A G+ YL        +
Sbjct: 104 GDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFV 160

Query: 447 HRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPG 505
           HRD+   N L+ E    K+ DFG+++    G  + +  R    + ++A E  L GK T  
Sbjct: 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTA 220

Query: 506 SDVYSFGVVLLELLS 520
           SDV++FGV L E+L 
Sbjct: 221 SDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 65.8 bits (160), Expect = 6e-12
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 32/220 (14%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF------KNCSKAGDANFKHEVEIIASV 371
           N+    ++G+G +G VY       G E+AVK+       +  SK  +A  + E++++ ++
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA-LECEIQLLKNL 61

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +H  +V    Y     P E    I V + +  GS+ D L   G   L+  +  R      
Sbjct: 62  RHDRIVQY--YGCLRDPEEKKLSIFV-EYMPGGSIKDQLKAYG--ALTENVTRRYTRQIL 116

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK------FNPEGITHLTTRV 485
           +G++YLH  +   I+HRDIK +NIL D A   K+GDFG +K       +  GI  +T   
Sbjct: 117 QGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT--- 170

Query: 486 AGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGK 522
            GT  +++PE      YG+    +DV+S    ++E+L+ K
Sbjct: 171 -GTPYWMSPEVISGEGYGR---KADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 8e-12
 Identities = 34/89 (38%), Positives = 45/89 (50%), Gaps = 8/89 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+  LH   Q  IIHRDIK  N+L+D+    K+ DFGL++           +  GT  Y+
Sbjct: 109 GVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYL 160

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSG 521
           APE  L       SD +S G V+ E L G
Sbjct: 161 APETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 50/188 (26%), Positives = 90/188 (47%), Gaps = 20/188 (10%)

Query: 345 VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN 403
           VAVK  + + +K    +F  E++I++ +K+ N++ L G   +  PL      ++ + + N
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPL-----CMITEYMEN 101

Query: 404 GSLYDHL----------FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS 453
           G L   L            + +  +S    L +A+  A G+ YL        +HRD+   
Sbjct: 102 GDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATR 158

Query: 454 NILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFG 512
           N L+   +  K+ DFG+++    G  + +  R    + ++A E  L GK T  SDV++FG
Sbjct: 159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218

Query: 513 VVLLELLS 520
           V L E+ +
Sbjct: 219 VTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 30/206 (14%)

Query: 326 IGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      G   A K  +  S+    +F  E++I++  KH N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE--- 69

Query: 385 ATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWP-----IRLRIALGTARGLAYL 437
                E    I++  CD    G+L      S M +L        IR  +       L +L
Sbjct: 70  -AYFYENKLWILIEFCD---GGAL-----DSIMLELERGLTEPQIRY-VCRQMLEALNFL 119

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      +IHRD+KA NILL    + K+ DFG++  N   +    T + GT  ++APE  
Sbjct: 120 H---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVV 175

Query: 498 L--YGKLTP---GSDVYSFGVVLLEL 518
                K  P    +D++S G+ L+EL
Sbjct: 176 ACETFKDNPYDYKADIWSLGITLIEL 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)

Query: 320 FSRENIIGKGGYGNV------YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH 373
           F    ++GKGG+G V        G +    ++  KR K   + G+A   +E  I+  V  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKRILEKVNS 59

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
             +V+L  Y+  T         +V  +++ G L  H++  G         +  A     G
Sbjct: 60  RFVVSL-AYAYET----KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCG 114

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L  L    +  I++RD+K  NILLD+    ++ D GLA   PEG T +  RV GT+GY+A
Sbjct: 115 LEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMA 169

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE     K T   D +  G ++ E++ G+
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 38/93 (40%), Positives = 52/93 (55%), Gaps = 6/93 (6%)

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV-AGTL 489
           A GL +LH      II+RD+K  N++LD     K+ DFG+ K N  G    TTR   GT 
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTP 165

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            Y+APE   Y       D ++FGV+L E+L+G+
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 79/286 (27%), Positives = 124/286 (43%), Gaps = 46/286 (16%)

Query: 326 IGKGGYGNVYKGM-LPNGTE-VAVKRFK-NCSKAG-DANFKHEVEII---ASVKHVNLVA 378
           IG+G YG V+K   L NG   VA+KR +    + G   +   EV ++    + +H N+V 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP------IRLRIALGTAR 432
           L  +   TV     +  +     H     D    + + K+  P      I+  +     R
Sbjct: 69  L--FDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIK-DMMFQLLR 121

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           GL +LH      ++HRD+K  NIL+  + + K+ DFGLA+          T V  TL Y 
Sbjct: 122 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVVTLWYR 176

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           APE  L        D++S G +  E+   K    + +G S        ++ + GK LDVI
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSS--------DVDQLGKILDVI 225

Query: 553 ----EENMP-EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
               EE+ P ++ LP          +  A PI +    +D++ K L
Sbjct: 226 GLPGEEDWPRDVALPRQA-----FHSKSAQPIEKFVTDIDELGKDL 266

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 57/210 (27%), Positives = 92/210 (43%), Gaps = 13/210 (6%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVA 378
           F    ++G G YG VYKG      ++A  +  + +   +   K E+ ++    H  N+  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
             G +     P    Q  +V +    GS+ D +  +    L       I     RGL++L
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H   Q  +IHRDIK  N+LL E  E K+ DFG++      +    T + GT  ++APE  
Sbjct: 128 H---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE-V 182

Query: 498 LYGKLTPG------SDVYSFGVVLLELLSG 521
           +     P       SD++S G+  +E+  G
Sbjct: 183 IACDENPDATYDFKSDLWSLGITAIEMAEG 212

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 71/276 (25%), Positives = 120/276 (43%), Gaps = 38/276 (13%)

Query: 325 IIGKGGYGNV-YKGMLPNGTEVAVKRF--KNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           ++GKG YG V       +G +  +K+   +N S+      + E ++++ +KH N+VA R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR- 65

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKL------SWPIRLRIALGTARGLA 435
               +   E     IV      G LY  L     K L       W +++ +AL       
Sbjct: 66  ---ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL------Q 116

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH   +  I+HRD+K  N+ L      KVGD G+A+   E    + + + GT  Y++PE
Sbjct: 117 YLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV-LENQCDMASTLIGTPYYMSPE 172

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN 555
                     SDV++ G  + E+ + K A       S++        + EGK        
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR------IIEGKL-----PP 221

Query: 556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
           MP+   PE+ E  ++   +   P  + RP++  I++
Sbjct: 222 MPKDYSPELGE--LIATMLSKRP--EKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 37/92 (40%), Positives = 50/92 (54%), Gaps = 5/92 (5%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           RGL Y+H      ++HRD+K SN+LL+   + K+ DFGLA+   E    +T  V  T  Y
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWY 174

Query: 492 VAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L   + T   DV+S G +  ELL  K
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 64.1 bits (156), Expect = 3e-11
 Identities = 55/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)

Query: 326 IGKGGYGNVYKGMLPNGTEVA---VKRFKNCSKAGDAN-FKHEVEIIASVKHVNLVALRG 381
           IG G +G V  G    G   A   VK  +  +   +   F  EV+    + H N++   G
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS--GMKKLSWP-IRLRIALGTARGLAYLH 438
               ++P      ++V +    G L ++L  +   + +++   +  R+A   A GL +LH
Sbjct: 63  QCIESIPY-----LLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH 117

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA--KFNPEGITHLTTRVAGTLGYVAPEY 496
              Q   IH D+   N  L      K+GD+GLA  ++ PE         A  L ++APE 
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQY-PEDYYITKDCHAVPLRWLAPEL 173

Query: 497 A-------LYGKLTPGSDVYSFGVVLLEL 518
                   L    T  S+++S GV + EL
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 82

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR------IALGTARGL 434
              T    LE    +          L  HL G+ +  +    +L       +     RGL
Sbjct: 83  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 134 KYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 185

Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 33/206 (16%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGY 382
           +G G YG+VYK   L  G   AVK  K   + GD  +  + E+ ++   KH N+VA  G 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIK--LEPGDDFSLIQQEIFMVKECKHCNIVAYFGS 74

Query: 383 STATVPLEGHQRIIVC-DLLHNGSLYD--HLFGSGMKKLSWPI-RLRIAL---GTARGLA 435
             +       +++ +C +    GSL D  H+ G        P+  L+IA     T +GLA
Sbjct: 75  YLS------REKLWICMEYCGGGSLQDIYHVTG--------PLSELQIAYVCRETLQGLA 120

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH       +HRDIK +NILL +  + K+ DFG+A      I    + + GT  ++APE
Sbjct: 121 YLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPE 176

Query: 496 YALY---GKLTPGSDVYSFGVVLLEL 518
            A     G      D+++ G+  +EL
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 36/93 (38%), Positives = 55/93 (59%), Gaps = 10/93 (10%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLG 490
           RGL Y+H      ++HRD+K SNIL++E  + K+ DFGLA+  +P+   +++TR      
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170

Query: 491 YVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           Y APE  L + K     D++S G +  E+L GK
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 13/210 (6%)

Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVA 378
           F    ++G G YG VYKG      ++A  +  + ++  +   K E+ ++    H  N+  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
             G +   + P    Q  +V +    GS+ D +  +    L       I     RGLA+L
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      +IHRDIK  N+LL E  E K+ DFG++      +    T + GT  ++APE  
Sbjct: 138 H---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPE-V 192

Query: 498 LYGKLTPG------SDVYSFGVVLLELLSG 521
           +     P       SD++S G+  +E+  G
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEG 222

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.3 bits (159), Expect = 3e-11
 Identities = 54/191 (28%), Positives = 89/191 (46%), Gaps = 41/191 (21%)

Query: 419 SWPIR----LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-- 472
           SWP+     LR +   A+G+ +L        IHRD+ A N+LL +   AK+ DFGLA+  
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262

Query: 473 -----FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI 527
                +  +G   L  +      ++APE       T  SDV+S+G++L E+ S       
Sbjct: 263 MNDSNYVVKGNARLPVK------WMAPESIFDCVYTVQSDVWSYGILLWEIFS------- 309

Query: 528 IQGKS----VLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR 583
             GKS    +L++   +++VK G  +       P+   PE+   Y +    C +     R
Sbjct: 310 -LGKSPYPGILVNSKFYKMVKRGYQMS-----RPDFAPPEI---YSIMKM-CWNLEPTER 359

Query: 584 PTMDQIVKILE 594
           PT  QI ++++
Sbjct: 360 PTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 64.8 bits (158), Expect = 3e-11
 Identities = 37/90 (41%), Positives = 51/90 (56%), Gaps = 4/90 (4%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           GL +LH   +  II+RD+K  N+LLD+    K+ DFG+ K N  G    +T   GT  Y+
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYI 163

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           APE     K     D +SFGV+L E+L G+
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 34/98 (34%), Positives = 55/98 (56%), Gaps = 5/98 (5%)

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
           +I++   RGL YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +   
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANS 157

Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
             GT  Y++PE       T  SD++S G+ L+E+  G+
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 55/193 (28%), Positives = 87/193 (45%), Gaps = 31/193 (16%)

Query: 345 VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN 403
           VAVK  + + S     +F  EV+I++ +   N+  L G  T   PL      ++ + + N
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPL-----CMIMEYMEN 103

Query: 404 GSLYDHL---------FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           G L   L              K LS+   L +A   A G+ YL        +HRD+   N
Sbjct: 104 GDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN 160

Query: 455 ILLDEAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSD 507
            L+ + +  K+ DFG+++       +  +G   L  R      ++A E  L GK T  SD
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIR------WMAWESVLLGKFTTKSD 214

Query: 508 VYSFGVVLLELLS 520
           V++FGV L E+L+
Sbjct: 215 VWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 70/222 (31%), Positives = 97/222 (43%), Gaps = 16/222 (7%)

Query: 310 IEEIKAATMNFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKHEVEII 368
           +E +   T  +     IGKG YG VYK     +G+  AVK     S   D   + E  I+
Sbjct: 14  LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV-DEEIEAEYNIL 72

Query: 369 ASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGS---LYDHLFGSGMKKLSWPIRL 424
            S+  H N+V   G       L G Q  +V +L + GS   L   L   G ++L   +  
Sbjct: 73  QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG-QRLDEAMIS 131

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
            I  G   GL +LH      IIHRD+K +NILL      K+ DFG++           T 
Sbjct: 132 YILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188

Query: 485 VAGTLGYVAPEYALYGKLTPGS-----DVYSFGVVLLELLSG 521
           V GT  ++APE     +    S     DV+S G+  +EL  G
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 38/90 (42%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           GL +LH      I++RD+K  NILLD     K+ DFG+ K N  G    T    GT  Y+
Sbjct: 108 GLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYI 163

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           APE  L  K     D +SFGV+L E+L G+
Sbjct: 164 APEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 18/209 (8%)

Query: 320 FSRENIIGKGGYGNV------YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH 373
           F    ++GKGG+G V        G +    ++  KR K   + G+A   +E +I+  V  
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKK--RKGEAMALNEKQILEKVNS 59

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
             +V+L  Y+  T         +V  L++ G L  H++  G         +  A     G
Sbjct: 60  RFVVSL-AYAYET----KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCG 114

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L  LH   +  I++RD+K  NILLD+    ++ D GLA   PEG T +  RV GT+GY+A
Sbjct: 115 LEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMA 169

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE     + T   D +  G ++ E++ GK
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 65/208 (31%), Positives = 91/208 (43%), Gaps = 38/208 (18%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK---HEVEIIASVKHVNLVALRG 381
           IG G +G VY    +     VA+K+     K  +  ++    EV  +  ++H N +  +G
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82

Query: 382 ----YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR-LRIA---LGTARG 433
                 TA + +E       C     GS  D L     KK   P++ + IA    G  +G
Sbjct: 83  CYLREHTAWLVME------YC----LGSASDIL--EVHKK---PLQEVEIAAICHGALQG 127

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           LAYLH       IHRDIKA NILL E    K+ DFG A      +        GT  ++A
Sbjct: 128 LAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSA-----SLVSPANSFVGTPYWMA 179

Query: 494 PEYALY---GKLTPGSDVYSFGVVLLEL 518
           PE  L    G+     DV+S G+  +EL
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.3 bits (156), Expect = 4e-11
 Identities = 43/127 (33%), Positives = 65/127 (51%), Gaps = 8/127 (6%)

Query: 397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           V + ++ G L   +   G  +   P  +  A   A GL +LH      II+RD+K  N++
Sbjct: 79  VMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVM 133

Query: 457 LDEAFEAKVGDFGLAKFNP-EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           LD     K+ DFG+ K N  +G+T  T    GT  Y+APE   Y       D ++FGV+L
Sbjct: 134 LDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 191

Query: 516 LELLSGK 522
            E+L+G+
Sbjct: 192 YEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 5e-11
 Identities = 41/127 (32%), Positives = 67/127 (52%), Gaps = 8/127 (6%)

Query: 397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           V + ++ G L  H+    + K   P  +  A   + GL +LH   +  II+RD+K  N++
Sbjct: 79  VMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVM 133

Query: 457 LDEAFEAKVGDFGLAKFNP-EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           LD     K+ DFG+ K +  +G+T  T    GT  Y+APE   Y       D +++GV+L
Sbjct: 134 LDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLL 191

Query: 516 LELLSGK 522
            E+L+G+
Sbjct: 192 YEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.8 bits (155), Expect = 5e-11
 Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           GL +LH      II+RD+K  N++LD     K+ DFG+ K N  G    +T   GT  Y+
Sbjct: 108 GLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYI 163

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           APE     K T   D +SFGV+L E+L G+
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 62.5 bits (152), Expect = 8e-11
 Identities = 60/232 (25%), Positives = 103/232 (44%), Gaps = 38/232 (16%)

Query: 320 FSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKH 373
           + +   IG+G +G   K +L     +G +  +K       S       + EV +++++KH
Sbjct: 2   YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG------SGMKKLSWPIRLRIA 427
            N+V  +         E     IV D    G LY  +           + L W +++ +A
Sbjct: 59  PNIVQYQESFE-----ENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA 113

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA- 486
           L       ++H      I+HRDIK+ NI L +    K+GDFG+A+     + + T  +A 
Sbjct: 114 L------KHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIAR-----VLNSTVELAR 159

Query: 487 ---GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL 535
              GT  Y++PE          SD+++ G VL E+ + K A E    K+++L
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 9e-11
 Identities = 60/217 (27%), Positives = 87/217 (40%), Gaps = 44/217 (20%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVK---HVNLV 377
             IG+G YG VYK   L  G  VA+K  R     +    +   E+ ++  ++   H N+V
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 378 ALRGYSTATVPLEGHQ-------RIIVCDLLHNGSLY-DHLFGSGM-----KKLSWPIRL 424
            L        P    +         +  DL    + Y       G+     K L   +  
Sbjct: 65  RL--LDVCHGPRTDRELKLTLVFEHVDQDL----ATYLSKCPKPGLPPETIKDLMRQL-- 116

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHL 481
                  RG+ +LH      I+HRD+K  NIL+    + K+ DFGLA+   F       L
Sbjct: 117 ------LRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE----MAL 163

Query: 482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
           T+ V  TL Y APE  L        D++S G +  EL
Sbjct: 164 TSVVV-TLWYRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 63.1 bits (153), Expect = 1e-10
 Identities = 71/210 (33%), Positives = 92/210 (43%), Gaps = 32/210 (15%)

Query: 325 IIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIA-------SVKHVNL 376
           +IGKG +G V       +G   AVK  +   K    N K +  I+A       +VKH  L
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQ---KKIVLNRKEQKHIMAERNVLLKNVKHPFL 58

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP---IRLRIALGTARG 433
           V L  YS  T      +   V D ++ G L+ HL     ++ S+P    R   A   A  
Sbjct: 59  VGLH-YSFQTT----EKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASA 108

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L YLH      I++RD+K  NILLD      + DFGL K   EGI     TT   GT  Y
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEY 162

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE           D +  G VL E+L G
Sbjct: 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.5 bits (157), Expect = 1e-10
 Identities = 62/204 (30%), Positives = 90/204 (44%), Gaps = 24/204 (11%)

Query: 342 GTEVAVKRFKNCSKAGD---ANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC 398
           G EVA+K  +  +   +   A F+ E  + A + H N+VAL     A           V 
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA----PPGLLFAVF 58

Query: 399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL- 457
           + +   +L + L   G   L      R+ L     LA  H      I+HRD+K  NI++ 
Sbjct: 59  EYVPGRTLREVLAADGA--LPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113

Query: 458 --DEAFEAKVGDFGLAKFNP------EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
                  AKV DFG+    P            TT V GT  Y APE      +TP SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 510 SFGVVLLELLSGKKACEIIQGKSV 533
           ++G++ LE L+G++    +QG SV
Sbjct: 174 AWGLIFLECLTGQRV---VQGASV 194

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 38/96 (39%), Positives = 52/96 (54%), Gaps = 9/96 (9%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNP---EGITHLTTRVAG 487
            GL Y+H      ++HRD+K  N+L++   E K+ DFGLA+ F+    E    +T  VA 
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA- 171

Query: 488 TLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y APE  L +   T   DV+S G +L ELL  K
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 63/210 (30%), Positives = 99/210 (47%), Gaps = 32/210 (15%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG V   +    G +VA+K+    F++   A  A    E+ ++  +KH N++ L 
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRA--YRELRLLKHMKHENVIGLL 80

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL---RIAL---GTARGL 434
              T  + L         D  H+  L     G+ + KL    +L   RI        +GL
Sbjct: 81  DVFTPDLSL---------DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K  N+ ++E  E K+ DFGLA+     +T ++ TR      Y A
Sbjct: 132 KYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRA 183

Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +   T   D++S G ++ E+L+GK
Sbjct: 184 PEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 42/127 (33%), Positives = 67/127 (52%), Gaps = 13/127 (10%)

Query: 416 KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP 475
           K++   I  ++++   RGLAYL    Q  I+HRD+K SNIL++   E K+ DFG++    
Sbjct: 98  KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSG--- 152

Query: 476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK--------KACEI 527
           + I  +     GT  Y++PE       +  SD++S G+ L+EL  G+        K  E 
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA 212

Query: 528 IQGKSVL 534
           I G+ V+
Sbjct: 213 IFGRPVV 219

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 61/220 (27%), Positives = 107/220 (48%), Gaps = 32/220 (14%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK------NCSKAGDANFKHEVEIIASV 371
           N+    ++G+G +G VY       G E+AVK+ +        SK  +A  + E++++ ++
Sbjct: 3   NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA-LECEIQLLKNL 61

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  +V    Y     P+E    I + + +  GS+ D L   G   L+  +  +      
Sbjct: 62  LHERIVQY--YGCLRDPMERTLSIFM-EHMPGGSIKDQLKSYG--ALTENVTRKYTRQIL 116

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK------FNPEGITHLTTRV 485
            G++YLH  +   I+HRDIK +NIL D     K+GDFG +K       +  G+  +T   
Sbjct: 117 EGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT--- 170

Query: 486 AGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGK 522
            GT  +++PE      YG+    +D++S G  ++E+L+ K
Sbjct: 171 -GTPYWMSPEVISGEGYGR---KADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 31/221 (14%)

Query: 319 NFSRENIIGKGGYGNVY--KGMLPNGTEVAVKRF---KNCSKAGDANFKHEVEIIASVKH 373
            +     IG+G +G +Y  K    +     +K     K   K  +A+ K EV ++A +KH
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDS-EHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKH 58

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDH-------LFGSGMKKLSWPIRLRI 426
            N+V    +++     E  +  IV +    G L          LF S  + LSW +++  
Sbjct: 59  PNIVTF--FASFQ---ENGRLFIVMEYCDGGDLMKRINRQRGVLF-SEDQILSWFVQI-- 110

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNPEGITHLTTRV 485
               + GL ++H      I+HRDIK+ NI L +    AK+GDFG+A+        L    
Sbjct: 111 ----SLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR-QLNDSMELAYTC 162

Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE 526
            GT  Y++PE          +D++S G VL EL + K   E
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 35/95 (36%), Positives = 53/95 (55%), Gaps = 8/95 (8%)

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L +LH   +  +I+RD+K  NILLD     K+ DFG+ K   EGI +   TT   GT  Y
Sbjct: 109 LMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE 526
           +APE     +  P  D ++ GV++ E+++G+   E
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 24/233 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRF--KNCSKAGDANFKHEVEIIASVKHVN 375
            + +  ++G+G +G V+          V +K+   +  +K      ++E +++  + H N
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           ++    Y      LE    +IV +    G+L +++       L     L   +     L 
Sbjct: 61  II---EYYENF--LEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH 115

Query: 436 YLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           ++H      I+HRD+K  NILLD+     K+GDFG++K            V GT  Y++P
Sbjct: 116 HVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYTVVGTPCYISP 170

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGKKACE----------IIQGKSVLLSD 537
           E          SD+++ G VL EL S K+A E          I+ G    +SD
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISD 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 54/178 (30%), Positives = 90/178 (50%), Gaps = 23/178 (12%)

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV-AGTLGYV 492
           L  +H+     +IHRDIK++NILL      K+GDFG +K     ++    R   GT  YV
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           APE       +  +D++S GV+L ELL+ K+  +    + V+            KTL   
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM-----------HKTLAGR 261

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKIFLAALL 610
            + +P    PEM E  ++TA + + P  + RP+  +++     ++P+   K+F++ LL
Sbjct: 262 YDPLPPSISPEMQE--IVTALLSSDP--KRRPSSSKLL-----NMPIC--KLFISGLL 308

Length = 496

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 61.0 bits (149), Expect = 3e-10
 Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 51/219 (23%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVK-HVNLVALRG 381
           +G G +G+VY       G  VA+K+ K    + +   N + EV+ +  +  H N+V L  
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-EVKSLRKLNEHPNIVKL-- 63

Query: 382 YSTATVPLEGHQRIIVCDLLH------NGSLYDHLFGSGMKKLSWPIRLR-IALGTARGL 434
                      +     D L+       G+LY  +     K  S    +R I     +GL
Sbjct: 64  ----------KEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFS-ESVIRSIIYQILQGL 112

Query: 435 AYLH---YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK----FNPEGITHLTTRVAG 487
           A++H   +       HRD+K  N+L+      K+ DFGLA+      P      T  V  
Sbjct: 113 AHIHKHGF------FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-----YTDYV-S 160

Query: 488 TLGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y APE  L    Y   +P  D+++ G ++ EL + +
Sbjct: 161 TRWYRAPEILLRSTSYS--SP-VDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 62/204 (30%), Positives = 86/204 (42%), Gaps = 20/204 (9%)

Query: 325 IIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVE----IIASVKHVNLVAL 379
           +IGKG +G V       +G+  AVK  +  +        H +     ++ ++KH  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
             YS  T      +   V D ++ G L+ HL     +    P     A   A  + YLH 
Sbjct: 62  H-YSFQT----AEKLYFVLDYVNGGELFFHL--QRERCFLEPRARFYAAEVASAIGYLH- 113

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGITHLTTRVAGTLGYVAPEYA 497
                II+RD+K  NILLD      + DFGL K    PE     T+   GT  Y+APE  
Sbjct: 114 --SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPEYLAPEVL 168

Query: 498 LYGKLTPGSDVYSFGVVLLELLSG 521
                    D +  G VL E+L G
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 38/93 (40%), Positives = 51/93 (54%), Gaps = 14/93 (15%)

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L +LH      II+RD+K  N+LLD     K+ DFG+ K   EGI +   T+   GT  Y
Sbjct: 109 LMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDY 162

Query: 492 VAPEY---ALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE     LYG   P  D ++ GV+L E+L G
Sbjct: 163 IAPEILQEMLYG---PSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 60/207 (28%), Positives = 95/207 (45%), Gaps = 23/207 (11%)

Query: 326 IGKGGYGNVY------KGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +GKGG+G V        G L    ++  KR K   + G      E  I+A V    +V+L
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58

Query: 380 R-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR---GLA 435
              + T T         +V  +++ G L  H++    +   +P   R    TA+   GL 
Sbjct: 59  AYAFQTKT------DLCLVMTIMNGGDLRYHIYNVDEENPGFP-EPRACFYTAQIISGLE 111

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           +LH   Q  II+RD+K  N+LLD     ++ D GLA    +G +  T   AGT G++APE
Sbjct: 112 HLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPE 167

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
                +     D ++ GV L E+++ +
Sbjct: 168 LLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 61  IVKLL-----DVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLA 114

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 115 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 170

Query: 496 YALYGKL-TPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 34/91 (37%), Positives = 48/91 (52%), Gaps = 8/91 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
           GL YLH   +  I++RD+K  N+LLD     K+ DFGL K   EG+     T+   GT  
Sbjct: 113 GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPE 166

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           ++APE       T   D +  GV++ E+L G
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.5 bits (147), Expect = 7e-10
 Identities = 60/227 (26%), Positives = 94/227 (41%), Gaps = 51/227 (22%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNL 376
           + +   IG+G +G V+K         VA+K+   +N  +        E++I+  +KH N+
Sbjct: 14  YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENV 73

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHN------GSLY------DH----LFGSGMKKLSW 420
           V L               I +C           GS Y      +H    L  +   K + 
Sbjct: 74  VNL---------------IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL 118

Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-----FNP 475
               ++      GL Y+H      I+HRD+KA+NIL+ +    K+ DFGLA+      N 
Sbjct: 119 SEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNS 175

Query: 476 EGITHLTTRVAGTLGYVAPEYAL----YGKLTPGSDVYSFGVVLLEL 518
           +     T RV  TL Y  PE  L    YG   P  D++  G ++ E+
Sbjct: 176 KP-NRYTNRVV-TLWYRPPELLLGERDYG---PPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.1 bits (145), Expect = 8e-10
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 28/209 (13%)

Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNLVALRGY- 382
           +G+G Y  VYKG    NG  VA+K  +   + G       E  ++  +KH N+V L    
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 383 ---STATVPLEGHQRIIVCDLL--HNGSLYDHLFGSGMKKLSWPIRLRIAL-GTARGLAY 436
               T T+  E +    +C  +  H G L+             P  +++ L    RGL+Y
Sbjct: 73  HTKETLTLVFE-YVHTDLCQYMDKHPGGLH-------------PENVKLFLFQLLRGLSY 118

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           +H   Q  I+HRD+K  N+L+ +  E K+ DFGLA+      +H  +    TL Y  P+ 
Sbjct: 119 IH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDV 174

Query: 497 AL-YGKLTPGSDVYSFGVVLLELLSGKKA 524
            L   + +   D++  G + +E++ G  A
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.9 bits (146), Expect = 9e-10
 Identities = 64/229 (27%), Positives = 91/229 (39%), Gaps = 62/229 (27%)

Query: 319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDANFKH---EVEIIASV 371
           +F     +G G +G V   ML     +G   A+K             +H   E  I+ S+
Sbjct: 2   DFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI 58

Query: 372 KHVNLVALRG--------YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
           +H  LV L G        Y             +V + +  G L+ HL  SG         
Sbjct: 59  RHPFLVNLYGSFQDDSNLY-------------LVMEYVPGGELFSHLRKSG--------- 96

Query: 424 LRIALGTAR--------GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP 475
            R     AR         L YLH      I++RD+K  N+LLD     K+ DFG AK   
Sbjct: 97  -RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152

Query: 476 EGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSG 521
                 T  + GT  Y+APE  L   YGK     D ++ G+++ E+L+G
Sbjct: 153 GR----TYTLCGTPEYLAPEIILSKGYGKA---VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 19/199 (9%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVALRGYST 384
           IG G YG+VYK    N  E+A  +        D A  + E+ ++   KH N+VA  G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY- 75

Query: 385 ATVPLEGHQRIIVCDLLHNGSLYD--HLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
               L   +  I  +    GSL D  H+ G     LS      ++  T +GL YLH    
Sbjct: 76  ----LRRDKLWICMEFCGGGSLQDIYHVTGP----LSESQIAYVSRETLQGLYYLH---S 124

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY--- 499
              +HRDIK +NILL +    K+ DFG++      I    + + GT  ++APE A     
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERK 183

Query: 500 GKLTPGSDVYSFGVVLLEL 518
           G      D+++ G+  +EL
Sbjct: 184 GGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 61.3 bits (149), Expect = 1e-09
 Identities = 69/278 (24%), Positives = 113/278 (40%), Gaps = 48/278 (17%)

Query: 325 IIGKGGYGNVYKGMLPN-GTEVAVKRFKN---CSKAGDANFKHEVEIIASVKHVNLVALR 380
           +IGKGG G VY    P     VA+K+ +     +      F  E +I A + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV- 67

Query: 381 GYSTA--------TVP-LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            YS          T+P +EG+    +  LL +    + L     +K S    L I     
Sbjct: 68  -YSICSDGDPVYYTMPYIEGYT---LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-------------NPEGI 478
             + Y+H      ++HRD+K  NILL    E  + D+G A F             +   I
Sbjct: 124 ATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 479 TH--LTT--RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            +  +T   ++ GT  Y+APE  L    +  +D+Y+ GV+L ++L+        +G+ + 
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS 240

Query: 535 LSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTA 572
             D           +    E  P  E+P  + Q  + A
Sbjct: 241 YRD----------VILSPIEVAPYREIPPFLSQIAMKA 268

Length = 932

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 54/167 (32%), Positives = 82/167 (49%), Gaps = 23/167 (13%)

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVAG 487
           ARG+ +L        IHRD+ A NILL E    K+ DFGLA+    +P+ +   + R+  
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP- 239

Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEG 546
            L ++APE       T  SDV+SFGV+L E+ S G      +Q     +++   + +K+G
Sbjct: 240 -LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ-----INEEFCQRLKDG 293

Query: 547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
             +       PE   PE+   Y +  A C     + RPT   +V+IL
Sbjct: 294 TRM-----RAPENATPEI---YRIMLA-CWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 46/163 (28%), Positives = 75/163 (46%), Gaps = 15/163 (9%)

Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL--HNGSLYDHLFGSGMKKLSWP 421
           E  I+ ++ H +++ L+G  T             C +L  +   LY +L  +  + ++  
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNK--------FTCLILPRYKTDLYCYL--AAKRNIAIC 182

Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             L I     R + YLH   +  IIHRDIKA NI ++   +  +GDFG A F  +   + 
Sbjct: 183 DILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK 239

Query: 482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKA 524
               AGT+   APE        P  D++S G+VL E+ +   +
Sbjct: 240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282

Length = 391

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 14/205 (6%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYS 383
           IGKG YG V+K +   NG++ AVK         D   + E  I+ ++  H N+V   G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI-DEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  G Q  +V +L + GS+ D + G     +++  PI   I      GL +LH   
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH--- 141

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY----- 496
               IHRD+K +NILL      K+ DFG++               GT  ++APE      
Sbjct: 142 VNKTIHRDVKGNNILLTTEGGVKLVDFGVSA-QLTSTRLRRNTSVGTPFWMAPEVIACEQ 200

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSG 521
            L        DV+S G+  +EL  G
Sbjct: 201 QLDSTYDARCDVWSLGITAIELGDG 225

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 20/201 (9%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      G   A K  +  S+    ++  E+EI+A+  H  +V L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG--- 76

Query: 385 ATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                +G   I++  C     G   D +     + L+ P    I       L YLH    
Sbjct: 77  -AFYWDGKLWIMIEFCP----GGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---S 128

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YG 500
             IIHRD+KA N+LL    + K+ DFG++  N + +    + + GT  ++APE  +    
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETM 187

Query: 501 KLTP---GSDVYSFGVVLLEL 518
           K TP    +D++S G+ L+E+
Sbjct: 188 KDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 36/89 (40%), Positives = 45/89 (50%), Gaps = 5/89 (5%)

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
             YLH      II+RD+K  N+LLD     K+ DFG AK    G    T    GT  YVA
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG--QKTWTFCGTPEYVA 160

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L        D +S G++L ELL+G+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 38/94 (40%), Positives = 50/94 (53%), Gaps = 8/94 (8%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLG 490
           RGL YLH      I+HRDIK  N+L++     K+ DFGLA+   P+   H+T  V  T  
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169

Query: 491 YVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           Y APE  L G    T   D++S G +  ELL  +
Sbjct: 170 YRAPEI-LMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)

Query: 326 IGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V    +  +G  VAVK+     +       +EV I+   +H N+V +  Y++
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM--YNS 85

Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   + L+ LH      
Sbjct: 86  YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLH---AQG 136

Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE        
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYG 194

Query: 504 PGSDVYSFGVVLLELLSGK 522
           P  D++S G++++E++ G+
Sbjct: 195 PEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 69/292 (23%), Positives = 125/292 (42%), Gaps = 39/292 (13%)

Query: 320 FSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFK---NCSKAGDANFKHEVEIIASVK 372
           F+   ++GKG +G+V +  L     +  +VAVK  K     S   +  F  E   +    
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIE-EFLREAACMKEFD 59

Query: 373 HVNLVALRGYSTATVPLEGHQRI----IVCDLLHNGSLYDHLFGS--GMKKLSWPIR--L 424
           H N++ L G S  +       R+    ++   + +G L+  L  S  G +  + P++  +
Sbjct: 60  HPNVIKLIGVSLRSRA---KGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLV 116

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
           R  +  A G+ YL        IHRD+ A N +L+E     V DFGL+K    G  +    
Sbjct: 117 RFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGC 173

Query: 485 VAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWEL 542
            +   + ++A E       T  SDV++FGV + E+++ G+     ++   +      +  
Sbjct: 174 ASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI------YNY 227

Query: 543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           + +G  L    + +   ++ E+M Q       C  P  + RP+   +   LE
Sbjct: 228 LIKGNRLKQPPDCLE--DVYELMCQ-------CWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V          +VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT--YRELRLLKHMKHENVIGLL 80

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
              T    +E    + +   L    L + +     +KLS      +     RGL Y+H  
Sbjct: 81  DVFTPATSIENFNEVYLVTNLMGADLNNIV---KCQKLSDEHVQFLIYQLLRGLKYIH-- 135

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYAL- 498
               IIHRD+K SN+ ++E  E ++ DFGLA+   + +T ++ TR      Y APE  L 
Sbjct: 136 -SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEIMLN 189

Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
           +       D++S G ++ ELL GK
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.6 bits (142), Expect = 2e-09
 Identities = 41/113 (36%), Positives = 53/113 (46%), Gaps = 31/113 (27%)

Query: 430 TARGLAYLH-YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR---- 484
           T   L YLH YG    I+HRD+K  N+L+      K+ DFGL+K    G+  LTT     
Sbjct: 110 TVLALEYLHNYG----IVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYEG 162

Query: 485 -------------VAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSG 521
                        V GT  Y+APE  L   YGK     D ++ G++L E L G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPV---DWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 59/201 (29%), Positives = 91/201 (45%), Gaps = 20/201 (9%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      G   A K     S+    ++  E++I+AS  H N+V L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL----L 68

Query: 385 ATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                E +  I++  C     G   D +     + L+ P    +   T   L YLH   +
Sbjct: 69  DAFYYENNLWILIEFC----AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH---E 121

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YG 500
             IIHRD+KA NIL     + K+ DFG++  N   I    + + GT  ++APE  +    
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETS 180

Query: 501 KLTP---GSDVYSFGVVLLEL 518
           K  P    +DV+S G+ L+E+
Sbjct: 181 KDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 52/184 (28%), Positives = 91/184 (49%), Gaps = 16/184 (8%)

Query: 341 NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDL 400
            G +VAVK+     +       +EV I+    H N+V +  Y++  V   G +  +V + 
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDM--YNSYLV---GDELWVVMEF 100

Query: 401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA 460
           L  G+L D +  + M +        + L   R L+YLH      +IHRDIK+ +ILL   
Sbjct: 101 LEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLH---NQGVIHRDIKSDSILLTSD 154

Query: 461 FEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGS--DVYSFGVVLLEL 518
              K+ DFG      + +    + V GT  ++APE  +  +L  G+  D++S G++++E+
Sbjct: 155 GRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPE--VISRLPYGTEVDIWSLGIMVIEM 211

Query: 519 LSGK 522
           + G+
Sbjct: 212 IDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVNLVALRGY 382
           +G+G Y  VYKG+   NG  VA+K     ++ G   F    E  ++  +KH N+V L   
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDI 71

Query: 383 ----STATVPLE-GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
                T T   E  H  +    + H G L+ +     M +L             RGLAY+
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQL------------LRGLAYI 119

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      I+HRD+K  N+L+    E K+ DFGLA+         ++ V  TL Y  P+  
Sbjct: 120 H---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPD-V 174

Query: 498 LYGKLTPGS--DVYSFGVVLLELLSGKKA 524
           L G     S  D++  G + +E+L G+ A
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 17/207 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR---FKNCSKAGDANFKHEVEIIASVKHV 374
           NF  E  IG+G +  VY+   L +   VA+K+   F+        +   E++++  + H 
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 375 NLVA-LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL--RIALGTA 431
           N++  L  +      +E ++  IV +L   G L   +     +K   P R   +  +   
Sbjct: 63  NVIKYLDSF------IEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC 116

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             + ++H      ++HRDIK +N+ +      K+GD GL +F     T   + V GT  Y
Sbjct: 117 SAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYY 172

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLEL 518
           ++PE          SD++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 38/220 (17%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK-HEVEIIASVKHVNL 376
           NF +   +G+G Y  VYKG     G  VA+K     ++ G  +    E+ ++  +KH N+
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF---GSGMKKLSWPIRLRIALGTA-- 431
           V L                   D++H  +    +F      +KK      +R AL     
Sbjct: 61  VRLH------------------DVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTV 102

Query: 432 --------RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
                   +G+A+ H   +  ++HRD+K  N+L+++  E K+ DFGLA+     +   + 
Sbjct: 103 KSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN 159

Query: 484 RVAGTLGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGK 522
            V  TL Y AP+  L  +    S D++S G ++ E+++G+
Sbjct: 160 EVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 15/206 (7%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR---FKNCSKAGDANFKHEVEIIASVKHV 374
           NF  E  IG+G +  VY+   L +G  VA+K+   F        A+   E++++  + H 
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL--RIALGTAR 432
           N++    Y  + +  E ++  IV +L   G L   +     +K   P +   +  +    
Sbjct: 63  NVIK---YYASFI--EDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            L ++H      ++HRDIK +N+ +      K+GD GL +F     T   + V GT  Y+
Sbjct: 118 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 173

Query: 493 APEYALYGKLTPGSDVYSFGVVLLEL 518
           +PE          SD++S G +L E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 57/227 (25%), Positives = 94/227 (41%), Gaps = 66/227 (29%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG+G YG VYK      G  VA+K  R +   +   +    E+ ++  + H N+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLL-- 64

Query: 383 STATVPLEGHQRIIVCDLLHNGS-LY--------------DHLFGSGM-----KKLSWPI 422
                           D++H+ + LY              D    +G+     K   + +
Sbjct: 65  ----------------DVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGI--- 478
                    +G+AY H      ++HRD+K  N+L+D     K+ DFGLA+ F   G+   
Sbjct: 109 --------LQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAF---GVPVR 154

Query: 479 --THLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
             TH       TL Y APE  L  +  +   D++S G +  E+++ +
Sbjct: 155 TYTHEVV----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 58.1 bits (140), Expect = 6e-09
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 38/241 (15%)

Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILER--NVAIKKLSR 59

Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRA--YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 117

Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLH---SAGIIHRDLKPSNIVVKSDC 163

Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

Query: 522 K 522
            
Sbjct: 222 G 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 41/213 (19%)

Query: 326 IGKGGYGNVYKGMLPNGTE-VAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG+G YG V+K       E VA+KR +  +  +   ++   E+ ++  +KH N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY-- 65

Query: 383 STATVPLEGHQRIIV-----------CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
               V     +  +V            D   NG +   +  S M +L             
Sbjct: 66  ---DVLHSDKKLTLVFEYCDQDLKKYFDSC-NGDIDPEIVKSFMFQL------------L 109

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI--THLTTRVAGTL 489
           +GLA+ H      ++HRD+K  N+L+++  E K+ DFGLA+    GI     +  V  TL
Sbjct: 110 KGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVV-TL 163

Query: 490 GYVAPEYALYGKLTPGS-DVYSFGVVLLELLSG 521
            Y  P+     KL   S D++S G +  EL + 
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 56.9 bits (137), Expect = 6e-09
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 326 IGKGGYGNVYKGMLPNG---TEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           IG G +G V  G + +G    +V VK  + + S      F  E +   S++H NL+   G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL---RIALGTARGLAYLH 438
             T   P      ++V +    G L  +L      +L  P      R+A   A GL +LH
Sbjct: 63  QCTEVTPY-----LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH 117

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT-RVAGTLGYVAPEYA 497
              +   IH D+   N LL      K+GD+GL+    +   ++T  ++   L ++APE  
Sbjct: 118 ---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 498 --LYGKL-----TPGSDVYSFGVVLLELL 519
             ++G L     T  S+V+S GV + EL 
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 54/170 (31%), Positives = 78/170 (45%), Gaps = 29/170 (17%)

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVAG 487
           A+G+ +L        IHRD+ A NILL E    K+ DFGLA+    +P+ +     R+  
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 244

Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS----VLLSDWAWELV 543
            L ++APE       T  SDV+SFGV+L E+ S         G S    V + +     +
Sbjct: 245 -LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS--------LGASPYPGVKIDEEFCRRL 295

Query: 544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
           KEG  +       P+   PEM +    T   C H     RPT  ++V+ L
Sbjct: 296 KEGTRM-----RAPDYTTPEMYQ----TMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 57.4 bits (138), Expect = 7e-09
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 21/205 (10%)

Query: 325 IIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASVKHVNLVALR 380
           ++GKG +G V       +G   A+K  K     +K   A+   E  ++ + +H  L +L+
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALGTARGLAYLHY 439
            YS  T      +   V + ++ G L+ HL     +++    R R         L YLH 
Sbjct: 62  -YSFQT----KDRLCFVMEYVNGGELFFHL---SRERVFSEDRTRFYGAEIVSALDYLHS 113

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAGTLGYVAPEYA 497
           G    I++RD+K  N++LD+    K+ DFGL K   EGIT   T     GT  Y+APE  
Sbjct: 114 G---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVL 167

Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
                    D +  GVV+ E++ G+
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 27/172 (15%)

Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV--CDLLHNGSLYD-------HL 410
           + + E  ++A +KH N+VA +    A    +GH  I++  CD    G L          L
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEA----DGHLYIVMEYCD---GGDLMQKIKLQRGKL 96

Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
           F      L W +++ +      G+ ++H   +  ++HRDIK+ NI L +  + K+GDFG 
Sbjct: 97  FPEDTI-LQWFVQMCL------GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGS 146

Query: 471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           A+       +  T V GT  YV PE          SD++S G +L EL + K
Sbjct: 147 ARLLTSPGAYACTYV-GTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 57.2 bits (138), Expect = 9e-09
 Identities = 55/214 (25%), Positives = 98/214 (45%), Gaps = 29/214 (13%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHV 374
           ++    +G G YG+V   +    G +VA+K+    F++   A  A    E+ ++  ++H 
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRA--YRELTLLKHMQHE 74

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR----IALGT 430
           N++ L    T+ V  +  Q   +        +  ++     K +  P+       +    
Sbjct: 75  NVIGLLDVFTSAVSGDEFQDFYL--------VMPYMQTDLQKIMGHPLSEDKVQYLVYQM 126

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTL 489
             GL Y+H      IIHRD+K  N+ ++E  E K+ DFGLA+  + E   ++ TR     
Sbjct: 127 LCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR----- 178

Query: 490 GYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
            Y APE  L +       D++S G ++ E+L+GK
Sbjct: 179 WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.9 bits (137), Expect = 1e-08
 Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 15/200 (7%)

Query: 326 IGKGGYGNVYKGMLPNGTEV-AVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALRG 381
           IGKG +G V +    +   + A+K  +       +   H   E  ++A V    +V L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
              +   L      +V   ++ G L+ HL   G   LS     R    TA  L  L    
Sbjct: 61  SFQSPEKL-----YLVLAFINGGELFHHLQREGRFDLS-----RARFYTAELLCALENLH 110

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           +  +I+RD+K  NILLD      + DFGL K N +     T    GT  Y+APE  L   
Sbjct: 111 KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHG 169

Query: 502 LTPGSDVYSFGVVLLELLSG 521
            T   D ++ GV+L E+L+G
Sbjct: 170 YTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 35/211 (16%)

Query: 325 IIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFK----HEVEIIASVKHVNLVAL 379
           ++G+G YG V K      G  VA+K+F       D   K     E+ ++  ++H NLV L
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKF--LESEDDKMVKKIAMREIRMLKQLRHENLVNL 65

Query: 380 ----RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM-KKLSWPIRLRIALGTARGL 434
               R      +  E     ++ DL      Y +       +K  + I         RG+
Sbjct: 66  IEVFRRKKRLYLVFEFVDHTVLDDLEK----YPNGLDESRVRKYLFQI--------LRGI 113

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            + H      IIHRDIK  NIL+ ++   K+ DFG A+         T  VA T  Y AP
Sbjct: 114 EFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAP 169

Query: 495 EYAL----YGKLTPGSDVYSFGVVLLELLSG 521
           E  +    YG+     D+++ G ++ E+L+G
Sbjct: 170 ELLVGDTKYGRAV---DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 51/220 (23%)

Query: 325 IIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEII----ASVKHVNLVALR 380
           IIG+GG+G VY                 C KA D    + ++ +      +K    +AL 
Sbjct: 1   IIGRGGFGEVY----------------GCRKA-DTGKMYAMKCLDKKRIKMKQGETLALN 43

Query: 381 GYSTATVPLEGHQRIIVC---------------DLLHNGSLYDHLFGSGM---KKLSWPI 422
                ++   G    IVC               DL++ G L+ HL   G+   K++ +  
Sbjct: 44  ERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRF-- 101

Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
               A     GL ++H      +++RD+K +NILLDE    ++ D GLA    +   H +
Sbjct: 102 ---YATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS 155

Query: 483 TRVAGTLGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSG 521
               GT GY+APE    G     S D +S G +L +LL G
Sbjct: 156 V---GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 43/218 (19%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALRG 381
           +GKG YG+VYK +  P G  +A+K  +   +  ++ F     E++I+       +V   G
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIR--LELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 382 YSTATVPLEGHQRIIVC-DLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLH 438
                  +EG   + +C + +  GSL D L+  G   + +   +  RI     +GL +L 
Sbjct: 67  AFF----IEG--AVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFG--------LAKFNPEGITHLTTRVAGTLG 490
                 IIHRD+K +N+L++   + K+ DFG        LAK N            G   
Sbjct: 120 EEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-----------IGCQS 166

Query: 491 YVAPEYALYGKL------TPGSDVYSFGVVLLELLSGK 522
           Y+APE    G        T  SDV+S G+ +LE+  G+
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 50/172 (29%), Positives = 81/172 (47%), Gaps = 31/172 (18%)

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------FNPEGITHLTT 483
           A+G+++L        IHRD+ A NILL      K+ DFGLA+       +  +G   L  
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWEL 542
           +      ++APE       T  SDV+S+G++L E+ S G      +   S       +++
Sbjct: 281 K------WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-----YKM 329

Query: 543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           +KEG  +       PE    EM +  ++ +   A P+   RPT  QIV+++E
Sbjct: 330 IKEGYRMLS-----PECAPSEMYD--IMKSCWDADPL--KRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 65/225 (28%), Positives = 94/225 (41%), Gaps = 61/225 (27%)

Query: 325 IIGKGGYGNVY------KGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IIG+GG+G VY       G +     +  KR K   K G+    +E  +++ V       
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLV------- 51

Query: 379 LRGYSTATVPLEGHQRIIVC---------------DLLHNGSLYDHLFGSG------MKK 417
               ST   P       IVC               DL++ G L+ HL   G      M+ 
Sbjct: 52  ----STGDCPF------IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRF 101

Query: 418 LSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG 477
            +  I L        GL ++H      +++RD+K +NILLDE    ++ D GLA    + 
Sbjct: 102 YAAEIIL--------GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 478 ITHLTTRVAGTLGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSG 521
             H +    GT GY+APE    G     S D +S G +L +LL G
Sbjct: 151 KPHASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 22/214 (10%)

Query: 319 NFSRENIIGKGGYGNVY---KGMLPN-GTEVAVKRFKNCSKAGDA----NFKHEVEIIAS 370
           NF    ++G G YG V+   K    + G   A+K  +  +    A    + + E  ++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60

Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG- 429
           V+    +    Y+  T   E    +I+ D +  G ++ HL+            +R   G 
Sbjct: 61  VRQSPFLVTLHYAFQT---EAKLHLIL-DYVSGGEMFTHLYQRDNFSED---EVRFYSGE 113

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
               L +LH   +  I++RDIK  NILLD      + DFGL+K         T    GT+
Sbjct: 114 IILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170

Query: 490 GYVAPEYALYGKLTPGS--DVYSFGVVLLELLSG 521
            Y+APE  + GK   G   D +S G+++ ELL+G
Sbjct: 171 EYMAPE-IIRGKGGHGKAVDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 57/185 (30%), Positives = 81/185 (43%), Gaps = 28/185 (15%)

Query: 357 GDANFKHEVEIIASVKH---VNLV-ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG 412
           G      E++I+ ++ H   +NL+ A R  ST  + +        CDL      + ++  
Sbjct: 129 GGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDL------FTYVDR 178

Query: 413 SGMKKLSWPIRLRIALGTARGL----AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF 468
           SG      P+ L  A+   R L    AYLH      IIHRD+K  NI LDE   A +GDF
Sbjct: 179 SG------PLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDF 229

Query: 469 GLA-KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI 527
           G A K +    T      +GTL   +PE          +D++S G+VL E+         
Sbjct: 230 GAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289

Query: 528 IQGKS 532
            Q KS
Sbjct: 290 KQVKS 294

Length = 392

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 45/196 (22%), Positives = 92/196 (46%), Gaps = 19/196 (9%)

Query: 334 VYKGMLPNGTEVAVKRFK---NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATV-PL 389
           +YKG+  N  EV ++ FK      K      ++E++ +  +   N++ + G+    V  L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH-YGVQPAIIHR 448
              +  ++ +    G L + L     K LS+  +L +A+   +GL  L+ Y  +P   ++
Sbjct: 95  P--RLSLILEYCTRGYLREVL--DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP---YK 147

Query: 449 DIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YGKLTPGS 506
           ++ + + L+ E ++ K+   GL K     ++    +    + Y + +     + + T   
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKD 203

Query: 507 DVYSFGVVLLELLSGK 522
           D+YS GVVL E+ +GK
Sbjct: 204 DIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 64/205 (31%), Positives = 86/205 (41%), Gaps = 22/205 (10%)

Query: 325 IIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIA-------SVKHVNLV 377
           +IGKG +G V   +  +  E      K   K      K E  I++       +VKH  LV
Sbjct: 2   VIGKGSFGKVL--LARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALGTARGLAY 436
            L  +S  T      +   V D ++ G L+ HL     ++     R R  A   A  L Y
Sbjct: 60  GLH-FSFQTA----DKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGY 111

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH      I++RD+K  NILLD      + DFGL K N E     T+   GT  Y+APE 
Sbjct: 112 LH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFCGTPEYLAPEV 167

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSG 521
                     D +  G VL E+L G
Sbjct: 168 LHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 37/93 (39%), Positives = 51/93 (54%), Gaps = 8/93 (8%)

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVAG 487
           ARG+ +L        IHRD+ A NILL E    K+ DFGLA+    +P+ +     R+  
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP- 238

Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 239 -LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 48/187 (25%), Positives = 90/187 (48%), Gaps = 19/187 (10%)

Query: 345 VAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN 403
           VAVK  + + +K    +F  E++I++ +K  N++ L      + PL      ++ + + N
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPL-----CMITEYMEN 103

Query: 404 GSLYDHL---------FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           G L   L           + +  +S+   + +A   A G+ YL        +HRD+   N
Sbjct: 104 GDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN 160

Query: 455 ILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGV 513
            L+ + +  K+ DFG+++    G  + +  R    + +++ E  L GK T  SDV++FGV
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGV 220

Query: 514 VLLELLS 520
            L E+L+
Sbjct: 221 TLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 3e-08
 Identities = 65/213 (30%), Positives = 90/213 (42%), Gaps = 42/213 (19%)

Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVNLVALRGY 382
           +G+G Y  VYKG     G  VA+K  +   + G A F    E  ++  +KH N+V L   
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDI 71

Query: 383 ----STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL-GTARGLAYL 437
                T T+  E        DL      Y    G G+        +R+ L    RGLAY 
Sbjct: 72  IHTKKTLTLVFEYLDT----DL----KQYMDDCGGGLS----MHNVRLFLFQLLRGLAYC 119

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL--AKFNPEGITHLTTRVAGTLGYVAPE 495
           H   Q  ++HRD+K  N+L+ E  E K+ DFGL  AK  P   +   +    TL Y  P+
Sbjct: 120 H---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVVTLWYRPPD 173

Query: 496 YALYGKLTPGSDVYS-------FGVVLLELLSG 521
             L      GS  YS        G +  E+ +G
Sbjct: 174 VLL------GSTEYSTSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 52/166 (31%), Positives = 78/166 (46%), Gaps = 25/166 (15%)

Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPI 422
           E  ++ + +H  L AL+ YS  T     H R+  V +  + G L+ HL  S  +  S   
Sbjct: 45  ESRVLQNTRHPFLTALK-YSFQT-----HDRLCFVMEYANGGELFFHL--SRERVFSED- 95

Query: 423 RLRI-ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH- 480
           R R         L YLH      +++RD+K  N++LD+    K+ DFGL K   EGI+  
Sbjct: 96  RARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDG 149

Query: 481 -LTTRVAGTLGYVAPEY---ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  GT  Y+APE      YG+     D +  GVV+ E++ G+
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAV---DWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 32/84 (38%), Positives = 44/84 (52%), Gaps = 12/84 (14%)

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPE-------YA 497
           IHRD+K  N+LLD++   K+ DFG   K +  G+    T V GT  Y++PE         
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 498 LYGKLTPGSDVYSFGVVLLELLSG 521
            YG+     D +S GV L E+L G
Sbjct: 223 YYGR---ECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
                  IG+G  G V        G +VAVK+     +       +EV I+   +H N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            +  YS+  V   G +  +V + L  G+L D +  + M +        + L   + L++L
Sbjct: 80  EM--YSSYLV---GDELWVVMEFLEGGALTDIVTHTRMNE---EQIATVCLAVLKALSFL 131

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY- 496
           H      +IHRDIK+ +ILL      K+ DFG      + +    + V GT  ++APE  
Sbjct: 132 H---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVI 187

Query: 497 --ALYGKLTPGSDVYSFGVVLLELLSGK 522
               YG      D++S G++++E++ G+
Sbjct: 188 SRLPYG---TEVDIWSLGIMVIEMVDGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 55.4 bits (133), Expect = 4e-08
 Identities = 43/148 (29%), Positives = 75/148 (50%), Gaps = 16/148 (10%)

Query: 395 IIVC-DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS 453
           I +C + +  GSL   L  +G  ++   I  ++++   +GL YL    +  I+HRD+K S
Sbjct: 78  ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPS 133

Query: 454 NILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGV 513
           NIL++   E K+ DFG++    + I  +     GT  Y++PE       +  SD++S G+
Sbjct: 134 NILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGL 190

Query: 514 VLLELLSGK--------KACEIIQGKSV 533
            L+E+  G+        K  E++ G  V
Sbjct: 191 SLVEMAIGRYPIPPPDAKELELMFGCPV 218

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 21/214 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCS---KAGDANF-KHEVEIIAS 370
           NF    ++G G YG V+     +G +     A+K  K  +   KA      + E +++  
Sbjct: 1   NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60

Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG- 429
           ++    +    Y+  T   +    +I+ D ++ G L+ HL  S  ++      ++I  G 
Sbjct: 61  IRQSPFLVTLHYAFQT---DTKLHLIL-DYINGGELFTHL--SQRERFK-EQEVQIYSGE 113

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
               L +LH   +  II+RDIK  NILLD      + DFGL+K   E          GT+
Sbjct: 114 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170

Query: 490 GYVAPEYALYGKL--TPGSDVYSFGVVLLELLSG 521
            Y+AP+    G        D +S GV++ ELL+G
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 33/235 (14%)

Query: 288 VTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAV 347
           V D  +P  +LE+        KI E     +  +RE                 +G +VAV
Sbjct: 13  VVDQGDPRSLLENY------IKIGEGSTGIVCIAREK---------------HSGRQVAV 51

Query: 348 KRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY 407
           K      +       +EV I+   +H N+V +  Y +  V   G +  ++ + L  G+L 
Sbjct: 52  KMMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--YKSYLV---GEELWVLMEFLQGGALT 106

Query: 408 DHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           D +      +L+      +     + L YLH      +IHRDIK+ +ILL      K+ D
Sbjct: 107 DIV---SQTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSD 160

Query: 468 FGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           FG      + +    + V GT  ++APE           D++S G++++E++ G+
Sbjct: 161 FGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 37/210 (17%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVK-HVNLVALRGY 382
           IG+G +  V K      G   A+K  K   K+ +  N   E++ +  +  H N++ L   
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 383 ----STATVPLEGHQRIIVCDLLHNGSLYDHLFG-----SGMKKLSWPIRLRIALGTARG 433
                T  + L       V +L+ + +LY+ + G        +  S+  +L       + 
Sbjct: 67  LFDRKTGRLAL-------VFELM-DMNLYELIKGRKRPLPEKRVKSYMYQL------LKS 112

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI--THLTTRVAGTLGY 491
           L ++H   +  I HRDIK  NIL+ +    K+ DFG  +    GI      T    T  Y
Sbjct: 113 LDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR----GIYSKPPYTEYISTRWY 164

Query: 492 VAPEYALY-GKLTPGSDVYSFGVVLLELLS 520
            APE  L  G   P  D+++ G V  E+LS
Sbjct: 165 RAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 5/86 (5%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+ Y+H   Q  I+HRD+KA NI L      K+GDFG+++    G   L T   GT  Y+
Sbjct: 118 GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL-LMGSCDLATTFTGTPYYM 172

Query: 493 APEYALYGKLTPGSDVYSFGVVLLEL 518
           +PE   +      SD++S G +L E+
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 60/212 (28%), Positives = 93/212 (43%), Gaps = 35/212 (16%)

Query: 325 IIGKGGYGNV----------YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV 374
           ++GKG +G V          Y  M     EV +      +K   A+   E  ++ + +H 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVTESRVLQNTRHP 55

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALGTAR 432
            L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R        
Sbjct: 56  FLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVS 106

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAGTLG 490
            L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     GT  
Sbjct: 107 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPE 160

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+APE           D +  GVV+ E++ G+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 59/208 (28%), Positives = 91/208 (43%), Gaps = 30/208 (14%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           IG G  G V        G  VAVK+    F+N + A  A    E+ ++  V H N+++L 
Sbjct: 29  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRA--YRELVLLKCVNHKNIISLL 86

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTARG 433
              T    LE  Q + +   L + +L        DH      +++S+ +   +      G
Sbjct: 87  NVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDH------ERMSYLLYQMLC-----G 135

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           + +LH      IIHRD+K SNI++      K+ DFGLA+        + T    T  Y A
Sbjct: 136 IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRA 190

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSG 521
           PE  L        D++S G ++ EL+ G
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLG 490
            L +LH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 108 ALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPN 161

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII 528
           Y+APE     +     D ++ GV++ E+++G+   +II
Sbjct: 162 YIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 53.7 bits (129), Expect = 1e-07
 Identities = 35/98 (35%), Positives = 56/98 (57%), Gaps = 10/98 (10%)

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLGY 491
           L +LH   +  II+RD+K  N+LLD     K+ D+G+ K   EGI     T+   GT  Y
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNY 162

Query: 492 VAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACEII 528
           +APE  L G+    S D ++ GV++ E+++G+   +I+
Sbjct: 163 IAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 37/206 (17%)

Query: 329 GGYGNVYKGMLPNGTEVAVK----RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           G YG ++K      TEV +K      +N S++    F     +++ + H +LV   G   
Sbjct: 20  GDYGELHK------TEVLLKVLDKSHRNYSES----FFEAASMMSQLSHKHLVLNYG--- 66

Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY-LHYGVQP 443
             V + G + I+V + +  GSL  +L     KK    I +   L  A+ LA+ LH+    
Sbjct: 67  --VCVCGDESIMVQEYVKFGSLDTYL-----KKNKNLINISWKLEVAKQLAWALHFLEDK 119

Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-------HLTTRVAGTLGYVAPEY 496
            + H ++ A N+LL    + K G+    K +  GI+        L  R+     +V PE 
Sbjct: 120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP----WVPPEC 175

Query: 497 ALYGK-LTPGSDVYSFGVVLLELLSG 521
               + L+  +D +SFG  L E+ SG
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 21/218 (9%)

Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT--EVAVKRFKNCSKAGDANFKH--- 363
           +  ++K    NF R   +G G +G V      N     VA+KRF+           H   
Sbjct: 23  RKNKMKYEDFNFIR--TLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS 80

Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
           E +I+  + H   V L G       L      +V + +  G  +  L     +   +P  
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYL-----YLVLEFVIGGEFFTFL----RRNKRFPND 131

Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           +      A+ +    Y     I++RD+K  N+LLD+    K+ DFG AK     +   T 
Sbjct: 132 VG-CFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRTY 186

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            + GT  Y+APE  L       +D ++ G+ + E+L G
Sbjct: 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 32/98 (32%), Positives = 52/98 (53%), Gaps = 8/98 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLG 490
            L YLH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 108 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 161

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII 528
           Y+APE           D ++ GV++ E+++G+   +I+
Sbjct: 162 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)

Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 25  IGSGAQGIVCAAYDAVLDR--NVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNHKNIIS 80

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 81  LLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 130

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 131 -GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 33/91 (36%), Positives = 45/91 (49%), Gaps = 5/91 (5%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           RGL +LH      I+HRD+K  NIL+    + K+ DFGLA+     +    T V  TL Y
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWY 173

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G +  E+   K
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 22/206 (10%)

Query: 325 IIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASVKHVNLVALR 380
           ++GKG +G V        G   A+K  K     +K   A+   E  ++ + +H  L AL+
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61

Query: 381 GYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALGTARGLAYLH 438
            YS  T     H R+  V +  + G L+ HL     +++    R R         L YLH
Sbjct: 62  -YSFQT-----HDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAEIVSALDYLH 112

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAGTLGYVAPEY 496
              +  +++RD+K  N++LD+    K+ DFGL K   EGI    T     GT  Y+APE 
Sbjct: 113 --SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEV 167

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                     D +  GVV+ E++ G+
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 16/201 (7%)

Query: 326 IGKGGYGNVYKGMLPNGTE--VAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGY 382
           +G+G Y  V+KG     TE  VA+K  +   + G       EV ++  +KH N+V L   
Sbjct: 14  LGEGTYATVFKGR-SKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD- 71

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
               V  +    ++   L  +   Y    G+ M   +  I L   L   RGLAY H   +
Sbjct: 72  ---IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQIL---RGLAYCH---R 122

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-YGK 501
             ++HRD+K  N+L++E  E K+ DFGLA+         +  V  TL Y  P+  L   +
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSE 181

Query: 502 LTPGSDVYSFGVVLLELLSGK 522
            +   D++  G +  E+ SG+
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 32/78 (41%), Positives = 41/78 (52%), Gaps = 6/78 (7%)

Query: 445 IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK-LT 503
            IHRD+K  N L+D +   K+ DFGL+K    GI      V G+  Y+APE  L GK   
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPE-VLRGKGYD 176

Query: 504 PGSDVYSFGVVLLELLSG 521
              D +S G +L E L G
Sbjct: 177 FTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 59/216 (27%), Positives = 100/216 (46%), Gaps = 30/216 (13%)

Query: 326 IGKGGYGNVYKGMLPNG---TEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +G+G YG+VYK    +G    E A+K+ +    +  A    E+ ++  +KH N++AL+  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSAC--REIALLRELKHPNVIALQ-- 64

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYD--HL--FGSGMKKLSWPIRLRIALGTARGLAY-- 436
               V L    R +   LL + + +D  H+  F    K    P++L  ++   + L Y  
Sbjct: 65  ---KVFLSHSDRKVW--LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSM--VKSLLYQI 117

Query: 437 ---LHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLT--TRVAG 487
              +HY     ++HRD+K +NIL+     E    K+ D G A+     +  L     V  
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177

Query: 488 TLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
           T  Y APE  L  +  T   D+++ G +  ELL+ +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYST 384
           +G+G YG+VYK    +G +      K     G   +   E+ ++  +KH N+++L+    
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQ---- 64

Query: 385 ATVPLEGHQRIIVCDLLHNGSLYD--HL--FGSGMKKLSWPIRLRIALGTARGLAY---- 436
             V L    R +   LL + + +D  H+  F    K    P++L    G  + L Y    
Sbjct: 65  -KVFLSHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQL--PRGMVKSLLYQILD 119

Query: 437 -LHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLT--TRVAGTL 489
            +HY     ++HRD+K +NIL+     E    K+ D G A+     +  L     V  T 
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179

Query: 490 GYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
            Y APE  L  +  T   D+++ G +  ELL+ +
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 32/86 (37%), Positives = 43/86 (50%), Gaps = 7/86 (8%)

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH      II+RD+K  N+LLD     KV DFG AK     +   T  + GT  Y+APE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYLAPE 185

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSG 521
                      D ++ GV+L E ++G
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAG 211

Length = 329

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 25/207 (12%)

Query: 325 IIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFK--HEVEIIASVKHVNLVAL-- 379
           ++G+G YG V K       E VA+K+FK+  +  +       E++++ ++K  N+V L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 380 ----RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
               RG             + + + + NG   +       K  S+  +L         + 
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE-------KVRSYIYQL---------IK 111

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
            +H+  +  I+HRDIK  N+L+      K+ DFG A+   EG     T    T  Y +PE
Sbjct: 112 AIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
             L        D++S G +L EL  G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.6 bits (126), Expect = 3e-07
 Identities = 34/92 (36%), Positives = 46/92 (50%), Gaps = 11/92 (11%)

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L +LH   +  I++RD+K  NILLD      + DFGL+K N       T    GT  Y+A
Sbjct: 109 LEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTFCGTTEYLA 164

Query: 494 PEYAL----YGKLTPGSDVYSFGVVLLELLSG 521
           PE  L    Y K     D +S GV++ E+  G
Sbjct: 165 PEVLLDEKGYTKHV---DFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 3e-07
 Identities = 49/208 (23%), Positives = 78/208 (37%), Gaps = 29/208 (13%)

Query: 329 GGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFK---HEVEIIASVKHVNLVALRGYSTA 385
               ++ K   P  T VAVK+  N       + K    E+     ++H N++        
Sbjct: 13  LMIVHLAKHK-PTNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYV----- 65

Query: 386 TVPLEGHQRIIVCDLLHNGS---LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
           T  +   +  +V  L+  GS   L    F  G+ +L+  I   I       L Y+H    
Sbjct: 66  TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA--IAF-ILKDVLNALDYIH---S 119

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEG-----ITHLTTRVAGTLGYVAPEY 496
              IHR +KAS+ILL    +  +     +      G     +          L +++PE 
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE- 178

Query: 497 ALYGKL---TPGSDVYSFGVVLLELLSG 521
            L   L      SD+YS G+   EL +G
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 55/220 (25%), Positives = 105/220 (47%), Gaps = 26/220 (11%)

Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           ++   ++   NIIG G +G VY+ +  + +E VA+K+        D  +K+ E+ I+ ++
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ-----DPQYKNRELLIMKNL 116

Query: 372 KHVNLVALRGYSTATVPLEGHQRI---IVCDLLHNGSLYDHLFGSGMKKLSWPIRL--RI 426
            H+N++ L+ Y       +  + I   +V + +   +++ ++        + P+ L    
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAK---FNPEGITHLT 482
           +    R LAY+H      I HRD+K  N+L+D      K+ DFG AK        ++++ 
Sbjct: 176 SYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC 232

Query: 483 TRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSG 521
           +R      Y APE  L     T   D++S G ++ E++ G
Sbjct: 233 SRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.3 bits (125), Expect = 4e-07
 Identities = 34/84 (40%), Positives = 45/84 (53%), Gaps = 12/84 (14%)

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEY-------A 497
           IHRD+K  N+LLD++   K+ DFG   K N EG+    T V GT  Y++PE         
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDG 222

Query: 498 LYGKLTPGSDVYSFGVVLLELLSG 521
            YG+     D +S GV L E+L G
Sbjct: 223 YYGR---ECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 18/202 (8%)

Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G Y  V+KG        VA+K  +   + G       EV ++ ++KH N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                L      +  DL       D+  G+ M   +  I +   L   RGL+Y H   + 
Sbjct: 73  HTERCLTLVFEYLDSDLKQ---YLDNC-GNLMSMHNVKIFMFQLL---RGLSYCH---KR 122

Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL- 502
            I+HRD+K  N+L++E  E K+ DFGLA+         +  V  TL Y  P+  L G   
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPD-VLLGSTE 180

Query: 503 --TPGSDVYSFGVVLLELLSGK 522
             TP  D++  G +L E+ +G+
Sbjct: 181 YSTP-IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 51.5 bits (124), Expect = 7e-07
 Identities = 35/107 (32%), Positives = 41/107 (38%), Gaps = 34/107 (31%)

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAK-----------------------FNPEGITHLT 482
           IHRDIK  NIL+D     K+ DFGL K                              H  
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 483 TRV-----AGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSG 521
            RV      GT  Y+APE      YG      D +S GV+L E+L G
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGLE---CDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 19/204 (9%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG+G YG VYKG     G  VA+K  R ++  +   +    E+ ++  ++H N+V L+  
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQ-- 65

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL-GTARGLAYLHYGV 441
               V ++  +  ++ + L +  L  +L      +      ++  L    +G+ + H   
Sbjct: 66  ---DVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH--- 118

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGI-THLTTRVAGTLGYVAPEYALY 499
              ++HRD+K  N+L+D     K+ DFGLA+ F   GI   + T    TL Y APE  L 
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF---GIPVRVYTHEVVTLWYRAPEVLLG 175

Query: 500 G-KLTPGSDVYSFGVVLLELLSGK 522
             + +   D++S G +  E+ + K
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 34/92 (36%), Positives = 46/92 (50%), Gaps = 13/92 (14%)

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG-LAKFNPEGITHLTTRVAGTLGYVAPE 495
           LHY      +HRDIK  N+LLD     ++ DFG   K N +G    +  V GT  Y++PE
Sbjct: 121 LHY------VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPE 173

Query: 496 YAL-----YGKLTPGSDVYSFGVVLLELLSGK 522
                    GK  P  D +S GV + E+L G+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 51.6 bits (123), Expect = 8e-07
 Identities = 31/92 (33%), Positives = 52/92 (56%), Gaps = 7/92 (7%)

Query: 445 IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLT 503
           ++HRD+K++NI L      K+GDFG +K   + ++  + +   GT  Y+APE     + +
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 504 PGSDVYSFGVVLLELLS------GKKACEIIQ 529
             +D++S GV+L ELL+      G    EI+Q
Sbjct: 250 KKADMWSLGVILYELLTLHRPFKGPSQREIMQ 281

Length = 478

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 51.2 bits (122), Expect = 8e-07
 Identities = 32/86 (37%), Positives = 44/86 (51%), Gaps = 12/86 (13%)

Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEY------ 496
            +IHRD+K  N+LLD+    K+ DFG   K +  G+    T V GT  Y++PE       
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLKSQGG 220

Query: 497 -ALYGKLTPGSDVYSFGVVLLELLSG 521
              YG+     D +S GV L E+L G
Sbjct: 221 DGYYGR---ECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 50.6 bits (121), Expect = 8e-07
 Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 8/94 (8%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEA-KVGDFGLAKFNPEGITHLTTRVAGTLG 490
           RG+AY H      ++HRD+K  N+L+D    A K+ DFGLA+     +   T  V  TL 
Sbjct: 113 RGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLW 168

Query: 491 YVAPEYALYGKL--TPGSDVYSFGVVLLELLSGK 522
           Y APE  L  +   TP  D++S G +  E+++ K
Sbjct: 169 YRAPEILLGSRHYSTP-VDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 50.5 bits (121), Expect = 1e-06
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 9/96 (9%)

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITH---LTTRVAG 487
           RGL Y+H      ++HRD+K +N+ ++ E    K+GDFGLA+      +H   L+  +  
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV- 180

Query: 488 TLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGK 522
           T  Y +P   L     T   D+++ G +  E+L+GK
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 14/212 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
            + +   IG+G YG VYK      G  VA+K  R +   +        E+ ++  +    
Sbjct: 2   AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61

Query: 376 LVALRGYSTATVPLEGHQRI-IVCDLLHNG--SLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            +             G   + +V + L +      D       + L             +
Sbjct: 62  YIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEA-KVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           G+A+ H   +  ++HRD+K  N+L+D+     K+ D GL +     +   T  +  TL Y
Sbjct: 122 GVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLWY 177

Query: 492 VAPEYALYGKL--TPGSDVYSFGVVLLELLSG 521
            APE  L      TP  D++S G +  E+   
Sbjct: 178 RAPEVLLGSTHYSTP-VDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 7/89 (7%)

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L YLH      I++RD+K  NILLD+    K+ DFG AK     +   T  + GT  Y+A
Sbjct: 114 LEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLA 166

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE           D ++ G+++ E+L G 
Sbjct: 167 PEVIQSKGHNKAVDWWALGILIYEMLVGY 195

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)

Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G Y  VYKG        VA+K  +   + G       EV ++  +KH N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                L      +V + L +  L  +L   G       ++L +     RGL Y H   + 
Sbjct: 74  HTEKSL-----TLVFEYL-DKDLKQYLDDCGNSINMHNVKLFL-FQLLRGLNYCH---RR 123

Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-YGKL 502
            ++HRD+K  N+L++E  E K+ DFGLA+         +  V  TL Y  P+  L     
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDY 182

Query: 503 TPGSDVYSFGVVLLELLSGK 522
           +   D++  G +  E+ +G+
Sbjct: 183 STQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 39/139 (28%), Positives = 59/139 (42%), Gaps = 31/139 (22%)

Query: 404 GSLYDH---------------LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHR 448
            S YD                L   G + L+    L      ARG+ +L        +HR
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHR 261

Query: 449 DIKASNILLDEAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           D+ A N+LL +    K+ DFGLA+       +  +G T L  +      ++APE      
Sbjct: 262 DLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVK------WMAPESIFDNL 315

Query: 502 LTPGSDVYSFGVVLLELLS 520
            T  SDV+S+G++L E+ S
Sbjct: 316 YTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.6 bits (116), Expect = 3e-06
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)

Query: 324 NIIGKGGYGNVYKGMLPNGT-----EVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLV 377
           +++ +G +G ++ G+L +       EV VK  K+  S+        E  ++  + H N++
Sbjct: 12  DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNIL 71

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHN-GSLYDHLFGSGMKKLSWPIRLR------IALGT 430
            +          E  +   V     N G+L   L    + + + P  L       +A+  
Sbjct: 72  PILHVCI-----EDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 431 ARGLAYLH-YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGITHLTTRVAG 487
           A G++YLH  GV    IH+DI A N ++DE  + K+ D  L++  F P     L      
Sbjct: 127 ACGMSYLHKRGV----IHKDIAARNCVIDEELQVKITDNALSRDLF-PMDYHCLGDNENR 181

Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E  +  + +  SDV+SFGV+L EL++
Sbjct: 182 PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 31/90 (34%), Positives = 46/90 (51%), Gaps = 5/90 (5%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y 
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYR 184

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           APE  L        D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.9 bits (114), Expect = 7e-06
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 13/92 (14%)

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG-LAKFNPEGITHLTTRVAGTLGYVAPE 495
           L Y      +HRDIK  N+LLD+    ++ DFG   +   +G       V GT  Y++PE
Sbjct: 121 LGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPE 173

Query: 496 Y--AL---YGKLTPGSDVYSFGVVLLELLSGK 522
              A+    G+  P  D +S GV + E+L G+
Sbjct: 174 ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 8e-06
 Identities = 37/113 (32%), Positives = 55/113 (48%), Gaps = 5/113 (4%)

Query: 406 LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV 465
           LY +L G+ ++ L       +A      + Y+H      IIHRDIK  N+L++   +  +
Sbjct: 246 LYTYL-GARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICL 301

Query: 466 GDFGLAKF-NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE 517
           GDFG A F      T     +AGT+   APE       TP  D++S G+V+ E
Sbjct: 302 GDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 47.8 bits (113), Expect = 9e-06
 Identities = 55/220 (25%), Positives = 92/220 (41%), Gaps = 32/220 (14%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKN----CSKAGDANFKHEVEIIASVKHV 374
           +F    +IG+G +G V    L N  +V   +  N      +A  A F+ E +++ +  + 
Sbjct: 2   DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSL------YDHLFGSGMKKLSWPIRLRIAL 428
            +  L  Y+      + +   +V D    G L      ++      M +  +   + IA+
Sbjct: 62  WITTLH-YAFQ----DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAI 115

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG-LAKFNPEGITHLTTRVAG 487
            +   L Y         +HRDIK  NIL+D     ++ DFG   K   +G    +  V G
Sbjct: 116 DSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-G 165

Query: 488 TLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSGK 522
           T  Y++PE         GK  P  D +S GV + E+L G+
Sbjct: 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 32/97 (32%), Positives = 49/97 (50%), Gaps = 16/97 (16%)

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------FNPEGITHLTT 483
           A G+ +L        +HRD+ A N+L+ E    K+ DFGLA+       +  +G T L  
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL-- 303

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                L ++APE       T  SDV+SFG++L E+ +
Sbjct: 304 ----PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 58/207 (28%), Positives = 86/207 (41%), Gaps = 46/207 (22%)

Query: 340 PNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV 397
           P GT V V+    +NC++      ++EV +    +H N++      T      G    ++
Sbjct: 23  PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-----GSWLWVI 77

Query: 398 CDLLHNGS---LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
              +  GS   L    F  GM   S  +   I  G  RGL YLH   Q   IHR+IKAS+
Sbjct: 78  SPFMAYGSANSLLKTYFPEGM---SEALIGNILFGALRGLNYLH---QNGYIHRNIKASH 131

Query: 455 ILLDEAFEAKVGDFGLAKFNPEGITHLTTRV----------------AGTLGYVAPEYA- 497
           IL+           GL   +  G++HL + V                   L +++PE   
Sbjct: 132 ILISGD--------GLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLR 181

Query: 498 --LYGKLTPGSDVYSFGVVLLELLSGK 522
             LYG     SD+YS G+   EL +G+
Sbjct: 182 QDLYG-YNVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 39/131 (29%), Positives = 60/131 (45%), Gaps = 18/131 (13%)

Query: 399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD 458
           DLL   + Y+  F   M +  +   L +A+ +   + Y         +HRDIK  N+L+D
Sbjct: 87  DLLSLLNRYEDQFDEDMAQF-YLAELVLAIHSVHQMGY---------VHRDIKPENVLID 136

Query: 459 EAFEAKVGDFG-LAKFNPEGITHLTTRVAGTLGYVAPEYAL----YGKLTPG--SDVYSF 511
                K+ DFG  A+     + +    V GT  Y+APE        GK T G   D +S 
Sbjct: 137 RTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195

Query: 512 GVVLLELLSGK 522
           GV+  E++ G+
Sbjct: 196 GVIAYEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 45.4 bits (108), Expect = 6e-05
 Identities = 31/116 (26%), Positives = 38/116 (32%), Gaps = 43/116 (37%)

Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKF---------------NPEGITHLTTR------ 484
           IHRDIK  N+LLD     K+ DFGL                                   
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 485 ----------------VAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSG 521
                             GT  Y+APE  L   Y K     D +S GV++ E+L G
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE---CDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.1 bits (104), Expect = 1e-04
 Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 30/212 (14%)

Query: 326 IGKGGYGNVYKGML---PNGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           IG G +G V    +        V VK  K N S      F  + +    ++H N++   G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 382 YSTATVPLEGHQRIIV---CDLLHNGSLYDHLFGSGMKKLSWPIRL--RIALGTARGLAY 436
                +P      ++V   C+L   G L  +L      + +  + L  R+A   A G+ +
Sbjct: 63  QCVEAIPY-----LLVFEYCEL---GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL--AKFNPEGITHLTTRVAGTLGYVAP 494
           +H   +   +H D+   N  L      KVGD+G+  +++  + I     +    L ++AP
Sbjct: 115 MH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAP 170

Query: 495 EY--ALYGKL-----TPGSDVYSFGVVLLELL 519
           E     +G L     T  S+V++ GV L EL 
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 45.1 bits (106), Expect = 1e-04
 Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 21/112 (18%)

Query: 445 IIHRDIKASNILLDEAFE-----------------AKVGDFGLAKFNPEGITHLTTRVAG 487
           ++HRD+K  NI L                      AK+GDFGL+K    GI  +     G
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGIESMAHSCVG 203

Query: 488 TLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD 537
           T  Y +PE  L+        SD+++ G ++ EL SGK         S L+S+
Sbjct: 204 TPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISE 255

Length = 1021

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 43.3 bits (103), Expect = 2e-04
 Identities = 45/135 (33%), Positives = 62/135 (45%), Gaps = 13/135 (9%)

Query: 389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHR 448
           L+GH  +++ D + +G L+D L   G  KLS     +I       L  LH      IIH 
Sbjct: 81  LKGH--VLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHN 133

Query: 449 DIKASNILLDEA-FEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSD 507
           DIK  N+L D A     + D+GL K     I    +   GTL Y +PE           D
Sbjct: 134 DIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEKIKGHNYDVSFD 188

Query: 508 VYSFGVVLLELLSGK 522
            ++ GV+  ELL+GK
Sbjct: 189 WWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 43.5 bits (102), Expect = 3e-04
 Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 21/159 (13%)

Query: 406 LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV 465
           +YD  F    + L    R  I       + Y+H      +IHRDIK  NI L+   +  +
Sbjct: 253 MYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVL 308

Query: 466 GDFGLAKFNPEGITHLTTRVAGTLGYV------APEYALYGKLTPGSDVYSFGVVLLELL 519
           GDFG A      +     R A   G+V      +PE          +D++S G++LL++L
Sbjct: 309 GDFGTA------MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Query: 520 SGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           S    C I  G          +L+K   +L V +E  P+
Sbjct: 363 S-HDFCPIGDGG----GKPGKQLLKIIDSLSVCDEEFPD 396

Length = 501

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 42.5 bits (100), Expect = 5e-04
 Identities = 35/119 (29%), Positives = 46/119 (38%), Gaps = 42/119 (35%)

Query: 446 IHRDIKASNILLDEAFEAKVGDFGL---------AKFNPEGITH---------------- 480
           IHRDIK  NIL+D     K+ DFGL         +K+  +G  H                
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 481 -----------------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
                            L   + GT  Y+APE  L    T   D +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 41.9 bits (98), Expect = 8e-04
 Identities = 35/117 (29%), Positives = 44/117 (37%), Gaps = 40/117 (34%)

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLA---------------KFNP----------- 475
           Q   IHRDIK  N+LLD     K+ DFGL                  NP           
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNS 178

Query: 476 --------EGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSG 521
                   +    L     GT  Y+APE  +   Y KL    D +S GV++ E+L G
Sbjct: 179 KRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC---DWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.8 bits (98), Expect = 0.001
 Identities = 19/42 (45%), Positives = 25/42 (59%), Gaps = 3/42 (7%)

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
           A  L YLH   +  IIHRD+K  N+L+      K+ DFGL+K
Sbjct: 114 ALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 33/114 (28%), Positives = 41/114 (35%), Gaps = 34/114 (29%)

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLA-------------KFN---PEGIT------ 479
           Q   IHRDIK  N+LLD     K+ DFGL                N   P   T      
Sbjct: 119 QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 480 ------------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
                        L     GT  Y+APE  +        D +S GV++ E+L G
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 36/123 (29%), Positives = 46/123 (37%), Gaps = 46/123 (37%)

Query: 446 IHRDIKASNILLDEAFEAKVGDFGL---------AKFNPEG------------------- 477
           IHRDIK  NIL+D     K+ DFGL         +K+   G                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 478 ------ITHLTTRVA------------GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL 519
                 +  L  R A            GT  Y+APE  L    T   D +S GV+L E+L
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Query: 520 SGK 522
            G+
Sbjct: 243 VGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 54/221 (24%), Positives = 89/221 (40%), Gaps = 40/221 (18%)

Query: 326 IGKGGYGNVYKGMLPN---------GTEVAVKRFKNCSKAG--DANFKHEVEIIASVKHV 374
           +G+G + N+YKG+L           G EV+V   K           F     +++ + H 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL-KVLGSDHRDSLAFFETASLMSQLSHK 61

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSL--YDHLFGSGMKKLSWPIRLRIALGTAR 432
           +LV L G           + I+V + +  G L  + H   + +  L W  +L +A   A 
Sbjct: 62  HLVKLYGVCVRD------ENIMVEEYVKFGPLDVFLHREKNNVS-LHW--KLDVAKQLAS 112

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEA-------FEAKVGDFGLAKFNPEGITHLTTRV 485
            L YL       ++H ++   NIL+             K+ D G+    P  +     RV
Sbjct: 113 ALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERV 165

Query: 486 AGTLGYVAPEY--ALYGKLTPGSDVYSFGVVLLELLSGKKA 524
              + ++APE        LT  +D +SFG  LLE+ S  + 
Sbjct: 166 E-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEE 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.0 bits (93), Expect = 0.003
 Identities = 35/124 (28%), Positives = 47/124 (37%), Gaps = 48/124 (38%)

Query: 446 IHRDIKASNILLDEAFEAKVGDFGL---------AKFNPEGITH---------------- 480
           IHRDIK  NIL+D     K+ DFGL         +K+  +G +H                
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWDDVS 181

Query: 481 ----------------------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
                                 L   + GT  Y+APE  L    T   D +S GV+L E+
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241

Query: 519 LSGK 522
           L G+
Sbjct: 242 LVGQ 245

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	614
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.96
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.96
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.96
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.95
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.95
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.91
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.81
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.78
PRK12274	218	serine/threonine protein kinase; Provisional	99.78
PRK10345	210	hypothetical protein; Provisional	99.77
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
smart00090	237	RIO RIO-like kinase.	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.72
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.71
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.71
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.7
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.56
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.49
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.47
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.38
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.26
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.12
KOG1243	690	consensus Protein kinase [General function predict	99.02
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.01
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.99
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.93
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.9
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.89
KOG3087	229	consensus Serine/threonine protein kinase [General	98.83
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.73
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.65
PRK09902	216	hypothetical protein; Provisional	98.63
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.56
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.52
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.51
COG4248	637	Uncharacterized protein with protein kinase and he	98.48
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.35
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.21
PF01657	106	Stress-antifung: Salt stress response/antifungal;	98.17
PF01636	239	APH: Phosphotransferase enzyme family This family	98.17
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.13
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.13
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.11
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.05
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.91
PLN02876	822	acyl-CoA dehydrogenase	97.72
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.69
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.65
PRK10593	297	hypothetical protein; Provisional	97.58
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.57
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.55
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.49
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.45
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.33
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.3
PRK05231	319	homoserine kinase; Provisional	97.18
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.14
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.02
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.76
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.6
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.6
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.58
PLN02236	344	choline kinase	96.47
COG2334	331	Putative homoserine kinase type II (protein kinase	96.17
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.87
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	95.84
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.66
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.63
PRK06148	1013	hypothetical protein; Provisional	95.42
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.39
PRK11768	325	serine/threonine protein kinase; Provisional	95.18
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.08
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	94.96
PLN02756	418	S-methyl-5-thioribose kinase	94.95
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	94.62
KOG2270	520	consensus Serine/threonine protein kinase involved	94.56
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.35
PF08693	40	SKG6: Transmembrane alpha-helix domain; InterPro:	94.25
PRK12396	409	5-methylribose kinase; Reviewed	94.07
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	93.4
KOG1236	565	consensus Predicted unusual protein kinase [Genera	93.36

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-60  Score=503.62  Aligned_cols=288  Identities=50%  Similarity=0.804  Sum_probs=257.0

Q ss_pred             CCcccCHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeee
Q 043267          304 NLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS  383 (614)
Q Consensus       304 ~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~  383 (614)
                      ....|++++|+.||++|+..++||+|+||.||+|.+++|+.||||++...+.+...+|.+|++++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            56789999999999999999999999999999999999999999998865543155699999999999999999999999


Q ss_pred             ecccCCCCc-eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          384 TATVPLEGH-QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       384 ~~~~~~~~~-~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      .     +++ +.+||||||+||||.++|+......++|.+|++||.++|+||+|||+.+.++||||||||+|||||++++
T Consensus       141 ~-----e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~  215 (361)
T KOG1187|consen  141 L-----EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN  215 (361)
T ss_pred             e-----cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence            8     455 5999999999999999998865448999999999999999999999998999999999999999999999


Q ss_pred             EEEeecCCceeCCC-CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccccc-CccchhhHHHH
Q 043267          463 AKVGDFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ-GKSVLLSDWAW  540 (614)
Q Consensus       463 ~kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~-~~~~~l~~~~~  540 (614)
                      +||+|||+|+..+. .....+.. .||.+|+||||+..+..++|+|||||||+|+||+||+++.+... .....+.+|++
T Consensus       216 aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~  294 (361)
T KOG1187|consen  216 AKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK  294 (361)
T ss_pred             EEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence            99999999987665 32222222 89999999999999999999999999999999999999986543 34456899999


Q ss_pred             HHHHcCCchhhhhccCC-CCCcH-HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          541 ELVKEGKTLDVIEENMP-EMELP-EMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ..+.+++..+++|+.+. ..+.. +++.++..++..|++.+|.+||+|.||+++|+...
T Consensus       295 ~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  295 PLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            99999999999999987 44444 68999999999999999999999999999996654

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=402.77  Aligned_cols=251  Identities=35%  Similarity=0.486  Sum_probs=206.4

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhh--hHHHHHHHHHHHHccccceeeeeeeeecccCCCCc-eEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH-QRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~-~~~lV~E  399 (614)
                      .+.||+|+||+||+|.+.....||||++.......  .++|.+|+.++.+++|||||+++|+|..     .. ...+|||
T Consensus        46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~-----~~~~~~iVtE  120 (362)
T KOG0192|consen   46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS-----PPGSLCIVTE  120 (362)
T ss_pred             hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-----CCCceEEEEE
Confidence            45599999999999999544449999998643222  5689999999999999999999999973     33 6899999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc-eEEeccCCCCeEECCCC-cEEEeecCCceeCCCC
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA-IIHRDIKASNILLDEAF-EAKVGDFGLAKFNPEG  477 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~-iiHrDIKp~NILLd~~~-~~kl~DFGla~~~~~~  477 (614)
                      ||++|+|.++++......++|..+++|+.|||+||.|||   +.+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            999999999998865678999999999999999999999   677 99999999999999997 9999999999865543


Q ss_pred             CccccccccCCCCcCchhhhc--cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          478 ITHLTTRVAGTLGYVAPEYAL--YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~--~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      . ...+...||+.|||||++.  ...|++|+|||||||++|||+||+.||.....     ...+......+.+...    
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-----~~~~~~v~~~~~Rp~~----  267 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-----VQVASAVVVGGLRPPI----  267 (362)
T ss_pred             c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcCCCCCC----
Confidence            2 2233478999999999999  56999999999999999999999999975543     1122233333333221    


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       +    ......+..++..||+.||+.||++.+++.+|+..
T Consensus       268 -p----~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  268 -P----KECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             -C----ccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence             1    12345677788889999999999999999999864

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-46  Score=396.59  Aligned_cols=251  Identities=32%  Similarity=0.461  Sum_probs=215.2

Q ss_pred             ccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          322 RENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ..+.||+|.||.||.|.++....||||.++..+ ...++|.+|+++|++|+|+|||+++|+|.     .++..+||||||
T Consensus       210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~-----~~~piyIVtE~m  283 (468)
T KOG0197|consen  210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCT-----KQEPIYIVTEYM  283 (468)
T ss_pred             HHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEe-----cCCceEEEEEec
Confidence            357899999999999999777799999998753 34567999999999999999999999997     445789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++|+|.++|....+..+...+.+.++.|||+|++||+   ++++|||||.++|||++++..+||+|||||+...++....
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999999999877788999999999999999999999   9999999999999999999999999999999666665555


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCC
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEME  560 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~  560 (614)
                      .....-...|.|||.+..+.++.|||||||||+||||+| |+.|+..+...+      +-+.+++|.+..         .
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e------v~~~le~GyRlp---------~  425 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE------VLELLERGYRLP---------R  425 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH------HHHHHhccCcCC---------C
Confidence            555556789999999999999999999999999999999 999987655422      224555554332         2


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          561 LPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      +......+.+++..||+.+|++|||++.+...|+..
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            334455677788889999999999999999988875

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=400.65  Aligned_cols=271  Identities=27%  Similarity=0.431  Sum_probs=226.2

Q ss_pred             cccCHHHHHHHhcCc---------cccceecccCceEEEEeEcC----CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc
Q 043267          306 ARFKIEEIKAATMNF---------SRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC-SKAGDANFKHEVEIIASV  371 (614)
Q Consensus       306 ~~f~~~el~~~t~~f---------~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l  371 (614)
                      ..++|||-..|...|         .++++||.|.||.||+|.++    ....||||.++.. .+....+|..|..||.++
T Consensus       608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF  687 (996)
T KOG0196|consen  608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF  687 (996)
T ss_pred             CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence            345665544444433         46689999999999999975    2357999999864 455677899999999999


Q ss_pred             cccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       372 ~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                      +||||++|.|+.+     ..+..+||.|||+||+|+.||+.+. ..+++.+...+.++||.|+.||.   +.++|||||.
T Consensus       688 dHPNIIrLEGVVT-----ks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLA  758 (996)
T KOG0196|consen  688 DHPNIIRLEGVVT-----KSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLA  758 (996)
T ss_pred             CCCcEEEEEEEEe-----cCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhh
Confidence            9999999999998     5667899999999999999998866 45999999999999999999999   9999999999


Q ss_pred             CCCeEECCCCcEEEeecCCceeCCCCCccccccccC--CCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccc
Q 043267          452 ASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG--TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEII  528 (614)
Q Consensus       452 p~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~  528 (614)
                      ++|||++.+...|++||||++...++.....+..-|  ..+|.|||.+.++++|.+||||||||+|||.++ |.+||.++
T Consensus       759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm  838 (996)
T KOG0196|consen  759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM  838 (996)
T ss_pred             hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence            999999999999999999999887765433333323  578999999999999999999999999999998 99999877


Q ss_pred             cCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          529 QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       529 ~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                      ..+++.      +         .+++..+-..+.+....+.+++++|||.|-.+||++.|++.+|++.+..|
T Consensus       839 SNQdVI------k---------aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  839 SNQDVI------K---------AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             chHHHH------H---------HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            654321      2         33333333345677788999999999999999999999999999986555

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=365.97  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=207.2

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeec-CChhhhHHHHHHHHHHHHccccceeeeeeeeec
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTA  385 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~  385 (614)
                      .+..||++       .+.||+|..|+|||+.++ +++.+|+|.+.. .+....+++.+|++++++.+||+||.++|.+..
T Consensus        76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            45555544       578999999999999975 688899999953 345567889999999999999999999999873


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                      .    +.+..++||||.+|||++.+...  +.+++...-+|+.+|.+||.|||+  +.+||||||||+|||++..|++||
T Consensus       149 ~----~~~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKi  220 (364)
T KOG0581|consen  149 N----GEEISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKI  220 (364)
T ss_pred             C----CceEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEe
Confidence            2    22699999999999999999654  469999999999999999999995  489999999999999999999999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      +|||.++...+.   .....+||..|||||.+.++.|+.++||||||+.++|+.+|+.|+...........+...     
T Consensus       221 cDFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~-----  292 (364)
T KOG0581|consen  221 CDFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLC-----  292 (364)
T ss_pred             ccccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHH-----
Confidence            999999876554   345578999999999999999999999999999999999999999654221111111111     


Q ss_pred             CCchhhhh---ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIE---ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          .+++   +.+++.   ....++..++-.|++.||.+||++.|+++
T Consensus       293 ----~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  293 ----AIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ----HHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                1222   222322   35567788888899999999999999874

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.4e-44  Score=399.85  Aligned_cols=260  Identities=28%  Similarity=0.433  Sum_probs=217.3

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      .+....+.||+|.||+||+|+..      +...||||.+++.... ...+|++|+++++.++|||||+|+|+|.     +
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~-----~  560 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR-----E  560 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc-----c
Confidence            34455678999999999999943      3467999999876554 7889999999999999999999999998     7


Q ss_pred             CceEEEEEeecCCCChhhhhhcC--------CCc----CCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGS--------GMK----KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~--------~~~----~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ++.+++|+|||..|+|.+||...        ...    +|+..+.+.||.|||.|++||-   +..+|||||..+|+|+.
T Consensus       561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVg  637 (774)
T KOG1026|consen  561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVG  637 (774)
T ss_pred             CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceec
Confidence            78899999999999999999742        122    3899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCceeC-CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhh
Q 043267          459 EAFEAKVGDFGLAKFN-PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLS  536 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~-~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~  536 (614)
                      ++..+||+||||++.. ..+..+......-.++|||||.+.+++||++||||||||+|||+++ |+-|+.....++    
T Consensus       638 e~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E----  713 (774)
T KOG1026|consen  638 ENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE----  713 (774)
T ss_pred             cceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH----
Confidence            9999999999999843 3333333323344679999999999999999999999999999999 999997665533    


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                        +.+.+++|+..+.         +.+...++..+++.||+.+|++||+++||-..|+.....+
T Consensus       714 --VIe~i~~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  714 --VIECIRAGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             --HHHHHHcCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence              4477777776432         3344557788899999999999999999999998875443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-42  Score=355.86  Aligned_cols=200  Identities=30%  Similarity=0.463  Sum_probs=179.3

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .+|...+.||+|+||+||+|+++ ++.+||||.+...  .....+.+..|+++|++++|||||.++.++.     ..+..
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~-----~~~~i   84 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIE-----DDDFI   84 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEe-----cCCeE
Confidence            46777788999999999999975 6899999999754  5666777899999999999999999999997     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC------CcEEEeec
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA------FEAKVGDF  468 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~------~~~kl~DF  468 (614)
                      ++|||||.+|+|.+||+..+  .+++.+.+.+..|+|.||++||   +++||||||||.||||+..      -.+||+||
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADF  159 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADF  159 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEeccc
Confidence            99999999999999997654  7999999999999999999999   9999999999999999765      46899999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccccc
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ  529 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  529 (614)
                      |+|+...++.  .....+|++.|||||++..++|+.|+|+||.|+++||+++|+.||+...
T Consensus       160 GfAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  160 GFARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             chhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9999887543  3456789999999999999999999999999999999999999997443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-43  Score=361.67  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=207.2

Q ss_pred             HhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCCh-------hhhHHHHHHHHHHHHccccceeeeeeeeeccc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSK-------AGDANFKHEVEIIASVKHVNLVALRGYSTATV  387 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~-------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~  387 (614)
                      ..+.|...+.||+|+||.|-+|.. ++|+.||||.+++...       .......+|+++|++++|||||++++++.   
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~---  246 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFE---  246 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeee---
Confidence            344678889999999999999995 5899999999974221       12234579999999999999999999997   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC---CcEE
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA---FEAK  464 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~---~~~k  464 (614)
                        ..+..|+|||||++|+|.+++-.++  .+.+..-..++.|++.|+.|||   ++||+||||||+|||+..+   ..+|
T Consensus       247 --~~ds~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llK  319 (475)
T KOG0615|consen  247 --VPDSSYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLK  319 (475)
T ss_pred             --cCCceEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEE
Confidence              5567799999999999999997654  5777778889999999999999   9999999999999999765   7899


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhccCC---CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK---LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      |+|||+|+...++  ....+.+||+.|.|||++.++.   +..|+|+||+||+||-+++|..||....+...     ..+
T Consensus       320 ItDFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----l~e  392 (475)
T KOG0615|consen  320 ITDFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----LKE  392 (475)
T ss_pred             ecccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----HHH
Confidence            9999999987643  3456689999999999998663   33488999999999999999999965443221     345


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ++..|+...      ......+..++..+++.+++..||++|||+.|+++
T Consensus       393 QI~~G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  393 QILKGRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             HHhcCcccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            566665432      12234456778899999999999999999999874

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-42  Score=371.30  Aligned_cols=249  Identities=30%  Similarity=0.420  Sum_probs=208.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ..|...+.||+|||+.||.++. ..|..||+|++.+.   .....+...+||++.+.|+|||||+++++++     +.+.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-----Ds~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-----DSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-----cCCc
Confidence            4688899999999999999997 78999999999752   3345667899999999999999999999997     6788


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .|+|.|+|++|+|..++.  .++.+++.+++.+..||+.||.|||   +.+|+|||||-.|++|++++++||+|||||..
T Consensus        93 VYivLELC~~~sL~el~K--rrk~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLK--RRKPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             eEEEEEecCCccHHHHHH--hcCCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeee
Confidence            999999999999999986  4568999999999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ...+. ....+.+|||.|+|||++....++..+||||+||+||-|+.|++||+...-.+     -. ..++.      -+
T Consensus       168 le~~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-----ty-~~Ik~------~~  234 (592)
T KOG0575|consen  168 LEYDG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-----TY-NKIKL------NE  234 (592)
T ss_pred             ecCcc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-----HH-HHHHh------cC
Confidence            76432 23455799999999999999999999999999999999999999996432111     11 11111      12


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHh
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV--KIL  593 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl--~~L  593 (614)
                      -.++.    .......+++..++++||.+|||+++|+  +.+
T Consensus       235 Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  235 YSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             ccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence            22222    3334556778889999999999999998  455

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.8e-43  Score=341.61  Aligned_cols=258  Identities=23%  Similarity=0.329  Sum_probs=209.0

Q ss_pred             CccccceecccCceEEEEeE-cCCCcEEEEEEee--cCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|.+.+.||+|.||+|||+. +.+|..||.|.+.  ..+.+..++...|+.+|+.|+|||||+.+++....   +.+...
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~---~~evln   96 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIE---DNEVLN   96 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhc---cchhhH
Confidence            47778899999999999999 5699999999886  34556677889999999999999999998854321   334489


Q ss_pred             EEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          396 IVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      |||||+..|+|.+.|..  +..+.++++.+++++.|+++||..+|... ++  |+||||||.||+||++|.+||+||||+
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~  175 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLG  175 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhH
Confidence            99999999999998864  55678999999999999999999999421 44  999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +++....+ .....+|||.||+||.+...+|+.||||||+||++|||+.-+.||...+     + .-..+.+..|+... 
T Consensus       176 r~l~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~-~~L~~KI~qgd~~~-  247 (375)
T KOG0591|consen  176 RFLSSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----L-LSLCKKIEQGDYPP-  247 (375)
T ss_pred             hHhcchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----H-HHHHHHHHcCCCCC-
Confidence            98876543 3445789999999999999999999999999999999999999996431     1 11234455553321 


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                          ++   .......+..++..|+.+||+.||+.-.+++-+..
T Consensus       248 ----~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  248 ----LP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             ----Cc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence                12   24456678888889999999999996555554444

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.1e-41  Score=402.24  Aligned_cols=268  Identities=26%  Similarity=0.417  Sum_probs=219.7

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecc
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTAT  386 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~  386 (614)
                      ++++++.   ..|...++||+|+||.||+|+. .+|..||||+++......    .+|++.+++++|||||+++|+|.  
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~--  753 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCR--  753 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEE--
Confidence            4444443   4578889999999999999996 578999999987543222    34688999999999999999997  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEe
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~  466 (614)
                         ++...++||||+++|+|.+++.     .++|.++.+|+.|+++||+|||+.++++|+||||||+||++++++.+++.
T Consensus       754 ---~~~~~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~  825 (968)
T PLN00113        754 ---SEKGAYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR  825 (968)
T ss_pred             ---cCCCCEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE
Confidence               4567899999999999999994     38999999999999999999998778899999999999999999998876


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                       ||.......     .....||+.|+|||++.++.++.|+|||||||++|||++|+.|++...+....+.+|+.......
T Consensus       826 -~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~  899 (968)
T PLN00113        826 -LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC  899 (968)
T ss_pred             -ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc
Confidence             665543221     12236789999999999999999999999999999999999999655444556777877665555


Q ss_pred             CchhhhhccCCC--CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          547 KTLDVIEENMPE--MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       547 ~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      ...+.+|+.+..  ....+++.++.+++..||+.+|++||||+||+++|+....
T Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            555556665532  2345667788999999999999999999999999998754

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.7e-41  Score=357.09  Aligned_cols=260  Identities=26%  Similarity=0.369  Sum_probs=205.3

Q ss_pred             hcCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVP  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~  388 (614)
                      .++|...+.||+|+||.||+|..      .+++.||||+++... ......+.+|++++.++ +||||+++++++..   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK---   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence            45788889999999999999973      235789999997533 23346789999999999 89999999998863   


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCC------------------------------------------------------
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSG------------------------------------------------------  414 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~------------------------------------------------------  414 (614)
                       .+...++||||+++|+|.+++....                                                      
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence             3456799999999999999986431                                                      


Q ss_pred             ------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcc-ccccccC
Q 043267          415 ------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAG  487 (614)
Q Consensus       415 ------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~g  487 (614)
                            ...+++.++++++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++........ ......+
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~  238 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL  238 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCC
Confidence                  134888999999999999999999   899999999999999999999999999999865433222 1223446


Q ss_pred             CCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHH
Q 043267          488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMME  566 (614)
Q Consensus       488 t~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~  566 (614)
                      +..|+|||++.+..++.++||||||+++|||++ |+.||.......     ........+....     .+    .....
T Consensus       239 ~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-----~~~~~~~~~~~~~-----~~----~~~~~  304 (338)
T cd05102         239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKDGTRMR-----AP----ENATP  304 (338)
T ss_pred             CccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-----HHHHHHhcCCCCC-----CC----CCCCH
Confidence            788999999999999999999999999999997 999986433211     1122233332211     11    12234


Q ss_pred             HHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          567 QYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       567 ~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      .+.+++..|++.||++|||+.|++++|+...
T Consensus       305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         305 EIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            6778999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=341.77  Aligned_cols=241  Identities=29%  Similarity=0.332  Sum_probs=196.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..++||+|+||+||.++.+ .++.+|+|.+++.   .....+...+|..++.+++||+||++.--+.     +++.
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ-----t~~k   99 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQ-----TEEK   99 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecc-----cCCe
Confidence            46899999999999999999965 5888999999753   2334567889999999999999999976654     6788


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +|+|+||+.||.|..+|.+++  .+++....-++.+|+.||.|||   +.+||||||||+|||||++|+++|+||||++.
T Consensus       100 LylVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  100 LYLVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEEEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            999999999999999997654  7999988889999999999999   99999999999999999999999999999985


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .-... ..+...+||+.|||||++....|+..+|+||+|+++|||++|.+||.....     ..+. +.+..++.     
T Consensus       175 ~~~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~-~~I~~~k~-----  242 (357)
T KOG0598|consen  175 DLKDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMY-DKILKGKL-----  242 (357)
T ss_pred             cccCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHH-HHHhcCcC-----
Confidence            44332 234558999999999999999999999999999999999999999964332     2222 22222221     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCC
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARP  584 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  584 (614)
                         +. .+.-......+++...++.||++|-
T Consensus       243 ---~~-~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 ---PL-PPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---CC-CCccCCHHHHHHHHHHhccCHHHhc
Confidence               10 1111334566777778999999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-41  Score=344.97  Aligned_cols=256  Identities=29%  Similarity=0.428  Sum_probs=203.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++...+.||+|+||.||++... +|...|||.+...+....+.+.+|+.++++++|||||+.+|.....   +.....+
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~---~~~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSR---ENDEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccc---cCeeeEe
Confidence            35677789999999999999975 4899999998765433366789999999999999999999975422   1136899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeecCCceeCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNP  475 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~~~  475 (614)
                      .|||+++|||.+++.+.+. .|++....+...|+++||.|||   +++|+||||||+|||++. ++.+||+|||+++...
T Consensus        94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999999988776 8999999999999999999999   999999999999999999 7999999999998655


Q ss_pred             C--CCccccccccCCCCcCchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          476 E--GITHLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       476 ~--~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .  ..........||+.|||||++..+. ...++||||+||+++||+||+.||...    .....+.......+..    
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~----~~~~~~~~~ig~~~~~----  241 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF----FEEAEALLLIGREDSL----  241 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh----cchHHHHHHHhccCCC----
Confidence            3  2222344578999999999999653 335999999999999999999999643    1112222222222211    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                       +.++    ........+++..|++.+|+.|||++++++--
T Consensus       242 -P~ip----~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  242 -PEIP----DSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             -CCCC----cccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence             1222    22344566778889999999999999998643

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.7e-40  Score=333.71  Aligned_cols=254  Identities=27%  Similarity=0.445  Sum_probs=208.4

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|+..++||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++|+|++++++.+.     ++...+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   79 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT-----KEEPIYII   79 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc-----CCCCcEEE
Confidence            4688889999999999999998888999999986533 34567899999999999999999998876     55678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.......+++.+++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            99999999999997766667999999999999999999999   899999999999999999999999999999876543


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........++..|+|||+...+.++.++||||||+++|||++ |+.||......  .    ....+..+...       
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~----~~~~~~~~~~~-------  223 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS--D----VMSALQRGYRM-------  223 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH--H----HHHHHHcCCCC-------
Confidence            3333333456778999999999999999999999999999998 99998533211  1    11222222111       


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      +  ........+.+++..|++.+|++||+++++.++|++
T Consensus       224 ~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         224 P--RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             C--CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0  111233467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.4e-40  Score=338.76  Aligned_cols=262  Identities=19%  Similarity=0.296  Sum_probs=205.1

Q ss_pred             CcccCHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhh---hHHHHHHHHHHHHccccceeeeee
Q 043267          305 LARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG---DANFKHEVEIIASVKHVNLVALRG  381 (614)
Q Consensus       305 ~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~---~~~f~~Ei~il~~l~H~niv~l~g  381 (614)
                      ...++.+++     +......||+|++|.||+|+. +|+.||||+++......   .+.+.+|++++++++||||++++|
T Consensus        12 ~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g   85 (283)
T PHA02988         12 IKCIESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG   85 (283)
T ss_pred             ceecCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence            344555655     233346799999999999998 78999999997543322   467889999999999999999999


Q ss_pred             eeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCC
Q 043267          382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEA  460 (614)
Q Consensus       382 ~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~  460 (614)
                      ++..... .....++||||+++|+|.+++.+.  ..++|..+++++.+++.||.|||   + .+++||||||+|||++++
T Consensus        86 ~~~~~~~-~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill~~~  159 (283)
T PHA02988         86 FIIDIVD-DLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLVTEN  159 (283)
T ss_pred             eEEeccc-CCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEECCC
Confidence            9864111 235679999999999999999654  47899999999999999999999   5 478899999999999999


Q ss_pred             CcEEEeecCCceeCCCCCccccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          461 FEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       461 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                      +.+||+|||+++......    ....|+..|+|||++.+  +.++.++|||||||++|||++|+.||.....     .+.
T Consensus       160 ~~~kl~dfg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~-----~~~  230 (283)
T PHA02988        160 YKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT-----KEI  230 (283)
T ss_pred             CcEEEcccchHhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH-----HHH
Confidence            999999999998644321    23468899999999976  7899999999999999999999999964332     111


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .......+..     ..++    ......+.+++..||+.||++|||+.|+++.|+..
T Consensus       231 ~~~i~~~~~~-----~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        231 YDLIINKNNS-----LKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             HHHHHhcCCC-----CCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            1122222211     1111    12344677888999999999999999999999864

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-39  Score=338.93  Aligned_cols=262  Identities=25%  Similarity=0.371  Sum_probs=201.9

Q ss_pred             cCccccceecccCceEEEEeEcCC-----------------CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeee
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN-----------------GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVAL  379 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l  379 (614)
                      ++|...+.||+|+||.||++.+++                 +..||+|.+... ......+|.+|++++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467888999999999999997532                 347999998753 33445679999999999999999999


Q ss_pred             eeeeecccCCCCceEEEEEeecCCCChhhhhhcCC-----------------CcCCChHHHHHHHHHHHHHHHHHhhcCC
Q 043267          380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-----------------MKKLSWPIRLRIALGTARGLAYLHYGVQ  442 (614)
Q Consensus       380 ~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~-----------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~  442 (614)
                      ++++.     +....++||||+++|+|.+++....                 ...++|..+++|+.|+++||.|||   +
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~  156 (304)
T cd05096          85 LGVCV-----DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---S  156 (304)
T ss_pred             EEEEe-----cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---H
Confidence            99987     4567899999999999999985421                 135789999999999999999999   8


Q ss_pred             CceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-
Q 043267          443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-  520 (614)
Q Consensus       443 ~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-  520 (614)
                      .+|+||||||+|||+++++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ 
T Consensus       157 ~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         157 LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHc
Confidence            8999999999999999999999999999986543322 12233456789999999999999999999999999999997 


Q ss_pred             -CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          521 -GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       521 -G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                       +..|+......  .....+............      ...++.....+.+++..||+.+|++|||+.||.++|++
T Consensus       237 ~~~~p~~~~~~~--~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         237 CKEQPYGELTDE--QVIENAGEFFRDQGRQVY------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCCCCCcCCHH--HHHHHHHHHhhhcccccc------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence             45566433221  122222222221111000      00112234567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6e-40  Score=334.90  Aligned_cols=255  Identities=24%  Similarity=0.369  Sum_probs=203.7

Q ss_pred             cCccccceecccCceEEEEeEcC----CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|+..+.||+|+||.||+|.++    .+..||+|.++.. +......+.+|++++++++|||+++++|++.     .+.
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            46888899999999999999853    4678999999764 3334567899999999999999999999986     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++.... ..++|.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+.
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~  155 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQ  155 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence            7899999999999999997643 47899999999999999999999   8999999999999999999999999999876


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ..............++..|+|||.+.++.++.++||||||+++||+++ |+.||.......      ..+.+.++...  
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~~--  227 (266)
T cd05064         156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------VIKAVEDGFRL--  227 (266)
T ss_pred             cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCCC--
Confidence            533222111222345678999999999999999999999999999876 999986443211      11222222111  


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                             ..+......+.+++..||+.+|++||++.++.+.|++.
T Consensus       228 -------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                   11222344677888999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=337.51  Aligned_cols=265  Identities=29%  Similarity=0.361  Sum_probs=201.3

Q ss_pred             ccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc--cccceeeeeeeeecccCCCCceEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l--~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ....++||+|+||.||||++ +++.||||++..   +..+.|++|-++++..  +|+||+++++.-..... .+.+.+||
T Consensus       212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~-~~~eywLV  286 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA-DRMEYWLV  286 (534)
T ss_pred             hhhHHHhhcCccceeehhhc-cCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCc-cccceeEE
Confidence            34457799999999999999 559999999964   4566788888887754  89999999998653332 35689999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc------CCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG------VQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~------~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +||.++|||.+||..   ..++|....+|+..+++||+|||++      .+++|+|||||++|||+.+|++..|+|||+|
T Consensus       287 t~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  287 TEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             eeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999999965   4699999999999999999999954      4678999999999999999999999999999


Q ss_pred             eeCCCCCcc-ccccccCCCCcCchhhhccC-CCC-----chhhHHHHHHHHHHHHhCCCCccc--ccCccch--------
Q 043267          472 KFNPEGITH-LTTRVAGTLGYVAPEYALYG-KLT-----PGSDVYSFGVVLLELLSGKKACEI--IQGKSVL--------  534 (614)
Q Consensus       472 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~-~~t-----~ksDVwS~Gvll~ElltG~~p~~~--~~~~~~~--------  534 (614)
                      ..+..+... .....+||.+|||||++.+. .+.     .+.||||+|.+||||++.....+.  ..+.+..        
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            877655443 23347899999999998754 222     468999999999999997654421  1111111        


Q ss_pred             -hhHHHHHHHHcC-CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          535 -LSDWAWELVKEG-KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       535 -l~~~~~~~~~~g-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       -.+-++..+-.. .+....+.-..    ...+.-+.+.+..||..||+.|.|+.=|-+.+...
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRK----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhc----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence             122233333322 22222222111    13466788899999999999999998888777665

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=330.94  Aligned_cols=255  Identities=30%  Similarity=0.440  Sum_probs=208.0

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|+..+.||+|+||.||+|...+++.||+|.++... ...+++.+|++++++++|+|++++++++.     .+...++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   78 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYI   78 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeee
Confidence            45688889999999999999998788899999987533 34567899999999999999999999886     5567899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      +|||+++++|.+++.......++|..+.+++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++....
T Consensus        79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999999999997765567999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ...........+..|+|||+..+..++.++||||||+++|||++ |+.|+......      -....+..+..       
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~~~~-------  222 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA------EVLQQVDQGYR-------  222 (261)
T ss_pred             CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC-------
Confidence            32222222333568999999999999999999999999999999 99888543211      11122222211       


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      .  .........+.+++..|++.+|++||++.++++.|++
T Consensus       223 ~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 M--PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             C--CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            0  1112234578889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-40  Score=353.59  Aligned_cols=265  Identities=29%  Similarity=0.426  Sum_probs=206.4

Q ss_pred             HHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeec--CChhhhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          311 EEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       311 ~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      ++.+...+.+.....||+|.||+||+|.+.  ..||||.++-  .+....+.|++|+.++++.+|.||+-+.|||..   
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~---  459 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN---  459 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC---
Confidence            333344445666788999999999999984  3499999974  344566889999999999999999999999963   


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                         ....||..++++-+|+.+|+..+ ..|+..+.+.|+.|||+|+.|||   .++|||||||..||+|.++++|||+||
T Consensus       460 ---p~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 ---PPLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             ---CceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecc
Confidence               34499999999999999998754 67999999999999999999999   999999999999999999999999999


Q ss_pred             CCceeCCC-CCccccccccCCCCcCchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          469 GLAKFNPE-GITHLTTRVAGTLGYVAPEYALYG---KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       469 Gla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      ||+..... ..........|...|||||++..+   +|+..|||||||+++|||++|..||.....+++.        +.
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi--------fm  604 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII--------FM  604 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE--------EE
Confidence            99864221 111222334577899999999854   7999999999999999999999999843333322        11


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      -|+-.-..|........   ...+.++...||..++++||.+.+++.+|+...+
T Consensus       605 VGrG~l~pd~s~~~s~~---pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  605 VGRGYLMPDLSKIRSNC---PKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ecccccCccchhhhccC---HHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            12221111222222222   3345566777999999999999999998888765

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=336.61  Aligned_cols=260  Identities=24%  Similarity=0.319  Sum_probs=207.1

Q ss_pred             cCccccceecccCceEEEEeE-cCCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.|+..+.||.|..++||+|. .+.+..||||++.-. .....+.+.+|+..++.++||||++.+..+.     .+.+++
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv-----v~~~LW  100 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV-----VDSELW  100 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE-----ecceeE
Confidence            468888999999999999999 567899999999732 2333688999999999999999999988776     678899


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||.||.+||+.+.++..-...+++..+..|..++++||.|||   ++|.||||||+.||||+++|.+||+|||.+..+.
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~  177 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF  177 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence            9999999999999998765566999999999999999999999   9999999999999999999999999999875433


Q ss_pred             CCCcc---ccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          476 EGITH---LTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       476 ~~~~~---~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      +....   ......||+.|||||+++.  ..|+.|+||||||++.+||.+|..||.....-...+     ..+ .|....
T Consensus       178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-----~tL-qn~pp~  251 (516)
T KOG0582|consen  178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-----LTL-QNDPPT  251 (516)
T ss_pred             ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-----HHh-cCCCCC
Confidence            22221   2256789999999999654  479999999999999999999999997655422221     111 121111


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..-..++.+........+.+++..|++.||++|||++++++
T Consensus       252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11112222222334457788889999999999999999984

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-40  Score=378.47  Aligned_cols=255  Identities=29%  Similarity=0.427  Sum_probs=208.0

Q ss_pred             CccccceecccCceEEEEeEcC--CCc----EEEEEEeec-CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP--NGT----EVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~--~g~----~VAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +....+.||+|.||.||.|...  +|.    .||||.++. .+.+...+|.+|..+|++++|||||+++|+|.     +.
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l-----~~  767 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL-----DS  767 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec-----CC
Confidence            4455678999999999999964  343    489999976 45677889999999999999999999999997     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCC-----CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEe
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSG-----MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~-----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~  466 (614)
                      ...++++|||++|+|..+|++.+     ...++....+.++.|||+|+.||+   ++++|||||.++|+||++...+||+
T Consensus       768 ~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIa  844 (1025)
T KOG1095|consen  768 GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIA  844 (1025)
T ss_pred             CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEc
Confidence            77899999999999999998752     356899999999999999999999   9999999999999999999999999


Q ss_pred             ecCCceeCCC-CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHH
Q 043267          467 DFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       467 DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      |||||+...+ +......+-.-...|||||.+..+.+|.|+|||||||++||++| |..||......+..     ....+
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-----~~~~~  919 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-----LDVLE  919 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-----HHHHh
Confidence            9999994332 22222222123468999999999999999999999999999999 99999755442221     12233


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .|++        +  .+....+++.+++..||+.+|++||++..+++.++..
T Consensus       920 ggRL--------~--~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  920 GGRL--------D--PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             CCcc--------C--CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            3322        1  2344556778999999999999999999999977665

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.8e-39  Score=328.69  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=203.1

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...+.||+|+||.||++.++++..+|+|.+... ....+++.+|++++++++|||++++++++.     +....++|
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCT-----QQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEc-----cCCCEEEE
Confidence            357778899999999999999988889999988643 333567899999999999999999999986     55678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.... ..++|..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~  153 (256)
T cd05114          78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD  153 (256)
T ss_pred             EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence            99999999999987543 36899999999999999999999   899999999999999999999999999999765433


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....     .+.. ..+..+....     .
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-----~~~~-~~i~~~~~~~-----~  222 (256)
T cd05114         154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-----YEVV-EMISRGFRLY-----R  222 (256)
T ss_pred             ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHH-HHHHCCCCCC-----C
Confidence            2222233345678999999998899999999999999999999 8888854322     1111 1222221110     0


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      +    ......+.+++..||+.+|++||++.+++++|.
T Consensus       223 ~----~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 P----KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             C----CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            1    112346788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-39  Score=350.42  Aligned_cols=257  Identities=26%  Similarity=0.371  Sum_probs=203.1

Q ss_pred             cCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ++|+..+.||+|+||.||+++.      .++..||||+++... ....+.+.+|+++++.+ +||||+++++++.     
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~-----  109 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT-----  109 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec-----
Confidence            4688889999999999999973      246689999997432 33456788999999999 8999999999986     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCC-------------------------------------------------------
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSG-------------------------------------------------------  414 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~-------------------------------------------------------  414 (614)
                      ++...++||||+++|+|.+++....                                                       
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence            5667899999999999999986422                                                       


Q ss_pred             ------------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          415 ------------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       415 ------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                                        ...++|..+++|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                              125789999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          477 GITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       477 ~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......     -..+.+..+....    
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-----~~~~~~~~~~~~~----  337 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-----KFYKMIKEGYRML----  337 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-----HHHHHHHhCccCC----
Confidence            3221 1222345678999999999999999999999999999998 888885433211     1122333332111    


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       .+    ......+.+++..|++.||++||++.||+++|++.
T Consensus       338 -~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 -SP----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             -CC----CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence             11    11134677889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.3e-40  Score=334.54  Aligned_cols=249  Identities=33%  Similarity=0.467  Sum_probs=195.8

Q ss_pred             ccceecccCceEEEEeEcC-----CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          322 RENIIGKGGYGNVYKGMLP-----NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ..+.||.|.||.||+|.+.     .+..|+||.++.. .....++|.+|++.+++++||||++++|++.     ..+..+
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~-----~~~~~~   77 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCI-----ENEPLF   77 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEE-----SSSSEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccc-----cccccc
Confidence            4578999999999999976     3578999999653 3345788999999999999999999999997     455689


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||+++|+|.++|.......+++.++.+|+.|+++||+|||   +.+++|+||+++||++++++.+||+|||+++...
T Consensus        78 lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~  154 (259)
T PF07714_consen   78 LVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS  154 (259)
T ss_dssp             EEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            9999999999999998876678999999999999999999999   7899999999999999999999999999998763


Q ss_pred             CCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          476 EGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       476 ~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .... .......+...|+|||.+....++.++||||||+++|||++ |+.|+.....     .+.. ..+.++....   
T Consensus       155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~-----~~~~-~~~~~~~~~~---  225 (259)
T PF07714_consen  155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN-----EEII-EKLKQGQRLP---  225 (259)
T ss_dssp             TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH-----HHHH-HHHHTTEETT---
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-----cccc-ccccccccce---
Confidence            3222 22333456789999999999999999999999999999999 6788754322     1222 2224443321   


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                            .+......+..++..||+.+|++|||+.++++.|
T Consensus       226 ------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  226 ------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                  1122244577889999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.5e-39  Score=329.35  Aligned_cols=254  Identities=28%  Similarity=0.402  Sum_probs=206.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +|...+.||+|+||.||+|... +++.||+|.+... .....++.+|+++++.++|+|++++++++.     .+...+++
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            4778899999999999999965 5889999998753 334567899999999999999999999986     45677999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++++|.+++.......+++..++.++.|+++||+|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            99999999999997766667999999999999999999999   899999999999999999999999999999865543


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........++..|+|||++.+..++.++||||||+++|||++ |..|+.....     .+ .+.....+..        
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~-~~~~~~~~~~--------  223 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ-VYELLEKGYR--------  223 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HH-HHHHHHCCCC--------
Confidence            3222222334678999999999999999999999999999998 8888853221     11 1222222211        


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       ..........+.+++..|++.+|++||++.+++++|+..
T Consensus       224 -~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         224 -MERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence             111122335677889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=9.7e-40  Score=331.12  Aligned_cols=256  Identities=27%  Similarity=0.436  Sum_probs=211.2

Q ss_pred             HhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ...+|...+.||+|+||.||+|...++..+|+|.+.........++.+|+++++.++|+|++++++++.     ++...+
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            345688889999999999999998889999999998766656678999999999999999999999886     556789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.+++.+.....+++.++.+++.+++.||+|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence            9999999999999998766678999999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ..... .....++..|+|||....+.++.++||||||+++|||++ |+.|+.......  .    ......+..      
T Consensus       156 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~----~~~~~~~~~------  222 (261)
T cd05148         156 EDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--V----YDQITAGYR------  222 (261)
T ss_pred             Ccccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--H----HHHHHhCCc------
Confidence            43222 223446778999999999999999999999999999998 888885433211  1    111111111      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                         ..........+.+++..|++.+|++|||+.++++.|+.
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 ---MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence               11112334567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.1e-39  Score=334.68  Aligned_cols=251  Identities=25%  Similarity=0.330  Sum_probs=200.7

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|+..+.||+|+||.||++.. .+|+.||||.+....   ......+.+|++++++++|+|++++.+++.     ++...
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~-----~~~~~   75 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEc-----cCCeE
Confidence            367789999999999999996 478999999986432   223456789999999999999999999886     56688


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|+||+++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++...
T Consensus        76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            99999999999999887655557999999999999999999999   899999999999999999999999999999875


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      .....  .....||..|+|||++.+..++.++|||||||++|||++|+.||........  .+-.......+        
T Consensus       153 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~--~~~~~~~~~~~--------  220 (285)
T cd05631         153 PEGET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVK--REEVDRRVKED--------  220 (285)
T ss_pred             CCCCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchh--HHHHHHHhhcc--------
Confidence            43322  2345689999999999999999999999999999999999999964332110  01111111111        


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                        ...........+.+++..|++.||++||+     ++++++
T Consensus       221 --~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         221 --QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              01112223446778889999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=355.82  Aligned_cols=255  Identities=29%  Similarity=0.409  Sum_probs=203.9

Q ss_pred             CccccceecccCceEEEEeEcC--CC---cEEEEEEeec---CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP--NG---TEVAVKRFKN---CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~--~g---~~VAVK~l~~---~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      +....++||+|+||.||+|++.  ++   ..||||..+.   .......+|.+|.+++++++|||||+++|++.     .
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~-----~  232 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV-----L  232 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc-----C
Confidence            3444589999999999999964  23   2389999984   44667789999999999999999999999997     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      +...++|||+++||+|.++|...+. .++..++++++.+.|+||+|||   +.++|||||.++|+|++.++.+||+||||
T Consensus       233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            5678999999999999999987653 7999999999999999999999   99999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHH-HcCCc
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELV-KEGKT  548 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~-~~g~~  548 (614)
                      ++.... .........-...|+|||.+..+.|+.++|||||||++||+++ |..||......+      +...+ .++..
T Consensus       309 s~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~------v~~kI~~~~~r  381 (474)
T KOG0194|consen  309 SRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE------VKAKIVKNGYR  381 (474)
T ss_pred             ccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH------HHHHHHhcCcc
Confidence            875431 1111111134678999999999999999999999999999999 888987554321      22222 33322


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      ..         .+......+..+...||..+|++||+|.++.+.|+....
T Consensus       382 ~~---------~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  382 MP---------IPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             CC---------CCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence            21         111223345556668999999999999999999987643

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=349.24  Aligned_cols=257  Identities=27%  Similarity=0.387  Sum_probs=202.4

Q ss_pred             cCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ++|...+.||+|+||.||+++.      .++..||||+++... ....+.+.+|+++++.+ +|+||+++++++.     
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~-----  112 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT-----  112 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec-----
Confidence            4688889999999999999873      234679999997543 33345688999999999 8999999999986     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCC-------------------------------------------------------
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSG-------------------------------------------------------  414 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~-------------------------------------------------------  414 (614)
                      +....++||||+++|+|.+++....                                                       
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            5567899999999999999985421                                                       


Q ss_pred             -------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcc-
Q 043267          415 -------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH-  480 (614)
Q Consensus       415 -------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~-  480 (614)
                                   ...+++.+.++|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++........ 
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                         124788999999999999999999   899999999999999999999999999999865433221 


Q ss_pred             ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCC
Q 043267          481 LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM  559 (614)
Q Consensus       481 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~  559 (614)
                      ......++..|+|||++..+.++.++||||||+++|||++ |+.||........     .+.....+..     ...+. 
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~-----~~~~~~~~~~-----~~~~~-  338 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK-----FYKMVKRGYQ-----MSRPD-  338 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH-----HHHHHHcccC-----ccCCC-
Confidence            1222345678999999999999999999999999999997 9999864332111     1122222211     11111 


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          560 ELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                         .....+.+++..|++.||++|||+.+|+++|++.
T Consensus       339 ---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 ---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1234677888899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.7e-39  Score=326.41  Aligned_cols=254  Identities=30%  Similarity=0.444  Sum_probs=206.1

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .+|...+.||+|+||.||+|+.+++..||+|.++... ...+++.+|+++++.++|+|++++++++.      +...++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv   78 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV   78 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC------CCCcEEE
Confidence            4688889999999999999998777789999997532 23467899999999999999999998763      3457899


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.......+++..+.+++.|+++||+|||   +.+++||||||+||++++++.+||+|||.++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            99999999999997655567899999999999999999999   899999999999999999999999999999866543


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........++..|+|||+..++.++.++||||||+++|||++ |+.||......      ........+.         
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~------~~~~~~~~~~---------  220 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGY---------  220 (262)
T ss_pred             ccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH------HHHHHHhcCC---------
Confidence            3222233456778999999999999999999999999999999 78887533211      1111111111         


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ......+....+.+++..|++.+|++||++.+++++|+..
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1111233455778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.5e-39  Score=325.44  Aligned_cols=253  Identities=28%  Similarity=0.434  Sum_probs=204.7

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|+..+.||+|+||.||++..+++..||+|.+..... ..+.+.+|++++++++|+|++++++++.      ....+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~------~~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS------EEPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC------CCCcEEE
Confidence            35777899999999999999988888999999875333 3467899999999999999999998863      3457899


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++++|.+++.+.....+++.++++++.+++.||.|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999999998765567999999999999999999999   889999999999999999999999999999865443


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........++..|+|||...++.++.++||||||+++|||++ |+.||.....     .+.. +.+..+..        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~-----~~~~-~~~~~~~~--------  221 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN-----REVL-EQVERGYR--------  221 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH-----HHHH-HHHHcCCC--------
Confidence            3222223345678999999999999999999999999999999 8888854321     1111 11111111        


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                       ..........+.+++..|++.+|++|||+.++.++|+.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 -MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             11112334568889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.4e-39  Score=329.32  Aligned_cols=254  Identities=28%  Similarity=0.460  Sum_probs=204.5

Q ss_pred             CccccceecccCceEEEEeEcCC------CcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +|+..+.||+|+||.||+|....      +..||+|.++... .....++.+|++++++++|||++++++++.     ..
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~   80 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----KE   80 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----CC
Confidence            57778899999999999998642      2579999987433 334567899999999999999999999986     45


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCC--------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGM--------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL  457 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~--------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL  457 (614)
                      ...+++|||+++|+|.+++.....              ..+++.+.+.++.|++.||.|||   +.+++||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~  157 (283)
T cd05048          81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLV  157 (283)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEE
Confidence            678999999999999999965321              46889999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEeecCCceeCCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchh
Q 043267          458 DEAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLL  535 (614)
Q Consensus       458 d~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l  535 (614)
                      ++++.+||+|||+++...... ........+++.|+|||++..+.++.++||||||+++|||++ |+.||......+   
T Consensus       158 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---  234 (283)
T cd05048         158 GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---  234 (283)
T ss_pred             cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence            999999999999998653322 122334456889999999999999999999999999999998 999986433211   


Q ss_pred             hHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          536 SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       536 ~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                         ....+..+....         ........+.+++..||+.+|.+||++.||++.|++
T Consensus       235 ---~~~~i~~~~~~~---------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 ---VIEMIRSRQLLP---------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---HHHHHHcCCcCC---------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence               122233332211         122344678889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.5e-39  Score=325.38  Aligned_cols=251  Identities=29%  Similarity=0.435  Sum_probs=203.0

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +|...+.||+|+||.||+|...++..+|||.++... ...+++.+|+.++++++||||+++++++.     +....+++|
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~   78 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIVT   78 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEEE
Confidence            467778999999999999998777789999987533 34567999999999999999999999986     455679999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++.... ..+++.++++++.|++.||+|||   +.+++|+||||+||++++++.+||+|||+++......
T Consensus        79 e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          79 EYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             EcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999999997643 36899999999999999999999   8999999999999999999999999999998654433


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      ........++..|+|||...++.++.++||||||+++|||++ |+.|+......     + .......+....     . 
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~-~~~~~~~~~~~~-----~-  222 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----E-TVEKVSQGLRLY-----R-  222 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----H-HHHHHhcCCCCC-----C-
Confidence            222223345678999999998899999999999999999999 99998543321     1 112222222110     1 


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                         .......+.+++..||+.+|++||++.++++.|+
T Consensus       223 ---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         223 ---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               1122457788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6e-39  Score=330.02  Aligned_cols=268  Identities=28%  Similarity=0.372  Sum_probs=203.9

Q ss_pred             ccccceecccCceEEEEeEc-----CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          320 FSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      |...+.||+|+||+||++..     .++..||+|.++... ......+.+|++++++++|||++++++++...   ....
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ---GGKG   82 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCce
Confidence            37778999999999987652     367899999987543 33456788999999999999999999987632   3456


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+++|||+++|+|.+++...   .+++.+++.++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            89999999999999999653   5999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          474 NPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       474 ~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ...+...  ......++..|+|||....+.++.++||||||+++|||++|+.|+............+...........+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence            6543221  12223456779999999989999999999999999999999999854332111111111101111111122


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .+..............+.+++..|++.+|++|||+++++++|+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            222221111223345788899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=9.6e-39  Score=324.19  Aligned_cols=253  Identities=27%  Similarity=0.425  Sum_probs=206.7

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...++||+|+||.||+|..++++.||+|.+.... ...+++.+|++++++++|+|++++.++..      ....+++
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v   78 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYII   78 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEEE
Confidence            4678889999999999999999899999999987533 33567899999999999999999998763      3457999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||++......
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999999998766678999999999999999999999   899999999999999999999999999999866533


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........++..|+|||++..+.++.++||||||+++|||++ |+.||......     +. ...+..+....     .
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~~-~~~~~~~~~~~-----~  224 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP-----EV-IQNLERGYRMP-----R  224 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH-----HH-HHHHHcCCCCC-----C
Confidence            2222233446788999999999999999999999999999999 99998643321     11 11222221111     1


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                          .......+.+++..|++.+|++||++++++++|+.
T Consensus       225 ----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ----PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                11223468889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-39  Score=324.42  Aligned_cols=251  Identities=26%  Similarity=0.388  Sum_probs=201.5

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +|+..+.||+|+||.||++..+++..+|+|.+.... ...+++.+|+++++.++|+|++++++++.     +....++|+
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~   78 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCT-----KQRPIFIVT   78 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEc-----CCCceEEEE
Confidence            467788999999999999998777889999986532 23457889999999999999999999876     556789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++++|.+++.... ..++|..++.|+.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...+..
T Consensus        79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999999997644 36899999999999999999999   8999999999999999999999999999998654332


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      ........++..|+|||...+..++.++||||||+++|||++ |+.|+.......      .......+..         
T Consensus       155 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~---------  219 (256)
T cd05059         155 YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------VVESVSAGYR---------  219 (256)
T ss_pred             ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------HHHHHHcCCc---------
Confidence            222222234568999999999999999999999999999999 788885432211      1112222211         


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ...+......+.+++..|++.+|++|||+.|++++|.
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence            1111223457888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.6e-38  Score=322.77  Aligned_cols=253  Identities=30%  Similarity=0.444  Sum_probs=204.4

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...+.||+|+||.||++..+++..+|+|++.... ...+.+.+|++++++++|+|++++++++.      ....+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS------EEPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc------CCCcEEE
Confidence            3577888999999999999998777789999886533 33467889999999999999999998863      3457899


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.......++|..+..++.+++.||.|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            99999999999997765567899999999999999999999   889999999999999999999999999999865443


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........++..|+|||+..++.++.++||||||+++|||++ |+.|+.......      .+.....+..        
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~--------  221 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE------VLEQVERGYR--------  221 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC--------
Confidence            2222223346778999999999999999999999999999999 888886432211      1122222111        


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                       ..........+.+++..|++.+|++||++++|+++|+.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             01112334567888999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=6.7e-39  Score=335.76  Aligned_cols=255  Identities=24%  Similarity=0.416  Sum_probs=202.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCc----EEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGT----EVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|+..+.||+|+||.||+|++. +|.    .||||.++... ....+++.+|+.+++.++||||++++|+|..      
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~------   80 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   80 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC------
Confidence            35888999999999999999864 343    48999987533 3445678999999999999999999999862      


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++++||+++|+|.+++.... ..+++..+++++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++
T Consensus        81 ~~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a  156 (316)
T cd05108          81 STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (316)
T ss_pred             CCceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEcccccc
Confidence            34679999999999999997643 46899999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccc-cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITHL-TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +......... .....++..|+|||++....++.++||||||+++|||++ |+.|+......     ++ ......+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~-----~~-~~~~~~~~~~  230 (316)
T cd05108         157 KLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-----EI-SSILEKGERL  230 (316)
T ss_pred             ccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-----HH-HHHHhCCCCC
Confidence            8665433221 122334678999999999999999999999999999998 99998643211     11 1222222111


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                             +  ........+..++..||+.+|++||++.+++..|....
T Consensus       231 -------~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         231 -------P--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             -------C--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                   1  11122346778899999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-38  Score=325.00  Aligned_cols=255  Identities=29%  Similarity=0.434  Sum_probs=205.0

Q ss_pred             cCccccceecccCceEEEEeEcCC----CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|+..+.||+|+||.||+|+++.    ...||||.++.. ......+|.+|+.++++++|+|++++++++.     ++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            468889999999999999999742    457999998753 3344567899999999999999999999886     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..+++|||+++|+|.+++.... ..+++.++++++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~  154 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhh
Confidence            7899999999999999997643 37899999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          473 FNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       473 ~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......      .......+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~------~~~~~~~~~~~~  228 (266)
T cd05033         155 RLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD------VIKAVEDGYRLP  228 (266)
T ss_pred             cccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence            7642221 12222345678999999999999999999999999999998 999985432211      112222221110


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                               ........+.+++..|++.+|++||++.||+++|+..
T Consensus       229 ---------~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         229 ---------PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     1122345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=343.56  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=208.3

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .|.....||+|+.|.||.+.. .++++||||++........+-+.+|+.+|+..+|+|||.++.-+.     .++++++|
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Syl-----v~deLWVV  348 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYL-----VGDELWVV  348 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhc-----ccceeEEE
Confidence            466667899999999999984 578999999998766666777899999999999999999988765     56889999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      ||||++|+|.|.+...   .+++.++..|+.++++||+|||   ..+|+|||||.+||||+.++.+||+|||++......
T Consensus       349 MEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  349 MEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             EeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999998543   4999999999999999999999   999999999999999999999999999999877665


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      ... .....||+.|||||++....|.+|.||||||++++||+-|.+||-....    + .-.|..-.+|..      .+.
T Consensus       423 ~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P----l-rAlyLIa~ng~P------~lk  490 (550)
T KOG0578|consen  423 QSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP----L-RALYLIATNGTP------KLK  490 (550)
T ss_pred             cCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh----H-HHHHHHhhcCCC------CcC
Confidence            543 4456899999999999999999999999999999999999999954221    1 111122222221      111


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                        ........+.++..+|++.|+++||++.|+|+  +|...
T Consensus       491 --~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  491 --NPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             --CccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence              22334556778888899999999999999984  45333

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.7e-39  Score=331.13  Aligned_cols=265  Identities=22%  Similarity=0.247  Sum_probs=198.0

Q ss_pred             CccccceecccCceEEEEeEcC--CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHc---cccceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP--NGTEVAVKRFKNCS--KAGDANFKHEVEIIASV---KHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l---~H~niv~l~g~~~~~~~~~~  391 (614)
                      +|...+.||+|+||.||+++..  +|+.||||+++...  ......+.+|+++++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            6888899999999999999863  47889999986432  22234566788777766   69999999999864332245


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||++ ++|.+++.......+++.++..|+.|+++||.|||   +.+|+||||||+|||+++++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            56899999996 69999997766667999999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc---CCc
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE---GKT  548 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~---g~~  548 (614)
                      +.....  .......||+.|+|||.+....++.++||||||+++|||++|+.||......+. +.. .......   ...
T Consensus       158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~-i~~~~~~~~~~~~  233 (290)
T cd07862         158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGK-ILDVIGLPGEEDW  233 (290)
T ss_pred             EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHH-HHHHhCCCChhhc
Confidence            865433  223445689999999999999999999999999999999999999964332111 100 0000000   000


Q ss_pred             -------hhhhhccCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          549 -------LDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       549 -------~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                             ..........   ...++....+.+++..|++.||++|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence                   0000000000   000122345678999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-39  Score=342.49  Aligned_cols=263  Identities=25%  Similarity=0.381  Sum_probs=211.4

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ....+.++||+|-||.|.......+..||||.++... .....+|.+|+++|.+++||||++|+|+|.     .++..++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~-----~DePicm  612 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV-----QDDPLCM  612 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee-----cCCchHH
Confidence            3456668899999999999999788999999998644 445689999999999999999999999998     4566799


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ++|||++|+|.+++..+....+.-..-.+|+.|||.|++||.   +.++|||||.++|+|+|+++++||+|||+++..-.
T Consensus       613 I~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys  689 (807)
T KOG1094|consen  613 ITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS  689 (807)
T ss_pred             HHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCccccccccc
Confidence            999999999999998875555666777889999999999999   99999999999999999999999999999995544


Q ss_pred             CCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          477 GITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS--GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       477 ~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      +..+ ...+..-.++|||||.+..+++|.+||||+||+++||+++  ..+||....++++  .+-.......+....+  
T Consensus       690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~~~~~~~--  765 (807)
T KOG1094|consen  690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRDQGRQVV--  765 (807)
T ss_pred             CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCCCCccee--
Confidence            4433 3344556789999999999999999999999999999876  7788865554322  1111222222111111  


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          -..++-....+.++++.||..+-++||+++++...|.++
T Consensus       766 ----l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 ----LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ----ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                011223445677899999999999999999999988765

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.1e-38  Score=326.82  Aligned_cols=255  Identities=27%  Similarity=0.439  Sum_probs=205.0

Q ss_pred             cCccccceecccCceEEEEeEcCC------CcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      .+|...+.||+|+||.||+|+..+      +..||||.++..... ..+.+.+|++++++++|+|++++++++.     .
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCT-----E   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEe-----c
Confidence            357778899999999999998643      478999999765443 4578999999999999999999999986     4


Q ss_pred             CceEEEEEeecCCCChhhhhhcCC------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSG------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      +...++||||+++|+|.+++...+            ...+++.++..++.|++.||.|||   +.+++||||||+||+++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~  156 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVG  156 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEc
Confidence            577899999999999999997532            245899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhh
Q 043267          459 EAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLS  536 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~  536 (614)
                      .++.+||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |+.||......     
T Consensus       157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-----  231 (280)
T cd05049         157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-----  231 (280)
T ss_pred             CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-----
Confidence            999999999999975433221 22233456788999999999999999999999999999999 99998543321     


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      + ..+....+....         ........+.+++..||+.||++||++.||++.|++
T Consensus       232 ~-~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         232 E-VIECITQGRLLQ---------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             H-HHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence            1 112222232211         112234567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-38  Score=327.17  Aligned_cols=264  Identities=20%  Similarity=0.187  Sum_probs=200.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||.||+++.+ +++.||||+++...  ....+.+.+|+++++.++|+||+++++++.     +++..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFR-----RRGKL   75 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEe-----cCCEE
Confidence            36888999999999999999975 68899999997532  233456889999999999999999999886     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||++++.+..+...  ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        76 ~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          76 YLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            999999998777654422  346899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh----------hHHHHHHHH
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL----------SDWAWELVK  544 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l----------~~~~~~~~~  544 (614)
                      ............||+.|+|||++.+..++.++||||+||++|||++|+.||..........          .++......
T Consensus       151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         151 SEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             cccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            5433333344678999999999999999999999999999999999999996433211100          000000000


Q ss_pred             cCCchhhhhccCCCC------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTLDVIEENMPEM------ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .........+.....      ........+.+++..|++.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000000000000000      00112346889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.3e-38  Score=329.42  Aligned_cols=258  Identities=26%  Similarity=0.405  Sum_probs=209.2

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|...+.||+|+||.||+|+..      ++..+++|+++.......+.+.+|++++++++|+|++++++++.     .+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            35777899999999999999842      35679999998766666678999999999999999999999986     55


Q ss_pred             ceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL  457 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL  457 (614)
                      ...++||||+++++|.+++....              ...++|..+++|+.|++.||+|||   +.+|+||||||+||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~  156 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLV  156 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEE
Confidence            67899999999999999996532              235899999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchh
Q 043267          458 DEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLL  535 (614)
Q Consensus       458 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l  535 (614)
                      +.++.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |+.|+......    
T Consensus       157 ~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----  232 (291)
T cd05094         157 GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----  232 (291)
T ss_pred             ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----
Confidence            9999999999999975543221 22334556889999999999999999999999999999999 99998543221    


Q ss_pred             hHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          536 SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       536 ~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                        -.++.+..+...+.         .......+.+++..|++.+|++||++.+|+++|+....
T Consensus       233 --~~~~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         233 --EVIECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             --HHHHHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence              12233333332211         11234467789999999999999999999999998744

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-40  Score=345.90  Aligned_cols=261  Identities=26%  Similarity=0.392  Sum_probs=220.8

Q ss_pred             hcCccccceecccCceEEEEeEcCC-CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ..+....++||-|.||.||.|+|+. ...||||.++.. .-..++|..|..+|+.++|||+|+|+|+|+     .+...|
T Consensus       266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT-----~EpPFY  339 (1157)
T KOG4278|consen  266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----HEPPFY  339 (1157)
T ss_pred             chheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhc-----cCCCeE
Confidence            3456777899999999999999874 678999999874 345678999999999999999999999998     456679


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ||.|||.+|+|.|||.+..+..++--..+.++.||+.|++||.   ..++|||||.++|.|+.++..+||+||||++++.
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt  416 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT  416 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence            9999999999999999988888999999999999999999999   9999999999999999999999999999999877


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      .+.........-.+.|.|||.+.+..++.|+|||+|||+||||.| |..||....      ...+..++++|-+.+    
T Consensus       417 gDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------lSqVY~LLEkgyRM~----  486 (1157)
T KOG4278|consen  417 GDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------LSQVYGLLEKGYRMD----  486 (1157)
T ss_pred             CCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------HHHHHHHHhcccccc----
Confidence            654333333334678999999999999999999999999999999 998886433      223456666664433    


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCC
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSN  601 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  601 (614)
                           .+.....++.++++.||+.+|.+||++.|+-+.+|......+
T Consensus       487 -----~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  487 -----GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             -----CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence                 233445578888999999999999999999999988754443

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1e-38  Score=338.18  Aligned_cols=260  Identities=27%  Similarity=0.352  Sum_probs=205.6

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ++|...+.||+|+||.||+|...      .++.||+|+++... ......+..|++++.++ +|+||++++++|..    
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~----   82 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK----   82 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec----
Confidence            46888899999999999999742      35789999987532 23345678899999999 89999999998863    


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCC-------------------------------------------------------
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSG-------------------------------------------------------  414 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~-------------------------------------------------------  414 (614)
                      .+...++++||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence            4567889999999999999986422                                                       


Q ss_pred             ----CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCC
Q 043267          415 ----MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTL  489 (614)
Q Consensus       415 ----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~  489 (614)
                          ...++|..+.+++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++........ ......++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                136899999999999999999999   899999999999999999999999999999865433322 223345678


Q ss_pred             CcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHH
Q 043267          490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQY  568 (614)
Q Consensus       490 ~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l  568 (614)
                      .|+|||++.+..++.++|||||||++|||++ |+.||......     +..+.....+....         .+......+
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~~---------~~~~~~~~~  305 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-----EEFCRRLKEGTRMR---------APEYATPEI  305 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-----HHHHHHHhccCCCC---------CCccCCHHH
Confidence            8999999999999999999999999999998 99998543221     11222222222111         112234567


Q ss_pred             HHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          569 VLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       569 ~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      .+++..|++.+|++||++.|++++|+..++
T Consensus       306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            889999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=338.97  Aligned_cols=250  Identities=25%  Similarity=0.361  Sum_probs=204.0

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC----Ch-hhhHHHHHHHHHHHHcc-ccceeeeeeeeeccc
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC----SK-AGDANFKHEVEIIASVK-HVNLVALRGYSTATV  387 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~----~~-~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~  387 (614)
                      ...++|...+.||+|+||+|+.|... +|..||||.+...    .. ...+.+.+|+.++++++ ||||++++.+..   
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---   90 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence            34568899999999999999999854 7899999976542    11 23456678999999998 999999999987   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-CcEEEe
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVG  466 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-~~~kl~  466 (614)
                        .....++||||+.+|+|++++.+  ..++.+....+++.|++.|++|+|   +.+|+||||||+|||+|.+ +++||+
T Consensus        91 --t~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   91 --TPTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             --cCCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEe
Confidence              44558999999999999999977  357888999999999999999999   9999999999999999999 999999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCC-CC-chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK-LT-PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      |||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||++...     .... ..+.
T Consensus       164 DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~-~ki~  236 (370)
T KOG0583|consen  164 DFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLY-RKIR  236 (370)
T ss_pred             ccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHH-HHHh
Confidence            999999774 2223445678999999999999977 86 789999999999999999999976221     1111 1122


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      .+..      .++....   ...+..++..|+..||.+|+|+.+++
T Consensus       237 ~~~~------~~p~~~~---S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  237 KGEF------KIPSYLL---SPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             cCCc------cCCCCcC---CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            2221      1222111   55678889999999999999999998

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.7e-38  Score=326.63  Aligned_cols=264  Identities=26%  Similarity=0.381  Sum_probs=203.9

Q ss_pred             cCccccceecccCceEEEEeEc-----CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .+|...+.||+|+||.||++..     .++..||+|++........+.+.+|++++++++|||++++.+++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            4677889999999999999974     25789999999876666677899999999999999999999987532   345


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++|+||+++|+|.+++.+.. ..++|..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            6899999999999999996543 46899999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC---
Q 043267          473 FNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK---  547 (614)
Q Consensus       473 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~---  547 (614)
                      ........  ......++..|+|||+..++.++.++||||||+++|||++|..+.......      + .+.+....   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~------~-~~~~~~~~~~~  229 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE------F-MRMMGNDKQGQ  229 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh------h-hhhcccccccc
Confidence            66543322  112223445699999999999999999999999999999988765322110      0 00000000   


Q ss_pred             -----chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          548 -----TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       548 -----~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                           ..+.+...............+.+++..||+.+|++|||+.||++.|+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence                 001111111111112334568889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.2e-38  Score=325.89  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=202.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCc----EEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGT----EVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||+|++. +|+    .+++|.+.... .....++..|+..+++++||||+++++++.      +.
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~------~~   81 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP------GA   81 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC------CC
Confidence            5677789999999999999963 454    47888876433 233467888898999999999999999874      34


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++++||+++|+|.+++.... ..++|..++.|+.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++
T Consensus        82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~  157 (279)
T cd05111          82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVAD  157 (279)
T ss_pred             ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccce
Confidence            5688999999999999997543 46899999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          473 FNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       473 ~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ....... .......++..|+|||++.++.++.++||||||+++|||++ |+.|+.......      ..+.+..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~~~~~~~~~  231 (279)
T cd05111         158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE------VPDLLEKGERLA  231 (279)
T ss_pred             eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHHCCCcCC
Confidence            6543322 22344567889999999999999999999999999999998 999985432211      112233332211


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                           .+.    .....+.+++..|++.+|++|||+.|+++.|+.....|
T Consensus       232 -----~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         232 -----QPQ----ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             -----CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence                 011    11234567888999999999999999999998865443

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-38  Score=320.03  Aligned_cols=255  Identities=31%  Similarity=0.460  Sum_probs=207.8

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|...+.||+|+||.||++..++++.||||.+.... ...+++.+|++++++++|+|++++++++.     .+...++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            45788899999999999999998888899999987533 34567999999999999999999999876     4567899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++++|.+++.......+++.++..++.+++.||.|||   +.+++|+||||+||++++++.+||+|||+++....
T Consensus        79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~  155 (261)
T cd05034          79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIED  155 (261)
T ss_pred             EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence            999999999999998766667999999999999999999999   88999999999999999999999999999986654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..........++..|+|||.+.++.++.++||||+|+++||+++ |+.||.......      ....+..+.        
T Consensus       156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~--------  221 (261)
T cd05034         156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------VLEQVERGY--------  221 (261)
T ss_pred             hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCC--------
Confidence            32222223345678999999999999999999999999999999 999985432111      111111111        


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                       ....+......+.+++..|++.+|++||+++++.+.|+.
T Consensus       222 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         222 -RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             101111224567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.2e-38  Score=327.13  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=207.6

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|...+.||+|+||+||++...      ++..+|+|.+...+......+.+|++++++++|+|++++++++.     .+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            46888899999999999999842      34568999998766666778999999999999999999999986     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCC-----------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSG-----------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA  460 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~-----------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~  460 (614)
                      ...++||||+++++|.+++...+           ...+++.++++++.|++.||+|||   +.+++||||||+||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~  156 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  156 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccC
Confidence            67899999999999999986432           235999999999999999999999   8999999999999999999


Q ss_pred             CcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHH
Q 043267          461 FEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       461 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~  538 (614)
                      +.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.......      
T Consensus       157 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------  230 (288)
T cd05093         157 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------  230 (288)
T ss_pred             CcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence            9999999999975533221 12233446788999999999999999999999999999998 888885332211      


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      ....+..+....     .+.    .....+.+++..|++.+|.+|||+.+|++.|+....
T Consensus       231 ~~~~i~~~~~~~-----~~~----~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         231 VIECITQGRVLQ-----RPR----TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             HHHHHHcCCcCC-----CCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            122233332211     111    123457889999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-38  Score=324.67  Aligned_cols=257  Identities=25%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             HhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      .+++|+..+.||+|+||.||+|...      .+..||||++.... .....++.+|+.+++.++|+|++++++++.    
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~----   79 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS----   79 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            4567999999999999999998743      35679999986432 334567899999999999999999999986    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCC--------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSG--------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA  460 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~--------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~  460 (614)
                       ++...++||||+++|+|.+++.+..        ...++|..++.++.|+++||.|||   +.+++||||||+||+++++
T Consensus        80 -~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~  155 (277)
T cd05062          80 -QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  155 (277)
T ss_pred             -CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCC
Confidence             5667899999999999999986532        234788999999999999999999   8899999999999999999


Q ss_pred             CcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHH
Q 043267          461 FEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       461 ~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~  538 (614)
                      +.+||+|||+++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.|+......     + 
T Consensus       156 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~-----~-  229 (277)
T cd05062         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE-----Q-  229 (277)
T ss_pred             CCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----H-
Confidence            99999999998754432221 1222345788999999999999999999999999999999 68887533211     1 


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ..+....+....     .    .......+.+++..|++.+|++|||+.|++++|++
T Consensus       230 ~~~~~~~~~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         230 VLRFVMEGGLLD-----K----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             HHHHHHcCCcCC-----C----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            112222221111     1    11223467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.3e-38  Score=342.99  Aligned_cols=260  Identities=24%  Similarity=0.339  Sum_probs=205.7

Q ss_pred             hcCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVP  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~  388 (614)
                      .++|...++||+|+||.||+|+..      .+..||||+++... ....+.+.+|+++++++. ||||+++++++.    
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~----  111 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT----  111 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc----
Confidence            457888899999999999999852      23579999997533 334567899999999996 999999999986    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCC------------------------------------------------------
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSG------------------------------------------------------  414 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~------------------------------------------------------  414 (614)
                       ++...++||||+++|+|.++|....                                                      
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (400)
T cd05105         112 -KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP  190 (400)
T ss_pred             -cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence             5677899999999999999886421                                                      


Q ss_pred             ----------------------------------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCC
Q 043267          415 ----------------------------------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN  454 (614)
Q Consensus       415 ----------------------------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~N  454 (614)
                                                              ...+++..+++++.|+++||.|||   +.+|+||||||+|
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~N  267 (400)
T cd05105         191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARN  267 (400)
T ss_pred             hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHh
Confidence                                                    134888999999999999999999   8999999999999


Q ss_pred             eEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCcc
Q 043267          455 ILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKS  532 (614)
Q Consensus       455 ILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~  532 (614)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... 
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-  346 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-  346 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh-
Confidence            99999999999999999865433221 2223456788999999999999999999999999999997 88988543221 


Q ss_pred             chhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          533 VLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       533 ~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                          +..+.....+....         ........+.+++..||+.+|++||++.+|.++|+...+
T Consensus       347 ----~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         347 ----STFYNKIKSGYRMA---------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             ----HHHHHHHhcCCCCC---------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence                11122223221111         112234567889999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3e-38  Score=332.89  Aligned_cols=267  Identities=23%  Similarity=0.330  Sum_probs=198.2

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|+||.||+|+.. +|+.||||++...  .......+.+|++++++++||||+++++++......+....+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4778899999999999999964 7899999998742  223345688999999999999999999987643322334689


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+. ++|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 6899888643  36999999999999999999999   8999999999999999999999999999997543


Q ss_pred             CCCc--cccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch--h-------hHHHHHH
Q 043267          476 EGIT--HLTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL--L-------SDWAWEL  542 (614)
Q Consensus       476 ~~~~--~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--l-------~~~~~~~  542 (614)
                      ....  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||.........  +       ....+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211  12234578999999999875  68899999999999999999999998543211000  0       0000111


Q ss_pred             HHcCCchhhhh---ccCCCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          543 VKEGKTLDVIE---ENMPEM---ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       543 ~~~g~~~~~~d---~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +......+.+.   ...+..   ..+.....+.+++..|++.||++|||++|+++
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            11111111111   111000   00112345678999999999999999999984

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=5.4e-38  Score=316.29  Aligned_cols=247  Identities=30%  Similarity=0.434  Sum_probs=199.7

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecC
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLH  402 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~  402 (614)
                      ++||+|+||.||+|..++++.+|+|.++... ......+.+|++++++++|+|++++++++.     .....++||||++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~~   75 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT-----QRQPIYIVMELVP   75 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEe-----cCCccEEEEECCC
Confidence            3699999999999998889999999987543 333457889999999999999999999986     4567899999999


Q ss_pred             CCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcccc
Q 043267          403 NGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT  482 (614)
Q Consensus       403 ~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~  482 (614)
                      +++|.+++.... ..+++.++..++.|++.+|.|||   +.+++||||||+||++++++.+||+|||++...........
T Consensus        76 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (250)
T cd05085          76 GGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS  151 (250)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccC
Confidence            999999986543 46899999999999999999999   89999999999999999999999999999976544332222


Q ss_pred             ccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          483 TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       483 ~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      ....++..|+|||+..++.++.++||||||+++||+++ |..||......      ........+...         ...
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~------~~~~~~~~~~~~---------~~~  216 (250)
T cd05085         152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ------QAREQVEKGYRM---------SCP  216 (250)
T ss_pred             CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHHcCCCC---------CCC
Confidence            22345678999999999999999999999999999998 99898543211      111222222111         111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          562 PEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ......+.+++..|++.+|++||++.|+++.|.
T Consensus       217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            223457888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.1e-38  Score=323.86  Aligned_cols=254  Identities=26%  Similarity=0.417  Sum_probs=201.4

Q ss_pred             CccccceecccCceEEEEeEc-----CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|+..+.||+|+||.||+|+.     .++..|++|.++... .....++.+|++++++++|+|++++++++.     .+.
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~   80 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT-----QEQ   80 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe-----cCC
Confidence            567778999999999999984     356789999997533 334467899999999999999999999876     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCC---------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSG---------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL  457 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~---------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL  457 (614)
                      ..++||||+++|+|.+++....               ...+++.+.+.++.|++.||+|||   +.+++||||||+|||+
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili  157 (283)
T cd05090          81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILI  157 (283)
T ss_pred             ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEE
Confidence            7899999999999999985321               235889999999999999999999   8899999999999999


Q ss_pred             CCCCcEEEeecCCceeCCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchh
Q 043267          458 DEAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLL  535 (614)
Q Consensus       458 d~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l  535 (614)
                      ++++.+||+|||+++...... ........++..|+|||+..++.++.++||||||+++|||++ |..|+.....     
T Consensus       158 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~-----  232 (283)
T cd05090         158 GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-----  232 (283)
T ss_pred             cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            999999999999997643322 122233446778999999998999999999999999999999 8888853221     


Q ss_pred             hHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          536 SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       536 ~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                       ....+....+....     .+    ......+.+++..|++.+|++||++.++.++|..
T Consensus       233 -~~~~~~~~~~~~~~-----~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         233 -QEVIEMVRKRQLLP-----CS----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHHHHHcCCcCC-----CC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             11112222222111     11    1223467788899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-39  Score=338.32  Aligned_cols=241  Identities=27%  Similarity=0.472  Sum_probs=198.5

Q ss_pred             ccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          322 RENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      +.+.||.|+.|.||+|++ .++.||||+++...       ..+|+-|++|+|+||+.+.|+|+     .....+|||||+
T Consensus       128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCt-----qsPcyCIiMEfC  194 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCT-----QSPCYCIIMEFC  194 (904)
T ss_pred             hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeec-----CCceeEEeeecc
Confidence            347899999999999999 57899999886532       24678899999999999999998     556789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      +.|-|...|+..  +.++-.....|..+||.|+.|||   ...|||||||.-||||..+..+||+|||-++...+.  ..
T Consensus       195 a~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--ST  267 (904)
T KOG4721|consen  195 AQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--ST  267 (904)
T ss_pred             ccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhhhhh--hh
Confidence            999999999654  47888889999999999999999   999999999999999999999999999999866543  12


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      ....+||..|||||++...+.++|+||||||||||||+||.-||.+.....+.     |   .-|.      ..+.-..+
T Consensus       268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII-----w---GVGs------NsL~LpvP  333 (904)
T KOG4721|consen  268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII-----W---GVGS------NSLHLPVP  333 (904)
T ss_pred             hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE-----E---eccC------CcccccCc
Confidence            23478999999999999999999999999999999999999999654432211     1   1111      11111122


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          562 PEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ....+-+..++++||+..|.+||++++++.-|+-.
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            34455677888999999999999999999988754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=328.83  Aligned_cols=245  Identities=22%  Similarity=0.242  Sum_probs=198.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||++... +|+.||+|++....   ....+.+.+|++++++++||||+++++++.     ++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   75 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEH-----DQRF   75 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhc-----cCCe
Confidence            36888899999999999999975 68999999986422   233456889999999999999999998875     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          76 LYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            89999999999999999654  36899999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......     . ..+.+..+..     
T Consensus       151 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~-----~-~~~~i~~~~~-----  215 (291)
T cd05612         151 LRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF-----G-IYEKILAGKL-----  215 (291)
T ss_pred             ccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHhCCc-----
Confidence            5432    22356899999999999999999999999999999999999998643211     1 1122222211     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVKI  592 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  592 (614)
                       .++.    .....+.+++..|++.||.+||+     ++++++.
T Consensus       216 -~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 -EFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             -CCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence             1111    12345678889999999999995     8887743

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6e-38  Score=319.95  Aligned_cols=258  Identities=24%  Similarity=0.372  Sum_probs=201.3

Q ss_pred             cccceecccCceEEEEeEcCC-Cc--EEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCceE
Q 043267          321 SRENIIGKGGYGNVYKGMLPN-GT--EVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGHQR  394 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~~~  394 (614)
                      ...+.||+|+||.||+|+..+ +.  .||+|.++..  +....+.+.+|+++++.++|+|++++++++...... .....
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999754 33  5899988643  344567789999999999999999999987543211 12357


Q ss_pred             EEEEeecCCCChhhhhhcC----CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          395 IIVCDLLHNGSLYDHLFGS----GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ++++||+++|+|.+++...    ....+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999999988532    2345899999999999999999999   89999999999999999999999999999


Q ss_pred             ceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          471 AKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       471 a~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      ++........ ......+++.|++||+..+..++.++||||||+++|||++ |+.||.....      ...++....+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~------~~~~~~~~~~~~  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN------SEIYDYLRQGNR  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH------HHHHHHHHcCCC
Confidence            9865433221 1222346778999999999999999999999999999999 7888854221      112233333322


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..         ........+.+++..|++.+|++|||+.++++.|+..
T Consensus       233 ~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 LK---------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11         1122344578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=7.1e-38  Score=315.91  Aligned_cols=250  Identities=25%  Similarity=0.307  Sum_probs=205.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeec--CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|++|.||+++.+ +|+.|++|.+..  .......++.+|++++++++|||++++++++.     ++...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            4777899999999999999975 689999999864  23455678999999999999999999999886     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++++|.+++.......+++.++.+++.+++.||.|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            9999999999999998765568999999999999999999999   8999999999999999999999999999998665


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .... ......|++.|+|||+..++.++.++||||||+++|||++|+.|+.....      .........+...     .
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~~-----~  220 (256)
T cd08529         153 DNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ------GALILKIIRGVFP-----P  220 (256)
T ss_pred             Cccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCCC-----C
Confidence            4322 22345688999999999999999999999999999999999999854331      1111111222111     1


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                          ........+.+++..|++.+|++||++.++++.
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         221 ----VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ----CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                111334567889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=7.7e-38  Score=330.31  Aligned_cols=261  Identities=24%  Similarity=0.319  Sum_probs=201.6

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|+..+.||+|+||.||+++.. +|..||+|.+... .....+.+.+|++++++++||||+++++++.     .++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCEE
Confidence            357889999999999999999975 6888999998753 2334567999999999999999999999986     45678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||+++.
T Consensus        79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccc
Confidence            9999999999999999654  36899999999999999999999   54 699999999999999999999999999975


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC-------
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG-------  546 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g-------  546 (614)
                      ....   ......||..|+|||++.+..++.++||||||+++|||++|+.||.......  +..........+       
T Consensus       154 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~  228 (331)
T cd06649         154 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHS  228 (331)
T ss_pred             cccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccc
Confidence            5432   2234568999999999999999999999999999999999999995322110  000000000000       


Q ss_pred             -----------------------Cchhhhh----ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          547 -----------------------KTLDVIE----ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       547 -----------------------~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                                             ...+..+    ...+..........+.+++..|++.||++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                   0000000    001111111234568889999999999999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=5.3e-38  Score=324.40  Aligned_cols=257  Identities=26%  Similarity=0.360  Sum_probs=203.7

Q ss_pred             CccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +|...+.||+|+||.||+|+..      ....+++|.+.... .....++.+|+++++.++||||+++++.+.     .+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            4677889999999999999852      23578999887533 334567899999999999999999999886     45


Q ss_pred             ceEEEEEeecCCCChhhhhhcC----------------------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEec
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGS----------------------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRD  449 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~----------------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrD  449 (614)
                      ...++++||+++|+|.+++...                      ....+++.+++.++.|++.||+|||   +.+++|||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~d  152 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRD  152 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhh
Confidence            6689999999999999998642                      1235889999999999999999999   89999999


Q ss_pred             cCCCCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCccc
Q 043267          450 IKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEI  527 (614)
Q Consensus       450 IKp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~  527 (614)
                      |||+|||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..
T Consensus       153 ikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         153 LAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999999999999999999755332221 1223345778999999999999999999999999999998 9988853


Q ss_pred             ccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          528 IQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       528 ~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      ...      ...++..+.+...     .    .+......+.+++..|++.+|++||++.|+++.|++...
T Consensus       233 ~~~------~~~~~~~~~~~~~-----~----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         233 IAP------ERLFNLLKTGYRM-----E----RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCH------HHHHHHHhCCCCC-----C----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            321      1223333332211     1    112233467889999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=335.92  Aligned_cols=246  Identities=27%  Similarity=0.347  Sum_probs=206.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|...+.||+|.||.||||+.+ +.+.||+|.+.+..  +.+.+.+.+|++++++++|||||.++.+++     ...+.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfE-----t~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFE-----TSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhc-----ccceE
Confidence            46777889999999999999976 67899999997643  344567899999999999999999999987     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|.||+.+ +|..+|...+  .+++++...|+.++..||.|||   +.+|+|||+||.||||+.++++|++|||+|+.+
T Consensus        77 ~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhc
Confidence            999999976 9999996644  7999999999999999999999   999999999999999999999999999999977


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ... ....+.+.||+.|||||...++.|+..+|+||+||++||+++|++||....     +...+....++        +
T Consensus       151 ~~~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-----i~~Lv~~I~~d--------~  216 (808)
T KOG0597|consen  151 STN-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-----ITQLVKSILKD--------P  216 (808)
T ss_pred             ccC-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-----HHHHHHHHhcC--------C
Confidence            653 445677899999999999999999999999999999999999999995321     22222222111        1


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .   ..+......+..++..-++.||..|.|-.+++.
T Consensus       217 v---~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  217 V---KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             C---CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            1   123355667888888899999999999998873

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.1e-38  Score=317.98  Aligned_cols=245  Identities=26%  Similarity=0.398  Sum_probs=196.4

Q ss_pred             eecccCceEEEEeEc---CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          325 IIGKGGYGNVYKGML---PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      .||+|+||.||+|.+   +++..+|+|+++...  ....+++.+|+++++.++|+|++++++++.      ++..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------~~~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE------AESWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc------CCCcEEEEe
Confidence            589999999999974   367889999986433  334567899999999999999999999874      345789999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT  479 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~  479 (614)
                      |+++|+|.+++...  ..+++..+.+++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.......
T Consensus        76 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~  150 (257)
T cd05116          76 LAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN  150 (257)
T ss_pred             cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCC
Confidence            99999999999653  36899999999999999999999   89999999999999999999999999999986544332


Q ss_pred             cc--cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          480 HL--TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       480 ~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ..  .....++..|+|||.+..+.++.++||||||+++|||++ |+.||......     ++ .+.++.+...+     .
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~-~~~i~~~~~~~-----~  219 (257)
T cd05116         151 YYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN-----EV-TQMIESGERME-----C  219 (257)
T ss_pred             eeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-----HH-HHHHHCCCCCC-----C
Confidence            21  122334678999999988899999999999999999998 99998643321     11 12233322111     1


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      +    ......+.+++..|++.||++||++.+|.++|++
T Consensus       220 ~----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         220 P----QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             C----CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            1    1233467789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-38  Score=334.09  Aligned_cols=253  Identities=23%  Similarity=0.245  Sum_probs=201.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++...   ......+.+|++++..++||||+++++++.     ++..
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~   75 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQ-----DDEY   75 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEE-----cCCE
Confidence            36888999999999999999975 58999999997532   233456889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.+...++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          76 LYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            99999999999999999653  36899999999999999999999   89999999999999999999999999999975


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ...    ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .+..+....  ....
T Consensus       151 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~--~~~~  218 (333)
T cd05600         151 IVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE------TWENLKYWK--ETLQ  218 (333)
T ss_pred             ccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHH------HHHHHHhcc--cccc
Confidence            443    2334579999999999999999999999999999999999999996433211      111111111  0011


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      ..............+.+++..|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         219 RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            101110011234567788889999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-39  Score=334.82  Aligned_cols=264  Identities=22%  Similarity=0.279  Sum_probs=205.4

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChh-hhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCc-
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKA-GDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGH-  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~-  392 (614)
                      .++|...+.||.|.||.||+|+. .+|..||||++++.-.. .+---.+|++.|++++ ||||++|..+..     +.+ 
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~-----d~~~   83 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIR-----DNDR   83 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhh-----ccCc
Confidence            35678889999999999999995 47899999999864322 2223468999999998 999999999887     334 


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      .+++|||||+ -+|++.+.++ ++.|+...+..|+.||.+||+|+|   +.|+.|||+||+|||+..+..+||+|||+|+
T Consensus        84 ~L~fVfE~Md-~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   84 ILYFVFEFMD-CNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eEeeeHHhhh-hhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEeccccccc
Confidence            8999999996 4999988776 789999999999999999999999   9999999999999999999999999999999


Q ss_pred             eCCCCCccccccccCCCCcCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh--hHH----HHHHHHc
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL--SDW----AWELVKE  545 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l--~~~----~~~~~~~  545 (614)
                      ....  ....+..+.|..|.|||++. .+-|+.+.|||++||+++|+.+-+.-|.+..+-+...  .+.    .++-|.+
T Consensus       159 ev~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~e  236 (538)
T KOG0661|consen  159 EVRS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPE  236 (538)
T ss_pred             cccc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchh
Confidence            6544  23456678899999999876 5789999999999999999999998886444321110  000    0111112


Q ss_pred             C-CchhhhhccCCCC-------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          546 G-KTLDVIEENMPEM-------ELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       546 g-~~~~~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      | .....+.-.++..       ..+......++++..|++.||.+|||+.|.+++
T Consensus       237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1 1111111122211       122356678899999999999999999999875

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.2e-38  Score=318.51  Aligned_cols=256  Identities=27%  Similarity=0.435  Sum_probs=203.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CC---cEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NG---TEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|+..+.||+|+||.||+|+.+ ++   ..+|+|.++.. .....+++.+|++++++++|+|++++.+++.     ..
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   78 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KF   78 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cC
Confidence            346888899999999999999975 33   37999998753 3344567899999999999999999999986     45


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++++|.+++.... ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~  154 (268)
T cd05063          79 KPAMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLS  154 (268)
T ss_pred             CCcEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccc
Confidence            67899999999999999986543 56899999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCcccc--ccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          472 KFNPEGITHLT--TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       472 ~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      ...........  .....+..|+|||++..+.++.++||||||+++|||++ |+.|+.....     .++. ..+..+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~-----~~~~-~~i~~~~~  228 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN-----HEVM-KAINDGFR  228 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH-----HHHH-HHHhcCCC
Confidence            76543322211  12223567999999999999999999999999999998 9999854322     1111 22222211


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                               .....+....+.+++..|++.+|++||++.+|++.|++.
T Consensus       229 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         229 ---------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     011112345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8.2e-38  Score=317.61  Aligned_cols=254  Identities=26%  Similarity=0.416  Sum_probs=206.3

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ..+|...+.||+|+||.||++...++..+|+|.+... ....+.+.+|++++++++|+|++++.+++.     + ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~-~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-----K-EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEc-----C-CCeEE
Confidence            3468888999999999999999878888999988753 234567899999999999999999998875     2 56799


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      +|||+++|+|.+++.......+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          78 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             EEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999999999998765667899999999999999999999   88999999999999999999999999999986554


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..........++..|+|||++..+.++.++|+||||+++||+++ |+.|+......  .    .......+...      
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~----~~~~~~~~~~~------  222 (260)
T cd05073         155 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--E----VIRALERGYRM------  222 (260)
T ss_pred             CCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--H----HHHHHhCCCCC------
Confidence            33222333446678999999999999999999999999999999 89888543211  1    11222222111      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                         .........+.+++..|++.+|++||++.++.++|+.
T Consensus       223 ---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         223 ---PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               1112234567788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=311.71  Aligned_cols=255  Identities=25%  Similarity=0.297  Sum_probs=203.9

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +|+..+.||.|+||+|.+++.+ +|.-+|+|++++..   ....+...+|..+|+.+.||+++++.+-+.     +....
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~-----d~~~l  119 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFK-----DNSNL  119 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeec-----cCCeE
Confidence            5777899999999999999975 68899999997643   233456788999999999999999998876     67889


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||.++|.|..+|++.+  +++.+..+-++.+|+.||+|||   +..|++||+||+|||||.+|.+||+|||.|+..
T Consensus       120 ymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v  194 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV  194 (355)
T ss_pred             EEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEe
Confidence            99999999999999997654  7999999999999999999999   999999999999999999999999999999976


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ...    +.+.+||+.|+|||.+....|..++|+|+|||++|||+.|..||.+.+.      .-..+.+-+|+.      
T Consensus       195 ~~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v------  258 (355)
T KOG0616|consen  195 SGR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKV------  258 (355)
T ss_pred             cCc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcc------
Confidence            543    5678999999999999999999999999999999999999999965443      112233333322      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCC-CCHH---------------HHHHHhhccCCCCCch
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQAR-PTMD---------------QIVKILETDVPLSNIK  603 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~---------------eVl~~L~~~~~~p~~p  603 (614)
                      .+    +......+.+++..-++.|-.+| =++.               ++.+.+...+++|-.|
T Consensus       259 ~f----P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p  319 (355)
T KOG0616|consen  259 KF----PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP  319 (355)
T ss_pred             cC----CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence            11    22223344455555666676666 2222               3455666666666555

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-38  Score=331.55  Aligned_cols=261  Identities=25%  Similarity=0.305  Sum_probs=201.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +.|+..+.||+|.||.|||++. .+|+.||+|++.-..  .....-..+||.+|++|+||||++|.+..+..   .....
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~~~si  193 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---LSGSI  193 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---CCceE
Confidence            4577778899999999999994 589999999997433  22334457899999999999999999998753   35789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      |||+|||+. +|.-++.. ..-.|+..++..++.|++.||+|+|   ..+|+|||||.+|||||.+|.+||+|||||+++
T Consensus       194 YlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  194 YLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             EEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeec
Confidence            999999976 77777644 4467999999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccch---------hhHHHHHHHH
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL---------LSDWAWELVK  544 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~---------l~~~~~~~~~  544 (614)
                      ........+..+-|.-|.|||.+.+. .|+.+.|+||.||+|.||+.|+..+....+-+..         -.+-.|.   
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~---  345 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP---  345 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc---
Confidence            76655555666679999999999875 7999999999999999999999888543321110         0011122   


Q ss_pred             cCCch--hhh------hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          545 EGKTL--DVI------EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       545 ~g~~~--~~~------d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      ..++.  ..+      ...+.+. ........++++..++..||.+|.|+.+++
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL  398 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSAL  398 (560)
T ss_pred             cccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHh
Confidence            11111  000      1111111 122334567788889999999999999987

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=317.60  Aligned_cols=259  Identities=24%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             ccccceecccCceEEEEeEcCC----CcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCCc
Q 043267          320 FSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEGH  392 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~~  392 (614)
                      |...+.||+|+||.||+|+...    +..||||+++..  +....+++.+|++.++.++|+|++++++++..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4567889999999999999642    367999998743  33445679999999999999999999998764322 1223


Q ss_pred             eEEEEEeecCCCChhhhhhcC----CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          393 QRIIVCDLLHNGSLYDHLFGS----GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                      ..++++||+++|+|.+++...    ....+++.....++.|++.||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence            478999999999999998653    2346899999999999999999999   889999999999999999999999999


Q ss_pred             CCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcC
Q 043267          469 GLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       469 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |+++........ ......++..|+|||++....++.++||||||+++|||++ |..|+......     +.. +....+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~-----~~~-~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-----EIY-DYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH-----HHH-HHHHcC
Confidence            999865433222 1222345678999999988999999999999999999999 88888543321     111 112222


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ...     ..    +......+.+++..|++.||++|||+.|+++.|+..
T Consensus       232 ~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 NRL-----KQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCC-----CC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111     11    123345778889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=8.4e-38  Score=315.54  Aligned_cols=247  Identities=27%  Similarity=0.416  Sum_probs=196.0

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      +.||+|+||.||+|+.. +|+.||+|.+... .......+.+|++++++++|+||+++++++.     .+...++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            36999999999999975 7899999988643 3344567999999999999999999999986     456789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++++|.+++.... ..+++.+++.++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++..........
T Consensus        76 ~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          76 QGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             cCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            9999999996533 46899999999999999999999   8999999999999999999999999999987544321111


Q ss_pred             -cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCC
Q 043267          482 -TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM  559 (614)
Q Consensus       482 -~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~  559 (614)
                       .....++..|+|||.+.++.++.++||||||+++|||++ |..|+.......      .......+         ....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~------~~~~~~~~---------~~~~  216 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ------TREAIEQG---------VRLP  216 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH------HHHHHHcC---------CCCC
Confidence             111223567999999999999999999999999999998 888875432211      11111111         1111


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          560 ELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ........+.+++..|++.+|++|||+.+|.++|.
T Consensus       217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            12223456788999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=5.6e-38  Score=325.72  Aligned_cols=259  Identities=27%  Similarity=0.386  Sum_probs=201.7

Q ss_pred             cCccccceecccCceEEEEeEcCC-Cc--EEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN-GT--EVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|+..+.||+|+||.||+|+..+ |.  .+++|.++.. .....+.+.+|++++.++ +|||++++++++.     +..
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACE-----NRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEc-----cCC
Confidence            468888999999999999999753 33  4789888743 334456789999999999 7999999999886     456


Q ss_pred             eEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ..++++||+++|+|.+++....              ...+++..+++|+.|++.||+|||   +.+|+||||||+|||++
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~  153 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVG  153 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEEC
Confidence            7899999999999999996532              135889999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhH
Q 043267          459 EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD  537 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~  537 (614)
                      +++.+||+|||++.......  .......+..|+|||+...+.++.++||||||+++|||++ |+.||.....     .+
T Consensus       154 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~-----~~  226 (297)
T cd05089         154 ENLASKIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC-----AE  226 (297)
T ss_pred             CCCeEEECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HH
Confidence            99999999999986432211  1111223567999999999999999999999999999998 9999854322     11


Q ss_pred             HHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCC
Q 043267          538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSN  601 (614)
Q Consensus       538 ~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  601 (614)
                       .......+..         ..........+.+++..|++.+|.+|||+.++++.|+.......
T Consensus       227 -~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~  280 (297)
T cd05089         227 -LYEKLPQGYR---------MEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK  280 (297)
T ss_pred             -HHHHHhcCCC---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence             1122222111         11111233467789999999999999999999999988754433

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=315.44  Aligned_cols=249  Identities=31%  Similarity=0.434  Sum_probs=204.8

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...+.||+|+||.||++.. .|+.||||.++.... ..+++.+|++++++++|+|++++++++.     .+...++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL-----QGNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc-----CCCCeEEE
Confidence            4677889999999999999997 488999999986544 5677899999999999999999999986     46778999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++++|.+++.......++|..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||.++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~  155 (256)
T cd05039          79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG  155 (256)
T ss_pred             EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccc
Confidence            99999999999997766567999999999999999999999   899999999999999999999999999999865332


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ..    ...++..|+|||++..+.++.++||||||+++||+++ |+.|+......      ........+...       
T Consensus       156 ~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~~-------  218 (256)
T cd05039         156 QD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVVPHVEKGYRM-------  218 (256)
T ss_pred             cc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHhcCCCC-------
Confidence            21    2334678999999999999999999999999999998 99888533211      111222222111       


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                        ..+......+.+++..|++.+|++||++.+++++|++
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 --EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             --CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence              1112234567788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.7e-38  Score=321.76  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=203.1

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +++...+.||+|+||.||++..+      ++..+|+|.+..........+.+|+++++.++|+||+++++++.     .+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCT-----EG   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEe-----cC
Confidence            35677789999999999999732      45689999998777677788999999999999999999999886     45


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCC-------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGM-------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~-------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ...++++||+++|+|.+++.....             ..+++.+++.++.|++.||+|||   +.+++||||||+|||++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~  156 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVG  156 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEc
Confidence            678999999999999999875321             35899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhh
Q 043267          459 EAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLS  536 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~  536 (614)
                      +++.+||+|||+++....... .......+++.|+|||...+..++.++||||||+++|||++ |+.||.......    
T Consensus       157 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  232 (280)
T cd05092         157 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE----  232 (280)
T ss_pred             CCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH----
Confidence            999999999999975443221 11223345788999999999999999999999999999998 898885332211    


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                       .. .....+...     .    .+......+.+++..||+.||++||++.+|++.|+.
T Consensus       233 -~~-~~~~~~~~~-----~----~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         233 -AI-ECITQGREL-----E----RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -HH-HHHHcCccC-----C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence             11 111121111     0    111223456788899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6.9e-38  Score=321.40  Aligned_cols=259  Identities=24%  Similarity=0.354  Sum_probs=207.4

Q ss_pred             hcCccccceecccCceEEEEeEcCC-----CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPN-----GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      .++|...+.||+|+||.||+|...+     +..|++|++... .....+.+.+|++++++++|+|++++++++..    +
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~----~   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIE----D   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec----C
Confidence            4578888999999999999999765     688999998753 33445678899999999999999999998863    3


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCC------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                      +...++++||+++|+|.+++.....      ..+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~k  157 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVK  157 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEE
Confidence            4678999999999999999865322      46999999999999999999999   89999999999999999999999


Q ss_pred             EeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHH
Q 043267          465 VGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       465 l~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      |+|||+++.......+ ......++..|+|||++.+..++.++||||||+++||+++ |+.|+.....     .++ ...
T Consensus       158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~-~~~  231 (280)
T cd05043         158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP-----FEM-AAY  231 (280)
T ss_pred             ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH-----HHH-HHH
Confidence            9999999865433222 2233456778999999998899999999999999999999 9999854322     111 122


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      +..+...       .  ......+.+.+++..|++.+|++|||+.+++++|+...
T Consensus       232 ~~~~~~~-------~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         232 LKDGYRL-------A--QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             HHcCCCC-------C--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            2222111       0  11122346788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=9.3e-38  Score=320.40  Aligned_cols=255  Identities=28%  Similarity=0.369  Sum_probs=200.2

Q ss_pred             hcCccccceecccCceEEEEeEcCC------CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      +++|...+.||+|+||.||+|...+      +..||+|.+... .......|.+|+.++++++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF-----   79 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----
Confidence            4678889999999999999999753      567899988643 3444567999999999999999999999876     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCC-----CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC---
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSG-----MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF---  461 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~-----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~---  461 (614)
                      +....++||||+++|+|.+++....     ...++|.++++++.|++.||+|||   +.+++||||||+||+++.++   
T Consensus        80 ~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~  156 (277)
T cd05036          80 ERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGR  156 (277)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCc
Confidence            4556799999999999999996543     135899999999999999999999   88999999999999998754   


Q ss_pred             cEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHH
Q 043267          462 EAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       462 ~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~  539 (614)
                      .+||+|||+++........ .......+..|+|||++.++.++.++|||||||++|||++ |+.||......     +..
T Consensus       157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-----~~~  231 (277)
T cd05036         157 VAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-----EVM  231 (277)
T ss_pred             ceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-----HHH
Confidence            5999999999865322111 1122234568999999999999999999999999999997 99888643221     111


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                       ..+..+..         ...+......+.+++..|++.+|++||++.+|++.|.
T Consensus       232 -~~~~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 -EFVTGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             11211111         1112223456788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-38  Score=333.11  Aligned_cols=243  Identities=22%  Similarity=0.281  Sum_probs=198.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||.+....   ....+.+.+|++++++++||||+++++++.     +++.
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~   92 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQ-----DENR   92 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----cCCE
Confidence            36888899999999999999975 68999999997532   233456889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        93 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         93 VYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            99999999999999999654  36889999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..+..    ....||+.|+|||.+.+..++.++|||||||++|||++|+.||......      -..+.+.++..     
T Consensus       168 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~-----  232 (329)
T PTZ00263        168 VPDRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILAGRL-----  232 (329)
T ss_pred             cCCCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhcCCc-----
Confidence            54322    2356899999999999999999999999999999999999999533211      11122222221     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIV  590 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl  590 (614)
                       .++.    ....++.+++..|++.||++||+     +++++
T Consensus       233 -~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll  269 (329)
T PTZ00263        233 -KFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVK  269 (329)
T ss_pred             -CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence             1111    12345678889999999999997     67766

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=321.58  Aligned_cols=251  Identities=26%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +|+..++||+|+||+||++... +++.||||.+....   ......+.+|+++++.++|+|++++++++.     .+...
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeec-----CCCeE
Confidence            4778899999999999999964 68999999986532   222345778999999999999999999886     55688


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++.......+++..+..++.|+++||.|||   +.+++||||||+||++++++.++|+|||+++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            99999999999999987655567999999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      .....  .....|+..|+|||.+.+..++.++||||+|+++|||++|+.||....... .. ..+...+..+        
T Consensus       153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~-~~-~~~~~~~~~~--------  220 (285)
T cd05605         153 PEGET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV-KR-EEVERRVKED--------  220 (285)
T ss_pred             CCCCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh-HH-HHHHHHhhhc--------
Confidence            43322  223468999999999999999999999999999999999999996432211 10 1111111111        


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                        ...........+.+++..|++.||++||     ++.++++
T Consensus       221 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 --QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             --ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence              1111223445677889999999999999     8888854

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.8e-39  Score=316.00  Aligned_cols=261  Identities=21%  Similarity=0.250  Sum_probs=199.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .|+...++|+|+||.|||.+.+ .|+.||||++.....  .-.+-..+|+++++.++|+|+|.|+.+|.     .....+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFr-----rkrklh   77 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFR-----RKRKLH   77 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHH-----hcceeE
Confidence            4666788999999999999976 599999999975332  23345689999999999999999999997     667889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ||+||++. ++.+-|.... ..++.+...+++.|+++|+.|+|   ++++|||||||+|||++.++.+||+|||+|+...
T Consensus        78 LVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   78 LVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             EEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhc
Confidence            99999976 4444443322 45888999999999999999999   9999999999999999999999999999999776


Q ss_pred             CCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh---------hHHHHHHHHc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL---------SDWAWELVKE  545 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l---------~~~~~~~~~~  545 (614)
                      . .....+..+.|..|.|||.+.+ .+|...+|||+.||++.||++|..-|...++-+...         ..--.+....
T Consensus       153 ~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  153 A-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             C-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            4 2334556678999999999988 699999999999999999999998886544322110         0000111111


Q ss_pred             C-Cc-----hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          546 G-KT-----LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       546 g-~~-----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      . ..     .+.-+..--+...+....-+++++..|++.||.+|++-+|++
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll  282 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLL  282 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHh
Confidence            1 10     111111111112234455678999999999999999999987

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.3e-37  Score=324.31  Aligned_cols=257  Identities=26%  Similarity=0.361  Sum_probs=205.0

Q ss_pred             cCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ++|...+.||+|+||.||++..      ..+..||||+++... ....+.+.+|+++++++ +|+||+++++++.     
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----  109 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACT-----  109 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEe-----
Confidence            4688899999999999999973      135579999987543 33346789999999999 7999999999986     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      ..+..++||||+++|+|.+++.......+++.++..++.+++.||+|||   +.+|+|+||||+|||++.++.+|++|||
T Consensus       110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg  186 (302)
T cd05055         110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFG  186 (302)
T ss_pred             cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCc
Confidence            4567899999999999999997655455899999999999999999999   8899999999999999999999999999


Q ss_pred             CceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCC
Q 043267          470 LAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       470 la~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +++........ ......++..|+|||.+..+.++.++||||+|+++|||++ |+.|+.......     -..+....+.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-----~~~~~~~~~~  261 (302)
T cd05055         187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-----KFYKLIKEGY  261 (302)
T ss_pred             ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-----HHHHHHHcCC
Confidence            99865433221 1222346788999999999999999999999999999998 999985433211     1112222221


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .         ..........+.+++..|++.+|++|||+.|+++.|+..
T Consensus       262 ~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 R---------MAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             c---------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1         111112234678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-38  Score=332.82  Aligned_cols=251  Identities=25%  Similarity=0.303  Sum_probs=202.9

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      +..++|..++.||+|+|++|++++.. .++++|||++.+.   .+...+.+..|-++|.+| .||.|++|+--+.     
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ-----  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ-----  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee-----
Confidence            33457888899999999999999954 6899999998642   223344567888999999 8999999987665     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      ++..+|+|+||++||+|.++|.+-  ..|+....+..+.+|+.||+|||   +.|||||||||+|||||+||++||+|||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFG  219 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFG  219 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeecc
Confidence            677899999999999999999765  47899999999999999999999   9999999999999999999999999999


Q ss_pred             CceeCCCCCcc---------c---cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhH
Q 043267          470 LAKFNPEGITH---------L---TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD  537 (614)
Q Consensus       470 la~~~~~~~~~---------~---~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~  537 (614)
                      -|+.++.....         .   ....+||..|.+||++..+..+..+|+|+|||+||+|+.|++||...++...    
T Consensus       220 sAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli----  295 (604)
T KOG0592|consen  220 SAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI----  295 (604)
T ss_pred             ccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH----
Confidence            99876532211         1   1347899999999999999999999999999999999999999975543111    


Q ss_pred             HHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       538 ~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        .+.      ...++-.+++..+    +...+++...+-.||.+|+|..|+-+
T Consensus       296 --Fqk------I~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  296 --FQK------IQALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             --HHH------HHHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhh
Confidence              111      1122333444333    45667777789999999999988864

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-38  Score=305.98  Aligned_cols=269  Identities=23%  Similarity=0.258  Sum_probs=214.7

Q ss_pred             HhcCccccceecccCceEEEEeE-cCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ..++|.+.+.||+|||+-||.++ ..++..+|+|++...+.++.+...+|++..++++|||+++++.++.....-..++.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            34578999999999999999999 56889999999998888888899999999999999999999998765544355678


Q ss_pred             EEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          395 IIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      +++++|...|||.+.+...  ++..+++.+.+.|+.++++||++||+. .+++.||||||.|||+.+.+.+++.|||.+.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~  177 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT  177 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence            9999999999999999763  445799999999999999999999933 3459999999999999999999999999987


Q ss_pred             eCCCCCcc--------ccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH
Q 043267          473 FNPEGITH--------LTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       473 ~~~~~~~~--------~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      ..+-....        .......|..|.|||.+.   +...++++|||||||++|+|+.|..||+..-++..++.     
T Consensus       178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla-----  252 (302)
T KOG2345|consen  178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA-----  252 (302)
T ss_pred             ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE-----
Confidence            54322111        112244689999999886   45788999999999999999999999963322211110     


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                             ..+....+.-.......+.+.+++.+|+++||.+||++.+++..++...
T Consensus       253 -------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 -------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                   1111112221122236778899999999999999999999999887653

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=345.64  Aligned_cols=250  Identities=18%  Similarity=0.211  Sum_probs=201.8

Q ss_pred             CccccceecccCceEEEEeEcC-C-CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-N-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~-g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .|...+.||+|+||.||++... + +..||+|.+..........+.+|+++++.++||||+++++++.     .++..++
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~l  142 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLLL  142 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEEE
Confidence            3888899999999999999854 3 6788999876555555567889999999999999999999987     5678999


Q ss_pred             EEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          397 VCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ||||+++|+|.+++.+.  ....+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            99999999999988652  3446899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          475 PEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       475 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.... ...+...    
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~-----~~~~~~-~~~~~~~----  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ-----REIMQQ-VLYGKYD----  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HHhCCCC----
Confidence            54322 223456799999999999999999999999999999999999999853321     111111 1112111    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ..    +......+.+++..|++.+|++||++.++++
T Consensus       290 -~~----~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        290 -PF----PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             -CC----CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence             01    1122346778889999999999999999864

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.1e-38  Score=332.24  Aligned_cols=241  Identities=23%  Similarity=0.276  Sum_probs=193.9

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +.||+|+||.||+++.. +|+.||||+++...   ......+.+|++++++++||||+++.+++.     .+...++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----cCCEEEEEEe
Confidence            46999999999999864 78999999997532   233456788999999999999999999886     5678899999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT  479 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~  479 (614)
                      |+++|+|.+++...  ..+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... .
T Consensus        76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~  149 (323)
T cd05571          76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-G  149 (323)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-C
Confidence            99999999998654  46899999999999999999999   899999999999999999999999999998753221 1


Q ss_pred             cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCC
Q 043267          480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM  559 (614)
Q Consensus       480 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~  559 (614)
                      .......||+.|+|||.+.+..++.++||||+||++|||++|+.||......  .    ....+..+.      ..++  
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~----~~~~~~~~~------~~~p--  215 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--K----LFELILMEE------IRFP--  215 (323)
T ss_pred             CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--H----HHHHHHcCC------CCCC--
Confidence            1233456999999999999999999999999999999999999999532211  0    111111111      1112  


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          560 ELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                        ......+.+++..|++.||++||     ++.++++
T Consensus       216 --~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         216 --RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             --CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence              22344677888999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.1e-37  Score=315.09  Aligned_cols=258  Identities=21%  Similarity=0.309  Sum_probs=206.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+...   .......+.+|+++++.++|||++++++++.     ....
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI-----EDNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEE-----ECCe
Confidence            47888999999999999999964 7899999987642   2334457889999999999999999999876     4567


Q ss_pred             EEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          394 RIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .++++||+++|+|.+++..  .....+++..+..++.|+++||.|||   +.+++||||||+||+++.++.++|+|||++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccc
Confidence            8999999999999998854  23346889999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ........ ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....   ...++.. ....+.    
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~---~~~~~~~-~~~~~~----  224 (267)
T cd08228         154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLFSLCQ-KIEQCD----  224 (267)
T ss_pred             eeccchhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc---cHHHHHH-HHhcCC----
Confidence            86543322 12234688899999999988999999999999999999999999853322   1112221 111111    


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          .+..........+.+++..||+.+|++||++.+|++.|++.
T Consensus       225 ----~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 ----YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             ----CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence                11111223345678889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.6e-37  Score=314.47  Aligned_cols=249  Identities=31%  Similarity=0.411  Sum_probs=201.2

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...+.||+|+||.||++.. .|..||+|.++...  ..+.+.+|+.++++++|+|++++++++..    ++...+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~lv   78 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIV   78 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEc----CCCceEEE
Confidence            3678889999999999999987 47889999986532  34578899999999999999999997642    44568999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      +||+++|+|.+++.......+++..+++++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.....
T Consensus        79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          79 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             EECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999999998766667999999999999999999999   899999999999999999999999999998754332


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .    ....++..|+|||++....++.++||||||+++|||++ |+.|+....     ..+.. ..+..+...     . 
T Consensus       156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-----~~~~~-~~~~~~~~~-----~-  219 (256)
T cd05082         156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-----LKDVV-PRVEKGYKM-----D-  219 (256)
T ss_pred             C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-----HHHHH-HHHhcCCCC-----C-
Confidence            1    22344678999999999999999999999999999998 998885322     11111 111222111     1 


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                         ........+.+++..|++.+|++|||+.++++.|++
T Consensus       220 ---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         220 ---APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             ---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence               112234467788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=320.62  Aligned_cols=275  Identities=27%  Similarity=0.339  Sum_probs=211.8

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc--cccceeeeeeeeecccCCC
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l--~H~niv~l~g~~~~~~~~~  390 (614)
                      .+...++....+.||+|.||.||+|.+ .|..||||++...   +++.+.+|.|++..+  +|+||+.+++.-..+.. .
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g-s  280 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNG-S  280 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCC-c
Confidence            355566788889999999999999999 6899999999754   355678899988765  99999998886544321 3


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhh-----cCCCceEEeccCCCCeEECCCCcEEE
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY-----GVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~-----~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                      -.+++||.+|.++|||+|||..   ..++-...++++..+|.||++||.     ..++.|.|||||+.|||+..++...|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence            3578999999999999999955   579999999999999999999993     34788999999999999999999999


Q ss_pred             eecCCceeCCCCCcc---ccccccCCCCcCchhhhccCC------CCchhhHHHHHHHHHHHHhCC----------CCcc
Q 043267          466 GDFGLAKFNPEGITH---LTTRVAGTLGYVAPEYALYGK------LTPGSDVYSFGVVLLELLSGK----------KACE  526 (614)
Q Consensus       466 ~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~~------~t~ksDVwS~Gvll~ElltG~----------~p~~  526 (614)
                      +|+|||-...++...   .....+||.+|||||++...-      .-..+||||||.++||+....          .||.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            999999765544222   234568999999999986531      224699999999999997532          4554


Q ss_pred             cccCccchhhHHHHHHHHcCCchhhhhccCCC-CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          527 IIQGKSVLLSDWAWELVKEGKTLDVIEENMPE-MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       527 ~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                      +..+.+..+     +.+++-.-.+.+.+.+++ ....+.+..+.++++.||+.+|..|-|+-.+-+.|.+....+
T Consensus       438 d~Vp~DPs~-----eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  438 DVVPSDPSF-----EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             cCCCCCCCH-----HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence            333322222     222222223334444443 233467888999999999999999999999999998876544

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-38  Score=329.97  Aligned_cols=241  Identities=23%  Similarity=0.248  Sum_probs=191.9

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||.||+++.. +++.||+|.++..   +......+.+|++++++++||||+++++++.     ++...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQ-----SPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEe-----cCCeEEEEEcCC
Confidence            799999999999975 5889999998742   2334566889999999999999999999886     567889999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++|+|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        76 ~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~  149 (312)
T cd05585          76 NGGELFHHLQRE--GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DK  149 (312)
T ss_pred             CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cc
Confidence            999999999654  36899999999999999999999   8999999999999999999999999999997543221 22


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      .....||+.|+|||.+.+..++.++||||+||++|||++|+.||.....     ....... ..+.      ..++    
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~-----~~~~~~~-~~~~------~~~~----  213 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV-----NEMYRKI-LQEP------LRFP----  213 (312)
T ss_pred             cccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH-----HHHHHHH-HcCC------CCCC----
Confidence            3446799999999999999999999999999999999999999964321     1111111 1111      1111    


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          562 PEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                      ......+.+++..|++.||++||+...+.+.|
T Consensus       214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            22334567888899999999998654443433

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-37  Score=318.86  Aligned_cols=258  Identities=25%  Similarity=0.405  Sum_probs=204.3

Q ss_pred             cCccccceecccCceEEEEeEc-CCCc----EEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGT----EVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|...+.||+|+||.||+|++ ++|+    .||+|.++.. ......++.+|+.+++.++|+|++++++++..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence            4678889999999999999985 3554    4899998753 34446678899999999999999999999852      


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++++||+++|+|.+++.... ..+++..++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~  156 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCce
Confidence            34679999999999999987543 46999999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +........ ......++..|+|||...++.++.++||||||+++|||++ |..|+......  .+    ...+..+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~----~~~~~~~~~~  230 (279)
T cd05109         157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EI----PDLLEKGERL  230 (279)
T ss_pred             eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HH----HHHHHCCCcC
Confidence            876533221 1222345678999999999999999999999999999998 88888543211  11    1222222211


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                      .         ........+.+++..|++.||++||++.++++.|+.....|
T Consensus       231 ~---------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 P---------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             C---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            1         11223346778899999999999999999999998875544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=7.2e-38  Score=323.38  Aligned_cols=258  Identities=28%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             HhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      ..++|+..+.||+|+||.||++...      +...+|+|++... ......++.+|++++.++ +|+|++++++++.   
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---   86 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT---   86 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc---
Confidence            3456888899999999999999863      2367999998753 334456788999999999 8999999999986   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhc--------------CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCC
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS  453 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~--------------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~  453 (614)
                        .+...+++|||+++|+|.+++..              .....+++..+++++.|++.||.|||   +.+|+||||||+
T Consensus        87 --~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~  161 (293)
T cd05053          87 --QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAAR  161 (293)
T ss_pred             --CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCcccccccee
Confidence              45678999999999999999864              22457999999999999999999999   899999999999


Q ss_pred             CeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCc
Q 043267          454 NILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGK  531 (614)
Q Consensus       454 NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~  531 (614)
                      ||++++++.+||+|||+++....... .......++..|+|||......++.++||||||+++|||++ |..|+......
T Consensus       162 Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  241 (293)
T cd05053         162 NVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  241 (293)
T ss_pred             eEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH
Confidence            99999999999999999986543322 12222345678999999999999999999999999999998 88888533211


Q ss_pred             cchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       532 ~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .      ..+....+...         ..+......+.+++..|++.+|++|||+.|+++.|+..
T Consensus       242 ~------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         242 E------LFKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             H------HHHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            1      11222222111         11122345678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=2.2e-37  Score=314.52  Aligned_cols=245  Identities=26%  Similarity=0.418  Sum_probs=195.6

Q ss_pred             ecccCceEEEEeEcC---CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP---NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||.||+|++.   ++..||+|.+.... ....+++.+|++++++++|+||+++++++.      ....++||||+
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~------~~~~~lv~e~~   76 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE------AEALMLVMEMA   76 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc------CCCeEEEEEeC
Confidence            899999999999753   45679999987543 334567999999999999999999999874      34679999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++|+|.+++... ...+++..+++++.|+++||.|||   +.+++||||||+|||++.++.+||+|||+++....+....
T Consensus        77 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  152 (257)
T cd05115          77 SGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY  152 (257)
T ss_pred             CCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence            999999998653 347899999999999999999999   8899999999999999999999999999997554332221


Q ss_pred             --cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          482 --TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       482 --~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                        .....++..|+|||.+..+.++.++||||||+++||+++ |+.||......     + +...+..+...+        
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----~-~~~~~~~~~~~~--------  218 (257)
T cd05115         153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP-----E-VMSFIEQGKRLD--------  218 (257)
T ss_pred             eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH-----H-HHHHHHCCCCCC--------
Confidence              122234678999999998899999999999999999996 99998644321     1 122333332211        


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                       .+....+.+.+++..||+.+|++||++.+|.+.|+.
T Consensus       219 -~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         219 -CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             -CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence             112234566778999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=8.5e-38  Score=321.24  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=200.4

Q ss_pred             CccccceecccCceEEEEeEcC------CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +|...+.||+|+||.||+|...      ++..||||+++.... ...+.+.+|+++++.++||||+++++++.     ..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~   80 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT-----KE   80 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC
Confidence            3566788999999999999853      357899999975433 23467889999999999999999999986     45


Q ss_pred             ceEEEEEeecCCCChhhhhhcC--------------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGS--------------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL  457 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~--------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL  457 (614)
                      ...++++||+++++|.+++...              ....+++..+++++.|+++||+|||   +.+|+||||||+||++
T Consensus        81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~  157 (283)
T cd05091          81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLV  157 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEe
Confidence            6789999999999999998531              1235889999999999999999999   8999999999999999


Q ss_pred             CCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchh
Q 043267          458 DEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLL  535 (614)
Q Consensus       458 d~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l  535 (614)
                      ++++.+||+|||+++....... .......+++.|+|||.+.++.++.++||||||+++|||++ |..|+.....     
T Consensus       158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----  232 (283)
T cd05091         158 FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----  232 (283)
T ss_pred             cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence            9999999999999886543221 12233446789999999999999999999999999999998 7778753321     


Q ss_pred             hHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          536 SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       536 ~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      .++ .+.+..+...         ....+....+..++..|++.+|++||++.+|++.|++
T Consensus       233 ~~~-~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 QDV-IEMIRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHH-HHHHHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            111 1222222211         1112234457788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.1e-38  Score=318.60  Aligned_cols=259  Identities=24%  Similarity=0.341  Sum_probs=203.0

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC-C
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL-E  390 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~-~  390 (614)
                      +.+++.|+..+.||+|+||.||+|... +++.||+|++.... ....++.+|+++++++ +|+|++++.+++...... .
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            346677888999999999999999965 68899999987543 3456788999999999 799999999998653221 1


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....+++|||+++|+|.+++.......++|..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence            346889999999999999998765567999999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      +........ ......|+..|+|||++.     ...++.++|||||||++|||++|+.|+.......    .. ......
T Consensus       158 ~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~----~~-~~~~~~  231 (272)
T cd06637         158 SAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR----AL-FLIPRN  231 (272)
T ss_pred             ceecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHH----HH-HHHhcC
Confidence            986543222 233456899999999986     3468889999999999999999999985432111    00 011111


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .      .....   .......+.+++..|++.+|.+|||+.|+++
T Consensus       232 ~------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 P------APRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C------CCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0      01111   1122346778899999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=2.1e-37  Score=322.37  Aligned_cols=263  Identities=22%  Similarity=0.287  Sum_probs=196.0

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||.+..... .....+.+|+++++.++||||+++++++.     ++...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            467889999999999999999975 789999999875332 23346778999999999999999999886     55678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||++ ++|.+++... ...+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..
T Consensus        79 ~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            99999995 6888887653 246889999999999999999999   899999999999999999999999999999754


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC------
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK------  547 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~------  547 (614)
                      .... .......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.........+.... .......      
T Consensus       154 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~  231 (303)
T cd07869         154 SVPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF-LVLGTPNEDTWPG  231 (303)
T ss_pred             cCCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH-HHhCCCChhhccc
Confidence            3221 22234568999999998875 4689999999999999999999999964432111111100 0000000      


Q ss_pred             ---chhhhhccCC---CCCcH------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 ---TLDVIEENMP---EMELP------EMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ---~~~~~d~~l~---~~~~~------~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ..........   .....      .....+.+++..|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence               0000000000   00000      11235668889999999999999999974

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-37  Score=321.17  Aligned_cols=262  Identities=27%  Similarity=0.390  Sum_probs=203.9

Q ss_pred             cCccccceecccCceEEEEeEc-----CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +.|...+.||+|+||.||+++.     .++..||+|.++... ......+.+|+++++.++|+|++++.+++...   ++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   80 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   80 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            3567788999999999999973     357889999987543 33456799999999999999999999988642   24


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++++|.+++.+.. ..++|..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence            56899999999999999986543 36899999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccC----------ccchhhHHH
Q 043267          472 KFNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG----------KSVLLSDWA  539 (614)
Q Consensus       472 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~----------~~~~l~~~~  539 (614)
                      +.......  .......++..|+|||+..++.++.++||||||+++|||++++.|......          ..... ...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  235 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV-TRL  235 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccH-HHH
Confidence            86543222  122334567789999999999999999999999999999998776422110          00011 111


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ......+...         .........+.+++..|++.+|++|||+.++++.|+..
T Consensus       236 ~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         236 VRVLEEGKRL---------PRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHHcCccC---------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1222222111         11223456788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.4e-37  Score=311.47  Aligned_cols=258  Identities=22%  Similarity=0.325  Sum_probs=207.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||.||+|+.. +|+.||+|.++..   .....+.+.+|++++++++|+|++++++++.     +.+.
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~-----~~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI-----ENNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeee-----cCCe
Confidence            57889999999999999999976 7999999988632   2333567899999999999999999999886     4567


Q ss_pred             EEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          394 RIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .++||||+++|+|.+++..  .....+++.++++++.++++||.|||   +.+++||||||+||+++.++.++|+|||++
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEecccee
Confidence            8999999999999999865  23456899999999999999999999   899999999999999999999999999998


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +....... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....   .+.+.. +....+..   
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~-~~~~~~~~---  225 (267)
T cd08224         154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM---NLYSLC-KKIEKCDY---  225 (267)
T ss_pred             eeccCCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc---cHHHHH-hhhhcCCC---
Confidence            76543221 12334688999999999998999999999999999999999999853321   111111 11111111   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           ...........+.+++..|++.+|++|||+.+|+++|++.
T Consensus       226 -----~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         226 -----PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             -----CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence                 1111123445678899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-37  Score=312.82  Aligned_cols=247  Identities=30%  Similarity=0.451  Sum_probs=197.8

Q ss_pred             ceecccCceEEEEeEcC--C--CcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP--N--GTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~--~--g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+|+..  +  +..+|+|.+..... ...+++.+|+++++.++|+|++++++++.      +...++||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~~~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK------GEPLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc------CCceEEEE
Confidence            46999999999999853  2  36899999875443 34567899999999999999999999874      45679999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++....  .+++..+..++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++......
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          75 ELAPLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             EeCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            9999999999997644  7899999999999999999999   8899999999999999999999999999998654433


Q ss_pred             ccc--cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          479 THL--TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       479 ~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ...  .....++..|+|||...+..++.++||||||+++|||++ |+.||......  .+    ...+..+...      
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~--~~----~~~~~~~~~~------  217 (257)
T cd05060         150 DYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA--EV----IAMLESGERL------  217 (257)
T ss_pred             cccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH--HH----HHHHHcCCcC------
Confidence            221  122234568999999999999999999999999999998 99998644321  11    1222222211      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                         .........+.+++..|++.+|++||++.+++++|++.
T Consensus       218 ---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         218 ---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             ---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence               11122335677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=345.60  Aligned_cols=263  Identities=21%  Similarity=0.269  Sum_probs=206.0

Q ss_pred             HHHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          312 EIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       312 el~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      +.+...++|...+.||+|+||+||+++. .+|+.||||++...  +......+.+|+.++..++|+|++++...+.....
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            3344556899999999999999999985 47999999998643  34455678899999999999999998876543221


Q ss_pred             C---CCceEEEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          389 L---EGHQRIIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       389 ~---~~~~~~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                      .   .....++||||+++|+|.+++...  ....+++..+..|+.|+++||.|||   +.+|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCE
Confidence            1   112467999999999999999653  2356899999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH
Q 043267          464 KVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       464 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      ||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....     ..+.... 
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~-----~~~~~~~-  256 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN-----MEEVMHK-  256 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC-----HHHHHHH-
Confidence            9999999986543322 22344679999999999999999999999999999999999999995322     1111111 


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      ...+...     .+    +......+.+++..|++.+|.+||++.++++.
T Consensus       257 ~~~~~~~-----~~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 TLAGRYD-----PL----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HhcCCCC-----CC----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1122111     11    12234467788999999999999999999763

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.9e-37  Score=313.98  Aligned_cols=258  Identities=21%  Similarity=0.331  Sum_probs=205.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||.||+++. .+|+.+|||.+...   ......++.+|+++++.++|+|++++++++.     +++.
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeE-----eCCe
Confidence            3677889999999999999995 48899999988642   2334467889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          394 RIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .+++|||+++++|.+++..  .....+++.++.+++.++++||.|||   +.+++|+||||+||+++.++.++|+|||++
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhh
Confidence            8999999999999998864  23456899999999999999999999   899999999999999999999999999998


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ........ ......|+..|+|||++.+..++.++||||||+++|||++|..|+......   ...+. +.....     
T Consensus       154 ~~~~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-~~~~~~-----  223 (267)
T cd08229         154 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLC-KKIEQC-----  223 (267)
T ss_pred             hccccCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch---HHHHh-hhhhcC-----
Confidence            76543322 123346889999999999999999999999999999999999998533211   11111 111111     


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..+..+   .......+.+++..|++.+|++||||.+|++++++.
T Consensus       224 ~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 DYPPLP---SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCCCCC---cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            011111   123445678888999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-37  Score=331.16  Aligned_cols=246  Identities=25%  Similarity=0.357  Sum_probs=190.6

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      |+..+.||+|+||.||+++.. +|+.||||.+... .......+.+|++++++++|+||+++++++.     +++..++|
T Consensus        76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv  150 (353)
T PLN00034         76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFD-----HNGEIQVL  150 (353)
T ss_pred             HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEec-----cCCeEEEE
Confidence            455688999999999999964 7899999999653 2334567899999999999999999999886     56788999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+..      ..++..+..|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus       151 ~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        151 LEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             EecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            9999999986542      3567778899999999999999   899999999999999999999999999999865432


Q ss_pred             CccccccccCCCCcCchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          478 ITHLTTRVAGTLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .. ......||..|+|||++..     ...+.++|||||||++|||++|+.||.....     .+|........      
T Consensus       222 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~~~~~~~~~~~------  289 (353)
T PLN00034        222 MD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----GDWASLMCAIC------  289 (353)
T ss_pred             cc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----ccHHHHHHHHh------
Confidence            21 1234578999999998743     2345689999999999999999999963221     11211111000      


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                       ..............+.+++..||+.||++|||+.|+++.
T Consensus       290 -~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        290 -MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000111122334567888999999999999999999864

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.8e-37  Score=312.18  Aligned_cols=251  Identities=27%  Similarity=0.419  Sum_probs=201.2

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +|+..+.||+|+||.||++.+.++..+|+|.+.... ....++.+|++++++++|||++++++++.     .....++|+
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~   78 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT-----ERSPICLVF   78 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEc-----cCCceEEEE
Confidence            567788999999999999998778899999887532 23457899999999999999999999876     456789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++++|.+++.... ..++++.+..++.+++.||+|||   +.+++||||||+||+++.++.+||+|||++....+..
T Consensus        79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          79 EFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             EcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            9999999999986543 36899999999999999999999   8899999999999999999999999999997654332


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      ........++.+|+|||...++.++.++||||||+++|||++ |+.|+.....     ...... ...+...  ..+   
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~-~~~~~~~--~~~---  223 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-----SEVVET-INAGFRL--YKP---  223 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-----HHHHHH-HhCCCCC--CCC---
Confidence            222223345678999999999999999999999999999998 8998853221     111111 1221110  011   


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                          ......+.+++..|++.+|++|||+.++++.|.
T Consensus       224 ----~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         224 ----RLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                112356888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.1e-37  Score=324.57  Aligned_cols=199  Identities=25%  Similarity=0.348  Sum_probs=172.6

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|+..+.||+|+||.||+++.. +|..+|+|.+... .......+.+|++++++++|+||+++++++.     +++..
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   78 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   78 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEE-----ECCEE
Confidence            357889999999999999999975 6888999988753 3334567899999999999999999999987     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++...  ..+++.....++.++++||.|||+  ..+++||||||+|||+++++.+||+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          79 SICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            9999999999999999654  358899999999999999999993  247999999999999999999999999998754


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      ...   ......||..|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       155 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~  204 (333)
T cd06650         155 IDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             hhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence            332   12335689999999999998999999999999999999999999853

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=316.94  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=203.6

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...+.||+|+||.||+|...      .+..||+|.+.... .....++.+|+++++.++|+|++++++++.     .
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~   80 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----T   80 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----C
Confidence            46888899999999999999864      24689999987543 344567889999999999999999999986     4


Q ss_pred             CceEEEEEeecCCCChhhhhhcCC--------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSG--------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~--------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      ....++||||+++|+|.+++....        ...++|..+++++.|++.||.|||   +.+++||||||+||++++++.
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~  157 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLT  157 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCC
Confidence            567899999999999999996532        234789999999999999999999   899999999999999999999


Q ss_pred             EEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHH
Q 043267          463 AKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~  540 (614)
                      +||+|||+++....... .......++..|+|||.+.++.++.++||||||+++||+++ |+.|+.......      ..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~  231 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------VL  231 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------HH
Confidence            99999999875443221 12233456789999999999999999999999999999998 888885332211      11


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      +....+...     ..+.    .....+.+++..|++.+|++|||+.++++.|+.
T Consensus       232 ~~~~~~~~~-----~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 KFVIDGGHL-----DLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             HHHhcCCCC-----CCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            222222211     1111    224567889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.9e-37  Score=314.83  Aligned_cols=255  Identities=28%  Similarity=0.433  Sum_probs=202.7

Q ss_pred             cCccccceecccCceEEEEeEcC----CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .+|...+.||+|+||.||+|+..    .+..+|+|.++... ....+.+.+|+++++.++|||++++++++.     .++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            46788899999999999999863    23479999986532 334567899999999999999999999986     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++.... ..+++.++++|+.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~  154 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSR  154 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCccc
Confidence            7899999999999999997643 46899999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCcccc--ccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          473 FNPEGITHLT--TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ..........  ....++..|+|||++.++.++.++||||||+++||+++ |+.|+......+      ......++.. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~~~~~~~~~~-  227 (267)
T cd05066         155 VLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------VIKAIEEGYR-  227 (267)
T ss_pred             ccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------HHHHHhCCCc-
Confidence            6654332221  22233568999999999999999999999999999887 999985433211      1122222211 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                            .+  ........+.+++..|++.+|++||++.++++.|+..
T Consensus       228 ------~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 ------LP--APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ------CC--CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                  01  1112344677889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.4e-37  Score=318.65  Aligned_cols=261  Identities=21%  Similarity=0.282  Sum_probs=196.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|... +++.||+|.++... ......+.+|++++++++||||+++++++.     .+...+
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~   79 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIH-----TERCLT   79 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEc-----CCCeEE
Confidence            46888899999999999999965 68999999987432 223456789999999999999999999876     456789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||++ |+|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        80 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          80 LVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            9999997 59999886533 45889999999999999999999   8999999999999999999999999999997644


Q ss_pred             CCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH--------HHHcC
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE--------LVKEG  546 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~--------~~~~g  546 (614)
                      .... ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........ + .....        .+..-
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~  231 (288)
T cd07871         155 VPTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-L-HLIFRLLGTPTEETWPGI  231 (288)
T ss_pred             CCCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHhCCCChHHhhcc
Confidence            3221 2233467999999998875 5689999999999999999999999854322111 0 00000        11100


Q ss_pred             Cch----hhhhccCCCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTL----DVIEENMPEME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~----~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...    ....+......    .+.......+++..|++.||.+|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000    00000000000    0112345678999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-37  Score=318.66  Aligned_cols=262  Identities=23%  Similarity=0.368  Sum_probs=200.1

Q ss_pred             cCccccceecccCceEEEEeEcCC---------------CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeee
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN---------------GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRG  381 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g  381 (614)
                      ++|+..+.||+|+||.||+++..+               ...||+|.++.. .......+.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            468888999999999999987532               235899998753 3344567999999999999999999999


Q ss_pred             eeecccCCCCceEEEEEeecCCCChhhhhhcCC----------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       382 ~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~----------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                      ++.     .....++||||+++++|.+++....          ...++|..+++++.|+++||+|||   +.+++|||||
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlk  156 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLA  156 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccC
Confidence            986     5567899999999999999986432          124789999999999999999999   8999999999


Q ss_pred             CCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCcccc
Q 043267          452 ASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS--GKKACEII  528 (614)
Q Consensus       452 p~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~~  528 (614)
                      |+||++++++.+||+|||+++....... .......++..|+|||+..++.++.++||||||+++|||++  |..|+...
T Consensus       157 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         157 TRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999999999975443221 12233445778999999999999999999999999999998  45566433


Q ss_pred             cCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          529 QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       529 ~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ....  ......+..........      ..........+.+++..|++.+|++||++.+|+++|+.
T Consensus       237 ~~~~--~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         237 SDEQ--VIENTGEFFRNQGRQIY------LSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ChHH--HHHHHHHhhhhcccccc------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            2211  11111111111110000      00111233578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=3.6e-37  Score=318.42  Aligned_cols=262  Identities=24%  Similarity=0.342  Sum_probs=203.4

Q ss_pred             cCccccceecccCceEEEEeEcCC-----------------CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeee
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN-----------------GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVAL  379 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l  379 (614)
                      .+|+..+.||+|+||.||+++..+                 +..||+|++... .....+++.+|++++++++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            468888999999999999988542                 246899998753 33456788999999999999999999


Q ss_pred             eeeeecccCCCCceEEEEEeecCCCChhhhhhcCC---------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEecc
Q 043267          380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG---------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDI  450 (614)
Q Consensus       380 ~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~---------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDI  450 (614)
                      ++++.     .+...++++||+++++|.+++.+..         ...+++..++.++.|+++||.|||   +.+++||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dl  156 (296)
T cd05051          85 LGVCT-----VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDL  156 (296)
T ss_pred             EEEEe-----cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCcccccc
Confidence            99986     4567899999999999999997543         236899999999999999999999   899999999


Q ss_pred             CCCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCccc
Q 043267          451 KASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS--GKKACEI  527 (614)
Q Consensus       451 Kp~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~  527 (614)
                      ||+||++++++.+||+|||+++....... .......+++.|+|||+...+.++.++||||||+++|||++  |..|+..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999975443221 22334556789999999999899999999999999999998  5666643


Q ss_pred             ccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          528 IQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       528 ~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ...  ...........+.+......+      ........+.+++..|++.+|++|||+.||++.|+.
T Consensus       237 ~~~--~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         237 LTD--QQVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cCh--HHHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            221  111112222211111111111      112233578889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.3e-37  Score=328.41  Aligned_cols=241  Identities=23%  Similarity=0.280  Sum_probs=193.6

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +.||+|+||.||++... +|+.||||.+...   .......+.+|+++++.++||||+++.+++.     .+...++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQ-----TKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCEEEEEEe
Confidence            46999999999999964 6899999999753   2334467889999999999999999998876     5678899999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT  479 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~  479 (614)
                      |+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...... 
T Consensus        76 y~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          76 YVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             CCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            99999999988654  46899999999999999999999   8999999999999999999999999999987533221 


Q ss_pred             cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCC
Q 043267          480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM  559 (614)
Q Consensus       480 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~  559 (614)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ... +.+..+      +..++. 
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~-~~~~~~------~~~~p~-  216 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLF-ELILME------DIKFPR-  216 (328)
T ss_pred             cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHH-HHhccC------CccCCC-
Confidence            1223457999999999999999999999999999999999999999532211     111 111111      111222 


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          560 ELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                         .....+.+++..|++.||++||     ++.|+++
T Consensus       217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         217 ---TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence               2234567788899999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2e-37  Score=322.53  Aligned_cols=258  Identities=27%  Similarity=0.400  Sum_probs=204.3

Q ss_pred             hcCccccceecccCceEEEEeEc--------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML--------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTAT  386 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~  386 (614)
                      ..+|...+.||+|+||.||+++.        .++..||+|.+... ......++.+|+++++.+ +|+||+++++++.  
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~--   91 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--   91 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe--
Confidence            34678889999999999999973        13457999998743 234456789999999999 8999999999986  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                         .....+++|||+++|+|.+++.+..              ...++|.++++++.|+++||+|||   +.+++||||||
T Consensus        92 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp  165 (304)
T cd05101          92 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAA  165 (304)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeeccccc
Confidence               4567899999999999999997532              245889999999999999999999   88999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~  530 (614)
                      +||++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... 
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-  244 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-  244 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC-
Confidence            9999999999999999999866543222 2233446778999999999999999999999999999998 777774322 


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                          ..++ .+....+....         ........+.+++..|++.+|++|||+.|+++.|++..
T Consensus       245 ----~~~~-~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         245 ----VEEL-FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             ----HHHH-HHHHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                1111 22222222111         11223456778899999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-37  Score=327.51  Aligned_cols=251  Identities=22%  Similarity=0.258  Sum_probs=196.3

Q ss_pred             CccccceecccCceEEEEeEc----CCCcEEEEEEeecCC----hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCS----KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      +|+..+.||+|+||.||+++.    .+|+.||+|++....    ....+.+.+|++++..+ +|+||+++++++.     
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ-----   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe-----
Confidence            477889999999999999875    368899999987422    22345678899999999 5999999998876     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      .+...++||||+++|+|.+++...  ..+++.+...++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG  150 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFG  150 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCc
Confidence            566789999999999999999654  36899999999999999999999   8999999999999999999999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      +++..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||........  .......+..   
T Consensus       151 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~~~~~~~~---  225 (332)
T cd05614         151 LSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNT--QSEVSRRILK---  225 (332)
T ss_pred             CCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCC--HHHHHHHHhc---
Confidence            9986543333333456799999999998865 478999999999999999999999954322111  1111111111   


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                         .+..++.    .....+.+++..|++.||++||     +++++++
T Consensus       226 ---~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         226 ---CDPPFPS----FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---CCCCCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence               1112221    2234567788899999999999     6777764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-37  Score=332.80  Aligned_cols=257  Identities=22%  Similarity=0.276  Sum_probs=194.3

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .+|+..+.||+|+||.||++... +++.||+|....      ..+.+|++++++++||||+++++++.     .+...++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~l  160 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFT-----YNKFTCL  160 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEE-----ECCeeEE
Confidence            57999999999999999999964 688999996532      34678999999999999999999886     4567899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+|++. ++|.+++...  ..+++..++.|+.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       161 v~e~~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        161 ILPRYK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EEecCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            999985 7898888653  46899999999999999999999   88999999999999999999999999999975433


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc--hhhHHHHHHHH-cCC------
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV--LLSDWAWELVK-EGK------  547 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~l~~~~~~~~~-~g~------  547 (614)
                      ..........||+.|+|||++.+..++.++|||||||++|||++|+.|+....+...  .........++ .|.      
T Consensus       235 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        235 INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            222233456799999999999999999999999999999999999988732211100  00000000000 000      


Q ss_pred             ------chhhh----h--ccCCCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 ------TLDVI----E--ENMPEME-----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ------~~~~~----d--~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            ..+..    .  ...+...     .......+..++..|++.||++|||++|+++
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  00000    0  0000000     0123446788999999999999999999984

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=345.73  Aligned_cols=255  Identities=27%  Similarity=0.413  Sum_probs=211.0

Q ss_pred             cccceecccCceEEEEeEc-CCCc----EEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          321 SRENIIGKGGYGNVYKGML-PNGT----EVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~-~~g~----~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ...++||+|+||+||||.+ ++|.    +||||++... +.+...++.+|+-+|.+++|||+++|+|+|..      ...
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~------s~~  772 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCML------STL  772 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhccc------chH
Confidence            4468899999999999995 5554    6899988653 44556789999999999999999999999963      347


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      .||++|||.|+|.||++.++ ..+..+..+.|..|||+||.|||   +++++||||.++|||+.+...+||.|||+++..
T Consensus       773 qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll  848 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL  848 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence            89999999999999998754 57899999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          475 PEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       475 ~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..+... ......-.+.|||-|.+....|+.+||||||||++||++| |.+|++....+++      .+.++.|.+..  
T Consensus       849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI------~dlle~geRLs--  920 (1177)
T KOG1025|consen  849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI------PDLLEKGERLS--  920 (1177)
T ss_pred             CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh------hHHHhccccCC--
Confidence            655433 2333334678999999999999999999999999999999 9999976554332      34555554421  


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                             .++.....+..++..||..|+..||+++++...+.+....|
T Consensus       921 -------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  921 -------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             -------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence                   23444557778889999999999999999998887765444

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.7e-37  Score=322.13  Aligned_cols=257  Identities=28%  Similarity=0.376  Sum_probs=202.3

Q ss_pred             cCccccceecccCceEEEEeEcC--------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP--------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      ++|...+.||+|+||.||+++..        ++..+|+|.++.. ......++.+|+++++++ +|+|++++++++.   
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~---   94 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---   94 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe---
Confidence            46888999999999999999742        2357999999753 234456788999999999 8999999999987   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCC
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS  453 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~  453 (614)
                        .+...++||||+++|+|.+++....              ...++|.++++++.|++.||+|||   +.+++||||||+
T Consensus        95 --~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~  169 (307)
T cd05098          95 --QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR  169 (307)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHH
Confidence              5567899999999999999997532              235899999999999999999999   899999999999


Q ss_pred             CeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCc
Q 043267          454 NILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGK  531 (614)
Q Consensus       454 NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~  531 (614)
                      ||+++.++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... 
T Consensus       170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~-  248 (307)
T cd05098         170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  248 (307)
T ss_pred             heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-
Confidence            99999999999999999875543211 11222234578999999999999999999999999999998 8888753221 


Q ss_pred             cchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       532 ~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                          .+.. +....+...         ..+......+.+++..|++.+|++|||+.+|++.|+...
T Consensus       249 ----~~~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 ----EELF-KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             ----HHHH-HHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence                1111 122222111         111223446778899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.2e-37  Score=327.75  Aligned_cols=241  Identities=22%  Similarity=0.280  Sum_probs=192.5

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +.||+|+||.||+++.. +|..||+|.++..   .......+.+|+++++.++||||+++++++.     .....++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-----~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCEEEEEEe
Confidence            46999999999999964 7899999999753   2234456778999999999999999999886     5568899999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT  479 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~  479 (614)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        76 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-  149 (323)
T cd05595          76 YANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-
Confidence            99999999988654  36899999999999999999999   8999999999999999999999999999987532211 


Q ss_pred             cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCC
Q 043267          480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM  559 (614)
Q Consensus       480 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~  559 (614)
                      .......||+.|+|||++.++.++.++|||||||++|||++|+.||.......      ..+.+..+.      ..++. 
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~~------~~~p~-  216 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEE------IRFPR-  216 (323)
T ss_pred             CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcCC------CCCCC-
Confidence            12234569999999999999999999999999999999999999985432111      111111111      11222 


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          560 ELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                         .....+.+++..|++.||++||     ++.++++
T Consensus       217 ---~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         217 ---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             ---CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence               2234567788889999999998     7888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-38  Score=332.83  Aligned_cols=252  Identities=22%  Similarity=0.257  Sum_probs=200.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||+++...   ......+.+|++++..++|+||+++++++.     ++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQ-----DEEH   75 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhee-----cCCe
Confidence            36888999999999999999975 68999999997532   234567889999999999999999998876     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          76 LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            99999999999999999765  47899999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCC----------------------------ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          474 NPEGI----------------------------THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       474 ~~~~~----------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      .....                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            54332                            11223456999999999999999999999999999999999999999


Q ss_pred             ccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 043267          526 EIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT-MDQIVKI  592 (614)
Q Consensus       526 ~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~~  592 (614)
                      ......     .. +..+.....    ...++.  .......+..++..|++ +|.+||+ +.++++.
T Consensus       231 ~~~~~~-----~~-~~~i~~~~~----~~~~p~--~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         231 YSDTLQ-----ET-YNKIINWKE----SLRFPP--DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCCCHH-----HH-HHHHhccCC----cccCCC--CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            643311     11 111111000    001111  11134456778888997 9999999 9999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.1e-37  Score=314.70  Aligned_cols=254  Identities=28%  Similarity=0.458  Sum_probs=200.3

Q ss_pred             CccccceecccCceEEEEeEcCC-C---cEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPN-G---TEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~-g---~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .|...+.||+|+||.||+|+... |   ..||||.++.. +.....+|.+|+++++.++|||++++.+++.     ++..
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~   79 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSRP   79 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC-----CCCc
Confidence            46778999999999999999653 3   36999998753 3445678999999999999999999999886     5667


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++.... ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~  155 (269)
T cd05065          80 VMIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  155 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccc
Confidence            899999999999999986543 46899999999999999999999   89999999999999999999999999999876


Q ss_pred             CCCCCccc--ccccc--CCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          474 NPEGITHL--TTRVA--GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       474 ~~~~~~~~--~~~~~--gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      ........  .....  .+..|+|||++.++.++.++||||||+++||+++ |+.||......  ...    ..+..+. 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~----~~i~~~~-  228 (269)
T cd05065         156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVI----NAIEQDY-  228 (269)
T ss_pred             cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHH----HHHHcCC-
Confidence            54332211  11111  2457999999999999999999999999999987 99998543321  111    1111111 


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                            ..+  ...+....+.+++..|++.+|++||++.+++++|+..
T Consensus       229 ------~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         229 ------RLP--PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ------cCC--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  111  1122334567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.2e-37  Score=318.47  Aligned_cols=260  Identities=27%  Similarity=0.402  Sum_probs=203.1

Q ss_pred             HhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      ..++|+..+.||+|+||.||+|..+      .+..||+|.+.... .....++.+|+++++.++|+|++++++++.    
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----   79 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS----   79 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc----
Confidence            4567889999999999999999753      24589999886433 233456889999999999999999999876    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCC--------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSG--------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA  460 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~--------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~  460 (614)
                       +....++||||+++|+|.+++....        ...+++..+.+++.|++.||.|||   +.+|+||||||+||+++++
T Consensus        80 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~  155 (288)
T cd05061          80 -KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHD  155 (288)
T ss_pred             -CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCC
Confidence             4567899999999999999996522        234678889999999999999999   8999999999999999999


Q ss_pred             CcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHH
Q 043267          461 FEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       461 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~  538 (614)
                      +.+||+|||+++....... .......++..|+|||...++.++.++||||||+++|||++ |+.|+.....     .+.
T Consensus       156 ~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~-----~~~  230 (288)
T cd05061         156 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQV  230 (288)
T ss_pred             CcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH-----HHH
Confidence            9999999999875433221 11222345678999999999999999999999999999999 7888753221     111


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      . .....+....     .+    ......+.+++..|++.+|++|||+.++++.|++...
T Consensus       231 ~-~~~~~~~~~~-----~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         231 L-KFVMDGGYLD-----QP----DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             H-HHHHcCCCCC-----CC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence            1 1111111110     11    1223578889999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.7e-37  Score=318.05  Aligned_cols=262  Identities=27%  Similarity=0.403  Sum_probs=204.5

Q ss_pred             CccccceecccCceEEEEeEcC-----CCcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-----NGTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-----~g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .|...+.||+|+||.||+++..     ++..||||.++..... ..++|.+|+++++.++|+|++++.+++...   .+.
T Consensus         5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~---~~~   81 (284)
T cd05038           5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKP---GGR   81 (284)
T ss_pred             hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecC---CCC
Confidence            4666789999999999999853     3688999999764443 467899999999999999999999988632   356


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..+++|||+++++|.+++.... ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            7899999999999999997643 36999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch---------hhHHHHH
Q 043267          473 FNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL---------LSDWAWE  541 (614)
Q Consensus       473 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~---------l~~~~~~  541 (614)
                      ........  ......++..|++||......++.++||||||+++|||++|+.|+.........         .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            66532221  122234566799999999999999999999999999999999987433221100         0011111


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ....+         ............+.+++.+|++.+|++|||+.||+++|+..
T Consensus       238 ~~~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEG---------ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcC---------CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111         11111122335688899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=328.82  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=207.5

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeec-CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .|...+.||+|.||.||||... .++.||+|++.- ..+...+++++|+.++..++++||.+.+|.+.     .+..+++
T Consensus        14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl-----~g~~Lwi   88 (467)
T KOG0201|consen   14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL-----KGTKLWI   88 (467)
T ss_pred             ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee-----ecccHHH
Confidence            4666688999999999999964 688999999974 34455678999999999999999999999875     6677899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      +|||+.+|++.+.|....  .+++....-|..++..||.|||   ..+.+|||||+.|||+..+|.+|++|||.+-....
T Consensus        89 iMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~  163 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTN  163 (467)
T ss_pred             HHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeec
Confidence            999999999999995433  4577777788999999999999   89999999999999999999999999999987766


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ..... ...+||+.|||||++....|+.|+||||+|++.+||.+|.+|+.+...-..               .-.+....
T Consensus       164 ~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv---------------lflIpk~~  227 (467)
T KOG0201|consen  164 TVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV---------------LFLIPKSA  227 (467)
T ss_pred             hhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE---------------EEeccCCC
Confidence            55444 667899999999999988999999999999999999999999965543211               12222333


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~  595 (614)
                      +..........+.+++..|++.||+.||++.++++  +++.
T Consensus       228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            32233344556778888899999999999999984  4555

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3e-37  Score=327.57  Aligned_cols=260  Identities=27%  Similarity=0.361  Sum_probs=202.6

Q ss_pred             cCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ++|...+.||+|+||.||+|..      .+++.||||+++... ......+.+|++++.++ +|+|++++++++..    
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~----   82 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK----   82 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeec----
Confidence            4688889999999999999973      357899999997533 33345688999999999 78999999998863    


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCC-------------------------------------------------------
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSG-------------------------------------------------------  414 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~-------------------------------------------------------  414 (614)
                      .+...+++|||+++|+|.+++....                                                       
T Consensus        83 ~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (343)
T cd05103          83 PGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVE  162 (343)
T ss_pred             CCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccch
Confidence            3456789999999999999986421                                                       


Q ss_pred             ----------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcc-ccc
Q 043267          415 ----------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTT  483 (614)
Q Consensus       415 ----------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~  483 (614)
                                ...++|.++.+++.|+++||+|||   +.+|+||||||+|||+++++++||+|||+++........ ...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         163 EEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                      124788999999999999999999   899999999999999999999999999999764332221 122


Q ss_pred             cccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcH
Q 043267          484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELP  562 (614)
Q Consensus       484 ~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~  562 (614)
                      ...++..|+|||.+.+..++.++||||||+++|||++ |..|+.......     ........+....     .+.    
T Consensus       240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-----~~~~~~~~~~~~~-----~~~----  305 (343)
T cd05103         240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRMR-----APD----  305 (343)
T ss_pred             CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-----HHHHHHhccCCCC-----CCC----
Confidence            2345678999999999999999999999999999997 888885432211     1122222322211     111    


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          563 EMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      .....+.+++..||+.+|++|||+.|+++.|+...+
T Consensus       306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            112357788899999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=344.29  Aligned_cols=262  Identities=22%  Similarity=0.279  Sum_probs=212.1

Q ss_pred             HhcCccccceecccCceEEEEeEcCCC-cEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeee-eeecccCCC-C
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLPNG-TEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRG-YSTATVPLE-G  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g-~~~~~~~~~-~  391 (614)
                      ...+..+++.|.+|||+.||.+....+ .++|+||+-..++...+...+||++|++|+ |+|||.+++ ......... .
T Consensus        35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~  114 (738)
T KOG1989|consen   35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV  114 (738)
T ss_pred             CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence            445778889999999999999997665 999999998878888999999999999996 999999998 433332222 4


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .+.+|.||||++|+|-|++.......|++.++++|+.|+++|+++||.. +++|||||||.+||||+.+++.||||||.+
T Consensus       115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  115 WEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             eEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            6889999999999999999876556699999999999999999999954 788999999999999999999999999998


Q ss_pred             eeCCCCC--ccc------cccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          472 KFNPEGI--THL------TTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       472 ~~~~~~~--~~~------~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                      .-.....  ...      .-...-|+.|.|||.+.   +..+++|+|||++||+||-|+....||+....          
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----------  263 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----------  263 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----------
Confidence            5221111  100      00123489999999874   56899999999999999999999999974322          


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                              ..++.....-...+.+..++..|+..||++||++||++-||++.+-..
T Consensus       264 --------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l  311 (738)
T KOG1989|consen  264 --------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL  311 (738)
T ss_pred             --------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence                    112222222222356788899999999999999999999999887665

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.7e-37  Score=316.59  Aligned_cols=245  Identities=24%  Similarity=0.315  Sum_probs=193.4

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||.||+++.+ +|+.||+|++....   ......+..|++++++++||||+++.+++.     .+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFE-----SKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEe-----cCCeEEEEEecC
Confidence            799999999999965 68999999986422   122345567999999999999999998876     566789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++|+|.+++.......+++..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.......  .
T Consensus        76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~  150 (277)
T cd05607          76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--T  150 (277)
T ss_pred             CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--e
Confidence            9999999987766667999999999999999999999   8999999999999999999999999999998655432  2


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      .....|+..|+|||++.++.++.++||||+||++|||++|+.||....... .......... .+        .... ..
T Consensus       151 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~-~~~~~~~~~~-~~--------~~~~-~~  219 (277)
T cd05607         151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV-AKEELKRRTL-ED--------EVKF-EH  219 (277)
T ss_pred             eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh-hHHHHHHHhh-cc--------cccc-cc
Confidence            234568999999999999999999999999999999999999986432211 1111111111 11        1110 01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          562 PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ......+.+++..|++.||++||+++|+++
T Consensus       220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~  249 (277)
T cd05607         220 QNFTEESKDICRLFLAKKPEDRLGSREKND  249 (277)
T ss_pred             ccCCHHHHHHHHHHhccCHhhCCCCccchh
Confidence            123445678888999999999999977653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.4e-37  Score=330.10  Aligned_cols=244  Identities=23%  Similarity=0.291  Sum_probs=198.0

Q ss_pred             cCccccceecccCceEEEEeEcCC--CcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN--GTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||.||+|+.++  +..||+|++...   .....+.+.+|+++++.++||||+++++++.     ++.
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFK-----DES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEE-----eCC
Confidence            358888999999999999998543  368999998642   2233456889999999999999999999986     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            889999999999999999654  36899999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....      ......+..+..    
T Consensus       180 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~~~~----  245 (340)
T PTZ00426        180 VVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP------LLIYQKILEGII----  245 (340)
T ss_pred             ecCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH------HHHHHHHhcCCC----
Confidence            65432    2345799999999999999999999999999999999999999964321      111222222211    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                        .++.    .....+.+++..|++.+|++|+     +++++++
T Consensus       246 --~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        246 --YFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             --CCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence              1111    1223467788899999999995     8888765

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-37  Score=313.53  Aligned_cols=249  Identities=30%  Similarity=0.439  Sum_probs=194.4

Q ss_pred             ceecccCceEEEEeEcCC-Cc--EEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLPN-GT--EVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-g~--~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      ++||+|+||.||+|+..+ |.  .+++|.++.. .....+.+.+|++++.++ +|||++++++++.     .....++||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-----~~~~~~lv~   75 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRGYLYLAI   75 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEe-----cCCCceEEE
Confidence            469999999999999753 43  4788988753 344556789999999999 8999999999986     456689999


Q ss_pred             eecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          399 DLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                      ||+++|+|.+++....              ...++++++..++.|++.||+|||   +.+++||||||+||++++++.+|
T Consensus        76 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~k  152 (270)
T cd05047          76 EYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAK  152 (270)
T ss_pred             EeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEE
Confidence            9999999999996532              235889999999999999999999   89999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      |+|||+++......  .......+..|+|||++....++.++||||||+++|||++ |+.||.....     .+ ..+..
T Consensus       153 l~dfgl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-----~~-~~~~~  224 (270)
T cd05047         153 IADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AE-LYEKL  224 (270)
T ss_pred             ECCCCCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-----HH-HHHHH
Confidence            99999986322111  1111234567999999999999999999999999999997 9999853321     11 11222


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ..+...+         ........+.+++..|++.+|.+|||+.++++.|+...
T Consensus       225 ~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         225 PQGYRLE---------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             hCCCCCC---------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            2221111         11122345778999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.8e-37  Score=311.34  Aligned_cols=247  Identities=30%  Similarity=0.447  Sum_probs=200.5

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +|...+.||+|+||.||++.. +++.||+|.++...  ..+.+.+|++++++++|||++++++++..      ...+++|
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------~~~~~v~   77 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH------NGLYIVM   77 (254)
T ss_pred             HceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC------CCcEEEE
Confidence            578889999999999999985 77889999986532  34578899999999999999999998752      3468999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++.......+++..+++++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9999999999998766567899999999999999999999   8999999999999999999999999999997643321


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                          .....+..|+|||++.++.++.++||||||+++|||++ |+.|+.....     .+. ......+...        
T Consensus       155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~-~~~~~~~~~~--------  216 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEV-KECVEKGYRM--------  216 (254)
T ss_pred             ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHH-HHHHhCCCCC--------
Confidence                22334578999999999999999999999999999998 9988854321     111 1222222111        


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       .........+.+++..|++.+|++||++.++++.|+.+
T Consensus       217 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  254 (254)
T cd05083         217 -EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE  254 (254)
T ss_pred             -CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence             11122345677899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-37  Score=308.59  Aligned_cols=248  Identities=31%  Similarity=0.439  Sum_probs=202.5

Q ss_pred             ceecccCceEEEEeEcCC----CcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLPN----GTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+++..+    +..|++|.++..... ..+++.+|+++++.++|+|++++++++.     .+...++||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCT-----EEEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeec-----CCCceEEEE
Confidence            469999999999999753    789999999764433 3678999999999999999999999886     467889999


Q ss_pred             eecCCCChhhhhhcCC-------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          399 DLLHNGSLYDHLFGSG-------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~-------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ||+++++|.+++....       ...+++..+.+++.|+++||+|||   +.+++||||||+||++++++.+||+|||.+
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~  152 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLS  152 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEcccccc
Confidence            9999999999997642       367999999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ........ .......++..|+|||.+....++.++||||+|+++|||++ |+.|+.....      ...++....+...
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~------~~~~~~~~~~~~~  226 (262)
T cd00192         153 RDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN------EEVLEYLRKGYRL  226 (262)
T ss_pred             cccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCCC
Confidence            86654321 22334567889999999998899999999999999999999 6999865422      1122222222111


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                               .........+.+++..|++.+|++|||+.|+++.|+
T Consensus       227 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         227 ---------PKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ---------CCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                     111222457788999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.9e-37  Score=328.38  Aligned_cols=200  Identities=25%  Similarity=0.341  Sum_probs=172.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+++.. +++.||||++....   ......+.+|++++.+++|+||+++++.+.     ++..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~-----~~~~   75 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQ-----DKLN   75 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCCe
Confidence            36888999999999999999864 68999999997532   223456788999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          76 LYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             EEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            89999999999999999654  46899999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCCCc----------------------------------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHH
Q 043267          474 NPEGIT----------------------------------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL  519 (614)
Q Consensus       474 ~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ell  519 (614)
                      ......                                  .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            432110                                  0112357999999999999999999999999999999999


Q ss_pred             hCCCCccc
Q 043267          520 SGKKACEI  527 (614)
Q Consensus       520 tG~~p~~~  527 (614)
                      +|+.||..
T Consensus       231 ~G~~Pf~~  238 (363)
T cd05628         231 IGYPPFCS  238 (363)
T ss_pred             hCCCCCCC
Confidence            99999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=5e-37  Score=316.58  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=202.9

Q ss_pred             hcCccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      .++|+..+.||+|+||.||++..+      ++..||+|.+... +.....++.+|++++++++|||++++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            457888899999999999999853      4678999998753 3344567999999999999999999999886     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCC--------------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEec
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSG--------------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRD  449 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~--------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrD  449 (614)
                      .+...++++||+++|+|.+++....                    ...+++.+++.++.|++.||+|||   +.+++|||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~d  155 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRD  155 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeeccc
Confidence            4567899999999999999996421                    235789999999999999999999   89999999


Q ss_pred             cCCCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCccc
Q 043267          450 IKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEI  527 (614)
Q Consensus       450 IKp~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~  527 (614)
                      |||+||++++++.+||+|||+++....... ........+..|+|||.+.++.++.++||||||+++|||++ |..|+..
T Consensus       156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999875432211 11222345678999999999999999999999999999998 8888743


Q ss_pred             ccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          528 IQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       528 ~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ...     .+.. .....+....     .    +......+.+++.+|++.+|++|||+.|+++.|+.
T Consensus       236 ~~~-----~~~~-~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         236 MAH-----EEVI-YYVRDGNVLS-----C----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCH-----HHHH-HHHhcCCCCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            221     1111 2222332211     1    11234567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-37  Score=309.93  Aligned_cols=251  Identities=24%  Similarity=0.345  Sum_probs=200.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-----hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-----KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|...+.||+|++|.||++... ++++||+|.+....     ......+.+|++++++++||||+++++++.     ++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~   76 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DD   76 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cC
Confidence            57888999999999999999964 68999999986432     122356889999999999999999999986     55


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++|+||+++++|.+++...  ..+++....+++.+++.||.|||   +.+++||||||+||++++++++||+|||++
T Consensus        77 ~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          77 ETLSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CeEEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence            6899999999999999998654  36889999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCcccc--ccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITHLT--TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~~~--~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +..........  ....|+..|+|||.+.+..++.++||||+|+++|||++|+.||.......     -.........  
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~--  224 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----AIFKIATQPT--  224 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----HHHHHhccCC--
Confidence            76543222111  33567889999999999999999999999999999999999985432210     0111111110  


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                         ...+    +......+.+++..|++.+|++|||+.|+++.
T Consensus       225 ---~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         225 ---NPQL----PSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---CCCC----CccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               0111    12233456778889999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.1e-37  Score=321.44  Aligned_cols=254  Identities=29%  Similarity=0.407  Sum_probs=198.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCc--EEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGT--EVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|+..+.||+|+||.||+|... +|.  .+|+|+++.. +......+.+|++++.++ +|+|++++++++.     .+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~-----~~~   81 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   81 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEEC-----CCC
Confidence            46788899999999999999964 454  4688877643 344556788999999999 8999999999986     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ..++|+||+++|+|.+++....              ...+++.+++.++.|++.||+|||   +.+++||||||+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~  158 (303)
T cd05088          82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  158 (303)
T ss_pred             CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEec
Confidence            7899999999999999997532              236899999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhH
Q 043267          459 EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD  537 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~  537 (614)
                      +++.+||+|||+++.....  .......++..|+|||++.+..++.++||||||+++|||++ |..||......     +
T Consensus       159 ~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~  231 (303)
T cd05088         159 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E  231 (303)
T ss_pred             CCCcEEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH-----H
Confidence            9999999999998632211  11122234678999999988899999999999999999998 99998533221     1


Q ss_pred             HHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       538 ~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .. +....+...         .........+.+++..|++.+|++||++.+++++|+..
T Consensus       232 ~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         232 LY-EKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             HH-HHHhcCCcC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11 111111110         01112234577899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.7e-38  Score=329.33  Aligned_cols=252  Identities=20%  Similarity=0.242  Sum_probs=199.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||+||+++.. +|+.||+|+++...   ......+.+|+++++.++|+||+++.+++.     ++..
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~-----~~~~   75 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQ-----DKDN   75 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCe
Confidence            46888999999999999999965 78999999997532   234456889999999999999999998876     5667


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++.... ..+++.....++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          76 LYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             EEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeE
Confidence            899999999999999997642 46999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYAL------YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      .............||+.|+|||++.      ...++.++|||||||++|||++|+.||.....     ............
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~  226 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS-----AKTYNNIMNFQR  226 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH-----HHHHHHHHcCCC
Confidence            6544333334457899999999987      45788999999999999999999999964322     111111111111


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...     .+.  .......+..++..|++ +|.+|||+.++++
T Consensus       227 ~~~-----~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         227 FLK-----FPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ccC-----CCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence            110     111  11233456677788997 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.7e-37  Score=325.08  Aligned_cols=242  Identities=22%  Similarity=0.308  Sum_probs=192.3

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+++.. +++.||+|.++..   .......+.+|+.++.++ +||||+++++++.     .+...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            46999999999999965 6789999999753   223345677899888877 8999999999886     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        76 E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          76 EYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            999999999888654  46999999999999999999999   8999999999999999999999999999987532211


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCc---cchhhHHHHHHHHcCCchhhhhcc
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK---SVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||......   .....++.++.+..+..      .
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~  223 (329)
T cd05618         151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------R  223 (329)
T ss_pred             -CccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------C
Confidence             1223457999999999999999999999999999999999999999532211   11223444444333221      1


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                      ++    ......+.+++..|++.||++||+.
T Consensus       224 ~p----~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 IP----RSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             CC----CCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            22    2223456788899999999999983

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.9e-37  Score=312.79  Aligned_cols=255  Identities=27%  Similarity=0.406  Sum_probs=203.3

Q ss_pred             cCccccceecccCceEEEEeEcCC----CcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .+|...+.||+|+||.||+|+..+    ...||||...... ....+.+.+|+.++++++|+|++++++++.      ..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~------~~   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT------EN   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc------CC
Confidence            357788999999999999998643    2468999887544 445668999999999999999999999875      24


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++.... ..+++..++.++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~  155 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR  155 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceee
Confidence            5689999999999999996543 36899999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ..........+...++..|+|||.+....++.++||||||+++||+++ |+.||.......     .. ..+..+.... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~-----~~-~~~~~~~~~~-  228 (270)
T cd05056         156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND-----VI-GRIENGERLP-  228 (270)
T ss_pred             ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HH-HHHHcCCcCC-
Confidence            665443222333345678999999988899999999999999999996 999985443211     11 1122222111 


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                          .+    ......+.+++..|+..+|++|||+.++++.|+...
T Consensus       229 ----~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         229 ----MP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ----CC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                11    122346778889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.6e-37  Score=311.24  Aligned_cols=256  Identities=23%  Similarity=0.302  Sum_probs=202.0

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++.+++++.....||+|+||.||+|+.. ++..||+|.+........+.+.+|+++++.++|+||+++++++.     .+
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   77 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS-----EN   77 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeec-----cC
Confidence            4556778888889999999999999954 67889999998766666778999999999999999999999986     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCC--ChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeec
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKL--SWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDF  468 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l--~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DF  468 (614)
                      +..++|+||+++++|.+++.... ..+  ++..+..++.|+++||+|||   +.+|+||||||+||+++. ++.+||+||
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          78 GFFKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             CEEEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecc
Confidence            78899999999999999997642 234  88889999999999999999   899999999999999986 679999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK--LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |++........ ......|+..|+|||+.....  ++.++||||||+++|||++|+.|+.........  .  +.   .+
T Consensus       154 g~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~--~--~~---~~  225 (268)
T cd06624         154 GTSKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA--M--FK---VG  225 (268)
T ss_pred             hhheecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh--H--hh---hh
Confidence            99875543221 223345889999999987654  789999999999999999999998543221110  0  00   00


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..  ...+.+    +......+..++..|++.+|++|||+.|+++
T Consensus       226 ~~--~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         226 MF--KIHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             hh--ccCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            00  001111    1223446778899999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.1e-37  Score=332.52  Aligned_cols=258  Identities=24%  Similarity=0.368  Sum_probs=202.6

Q ss_pred             hcCccccceecccCceEEEEeEcC------CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHcc-ccceeeeeeeeecccC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVK-HVNLVALRGYSTATVP  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~  388 (614)
                      .++|...+.||+|+||.||+|++.      .+..||||+++.... ...+.+.+|++++.++. ||||+++++++.    
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~----  111 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT----  111 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc----
Confidence            345777899999999999999853      346899999975432 23456889999999997 999999999986    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCC------------------------------------------------------
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSG------------------------------------------------------  414 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~------------------------------------------------------  414 (614)
                       .....++|+||+++|+|.++++..+                                                      
T Consensus       112 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         112 -KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             -cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence             4567899999999999999996532                                                      


Q ss_pred             ------------------------------------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          415 ------------------------------------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       415 ------------------------------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                                                                ...++|...++|+.|+++||+|||   +.+++||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence                                                      124788889999999999999999   89999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~  530 (614)
                      +|||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.|+.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986433221 11223456889999999999999999999999999999998 8888854322


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           .+........+...         ..+......+.+++..||+.+|++||+++|+++.|+..
T Consensus       348 -----~~~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         348 -----NEQFYNAIKRGYRM---------AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             -----hHHHHHHHHcCCCC---------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                 11122222222111         01112234677888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.8e-37  Score=310.04  Aligned_cols=248  Identities=29%  Similarity=0.424  Sum_probs=199.1

Q ss_pred             ceecccCceEEEEeEcCC--C--cEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLPN--G--TEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~--g--~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|++++++++|+|++++++.+.     + ...++|+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~-~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVL-----T-HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEc-----C-CeEEEEE
Confidence            468999999999999643  3  3699999986555 55678999999999999999999999875     3 6789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++.+.....++|.....++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++......
T Consensus        75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~  151 (257)
T cd05040          75 ELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE  151 (257)
T ss_pred             EecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccc
Confidence            9999999999997754357899999999999999999999   8999999999999999999999999999998664422


Q ss_pred             cc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          479 TH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       479 ~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..  ......++..|+|||++....++.++||||||+++|||++ |+.|+......     +........+..       
T Consensus       152 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~-------  219 (257)
T cd05040         152 DHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-----QILKKIDKEGER-------  219 (257)
T ss_pred             cceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcCCc-------
Confidence            21  1223457889999999999999999999999999999999 99998533221     111111111111       


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ..  ........+.+++..|++.+|++||++.++++.|.
T Consensus       220 ~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 LE--RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CC--CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            10  11123456788999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=5.3e-37  Score=312.35  Aligned_cols=254  Identities=26%  Similarity=0.330  Sum_probs=199.8

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||.||+|+. .+|+.||+|++..........+.+|+.++++++|+|++++++++.     .+...++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~-----~~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL-----SREKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE-----eCCEEEE
Confidence            4688889999999999999996 478899999997654445567889999999999999999999886     5568899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++++|.+++...  ..+++.++..++.|+++||.|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          84 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999999998653  36899999999999999999999   88999999999999999999999999999986543


Q ss_pred             CCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          477 GITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ... ......|+..|+|||.+.   ...++.++||||||+++|||++|+.|+..........      .+....   ...
T Consensus       159 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~~~---~~~  228 (267)
T cd06646         159 TIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSKSN---FQP  228 (267)
T ss_pred             ccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeecCC---CCC
Confidence            221 123346889999999874   4457889999999999999999999985332211100      000000   000


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                      +....  .......+.+++..|++.+|++|||++++++.|
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         229 PKLKD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCcc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            11111  112345678889999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=332.29  Aligned_cols=251  Identities=22%  Similarity=0.268  Sum_probs=195.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||.||+++.. +|+.||||++....   ......+.+|++++..++|+||+++++++.     ++..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~   75 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQ-----DENY   75 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEE-----cCCe
Confidence            46888999999999999999965 68999999997532   233456788999999999999999999887     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          76 LYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             EEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeeccccee
Confidence            99999999999999999654  36999999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCCCcc-------------------------------------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHH
Q 043267          474 NPEGITH-------------------------------------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLL  516 (614)
Q Consensus       474 ~~~~~~~-------------------------------------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~  516 (614)
                      .......                                     ......||+.|+|||++....++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            4321100                                     011246999999999999999999999999999999


Q ss_pred             HHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 043267          517 ELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT---MDQIVK  591 (614)
Q Consensus       517 ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~eVl~  591 (614)
                      ||++|+.||.......     ...... .....    ...+..  ......+.+++..|+. +|.+|++   +.|+++
T Consensus       231 el~~G~~Pf~~~~~~~-----~~~~i~-~~~~~----~~~~~~--~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQE-----TYRKII-NWKET----LQFPDE--VPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHH-----HHHHHH-cCCCc----cCCCCC--CCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            9999999996433211     111111 11100    011111  1122345566667886 9999998   888875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.7e-37  Score=317.01  Aligned_cols=265  Identities=24%  Similarity=0.272  Sum_probs=196.6

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHc---cccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASV---KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l---~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|+..+.||+|+||.||+++.. +|+.||+|.++....  .....+.+|+++++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999965 688999999874321  1233566788777766   699999999987643333355


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..+++|||++ ++|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            6899999997 58999887655567999999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC---Cch
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG---KTL  549 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g---~~~  549 (614)
                      ......  ......||..|+|||++.+..++.++||||+||++|||++|+.||....... .+.. ........   ...
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~-~~~~~~~~~~~~~~  232 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGK-IFDLIGLPPEDDWP  232 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHH-HHHHhCCCChhhCc
Confidence            654322  2234568999999999999999999999999999999999999985332211 1100 00000000   000


Q ss_pred             -------hhhhccCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 -------DVIEENMP---EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 -------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                             ....+...   ....++..+.+.+++..|++.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                   00000000   0001123456778999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.9e-37  Score=332.36  Aligned_cols=251  Identities=23%  Similarity=0.270  Sum_probs=192.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|...+.||+|+||+||+|+.. +++.||||++....   ......+.+|++++++++|+||+++++++.     ++...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            5788899999999999999864 68899999997532   234457889999999999999999999987     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++...  ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            9999999999999999654  36889999999999999999999   899999999999999999999999999997532


Q ss_pred             CCCCc----------------------------------------------cccccccCCCCcCchhhhccCCCCchhhH
Q 043267          475 PEGIT----------------------------------------------HLTTRVAGTLGYVAPEYALYGKLTPGSDV  508 (614)
Q Consensus       475 ~~~~~----------------------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDV  508 (614)
                      .....                                              .......||+.|+|||.+.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                              00123569999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHH--ccccCCCCCCCH
Q 043267          509 YSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAI--CAHPILQARPTM  586 (614)
Q Consensus       509 wS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~  586 (614)
                      |||||++|||++|+.||........     ..........     ...+..  ......+.+++..  |+..+|..||++
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~-----~~~i~~~~~~-----~~~~~~--~~~s~~~~dli~~ll~~~~~~~~R~~~  299 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTET-----QLKVINWENT-----LHIPPQ--VKLSPEAVDLITKLCCSAEERLGRNGA  299 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHH-----HHHHHccccc-----cCCCCC--CCCCHHHHHHHHHHccCcccccCCCCH
Confidence            9999999999999999964332111     0111110000     011110  0112233444433  677788889999


Q ss_pred             HHHHH
Q 043267          587 DQIVK  591 (614)
Q Consensus       587 ~eVl~  591 (614)
                      .|+++
T Consensus       300 ~~~l~  304 (381)
T cd05626         300 DDIKA  304 (381)
T ss_pred             HHHhc
Confidence            99985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6e-37  Score=315.52  Aligned_cols=245  Identities=23%  Similarity=0.291  Sum_probs=192.9

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||+||+++.. +|+.||+|.+....   ....+.+..|+++++.++|+|++++.+++.     .+...++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQ-----TKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEc-----CCCeEEEEEeCC
Confidence            799999999999964 78999999986432   223356788999999999999999998876     556789999999


Q ss_pred             CCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc
Q 043267          402 HNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT  479 (614)
Q Consensus       402 ~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~  479 (614)
                      ++|+|.+++..  .....+++..+..++.|+++||.|||   +.+|+||||||+||++++++.+||+|||++........
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            99999988854  23456999999999999999999999   89999999999999999999999999999976544322


Q ss_pred             cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCC
Q 043267          480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM  559 (614)
Q Consensus       480 ~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~  559 (614)
                       ......||+.|+|||.+.++.++.++||||||+++|||++|+.||........ ... .....        .....  .
T Consensus       153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-~~~-~~~~~--------~~~~~--~  219 (280)
T cd05608         153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-NKE-LKQRI--------LNDSV--T  219 (280)
T ss_pred             -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-HHH-HHHhh--------cccCC--C
Confidence             23345789999999999999999999999999999999999999964322110 000 00000        00000  1


Q ss_pred             CcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          560 ELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       560 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                      ........+.+++..|++.||++||     +++++++
T Consensus       220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         220 YPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            1122345677888899999999999     7777774

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6.1e-37  Score=310.79  Aligned_cols=250  Identities=28%  Similarity=0.399  Sum_probs=193.1

Q ss_pred             ceecccCceEEEEeEcC----CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+|+..    ++..||+|++... .....+.+.+|+.+++.++|||++++++++..    .+...++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~----~~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLP----SEGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeec----CCCCcEEEE
Confidence            46999999999999853    2457999998643 33445678899999999999999999998753    344578999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++.+.. ..+++..++.++.|+++||.|||   +.+++||||||+|||+++++.+||+|||+++......
T Consensus        77 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          77 PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             ecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            9999999999996543 35788888999999999999999   8999999999999999999999999999997543321


Q ss_pred             c---cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          479 T---HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG-KKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       479 ~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      .   .......++..|+|||+.....++.++||||||+++|||++| ..|+.....     .+... ....+...     
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~-----~~~~~-~~~~~~~~-----  221 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS-----FDITV-YLLQGRRL-----  221 (262)
T ss_pred             ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH-HHhcCCCC-----
Confidence            1   111234567789999999989999999999999999999995 455543221     11111 11122111     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                        .  ........+.+++..|++.+|++||++.|+++.|+..
T Consensus       222 --~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         222 --L--QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             --C--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence              0  0111234677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=307.01  Aligned_cols=248  Identities=31%  Similarity=0.444  Sum_probs=197.9

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecC
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLH  402 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~  402 (614)
                      ++||+|+||.||++...+++.||+|.+..... ....++.+|++++++++|+||+++++++.     +....++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~~   75 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELVP   75 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcCC
Confidence            46999999999999987799999999875433 35568999999999999999999999886     5567899999999


Q ss_pred             CCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcccc
Q 043267          403 NGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT  482 (614)
Q Consensus       403 ~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~  482 (614)
                      +++|.+++.... ..+++..++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++..........
T Consensus        76 ~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  151 (251)
T cd05041          76 GGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS  151 (251)
T ss_pred             CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec
Confidence            999999996543 36899999999999999999999   89999999999999999999999999999976543221111


Q ss_pred             -ccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCC
Q 043267          483 -TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEME  560 (614)
Q Consensus       483 -~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~  560 (614)
                       ....++..|+|||.+.++.++.++||||||+++|||++ |..|+......  .    ....+..+.         ....
T Consensus       152 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~--~----~~~~~~~~~---------~~~~  216 (251)
T cd05041         152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ--Q----TRERIESGY---------RMPA  216 (251)
T ss_pred             cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH--H----HHHHHhcCC---------CCCC
Confidence             12234667999999999999999999999999999999 88887543211  0    111111111         1111


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          561 LPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      +......+.+++..|++.+|++|||+.|+++.|+.
T Consensus       217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            12234567889999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.5e-36  Score=306.80  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=202.0

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|++|.||+++.+ +++.||+|++...  .....+.+.+|++++++++|+|++++.+.+..    .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~----~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEG----EDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecC----CCCEEE
Confidence            4778899999999999999965 5789999998643  23445678899999999999999999887642    344678


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ++|||+++++|.+++.......+++.++.+++.+++.||+|||   +.+++||||||+||++++++.++|+|||+++...
T Consensus        77 lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~  153 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLE  153 (257)
T ss_pred             EEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEec
Confidence            9999999999999998765567999999999999999999999   8999999999999999999999999999998664


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .... ......+++.|+|||...++.++.++||||+|++++||++|+.|+....     ...+.... ..+...      
T Consensus       154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~-----~~~~~~~~-~~~~~~------  220 (257)
T cd08223         154 NQCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD-----MNSLVYRI-IEGKLP------  220 (257)
T ss_pred             ccCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHH-HhcCCC------
Confidence            3222 2334568899999999999999999999999999999999999985322     12222222 222211      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .........+.+++..|++.+|++|||+.++++
T Consensus       221 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         221 ---PMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ---CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               112234456788999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.6e-37  Score=311.67  Aligned_cols=252  Identities=24%  Similarity=0.334  Sum_probs=190.1

Q ss_pred             ceecccCceEEEEeEcCC---CcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          324 NIIGKGGYGNVYKGMLPN---GTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +.||+|+||.||+|+..+   +..+|+|.++... ......+.+|+.++++++|||++++++++.     +....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            359999999999998643   4579999887533 334457889999999999999999999886     4556799999


Q ss_pred             ecCCCChhhhhhcCC---CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          400 LLHNGSLYDHLFGSG---MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+++|+|.+++....   ....++..+++++.|+++||+|||   +.+++||||||+||+++.++++||+|||+++....
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~  152 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYK  152 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccC
Confidence            999999999997532   235678888999999999999999   89999999999999999999999999999975433


Q ss_pred             CCcc-ccccccCCCCcCchhhhccC-------CCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCC
Q 043267          477 GITH-LTTRVAGTLGYVAPEYALYG-------KLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       477 ~~~~-~~~~~~gt~~Y~APE~~~~~-------~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      .... ......++..|+|||++...       .++.++||||||+++|||++ |+.||......+.  ..   ..+. +.
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~---~~~~-~~  226 (269)
T cd05087         153 EDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LT---YTVR-EQ  226 (269)
T ss_pred             cceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HH---HHhh-cc
Confidence            2221 12334578899999988642       35789999999999999996 9999964332111  00   1111 11


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      .....++.+..    ...+.+.+++..|+ .+|++|||++||++.|+
T Consensus       227 ~~~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         227 QLKLPKPRLKL----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             cCCCCCCccCC----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111222111    12234566777898 58999999999999886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2e-37  Score=301.88  Aligned_cols=271  Identities=23%  Similarity=0.249  Sum_probs=205.1

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChh--hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKA--GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .+|...+.||+|.||.||+|+. ..|+.||||+++.....  -.....+|++.++.++|+||+.|++++.     .....
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~-----~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFP-----HKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhcc-----CCCce
Confidence            3577788999999999999995 57999999999753322  1345789999999999999999999986     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      .||+|||+. +|...|+++ ...++..+...++.++.+||+|+|   ...|+||||||.|+|++++|.+||+|||+++.+
T Consensus        77 ~lVfEfm~t-dLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPT-DLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccc-cHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhcc
Confidence            999999974 888888664 367999999999999999999999   999999999999999999999999999999987


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH--------HHHc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE--------LVKE  545 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~--------~~~~  545 (614)
                      .......+. .+-|.-|.|||.+.+ .+|+...||||.||++.||+-|.+-+...++-+.  ...+..        .|.+
T Consensus       152 ~~p~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  152 GSPNRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             CCCCccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCcc
Confidence            654433332 367899999998876 4799999999999999999998866643332110  011000        0100


Q ss_pred             -CCchhhhhcc-----CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccCCCCCc
Q 043267          546 -GKTLDVIEEN-----MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI--LETDVPLSNI  602 (614)
Q Consensus       546 -g~~~~~~d~~-----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~  602 (614)
                       -...+..+-.     ..+...+...+..++++..++..||.+|+|++|++++  +.+ .|.|..
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~-~P~pt~  292 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS-LPLPTP  292 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc-CCCCCC
Confidence             0111111111     1111234455667889999999999999999999865  333 455543

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.4e-37  Score=323.69  Aligned_cols=246  Identities=22%  Similarity=0.305  Sum_probs=195.8

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      ++||+|+||.||+++.. +++.||||.++..   .....+.+..|..++..+ +||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEE-----cCCEEEEEE
Confidence            46999999999999965 6889999999753   223345678899999998 7999999999886     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        76 e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  149 (329)
T cd05588          76 EFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-  149 (329)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccC-
Confidence            999999999988654  46999999999999999999999   899999999999999999999999999998742211 


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCc---cchhhHHHHHHHHcCCchhhhhcc
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK---SVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||+.....   .....++..+.+..+..      .
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~  223 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------R  223 (329)
T ss_pred             CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------C
Confidence            11233467999999999999999999999999999999999999999532211   11223444444433321      1


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCC------HHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPT------MDQIV  590 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~eVl  590 (614)
                      ++.    .....+.+++..|++.||.+||+      +++++
T Consensus       224 ~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         224 IPR----SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             CCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence            221    22345778889999999999997      66765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=9.3e-37  Score=327.21  Aligned_cols=265  Identities=22%  Similarity=0.258  Sum_probs=197.6

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|+||.||++... +|+.||||++...  .......+.+|+++++.++|+||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4778899999999999999964 7899999998643  233456788999999999999999999988643211123689


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||+. ++|.+.+...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 5788877543  46999999999999999999999   8999999999999999999999999999998655


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccc-----------hhhHH-----
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV-----------LLSDW-----  538 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-----------~l~~~-----  538 (614)
                      ...........+|+.|+|||.+.+. .++.++||||+||++|||++|+.||........           ...++     
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            4333333445689999999998874 579999999999999999999999954322110           00000     


Q ss_pred             -HHHHHHcC-CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 -AWELVKEG-KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 -~~~~~~~g-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ....+... ..........  .......+.+.+++..|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLY--TLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhc--ccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence             00000000 0000000000  001122456788999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2e-36  Score=313.81  Aligned_cols=262  Identities=22%  Similarity=0.356  Sum_probs=200.5

Q ss_pred             cCccccceecccCceEEEEeEcC-----------------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeee
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-----------------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVAL  379 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-----------------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l  379 (614)
                      ++|+..+.||+|+||.||++...                 ++..||+|++... ......++.+|++++++++|+|++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            46888899999999999998532                 2446899999753 34445689999999999999999999


Q ss_pred             eeeeecccCCCCceEEEEEeecCCCChhhhhhcCC---------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEecc
Q 043267          380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG---------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDI  450 (614)
Q Consensus       380 ~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~---------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDI  450 (614)
                      ++++.     .+...+++|||+++|+|.+++....         ...+++.+..+++.|++.||+|||   +.+++||||
T Consensus        85 ~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl  156 (296)
T cd05095          85 LAVCI-----TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDL  156 (296)
T ss_pred             EEEEe-----cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccC
Confidence            99986     4567899999999999999987532         134788999999999999999999   889999999


Q ss_pred             CCCCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh--CCCCccc
Q 043267          451 KASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS--GKKACEI  527 (614)
Q Consensus       451 Kp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt--G~~p~~~  527 (614)
                      ||+|||+++++.+||+|||+++........ ......++..|++||....+.++.++||||||+++|||++  |..|+..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         157 ATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             ChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999999999999999999755332221 1223345678999999999999999999999999999998  6677753


Q ss_pred             ccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          528 IQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       528 ~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      .....  ......+..........    .+  ........+.+++.+|++.||++||++.+|++.|+.
T Consensus       237 ~~~~~--~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         237 LSDEQ--VIENTGEFFRDQGRQVY----LP--KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             cChHH--HHHHHHHHHhhcccccc----CC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            32211  11111111111111000    00  112233577889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.8e-37  Score=332.97  Aligned_cols=253  Identities=21%  Similarity=0.227  Sum_probs=198.6

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ..++|...+.||+|+||.||+++.. +|+.||+|++...   .....+.+.+|+++++.++||||+++++++.     ++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~-----~~  115 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ-----DD  115 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            4457899999999999999999965 6889999999642   2233455788999999999999999998876     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++|+|.+++...   .++......++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence            7899999999999999998543   4788889999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYG----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +..............||+.|+|||.+...    .++.++|||||||++|||++|+.||......     . ....+..+.
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~-~~~~i~~~~  263 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----G-TYSKIMDHK  263 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH-----H-HHHHHHcCC
Confidence            86543322233446799999999998653    4889999999999999999999999643211     1 111111111


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQA--RPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~  591 (614)
                      ..    ...+.  .......+.+++..|++.+|.+  ||++.|+++
T Consensus       264 ~~----~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         264 NS----LTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             Cc----CCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence            00    01111  1123446677888899999987  999999964

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=7.5e-37  Score=315.76  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=198.6

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      |+..+.||+|+||.||++... +++.||||.+....   ......+.+|+.++++++|+|++++.+.+.     .+...+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYE-----TKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEe-----cCCEEE
Confidence            677789999999999999965 68999999986432   222345778999999999999999999886     456789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.+++.......+++.++..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++....
T Consensus        77 lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~  153 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  153 (285)
T ss_pred             EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence            9999999999999997655567999999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .+..  .....|+..|+|||.+.++.++.++||||+|+++|||++|+.||....... . .+-.......      ....
T Consensus       154 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~-~-~~~~~~~~~~------~~~~  223 (285)
T cd05630         154 EGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKI-K-REEVERLVKE------VQEE  223 (285)
T ss_pred             CCcc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccc-h-HHHHHhhhhh------hhhh
Confidence            3322  123468999999999999999999999999999999999999996432211 0 0001111110      0011


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                      ..    ......+.+++..|++.||++|||     +.|+++
T Consensus       224 ~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         224 YS----EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             cC----ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            11    122345678888999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-37  Score=323.58  Aligned_cols=241  Identities=27%  Similarity=0.363  Sum_probs=192.7

Q ss_pred             ceecccCceEEEEeEc----CCCcEEEEEEeecC----ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          324 NIIGKGGYGNVYKGML----PNGTEVAVKRFKNC----SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~----~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.||+|+||.||+++.    .+++.||||.++..    .......+.+|+++++.++||||+++++++.     .++..+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            5799999999999985    35789999999752    1223456788999999999999999999886     556789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.+++...  ..+++.....++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        77 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (323)
T cd05584          77 LILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESI  151 (323)
T ss_pred             EEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecc
Confidence            999999999999998654  36888899999999999999999   8999999999999999999999999999987543


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .... ......||+.|+|||++.+..++.++||||||+++|||++|+.||......     . ....+..+..      .
T Consensus       152 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~-----~-~~~~~~~~~~------~  218 (323)
T cd05584         152 HEGT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK-----K-TIDKILKGKL------N  218 (323)
T ss_pred             cCCC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH-----H-HHHHHHcCCC------C
Confidence            2221 233457999999999999999999999999999999999999999643211     1 1112222211      1


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                      ++    ......+.+++..|++.+|++||     ++.++++
T Consensus       219 ~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 LP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             CC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            11    12234577888999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1e-36  Score=318.97  Aligned_cols=256  Identities=27%  Similarity=0.398  Sum_probs=201.5

Q ss_pred             cCccccceecccCceEEEEeEcC--------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP--------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      .+|...+.||+|+||.||+++..        ++..||+|.++.. ......++.+|+++++++ +||||+++++++.   
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT---   88 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc---
Confidence            46788899999999999999742        3457999998753 234456788999999999 6999999999986   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCC
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS  453 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~  453 (614)
                        .+...++++||+++|+|.+++....              ...++|.++.+++.|++.||.|||   +.+++||||||+
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~  163 (314)
T cd05099          89 --QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAAR  163 (314)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccce
Confidence              4567899999999999999996532              245899999999999999999999   899999999999


Q ss_pred             CeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCc
Q 043267          454 NILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGK  531 (614)
Q Consensus       454 NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~  531 (614)
                      |||+++++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |+.|+..... 
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~-  242 (314)
T cd05099         164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV-  242 (314)
T ss_pred             eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH-
Confidence            999999999999999999865432211 1222234568999999999999999999999999999999 8888853321 


Q ss_pred             cchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       532 ~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           .........+...+         ........+.+++..|++.+|++|||+.|+++.|+..
T Consensus       243 -----~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         243 -----EELFKLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             -----HHHHHHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                 11122222222111         1122234677889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-37  Score=333.31  Aligned_cols=245  Identities=27%  Similarity=0.329  Sum_probs=206.1

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      -|+.++.||+|+-|.|-.|++ ..|+.+|||.+.+..   ......+.+|+-+|+.++|||+++|+.++.     +..++
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-----~~~~l   87 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-----NKQHL   87 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-----cCceE
Confidence            466778999999999999996 479999999997653   223456789999999999999999999986     67889


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      |+|.||+++|.|++++..++  .++..+..+.+.||..|+.|.|   ..+|+|||+||+|+|||..+++||+|||+|...
T Consensus        88 ylvlEyv~gGELFdylv~kG--~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   88 YLVLEYVPGGELFDYLVRKG--PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEEEEecCCchhHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence            99999999999999997654  7999999999999999999999   899999999999999999999999999999875


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLT-PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .++.  .....+|.+.|.+||++.+.+|. .++||||.||+||.|++|+.||++.+-      +-....++.|...    
T Consensus       163 ~~gk--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi------r~LLlKV~~G~f~----  230 (786)
T KOG0588|consen  163 VPGK--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI------RVLLLKVQRGVFE----  230 (786)
T ss_pred             cCCc--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH------HHHHHHHHcCccc----
Confidence            5543  34557899999999999999986 689999999999999999999974332      1223445555432    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ++    .....+..+++..|+..||+.|.|++||++
T Consensus       231 --MP----s~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  231 --MP----SNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             --CC----CcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence              22    223345667788899999999999999986

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-36  Score=311.31  Aligned_cols=256  Identities=22%  Similarity=0.300  Sum_probs=203.2

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      .+|+..+.||+|+||.||+|+.+      +...|++|.+...... ..+++.+|++++++++|+|++++++++.     +
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR-----E   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC-----C
Confidence            46888899999999999999953      3467999988764433 4567999999999999999999999986     4


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCC-------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGM-------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~-------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                      ....++||||+++|+|.+++.....       ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~  156 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREV  156 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcE
Confidence            5678999999999999999975442       26899999999999999999999   8899999999999999999999


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHH
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      |++|||+++..............++..|+|||.+.++.++.++||||||+++|||++ |..||.......      ....
T Consensus       157 ~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~  230 (275)
T cd05046         157 KVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNR  230 (275)
T ss_pred             EEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHH
Confidence            999999987543322222333456778999999998889999999999999999999 778875332211      1122


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ...+.....        ........+.+++..|++.+|++||++.|++++|.+
T Consensus       231 ~~~~~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         231 LQAGKLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHcCCcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            222222111        111233467889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-36  Score=307.64  Aligned_cols=250  Identities=21%  Similarity=0.267  Sum_probs=202.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +|+..+.||+|+||.||+++.. +++.+|+|.++.. .....+.+.+|+++++.++|+|++++.+.+.     .+...++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFE-----ADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----ECCEEEE
Confidence            4677899999999999999965 6899999998642 3344567889999999999999999999886     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      +|||+++|+|.+++.......+++...++++.|++.||.|||   +.+++|+||||+||++++++.++++|||++.....
T Consensus        76 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            999999999999987655567899999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .. .......|++.|+|||.+.+..++.++||||||+++|+|++|+.||.....     ....... ..+....     +
T Consensus       153 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~-----~~~~~~~-~~~~~~~-----~  220 (255)
T cd08219         153 PG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW-----KNLILKV-CQGSYKP-----L  220 (255)
T ss_pred             cc-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH-----HHHHHHH-hcCCCCC-----C
Confidence            22 122345688999999999999999999999999999999999999864221     1112221 1221111     1


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                          +......+.+++..|++.||++||++.+++..
T Consensus       221 ----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         221 ----PSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ----CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                11223457788899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6e-37  Score=321.56  Aligned_cols=240  Identities=25%  Similarity=0.310  Sum_probs=188.3

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+|+.. +++.||||.++...   ....+.+..|.+++... +||||+++++++.     .+...++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999965 57889999997532   22334556677777654 8999999998876     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        76 e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          76 EYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            999999999998654  36899999999999999999999   8999999999999999999999999999998643322


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                       .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ... ..+....      +.++ 
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~-----~~~-~~i~~~~------~~~~-  216 (316)
T cd05592         151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED-----ELF-DSILNDR------PHFP-  216 (316)
T ss_pred             -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH-----HHH-HHHHcCC------CCCC-
Confidence             2234467999999999999999999999999999999999999999643321     111 1111110      1111 


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMD-QIV  590 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl  590 (614)
                         ......+.+++..|++.+|++||++. +++
T Consensus       217 ---~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         217 ---RWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             ---CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence               12234566788899999999999976 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-36  Score=314.26  Aligned_cols=250  Identities=24%  Similarity=0.333  Sum_probs=197.6

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      |+..+.||+|+||+||++... +|+.||+|.+....   ......+.+|+++++.++|+|++++.+.+.     .++..+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~-----~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE-----TKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe-----cCCEEE
Confidence            667789999999999999964 78999999986432   223345788999999999999999988876     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ++|||+++|+|.+++.......+++..+..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~  153 (285)
T cd05632          77 LVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIP  153 (285)
T ss_pred             EEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence            9999999999999987655567999999999999999999999   8999999999999999999999999999997654


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ....  .....|+..|+|||++.+..++.++|+||||+++|||++|+.||....... .... .......+.      ..
T Consensus       154 ~~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~-~~~~-~~~~~~~~~------~~  223 (285)
T cd05632         154 EGES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV-KREE-VDRRVLETE------EV  223 (285)
T ss_pred             CCCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHH-HHHhhhccc------cc
Confidence            3221  233568999999999999999999999999999999999999996432211 0111 111111110      01


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                      .    .......+.+++..|++.||++||+     +.++++
T Consensus       224 ~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 Y----SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             c----CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            1    1222345677888899999999999     566654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-37  Score=325.20  Aligned_cols=241  Identities=23%  Similarity=0.282  Sum_probs=192.2

Q ss_pred             ceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          324 NIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +.||+|+||.||+++. .+|+.||+|.++..   .......+.+|++++..++||||+++.+++.     .....++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~-----~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----cCCEEEEEEe
Confidence            4699999999999986 47899999999753   2233456788999999999999999998876     5678899999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      |+++|+|.+++...  ..+++..+..++.|++.||+|||   + .+|+||||||+|||+++++.+||+|||+++......
T Consensus        76 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            99999999988653  36899999999999999999999   6 799999999999999999999999999987533221


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      . ......||+.|+|||++.++.++.++||||||+++|||++|+.||......     . ..+....+.      ..++.
T Consensus       151 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~-~~~~i~~~~------~~~p~  217 (325)
T cd05594         151 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----K-LFELILMEE------IRFPR  217 (325)
T ss_pred             c-ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----H-HHHHHhcCC------CCCCC
Confidence            1 223456999999999999999999999999999999999999999533211     0 111111111      11122


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                          .....+.+++..|++.||++||     ++.++++
T Consensus       218 ----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         218 ----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             ----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                2234567788899999999996     8998874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-36  Score=312.68  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=196.5

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +|+..++||+|+||.||+|+. .+++.||+|.+... ......++.+|++++++++|||++++++++.     ..+..++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF-----VENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----ECCEEEE
Confidence            567778999999999999985 47899999998653 3344567899999999999999999999987     4567889


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|..+.      .+++.....++.|++.||.|||   +.+|+|+||||+|||++.++.+||+|||++.....
T Consensus        77 v~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            99999999997653      4788899999999999999999   89999999999999999999999999999976543


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh-HHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS-DWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~-~~~~~~~~~g~~~~~~d~~  555 (614)
                      .   ......||..|+|||++....++.++||||||+++|||++|+.||........... .-..+.+....     ...
T Consensus       148 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~  219 (279)
T cd06619         148 S---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPV  219 (279)
T ss_pred             c---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCC
Confidence            2   22345789999999999999999999999999999999999999954332211110 00011111110     111


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      ++   .......+.+++..|++.+|++||+++|+++.
T Consensus       220 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 LP---VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CC---CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11   11233467788999999999999999998754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-36  Score=305.13  Aligned_cols=251  Identities=32%  Similarity=0.463  Sum_probs=201.7

Q ss_pred             ccccceecccCceEEEEeEcCC-----CcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          320 FSRENIIGKGGYGNVYKGMLPN-----GTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      |...+.||+|+||.||+++..+     +..||+|.++..... ....+.+|++++..++|+|++++++++.     +...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCT-----EEEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEc-----CCCe
Confidence            3456889999999999999753     488999999764433 5678999999999999999999999886     4578


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+++|||+++++|.+++.......+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~  152 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRD  152 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCcee
Confidence            899999999999999997654434999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .............+++.|+|||.+.+..++.++||||+|++++||++ |+.|+.....     .+ ..+....+....  
T Consensus       153 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~-----~~-~~~~~~~~~~~~--  224 (258)
T smart00219      153 LYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN-----EE-VLEYLKKGYRLP--  224 (258)
T ss_pred             cccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH-----HH-HHHHHhcCCCCC--
Confidence            65543222222347889999999988899999999999999999998 7888754221     11 112222222111  


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                             ........+.+++..|++.+|++|||+.|++++|
T Consensus       225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 -------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                   1112345678899999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-38  Score=300.22  Aligned_cols=247  Identities=25%  Similarity=0.361  Sum_probs=207.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+.++.||+|.||.||.|+.+ ++-.||+|++.+.   ..+-..++.+|+++-+.|+||||++++|++.     +...
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh-----d~~r   96 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH-----DSKR   96 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee-----ccce
Confidence            35889999999999999999964 6788999999753   2233567899999999999999999999997     6778


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .||++||.++|+|...|.+.....++......++.|+|.||.|+|   .+++|||||||+|+|++..+..||+|||.+-.
T Consensus        97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            999999999999999999878888999999999999999999999   99999999999999999999999999999976


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .+.+   .....+||..|.+||...+..++...|+|++|++.||++.|.+||......+.      .+.+.      .+|
T Consensus       174 ~p~~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~------k~~  238 (281)
T KOG0580|consen  174 APSN---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIR------KVD  238 (281)
T ss_pred             cCCC---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHH------Hcc
Confidence            5532   34567899999999999999999999999999999999999999964442111      11111      122


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      -.++    ........+++..|+..+|.+|.+..|+++
T Consensus       239 ~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  239 LKFP----STISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ccCC----cccChhHHHHHHHHhccCccccccHHHHhh
Confidence            2222    233445677888899999999999999875

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=3.7e-37  Score=330.54  Aligned_cols=257  Identities=21%  Similarity=0.226  Sum_probs=197.3

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      +....++|+..+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+++++.++||||+++++++.    
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~----  113 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ----  113 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE----
Confidence            3444568999999999999999999975 6889999998642   2233456789999999999999999999886    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                       ++...++||||+++|+|.+++...   .+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+||
T Consensus       114 -~~~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DF  186 (370)
T cd05621         114 -DDKYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADF  186 (370)
T ss_pred             -cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEec
Confidence             567899999999999999998543   5889999999999999999999   899999999999999999999999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYG----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      |+++..............||+.|+|||.+...    .++.++||||+||++|||++|+.||.....     .........
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~-----~~~~~~i~~  261 (370)
T cd05621         187 GTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL-----VGTYSKIMD  261 (370)
T ss_pred             ccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH-----HHHHHHHHh
Confidence            99986543322233456799999999998754    378999999999999999999999964321     111111111


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQ--ARPTMDQIVKI  592 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~--~RPt~~eVl~~  592 (614)
                      .....     ..+.  .......+.+++..|++.++.  .||++.|+++.
T Consensus       262 ~~~~~-----~~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKNSL-----NFPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCccc-----CCCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            11110     1111  112233455666778875554  38899998864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-37  Score=319.21  Aligned_cols=258  Identities=25%  Similarity=0.282  Sum_probs=203.7

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--------------hhhHHHHHHHHHHHHccccceee
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--------------AGDANFKHEVEIIASVKHVNLVA  378 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------------~~~~~f~~Ei~il~~l~H~niv~  378 (614)
                      ++.-++|...+.||+|.||.|-+|... +++.||||++.+...              ...+...+||.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            444568999999999999999999964 789999999864211              11357889999999999999999


Q ss_pred             eeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       379 l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      |+.+....   +....|||+||+..|.+...=.  ....++..+.++++.++..||+|||   .++||||||||+|+||+
T Consensus       173 LiEvLDDP---~s~~~YlVley~s~G~v~w~p~--d~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~  244 (576)
T KOG0585|consen  173 LIEVLDDP---ESDKLYLVLEYCSKGEVKWCPP--DKPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLS  244 (576)
T ss_pred             EEEeecCc---ccCceEEEEEeccCCccccCCC--CcccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEc
Confidence            99987654   6678999999999998765321  2223999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCC----ccccccccCCCCcCchhhhccCC----CCchhhHHHHHHHHHHHHhCCCCcccccC
Q 043267          459 EAFEAKVGDFGLAKFNPEGI----THLTTRVAGTLGYVAPEYALYGK----LTPGSDVYSFGVVLLELLSGKKACEIIQG  530 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~----~~~~~~~~gt~~Y~APE~~~~~~----~t~ksDVwS~Gvll~ElltG~~p~~~~~~  530 (614)
                      ++|++||+|||.+...+.+.    .....+.+||+.|+|||...++.    .+.+-||||+||+||-|+.|+.||.+...
T Consensus       245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            99999999999998663321    12234578999999999988743    34678999999999999999999953221


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                               .++.+     .++...+.-...+++-+.+.++++.++..||+.|.+..+|..-.
T Consensus       325 ---------~~l~~-----KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  325 ---------LELFD-----KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             ---------HHHHH-----HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence                     11111     22233333323345667788999999999999999999987654

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.2e-37  Score=321.82  Aligned_cols=244  Identities=24%  Similarity=0.302  Sum_probs=191.3

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHH---HHccccceeeeeeeeecccCCCCc
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEII---ASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il---~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      |...+.||+|+||.||++... +|+.||||+++...   ....+.+.+|++++   +.++||||+++++++.     .+.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~-----~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQ-----TED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEE-----cCC
Confidence            566789999999999999964 68999999997432   22334566676655   5668999999999886     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|..++..   ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            89999999999999988854   46999999999999999999999   8999999999999999999999999999987


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..... ........||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +.. ..+..+..    
T Consensus       150 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-----~~~-~~i~~~~~----  218 (324)
T cd05589         150 EGMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-----EVF-DSIVNDEV----  218 (324)
T ss_pred             cCCCC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-----HHH-HHHHhCCC----
Confidence            43221 12233467999999999999999999999999999999999999999643221     111 11111111    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                        ..+    ......+.+++..|++.||.+||     ++.++++
T Consensus       219 --~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 --RYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             --CCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence              111    12234567889999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.9e-37  Score=321.52  Aligned_cols=241  Identities=25%  Similarity=0.310  Sum_probs=190.6

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHcccc-ceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHV-NLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~-niv~l~g~~~~~~~~~~~~  393 (614)
                      +|+..+.||+|+||.||+|+.. +++.||||++...   .....+.+..|.+++..++|+ +++++.+++.     +.+.
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            4778899999999999999965 5789999999753   223455678899999999765 5777887775     5567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            89999999999999998654  36899999999999999999999   89999999999999999999999999999874


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.......     . ...+..+.      
T Consensus       151 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~-----~-~~~i~~~~------  217 (324)
T cd05587         151 NIFGG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-----L-FQSIMEHN------  217 (324)
T ss_pred             cCCCC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-----H-HHHHHcCC------
Confidence            32211 12234569999999999999999999999999999999999999996432211     1 11111111      


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                      ..++    ......+.+++..|++.||.+||+.
T Consensus       218 ~~~~----~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         218 VSYP----KSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CCCC----CCCCHHHHHHHHHHhhcCHHHcCCC
Confidence            1111    1223456788899999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.1e-36  Score=307.71  Aligned_cols=252  Identities=31%  Similarity=0.390  Sum_probs=198.0

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhH--HHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~--~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      |+..+.||+|+||+||+++.. +++.+|+|.+.........  ...+|+.++++++|+||++++++..     .....++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQ-----DDNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEE-----ESSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccc-----ccccccc
Confidence            566789999999999999976 5678999999875543332  3456999999999999999999987     4678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++++|.+++.  ....+++.++..++.|+++||.+||   +.+++||||||+||+++++++++|+|||.+.....
T Consensus        76 v~~~~~~~~L~~~l~--~~~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~  150 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQ--KNKPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE  150 (260)
T ss_dssp             EEEEETTEBHHHHHH--HHSSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS
T ss_pred             ccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            999999999999997  2346899999999999999999999   88999999999999999999999999999986422


Q ss_pred             CCccccccccCCCCcCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                       .........++..|+|||.+. +..++.++||||+|+++|+|++|+.|+.......  ..    ...............
T Consensus       151 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~--~~----~~~~~~~~~~~~~~~  223 (260)
T PF00069_consen  151 -NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDD--QL----EIIEKILKRPLPSSS  223 (260)
T ss_dssp             -TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHH--HH----HHHHHHHHTHHHHHT
T ss_pred             -cccccccccccccccccccccccccccccccccccccccccccccccccccccchh--hh----hhhhhcccccccccc
Confidence             222344567899999999998 8899999999999999999999999996541100  00    001100000111111


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..   .......+.+++..|++.||++||++.++++
T Consensus       224 ~~---~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  224 QQ---SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             TS---HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cc---cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10   1111267888999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.9e-36  Score=312.27  Aligned_cols=264  Identities=22%  Similarity=0.341  Sum_probs=209.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .+|...+.||+|+||.||+++. .+|+.||+|.+........+.+.+|+.+++.++|+|++++++++.     .+...++
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   93 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   93 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEEE
Confidence            4788889999999999999996 479999999997655555677889999999999999999999986     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++++|.+++.+   ..+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             eecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            9999999999999854   35899999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .... .....+++.|+|||...+..++.++||||||+++|||++|+.||..........     .....+..      ..
T Consensus       168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~~~------~~  235 (297)
T cd06656         168 EQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGTP------EL  235 (297)
T ss_pred             CccC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCCCC------CC
Confidence            3221 233468899999999999999999999999999999999999995432211100     00011100      00


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCchhhH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIKIFL  606 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p~~~  606 (614)
                        .........+.+++..|++.+|++||++.++++  .++...+.+...-+.
T Consensus       236 --~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~~~  285 (297)
T cd06656         236 --QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSSLTPLI  285 (297)
T ss_pred             --CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccccCHHH
Confidence              011222345677888999999999999999997  666665555554443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=327.84  Aligned_cols=251  Identities=21%  Similarity=0.265  Sum_probs=209.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeec--CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce-
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ-  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~-  393 (614)
                      ++|...+.+|+|+||.++..+.+ ++..+++|.+.-  .+....+...+|+.++++++|||||...+.+.     +++. 
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~-----~~~~~   78 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE-----EDGQL   78 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh-----cCCce
Confidence            46778899999999999998865 678999998863  34445557889999999999999999998876     4444 


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+|||+|++||+|.+.|.+.++..++.+...+++.|+..|+.|||   +..|+|||||+.||+++.+..+||+|||+|+.
T Consensus        79 l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   79 LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhh
Confidence            899999999999999998887788999999999999999999999   89999999999999999999999999999998


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ...... ....+.||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+-     ...+.+..+         
T Consensus       156 l~~~~~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-----~~Li~ki~~---------  220 (426)
T KOG0589|consen  156 LNPEDS-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-----SELILKINR---------  220 (426)
T ss_pred             cCCchh-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-----HHHHHHHhh---------
Confidence            776542 34557899999999999999999999999999999999999999964332     111211111         


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                       ......+..+...+..++..|++.+|+.||++.+++.+
T Consensus       221 -~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 -GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             11111233445667788889999999999999999875

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.2e-36  Score=304.99  Aligned_cols=249  Identities=26%  Similarity=0.340  Sum_probs=201.5

Q ss_pred             cCccccceecccCceEEEEeEcCC-CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|+..+.||+|+||.||+|+..+ ++.+++|.+.....  .+++.+|++++++++|+|++++++++.     ++...++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l   75 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYF-----KNTDLWI   75 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCcEEE
Confidence            578888999999999999999764 88999999875432  678999999999999999999999886     5578899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ++||+++++|.+++.... ..+++..+..++.|+++||.|||   +.+++||||+|+||++++++.+||+|||++.....
T Consensus        76 ~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          76 VMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999999986533 57899999999999999999999   88999999999999999999999999999986544


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+.........      .......     ...+
T Consensus       152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~~~~~~-----~~~~  219 (256)
T cd06612         152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FMIPNKP-----PPTL  219 (256)
T ss_pred             Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hhhccCC-----CCCC
Confidence            321 223345789999999999999999999999999999999999998643221110      0000000     0001


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .  ........+.+++..|++.+|++|||+.|+++
T Consensus       220 ~--~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         220 S--DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             C--chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            1  11223346788899999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=3.1e-36  Score=304.51  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=204.6

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|+||.||.++. .+++.+++|.+...  +.....++.+|++++++++|+|++++++++.     ++...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM-----DDNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe-----cCCeEE
Confidence            478889999999999999885 46889999998643  3455667899999999999999999999986     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ++|||+++|+|.+++.......+++.++..++.|+++||.|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        76 ~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            9999999999999997765567999999999999999999999   8899999999999999999999999999998664


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .... ......|++.|+|||...+..++.++||||||+++|||++|+.|+.....     .+..... ..+....     
T Consensus       153 ~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~-----~~~~~~~-~~~~~~~-----  220 (256)
T cd08221         153 SEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP-----LNLVVKI-VQGNYTP-----  220 (256)
T ss_pred             cccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH-HcCCCCC-----
Confidence            4332 22345689999999999988899999999999999999999999853221     1222222 1221111     


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                          ........+.+++..|++.+|.+||++.++++.+
T Consensus       221 ----~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         221 ----VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ----CccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                1122344677888899999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=7.4e-37  Score=321.33  Aligned_cols=241  Identities=26%  Similarity=0.320  Sum_probs=191.7

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      ++||+|+||.||+|+.. +|+.||||+++..   .....+.+..|.+++..+ +||||+++++++.     .+...++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~-----~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQ-----TKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCeEEEEE
Confidence            46999999999999975 5789999999753   223345677899998876 8999999999986     566789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        76 E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          76 EYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            999999999988654  36899999999999999999999   8999999999999999999999999999987533221


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||......     +. .+.+..+..      ..+.
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-----~~-~~~i~~~~~------~~p~  217 (321)
T cd05591         151 -VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-----DL-FESILHDDV------LYPV  217 (321)
T ss_pred             -ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-----HH-HHHHHcCCC------CCCC
Confidence             1233456899999999999999999999999999999999999999643321     11 111211111      1111


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCC-------CHHHHHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARP-------TMDQIVK  591 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~eVl~  591 (614)
                          .....+.+++..|++.||++||       ++.++++
T Consensus       218 ----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         218 ----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             ----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                1234567888899999999999       7777763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.1e-36  Score=308.62  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=188.2

Q ss_pred             eecccCceEEEEeEcCC---CcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEee
Q 043267          325 IIGKGGYGNVYKGMLPN---GTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~~---g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      .||+|+||.||+|+..+   ...+++|.+.... ......+.+|+++++.++|+||+++++.+.     .....++||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence            59999999999997543   3568888876432 334567889999999999999999999886     55678999999


Q ss_pred             cCCCChhhhhhcCC---CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          401 LHNGSLYDHLFGSG---MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       401 ~~~GsL~~~L~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      +++|+|.+++....   ....++...++++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence            99999999997643   234578888999999999999999   899999999999999999999999999998653322


Q ss_pred             Cc-cccccccCCCCcCchhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          478 IT-HLTTRVAGTLGYVAPEYALY-------GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       478 ~~-~~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      .. .......++..|+|||+...       ..++.++||||||+++|||++ |+.|+.......     -.......+. 
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~~~~~~~~~~-  227 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-----VLKQVVREQD-  227 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-----HHHHHhhccC-
Confidence            11 11233446778999998753       357889999999999999999 778875433211     1112222221 


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ....++.+.    ......+.+++..|+ .||++|||+++|+++|.
T Consensus       228 ~~~~~~~~~----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         228 IKLPKPQLD----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ccCCCCccc----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            111122222    122334555667788 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-36  Score=309.43  Aligned_cols=247  Identities=24%  Similarity=0.356  Sum_probs=200.8

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +|+..+.||.|+||.||+|+.. +++.||+|.+.... ......+.+|+++++.++|+|++++.+++.     ++...++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL-----KGSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE-----ECCeEEE
Confidence            5777889999999999999965 68899999987533 344567889999999999999999999886     5578899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++++|.+++...   .+++..+..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++....
T Consensus        77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  150 (274)
T cd06609          77 IMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS  150 (274)
T ss_pred             EEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence            99999999999998643   7899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......++..|+|||++.+..++.++||||||+++|||++|+.|+......     ... ..+..+..     +.+
T Consensus       151 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~-----~~~-~~~~~~~~-----~~~  218 (274)
T cd06609         151 TMS-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM-----RVL-FLIPKNNP-----PSL  218 (274)
T ss_pred             ccc-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH-----HHH-HHhhhcCC-----CCC
Confidence            322 223456889999999999999999999999999999999999998543311     111 11111111     111


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...   .....+.+++..|++.+|++|||++++++
T Consensus       219 ~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         219 EGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111   13445778889999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.2e-36  Score=314.00  Aligned_cols=250  Identities=22%  Similarity=0.323  Sum_probs=201.6

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .+|+..+.||+|+||.||+|+. .+++.||+|.+........+.+.+|+++++.++|+|++++++.+.     .+...++
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~-----~~~~~~l   94 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   94 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE-----eCCEEEE
Confidence            4688889999999999999995 478999999998655555677899999999999999999999886     4568899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++++|.+++.+   ..+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        95 v~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~  168 (296)
T cd06654          95 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (296)
T ss_pred             eecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence            9999999999999854   35899999999999999999999   89999999999999999999999999999875433


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......|++.|+|||...+..++.++||||||+++|||++|+.||.......     +.......+..      .+
T Consensus       169 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~------~~  236 (296)
T cd06654         169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-----ALYLIATNGTP------EL  236 (296)
T ss_pred             ccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH-----hHHHHhcCCCC------CC
Confidence            221 1223468899999999999899999999999999999999999995433211     11111111110      01


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      .  ........+.+++..|+..+|++|||+.++++.
T Consensus       237 ~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 Q--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             C--CccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            1  112233467788899999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.9e-36  Score=305.98  Aligned_cols=238  Identities=23%  Similarity=0.356  Sum_probs=188.5

Q ss_pred             ceecccCceEEEEeEcCCCc-----------EEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          324 NIIGKGGYGNVYKGMLPNGT-----------EVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~-----------~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +.||+|+||.||+|+..+..           .|++|.+...... ...+.+|++++++++|+|++++++++.     . .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~-~   73 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCV-----R-D   73 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEe-----c-C
Confidence            46999999999999976433           5788877654333 678899999999999999999999886     3 4


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-------cEEE
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-------EAKV  465 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-------~~kl  465 (614)
                      ..++|+||+++|+|.+++..... .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++       .+||
T Consensus        74 ~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          74 ENIMVEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             CcEEEEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEe
Confidence            56999999999999999976442 7899999999999999999999   89999999999999999888       7999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccC--CCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHH
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      +|||++.....     .....++..|+|||++...  .++.++||||||+++|||++ |..|+......     .+. ..
T Consensus       150 ~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~-----~~~-~~  218 (259)
T cd05037         150 SDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS-----EKE-RF  218 (259)
T ss_pred             CCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch-----hHH-HH
Confidence            99999975443     2223467789999998876  78999999999999999999 56666433211     111 11


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      +....       ..+.    .....+.+++..|++.+|.+|||+.++++.|+
T Consensus       219 ~~~~~-------~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         219 YQDQH-------RLPM----PDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             HhcCC-------CCCC----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            11110       0111    01157788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.3e-36  Score=316.60  Aligned_cols=254  Identities=27%  Similarity=0.446  Sum_probs=199.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCc----EEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGT----EVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|...+.||+|+||.||+|+.. +|.    .||+|.+.... .....++.+|+.+++.++|+|+++++|++..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~------   80 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS------   80 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC------
Confidence            35777889999999999999864 444    47889886533 2334578899999999999999999998852      


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++++||+++|+|.+++.... ..+++..++.++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~  156 (303)
T cd05110          81 PTIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLA  156 (303)
T ss_pred             CCceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccc
Confidence            34579999999999999986543 46899999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +........ ......++..|+|||++.+..++.++||||||+++|||++ |+.|+.....      ....+....+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~------~~~~~~~~~~~~~  230 (303)
T cd05110         157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT------REIPDLLEKGERL  230 (303)
T ss_pred             ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHCCCCC
Confidence            865433222 2223445778999999999999999999999999999998 8898854321      1112222222211


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                             +.  .......+..++..|+..+|++||++.++++.|+..
T Consensus       231 -------~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         231 -------PQ--PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             -------CC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   10  112234677889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=310.13  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=203.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCc----EEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGT----EVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|...+.||+|+||.||+|..+ +|.    .||+|.+.... .....++.+|++++++++|+|++++++++..      
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------   80 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS------   80 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec------
Confidence            45777899999999999999964 333    58999887543 3445678999999999999999999999862      


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++|+||+++|+|.+++.... ..+++..+++++.|++.||+|||   +.+++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~  156 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLA  156 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCccc
Confidence            57899999999999999997643 35899999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccc-cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITHL-TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~~-~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +......... .....++..|+|||....+.++.++|+||||+++||+++ |+.|+.....     .++. ..+..+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~-~~~~~~~~~  230 (279)
T cd05057         157 KLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIP-DLLEKGERL  230 (279)
T ss_pred             ccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHH-HHHhCCCCC
Confidence            8655332221 122234678999999998999999999999999999999 9999864322     1111 222222111


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL  599 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  599 (614)
                             .  .+......+.+++..||..+|..||++.++++.|++....
T Consensus       231 -------~--~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         231 -------P--QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             -------C--CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence                   0  1111234577888999999999999999999999986443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.7e-37  Score=320.91  Aligned_cols=236  Identities=25%  Similarity=0.313  Sum_probs=189.1

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+++.+ +++.||||+++..   .....+.+..|.+++..+ +||||+++++++.     .....++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~-----~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQ-----TPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEE-----cCCEEEEEE
Confidence            46999999999999975 6889999998742   223345677888888877 6999999999886     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        76 Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          76 EFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             cCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            999999999998654  36899999999999999999999   8999999999999999999999999999987533221


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                       .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     + ..+.+..+..      ..+ 
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~-----~-~~~~i~~~~~------~~~-  216 (320)
T cd05590         151 -KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED-----D-LFEAILNDEV------VYP-  216 (320)
T ss_pred             -CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH-----H-HHHHHhcCCC------CCC-
Confidence             1233457999999999999999999999999999999999999999643321     1 1122222211      111 


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                         ......+.+++..|++.||++||++
T Consensus       217 ---~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         217 ---TWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ---CCCCHHHHHHHHHHcccCHHHCCCC
Confidence               1223456788899999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-37  Score=330.58  Aligned_cols=241  Identities=24%  Similarity=0.288  Sum_probs=198.2

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~  390 (614)
                      .-++|...++||+|+||+|+++.++ +++.+|||.+++..   ..+.+....|..++... +||.++.|+.++.     .
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-----T  440 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-----T  440 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-----c
Confidence            3457999999999999999999976 67889999998743   34456677888887777 5999999998876     6


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....++||||..||++..+.   ....++.....-++..|+.||+|||   +++|||||||-+|||||.+|++||+||||
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~---~~~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHI---HTDVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEE---ecccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccc
Confidence            67899999999999965554   3356999999999999999999999   99999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++..... ...+.+.+||+.|||||++.++.|+..+|+|||||+||||+.|..||....+++                  
T Consensus       515 cKe~m~~-g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------------------  575 (694)
T KOG0694|consen  515 CKEGMGQ-GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------------------  575 (694)
T ss_pred             ccccCCC-CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------------------
Confidence            9854322 225677899999999999999999999999999999999999999996443321                  


Q ss_pred             hhhccCC--CCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          551 VIEENMP--EMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       551 ~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                      +.|.-+.  ..++.....+.+.++...+..+|++|.-+
T Consensus       576 ~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  576 VFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            1111111  11233445567788888999999999877

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.3e-36  Score=319.70  Aligned_cols=241  Identities=25%  Similarity=0.294  Sum_probs=191.5

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      +|...+.||+|+||.||+|+.. +++.||||.++...   ....+.+..|..++..+ +|++++++.+++.     ..+.
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQ-----TMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEe-----cCCE
Confidence            4778899999999999999965 57899999987532   22334567788888877 5889999988876     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            89999999999999998654  36899999999999999999999   89999999999999999999999999999975


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..... .......||+.|+|||++.++.++.++|||||||++|||++|+.||......     +.. ..+..+..     
T Consensus       151 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-----~~~-~~i~~~~~-----  218 (323)
T cd05616         151 NMWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----ELF-QSIMEHNV-----  218 (323)
T ss_pred             cCCCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-----HHH-HHHHhCCC-----
Confidence            43221 1233467999999999999999999999999999999999999999643321     111 11212111     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                       ..+    ......+.+++..|++.+|++|++.
T Consensus       219 -~~p----~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 -AYP----KSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             -CCC----CcCCHHHHHHHHHHcccCHHhcCCC
Confidence             111    2234467788899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-36  Score=309.38  Aligned_cols=249  Identities=31%  Similarity=0.467  Sum_probs=195.5

Q ss_pred             ceecccCceEEEEeEcCC-------CcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          324 NIIGKGGYGNVYKGMLPN-------GTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.||+|+||.||+|+..+       +..+|||.+.... .....++.+|+++++.++||||+++++++.     .....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            469999999999998642       2579999886532 234567899999999999999999999986     456789


Q ss_pred             EEEeecCCCChhhhhhcC-----CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-----cEEE
Q 043267          396 IVCDLLHNGSLYDHLFGS-----GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-----EAKV  465 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~-----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-----~~kl  465 (614)
                      +||||+++|+|.+++.+.     ....++|.+++.++.|++.||.|||   +.+++|+||||+||+++.+.     .+|+
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l  152 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKI  152 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEE
Confidence            999999999999999753     2234899999999999999999999   88999999999999999877     8999


Q ss_pred             eecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHH
Q 043267          466 GDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       466 ~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      +|||+++....... .......++..|+|||++.++.++.++||||||+++|||++ |+.|+......     +.. ...
T Consensus       153 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~-----~~~-~~~  226 (269)
T cd05044         153 GDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ-----EVL-QHV  226 (269)
T ss_pred             CCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH-----HHH-HHH
Confidence            99999975433221 11222345788999999999999999999999999999998 99998533211     111 111


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ..+...         .........+.+++..|++.+|++||++.+|+++|+.
T Consensus       227 ~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         227 TAGGRL---------QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             hcCCcc---------CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            111111         1112234567889999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.1e-36  Score=306.20  Aligned_cols=254  Identities=26%  Similarity=0.349  Sum_probs=199.9

Q ss_pred             CccccceecccCceEEEEeEcCC--CcEEEEEEeecC----------ChhhhHHHHHHHHHHHH-ccccceeeeeeeeec
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPN--GTEVAVKRFKNC----------SKAGDANFKHEVEIIAS-VKHVNLVALRGYSTA  385 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~----------~~~~~~~f~~Ei~il~~-l~H~niv~l~g~~~~  385 (614)
                      +|+..+.||+|+||.||+|....  ++.+|+|.+...          ......++.+|+.++.+ ++|+|++++++++. 
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-   79 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFL-   79 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEc-
Confidence            47778899999999999999764  688999987532          22234557788888875 79999999999986 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                          ++...+++|||+++++|.+++..  .....+++..+++++.|++.||.|||.  ..+++||||||+||++++++.+
T Consensus        80 ----~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          80 ----ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             ----cCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcE
Confidence                56788999999999999998854  234568999999999999999999992  2679999999999999999999


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      ||+|||++.......  ......|+..|+|||...++.++.++||||||+++|||++|+.|+.....     ...... .
T Consensus       154 ~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~-----~~~~~~-~  225 (269)
T cd08528         154 TITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM-----LSLATK-I  225 (269)
T ss_pred             EEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH-----HHHHHH-H
Confidence            999999998654432  23445689999999999999999999999999999999999999853221     111111 1


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ..+....     ...   ......+.+++.+|++.||++||++.||..+++.
T Consensus       226 ~~~~~~~-----~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         226 VEAVYEP-----LPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             hhccCCc-----CCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence            1111110     111   1223467788889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.5e-36  Score=309.31  Aligned_cols=250  Identities=24%  Similarity=0.325  Sum_probs=197.5

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      |+..+.||+|+||.||+|... ++..+++|.+...+....+.+.+|+++++.++|+|++++++++.     .+...++|+
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~~v~   81 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWILI   81 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEe-----eCCEEEEEE
Confidence            456688999999999999975 57888999987666666778899999999999999999999886     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++.+. ...+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++.......
T Consensus        82 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          82 EFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            999999999987653 347999999999999999999999   8999999999999999999999999999987543322


Q ss_pred             ccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          479 THLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                       .......++..|+|||++.     ...++.++|||||||++|||++|+.|+.......     ...... .+...    
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-----~~~~~~-~~~~~----  226 (282)
T cd06643         158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-----VLLKIA-KSEPP----  226 (282)
T ss_pred             -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-----HHHHHh-hcCCC----
Confidence             1223356899999999984     4467889999999999999999999985432211     111111 11100    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                       .+.  .+......+.+++..|++.+|++||++.++++.
T Consensus       227 -~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         227 -TLA--QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011  111233467788899999999999999988743

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-37  Score=329.52  Aligned_cols=252  Identities=22%  Similarity=0.254  Sum_probs=192.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||++... +|+.||||++....   ....+.+.+|++++++++||||+++++++.     +...
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~   75 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQ-----DAQY   75 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCe
Confidence            36888899999999999999864 78999999986422   233456889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          76 LYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccc
Confidence            99999999999999999653  46889999999999999999999   89999999999999999999999999999863


Q ss_pred             CCCCCc-------------c---------------------------------ccccccCCCCcCchhhhccCCCCchhh
Q 043267          474 NPEGIT-------------H---------------------------------LTTRVAGTLGYVAPEYALYGKLTPGSD  507 (614)
Q Consensus       474 ~~~~~~-------------~---------------------------------~~~~~~gt~~Y~APE~~~~~~~t~ksD  507 (614)
                      ......             .                                 ......||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            211000             0                                 001246999999999999999999999


Q ss_pred             HHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCC---C
Q 043267          508 VYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR---P  584 (614)
Q Consensus       508 VwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---P  584 (614)
                      ||||||++|||++|+.||.......     ............     .+++.  ......+.+++..|++ +|.+|   |
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~-----~~~~i~~~~~~~-----~~p~~--~~~s~~~~dli~~lL~-~~~~r~~r~  297 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHE-----TYRKIINWRETL-----YFPDD--IHLSVEAEDLIRRLIT-NAENRLGRG  297 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHH-----HHHHHHccCCcc-----CCCCC--CCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence            9999999999999999995433211     111111100000     11111  1122345667777887 66665   6


Q ss_pred             CHHHHHHH
Q 043267          585 TMDQIVKI  592 (614)
Q Consensus       585 t~~eVl~~  592 (614)
                      ++.|+++.
T Consensus       298 ~~~~~l~h  305 (377)
T cd05629         298 GAHEIKSH  305 (377)
T ss_pred             CHHHHhcC
Confidence            99888764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-36  Score=319.37  Aligned_cols=241  Identities=26%  Similarity=0.340  Sum_probs=192.6

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||+||+++.. +++.||||.++...   ......+..|.+++..+ +||||+++++++.     ..+..++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999975 57899999997532   23345677899999888 7999999999886     566889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.++..++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          76 EYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            999999999988654  36999999999999999999999   8999999999999999999999999999987532211


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     . ....+..+..      ..+ 
T Consensus       151 -~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~-----~-~~~~i~~~~~------~~~-  216 (318)
T cd05570         151 -VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED-----E-LFQSILEDEV------RYP-  216 (318)
T ss_pred             -CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH-----H-HHHHHHcCCC------CCC-
Confidence             1223456899999999999999999999999999999999999999643211     1 1111211111      111 


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTM-----DQIVK  591 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl~  591 (614)
                         ......+.+++..|++.||.+||++     .++++
T Consensus       217 ---~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         217 ---RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             ---CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence               1223467788999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.7e-36  Score=314.07  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+++.. +|..+|+|.+... ......++.+|++++++++||||+++++++.     +++..+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   75 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY-----SDGEIS   75 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCEEE
Confidence            36888999999999999999965 6788999988653 2334456889999999999999999999986     567899


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||+++++|.+++...  ..+++..+..++.|+++||.|||+  ..+++||||||+|||+++++.+||+|||++....
T Consensus        76 lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  151 (308)
T cd06615          76 ICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  151 (308)
T ss_pred             EEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence            999999999999999654  468999999999999999999993  2589999999999999999999999999987543


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC--------
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK--------  547 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~--------  547 (614)
                      ...   .....|+..|+|||...+..++.++||||||+++|||++|+.|+......  .+..+.........        
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         152 DSM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK--ELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             ccc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh--hHHHhhcCccccccccCCcccc
Confidence            321   23356889999999998888999999999999999999999998532211  11000000000000        


Q ss_pred             ------------chhhhhc----cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          548 ------------TLDVIEE----NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       548 ------------~~~~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                                  ..+..+.    ..+..........+.+++.+|++.+|++|||+.|+++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                        0000000    00000011133457889999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.3e-36  Score=312.10  Aligned_cols=266  Identities=26%  Similarity=0.343  Sum_probs=207.4

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeec
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTA  385 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~  385 (614)
                      +..+++..++++|...+.||+|+||.||++... +++.+|+|.+.... ....++.+|+.++.++ +|+|++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            555677778899999999999999999999964 68899999986532 2345678899999999 89999999999875


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                      .....+...++|+||+++|+|.+++..  .....+++..++.++.|++.||+|||   +.+++||||||+||++++++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCE
Confidence            433344678999999999999998864  23457899999999999999999999   8899999999999999999999


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                      ||+|||++........ ......|+..|+|||.+..+     .++.++||||||+++|||++|+.|+....... .    
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~-~----  241 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK-T----  241 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH-H----
Confidence            9999999875443221 12234688999999987654     36899999999999999999999985432211 0    


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+ +..+...     .+.  ........+.+++..|++.+|++||++.|+++
T Consensus       242 ~~~-~~~~~~~-----~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 LFK-IPRNPPP-----TLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             HHH-HhcCCCC-----CCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            111 1111111     111  01123346788999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-37  Score=313.09  Aligned_cols=245  Identities=24%  Similarity=0.345  Sum_probs=205.5

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .+|++.+.||+|.||+|-++.. ..|++||||.+++.   ++++.-.+.+|+++|+.|+||||+.++.++.     +.+.
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE-----NkdK  127 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE-----NKDK  127 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc-----CCce
Confidence            3577778999999999999985 68999999999753   4555667889999999999999999999986     5677


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+|||||..+|.|+||+.+.  ..|++.+...++.||..|+.|.|   +++++|||||.+|||||.|+++||+|||++..
T Consensus       128 IvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNl  202 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNL  202 (668)
T ss_pred             EEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhh
Confidence            89999999999999999654  47999999999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLT-PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      +.++.  ..+..+|.+-|.+||++.+.+|. +..|-||+||+||-|+.|..||+...-     .. ..+.+..|...   
T Consensus       203 y~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh-----k~-lvrQIs~GaYr---  271 (668)
T KOG0611|consen  203 YADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH-----KR-LVRQISRGAYR---  271 (668)
T ss_pred             hcccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH-----HH-HHHHhhccccc---
Confidence            76543  44668999999999999999885 789999999999999999999975432     11 12333344322   


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ++        +......-++.||+..+|++|.|+.+|..
T Consensus       272 EP--------~~PSdA~gLIRwmLmVNP~RRATieDiAs  302 (668)
T KOG0611|consen  272 EP--------ETPSDASGLIRWMLMVNPERRATIEDIAS  302 (668)
T ss_pred             CC--------CCCchHHHHHHHHHhcCcccchhHHHHhh
Confidence            22        22334567888999999999999999875

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.2e-36  Score=307.13  Aligned_cols=240  Identities=20%  Similarity=0.303  Sum_probs=187.1

Q ss_pred             ceecccCceEEEEeEcCC-------------CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          324 NIIGKGGYGNVYKGMLPN-------------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-------------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      +.||+|+||.||+|+..+             ...|++|.+..........+.+|+.+++.++||||+++++++.     .
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~-----~   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCV-----R   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEe-----c
Confidence            368999999999998532             2258999887655555567889999999999999999999986     4


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc-------E
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE-------A  463 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~-------~  463 (614)
                      ....++||||+++|+|..++.... ..+++..+++|+.|+++||+|||   +.+|+||||||+|||++.++.       +
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCcee
Confidence            566799999999999998886533 46899999999999999999999   899999999999999987664       8


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhc-cCCCCchhhHHHHHHHHHHHH-hCCCCcccccCccchhhHHHHH
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELL-SGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVwS~Gvll~Ell-tG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      |++|||++......     ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+.......     . ..
T Consensus       152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-----~-~~  220 (262)
T cd05077         152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE-----K-ER  220 (262)
T ss_pred             EeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH-----H-HH
Confidence            99999998654321     2245788999999887 467899999999999999998 4887774322110     0 01


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      .. .+..      ...    ......+.+++..||+.||++||++.++++.|+
T Consensus       221 ~~-~~~~------~~~----~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 FY-EGQC------MLV----TPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             HH-hcCc------cCC----CCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            11 1110      011    111345778899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=2.5e-36  Score=309.64  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=198.6

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .|+..+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++++++++|+|++++++++.     .+...++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            3566788999999999999864 67899999987432 344567899999999999999999999886     5667899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++++|.+++..   ..+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06642          80 IMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence            9999999999998853   46899999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+.......     ... .+..+.         
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-----~~~-~~~~~~---------  217 (277)
T cd06642         154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-----VLF-LIPKNS---------  217 (277)
T ss_pred             cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-----HHh-hhhcCC---------
Confidence            221 2223468899999999999999999999999999999999999985332211     111 111111         


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      ...........+.+++..|++.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            111112334567788999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3e-37  Score=323.73  Aligned_cols=238  Identities=26%  Similarity=0.310  Sum_probs=190.3

Q ss_pred             ceecccCceEEEEeEc----CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          324 NIIGKGGYGNVYKGML----PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +.||+|+||.||+++.    .+|+.||+|+++...  ......+.+|++++++++||||+++++++.     .+...++|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQ-----TEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCEEEEE
Confidence            5799999999999874    368899999997532  223445778999999999999999999886     56788999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        77 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  151 (318)
T cd05582          77 LDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  151 (318)
T ss_pred             EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC
Confidence            9999999999998653  36899999999999999999999   899999999999999999999999999999764432


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      . .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +.. ..+..+..      .++
T Consensus       152 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~-~~i~~~~~------~~p  218 (318)
T cd05582         152 E-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK-----ETM-TMILKAKL------GMP  218 (318)
T ss_pred             C-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH-----HHH-HHHHcCCC------CCC
Confidence            2 2233467899999999999989999999999999999999999999643211     111 11111111      111


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQ  588 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  588 (614)
                      .    .....+.+++..|++.||++||++.+
T Consensus       219 ~----~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 Q----FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             C----CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            1    22345677888999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.9e-37  Score=329.40  Aligned_cols=199  Identities=26%  Similarity=0.306  Sum_probs=170.2

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|...+.||+|+||.||+|+.. +++.||+|++....   ......+.+|++++++++|+||+++++.+.     ++...
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            5888899999999999999964 68899999987532   233457889999999999999999999886     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++...  ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            9999999999999999654  36889999999999999999999   899999999999999999999999999997532


Q ss_pred             CCCC----------------------------------------------ccccccccCCCCcCchhhhccCCCCchhhH
Q 043267          475 PEGI----------------------------------------------THLTTRVAGTLGYVAPEYALYGKLTPGSDV  508 (614)
Q Consensus       475 ~~~~----------------------------------------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDV  508 (614)
                      ....                                              ........||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            1000                                              000123469999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCccc
Q 043267          509 YSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       509 wS~Gvll~ElltG~~p~~~  527 (614)
                      ||+||++|||++|+.||..
T Consensus       232 wSlGvil~elltG~~Pf~~  250 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             EechHHHHHHHhCCCCCCC
Confidence            9999999999999999964

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5.1e-36  Score=302.97  Aligned_cols=255  Identities=23%  Similarity=0.283  Sum_probs=204.5

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|+||.||++... +|..||+|++...  .....+.+.+|++++++++|+|++++++++...   .+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDR---SNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecC---CCCEEE
Confidence            4777899999999999999864 6889999998642  344456788999999999999999999877532   345679


Q ss_pred             EEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcC--CCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          396 IVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGV--QPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~--~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ++|||+++++|.+++...  ....+++..++.++.++++||.|||...  +.+++|+||||+||++++++.+||+|||++
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999998653  2457999999999999999999999554  678999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ......... .....+++.|+|||.+....++.++||||||+++|+|++|+.|+.....     .... +.+..+..   
T Consensus       158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~-~~~~~~~~---  227 (265)
T cd08217         158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLA-SKIKEGKF---  227 (265)
T ss_pred             ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHH-HHHhcCCC---
Confidence            876543321 2334689999999999999999999999999999999999999864321     1111 22222211   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                            ..........+.+++..|++.+|++||++.+|++.
T Consensus       228 ------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 ------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  11222344577889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-36  Score=329.48  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=194.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .+|...+.||+|+||.||+++.+ .++.||||....      ..+.+|++++++++|+||+++++++.     .+...++
T Consensus       169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~-----~~~~~~l  237 (461)
T PHA03211        169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRV-----VGGLTCL  237 (461)
T ss_pred             CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEEEE
Confidence            36889999999999999999976 578899996432      24568999999999999999999886     5667899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |||++. ++|.+++.... ..++|.++++|+.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       238 v~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        238 VLPKYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             EEEccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            999994 78988886533 47999999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCc--cchhhHHHHHHHHcCCch--h-
Q 043267          477 GIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK--SVLLSDWAWELVKEGKTL--D-  550 (614)
Q Consensus       477 ~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~--~~~l~~~~~~~~~~g~~~--~-  550 (614)
                      ... .......||..|+|||++.+..++.++|||||||++|||++|..++......  .......+.+.++.....  + 
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            322 2233467999999999999999999999999999999999988765222111  111111122222221110  0 


Q ss_pred             ----------hhh-----ccCCC---CCc---HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          551 ----------VIE-----ENMPE---MEL---PEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       551 ----------~~d-----~~l~~---~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                                ...     ...+.   ...   ......+.+++..|++.||.+|||+.|+++.
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                      000     00000   000   0112356778899999999999999999863

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.9e-36  Score=317.90  Aligned_cols=242  Identities=23%  Similarity=0.294  Sum_probs=192.3

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||+||+++.. +++.||+|+++...   ....+.+.+|+.++.++ +|+||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQ-----TTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEE-----eCCEEEEEE
Confidence            46999999999999965 67899999997532   23345678899999888 6999999999886     556789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        76 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          76 EYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            999999999988653  36999999999999999999999   8999999999999999999999999999997532211


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCc-cchhhHHHHHHHHcCCchhhhhccCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK-SVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~-~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.||...... .....++.++.+..+..      .++
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p  223 (327)
T cd05617         151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIP  223 (327)
T ss_pred             -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCC
Confidence             1233467999999999999999999999999999999999999999543322 12223344443332211      111


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                          ......+.+++..|++.||++||++
T Consensus       224 ----~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         224 ----RFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             ----CCCCHHHHHHHHHHhccCHHHcCCC
Confidence                1223456788889999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.9e-37  Score=329.73  Aligned_cols=200  Identities=26%  Similarity=0.307  Sum_probs=170.4

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +|+..+.||+|+||.||+++.. +|+.||||.+....   ......+.+|++++++++|+||+++++.+.     +++..
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEE-----cCCEE
Confidence            6888999999999999999964 68999999986422   223456889999999999999999999886     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++...  ..++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++...
T Consensus        77 ~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            9999999999999999654  36888999999999999999999   899999999999999999999999999997522


Q ss_pred             CCC------------------------------------------CccccccccCCCCcCchhhhccCCCCchhhHHHHH
Q 043267          475 PEG------------------------------------------ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFG  512 (614)
Q Consensus       475 ~~~------------------------------------------~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~G  512 (614)
                      ...                                          .........||+.|+|||++.+..++.++||||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            100                                          00001234699999999999999999999999999


Q ss_pred             HHHHHHHhCCCCcccc
Q 043267          513 VVLLELLSGKKACEII  528 (614)
Q Consensus       513 vll~ElltG~~p~~~~  528 (614)
                      |++|||++|+.||...
T Consensus       232 vilyell~G~~Pf~~~  247 (376)
T cd05598         232 VILYEMLVGQPPFLAD  247 (376)
T ss_pred             ceeeehhhCCCCCCCC
Confidence            9999999999999643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.9e-36  Score=305.71  Aligned_cols=248  Identities=25%  Similarity=0.372  Sum_probs=197.0

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh---------hhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA---------GDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---------~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      +|...+.||+|+||.||+|... +++.||+|.+......         ..+.+.+|++++++++|||++++++++.    
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~----   76 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSL----   76 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE----
Confidence            3667789999999999999864 6889999988643221         2256889999999999999999999886    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                       +....++++||+++++|.+++...  ..+++..+..++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        77 -~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          77 -DADHLNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             -eCCccEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEeccc
Confidence             556789999999999999999654  46899999999999999999999   889999999999999999999999999


Q ss_pred             CCceeCCCCCcc-----ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH
Q 043267          469 GLAKFNPEGITH-----LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       469 Gla~~~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      |+++........     ......|+..|+|||.+.++.++.++||||+|+++|||++|+.||........     ... .
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~-~  224 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA-----IFK-I  224 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH-----HHH-H
Confidence            998765422111     11234588999999999999999999999999999999999999964322110     001 1


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+     ..+.+    +....+.+.+++..|++.+|.+||++.|+++
T Consensus       225 ~~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 GEN-----ASPEI----PSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             hcc-----CCCcC----CcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            111     11111    1233456778889999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.2e-36  Score=318.45  Aligned_cols=255  Identities=20%  Similarity=0.263  Sum_probs=192.9

Q ss_pred             cceeccc--CceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          323 ENIIGKG--GYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       323 ~~~LG~G--~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .++||+|  +||+||+++. ++|+.||||+++..  .....+.+.+|+++++.++||||+++++++.     .++..++|
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~-----~~~~~~lv   77 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----ADNELWVV   77 (327)
T ss_pred             hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEE-----ECCEEEEE
Confidence            4679999  7899999986 47899999999753  2333456788999999999999999999987     55678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC-
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-  476 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~-  476 (614)
                      +||+++|+|.+++.......+++..+++++.|++.||.|||   +.+|+||||||+|||++.++.++++||+....... 
T Consensus        78 ~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~  154 (327)
T cd08227          78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINH  154 (327)
T ss_pred             EeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhccccc
Confidence            99999999999997655556999999999999999999999   89999999999999999999999999987543221 


Q ss_pred             CCcc-----ccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          477 GITH-----LTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       477 ~~~~-----~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +...     ......++..|+|||++.+  ..++.++|||||||++|||++|+.||.........     ... ..+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-----~~~-~~~~~~  228 (327)
T cd08227         155 GQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-----LEK-LNGTVP  228 (327)
T ss_pred             cccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-----HHH-hcCCcc
Confidence            1100     1122356788999999976  46899999999999999999999999643321110     000 001110


Q ss_pred             hhhh-------------------ccC-----------------CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIE-------------------ENM-----------------PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d-------------------~~l-----------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...+                   ...                 ...........+.+++..|++.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         229 CLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence            0000                   000                 00011123446788999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.7e-36  Score=310.25  Aligned_cols=266  Identities=24%  Similarity=0.321  Sum_probs=205.1

Q ss_pred             CHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecc
Q 043267          309 KIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTAT  386 (614)
Q Consensus       309 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~  386 (614)
                      .++.+..+.++|+..+.||+|+||.||+++.. +++.+|+|.+.... ....++.+|+.+++++ +|+|++++++++...
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34556677889999999999999999999864 68899999886532 2345688999999999 699999999987543


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                      ....+...++||||+++++|.+++..  .....+++..+..++.|+++||.|||   +.+++||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~k  164 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVK  164 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEE
Confidence            32245678999999999999998864  23456899999999999999999999   89999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~  539 (614)
                      |+|||+++....... ......|++.|+|||++..     ..++.++||||+||++|||++|+.|+.......    ...
T Consensus       165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~----~~~  239 (286)
T cd06638         165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR----ALF  239 (286)
T ss_pred             EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH----HHh
Confidence            999999986543221 2233468999999998753     457899999999999999999999985432211    000


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                       . ...+.     ......  .......+..++..|++.+|++|||+.|+++-
T Consensus       240 -~-~~~~~-----~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 -K-IPRNP-----PPTLHQ--PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             -h-ccccC-----CCcccC--CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence             0 00110     001100  11123457788999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.3e-36  Score=310.41  Aligned_cols=239  Identities=22%  Similarity=0.341  Sum_probs=186.5

Q ss_pred             eecccCceEEEEeEcCC-------------------------CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeee
Q 043267          325 IIGKGGYGNVYKGMLPN-------------------------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL  379 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~~-------------------------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l  379 (614)
                      +||+|+||.||+|++..                         ...|++|.+.........++.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998421                         13589999876444445678899999999999999999


Q ss_pred             eeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC
Q 043267          380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE  459 (614)
Q Consensus       380 ~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~  459 (614)
                      ++++.     ++...++||||+++|+|++++... ...+++..+.+++.|+++||+|||   +.+|+||||||+|||++.
T Consensus        82 ~~~~~-----~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCV-----RGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEE-----eCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEec
Confidence            99987     556789999999999999988653 346899999999999999999999   899999999999999976


Q ss_pred             CC-------cEEEeecCCceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHH-hCCCCcccccC
Q 043267          460 AF-------EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELL-SGKKACEIIQG  530 (614)
Q Consensus       460 ~~-------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~Ell-tG~~p~~~~~~  530 (614)
                      .+       .+|++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+.....
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            44       3799999988643221     12347788999998875 56899999999999999995 68888854322


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ...  .    .....       ...++..    ....+.+++..||+.+|++|||+.++++.|+
T Consensus       228 ~~~--~----~~~~~-------~~~~~~~----~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 SEK--E----RFYEK-------KHRLPEP----SCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH--H----HHHHh-------ccCCCCC----CChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            110  0    11111       0111111    1235778899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.1e-36  Score=317.51  Aligned_cols=240  Identities=26%  Similarity=0.329  Sum_probs=189.4

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+|+.. +++.||||+++...   ......+..|..++... +||||+++++++.     +....++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            46999999999999975 57899999997531   22334566788888765 9999999999886     556789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.+...++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        76 ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          76 EYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             eCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            999999999998653  46899999999999999999999   8999999999999999999999999999997533221


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......     + ..+.+..+.      ...+.
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~-----~-~~~~i~~~~------~~~~~  217 (316)
T cd05619         151 -AKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE-----E-LFQSIRMDN------PCYPR  217 (316)
T ss_pred             -CceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHhCC------CCCCc
Confidence             1223457899999999999999999999999999999999999999643211     1 111111111      11111


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMD-QIV  590 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl  590 (614)
                          .....+.+++..|++.||++||++. ++.
T Consensus       218 ----~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         218 ----WLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ----cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                1234567888899999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=5.7e-36  Score=313.18  Aligned_cols=196  Identities=23%  Similarity=0.366  Sum_probs=161.3

Q ss_pred             cceecccCceEEEEeEcC---CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLP---NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      .++||+|+||.||+|+..   +++.||+|.+....  ....+.+|++++++++||||+++++++...   .+...++++|
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEe
Confidence            367999999999999864   46789999987532  234577899999999999999999987532   3456889999


Q ss_pred             ecCCCChhhhhhcC-------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE----CCCCcEEEeec
Q 043267          400 LLHNGSLYDHLFGS-------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDF  468 (614)
Q Consensus       400 ~~~~GsL~~~L~~~-------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL----d~~~~~kl~DF  468 (614)
                      |+. ++|.+++...       ....+++.....|+.|++.||.|||   +.+|+||||||+|||+    +.++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            986 5888877532       1235899999999999999999999   8999999999999999    46678999999


Q ss_pred             CCceeCCCCCcc--ccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          469 GLAKFNPEGITH--LTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       469 Gla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      |+++........  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            999865443221  23446789999999998874 589999999999999999999999953

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-36  Score=318.57  Aligned_cols=257  Identities=27%  Similarity=0.387  Sum_probs=202.3

Q ss_pred             cCccccceecccCceEEEEeEcC--------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP--------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      .+|...+.||+|+||.||++...        .+..||+|.++.. .....+++.+|+++++++ +|+||+++++++.   
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---   88 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT---   88 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc---
Confidence            35788899999999999999742        1246899988753 234456889999999999 8999999999986   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCC
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS  453 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~  453 (614)
                        .+...++++||+++|+|.+++....              ...++|.++++++.|+++||.|||   +.+++||||||+
T Consensus        89 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~  163 (334)
T cd05100          89 --QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR  163 (334)
T ss_pred             --cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence              4567899999999999999996532              245899999999999999999999   899999999999


Q ss_pred             CeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCc
Q 043267          454 NILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGK  531 (614)
Q Consensus       454 NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~  531 (614)
                      |||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+....  
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--  241 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--  241 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC--
Confidence            999999999999999999865432211 1222334578999999999999999999999999999998 888875332  


Q ss_pred             cchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       532 ~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                         ..++. ..+..+...         .........+.+++..|++.+|++||++.|+++.|+...
T Consensus       242 ---~~~~~-~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         242 ---VEELF-KLLKEGHRM---------DKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ---HHHHH-HHHHcCCCC---------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence               11211 222222111         111223446778899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-36  Score=326.42  Aligned_cols=260  Identities=19%  Similarity=0.221  Sum_probs=200.1

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeec
Q 043267          310 IEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTA  385 (614)
Q Consensus       310 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~  385 (614)
                      +.+++...++|...+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+++++.++||||+++++.+. 
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~-  113 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ-  113 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-
Confidence            4455566689999999999999999999975 6889999998642   2233456788999999999999999999886 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                          ++...++||||+++|+|.+++...   .++...+..++.|++.||+|||   +.+|+||||||+|||++.++++||
T Consensus       114 ----~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         114 ----DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             ----cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEE
Confidence                567899999999999999998543   4888889999999999999999   899999999999999999999999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      +|||+++..............||+.|+|||++...    .++.++|||||||++|||++|+.||.....     ......
T Consensus       184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~  258 (371)
T cd05622         184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL-----VGTYSK  258 (371)
T ss_pred             EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH-----HHHHHH
Confidence            99999986654333233456799999999998754    388999999999999999999999964321     111111


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQA--RPTMDQIVKI  592 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~~  592 (614)
                      ........     ..+.  .......+..++..|+..++.+  ||++.|+++.
T Consensus       259 i~~~~~~~-----~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         259 IMNHKNSL-----TFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHcCCCcc-----cCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            11111111     1111  1223445667777888744433  7899988874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.9e-36  Score=309.67  Aligned_cols=265  Identities=24%  Similarity=0.351  Sum_probs=206.4

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeec
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTA  385 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~  385 (614)
                      .++.++....+.|+..+.||+|+||.||+|+.. +++.+|+|.+.... ....++..|+.+++++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            355666677788999999999999999999964 68899999886533 3445688999999999 79999999998754


Q ss_pred             ccC-CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          386 TVP-LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       386 ~~~-~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                      ... ..+...+++|||+++|+|.+++.......+++..+..++.|+++||.|||   +.+|+||||||+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEE
Confidence            321 13467899999999999999997766667899999999999999999999   88999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~  539 (614)
                      |+|||++........ ......|+..|+|||.+.     ...++.++||||||+++|||++|+.|+.........     
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-----  235 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-----  235 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence            999999875432211 123356899999999876     346888999999999999999999998543211100     


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ..      .................+.+++..|++.||.+|||+.|+++
T Consensus       236 ---~~------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 ---FL------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---hh------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence               00      00000111111223456788899999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.2e-36  Score=302.92  Aligned_cols=249  Identities=23%  Similarity=0.328  Sum_probs=202.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|+||.||+++.. +|+.||+|++...  ......++.+|++++++++|+|++++.+++.     +....+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE-----ENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec-----CCCeEE
Confidence            4778899999999999999864 6899999998742  3344567899999999999999999999886     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||+++++|.+++.......+++.++++++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            9999999999999997655557899999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .... ......|++.|+|||+..++.++.++||||||++++||++|+.|+....     ..+.+.... .+...      
T Consensus       153 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-----~~~~~~~~~-~~~~~------  219 (256)
T cd08218         153 STVE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN-----MKNLVLKII-RGSYP------  219 (256)
T ss_pred             cchh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC-----HHHHHHHHh-cCCCC------
Confidence            4322 1223458899999999999999999999999999999999999985322     122222221 12111      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .........+.+++..|++.+|.+||++.+|++
T Consensus       220 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         220 ---PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ---CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               011223446778899999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.7e-36  Score=305.04  Aligned_cols=250  Identities=24%  Similarity=0.383  Sum_probs=198.3

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCC------hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS------KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~------~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||+|...+|+.+|||.++...      ......+.+|++++++++|+|++++.+++.     +..
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   75 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCL-----DDN   75 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEee-----cCC
Confidence            367788999999999999998889999999886422      122356889999999999999999999987     557


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++++||+++++|.+++.+.  ..+++..+..++.|++.||+|||   +.+|+|+||||+||++++++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~  150 (265)
T cd06631          76 TISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR  150 (265)
T ss_pred             eEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhH
Confidence            889999999999999999654  36889999999999999999999   8899999999999999999999999999987


Q ss_pred             eCCCC-----CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          473 FNPEG-----ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       473 ~~~~~-----~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      .....     .........|+..|+|||++.+..++.++||||||+++|||++|+.||......    ....  ......
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~~--~~~~~~  224 (265)
T cd06631         151 RLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRL----AAMF--YIGAHR  224 (265)
T ss_pred             hhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChH----HHHH--Hhhhcc
Confidence            54221     111223456899999999999999999999999999999999999999543211    1110  011110


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ...+.++    ......+..++..|++.+|++||++.|+++
T Consensus       225 ---~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 ---GLMPRLP----DSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---CCCCCCC----CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence               0011111    223445678889999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.8e-36  Score=319.06  Aligned_cols=193  Identities=26%  Similarity=0.379  Sum_probs=164.6

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ....+|...+.||+|+||.||+|+.. ++..||+|.....      ....|+.++++++|+||+++++++.     .+..
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~  131 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLV-----SGAI  131 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEE-----eCCe
Confidence            34567999999999999999999975 5778999975432      2346899999999999999999987     5567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|+||+. ++|.+++... ...++|..+++|+.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       132 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  206 (357)
T PHA03209        132 TCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF  206 (357)
T ss_pred             eEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccc
Confidence            899999994 6898888653 357999999999999999999999   88999999999999999999999999999975


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      ....  .......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus       207 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        207 PVVA--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccC--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            3322  1223456999999999999999999999999999999999966555

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=6.4e-36  Score=304.73  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=193.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-----hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-----KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|...+.||+|+||.||++... +|..||+|++....     ......+.+|+++++.++|+|++++++++...   .+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDR---AE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcC---CC
Confidence            47888999999999999999964 68999999886321     22345688999999999999999999987532   34


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++++||+++++|.+++....  .+++...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            57789999999999999996543  5899999999999999999999   899999999999999999999999999998


Q ss_pred             eeCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +.......  .......++..|+|||++.+..++.++||||||+++|||++|+.||......     ...........  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~~~~~~~~~--  226 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAIFKIATQPT--  226 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHHHHHhcCCC--
Confidence            75432111  1122345889999999999989999999999999999999999998643210     00111111110  


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .+.++    ......+..++ .|+..+|++||+++||++
T Consensus       227 ---~~~~~----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 ---NPQLP----SHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---CCCCc----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               11111    11222333333 688899999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.2e-36  Score=330.68  Aligned_cols=269  Identities=22%  Similarity=0.264  Sum_probs=196.1

Q ss_pred             HHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHcccc------ceeeeeeee
Q 043267          311 EEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV------NLVALRGYS  383 (614)
Q Consensus       311 ~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~------niv~l~g~~  383 (614)
                      +++...+++|...++||+|+||+||+++.. .++.||||+++... ....++..|++++.+++|.      +++++.+++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            345556788999999999999999999964 67889999997532 2334566788888887655      488888877


Q ss_pred             ecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCCC-
Q 043267          384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEAF-  461 (614)
Q Consensus       384 ~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~~-  461 (614)
                      ..    +....++|||++ +++|.+++.+.  ..+++..+..|+.|++.||.|||   + .+|+||||||+|||++.++ 
T Consensus       201 ~~----~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        201 QN----ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDT  270 (467)
T ss_pred             Ec----CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCc
Confidence            53    345688999988 77899988654  46999999999999999999999   6 5999999999999998765 


Q ss_pred             ---------------cEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Q 043267          462 ---------------EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE  526 (614)
Q Consensus       462 ---------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~  526 (614)
                                     .+||+|||.+....    ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~  346 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD  346 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence                           49999999876422    22345679999999999999999999999999999999999999996


Q ss_pred             cccCccch-h---------hHHHHHHHHcCCchhhhhc------cC---------CCCCc--HHHHHHHHHHHHHccccC
Q 043267          527 IIQGKSVL-L---------SDWAWELVKEGKTLDVIEE------NM---------PEMEL--PEMMEQYVLTAAICAHPI  579 (614)
Q Consensus       527 ~~~~~~~~-l---------~~~~~~~~~~g~~~~~~d~------~l---------~~~~~--~~~~~~l~~l~~~Cl~~d  579 (614)
                      .....+.. +         ..|.... ......+..+.      ..         .....  ......+.+++..|++.|
T Consensus       347 ~~~~~~~~~~i~~~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  425 (467)
T PTZ00284        347 THDNLEHLHLMEKTLGRLPSEWAGRC-GTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD  425 (467)
T ss_pred             CCChHHHHHHHHHHcCCCCHHHHhhc-cchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence            43321100 0         0111000 00000000000      00         00000  011245778999999999


Q ss_pred             CCCCCCHHHHHH--Hhhc
Q 043267          580 LQARPTMDQIVK--ILET  595 (614)
Q Consensus       580 P~~RPt~~eVl~--~L~~  595 (614)
                      |++|||++|+++  .+..
T Consensus       426 P~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        426 RQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             hhhCCCHHHHhcCccccc
Confidence            999999999986  4444

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.3e-36  Score=317.11  Aligned_cols=240  Identities=25%  Similarity=0.290  Sum_probs=189.7

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+++.. +|..||+|.++...   ......+..|.+++... +|||++++++++.     ++...++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQ-----TKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEE-----eCCEEEEEE
Confidence            46999999999999975 68899999997532   22344567788887765 8999999999886     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.+...++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus        76 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          76 EFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             CCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            999999999998654  36899999999999999999999   8999999999999999999999999999987432221


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                       .......||+.|+|||++.+..++.++||||+||++|||++|+.||......      -.++.+..+.      ..++.
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~~~------~~~~~  217 (316)
T cd05620         151 -NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRVDT------PHYPR  217 (316)
T ss_pred             -CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC------CCCCC
Confidence             1234467999999999999999999999999999999999999999543211      1112222111      11121


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMD-QIV  590 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl  590 (614)
                          .....+.+++..|++.||++||++. ++.
T Consensus       218 ----~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         218 ----WITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ----CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                1234567788899999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.8e-36  Score=330.96  Aligned_cols=263  Identities=20%  Similarity=0.255  Sum_probs=191.7

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC---CCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP---LEG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~---~~~  391 (614)
                      ...+|...+.||+|+||.||+|+.. +++.||||++....    ....+|+.+++.++|+||+++++++.....   ...
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3457999999999999999999964 68899999886432    234579999999999999999887643211   112


Q ss_pred             ceEEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeec
Q 043267          392 HQRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDF  468 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DF  468 (614)
                      ...++||||+++ +|.+++..  .....+++.....++.|+++||+|||   +.+|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeecc
Confidence            346789999974 77777653  23457999999999999999999999   89999999999999999664 7999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      |+++.......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.... +....-.
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~-~~~~~p~  291 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRII-QVLGTPT  291 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHH-HHhCCCC
Confidence            99986543322  2335689999999998764 69999999999999999999999996433211 111100 0000000


Q ss_pred             c-------hhhhhccCCCC--------CcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          548 T-------LDVIEENMPEM--------ELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       548 ~-------~~~~d~~l~~~--------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      .       ....+..++..        .+......+.+++..|++.||.+|||+.|++
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            0       00000001100        0111234678899999999999999999988

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.5e-36  Score=301.18  Aligned_cols=247  Identities=24%  Similarity=0.388  Sum_probs=199.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-----hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-----KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||+|+.. +++.|++|.+....     ....+.+.+|+++++.++|+|++++.+++.     .+.
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTER-----EED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEe-----cCC
Confidence            3667789999999999999976 78999999986432     234567899999999999999999999886     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++++||+++++|.+++.+.  ..+++..+..++.|+++||.|||   +.+++|+||||+||+++.++.+||+|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccce
Confidence            889999999999999999654  36899999999999999999999   8999999999999999999999999999987


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ......  ......|+..|++||.+.... ++.++|+||||+++|||++|+.|+.....     .+..+.....+...  
T Consensus       151 ~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~--  221 (258)
T cd06632         151 QVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-----VAAVFKIGRSKELP--  221 (258)
T ss_pred             eccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH-----HHHHHHHHhcccCC--
Confidence            654332  223456889999999998776 89999999999999999999999854331     11122211111111  


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .+    .......+.+++..|++.+|++||++.++++
T Consensus       222 ---~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         222 ---PI----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ---Cc----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence               11    1223356677889999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-35  Score=304.36  Aligned_cols=247  Identities=26%  Similarity=0.355  Sum_probs=201.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .|+..+.||+|+||.||+|+.. ++..||+|.++.. .......+.+|++++++++|+|++++++++.     ++...++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            4667788999999999999965 6889999998743 3445667899999999999999999999987     5678999


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++..   ..+++.+...++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++.....
T Consensus        80 v~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06640          80 IMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD  153 (277)
T ss_pred             EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence            9999999999999854   35899999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......++..|+|||++.+..++.++||||||+++|||++|+.|+........     . .         .+....
T Consensus       154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-----~-~---------~~~~~~  217 (277)
T cd06640         154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----L-F---------LIPKNN  217 (277)
T ss_pred             Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH-----h-h---------hhhcCC
Confidence            221 22334678899999999998999999999999999999999999854322110     0 0         111111


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      ...........+.+++..|++.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            122233455678899999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.1e-36  Score=308.65  Aligned_cols=255  Identities=25%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|+..+.||+|+||+||++... +|+.||+|.+.... ....+.+.+|+++++.++|||++++++++.     .....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            45777789999999999999964 68899999886532 344567899999999999999999999987     457889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.+++...  ..+++.....++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++....
T Consensus        80 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~  155 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI  155 (284)
T ss_pred             EEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence            999999999999988653  368999999999999999999993  2589999999999999999999999999986543


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCcc------chhhHHHHHHHHcCCch
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS------VLLSDWAWELVKEGKTL  549 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~------~~l~~~~~~~~~~g~~~  549 (614)
                      ...   .....|+..|+|||++.++.++.++|||||||++|||++|+.||.......      ..+.++....+...   
T Consensus       156 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  229 (284)
T cd06620         156 NSI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---  229 (284)
T ss_pred             hhc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence            221   224568999999999998899999999999999999999999996433211      01112221111110   


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                         .+.+.   .......+.+++..|++.||++|||+.|++++.
T Consensus       230 ---~~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 ---PPRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             ---CCCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence               01111   112344677888899999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.6e-36  Score=319.10  Aligned_cols=237  Identities=27%  Similarity=0.310  Sum_probs=186.6

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHH-HHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVE-IIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||+||+++.. +|+.||||++....   .....++..|.. +++.++||||+++++++.     +....++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            46999999999999975 78999999997422   222334555554 567899999999998876     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.....++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        76 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-  149 (323)
T cd05575          76 DYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-  149 (323)
T ss_pred             cCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-
Confidence            999999999998653  46899999999999999999999   899999999999999999999999999998753221 


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .+.. +.+..+..      .++ 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~-~~i~~~~~------~~~-  216 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMY-DNILNKPL------RLK-  216 (323)
T ss_pred             CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHH-HHHHcCCC------CCC-
Confidence            1223445799999999999999999999999999999999999999964321     1111 11111110      111 


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMD  587 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  587 (614)
                         +.....+.+++..|++.||++||++.
T Consensus       217 ---~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         217 ---PNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             ---CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence               12244677888999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=5.2e-36  Score=306.16  Aligned_cols=251  Identities=20%  Similarity=0.308  Sum_probs=188.3

Q ss_pred             eecccCceEEEEeEcCCC---cEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEee
Q 043267          325 IIGKGGYGNVYKGMLPNG---TEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      .||+|+||+||+|...++   ..+++|.++... ....+.+.+|+++++.++|||++++++.+.     .....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            599999999999985443   346677765432 345678999999999999999999999987     45678999999


Q ss_pred             cCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC-
Q 043267          401 LHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG-  477 (614)
Q Consensus       401 ~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~-  477 (614)
                      +++|+|.+++.+..  ...+++.....++.|+++||+|||   +.+++||||||+|||++.++.+||+|||++...... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence            99999999997642  245677788899999999999999   889999999999999999999999999998642221 


Q ss_pred             CccccccccCCCCcCchhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          478 ITHLTTRVAGTLGYVAPEYALY-------GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      .........++..|+|||+...       ..++.++||||||+++|||++ |..|+.....     .+.....++ +...
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~-----~~~~~~~~~-~~~~  227 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD-----REVLNHVIK-DQQV  227 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHh-hccc
Confidence            1122234567899999998753       246789999999999999997 5667743221     112222222 2222


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ...++.+...    ...++.+++..|| .+|++||++++|+++|.
T Consensus       228 ~~~~~~~~~~----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQLELP----YSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCccCCC----CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3333333322    2345666777899 57999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=8.4e-36  Score=317.57  Aligned_cols=267  Identities=21%  Similarity=0.211  Sum_probs=197.8

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~  391 (614)
                      ..++|...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...... +.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4468999999999999999999864 6889999999753  233445678899999999999999999987643221 23


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            457999999964 6777663    25889999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch----------hhH----
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL----------LSD----  537 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----------l~~----  537 (614)
                      +.....  .......||..|+|||.+.+..++.++||||||+++|||++|+.||.........          ..+    
T Consensus       167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            864432  2223456899999999999999999999999999999999999999532210000          000    


Q ss_pred             ---HHHHHHHcCCc------hhhhhcc-CC--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          538 ---WAWELVKEGKT------LDVIEEN-MP--EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       538 ---~~~~~~~~g~~------~~~~d~~-l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                         ...........      ....... .+  ..........+.+++..|++.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence               00000000000      0000000 00  00111223467889999999999999999999973

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.3e-36  Score=307.11  Aligned_cols=262  Identities=21%  Similarity=0.263  Sum_probs=195.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|++|.||+|+.. +|..||||+++...  ......+.+|++++++++|||++++++++.     ++...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM-----QESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe-----eCCeEE
Confidence            4777889999999999999975 68999999986432  223457889999999999999999999986     567889


Q ss_pred             EEEeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      +|+||++ ++|.+++.... ...+++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          76 LIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            9999997 68988886533 357999999999999999999999   899999999999999999999999999999755


Q ss_pred             CCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH-------HHHHHcC
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA-------WELVKEG  546 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~-------~~~~~~g  546 (614)
                      .... .......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+......... ....       ...+...
T Consensus       152 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPV-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL-FRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCc-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHHhCCCChhhhhcc
Confidence            4322 122334578899999988754 5789999999999999999999998533211100 0000       0000000


Q ss_pred             CchhhhhccCCC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPE-------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..........+.       .........+.+++..|++.||++|||+.+|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000000       001112345678999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=7.4e-36  Score=318.60  Aligned_cols=266  Identities=23%  Similarity=0.251  Sum_probs=196.5

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~  391 (614)
                      ..++|...+.||+|+||.||++... +|..||||++...  .......+.+|+.+++.++||||+++++++...... +.
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3468999999999999999999964 6899999998642  233456788999999999999999999987643221 22


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++ +|.+.+.    ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence            457999999965 6666663    24888999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch----------hhHH---
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL----------LSDW---  538 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----------l~~~---  538 (614)
                      +.....  .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.........          ...+   
T Consensus       171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            754322  1233456899999999999999999999999999999999999999643211000          0000   


Q ss_pred             ----HHHHHHcCCc-h-hhhhccCCC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 ----AWELVKEGKT-L-DVIEENMPE-------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ----~~~~~~~g~~-~-~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          +......... . .......+.       .........+.+++..|++.||++|||+.|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                0000000000 0 000000000       000112345788999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=8e-37  Score=324.51  Aligned_cols=252  Identities=28%  Similarity=0.443  Sum_probs=212.1

Q ss_pred             ccccceecccCceEEEEeEcC---CC--cEEEEEEeec-CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          320 FSRENIIGKGGYGNVYKGMLP---NG--TEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~---~g--~~VAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ....++||.|-||.||+|+..   .|  -.||||.-+. +.....+.|..|..+|++++||||++|+|+|.      +..
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~------e~P  464 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCV------EQP  464 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeee------ccc
Confidence            445578999999999999942   23  3589998876 55666889999999999999999999999995      467


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|||.++-|.|..||..++ ..|+.......+.|+..+|+|||   +.++|||||.++|||+.+.--+|++|||+++.
T Consensus       465 ~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhh
Confidence            899999999999999997654 57899999999999999999999   99999999999999999999999999999998


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..++.....++..-.+.|||||.+...++|.+||||-|||.+|||++ |.+||......++.      -.+++|.+.   
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI------~~iEnGeRl---  611 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI------GHIENGERL---  611 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE------EEecCCCCC---
Confidence            88776665556666889999999999999999999999999999998 99999765554432      223333332   


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                            ..++.....+..+...||..+|.+||++.|+...|+..
T Consensus       612 ------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv  649 (974)
T KOG4257|consen  612 ------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV  649 (974)
T ss_pred             ------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence                  22344555777888999999999999999998887654

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-36  Score=315.17  Aligned_cols=201  Identities=24%  Similarity=0.335  Sum_probs=172.3

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .....+.+.+|+.++..++|+||+++++++.     ++..
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQ-----DENN   75 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEe-----cCCe
Confidence            36888999999999999999965 6899999999642   2233456889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++.+. ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||++..
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          76 LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             EEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceee
Confidence            99999999999999999653 346899999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCCccccccccCCCCcCchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      .............||+.|+|||++..     +.++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence            54433333333569999999999873     4678899999999999999999999954

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-36  Score=308.16  Aligned_cols=240  Identities=22%  Similarity=0.336  Sum_probs=188.3

Q ss_pred             ceecccCceEEEEeEcCC--------CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          324 NIIGKGGYGNVYKGMLPN--------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.||+|+||.||+|....        ..+|++|.+........+++.+|+.+++.++|||++++++++.     .+...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~-----~~~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCV-----CGDESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEE-----eCCCcE
Confidence            369999999999998642        2358899887655555678899999999999999999999987     456679


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc--------EEEee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE--------AKVGD  467 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~--------~kl~D  467 (614)
                      +||||+++|+|.+++...+ ..+++..+++++.|++.||+|||   +.+|+||||||+||+++.++.        +|++|
T Consensus        76 lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence            9999999999999997643 36899999999999999999999   899999999999999987765        58999


Q ss_pred             cCCceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCC-CCcccccCccchhhHHHHHHHHc
Q 043267          468 FGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGK-KACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       468 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~-~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      ||++.....     .....++..|+|||++.+. .++.++||||||+++|||++|. .|+......     ..  .....
T Consensus       152 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~-----~~--~~~~~  219 (258)
T cd05078         152 PGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----KK--LQFYE  219 (258)
T ss_pred             cccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH-----HH--HHHHH
Confidence            998864332     2234578899999999874 5899999999999999999985 454322210     00  00111


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      .      ...++.    .....+.+++..|++.+|++|||++++++.|+
T Consensus       220 ~------~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 D------RHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             c------cccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0      011121    22345778899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=8.2e-36  Score=311.52  Aligned_cols=196  Identities=24%  Similarity=0.373  Sum_probs=160.9

Q ss_pred             cceecccCceEEEEeEcC---CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLP---NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      .++||+|+||.||+|+..   ++..||+|.+....  ....+.+|++++++++|||++++++++...   .+...++|+|
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEe
Confidence            367999999999999964   45789999987532  234578899999999999999999987532   4567899999


Q ss_pred             ecCCCChhhhhhcC-------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE----CCCCcEEEeec
Q 043267          400 LLHNGSLYDHLFGS-------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDF  468 (614)
Q Consensus       400 ~~~~GsL~~~L~~~-------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL----d~~~~~kl~DF  468 (614)
                      |++ ++|.+++...       ....+++..+.+++.|++.||.|||   +.+|+||||||+|||+    ++++.+||+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            986 4787776421       2235889999999999999999999   8999999999999999    56779999999


Q ss_pred             CCceeCCCCCcc--ccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          469 GLAKFNPEGITH--LTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       469 Gla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      |+++........  ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            999866543221  22345689999999998764 589999999999999999999999853

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=9.5e-36  Score=303.16  Aligned_cols=252  Identities=25%  Similarity=0.316  Sum_probs=198.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++.........+.+|+.+++.++|||++++++.+.     .+...++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~-----~~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL-----RRDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE-----eCCEEEE
Confidence            46777889999999999999864 68899999987655555567889999999999999999999876     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++++|.+++...  ..+++.+.+.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++.....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          84 CMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            99999999999998654  36899999999999999999999   88999999999999999999999999999876543


Q ss_pred             CCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          477 GITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .. .......|+..|+|||++.   .+.++.++||||+||++|||++|+.|+........     .+........    .
T Consensus       159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-----~~~~~~~~~~----~  228 (267)
T cd06645         159 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-----LFLMTKSNFQ----P  228 (267)
T ss_pred             cc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-----HHhhhccCCC----C
Confidence            22 1223456899999999875   45688999999999999999999999853322110     1111111100    0


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +....  .......+.+++..|++.+|++||+++++++
T Consensus       229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            11111  0112345778899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-36  Score=311.27  Aligned_cols=252  Identities=23%  Similarity=0.242  Sum_probs=201.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||++... +++.||+|.+.....   .....+.+|+++++.++|+||+++++.+.     ++..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~   75 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQ-----TETY   75 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeee-----cCCE
Confidence            36888899999999999999975 589999999975432   24557889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++.......+++..+..++.|+++||+|||   +.+++||||||+||+++.++.++|+|||++..
T Consensus        76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            899999999999999997665678999999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCCCcc----------------------------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          474 NPEGITH----------------------------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       474 ~~~~~~~----------------------------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      .......                            ......||..|+|||++.+..++.++||||||+++|||++|+.||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4322110                            111346889999999999999999999999999999999999998


Q ss_pred             ccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC----HHHHHH
Q 043267          526 EIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT----MDQIVK  591 (614)
Q Consensus       526 ~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~eVl~  591 (614)
                      ........    + ..         ..+..............+.+++..|++.+|++|||    +.|+++
T Consensus       233 ~~~~~~~~----~-~~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         233 KGSNRDET----F-SN---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CCCchHHH----H-HH---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            64332110    0 01         11111111111124567888999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8e-36  Score=311.34  Aligned_cols=261  Identities=23%  Similarity=0.344  Sum_probs=196.0

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+.+ +++.||+|+++... ......+.+|++++++++|+|++++++++.     .+...+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH-----TDKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe-----eCCeEE
Confidence            46888899999999999999965 67889999987433 223446788999999999999999999986     556789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++ +|.+++...+ ..+++..+..++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        81 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecC
Confidence            99999975 8888876543 45899999999999999999999   8999999999999999999999999999997543


Q ss_pred             CCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch-h--------hHHHHHHHHc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL-L--------SDWAWELVKE  545 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-l--------~~~~~~~~~~  545 (614)
                      .... ......+|+.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+.. .        .+..|..+..
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (309)
T cd07872         156 VPTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS  234 (309)
T ss_pred             CCcc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcc
Confidence            3221 1233467899999998865 46899999999999999999999999543321100 0        0001111111


Q ss_pred             CCchhhhhccCCCC-------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIEENMPEM-------ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..  +..+...+..       ..+.....+.+++..|++.||++|||+.|+++
T Consensus       235 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         235 ND--EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hh--hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00  0000000100       00122345678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.3e-36  Score=316.06  Aligned_cols=241  Identities=23%  Similarity=0.301  Sum_probs=190.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~  393 (614)
                      +|...+.||+|+||.||+++.. +|+.||+|.+....   ....+.+..|.+++..+. |++++++.+++.     +.+.
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQ-----TVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEe-----cCCE
Confidence            3677899999999999999964 68999999997532   233456778999998885 567777887775     4567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.++..|+.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccc
Confidence            89999999999999998654  36999999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..... .......||+.|+|||++.++.++.++||||+||++|||++|+.||......     . ..+.+..+..     
T Consensus       151 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-----~-~~~~i~~~~~-----  218 (323)
T cd05615         151 HMVDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED-----E-LFQSIMEHNV-----  218 (323)
T ss_pred             cCCCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHhCCC-----
Confidence            33221 1233456899999999999999999999999999999999999999643321     1 1111111111     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                       ..+    ......+.+++..|++.+|.+|++.
T Consensus       219 -~~p----~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 -SYP----KSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             -CCC----ccCCHHHHHHHHHHcccCHhhCCCC
Confidence             111    1223456788899999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.4e-36  Score=304.03  Aligned_cols=253  Identities=24%  Similarity=0.374  Sum_probs=197.4

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh----------hhhHHHHHHHHHHHHccccceeeeeeeeeccc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK----------AGDANFKHEVEIIASVKHVNLVALRGYSTATV  387 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~----------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~  387 (614)
                      +|...+.||+|+||.||+|... +|+.||+|.++....          ...+.+.+|+++++.++|+|++++++++.   
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---   78 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFET---   78 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEec---
Confidence            4677889999999999999864 689999998853211          11246788999999999999999999886   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEee
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                        .....++|+||+++|+|.+++.+.  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|
T Consensus        79 --~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          79 --TEEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             --cCCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEee
Confidence              567789999999999999999665  46899999999999999999999   88999999999999999999999999


Q ss_pred             cCCceeCCCCCcc-ccccccCCCCcCchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          468 FGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGK--LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       468 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      ||+++........ ......|+..|+|||......  ++.++||||||+++||+++|+.|+.....    . ....+...
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~-~~~~~~~~  226 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----I-AAMFKLGN  226 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----H-HHHHHhhc
Confidence            9999765432221 223456889999999988655  88999999999999999999999853221    1 11111111


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....     ...+..........+.+++..|++.+|++||++.+|++
T Consensus       227 ~~~~-----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         227 KRSA-----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cccC-----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111     11111112233456778889999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.8e-36  Score=302.88  Aligned_cols=252  Identities=23%  Similarity=0.326  Sum_probs=201.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +|+..+.||+|+||.||++... +++.||+|++.... .....++.+|++++++++|||++++++.+.     .+...++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY-----NNGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee-----cCCEEEE
Confidence            5777789999999999999975 68999999987643 345567899999999999999999999886     4578899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ++||+++++|.+++.... ..+++....+++.|+++||+|||   + .+++||||||+||++++++.+||+|||.+....
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          77 CMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            999999999999987643 57899999999999999999999   7 899999999999999999999999999987543


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ....   ....++..|+|||+..+..++.++||||||+++|||++|+.|+...........+..... ..+..     +.
T Consensus       153 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~-----~~  223 (265)
T cd06605         153 NSLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPP-----PR  223 (265)
T ss_pred             HHHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCC-----CC
Confidence            2211   126688999999999999999999999999999999999999864432111222222111 11110     11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ++   .......+.+++..|++.+|++|||+.++++
T Consensus       224 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         224 LP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            11   1114456788899999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=7.4e-36  Score=343.51  Aligned_cols=258  Identities=24%  Similarity=0.320  Sum_probs=200.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...++||+|+||.||+|+.. +|+.||||++...   .....+.+.+|++++++++|||++++++++.     +++.
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            47888999999999999999965 6899999998642   2233567899999999999999999999986     5678


Q ss_pred             EEEEEeecCCCChhhhhhcC---------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          394 RIIVCDLLHNGSLYDHLFGS---------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~---------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                      .++||||+++|+|.+++...         ....+++..+++|+.|+++||+|||   +.+|+||||||+|||++.++.+|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEE
Confidence            89999999999999998641         1234678889999999999999999   88999999999999999999999


Q ss_pred             EeecCCceeCCCCCc-----------------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          465 VGDFGLAKFNPEGIT-----------------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       465 l~DFGla~~~~~~~~-----------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      |+|||+++.......                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999986521100                 011235699999999999999999999999999999999999999964


Q ss_pred             ccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhcc
Q 043267          528 IQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARP-TMDQIVKILETD  596 (614)
Q Consensus       528 ~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~~  596 (614)
                      .......     ..    .......+  ..  ...+....+.+++..|++.||++|| +++++++.|+..
T Consensus       234 ~~~~ki~-----~~----~~i~~P~~--~~--p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~  290 (932)
T PRK13184        234 KKGRKIS-----YR----DVILSPIE--VA--PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH  290 (932)
T ss_pred             cchhhhh-----hh----hhccChhh--cc--ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            3221111     00    00000000  00  0112334567888999999999995 567777777665

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2e-36  Score=319.61  Aligned_cols=249  Identities=21%  Similarity=0.232  Sum_probs=193.8

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh---hhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA---GDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      +...++|+..+.||+|+||.||+++.+ .|..+|+|++++....   ..+.+..|-.+|....++.||+|+-.+.     
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQ-----  211 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQ-----  211 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEec-----
Confidence            335568999999999999999999965 6899999999875433   3456778999999999999999987665     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      +...+||||||+|||++..+|...+  .|+.......+.+++.|+.-||   +.|+|||||||+|+|||..|++||+|||
T Consensus       212 D~~~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFG  286 (550)
T KOG0605|consen  212 DKEYLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFG  286 (550)
T ss_pred             CCCeeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccc
Confidence            6788999999999999999997644  7999999999999999999999   9999999999999999999999999999


Q ss_pred             CceeCCC-----------------------CCc----cc-------------------cccccCCCCcCchhhhccCCCC
Q 043267          470 LAKFNPE-----------------------GIT----HL-------------------TTRVAGTLGYVAPEYALYGKLT  503 (614)
Q Consensus       470 la~~~~~-----------------------~~~----~~-------------------~~~~~gt~~Y~APE~~~~~~~t  503 (614)
                      |+.-...                       +..    ..                   ....+|||.|||||++.+..|+
T Consensus       287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~  366 (550)
T KOG0605|consen  287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG  366 (550)
T ss_pred             ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence            9842110                       000    00                   0114699999999999999999


Q ss_pred             chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCC
Q 043267          504 PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR  583 (614)
Q Consensus       504 ~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  583 (614)
                      ...|+||+||++|||+.|-+||......      -.|+.+...+.      .+..........+..+++..|+. ||++|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~------~T~rkI~nwr~------~l~fP~~~~~s~eA~DLI~rll~-d~~~R  433 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQ------ETYRKIVNWRE------TLKFPEEVDLSDEAKDLITRLLC-DPENR  433 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHHHhh------hccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence            9999999999999999999999644322      12232222211      11110111112455667766776 99999


Q ss_pred             CC
Q 043267          584 PT  585 (614)
Q Consensus       584 Pt  585 (614)
                      --
T Consensus       434 LG  435 (550)
T KOG0605|consen  434 LG  435 (550)
T ss_pred             cC
Confidence            76

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.5e-36  Score=303.88  Aligned_cols=259  Identities=25%  Similarity=0.372  Sum_probs=199.3

Q ss_pred             ccccceecccCceEEEEeEcC----CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC-Cc
Q 043267          320 FSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE-GH  392 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~-~~  392 (614)
                      |...+.||+|+||.||+|.+.    +++.||||++...  +....+++.+|++++++++|||++++++++....... ..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            456788999999999999853    4688999998643  3344667889999999999999999999876432111 12


Q ss_pred             eEEEEEeecCCCChhhhhhcC----CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          393 QRIIVCDLLHNGSLYDHLFGS----GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                      ..++++||+++|+|.+++...    ....+++...++++.|++.||+|||   +.+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence            357889999999999887542    2235889999999999999999999   889999999999999999999999999


Q ss_pred             CCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcC
Q 043267          469 GLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       469 Gla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |+++........ ......+++.|++||....+.++.++||||||+++|||++ |+.|+.....  ..+    ...+..+
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~--~~~----~~~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN--SEI----YNYLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH--HHH----HHHHHcC
Confidence            999865432211 2223345678999999999999999999999999999999 8888753321  111    1122222


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ...       .  ........+.+++..|++.+|++||++.++++.|++.
T Consensus       232 ~~~-------~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 NRL-------K--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CcC-------C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            111       0  1122345788899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=300.23  Aligned_cols=253  Identities=26%  Similarity=0.321  Sum_probs=203.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||.||++... +++.+++|.+........+.+.+|++++++++|||++++++++.     .+...++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL-----RRDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEE-----eCCEEEE
Confidence            57888899999999999999975 57889999998655556678999999999999999999999876     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      +|||+++++|.+++... ...+++.++..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        78 ~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          78 VMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            99999999999988654 246899999999999999999999   89999999999999999999999999999875543


Q ss_pred             CCccccccccCCCCcCchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYG---KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ... ......++..|+|||.+...   .++.++||||||+++|||++|+.|+.........     .. ......   ..
T Consensus       154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~-----~~-~~~~~~---~~  223 (262)
T cd06613         154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL-----FL-ISKSNF---PP  223 (262)
T ss_pred             hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-----HH-HHhccC---CC
Confidence            221 22335688899999998876   8999999999999999999999998643321110     01 111100   00


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+.  ........+.+++.+|++.+|.+|||+.+|++
T Consensus       224 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         224 PKLK--DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             cccc--chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1111  12334556889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1e-35  Score=300.14  Aligned_cols=248  Identities=23%  Similarity=0.307  Sum_probs=200.0

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|+||.||++... +++.+|||++...  +......+.+|+++++.++|+|++++++.+.     .+...+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            4778899999999999999864 6889999998643  3344567899999999999999999998875     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-CcEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-~~~kl~DFGla~~~  474 (614)
                      +|+||+++++|.+++.......+++..+.+++.++++||.|||   +.+++||||||+||+++++ +.+||+|||++...
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            9999999999999998765567999999999999999999999   8999999999999999854 46899999999866


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ....  ......|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....     ...+..... +...     
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~-~~~~-----  219 (256)
T cd08220         153 SSKS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL-----PALVLKIMS-GTFA-----  219 (256)
T ss_pred             CCCc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch-----HHHHHHHHh-cCCC-----
Confidence            5432  12235688999999999988899999999999999999999999854321     111111111 1110     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .+    .......+.+++..|++.+|++|||+.|+++
T Consensus       220 ~~----~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         220 PI----SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CC----CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11    1123446778899999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.3e-35  Score=301.10  Aligned_cols=255  Identities=25%  Similarity=0.357  Sum_probs=203.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|+..+.||+|+||+||+|... ++..+++|++.... ......+.+|+++++.++|+|++++.+.+.     .+...+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV-----VGDELW   75 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe-----eCCEEE
Confidence            46888999999999999999964 68899999986432 335677899999999999999999999876     567889


Q ss_pred             EEEeecCCCChhhhhhcCCC-cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGM-KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      +|+|++++++|.+++..... ..+++.....++.|++.||.|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        76 iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            99999999999999976432 57899999999999999999999   899999999999999999999999999998755


Q ss_pred             CCCCcc---ccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          475 PEGITH---LTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       475 ~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ......   ......|+..|+|||++... .++.++||||||+++|||++|+.|+........     ..+.....    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~~~----  223 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTLQND----  223 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-----HHHHhcCC----
Confidence            433221   22345689999999999877 789999999999999999999999964432111     11111111    


Q ss_pred             hhhccCCCCC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEME-LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ...+.... .......+.+++..|++.||++||++.++++
T Consensus       224 --~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         224 --PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             --CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              11111111 1234466788999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.6e-35  Score=307.72  Aligned_cols=256  Identities=21%  Similarity=0.337  Sum_probs=203.7

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .+|+..+.||.|+||.||+|+. .+|+.|++|.+........+.+.+|+++++.++|+|++++++++.     .+...++
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   93 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELFV   93 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEEE
Confidence            3688889999999999999985 478999999997655555677899999999999999999999986     5678999


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++++|.+++.+   ..+++.++..++.+++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~  167 (296)
T cd06655          94 VMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP  167 (296)
T ss_pred             EEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence            9999999999998854   35899999999999999999999   89999999999999999999999999999875543


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......++..|+|||.+.++.++.++|||||||++|||++|+.||.......     ........+ ..     .+
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~-----~~~~~~~~~-~~-----~~  235 (296)
T cd06655         168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIATNG-TP-----EL  235 (296)
T ss_pred             ccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHhcC-Cc-----cc
Confidence            322 1233468899999999999999999999999999999999999985433211     111111111 00     00


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCC
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVP  598 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~  598 (614)
                      .  ........+.+++..|++.+|++||++.++++  .+....+
T Consensus       236 ~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~  277 (296)
T cd06655         236 Q--NPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP  277 (296)
T ss_pred             C--CcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence            0  11122345677889999999999999999883  4444333

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.4e-36  Score=310.60  Aligned_cols=260  Identities=21%  Similarity=0.271  Sum_probs=202.8

Q ss_pred             ccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEee
Q 043267          322 RENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      ....||+|+||.||++... ++..||||.+........+.+.+|+.+++.++|+|++++++.+.     .++..++||||
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv~e~  100 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVVMEF  100 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEEEeC
Confidence            3466999999999999864 68899999987655556677899999999999999999999876     56788999999


Q ss_pred             cCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcc
Q 043267          401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH  480 (614)
Q Consensus       401 ~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~  480 (614)
                      +++++|.+++..   ..+++.++..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||++........ 
T Consensus       101 ~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         101 LEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            999999998843   35899999999999999999999   88999999999999999999999999999875433222 


Q ss_pred             ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCC
Q 043267          481 LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEME  560 (614)
Q Consensus       481 ~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~  560 (614)
                      ......|+..|+|||......++.++||||||+++|||++|+.|+........     . ..+..     ........  
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~-~~~~~-----~~~~~~~~--  240 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA-----M-RRIRD-----NLPPRVKD--  240 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----H-HHHHh-----cCCCcccc--
Confidence            22335689999999999988999999999999999999999999853321110     0 11111     11111111  


Q ss_pred             cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH-hhccCCCCCchhhH
Q 043267          561 LPEMMEQYVLTAAICAHPILQARPTMDQIVKI-LETDVPLSNIKIFL  606 (614)
Q Consensus       561 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~-L~~~~~~p~~p~~~  606 (614)
                      .......+..++..|++.+|++|||++|+++. +-.....|+.+.|+
T Consensus       241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~~~~~~  287 (292)
T cd06658         241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPSCIVPL  287 (292)
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCccccchh
Confidence            11223356677888999999999999999864 22334555555554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-35  Score=302.61  Aligned_cols=262  Identities=22%  Similarity=0.270  Sum_probs=197.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||.||+|+.+ +|+.||+|++....  ....+.+.+|+++++.++|+|++++++++.     .+...
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence            36788899999999999999976 68999999986432  223456789999999999999999999886     55678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++++|..++...  ..+++..+++++.|++.||+|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceec
Confidence            9999999998888876443  36899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH-------H---HHH
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA-------W---ELV  543 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~-------~---~~~  543 (614)
                      ..... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. +....       .   +.+
T Consensus       151 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQ-LYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCChHHhhhc
Confidence            44321 2223457889999999876 5688999999999999999999999864332111 00000       0   000


Q ss_pred             HcCCchh-hhhccCCCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          544 KEGKTLD-VIEENMPEME-----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       544 ~~g~~~~-~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+.... ...+......     .......+.+++..|++.+|++||++.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000000 0000000000     1122456788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.3e-35  Score=306.79  Aligned_cols=251  Identities=22%  Similarity=0.310  Sum_probs=199.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|+..+.||+|+||.||+|+.. ++..|++|.+...+....+.+.+|+++++.++|+|++++++.+.     .+...++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY-----WDGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEE-----eCCeEEE
Confidence            45778889999999999999975 58899999998766666778999999999999999999999886     4567899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++++|..++.+.. ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          87 MIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999999988876533 46899999999999999999999   89999999999999999999999999999875433


Q ss_pred             CCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          477 GITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      .. .......++..|+|||++.     ...++.++||||||+++|||++|+.|+......     ..... ......   
T Consensus       163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-----~~~~~-~~~~~~---  232 (292)
T cd06644         163 TL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM-----RVLLK-IAKSEP---  232 (292)
T ss_pred             cc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH-----HHHHH-HhcCCC---
Confidence            21 1223456889999999885     345788999999999999999999998543211     11111 111111   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        +...  ........+.+++..|++.+|++||++.++++
T Consensus       233 --~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 --PTLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             --ccCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              0111  11223346778899999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.1e-36  Score=316.56  Aligned_cols=201  Identities=25%  Similarity=0.334  Sum_probs=171.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.+ +++.+|+|.+.+.   .......+.+|+.++..++|+||+++.+++.     +...
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQ-----DENN   75 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cCCE
Confidence            36888899999999999999975 5788999998642   1223345888999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchhee
Confidence            899999999999999997532 46899999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      .............||+.|+|||++.     .+.++.++|||||||++|||++|+.||..
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence            5433333334467999999999986     35689999999999999999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-36  Score=303.51  Aligned_cols=259  Identities=28%  Similarity=0.367  Sum_probs=203.5

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccC-CCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVP-LEG  391 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~-~~~  391 (614)
                      ..+++|+..+.||+|+||.||+|..+ +++.+++|.+..... ..+++.+|+++++++ +|+|++++++++..... ..+
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35678999999999999999999975 678999999876433 456789999999999 79999999999875432 235


Q ss_pred             ceEEEEEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      ...++||||+++++|.+++....  ...+++..+..++.|+++||.|||   +.+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCc
Confidence            66899999999999999986533  467999999999999999999999   8999999999999999999999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      ++........ ......|+..|+|||.+..     ..++.++||||||+++|||++|+.|+....... .    . ..+.
T Consensus       159 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~----~-~~~~  231 (275)
T cd06608         159 VSAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR-A----L-FKIP  231 (275)
T ss_pred             cceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH-H----H-HHhh
Confidence            9876543222 2233568999999998753     357789999999999999999999985332111 0    0 1111


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .+..     +.+.  ........+.+++..|+..||++|||+.|+++
T Consensus       232 ~~~~-----~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         232 RNPP-----PTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             ccCC-----CCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1111     1111  11224456788999999999999999999976

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.8e-36  Score=305.86  Aligned_cols=262  Identities=23%  Similarity=0.310  Sum_probs=197.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||.||++..+ +++.||+|++....  ....+.+.+|+++++.++|+|++++++++.     .+...
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   75 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFR-----RKKRL   75 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcc-----cCCeE
Confidence            36788899999999999999975 58999999886432  223456889999999999999999999986     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|+||+++++|.++....  ..++|.+++.++.|+++||.|||   +.+++||||+|+||++++++.+||+|||++...
T Consensus        76 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          76 YLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            9999999999998876443  35899999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH----------HHHH
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA----------WELV  543 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~----------~~~~  543 (614)
                      .... .......++..|+|||+..+ ..++.++||||||+++|||++|+.|+....... .+.+..          ....
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDID-QLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHH-HHHHHHHHhCCCchhhHHHh
Confidence            4432 22333567899999999875 457889999999999999999998885322110 000000          0000


Q ss_pred             HcCCch-hhhhccCCCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          544 KEGKTL-DVIEENMPEM-----ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       544 ~~g~~~-~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...... ....+.....     ..+.....+.+++..|++.+|++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000 0000000000     01123456888999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.7e-36  Score=317.65  Aligned_cols=240  Identities=26%  Similarity=0.282  Sum_probs=186.3

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHH-HHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVE-IIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+++.. +++.||+|++....   .....++..|.. +++.++|+||+++++++.     +++..++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            46999999999999965 67889999987422   122334444444 567889999999999886     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.....++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        76 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-  149 (325)
T cd05602          76 DYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-  149 (325)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-
Confidence            999999999999653  35788888899999999999999   899999999999999999999999999999753221 


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      ........||+.|+|||++.+..++.++||||+||++|||++|+.||.....     .+.. +.+..+..      .   
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~-~~i~~~~~------~---  214 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMY-DNILNKPL------Q---  214 (325)
T ss_pred             CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH-----HHHH-HHHHhCCc------C---
Confidence            1123446799999999999999999999999999999999999999964321     1111 11111110      0   


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                       ..+.....+.+++..|++.+|.+||++.+.+
T Consensus       215 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         215 -LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             -CCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence             1122334567888889999999999987533

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.9e-36  Score=318.78  Aligned_cols=238  Identities=26%  Similarity=0.297  Sum_probs=186.7

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHH-HHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVE-IIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~-il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+++.. +|+.||+|++...   ......++..|.. +++.++||||+++++++.     .+...++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----cCCEEEEEE
Confidence            46999999999999964 7899999999643   2223345556655 467789999999998886     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.....++.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        76 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-  149 (325)
T cd05604          76 DFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-  149 (325)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-
Confidence            999999999988643  46899999999999999999999   899999999999999999999999999998743221 


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      ........||+.|+|||.+.++.++.++|||||||++|||++|+.||.....     .+.. +.+..+..      .+. 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~-~~~~~~~~------~~~-  216 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV-----AEMY-DNILHKPL------VLR-  216 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH-----HHHH-HHHHcCCc------cCC-
Confidence            1123445799999999999999999999999999999999999999954321     1111 11111111      111 


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMDQ  588 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  588 (614)
                         +.....+.+++..|++.+|++||++.+
T Consensus       217 ---~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         217 ---PGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             ---CCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence               123345677888999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.4e-36  Score=316.17  Aligned_cols=237  Identities=27%  Similarity=0.295  Sum_probs=185.5

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHH-HHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVE-IIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~-il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      ++||+|+||.||+++.. +|+.||+|++....   .....++..|.. +++.++||||+++++++.     +.+..++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~-----~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQ-----TAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCEEEEEE
Confidence            46999999999999975 68899999987432   222334555554 578899999999998876     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.+...++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++..... 
T Consensus        76 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  149 (321)
T cd05603          76 DYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-  149 (321)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-
Confidence            999999999888653  46888999999999999999999   899999999999999999999999999998753221 


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.....     .... +.+..+.      ..++ 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~-~~i~~~~------~~~~-  216 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV-----SQMY-DNILHKP------LQLP-  216 (321)
T ss_pred             CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH-----HHHH-HHHhcCC------CCCC-
Confidence            1223445789999999999999999999999999999999999999954321     1111 1111111      0111 


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMD  587 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  587 (614)
                         ......+.+++..|++.+|.+||+..
T Consensus       217 ---~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         217 ---GGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence               22334677889999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.4e-36  Score=316.39  Aligned_cols=254  Identities=20%  Similarity=0.257  Sum_probs=194.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .......+.+|+.++..++|+||+++.+++.     +++.
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~-----~~~~   75 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQ-----DENY   75 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence            46888999999999999999965 6788999998642   2233455888999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++.... ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          76 LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceee
Confidence            899999999999999997532 46899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      .............||+.|+|||++..     +.++.++||||||+++|||++|+.||.....     .+........+..
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~-----~~~~~~i~~~~~~  226 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL-----VETYGKIMNHEER  226 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH-----HHHHHHHHcCCCc
Confidence            55433333334579999999999875     5688999999999999999999999954321     1111111111111


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQA--RPTMDQIVK  591 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~  591 (614)
                      .     .++. ...+..+.+.+++..|+..++.+  |++++++++
T Consensus       227 ~-----~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 F-----QFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             c-----cCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0     0111 11122345666777777655433  568887764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.7e-35  Score=302.37  Aligned_cols=261  Identities=22%  Similarity=0.264  Sum_probs=199.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|+||.||+|+.. +|+.||||++....  ......+.+|++++++++|+|++++++++.     .+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            4777899999999999999964 78999999997543  333567899999999999999999999886     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||+ +++|.+++.... ..+++.++++++.|+++||+|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            999999 999999987644 56999999999999999999999   8899999999999999999999999999998665


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC-------
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK-------  547 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~-------  547 (614)
                      ...........|+..|+|||.+.+. .++.++||||+|++++||++|+.++......  ....+.........       
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI--EQLAIVFRTLGTPNEETWPGL  228 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH--HHHHHHHHHcCCCChHHHhhc
Confidence            4332233445689999999988754 4689999999999999999997777432211  11111111000000       


Q ss_pred             --chhhhhccCCC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 --TLDVIEENMPE-------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 --~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ..+......+.       ...++....+.+++..|++.+|++|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence              00000000000       001123467888999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-35  Score=315.17  Aligned_cols=264  Identities=21%  Similarity=0.221  Sum_probs=196.9

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~  392 (614)
                      .++|...+.||+|+||.||++... .++.||||++...  .......+.+|+.+++.++||||+++++++...... +..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            467999999999999999999964 6889999999743  233445678999999999999999999987543221 234


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++ +|.+.+.    ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHH----hcCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            57999999964 7777763    24889999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH----------HHHH
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW----------AWEL  542 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~----------~~~~  542 (614)
                      .....  .......||..|+|||++.+..++.++|||||||++|||++|+.||....... .+...          .+..
T Consensus       175 ~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         175 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             ccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHh
Confidence            65432  12234568999999999999999999999999999999999999995432110 00000          0000


Q ss_pred             HHcCCchhhhhcc-----------CC-------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          543 VKEGKTLDVIEEN-----------MP-------EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       543 ~~~g~~~~~~d~~-----------l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      +... .....+..           .+       ..........+.+++..|++.||.+|||+.|+++.
T Consensus       252 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         252 LQPT-VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhHH-HHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0000 00000000           00       00011123467889999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-35  Score=299.84  Aligned_cols=251  Identities=22%  Similarity=0.327  Sum_probs=194.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-----hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-----KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|...+.||+|+||.||+|... +|+.||||.+....     ....+.+.+|++++++++|+|++++++++...   .+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDP---ME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccC---CC
Confidence            47888999999999999999965 68999999885321     22345788899999999999999999987532   23


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...+++|||+++++|.+++.+.  ..+++...++++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            5678999999999999998654  35889999999999999999999   889999999999999999999999999998


Q ss_pred             eeCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +.......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.|+......    .. ..+.....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~-~~~~~~~~---  225 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AA-IFKIATQP---  225 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HH-HHHHhcCC---
Confidence            75432111  1123346889999999999889999999999999999999999998543211    00 00111000   


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            .....+......+..++..|+. +|++||+++|+++
T Consensus       226 ------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 ------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             ------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                  0111123344556677777884 8999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.5e-35  Score=301.05  Aligned_cols=261  Identities=24%  Similarity=0.240  Sum_probs=203.0

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|++|.||++... +++.+|+|.+.... .....++.+|++++++++||||+++++++...   .....+
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   77 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIG   77 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEE
Confidence            36788899999999999999975 68899999987432 34456789999999999999999999988532   345689


Q ss_pred             EEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +||||+++++|.+++..  .....+++.....|+.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++..
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~  154 (287)
T cd06621          78 IAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGE  154 (287)
T ss_pred             EEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccc
Confidence            99999999999998754  23456899999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .....   .....++..|+|||.+.+..++.++||||+|+++|||++|+.|+...........+.. .......... +.
T Consensus       155 ~~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~-~~  229 (287)
T cd06621         155 LVNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPNPE-LK  229 (287)
T ss_pred             ccccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCchh-hc
Confidence            43322   1234578899999999999999999999999999999999999964422111111111 1111111111 11


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .....  .....+.+.+++..|++.+|++|||+.|+++
T Consensus       230 ~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         230 DEPGN--GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             cCCCC--CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            11110  1123457889999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.4e-35  Score=304.63  Aligned_cols=268  Identities=23%  Similarity=0.343  Sum_probs=211.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++|||++++++++.     ..+..++
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~l   93 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL-----VGDELWV   93 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee-----eCCcEEE
Confidence            57888899999999999999854 68899999987555555677899999999999999999999886     4567899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++++|.+++.+   ..+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        94 v~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          94 VMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             EEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            9999999999999854   35889999999999999999999   89999999999999999999999999999875543


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......|++.|+|||.+..+.++.++||||||+++||+++|+.||.........     ......+..      ..
T Consensus       168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~------~~  235 (293)
T cd06647         168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLIATNGTP------EL  235 (293)
T ss_pred             ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe-----eehhcCCCC------CC
Confidence            222 223346889999999999889999999999999999999999999643321110     011111110      01


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhccCCCCCchhhHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI--LETDVPLSNIKIFLAALL  610 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p~~~~~~~  610 (614)
                      .  ........+.+++..|++.+|++||++.++++.  +....+..++|.-+++.-
T Consensus       236 ~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~~~~~~~  289 (293)
T cd06647         236 Q--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTPLIAAAK  289 (293)
T ss_pred             C--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccchHHHhh
Confidence            1  112233457788899999999999999999954  566666666665555443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-35  Score=304.70  Aligned_cols=251  Identities=24%  Similarity=0.348  Sum_probs=197.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +|+..+.||+|+||.||++..+ +|..||+|.++.. .......+.+|++++++++|+|++++++.+.     .....++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            5777889999999999999975 7899999988753 3334567889999999999999999999876     5678899


Q ss_pred             EEeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          397 VCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      |+||+++++|.+++.... ...+++..+.+++.+++.||.|||+  +.+++||||||+||+++.++.+||+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            999999999999886532 3468999999999999999999993  3589999999999999999999999999987543


Q ss_pred             CCCccccccccCCCCcCchhhhccC------CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG------KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~------~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ..   ......++..|+|||.+.+.      .++.++|||||||++|||++|+.||.......  ... .......+.  
T Consensus       155 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~-~~~~~~~~~--  226 (286)
T cd06622         155 AS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFA-QLSAIVDGD--  226 (286)
T ss_pred             CC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHH-HHHHHhhcC--
Confidence            22   22334688899999998654      35889999999999999999999985432111  000 001111111  


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                             ....+......+..++..|++.+|++||++.+++.
T Consensus       227 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 -------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             -------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence                   11122334566788999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.3e-36  Score=322.71  Aligned_cols=201  Identities=25%  Similarity=0.338  Sum_probs=172.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||.||+++.. +|+.||||.++...   ......+.+|++++..++|+|++++++.+.     ++..
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~-----~~~~   75 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQ-----DKRN   75 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCE
Confidence            36888899999999999999965 68999999997422   233456788999999999999999999876     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          76 LYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            89999999999999999654  36899999999999999999999   89999999999999999999999999999864


Q ss_pred             CCCCCc----------------------------------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHH
Q 043267          474 NPEGIT----------------------------------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL  519 (614)
Q Consensus       474 ~~~~~~----------------------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ell  519 (614)
                      ......                                  .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            322100                                  0112357999999999999999999999999999999999


Q ss_pred             hCCCCcccc
Q 043267          520 SGKKACEII  528 (614)
Q Consensus       520 tG~~p~~~~  528 (614)
                      +|+.||...
T Consensus       231 tG~~Pf~~~  239 (360)
T cd05627         231 IGYPPFCSE  239 (360)
T ss_pred             cCCCCCCCC
Confidence            999999643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.3e-35  Score=299.90  Aligned_cols=252  Identities=21%  Similarity=0.343  Sum_probs=199.1

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCC------hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS------KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~------~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +|+..+.||+|+||.||++.. .+++.||+|.+....      ....+.+.+|++++++++|+|++++++++.     ++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATC-----ED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceec-----cC
Confidence            477889999999999999985 578999999986432      123467889999999999999999999986     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCC
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGL  470 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGl  470 (614)
                      +..++|+||+++++|.+++.+.  ..+++..+.+++.|++.||.|||   +.+++||||||+||+++.++ .+||+|||+
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            7889999999999999999653  36899999999999999999999   89999999999999998776 599999999


Q ss_pred             ceeCCCCCc---cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          471 AKFNPEGIT---HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       471 a~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +........   .......|+..|+|||.+.+..++.++||||+|+++|||++|+.|+.......  ...........  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~--  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFKIASA--  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc--hHHHHHHHhcc--
Confidence            876543321   11233568899999999988899999999999999999999999985332211  11111111110  


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                             ......+......+.+++..|++.+|++||++.++++
T Consensus       227 -------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 -------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             -------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                   1111122334457788999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.4e-35  Score=298.50  Aligned_cols=252  Identities=26%  Similarity=0.362  Sum_probs=204.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|+..+.||+|++|.||+++.. +|+.|+||++..... ....++.+|++.+.+++|+|++++++++.     .....+
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEIS   75 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEE
Confidence            36788899999999999999976 589999999876443 44678999999999999999999999986     557899


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      +|+||+++++|.+++...  ..+++..+++++.|+++||+|||   + .+++||||+|+||+++.++.++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~  150 (264)
T cd06623          76 IVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVL  150 (264)
T ss_pred             EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceec
Confidence            999999999999999654  57899999999999999999999   8 99999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ...... .....++..|+|||....+.++.++||||||+++|||++|+.|+......  ...+.. ..+..+        
T Consensus       151 ~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~-~~~~~~--------  218 (264)
T cd06623         151 ENTLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP--SFFELM-QAICDG--------  218 (264)
T ss_pred             ccCCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc--CHHHHH-HHHhcC--------
Confidence            543322 22456789999999999999999999999999999999999998644320  111111 111111        


Q ss_pred             cCCCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          555 NMPEMELPE-MMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       555 ~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      .... .... ..+.+.+++..|++.+|++||++.|+++.
T Consensus       219 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 PPPS-LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCC-CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1111 1112 45678889999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=304.51  Aligned_cols=251  Identities=23%  Similarity=0.302  Sum_probs=200.3

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||.||++... ++..||+|.++.......+.+.+|++++++++|+|++++++.+.     .+...++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence            46888899999999999999975 68999999998766666778999999999999999999999886     5667899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++++|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          80 LIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999999986533 46999999999999999999999   89999999999999999999999999999875433


Q ss_pred             CCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          477 GITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ... ......|++.|+|||.+.     ...++.++||||||+++|||++|+.|+.......     .. ..+..+...  
T Consensus       156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-----~~-~~~~~~~~~--  226 (280)
T cd06611         156 TLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-----VL-LKILKSEPP--  226 (280)
T ss_pred             ccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-----HH-HHHhcCCCC--
Confidence            221 223356899999999875     3457789999999999999999999986432211     01 111111110  


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .+.  ........+.+++..|++.+|.+||++.++++
T Consensus       227 ---~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         227 ---TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             ---CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence               110  01122345677888999999999999999975

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=2.7e-35  Score=298.47  Aligned_cols=251  Identities=28%  Similarity=0.410  Sum_probs=199.8

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|+||.||+|+.. +++.|++|.++....  ...+.+.+|++++++++|+||+++++++.     .....+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV-----HREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe-----cCCEEE
Confidence            4777899999999999999964 789999999875433  35678999999999999999999999875     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||+++++|.+++...  ..+++..+..|+.++++||.|||   +.+++|+||||+||++++++.+||+|||++....
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          76 IFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            999999999999999654  35889999999999999999999   8999999999999999999999999999998655


Q ss_pred             CCCcccc---ccccCCCCcCchhhhccCC---CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          476 EGITHLT---TRVAGTLGYVAPEYALYGK---LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       476 ~~~~~~~---~~~~gt~~Y~APE~~~~~~---~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      .......   ....++..|+|||++....   ++.++||||||+++||+++|+.||.....      .+.........  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~------~~~~~~~~~~~--  222 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN------EFQIMFHVGAG--  222 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc------hHHHHHHHhcC--
Confidence            4332221   2356789999999998776   89999999999999999999999964321      11111111110  


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ..+.++.  .......+.+++..|++.+|++|||+.|+++
T Consensus       223 --~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         223 --HKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             --CCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              0111111  1112445678889999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-35  Score=299.33  Aligned_cols=249  Identities=25%  Similarity=0.342  Sum_probs=200.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|+||.||+|... +|..||+|.+...  +....+.+.+|+++++.++|+|++++++.+.     .+...+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~-----~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ-----ENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec-----cCCeEE
Confidence            4778899999999999999975 6889999998643  2234567889999999999999999999886     566789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGla~~~  474 (614)
                      +|+||+++++|.+++.+.....+++..+..++.|+++||.|||   +.+++|+||||+||++++++ .+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            9999999999999997766567899999999999999999999   88999999999999999885 4699999998765


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ..... ......|++.|+|||+.....++.++||||||+++|||++|+.|+....     ..++..+... +..      
T Consensus       153 ~~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~-~~~------  219 (257)
T cd08225         153 NDSME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-----LHQLVLKICQ-GYF------  219 (257)
T ss_pred             cCCcc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHHHHHHhc-ccC------
Confidence            43322 2223458999999999998899999999999999999999999985322     2223322221 111      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        .. ..+.....+.+++.+|++.+|++|||+.|+++
T Consensus       220 --~~-~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 --AP-ISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --CC-CCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              10 11122346778889999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.5e-35  Score=307.91  Aligned_cols=263  Identities=21%  Similarity=0.286  Sum_probs=195.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+.. +++.||+|.++... ......+.+|++++++++|+||+++++++.     .+...+
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~~   80 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   80 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeEE
Confidence            46888899999999999999865 68899999987432 233456778999999999999999999986     566789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||++ ++|.+++.... ..+++.....++.|+++||.|||   +.+|+||||||+||++++++.+||+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          81 LVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            9999997 68998886543 46899999999999999999999   8999999999999999999999999999997543


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccch---------hhHHHHHHHHc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL---------LSDWAWELVKE  545 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~---------l~~~~~~~~~~  545 (614)
                      .... ......+++.|+|||.+.+. .++.++||||||+++|||++|+.||.........         ..+..|..+..
T Consensus       156 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         156 IPTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            2221 12234578899999988754 5889999999999999999999998543221100         00011111100


Q ss_pred             CC-chhhhhccCCCC----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GK-TLDVIEENMPEM----ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~-~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .. ....-.+.....    ........+.+++..|++.||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00 000000000000    00122345678899999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.2e-35  Score=305.52  Aligned_cols=244  Identities=21%  Similarity=0.276  Sum_probs=195.5

Q ss_pred             cceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          323 ENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|||++++++++.     .++..++++||+
T Consensus        26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~-----~~~~~~iv~e~~  100 (297)
T cd06659          26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL-----VGEELWVLMEFL  100 (297)
T ss_pred             hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhhee-----eCCeEEEEEecC
Confidence            456999999999999864 78999999987655555667889999999999999999999886     567889999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++++|.+++..   ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++........ .
T Consensus       101 ~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~  173 (297)
T cd06659         101 QGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-K  173 (297)
T ss_pred             CCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc-c
Confidence            99999998744   45899999999999999999999   89999999999999999999999999999875443322 1


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......     .. ..+.....     ....  ..
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~~-~~~~~~~~-----~~~~--~~  240 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----AM-KRLRDSPP-----PKLK--NA  240 (297)
T ss_pred             ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HH-HHHhccCC-----CCcc--cc
Confidence            233568999999999999899999999999999999999999985322111     01 11111110     0000  01


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          562 PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ......+.+++..|++.+|++||+++++++
T Consensus       241 ~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         241 HKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            122345678888999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=5.9e-35  Score=292.07  Aligned_cols=249  Identities=30%  Similarity=0.407  Sum_probs=202.4

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .|+..+.||+|++|.||++... ++..+++|++.........++.+|++++++++|+|++++.+++.     .....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL-----KKDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEEEE
Confidence            3677789999999999999975 78999999998755556678999999999999999999999886     45778999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      +||+++++|.+++.... ..+++..+..++.++++||.|||   +.+++||||+|+||++++++.+||+|||.+......
T Consensus        76 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          76 MEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            99999999999986643 57999999999999999999999   899999999999999999999999999999765543


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      ..  .....++..|++||++....++.++||||||++++||++|+.|+......     ..... .......     .+.
T Consensus       152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~-~~~~~~~-----~~~  218 (253)
T cd05122         152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM-----KALFK-IATNGPP-----GLR  218 (253)
T ss_pred             cc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH-----HHHHH-HHhcCCC-----CcC
Confidence            32  33456889999999999888999999999999999999999998643211     11111 1111110     111


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .  .......+.+++..|++.||++|||+.|+++
T Consensus       219 ~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         219 N--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             c--ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1  1111356788899999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-35  Score=301.30  Aligned_cols=259  Identities=23%  Similarity=0.254  Sum_probs=199.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||.||+|+.+ +++.||||+++..  .....+.+.+|++++++++|+|++++++++.     .++..
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   75 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFR-----RKGRL   75 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEE-----ECCEE
Confidence            36888899999999999999976 5889999988642  2334567899999999999999999999986     46678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      +++|||++++.+..++..  ...+++.++..++.++++||.|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        76 ~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          76 YLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            999999998777665533  245899999999999999999999   889999999999999999999999999999866


Q ss_pred             CCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH---------
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK---------  544 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~---------  544 (614)
                      ............++..|+|||++... .++.++||||||+++|||++|+.|+......     +..+....         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~  225 (288)
T cd07833         151 RARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSH  225 (288)
T ss_pred             CCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHH
Confidence            54433233445688999999999888 8899999999999999999999988543221     11111100         


Q ss_pred             ------cCCch--hhhhccC----CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 ------EGKTL--DVIEENM----PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ------~g~~~--~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            .....  +..+...    ...........+.+++..|++.+|++||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         226 QELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             hhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence                  00000  0000000    00011122567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.7e-35  Score=302.59  Aligned_cols=260  Identities=24%  Similarity=0.350  Sum_probs=196.0

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|++|.||+|+.. +|+.||||+++...  ......+.+|++++++++|||++++++++.     ++...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            5788899999999999999865 68999999886432  223357889999999999999999999886     567789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+. ++|.+++.......+++..+..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        76 ~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999995 68999987766678999999999999999999999   8899999999999999999999999999987554


Q ss_pred             CCCccccccccCCCCcCchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccccCccchh---------hHHHHHHHHc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL---------SDWAWELVKE  545 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l---------~~~~~~~~~~  545 (614)
                      .... ......++..|+|||...+.. ++.++||||||+++|||++|+.||..........         .+..|.....
T Consensus       152 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         152 VPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             cCcc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhH
Confidence            3221 123345688999999887644 6889999999999999999999985332211000         0011110000


Q ss_pred             CCchhhhhccCCC---CC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIEENMPE---ME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~---~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      -  .+ .....+.   ..    .+.....+.+++..|++.||++|||++++++
T Consensus       231 ~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         231 L--PD-YKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             H--HH-HHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0  00 0000000   00    0112235678899999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3e-35  Score=314.00  Aligned_cols=251  Identities=25%  Similarity=0.305  Sum_probs=211.9

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh---hhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA---GDANFKHEVEIIASVK-HVNLVALRGYSTATVPLE  390 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~  390 (614)
                      ....|...+.||+|.||.||+++.+ +|+.+|+|.+.+....   ..+.+.+|+.+|+++. |||+|.+.+.+.     .
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e-----~  107 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFE-----D  107 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEE-----c
Confidence            3446888899999999999999976 4999999999764432   3468899999999998 999999999997     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC----CcEEEe
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA----FEAKVG  466 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~----~~~kl~  466 (614)
                      ....++|||++.+|.|.+.|...   .++......++.|++.++.|||   +.+|+||||||+|+|+...    +.+|++
T Consensus       108 ~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~  181 (382)
T KOG0032|consen  108 PDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLI  181 (382)
T ss_pred             CCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEe
Confidence            56899999999999999999766   3999999999999999999999   8999999999999999643    579999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |||++.....  .......+||+.|+|||++....|+..+||||.||++|.|++|..||.........      ..+..+
T Consensus       182 DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~------~~i~~~  253 (382)
T KOG0032|consen  182 DFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF------LAILRG  253 (382)
T ss_pred             eCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH------HHHHcC
Confidence            9999998766  34556789999999999999999999999999999999999999999755532222      123333


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.      .......+...+..-+++..++..||..|+|+.++++
T Consensus       254 ~~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  254 DF------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             CC------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            32      3344445566677788889999999999999999998

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.7e-35  Score=304.98  Aligned_cols=256  Identities=20%  Similarity=0.208  Sum_probs=201.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||++... .++.|++|.+....   ......+.+|+++++.++|+||+++++.+.     .+..
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~   75 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFE-----TKRH   75 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEe-----cCCE
Confidence            36888899999999999999965 57899999987543   233457889999999999999999999876     5667


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++...  ..+++..+..++.++++||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          76 LCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            89999999999999999654  36899999999999999999999   88999999999999999999999999999874


Q ss_pred             CCCCC--------------ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH
Q 043267          474 NPEGI--------------THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       474 ~~~~~--------------~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~  539 (614)
                      .....              ........|+..|+|||++.++.++.++|+||||+++|||++|+.||.....     .++.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~  225 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELF  225 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence            21110              0111234578899999999999999999999999999999999999853221     1111


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       .....+...   .+..    .......+.+++..|++.+|++||+..++.++|+..
T Consensus       226 -~~~~~~~~~---~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~  274 (305)
T cd05609         226 -GQVISDDIE---WPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHR  274 (305)
T ss_pred             -HHHHhcccC---CCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCc
Confidence             111111110   0000    112234567889999999999999988888888764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=6.2e-35  Score=299.47  Aligned_cols=246  Identities=25%  Similarity=0.332  Sum_probs=198.1

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      |+..+.||+|+||.||+|... ++..||||.+.... ......+.+|++++++++|+|++++++++.     ++...++|
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   80 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWII   80 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEEE
Confidence            667788999999999999864 68899999886432 334567889999999999999999999986     56788999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++++|.+++..   ..+++.....++.+++.|+.|||   +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06641          81 MEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  154 (277)
T ss_pred             EEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence            999999999999854   35899999999999999999999   899999999999999999999999999998765432


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      .. ......++..|+|||...+..++.++||||||+++|||++|+.|+......     .+. ..+..+..         
T Consensus       155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~---------  218 (277)
T cd06641         155 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM-----KVL-FLIPKNNP---------  218 (277)
T ss_pred             hh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH-----HHH-HHHhcCCC---------
Confidence            21 223346888999999999889999999999999999999999998532211     111 11111111         


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      ..........+.+++..|++.+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11112233456788899999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.1e-35  Score=309.94  Aligned_cols=264  Identities=23%  Similarity=0.262  Sum_probs=195.3

Q ss_pred             HHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LE  390 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~  390 (614)
                      ...++|...+.||+|+||.||++.. .+++.||||++....  ......+.+|++++++++|+||+++++++..... ..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3456788899999999999999986 468899999986532  2334567789999999999999999998753221 12


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....++++|++ +++|.+++..   ..+++..+..|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~  164 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGL  164 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCcc
Confidence            24578999987 7899887743   46999999999999999999999   89999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH----------
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA----------  539 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~----------  539 (614)
                      ++.....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+..+.          
T Consensus       165 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~  239 (343)
T cd07878         165 ARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPEV  239 (343)
T ss_pred             ceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHHH
Confidence            9865432    233568999999999876 578999999999999999999999985432110 000000          


Q ss_pred             HHHHHcCCchhhhhccCCCCCc-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          540 WELVKEGKTLDVIEENMPEMEL-------PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...+........ ...++....       ......+.+++..|++.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         240 LKKISSEHARKY-IQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhcchhhHHHH-hhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000000 001110000       011234678899999999999999999984

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-35  Score=318.79  Aligned_cols=259  Identities=22%  Similarity=0.207  Sum_probs=194.7

Q ss_pred             hcCccccceecccCceEEEEeEcC---CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP---NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ..+|...+.||+|+||.||++...   .+..||||.+...     ....+|++++++++||||+++++++.     ....
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~-----~~~~  160 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR-----WKST  160 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe-----eCCE
Confidence            457999999999999999999753   4678999988652     23568999999999999999999876     4567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|||++. ++|.+++.  ....+++..++.|+.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       161 ~~lv~e~~~-~~l~~~l~--~~~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVD--RSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEehhcC-CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            899999985 68988883  3357999999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc--hhhHHHHHHHHcCC---
Q 043267          474 NPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV--LLSDWAWELVKEGK---  547 (614)
Q Consensus       474 ~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~l~~~~~~~~~~g~---  547 (614)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .+.... +......   
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~-~~~~~~~~~~  313 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSII-RCMQVHPLEF  313 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHH-HHhccCcccc
Confidence            543322 223346799999999999999999999999999999999999999954332110  010000 0000000   


Q ss_pred             ----ch---hh---hhccCCCCC-c------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          548 ----TL---DV---IEENMPEME-L------PEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       548 ----~~---~~---~d~~l~~~~-~------~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                          ..   +.   ......... .      ......+..++..|++.||++|||+.|++..
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                00   00   000000000 0      0112356678889999999999999999864

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3.8e-35  Score=300.99  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=192.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHH-HHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEI-IASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~i-l~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||.||+++.. +|+.||+|+++... .....++..|++. ++..+|+|++++++++.     .+...
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~-----~~~~~   75 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALF-----REGDV   75 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEe-----cCCcE
Confidence            46888899999999999999975 68999999987532 2334456667665 66679999999999986     55678


Q ss_pred             EEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +++|||++ |+|.+++...  ....+++..+++++.|++.||+|||   +. +++||||||+||+++.++.+||+|||++
T Consensus        76 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~  151 (283)
T cd06617          76 WICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS  151 (283)
T ss_pred             EEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            99999996 7888887642  3357999999999999999999999   65 9999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALY----GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +......  ..+...|+..|+|||.+.+    ..++.++|+||||+++|||++|+.|+.........    ..... .+.
T Consensus       152 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~-~~~  224 (283)
T cd06617         152 GYLVDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ----LKQVV-EEP  224 (283)
T ss_pred             ccccccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH----HHHHH-hcC
Confidence            8654322  1233568899999998864    45789999999999999999999998543221111    11111 111


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ...++.   ......+.+++..|++.+|++||++.++++
T Consensus       225 -----~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         225 -----SPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             -----CCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 111111   122346778899999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.4e-35  Score=302.65  Aligned_cols=262  Identities=23%  Similarity=0.209  Sum_probs=197.0

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh-----hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA-----GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||+|... +|+.||||+++.....     ....+.+|++++++++|+|++++++++.     ++.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            4677889999999999999965 6899999999754322     2345778999999999999999999986     467


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+ +|+|.+++.... ..+++..+.+++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++
T Consensus        76 ~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             EEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeee
Confidence            889999999 999999996543 47999999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH-------HHH
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE-------LVK  544 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~-------~~~  544 (614)
                      ....... ......++..|+|||.+.+ ..++.++||||||+++|||++|..++....... .+......       .+.
T Consensus       151 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         151 SFGSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eccCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhh
Confidence            6654322 2233456788999998865 467899999999999999999977765332211 00000000       000


Q ss_pred             -cCCchhhhhccCCC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          545 -EGKTLDVIEENMPE-----MELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       545 -~g~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                       ..............     .........+.+++..|++.+|++|||+.|+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             00000000000000     0012234577889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-35  Score=303.38  Aligned_cols=261  Identities=20%  Similarity=0.240  Sum_probs=194.2

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|+||.||+|+.. +|+.||+|+++...  ......+.+|++++++++|+|++++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH-----SDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc-----cCCceE
Confidence            4777889999999999999975 68999999986432  222356788999999999999999999876     566789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +++||++ ++|.+++.... ..+++...+.++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        76 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            9999997 58888876533 46999999999999999999999   8999999999999999999999999999998654


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh----------HHHHHHHH
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS----------DWAWELVK  544 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~----------~~~~~~~~  544 (614)
                      .... ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+....+....+.          .+.|..+.
T Consensus       151 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         151 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             CCCC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhh
Confidence            3222 12334578899999998765 478999999999999999999988643222111100          01111111


Q ss_pred             cCCchhhhhccCCC-----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTLDVIEENMPE-----MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .-...... +....     ...+.....+.+++..|++.||.+|||++++++
T Consensus       230 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         230 KLPDYKPY-PMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hccccccc-CCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000 00000     001123456778999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-35  Score=295.48  Aligned_cols=260  Identities=26%  Similarity=0.270  Sum_probs=197.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hh-hHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AG-DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~-~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.|++|.||.||+|+.+ +++.||+|+++-... .+ ----.+||.+|.+.+|||||.+..+....   +-+..|
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~---~~d~iy  153 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGS---NMDKIY  153 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecc---ccceee
Confidence            5777899999999999999975 688999999974321 11 12357899999999999999999887643   456799


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||++. +|...+..-+ +++...+..-+..|+++|++|||   ..-|+|||||++|+|++..|.+||+|||+|+.++
T Consensus       154 ~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  154 IVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             eeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhc
Confidence            99999975 7888776543 68999999999999999999999   9999999999999999999999999999999887


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      +.... .+..+-|.-|.|||.+.+. .|++..|+||+||++.||+++++.|.....-  +..+-+...+  |.-.+.+-+
T Consensus       229 sp~k~-~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~--dQl~~If~ll--GtPte~iwp  303 (419)
T KOG0663|consen  229 SPLKP-YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI--DQLDKIFKLL--GTPSEAIWP  303 (419)
T ss_pred             CCccc-CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchH--HHHHHHHHHh--CCCccccCC
Confidence            65433 4556679999999999865 7999999999999999999999888543321  1111111111  111111111


Q ss_pred             -------------------cCCCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 -------------------NMPEMELPE-MMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 -------------------~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                                         .+...+... ..+.-.++....+..||.+|.|++|.++
T Consensus       304 g~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  304 GYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                               111111111 2245566777789999999999999874

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-35  Score=299.23  Aligned_cols=247  Identities=23%  Similarity=0.377  Sum_probs=197.3

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHcc---ccceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVK---HVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~---H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .|+..+.||+|+||.||+|+. .+|+.||+|.+... ......++.+|++++++++   |+|++++++++.     ++..
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            467778999999999999996 47899999998643 3344567889999999997   999999999886     5677


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++...   .+++...+.++.++++||.|||   +.+++||||+|+||++++++.++|+|||++..
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            89999999999999998543   6899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ....... .....|+..|+|||.+.++ .++.++||||||+++|||++|+.|+......     .+.. .....     .
T Consensus       151 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-----~~~~-~~~~~-----~  218 (277)
T cd06917         151 LNQNSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF-----RAMM-LIPKS-----K  218 (277)
T ss_pred             cCCCccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh-----hhhh-ccccC-----C
Confidence            6543322 2334689999999998764 4689999999999999999999998543211     1110 00010     1


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .+.+...   .....+.+++..|++.||++||++.++++
T Consensus       219 ~~~~~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         219 PPRLEDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             CCCCCcc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            1112211   13446778888999999999999999985

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-35  Score=300.36  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=194.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|+..+.||+|++|.||+|+.+ +++.||||.+..... .....+.+|++++++++|+||+++++++.     ++...+
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIH-----TKKTLT   79 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEe-----cCCeEE
Confidence            46888899999999999999975 689999999865322 22345778999999999999999999986     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||++ ++|.+++.... ..+++.....++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++...
T Consensus        80 lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          80 LVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccC
Confidence            9999998 49999886544 37899999999999999999999   8999999999999999999999999999987533


Q ss_pred             CCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch-----
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL-----  549 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~-----  549 (614)
                      .... ......++..|+|||...+ ..++.++||||+|+++|||++|+.||.........+ ...+..+......     
T Consensus       155 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         155 VPSK-TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL-HKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             CCCc-cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH-HHHHHhcCCCChhhhhhh
Confidence            2111 1122346889999998875 468999999999999999999999985433111000 0011111000000     


Q ss_pred             ----------------hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 ----------------DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ----------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                                      ..+......   ......+.+++..|++.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPR---LDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hhccccccccccccCChhHHHhCcC---CCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                            000000000   011246678899999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-35  Score=300.08  Aligned_cols=269  Identities=23%  Similarity=0.285  Sum_probs=205.0

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeec--CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~--~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ...|...+.||+|+||.|.+++.. +|..||||++.+  .+....+.-.+|+++++.++|+||+.++.....+...+-+.
T Consensus        21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D  100 (359)
T KOG0660|consen   21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND  100 (359)
T ss_pred             cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence            345555688999999999999964 789999999974  33444567789999999999999999999887644445678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .|+|+|+| .-+|...|+.+  +.|+......+.+|+.+||.|+|   +.+|+|||+||+|+|++.+...||+|||+|+.
T Consensus       101 vYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  101 VYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             eEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence            99999999 45888888543  35999999999999999999999   99999999999999999999999999999997


Q ss_pred             CCCCC-ccccccccCCCCcCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc-h--------hhHHHHHH
Q 043267          474 NPEGI-THLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV-L--------LSDWAWEL  542 (614)
Q Consensus       474 ~~~~~-~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~--------l~~~~~~~  542 (614)
                      ..... ....+..+.|..|.|||... ...||...||||.||++.||++|+.-|.+...-+. .        -.+.....
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            75431 12335667899999999886 45899999999999999999999988853321110 0        01122233


Q ss_pred             HHcCCchhhhhccCC--CCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          543 VKEGKTLDVIEENMP--EME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +...+....+.....  ...    .+......++++..|+..||.+|+|++|.++
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            333333333221111  111    1223345678888999999999999999984

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-35  Score=301.75  Aligned_cols=261  Identities=22%  Similarity=0.272  Sum_probs=196.0

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      |+..+.||+|++|.||+|... +|..||+|++....  ......+.+|++++++++|+|++++++++.     ++...++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            566788999999999999964 79999999987432  223356889999999999999999999986     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      +|||++ ++|.+++.......+++..+++++.|+++||+|||   +.+++||||+|+||+++.++.+||+|||+++....
T Consensus        76 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            999995 79999987655567999999999999999999999   88999999999999999999999999999975543


Q ss_pred             CCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhH----------HHHHHHHc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD----------WAWELVKE  545 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~----------~~~~~~~~  545 (614)
                      ... ......++..|+|||++.+. .++.++||||||+++|||++|+.||........ +..          ..|..+..
T Consensus       152 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         152 PVR-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ-LFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             Ccc-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhhhhh
Confidence            221 12233568899999987764 578999999999999999999999854322110 000          11111000


Q ss_pred             C-Cchhhhhc---cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 G-KTLDVIEE---NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g-~~~~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      - ........   .......+.....+.+++..|++.+|++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0 00000000   0000011223356788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=6.3e-35  Score=300.62  Aligned_cols=252  Identities=24%  Similarity=0.343  Sum_probs=202.8

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .+++|+..+.||+|+||.||+|..+ ++..|++|+++.... ..+.+.+|+++++.++|+|++++++++.     .+...
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~   90 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYL-----VGDEL   90 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEE-----ECCEE
Confidence            4567888899999999999999986 689999999976444 5667889999999999999999999887     45788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++++||+++++|.+++.... ..+++..+..++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~  166 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL  166 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence            99999999999999997654 47999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ..... ......++..|++||.+.+..++.++||||||+++|||++|+.|+.......     .... +..+...     
T Consensus       167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~-----~~~~-~~~~~~~-----  234 (286)
T cd06614         167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR-----ALFL-ITTKGIP-----  234 (286)
T ss_pred             ccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH-----HHHH-HHhcCCC-----
Confidence            33211 2233457889999999998899999999999999999999999985432211     0111 1111110     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...  ........+.+++..|++.+|.+||++.++++
T Consensus       235 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         235 PLK--NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             CCc--chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence            011  11113346778899999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.1e-36  Score=305.29  Aligned_cols=264  Identities=23%  Similarity=0.278  Sum_probs=195.9

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +-.|...+++|.|+||.||+|++. ++.+||||++....+    .-.+|+++|+++.|||||+|+-++......++-...
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            345777899999999999999965 578999999865332    224699999999999999999887765432234567


Q ss_pred             EEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-CcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-~~~kl~DFGla~  472 (614)
                      +||||||. +|.+.+..  ..+..++...+.-+..|+.+||.|||   +.+|+||||||.|+|+|.+ |.+||+|||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            89999986 89988864  23456787888889999999999999   8999999999999999965 999999999999


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH-------HHHH
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW-------ELVK  544 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~-------~~~~  544 (614)
                      ....+....  ...-|..|.|||.+.+. .|+.+.||||.||++.||+-|+.-|...++.+. +...+.       +.+.
T Consensus       175 ~L~~~epni--SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ-L~eIik~lG~Pt~e~I~  251 (364)
T KOG0658|consen  175 VLVKGEPNI--SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ-LVEIIKVLGTPTREDIK  251 (364)
T ss_pred             eeccCCCce--eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH-HHHHHHHhCCCCHHHHh
Confidence            876554432  23357889999998864 899999999999999999999998865433221 111110       1111


Q ss_pred             cCCc--hhhhhccCCCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKT--LDVIEENMPEM-----ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~--~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....  .+.-.+.+...     .........++++..+++.+|.+|.++.|++.
T Consensus       252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1000  01111111111     12234456788899999999999999999883

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-36  Score=314.38  Aligned_cols=240  Identities=25%  Similarity=0.264  Sum_probs=184.9

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc---cccceeeeeeeeecccCCCCceEEEEE
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV---KHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l---~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      ||+|+||+||+|+.. +|+.||||++....   ......+..|..++...   +||||+++++++.     +....++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~-----~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQ-----TDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEe-----cCCeEEEEE
Confidence            799999999999965 68999999986422   12233455677777665   6999999998876     567789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        76 e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          76 DYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             cCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            999999999998653  46899999999999999999999   8999999999999999999999999999987533221


Q ss_pred             ccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                       .......||..|+|||.+.+. .++.++||||+||++|||++|+.||.....      ......+..+..      .++
T Consensus       151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~------~~~~~~i~~~~~------~~~  217 (330)
T cd05586         151 -KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT------QQMYRNIAFGKV------RFP  217 (330)
T ss_pred             -CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH------HHHHHHHHcCCC------CCC
Confidence             123346799999999998765 489999999999999999999999854221      111222222221      111


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARP----TMDQIVK  591 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~eVl~  591 (614)
                      ..   .....+.+++..|++.||.+||    ++.++++
T Consensus       218 ~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 KN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             Cc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            11   1234566788899999999998    4555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.3e-35  Score=303.38  Aligned_cols=246  Identities=28%  Similarity=0.386  Sum_probs=194.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ..|...+.||+|+||.||+|+.. +|+.||+|.+....   .....++.+|+++++.++|||++++.+++.     .+..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~-----~~~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL-----REHT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE-----eCCe
Confidence            34777889999999999999965 68999999986432   233457889999999999999999999987     5567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|+||++ |+|.+++.... ..+++..+..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++..
T Consensus        90 ~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCccee
Confidence            899999996 67877775433 46999999999999999999999   89999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ....     ....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+......     ...... ..+.   
T Consensus       165 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~-----~~~~~~-~~~~---  230 (307)
T cd06607         165 VSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYHI-AQND---  230 (307)
T ss_pred             cCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH-----HHHHHH-hcCC---
Confidence            4432     2346788999999874   467889999999999999999999998533211     111111 1110   


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                           .+..........+.+++..||+.+|++||++.++++.
T Consensus       231 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         231 -----SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             -----CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                 1111122334568889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-36  Score=321.80  Aligned_cols=246  Identities=25%  Similarity=0.348  Sum_probs=203.8

Q ss_pred             cceecccCceEEEEeEcC--CCc--EEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          323 ENIIGKGGYGNVYKGMLP--NGT--EVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~--~g~--~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .++||+|.||.|++|.|.  +|+  .||||.++..... ...+|.+|+.+|.+|+|+|+++|+|+..      +....+|
T Consensus       115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl------~qp~mMV  188 (1039)
T KOG0199|consen  115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVL------DQPAMMV  188 (1039)
T ss_pred             HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeec------cchhhHH
Confidence            478999999999999975  444  5899999865543 6788999999999999999999999974      3567899


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      +|+++.|||.+.|++.....|-......++.|||.|+.||.   .+++|||||.++|+||-....+||+||||.+.++.+
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            99999999999999866677888888999999999999999   999999999999999999999999999999977654


Q ss_pred             Ccc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          478 ITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       478 ~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ..+  ......-...|.|||.+..++++.+||||+|||++|||+| |..||....+.++               .+.+|.
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qI---------------L~~iD~  330 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQI---------------LKNIDA  330 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHH---------------HHhccc
Confidence            433  2222334678999999999999999999999999999999 8888865443221               223332


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      .-.-..+....+++.++++.||..+|++|||+..+.+.
T Consensus       331 ~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  331 GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence            22222345667889999999999999999999999743

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=3.9e-35  Score=302.21  Aligned_cols=253  Identities=27%  Similarity=0.362  Sum_probs=192.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|+||.||+++.. +|+.||+|.+.... ......+.+|+.++.++. |+||+++++++.     .+...+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~-----~~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF-----REGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe-----cCCcEE
Confidence            3455678999999999999964 68999999986432 344567889999999996 999999999876     456788


Q ss_pred             EEEeecCCCChhhh---hhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDH---LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~---L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ++|||++ +++.++   +.......+++....+++.++++||+|||+  +.+++||||||+||++++++.+||+|||+++
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            9999986 455543   333344679999999999999999999993  3589999999999999999999999999997


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYG---KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      .......  .....|+..|+|||.+...   .++.++||||||+++|||++|+.||.....    ......+.. .+.  
T Consensus       157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~-~~~--  227 (288)
T cd06616         157 QLVDSIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS----VFDQLTQVV-KGD--  227 (288)
T ss_pred             HhccCCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch----HHHHHhhhc-CCC--
Confidence            5443221  2334588999999998876   689999999999999999999999854321    111111111 111  


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .+.+...........+.+++..|++.+|++|||+.+|++
T Consensus       228 ---~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         228 ---PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             ---CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               112222222234557888999999999999999999885

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=8e-35  Score=300.45  Aligned_cols=247  Identities=21%  Similarity=0.294  Sum_probs=198.7

Q ss_pred             ccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      |...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|+|++++++++.     .+...++++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~-----~~~~~~~v~   95 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL-----VGDELWVVM   95 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEE-----cCCeEEEEE
Confidence            44457899999999999996 478999999987655555667889999999999999999999876     567789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++++|.+++..   ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||.+.......
T Consensus        96 e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~  169 (285)
T cd06648          96 EFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV  169 (285)
T ss_pred             eccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence            99999999999865   35899999999999999999999   8999999999999999999999999999887544322


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      . ......|++.|+|||...+..++.++||||||+++|||++|+.|+.....     .... .....+.     .+.+..
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~-----~~~~-~~~~~~~-----~~~~~~  237 (285)
T cd06648         170 P-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP-----LQAM-KRIRDNL-----PPKLKN  237 (285)
T ss_pred             c-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH-----HHHH-HHHHhcC-----CCCCcc
Confidence            2 12334689999999999988999999999999999999999999853221     1111 1111111     011111


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        .......+.+++..|++.+|++||++.++++
T Consensus       238 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         238 --LHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence              1123456888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=302.31  Aligned_cols=266  Identities=23%  Similarity=0.304  Sum_probs=195.6

Q ss_pred             CccccceecccCceEEEEeEcC---CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP---NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||+|+..   +++.||+|.+....   ....+.+.+|++++++++|||++++++++...   ++.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            4677889999999999999974   47899999997632   33345678899999999999999999998732   236


Q ss_pred             eEEEEEeecCCCChhhhhhcC---CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC----CCcEEE
Q 043267          393 QRIIVCDLLHNGSLYDHLFGS---GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE----AFEAKV  465 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~---~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~----~~~~kl  465 (614)
                      ..++||||+++ +|.+++...   ....+++.....|+.|++.||.|||   +.+|+||||||+||+++.    ++.+||
T Consensus        78 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl  153 (316)
T cd07842          78 SVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKI  153 (316)
T ss_pred             eEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEE
Confidence            78999999975 777766432   2236899999999999999999999   899999999999999999    999999


Q ss_pred             eecCCceeCCCCCc--cccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccc--------h
Q 043267          466 GDFGLAKFNPEGIT--HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV--------L  534 (614)
Q Consensus       466 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--------~  534 (614)
                      +|||+++.......  .......++..|+|||.+.+. .++.++||||||++++||++|+.|+........        .
T Consensus       154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~  233 (316)
T cd07842         154 GDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQ  233 (316)
T ss_pred             CCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHH
Confidence            99999986543322  123345678999999988764 589999999999999999999999954433220        0


Q ss_pred             hhHH----------HHHHHHcC-Cchhhhhc----cCCCCCcH-------HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          535 LSDW----------AWELVKEG-KTLDVIEE----NMPEMELP-------EMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       535 l~~~----------~~~~~~~g-~~~~~~d~----~l~~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +...          .|...... ......+.    ..+.....       ....++.+++..|++.||++|||+.|+++
T Consensus       234 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         234 LERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000          00000000 00000000    00000000       22346788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.2e-34  Score=299.38  Aligned_cols=264  Identities=23%  Similarity=0.289  Sum_probs=194.8

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|+++++.++|+|++++.+++.     .+..
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~   77 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKET   77 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCe
Confidence            4568999999999999999999864 689999999875332 23346788999999999999999999886     5567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|+||+. ++|.+++.... ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++++||+|||+++.
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  152 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARA  152 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccc
Confidence            899999995 78877775433 45788899999999999999999   88999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC------
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG------  546 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g------  546 (614)
                      ..... .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.........+.. .|..+...      
T Consensus       153 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (291)
T cd07870         153 KSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK-IWTVLGVPTEDTWP  230 (291)
T ss_pred             cCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH-HHHHcCCCChhhhh
Confidence            43221 112234578999999998764 5889999999999999999999999643321111100 11100000      


Q ss_pred             ---CchhhhhccC----CCCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 ---KTLDVIEENM----PEME-----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ---~~~~~~d~~l----~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ......+...    +...     .......+.+++..|++.||++|||+.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               0000000000    0000     0011345667889999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.1e-34  Score=289.34  Aligned_cols=252  Identities=28%  Similarity=0.392  Sum_probs=203.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|++|.||+|+.. +++.|++|.+....  ....+.+.+|++++++++|+|++++++.+...   .....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDE---EKNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecC---CCCeEE
Confidence            4677899999999999999976 78999999987543  24567889999999999999999999988632   126789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +++||+++++|.+++....  .+++..+..++.++++||+|||   +.+++|+||+|+||+++.++.+||+|||.+....
T Consensus        78 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          78 IFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            9999999999999997654  8999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          476 EGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       476 ~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ..... ......++..|+|||.......+.++||||||++++||++|+.|+.....    .....+.....+..      
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~------  222 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN----PMAALYKIGSSGEP------  222 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----hHHHHHhccccCCC------
Confidence            44321 12345688999999999988899999999999999999999999864431    11111111110111      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ...+......+.+++..|++.+|++||++.++++
T Consensus       223 ---~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 ---PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence               1111222456788889999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=305.49  Aligned_cols=270  Identities=24%  Similarity=0.311  Sum_probs=200.5

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +++|...+.||+|+||.||+|+. .+|+.||||+++... ......+.+|+.++++++|+|++++++++...........
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46899999999999999999985 478999999986432 2344568889999999999999999998765433334568


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++++||++ ++|.+.+..   ..+++..+..++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeec
Confidence            99999996 488877743   46999999999999999999999   899999999999999999999999999999765


Q ss_pred             CCCCcc--ccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH-------
Q 043267          475 PEGITH--LTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK-------  544 (614)
Q Consensus       475 ~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~-------  544 (614)
                      ......  ......||..|+|||.+.+ ..++.++||||+|+++|||++|+.||......  ...........       
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~--~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL--HQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHcCCCCHHHH
Confidence            432221  2233568999999998765 56899999999999999999999998532210  00000000000       


Q ss_pred             ----cCCchhhhhccCCCCC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 043267          545 ----EGKTLDVIEENMPEME-------LPEMMEQYVLTAAICAHPILQARPTMDQIVKI--LETD  596 (614)
Q Consensus       545 ----~g~~~~~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~  596 (614)
                          .....+.. ...+...       .+.....+.+++..|++.+|++|||+.|+++.  ++..
T Consensus       235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         235 NCIISLRARNYI-KSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHhhchhhhhHH-hhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                00000000 0000000       01224567899999999999999999999875  5544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-35  Score=336.62  Aligned_cols=260  Identities=22%  Similarity=0.293  Sum_probs=199.6

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ...++|.+.+.||+|+||+||++... ++..||+|.+...  .......+..|+.+++.++||||+++++++...   ..
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~~   86 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---AN   86 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---CC
Confidence            34467999999999999999999965 5778999988642  334456789999999999999999999987532   34


Q ss_pred             ceEEEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcC----CCceEEeccCCCCeEECC------
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGV----QPAIIHRDIKASNILLDE------  459 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~----~~~iiHrDIKp~NILLd~------  459 (614)
                      ...++||||+++|+|.++|...  ....+++..++.|+.||+.||.|||...    ..+|+||||||+||||+.      
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            5689999999999999999752  2346999999999999999999999421    146999999999999964      


Q ss_pred             -----------CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcc
Q 043267          460 -----------AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACE  526 (614)
Q Consensus       460 -----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~  526 (614)
                                 ...+||+|||+++......  ......||+.|+|||++..  ..++.++|||||||++|||++|+.||.
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                       3358999999998654321  2234579999999999864  458999999999999999999999996


Q ss_pred             cccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhh
Q 043267          527 IIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV--KILE  594 (614)
Q Consensus       527 ~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl--~~L~  594 (614)
                      ....    ... ....+..+.       .++.   ......+.+++..||+.+|.+||++.|++  ..+.
T Consensus       245 ~~~~----~~q-li~~lk~~p-------~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik  299 (1021)
T PTZ00266        245 KANN----FSQ-LISELKRGP-------DLPI---KGKSKELNILIKNLLNLSAKERPSALQCLGYQIIK  299 (1021)
T ss_pred             cCCc----HHH-HHHHHhcCC-------CCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHh
Confidence            4322    111 112222211       1111   11234577888999999999999999998  4444

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-35  Score=299.21  Aligned_cols=262  Identities=26%  Similarity=0.288  Sum_probs=196.5

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      |+..+.||+|+||.||+|+.. +|+.+|+|++....  ......+.+|+++++.++|+|++++++++...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            556788999999999999975 58999999998642  33345688999999999999999999998632   1368999


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++ +|.+++.... ..+++..++.++.|+++||+|||   +.+++|+||||+||++++++.+||+|||++.....
T Consensus        78 v~e~~~~-~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDH-DLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             Eeccccc-cHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            9999974 8988886543 47999999999999999999999   88999999999999999999999999999986654


Q ss_pred             CCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH-----------
Q 043267          477 GITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK-----------  544 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~-----------  544 (614)
                      ......+...++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .+. .......           
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~  230 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLE-KIFELCGSPTDENWPGVS  230 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHH-HHHHHhCCCchhhccccc
Confidence            43223344567889999997765 468999999999999999999999985433211 000 0000000           


Q ss_pred             c------CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 E------GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~------g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .      ..........+.+.....+...+.+++..|++.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0      0000000000000000112457789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.8e-36  Score=290.67  Aligned_cols=253  Identities=25%  Similarity=0.337  Sum_probs=204.7

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-----hh---hhHHHHHHHHHHHHc-cccceeeeeeeee
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-----KA---GDANFKHEVEIIASV-KHVNLVALRGYST  384 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~---~~~~f~~Ei~il~~l-~H~niv~l~g~~~  384 (614)
                      ..-.+|...++||+|..+.|.+...+ .|.+.|+|++....     ..   -.++-..|+++++++ .||+|+.+.+++.
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            34456888899999999999888764 78999999986321     11   124456799999999 7999999999987


Q ss_pred             cccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                           .....++|+|.|+.|.|.|+|.+  ...++++...+|..|+.+|++|||   ..+|+||||||+|||+|+++++|
T Consensus        94 -----s~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   94 -----SDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             -----CcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceE
Confidence                 44567999999999999999965  347999999999999999999999   99999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                      |+|||.+...+.+..  ....+||++|+|||.+..      ..|+...|+|+.||+||-|+.|..||....      .-.
T Consensus       164 isDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------Qml  235 (411)
T KOG0599|consen  164 ISDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QML  235 (411)
T ss_pred             EeccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHH
Confidence            999999998876543  456899999999998863      368889999999999999999999984211      011


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.+.+.+|+.      .+.+....+.....-+++..|++.||++|.|.+|++.
T Consensus       236 MLR~ImeGky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  236 MLRMIMEGKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHhccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            2234444433      1233344566667788999999999999999999873

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.4e-34  Score=299.00  Aligned_cols=243  Identities=26%  Similarity=0.321  Sum_probs=198.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++++.     ++..
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   75 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSN   75 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCe
Confidence            36888899999999999999965 68999999986432   233466889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++...  ..+++..+..++.|+++||.|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        76 ~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          76 LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            89999999999999999654  47899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ....    .....|++.|+|||.+.++..+.++||||||+++|||++|+.|+.....      ....+....+..     
T Consensus       151 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~~-----  215 (290)
T cd05580         151 VKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP------IQIYEKILEGKV-----  215 (290)
T ss_pred             cCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHhcCCc-----
Confidence            5543    2345689999999999988899999999999999999999999854331      111122222211     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIV  590 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl  590 (614)
                       .++.    .....+.+++..|++.+|.+||     +++|++
T Consensus       216 -~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~  252 (290)
T cd05580         216 -RFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK  252 (290)
T ss_pred             -cCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence             1111    2245677888999999999999     666665

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.4e-34  Score=298.58  Aligned_cols=259  Identities=19%  Similarity=0.182  Sum_probs=182.9

Q ss_pred             cCccccceecccCceEEEEeEcCC----CcEEEEEEeecCChhhh-----------HHHHHHHHHHHHccccceeeeeee
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNCSKAGD-----------ANFKHEVEIIASVKHVNLVALRGY  382 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~-----------~~f~~Ei~il~~l~H~niv~l~g~  382 (614)
                      ++|...++||+|+||.||+|...+    +..+|+|..........           .....+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            578889999999999999999754    34566665432221110           112233344556789999999987


Q ss_pred             eecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       383 ~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      +..... .....++++|++. .++.+.+...  ...++..+..|+.|+++||+|||   +.+|+||||||+|||++.++.
T Consensus        92 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~  164 (294)
T PHA02882         92 GSFKRC-RMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNR  164 (294)
T ss_pred             eeEecC-CceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCc
Confidence            653321 1234567777764 3566655332  34678889999999999999999   899999999999999999999


Q ss_pred             EEEeecCCceeCCCCCc------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh
Q 043267          463 AKVGDFGLAKFNPEGIT------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS  536 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~  536 (614)
                      +||+|||+++.......      .......||+.|+|||...+..++.++|||||||++|||++|+.||...........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~  244 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH  244 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence            99999999986532211      112234699999999999999999999999999999999999999965532221111


Q ss_pred             HHHH---HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          537 DWAW---ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       537 ~~~~---~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ....   ..+..+..      .+.     .....+.+++..|++.+|++||++.++++.|+
T Consensus       245 ~~~~~~~~~~~~~~~------~~~-----~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        245 AAKCDFIKRLHEGKI------KIK-----NANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HhHHHHHHHhhhhhh------ccC-----CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1111   11111111      011     11345667788899999999999999999874

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-34  Score=301.58  Aligned_cols=252  Identities=29%  Similarity=0.380  Sum_probs=197.5

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      |...+.||+|+||.||+++.. +|..||+|++....   .....++.+|++++++++|+|++++++++.     ++...+
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~  101 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL-----REHTAW  101 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----eCCeEE
Confidence            667789999999999999964 68899999986432   223457889999999999999999999986     556789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||++ |+|.+.+... ...++|.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus       102 lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~  176 (317)
T cd06635         102 LVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS  176 (317)
T ss_pred             EEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccC
Confidence            9999996 5888877543 346899999999999999999999   8999999999999999999999999999987543


Q ss_pred             CCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          476 EGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .     .....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+......     ... ..+..+..    
T Consensus       177 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~-----~~~-~~~~~~~~----  241 (317)
T cd06635         177 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SAL-YHIAQNES----  241 (317)
T ss_pred             C-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH-----HHH-HHHHhccC----
Confidence            3     22346888999999974   467899999999999999999999998543211     001 11111111    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                          ...........+.+++..|++.+|++||++.++++.+--....+
T Consensus       242 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         242 ----PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             ----CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence                11111223446788899999999999999999998665544433

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3e-34  Score=296.38  Aligned_cols=264  Identities=19%  Similarity=0.213  Sum_probs=194.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||.||+|... +|+.||||.++...  ......+.+|+++++.++ |+|++++++++..........
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999965 68999999886432  223457888999999995 699999999886433222334


Q ss_pred             EEEEEeecCCCChhhhhhcCC---CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeecC
Q 043267          394 RIIVCDLLHNGSLYDHLFGSG---MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFG  469 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DFG  469 (614)
                      .++||||+++ +|.+++....   ...+++..++.++.||++||.|||   +.+|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 8988886532   346899999999999999999999   899999999999999998 8999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc-CC
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE-GK  547 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~-g~  547 (614)
                      +++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||.......     ......+. +.
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~  230 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-----QLLHIFKLLGT  230 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHHHHhCC
Confidence            9975433211 1223356889999998865 467999999999999999999999985432211     11111110 00


Q ss_pred             chhhhh------------ccCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIE------------ENMP----EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d------------~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ......            +...    ....+.....+.+++..|++.||.+||++.|++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000            0000    0001123456788999999999999999999874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.2e-34  Score=299.52  Aligned_cols=265  Identities=22%  Similarity=0.241  Sum_probs=196.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh--hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA--GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||.||+|+.+ +++.+|+|.++.....  ....+.+|++++++++|||++++++++...   +....
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~---~~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGS---NLDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEec---CCCcE
Confidence            36788899999999999999976 6889999999743322  233567899999999999999999987632   23789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|+||++ ++|.+++.... ..+++..++.|+.|++.||+|||   +.+++||||||+||++++++.+||+|||++...
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99999997 59998886543 36999999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccch--h-------hHHHHHHHH
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL--L-------SDWAWELVK  544 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--l-------~~~~~~~~~  544 (614)
                      ..... ......+++.|+|||.+.+. .++.++|+||+|+++|||++|+.|+.........  +       .+..|..+.
T Consensus       157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            54321 12334578899999988764 4689999999999999999999998543221100  0       001111111


Q ss_pred             c------CCchhhhhccCCCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 E------GKTLDVIEENMPEMELPE-MMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~------g~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .      ..........+....... ....+.+++..|++.+|++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0      000000011111111111 2456778899999999999999999975

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-34  Score=290.19  Aligned_cols=249  Identities=26%  Similarity=0.348  Sum_probs=203.0

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|+||.||++... ++..|++|++....  .....++.+|+++++.++|+|++++.+.+.     .+...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-----~~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE-----EKGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe-----cCCEEE
Confidence            4777899999999999999975 68999999997543  245667899999999999999999999876     457889


Q ss_pred             EEEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +|+||+++++|.+++....  ...+++..+.+++.++++||.|||   +.+++|+||+|+||+++.++.++|+|||.+..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceee
Confidence            9999999999999997643  467999999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..... .......|++.|+|||......++.++||||+|+++++|++|+.|+.....     .+...... .+...    
T Consensus       153 ~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~-~~~~~----  221 (258)
T cd08215         153 LSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKIL-KGQYP----  221 (258)
T ss_pred             cccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHh-cCCCC----
Confidence            55432 223335688999999999999999999999999999999999999853321     11121211 11111    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       .++    ......+.+++..|++.+|++|||+.++++
T Consensus       222 -~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         222 -PIP----SQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             111    123456778899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-34  Score=293.71  Aligned_cols=247  Identities=28%  Similarity=0.279  Sum_probs=199.8

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +|...+.||+|+||.||++... ++..||+|.+....   ....+.+.+|++++++++|||++++++++.     ++...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQ-----DEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhc-----CCCeE
Confidence            5788899999999999999975 58999999997432   234578899999999999999999998875     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|+||+++++|.+++...  ..+++.....|+.|+++||.|||   +.+++|+||||+||++++++.++|+|||++...
T Consensus        76 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            9999999999999999654  47899999999999999999999   889999999999999999999999999998765


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ....  ......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.|+......   ..++.......      ...
T Consensus       151 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~------~~~  219 (258)
T cd05578         151 TPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT---IRDQIRAKQET------ADV  219 (258)
T ss_pred             CCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc---HHHHHHHHhcc------ccc
Confidence            4432  223456888999999999989999999999999999999999998644321   11122111111      001


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTM--DQIV  590 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~eVl  590 (614)
                      ..    +......+.+++..|++.+|.+||+.  +|++
T Consensus       220 ~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LY----PATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cC----cccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            11    12223567788899999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.9e-34  Score=290.54  Aligned_cols=247  Identities=28%  Similarity=0.333  Sum_probs=201.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|+||.||+++.. ++..+++|.+...  ......++.+|++++++++|+|++++.+++.     ++...+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL-----DGNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc-----cCCEEE
Confidence            4778899999999999999854 7889999998743  2344567889999999999999999998876     557899


Q ss_pred             EEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +|+||+++++|.+++.+.  ....+++..+..++.++++||.|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhh
Confidence            999999999999998652  2357899999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ....   ......++..|++||...+..++.++|+||+|+++|||++|+.|+......     ... ..+..+...    
T Consensus       153 ~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~-----~~~-~~~~~~~~~----  219 (256)
T cd08530         153 LKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQ-----DLR-YKVQRGKYP----  219 (256)
T ss_pred             hccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHH-HHHhcCCCC----
Confidence            6544   222345789999999999999999999999999999999999998543221     111 111111111    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           .........+..++..|++.+|++||++.++++
T Consensus       220 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         220 -----PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             -----CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 112234556889999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=8.9e-35  Score=293.88  Aligned_cols=247  Identities=26%  Similarity=0.305  Sum_probs=197.0

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||.||+++.. +|+.+++|.+.....   ...+.+.+|++++++++|+|++++++.+.     .+...++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ-----GKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhee-----cCcEEEEEEecC
Confidence            689999999999976 489999999875433   44567889999999999999999998875     567889999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc--
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--  479 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~--  479 (614)
                      ++++|.+++.+.+  .+++..+.+++.|+++||+|||   +.+++||||+|+||++++++.+||+|||++........  
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          76 PGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            9999999997644  7899999999999999999999   89999999999999999999999999999875433211  


Q ss_pred             -----cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          480 -----HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       480 -----~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                           .......++..|++||......++.++||||||+++|||++|+.|+.....     ...... ...+...     
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~-~~~~~~~-----  219 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP-----EEIFQN-ILNGKIE-----  219 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHH-HhcCCcC-----
Confidence                 122345678899999999988899999999999999999999999853321     111111 1111110     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       .+.  .......+..++..|++.+|.+|||+.++.+.|+..
T Consensus       220 -~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~  258 (265)
T cd05579         220 -WPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHP  258 (265)
T ss_pred             -CCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCc
Confidence             111  111245678889999999999999997777777653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-34  Score=298.81  Aligned_cols=262  Identities=22%  Similarity=0.260  Sum_probs=195.0

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|++|.||+|+.. +|+.||+|.+....  ....+.+.+|++++++++|+|++++++++.     .+...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            46888899999999999999975 78999999986432  223456889999999999999999999986     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~  473 (614)
                      ++||||++ ++|.+++.......+++.....++.|++.||+|||   +.+++||||||+||+++. ++.+||+|||++..
T Consensus        77 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         77 YLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            99999996 68888886655555788889999999999999999   889999999999999985 56799999999975


Q ss_pred             CCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC------
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG------  546 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g------  546 (614)
                      ...... ..+...+++.|+|||++.+. .++.++||||+|+++|||++|+.||......... .. ........      
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~-~~-~~~~~~~~~~~~~~  229 (294)
T PLN00009        153 FGIPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL-FK-IFRILGTPNEETWP  229 (294)
T ss_pred             cCCCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH-HHHHhCCCChhhcc
Confidence            543221 12334578899999988764 5789999999999999999999998543221110 00 00000000      


Q ss_pred             --C-chhhh--hccCCCC----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 --K-TLDVI--EENMPEM----ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 --~-~~~~~--d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        . ..+..  .+.....    ..+.....+.+++..|++.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0 00000  0000000    01123445788999999999999999999985

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=315.37  Aligned_cols=244  Identities=26%  Similarity=0.375  Sum_probs=200.2

Q ss_pred             eecccCceEEEEeEcCC-CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCC
Q 043267          325 IIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN  403 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~  403 (614)
                      +||+|.||+||-|+..+ ...+|||-+...+....+.+.+|+.+.+.++|+|||+.+|.+.     +++..-+.||..||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~s-----enGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVS-----ENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccC-----CCCeEEEEeecCCC
Confidence            69999999999999764 4568999998766667778899999999999999999999986     66778899999999


Q ss_pred             CChhhhhhcCCCcCC--ChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-CCCcEEEeecCCceeCCCCCcc
Q 043267          404 GSLYDHLFGSGMKKL--SWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITH  480 (614)
Q Consensus       404 GsL~~~L~~~~~~~l--~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-~~~~~kl~DFGla~~~~~~~~~  480 (614)
                      |||.+.|...- .++  ++.+.--...||.+||.|||   ++.|||||||-+|||++ -.|.+||+|||-++... +...
T Consensus       657 GSLSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP  731 (1226)
T KOG4279|consen  657 GSLSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINP  731 (1226)
T ss_pred             CcHHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhc-cCCc
Confidence            99999997642 344  67777788999999999999   99999999999999996 67899999999988654 3455


Q ss_pred             ccccccCCCCcCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          481 LTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       481 ~~~~~~gt~~Y~APE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      .+....||..|||||++..|  .|..++|||||||++.||.|||+||......+.       ...+-|-.  .+.+.   
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-------AMFkVGmy--KvHP~---  799 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-------AMFKVGMY--KVHPP---  799 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-------hhhhhcce--ecCCC---
Confidence            67778899999999999876  588999999999999999999999965443221       11222211  11222   


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       -+.+...+...+++.|..+||.+||+++++++
T Consensus       800 -iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  800 -IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             -CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence             23455667888999999999999999999874

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6e-34  Score=291.69  Aligned_cols=257  Identities=23%  Similarity=0.249  Sum_probs=191.4

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      |...+.||+|+||.||+|+.. +++.||+|+++... ........+|+.++.++. |+|++++++++...   +.+..++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            456788999999999999964 68999999987532 222334557899999885 99999999998632   2367899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||++ |+|.+++.... ..++|.++..++.|++.||+|||   +.+++||||||+||+++. +.+||+|||+++....
T Consensus        78 v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            999996 68888886533 47899999999999999999999   889999999999999999 9999999999976543


Q ss_pred             CCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh-----
Q 043267          477 GITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD-----  550 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~-----  550 (614)
                      ...  .....++..|+|||+... +.++.++||||+||++|||++|+.||......+  ...+.....  +...+     
T Consensus       152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~--~~~~~~~~~~  225 (282)
T cd07831         152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVL--GTPDAEVLKK  225 (282)
T ss_pred             CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHc--CCCCHHHHHh
Confidence            221  223457899999997654 567899999999999999999999995433211  111111100  10000     


Q ss_pred             -----hhhccCCCCC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 -----VIEENMPEME-------LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 -----~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ..+...+...       .......+.+++..|++.+|++||+++++++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence                 0000000000       1133567889999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-34  Score=287.56  Aligned_cols=247  Identities=27%  Similarity=0.402  Sum_probs=201.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|+..+.||+|++|.||+++.. +++.|++|.+.....  ...+.+.+|++++++++|+|++++.+++.     ++...+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE-----TSDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE-----eCCEEE
Confidence            4677899999999999999865 678999999976543  45568999999999999999999999886     557889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +++||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        76 ~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          76 IILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            999999999999998654  47999999999999999999999   8999999999999999999999999999998665


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..... .....++..|+|||......++.++||||+|+++|||++|+.|+......     ...+.... +..     ..
T Consensus       151 ~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~-~~~-----~~  218 (254)
T cd06627         151 DVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-----AALFRIVQ-DDH-----PP  218 (254)
T ss_pred             CCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-----HHHHHHhc-cCC-----CC
Confidence            43322 23356889999999998888999999999999999999999998643311     11111111 110     11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ++    ......+..++..|++.+|++|||+.+++.
T Consensus       219 ~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 LP----EGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CC----CCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11    222456778889999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.8e-34  Score=294.78  Aligned_cols=260  Identities=22%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +|+..+.||+|++|.||+|+.. +|..||||.++.... .....+.+|++++++++|+|++++++++.     +.+..++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIH-----TENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEe-----eCCcEEE
Confidence            5788899999999999999975 689999999875432 23456778999999999999999999987     4567899


Q ss_pred             EEeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          397 VCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ||||+++ +|.+++.... ...+++..+.+++.|+++||.|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        76 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          76 VFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9999984 8988886543 346899999999999999999999   8899999999999999999999999999997543


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchh---------hHHHHHHHHc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL---------SDWAWELVKE  545 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l---------~~~~~~~~~~  545 (614)
                      .... ......++..|++||.+.+. .++.++||||||+++|||++|+.|+..........         ..-.|+.+..
T Consensus       152 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         152 IPVN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             CCcc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence            3221 12234578899999988664 57899999999999999999999985433211000         0001111111


Q ss_pred             CCchhhhhccCCCC-------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIEENMPEM-------ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~~-------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .   .......+..       ..+.....+.+++..|++.||.+||++.|+++
T Consensus       231 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         231 L---PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             C---chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0   0001111100       01122346778999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=290.85  Aligned_cols=251  Identities=24%  Similarity=0.336  Sum_probs=196.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-----ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-----SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|...+.||+|+||.||+|+.. +|..||+|.+...     .......+.+|++++++++|+|++++++++...   ++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~---~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDP---EE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcC---CC
Confidence            46888999999999999999964 6899999987532     123345788999999999999999999987532   34


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++++||+++++|.+++....  .+++....+++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence            56889999999999999986543  5889999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +.......  ...+...|+..|+|||++.+..++.++||||||+++|||++|+.||.......     -..+..      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~------  222 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----AIFKIA------  222 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----HHHHHH------
Confidence            75432111  11233568999999999998889999999999999999999999986432110     011111      


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ........+....+.+.+++..|++ +|..||+..++++
T Consensus       223 ---~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 ---TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             ---cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence               0111111223344567778888998 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3e-34  Score=294.41  Aligned_cols=244  Identities=24%  Similarity=0.300  Sum_probs=192.0

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||+||++... +|+.||+|.+....   ......+.+|+++++.++|||++++.+.+.     ..+..++||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFE-----TKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEe-----cCCeEEEEEecC
Confidence            699999999999854 68999999986432   223445678999999999999999998876     456789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++++|.+++.......+++..++.++.|+++||.|||   +.+++||||||+||++++++.+||+|||++.......  .
T Consensus        76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~  150 (277)
T cd05577          76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--K  150 (277)
T ss_pred             CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--c
Confidence            9999999998766567999999999999999999999   8999999999999999999999999999987554321  2


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      .....++..|+|||+..++.++.++||||+|++++||++|+.||........ .     ..+......  ....    ..
T Consensus       151 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~-----~~~~~~~~~--~~~~----~~  218 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-K-----EELKRRTLE--MAVE----YP  218 (277)
T ss_pred             cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-H-----HHHHhcccc--cccc----CC
Confidence            2334578899999999988899999999999999999999999854332110 0     111111000  0111    11


Q ss_pred             HHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          562 PEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                      ......+.+++..|++.+|++||     ++.++++
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         219 DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            22344677889999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.7e-34  Score=295.35  Aligned_cols=268  Identities=25%  Similarity=0.284  Sum_probs=198.1

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccC---
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVP---  388 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~---  388 (614)
                      ...++|+..+.||+|+||.||+|+.+ +|+.||||+++...  ......+.+|+++++.++|||++++++++.....   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45568899999999999999999975 68999999997532  2233567889999999999999999998864320   


Q ss_pred             --CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEe
Q 043267          389 --LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       389 --~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~  466 (614)
                        .+....++|+||+++ ++.+.+... ...+++..+..|+.|++.||+|||   +.+|+||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeC
Confidence              012378999999976 777777543 347999999999999999999999   8999999999999999999999999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      |||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .+.. +.+... 
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~-~~~~-~~~~~~-  235 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA-QLEL-ISRLCG-  235 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH-HHHH-HHHHhC-
Confidence            999998655433222333456788999998865 457899999999999999999999986432211 1100 111100 


Q ss_pred             CCchh----h--------hhc------cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLD----V--------IEE------NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~----~--------~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +....    .        .+.      .... ........+.+++..|++.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000    0        000      0000 00112356788999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-36  Score=288.87  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=204.9

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEee--cCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~--~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      +++|+..+.||+|.|+.||+... +.|+.+|+|.+.  +.+..+.+++.+|+.+-+.++||||++|..-..     +...
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~-----~~~~   84 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF   84 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhc-----ccce
Confidence            44677778999999999999875 579999999875  344557788999999999999999999987664     6788


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC---CCCcEEEeecCC
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD---EAFEAKVGDFGL  470 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd---~~~~~kl~DFGl  470 (614)
                      +++|+|+|.+|+|..-|-..  ..+++...-..+.||+++|.|.|   .++|||||+||.|+||-   ..--+||+|||+
T Consensus        85 ~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGv  159 (355)
T KOG0033|consen   85 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGL  159 (355)
T ss_pred             eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccce
Confidence            99999999999998766443  45778888889999999999999   99999999999999994   344589999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      |....+  .......+|||+|||||++...+|+..+|||+.||+||-|+.|+.||.+.....      ..+.+..|..  
T Consensus       160 Ai~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r------lye~I~~g~y--  229 (355)
T KOG0033|consen  160 AIEVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------LYEQIKAGAY--  229 (355)
T ss_pred             EEEeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH------HHHHHhcccc--
Confidence            997763  234456789999999999999999999999999999999999999997533211      2344444432  


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          .++..+.+...+....++..|+..||.+|.|+.|.++
T Consensus       230 ----d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  230 ----DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ----CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence                2333344455667778889999999999999998763

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.8e-34  Score=298.81  Aligned_cols=260  Identities=19%  Similarity=0.176  Sum_probs=192.4

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEee
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      .+.+|.|+++.||+++. +|+.||||++...  +....+.+.+|+++++.++|+||+++++++.     +.+..+++|||
T Consensus         7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~-----~~~~~~~~~e~   80 (314)
T cd08216           7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFI-----VDSELYVVSPL   80 (314)
T ss_pred             hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheee-----cCCeEEEEEec
Confidence            34455666666666665 7899999998753  3445678999999999999999999999876     56778999999


Q ss_pred             cCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc-
Q 043267          401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-  479 (614)
Q Consensus       401 ~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~-  479 (614)
                      +++|+|.+++.......+++.....++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||.+........ 
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99999999998765567899999999999999999999   88999999999999999999999999998864432111 


Q ss_pred             -----cccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH---HHHHHcC---
Q 043267          480 -----HLTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA---WELVKEG---  546 (614)
Q Consensus       480 -----~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~---~~~~~~g---  546 (614)
                           .......++..|+|||++..  ..++.++||||||+++|||++|+.||.........+....   ...+...   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchh
Confidence                 11233457889999999876  3588999999999999999999999964332111110000   0000000   


Q ss_pred             ----Cchh----hhhc----cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 ----KTLD----VIEE----NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ----~~~~----~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          ...+    ..+.    .............+.+++..||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                0000    0000    0011112234457888999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-34  Score=290.96  Aligned_cols=259  Identities=24%  Similarity=0.295  Sum_probs=197.3

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      |...+.||+|++|.||+++.+ +|+.+++|++.....  .....+.+|++++++++|+|++++++++.     .+...++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            455678999999999999975 788999999875332  24567889999999999999999999886     5578899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||+++ +|.+++.... ..+++.++..++.++++||.|||   +.+++|+||||+||++++++.+||+|||.+.....
T Consensus        76 v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            9999975 8888886643 57999999999999999999999   89999999999999999999999999999986654


Q ss_pred             CCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchh---------hHHHHHHHHcC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL---------SDWAWELVKEG  546 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l---------~~~~~~~~~~g  546 (614)
                      .. .......++..|+|||...+. .++.++||||+|+++|||++|+.||......+...         ....|......
T Consensus       151 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd05118         151 PV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL  229 (283)
T ss_pred             Cc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhh
Confidence            43 122334578899999998877 78999999999999999999999985433211000         00000000000


Q ss_pred             CchhhhhccCC-------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMP-------EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ........+       ....+.....+.+++..|++.||.+||++++++.
T Consensus       230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         230 --ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             --hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              000000000       0011234567889999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=326.80  Aligned_cols=259  Identities=27%  Similarity=0.401  Sum_probs=209.8

Q ss_pred             HhcCccccceecccCceEEEEeEcC----C----CcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeec
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP----N----GTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTA  385 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~----~----g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~  385 (614)
                      ..++....+.||+|.||.|++|...    .    ...||||.++... ....+.+..|+++++.+ +|+|++.++|+|. 
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t-  372 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT-  372 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec-
Confidence            3344555669999999999999842    1    4579999998543 34567899999999999 6999999999998 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCC------------C--cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSG------------M--KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~------------~--~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                          .+...++|.||++.|+|.++|+..+            .  ..++....+.++.|||.|++||+   +.+++||||.
T Consensus       373 ----~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLA  445 (609)
T KOG0200|consen  373 ----QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLA  445 (609)
T ss_pred             ----cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhh
Confidence                4677899999999999999997654            1  23889999999999999999999   8999999999


Q ss_pred             CCCeEECCCCcEEEeecCCceeCCCCCccccccccC--CCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccc
Q 043267          452 ASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG--TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEII  528 (614)
Q Consensus       452 p~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~g--t~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~  528 (614)
                      ++|||+.++..+||+|||+++..............|  ...|||||.+....|+.|||||||||+||||+| |..|+...
T Consensus       446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999999655443333232233  456999999999999999999999999999999 88898642


Q ss_pred             cCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          529 QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       529 ~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..    ..+. ++.+++|...+.         +.....++..+++.||+.+|++||+..++++.|+..
T Consensus       526 ~~----~~~l-~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  526 PP----TEEL-LEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             Cc----HHHH-HHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            21    2222 567778766543         122244566888889999999999999999999884

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.2e-34  Score=302.17  Aligned_cols=266  Identities=21%  Similarity=0.227  Sum_probs=198.0

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~  391 (614)
                      ..++|+..+.||+|+||.||+++.. +|+.||||++...  +......+.+|++++++++|+|++++++++...... +.
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            3467999999999999999999964 7899999998642  233445677899999999999999999987643222 22


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+. ++|.+.+..    .+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM----DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            45799999995 588888743    2889999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc----------hhhHHH--
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV----------LLSDWA--  539 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~----------~l~~~~--  539 (614)
                      +.......  .....++..|+|||.+.+..++.++||||||+++|||++|+.||........          ...++.  
T Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            86543321  2334578999999999999999999999999999999999999853321000          000000  


Q ss_pred             -----HHHHHcCC------chhhhhccC----CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          540 -----WELVKEGK------TLDVIEENM----PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       540 -----~~~~~~g~------~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ........      ..+.....+    ...........+.+++..|++.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00000000      000000000    00001123456789999999999999999999984

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2e-34  Score=304.47  Aligned_cols=268  Identities=24%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|+..+.||+|+||.||+|+.. +|..||+|++....  ......+.+|++++++++|+||+++.+++.... .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~   82 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKD   82 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCce
Confidence            368899999999999999999964 68999999987532  233456788999999999999999999875432 23457


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|+||+. |+|.+++...  ..+++.....++.|+++||.|||   +.+|+||||||+||++++++.+||+|||+++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence            899999995 6899988543  35999999999999999999999   89999999999999999999999999999975


Q ss_pred             CCCCCc---cccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch---------hhHHHH
Q 043267          474 NPEGIT---HLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL---------LSDWAW  540 (614)
Q Consensus       474 ~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~---------l~~~~~  540 (614)
                      ......   .......|+..|+|||.+.. ..++.++||||||+++|||++|+.||.........         ...-.+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~  236 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL  236 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence            433221   11234578999999998865 46899999999999999999999999543211000         000000


Q ss_pred             HHHHcCCchhhhhccCC-CCC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          541 ELVKEGKTLDVIEENMP-EME-----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~-~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +........+..+..-. ...     .+.....+.+++..|++.+|++||++.+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            11111111111111000 000     1223567889999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=292.64  Aligned_cols=265  Identities=22%  Similarity=0.246  Sum_probs=195.4

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHc---cccceeeeeeeeecccCCCCce
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASV---KHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l---~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      |+..+.||+|+||.||+|+.+ +++.||+|+++....  .....+.+|+++++++   +|+|++++.+++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            566789999999999999976 589999999974222  2234566788877766   5999999999987533222234


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+++|||++ ++|.+++.......+++..+..++.|+++||.|||   +.+++|+||||+||++++++.+||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            899999997 58999887655557999999999999999999999   88999999999999999999999999999976


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc-----
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT-----  548 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~-----  548 (614)
                      ......  .....++..|+|||++.+..++.++||||||+++|||++|+.|+....... .+..........+..     
T Consensus       157 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         157 YSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD-QLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             ccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH-HHHHHHHHcCCCChHhcCCC
Confidence            543321  223457889999999999999999999999999999999998885433211 111111000000000     


Q ss_pred             ----hhhhhccCC---CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          549 ----LDVIEENMP---EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       549 ----~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          .........   ....++....+.+++..|++.||.+||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                000000000   0011233456788999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.6e-34  Score=302.64  Aligned_cols=265  Identities=25%  Similarity=0.298  Sum_probs=197.9

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~  391 (614)
                      ..++|+..+.||+|+||.||+|... +|+.+|||++...  .......+.+|+.+++++ +|+||+++++++...   ++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~---~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAE---ND   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccC---CC
Confidence            3457888899999999999999975 6889999988542  233445677899999999 999999999987532   34


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||++ ++|.+++...   .++|..+..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            56899999997 5998888543   6899999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCc----cccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhH---------
Q 043267          472 KFNPEGIT----HLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD---------  537 (614)
Q Consensus       472 ~~~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~---------  537 (614)
                      +.......    .......||..|+|||.+.. ..++.++||||||+++|||++|+.||........ ...         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~  233 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPS  233 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCC
Confidence            75543321    12334568999999998765 4678999999999999999999999853322110 000         


Q ss_pred             -HHHHHHHcCCchhhhhccCC-------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          538 -WAWELVKEGKTLDVIEENMP-------EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       538 -~~~~~~~~g~~~~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                       -.+..+......+.++ ...       ....+.....+.+++..|++.+|++|||+.++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         234 AEDIESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence             0000110000001111 000       00011134567889999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.6e-34  Score=289.92  Aligned_cols=242  Identities=24%  Similarity=0.234  Sum_probs=193.4

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||.||+++.. +++.||+|.+....   ....+.+.+|+++++.++|+|++++++++.     ++...++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            699999999999975 48999999986432   234467899999999999999999999876     567789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++++|.+++.+.  ..+++..+..++.|+++||.|||   +.+++|+||||+||++++++.+||+|||+++......  .
T Consensus        76 ~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~  148 (262)
T cd05572          76 LGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--K  148 (262)
T ss_pred             CCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--c
Confidence            999999999654  35899999999999999999999   8999999999999999999999999999998665432  2


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      .....|+..|++||.+....++.++|+||+|+++|||++|+.|+.....+.   .+.... +..+.        .....+
T Consensus       149 ~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~-~~~~~--------~~~~~~  216 (262)
T cd05572         149 TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYND-ILKGN--------GKLEFP  216 (262)
T ss_pred             cccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH---HHHHHH-HhccC--------CCCCCC
Confidence            233468899999999988889999999999999999999999996443211   111111 11110        011111


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          562 PEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                      ......+..++..|++.+|++||+     +.|+++
T Consensus       217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            222457788999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.5e-34  Score=289.84  Aligned_cols=249  Identities=23%  Similarity=0.230  Sum_probs=191.1

Q ss_pred             HHHHHHhcCcccccee--cccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecc
Q 043267          311 EEIKAATMNFSRENII--GKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTAT  386 (614)
Q Consensus       311 ~el~~~t~~f~~~~~L--G~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~  386 (614)
                      .++....++|+..+.+  |+|+||.||+++.+ ++..+|+|.+.......     .|+.....+ +|+|++++++++.  
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~--   79 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVT--   79 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEe--
Confidence            3444445667776666  99999999999964 68889999886532111     122222222 7999999999987  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEE
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKV  465 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl  465 (614)
                         .....++||||+++|+|.+++....  .++|.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|
T Consensus        80 ---~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         80 ---TLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             ---cCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEE
Confidence               4568899999999999999996543  7999999999999999999999   88999999999999999998 9999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      +|||+++.....     ....|+..|+|||++.+..++.++||||+|+++|||++|+.|+............+....  .
T Consensus       152 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~  224 (267)
T PHA03390        152 CDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--Q  224 (267)
T ss_pred             ecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--c
Confidence            999998765432     224588999999999999999999999999999999999999974443332222222211  0


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT-MDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~  591 (614)
                              ...  .........+.+++..|++.+|.+||+ ++|+++
T Consensus       225 --------~~~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        225 --------KKL--PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             --------ccC--CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                    000  011133456778888999999999996 688863

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.3e-34  Score=301.08  Aligned_cols=260  Identities=22%  Similarity=0.261  Sum_probs=191.3

Q ss_pred             ceeccc--CceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKG--GYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      ..||+|  +||+||+++.. +|+.||||.+...  .....+.+.+|+.+++.++||||+++++++.     .+...++|+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            457777  89999999964 7999999998643  2333467889999999999999999999987     566789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++.......+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+|++||+.+.......
T Consensus        79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            9999999999997765557999999999999999999999   8999999999999999999999999998653221111


Q ss_pred             cc------ccccccCCCCcCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhH--------H----
Q 043267          479 TH------LTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD--------W----  538 (614)
Q Consensus       479 ~~------~~~~~~gt~~Y~APE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~--------~----  538 (614)
                      ..      ......++..|+|||++.++  .++.++||||||+++|||++|+.||............        |    
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccc
Confidence            00      01112356779999998764  5789999999999999999999999543211100000        0    


Q ss_pred             ---HHHHHH----------------cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 ---AWELVK----------------EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ---~~~~~~----------------~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         -...+.                .+......+..+...........+.+++..|++.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               000000                00000011111111112335567889999999999999999999973

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-34  Score=321.76  Aligned_cols=201  Identities=20%  Similarity=0.291  Sum_probs=160.1

Q ss_pred             HHhcCccccceecccCceEEEEeEcCC--CcEEEEE------------------EeecCChhhhHHHHHHHHHHHHcccc
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLPN--GTEVAVK------------------RFKNCSKAGDANFKHEVEIIASVKHV  374 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK------------------~l~~~~~~~~~~f~~Ei~il~~l~H~  374 (614)
                      ....+|...+.||+|+||+||++..+.  +..+++|                  .+. ........+.+|++++++++|+
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            345689999999999999999987532  2222222                  111 1222345688999999999999


Q ss_pred             ceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCC---CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG---MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       375 niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~---~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                      ||+++++++.     .....++|+|++. ++|.+++....   .......+..+|+.|++.||+|||   +.+|+|||||
T Consensus       224 nIv~l~~~~~-----~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLK  294 (501)
T PHA03210        224 NILKIEEILR-----SEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIK  294 (501)
T ss_pred             CcCcEeEEEE-----ECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            9999999987     4567899999984 67877775432   122345667789999999999999   8999999999


Q ss_pred             CCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          452 ASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       452 p~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      |+|||++.++.+||+|||+++..............||..|+|||++.+..++.++|||||||++|||++|+.+.
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p  368 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP  368 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence            99999999999999999999876554333344567999999999999999999999999999999999987543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.5e-34  Score=292.47  Aligned_cols=242  Identities=23%  Similarity=0.273  Sum_probs=184.8

Q ss_pred             eecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHH---ccccceeeeeeeeecccCCCCceEEEE
Q 043267          325 IIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIAS---VKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~---l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +||+|+||.||++... +|+.+|+|.+....   ......+.+|..+++.   .+|+|++.+.+++.     .++..++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFH-----TPDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEe-----cCCeEEEE
Confidence            4899999999999964 68999999886432   1222334455544443   47999999988876     45678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++...  ..+++.....|+.|++.||+|||   +.+|+||||||+|||+++++.+||+|||++......
T Consensus        76 ~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          76 LDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            9999999999998654  36999999999999999999999   899999999999999999999999999998754432


Q ss_pred             CccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .   .....||..|+|||.... ..++.++||||+|+++|||++|+.||........   ........      .....+
T Consensus       151 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~~~~~------~~~~~~  218 (279)
T cd05633         151 K---PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK---HEIDRMTL------TVNVEL  218 (279)
T ss_pred             C---ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH---HHHHHHhh------cCCcCC
Confidence            2   223468999999999874 5689999999999999999999999964332111   01111100      011112


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVKI  592 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  592 (614)
                      +    ......+.+++..|++.||++||     +++|+++.
T Consensus       219 ~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 P----DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             c----cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            2    22345677888999999999999     59998874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.6e-34  Score=302.95  Aligned_cols=272  Identities=24%  Similarity=0.304  Sum_probs=201.0

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||+||+++.. +|..||||.+...  .......+.+|+++++.++|+|++++++++..........
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999964 6899999998642  2333456778999999999999999999876432222245


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|+||+. ++|.+++...  ..+++.....++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            899999996 7898888643  46999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch--hh-------HHHHHHH
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL--LS-------DWAWELV  543 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--l~-------~~~~~~~  543 (614)
                      ..... .......++..|+|||.+.. ..++.++||||||+++|||++|+.||.........  ..       +-.+...
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            54332 22233467889999998875 46899999999999999999999998543211000  00       0001111


Q ss_pred             HcCCchhhhhccC--CC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhc
Q 043267          544 KEGKTLDVIEENM--PE----MELPEMMEQYVLTAAICAHPILQARPTMDQIVKI--LET  595 (614)
Q Consensus       544 ~~g~~~~~~d~~l--~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~  595 (614)
                      ..+...+.+....  ..    ...+.....+.+++..|++.+|++|||++|+++-  ++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             CchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence            1111111111000  00    0011234567899999999999999999999865  544

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.2e-34  Score=292.92  Aligned_cols=267  Identities=21%  Similarity=0.241  Sum_probs=198.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh--hhHHHHHHHHHHHHccccc-eeeeeeeeecccCC-CCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA--GDANFKHEVEIIASVKHVN-LVALRGYSTATVPL-EGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--~~~~f~~Ei~il~~l~H~n-iv~l~g~~~~~~~~-~~~~  393 (614)
                      .|...++||+|.||+||+|+.+ +|+.||+|++.-..+.  ......+|+.++++++|+| |++|.+++...... ....
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~   91 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK   91 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence            4555677999999999999954 7899999999754331  2344578999999999999 99999998753321 1236


Q ss_pred             EEEEEeecCCCChhhhhhcCCC--cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGM--KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~--~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .++|+||+. -+|.+++.....  ..++...+..+..|+.+||+|||   +.+|+||||||.|||++++|.+||+|||+|
T Consensus        92 l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   92 LYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             EEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence            789999995 589999876443  35777889999999999999999   999999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc---CC
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE---GK  547 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~---g~  547 (614)
                      +...-... ..+...+|.-|.|||++.+. .|+...||||+||++.||++++.-|....+.+.  ..-+.+....   ..
T Consensus       168 ra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  168 RAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPNEKD  244 (323)
T ss_pred             HHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCCccC
Confidence            96553322 24556789999999999877 799999999999999999998888754443111  1111111100   00


Q ss_pred             chh-----hhhccCCCCC-c-------HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          548 TLD-----VIEENMPEME-L-------PEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       548 ~~~-----~~d~~l~~~~-~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      +..     -.+...+... .       +.......+++..|++.+|.+|.|++.++++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            000     0000111111 0       1112367888999999999999999999875

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=293.10  Aligned_cols=261  Identities=23%  Similarity=0.284  Sum_probs=195.7

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      |...+.||+|+||+||+|+.. +++.|+||++..... .......+|++.+++++ |+|++++++++.     .+...++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~-----~~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFR-----ENDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhh-----cCCcEEE
Confidence            556788999999999999975 578899999865322 23334567999999998 999999999986     4678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+ +|+|.+++.......+++.++..++.|++++|.|||   +.+++|+||||+||++++++.++|+|||+++....
T Consensus        76 v~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            99999 889999987765567999999999999999999999   89999999999999999999999999999986543


Q ss_pred             CCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch-----------hhHHHHHHHH
Q 043267          477 GITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL-----------LSDWAWELVK  544 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-----------l~~~~~~~~~  544 (614)
                      ...  .....++..|+|||.+.. ..++.++|+||||++++||++|+.|+.........           -..|......
T Consensus       152 ~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07830         152 RPP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL  229 (283)
T ss_pred             CCC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence            222  233467889999998754 46899999999999999999999988543221100           0011111111


Q ss_pred             cCCchhhhhccCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .......+......   ...+.....+.+++..|++.+|++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            11111010000000   000112356889999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.3e-34  Score=295.79  Aligned_cols=243  Identities=22%  Similarity=0.310  Sum_probs=194.6

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecC
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLH  402 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~  402 (614)
                      ..||+|+||.||++... +|+.||||++..........+.+|+.+++.++|+|++++++++.     .++..++||||++
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e~~~  100 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWVVMEFLE  100 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEE-----eCCEEEEEEecCC
Confidence            67999999999999874 78999999987655556677999999999999999999999886     5678899999999


Q ss_pred             CCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCcccc
Q 043267          403 NGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT  482 (614)
Q Consensus       403 ~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~  482 (614)
                      +++|.+++..   ..+++.....++.|++.||+|||   +.+++||||||+||++++++.++|+|||++....... ...
T Consensus       101 ~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~  173 (292)
T cd06657         101 GGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRR  173 (292)
T ss_pred             CCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccc
Confidence            9999998743   35899999999999999999999   8899999999999999999999999999987554322 122


Q ss_pred             ccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcH
Q 043267          483 TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELP  562 (614)
Q Consensus       483 ~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~  562 (614)
                      ....|++.|+|||...+..++.++|+||+|+++|||++|+.|+.......     . ......+     ....+..  ..
T Consensus       174 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~-----~-~~~~~~~-----~~~~~~~--~~  240 (292)
T cd06657         174 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-----A-MKMIRDN-----LPPKLKN--LH  240 (292)
T ss_pred             cccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----H-HHHHHhh-----CCcccCC--cc
Confidence            33568899999999988899999999999999999999999985322110     0 0111111     0111111  11


Q ss_pred             HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          563 EMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       563 ~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .....+.+++..|++.+|.+||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            22335667888999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6e-34  Score=295.19  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=192.2

Q ss_pred             cCccccceecccCceEEEEeEcCC-CcEEEEEEeecCC-hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCS-KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|...+.||+|+||.||+|+.++ ++.||||+++... .....++..|++++.+.. |+|++++++++.     ++...
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~   89 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDSDV   89 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCCeE
Confidence            457778999999999999999864 8999999997533 233456677888777775 999999999986     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +++|||++ ++|.+.+.... ..+++..+.+|+.++++||+|||   + .+|+||||+|+||++++++.+||+|||++..
T Consensus        90 ~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~  164 (296)
T cd06618          90 FICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGISGR  164 (296)
T ss_pred             EEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccchh
Confidence            99999985 47777665433 47999999999999999999999   5 5899999999999999999999999999876


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCC----CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGK----LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ......  .....++..|+|||.+....    ++.++||||||+++|||++|+.|+.......    +......... . 
T Consensus       165 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~-~-  236 (296)
T cd06618         165 LVDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF----EVLTKILQEE-P-  236 (296)
T ss_pred             ccCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH----HHHHHHhcCC-C-
Confidence            543222  22345788999999987553    8899999999999999999999985422111    1111111111 0 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                          ...+.  .......+.+++..|++.+|++||++.++++.
T Consensus       237 ----~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 ----PSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ----CCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                01111  11234567889999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=294.84  Aligned_cols=245  Identities=26%  Similarity=0.325  Sum_probs=205.7

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      |....+||+|+||.|||+.++ .|+.||||.+.-.  .+.+++..|+.++.+.+.|++|+.+|-+.     ....+++||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYF-----K~sDLWIVM  107 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYF-----KHSDLWIVM  107 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhc-----cCCceEeeh
Confidence            667788999999999999976 6999999998753  35678999999999999999999999765     567789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      |||..||..|.++.. +++|+..++..|..+.++||+|||   ...-||||||+.||||+.+|.+||+|||.+....+..
T Consensus       108 EYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  108 EYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence            999999999988654 478999999999999999999999   7888999999999999999999999999998766554


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      .. ...+.||+.|||||++..-.|..++||||+|+...||.-|++||.+...-.               ..-.+.-..+.
T Consensus       184 AK-RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---------------AIFMIPT~PPP  247 (502)
T KOG0574|consen  184 AK-RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR---------------AIFMIPTKPPP  247 (502)
T ss_pred             Hh-hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc---------------eeEeccCCCCC
Confidence            44 345789999999999999999999999999999999999999996544311               11111111111


Q ss_pred             C--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          559 M--ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       559 ~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .  .+......+-++++.|+-.+|++|-|+.++++
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            1  23345667889999999999999999988875

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=8.5e-34  Score=295.86  Aligned_cols=266  Identities=25%  Similarity=0.294  Sum_probs=194.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|+++....  .....+.+|++++++++|+|++++++++...   ..+.
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            357888999999999999999975 689999999864322  1233567899999999999999999987632   2356


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+. ++|.+++.... ..+++.++..++.|+++||+|||   +.+++||||||+||++++++.+||+|||++..
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence            899999996 58888886533 57999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch--hh-------HHHHHHH
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL--LS-------DWAWELV  543 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--l~-------~~~~~~~  543 (614)
                      ...... ..+...++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.........  +.       ...|...
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            543321 1223345788999999875 46899999999999999999999998643321100  00       0011111


Q ss_pred             HcCCchhhhh---ccCCC--CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          544 KEGKTLDVIE---ENMPE--MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       544 ~~g~~~~~~d---~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..........   .....  .........+.+++..|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000000   00000  000112345678899999999999999999884

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.1e-33  Score=291.69  Aligned_cols=256  Identities=24%  Similarity=0.291  Sum_probs=198.9

Q ss_pred             CccccceecccCceEEEEeEc----CCCcEEEEEEeecCC----hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCS----KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      +|...+.||+|+||.||+++.    .+++.||||.++...    ....+.+.+|++++.++ +|+|++++.+.+.     
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~-----   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQ-----   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeee-----
Confidence            467788999999999999884    357889999987432    22345688999999999 5999999998775     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      .+...++||||+++|+|.+++...  ..+++.....++.|+++||.|||   +.+++||||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg  150 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFG  150 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECc
Confidence            456789999999999999998653  46899999999999999999999   8999999999999999999999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGK--LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +++..............|+..|+|||...+..  .+.++||||||+++|||++|+.|+...... .............  
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~--  227 (288)
T cd05583         151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ-NSQSEISRRILKS--  227 (288)
T ss_pred             cccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc-chHHHHHHHHHcc--
Confidence            98765433322233356889999999987765  788999999999999999999998532211 1111111111110  


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           ....+    ......+.+++..|++.+|++|||+.++.+.|+..
T Consensus       228 -----~~~~~----~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~  267 (288)
T cd05583         228 -----KPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP  267 (288)
T ss_pred             -----CCCCC----cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence                 11111    12234567788899999999999999998888764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-34  Score=288.48  Aligned_cols=245  Identities=24%  Similarity=0.227  Sum_probs=190.1

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHHH-HHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEII-ASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~il-~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+|... +|+.||||.+.....   .....+..|..++ ...+|+|++++++++.     ++...++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            46999999999999964 689999999865332   2223344555544 4458999999999986     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++++|.+++...  ..+++..+.+++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++....  
T Consensus        77 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          77 EYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             eccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            999999999999653  36899999999999999999999   88999999999999999999999999999875433  


Q ss_pred             ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                         .....|+..|+|||...++.++.++||||||+++|||++|+.|+......      -.+..+..+...      .+.
T Consensus       150 ---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~------~~~  214 (260)
T cd05611         150 ---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRRIN------WPE  214 (260)
T ss_pred             ---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccC------CCC
Confidence               22345888999999999888999999999999999999999998533221      112222222111      111


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      .........+.+++..|++.+|++||++.++.++|+.
T Consensus       215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            1111234567889999999999999988777776654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.4e-34  Score=292.24  Aligned_cols=250  Identities=24%  Similarity=0.216  Sum_probs=203.3

Q ss_pred             CccccceecccCceEEEEeEcCC-CcEEEEEEeecCChh---hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA---GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|+..+.||+|.-|+||++.+.+ +..+|+|++.+....   .....+.|-+||+.++||.+..|++.+.     ..+..
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fe-----t~~~~  152 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFE-----TDKYS  152 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheee-----cccee
Confidence            35556889999999999999864 588999999864433   3445678999999999999999999987     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      +++||||+||+|...++++..+.++....+-.+.++.-||+|||   ..|||+|||||+||||-++|++.|+||.|+...
T Consensus       153 cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~  229 (459)
T KOG0610|consen  153 CLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRC  229 (459)
T ss_pred             EEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999987422


Q ss_pred             CC---------------------------------CCc----------------------cccccccCCCCcCchhhhcc
Q 043267          475 PE---------------------------------GIT----------------------HLTTRVAGTLGYVAPEYALY  499 (614)
Q Consensus       475 ~~---------------------------------~~~----------------------~~~~~~~gt~~Y~APE~~~~  499 (614)
                      .-                                 ...                      ......+||..|+|||++.+
T Consensus       230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G  309 (459)
T KOG0610|consen  230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG  309 (459)
T ss_pred             CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence            10                                 000                      00112469999999999999


Q ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccC
Q 043267          500 GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPI  579 (614)
Q Consensus       500 ~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~d  579 (614)
                      ...+.++|+|+|||++|||+.|+-||.....++. +             ..++-+.+.-...++.+..+.+++..-+-.|
T Consensus       310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T-l-------------~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET-L-------------RNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh-H-------------HHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence            9999999999999999999999999965443222 1             1223222222223355677889999999999


Q ss_pred             CCCCCC----HHHHH
Q 043267          580 LQARPT----MDQIV  590 (614)
Q Consensus       580 P~~RPt----~~eVl  590 (614)
                      |++|..    +.||-
T Consensus       376 P~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIK  390 (459)
T ss_pred             hhhhhccccchHHhh
Confidence            999998    77665

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-33  Score=291.16  Aligned_cols=251  Identities=24%  Similarity=0.290  Sum_probs=194.6

Q ss_pred             CccccceecccCceEEEEeEc----CCCcEEEEEEeecCC----hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCS----KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      +|+..+.||+|+||.||++..    .+|..||+|++....    ....+.+.+|++++.++ +|+||+++.+++.     
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~-----   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ-----   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEee-----
Confidence            467788999999999999985    378999999997532    22345678899999999 6999999998876     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      .+...++|+||+++++|.+++...  ..+++.....++.|+++||.|||   +.+++||||||+|||+++++.+||+|||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg  150 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG  150 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCc
Confidence            456789999999999999999654  36889999999999999999999   8999999999999999999999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +++..............|+..|+|||.+..+  .++.++||||||+++|||++|+.|+..... .....++.......+ 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~-~~~~~~~~~~~~~~~-  228 (290)
T cd05613         151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE-KNSQAEISRRILKSE-  228 (290)
T ss_pred             cceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc-cccHHHHHHHhhccC-
Confidence            9986544332223345689999999998753  478899999999999999999999853221 111222222211111 


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                            ...    +......+..++..|++.+|++||     ++.++++
T Consensus       229 ------~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         229 ------PPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ------CCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                  111    122334567888899999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=310.43  Aligned_cols=245  Identities=31%  Similarity=0.388  Sum_probs=198.9

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh---hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA---GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|+..+.||.|+||.||-++.. +...||||++.-..++   ...++..|+..|.+++|||++...||+-     .+...
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyL-----re~Ta  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYL-----REHTA  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceee-----ccchH
Confidence            3677788999999999999964 6788999999754433   3467889999999999999999999986     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      +||||||- ||-.|.+.-. .+++....+..|..+.+.||+|||   +.+.||||||+.||||++.|.+||+|||.|...
T Consensus       102 WLVMEYCl-GSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHh-ccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence            99999994 6777776443 367889999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ..     ....+|||.|||||++.   .|+|+-|+||||+|++-.||.-.++|+..++.-.      +..++....    
T Consensus       177 ~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS------ALYHIAQNe----  241 (948)
T KOG0577|consen  177 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE----  241 (948)
T ss_pred             Cc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH------HHHHHHhcC----
Confidence            43     23468999999999986   6899999999999999999999999985443210      111222211    


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                       .+.+.   .++....++.++..|++.-|.+|||..++++-
T Consensus       242 -sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 -SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             -CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence             12222   34556678888888999999999999998753

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.6e-33  Score=292.58  Aligned_cols=267  Identities=21%  Similarity=0.218  Sum_probs=193.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCC---CC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL---EG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~---~~  391 (614)
                      ++|+..+.||+|+||.||+++.. +++.||||.+....  ......+.+|++++++++|||++++++++......   ..
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            36888999999999999999965 68999999986432  22234567899999999999999999988643211   23


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+. ++|.+.+.... ..+++.+...++.|+++||+|||   +.+++|+||||+||+++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence            45699999996 58888775432 46899999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCc---cccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH----
Q 043267          472 KFNPEGIT---HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV----  543 (614)
Q Consensus       472 ~~~~~~~~---~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~----  543 (614)
                      ........   .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.......  .........    
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~--~~~~~~~~~~~~~  244 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQH--QLTLISQLCGSIT  244 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            75543221   122334578899999988765 47899999999999999999999885432211  011111100    


Q ss_pred             ----HcCCchhhhhc-cCCCCCc---------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          544 ----KEGKTLDVIEE-NMPEMEL---------PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       544 ----~~g~~~~~~d~-~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          ......+..+. ..+....         ......+.+++..|++.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence                00000000000 0000000         001235668999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.7e-33  Score=293.96  Aligned_cols=248  Identities=30%  Similarity=0.396  Sum_probs=194.4

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|...+.||+|+||.||+|+.. ++..+|+|.+...   ......++.+|+++++.++|+|++++.+++.     .....
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   90 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEE-----cCCee
Confidence            3666688999999999999965 6788999998632   2333456889999999999999999999986     55778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|+||+. |+|.+.+.... ..+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        91 ~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          91 WLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            99999996 68888775433 45899999999999999999999   889999999999999999999999999998764


Q ss_pred             CCCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ...     ....|+..|+|||.+.   .+.++.++||||||+++|||++|+.|+......     +.... +..+..   
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~-~~~~~~---  231 (308)
T cd06634         166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM-----SALYH-IAQNES---  231 (308)
T ss_pred             cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH-----HHHHH-HhhcCC---
Confidence            432     2345788999999975   457889999999999999999999998543211     11111 111111   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                           +..........+.+++..|++.+|++||++.++++..--
T Consensus       232 -----~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         232 -----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             -----CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccc
Confidence                 111112334567788999999999999999999876433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=8.3e-34  Score=289.79  Aligned_cols=248  Identities=24%  Similarity=0.285  Sum_probs=199.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||.||+++.. +|+.||+|.+...   .....+.+.+|++++++++ |+|++++++++.     .+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~   75 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQ-----DEE   75 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhc-----CCc
Confidence            36888899999999999999975 7899999998642   2334567889999999998 999999999876     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++++|.+++.+.+  .+++..++.|+.|++.||.|||   +.+++|+||||+||+++.++.++++|||++.
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          76 NLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             eEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccc
Confidence            8899999999999999996543  6999999999999999999999   8999999999999999999999999999987


Q ss_pred             eCCCCCc-------------------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc
Q 043267          473 FNPEGIT-------------------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV  533 (614)
Q Consensus       473 ~~~~~~~-------------------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~  533 (614)
                      .......                   .......++..|+|||......++.++||||||++++|+++|+.|+....... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL-  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH-
Confidence            6543221                   11223457899999999998899999999999999999999999986433110 


Q ss_pred             hhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH----HHHHH
Q 043267          534 LLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTM----DQIVK  591 (614)
Q Consensus       534 ~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~eVl~  591 (614)
                      .    . .....      ....+    +......+.+++..|++.+|++||++    +++++
T Consensus       230 ~----~-~~~~~------~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 T----F-QKILK------LEYSF----PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             H----H-HHHHh------cCCCC----CCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            0    0 11110      01111    12234567889999999999999999    76653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-33  Score=295.43  Aligned_cols=266  Identities=23%  Similarity=0.303  Sum_probs=194.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||++...  .......+.+|+++++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            68999999999999999999964 7899999998642  22234567899999999999999999998764322 12345


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|+||+.. +|.+++    ...+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++.
T Consensus        95 ~~lv~e~~~~-~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQT-DLQKIM----GHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             EEEEeccccc-CHHHHH----cCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            7899999964 676654    236899999999999999999999   88999999999999999999999999999875


Q ss_pred             CCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH----------HHH
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA----------WEL  542 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~----------~~~  542 (614)
                      ....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... .+....          ++.
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHHHH
Confidence            4322    223457889999999876 468999999999999999999999996432110 000000          000


Q ss_pred             HHcCCchhhhhc--cCCCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhhcc
Q 043267          543 VKEGKTLDVIEE--NMPEME----LPEMMEQYVLTAAICAHPILQARPTMDQIV--KILETD  596 (614)
Q Consensus       543 ~~~g~~~~~~d~--~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl--~~L~~~  596 (614)
                      +...........  ..+...    .+.....+.+++..|++.||++||++.+++  ..+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence            100000000000  000000    011234577899999999999999999998  346554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-34  Score=307.13  Aligned_cols=249  Identities=24%  Similarity=0.384  Sum_probs=199.0

Q ss_pred             ceecccCceEEEEeEcC-CCcEEEEEEe--ec--CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP-NGTEVAVKRF--KN--CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~-~g~~VAVK~l--~~--~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      .+||+|+|-+||||... +|-+||=-.+  .+  .+....+.|..|+.+|+.|+|+||++++..+...   ......+|+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~---~n~~in~iT  122 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT---DNKTINFIT  122 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC---CCceeeeee
Confidence            56999999999999975 5778873222  11  2344457899999999999999999999987654   346788999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeecCCceeCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~~~~~  477 (614)
                      |.|..|+|..|+.+.+  .++.....+|+.||.+||.|||.. .++|||||||-+||+|+. .|.+||+|+|||......
T Consensus       123 EL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             ecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999999997755  678889999999999999999975 789999999999999985 589999999999875542


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      .   ...+.|||.|||||... ..|++..||||||+.|+||+|+..||..-..     .-.+.+.+..|.....+..-- 
T Consensus       200 ~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----~AQIYKKV~SGiKP~sl~kV~-  269 (632)
T KOG0584|consen  200 H---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----PAQIYKKVTSGIKPAALSKVK-  269 (632)
T ss_pred             c---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----HHHHHHHHHcCCCHHHhhccC-
Confidence            2   23378999999999776 7899999999999999999999999964333     222446666676655443211 


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                         +    ..+.+++..|+.. .++|||+.|+|+  +|..+
T Consensus       270 ---d----Pevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  270 ---D----PEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ---C----HHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence               1    2456788889999 999999999984  55443

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.9e-34  Score=294.59  Aligned_cols=270  Identities=23%  Similarity=0.253  Sum_probs=195.1

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccC---CC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVP---LE  390 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~---~~  390 (614)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.....  .....+.+|++++++++|+||+++++++.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            468999999999999999999965 689999999864322  223457789999999999999999987654321   12


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....++|+||+.. +|...+... ...+++.++..++.|+++||.|||   +.+++||||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCcc
Confidence            3467999999964 677776543 347999999999999999999999   89999999999999999999999999999


Q ss_pred             ceeCCCCCcc----------ccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccch-----
Q 043267          471 AKFNPEGITH----------LTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL-----  534 (614)
Q Consensus       471 a~~~~~~~~~----------~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-----  534 (614)
                      ++........          ..+...+++.|+|||.+.+. .++.++||||||+++|||++|+.|+.........     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9754332211          12334578889999988654 5899999999999999999999998543321100     


Q ss_pred             ----hhHHHHHHHHcCCchh--hhhccCCCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          535 ----LSDWAWELVKEGKTLD--VIEENMPEM---ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       535 ----l~~~~~~~~~~g~~~~--~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          ..++.|..+.......  ......+..   ........+.+++..|++.+|++|||+.|++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence                0001111111000000  000000000   00112256788999999999999999999874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-33  Score=294.07  Aligned_cols=272  Identities=24%  Similarity=0.284  Sum_probs=202.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...+.||+|+||.||+++.. +|..||||++....  ....+.+.+|+++++.++|+|++++.+++...........+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999975 58999999987543  34456789999999999999999999988643222234689


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ++|||++ ++|.+++....  .+++..+..++.++++||.|||   +.+|+||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999998 58988885533  7999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCc--cccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccch--hhH-------HHHHHH
Q 043267          476 EGIT--HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL--LSD-------WAWELV  543 (614)
Q Consensus       476 ~~~~--~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--l~~-------~~~~~~  543 (614)
                      ....  .......++..|+|||.+.+. .++.++||||||+++|||++|+.||.........  +.+       -.+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            4321  123345678899999999888 8999999999999999999999998543321100  000       000000


Q ss_pred             HcCCchhhhhccCCCC------CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH--hhcc
Q 043267          544 KEGKTLDVIEENMPEM------ELPEMMEQYVLTAAICAHPILQARPTMDQIVKI--LETD  596 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~  596 (614)
                      ......+.+.......      ..+.....+.+++..|++.+|++||++.++++.  +++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            0111111111000000      011234567889999999999999999999973  5443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4.5e-33  Score=291.57  Aligned_cols=244  Identities=29%  Similarity=0.413  Sum_probs=191.5

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      |...+.||+|+||+||+|+.. +|..|++|++....   ......+.+|+++++.++|+|++++.+++.     ++...+
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   97 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL-----KEHTAW   97 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEEE
Confidence            555678999999999999964 68899999986432   233456889999999999999999999987     567789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+. |+|.+++.... ..+++.++..++.|++.||.|||   +.+++||||||+||++++++.+||+|||++....
T Consensus        98 lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~  172 (313)
T cd06633          98 LVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS  172 (313)
T ss_pred             EEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccC
Confidence            9999995 68888775433 46899999999999999999999   8899999999999999999999999999986432


Q ss_pred             CCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          476 EGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .     .....|+..|+|||++.   .+.++.++||||||+++|||++|+.|+.....     ......... +..    
T Consensus       173 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~-----~~~~~~~~~-~~~----  237 (313)
T cd06633         173 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQ-NDS----  237 (313)
T ss_pred             C-----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHh-cCC----
Confidence            2     22356889999999974   46789999999999999999999999854322     111111111 111    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                          +..........+.+++..|++.+|++||++.++++.
T Consensus       238 ----~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 ----PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                111111223457788889999999999999999853

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.6e-33  Score=294.47  Aligned_cols=271  Identities=25%  Similarity=0.297  Sum_probs=199.4

Q ss_pred             CHHHHHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeec
Q 043267          309 KIEEIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTA  385 (614)
Q Consensus       309 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~  385 (614)
                      ..+++...+++|...+.||+|+||.||++.. .+|+.||+|+++..  +....+.+.+|++++++++|+||+++.+++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            3456677889999999999999999999985 47899999998753  22334567889999999999999999998754


Q ss_pred             ccCC-CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          386 TVPL-EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       386 ~~~~-~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                      .... .....+++++++ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEcCCCCEE
Confidence            3221 223467788876 7899888743   35899999999999999999999   89999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhH------
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD------  537 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~------  537 (614)
                      |+|||+++.....    .....++..|+|||...+ ..++.++||||||+++|||++|+.||....... .+..      
T Consensus       161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            9999998754322    233467899999998866 578899999999999999999999985322111 0000      


Q ss_pred             ----HHHHHHHcCCchhhhh--ccCCCCCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          538 ----WAWELVKEGKTLDVIE--ENMPEMEL----PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       538 ----~~~~~~~~g~~~~~~d--~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          .....+........+.  +..+....    ......+.+++..|++.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence                0011010000000000  00000000    012345778999999999999999999874

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.4e-33  Score=286.44  Aligned_cols=241  Identities=23%  Similarity=0.285  Sum_probs=184.6

Q ss_pred             eecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHH---HHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          325 IIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEI---IASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~i---l~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +||+|+||.||++... +|+.||+|.+.....   .....+..|..+   ++...|||++++.+++.     ++...++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----TPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeee-----cCCEEEEE
Confidence            4899999999999864 688999999864321   222234445443   44457999999998876     55678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++...  ..+++..+..|+.|+++||.|||   +.+++||||||+||++++++.+||+|||++......
T Consensus        76 ~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          76 LDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            9999999999988653  46999999999999999999999   899999999999999999999999999998754332


Q ss_pred             CccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .   .....|+..|+|||.+..+ .++.++||||+|+++|||++|+.||.........   ........      ....+
T Consensus       151 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~------~~~~~  218 (278)
T cd05606         151 K---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT------MAVEL  218 (278)
T ss_pred             C---CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH---HHHHHhhc------cCCCC
Confidence            1   2234689999999998755 6899999999999999999999999654321111   01111111      11112


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                      +.    .....+.+++..|++.+|.+||     ++.++++
T Consensus       219 ~~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 PD----SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             CC----cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            21    2245677888899999999999     9999985

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.7e-33  Score=295.65  Aligned_cols=278  Identities=23%  Similarity=0.267  Sum_probs=200.7

Q ss_pred             Ccc-ccceecccCceEEEEeEcC-CCcEEEEEEeecCChhh--------------hHHHHHHHHHHHHccccceeeeeee
Q 043267          319 NFS-RENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAG--------------DANFKHEVEIIASVKHVNLVALRGY  382 (614)
Q Consensus       319 ~f~-~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~--------------~~~f~~Ei~il~~l~H~niv~l~g~  382 (614)
                      +|. ..+.||+|+||.||+|+.. +|+.||||.++......              ...+.+|+++++.++|+|+++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            444 3477999999999999965 68999999986432211              1247789999999999999999999


Q ss_pred             eecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       383 ~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      +.     .+...++||||++ |+|.+++...  ..+++.....++.|++.||+|||   +.+++||||||+||+++.++.
T Consensus        89 ~~-----~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         89 YV-----EGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             Ee-----cCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCC
Confidence            86     5678899999996 6999988543  46899999999999999999999   899999999999999999999


Q ss_pred             EEEeecCCceeCCCCC-------------ccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccc
Q 043267          463 AKVGDFGLAKFNPEGI-------------THLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEII  528 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~  528 (614)
                      +||+|||+++......             ........++..|+|||++.+. .++.++||||+|+++|||++|+.|+...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999997654110             0111223468899999998764 4789999999999999999999998644


Q ss_pred             cCccchhhHHHHHHHHcCCch---h--------hhhccCCCC---CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh-
Q 043267          529 QGKSVLLSDWAWELVKEGKTL---D--------VIEENMPEM---ELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL-  593 (614)
Q Consensus       529 ~~~~~~l~~~~~~~~~~g~~~---~--------~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L-  593 (614)
                      ....  ....+..........   +        ......+..   ........+.+++..|++.+|++|||++|++..- 
T Consensus       238 ~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        238 NEID--QLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             CHHH--HHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            3211  111111111110000   0        000000000   0112245677899999999999999999998532 


Q ss_pred             -hcc-CCCCCchhhHHHH
Q 043267          594 -ETD-VPLSNIKIFLAAL  609 (614)
Q Consensus       594 -~~~-~~~p~~p~~~~~~  609 (614)
                       .+. .+.-..|+|++.+
T Consensus       316 ~~~~~~~~~~~~~~~~~~  333 (335)
T PTZ00024        316 FKSDPLPCDPSQLPFNFL  333 (335)
T ss_pred             cCCCCCCCCcccCChhhh
Confidence             222 3444566777654

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.3e-33  Score=283.35  Aligned_cols=248  Identities=24%  Similarity=0.279  Sum_probs=191.7

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC-----ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-----SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||+++.. .+..+++|.++..     ......++..|++++++++|||++++++++.     +..
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            4677889999999999999864 3445556655431     2223445778999999999999999999876     456


Q ss_pred             eEEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          393 QRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ..++|+||+++++|.+++..  .....+++.+++.++.|+++||.|||   +.+++|+||||+||++++ +.+||+|||+
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCc
Confidence            78999999999999998865  33457999999999999999999999   899999999999999986 4699999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++....... ......|+..|+|||...+..++.++|+||||+++|+|++|+.|+.....     ...... ...+..  
T Consensus       152 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~-----~~~~~~-~~~~~~--  222 (260)
T cd08222         152 SRLLMGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF-----LSVVLR-IVEGPT--  222 (260)
T ss_pred             eeecCCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH-----HHHHHH-HHcCCC--
Confidence            976543221 22335678899999999888899999999999999999999999853221     111111 111111  


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                             ..........+.+++..|++.+|++||++.|+++
T Consensus       223 -------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 -------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                   1112233456778899999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=293.88  Aligned_cols=262  Identities=22%  Similarity=0.308  Sum_probs=212.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .-|..++.||+|.|..|-++++- .|..||||++.+.  +......+..|+..|+.++|||||+|+.+..     ....+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViD-----TQTKl   92 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVID-----TQTKL   92 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhc-----ccceE
Confidence            34667788999999999988853 8999999999753  3445567889999999999999999999876     45678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE-CCCCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL-DEAFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL-d~~~~~kl~DFGla~~  473 (614)
                      |||.|.-.+|+|+|||.++. ..+.+....+++.||..|+.|.|   +..+|||||||+||.+ ..-|-+||.|||++..
T Consensus        93 yLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNk  168 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNK  168 (864)
T ss_pred             EEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeecccccc
Confidence            99999999999999998754 46899999999999999999999   9999999999999876 5678899999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLT-PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      +..+..  .+..+|...|-|||++.+..|+ ++.||||+||+||.|++|+.||+..++.+..              ..++
T Consensus       169 f~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL--------------TmIm  232 (864)
T KOG4717|consen  169 FQPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL--------------TMIM  232 (864)
T ss_pred             CCCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh--------------hhhh
Confidence            665543  3557899999999999999987 6899999999999999999999765543321              1222


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCchhhH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIKIFL  606 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p~~~  606 (614)
                      |-.  -..+.....++.+++..|+..||.+|.+.+|++.  .|....+.++-.|||
T Consensus       233 DCK--YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPL  286 (864)
T KOG4717|consen  233 DCK--YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPL  286 (864)
T ss_pred             ccc--ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCce
Confidence            322  1234556778999999999999999999999874  344444444434554

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-33  Score=284.94  Aligned_cols=258  Identities=25%  Similarity=0.304  Sum_probs=196.5

Q ss_pred             ccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      |+..+.||+|+||.||+|+.. +++.||+|.+....  ....+.+.+|++++++++|+|++++.+++.     +....++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            455678999999999999976 58999999997643  333467788999999999999999999986     4578899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |+||++ ++|.+++.... ..+++..+.+++.++++||+|||   +.+|+||||+|+||++++++.+||+|||+++....
T Consensus        76 v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            999998 59999997643 46999999999999999999999   88999999999999999999999999999986544


Q ss_pred             CCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccch---------hhHHHHHHHHcC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL---------LSDWAWELVKEG  546 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~---------l~~~~~~~~~~g  546 (614)
                      ... ......++..|+|||.+... .++.++||||||+++|||++|+.|+.........         ..+..|..+..-
T Consensus       151 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07829         151 PLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL  229 (282)
T ss_pred             Ccc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccc
Confidence            322 22234467889999998877 8899999999999999999999988543211000         001111111110


Q ss_pred             CchhhhhccCCC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPE-------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .   ..+...+.       ...+.....+.+++..|++.+|++||++.+++.
T Consensus       230 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         230 P---DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             c---cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0   00100100       001122456889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=295.33  Aligned_cols=245  Identities=25%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      +.|+.-++||+||||.||-.+.. .|+.+|.|++.+.   .++++.-..+|-.++.+++.+.||.+--.+.     ..+.
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe-----Tkd~  259 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE-----TKDA  259 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec-----CCCc
Confidence            46888899999999999988854 6999999988542   2445666789999999999999998855554     5677


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +++|+..|.||+|.-||.+.+...++++..+-.+.+|+-||++||   +.+||+||+||+|||||+.|+++|+|.|||..
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEe
Confidence            899999999999999999888888999999999999999999999   99999999999999999999999999999998


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ++++...  ...+||.||||||++..+.|+...|+||+||++|||+.|+.||.......      .|         +-+|
T Consensus       337 i~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------k~---------eEvd  399 (591)
T KOG0986|consen  337 IPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------KR---------EEVD  399 (591)
T ss_pred             cCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------hH---------HHHH
Confidence            8776544  23389999999999999999999999999999999999999995332210      11         1112


Q ss_pred             ccC---CCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 043267          554 ENM---PEMELPEMMEQYVLTAAICAHPILQARPTMD  587 (614)
Q Consensus       554 ~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  587 (614)
                      .+.   +..++....+....+-..-++.||++|.--+
T Consensus       400 rr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  400 RRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             HHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            111   1222333344455555567899999886543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.7e-34  Score=321.79  Aligned_cols=267  Identities=25%  Similarity=0.301  Sum_probs=194.7

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecc-----
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTAT-----  386 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~-----  386 (614)
                      .+--.+|++.++||+||||.|||++.+ ||+.+|||++.-. +......+.+|+.++++|+|||+|+++......     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            345568999999999999999999976 9999999999743 344456788999999999999999986511000     


Q ss_pred             -------------------------------------------------------------------------------c
Q 043267          387 -------------------------------------------------------------------------------V  387 (614)
Q Consensus       387 -------------------------------------------------------------------------------~  387 (614)
                                                                                                     .
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                           0


Q ss_pred             CCC----------------------C--------ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHH
Q 043267          388 PLE----------------------G--------HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL  437 (614)
Q Consensus       388 ~~~----------------------~--------~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yL  437 (614)
                      ..+                      +        ..+||-||||+.-.|.+++.++.... .-...++++.+|++||.|+
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHH
Confidence            000                      0        23577799999888887776543211 3566789999999999999


Q ss_pred             hhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC------C-----------CCccccccccCCCCcCchhhhccC
Q 043267          438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP------E-----------GITHLTTRVAGTLGYVAPEYALYG  500 (614)
Q Consensus       438 H~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~------~-----------~~~~~~~~~~gt~~Y~APE~~~~~  500 (614)
                      |   +.+||||||||.||+||++..+||+|||+|....      +           ......+..+||.-|+|||.+...
T Consensus       714 H---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 H---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             H---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9   8999999999999999999999999999997511      0           011134567899999999998754


Q ss_pred             ---CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccc
Q 043267          501 ---KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAH  577 (614)
Q Consensus       501 ---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  577 (614)
                         +|+.|+|+||+||+++||+.   ||....+...     +...+++|.+..-      .....+.+..-.+++.++++
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~-----iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS-----ILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHhc---cCCchHHHHH-----HHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence               59999999999999999996   4532222111     1122233333222      11233445556788999999


Q ss_pred             cCCCCCCCHHHHHHHhhccCCCCC
Q 043267          578 PILQARPTMDQIVKILETDVPLSN  601 (614)
Q Consensus       578 ~dP~~RPt~~eVl~~L~~~~~~p~  601 (614)
                      .||.+|||+.|++   ..++..|+
T Consensus       857 hdP~kRPtA~eLL---~s~llppe  877 (1351)
T KOG1035|consen  857 HDPSKRPTATELL---NSELLPPE  877 (1351)
T ss_pred             CCCccCCCHHHHh---hccCCCcc
Confidence            9999999999884   45544433

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-33  Score=305.07  Aligned_cols=195  Identities=30%  Similarity=0.415  Sum_probs=170.1

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-c-----cceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-H-----VNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H-----~niv~l~g~~~~~~~~~~  391 (614)
                      +|.+.++||+|.||.|.|+.. ++++.||||++++.. .-..+-..|+.+|..++ |     -|+|++++++.     ..
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~-----fr  260 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFY-----FR  260 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccc-----cc
Confidence            788999999999999999995 469999999998743 33455678999999996 3     38999999987     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC--CCcEEEeecC
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE--AFEAKVGDFG  469 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~--~~~~kl~DFG  469 (614)
                      +.++||+|.+. -+|.++|..++...++....+.|+.||+.||.+||   +.+|||+||||+||||.+  ...+||+|||
T Consensus       261 ~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  261 NHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             cceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEecc
Confidence            78999999995 59999999988889999999999999999999999   999999999999999964  3479999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      .+.+......    ...-+..|.|||++.+.+|+.+.|||||||++.||++|.+.|..
T Consensus       337 SSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG  390 (586)
T KOG0667|consen  337 SSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG  390 (586)
T ss_pred             cccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence            9987554322    34567889999999999999999999999999999999777643

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.6e-33  Score=293.08  Aligned_cols=265  Identities=23%  Similarity=0.276  Sum_probs=198.1

Q ss_pred             HHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          312 EIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       312 el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      ++...+++|+..+.||+|+||.||++... +|..||||++...  .....+.+.+|+++++.++|||++++.+++..   
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~---   80 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFIS---   80 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEec---
Confidence            34457789999999999999999999854 7899999988542  22334667899999999999999999998753   


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                       .+...++++||+ +++|.+++..   ..+++.....++.|+++||.|||   +.+++||||||+||++++++.+||+||
T Consensus        81 -~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~df  152 (328)
T cd07856          81 -PLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDF  152 (328)
T ss_pred             -CCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcc
Confidence             345688999998 5689888753   35888889999999999999999   899999999999999999999999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccc--hh--------hH
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV--LL--------SD  537 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~l--------~~  537 (614)
                      |++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||........  .+        .+
T Consensus       153 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         153 GLARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             ccccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            998754322    123457889999998766 5789999999999999999999999853321100  00        01


Q ss_pred             HHHHHHHcCCchhhhhcc-CCCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          538 WAWELVKEGKTLDVIEEN-MPEMEL-----PEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       538 ~~~~~~~~g~~~~~~d~~-l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      +. +.+..+...+.+... .....+     +.....+.+++..|++.+|++|||+.+++..
T Consensus       229 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         229 VI-NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HH-HhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11 111111111111110 000001     1123577889999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-32  Score=290.39  Aligned_cols=268  Identities=24%  Similarity=0.325  Sum_probs=198.1

Q ss_pred             HHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC-
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE-  390 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~-  390 (614)
                      ...++|...+.||+|+||.||++.. .+|..||||++...  .......+.+|++++++++|+||+++++++....... 
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3566899999999999999999985 47899999998642  2333456889999999999999999999876432211 


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....++||||+ +++|.+++..   ..+++..++.++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence            13568999998 7799888753   36899999999999999999999   89999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch----------hhHHH
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL----------LSDWA  539 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----------l~~~~  539 (614)
                      +......    .....+++.|+|||.+.+ ..++.++|+||+|+++||+++|+.||.........          ..++ 
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-  239 (343)
T cd07880         165 ARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF-  239 (343)
T ss_pred             ccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH-
Confidence            9754432    223457889999999876 46889999999999999999999998533211000          0000 


Q ss_pred             HHHHHcCCchhhhhccCCCCC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhhc
Q 043267          540 WELVKEGKTLDVIEENMPEME-------LPEMMEQYVLTAAICAHPILQARPTMDQIV--KILET  595 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl--~~L~~  595 (614)
                      +..+.......... .++...       .......+.+++..|++.||++|||+.+++  ..++.
T Consensus       240 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~  303 (343)
T cd07880         240 VQKLQSEDAKNYVK-KLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEE  303 (343)
T ss_pred             HHhhcchhHHHHHH-hccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhh
Confidence            01111111111110 010000       012233577899999999999999999998  44444

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-33  Score=295.25  Aligned_cols=250  Identities=20%  Similarity=0.294  Sum_probs=200.5

Q ss_pred             HHhcCccccceecccCceEEEEeEcCCCcEEEEEEee--cCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~  391 (614)
                      .....|++.+.||+||.++||++...+.+.+|+|++.  ..+.+...-|.+|+++|.++ .|.+||+|++|-.     .+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv-----~d  432 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV-----TD  432 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-----cC
Confidence            3445688889999999999999999888999999875  34566678899999999999 5999999999975     57


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +.+|+||||= +-+|..+|.+.......| .+..+..||+.++.++|   +.+|||.||||.|+|+-. |.+||+|||+|
T Consensus       433 ~~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlVk-G~LKLIDFGIA  506 (677)
T KOG0596|consen  433 GYLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLVK-GRLKLIDFGIA  506 (677)
T ss_pred             ceEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEEe-eeEEeeeechh
Confidence            8899999996 458999998776666667 67778999999999999   999999999999999976 47999999999


Q ss_pred             eeCCCCCcc-ccccccCCCCcCchhhhccC-----------CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH
Q 043267          472 KFNPEGITH-LTTRVAGTLGYVAPEYALYG-----------KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       472 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~-----------~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~  539 (614)
                      .....+... .....+||..||+||.+...           +.+.+|||||+||+||+|+.|+.||.....      .| 
T Consensus       507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n------~~-  579 (677)
T KOG0596|consen  507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN------QI-  579 (677)
T ss_pred             cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH------HH-
Confidence            987765443 34557899999999988633           356789999999999999999999963321      11 


Q ss_pred             HHHHHcCCchhhhhccC----CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          540 WELVKEGKTLDVIEENM----PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ..     +..+.|+.-    +......   .++++++.|++.||.+||++.|+++
T Consensus       580 -aK-----l~aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 -AK-----LHAITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             -HH-----HHhhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhc
Confidence             11     122333321    1111122   2889999999999999999999975

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-32  Score=292.01  Aligned_cols=269  Identities=21%  Similarity=0.242  Sum_probs=195.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC--------
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP--------  388 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~--------  388 (614)
                      .+|...+.||+|+||.||+|+.. +|..||+|.+........+.+.+|++++++++|||++++++++.....        
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            57889999999999999999964 689999999976555566778899999999999999999987653211        


Q ss_pred             -CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-CCCcEEEe
Q 043267          389 -LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVG  466 (614)
Q Consensus       389 -~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-~~~~~kl~  466 (614)
                       .+....++|+||++ ++|.+++..   ..+++.....++.|+++||.|||   +.+++||||||+||+++ +++.+|++
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEEC
Confidence             01235789999997 588888743   35899999999999999999999   88999999999999997 55678999


Q ss_pred             ecCCceeCCCCCcc--ccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH---
Q 043267          467 DFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW---  540 (614)
Q Consensus       467 DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~---  540 (614)
                      |||+++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||........ ......   
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~~~~  236 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILESVP  236 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcC
Confidence            99999765332211  1233457889999998764 4688899999999999999999999954322110 000000   


Q ss_pred             -------HHHHcCCchhhhh--ccCCCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhhc
Q 043267          541 -------ELVKEGKTLDVIE--ENMPEME----LPEMMEQYVLTAAICAHPILQARPTMDQIV--KILET  595 (614)
Q Consensus       541 -------~~~~~g~~~~~~d--~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl--~~L~~  595 (614)
                             .....+ ......  .......    .......+.+++..|++.||++|||+.|++  ..++.
T Consensus       237 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~  305 (342)
T cd07854         237 VVREEDRNELLNV-IPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC  305 (342)
T ss_pred             CCChHHhhhhhhh-hhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence                   000000 000000  0000000    012234677899999999999999999998  44543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.4e-33  Score=293.75  Aligned_cols=264  Identities=23%  Similarity=0.285  Sum_probs=195.8

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~  391 (614)
                      ..++|...+.||+|+||.||+|+.. +++.||||++...  +......+.+|++++++++|+|++++.+++..... .+.
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4568999999999999999999975 6889999998642  22334567789999999999999999987653221 122


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++|+||+ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+||++++++.+||+|||++
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~  165 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLA  165 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence            3479999998 6799998854   46999999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhH----------HHH
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD----------WAW  540 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~----------~~~  540 (614)
                      ......    .....++..|+|||.... ..++.++||||||+++||+++|+.||........ +..          -.+
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~-~~~i~~~~~~~~~~~~  240 (343)
T cd07851         166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQ-LKRIMNLVGTPDEELL  240 (343)
T ss_pred             cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHhcCCCCHHHH
Confidence            865432    233457889999999865 3688999999999999999999999853322110 000          000


Q ss_pred             HHHHcCCchhhhhccCC--CCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          541 ELVKEGKTLDVIEENMP--EME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~--~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+........+.....  ...    .......+.+++..|++.+|++|||+.+|++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00000000001000000  000    0112457889999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.5e-32  Score=288.18  Aligned_cols=264  Identities=22%  Similarity=0.260  Sum_probs=191.5

Q ss_pred             CccccceecccCceEEEEeEcC-C--CcEEEEEEeecC--ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-N--GTEVAVKRFKNC--SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~--g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||+++.. .  +..||+|++...  .......+.+|+++++++ +|+||+++++.+.... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            4777899999999999999964 3  788999998642  222345678899999999 5999999998754321 1234


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++++||+. ++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            5678888885 6899888543  46899999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCcc---ccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch----------hhHH
Q 043267          473 FNPEGITH---LTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL----------LSDW  538 (614)
Q Consensus       473 ~~~~~~~~---~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~----------l~~~  538 (614)
                      ........   ......||..|+|||+..+ ..++.++||||+|+++|||++|+.|+.........          ..++
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            65432211   1234568999999998766 46899999999999999999999998543211000          0001


Q ss_pred             HHHHHHcCCchhhhhc--cCCC----CCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          539 AWELVKEGKTLDVIEE--NMPE----MELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~--~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      . ..+...........  ..+.    ...+.....+.+++..|++.||++|||+.+++
T Consensus       234 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll  290 (332)
T cd07857         234 L-SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL  290 (332)
T ss_pred             H-HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            0 00000000000000  0000    00011234678899999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-34  Score=303.80  Aligned_cols=249  Identities=22%  Similarity=0.301  Sum_probs=198.7

Q ss_pred             ccccceecccCceEEEEeEcCC-CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      |.+...||.|+||+|||++.++ +-..|-|.+...+....++|.-||++|+...||+||+|++.+.     .++.+++..
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy-----~enkLwili  108 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYY-----FENKLWILI  108 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHh-----ccCceEEEE
Confidence            4455679999999999999775 3445788888878888899999999999999999999999765     467789999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      |||.||-.+..+..- .+.|+..++.-++++++.||.|||   +.+|||||||+.|||++-+|.++|+|||.+...... 
T Consensus       109 EFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-  183 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-  183 (1187)
T ss_pred             eecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEeeecccccccchhH-
Confidence            999999998877553 367999999999999999999999   999999999999999999999999999997543221 


Q ss_pred             ccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          479 THLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       479 ~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ........||+.|||||+.+     ..+|+.++||||||++|.||..+.+|-.....-.+.     .+ +....     .
T Consensus       184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl-----lK-iaKSe-----P  252 (1187)
T KOG0579|consen  184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-----LK-IAKSE-----P  252 (1187)
T ss_pred             HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH-----HH-HhhcC-----C
Confidence            22345578999999999876     458999999999999999999999987543321111     01 11100     1


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.+.  .+......+.++...|+..||..||++.++++
T Consensus       253 PTLl--qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  253 PTLL--QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             Cccc--CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1111  12344556778888899999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=282.85  Aligned_cols=264  Identities=23%  Similarity=0.317  Sum_probs=214.5

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeee
Q 043267          310 IEEIKAATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGY  382 (614)
Q Consensus       310 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~  382 (614)
                      ..++.....++....++-+|.||.||.|.+.      +.++|-||.++.. +.-....+..|.-++..+.|||+....++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3455556667888888999999999999653      3466888888753 44445678889999999999999999999


Q ss_pred             eecccCCCCceEEEEEeecCCCChhhhhhc------CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeE
Q 043267          383 STATVPLEGHQRIIVCDLLHNGSLYDHLFG------SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL  456 (614)
Q Consensus       383 ~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NIL  456 (614)
                      +..    +....++.|.++.-|+|..+|..      +..+.++-.+...++.|++.|++|||   +.++||.||.++|.+
T Consensus       356 ~ie----~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCv  428 (563)
T KOG1024|consen  356 SIE----DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCV  428 (563)
T ss_pred             Eee----ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcce
Confidence            985    56678899999999999999982      33456888889999999999999999   999999999999999


Q ss_pred             ECCCCcEEEeecCCceeC-CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccch
Q 043267          457 LDEAFEAKVGDFGLAKFN-PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL  534 (614)
Q Consensus       457 Ld~~~~~kl~DFGla~~~-~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~  534 (614)
                      +|+...+||+|-.+++.. +.+.............||+||.+....|+..+|||||||+||||+| |+.|+......+  
T Consensus       429 Idd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE--  506 (563)
T KOG1024|consen  429 IDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE--  506 (563)
T ss_pred             ehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH--
Confidence            999999999999999854 4443334444556789999999999999999999999999999999 999986444322  


Q ss_pred             hhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          535 LSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       535 l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                          +...+++|.+...         +.+...++..++.-||..+|++||+.+|++.-|.+
T Consensus       507 ----m~~ylkdGyRlaQ---------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  507 ----MEHYLKDGYRLAQ---------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ----HHHHHhccceecC---------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence                2355666655422         23445567888888999999999999999988875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-33  Score=303.82  Aligned_cols=206  Identities=31%  Similarity=0.414  Sum_probs=175.1

Q ss_pred             ccccceecccCceEEEEeEc-CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeeccc-CCCCceEEE
Q 043267          320 FSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATV-PLEGHQRII  396 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~-~~~~~~~~l  396 (614)
                      +...+.||+|+||.||+|+. ..|+.||||.++.. .....+...+|++++++++|+|||++++.-.... .......++
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            45567899999999999995 47999999999753 3455677899999999999999999998754332 112457899


Q ss_pred             EEeecCCCChhhhhhc-CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC--CCC--cEEEeecCCc
Q 043267          397 VCDLLHNGSLYDHLFG-SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD--EAF--EAKVGDFGLA  471 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd--~~~--~~kl~DFGla  471 (614)
                      ||||+.+|||...|.+ ++...|+..+.+.+..++..||.|||   +++|+||||||.||++-  ++|  .-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999976 34567999999999999999999999   99999999999999993  223  4699999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccC
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQG  530 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  530 (614)
                      +..+++.  ..+...||..|++||.... +.|+...|.|||||++||.+||..||....+
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~  229 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG  229 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence            9877654  5566889999999999984 8899999999999999999999999954443

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-32  Score=273.56  Aligned_cols=236  Identities=27%  Similarity=0.273  Sum_probs=190.3

Q ss_pred             ecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       326 LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ||+|+||.||+++.. +++.+|+|.+.....   ...+.+.+|++++++++|+|++++++.+.     .+...+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQ-----TEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHee-----cCCeeEEEEecC
Confidence            699999999999975 589999999875332   24567899999999999999999998875     567889999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      ++++|.+++....  .+++.....++.|+++||.|||   +.+++|+||||+||+++.++.++|+|||++....... ..
T Consensus        76 ~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~  149 (250)
T cd05123          76 PGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SR  149 (250)
T ss_pred             CCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cc
Confidence            9999999996543  6899999999999999999999   8999999999999999999999999999997654322 12


Q ss_pred             cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      .....++..|++||...+...+.++|+||||+++||+++|+.||.....     ....... ..+      ...++.   
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~-~~~------~~~~~~---  214 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-----KEIYEKI-LKD------PLRFPE---  214 (250)
T ss_pred             ccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHH-hcC------CCCCCC---
Confidence            3445688999999999988899999999999999999999999853321     1111111 111      111111   


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHH
Q 043267          562 PEMMEQYVLTAAICAHPILQARPTMDQ  588 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt~~e  588 (614)
                       .....+.+++..|+..||++||++.+
T Consensus       215 -~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 -FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             -CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence             12346678899999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=272.60  Aligned_cols=246  Identities=24%  Similarity=0.334  Sum_probs=190.5

Q ss_pred             cceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      ...||.|..|.|++.+.. .|..+|||.+.... ....+.+...++++.+-+ .|.||+.+||+.     .+....+.||
T Consensus        97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi-----~n~dV~IcMe  171 (391)
T KOG0983|consen   97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI-----TNTDVFICME  171 (391)
T ss_pred             HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe-----eCchHHHHHH
Confidence            467999999999999965 68899999997643 444566778888776664 899999999997     4455678888


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT  479 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~  479 (614)
                      .|. .-++.++.. -..++++...-++...+.+||.||.+  +.+|+|||+||+|||+|+.|++|++|||++-.+-+.. 
T Consensus       172 lMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  172 LMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             HHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            883 234444433 33568888889999999999999996  7799999999999999999999999999997665543 


Q ss_pred             cccccccCCCCcCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          480 HLTTRVAGTLGYVAPEYALY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       480 ~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                       ..++.+|-+.|||||.+.-   ..|+.++||||||+.++||.||+.||.....+-..+.    ...      +-..+.+
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~lt----kvl------n~ePP~L  315 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLT----KVL------NEEPPLL  315 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHH----HHH------hcCCCCC
Confidence             4567789999999998863   4799999999999999999999999965443222111    111      1111333


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +..  ......+.+++..|++.|+.+||...++++
T Consensus       316 ~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  316 PGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             Ccc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            321  125567888999999999999999998875

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-32  Score=294.39  Aligned_cols=248  Identities=27%  Similarity=0.336  Sum_probs=200.4

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ...+|.+.+.||+|.|++|..++.. .|.+||||.+++..  ......+.+|+++|+.++|||||+++++..     ...
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~-----t~~  128 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE-----TEA  128 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee-----ecc
Confidence            3457888999999999999999965 69999999997633  333456889999999999999999999986     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      .+++||||..+|.+++++..++  .+.......++.|+.++++|+|   +..|+|||||++||||+.++++||+|||++.
T Consensus       129 ~lylV~eya~~ge~~~yl~~~g--r~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHG--RMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcc--cchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccce
Confidence            8999999999999999998765  4555888889999999999999   9999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLT-PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      .+..+  ......+|++.|.|||++.+.+|. ++.|+||+|+++|-|++|..||+...-...              ...+
T Consensus       204 ~~~~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L--------------r~rv  267 (596)
T KOG0586|consen  204 FFDYG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL--------------RPRV  267 (596)
T ss_pred             eeccc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc--------------cchh
Confidence            77643  345567899999999999988764 799999999999999999999974321110              0111


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +...++-  +......+-+++...+-.+|.+|++++++.+
T Consensus       268 l~gk~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  268 LRGKYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             eeeeecc--cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence            1111111  1112234566777788899999999999864

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.4e-34  Score=322.76  Aligned_cols=256  Identities=28%  Similarity=0.357  Sum_probs=201.9

Q ss_pred             HHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      +...+-++...+.||.|.||.||.+.. .+|.-.|+|-++..  .......+.+|..++..++|||+|+.+|+-.     
T Consensus      1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv----- 1304 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV----- 1304 (1509)
T ss_pred             hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-----
Confidence            445566788889999999999999995 46888999987643  2344567889999999999999999999865     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      ..+..+|.||||++|+|.+.+...  +-.++..-..+..|++.|+.|||   +.+||||||||.||+||.+|-+|++|||
T Consensus      1305 HRekv~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFG 1379 (1509)
T KOG4645|consen 1305 HREKVYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFG 1379 (1509)
T ss_pred             cHHHHHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeeccc
Confidence            566788999999999999998543  34555666667889999999999   9999999999999999999999999999


Q ss_pred             CceeCCCCC---ccccccccCCCCcCchhhhccC---CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH-HHH
Q 043267          470 LAKFNPEGI---THLTTRVAGTLGYVAPEYALYG---KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA-WEL  542 (614)
Q Consensus       470 la~~~~~~~---~~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~-~~~  542 (614)
                      .|.......   ........||+.|||||++.+.   ....+.||||+|||++||+||++||.....      +|+ .-+
T Consensus      1380 sa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn------e~aIMy~ 1453 (1509)
T KOG4645|consen 1380 SAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN------EWAIMYH 1453 (1509)
T ss_pred             ceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc------hhHHHhH
Confidence            998655432   1223456899999999999754   356789999999999999999999965543      232 234


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                      +..|...++-+         .....=.+++..|++.||++|-++.|+++.=
T Consensus      1454 V~~gh~Pq~P~---------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1454 VAAGHKPQIPE---------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             HhccCCCCCch---------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence            45555443321         2334456677789999999998888777653

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=5.9e-34  Score=277.30  Aligned_cols=251  Identities=26%  Similarity=0.289  Sum_probs=194.9

Q ss_pred             cceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      ...||.|.||+|+|-.++ .|+..|||++.... ..+..++..|.+...+- +.||||+++|.+.     .++..++-||
T Consensus        69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F-----~EGdcWiCME  143 (361)
T KOG1006|consen   69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALF-----SEGDCWICME  143 (361)
T ss_pred             HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhh-----cCCceeeeHH
Confidence            467999999999999864 79999999998543 46677899999876555 7899999999886     6677899999


Q ss_pred             ecCCCChhhhhh---cCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          400 LLHNGSLYDHLF---GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       400 ~~~~GsL~~~L~---~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      .|. -||+.+..   .-....+++...-.|...+..||.||-+  +..|||||+||+|||||..|.+||+|||++-...+
T Consensus       144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~  220 (361)
T KOG1006|consen  144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD  220 (361)
T ss_pred             HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence            994 57766543   3345679999999999999999999997  67899999999999999999999999999976544


Q ss_pred             CCccccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      .  ...+.-+|-..|||||.+..  ..|+.+|||||+|++|+|+.||+.|+....+    +-+.+.. +-.|....+.  
T Consensus       221 S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~-Vv~gdpp~l~--  291 (361)
T KOG1006|consen  221 S--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQ-VVIGDPPILL--  291 (361)
T ss_pred             H--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHH-HHcCCCCeec--
Confidence            3  23455678999999998863  3599999999999999999999999965443    1122211 2222222111  


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                        .+....+....++.++-.|+-.|-.+||...++.++
T Consensus       292 --~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 --FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             --CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              111223345567788888999999999999988753

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=1.1e-31  Score=302.06  Aligned_cols=263  Identities=18%  Similarity=0.157  Sum_probs=170.9

Q ss_pred             HhcCccccceecccCceEEEEeEcC-C----CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeee-eecccCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-N----GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY-STATVPL  389 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~----g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~-~~~~~~~  389 (614)
                      ..++|...+.||+|+||.||+|++. +    +..||||++.....  .+.+.+|  .+....+.++..+... .......
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4568999999999999999999975 4    68999998864321  1111111  1222222333222221 1111112


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCC------------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGM------------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~------------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                      .+...++||||+++++|.+++.....                  .......+..|+.|+++||+|||   +.+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCC
Confidence            56788999999999999999865321                  01123345679999999999999   8899999999


Q ss_pred             CCCeEECC-CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccC----------------------CCCchhhH
Q 043267          452 ASNILLDE-AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG----------------------KLTPGSDV  508 (614)
Q Consensus       452 p~NILLd~-~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~----------------------~~t~ksDV  508 (614)
                      |+|||+++ ++.+||+|||+++....+.........+|+.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 68999999999986655444445567789999999965422                      24456799


Q ss_pred             HHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh----hhhccCCCC------CcHHHHHHHHHHHHHcccc
Q 043267          509 YSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD----VIEENMPEM------ELPEMMEQYVLTAAICAHP  578 (614)
Q Consensus       509 wS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~----~~d~~l~~~------~~~~~~~~l~~l~~~Cl~~  578 (614)
                      |||||++|||+++..+.+..      +..+.......+....    .+++.....      ..........+++..|++.
T Consensus       363 wSlGviL~el~~~~~~~~~~------~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSN------LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchH------HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            99999999999977654321      1111111111111000    001110000      0000111344788999999


Q ss_pred             CCCCCCCHHHHHH
Q 043267          579 ILQARPTMDQIVK  591 (614)
Q Consensus       579 dP~~RPt~~eVl~  591 (614)
                      ||++|||+.|+++
T Consensus       437 dP~kR~ta~e~L~  449 (566)
T PLN03225        437 KGRQRISAKAALA  449 (566)
T ss_pred             CcccCCCHHHHhC
Confidence            9999999999986

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=1.6e-31  Score=265.00  Aligned_cols=238  Identities=29%  Similarity=0.322  Sum_probs=192.4

Q ss_pred             CceEEEEeEcC-CCcEEEEEEeecCChhh-hHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChh
Q 043267          330 GYGNVYKGMLP-NGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY  407 (614)
Q Consensus       330 ~fG~Vykg~~~-~g~~VAVK~l~~~~~~~-~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~  407 (614)
                      +||.||+|+.. +|+.+|+|++....... .+.+.+|++.+++++|+|++++.+++.     .....++++||+++++|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFE-----DEDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhhee-----eCCEEEEEEeCCCCCCHH
Confidence            58999999986 58999999997654444 678999999999999999999999986     457889999999999999


Q ss_pred             hhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccC
Q 043267          408 DHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG  487 (614)
Q Consensus       408 ~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~g  487 (614)
                      +++....  .+++..+..++.++++++.|||   +.+++|+||+|+||++++++.++|+|||.+.......  ......+
T Consensus        76 ~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~  148 (244)
T smart00220       76 DLLKKRG--RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVG  148 (244)
T ss_pred             HHHHhcc--CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccC
Confidence            9986543  3899999999999999999999   8899999999999999999999999999998665432  2334568


Q ss_pred             CCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHH
Q 043267          488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQ  567 (614)
Q Consensus       488 t~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~  567 (614)
                      +..|++||......++.++||||+|++++||++|+.|+.......     -..+....+....       ..........
T Consensus       149 ~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-----~~~~~~~~~~~~~-------~~~~~~~~~~  216 (244)
T smart00220      149 TPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-----ELFKKIGKPKPPF-------PPPEWKISPE  216 (244)
T ss_pred             CcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HHHHHHhccCCCC-------ccccccCCHH
Confidence            889999999998899999999999999999999999985422111     1112222211110       0000003457


Q ss_pred             HHHHHHHccccCCCCCCCHHHHHH
Q 043267          568 YVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       568 l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.+++.+|+..+|++||++.++++
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhh
Confidence            888999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.98  E-value=2.1e-32  Score=270.41  Aligned_cols=271  Identities=22%  Similarity=0.255  Sum_probs=217.3

Q ss_pred             hcCcccc-ceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRE-NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      |++|++. ++||-|-.|+|.....+ .|+.+|+|++.+.     ....+|+++.-.. .|||||.+++++..... ....
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~-~rkc  133 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQ-GRKC  133 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhcc-Ccee
Confidence            4445443 57999999999988865 7889999988752     3456788875555 79999999999875543 4567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCcEEEeecCC
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFEAKVGDFGL  470 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~~kl~DFGl  470 (614)
                      +++|||.|+||.|+..+.+++...+++.+.-+|..||+.|+.|||   +.+|.||||||+|+|.+.   |-.+||+|||+
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEeccccc
Confidence            889999999999999999998889999999999999999999999   999999999999999964   55689999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      |+.....  ......+-|+.|.|||++...+|+...|+||+||++|-|++|.+||....+.  .+..-+...++.|..  
T Consensus       211 AK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~--aispgMk~rI~~gqy--  284 (400)
T KOG0604|consen  211 AKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL--AISPGMKRRIRTGQY--  284 (400)
T ss_pred             ccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc--cCChhHHhHhhccCc--
Confidence            9965432  2234456799999999999999999999999999999999999999765552  333334444444432  


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCchhhH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIKIFL  606 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p~~~  606 (614)
                          .+++.......+..-++++..+..+|.+|.|+.|++.  .+.+...+|..|+.-
T Consensus       285 ----~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~t  338 (400)
T KOG0604|consen  285 ----EFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLST  338 (400)
T ss_pred             ----cCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCchh
Confidence                3455556677777888999999999999999999984  455566677766543

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=1.1e-31  Score=269.66  Aligned_cols=220  Identities=22%  Similarity=0.209  Sum_probs=174.8

Q ss_pred             cCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChh
Q 043267          329 GGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY  407 (614)
Q Consensus       329 G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~  407 (614)
                      |.||.||+++.. +|+.+|+|++...+     .+..|...+....|||++++++++.     ++...+++|||+++|+|.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~   73 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLW   73 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHH
Confidence            899999999965 78999999997632     2344555566678999999999876     567889999999999999


Q ss_pred             hhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccC
Q 043267          408 DHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG  487 (614)
Q Consensus       408 ~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~g  487 (614)
                      +++....  .+++.....++.|+++||+|||   +.+++||||||+||++++++.++++|||.+......    .....+
T Consensus        74 ~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~  144 (237)
T cd05576          74 SHISKFL--NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAV  144 (237)
T ss_pred             HHHHHhc--CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCc
Confidence            9986543  5899999999999999999999   899999999999999999999999999987654332    122345


Q ss_pred             CCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHH
Q 043267          488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQ  567 (614)
Q Consensus       488 t~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~  567 (614)
                      +..|+|||....+.++.++||||+|+++|||++|+.|+......           +...     ....++    ......
T Consensus       145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----------~~~~-----~~~~~~----~~~~~~  204 (237)
T cd05576         145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----------INTH-----TTLNIP----EWVSEE  204 (237)
T ss_pred             CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----------cccc-----cccCCc----ccCCHH
Confidence            77899999998888999999999999999999999876422110           0000     000111    122346


Q ss_pred             HHHHHHHccccCCCCCCCHH
Q 043267          568 YVLTAAICAHPILQARPTMD  587 (614)
Q Consensus       568 l~~l~~~Cl~~dP~~RPt~~  587 (614)
                      +.+++..|++.||++||++.
T Consensus       205 ~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         205 ARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHHccCCHHHhcCCC
Confidence            77888999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-32  Score=270.01  Aligned_cols=262  Identities=23%  Similarity=0.311  Sum_probs=202.9

Q ss_pred             CHHHHHHHhcCccccceecccCceEEEEeE-cCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecc
Q 043267          309 KIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTAT  386 (614)
Q Consensus       309 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~  386 (614)
                      +++++-+.|     .++||+|+|+.|-..+ +.+|.++|||++.+..........+|++++... .|+||+.|+.|+.  
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE--  146 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFE--  146 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhc--
Confidence            456666555     3689999999999887 578999999999988777788899999999999 5999999999997  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC---cE
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF---EA  463 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~---~~  463 (614)
                         ++...|||||-|.+|+|..+|.+.  +.+++.+..++..+|+.||.+||   .++|.|||+||+|||-....   -+
T Consensus       147 ---dd~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPv  218 (463)
T KOG0607|consen  147 ---DDTRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPV  218 (463)
T ss_pred             ---ccceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCce
Confidence               667889999999999999999764  47999999999999999999999   99999999999999997654   47


Q ss_pred             EEeecCCceeC--CCCCc----cccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCcc
Q 043267          464 KVGDFGLAKFN--PEGIT----HLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS  532 (614)
Q Consensus       464 kl~DFGla~~~--~~~~~----~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~  532 (614)
                      ||+||.+..-.  ..+.+    ......+|+..|||||+..     ...|+.+.|.||+||++|-|++|..||...-+.+
T Consensus       219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d  298 (463)
T KOG0607|consen  219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD  298 (463)
T ss_pred             eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence            99999987532  22222    2233467888999999864     2368899999999999999999999996554422


Q ss_pred             ch---------hhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          533 VL---------LSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       533 ~~---------l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      --         =.....+.+.+|+.      .+++.......+..-+++...+-.++.+|-++.+++.
T Consensus       299 CGWdrGe~Cr~CQ~~LFesIQEGkY------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  299 CGWDRGEVCRVCQNKLFESIQEGKY------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccCCCccHHHHHHHHHHHhccCC------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            10         01112233333332      1233333344445556666667799999999999886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=3.6e-31  Score=304.28  Aligned_cols=145  Identities=28%  Similarity=0.351  Sum_probs=128.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|... +++.||||+++...   ......+..|+++++.++|+||+++++++.     ....
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~   78 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ-----SANN   78 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEE-----ECCE
Confidence            57888999999999999999975 68999999997532   233467889999999999999999998876     5568


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      .++||||+++++|.+++...  ..+++...++|+.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++
T Consensus        79 ~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          79 VYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            89999999999999999653  35889999999999999999999   8899999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.3e-31  Score=293.26  Aligned_cols=265  Identities=22%  Similarity=0.243  Sum_probs=182.3

Q ss_pred             HhcCccccceecccCceEEEEeEc-----------------CCCcEEEEEEeecCChhhhHHH--------------HHH
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-----------------PNGTEVAVKRFKNCSKAGDANF--------------KHE  364 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~VAVK~l~~~~~~~~~~f--------------~~E  364 (614)
                      ..++|+..++||+|+||.||+|..                 .+++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            356899999999999999999963                 2457899999875433333333              346


Q ss_pred             HHHHHHccccce-----eeeeeeeeccc---CCCCceEEEEEeecCCCChhhhhhcCC----------------------
Q 043267          365 VEIIASVKHVNL-----VALRGYSTATV---PLEGHQRIIVCDLLHNGSLYDHLFGSG----------------------  414 (614)
Q Consensus       365 i~il~~l~H~ni-----v~l~g~~~~~~---~~~~~~~~lV~E~~~~GsL~~~L~~~~----------------------  414 (614)
                      +.++.+++|.++     ++++++|....   ..+....++||||+++|+|.++++...                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            677777876654     67788876431   123457899999999999999986421                      


Q ss_pred             CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCch
Q 043267          415 MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP  494 (614)
Q Consensus       415 ~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~AP  494 (614)
                      ...++|..+..|+.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++....+.........+|+.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            123578889999999999999999   88999999999999999999999999999975543322222223458899999


Q ss_pred             hhhccCCC----------------------CchhhHHHHHHHHHHHHhCCC-CcccccCccchhhH-----HHHHHHHcC
Q 043267          495 EYALYGKL----------------------TPGSDVYSFGVVLLELLSGKK-ACEIIQGKSVLLSD-----WAWELVKEG  546 (614)
Q Consensus       495 E~~~~~~~----------------------t~ksDVwS~Gvll~ElltG~~-p~~~~~~~~~~l~~-----~~~~~~~~g  546 (614)
                      |.+.....                      ..+.||||+||+++||++|.. |+.........+..     -.|+.++.+
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98764321                      234799999999999999875 55422111111110     112222222


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCC---CCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPIL---QARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~eVl~  591 (614)
                      ..    +-..    .....+...+++..++..+|   .+|+|++|+++
T Consensus       460 ~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        460 KY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             CC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11    1111    11123345566666777655   68999999874

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=296.51  Aligned_cols=266  Identities=24%  Similarity=0.335  Sum_probs=217.4

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeec
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTA  385 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~  385 (614)
                      ..++.+..-++.|++.+.||+|.+|.||+++. ++|+.+|||++.. .....++...|.++++.. .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34444555667899999999999999999995 5789999998865 344566788899999988 79999999999888


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                      ..+-.+++++||||||.+||..|.+.+-.+..+.|+.+..|++.+++||++||   ...++|||||-.||||+.++.+|+
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEE
Confidence            77778899999999999999999998877889999999999999999999999   999999999999999999999999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                      .|||++........ ......||+.|||||++...     .|+.++|+||+|++..||--|.+|+.++..-...      
T Consensus       165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL------  237 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL------  237 (953)
T ss_pred             eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh------
Confidence            99999987654432 34456799999999999754     4778999999999999999999999765531111      


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ..   +...-.+.+  ..+..-..++.+++..|+..|-++||++.++++
T Consensus       238 --F~---IpRNPPPkL--krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  238 --FL---IPRNPPPKL--KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             --cc---CCCCCCccc--cchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence              10   011111111  123455678899999999999999999998874

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=267.26  Aligned_cols=200  Identities=26%  Similarity=0.324  Sum_probs=171.2

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...++||+|.||+|-+.+-+ .|+.+|+|++++.--   .....-..|-.++...+||.+..|.--+.     ...
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQ-----t~d  241 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQ-----TQD  241 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhc-----cCc
Confidence            457888999999999999999854 789999999986432   23334567888999999999988864443     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      .+++||||..+|.|.-+|..  .+.++.....-.-..|..||.|||   +.+||.||||.+|.|||.+|++||+|||+++
T Consensus       242 rlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCK  316 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCK  316 (516)
T ss_pred             eEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccch
Confidence            89999999999999999955  457888888888999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      ..-. ....+...+||+.|+|||++....|....|+|.+||++|||++|+.||..
T Consensus       317 E~I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn  370 (516)
T KOG0690|consen  317 EEIK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN  370 (516)
T ss_pred             hccc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence            4221 12245668999999999999999999999999999999999999999954

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=302.06  Aligned_cols=208  Identities=25%  Similarity=0.320  Sum_probs=180.7

Q ss_pred             CHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeee
Q 043267          309 KIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYST  384 (614)
Q Consensus       309 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~  384 (614)
                      ...+++-...+|.+.++||+|+||.|..++.+ .++.+|+|++.+.   ......-|..|-++|..-+.+-|+.|.-.+.
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            45667777789999999999999999999975 5788999999863   3344567889999999999999999876554


Q ss_pred             cccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                           ++.++|+|||||+||+|...+.+..  .++.....-++..|..||.-||   +.|+|||||||+|||||..|++|
T Consensus       146 -----D~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHik  215 (1317)
T KOG0612|consen  146 -----DERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIK  215 (1317)
T ss_pred             -----CccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEe
Confidence                 7789999999999999999996654  6888888888999999999999   99999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhc----c-CCCCchhhHHHHHHHHHHHHhCCCCcc
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL----Y-GKLTPGSDVYSFGVVLLELLSGKKACE  526 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~----~-~~~t~ksDVwS~Gvll~ElltG~~p~~  526 (614)
                      |+|||.+-.+..+..-.....+|||.|++||++.    + +.|.+..|+||+||++|||+.|..||.
T Consensus       216 LADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFY  282 (1317)
T KOG0612|consen  216 LADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFY  282 (1317)
T ss_pred             eccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcch
Confidence            9999998766655555556678999999999986    3 679999999999999999999999995

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-31  Score=284.97  Aligned_cols=238  Identities=24%  Similarity=0.276  Sum_probs=191.6

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +..|.....+|.|+|+.|-+... +++++.+||++.+.    ..+-.+|+.++... +|+|++++.+.+.     ++.+.
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~----~~~~~~e~~~~~~~~~h~niv~~~~v~~-----~~~~~  391 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR----ADDNQDEIPISLLVRDHPNIVKSHDVYE-----DGKEI  391 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccc----ccccccccchhhhhcCCCcceeecceec-----CCcee
Confidence            45677777799999999999885 47889999999764    22344677776666 7999999999987     77899


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE-CCCCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL-DEAFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL-d~~~~~kl~DFGla~~  473 (614)
                      ++|||.+.+|-|.+.+...+  .+. ..+..|+.+|+.++.|||   .++++||||||+|||+ ++.++++|+|||.++.
T Consensus       392 ~~v~e~l~g~ell~ri~~~~--~~~-~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~  465 (612)
T KOG0603|consen  392 YLVMELLDGGELLRRIRSKP--EFC-SEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSE  465 (612)
T ss_pred             eeeehhccccHHHHHHHhcc--hhH-HHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhh
Confidence            99999999999999886544  233 777789999999999999   8999999999999999 5999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ...+    ....+-|..|.|||+.....|++++||||||++||||++|+.|+...+.+..     ....+..++      
T Consensus       466 ~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-----i~~~i~~~~------  530 (612)
T KOG0603|consen  466 LERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-----IHTRIQMPK------  530 (612)
T ss_pred             Cchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-----HHHhhcCCc------
Confidence            6654    2334568899999999999999999999999999999999999965544311     111111111      


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                            +.........+++.+|+|.||.+||+|.++.
T Consensus       531 ------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~  561 (612)
T KOG0603|consen  531 ------FSECVSDEAKDLLQQLLQVDPALRLGADEIG  561 (612)
T ss_pred             ------cccccCHHHHHHHHHhccCChhhCcChhhhc
Confidence                  1133445667888889999999999999987

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.97  E-value=1.9e-30  Score=257.49  Aligned_cols=199  Identities=28%  Similarity=0.419  Sum_probs=166.1

Q ss_pred             CccccceecccCceEEEEeEcC---C--CcEEEEEEeecCCh-hh-hHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP---N--GTEVAVKRFKNCSK-AG-DANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~---~--g~~VAVK~l~~~~~-~~-~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .|+....||+|.||.|||++-.   +  ...+|||+++..+. .+ .....+|+.+++.++|+|++.|..++..    .+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~----~d  100 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLS----HD  100 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc----cC
Confidence            5778889999999999999743   2  23789999975422 11 3456789999999999999999888752    36


Q ss_pred             ceEEEEEeecCCCChhhhhhc---CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC----CcEE
Q 043267          392 HQRIIVCDLLHNGSLYDHLFG---SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA----FEAK  464 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~---~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~----~~~k  464 (614)
                      ...++++||.+. +|.+.|+-   ...+.++-.....|..||..|+.|||   ++=|+||||||.|||+..+    |.+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeE
Confidence            788999999976 88887753   23457889999999999999999999   8889999999999999887    9999


Q ss_pred             EeecCCceeCCCCCcc--ccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          465 VGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       465 l~DFGla~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      |+|+|+++.+.+....  ....++-|.-|.|||.+.+. .||.+.|||+.||+..||++-++-|
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF  240 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLF  240 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccc
Confidence            9999999987655433  34567789999999999875 7999999999999999999988776

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-31  Score=267.41  Aligned_cols=240  Identities=26%  Similarity=0.329  Sum_probs=184.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhh---hHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAG---DANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~---~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .+|....+||+|+||+|.++..+ ....+|||++++...-.   .+--..|-.+|+.. +-|.++++..++.     ..+
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQ-----TmD  423 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQ-----TMD  423 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhh-----hhh
Confidence            36888899999999999999975 45678999998643211   12224566666666 5788999988876     557


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      .+++||||+.+|+|..+|++-+  .+.++...-.+..||-||-+||   +.+||.||||.+|||||.+|++||+|||+++
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence            7899999999999999997644  6888889999999999999999   9999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..--+ ...+...+||+.|+|||++.+++|...+|+|||||+||||+.|+.||+...+++.      .+.        +.
T Consensus       499 Eni~~-~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~el------F~a--------I~  563 (683)
T KOG0696|consen  499 ENIFD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQA--------IM  563 (683)
T ss_pred             ccccC-CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHH--------HH
Confidence            43221 2234568999999999999999999999999999999999999999975443221      111        11


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARP  584 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  584 (614)
                      +....  ++.....+.+.+...-+..+|.+|.
T Consensus       564 ehnvs--yPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 EHNVS--YPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HccCc--CcccccHHHHHHHHHHhhcCCcccc
Confidence            22221  2333344455565556777777764

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-30  Score=246.05  Aligned_cols=204  Identities=26%  Similarity=0.334  Sum_probs=169.1

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeec-CChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~-~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .+.......||+|+||.|-+-++ .+|+..|+|++.. ...+..++..+|+++..+. ..|.+|.++|...     .+..
T Consensus        45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~-----regd  119 (282)
T KOG0984|consen   45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALF-----REGD  119 (282)
T ss_pred             hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhh-----cccc
Confidence            34445567899999999988885 5899999999974 3455667788999986655 7999999999654     5677


Q ss_pred             EEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          394 RIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .++.||.|. -||+.+-.+  ..+..+++...-+|+..+.+||.|||+  +..+||||+||+|||++.+|++|++|||++
T Consensus       120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccc
Confidence            899999995 588877654  345679999999999999999999996  789999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhcc----CCCCchhhHHHHHHHHHHHHhCCCCcccccC
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALY----GKLTPGSDVYSFGVVLLELLSGKKACEIIQG  530 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  530 (614)
                      -...+...  .+..+|-..|||||.+..    ..|+.||||||+|+.+.||.+++.||+....
T Consensus       197 G~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  197 GYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            87665432  233568889999998863    3799999999999999999999999975443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7e-31  Score=270.09  Aligned_cols=256  Identities=27%  Similarity=0.349  Sum_probs=200.3

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeec---CChhh----hHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKN---CSKAG----DANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~---~~~~~----~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      ++|-..++||+|||+.|||+.. ...+-||||+-.-   .....    .+...+|..+.+.|.||.||++++++.-    
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl----  538 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL----  538 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee----
Confidence            4567778999999999999984 5678899997532   11111    2345789999999999999999999873    


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC---CCCcEEEe
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD---EAFEAKVG  466 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd---~~~~~kl~  466 (614)
                      +.+..+-|.||+++.+|+-+|..++  .+++.+...|+.||+.||.||.+. +++|||-||||.||||.   .-|.+||.
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence            6677899999999999999997654  689999999999999999999965 78999999999999995   45789999


Q ss_pred             ecCCceeCCCCCc------cccccccCCCCcCchhhhccC----CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh
Q 043267          467 DFGLAKFNPEGIT------HLTTRVAGTLGYVAPEYALYG----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS  536 (614)
Q Consensus       467 DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~  536 (614)
                      ||||++.+.++..      ..+...+||..|++||.+.-+    +.+.|+||||.||++|..+.|++||.......    
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ----  691 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ----  691 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH----
Confidence            9999998765432      245667899999999998754    57889999999999999999999996444322    


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                          +.+....+....+-.++..  +-.....-.++..|++..-++|....++.
T Consensus       692 ----dILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 ----DILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ----HHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                2334445555545455432  23334455677889998888887776654

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=270.44  Aligned_cols=193  Identities=28%  Similarity=0.458  Sum_probs=168.2

Q ss_pred             cceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +++||+|-||+||-|++ ++|+.||||++.+.  ....+.++.+|+.+|.+++||.||.+.--|+     ..+..++|||
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~E-----T~ervFVVME  643 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFE-----TPERVFVVME  643 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeec-----CCceEEEEeh
Confidence            47899999999999996 48999999999753  3445678999999999999999999987775     4567889999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCcEEEeecCCceeCCC
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~~kl~DFGla~~~~~  476 (614)
                      -+ +|+..+.|..+...+|+...-.-++.||+.||.|||   .++|+|.||||+||||.+   .-.+||+|||.|+..++
T Consensus       644 Kl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  644 KL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            99 567666666666678999988889999999999999   899999999999999964   34699999999998876


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE  526 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~  526 (614)
                      .  .....++||+.|+|||++..+.|...-|+||.||++|--++|..||.
T Consensus       720 k--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN  767 (888)
T KOG4236|consen  720 K--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN  767 (888)
T ss_pred             h--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC
Confidence            3  33455889999999999999999999999999999999999999995

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=3e-28  Score=234.90  Aligned_cols=210  Identities=35%  Similarity=0.492  Sum_probs=182.2

Q ss_pred             ecccCceEEEEeEcCC-CcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCC
Q 043267          326 IGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN  403 (614)
Q Consensus       326 LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~  403 (614)
                      ||+|++|.||+++..+ |+++++|++...... ..+.+.+|++.++.++|++++++++++.     .....++++||+++
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFE-----DENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeee-----cCCeEEEEEecCCC
Confidence            6899999999999864 899999999764432 3467899999999999999999999986     44688999999999


Q ss_pred             CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeecCCceeCCCCCcccc
Q 043267          404 GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNPEGITHLT  482 (614)
Q Consensus       404 GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~~~~~~~~~~  482 (614)
                      ++|.+++.... ..+++..+..++.+++++|++||   +.+++|+||+|.||+++. ++.++|+|||.+........ ..
T Consensus        76 ~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~  150 (215)
T cd00180          76 GSLKDLLKENE-GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LL  150 (215)
T ss_pred             CcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hh
Confidence            99999986542 46899999999999999999999   889999999999999999 89999999999986654321 22


Q ss_pred             ccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCc
Q 043267          483 TRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMEL  561 (614)
Q Consensus       483 ~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~  561 (614)
                      ....+...|++||..... .++.++|+|++|+++++|                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            335578899999999887 889999999999999998                                           


Q ss_pred             HHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          562 PEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       562 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                          ..+.+++..|++.+|++||++.++++.
T Consensus       188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ----PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                467788888999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=284.16  Aligned_cols=244  Identities=28%  Similarity=0.373  Sum_probs=185.4

Q ss_pred             CccccceecccCceE-EEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGN-VYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      -|...+++|.|+-|+ ||+|.. +|++||||++-..   ..+-..+|+..++.- +|||||+.++.-.     +....|+
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~-----d~qF~YI  580 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQ-----DRQFLYI  580 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeecc-----CCceEEE
Confidence            466778899999876 799999 7899999998542   233457899999888 7999999976543     5678899


Q ss_pred             EEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-----CCcEEEeecC
Q 043267          397 VCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-----AFEAKVGDFG  469 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-----~~~~kl~DFG  469 (614)
                      ..|.|. -+|.|++....  .....-...+.+..|+++||++||   +.+||||||||.||||+.     ...++|+|||
T Consensus       581 alELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg  656 (903)
T KOG1027|consen  581 ALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFG  656 (903)
T ss_pred             EehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccc
Confidence            999995 59999997641  111111345678899999999999   899999999999999975     3578999999


Q ss_pred             CceeCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcC
Q 043267          470 LAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       470 la~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      +++....+.+.  ......||.||+|||.+....-+..+||||+||++|+.++ |.+||.+.-..+..+.       ...
T Consensus       657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl-------~~~  729 (903)
T KOG1027|consen  657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL-------TGN  729 (903)
T ss_pred             cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh-------cCc
Confidence            99988766543  2456789999999999999988899999999999999999 5999964433222210       000


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      ....    .+...  .+.  ...+++..|++++|..||++.+|+
T Consensus       730 ~~L~----~L~~~--~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  730 YTLV----HLEPL--PDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             ccee----eeccC--chH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            0000    11110  111  567788889999999999999986

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=250.37  Aligned_cols=247  Identities=21%  Similarity=0.284  Sum_probs=196.4

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|...++||+|+|.+|..++++ ..+.+|+|++++.   +..+.+-.+.|-.+.... +||.+|-|..++.     .+
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-----te  323 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-----TE  323 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-----cc
Confidence            346888899999999999999975 5788999998752   233344556677777666 8999999998876     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ..+++|.||.++|+|.-++.+.  +.|+++...-....|..||.|||   +.+||.||||.+|||||..|++|+.|+|+.
T Consensus       324 srlffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  324 SRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             ceEEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchh
Confidence            7889999999999998887554  47999999999999999999999   999999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc--ccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI--IQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~--~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +..-. ....+...+||+.|+|||++.+..|....|+|++||+++||+.|+.||+.  ++..+....++..+.+-+..+.
T Consensus       399 ke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir  477 (593)
T KOG0695|consen  399 KEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR  477 (593)
T ss_pred             hcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc
Confidence            84322 22346678999999999999999999999999999999999999999953  3333445667766665443331


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARP  584 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  584 (614)
                            +    +....-+...+.+.-+..||.+|.
T Consensus       478 ------i----prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  478 ------I----PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ------c----cceeehhhHHHHHHhhcCCcHHhc
Confidence                  1    112223445566667888888774

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.96  E-value=1.9e-29  Score=257.11  Aligned_cols=261  Identities=23%  Similarity=0.271  Sum_probs=199.4

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccc--c----ceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH--V----NLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H--~----niv~l~g~~~~~~~~  389 (614)
                      +++|.+..++|+|.||.|-+.... .+..||||+++...+.. +...-|++++.++.+  |    -+|.+.+|+.     
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYr-eAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd-----  161 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYR-EAALIEIEVLQKINESDPNGKFRCVQMRDWFD-----  161 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHh-hHHHHHHHHHHHHHhcCCCCceEEEeeehhhh-----
Confidence            678899999999999999988754 47899999998754433 345679999999932  2    2677777775     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC----------
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE----------  459 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~----------  459 (614)
                      -.+..++|+|.| |-|+.++|..++..+++..+++.|+.|++++++|||   +.+++|-||||+|||+.+          
T Consensus       162 yrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k  237 (415)
T KOG0671|consen  162 YRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPK  237 (415)
T ss_pred             ccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccC
Confidence            456789999999 559999999988889999999999999999999999   999999999999999931          


Q ss_pred             ----------CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccccc
Q 043267          460 ----------AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ  529 (614)
Q Consensus       460 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  529 (614)
                                +..+||+|||.|....+..    +.++.|..|.|||++.+-.++.++||||+||+|.|+.+|...|+...
T Consensus       238 ~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe  313 (415)
T KOG0671|consen  238 KKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE  313 (415)
T ss_pred             CccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence                      3468999999998755432    45678999999999999999999999999999999999998885443


Q ss_pred             Cccch---------hhHH------HHHHHHcCCch-----------hhhhccCC----CCCcHHHHHHHHHHHHHccccC
Q 043267          530 GKSVL---------LSDW------AWELVKEGKTL-----------DVIEENMP----EMELPEMMEQYVLTAAICAHPI  579 (614)
Q Consensus       530 ~~~~~---------l~~~------~~~~~~~g~~~-----------~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~d  579 (614)
                      +.+..         ++..      +.+....|++.           .+.+...+    -.....+..++++++..++..|
T Consensus       314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD  393 (415)
T KOG0671|consen  314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD  393 (415)
T ss_pred             cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence            21110         0000      11222222110           11111111    0112355668999999999999


Q ss_pred             CCCCCCHHHHHH
Q 043267          580 LQARPTMDQIVK  591 (614)
Q Consensus       580 P~~RPt~~eVl~  591 (614)
                      |.+|+|+.|++.
T Consensus       394 P~~RiTl~EAL~  405 (415)
T KOG0671|consen  394 PARRITLREALS  405 (415)
T ss_pred             ccccccHHHHhc
Confidence            999999999874

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.6e-30  Score=250.05  Aligned_cols=268  Identities=24%  Similarity=0.302  Sum_probs=191.4

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeec-CChhh-hHHHHHHHHHHHHccccceeeeeeeeecccC---CCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN-CSKAG-DANFKHEVEIIASVKHVNLVALRGYSTATVP---LEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~-~~~~~-~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~---~~~~  392 (614)
                      .|....+||+|.||.||+++.+ .|+.||+|++.- ..+.+ -....+|++++..++|+|++.++..|.....   ....
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3455578999999999999965 578899887632 11211 2345789999999999999999998865322   1234


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++|+++++. +|.-.|.+ ...+++..++.++..++..||.|+|   ...|+|||+||.|+|++.++.+||+|||+++
T Consensus        98 t~ylVf~~ceh-DLaGlLsn-~~vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSN-RKVRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcC-ccccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            57999999975 77777744 3367999999999999999999999   9999999999999999999999999999997


Q ss_pred             eCCCCC---ccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccc-hhh--------HHH
Q 043267          473 FNPEGI---THLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV-LLS--------DWA  539 (614)
Q Consensus       473 ~~~~~~---~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~l~--------~~~  539 (614)
                      .+....   ....+..+-|..|.+||.+.+ ..|+++.|||.-||++.||++|.+-++.....+. .+.        .-+
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            654322   223344556999999999886 5799999999999999999999887754433221 111        112


Q ss_pred             HHHHHcCCchhhhhcc-CCCCCc---HHHHH------HHHHHHHHccccCCCCCCCHHHHHH
Q 043267          540 WELVKEGKTLDVIEEN-MPEMEL---PEMME------QYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~-l~~~~~---~~~~~------~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      |.-+.+-..-+.++.. ++....   .+.+.      ..++++..++..||.+||++++++.
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            2211111111111100 111110   11111      4566777799999999999999873

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=225.63  Aligned_cols=197  Identities=25%  Similarity=0.353  Sum_probs=162.3

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +|...++||+|.||+||||+.. .++.||+|+++-.  ++.-.....+|+-+++.++|+|||+++....     .++...
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh-----sdkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc-----cCceeE
Confidence            3555678999999999999965 5788999998642  2222356789999999999999999999876     567789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +|+||+. .+|..+.. +-...++.+....+..|+.+||.+.|   +.++.|||+||.|.|++.+|+.|++|||+++.++
T Consensus        78 lvfe~cd-qdlkkyfd-slng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCD-QDLKKYFD-SLNGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhh-HHHHHHHH-hcCCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcC
Confidence            9999995 46766653 33457899999999999999999999   8999999999999999999999999999999766


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHh-CCCCcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLS-GKKACE  526 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~Ellt-G~~p~~  526 (614)
                      -... ......-|.-|.+|.++.+. -|+...|+||-||++.|+.. |++.|.
T Consensus       153 ipvr-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfp  204 (292)
T KOG0662|consen  153 IPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_pred             CceE-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCC
Confidence            4332 23334568999999998875 58899999999999999998 554443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.4e-27  Score=234.97  Aligned_cols=199  Identities=33%  Similarity=0.445  Sum_probs=171.6

Q ss_pred             ccccceecccCceEEEEeEcCC-CcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      |...+.||+|++|.||+++..+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++.     .....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~-----~~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFE-----DPEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeee-----cCCceEEE
Confidence            4566889999999999999865 899999999765443 5678899999999999999999999886     45678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      +||+++++|.+++..... .+++.....++.+++++|.+||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        76 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       76 MEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            999999999999865432 2899999999999999999999   889999999999999999999999999999876554


Q ss_pred             CccccccccCCCCcCchhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          478 ITHLTTRVAGTLGYVAPEYA-LYGKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~-~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      .........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       152 ~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            31122345678899999998 677888899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=262.66  Aligned_cols=240  Identities=23%  Similarity=0.274  Sum_probs=190.2

Q ss_pred             ccccceecccCceEEEEeEcCCCc-EEEEEEeec---CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKN---CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~g~-~VAVK~l~~---~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.....||-||||.|-++..+... .+|+|.+++   .+....+....|-.+|...+.|.||+++--+.     +.+..|
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr-----d~kyvY  496 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR-----DSKYVY  496 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc-----cchhhh
Confidence            444567999999999998875433 478888764   23444566788999999999999999998776     678889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +.||-|-+|.|+..|.+.+  .++..+..-++..+.+|++|||   ..+||+|||||+|.+||.+|-+||.|||.|+...
T Consensus       497 mLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            9999999999999997654  6888888999999999999999   9999999999999999999999999999999876


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .+.  .+-..+||+.|.|||++.....+..+|.||+|+++|||++|++||+....-.      ...++-.|--  .++  
T Consensus       572 ~g~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk------tYn~ILkGid--~i~--  639 (732)
T KOG0614|consen  572 SGR--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK------TYNLILKGID--KIE--  639 (732)
T ss_pred             cCC--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH------HHHHHHhhhh--hhh--
Confidence            643  3455799999999999999999999999999999999999999996543211      1122222211  111  


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCC
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPT  585 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  585 (614)
                          .+........++++..+..+|.+|.-
T Consensus       640 ----~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  640 ----FPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             ----cccccchhHHHHHHHHHhcCcHhhhc
Confidence                11222334455666667789999876

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=5.9e-28  Score=257.48  Aligned_cols=209  Identities=27%  Similarity=0.345  Sum_probs=170.5

Q ss_pred             CHHHHHHHh---cCccccceecccCceEEEEeEcCC-CcEEEEEEeecCCh---hhhHHHHHHHHHHHHccccceeeeee
Q 043267          309 KIEEIKAAT---MNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSK---AGDANFKHEVEIIASVKHVNLVALRG  381 (614)
Q Consensus       309 ~~~el~~~t---~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~niv~l~g  381 (614)
                      +|-.|+++.   .-|...+.||-|+||+|.++..-| ...+|.|.+.+.+.   ......+.|-+||.....+-||+|+-
T Consensus       617 nYiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyy  696 (1034)
T KOG0608|consen  617 NYIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYY  696 (1034)
T ss_pred             hHHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEE
Confidence            344444443   357788899999999999998544 56689999876443   23445778999999999999999986


Q ss_pred             eeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC
Q 043267          382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF  461 (614)
Q Consensus       382 ~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~  461 (614)
                      -+.     +.+.+|+||||++||++..+|.+.+  -|.+...+-.+.++..|+++.|   +.|+|||||||+|||||.+|
T Consensus       697 SFQ-----DkdnLYFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdG  766 (1034)
T KOG0608|consen  697 SFQ-----DKDNLYFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDG  766 (1034)
T ss_pred             Eec-----cCCceEEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCC
Confidence            665     6788999999999999999986544  6777777788889999999999   99999999999999999999


Q ss_pred             cEEEeecCCce---------eCCCCCccc--------------------------------cccccCCCCcCchhhhccC
Q 043267          462 EAKVGDFGLAK---------FNPEGITHL--------------------------------TTRVAGTLGYVAPEYALYG  500 (614)
Q Consensus       462 ~~kl~DFGla~---------~~~~~~~~~--------------------------------~~~~~gt~~Y~APE~~~~~  500 (614)
                      ++||.||||+.         ++.++..+.                                ....+||+.|+|||++...
T Consensus       767 HIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~  846 (1034)
T KOG0608|consen  767 HIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLART  846 (1034)
T ss_pred             ceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhccc
Confidence            99999999974         222111100                                0114699999999999999


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          501 KLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       501 ~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      .|+...|+||.||+||||+.|+.||-.
T Consensus       847 g~~q~cdwws~gvil~em~~g~~pf~~  873 (1034)
T KOG0608|consen  847 GYTQLCDWWSVGVILYEMLVGQPPFLA  873 (1034)
T ss_pred             CccccchhhHhhHHHHHHhhCCCCccC
Confidence            999999999999999999999999943

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-29  Score=247.13  Aligned_cols=268  Identities=24%  Similarity=0.286  Sum_probs=196.3

Q ss_pred             cccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          321 SRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +..+.||-|+||.||.++.+ +|+.||.|++.+.  +-...+.+.+|++++..++|.|++..++...-....--.+.|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            44578999999999999976 8999999998752  33445678899999999999999999887543322122456788


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      .|.|. .+|...|-.  -+.++-....-+.+||.+||.|||   +.+|.||||||.|.|+++|-..||+|||+++....+
T Consensus       136 TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  136 TELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccccchh
Confidence            88884 477777644  246888888889999999999999   999999999999999999999999999999987766


Q ss_pred             CccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccc--hhhHH-------HHHHHHcCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV--LLSDW-------AWELVKEGK  547 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~l~~~-------~~~~~~~g~  547 (614)
                      .....+...-|..|.|||.+++. .|+.+.||||.||++.|++..+-.|+....-+.  .+.+.       ..+.--+|.
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            66656666679999999999875 799999999999999999988877743322110  11111       111112222


Q ss_pred             chhhhhccCCCC-----C----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          548 TLDVIEENMPEM-----E----LPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       548 ~~~~~d~~l~~~-----~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      ...++.......     +    ....-...+.+...+++.||..|.+..+.+..+.
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            222222111100     0    0111223456667789999999999998887654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=1.2e-26  Score=222.08  Aligned_cols=258  Identities=18%  Similarity=0.260  Sum_probs=190.9

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|++.+++|+|.|+.||.|.. .+.+.++||.++..   ..+.+.+|+.++..+. ||||++|+.....+   +....
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp---~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDP---ESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCc---cccCc
Confidence            34678889999999999999994 57889999999753   3456889999999996 99999999987654   55677


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~  473 (614)
                      .|++||..+.+.....     ..|+...+...+.++++||.|.|   +.||.|||+||.|+++|. .-..+|+|+|+|.+
T Consensus       111 aLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhh
Confidence            8999999987765544     45788888899999999999999   999999999999999994 56799999999998


Q ss_pred             CCCCCccccccccCCCCcCchhhhc-cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH--------HHHHH
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA--------WELVK  544 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~--------~~~~~  544 (614)
                      +..+....  -...+..|--||.+. .+.|+..-|+|||||++.+|+..+.||-...+....+...+        ...+.
T Consensus       183 YHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  183 YHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             cCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            77654431  123456688999876 56788999999999999999999999954433322222211        11111


Q ss_pred             cCCc------hhhhhc-------cCCCCCcHH-HHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          545 EGKT------LDVIEE-------NMPEMELPE-MMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       545 ~g~~------~~~~d~-------~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      .-.+      .+++..       ++....... ...+.++++...+..|-++|||++|..
T Consensus       261 KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam  320 (338)
T KOG0668|consen  261 KYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM  320 (338)
T ss_pred             HHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence            1111      011110       011111111 124566777778899999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.2e-25  Score=233.00  Aligned_cols=136  Identities=24%  Similarity=0.326  Sum_probs=117.3

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-----c---cceeeeeeeeeccc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-----H---VNLVALRGYSTATV  387 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-----H---~niv~l~g~~~~~~  387 (614)
                      ..+|...++||.|.|++||++.. .+.+-||+|+.+... .-.+....||++|+.++     |   ..||+|+..+....
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            35788999999999999999985 467889999998643 23345678999999983     3   36999999988766


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL  457 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL  457 (614)
                      + .+...++|+|++ +-+|..+|....-+.++...+.+|++||+.||.|||.  +.+|||-||||+||||
T Consensus       156 p-NG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  156 P-NGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLL  221 (590)
T ss_pred             C-CCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeee
Confidence            5 788999999999 6799999998888889999999999999999999997  5599999999999999

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=2.2e-26  Score=244.12  Aligned_cols=195  Identities=24%  Similarity=0.361  Sum_probs=165.4

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh--------hhHHHHHHHHHHHHcc---ccceeeeeeeeecc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA--------GDANFKHEVEIIASVK---HVNLVALRGYSTAT  386 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~--------~~~~f~~Ei~il~~l~---H~niv~l~g~~~~~  386 (614)
                      .|...+.+|+|+||.|+.++++ +..+|+||.+.+..--        ..-..-.|+.+|+.++   |+||++++.+++  
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE--  639 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE--  639 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee--
Confidence            5788889999999999999976 5678999988653211        1112456999999997   999999999997  


Q ss_pred             cCCCCceEEEEEeec-CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          387 VPLEGHQRIIVCDLL-HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~-~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                         +.+..+|++|-. ++-+|+++|..  ...+++.....|+.||+.|+++||   +.+|||||||-+||.+|.+|-+||
T Consensus       640 ---ddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  640 ---DDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             ---cCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEE
Confidence               677889999875 45688999854  347999999999999999999999   999999999999999999999999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCcc
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTP-GSDVYSFGVVLLELLSGKKACE  526 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~-ksDVwS~Gvll~ElltG~~p~~  526 (614)
                      +|||.+.+...+   .....+||.+|.|||++.+.+|-- .-|||++|++||-++....||.
T Consensus       712 idfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999766554   345578999999999999888754 5799999999999999888874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.93  E-value=4.6e-26  Score=227.75  Aligned_cols=259  Identities=22%  Similarity=0.265  Sum_probs=191.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~~  393 (614)
                      .+|...+.+|.|.- .|-.+... .++.||+|++...  .........+|..++..++|+|+++++.+++..... +..+
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            35666677888887 55555433 6899999988532  233445677899999999999999999988754332 3356


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|||+| ..+|...+.    ..++-++...|..|+..|++|||   +.+|+||||||+||++..+..+||.|||+++.
T Consensus        96 ~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcc
Confidence            89999999 568988886    35788889999999999999999   99999999999999999999999999999985


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH-------------
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW-------------  540 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~-------------  540 (614)
                      ...+  -..+....|..|.|||++.+..|.+.+||||.||++.||++|+.-|....    .+..|-.             
T Consensus       168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d----~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD----HIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch----HHHHHHHHHHHhcCCCHHHH
Confidence            4433  34566778999999999999889999999999999999999997774211    2222211             


Q ss_pred             --------HHHHcCCch--hhhhccCCCCC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          541 --------ELVKEGKTL--DVIEENMPEME-------LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       541 --------~~~~~g~~~--~~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                              ..++.....  -.....+++..       .+........++..|+-.+|++|-+++++++
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                    111100000  00111111111       1122345667888999999999999999985

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=5.6e-26  Score=222.28  Aligned_cols=255  Identities=18%  Similarity=0.294  Sum_probs=193.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.|.+.+.||+|.||.+-++.++ ..+.+++|-+... .....+|.+|...--.| .|.||+.-+.....    ..+..+
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d~Yv   98 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSDAYV   98 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhh----cCceEE
Confidence            46888899999999999999975 5678999988753 33467888888764455 68999988776543    345778


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC--CCCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd--~~~~~kl~DFGla~~  473 (614)
                      +++||+|.|+|...+...   .+.+....+++.|+++||.|+|   +.++||||||.+|||+-  +..++|++|||+.+.
T Consensus        99 F~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             EeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccc
Confidence            999999999999988554   4788888999999999999999   99999999999999993  445899999999875


Q ss_pred             CCCCCccccccccCCCCcCchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYG-----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      .+....    +..-+..|.+||.....     +..+.+|||.||++++.+++|+.|++.....  +-.-|-|..|..+..
T Consensus       173 ~g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~--d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  173 VGTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM--DKPYWEWEQWLKRKN  246 (378)
T ss_pred             cCceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc--CchHHHHHHHhcccC
Confidence            443221    22235678999976532     3567899999999999999999999743332  334567777877766


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ...     +.. .....++..++.+.-+.+++++|-...++-+|-..
T Consensus       247 ~~~-----P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~  287 (378)
T KOG1345|consen  247 PAL-----PKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKC  287 (378)
T ss_pred             ccC-----chh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHH
Confidence            522     221 12334566677777899999999777777666543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.93  E-value=3.2e-25  Score=211.85  Aligned_cols=167  Identities=23%  Similarity=0.183  Sum_probs=125.9

Q ss_pred             CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccc
Q 043267          404 GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT  483 (614)
Q Consensus       404 GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~  483 (614)
                      |||.+++... ...++|.+++.|+.|+++||+|||   +.+      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            7899999753 346999999999999999999999   544      999999999999999  99998654422     


Q ss_pred             cccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHH
Q 043267          484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPE  563 (614)
Q Consensus       484 ~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~  563 (614)
                       ..||+.|||||++.++.++.++|||||||++|||++|+.|+.........+.    .........   +... ......
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~----~~~~~~~~~---~~~~-~~~~~~  134 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILE----ILLNGMPAD---DPRD-RSNLES  134 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHH----HHHHHhccC---Cccc-cccHHH
Confidence             2589999999999999999999999999999999999999854332111111    111111000   0000 001122


Q ss_pred             HHH--HHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          564 MME--QYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       564 ~~~--~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ...  .+.+++..|++.+|++||++.|+++.+...
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            222  588999999999999999999999987653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=5.7e-26  Score=266.68  Aligned_cols=201  Identities=16%  Similarity=0.143  Sum_probs=139.3

Q ss_pred             HHccc-cceeeeeeeeecccC--CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCce
Q 043267          369 ASVKH-VNLVALRGYSTATVP--LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI  445 (614)
Q Consensus       369 ~~l~H-~niv~l~g~~~~~~~--~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~i  445 (614)
                      +.++| +||+++++++.....  .+....+.++||+ +++|.++|... ...+++.+++.|+.||++||.|||   +.+|
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~gI  101 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAH---SQGI  101 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            34455 578888887632211  1234567778887 66999999653 356999999999999999999999   8999


Q ss_pred             EEeccCCCCeEECC-------------------CCcEEEeecCCceeCCCCCc---------------cccccccCCCCc
Q 043267          446 IHRDIKASNILLDE-------------------AFEAKVGDFGLAKFNPEGIT---------------HLTTRVAGTLGY  491 (614)
Q Consensus       446 iHrDIKp~NILLd~-------------------~~~~kl~DFGla~~~~~~~~---------------~~~~~~~gt~~Y  491 (614)
                      +||||||+||||+.                   ++.+|++|||+++.......               .......||+.|
T Consensus       102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y  181 (793)
T PLN00181        102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY  181 (793)
T ss_pred             eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence            99999999999965                   44556666666653211000               001123578899


Q ss_pred             CchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHH
Q 043267          492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLT  571 (614)
Q Consensus       492 ~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l  571 (614)
                      ||||++.+..++.++|||||||+||||++|..|+.....   .+     ..+...    ...+.     ..........+
T Consensus       182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---~~-----~~~~~~----~~~~~-----~~~~~~~~~~~  244 (793)
T PLN00181        182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR---TM-----SSLRHR----VLPPQ-----ILLNWPKEASF  244 (793)
T ss_pred             EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---HH-----HHHHHh----hcChh-----hhhcCHHHHHH
Confidence            999999999999999999999999999998887642110   00     111110    00110     01112334567


Q ss_pred             HHHccccCCCCCCCHHHHHH
Q 043267          572 AAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       572 ~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +..|++++|.+||+|.|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            78899999999999999975

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-25  Score=242.35  Aligned_cols=252  Identities=25%  Similarity=0.322  Sum_probs=195.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|+....+|.|.||.|||++.. .+...|||.++-.-.....-.+.|+-+++..+|+||+.++|-+.     .....++
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl-----r~dklwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL-----RRDKLWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh-----hhcCcEE
Confidence            45777788999999999999965 68899999998655556667788999999999999999999775     5567899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      .|||+.+|+|.+.-+..  ..+++.+.........+||+|||   +.+=+|||||-.|||+++.+.+|++|||.+-.+..
T Consensus        90 cMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999999977543  47999999999999999999999   88989999999999999999999999999865443


Q ss_pred             CCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          477 GITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ... ......||+.|||||+..   .+.|..++|||+.|+...|+---..|..+...-...     .-.-+.+--    .
T Consensus       165 ti~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l-----~LmTkS~~q----p  234 (829)
T KOG0576|consen  165 TIA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL-----FLMTKSGFQ----P  234 (829)
T ss_pred             hhh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH-----HHhhccCCC----C
Confidence            222 234467999999999875   568999999999999999998777765332221111     011111111    1


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.+.+  ...-.+-+-++++.|+-.+|.+||+++.+++
T Consensus       235 p~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CcccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11111  1223445667788899999999999987653

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=9.3e-25  Score=225.72  Aligned_cols=264  Identities=26%  Similarity=0.305  Sum_probs=193.8

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcC----CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      +....+.|...++||+|.|++||++++.    .++.||+|.+...+.  ...+.+|++++..+ .+.||+++.++..   
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~r---  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFR---  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhc---
Confidence            3445567888999999999999999964    467899999976443  34588999999999 6899999999886   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-CCCcEEEe
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVG  466 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-~~~~~kl~  466 (614)
                        .+++..+|+||++.-.-.+++.     .++...+...+..+.+||.++|   ..|||||||||+|+|.+ ..+.-.|.
T Consensus       106 --nnd~v~ivlp~~~H~~f~~l~~-----~l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~Lv  175 (418)
T KOG1167|consen  106 --NNDQVAIVLPYFEHDRFRDLYR-----SLSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLV  175 (418)
T ss_pred             --cCCeeEEEecccCccCHHHHHh-----cCCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEE
Confidence              6788999999999988888874     4678889999999999999999   99999999999999997 45667899


Q ss_pred             ecCCceeCC-----------------C--CC----------------c--------cccccccCCCCcCchhhhc-cCCC
Q 043267          467 DFGLAKFNP-----------------E--GI----------------T--------HLTTRVAGTLGYVAPEYAL-YGKL  502 (614)
Q Consensus       467 DFGla~~~~-----------------~--~~----------------~--------~~~~~~~gt~~Y~APE~~~-~~~~  502 (614)
                      |||+|....                 .  +.                .        ......+||+||.|||++. .+..
T Consensus       176 DFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Q  255 (418)
T KOG1167|consen  176 DFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQ  255 (418)
T ss_pred             echhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCc
Confidence            999986110                 0  00                0        0011246999999999886 5678


Q ss_pred             CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH----HHH-----HcCC-----------chhh------hh-cc
Q 043267          503 TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW----ELV-----KEGK-----------TLDV------IE-EN  555 (614)
Q Consensus       503 t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~----~~~-----~~g~-----------~~~~------~d-~~  555 (614)
                      ++++||||-||+++-+++++.||-...++-..+.+.+.    .-+     -.|+           ..+.      ++ +.
T Consensus       256 ttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~  335 (418)
T KOG1167|consen  256 TTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIES  335 (418)
T ss_pred             CCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhh
Confidence            99999999999999999999999443333222222210    000     0011           0000      10 00


Q ss_pred             CCC---------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPE---------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~---------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +..         .........++++...|+..||.+|.|+++.|+
T Consensus       336 ~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  336 IYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            110         001112336788899999999999999999874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.90  E-value=3.7e-24  Score=224.72  Aligned_cols=264  Identities=23%  Similarity=0.246  Sum_probs=196.2

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHcc------ccceeeeeeeeecc
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVK------HVNLVALRGYSTAT  386 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~------H~niv~l~g~~~~~  386 (614)
                      +....+|......|+|-|++|.+|... .|++||||++.+.. .....=+.|+++|++|+      -.|+++|+-.+.  
T Consensus       428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~--  504 (752)
T KOG0670|consen  428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK--  504 (752)
T ss_pred             hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh--
Confidence            335568888889999999999999964 58899999998743 23344467999999994      346788776654  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcC-CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEE
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAK  464 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~-~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~k  464 (614)
                         ..+.++||+|-+ .-+|.+.|..- ....|....+..++.|+.-||..|-   +.+|+|.||||+|||+++.- .+|
T Consensus       505 ---hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  505 ---HKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             ---hcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceee
Confidence               567899999988 45899999763 3456888999999999999999999   89999999999999998764 579


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch--hh----HH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL--LS----DW  538 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~--l~----~~  538 (614)
                      |||||.|....+..   .+...-+..|.|||++.+-+|+..-|+||.||.||||.||+-.|......+..  ..    .+
T Consensus       578 LCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  578 LCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            99999997655432   22223355799999999999999999999999999999999888544332211  00    01


Q ss_pred             HHHHHHcCCch-hhhhc--------------------------------------cCCCCCcHHHHHHHHHHHHHccccC
Q 043267          539 AWELVKEGKTL-DVIEE--------------------------------------NMPEMELPEMMEQYVLTAAICAHPI  579 (614)
Q Consensus       539 ~~~~~~~g~~~-~~~d~--------------------------------------~l~~~~~~~~~~~l~~l~~~Cl~~d  579 (614)
                      ...+++.|... +-+|.                                      .+++ ..+..+..+..+...|+..|
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d-eq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD-EQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc-hhHHHHHHHHHHHHHHhccC
Confidence            12223332211 01111                                      1111 12345667888999999999


Q ss_pred             CCCCCCHHHHHH
Q 043267          580 LQARPTMDQIVK  591 (614)
Q Consensus       580 P~~RPt~~eVl~  591 (614)
                      |++|.|..|.|+
T Consensus       734 P~KRit~nqAL~  745 (752)
T KOG0670|consen  734 PEKRITVNQALK  745 (752)
T ss_pred             hhhcCCHHHHhc
Confidence            999999998874

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=3.1e-23  Score=219.98  Aligned_cols=168  Identities=21%  Similarity=0.163  Sum_probs=130.7

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcC--CCcEEEEEEeecC-----ChhhhHHHHHHHHHHHHccccceeeeeeeeec
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLP--NGTEVAVKRFKNC-----SKAGDANFKHEVEIIASVKHVNLVALRGYSTA  385 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~  385 (614)
                      +....++|...+.||+|+||+||+|...  +++.||||++...     .....+.+.+|++++++++|+|+++.+..   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            3455678999999999999999999864  5778899987532     12235568999999999999999853321   


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEecc-CCCCeEECCCCcEE
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDI-KASNILLDEAFEAK  464 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDI-Kp~NILLd~~~~~k  464 (614)
                           ....++||||+++++|.. +....        ...++.+++++|.|||   +.+|+|||| ||+|||++.++++|
T Consensus        90 -----~~~~~LVmE~~~G~~L~~-~~~~~--------~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ik  152 (365)
T PRK09188         90 -----TGKDGLVRGWTEGVPLHL-ARPHG--------DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAA  152 (365)
T ss_pred             -----cCCcEEEEEccCCCCHHH-hCccc--------hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEE
Confidence                 124699999999999963 21111        1467889999999999   899999999 99999999999999


Q ss_pred             EeecCCceeCCCCCcc-------ccccccCCCCcCchhhhccC
Q 043267          465 VGDFGLAKFNPEGITH-------LTTRVAGTLGYVAPEYALYG  500 (614)
Q Consensus       465 l~DFGla~~~~~~~~~-------~~~~~~gt~~Y~APE~~~~~  500 (614)
                      |+|||+++........       ..+...+++.|+|||++...
T Consensus       153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999999866543211       11456788999999988644

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3e-22  Score=211.07  Aligned_cols=259  Identities=23%  Similarity=0.236  Sum_probs=190.0

Q ss_pred             CccccceecccCceEEEEeEcCCC--cEEEEEEeecCChhhhHHHHHHHHHHHHccc----cceeeeeeeeecccCCCCc
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNG--TEVAVKRFKNCSKAGDANFKHEVEIIASVKH----VNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g--~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H----~niv~l~g~~~~~~~~~~~  392 (614)
                      +|...+.||+|+||.||++...+.  ..+|+|............+..|+.++..+.+    +++..++....    ..+.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            789999999999999999996543  4788888765433333378889999999973    46666666552    1456


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-----CcEEEee
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-----FEAKVGD  467 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-----~~~kl~D  467 (614)
                      ..++||+.. +.||.++......+.++..+.++|+.|+..+|++||   +.+++||||||.|+++...     ..+.|.|
T Consensus        95 ~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   95 FNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             eeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            789999988 789999876655678999999999999999999999   9999999999999999754     4699999


Q ss_pred             cCCce--eCCCCC----ccc---cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          468 FGLAK--FNPEGI----THL---TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       468 FGla~--~~~~~~----~~~---~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                      ||+++  ......    ...   .....||..|.++....+...+.+.|+||++.++.|+..|..|+........ .   
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~---  246 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-K---  246 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-H---
Confidence            99998  322111    111   1235699999999999999999999999999999999999999854443211 0   


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                        ..............  .....+.+.   .++...+-..+...+|....+.+.|...
T Consensus       247 --~~~~~~~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  247 --SKFEKDPRKLLTDR--FGDLKPEEF---AKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             --HHHHHHhhhhcccc--ccCCChHHH---HHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence              11111101111111  111223333   3344445558899999999999988665

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=205.97  Aligned_cols=246  Identities=21%  Similarity=0.340  Sum_probs=184.6

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEee--cCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      .+|.+...|..|+|+++ |..+++|++.  ..+....++|..|.-.++.+.||||.+++|.|.     ......++..||
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn-----sppnlv~isq~m  269 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN-----SPPNLVIISQYM  269 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc-----CCCCceEeeeec
Confidence            46888999999999995 4456667664  344455678999999999999999999999997     446789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL  481 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~  481 (614)
                      +.|||+..|++......+-.+..+++.++|+|++|||+- ++-|.---|.+..|++|++.+++|+ .+-.++.-.     
T Consensus       270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~kfsfq-----  342 (448)
T KOG0195|consen  270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTKFSFQ-----  342 (448)
T ss_pred             cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccceeeee-----
Confidence            999999999998878889999999999999999999953 3334444689999999999999885 222221111     


Q ss_pred             cccccCCCCcCchhhhccCCCC---chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCC
Q 043267          482 TTRVAGTLGYVAPEYALYGKLT---PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE  558 (614)
Q Consensus       482 ~~~~~gt~~Y~APE~~~~~~~t---~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~  558 (614)
                      .....-.+.||+||.+...+-+   ...|+|||.+++||+.|...||.+.+.-+.-     .+     ...+-+...+  
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-----mk-----ialeglrv~i--  410 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-----MK-----IALEGLRVHI--  410 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-----hh-----hhhccccccC--
Confidence            1112236789999999876543   5799999999999999999999755431111     00     1112222222  


Q ss_pred             CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       559 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                        ++.....+.+++..|...||.+||.+..|+-+||+.
T Consensus       411 --ppgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  411 --PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             --CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence              333444555666669999999999999999999874

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=5.2e-21  Score=194.96  Aligned_cols=260  Identities=28%  Similarity=0.338  Sum_probs=194.7

Q ss_pred             ccccceecccCceEEEEeEcCCCcEEEEEEeecCChh---hhHHHHHHHHHHHHcccc-ceeeeeeeeecccCCCCceEE
Q 043267          320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA---GDANFKHEVEIIASVKHV-NLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---~~~~f~~Ei~il~~l~H~-niv~l~g~~~~~~~~~~~~~~  395 (614)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.+++.+.|+ +++++..+..     .....+
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~   74 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQ-----DEGSLY   74 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEe-----cCCEEE
Confidence            556788999999999999986  88999998753322   367899999999999988 7999998874     344479


Q ss_pred             EEEeecCCCChhhhhhcCCC-cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGM-KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGla~~  473 (614)
                      ++++++.++++.+++..... ..++......+..+++.++.|+|   +.+++|||+||+||+++... .+++.|||+++.
T Consensus        75 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          75 LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            99999999999976654322 26889999999999999999999   88999999999999999988 799999999986


Q ss_pred             CCCCCcc-----ccccccCCCCcCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          474 NPEGITH-----LTTRVAGTLGYVAPEYALY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       474 ~~~~~~~-----~~~~~~gt~~Y~APE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      .......     ......||..|++||....   ..++...|+||+|++++++++|..|+......  ......++.+..
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~  229 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILE  229 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHh
Confidence            5543322     2456789999999999987   68899999999999999999999996433321  011112222222


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      .... .................+.+++..|+..+|..|.++.+....
T Consensus       230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         230 LPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            2111 000000000001223456777888999999999999887653

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=8e-21  Score=183.51  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=186.8

Q ss_pred             hcCccccceecccCceEEEEeE-cCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccc-cceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H-~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...++||.|+||.+|.|. ..+|.+||||.-.+..  ...++.-|..+.+.++| ..|..+..|..     ++..-
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~-----e~~yn   86 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGT-----EKDYN   86 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhcc-----ccccc
Confidence            3578899999999999999999 5689999999765433  34467789999999976 45555555554     66778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC---CcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA---FEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~---~~~kl~DFGla  471 (614)
                      .+|||.+ +.||.+...- -.+.++..+.+-++-|+..-++|+|   ..++|||||||+|+|..-+   ..+.++|||++
T Consensus        87 vlVMdLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eeeeecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccch
Confidence            9999998 7788887643 3357999999999999999999999   8999999999999999643   45889999999


Q ss_pred             eeCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          472 KFNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       472 ~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      +.+.+..+.      ......||..|.+--...+...+.+.|+-|+|.+|.++--|..||+......   .....+.+.+
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t---k~QKyEkI~E  238 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT---KKQKYEKISE  238 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh---HHHHHHHHHH
Confidence            866543221      2344679999999888888889999999999999999999999997654321   1112233333


Q ss_pred             CCch---hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          546 GKTL---DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       546 g~~~---~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                      .++.   +.+-..++        .++...+.-|-...-++-|...-+-+++
T Consensus       239 kK~s~~ie~LC~G~P--------~EF~myl~Y~R~L~F~E~Pdy~ylrqlF  281 (341)
T KOG1163|consen  239 KKMSTPIEVLCKGFP--------AEFAMYLNYCRGLGFEEKPDYMYLRQLF  281 (341)
T ss_pred             hhcCCCHHHHhCCCc--------HHHHHHHHHHhhcCCCCCCcHHHHHHHH
Confidence            3222   22222222        2333444457666677777765554443

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=7.9e-20  Score=183.83  Aligned_cols=257  Identities=23%  Similarity=0.303  Sum_probs=188.4

Q ss_pred             cCccccceecccCceEEEEeE-cCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      -+|...++||+|.||..+.|+ +-+++.||||.-...+  ..-++..|....+.|. .++|...+-|-.     ++..-.
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGq-----eG~~Ni  100 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQ-----EGKYNI  100 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeecc-----ccchhh
Confidence            368889999999999999999 4589999999765433  3346778999988884 577776665543     677789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-----CcEEEeecCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-----FEAKVGDFGL  470 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-----~~~kl~DFGl  470 (614)
                      ||+|.+ +.||.|+. +--.+.|+.++...||.|+..-++|+|   +..+|.|||||+|+||...     ..+.|.|||+
T Consensus       101 LVidLL-GPSLEDLF-D~CgR~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLF-DLCGRRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhh-CcCHHHHH-HHhcCcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            999998 77888865 434568999999999999999999999   8999999999999999643     3589999999


Q ss_pred             ceeCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          471 AKFNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       471 a~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      |+.+.+..+.      ......||.+||+--...+.+.+.+.|+-|+|-++.+.+-|..||+.......   ....+.+.
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn---K~kYeKIG  252 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN---KEKYEKIG  252 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch---HHHHHHhc
Confidence            9977654332      23346799999999999999999999999999999999999999976553221   11122222


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      +.+..-.++.-..  ..++++.++++.++   ..+-++-|..+-+.+.+.
T Consensus       253 e~Kr~T~i~~Lc~--g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~  297 (449)
T KOG1165|consen  253 ETKRSTPIEVLCE--GFPEEFATYLRYVR---RLDFFETPDYDYLRKLFD  297 (449)
T ss_pred             cccccCCHHHHHh--cCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHH
Confidence            2222212221111  13555666666543   345556677655544443

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=2.9e-21  Score=217.61  Aligned_cols=253  Identities=21%  Similarity=0.248  Sum_probs=181.2

Q ss_pred             cccceecccCceEEEEeEcC-CCcEEEEEEee-----cCChhh-hHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          321 SRENIIGKGGYGNVYKGMLP-NGTEVAVKRFK-----NCSKAG-DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~-----~~~~~~-~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ...+++|.|.+|.|+..+.. .....+.|...     ..+... ...+..|+.+-..++|+|++..+....     +...
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~-----~~~~  395 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQ-----EIDG  395 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHh-----hccc
Confidence            35678999999988877643 33334444322     111111 112566777788889999987766654     3333


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      ..-+|||+++ +|...+...  ..++...+-.++.|+..|+.|+|   ..+|.|||+|++|++++.++.+||+|||.+..
T Consensus       396 ~~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~v  469 (601)
T KOG0590|consen  396 ILQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASV  469 (601)
T ss_pred             chhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCccee
Confidence            3444999999 999999664  36888889999999999999999   99999999999999999999999999999976


Q ss_pred             CCCCCc---cccccccCCCCcCchhhhccCCCCc-hhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          474 NPEGIT---HLTTRVAGTLGYVAPEYALYGKLTP-GSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       474 ~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~-ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +.....   .......|...|+|||.+...+|.+ ..||||.|+++..|++|+.||.....++..+      .-..+...
T Consensus       470 f~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~  543 (601)
T KOG0590|consen  470 FRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQ  543 (601)
T ss_pred             eccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccc
Confidence            543332   4567788999999999999999987 4899999999999999999995443322211      00000000


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+. .-+.........+...++..+++.+|.+|.|+++|++
T Consensus       544 ~~~~-~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIF-EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccc-cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            0000 0001112234456678888899999999999999875

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=3.4e-20  Score=180.66  Aligned_cols=139  Identities=16%  Similarity=0.175  Sum_probs=108.3

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChh--h-------hHH-----------------HHHHHHHHHHccccce
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA--G-------DAN-----------------FKHEVEIIASVKHVNL  376 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~-------~~~-----------------f~~Ei~il~~l~H~ni  376 (614)
                      ...||+|+||.||+|..++|+.||||+++.....  .       ...                 ...|++.+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            3679999999999999889999999999753211  1       112                 2349999999988776


Q ss_pred             eeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHH-hhcCCCceEEeccCCCCe
Q 043267          377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL-HYGVQPAIIHRDIKASNI  455 (614)
Q Consensus       377 v~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yL-H~~~~~~iiHrDIKp~NI  455 (614)
                      .....+.       ....++||||++++++......  ...+++....+++.|++.+|.|+ |   +.+|+||||||+||
T Consensus        82 ~~p~~~~-------~~~~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NI  149 (190)
T cd05147          82 PCPEPIL-------LKSHVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNL  149 (190)
T ss_pred             CCCcEEE-------ecCCEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHE
Confidence            4332221       1223899999998877655332  24689999999999999999999 6   78999999999999


Q ss_pred             EECCCCcEEEeecCCceeC
Q 043267          456 LLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       456 LLd~~~~~kl~DFGla~~~  474 (614)
                      |++ ++.++|+|||++...
T Consensus       150 li~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEE-CCcEEEEEccccccC
Confidence            998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.81  E-value=1.6e-20  Score=212.06  Aligned_cols=249  Identities=21%  Similarity=0.235  Sum_probs=181.6

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCC-hhhhHHHHHHHHH--HHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS-KAGDANFKHEVEI--IASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~-~~~~~~f~~Ei~i--l~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++...+-||++.|=+|.+++.++|. |+||++-+.. ....+.|.++++-  ...++|||.+++..+-.     ..+..|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~-----t~kAAy   97 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLV-----TDKAAY   97 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHH-----hhHHHH
Confidence            4566678999999999999998888 8999886543 4445555555544  44559999998876643     345567


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce--e
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--F  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~--~  473 (614)
                      +|-+|..+ +|+|.|.  .+.-+...+..-|+.|+..||...|   ..+|+|+|||.+|||++.-.-+.|+||..-|  +
T Consensus        98 lvRqyvkh-nLyDRlS--TRPFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtY  171 (1431)
T KOG1240|consen   98 LVRQYVKH-NLYDRLS--TRPFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTY  171 (1431)
T ss_pred             HHHHHHhh-hhhhhhc--cchHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCcc
Confidence            78788754 8888883  3445778888889999999999999   9999999999999999999999999998876  3


Q ss_pred             CCCCCcc----ccccccCCCCcCchhhhccC-----------CCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhH
Q 043267          474 NPEGITH----LTTRVAGTLGYVAPEYALYG-----------KLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD  537 (614)
Q Consensus       474 ~~~~~~~----~~~~~~gt~~Y~APE~~~~~-----------~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~  537 (614)
                      .+++...    ...+......|+|||.+...           ..+++.||||.||++.||++ |+++|.-.+        
T Consensus       172 LPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ--------  243 (1431)
T KOG1240|consen  172 LPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ--------  243 (1431)
T ss_pred             CCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH--------
Confidence            3433222    22333345679999987642           26789999999999999999 787774211        


Q ss_pred             HHHHHHHcC--CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          538 WAWELVKEG--KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       538 ~~~~~~~~g--~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..  ..+.|  ...+.+-+.+.+       ..+..+++.|++.||++|.++++.++.-.+.
T Consensus       244 L~--aYr~~~~~~~e~~Le~Ied-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~  295 (1431)
T KOG1240|consen  244 LL--AYRSGNADDPEQLLEKIED-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRGL  295 (1431)
T ss_pred             HH--hHhccCccCHHHHHHhCcC-------ccHHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence            11  11222  122222222322       1567788889999999999999999875554

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.81  E-value=5.8e-20  Score=182.47  Aligned_cols=178  Identities=13%  Similarity=0.108  Sum_probs=136.0

Q ss_pred             HHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhH---------HHHHHHHHHHHccccceeeeeeeeec
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA---------NFKHEVEIIASVKHVNLVALRGYSTA  385 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~---------~f~~Ei~il~~l~H~niv~l~g~~~~  385 (614)
                      ...++|...++||.|+||.||.... ++..+|||.+.........         .+.+|+..+.+++|+++..+..+...
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4567899999999999999999655 6778999999743222222         26789999999999999999887543


Q ss_pred             ccC---CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          386 TVP---LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       386 ~~~---~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      ...   ......+++|||++|.+|.++..      ++.    ....+++.+|..+|   +.+++|||+||+||+++.++ 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-
Confidence            211   01245799999999999988741      222    34569999999999   99999999999999999988 


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS  520 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt  520 (614)
                      ++|+|||......+....             ..+.....|..++|+||||+.+.....
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999988755332111             114555667789999999999876653

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=2.3e-19  Score=174.78  Aligned_cols=141  Identities=17%  Similarity=0.146  Sum_probs=111.0

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChh---------------------h-----hHHHHHHHHHHHHccccce
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA---------------------G-----DANFKHEVEIIASVKHVNL  376 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~---------------------~-----~~~f~~Ei~il~~l~H~ni  376 (614)
                      ...||+|+||.||+|+..+|+.||||+++.....                     .     ...+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4679999999999999888999999998753211                     0     1123578999999999987


Q ss_pred             eeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCe
Q 043267          377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNI  455 (614)
Q Consensus       377 v~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NI  455 (614)
                      .....+..       ...++||||++++++......  ...++.....+++.+++.++.++|   + .+|+||||||+||
T Consensus        82 ~~p~~~~~-------~~~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NI  149 (190)
T cd05145          82 PVPEPILL-------KKNVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNI  149 (190)
T ss_pred             CCceEEEe-------cCCEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhE
Confidence            54443322       124899999998865443222  235778889999999999999999   7 8999999999999


Q ss_pred             EECCCCcEEEeecCCceeCCC
Q 043267          456 LLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       456 LLd~~~~~kl~DFGla~~~~~  476 (614)
                      |++ ++.++|+|||++...+.
T Consensus       150 ll~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         150 LYH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EEE-CCCEEEEEcccceecCC
Confidence            999 88999999999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.78  E-value=5.2e-19  Score=191.46  Aligned_cols=217  Identities=28%  Similarity=0.399  Sum_probs=161.4

Q ss_pred             HHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCce-E
Q 043267          368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI-I  446 (614)
Q Consensus       368 l~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~i-i  446 (614)
                      |+.+.|.|+.+++|.+.     ++...+.|.+|+..|+|.|.+.. ....++|.-...+..++++||+|||   ..+| .
T Consensus         1 l~~l~h~n~~~f~g~~~-----~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh---~s~i~~   71 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASV-----DGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLH---NSPIGY   71 (484)
T ss_pred             CcccchhhhhhheeeEe-----cCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHh---cCccee
Confidence            35679999999999997     56888999999999999999976 3467999999999999999999999   4444 9


Q ss_pred             EeccCCCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccC-------CCCchhhHHHHHHHHHHH
Q 043267          447 HRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYG-------KLTPGSDVYSFGVVLLEL  518 (614)
Q Consensus       447 HrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~-------~~t~ksDVwS~Gvll~El  518 (614)
                      |+.++++|.++|..+.+||+|||+.....+... .......-..-|.|||.+...       ..+.+.||||||++++|+
T Consensus        72 hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   72 HGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            999999999999999999999999876543110 111112234569999998763       146789999999999999


Q ss_pred             HhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          519 LSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       519 ltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      ++.+.||+........ .+.+.. ++++ ......+.+....  +..+.+..++..||..+|++||++++|-..++....
T Consensus       152 ~~r~~~~~~~~~~~~~-~eii~~-~~~~-~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDP-DEIILR-VKKG-GSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             HhccCccccccccCCh-HHHHHH-HHhc-CCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            9999999654332221 122222 2221 1111222222111  333368889999999999999999999999887644

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.78  E-value=3e-18  Score=167.14  Aligned_cols=183  Identities=13%  Similarity=0.055  Sum_probs=139.8

Q ss_pred             cccceecccCceEEEEeEcCCCcEEEEEEeecCChhh----hHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEE
Q 043267          321 SRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG----DANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~----~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .....|++|+||+||.+.. ++.+++.+.+.......    ...+.+|+++++++. |+++.+++++.         ..+
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~---------~~~   74 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD---------GRH   74 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc---------CEE
Confidence            4457899999999997766 77888888776533311    124789999999995 57888888752         359


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEecc-CCCCeEECCCCcEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDI-KASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDI-Kp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|||+++.+|.+.+..         ....+..++.++|.++|   +.+|+|||| ||+|||++.++.++|+|||++...
T Consensus        75 lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         75 LDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             EEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            99999999998754411         12357789999999999   899999999 799999999999999999999865


Q ss_pred             CCCCcc----c--------cccccCCCCcCchhhhccC-CCC-chhhHHHHHHHHHHHHhCCCCc
Q 043267          475 PEGITH----L--------TTRVAGTLGYVAPEYALYG-KLT-PGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       475 ~~~~~~----~--------~~~~~gt~~Y~APE~~~~~-~~t-~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      ......    .        ......++.|++|+-..-- ..+ ...++++-|.-+|.++|++.+.
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~  207 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLH  207 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCc
Confidence            543210    0        1123368889999865432 333 6789999999999999999876

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=4.1e-18  Score=168.15  Aligned_cols=140  Identities=16%  Similarity=0.189  Sum_probs=107.4

Q ss_pred             ccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-----cccceeeeeeeeecccCCCCce-
Q 043267          320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-----KHVNLVALRGYSTATVPLEGHQ-  393 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-----~H~niv~l~g~~~~~~~~~~~~-  393 (614)
                      .+..+.||+|+||.||.  +++....+||++........+++.+|+++++.+     .||||++++|+.....  .... 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v   79 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYV   79 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEE
Confidence            45568899999999996  544333479988765444567899999999999     5799999999987531  1123 


Q ss_pred             EEEEEee--cCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHH-HHHhhcCCCceEEeccCCCCeEECC----CCcEEEe
Q 043267          394 RIIVCDL--LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL-AYLHYGVQPAIIHRDIKASNILLDE----AFEAKVG  466 (614)
Q Consensus       394 ~~lV~E~--~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL-~yLH~~~~~~iiHrDIKp~NILLd~----~~~~kl~  466 (614)
                      ..+|+||  +++|+|.+++.+.   .+++.  ..++.++..++ +|||   +.+|+||||||+|||++.    +..++|+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            3478999  6689999999552   35555  35677888777 9999   999999999999999973    3479999


Q ss_pred             ecCCc
Q 043267          467 DFGLA  471 (614)
Q Consensus       467 DFGla  471 (614)
                      ||+.+
T Consensus       152 Dg~G~  156 (210)
T PRK10345        152 DNIGE  156 (210)
T ss_pred             ECCCC
Confidence            95433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=3.3e-18  Score=174.83  Aligned_cols=237  Identities=22%  Similarity=0.279  Sum_probs=150.5

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHcc----------ccceeeeeeeee
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVK----------HVNLVALRGYST  384 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~----------H~niv~l~g~~~  384 (614)
                      ++...+.||.|+++.||.++.. .|+++|||.+...   +....+++++|.-.+..+.          |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4566788999999999999986 5899999988532   2334566777775555532          212222222111


Q ss_pred             ccc-------CCCCc-----eEEEEEeecCCCChhhhhh---cC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEE
Q 043267          385 ATV-------PLEGH-----QRIIVCDLLHNGSLYDHLF---GS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIH  447 (614)
Q Consensus       385 ~~~-------~~~~~-----~~~lV~E~~~~GsL~~~L~---~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiH  447 (614)
                      ...       .....     ..+++|+-+ .++|.+.+.   ..  ....+....++.+..|+.+.+++||   ..+++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEe
Confidence            100       00011     236677777 568887753   22  2234667778889999999999999   899999


Q ss_pred             eccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccC--------CCCchhhHHHHHHHHHHHH
Q 043267          448 RDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG--------KLTPGSDVYSFGVVLLELL  519 (614)
Q Consensus       448 rDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--------~~t~ksDVwS~Gvll~Ell  519 (614)
                      +||||+|++++.+|.++|+||+.....+.....    ...+..|.+||.....        .++.+.|.|++|+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999987654432211    2345789999977542        5789999999999999999


Q ss_pred             hCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCC
Q 043267          520 SGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR  583 (614)
Q Consensus       520 tG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  583 (614)
                      +|+.|+.........  +|                .+.. .. +..+.+..++...++.||++|
T Consensus       245 C~~lPf~~~~~~~~~--~~----------------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADP--EW----------------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTS--GG----------------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccc--cc----------------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            999999644322111  11                1111 12 556677778888999999988

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=4e-17  Score=164.51  Aligned_cols=148  Identities=14%  Similarity=0.128  Sum_probs=113.2

Q ss_pred             HHHHhcCccccceecccCceEEEEeE--cCCCcEEEEEEeecCChh------------------------hhHHHHHHHH
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGM--LPNGTEVAVKRFKNCSKA------------------------GDANFKHEVE  366 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~--~~~g~~VAVK~l~~~~~~------------------------~~~~f~~Ei~  366 (614)
                      +.+....|...+.||+|+||.||+|+  ..+|+.||||.++.....                        ....+..|++
T Consensus        23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            33444457888999999999999998  568999999998743210                        0123568999


Q ss_pred             HHHHccccc--eeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc
Q 043267          367 IIASVKHVN--LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA  444 (614)
Q Consensus       367 il~~l~H~n--iv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~  444 (614)
                      ++.++.+.+  +.+.+++         ...++||||+++++|.......  ..+...+...++.|++.+|++||   +.+
T Consensus       103 ~L~~L~~~~i~~p~~~~~---------~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~g  168 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW---------RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLY---KEG  168 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe---------cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHH---hcC
Confidence            999997633  2333322         2348999999998887665322  24556667899999999999999   888


Q ss_pred             -eEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          445 -IIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       445 -iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                       ++||||||+||+++ +++++|+|||.+....
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence             99999999999999 8899999999987543

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=5.5e-17  Score=158.85  Aligned_cols=144  Identities=17%  Similarity=0.150  Sum_probs=111.8

Q ss_pred             HHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCCh----------------------hhhHHHHHHHHHHH
Q 043267          312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK----------------------AGDANFKHEVEIIA  369 (614)
Q Consensus       312 el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----------------------~~~~~f~~Ei~il~  369 (614)
                      ++......|...+.||+|+||.||++..++|+.||||++.....                      .....+..|..++.
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            44444445777899999999999999998999999998754220                      01123677899999


Q ss_pred             Hccccc--eeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEE
Q 043267          370 SVKHVN--LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIH  447 (614)
Q Consensus       370 ~l~H~n--iv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiH  447 (614)
                      .+.|++  +...++         ....++||||+++++|.+....        ....+++.++++++.++|   +.+++|
T Consensus        89 ~l~~~~i~v~~~~~---------~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh---~~gi~H  148 (198)
T cd05144          89 ALYEEGFPVPKPID---------WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAY---KHGIIH  148 (198)
T ss_pred             HHHHcCCCCCceee---------cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHH---HCCCCc
Confidence            998874  333332         2345899999999998765421        345678899999999999   899999


Q ss_pred             eccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          448 RDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       448 rDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      |||||+||++++++.++|+|||++....
T Consensus       149 ~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         149 GDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCCcccEEEcCCCcEEEEECCccccCC
Confidence            9999999999999999999999996443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=4.9e-17  Score=187.44  Aligned_cols=197  Identities=24%  Similarity=0.258  Sum_probs=152.8

Q ss_pred             HHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc---ccceeeeeeeeecccC
Q 043267          312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK---HVNLVALRGYSTATVP  388 (614)
Q Consensus       312 el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~---H~niv~l~g~~~~~~~  388 (614)
                      +.+.....|.+.+.||+|+||+||+|+..+|+.||+|.=+..+...   |--=.+++.+|+   -+-|+.+.....    
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~----  764 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHV----  764 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHc----
Confidence            4445566788999999999999999998889999999876543321   111112233333   112222222221    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-------CCC
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-------EAF  461 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-------~~~  461 (614)
                       ..+.-++|+||.+.|+|.+++.  ..+.++|.....++.++++.++.||   ..+|||+||||+|.||.       ++.
T Consensus       765 -~~~~S~lv~ey~~~Gtlld~~N--~~~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  765 -FQNASVLVSEYSPYGTLLDLIN--TNKVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             -cCCcceeeeeccccccHHHhhc--cCCCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCccc
Confidence             3455689999999999999996  5568999999999999999999999   99999999999999994       345


Q ss_pred             cEEEeecCCce---eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 043267          462 EAKVGDFGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK  523 (614)
Q Consensus       462 ~~kl~DFGla~---~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~  523 (614)
                      -++|+|||-+-   .++++  .......+|-++-.+|...+..++.+.|-|.+.-+++-|+.|+.
T Consensus       839 ~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            58999999884   34443  23455778999999999999999999999999999999999984

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=4.9e-17  Score=160.22  Aligned_cols=134  Identities=24%  Similarity=0.355  Sum_probs=111.5

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCCh--------hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK--------AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.||+|++|.||+|.. +|..|+||+......        .....+.+|++++..++|+++.....++.     .....+
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~   75 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFV-----DPENFI   75 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEE-----eCCCCE
Confidence            5799999999999998 778899998653221        11245788999999999999877766654     345678


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      ++|||+++++|.+++....     + .+..++.+++.+|.++|   +.+++|||++|.|||++ ++.++|+|||.+..
T Consensus        76 lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         76 IVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999999999985422     2 88899999999999999   89999999999999999 78999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.71  E-value=2e-18  Score=187.12  Aligned_cols=186  Identities=29%  Similarity=0.312  Sum_probs=151.0

Q ss_pred             eecccCceEEEEeE----cCCCcEEEEEEeecCChhh--hHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEEEE
Q 043267          325 IIGKGGYGNVYKGM----LPNGTEVAVKRFKNCSKAG--DANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       325 ~LG~G~fG~Vykg~----~~~g~~VAVK~l~~~~~~~--~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .+|+|.||.|+...    .+.|.-+|.|.+++.+...  ......|-.++...+ ||.+|++.-.+.     .+...+++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-----t~~kl~l~   75 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-----TDGKLYLI   75 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-----cccchhHh
Confidence            37999999999765    2356778888886533211  124556778888886 999999976554     55678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      .++..+|.|...+.+.  ..++..........++-+++.+|   +.+|+|||+|++||+++.+|++|+.|||+++..-+.
T Consensus        76 ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~  150 (612)
T KOG0603|consen   76 LDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE  150 (612)
T ss_pred             hhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhh
Confidence            9999999999888544  35667777777888999999999   999999999999999999999999999999854432


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      ..     .+||..|||||++.  .....+|.||||++++||++|..||..
T Consensus       151 ~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  151 KI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             hh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            21     18999999999988  567899999999999999999999864

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.71  E-value=6.1e-17  Score=158.18  Aligned_cols=130  Identities=22%  Similarity=0.332  Sum_probs=105.0

Q ss_pred             eecccCceEEEEeEcCCCcEEEEEEeecCCh--------hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          325 IIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK--------AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +||+|+||.||+|.+ +|..|++|+......        .....+.+|++++..++|+++.....++.     .....++
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-----~~~~~~l   74 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV-----DPDNKTI   74 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE-----ECCCCEE
Confidence            489999999999996 678899998653211        11355778999999999887654444443     3345689


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      ||||+++++|.+.+.....         .++.+++.+|.+||   +.+++|||+||.||+++ ++.+++.|||+++.
T Consensus        75 v~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        75 VMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999999998754221         78999999999999   89999999999999999 88999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.71  E-value=4.8e-18  Score=181.03  Aligned_cols=171  Identities=27%  Similarity=0.333  Sum_probs=129.2

Q ss_pred             eEEEEEeecCCCChhhhhhc-CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          393 QRIIVCDLLHNGSLYDHLFG-SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ..++.|+++...+|.+||.. ......+|...+.++.|++.|+.|      ++.+|||+||.||....+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhe
Confidence            57899999999999999974 445678999999999999999999      68899999999999999999999999998


Q ss_pred             eeCCCCC-----ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHc
Q 043267          472 KFNPEGI-----THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       472 ~~~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      .......     ....+...||..||+||.+.+..|+.|+||||+|++++|++. =.-++.                 +.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e-----------------r~  466 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE-----------------RI  466 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH-----------------HH
Confidence            7665544     234566789999999999999999999999999999999997 221111                 11


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMD  587 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  587 (614)
                      +...++-|..++.....+..+ -..+..+++++.|.+||++.
T Consensus       467 ~t~~d~r~g~ip~~~~~d~p~-e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  467 ATLTDIRDGIIPPEFLQDYPE-EYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             HhhhhhhcCCCChHHhhcCcH-HHHHHHHhcCCCcccCchHH
Confidence            111122222222111111111 23456779999999999443

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.70  E-value=5.8e-17  Score=182.37  Aligned_cols=141  Identities=19%  Similarity=0.301  Sum_probs=111.7

Q ss_pred             HHHhcCccccceecccCceEEEEeEcCCCcEEEEEE-eecC-C------hhhhHHHHHHHHHHHHccccceeeeeeeeec
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR-FKNC-S------KAGDANFKHEVEIIASVKHVNLVALRGYSTA  385 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~-l~~~-~------~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~  385 (614)
                      +.....|...+.||+|+||.||+|.+.+.. +++|+ +.+. .      ....+.+.+|+++++.++|++++....++. 
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~-  406 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV-  406 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE-
Confidence            334445667889999999999999975444 44443 2221 1      112356889999999999999988776665 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                          .....++||||+++++|.+++.          .+.+++.+++++|.|||   +.+++||||||+|||+ +++.++|
T Consensus       407 ----~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~l  468 (535)
T PRK09605        407 ----DPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYL  468 (535)
T ss_pred             ----eCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEE
Confidence                3345689999999999999884          45789999999999999   8999999999999999 6789999


Q ss_pred             eecCCceeC
Q 043267          466 GDFGLAKFN  474 (614)
Q Consensus       466 ~DFGla~~~  474 (614)
                      +|||+++..
T Consensus       469 iDFGla~~~  477 (535)
T PRK09605        469 IDFGLGKYS  477 (535)
T ss_pred             EeCcccccC
Confidence            999999753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.68  E-value=8.6e-17  Score=165.24  Aligned_cols=201  Identities=18%  Similarity=0.166  Sum_probs=135.3

Q ss_pred             cccceeeeeeeeecccCC----------------------CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHH
Q 043267          372 KHVNLVALRGYSTATVPL----------------------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG  429 (614)
Q Consensus       372 ~H~niv~l~g~~~~~~~~----------------------~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~  429 (614)
                      +|||||++.+++..+...                      ++..+|+||.-.+ -+|.+++-.   +..+...+.-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~---~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT---RHRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc---CCCchHHHHHHHHH
Confidence            599999999876554321                      2346788887664 488888844   34666777778999


Q ss_pred             HHHHHHHHhhcCCCceEEeccCCCCeEEC--CCC--cEEEeecCCceeCCCC-----CccccccccCCCCcCchhhhccC
Q 043267          430 TARGLAYLHYGVQPAIIHRDIKASNILLD--EAF--EAKVGDFGLAKFNPEG-----ITHLTTRVAGTLGYVAPEYALYG  500 (614)
Q Consensus       430 ia~gL~yLH~~~~~~iiHrDIKp~NILLd--~~~--~~kl~DFGla~~~~~~-----~~~~~~~~~gt~~Y~APE~~~~~  500 (614)
                      +.+|+.|||   +.+|.|||+|++|||+.  +|.  ...|+|||.+-.....     .....-..-|...-||||+....
T Consensus       350 lLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            999999999   99999999999999993  333  4688999987532221     11111223467788999988643


Q ss_pred             C------CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHH
Q 043267          501 K------LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAI  574 (614)
Q Consensus       501 ~------~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~  574 (614)
                      +      --.|+|.|+.|-+.||++....||.....-......          ..+.--+.+++..+    ..+.+++..
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~----------Yqe~qLPalp~~vp----p~~rqlV~~  492 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT----------YQESQLPALPSRVP----PVARQLVFD  492 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh----------hhhhhCCCCcccCC----hHHHHHHHH
Confidence            2      236899999999999999999999542211111111          11111123333332    245567777


Q ss_pred             ccccCCCCCCCHHHHHHHh
Q 043267          575 CAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       575 Cl~~dP~~RPt~~eVl~~L  593 (614)
                      -+++||++||+..-....|
T Consensus       493 lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HhcCCccccCCccHHHhHH
Confidence            8999999999876544444

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=3e-15  Score=137.38  Aligned_cols=135  Identities=19%  Similarity=0.168  Sum_probs=112.7

Q ss_pred             ccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccc--cceeeeeeeeecccCCCCceEEEEEe
Q 043267          322 RENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH--VNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H--~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +.+.||+|.++.||++..++ ..+++|.......  ...+.+|+.++..++|  .++.+++++..     .++..++++|
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~-----~~~~~~~v~e   73 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGE-----SDGWSYLLME   73 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcC-----CCCccEEEEE
Confidence            34679999999999999854 7899999865433  5678999999999977  48888877765     3467899999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      |++++++..+         ++.....++.+++++|.+||.....+++|+|+||+||++++++.+++.|||.+..
T Consensus        74 ~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          74 WIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            9998877654         5677788999999999999954446899999999999999999999999999874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.8e-15  Score=146.19  Aligned_cols=136  Identities=16%  Similarity=0.179  Sum_probs=97.0

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChh--hhHHH----------------------HHHHHHHHHccccc--e
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA--GDANF----------------------KHEVEIIASVKHVN--L  376 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~--~~~~f----------------------~~Ei~il~~l~H~n--i  376 (614)
                      .+.||+|+||.||+|...+|+.||||++......  ....+                      ..|.+.+.++.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            4679999999999999888999999998753211  11111                      34555555554433  2


Q ss_pred             eeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCe
Q 043267          377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNI  455 (614)
Q Consensus       377 v~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NI  455 (614)
                      .+.+++         ...++||||++++.+.........  .. .....++.+++.++.++|   . .+|+||||||+||
T Consensus        82 ~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Ni  146 (187)
T cd05119          82 PKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNI  146 (187)
T ss_pred             CceEec---------CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhE
Confidence            223221         235899999999654322111110  11 567889999999999999   7 8999999999999


Q ss_pred             EECCCCcEEEeecCCceeC
Q 043267          456 LLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       456 LLd~~~~~kl~DFGla~~~  474 (614)
                      +++ ++.++++|||.+...
T Consensus       147 li~-~~~~~liDfg~a~~~  164 (187)
T cd05119         147 LVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EEE-CCcEEEEECcccccc
Confidence            999 899999999999643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.59  E-value=1.3e-15  Score=172.69  Aligned_cols=165  Identities=28%  Similarity=0.406  Sum_probs=118.0

Q ss_pred             hcCccccceecccCceEEEEeEcCC-CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ..+|..+++|..|+||.||..+++. .+.+|+| +.+..     .+.+-  ++.....|.+                   
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfv-------------------  134 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFV-------------------  134 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCcce-------------------
Confidence            4578889999999999999998764 5667874 32211     01100  1111122222                   


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                       |      |+=.+.+...+  .++        .+++.+++|||   ..+|+|||+||+|.+++.-|++|+.|||+++...
T Consensus       135 -v------gDc~tllk~~g--~lP--------vdmvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL  194 (1205)
T KOG0606|consen  135 -V------GDCATLLKNIG--PLP--------VDMVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL  194 (1205)
T ss_pred             -e------chhhhhcccCC--CCc--------chhhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence             2      33233332222  222        12378999999   9999999999999999999999999999987432


Q ss_pred             CCC------------cc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccc
Q 043267          476 EGI------------TH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII  528 (614)
Q Consensus       476 ~~~------------~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~  528 (614)
                      ...            .+  ....++||+.|.|||++..+.|...+|+|++|+++||.+-|+.||...
T Consensus       195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC
Confidence            111            11  134578999999999999999999999999999999999999999644

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.56  E-value=3.9e-14  Score=143.03  Aligned_cols=139  Identities=17%  Similarity=0.171  Sum_probs=106.0

Q ss_pred             cceec-ccCceEEEEeEcCCCcEEEEEEeecCC-------------hhhhHHHHHHHHHHHHccccce--eeeeeeeecc
Q 043267          323 ENIIG-KGGYGNVYKGMLPNGTEVAVKRFKNCS-------------KAGDANFKHEVEIIASVKHVNL--VALRGYSTAT  386 (614)
Q Consensus       323 ~~~LG-~G~fG~Vykg~~~~g~~VAVK~l~~~~-------------~~~~~~f~~Ei~il~~l~H~ni--v~l~g~~~~~  386 (614)
                      ...|| .||.|+||++.. ++..++||++....             ......+.+|++++.+++|+++  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            36788 899999999988 47789999885311             1223467889999999998875  6666664422


Q ss_pred             cCCCCceEEEEEeecCC-CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          387 VPLEGHQRIIVCDLLHN-GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~-GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                      .. .....++|+|++++ .+|.+++.+.   .++..    ...+++.+|.+||   +.+|+||||||.|||++.++.++|
T Consensus       115 ~~-~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HG-LFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cC-cceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEE
Confidence            11 11234699999997 6898887542   34433    3568999999999   999999999999999999999999


Q ss_pred             eecCCcee
Q 043267          466 GDFGLAKF  473 (614)
Q Consensus       466 ~DFGla~~  473 (614)
                      +|||.+..
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=3e-15  Score=169.02  Aligned_cols=254  Identities=24%  Similarity=0.295  Sum_probs=184.7

Q ss_pred             CccccceecccCceEEEEeEcCC--CcEEEEEEeecCC--hhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPN--GTEVAVKRFKNCS--KAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-+.+. |+|++.+++...     +...
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~-----~~~~   95 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS-----SPRS   95 (601)
T ss_pred             cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC-----CCcc
Confidence            45556679999999998887643  3456777665432  222334455777777776 999999998765     5677


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCCce
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAK  472 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGla~  472 (614)
                      .++..+|..+|++.+.+........+....-....|+..++.|+|.  ..++.||||||+|.+++..+ ..|++|||+|.
T Consensus        96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchhhc
Confidence            8999999999999998843232245666677789999999999995  67899999999999999999 99999999998


Q ss_pred             eCCC--CCccccccccC-CCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          473 FNPE--GITHLTTRVAG-TLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       473 ~~~~--~~~~~~~~~~g-t~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      .+..  +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++...........|....   +..
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~---~~~  250 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNK---GRF  250 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccc---ccc
Confidence            6655  33344455678 9999999988884 456789999999999999999999965554443333332111   110


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      ..        ............+...++..+|..|.+.+++-
T Consensus       251 ~~--------~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  251 TQ--------LPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             cc--------CccccCChhhhhcccccccCCchhcccccccc
Confidence            01        11122233455666667888999999887754

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.47  E-value=2.8e-13  Score=148.35  Aligned_cols=143  Identities=20%  Similarity=0.186  Sum_probs=101.7

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhh----------------------------------------hHHHH
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG----------------------------------------DANFK  362 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~----------------------------------------~~~f~  362 (614)
                      .+.||.|++|.||+|++++|+.||||+.+......                                        +-+|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999999999999986431110                                        01244


Q ss_pred             HHHHHHHHcc----ccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHH-HHHHH
Q 043267          363 HEVEIIASVK----HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR-GLAYL  437 (614)
Q Consensus       363 ~Ei~il~~l~----H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~-gL~yL  437 (614)
                      +|...+.+++    |.+-+..-.++..    .....++||||+++++|.+....... ..   .+.+++..++. .+..+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~----~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWD----RTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehh----hcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHH
Confidence            5555555552    3333333333321    22357999999999999987643211 12   34567777766 46788


Q ss_pred             hhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       438 H~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |   ..+++|+|+||.||+++.++++++.|||++...++
T Consensus       274 ~---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 L---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             H---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   88999999999999999999999999999976553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=9.7e-13  Score=132.99  Aligned_cols=157  Identities=24%  Similarity=0.299  Sum_probs=122.2

Q ss_pred             HHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCC
Q 043267          366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQP  443 (614)
Q Consensus       366 ~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~  443 (614)
                      .-|-.+.|-|||++..|.......+.....++.|||..|++..+|++.  ....+....-.+|+.||..||.|||. +.+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            345566899999999988765544666788999999999999999863  34567777788999999999999995 489


Q ss_pred             ceEEeccCCCCeEECCCCcEEEeecCCceeC---CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh
Q 043267          444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFN---PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS  520 (614)
Q Consensus       444 ~iiHrDIKp~NILLd~~~~~kl~DFGla~~~---~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt  520 (614)
                      +|+|+++.-+.|++..++-+|++----...-   ............+-++|.+||+-...+.+..+|||+||+..+||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            9999999999999999998888522111100   0111112333457889999998888888899999999999999988


Q ss_pred             CCC
Q 043267          521 GKK  523 (614)
Q Consensus       521 G~~  523 (614)
                      |..
T Consensus       278 lEi  280 (458)
T KOG1266|consen  278 LEI  280 (458)
T ss_pred             hee
Confidence            764

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.29  E-value=1.2e-11  Score=117.17  Aligned_cols=130  Identities=16%  Similarity=0.119  Sum_probs=95.2

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceee-eeeeeecccCCCCceEEEEEeecC
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA-LRGYSTATVPLEGHQRIIVCDLLH  402 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~-l~g~~~~~~~~~~~~~~lV~E~~~  402 (614)
                      +.|+.|.++.||+++.. |..+++|....... ....+..|+++++.+.+.++++ ++.+.       ....++||||++
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~-------~~~~~lv~e~i~   74 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD-------PETGVLITEFIE   74 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe-------CCCCeEEEEecC
Confidence            56899999999999874 77899998765322 2335678999999997665543 44332       223579999999


Q ss_pred             CCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcC--CCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          403 NGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV--QPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       403 ~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~--~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +.++.+.-       .   ....+..+++++|+.||...  ...++|+|+||.||+++ ++.+++.|||.+..
T Consensus        75 G~~l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          75 GSELLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CCcccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            98876530       1   11345678999999999321  12369999999999999 66899999998863

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.26  E-value=3.1e-10  Score=126.33  Aligned_cols=145  Identities=13%  Similarity=0.112  Sum_probs=91.1

Q ss_pred             CccccceecccCceEEEEeEcCC-CcEEEEEEeecCChh----------------------------------hhH----
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA----------------------------------GDA----  359 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~----------------------------------~~~----  359 (614)
                      .|+. +.||.|++|.||+|++++ |++||||+.+..-..                                  -.+    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4666 789999999999999987 999999998643110                                  011    


Q ss_pred             --HHHHHHHHHHHcc----ccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHH
Q 043267          360 --NFKHEVEIIASVK----HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG  433 (614)
Q Consensus       360 --~f~~Ei~il~~l~----H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~g  433 (614)
                        ++.+|+..+.+++    +.+.+.+-.++..    -....+|||||++|+.+.+.-.-.. ...+   +..++...++.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d----~st~~VLvmE~i~G~~l~d~~~l~~-~g~d---~~~la~~~v~~  271 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWD----YCSETVMVMERMYGIPVSDVAALRA-AGTD---MKLLAERGVEV  271 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecc----cCCCceEEEeeecCccHHhHHHHHh-cCCC---HHHHHHHHHHH
Confidence              2334444444442    3333332222211    1245789999999999987421111 1111   12222222221


Q ss_pred             -HHHHhhcCCCceEEeccCCCCeEECCCC----cEEEeecCCceeCC
Q 043267          434 -LAYLHYGVQPAIIHRDIKASNILLDEAF----EAKVGDFGLAKFNP  475 (614)
Q Consensus       434 -L~yLH~~~~~~iiHrDIKp~NILLd~~~----~~kl~DFGla~~~~  475 (614)
                       +..++   ..+++|+|+||.||+++.++    .+++.|||+....+
T Consensus       272 ~~~Qif---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        272 FFTQVF---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             HHHHHH---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence             22233   67999999999999999888    99999999997554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=2.1e-11  Score=132.81  Aligned_cols=246  Identities=22%  Similarity=0.206  Sum_probs=172.6

Q ss_pred             Cccccceecc--cCceEEEEeEc--C-CCcEEEEEEeecCCh--hhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCC
Q 043267          319 NFSRENIIGK--GGYGNVYKGML--P-NGTEVAVKRFKNCSK--AGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       319 ~f~~~~~LG~--G~fG~Vykg~~--~-~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~  390 (614)
                      .|...+.+|.  |.+|.||.+..  . ++..+|+|+-+..-.  .....-.+|+...+++ .|+|.++......     +
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e-----~  189 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE-----G  189 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc-----c
Confidence            4566678999  99999999987  3 688899998543222  2223334677776777 5999998554443     4


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHH----HHHHHhhcCCCceEEeccCCCCeEECCC-CcEEE
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR----GLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKV  465 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~----gL~yLH~~~~~~iiHrDIKp~NILLd~~-~~~kl  465 (614)
                      ++..++-.|++ +.+|..+.+... ..++....+.+..+..+    ||..+|   ...++|-|+||.||++..+ ...++
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeec
Confidence            55666777776 578887775432 33666667777777777    999999   9999999999999999999 88999


Q ss_pred             eecCCceeCCCCC-c---cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH
Q 043267          466 GDFGLAKFNPEGI-T---HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       466 ~DFGla~~~~~~~-~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      +|||+.....++. .   ....+..|...|++||. ..+-++..+|+|++|.+.+|-.+|-+.....-     ..  .|.
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~-~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~-----~~--~W~  336 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL-LNGLATFASDIFSLGEVILEAILGSHLPSVGK-----NS--SWS  336 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhh-hccccchHhhhcchhhhhHhhHhhcccccCCC-----CC--Ccc
Confidence            9999998766543 1   12233467888999995 55678999999999999999999876542110     01  233


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      ..+.+.+.        .++......++.....++++.+|..|++.+.+.
T Consensus       337 ~~r~~~ip--------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~  377 (524)
T KOG0601|consen  337 QLRQGYIP--------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILT  377 (524)
T ss_pred             ccccccCc--------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence            33333322        111111222344477789999999999988765

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.12  E-value=6.5e-10  Score=109.66  Aligned_cols=145  Identities=19%  Similarity=0.202  Sum_probs=110.6

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCCh-hhhHHHHHHHHHHHHcccc--ceeeeeeeeecccCCCCceEEEEEee
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHV--NLVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~--niv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      +.|+.|..+.||+++..+|..+++|....... .....+..|+++++.+++.  ++.+++.+.....  ..+..++||||
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~--~~~~~~~v~e~   81 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPS--VLGTPFYVMER   81 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCC--ccCCceEEEEE
Confidence            56899999999999987778999998764322 2345788999999999764  3566666654211  11345899999


Q ss_pred             cCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 043267          401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG----------------------------------------  440 (614)
Q Consensus       401 ~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~----------------------------------------  440 (614)
                      +++.++.+.+..   ..++..++..++.+++++|.+||+.                                        
T Consensus        82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            999988876532   3577788888899999999999832                                        


Q ss_pred             -------------CCCceEEeccCCCCeEECC--CCcEEEeecCCcee
Q 043267          441 -------------VQPAIIHRDIKASNILLDE--AFEAKVGDFGLAKF  473 (614)
Q Consensus       441 -------------~~~~iiHrDIKp~NILLd~--~~~~kl~DFGla~~  473 (614)
                                   ....++|+|+++.||+++.  ++.+.|.||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         1356899999999999998  66789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.02  E-value=2.3e-09  Score=118.23  Aligned_cols=166  Identities=17%  Similarity=0.176  Sum_probs=122.7

Q ss_pred             cCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCC
Q 043267          339 LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKL  418 (614)
Q Consensus       339 ~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l  418 (614)
                      ..++.+|.|...+.......+...+-++.++.+|||||++++....     +++..|+|+|-+  ..|..++.+     +
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e-----~~~~~ylvTErV--~Pl~~~lk~-----l  101 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTE-----EEGTLYLVTERV--RPLETVLKE-----L  101 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhc-----ccCceEEEeecc--ccHHHHHHH-----h
Confidence            3478899999888765533455677888999999999999998775     556889999987  356666643     3


Q ss_pred             ChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhc
Q 043267          419 SWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL  498 (614)
Q Consensus       419 ~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~  498 (614)
                      +.....-.+.||+.||.|||+  +.+++|++|.-..|++++.|+.||++|.++........ ......--..|..|+.+.
T Consensus       102 ~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~  178 (690)
T KOG1243|consen  102 GKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEID  178 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcC
Confidence            344555678899999999986  67899999999999999999999999998754332111 011111122456666433


Q ss_pred             cCCCCchhhHHHHHHHHHHHHhC
Q 043267          499 YGKLTPGSDVYSFGVVLLELLSG  521 (614)
Q Consensus       499 ~~~~t~ksDVwS~Gvll~ElltG  521 (614)
                      ...  -..|.|-||++++|++.|
T Consensus       179 ~s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  179 PSE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccc--cchhhhhHHHHHHHHhCc
Confidence            222  356999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.01  E-value=3.5e-09  Score=103.24  Aligned_cols=135  Identities=15%  Similarity=0.112  Sum_probs=96.0

Q ss_pred             ceecccCceEEEEeEcCC-------CcEEEEEEeecCC----------------------hhhhHHH----HHHHHHHHH
Q 043267          324 NIIGKGGYGNVYKGMLPN-------GTEVAVKRFKNCS----------------------KAGDANF----KHEVEIIAS  370 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~----------------------~~~~~~f----~~Ei~il~~  370 (614)
                      ..||.|--+.||.|...+       +..+|||..+...                      ......+    .+|...|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653       4799999764210                      0011222    378989998


Q ss_pred             ccc--cceeeeeeeeecccCCCCceEEEEEeecCCCChhh-hhhcCCCcCCChHHHHHHHHHHHHHHHHH-hhcCCCceE
Q 043267          371 VKH--VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD-HLFGSGMKKLSWPIRLRIALGTARGLAYL-HYGVQPAII  446 (614)
Q Consensus       371 l~H--~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~-~L~~~~~~~l~~~~~~~I~~~ia~gL~yL-H~~~~~~ii  446 (614)
                      +..  -++...+.+         ...++||||+.++.+.. .+.+   ..++.++..++..++..+|..| |   +.+++
T Consensus        83 l~~~Gv~vP~pi~~---------~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H---~~glV  147 (197)
T cd05146          83 MQKAGIPCPEVVVL---------KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYK---ECNLV  147 (197)
T ss_pred             HHHcCCCCCeEEEe---------cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHH---hCCee
Confidence            854  344445443         34689999997654422 2221   1344556677889999999999 7   88999


Q ss_pred             EeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          447 HRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       447 HrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      |+||++.|||+++ +.+.|+|||.+-..
T Consensus       148 HGDLs~~NIL~~~-~~v~iIDF~qav~~  174 (197)
T cd05146         148 HADLSEYNMLWHD-GKVWFIDVSQSVEP  174 (197)
T ss_pred             cCCCCHHHEEEEC-CcEEEEECCCceeC
Confidence            9999999999974 67999999988643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.99  E-value=1.1e-08  Score=109.77  Aligned_cols=172  Identities=19%  Similarity=0.248  Sum_probs=133.9

Q ss_pred             ceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCC-CChhh
Q 043267          331 YGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN-GSLYD  408 (614)
Q Consensus       331 fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~-GsL~~  408 (614)
                      -.+.||+... ||..+++||++....+....-..-++.++++.|.|+|++..++. +..+.....++||+|.|+ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~-t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFL-TYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhh-hhccCcceEEEEEecCCCCchHHH
Confidence            3568888854 89999999995443333334456688999999999999999876 333467789999999985 57877


Q ss_pred             hhhcC-------------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          409 HLFGS-------------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       409 ~L~~~-------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      .-+..             .....++...+.++.|++.||.++|   +.|+.-+-|.+++||++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            66532             1234778899999999999999999   8899999999999999999999999999887655


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKA  524 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p  524 (614)
                      ++..               |-+..   ..+-|.=-||.+++.|.+|...
T Consensus       445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            4431               11111   2367888999999999999754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.93  E-value=4.7e-10  Score=122.43  Aligned_cols=250  Identities=21%  Similarity=0.185  Sum_probs=167.9

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcC--CCcEEEEEEeecCChhhhH--HHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLP--NGTEVAVKRFKNCSKAGDA--NFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~~~~~~~--~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      ....+.+|.....||.|.|+.|++...+  ++..+++|.+.+.......  .-..|+-+...+ .|.+.+....-..   
T Consensus       260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~---  336 (524)
T KOG0601|consen  260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWS---  336 (524)
T ss_pred             ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcc---
Confidence            3445567888999999999999987743  6788999988754322222  223566555555 4667666443322   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-CcEEEe
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVG  466 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-~~~kl~  466 (614)
                        .....++--||++++++...+  .-...++...++++..+++.++.++|   ++.++|+|+||+||++..+ +.-+++
T Consensus       337 --~~r~~~ip~e~~~~~s~~l~~--~~~~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~  409 (524)
T KOG0601|consen  337 --QLRQGYIPLEFCEGGSSSLRS--VTSQMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLG  409 (524)
T ss_pred             --ccccccCchhhhcCcchhhhh--HHHHhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhcc
Confidence              345566888999999987766  22345777888999999999999999   9999999999999999886 888999


Q ss_pred             ecCCceeCCCCCccccccccCCCCc-CchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGY-VAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y-~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      |||....+.-.   .......+..| .+++......+-.+.|++|||.-+.|.++|..--.....         |..++.
T Consensus       410 ~~~~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~---------~~~i~~  477 (524)
T KOG0601|consen  410 DFGCWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ---------SLTIRS  477 (524)
T ss_pred             cccccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCccccc---------ceeeec
Confidence            99998632110   00111122233 355555566788999999999999999998754321111         122222


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhh
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE  594 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  594 (614)
                      |...     .++.     ....+..+...+..+++..||.+.+...+.+
T Consensus       478 ~~~p-----~~~~-----~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  478 GDTP-----NLPG-----LKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             cccc-----CCCc-----hHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            2221     1111     1133444555588999999999988776554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.90  E-value=2.6e-08  Score=102.10  Aligned_cols=146  Identities=15%  Similarity=0.080  Sum_probs=104.0

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChh-----------hhHHHHHHHHHHHHccccc--eeeeeeeeecccCCC
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA-----------GDANFKHEVEIIASVKHVN--LVALRGYSTATVPLE  390 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~  390 (614)
                      +.+-......|++..+ +|+.+.||+.......           ....+.+|...+.++...+  ....+++........
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4454444555777776 6788999987543211           1124778999998885433  334455543221111


Q ss_pred             CceEEEEEeecCCC-ChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-------CCc
Q 043267          391 GHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-------AFE  462 (614)
Q Consensus       391 ~~~~~lV~E~~~~G-sL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-------~~~  462 (614)
                      ....++|+|++++- +|.+++........+...+..++.+++..+.-||   ..+|+|+|++++|||++.       +..
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~~  183 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDLK  183 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCce
Confidence            34578999999986 8998885432344566778899999999999999   999999999999999975       578


Q ss_pred             EEEeecCCcee
Q 043267          463 AKVGDFGLAKF  473 (614)
Q Consensus       463 ~kl~DFGla~~  473 (614)
                      +.++||+.++.
T Consensus       184 ~~LIDl~r~~~  194 (268)
T PRK15123        184 LSVIDLHRAQI  194 (268)
T ss_pred             EEEEECCcccc
Confidence            99999998863

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=1.8e-08  Score=95.76  Aligned_cols=132  Identities=23%  Similarity=0.347  Sum_probs=95.7

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEE-eecCCh-------hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKR-FKNCSK-------AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~-l~~~~~-------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ..+++|+-+.+|.+.+. |.++++|. +++.-.       -....-.+|..++.+++--.+-...-+..     +.....
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv-----D~~~~~   75 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV-----DPDNGL   75 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE-----cCCCCE
Confidence            35889999999999874 44466663 332111       11234567999999886433322222222     456678


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|||.++..|.+.+...         +..+...+-+-+.-||   ..+|+|+||.++||++.++. +.++||||+...
T Consensus        76 I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          76 IVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             EEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999999999888543         3567777888888899   99999999999999998875 999999999854

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.83  E-value=3.6e-08  Score=93.40  Aligned_cols=143  Identities=22%  Similarity=0.275  Sum_probs=102.8

Q ss_pred             ccceecccCceEEEEeEcCCCcEEEEEE-eecC-------ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          322 RENIIGKGGYGNVYKGMLPNGTEVAVKR-FKNC-------SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~-l~~~-------~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ...++-||+-+.|+++.+ .|+...||. +.+.       ..-....-.+|+.++.+++--.|.-..-++.     +...
T Consensus        11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~-----D~~~   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFI-----DTYG   84 (229)
T ss_pred             cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEE-----ecCC
Confidence            457899999999999998 577766663 3221       1122345678999999886444433222322     3445


Q ss_pred             EEEEEeecCC-CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC---cEEEeecC
Q 043267          394 RIIVCDLLHN-GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF---EAKVGDFG  469 (614)
Q Consensus       394 ~~lV~E~~~~-GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~---~~kl~DFG  469 (614)
                      ..|+|||+++ .++.+++...-......+.....+..+-+.+.-||   ...|+|+||..+||+|..++   .+.++|||
T Consensus        85 ~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfg  161 (229)
T KOG3087|consen   85 GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFG  161 (229)
T ss_pred             CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeec
Confidence            6899999976 47888887654444444444788899999999999   99999999999999996554   45899999


Q ss_pred             Ccee
Q 043267          470 LAKF  473 (614)
Q Consensus       470 la~~  473 (614)
                      ++..
T Consensus       162 ls~~  165 (229)
T KOG3087|consen  162 LSSV  165 (229)
T ss_pred             chhc
Confidence            9864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=1.7e-07  Score=90.90  Aligned_cols=126  Identities=25%  Similarity=0.316  Sum_probs=82.9

Q ss_pred             EEEEeEcCCCcEEEEEEeecCC--------------h------------hhhHHHHHHHHHHHHcccc--ceeeeeeeee
Q 043267          333 NVYKGMLPNGTEVAVKRFKNCS--------------K------------AGDANFKHEVEIIASVKHV--NLVALRGYST  384 (614)
Q Consensus       333 ~Vykg~~~~g~~VAVK~l~~~~--------------~------------~~~~~f~~Ei~il~~l~H~--niv~l~g~~~  384 (614)
                      .||.|..++|..+|||..+...              .            .......+|.+.|.++...  ++.+.+.+. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            4899999999999999864210              0            0113357799999999765  445555432 


Q ss_pred             cccCCCCceEEEEEeecC--CCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHH-HhhcCCCceEEeccCCCCeEECCCC
Q 043267          385 ATVPLEGHQRIIVCDLLH--NGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY-LHYGVQPAIIHRDIKASNILLDEAF  461 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~--~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~y-LH~~~~~~iiHrDIKp~NILLd~~~  461 (614)
                              ..++||||++  +..+.. |.+..   ++.+....++.++...+.. +|   ..+|+|+|+.+.|||++++ 
T Consensus        80 --------~~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 --------RNVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             --------TTEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-
T ss_pred             --------CCEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-
Confidence                    3489999998  444433 32221   2245566778888885555 57   8999999999999999988 


Q ss_pred             cEEEeecCCceeCC
Q 043267          462 EAKVGDFGLAKFNP  475 (614)
Q Consensus       462 ~~kl~DFGla~~~~  475 (614)
                      .+.|+|||.+....
T Consensus       144 ~~~iIDf~qav~~~  157 (188)
T PF01163_consen  144 KVYIIDFGQAVDSS  157 (188)
T ss_dssp             CEEE--GTTEEETT
T ss_pred             eEEEEecCcceecC
Confidence            99999999886543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.65  E-value=1e-08  Score=117.61  Aligned_cols=205  Identities=21%  Similarity=0.199  Sum_probs=139.0

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .-+.|.+.+-+-+|.++.++...-. .|...++|......   ....+....+-.+.-..+||-++...--.     ...
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~r  876 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCR  876 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCC
Confidence            4456777788889999999887643 23333444332211   11111122222222223445544332221     145


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ....|+++|..+++|...|+..+  ..+.+-....+..+...++|||   ...+.|||++|.|.|...+++.+++|||..
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~  951 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTL  951 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCccccc
Confidence            66799999999999999987654  4444444556667788999999   777999999999999999999999999843


Q ss_pred             eeCC-------C--------------CCc---------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhC
Q 043267          472 KFNP-------E--------------GIT---------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG  521 (614)
Q Consensus       472 ~~~~-------~--------------~~~---------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG  521 (614)
                      ....       .              ...         .......||+.|.+||...+......+|+|+.|+.++|.++|
T Consensus       952 ~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  952 SKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             cccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcC
Confidence            2110       0              000         011235689999999999999999999999999999999999


Q ss_pred             CCCcccccC
Q 043267          522 KKACEIIQG  530 (614)
Q Consensus       522 ~~p~~~~~~  530 (614)
                      ..|+.....
T Consensus      1032 ~pp~na~tp 1040 (1205)
T KOG0606|consen 1032 IPPFNAETP 1040 (1205)
T ss_pred             CCCCCCcch
Confidence            999965443

>PRK09902 hypothetical protein; Provisional

Probab=98.63  E-value=4.8e-07  Score=88.72  Aligned_cols=142  Identities=17%  Similarity=0.164  Sum_probs=108.0

Q ss_pred             ecccCceEEEEeEcCCCcEEEEEEeecC---C---hhhhHHHHHHHHHHHHccccc--eeeeeeeeecccCCCCceEEEE
Q 043267          326 IGKGGYGNVYKGMLPNGTEVAVKRFKNC---S---KAGDANFKHEVEIIASVKHVN--LVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       326 LG~G~fG~Vykg~~~~g~~VAVK~l~~~---~---~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      -|+||.+.|++-.+ +|..+-+|+-.+.   +   ..+...|.+|+..|.++...+  +.+.. ++.....-....-+||
T Consensus        26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            46799999999877 4557999987521   1   336678999999999995433  33443 3322211124457899


Q ss_pred             EeecCC-CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc--EEEeecCCce
Q 043267          398 CDLLHN-GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE--AKVGDFGLAK  472 (614)
Q Consensus       398 ~E~~~~-GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~--~kl~DFGla~  472 (614)
                      +|-+++ -+|.+++.+....+.+...+..+..++++.+.-||   +.++.|+|+-+.||+++.++.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997753 58988987665556788888999999999999999   999999999999999986666  9999998765

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.56  E-value=5.6e-07  Score=88.84  Aligned_cols=129  Identities=23%  Similarity=0.229  Sum_probs=93.7

Q ss_pred             CCcEEEEEEeecC-Ch------hhhHHHHHHHHHHHHcccc--ceeeeeeeeecccCCCCceEEEEEeecCCC-Chhhhh
Q 043267          341 NGTEVAVKRFKNC-SK------AGDANFKHEVEIIASVKHV--NLVALRGYSTATVPLEGHQRIIVCDLLHNG-SLYDHL  410 (614)
Q Consensus       341 ~g~~VAVK~l~~~-~~------~~~~~f~~Ei~il~~l~H~--niv~l~g~~~~~~~~~~~~~~lV~E~~~~G-sL~~~L  410 (614)
                      .++.+.+|..... ..      .......+|...+..+...  ...+.+++....... ....++|+|++++- +|.+++
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~  109 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLL  109 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHH
Confidence            3556666654321 11      2344677888888888533  345556665543221 24568999999874 799988


Q ss_pred             hcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC---cEEEeecCCceeCC
Q 043267          411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF---EAKVGDFGLAKFNP  475 (614)
Q Consensus       411 ~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~---~~kl~DFGla~~~~  475 (614)
                      .+...  ++...+..++.++++.+.-||   ..+|+|+|+++.|||++.+.   .+.++||+-++...
T Consensus       110 ~~~~~--~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~  172 (206)
T PF06293_consen  110 QQWEQ--LDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP  172 (206)
T ss_pred             Hhhcc--cchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence            65332  666778899999999999999   99999999999999999887   89999999887533

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.52  E-value=2.9e-08  Score=110.06  Aligned_cols=150  Identities=22%  Similarity=0.325  Sum_probs=98.7

Q ss_pred             HHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccc---cc-----cccCCCCcCchhhhccC
Q 043267          429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL---TT-----RVAGTLGYVAPEYALYG  500 (614)
Q Consensus       429 ~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~---~~-----~~~gt~~Y~APE~~~~~  500 (614)
                      +++.||.|+|.  +.++||++|.|++|.+++++..||+.|+.+-.........   .+     -..-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            44599999996  6799999999999999999999999999875333211110   00     01234579999999998


Q ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCC
Q 043267          501 KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPIL  580 (614)
Q Consensus       501 ~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP  580 (614)
                      ..+.++|+||+|+++|-+..|.++.-...+....   +..+    +...+.--..    +..+..+++.+=+...+..++
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~---~~~~----~~~~~~~~~~----~s~~~p~el~~~l~k~l~~~~  253 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLS---YSFS----RNLLNAGAFG----YSNNLPSELRESLKKLLNGDS  253 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcch---hhhh----hccccccccc----ccccCcHHHHHHHHHHhcCCc
Confidence            8999999999999999999666555222221111   0000    1111110111    112333445555666899999


Q ss_pred             CCCCCHHHHHH
Q 043267          581 QARPTMDQIVK  591 (614)
Q Consensus       581 ~~RPt~~eVl~  591 (614)
                      ..||++.++..
T Consensus       254 ~~rp~~~~l~~  264 (700)
T KOG2137|consen  254 AVRPTLDLLLS  264 (700)
T ss_pred             ccCcchhhhhc
Confidence            99998877654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.51  E-value=9.3e-07  Score=88.91  Aligned_cols=135  Identities=21%  Similarity=0.175  Sum_probs=94.0

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecC----------Ch------------hhhHHHHHHHHHHHHcccc--
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC----------SK------------AGDANFKHEVEIIASVKHV--  374 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----------~~------------~~~~~f~~Ei~il~~l~H~--  374 (614)
                      -....+.||-|--+.||.|..++|.++|||.=+..          ..            ......++|.++|.++...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            34556889999999999999999999999953210          00            1123456788888888554  


Q ss_pred             ceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCC
Q 043267          375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN  454 (614)
Q Consensus       375 niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~N  454 (614)
                      .+.+.+         ..+...+||||.++-.|...-       ++-+..-.|+..|.+-+.-+-   ..+|||+|+.+-|
T Consensus       172 ~VP~P~---------~~nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefN  232 (304)
T COG0478         172 KVPKPI---------AWNRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFN  232 (304)
T ss_pred             CCCCcc---------ccccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchhe
Confidence            444333         456679999999886665432       122233334444444444444   5789999999999


Q ss_pred             eEECCCCcEEEeecCCce
Q 043267          455 ILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       455 ILLd~~~~~kl~DFGla~  472 (614)
                      |+++++|.+.++||--+-
T Consensus       233 IlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             EEEecCCCEEEEeCcccc
Confidence            999999999999997554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.48  E-value=6e-06  Score=87.11  Aligned_cols=262  Identities=17%  Similarity=0.180  Sum_probs=153.9

Q ss_pred             cccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc--CCCCceEEEE
Q 043267          321 SRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATV--PLEGHQRIIV  397 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~--~~~~~~~~lV  397 (614)
                      ...+.||+|+-+.+|-.--- +.. +-|+..........+   .++.|.+. .||-+-.-+.|-....  ..++...-+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh-hch-hheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            34567999999999964321 222 346665543333322   22333333 5664433122211110  0122224466


Q ss_pred             EeecCCCC-hhhhhhc----CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          398 CDLLHNGS-LYDHLFG----SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       398 ~E~~~~Gs-L~~~L~~----~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      |..+++.. ..+++..    ..-....|+-.++.+..+|.+.+-||   ..|.+-+|+.++|+|+.+++.+.+.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEccccee
Confidence            66665542 2222221    22345899999999999999999999   8899999999999999999999999866544


Q ss_pred             eCCCCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhC-CCCcccccC---ccchhhHHHHHHH
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSG-KKACEIIQG---KSVLLSDWAWELV  543 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~---~~~~l~~~~~~~~  543 (614)
                      ...++.  .....+|...|.+||.-.     +-.-+..+|-|.+||++++++.| ++||.....   ....+.    ..+
T Consensus       166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E----~~I  239 (637)
T COG4248         166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE----TDI  239 (637)
T ss_pred             eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch----hhh
Confidence            433332  233456889999999765     33557789999999999999885 999954321   111111    112


Q ss_pred             HcCCchhhhhccCC------CCCcHHHHHHHHHHHHHccccC--CCCCCCHHHHHHHhhcc
Q 043267          544 KEGKTLDVIEENMP------EMELPEMMEQYVLTAAICAHPI--LQARPTMDQIVKILETD  596 (614)
Q Consensus       544 ~~g~~~~~~d~~l~------~~~~~~~~~~l~~l~~~Cl~~d--P~~RPt~~eVl~~L~~~  596 (614)
                      ..|.....-+..-.      +....-....+--+...|+...  +.-|||++-++..|...
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            22222222221111      1111111223334445566443  56899999998877553

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.35  E-value=2.8e-06  Score=94.44  Aligned_cols=143  Identities=18%  Similarity=0.180  Sum_probs=92.3

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChh----------------------------------------hhHHHHH
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA----------------------------------------GDANFKH  363 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~----------------------------------------~~~~f~~  363 (614)
                      +.|+.++-|.||+|++++|++||||+....-..                                        .+-++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            579999999999999999999999986432110                                        0011334


Q ss_pred             HHHHHHHcc----ccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHH-HHHHh
Q 043267          364 EVEIIASVK----HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG-LAYLH  438 (614)
Q Consensus       364 Ei~il~~l~----H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~g-L~yLH  438 (614)
                      |...+.+++    +..-+++-.++..    -....+|+|||++|-.+.+...-.. ..++   +..|+..++++ +..+=
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we----~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWE----YTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehh----ccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHHHHHHH
Confidence            444444442    2222222223321    2356799999999999988743221 2344   33444444443 12222


Q ss_pred             hcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       439 ~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                         ..+++|.|.+|.||+++.++++-+.|||+....++.
T Consensus       283 ---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         283 ---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ---hcCccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence               468999999999999999999999999998765543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.21  E-value=1.9e-05  Score=77.97  Aligned_cols=143  Identities=10%  Similarity=0.083  Sum_probs=94.0

Q ss_pred             HhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHH---------HHHHHHHHHHcccc---ceeeeeeee
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDAN---------FKHEVEIIASVKHV---NLVALRGYS  383 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~---------f~~Ei~il~~l~H~---niv~l~g~~  383 (614)
                      ..++|...+++-......|.+-.. +|..+++|.........++.         ..+++..+.+++..   ....++...
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            456788778887777777777666 67889999876544333322         23344444444322   222222222


Q ss_pred             ecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       384 ~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                      ...........+++|||++|..|.+...      ++.    .++..+.+.+.-||   +.|++|+|.+|.|+++++++ +
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i  173 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-I  173 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-E
Confidence            2111112345678999999988876541      222    35566778899999   99999999999999999665 9


Q ss_pred             EEeecCCcee
Q 043267          464 KVGDFGLAKF  473 (614)
Q Consensus       464 kl~DFGla~~  473 (614)
                      ++.||+..+.
T Consensus       174 ~iID~~~k~~  183 (229)
T PF06176_consen  174 RIIDTQGKRM  183 (229)
T ss_pred             EEEECccccc
Confidence            9999987764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=98.17  E-value=2.5e-07  Score=81.35  Aligned_cols=51  Identities=16%  Similarity=0.154  Sum_probs=46.3

Q ss_pred             hHhhhcccCCCCCccchhHHHHHHHHhhhhhcCCCCCCCcccCCCCCccccc
Q 043267          163 QEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLY  214 (614)
Q Consensus       163 ~~l~~qC~~dL~~~~~C~~CL~~~~~~~~~~l~g~~Gg~~~~~~C~~r~~~y  214 (614)
                      .|.++||++|| ++.+|..||+.++..++.+|.++.||++...+|++||+.|
T Consensus        54 vYgl~qC~~Dl-s~~dC~~Cl~~a~~~~~~~C~~~~g~~v~~~~C~lRY~~~  104 (106)
T PF01657_consen   54 VYGLAQCRGDL-SPSDCRACLADAVANISSCCPGSRGGRVWYDSCFLRYENY  104 (106)
T ss_dssp             EEEEEEE-TTS--HHHHHHHHHHHHCCHHHHTTSBSSEEEEESSEEEEEESS
T ss_pred             EEEEEEcCCCC-ChhhhHHHHHHHHHHHHHhCCCCceEEEECCCEEEEEECC
Confidence            47799999999 8999999999999999999999999999999999999876

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.17  E-value=2.1e-05  Score=77.77  Aligned_cols=145  Identities=15%  Similarity=0.164  Sum_probs=87.0

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeecccCCCCceEEEEEeec
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      +.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+....  +.+++.++....  .....+++|+++
T Consensus         3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~--~~~~~~~~~~~i   77 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDE--FNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETE--ETSEEEEEEEEE
T ss_pred             ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccc--ccccceEEEEEe
Confidence            578999999999999877 68999987653  45567889999999886443  445555443221  233478999999


Q ss_pred             CCCChhh----------------hh---hcC--CCcCCChHHH---------HHH------------HHHHHH-HHHHHh
Q 043267          402 HNGSLYD----------------HL---FGS--GMKKLSWPIR---------LRI------------ALGTAR-GLAYLH  438 (614)
Q Consensus       402 ~~GsL~~----------------~L---~~~--~~~~l~~~~~---------~~I------------~~~ia~-gL~yLH  438 (614)
                      ++..+.+                .+   +..  ....+.+...         ...            ...+.+ .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   111  1111111110         000            111222 233333


Q ss_pred             h----cCCCceEEeccCCCCeEEC-CCCcEEEeecCCcee
Q 043267          439 Y----GVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKF  473 (614)
Q Consensus       439 ~----~~~~~iiHrDIKp~NILLd-~~~~~kl~DFGla~~  473 (614)
                      .    .....++|+|+.|.|||++ +++.+-|.||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    2367899999999999999 666678999988753

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.13  E-value=4e-05  Score=76.83  Aligned_cols=138  Identities=13%  Similarity=0.156  Sum_probs=81.7

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccce--eeeeeeeecccCCCCceEEEEEeec
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL--VALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni--v~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      ..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.+  .+.++++.     ..+...+|||++
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~-----~~~~~glv~e~i   76 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVE-----DGGRLGLIYELI   76 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEe-----cCCeeeeeeeec
Confidence            56999999999983   25567788876432  33456889999999865444  44555553     334457899999


Q ss_pred             CCCC-hhhhh---------------------hcCCCcCCChHHHHH-HHH----------HHHH-HHHHHhh-cCCCceE
Q 043267          402 HNGS-LYDHL---------------------FGSGMKKLSWPIRLR-IAL----------GTAR-GLAYLHY-GVQPAII  446 (614)
Q Consensus       402 ~~Gs-L~~~L---------------------~~~~~~~l~~~~~~~-I~~----------~ia~-gL~yLH~-~~~~~ii  446 (614)
                      +|.. +...+                     +.-.........+.. +..          .+.+ ...+|.. .....++
T Consensus        77 ~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~  156 (226)
T TIGR02172        77 VGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL  156 (226)
T ss_pred             CCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence            8863 21111                     110001111111110 000          0111 1122221 1234678


Q ss_pred             EeccCCCCeEECCCCcEEEeecCCce
Q 043267          447 HRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       447 HrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      |+|+.|.||++++++ +.|.||+.+.
T Consensus       157 HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       157 HGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ecCCCCCcEEEcCCC-cEEEechhcC
Confidence            999999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.13  E-value=3.9e-07  Score=100.22  Aligned_cols=197  Identities=20%  Similarity=0.097  Sum_probs=137.0

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc-eeeeeeeeecc
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN-LVALRGYSTAT  386 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n-iv~l~g~~~~~  386 (614)
                      |+...++..+.-+..-+-+++|++++++|.+-...+...++.+...     ....-++++|.+++||| .+..++-+.  
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~--  304 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYD--  304 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCC--
Confidence            4444455555556666779999999999987433334445555331     44567899999999999 444444332  


Q ss_pred             cCCCCceEEEEEeecCCC-ChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          387 VPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~G-sL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                         .+....++++++..| +-..-.. .....+...+...+...-+++++|||   +..=+|||    ||+..+ ...|.
T Consensus       305 ---~E~~~~i~~~i~s~~rs~~~~~~-~se~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~  372 (829)
T KOG0576|consen  305 ---GEDYLWIPMRICSTGRSSALEMT-VSEIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKL  372 (829)
T ss_pred             ---cccccchhhhhhcCCccccccCC-hhhHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-ccccc
Confidence               456678899999877 2222111 11122444445556677788999999   54457888    777776 57899


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      +||+....+....  ......+|+.++|||....+.+..+.|+|+.|+--.++--|-.|-
T Consensus       373 ~~~~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  373 LDFAVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccccCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            9999987666544  234467899999999999999999999999998777777776665

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=1e-05  Score=78.71  Aligned_cols=103  Identities=21%  Similarity=0.208  Sum_probs=83.5

Q ss_pred             HHHHHHHHHccc-cceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhc-CCCcCCChHHHHHHHHHHHHHHHHHhh
Q 043267          362 KHEVEIIASVKH-VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG-SGMKKLSWPIRLRIALGTARGLAYLHY  439 (614)
Q Consensus       362 ~~Ei~il~~l~H-~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~  439 (614)
                      .+|.-++..+++ +++.+++|.|-         .++|.||.+.+++...-.. ..-...+|+.|.+||.++++.+.+|++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG---------~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCG---------RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECC---------CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            458888899976 69999999995         3889999988766432000 111257899999999999999999997


Q ss_pred             cCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       440 ~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .....+.-.|++++|+-+++++++|+.|...+..
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            7667788899999999999999999999987653

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.11  E-value=1.9e-05  Score=78.89  Aligned_cols=154  Identities=17%  Similarity=0.194  Sum_probs=98.1

Q ss_pred             ccCHHHHHHHhcCccccceec---ccCceEEEEeEcCCCcEEEEEEeecCChhh---------hHH--------------
Q 043267          307 RFKIEEIKAATMNFSRENIIG---KGGYGNVYKGMLPNGTEVAVKRFKNCSKAG---------DAN--------------  360 (614)
Q Consensus       307 ~f~~~el~~~t~~f~~~~~LG---~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~---------~~~--------------  360 (614)
                      ..+++.|.....+..+....|   +|--+.||+|.-.++..+|||+++......         ...              
T Consensus        34 ~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          34 KRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             hHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            445666777666666666654   677788999998889999999986432111         111              


Q ss_pred             -HHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCC-hhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHh
Q 043267          361 -FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGS-LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH  438 (614)
Q Consensus       361 -f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~Gs-L~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH  438 (614)
                       ..+|..-|.++..-.       ...+.++....-.|||||+.... -.-.|.+   ..+.......+..++.+.+.-|-
T Consensus       114 W~~kEf~NL~R~~eAG-------VrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         114 WARKEFRNLKRAYEAG-------VRVPEPIAFRNNVLVMEFIGDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHcC-------CCCCCceeecCCeEEEEeccCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHH
Confidence             123444455442211       11222333445689999996541 1111211   12333346667777888877776


Q ss_pred             hcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       439 ~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .  ..++||+||..-|||+. ++.+.|+|+|-|-.
T Consensus       184 ~--~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~  215 (268)
T COG1718         184 K--EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVT  215 (268)
T ss_pred             H--hcCcccccchhhheEEE-CCeEEEEECccccc
Confidence            2  37999999999999999 88999999997753

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.05  E-value=3.3e-05  Score=85.81  Aligned_cols=143  Identities=20%  Similarity=0.180  Sum_probs=90.9

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChh-------------------------------------hhHHHHHHHH
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA-------------------------------------GDANFKHEVE  366 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~-------------------------------------~~~~f~~Ei~  366 (614)
                      +.||..+.|.||+|++++|+.||||+-+..-+.                                     .+-+|.+|.+
T Consensus       167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~  246 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK  246 (538)
T ss_pred             chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence            579999999999999999999999985421110                                     1112555655


Q ss_pred             HHHHc----cccc---eeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhh
Q 043267          367 IIASV----KHVN---LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY  439 (614)
Q Consensus       367 il~~l----~H~n---iv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~  439 (614)
                      -..+.    +|-+   -|..-.++..    -...+.|+||||+|..+.|.-.-. ...++-.   +|+..+.++  |++.
T Consensus       247 Nae~~~~~f~~~~~~~~V~VP~Vy~~----~st~RVLtME~~~G~~i~Dl~~i~-~~gi~~~---~i~~~l~~~--~~~q  316 (538)
T KOG1235|consen  247 NAERFRENFKDFSLLTYVLVPKVYWD----LSTKRVLTMEYVDGIKINDLDAID-KRGISPH---DILNKLVEA--YLEQ  316 (538)
T ss_pred             hHHHHHHHHHhcccccceeCCeehhh----cCcceEEEEEecCCccCCCHHHHH-HcCCCHH---HHHHHHHHH--HHHH
Confidence            44443    4555   1222222221    224689999999999887753221 1224433   344433333  2222


Q ss_pred             cCCCceEEeccCCCCeEEC----CCCcEEEeecCCceeCCC
Q 043267          440 GVQPAIIHRDIKASNILLD----EAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       440 ~~~~~iiHrDIKp~NILLd----~~~~~kl~DFGla~~~~~  476 (614)
                      -...|++|.|=+|-||+++    .++.+.+-|||+......
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2256899999999999998    467899999999876544

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.91  E-value=0.00015  Score=73.22  Aligned_cols=138  Identities=14%  Similarity=0.083  Sum_probs=82.6

Q ss_pred             ecccCc-eEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEEEEEeecCC
Q 043267          326 IGKGGY-GNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRIIVCDLLHN  403 (614)
Q Consensus       326 LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~  403 (614)
                      |-.|.. ..||+...+ +..+.||+.....   ..+..+|+++++.+. +--+.+++++..     .++..++|||+++|
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGS-----DDGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEe-----cCCccEEEEEeeCC
Confidence            445555 789998874 4778888876543   345678999988884 333445555543     23457899999998


Q ss_pred             CChhhhh-------------------hcCC--CcCCC--hHHHHHHHH--------------------HHHHHHHHHh--
Q 043267          404 GSLYDHL-------------------FGSG--MKKLS--WPIRLRIAL--------------------GTARGLAYLH--  438 (614)
Q Consensus       404 GsL~~~L-------------------~~~~--~~~l~--~~~~~~I~~--------------------~ia~gL~yLH--  438 (614)
                      .+|.+..                   +.-.  ...+.  +..+.....                    .+...+..|-  
T Consensus        77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  156 (244)
T cd05150          77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT  156 (244)
T ss_pred             ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence            8776432                   1100  00111  001110000                    0111122221  


Q ss_pred             --hcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          439 --YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       439 --~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                        ......++|+|+.|.|||++++....|+||+.+.
T Consensus       157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence              1124669999999999999998778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=97.72  E-value=0.00049  Score=81.81  Aligned_cols=82  Identities=10%  Similarity=0.141  Sum_probs=57.1

Q ss_pred             cceecccCceEEEEeEcCCC---cEEEEEEeecCC-hhhhHHHHHHHHHHHHcc-ccce--eeeeeeeecccCCCCceEE
Q 043267          323 ENIIGKGGYGNVYKGMLPNG---TEVAVKRFKNCS-KAGDANFKHEVEIIASVK-HVNL--VALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g---~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~-H~ni--v~l~g~~~~~~~~~~~~~~  395 (614)
                      .+.++.|.++.+|+....++   ..+++|+..... ......+.+|+++++.+. |.++  .+.+++|....  ..+..+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~--v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDAS--VIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCC--cCCCce
Confidence            46688999999999887554   467788765322 223456889999999995 6665  66777775321  124568


Q ss_pred             EEEeecCCCCh
Q 043267          396 IVCDLLHNGSL  406 (614)
Q Consensus       396 lV~E~~~~GsL  406 (614)
                      +||||+++..+
T Consensus       121 lVME~v~G~~~  131 (822)
T PLN02876        121 YIMEYLEGRIF  131 (822)
T ss_pred             EEEEecCCccc
Confidence            99999987654

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.69  E-value=0.00081  Score=65.92  Aligned_cols=135  Identities=19%  Similarity=0.258  Sum_probs=91.9

Q ss_pred             cccceecccCceEEEEeEcCCCcEEEEEEeecCC----------------hhhhHHHHHHHHHHHHcc------ccceee
Q 043267          321 SRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS----------------KAGDANFKHEVEIIASVK------HVNLVA  378 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~----------------~~~~~~f~~Ei~il~~l~------H~niv~  378 (614)
                      +....||+|+.-.||.  +++.....||++....                .....+..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            4457899999999996  6677778889887544                223456777777766666      788999


Q ss_pred             eeeeeecccCCCCceEEEEEeecCC------CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          379 LRGYSTATVPLEGHQRIIVCDLLHN------GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       379 l~g~~~~~~~~~~~~~~lV~E~~~~------GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                      ++|+..     .....-+|+|...+      -+|.+++.+.   .++. ...+.+.+.   ..||-   +..|+.+|++|
T Consensus        82 ~~G~ve-----T~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~---~~~Iv~~dl~~  146 (199)
T PF10707_consen   82 FYGFVE-----TNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLL---DHHIVIRDLNP  146 (199)
T ss_pred             EeEEEe-----cCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHH---HcCCeecCCCc
Confidence            999987     34456778877643      3577777443   3554 333344443   44555   67799999999


Q ss_pred             CCeEECCC--C--cEEEee-cCCce
Q 043267          453 SNILLDEA--F--EAKVGD-FGLAK  472 (614)
Q Consensus       453 ~NILLd~~--~--~~kl~D-FGla~  472 (614)
                      .||++..+  +  .+.|.| ||-..
T Consensus       147 ~NIv~~~~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  147 HNIVVQRRDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             ccEEEEecCCCceEEEEEeCCCCcc
Confidence            99999532  2  466776 55443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.65  E-value=0.00051  Score=69.03  Aligned_cols=142  Identities=15%  Similarity=0.129  Sum_probs=76.8

Q ss_pred             ceecccCce-EEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcccc---ceeeeeeeeecccCCCCceEEEEEe
Q 043267          324 NIIGKGGYG-NVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV---NLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       324 ~~LG~G~fG-~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~---niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      +.|+.||.. .||+.    +..+++|..+.  .....++.+|.+++..+...   -+.+.++.....  ......+++|+
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~--~~~~~~~~l~~   74 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPG--EGYPWPWSVYR   74 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCc--cCCCcceEEEE
Confidence            457877766 48874    23577776543  22345788999999888532   222333322211  01123478999


Q ss_pred             ecCCCChhhh------------------hhcCCCc--CC-------------ChHHHH--HHH-------HHHHHH-HHH
Q 043267          400 LLHNGSLYDH------------------LFGSGMK--KL-------------SWPIRL--RIA-------LGTARG-LAY  436 (614)
Q Consensus       400 ~~~~GsL~~~------------------L~~~~~~--~l-------------~~~~~~--~I~-------~~ia~g-L~y  436 (614)
                      +++|.++.+.                  |+.-...  ..             .|....  .+.       .+.... ++.
T Consensus        75 ~i~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  154 (235)
T cd05155          75 WLEGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEA  154 (235)
T ss_pred             eecCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHH
Confidence            9998777432                  1110000  00             121110  000       011111 111


Q ss_pred             -Hhh--cCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          437 -LHY--GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       437 -LH~--~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                       ++.  .....++|+|+.+.||+++++...-|.||+.+..
T Consensus       155 ~~~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         155 ALRAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             HhcccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence             111  1245699999999999999776667999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK10593 hypothetical protein; Provisional

Probab=97.58  E-value=0.0018  Score=67.69  Aligned_cols=81  Identities=14%  Similarity=0.122  Sum_probs=57.3

Q ss_pred             cccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccc---cceeeeeeeeecccCCCCceEEEE
Q 043267          321 SRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH---VNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H---~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ...+.||+|..+.||+....+++ +.+|..+.  ......+.+|.+.++.+..   ..+.+.+++|....  ..+..++|
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~--~~g~~~LV   91 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ--SPGPDVLL   91 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC--cCCCeEEE
Confidence            33467999999999998876664 66676443  1123578899999998853   35677777765321  23557999


Q ss_pred             EeecCCCCh
Q 043267          398 CDLLHNGSL  406 (614)
Q Consensus       398 ~E~~~~GsL  406 (614)
                      ||+++++++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.57  E-value=0.00035  Score=68.27  Aligned_cols=130  Identities=27%  Similarity=0.317  Sum_probs=91.6

Q ss_pred             cCccccceecccCc-eEEEEeEcCCCcEEEEEEeecC---C---------h---------hhhHHHHHHHHHHHHcc---
Q 043267          318 MNFSRENIIGKGGY-GNVYKGMLPNGTEVAVKRFKNC---S---------K---------AGDANFKHEVEIIASVK---  372 (614)
Q Consensus       318 ~~f~~~~~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~---~---------~---------~~~~~f~~Ei~il~~l~---  372 (614)
                      .+++..+.||.|.- |.|||++. +|+.+|+|.++..   .         .         .-.+.|..|.....+++   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888899999999 99999999 7889999993210   0         0         11235888999888884   


Q ss_pred             ccce--eeeeeeeeccc--C-----------CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHH
Q 043267          373 HVNL--VALRGYSTATV--P-----------LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL  437 (614)
Q Consensus       373 H~ni--v~l~g~~~~~~--~-----------~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yL  437 (614)
                      +.++  |+.+||..-+.  .           .......||.||.+...           .++.    +=+.+|.+-|..+
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~----~~~~~~~~dl~~~  180 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQI----RDIPQMLRDLKIL  180 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccch----hHHHHHHHHHHHH
Confidence            4455  89999874331  0           01123467888876543           1222    2345666777888


Q ss_pred             hhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       438 H~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      |   +.+|+-+|+|+.|..     .-||+|||.+
T Consensus       181 ~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  181 H---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             H---HCCeeeccCcccccc-----CCEEEecccC
Confidence            9   999999999999975     3589999864

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.55  E-value=0.0005  Score=65.43  Aligned_cols=127  Identities=22%  Similarity=0.240  Sum_probs=87.2

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceee-eeeeeecccCCCCceEEEEEeec
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA-LRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~-l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      .+.||+|.+|.||+|.+. |.++|+|.-...+  ....+..|++++..++--++-+ ++.|-         .-.+.|||.
T Consensus        27 ~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg---------~~~i~me~i   94 (201)
T COG2112          27 EKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG---------EDFIRMEYI   94 (201)
T ss_pred             hhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec---------hhhhhhhhh
Confidence            467999999999999994 5688988776543  3557889999999987666543 33332         224559999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC-CCCeEECCCCcEEEeecCCcee
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK-ASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK-p~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+-+|.++-...     +-.+    ...+++.---|.   ..+|-|..|. |...+|.++..+.|+||..|..
T Consensus        95 ~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          95 DGRPLGKLEIGG-----DRKH----LLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             cCcchhhhhhcc-----cHHH----HHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            988887765321     2222    334444433445   6788888886 5555555555999999998873

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.49  E-value=0.0013  Score=65.75  Aligned_cols=140  Identities=17%  Similarity=0.158  Sum_probs=81.7

Q ss_pred             ceecccCceEEEEeEcCC--CcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCceEEEEEee
Q 043267          324 NIIGKGGYGNVYKGMLPN--GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~--g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      +.|..|-...+|+....+  +..+++|....... ...+..+|+.+++.+...+++ ++++..      +   ..++|||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~------~---~~~l~e~   73 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF------Q---NGLIYEF   73 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe------C---CcEEEEe
Confidence            567788889999998764  67888997654322 122335788888888544443 333322      1   1479999


Q ss_pred             cCCCChhhh-----------------hhcCC--C-------cCC-ChHHHHHHHH----------------------HHH
Q 043267          401 LHNGSLYDH-----------------LFGSG--M-------KKL-SWPIRLRIAL----------------------GTA  431 (614)
Q Consensus       401 ~~~GsL~~~-----------------L~~~~--~-------~~l-~~~~~~~I~~----------------------~ia  431 (614)
                      +++.++...                 ++...  .       ... -|+....+..                      .+.
T Consensus        74 i~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  153 (235)
T cd05157          74 IPGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLR  153 (235)
T ss_pred             eCCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHH
Confidence            998776321                 11100  0       011 1222112111                      111


Q ss_pred             ---HHHH-HHhh-cCCCceEEeccCCCCeEECC-CCcEEEeecCCcee
Q 043267          432 ---RGLA-YLHY-GVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKF  473 (614)
Q Consensus       432 ---~gL~-yLH~-~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~  473 (614)
                         ..|. .+.. .....++|+|+++.|||+++ +..+.+.||..+..
T Consensus       154 ~~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         154 DEISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             HHHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence               1111 1111 12457999999999999998 57899999988753

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.45  E-value=0.00076  Score=68.64  Aligned_cols=137  Identities=16%  Similarity=0.114  Sum_probs=78.9

Q ss_pred             ecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCceEEEEEeecCCC
Q 043267          326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQRIIVCDLLHNG  404 (614)
Q Consensus       326 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~~~lV~E~~~~G  404 (614)
                      +..|-.+.+|+... +|..+++|+.......-.....+|.++++.+....+. ++++..         ...+||||+++.
T Consensus         4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~---------~~~~v~e~i~G~   73 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN---------EHWLLVEWLEGE   73 (256)
T ss_pred             CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe---------CCEEEEEeccCc
Confidence            55677889998874 6778888876543222112357899999988654343 233322         126899999987


Q ss_pred             Chhhh-----------------hhcCC--CcCCChHHHH-HHHH---------HHHHHHHHHhh-----cCCCceEEecc
Q 043267          405 SLYDH-----------------LFGSG--MKKLSWPIRL-RIAL---------GTARGLAYLHY-----GVQPAIIHRDI  450 (614)
Q Consensus       405 sL~~~-----------------L~~~~--~~~l~~~~~~-~I~~---------~ia~gL~yLH~-----~~~~~iiHrDI  450 (614)
                      .+...                 |+...  ...++...+. ....         .+.+-+..+-.     .....++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            66421                 11111  1122222111 1110         11111221211     11346899999


Q ss_pred             CCCCeEECCCCcEEEeecCCcee
Q 043267          451 KASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       451 Kp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .|.||++++++ +++.||..+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.33  E-value=0.0013  Score=68.32  Aligned_cols=147  Identities=16%  Similarity=0.134  Sum_probs=87.2

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeecc-cCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTAT-VPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~-~~~~~~~~~lV~E  399 (614)
                      .+.|..|....+|+....+ ..+++|+...   ...++...|++++..+.+.+  +.+.+...... ....++..+++++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            4567778888999987644 4688898764   23455677888888885443  33333321100 0002345689999


Q ss_pred             ecCCCChhh----h----------hhc--CC-------CcCCChHHHHH----------HHHHHHHHHHHHhh----cCC
Q 043267          400 LLHNGSLYD----H----------LFG--SG-------MKKLSWPIRLR----------IALGTARGLAYLHY----GVQ  442 (614)
Q Consensus       400 ~~~~GsL~~----~----------L~~--~~-------~~~l~~~~~~~----------I~~~ia~gL~yLH~----~~~  442 (614)
                      |++|..+..    .          ++.  ..       .....|.....          ....+...+.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            999877532    0          111  00       01123332211          11123334445442    223


Q ss_pred             CceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       443 ~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+++|+|+.|.||+++++..+.|.||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            5799999999999999987778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.30  E-value=0.0036  Score=67.86  Aligned_cols=75  Identities=17%  Similarity=0.137  Sum_probs=52.9

Q ss_pred             ceecccCceEEEEeEcCCC-cEEEEEEeecC-----C--hhhhHHHHHHHHHHHHcc---ccceeeeeeeeecccCCCCc
Q 043267          324 NIIGKGGYGNVYKGMLPNG-TEVAVKRFKNC-----S--KAGDANFKHEVEIIASVK---HVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~-----~--~~~~~~f~~Ei~il~~l~---H~niv~l~g~~~~~~~~~~~  392 (614)
                      +.||.|.+..||++...+| +.|+||.-...     .  ....+.+..|.+.|..+.   ..++.+++.+.       ..
T Consensus        32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-------~~  104 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-------EE  104 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-------CC
Confidence            5699999999999998877 58999985421     1  123456677888888762   23466666653       34


Q ss_pred             eEEEEEeecCCCC
Q 043267          393 QRIIVCDLLHNGS  405 (614)
Q Consensus       393 ~~~lV~E~~~~Gs  405 (614)
                      ..++||||+++..
T Consensus       105 ~~~lVME~L~~~~  117 (401)
T PRK09550        105 LAVTVMEDLSDHK  117 (401)
T ss_pred             CCEEEEecCCCcc
Confidence            5789999998744

>PRK05231 homoserine kinase; Provisional

Probab=97.18  E-value=0.0054  Score=64.45  Aligned_cols=145  Identities=15%  Similarity=0.162  Sum_probs=78.2

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccce--eeeeeeeeccc-CCCCceEEEEEee
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL--VALRGYSTATV-PLEGHQRIIVCDL  400 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni--v~l~g~~~~~~-~~~~~~~~lV~E~  400 (614)
                      +.|+.|....+|+....+| .+++|+....   ..++...|++++..+...++  .+.+....... ...++..++++||
T Consensus        28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~  103 (319)
T PRK05231         28 KGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF  103 (319)
T ss_pred             chhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence            4466777789999887555 6888987521   23344456667766643332  22221100000 0023456899999


Q ss_pred             cCCCChhh-----------h---hhcCC---------CcCCCh-HHHHH------------HH-HHHHHHHHHHhhc---
Q 043267          401 LHNGSLYD-----------H---LFGSG---------MKKLSW-PIRLR------------IA-LGTARGLAYLHYG---  440 (614)
Q Consensus       401 ~~~GsL~~-----------~---L~~~~---------~~~l~~-~~~~~------------I~-~~ia~gL~yLH~~---  440 (614)
                      ++|..+..           .   ++...         ...+.| .....            .. ..+...+..+...   
T Consensus       104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  183 (319)
T PRK05231        104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP  183 (319)
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence            99875421           1   11100         011222 11111            01 1111122222211   


Q ss_pred             -CCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          441 -VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       441 -~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                       ...+++|+|++|.||+++++...-|.||+.+.
T Consensus       184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence             34589999999999999977656899999875

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.14  E-value=0.0032  Score=65.65  Aligned_cols=140  Identities=21%  Similarity=0.249  Sum_probs=83.4

Q ss_pred             ceecccCceEEEEeEcCC-------CcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCceEE
Q 043267          324 NIIGKGGYGNVYKGMLPN-------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~~~  395 (614)
                      +.|..|-...+|+....+       ++.+++|+..... ....+..+|.+++..+...++. ++++++.         ..
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~---------~~   73 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP---------NG   73 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC---------CC
Confidence            456667778899988765       5789999876533 2234567888888888543333 3444332         13


Q ss_pred             EEEeecCCCChhhh-----------------hhcCCCc-------C--CChHHHHHH-----------------------
Q 043267          396 IVCDLLHNGSLYDH-----------------LFGSGMK-------K--LSWPIRLRI-----------------------  426 (614)
Q Consensus       396 lV~E~~~~GsL~~~-----------------L~~~~~~-------~--l~~~~~~~I-----------------------  426 (614)
                      +|+||++|..+...                 ++.....       .  .-|....++                       
T Consensus        74 ~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (302)
T cd05156          74 RIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVEL  153 (302)
T ss_pred             chhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhH
Confidence            58999988776431                 1111100       0  011111111                       


Q ss_pred             ---HHHHHHHHHHHhh------cCCCceEEeccCCCCeEECCC----CcEEEeecCCcee
Q 043267          427 ---ALGTARGLAYLHY------GVQPAIIHRDIKASNILLDEA----FEAKVGDFGLAKF  473 (614)
Q Consensus       427 ---~~~ia~gL~yLH~------~~~~~iiHrDIKp~NILLd~~----~~~kl~DFGla~~  473 (614)
                         ...+.+-+.+|-.      .....++|+|+.+.|||++++    +.++++||..+..
T Consensus       154 ~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         154 SLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence               1122222333431      246789999999999999985    8899999998853

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.02  E-value=0.002  Score=76.17  Aligned_cols=200  Identities=17%  Similarity=0.145  Sum_probs=131.4

Q ss_pred             HHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc
Q 043267          361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG  440 (614)
Q Consensus       361 f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~  440 (614)
                      ...|.+.+.++.|+|++.+++|-..... .+-...+..|++..-++...+...  ...+..+.+.+..+..+||.|+|  
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~-~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h--  303 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLF-RGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLH--  303 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhc-chHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHH--
Confidence            4456777888999999999888653321 111222345777777777777443  36788888889999999999999  


Q ss_pred             CCCceEEeccCCC---CeEECCCCcEEEe--ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCc--hhhHHHHHH
Q 043267          441 VQPAIIHRDIKAS---NILLDEAFEAKVG--DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTP--GSDVYSFGV  513 (614)
Q Consensus       441 ~~~~iiHrDIKp~---NILLd~~~~~kl~--DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~--ksDVwS~Gv  513 (614)
                       .....|.-+..+   +.-.+..+...++  ||+..+..++......  ..-+..|.+||......+..  ..|+|.+|.
T Consensus       304 -~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  304 -SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             -HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence             555556655555   5556677777777  9988876654322211  12345677888777766554  479999999


Q ss_pred             HHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHh
Q 043267          514 VLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL  593 (614)
Q Consensus       514 ll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  593 (614)
                      +...+..|..+-.....                 ....++...    . .   ........|...++++|++..+++...
T Consensus       381 l~~~~~~~~~i~~~~~~-----------------~~~~l~~~~----~-~---~~~d~~~~~~~~~~~~Rl~~~~ll~~~  435 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAV-----------------PVSLLDVLS----T-S---ELLDALPKCLDEDSEERLSALELLTHP  435 (1351)
T ss_pred             HHhhhhhcCcccccccc-----------------hhhhhcccc----c-h---hhhhhhhhhcchhhhhccchhhhhhch
Confidence            99999987754321110                 001111111    0 0   234445569999999999999998765

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.76  E-value=0.029  Score=58.67  Aligned_cols=147  Identities=14%  Similarity=0.140  Sum_probs=84.1

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeecc-cCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTAT-VPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~-~~~~~~~~~lV~E  399 (614)
                      .+.++.|-...+|+....+| .+++|+.....  ..++...|++++..+....  +.+.+...... ....++..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            34577777789999876555 57788765422  2344566778887774333  33333321100 0012345789999


Q ss_pred             ecCCCChhhh--------------hhc--CC----C----cCCChHHHHH------------HHHHHHHHHHHHhh----
Q 043267          400 LLHNGSLYDH--------------LFG--SG----M----KKLSWPIRLR------------IALGTARGLAYLHY----  439 (614)
Q Consensus       400 ~~~~GsL~~~--------------L~~--~~----~----~~l~~~~~~~------------I~~~ia~gL~yLH~----  439 (614)
                      |++|..+...              ++.  ..    .    ..-.|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9988654210              111  00    0    0112221110            11123344555542    


Q ss_pred             cCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       440 ~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ....+++|+|+++.||++++++...|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            235789999999999999998777899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.60  E-value=0.025  Score=58.43  Aligned_cols=32  Identities=28%  Similarity=0.481  Sum_probs=26.3

Q ss_pred             CCceEEeccCCCCeEECCCCc-EEEeecCCcee
Q 043267          442 QPAIIHRDIKASNILLDEAFE-AKVGDFGLAKF  473 (614)
Q Consensus       442 ~~~iiHrDIKp~NILLd~~~~-~kl~DFGla~~  473 (614)
                      ...++|+|+++.||+++++++ .-|.||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            356899999999999997555 46999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.60  E-value=0.0047  Score=64.10  Aligned_cols=135  Identities=18%  Similarity=0.180  Sum_probs=90.2

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEee----------cCC-------h-----hhhHHHHHHHHHHHHccccce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFK----------NCS-------K-----AGDANFKHEVEIIASVKHVNL  376 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~----------~~~-------~-----~~~~~f~~Ei~il~~l~H~ni  376 (614)
                      -++..+.||-|--+.||.+...+|++.++|.-.          ...       .     -+.-...+|...|+.+..+..
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            357788999999999999999999999988421          000       0     011224567777877743211


Q ss_pred             eeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeE
Q 043267          377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL  456 (614)
Q Consensus       377 v~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NIL  456 (614)
                             ..+.+++....++|||++.+-.|...-+     ..+.++...-   +..-+--|-   ..|+||+|..--||+
T Consensus       173 -------pVPkpiD~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~---lm~~Iv~la---~~GlIHgDFNEFNim  234 (465)
T KOG2268|consen  173 -------PVPKPIDHNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDD---LMGLIVRLA---NHGLIHGDFNEFNIM  234 (465)
T ss_pred             -------CCCCcccccceeeHHHhhcccceeeeee-----cCChHHHHHH---HHHHHHHHH---HcCceecccchheeE
Confidence                   1122335567899999998877765321     1223333332   333333444   789999999999999


Q ss_pred             ECCCCcEEEeecCCc
Q 043267          457 LDEAFEAKVGDFGLA  471 (614)
Q Consensus       457 Ld~~~~~kl~DFGla  471 (614)
                      ++++..++++||--.
T Consensus       235 v~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  235 VKDDDKIVVIDFPQM  249 (465)
T ss_pred             EecCCCEEEeechHh
Confidence            999999999999744

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.58  E-value=0.00052  Score=82.47  Aligned_cols=160  Identities=14%  Similarity=0.049  Sum_probs=111.4

Q ss_pred             HHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhh
Q 043267          362 KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHY  439 (614)
Q Consensus       362 ~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~  439 (614)
                      ..|.+-.++..|+++.....-..   +.+..+.+.+++|+..|.+.+.|.+..  ...++..-....-.+......-.|.
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~---ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIP---PSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCC---CCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            34444556678988776543222   235567789999999999999987632  2233333232222232444444442


Q ss_pred             --cCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHH
Q 043267          440 --GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE  517 (614)
Q Consensus       440 --~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~E  517 (614)
                        ....-.+|+++|+.|.+|+.+.++|++++|+.+....... ......+++-|+.|+....-+++.++|+|..|+.+|+
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s-f~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS-FFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCchHh-hhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence              2234578999999999999999999999999994333222 2233457788999999999999999999999999999


Q ss_pred             HHhCCCCc
Q 043267          518 LLSGKKAC  525 (614)
Q Consensus       518 lltG~~p~  525 (614)
                      .--|..++
T Consensus      1433 rs~~n~~f 1440 (2724)
T KOG1826|consen 1433 RSDGNAYF 1440 (2724)
T ss_pred             HhcccHHH
Confidence            98888766

>PLN02236 choline kinase

Probab=96.47  E-value=0.03  Score=59.74  Aligned_cols=140  Identities=17%  Similarity=0.195  Sum_probs=80.7

Q ss_pred             eecccCceEEEEeEcCC-----CcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCceEEEEE
Q 043267          325 IIGKGGYGNVYKGMLPN-----GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      .|-.|-...+|+...++     ++.|++|.......... +-.+|..+++.+...++- ++++...      +.   .|+
T Consensus        43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~------~g---~v~  112 (344)
T PLN02236         43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFP------NG---RVE  112 (344)
T ss_pred             EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEEC------Cc---eEE
Confidence            45457778888887532     36788888765433222 236788888888554443 3444432      11   579


Q ss_pred             eecCCCChhhh-----------------hhcCC---Cc-CCChHHHHHHHHH-----------------HHHHHHHH---
Q 043267          399 DLLHNGSLYDH-----------------LFGSG---MK-KLSWPIRLRIALG-----------------TARGLAYL---  437 (614)
Q Consensus       399 E~~~~GsL~~~-----------------L~~~~---~~-~l~~~~~~~I~~~-----------------ia~gL~yL---  437 (614)
                      ||+++.+|...                 ++...   .. ...|.+..++..+                 +..-+..|   
T Consensus       113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~  192 (344)
T PLN02236        113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE  192 (344)
T ss_pred             EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence            99987776421                 11111   01 1123333232211                 11112222   


Q ss_pred             -hh-cCCCceEEeccCCCCeEECC-CCcEEEeecCCceeC
Q 043267          438 -HY-GVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFN  474 (614)
Q Consensus       438 -H~-~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~~  474 (614)
                       .. .....++|+|+++.|||+++ ++.++++||..+...
T Consensus       193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~  232 (344)
T PLN02236        193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN  232 (344)
T ss_pred             hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence             21 22457899999999999986 478999999988643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.17  E-value=0.077  Score=56.22  Aligned_cols=142  Identities=18%  Similarity=0.285  Sum_probs=82.7

Q ss_pred             ecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee---e---eeeeeecccCCCCceEEEEEe
Q 043267          326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV---A---LRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       326 LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv---~---l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      |.+ .-..+|+....+|+. ++|.....  ....+...|++.+..+.-..+.   +   +-|-...... .+...+-+++
T Consensus        34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~-~~~r~a~lf~  108 (331)
T COG2334          34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALS-GGPRPAALFE  108 (331)
T ss_pred             ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhcc-CCceeEEEEE
Confidence            444 456789988877776 77877654  4556677888888888433221   1   1121111100 1136788999


Q ss_pred             ecCCCChhh-h--------------hhc--C--------CCcCCChHH---H----------HHHHHHHHHHHHHHh---
Q 043267          400 LLHNGSLYD-H--------------LFG--S--------GMKKLSWPI---R----------LRIALGTARGLAYLH---  438 (614)
Q Consensus       400 ~~~~GsL~~-~--------------L~~--~--------~~~~l~~~~---~----------~~I~~~ia~gL~yLH---  438 (614)
                      |++|..+.. .              |+.  .        ......|..   +          .....++...+..+.   
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999988872 1              110  0        112345541   0          112222333333333   


Q ss_pred             -hcCCCc---eEEeccCCCCeEECCCCc-EEEeecCCce
Q 043267          439 -YGVQPA---IIHRDIKASNILLDEAFE-AKVGDFGLAK  472 (614)
Q Consensus       439 -~~~~~~---iiHrDIKp~NILLd~~~~-~kl~DFGla~  472 (614)
                       ......   +||+|+.|.||+++.+.. ..+.|||-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence             111223   999999999999999885 8899999775

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.87  E-value=0.057  Score=56.15  Aligned_cols=140  Identities=21%  Similarity=0.277  Sum_probs=71.0

Q ss_pred             cccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc---ccceeeeeeeeecccCCCCceEEEE
Q 043267          321 SRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK---HVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~---H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ...+.++.|.-..+|+.. .+++.+.||.-.   ......|..|.+-|+.|.   --.+.+.+++...     ....+|+
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-----~~~~fLl   90 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-----DDDAFLL   90 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE------SSCCEEE
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-----cCCceEE
Confidence            344668989999999988 578889999776   233456888998888883   3346667776542     3345999


Q ss_pred             EeecCCCCh--hh---------hhhc-CCCc-------------------CCChHH-----HHHHHH-------------
Q 043267          398 CDLLHNGSL--YD---------HLFG-SGMK-------------------KLSWPI-----RLRIAL-------------  428 (614)
Q Consensus       398 ~E~~~~GsL--~~---------~L~~-~~~~-------------------~l~~~~-----~~~I~~-------------  428 (614)
                      +||++.+..  .+         .|+. ....                   .-+|..     |+.-..             
T Consensus        91 le~l~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~  170 (288)
T PF03881_consen   91 LEFLEMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAEL  170 (288)
T ss_dssp             EE--------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHH
T ss_pred             EEeecCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHH
Confidence            999987711  11         1222 1111                   123332     111111             


Q ss_pred             -HHHHHHH-HHh-hcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          429 -GTARGLA-YLH-YGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       429 -~ia~gL~-yLH-~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                       .+.+.+. .|+ ....+.++|+||-+.|++.+.++.+.|.|=.
T Consensus       171 ~~l~~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa  214 (288)
T PF03881_consen  171 ERLVERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA  214 (288)
T ss_dssp             HHHHHHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred             HHHHHHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence             1111111 123 1235789999999999999999889888754

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=95.84  E-value=0.14  Score=53.96  Aligned_cols=131  Identities=18%  Similarity=0.195  Sum_probs=76.6

Q ss_pred             EEEEeEcCCCcEEEEEEee--cCChhhhHHHHHHHHHHHHccc--cceeeeeeeeecccCCCCceEEEEEeecCCCChhh
Q 043267          333 NVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKH--VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD  408 (614)
Q Consensus       333 ~Vykg~~~~g~~VAVK~l~--~~~~~~~~~f~~Ei~il~~l~H--~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~  408 (614)
                      .+|.... ++++++++ ..  ...........+|.++|+.+.-  .-+...+++|....   -...+.||+|.++..+.+
T Consensus        40 ~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~---~g~pf~v~~~veGe~~~~  114 (321)
T COG3173          40 DTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY---LGTPFYVMEWVEGEVVWS  114 (321)
T ss_pred             ceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC---CCCceEEEEEecceeccC
Confidence            3444443 37778887 32  1223334556778888888743  22334456665211   246799999998854433


Q ss_pred             hhhcCCCcCCChHHHHHHH-HHHHHHHHHHh-------------------------------------------------
Q 043267          409 HLFGSGMKKLSWPIRLRIA-LGTARGLAYLH-------------------------------------------------  438 (614)
Q Consensus       409 ~L~~~~~~~l~~~~~~~I~-~~ia~gL~yLH-------------------------------------------------  438 (614)
                      .+....     ..  .+.+ ..+++.|.-||                                                 
T Consensus       115 ~~~~~~-----~~--~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl  187 (321)
T COG3173         115 ALPPES-----LG--RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL  187 (321)
T ss_pred             cCCccc-----ch--HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence            221110     00  0111 23333333333                                                 


Q ss_pred             -h-----cCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          439 -Y-----GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       439 -~-----~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                       .     .....++|+|+++.|++++.+..+=|.||+++....
T Consensus       188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence             1     124679999999999999998889999999997543

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.66  E-value=0.12  Score=55.35  Aligned_cols=73  Identities=14%  Similarity=0.096  Sum_probs=47.9

Q ss_pred             eecccCceEEEEeEcCCC-cEEEEEEeecC------C-hhhhHHHHHHHHHHHHcc--cc-ceeeeeeeeecccCCCCce
Q 043267          325 IIGKGGYGNVYKGMLPNG-TEVAVKRFKNC------S-KAGDANFKHEVEIIASVK--HV-NLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       325 ~LG~G~fG~Vykg~~~~g-~~VAVK~l~~~------~-~~~~~~f~~Ei~il~~l~--H~-niv~l~g~~~~~~~~~~~~  393 (614)
                      .||.|...-||++..++| +.|+||.-...      + ....+...-|.+.|+...  -| .+.+++.+       +...
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~-------D~e~   74 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF-------DTEM   74 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE-------cccc
Confidence            479999999999998765 68999975321      1 222344456777776652  23 34445554       4566


Q ss_pred             EEEEEeecCCC
Q 043267          394 RIIVCDLLHNG  404 (614)
Q Consensus       394 ~~lV~E~~~~G  404 (614)
                      ..+|||+++..
T Consensus        75 ~~~vMEdL~~~   85 (370)
T TIGR01767        75 AVTVMEDLSHH   85 (370)
T ss_pred             ceehHhhCccc
Confidence            78999999654

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.63  E-value=0.11  Score=54.22  Aligned_cols=30  Identities=33%  Similarity=0.391  Sum_probs=26.2

Q ss_pred             CCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       442 ~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..+++|+|+++.||+++. +.+.|.||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            468999999999999998 578999999765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK06148 hypothetical protein; Provisional

Probab=95.42  E-value=0.2  Score=61.11  Aligned_cols=145  Identities=17%  Similarity=0.251  Sum_probs=81.0

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-------ccceeeee-ee--eecccCCCCc-
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-------HVNLVALR-GY--STATVPLEGH-  392 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-------H~niv~l~-g~--~~~~~~~~~~-  392 (614)
                      +.|+ |..-.+|+....+|..+++|+.....  .......|.+.+..+.       -|.+++-. |-  ...... ++. 
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~-~G~~  106 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDP-DGEP  106 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecC-CCce
Confidence            3453 45678899888888899999987532  2334445556666552       22223221 11  110000 122 


Q ss_pred             eEEEEEeecCCCChhhh-----------------hhc--------CCCcCCChHH-----------------HHHHHHHH
Q 043267          393 QRIIVCDLLHNGSLYDH-----------------LFG--------SGMKKLSWPI-----------------RLRIALGT  430 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~-----------------L~~--------~~~~~l~~~~-----------------~~~I~~~i  430 (614)
                      ..+-+++|+++..+.+.                 ++.        .....+.|..                 +..++.++
T Consensus       107 ~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~  186 (1013)
T PRK06148        107 RLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERF  186 (1013)
T ss_pred             EEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHH
Confidence            45678999999777541                 000        0112344532                 12222233


Q ss_pred             HHHHH-----HHhhcCCCceEEeccCCCCeEECCCC--cEE-EeecCCcee
Q 043267          431 ARGLA-----YLHYGVQPAIIHRDIKASNILLDEAF--EAK-VGDFGLAKF  473 (614)
Q Consensus       431 a~gL~-----yLH~~~~~~iiHrDIKp~NILLd~~~--~~k-l~DFGla~~  473 (614)
                      .+...     .|. ....++||+|+.+.|||++.+.  ++. |+|||.+..
T Consensus       187 ~~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        187 LARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            33222     121 2346799999999999999875  555 999998753

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.39  E-value=0.019  Score=62.90  Aligned_cols=50  Identities=22%  Similarity=0.242  Sum_probs=37.5

Q ss_pred             HHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcC
Q 043267          359 ANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS  413 (614)
Q Consensus       359 ~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~  413 (614)
                      .++.....+++.+.|+|+-..+.+...    .....++|+|++ +.||.|.+...
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~----~~~r~IVV~e~~-~~Sled~~~~~   76 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRG----KHERVIVVMEHY-TMSLEDILKTG   76 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecC----ccceEEEEehhh-ccchHHHHHhc
Confidence            456677888999999999988877653    223478889998 67999888543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.18  E-value=0.59  Score=49.41  Aligned_cols=77  Identities=16%  Similarity=0.113  Sum_probs=45.8

Q ss_pred             cCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeecccCCCCceEEEEEeecCCCCh
Q 043267          329 GGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTATVPLEGHQRIIVCDLLHNGSL  406 (614)
Q Consensus       329 G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL  406 (614)
                      +.-..||+...++|..+++|.... ......+...|++.+..+....  ++.....-.......++..+.++++++|...
T Consensus        36 s~eN~vy~v~~~~~~~~vlKv~r~-~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         36 SYENRVYQFGDEDGRRVVAKFYRP-ERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             cccceEEEEecCCCCEEEEEEcCc-ccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            445779999888888899998753 2234566778888888774322  2222110000000013456789999987653

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.08  E-value=0.085  Score=51.93  Aligned_cols=32  Identities=31%  Similarity=0.488  Sum_probs=22.6

Q ss_pred             CCceEEeccCCCCeEE-CCCCcEEEeecCCcee
Q 043267          442 QPAIIHRDIKASNILL-DEAFEAKVGDFGLAKF  473 (614)
Q Consensus       442 ~~~iiHrDIKp~NILL-d~~~~~kl~DFGla~~  473 (614)
                      ...++|.|+.+.|||+ +.++.++++||..+..
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            3568899999999999 8899999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=94.96  E-value=0.21  Score=53.05  Aligned_cols=141  Identities=16%  Similarity=0.193  Sum_probs=79.3

Q ss_pred             ceecccCceEEEEeEcCC----CcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLPN----GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.|..|=...+|+....+    +..|++|........ .-+-.+|..+++.+...++- +++++..     .+    +|.
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-----~G----~i~   89 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-----NG----MIQ   89 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-----Cc----Eee
Confidence            345557778889887543    247888887654332 22346788888888655553 3444432     11    488


Q ss_pred             eecCCCChhhh-----------------hhcCC---Cc-CCChHHHHHHHHHH----------------------HHHHH
Q 043267          399 DLLHNGSLYDH-----------------LFGSG---MK-KLSWPIRLRIALGT----------------------ARGLA  435 (614)
Q Consensus       399 E~~~~GsL~~~-----------------L~~~~---~~-~l~~~~~~~I~~~i----------------------a~gL~  435 (614)
                      +|+++..|...                 ++...   .. .--|....++..++                      .+-+.
T Consensus        90 ~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  169 (330)
T PLN02421         90 SFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIV  169 (330)
T ss_pred             hhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHH
Confidence            99877655320                 11111   11 11233322222111                      11111


Q ss_pred             HHhh-----cCCCceEEeccCCCCeEECC-CCcEEEeecCCceeC
Q 043267          436 YLHY-----GVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFN  474 (614)
Q Consensus       436 yLH~-----~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~~  474 (614)
                      .+..     ....-++|.|+.+.|||+++ ++.++++||..|...
T Consensus       170 ~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~n  214 (330)
T PLN02421        170 ELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYS  214 (330)
T ss_pred             HHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCC
Confidence            1111     12345899999999999974 578999999988643

>PLN02756 S-methyl-5-thioribose kinase

Probab=94.95  E-value=0.34  Score=52.75  Aligned_cols=73  Identities=11%  Similarity=0.096  Sum_probs=48.2

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecC----Ch---hhhHHHHHHHHHHHHcc---ccceeeeeeeeecccCCCCc
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC----SK---AGDANFKHEVEIIASVK---HVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~---~~~~~f~~Ei~il~~l~---H~niv~l~g~~~~~~~~~~~  392 (614)
                      .+.||.|....||+...+ +..++||+-...    +.   .....-..|.+.|+.+.   ..++.+++.++.       +
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-------d  108 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-------T  108 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-------C
Confidence            356899999999998874 556999986511    11   12223334566666553   346777888764       3


Q ss_pred             eEEEEEeecCC
Q 043267          393 QRIIVCDLLHN  403 (614)
Q Consensus       393 ~~~lV~E~~~~  403 (614)
                      ..+++|||+++
T Consensus       109 ~~vlvME~L~~  119 (418)
T PLN02756        109 MALIGMRYLEP  119 (418)
T ss_pred             CCEEEEeecCC
Confidence            46889999976

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=94.62  E-value=0.1  Score=53.20  Aligned_cols=76  Identities=16%  Similarity=0.073  Sum_probs=53.9

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHH---HHHHHccccceeeeeeeeecccCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEV---EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei---~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      ...+..|..+.|++++..+|+++++|.......     ...|.   ..|+..+-...|+++..-       .....+.+|
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d-------~~~~AlLLE   74 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAAD-------PERGALLLE   74 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccc-------cccchhhhh
Confidence            345667899999999999999999998864322     22233   457777778889998753       345678888


Q ss_pred             ec-CCCChhhhh
Q 043267          400 LL-HNGSLYDHL  410 (614)
Q Consensus       400 ~~-~~GsL~~~L  410 (614)
                      .+ ++.+|.+..
T Consensus        75 rl~~g~~L~~~~   86 (253)
T PF04655_consen   75 RLDPGRSLASLP   86 (253)
T ss_pred             hccCCCchhhcc
Confidence            88 555665543

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=94.56  E-value=0.23  Score=52.75  Aligned_cols=136  Identities=18%  Similarity=0.250  Sum_probs=88.9

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecC-------Ch--hhhH-----------------HHHHHHHHHHHcccccee
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNC-------SK--AGDA-----------------NFKHEVEIIASVKHVNLV  377 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~-------~~--~~~~-----------------~f~~Ei~il~~l~H~niv  377 (614)
                      ..|..|--..||.++-.+|..+|||+++..       ..  .++-                 -...|+.-|++++...|.
T Consensus       150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP  229 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP  229 (520)
T ss_pred             cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            458889999999999999999999987521       00  0111                 123466666666554432


Q ss_pred             eeeeeeecccCCCCceEEEEEeecCCCC-hhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeE
Q 043267          378 ALRGYSTATVPLEGHQRIIVCDLLHNGS-LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL  456 (614)
Q Consensus       378 ~l~g~~~~~~~~~~~~~~lV~E~~~~Gs-L~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NIL  456 (614)
                             .+.++.-...+|||+|+.... -.-.|   +.-.++.......-.+++.-+.-|-+  ..++||.||.--|+|
T Consensus       230 -------~PePIlLk~hVLVM~FlGrdgw~aPkL---Kd~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~L  297 (520)
T KOG2270|consen  230 -------CPEPILLKNHVLVMEFLGRDGWAAPKL---KDASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLL  297 (520)
T ss_pred             -------CCCceeeecceEeeeeccCCCCcCccc---ccccCChHHHHHHHHHHHHHHHHHHH--Hhceeccchhhhhhe
Confidence                   112223356789999985211 11112   12346666677777778777777764  558999999999998


Q ss_pred             ECCCCcEEEeecCCce
Q 043267          457 LDEAFEAKVGDFGLAK  472 (614)
Q Consensus       457 Ld~~~~~kl~DFGla~  472 (614)
                      +-+ |.+.|+|-+-+-
T Consensus       298 yhd-G~lyiIDVSQSV  312 (520)
T KOG2270|consen  298 YHD-GKLYIIDVSQSV  312 (520)
T ss_pred             EEC-CEEEEEEccccc
Confidence            865 578999987654

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.35  E-value=0.28  Score=51.32  Aligned_cols=32  Identities=25%  Similarity=0.396  Sum_probs=28.9

Q ss_pred             CCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       442 ~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      ..+++|+|+.+.|||+++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            56899999999999999999999999998764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF08693 SKG6: Transmembrane alpha-helix domain; InterPro: IPR014805 SKG6 and AXL2 are membrane proteins that show polarised intracellular localisation [, ]

Probab=94.25  E-value=0.032  Score=39.47  Aligned_cols=33  Identities=27%  Similarity=0.441  Sum_probs=16.2

Q ss_pred             CCceeEEEEehHHHHHHHHHHHHHHHHHHhhhcc
Q 043267          246 NKRHEIVIYGLVLGSVIGILGAFTAFWFLFTRSK  279 (614)
Q Consensus       246 ~~~~~~~ii~i~~~~v~~vl~~~~~~~~~~~r~k  279 (614)
                      +++...+.+|+++.++++++ ++.+++++++||+
T Consensus         7 ~~~~vaIa~~VvVPV~vI~~-vl~~~l~~~~rR~   39 (40)
T PF08693_consen    7 NSNTVAIAVGVVVPVGVIII-VLGAFLFFWYRRK   39 (40)
T ss_pred             CCceEEEEEEEEechHHHHH-HHHHHhheEEecc
Confidence            34445566666666555544 3333334344443

This entry represents the highly conserved transmembrane alpha-helical domain found in these proteins [, ]. The full-length AXL2 protein has a negative regulatory function in cytokinesis [].

>PRK12396 5-methylribose kinase; Reviewed

Probab=94.07  E-value=0.22  Score=53.95  Aligned_cols=73  Identities=15%  Similarity=0.183  Sum_probs=49.1

Q ss_pred             ceecccCceEEEEeEcCC-CcEEEEEEeecC-----C-hhhhHHHHHHHHHHHHcc--cc-ceeeeeeeeecccCCCCce
Q 043267          324 NIIGKGGYGNVYKGMLPN-GTEVAVKRFKNC-----S-KAGDANFKHEVEIIASVK--HV-NLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~-----~-~~~~~~f~~Ei~il~~l~--H~-niv~l~g~~~~~~~~~~~~  393 (614)
                      +.||.|.-.-||++..++ ++.|+||.-...     + .-..+...-|.+.|+...  -| .+.+++.+       +...
T Consensus        35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~-------D~e~  107 (409)
T PRK12396         35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF-------DSVM  107 (409)
T ss_pred             eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE-------CcHH
Confidence            578999999999999753 678999975321     1 223345566777777662  34 34456554       4566


Q ss_pred             EEEEEeecCC
Q 043267          394 RIIVCDLLHN  403 (614)
Q Consensus       394 ~~lV~E~~~~  403 (614)
                      ..+|||+++.
T Consensus       108 ~~~vMEdL~~  117 (409)
T PRK12396        108 NCCVMEDLSD  117 (409)
T ss_pred             hhHHHHhCcc
Confidence            7899999965

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=93.40  E-value=0.78  Score=48.88  Aligned_cols=114  Identities=18%  Similarity=0.116  Sum_probs=74.5

Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      +....+++|++. ++++.-      .+.-.|++...|+.+-+.-+.-+..  +.+.-|||+.-.||||+ +|++-|+||-
T Consensus       297 e~~y~yl~~kdh-gt~is~------ik~~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfk  366 (488)
T COG5072         297 ETLYLYLHFKDH-GTPISI------IKADRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFK  366 (488)
T ss_pred             CceEEEEEEecC-Cceeee------eecccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEee
Confidence            445566777765 344421      1345789999999988888777764  56788999999999999 9999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCC
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK  523 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~  523 (614)
                      +++....+..-...      ..--|..+. |.-+.+-|||-+   |--|+.|+.
T Consensus       367 lsRl~~~q~~isy~------rldhp~lF~-G~dd~QFeIYrl---Mr~l~~g~w  410 (488)
T COG5072         367 LSRLSYSQGIISYN------RLDHPDLFN-GVDDYQFEIYRL---MRRLLKGRW  410 (488)
T ss_pred             eeecccCCceeecc------ccCchhhhc-CccceeeeHHHH---HHHHhcCcH
Confidence            99853332211111      123454444 444667777752   333444553

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=93.36  E-value=0.24  Score=53.30  Aligned_cols=61  Identities=13%  Similarity=0.125  Sum_probs=45.2

Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ...++-+|+++-++..++...+   .+++.+.+++.-.+++|.-+-.  -.+.+|.|++|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEE
Confidence            3467778899999998885443   4446677777777777654432  46899999999999995

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	614
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-61
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-58
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		7e-45
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-44
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-39
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-37
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-25
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-25
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-24
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		7e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-22
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-22
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		6e-22
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-22
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-22
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-22
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-21
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-21
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-21
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-21
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-21
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-21
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-21
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-21
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-21
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-21
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-21
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-21
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-21
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-21
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-21
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		7e-21
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		6e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		7e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		8e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		9e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		6e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		7e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		7e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		8e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		8e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		8e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		8e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		8e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		8e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		9e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		3e-17
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-17
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-17
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		7e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		8e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		9e-17
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		9e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-16
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-16
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-16
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-16
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-16
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-16
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-16
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-16
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-16
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-16
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-16
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		3e-16
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-16
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-16
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-16
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		9e-16
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		9e-16
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-15
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-15
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		5e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		8e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		8e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		8e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		8e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		8e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		9e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		9e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-14
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-14
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-14
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-14
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		9e-14
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-13
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-13
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-13
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-13
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		4e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-13
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-13
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		4e-13
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		5e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-13
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		6e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-13
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-13
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-13
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		8e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-13
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		9e-13
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		9e-13
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-12
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-12
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-12
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-12
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-12
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-12
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-12
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-12
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-12
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-12
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-12
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-12
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-12
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-12
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-12
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		7e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		7e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		8e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-12
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		8e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-12
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-11
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-11
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-11
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-11
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-11
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-11
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		1e-11
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-11
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-11
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-11
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-11
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-11
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-11
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-11
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-11
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-11
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-11
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-11
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-11
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-11
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-11
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-11
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		3e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-11
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-11
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-11
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-11
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		5e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		5e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-11
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-11
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-11
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		6e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		7e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		7e-11
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		7e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		7e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		8e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		8e-11
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		8e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		9e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-10
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-10
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-10
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-10
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		3e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-10
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		4e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-10
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		5e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		7e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-10
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-10
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		9e-10
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-09
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-09
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-09
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-09
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-09
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-09
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-09
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		4e-09
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		4e-09
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-09
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-09
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-09
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-09
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-09
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-09
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-09
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-09
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-09
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-09
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-09
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-09
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-09
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-09
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-09
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		6e-09
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-09
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-09
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-09
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		6e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-09
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-09
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		7e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		7e-09
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		7e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-09
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-09
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		7e-09
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		7e-09
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		7e-09
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		8e-09
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-09
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		8e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		8e-09
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		8e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		9e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		9e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-08
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-08
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-08
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-08
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-08
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-08
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-08
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		4e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-08
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		5e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		5e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-08
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		6e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		6e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		6e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-08
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		8e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-08
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-08
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-08
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-08
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-08
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-08
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-08
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		1e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-07
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-07
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		3e-07
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-07
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		5e-07
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		6e-07
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		8e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		9e-07
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-06
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-06
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-06
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-06
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-06
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-06
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-06
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-06
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-06
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-06
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-06
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-06
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-06
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-06
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-06
3soa_A	444	Full-Length Human Camkii Length = 444		2e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-06
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-06
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-06
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		5e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		6e-06
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		6e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-06
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		7e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-06
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		7e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-06
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		9e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-05
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-05
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-05
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-05
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-05
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-05
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-05
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-05
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-05
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-05
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-05
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-05
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-05
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		4e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		5e-05
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		6e-05
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-05
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		9e-05
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		9e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		1e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		1e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		1e-04
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		1e-04
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-04
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-04
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-04
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-04
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-04
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		3e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-04
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-04
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-04
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		3e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-04
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		4e-04
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		4e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  232 bits (591), Expect = 5e-61,   Method: Compositional matrix adjust.
 Identities = 132/326 (40%), Positives = 187/326 (57%), Gaps = 15/326 (4%)
Query: 277 RSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYK 336
           R KK ++    V   ++P + L      L RF + E++ A+ NFS +NI+G+GG+G VYK
Sbjct: 1   RRKKPQDHFFDVPAEEDPEVHL----GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYK 56
Query: 337 GMLPNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI 395
           G L +GT VAVKR K    + G+  F+ EVE+I+   H NL+ LRG+          +R+
Sbjct: 57  GRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT-----ERL 111
Query: 396 IVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS 453
           +V   + NGS+   L         L WP R RIALG+ARGLAYLH    P IIHRD+KA+
Sbjct: 112 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 171
Query: 454 NILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGV 513
           NILLDE FEA VGDFGLAK       H+   V GT+G++APEY   GK +  +DV+ +GV
Sbjct: 172 NILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 231
Query: 514 VLLELLSGKKACEIIQ---GKSVLLSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVL 570
           +LLEL++G++A ++ +      V+L DW   L+KE K   ++              Q + 
Sbjct: 232 MLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQ 291
Query: 571 TAAICAHPILQARPTMDQIVKILETD 596
            A +C       RP M ++V++LE D
Sbjct: 292 VALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  222 bits (565), Expect = 5e-58,   Method: Compositional matrix adjust.
 Identities = 123/300 (41%), Positives = 174/300 (58%), Gaps = 11/300 (3%)
Query: 303 SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKN-CSKAGDANF 361
             L RF + E++ A+ NF  +NI+G+GG+G VYKG L +G  VAVKR K   ++ G+  F
Sbjct: 15  GQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQF 74
Query: 362 KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--SGMKKLS 419
           + EVE+I+   H NL+ LRG+          +R++V   + NGS+   L         L 
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPT-----ERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
           WP R RIALG+ARGLAYLH    P IIHRD+KA+NILLDE FEA VGDFGLAK       
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ---GKSVLLS 536
           H+   V G +G++APEY   GK +  +DV+ +GV+LLEL++G++A ++ +      V+L 
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 537 DWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILETD 596
           DW   L+KE K   ++              Q +  A +C       RP M ++V++LE D
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  178 bits (452), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 116/294 (39%), Positives = 168/294 (57%), Gaps = 16/294 (5%)
Query: 307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVE 366
           R  + +++ AT NF  + +IG G +G VYKG+L +G +VA+KR    S  G   F+ E+E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK--KLSWPIRL 424
            ++  +H +LV+L G+       E ++ I++   + NG+L  HL+GS +    +SW  RL
Sbjct: 88  TLSFCRHPHLVSLIGFCD-----ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTT 483
            I +G ARGL YLH     AIIHRD+K+ NILLDE F  K+ DFG++K   E G THL  
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXX 199
Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG---KSVLLSDWAW 540
            V GTLGY+ PEY + G+LT  SDVYSFGVVL E+L  + A  I+Q    + V L++WA 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--IVQSLPREMVNLAEWAV 257
Query: 541 ELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
           E    G+   ++              ++  TA  C     + RP+M  ++  LE
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  176 bits (446), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 115/294 (39%), Positives = 167/294 (56%), Gaps = 16/294 (5%)
Query: 307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVE 366
           R  + +++ AT NF  + +IG G +G VYKG+L +G +VA+KR    S  G   F+ E+E
Sbjct: 28  RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK--KLSWPIRL 424
            ++  +H +LV+L G+       E ++ I++   + NG+L  HL+GS +    +SW  RL
Sbjct: 88  TLSFCRHPHLVSLIGFCD-----ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRL 142
Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTT 483
            I +G ARGL YLH     AIIHRD+K+ NILLDE F  K+ DFG++K   E   THL  
Sbjct: 143 EICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXX 199
Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG---KSVLLSDWAW 540
            V GTLGY+ PEY + G+LT  SDVYSFGVVL E+L  + A  I+Q    + V L++WA 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA--IVQSLPREMVNLAEWAV 257
Query: 541 ELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
           E    G+   ++              ++  TA  C     + RP+M  ++  LE
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 112/309 (36%), Positives = 164/309 (53%), Gaps = 23/309 (7%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRE------NIIGKGGYGNVYKGMLPNGTEVAVKRFK 351
           LE   +    F   E+K  T NF         N +G+GG+G VYKG + N T VAVK+  
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63
Query: 352 N----CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY 407
                 ++     F  E++++A  +H NLV L G+S+     +G    +V   + NGSL 
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLL 118
Query: 408 DHLFG-SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
           D L    G   LSW +R +IA G A G+ +LH   +   IHRDIK++NILLDEAF AK+ 
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKIS 175
Query: 467 DFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC 525
           DFGLA+ + +   T + +R+ GT  Y+APE AL G++TP SD+YSFGVVLLE+++G  A 
Sbjct: 176 DFGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 526 EIIQGKSVLLSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPT 585
           +  +   +LL        +E    D I               Y + A+ C H     RP 
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV-ASQCLHEKKNKRPD 293
Query: 586 MDQIVKILE 594
           + ++ ++L+
Sbjct: 294 IKKVQQLLQ 302

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 112/309 (36%), Positives = 163/309 (52%), Gaps = 23/309 (7%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRE------NIIGKGGYGNVYKGMLPNGTEVAVKRFK 351
           LE   +    F   E+K  T NF         N +G+GG+G VYKG + N T VAVK+  
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63
Query: 352 N----CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY 407
                 ++     F  E++++A  +H NLV L G+S+     +G    +V   + NGSL 
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLL 118
Query: 408 DHLFG-SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
           D L    G   LSW +R +IA G A G+ +LH   +   IHRDIK++NILLDEAF AK+ 
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKIS 175
Query: 467 DFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC 525
           DFGLA+ + +   T +  R+ GT  Y+APE AL G++TP SD+YSFGVVLLE+++G  A 
Sbjct: 176 DFGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAV 234
Query: 526 EIIQGKSVLLSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPT 585
           +  +   +LL        +E    D I               Y + A+ C H     RP 
Sbjct: 235 DEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV-ASQCLHEKKNKRPD 293
Query: 586 MDQIVKILE 594
           + ++ ++L+
Sbjct: 294 IKKVQQLLQ 302

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  159 bits (402), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 109/299 (36%), Positives = 159/299 (53%), Gaps = 23/299 (7%)
Query: 308 FKIEEIKAATMNFSRE------NIIGKGGYGNVYKGMLPNGTEVAVKRFKN----CSKAG 357
           F   E+K  T NF         N +G+GG+G VYKG + N T VAVK+        ++  
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 358 DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG-SGMK 416
              F  E++++A  +H NLV L G+S+     +G    +V   + NGSL D L    G  
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDGTP 122
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
            LSW +R +IA G A G+ +LH   +   IHRDIK++NILLDEAF AK+ DFGLA+ + +
Sbjct: 123 PLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 179
Query: 477 -GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL 535
                +  R+ GT  Y+APE AL G++TP SD+YSFGVVLLE+++G  A +  +   +LL
Sbjct: 180 FAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 238
Query: 536 SDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                   +E    D I               Y + A+ C H     RP + ++ ++L+
Sbjct: 239 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV-ASQCLHEKKNKRPDIKKVQQLLQ 296

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  154 bits (388), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 110/299 (36%), Positives = 156/299 (52%), Gaps = 23/299 (7%)
Query: 308 FKIEEIKAATMNFSRE------NIIGKGGYGNVYKGMLPNGTEVAVKRFKN----CSKAG 357
           F   E+K  T NF         N  G+GG+G VYKG + N T VAVK+        ++  
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 358 DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG-SGMK 416
              F  E+++ A  +H NLV L G+S+     +G    +V     NGSL D L    G  
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSS-----DGDDLCLVYVYXPNGSLLDRLSCLDGTP 119
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
            LSW  R +IA G A G+ +LH   +   IHRDIK++NILLDEAF AK+ DFGLA+ + +
Sbjct: 120 PLSWHXRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEK 176
Query: 477 GITHL-TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL 535
               +  +R+ GT  Y APE AL G++TP SD+YSFGVVLLE+++G  A +  +   +LL
Sbjct: 177 FAQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL 235
Query: 536 SDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                   +E    D I               Y + A+ C H     RP + ++ ++L+
Sbjct: 236 DIKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSV-ASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  112 bits (281), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 79/206 (38%), Positives = 108/206 (52%), Gaps = 24/206 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYSTA
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 91
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSG----MKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL  S     MKKL     + IA  TARG+ YLH   
Sbjct: 92  P------QLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH--- 137
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLA--KFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +IIHRD+K++NI L E    K+GDFGLA  K    G +H   +++G++ ++APE    
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRM 196
Query: 500 GKLTP---GSDVYSFGVVLLELLSGK 522
               P    SDVY+FG+VL EL++G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  112 bits (279), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 76/205 (37%), Positives = 105/205 (51%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 20  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 79
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSG----MKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL  S     MKKL     + IA  TARG+ YLH   
Sbjct: 80  P------QLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH--- 125
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 126 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  110 bits (276), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 107/206 (51%), Gaps = 24/206 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 32  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 91
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSG----MKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL  S     MKKL     + IA  TARG+ YLH   
Sbjct: 92  P------QLAIVTQWCEGSSLYHHLHASETKFEMKKL-----IDIARQTARGMDYLH--- 137
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLA--KFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +IIHRD+K++NI L E    K+GDFGLA  K    G +H   +++G++ ++APE    
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRM 196
Query: 500 GKLTP---GSDVYSFGVVLLELLSGK 522
               P    SDVY+FG+VL EL++G+
Sbjct: 197 QDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  107 bits (266), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/205 (36%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYSTA
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 76  P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 121
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 81/228 (35%), Positives = 118/228 (51%), Gaps = 28/228 (12%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA----NFKHEVEIIASVKHVN 375
            + E IIG GG+G VY+     G EVAVK  ++      +    N + E ++ A +KH N
Sbjct: 9   LTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           ++ALRG     V L+     +V +    G L   L G   K++   I +  A+  ARG+ 
Sbjct: 68  IIALRG-----VCLKEPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMN 119
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFE--------AKVGDFGLAKFNPEGITHLTTRV-- 485
           YLH      IIHRD+K+SNIL+ +  E         K+ DFGLA+       H TT++  
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE-----WHRTTKMSA 174
Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
           AG   ++APE       + GSDV+S+GV+L ELL+G+     I G +V
Sbjct: 175 AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV 222

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  105 bits (261), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 18  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 77
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 78  P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 123
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 124 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 76  P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 121
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 67/195 (34%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IVC+ +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 81  P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 126
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 127 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 21  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 80
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 81  P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 126
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 127 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/206 (36%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 16  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 75
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 76  P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 121
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLA--KFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +IIHRD+K++NI L E    K+GDFGLA  K    G +H   +++G++ ++APE    
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRM 180
Query: 500 GKLTP---GSDVYSFGVVLLELLSGK 522
               P    SDVY+FG+VL EL++G+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 43  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 102
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 103 P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 148
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 149 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/206 (36%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 36  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 95
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 96  P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 141
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLA--KFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +IIHRD+K++NI L E    K+GDFGLA  K    G +H   +++G++ ++APE    
Sbjct: 142 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRM 200
Query: 500 GKLTP---GSDVYSFGVVLLELLSGK 522
               P    SDVY+FG+VL EL++G+
Sbjct: 201 QDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/205 (35%), Positives = 103/205 (50%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 104 P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 149
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYG 500
             +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE     
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 501 KLTP---GSDVYSFGVVLLELLSGK 522
              P    SDVY+FG+VL EL++G+
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/206 (36%), Positives = 105/206 (50%), Gaps = 24/206 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G VYKG       V +      +      FK+EV ++   +HVN++   GYST 
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK 103
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  Q  IV       SLY HL        M KL     + IA  TA+G+ YLH   
Sbjct: 104 P------QLAIVTQWCEGSSLYHHLHIIETKFEMIKL-----IDIARQTAQGMDYLH--- 149
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLA--KFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +IIHRD+K++NI L E    K+GDFGLA  K    G +H   +++G++ ++APE    
Sbjct: 150 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSG-SHQFEQLSGSILWMAPEVIRM 208
Query: 500 GKLTP---GSDVYSFGVVLLELLSGK 522
               P    SDVY+FG+VL EL++G+
Sbjct: 209 QDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 75  E-PI-----XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 125
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 186 SDVWSFGILLTELTT 200

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L     +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 250 EEPI-----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  102 bits (253), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L     +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 250 EEPI-----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 78  E-PI-----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 128
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 188
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 189 SDVWSFGILLTELTT 203

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + ++ GSL D L G   K L  P  + ++   A G+AY+    +   
Sbjct: 82  E-PI-----YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNY 132
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 76  E-PI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 126
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 187 SDVWSFGILLTELTT 201

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 71/215 (33%), Positives = 106/215 (49%), Gaps = 16/215 (7%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI+A+ +  S    IG G +G VYKG       V + +  + +      F++EV ++   
Sbjct: 32  EIEASEVMLSTR--IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKT 89
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +HVN++   GY T           IV       SLY HL     K   + + + IA  TA
Sbjct: 90  RHVNILLFMGYMTKD------NLAIVTQWCEGSSLYKHLHVQETKFQMFQL-IDIARQTA 142
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE-GITHLTTRVAGTLG 490
           +G+ YLH      IIHRD+K++NI L E    K+GDFGLA        +    +  G++ 
Sbjct: 143 QGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 491 YVAPEYALYGKLTP---GSDVYSFGVVLLELLSGK 522
           ++APE        P    SDVYS+G+VL EL++G+
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGE 234

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  101 bits (252), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 74  E-PI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 124
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 184
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 185 SDVWSFGILLTELTT 199

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 103/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + ++ GSL D L G   K L  P  + ++   A G+AY+    +   
Sbjct: 82  E-PI-----YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNY 132
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 192
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 193 SDVWSFGILLTELTT 207

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 72/197 (36%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLVALRGYS 383
           IG G +G V++    +G++VAVK         +    F  EV I+  ++H N+V   G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-KLSWPIRLRIALGTARGLAYLHYGVQ 442
           T    L      IV + L  GSLY  L  SG + +L    RL +A   A+G+ YLH    
Sbjct: 104 TQPPNLS-----IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGYVAPEYALYGK 501
           P I+HR++K+ N+L+D+ +  KV DFGL++   +  T L+++  AGT  ++APE      
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEP 215
Query: 502 LTPGSDVYSFGVVLLEL 518
               SDVYSFGV+L EL
Sbjct: 216 SNEKSDVYSFGVILWEL 232

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L     +
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 249
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 250 EEPI-----YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 301
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 362 SDVWSFGILLTELTT 376

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 71/196 (36%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLVALRGYS 383
           IG G +G V++    +G++VAVK         +    F  EV I+  ++H N+V   G  
Sbjct: 45  IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-KLSWPIRLRIALGTARGLAYLHYGVQ 442
           T    L      IV + L  GSLY  L  SG + +L    RL +A   A+G+ YLH    
Sbjct: 104 TQPPNLS-----IVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRN 157
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL 502
           P I+HRD+K+ N+L+D+ +  KV DFGL++         +   AGT  ++APE       
Sbjct: 158 PPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPEWMAPEVLRDEPS 216
Query: 503 TPGSDVYSFGVVLLEL 518
              SDVYSFGV+L EL
Sbjct: 217 NEKSDVYSFGVILWEL 232

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L     +
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 332
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 333 EEPI-----YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNY 384
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 444
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 445 SDVWSFGILLTELTT 459

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 66/195 (33%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD+ A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L     +
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQLYAV-VS 250
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  GSL D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 251 EEPI-----YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 302
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGL +   +            + + APE ALYG+ T  
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 362
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 363 SDVWSFGILLTELTT 377

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 99.4 bits (246), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  G L D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 101/195 (51%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L    + 
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + +  G L D L G   K L  P  + +A   A G+AY+    +   
Sbjct: 85  E-PI-----YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALYG+ T  
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL +
Sbjct: 196 SDVWSFGILLTELTT 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 63/195 (32%), Positives = 102/195 (52%), Gaps = 10/195 (5%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VA+K  K  + + ++ F  E +I+  +KH  LV L    + 
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPES-FLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      IV + ++ GSL D L     + L  P  + +A   A G+AY+    +   
Sbjct: 76  E-PI-----YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNY 126
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++++NIL+      K+ DFGLA+   +            + + APE ALYG+ T  
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L EL++
Sbjct: 187 SDVWSFGILLTELVT 201

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 81  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 131
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 191
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 192 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 222

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 86  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 136
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 197 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 82  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 132
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 192
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 193 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 223

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 80  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 89  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 139
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 199
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 200 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 230

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 88  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 138
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 198
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 199 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 229

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 80  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 86  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 136
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 196
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 197 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 227

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 95.5 bits (236), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 85  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 135
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 195
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 196 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 226

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 80  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 75  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 125
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 185
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 186 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 90  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 140
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 200
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 201 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 231

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G  G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 80  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 130
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 191 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 9/195 (4%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G   N T+VAVK  K  + +  A F  E  ++ +++H  LV L    T 
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + +  GSL D L      K+  P  +  +   A G+AY+    +   
Sbjct: 80  EEPI-----YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNY 131
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHRD++A+N+L+ E+   K+ DFGLA+   +            + + APE   +G  T  
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 506 SDVYSFGVVLLELLS 520
           SDV+SFG++L E+++
Sbjct: 192 SDVWSFGILLYEIVT 206

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L    T 
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
             P+      I+ + + NGSL D L      KL+    L +A   A G+A++    +   
Sbjct: 76  E-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNY 126
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           IHR+++A+NIL+ +    K+ DFGLA+   +            + + APE   YG  T  
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 186
Query: 506 SDVYSFGVVLLELLS-------GKKACEIIQ 529
           SDV+SFG++L E+++       G    E+IQ
Sbjct: 187 SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 217

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 105/209 (50%), Gaps = 19/209 (9%)
Query: 321 SRENIIGKGGYGNVYKGMLPNGT-----EVAVKRFK-NCSKAGDANFKHEVEIIASVKHV 374
           +R+ +IG G +G VYKGML   +      VA+K  K   ++    +F  E  I+    H 
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N++ L G  +   P+     +I+ + + NG+L D        + S    + +  G A G+
Sbjct: 107 NIIRLEGVISKYKPM-----MIITEYMENGAL-DKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGTLGY 491
            YL        +HRD+ A NIL++     KV DFGL++    +PE  T+ T+     + +
Sbjct: 161 KYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-TYTTSGGKIPIRW 216
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            APE   Y K T  SDV+SFG+V+ E+++
Sbjct: 217 TAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 322 RENI-----IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL 376
           RE+I     +G G +G V+ G   N T+VAVK  K  + +  A F  E  ++ +++H  L
Sbjct: 11  RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQA-FLEEANLMKTLQHDKL 69
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           V L    T   P+      I+ + +  GSL D L      K+  P  +  +   A G+AY
Sbjct: 70  VRLYAVVTKEEPI-----YIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           +    +   IHRD++A+N+L+ E+   K+ DFGLA+   +            + + APE 
Sbjct: 125 IE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEA 181
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
             +G  T  S+V+SFG++L E+++
Sbjct: 182 INFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 81  GVCYSAGRRNLK-----LIMEYLPYGSLRDYLQAHA-ERIDHIKLLQYTSQICKGMEYL- 133
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 134 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E  +G G +G V+       T+VAVK  K  S + +A F  E  ++ +++H  LV L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 78
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
            T   P+      I+ + +  GSL D L      K   P  +  +   A G+A++    Q
Sbjct: 79  VTKE-PI-----YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 129
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL 502
              IHRD++A+NIL+  +   K+ DFGLA+   +            + + APE   +G  
Sbjct: 130 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189
Query: 503 TPGSDVYSFGVVLLELLS 520
           T  SDV+SFG++L+E+++
Sbjct: 190 TIKSDVWSFGILLMEIVT 207

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 82  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 134
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 135 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 77  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 129
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 130 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 78  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 131 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 76  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 128
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 129 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 109 GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 161
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 162 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 78  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 131 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 83  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 135
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 136 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 84  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 136
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 137 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 81  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 134 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 25/228 (10%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKA 356
           S N+ +F+   +K           +GKG +G+V    Y  +  N G  VAVK+ ++ ++ 
Sbjct: 19  SHNMTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 71
Query: 357 GDANFKHEVEIIASVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG 414
              +F+ E+EI+ S++H N+V  +G  YS     L+     ++ + L  GSL D+L    
Sbjct: 72  HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKH 125
Query: 415 MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN 474
            +++     L+      +G+ YL  G +   IHRD+   NIL++     K+GDFGL K  
Sbjct: 126 KERIDHIKLLQYTSQICKGMEYL--GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVL 182
Query: 475 PEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           P+       +  G   + + APE     K +  SDV+SFGVVL EL +
Sbjct: 183 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 85  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 137
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 138 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 78  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 130
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 131 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 114/228 (50%), Gaps = 25/228 (10%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKA 356
           S N+ +F+   +K           +GKG +G+V    Y  +  N G  VAVK+ ++ ++ 
Sbjct: 19  SHNMTQFEERHLKFLQQ-------LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 71
Query: 357 GDANFKHEVEIIASVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG 414
              +F+ E+EI+ S++H N+V  +G  YS     L+     ++ + L  GSL D+L    
Sbjct: 72  HLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKH 125
Query: 415 MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN 474
            +++     L+      +G+ YL  G +   IHRD+   NIL++     K+GDFGL K  
Sbjct: 126 KERIDHIKLLQYTSQICKGMEYL--GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVL 182
Query: 475 PEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           P+       +  G   + + APE     K +  SDV+SFGVVL EL +
Sbjct: 183 PQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E  +G G +G V+       T+VAVK  K  S + +A F  E  ++ +++H  LV L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 251
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
            T   P+      I+ + +  GSL D L      K   P  +  +   A G+A++    Q
Sbjct: 252 VTKE-PI-----YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL 502
              IHRD++A+NIL+  +   K+ DFGLA+   +            + + APE   +G  
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 503 TPGSDVYSFGVVLLELLS 520
           T  SDV+SFG++L+E+++
Sbjct: 363 TIKSDVWSFGILLMEIVT 380

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  IG G +G V+ G   N  +VA+K  K  S + D +F  E E++  + 
Sbjct: 24  IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED-DFIEEAEVMMKLS 80
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G      P+      +V + + +G L D+L  +     +    L + L    
Sbjct: 81  HPKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 134
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+AYL    +  +IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + 
Sbjct: 135 GMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 191
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +PE   + + +  SDV+SFGV++ E+ S  K
Sbjct: 192 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 222

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL D+L     +++     L+      +G+ YL 
Sbjct: 79  GVCYSAGRRNLK-----LIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL- 131
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHR++   NIL++     K+GDFGL K  P+   +   +  G   + + APE 
Sbjct: 132 -GTK-RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 18/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++ ++    +F+ E+EI+ S++H N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 381 G--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           G  YS     L+     ++ + L  GSL ++L     +++     L+      +G+ YL 
Sbjct: 81  GVCYSAGRRNLK-----LIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL- 133
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEY 496
            G +   IHRD+   NIL++     K+GDFGL K  P+       +  G   + + APE 
Sbjct: 134 -GTK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
               K +  SDV+SFGVVL EL +
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 110/231 (47%), Gaps = 27/231 (11%)
Query: 308 FKIEEIKAATMNFSRE---------NIIGKGGYGNVYKG--MLPNGTE--VAVKRFKNC- 353
           F  E+   A   F++E          +IG G +G V  G   LP   E  VA+K  K+  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
           ++    +F  E  I+    H N++ L G  T + P+     +I+ + + NGSL D     
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-----MIITEFMENGSL-DSFLRQ 127
Query: 414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
              + +    + +  G A G+ YL        +HRD+ A NIL++     KV DFGL++F
Sbjct: 128 NDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 474 NPEGITH--LTTRVAGTLG--YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             +  +    T+ + G +   + APE   Y K T  SDV+S+G+V+ E++S
Sbjct: 185 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGLA+    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 28/215 (13%)
Query: 323 ENIIGKGGYGNVYKG-MLPNGTEVAVKRFKNCSKAGDA-------NFKHEVEIIASVKHV 374
           E  IGKGG+G V+KG ++ + + VA+K        G+         F+ EV I++++ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N+V L G       L  +   +V + +  G LY  L       + W ++LR+ L  A G+
Sbjct: 84  NIVKLYG-------LMHNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGI 135
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFE-----AKVGDFGLAKFNPEGITHLTTRVAGTL 489
            Y+     P I+HRD+++ NI L    E     AKV DFGL++ +     H  + + G  
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS----VHSVSGLLGNF 190
Query: 490 GYVAPEY--ALYGKLTPGSDVYSFGVVLLELLSGK 522
            ++APE   A     T  +D YSF ++L  +L+G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 77  PNIIRLEGVVTKSKPV-----MIVTEXMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 126
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIP 184
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 323 ENIIGKGGYGNVYKGML--PNGTE--VAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLV 377
           E +IG G +G V +G L  P   E  VA+K  K   ++     F  E  I+   +H N++
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 78
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-FGSGMKKLSWPIRLRIALGTARGLAY 436
            L G  T ++P+     +I+ + + NG+L   L    G   +   I+L   +G  RG+A 
Sbjct: 79  RLEGVVTNSMPV-----MILTEFMENGALDSFLRLNDGQFTV---IQL---VGMLRGIAS 127
Query: 437 -LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG--Y 491
            + Y  + + +HRD+ A NIL++     KV DFGL++F  E  +    T+ + G +   +
Sbjct: 128 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            APE   + K T  SD +S+G+V+ E++S
Sbjct: 188 TAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 17  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 77  PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 126
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 127 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIP 184
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 185 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 97/198 (48%), Gaps = 20/198 (10%)
Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E  +G G +G V+       T+VAVK  K  S + +A F  E  ++ +++H  LV L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 245
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
            T   P+      I+ + +  GSL D L      K   P  +  +   A G+A++    Q
Sbjct: 246 VTKE-PI-----YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 296
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL 502
              IHRD++A+NIL+  +   K+ DFGLA+                + + APE   +G  
Sbjct: 297 RNYIHRDLRAANILVSASLVCKIADFGLARVG----------AKFPIKWTAPEAINFGSF 346
Query: 503 TPGSDVYSFGVVLLELLS 520
           T  SDV+SFG++L+E+++
Sbjct: 347 TIKSDVWSFGILLMEIVT 364

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEXMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 34  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 94  PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 143
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 144 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA--AYTTRGGKIP 201
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 202 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 112/225 (49%), Gaps = 21/225 (9%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKNCSKA 356
           ++  S N  ++++E       + + ++ +G G YG VY+G+    +  VAVK  K  +  
Sbjct: 3   MDPSSPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 357 GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
            +  F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +
Sbjct: 58  VE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQ 111
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
           ++S  + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    
Sbjct: 112 EVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT- 167
Query: 477 GITHLTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
           G T+  T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 168 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 44  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 104 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 153
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 154 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 211
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 212 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEXMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  IG G +G V+ G   N  +VA+K  +  + + + +F  E E++  + 
Sbjct: 5   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS 61
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G      P+      +V + + +G L D+L  +     +    L + L    
Sbjct: 62  HPKLVQLYGVCLEQAPI-----CLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 115
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+AYL    +  +IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + 
Sbjct: 116 GMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +PE   + + +  SDV+SFGV++ E+ S  K
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 203

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 106/212 (50%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL++    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 323 ENIIGKGGYGNVYKGML--PNGTE--VAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLV 377
           E +IG G +G V +G L  P   E  VA+K  K   ++     F  E  I+   +H N++
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-FGSGMKKLSWPIRLRIALGTARGLAY 436
            L G  T ++P+     +I+ + + NG+L   L    G   +   I+L   +G  RG+A 
Sbjct: 81  RLEGVVTNSMPV-----MILTEFMENGALDSFLRLNDGQFTV---IQL---VGMLRGIAS 129
Query: 437 -LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF------NPEGITHLTTRVAGTL 489
            + Y  + + +HRD+ A NIL++     KV DFGL++F      +P   + L  ++   +
Sbjct: 130 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP--I 187
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + APE   + K T  SD +S+G+V+ E++S
Sbjct: 188 RWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 2   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 55
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +++S 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSA 110
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 166
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 167 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/212 (32%), Positives = 105/212 (49%), Gaps = 22/212 (10%)
Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           N S + ++G G +G V  G   LP+  E  VA+K  K   ++    +F  E  I+    H
Sbjct: 46  NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L G  T + P+     +IV + + NGSL      S ++K      +   +G  RG
Sbjct: 106 PNIIRLEGVVTKSKPV-----MIVTEYMENGSL-----DSFLRKHDAQFTVIQLVGMLRG 155
Query: 434 LAY-LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGT- 488
           +A  + Y      +HRD+ A NIL++     KV DFGL +    +PE     TTR     
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--YTTRGGKIP 213
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + + +PE   Y K T  SDV+S+G+VL E++S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 15/222 (6%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA 356
           ++  S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +  
Sbjct: 3   MDPSSPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 357 GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
            +  F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +
Sbjct: 58  VE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQ 111
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
           +++  + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    
Sbjct: 112 EVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 168
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
                       + + APE   Y K +  SDV++FGV+L E+
Sbjct: 169 DTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 2   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 55
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +++S 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVSA 110
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 166
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 167 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA 356
           ++  S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +  
Sbjct: 3   MDPSSPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 357 GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
            +  F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +
Sbjct: 58  VE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQ 111
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
           +++  + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    
Sbjct: 112 EVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT- 167
Query: 477 GITHLTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
           G T+  T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 168 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 2   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 55
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +++S 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSA 110
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 166
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 167 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 12/211 (5%)
Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  IG G +G V+ G   N  +VA+K  +  + + + +F  E E++  + 
Sbjct: 4   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS 60
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G      P+      +V + + +G L D+L  +     +    L + L    
Sbjct: 61  HPKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 114
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+AYL    + ++IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + 
Sbjct: 115 GMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 171
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +PE   + + +  SDV+SFGV++ E+ S  K
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  IG G +G V+ G   N  +VA+K  +  + + + +F  E E++  + 
Sbjct: 2   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS 58
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G      P+      +V + + +G L D+L  +     +    L + L    
Sbjct: 59  HPKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 112
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+AYL    +  +IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + 
Sbjct: 113 GMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 169
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +PE   + + +  SDV+SFGV++ E+ S  K
Sbjct: 170 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 200

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  IG G +G V+ G   N  +VA+K  +  + + + +F  E E++  + 
Sbjct: 4   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS 60
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G      P+      +V + + +G L D+L  +     +    L + L    
Sbjct: 61  HPKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 114
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+AYL    +  +IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + 
Sbjct: 115 GMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 171
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +PE   + + +  SDV+SFGV++ E+ S  K
Sbjct: 172 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 202

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 2   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 55
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +++S 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVSA 110
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 166
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 167 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA 356
           ++  S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +  
Sbjct: 3   MDPSSPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 357 GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
            +  F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +
Sbjct: 58  VE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQ 111
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
           +++  + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    
Sbjct: 112 EVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT- 167
Query: 477 GITHLTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
           G T+  T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 168 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           + + ++ +G G YG VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 70
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T   P       I+ + +  G+L D+L     +++S  + L +A   +  + YL
Sbjct: 71  QLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
               +   IHRD+ A N L+ E    KV DFGL++                + + APE  
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 498 LYGKLTPGSDVYSFGVVLLEL 518
            Y K +  SDV++FGV+L E+
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEI 203

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I  + + F +E  IG G +G V+ G   N  +VA+K  +  + + + +F  E E++  + 
Sbjct: 7   IDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLS 63
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G      P+      +V + + +G L D+L  +     +    L + L    
Sbjct: 64  HPKLVQLYGVCLEQAPI-----CLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCE 117
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+AYL    +  +IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + 
Sbjct: 118 GMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 174
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +PE   + + +  SDV+SFGV++ E+ S  K
Sbjct: 175 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 323 ENIIGKGGYGNVYKG-MLPNGTEVAVKRFKNCSKAGDA-------NFKHEVEIIASVKHV 374
           E  IGKGG+G V+KG ++ + + VA+K        G+         F+ EV I++++ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N+V L G       L  +   +V + +  G LY  L       + W ++LR+ L  A G+
Sbjct: 84  NIVKLYG-------LMHNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGI 135
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFE-----AKVGDFGLAKFNPEGITHLTTRVAGTL 489
            Y+     P I+HRD+++ NI L    E     AKV DFG ++ +     H  + + G  
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS----VHSVSGLLGNF 190
Query: 490 GYVAPEY--ALYGKLTPGSDVYSFGVVLLELLSGK 522
            ++APE   A     T  +D YSF ++L  +L+G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 111/225 (49%), Gaps = 21/225 (9%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKA 356
           ++  S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +  
Sbjct: 3   MDPSSPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME 57
Query: 357 GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
            +  F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +
Sbjct: 58  VE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQ 111
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
           +++  + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    
Sbjct: 112 EVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT- 167
Query: 477 GITHLTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
           G T+  T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 168 GDTY--TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 323 ENIIGKGGYGNVYKG-MLPNGTEVAVKRFKNCSKAGDA-------NFKHEVEIIASVKHV 374
           E  IGKGG+G V+KG ++ + + VA+K        G+         F+ EV I++++ H 
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N+V L G       L  +   +V + +  G LY  L       + W ++LR+ L  A G+
Sbjct: 84  NIVKLYG-------LMHNPPRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGI 135
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFE-----AKVGDFGLAKFNPEGITHLTTRVAGTL 489
            Y+     P I+HRD+++ NI L    E     AKV DF L++ +     H  + + G  
Sbjct: 136 EYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS----VHSVSGLLGNF 190
Query: 490 GYVAPEY--ALYGKLTPGSDVYSFGVVLLELLSGK 522
            ++APE   A     T  +D YSF ++L  +L+G+
Sbjct: 191 QWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 3   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 56
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 111
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 112 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 167
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 168 --TAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+    +  VAVK  K  +   +  
Sbjct: 15  SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 68
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 69  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 123
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 124 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 179
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 180 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 218

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 4   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 57
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 112
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 113 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 168
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 169 --TAPAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+    +  VAVK  K  +   +  
Sbjct: 2   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 55
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 110
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 166
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 167 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           + + ++ +G G YG VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 70
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T   P       I+ + +  G+L D+L     +++S  + L +A   +  + YL
Sbjct: 71  QLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
               +   IHRD+ A N L+ E    KV DFGL++                + + APE  
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESL 182
Query: 498 LYGKLTPGSDVYSFGVVLLEL 518
            Y K +  SDV++FGV+L E+
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEI 203

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+    +  VAVK  K  +   +  
Sbjct: 2   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 55
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 56  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 110
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 166
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 167 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 205

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 103/218 (47%), Gaps = 15/218 (6%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 3   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 56
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 57  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIIIEFMTYGNLLDYLRECNRQEVNA 111
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++        
Sbjct: 112 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT 168
Query: 481 LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
                   + + APE   Y K +  SDV++FGV+L E+
Sbjct: 169 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 206

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+    +  VAVK  K  +   +  
Sbjct: 6   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 59
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 60  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 114
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 115 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 170
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 171 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 209

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 109/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+       VAVK  K  +   +  
Sbjct: 4   SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 57
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 58  FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 112
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 113 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY 168
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 169 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 107/210 (50%), Gaps = 26/210 (12%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           +GKG YG V++G+  +G  VAVK F   S   + ++  E EI  +V  +H N++     S
Sbjct: 16  VGKGRYGEVWRGLW-HGESVAVKIF---SSRDEQSWFRETEIYNTVLLRHDNILGFIA-S 70
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH---YG 440
             T      Q  ++     +GSLYD L     + L   + LR+A+  A GLA+LH   +G
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFL---QRQTLEPHLALRLAVSAACGLAHLHVEIFG 127
Query: 441 VQ--PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL----TTRVAGTLGYVAP 494
            Q  PAI HRD K+ N+L+    +  + D GLA  + +G  +L      RV GT  Y+AP
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYMAP 186
Query: 495 EYALYGKLT------PGSDVYSFGVVLLEL 518
           E       T        +D+++FG+VL E+
Sbjct: 187 EVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 24/220 (10%)
Query: 311 EEIKAATMNFSRENIIGKGGYGNVYKG--MLPNGTE--VAVKRFK-NCSKAGDANFKHEV 365
           +EI+A+ +   R  +IG G +G V  G   LP   E  VA+K  K   ++    +F  E 
Sbjct: 17  KEIEASCITIER--VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEA 74
Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
            I+    H N++ L G  T + P+     +IV + + NGSL      + +KK      + 
Sbjct: 75  SIMGQFDHPNIIHLEGVVTKSKPV-----MIVTEYMENGSL-----DTFLKKNDGQFTVI 124
Query: 426 IALGTARGL-AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHL 481
             +G  RG+ A + Y      +HRD+ A NIL++     KV DFGL++    +PE     
Sbjct: 125 QLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--Y 182
Query: 482 TTRVAGT-LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           TTR     + + APE   + K T  SDV+S+G+V+ E++S
Sbjct: 183 TTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVS 222

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 18/207 (8%)
Query: 323 ENIIGKGGYGNVYKG--MLPNGTE--VAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLV 377
           E +IG G +G V  G   LP   E  VA+K  K+  ++    +F  E  I+    H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T + P+     +I+ + + NGSL D        + +    + +  G A G+ YL
Sbjct: 72  HLEGVVTKSTPV-----MIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 125
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG--YVA 493
                   +HR + A NIL++     KV DFGL++F  +  +    T+ + G +   + A
Sbjct: 126 ---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 182
Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLS 520
           PE   Y K T  SDV+S+G+V+ E++S
Sbjct: 183 PEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IGKG +G+V  G    G +VAVK  KN + A    F  E  ++  ++H NLV L G    
Sbjct: 14  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG---- 66
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
            +  E     IV + +  GSL D+L   G   L     L+ +L     + YL        
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 123
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLT 503
           +HRD+ A N+L+ E   AKV DFGL K         +T+  G L   + APE     K +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 504 PGSDVYSFGVVLLELLS 520
             SDV+SFG++L E+ S
Sbjct: 178 TKSDVWSFGILLWEIYS 194

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 125/285 (43%), Gaps = 35/285 (12%)
Query: 318 MNFSRENI-----IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           M   RE I     +G G +G V  G      +VAVK  K  S + D  F+ E + +  + 
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQ-EAQTMMKLS 61
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV   G  +   P+      IV + + NG L ++L   G K L     L +      
Sbjct: 62  HPKLVKFYGVCSKEYPI-----YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCE 115
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+A+L        IHRD+ A N L+D     KV DFG+ ++  + + ++ + T+    + 
Sbjct: 116 GMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFP--VK 170
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
           + APE   Y K +  SDV++FG+++ E+ S GK   ++     V+L       V +G  L
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK------VSQGHRL 224
Query: 550 DVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                            Q + +   C H + + RPT  Q++  +E
Sbjct: 225 ------YRPHLASDTIYQIMYS---CWHELPEKRPTFQQLLSSIE 260

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           + + ++ +G G YG VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 74
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T   P       I+ + +  G+L D+L     ++++  + L +A   +  + YL
Sbjct: 75  QLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYL 129
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT---LGYVAP 494
               +   IHRD+ A N L+ E    KV DFGL++    G T+  T  AG    + + AP
Sbjct: 130 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTY--TAHAGAKFPIKWTAP 183
Query: 495 EYALYGKLTPGSDVYSFGVVLLEL 518
           E   Y K +  SDV++FGV+L E+
Sbjct: 184 ESLAYNKFSIKSDVWAFGVLLWEI 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IGKG +G+V  G    G +VAVK  KN + A    F  E  ++  ++H NLV L G    
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG---- 253
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
            +  E     IV + +  GSL D+L   G   L     L+ +L     + YL        
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLT 503
           +HRD+ A N+L+ E   AKV DFGL K         +T+  G L   + APE     K +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 504 PGSDVYSFGVVLLELLS 520
             SDV+SFG++L E+ S
Sbjct: 365 TKSDVWSFGILLWEIYS 381

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 10/201 (4%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           + + ++ +G G +G VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 70
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T   P       I+ + +  G+L D+L     +++S  + L +A   +  + YL
Sbjct: 71  QLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 125
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
               +   IHRD+ A N L+ E    KV DFGL++                + + APE  
Sbjct: 126 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESL 182
Query: 498 LYGKLTPGSDVYSFGVVLLEL 518
            Y K +  SDV++FGV+L E+
Sbjct: 183 AYNKFSIKSDVWAFGVLLWEI 203

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/197 (34%), Positives = 95/197 (48%), Gaps = 18/197 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IGKG +G+V  G    G +VAVK  KN + A    F  E  ++  ++H NLV L G    
Sbjct: 29  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG---- 81
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
            +  E     IV + +  GSL D+L   G   L     L+ +L     + YL        
Sbjct: 82  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 138
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLT 503
           +HRD+ A N+L+ E   AKV DFGL K         +T+  G L   + APE     K +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 504 PGSDVYSFGVVLLELLS 520
             SDV+SFG++L E+ S
Sbjct: 193 TKSDVWSFGILLWEIYS 209

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 323 ENIIGKGGYGNVYKGML--PNGTEVAV--KRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
           E +IG G +G V  G L  P   +VAV  K  K   ++    +F  E  I+    H N+V
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY- 436
            L G  T   P+     +IV + + NG+L      + ++K      +   +G  RG+A  
Sbjct: 108 HLEGVVTRGKPV-----MIVIEFMENGAL-----DAFLRKHDGQFTVIQLVGMLRGIAAG 157
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGTLGYVA 493
           + Y      +HRD+ A NIL++     KV DFGL++    +PE + + TT     + + A
Sbjct: 158 MRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV-YTTTGGKIPVRWTA 216
Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLS 520
           PE   Y K T  SDV+S+G+V+ E++S
Sbjct: 217 PEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 34/214 (15%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           +GKG YG V++G    G  VAVK F   S   + ++  E E+  +V  +H N++     S
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA-S 70
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH---YG 440
             T      Q  ++      GSLYD+L  + +  +S    LRI L  A GLA+LH   +G
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFG 127
Query: 441 VQ--PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT----RVAGTLGYVAP 494
            Q  PAI HRD+K+ NIL+ +  +  + D GLA  + +    L      RV GT  Y+AP
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAP 186
Query: 495 E----------YALYGKLTPGSDVYSFGVVLLEL 518
           E          +  Y ++    D+++FG+VL E+
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEV 216

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 34/214 (15%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           +GKG YG V++G    G  VAVK F   S   + ++  E E+  +V  +H N++     S
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA-S 70
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH---YG 440
             T      Q  ++      GSLYD+L  + +  +S    LRI L  A GLA+LH   +G
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFG 127
Query: 441 VQ--PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT----RVAGTLGYVAP 494
            Q  PAI HRD+K+ NIL+ +  +  + D GLA  + +    L      RV GT  Y+AP
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAP 186
Query: 495 E----------YALYGKLTPGSDVYSFGVVLLEL 518
           E          +  Y ++    D+++FG+VL E+
Sbjct: 187 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEV 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 107/214 (50%), Gaps = 34/214 (15%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           +GKG YG V++G    G  VAVK F   S   + ++  E E+  +V  +H N++     S
Sbjct: 45  VGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA-S 99
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH---YG 440
             T      Q  ++      GSLYD+L  + +  +S    LRI L  A GLA+LH   +G
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVS---CLRIVLSIASGLAHLHIEIFG 156
Query: 441 VQ--PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT----RVAGTLGYVAP 494
            Q  PAI HRD+K+ NIL+ +  +  + D GLA  + +    L      RV GT  Y+AP
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYMAP 215
Query: 495 E----------YALYGKLTPGSDVYSFGVVLLEL 518
           E          +  Y ++    D+++FG+VL E+
Sbjct: 216 EVLDETIQVDCFDSYKRV----DIWAFGLVLWEV 245

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +G+G +G V    Y     N G +VAVK  K  S     A+ K E+EI+ ++ H N+V  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           +G  T      G+   ++ + L +GSL ++L      K++   +L+ A+   +G+ YL  
Sbjct: 89  KGICTED---GGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG- 143
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVAGTLGYVAPEY 496
                 +HRD+ A N+L++   + K+GDFGL K    + E  T    R +    Y APE 
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 200
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            +  K    SDV+SFGV L ELL+
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 104/204 (50%), Gaps = 17/204 (8%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +G+G +G V    Y     N G +VAVK  K  S     A+ K E+EI+ ++ H N+V  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           +G  T      G+   ++ + L +GSL ++L      K++   +L+ A+   +G+ YL  
Sbjct: 77  KGICTED---GGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLG- 131
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVAGTLGYVAPEY 496
                 +HRD+ A N+L++   + K+GDFGL K    + E  T    R +    Y APE 
Sbjct: 132 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APEC 188
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            +  K    SDV+SFGV L ELL+
Sbjct: 189 LMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 311 EEIKAATMNFSRENIIGKGGYGNVYKGML--PNGTE--VAVKRFK-NCSKAGDANFKHEV 365
           +EI A+ +    E +IG G +G V  G L  P   E  VA+K  K   +     +F  E 
Sbjct: 24  KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 81
Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
            I+    H N++ L G  T   P+     +I+ + + NGSL D        + +    + 
Sbjct: 82  SIMGQFDHPNIIHLEGVVTKCKPV-----MIITEYMENGSL-DAFLRKNDGRFTVIQLVG 135
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLT 482
           +  G   G+ YL      + +HRD+ A NIL++     KV DFG+++    +PE     T
Sbjct: 136 MLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA--AYT 190
Query: 483 TRVAGT-LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           TR     + + APE   Y K T  SDV+S+G+V+ E++S
Sbjct: 191 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 311 EEIKAATMNFSRENIIGKGGYGNVYKGML--PNGTE--VAVKRFK-NCSKAGDANFKHEV 365
           +EI A+ +    E +IG G +G V  G L  P   E  VA+K  K   +     +F  E 
Sbjct: 9   KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 66
Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
            I+    H N++ L G  T   P+     +I+ + + NGSL D        + +    + 
Sbjct: 67  SIMGQFDHPNIIHLEGVVTKCKPV-----MIITEYMENGSL-DAFLRKNDGRFTVIQLVG 120
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLT 482
           +  G   G+ YL      + +HRD+ A NIL++     KV DFG+++    +PE     T
Sbjct: 121 MLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE--AAYT 175
Query: 483 TRVAGT-LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           TR     + + APE   Y K T  SDV+S+G+V+ E++S
Sbjct: 176 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 119/265 (44%), Gaps = 47/265 (17%)
Query: 310 IEEIKAATMNFSRENIIGKGGYGNVY----KGMLPNGTE--VAVKRFKNCSKAGDANFKH 363
           ++ IK   +   RE  +G+G +G V+      + P   +  VAVK  K+ S     +F  
Sbjct: 7   VQHIKRHNIVLKRE--LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR 64
Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK------- 416
           E E++ +++H ++V   G     V +EG   I+V + + +G L   L   G         
Sbjct: 65  EAELLTNLQHEHIVKFYG-----VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG 119
Query: 417 ----KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
               +L+    L IA   A G+ YL        +HRD+   N L+ E    K+GDFG+++
Sbjct: 120 NPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 176
Query: 473 -------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKA 524
                  +   G T L  R      ++ PE  +Y K T  SDV+S GVVL E+ + GK+ 
Sbjct: 177 DVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230
Query: 525 CEIIQGKSVLLSDWAWELVKEGKTL 549
              +    V+      E + +G+ L
Sbjct: 231 WYQLSNNEVI------ECITQGRVL 249

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 95/186 (51%), Gaps = 18/186 (9%)
Query: 341 NGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVC 398
            G  VAVK  K +C     + +K E++I+ ++ H +++  +G        +G + + +V 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED----QGEKSLQLVM 97
Query: 399 DLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           + +  GSL D+L     G+ +L     L  A     G+AYLH       IHR++ A N+L
Sbjct: 98  EYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---SQHYIHRNLAARNVL 149
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYSFGVV 514
           LD     K+GDFGLAK  PEG  +   R  G   + + APE     K    SDV+SFGV 
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 515 LLELLS 520
           L ELL+
Sbjct: 210 LYELLT 215

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 105/219 (47%), Gaps = 22/219 (10%)
Query: 311 EEIKAATMNFSRENIIGKGGYGNVYKGML--PNGTE--VAVKRFK-NCSKAGDANFKHEV 365
           +EI A+ +    E +IG G +G V  G L  P   E  VA+K  K   +     +F  E 
Sbjct: 3   KEIDASCIKI--EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEA 60
Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
            I+    H N++ L G  T   P+     +I+ + + NGSL D        + +    + 
Sbjct: 61  SIMGQFDHPNIIHLEGVVTKCKPV-----MIITEYMENGSL-DAFLRKNDGRFTVIQLVG 114
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLT 482
           +  G   G+ YL      + +HRD+ A NIL++     KV DFG+++    +PE     T
Sbjct: 115 MLRGIGSGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPE--AAYT 169
Query: 483 TRVAGT-LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           TR     + + APE   Y K T  SDV+S+G+V+ E++S
Sbjct: 170 TRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/186 (34%), Positives = 95/186 (51%), Gaps = 18/186 (9%)
Query: 341 NGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVC 398
            G  VAVK  K +C     + +K E++I+ ++ H +++  +G        +G + + +V 
Sbjct: 42  TGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED----QGEKSLQLVM 97
Query: 399 DLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           + +  GSL D+L     G+ +L     L  A     G+AYLH       IHR++ A N+L
Sbjct: 98  EYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---AQHYIHRNLAARNVL 149
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYSFGVV 514
           LD     K+GDFGLAK  PEG  +   R  G   + + APE     K    SDV+SFGV 
Sbjct: 150 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 209
Query: 515 LLELLS 520
           L ELL+
Sbjct: 210 LYELLT 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 21/221 (9%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+    +  VAVK  K  +   +  
Sbjct: 209 SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 262
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     +++S 
Sbjct: 263 FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSA 317
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHR++ A N L+ E    KV DFGL++    G T+
Sbjct: 318 VVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM-TGDTY 373
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y K +  SDV++FGV+L E+
Sbjct: 374 --TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/197 (34%), Positives = 94/197 (47%), Gaps = 18/197 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IGKG +G+V  G    G +VAVK  KN + A    F  E  ++  ++H NLV L G    
Sbjct: 20  IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLG---- 72
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
            +  E     IV + +  GSL D+L   G   L     L+ +L     + YL        
Sbjct: 73  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 129
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLT 503
           +HRD+ A N+L+ E   AKV DFGL K         +T+  G L   + APE       +
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 504 PGSDVYSFGVVLLELLS 520
             SDV+SFG++L E+ S
Sbjct: 184 TKSDVWSFGILLWEIYS 200

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 326 IGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYS 383
           IG+G +G V+ G L  + T VAVK  +        A F  E  I+    H N+V L G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
           T   P+      IV +L+  G     L   G + L     L++    A G+ YL      
Sbjct: 182 TQKQPI-----YIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT-LGYVAPEYALYGKL 502
             IHRD+ A N L+ E    K+ DFG+++   +G+   +  +    + + APE   YG+ 
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 503 TPGSDVYSFGVVLLELLS 520
           +  SDV+SFG++L E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/228 (32%), Positives = 103/228 (45%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I A + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 41/279 (14%)
Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E ++G+G +G V K       +VA+K+ +  S++    F  E+  ++ V H N+V L G 
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFG-------SGMKKLSWPIRLRIALGTARGLA 435
               V        +V +    GSLY+ L G       +    +SW       L  ++G+A
Sbjct: 70  CLNPV-------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVA 116
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEA-KVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           YLH     A+IHRD+K  N+LL       K+ DFG A    +  TH+T    G+  ++AP
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN-KGSAAWMAP 172
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIXX 554
           E       +   DV+S+G++L E+++ +K  + I G +  +  WA   V  G    +I  
Sbjct: 173 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WA---VHNGTRPPLI-- 226
Query: 555 XXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKIL 593
                       + ++T      P    RP+M++IVKI+
Sbjct: 227 -----KNLPKPIESLMTRCWSKDP--SQRPSMEEIVKIM 258

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 41/279 (14%)
Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E ++G+G +G V K       +VA+K+ +  S++    F  E+  ++ V H N+V L G 
Sbjct: 14  EEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 70
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFG-------SGMKKLSWPIRLRIALGTARGLA 435
               V        +V +    GSLY+ L G       +    +SW       L  ++G+A
Sbjct: 71  CLNPV-------CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEA-KVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           YLH     A+IHRD+K  N+LL       K+ DFG A    +  TH+T    G+  ++AP
Sbjct: 118 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC---DIQTHMTNN-KGSAAWMAP 173
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIXX 554
           E       +   DV+S+G++L E+++ +K  + I G +  +  WA   V  G    +I  
Sbjct: 174 EVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM-WA---VHNGTRPPLI-- 227
Query: 555 XXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKIL 593
                       + ++T      P    RP+M++IVKI+
Sbjct: 228 -----KNLPKPIESLMTRCWSKDP--SQRPSMEEIVKIM 259

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 16/221 (7%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           + NL    +++ +    + + ++ +G G YG VY G+       VAVK  K  +   +  
Sbjct: 16  TENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE-E 74
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       IV + +  G+L D+L     ++++ 
Sbjct: 75  FLKEAAVMKEIKHPNLVQLLGVCTLEPPF-----YIVTEYMPYGNLLDYLRECNREEVTA 129
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHRD+ A N L+ E    KV DFGL++    G T+
Sbjct: 130 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTY 185
Query: 481 LTTRVAGT---LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
             T  AG    + + APE   Y   +  SDV++FGV+L E+
Sbjct: 186 --TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEI 224

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 326 IGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYS 383
           IG+G +G V+ G L  + T VAVK  +        A F  E  I+    H N+V L G  
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
           T   P+      IV +L+  G     L   G + L     L++    A G+ YL      
Sbjct: 182 TQKQPI-----YIVMELVQGGDFLTFLRTEGAR-LRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT-LGYVAPEYALYGKL 502
             IHRD+ A N L+ E    K+ DFG+++   +G+   +  +    + + APE   YG+ 
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 503 TPGSDVYSFGVVLLELLS 520
           +  SDV+SFG++L E  S
Sbjct: 293 SSESDVWSFGILLWETFS 310

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 341 NGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVC 398
            G  VAVK  K  C     + ++ E+EI+ ++ H ++V  +G        +G + + +V 
Sbjct: 37  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED----QGEKSVQLVM 92
Query: 399 DLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           + +  GSL D+L     G+ +L     L  A     G+AYLH       IHR + A N+L
Sbjct: 93  EYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH---AQHYIHRALAARNVL 144
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYSFGVV 514
           LD     K+GDFGLAK  PEG  +   R  G   + + APE     K    SDV+SFGV 
Sbjct: 145 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 204
Query: 515 LLELLS 520
           L ELL+
Sbjct: 205 LYELLT 210

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 15/218 (6%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGT-EVAVKRFKNCSKAGDAN 360
           S N  ++++E       + + ++ +G G YG VY+G+    +  VAVK  K  +   +  
Sbjct: 248 SPNYDKWEMERT-----DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-E 301
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F  E  ++  +KH NLV L G  T   P       I+ + +  G+L D+L     ++++ 
Sbjct: 302 FLKEAAVMKEIKHPNLVQLLGVCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVNA 356
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            + L +A   +  + YL    +   IHR++ A N L+ E    KV DFGL++        
Sbjct: 357 VVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 413
Query: 481 LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
                   + + APE   Y K +  SDV++FGV+L E+
Sbjct: 414 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 451

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/186 (34%), Positives = 93/186 (50%), Gaps = 18/186 (9%)
Query: 341 NGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVC 398
            G  VAVK  K  C     + ++ E+EI+ ++ H ++V  +G        +G + + +V 
Sbjct: 36  TGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED----QGEKSVQLVM 91
Query: 399 DLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           + +  GSL D+L     G+ +L     L  A     G+AYLH       IHR + A N+L
Sbjct: 92  EYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLH---AQHYIHRALAARNVL 143
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYSFGVV 514
           LD     K+GDFGLAK  PEG  +   R  G   + + APE     K    SDV+SFGV 
Sbjct: 144 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVT 203
Query: 515 LLELLS 520
           L ELL+
Sbjct: 204 LYELLT 209

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 125/291 (42%), Gaps = 34/291 (11%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFK-NCSKAGDANFKHEVE 366
           EI+A+ ++   E IIG G  G V  G L         VA+K  K   ++    +F  E  
Sbjct: 45  EIEASRIHI--EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           I+    H N++ L G  T      G   +IV + + NGSL D    +   + +    + +
Sbjct: 103 IMGQFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGM 156
Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
             G   G+ YL        +HRD+ A N+L+D     KV DFGL++   +      T   
Sbjct: 157 LRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTG 213
Query: 487 GTLG--YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELV 543
           G +   + APE   +   +  SDV+SFGVV+ E+L+ G++    +  + V+ S      V
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS------V 267
Query: 544 KEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
           +EG  L                 Q +L    C H     RP   QIV +L+
Sbjct: 268 EEGYRLPA------PMGCPHALHQLMLD---CWHKDRAQRPRFSQIVSVLD 309

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 128/292 (43%), Gaps = 36/292 (12%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFK-NCSKAGDANFKHEVE 366
           EI+A+ ++   E IIG G  G V  G L         VA+K  K   ++    +F  E  
Sbjct: 45  EIEASRIHI--EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEAS 102
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           I+    H N++ L G  T      G   +IV + + NGSL D    +   + +    + +
Sbjct: 103 IMGQFDHPNIIRLEGVVT-----RGRLAMIVTEYMENGSL-DTFLRTHDGQFTIMQLVGM 156
Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTT 483
             G   G+ YL        +HRD+ A N+L+D     KV DFGL++    +P+   + TT
Sbjct: 157 LRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA-AYTTT 212
Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWEL 542
                + + APE   +   +  SDV+SFGVV+ E+L+ G++    +  + V+ S      
Sbjct: 213 GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISS------ 266
Query: 543 VKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
           V+EG  L                 Q +L    C H     RP   QIV +L+
Sbjct: 267 VEEGYRLPA------PMGCPHALHQLMLD---CWHKDRAQRPRFSQIVSVLD 309

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 73  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 122
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 123 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/213 (34%), Positives = 107/213 (50%), Gaps = 32/213 (15%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           IGKG YG V+ G    G +VAVK F       +A++  E EI  +V  +H N++   G+ 
Sbjct: 45  IGKGRYGEVWMGKW-RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENIL---GFI 97
Query: 384 TATVPLEGH--QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
            A +   G   Q  ++ D   NGSLYD+L  + +   S    L++A  +  GL +LH  +
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKS---MLKLAYSSVSGLCHLHTEI 154
Query: 442 -----QPAIIHRDIKASNILLDEAFEAKVGDFGLA-KF---NPEGITHLTTRVAGTLGYV 492
                +PAI HRD+K+ NIL+ +     + D GLA KF     E      TRV GT  Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213
Query: 493 APEYALYGKLTPG-------SDVYSFGVVLLEL 518
            PE  L   L          +D+YSFG++L E+
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDW-----KEKKT 225

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 279 KKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM 338
           K S+ R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G 
Sbjct: 12  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQ 67
Query: 339 L------PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG 391
           +      P+  +VAVK     CS+  + +F  E  II+   H N+V   G S  ++P   
Sbjct: 68  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--- 124
Query: 392 HQRIIVCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAII 446
             R I+ +L+  G L   L       S    L+    L +A   A G  YL    +   I
Sbjct: 125 --RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFI 179
Query: 447 HRDIKASNILLD---EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEY 496
           HRDI A N LL        AK+GDFG+A+       +   G   L  +      ++ PE 
Sbjct: 180 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEA 233
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            + G  T  +D +SFGV+L E+ S
Sbjct: 234 FMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 279 KKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM 338
           K S+ R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G 
Sbjct: 36  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQ 91
Query: 339 L------PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG 391
           +      P+  +VAVK     CS+  + +F  E  II+   H N+V   G S  ++P   
Sbjct: 92  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--- 148
Query: 392 HQRIIVCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAII 446
             R I+ +L+  G L   L       S    L+    L +A   A G  YL    +   I
Sbjct: 149 --RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFI 203
Query: 447 HRDIKASNILLD---EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEY 496
           HRDI A N LL        AK+GDFG+A+       +   G   L  +      ++ PE 
Sbjct: 204 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK------WMPPEA 257
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            + G  T  +D +SFGV+L E+ S
Sbjct: 258 FMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 279 KKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM 338
           K S+ R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G 
Sbjct: 13  KLSKLRTSTIMTDYNPNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQ 68
Query: 339 L------PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG 391
           +      P+  +VAVK     CS+  + +F  E  II+   H N+V   G S  ++P   
Sbjct: 69  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--- 125
Query: 392 HQRIIVCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAII 446
             R I+ +L+  G L   L       S    L+    L +A   A G  YL    +   I
Sbjct: 126 --RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFI 180
Query: 447 HRDIKASNILL---DEAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEY 496
           HRDI A N LL        AK+GDFG+A+       +   G   L  +      ++ PE 
Sbjct: 181 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK------WMPPEA 234
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            + G  T  +D +SFGV+L E+ S
Sbjct: 235 FMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 323 ENIIGKGGYGNVYKGMLPNG---TEVAVKRFKN-CSKAGDANFKHEVEIIASVKH----V 374
           +++IG+G +G V K  +       + A+KR K   SK    +F  E+E++  + H    +
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 375 NLVAL---RGYSTATVPLEGHQRIIVCDLLHNGSLYD-----HLFGSGMKKLSWPIRLRI 426
           NL+     RGY    +    H  ++  D L    + +      +  S    LS    L  
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 137
Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           A   ARG+ YL    Q   IHRD+ A NIL+ E + AK+ DFGL++     +     R+ 
Sbjct: 138 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 194
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             + ++A E   Y   T  SDV+S+GV+L E++S
Sbjct: 195 --VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 118/261 (45%), Gaps = 50/261 (19%)
Query: 299 ESRSSNLARFKIEEIK----AATMNFSRENII-----GKGGYGNVY----KGMLPNGTE- 344
           E + S L    IE  +    A   +  R +I+     G+G +G V+      +LP   + 
Sbjct: 13  EGKGSGLQGHIIENPQYFSDACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKM 72
Query: 345 -VAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN 403
            VAVK  K  S++   +F+ E E++  ++H ++V   G  T   PL     ++V + + +
Sbjct: 73  LVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL-----LMVFEYMRH 127
Query: 404 GSLYD---------HLFGSGMKKLSWPIRL----RIALGTARGLAYLHYGVQPAIIHRDI 450
           G L            L   G      P+ L     +A   A G+ YL  G+    +HRD+
Sbjct: 128 GDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDL 184
Query: 451 KASNILLDEAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
              N L+ +    K+GDFG+++       +   G T L  R      ++ PE  LY K T
Sbjct: 185 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR------WMPPESILYRKFT 238
Query: 504 PGSDVYSFGVVLLELLS-GKK 523
             SDV+SFGVVL E+ + GK+
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQ 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 46/241 (19%)
Query: 315 AATMNFSRENII-----GKGGYGNVY----KGMLPNGTE--VAVKRFKNCSKAGDANFKH 363
           A   +  R +I+     G+G +G V+      +LP   +  VAVK  K  S++   +F+ 
Sbjct: 10  ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR 69
Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD---------HLFGSG 414
           E E++  ++H ++V   G  T   PL     ++V + + +G L            L   G
Sbjct: 70  EAELLTMLQHQHIVRFFGVCTEGRPL-----LMVFEYMRHGDLNRFLRSHGPDAKLLAGG 124
Query: 415 MKKLSWPIRL----RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                 P+ L     +A   A G+ YL  G+    +HRD+   N L+ +    K+GDFG+
Sbjct: 125 EDVAPGPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGM 181
Query: 471 AK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GK 522
           ++       +   G T L  R      ++ PE  LY K T  SDV+SFGVVL E+ + GK
Sbjct: 182 SRDIYSTDYYRVGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235
Query: 523 K 523
           +
Sbjct: 236 Q 236

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 75  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 124
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 125 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 226

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 72/228 (31%), Positives = 102/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G YG V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 279 KKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM 338
           K S+ R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G 
Sbjct: 2   KLSKLRTSTIMTDYNPNYSFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQ 57
Query: 339 L------PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG 391
           +      P+  +VAVK     CS+  + +F  E  II+   H N+V   G S  ++P   
Sbjct: 58  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--- 114
Query: 392 HQRIIVCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAII 446
             R I+ +L+  G L   L       S    L+    L +A   A G  YL    +   I
Sbjct: 115 --RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFI 169
Query: 447 HRDIKASNILLD---EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEY 496
           HRDI A N LL        AK+GDFG+A+       +   G   L  +      ++ PE 
Sbjct: 170 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEA 223
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            + G  T  +D +SFGV+L E+ S
Sbjct: 224 FMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 117/264 (44%), Gaps = 40/264 (15%)
Query: 279 KKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM 338
           K S+ R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G 
Sbjct: 22  KLSKLRTSTIMTDYNPNYSFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQ 77
Query: 339 L------PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG 391
           +      P+  +VAVK     CS+  + +F  E  II+   H N+V   G S  ++P   
Sbjct: 78  VSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP--- 134
Query: 392 HQRIIVCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAII 446
             R I+ +L+  G L   L       S    L+    L +A   A G  YL    +   I
Sbjct: 135 --RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFI 189
Query: 447 HRDIKASNILLD---EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEY 496
           HRDI A N LL        AK+GDFG+A+       +   G   L  +      ++ PE 
Sbjct: 190 HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEA 243
Query: 497 ALYGKLTPGSDVYSFGVVLLELLS 520
            + G  T  +D +SFGV+L E+ S
Sbjct: 244 FMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 323 ENIIGKGGYGNVYKGMLPNG---TEVAVKRFKN-CSKAGDANFKHEVEIIASVKH----V 374
           +++IG+G +G V K  +       + A+KR K   SK    +F  E+E++  + H    +
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 375 NLVAL---RGYSTATVPLEGHQRIIVCDLLHNGSLYD-----HLFGSGMKKLSWPIRLRI 426
           NL+     RGY    +    H  ++  D L    + +      +  S    LS    L  
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 147
Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           A   ARG+ YL    Q   IHRD+ A NIL+ E + AK+ DFGL++     +     R+ 
Sbjct: 148 AADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 204
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             + ++A E   Y   T  SDV+S+GV+L E++S
Sbjct: 205 --VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 111/241 (46%), Gaps = 46/241 (19%)
Query: 315 AATMNFSRENII-----GKGGYGNVY----KGMLPNGTE--VAVKRFKNCSKAGDANFKH 363
           A   +  R +I+     G+G +G V+      +LP   +  VAVK  K  S++   +F+ 
Sbjct: 4   ACVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR 63
Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD---------HLFGSG 414
           E E++  ++H ++V   G  T   PL     ++V + + +G L            L   G
Sbjct: 64  EAELLTMLQHQHIVRFFGVCTEGRPL-----LMVFEYMRHGDLNRFLRSHGPDAKLLAGG 118
Query: 415 MKKLSWPIRL----RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                 P+ L     +A   A G+ YL  G+    +HRD+   N L+ +    K+GDFG+
Sbjct: 119 EDVAPGPLGLGQLLAVASQVAAGMVYL-AGLH--FVHRDLATRNCLVGQGLVVKIGDFGM 175
Query: 471 AK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GK 522
           ++       +   G T L  R      ++ PE  LY K T  SDV+SFGVVL E+ + GK
Sbjct: 176 SRDIYSTDYYRVGGRTMLPIR------WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229
Query: 523 K 523
           +
Sbjct: 230 Q 230

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 115/259 (44%), Gaps = 40/259 (15%)
Query: 284 RVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML---- 339
           R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G +    
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMP 56
Query: 340 --PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII 396
             P+  +VAVK     CS+  + +F  E  II+ + H N+V   G S  ++P     R I
Sbjct: 57  NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLP-----RFI 111
Query: 397 VCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK 451
           + +L+  G L   L       S    L+    L +A   A G  YL    +   IHRDI 
Sbjct: 112 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIA 168
Query: 452 ASNILLD---EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           A N LL        AK+GDFG+A+       +   G   L  +      ++ PE  + G 
Sbjct: 169 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGI 222
Query: 502 LTPGSDVYSFGVVLLELLS 520
            T  +D +SFGV+L E+ S
Sbjct: 223 FTSKTDTWSFGVLLWEIFS 241

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/211 (35%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
            +  +G +G V+K  L N   VAVK F    K    N ++EV  +  +KH N++   G  
Sbjct: 30  EVKARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQN-EYEVYSLPGMKHENILQFIGAE 87
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY---- 439
                ++    +I       GSL D L  +    +SW     IA   ARGLAYLH     
Sbjct: 88  KRGTSVDVDLWLITA-FHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 440 ---GVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPE 495
              G +PAI HRDIK+ N+LL     A + DFGLA KF        T    GT  Y+APE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 496 YALYGKLTPGS------DVYSFGVVLLELLS 520
             L G +          D+Y+ G+VL EL S
Sbjct: 204 -VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/221 (33%), Positives = 107/221 (48%), Gaps = 28/221 (12%)
Query: 324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIAS--VKHVNLVALRG 381
            I  +G +G V+K  L N   VAVK F    K    +++ E EI ++  +KH NL+    
Sbjct: 21  EIKARGRFGCVWKAQLMNDF-VAVKIFPLQDKQ---SWQSEREIFSTPGMKHENLLQFIA 76
Query: 382 YSTATVPLEGHQRIIVCDLLHN-GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
                  LE    +I     H+ GSL D+L G+    ++W     +A   +RGL+YLH  
Sbjct: 77  AEKRGSNLEVELWLITA--FHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHED 131
Query: 441 V--------QPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
           V        +P+I HRD K+ N+LL     A + DFGLA +F P      T    GT  Y
Sbjct: 132 VPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRY 191
Query: 492 VAPEYALYGKLTPGS------DVYSFGVVLLELLSGKKACE 526
           +APE  L G +          D+Y+ G+VL EL+S  KA +
Sbjct: 192 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 40/249 (16%)
Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAV 347
           P+     ++S+++  K  E+    +   R   +G G +G VY+G +      P+  +VAV
Sbjct: 25  PNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAV 80
Query: 348 KRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL 406
           K     CS+  + +F  E  II+ + H N+V   G S  ++P     R I+ +L+  G L
Sbjct: 81  KTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLP-----RFILLELMAGGDL 135
Query: 407 YDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---D 458
              L       S    L+    L +A   A G  YL    +   IHRDI A N LL    
Sbjct: 136 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 192
Query: 459 EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSF 511
               AK+GDFG+A+       +   G   L  +      ++ PE  + G  T  +D +SF
Sbjct: 193 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSF 246
Query: 512 GVVLLELLS 520
           GV+L E+ S
Sbjct: 247 GVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 114/259 (44%), Gaps = 40/259 (15%)
Query: 284 RVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML---- 339
           R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G +    
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMP 56
Query: 340 --PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII 396
             P+  +VAVK     CS+  + +F  E  II+   H N+V   G S  ++P     R I
Sbjct: 57  NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-----RFI 111
Query: 397 VCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK 451
           + +L+  G L   L       S    L+    L +A   A G  YL    +   IHRDI 
Sbjct: 112 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIA 168
Query: 452 ASNILLD---EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           A N LL        AK+GDFG+A+       +   G   L  +      ++ PE  + G 
Sbjct: 169 ARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGI 222
Query: 502 LTPGSDVYSFGVVLLELLS 520
            T  +D +SFGV+L E+ S
Sbjct: 223 FTSKTDTWSFGVLLWEIFS 241

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 104/237 (43%), Gaps = 45/237 (18%)
Query: 320 FSRENI-----IGKGGYGNVYK----GMLPNG--TEVAVKRFKNCSKAG-DANFKHEVEI 367
           + R NI     IG+G +G V++    G+LP    T VAVK  K  + A   A+F+ E  +
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 368 IASVKHVNLVALRGYSTATVP----------------LEGHQRIIVCDLLHNG-SLYDHL 410
           +A   + N+V L G      P                L       VC L H+  S    +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
              G   LS   +L IA   A G+AYL    +   +HRD+   N L+ E    K+ DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 471 AK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           ++       +  +G   +  R      ++ PE   Y + T  SDV+++GVVL E+ S
Sbjct: 221 SRNIYSADYYKADGNDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 114/259 (44%), Gaps = 40/259 (15%)
Query: 284 RVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML---- 339
           R   +  +  P+     ++S+++  K  E+    +   R   +G G +G VY+G +    
Sbjct: 1   RTSTIMTDYNPNYSFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMP 56
Query: 340 --PNGTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII 396
             P+  +VAVK     CS+  + +F  E  II+   H N+V   G S  ++P     R I
Sbjct: 57  NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-----RFI 111
Query: 397 VCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK 451
           + +L+  G L   L       S    L+    L +A   A G  YL    +   IHRDI 
Sbjct: 112 LLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIA 168
Query: 452 ASNILLD---EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           A N LL        AK+GDFG+A+       +   G   L  +      ++ PE  + G 
Sbjct: 169 ARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK------WMPPEAFMEGI 222
Query: 502 LTPGSDVYSFGVVLLELLS 520
            T  +D +SFGV+L E+ S
Sbjct: 223 FTSKTDTWSFGVLLWEIFS 241

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVN 375
           M+F    +IG GG+G V+K     +G    +KR K N  KA     + EV+ +A + HVN
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA-----EREVKALAKLDHVN 65
Query: 376 LVALRG------YSTATVPLEGHQRIIVC-----DLLHNGSLYDHLFGSGMKKLSWPIRL 424
           +V   G      Y   T      +    C     +    G+L   +     +KL   + L
Sbjct: 66  IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT- 483
            +     +G+ Y+H      +I+RD+K SNI L +  + K+GDFGL       +T L   
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL-------VTSLKND 175
Query: 484 ----RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL 519
               R  GTL Y++PE           D+Y+ G++L ELL
Sbjct: 176 GKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 111/249 (44%), Gaps = 40/249 (16%)
Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAV 347
           P+     ++S+++  K  E+    +   R   +G G +G VY+G +      P+  +VAV
Sbjct: 10  PNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 348 KRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL 406
           K     CS+  + +F  E  II+   H N+V   G S  ++P     R I+ +L+  G L
Sbjct: 66  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-----RFILMELMAGGDL 120
Query: 407 YDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD--- 458
              L       S    L+    L +A   A G  YL    +   IHRDI A N LL    
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 177
Query: 459 EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSF 511
               AK+GDFG+A+       +   G   L  +      ++ PE  + G  T  +D +SF
Sbjct: 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSF 231
Query: 512 GVVLLELLS 520
           GV+L E+ S
Sbjct: 232 GVLLWEIFS 240

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 111/249 (44%), Gaps = 40/249 (16%)
Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAV 347
           P+     ++S+++  K  E+    +   R   +G G +G VY+G +      P+  +VAV
Sbjct: 25  PNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAV 80
Query: 348 KRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL 406
           K     CS+  + +F  E  II+   H N+V   G S  ++P     R I+ +L+  G L
Sbjct: 81  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-----RFILMELMAGGDL 135
Query: 407 YDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---D 458
              L       S    L+    L +A   A G  YL    +   IHRDI A N LL    
Sbjct: 136 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 192
Query: 459 EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSF 511
               AK+GDFG+A+       +   G   L  +      ++ PE  + G  T  +D +SF
Sbjct: 193 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSF 246
Query: 512 GVVLLELLS 520
           GV+L E+ S
Sbjct: 247 GVLLWEIFS 255

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 131/281 (46%), Gaps = 34/281 (12%)
Query: 286 VKVTDNDEPSLVLESRSSNLARF-KIEEIKAATMNFSRENII------GKGGYGNVYKG- 337
            ++T  D+P  +    S   + F   EE+K   +   R+N++      G G +G+V +G 
Sbjct: 297 ARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGV 356
Query: 338 --MLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR 394
             M     +VA+K  K  ++  D      E +I+  + +  +V L G   A         
Sbjct: 357 YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA------L 410
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIR--LRIALGTARGLAYLHYGVQPAIIHRDIKA 452
           ++V ++   G L+  L G   K+   P+     +    + G+ YL    +   +HR++ A
Sbjct: 411 MLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAA 464
Query: 453 SNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYS 510
            N+LL     AK+ DFGL+K      ++ T R AG   L + APE   + K +  SDV+S
Sbjct: 465 RNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWS 524
Query: 511 FGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           +GV + E LS G+K  + ++G  V+        +++GK ++
Sbjct: 525 YGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRME 559

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 111/249 (44%), Gaps = 40/249 (16%)
Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAV 347
           P+     ++S+++  K  E+    +   R   +G G +G VY+G +      P+  +VAV
Sbjct: 10  PNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAV 65
Query: 348 KRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL 406
           K     CS+  + +F  E  II+   H N+V   G S  ++P     R I+ +L+  G L
Sbjct: 66  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-----RFILLELMAGGDL 120
Query: 407 YDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD--- 458
              L       S    L+    L +A   A G  YL    +   IHRDI A N LL    
Sbjct: 121 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 177
Query: 459 EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSF 511
               AK+GDFG+A+       +   G   L  +      ++ PE  + G  T  +D +SF
Sbjct: 178 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSF 231
Query: 512 GVVLLELLS 520
           GV+L E+ S
Sbjct: 232 GVLLWEIFS 240

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/187 (34%), Positives = 91/187 (48%), Gaps = 20/187 (10%)
Query: 341 NGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVALRG--YSTATVPLEGHQRIIV 397
            G  VAVK  K +      + +K E++I+ ++ H +++  +G         L+     +V
Sbjct: 59  TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ-----LV 113
Query: 398 CDLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
            + +  GSL D+L     G+ +L     L  A     G+AYLH       IHRD+ A N+
Sbjct: 114 MEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLH---AQHYIHRDLAARNV 165
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYALYGKLTPGSDVYSFGV 513
           LLD     K+GDFGLAK  PEG      R  G   + + APE     K    SDV+SFGV
Sbjct: 166 LLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGV 225
Query: 514 VLLELLS 520
            L ELL+
Sbjct: 226 TLYELLT 232

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 111/249 (44%), Gaps = 40/249 (16%)
Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAV 347
           P+     ++S+++  K  E+    +   R   +G G +G VY+G +      P+  +VAV
Sbjct: 2   PNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAV 57
Query: 348 KRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL 406
           K     CS+  + +F  E  II+   H N+V   G S  ++P     R I+ +L+  G L
Sbjct: 58  KTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-----RFILLELMAGGDL 112
Query: 407 YDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---D 458
              L       S    L+    L +A   A G  YL    +   IHRDI A N LL    
Sbjct: 113 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 169
Query: 459 EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSF 511
               AK+GDFG+A+       +   G   L  +      ++ PE  + G  T  +D +SF
Sbjct: 170 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSF 223
Query: 512 GVVLLELLS 520
           GV+L E+ S
Sbjct: 224 GVLLWEIFS 232

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 23/214 (10%)
Query: 323 ENIIGKGGYGNVYKGMLPNG---TEVAVKRFKN-CSKAGDANFKHEVEIIASVKH----V 374
           +++IG+G +G V K  +       + A+KR K   SK    +F  E+E++  + H    +
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 375 NLVAL---RGYSTATVPLEGHQRIIVCDLLHNGSLYD-----HLFGSGMKKLSWPIRLRI 426
           NL+     RGY    +    H  ++  D L    + +      +  S    LS    L  
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 144
Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           A   ARG+ YL    Q   IHR++ A NIL+ E + AK+ DFGL++     +     R+ 
Sbjct: 145 AADVARGMDYLS---QKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 201
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             + ++A E   Y   T  SDV+S+GV+L E++S
Sbjct: 202 --VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 100/229 (43%), Gaps = 38/229 (16%)
Query: 318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVN 375
           M+F    +IG GG+G V+K     +G    ++R K N  KA     + EV+ +A + HVN
Sbjct: 12  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA-----EREVKALAKLDHVN 66
Query: 376 LVALRGY--------STATVPLEGHQR----------------IIVCDLLHNGSLYDHLF 411
           +V   G          T+   LE                     I  +    G+L   + 
Sbjct: 67  IVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 126
Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL- 470
               +KL   + L +     +G+ Y+H      +IHRD+K SNI L +  + K+GDFGL 
Sbjct: 127 KRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLV 183
Query: 471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL 519
                +G     TR  GTL Y++PE           D+Y+ G++L ELL
Sbjct: 184 TSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 105/227 (46%), Gaps = 16/227 (7%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKG----MLPNGTEVAVKRFKNCSKAG 357
           S+ LA  K   I    +    + +IGKG +G VY G       N  + A+K     ++  
Sbjct: 5   SALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQ 64
Query: 358 DAN-FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
               F  E  ++  + H N++AL G     +P EG   +++  + H   L      S  +
Sbjct: 65  QVEAFLREGLLMRGLNHPNVLALIG---IMLPPEGLPHVLLPYMCHGDLL--QFIRSPQR 119
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FN 474
             +    +   L  ARG+ YL    +   +HRD+ A N +LDE+F  KV DFGLA+   +
Sbjct: 120 NPTVKDLISFGLQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILD 176
Query: 475 PEGITHLTTRVAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            E  +    R A   + + A E     + T  SDV+SFGV+L ELL+
Sbjct: 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 118/269 (43%), Gaps = 50/269 (18%)
Query: 310 IEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTE------VAVKRFKNCSKAGDANFKH 363
           ++ IK   +   RE  +G+G +G V+     N +       VAVK  K+ + A   +F+ 
Sbjct: 9   VQHIKRRDIVLKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR 66
Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--------- 414
           E E++ +++H ++V   G      PL     I+V + + +G L   L   G         
Sbjct: 67  EAELLTNLQHEHIVKFYGVCGDGDPL-----IMVFEYMKHGDLNKFLRAHGPDAMILVDG 121
Query: 415 -----MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG 469
                  +L     L IA   A G+ YL        +HRD+   N L+      K+GDFG
Sbjct: 122 QPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFG 178
Query: 470 LAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-G 521
           +++       +   G T L  R      ++ PE  +Y K T  SDV+SFGV+L E+ + G
Sbjct: 179 MSRDVYSTDYYRVGGHTMLPIR------WMPPESIMYRKFTTESDVWSFGVILWEIFTYG 232
Query: 522 KKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           K+    +    V+      E + +G+ L+
Sbjct: 233 KQPWFQLSNTEVI------ECITQGRVLE 255

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/228 (31%), Positives = 101/228 (44%), Gaps = 21/228 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G  G V   +     E    +  +  +A D   N K E+ I   + H N+V   G+ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG+ + +  +    G L+D +    GM +   P   R       G+ YLH G+ 
Sbjct: 74  R-----EGNIQYLFLEYCSGGELFDRIEPDIGMPE---PDAQRFFHQLMAGVVYLH-GI- 123
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGK 501
             I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE     +
Sbjct: 124 -GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 502 L-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
                 DV+S G+VL  +L+G+   +         SDW     KE KT
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKT 225

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 141
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKL 198
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++
Sbjct: 4   EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNL 60
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G  T   P+      I+ + + NG L ++L      +      L +     
Sbjct: 61  SHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVC 114
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             + YL        +HRD+ A N L+++    KV DFGL+++  +     +      + +
Sbjct: 115 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 171
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             PE  +Y K +  SD+++FGV++ E+ S
Sbjct: 172 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 200

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++
Sbjct: 5   EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNL 61
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G  T   P+      I+ + + NG L ++L      +      L +     
Sbjct: 62  SHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVC 115
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             + YL        +HRD+ A N L+++    KV DFGL+++  +     +      + +
Sbjct: 116 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 172
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             PE  +Y K +  SD+++FGV++ E+ S
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++       +F+ E++I+ ++    +V  R
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 381 GYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY--- 436
           G S       G Q + +V + L +G L D L            R R  L  +R L Y   
Sbjct: 78  GVSYGP----GRQSLRLVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQ 122
Query: 437 ----LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LG 490
               + Y      +HRD+ A NIL++     K+ DFGLAK  P    +   R  G   + 
Sbjct: 123 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 182
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + APE       +  SDV+SFGVVL EL +
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALRG 381
           IG G YG V        G +VA+K+  N       N K    E++I+   KH N++A++ 
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKD 121
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL-GTARGLAYLHYG 440
               TVP    + + V   L    L+  +  S    L     +R  L    RGL Y+H  
Sbjct: 122 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE---HVRYFLYQLLRGLKYMHSA 178
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVAGTLGYVAPEYA 497
               +IHRD+K SN+L++E  E K+GDFG+A+    +P    +  T    T  Y APE  
Sbjct: 179 ---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 498 L-YGKLTPGSDVYSFGVVLLELLSGKK 523
           L   + T   D++S G +  E+L+ ++
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALRG 381
           IG G YG V        G +VA+K+  N       N K    E++I+   KH N++A++ 
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVV-TNAKRTLRELKILKHFKHDNIIAIKD 120
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL-GTARGLAYLHYG 440
               TVP    + + V   L    L+  +  S    L     +R  L    RGL Y+H  
Sbjct: 121 ILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLE---HVRYFLYQLLRGLKYMHSA 177
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVAGTLGYVAPEYA 497
               +IHRD+K SN+L++E  E K+GDFG+A+    +P    +  T    T  Y APE  
Sbjct: 178 ---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 498 L-YGKLTPGSDVYSFGVVLLELLSGKK 523
           L   + T   D++S G +  E+L+ ++
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDAN--FKHEVEIIASVK 372
              R  ++G G +G VYKG+ +P G  V +    +  N +    AN  F  E  I+AS+ 
Sbjct: 16  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 75
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           H +LV L G   + T+ L       V  L+ +G L +++       GS +  L+W +++ 
Sbjct: 76  HPHLVRLLGVCLSPTIQL-------VTQLMPHGCLLEYVHEHKDNIGSQLL-LNWCVQI- 126
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV 485
                A+G+ YL    +  ++HRD+ A N+L+      K+ DFGLA+   EG        
Sbjct: 127 -----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNAD 177
Query: 486 AGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            G +   ++A E   Y K T  SDV+S+GV + EL++
Sbjct: 178 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++       +F+ E++I+ ++    +V  R
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 381 GYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY--- 436
           G S       G Q + +V + L +G L D L            R R  L  +R L Y   
Sbjct: 91  GVSYGP----GRQSLRLVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQ 135
Query: 437 ----LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LG 490
               + Y      +HRD+ A NIL++     K+ DFGLAK  P    +   R  G   + 
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + APE       +  SDV+SFGVVL EL +
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++
Sbjct: 20  EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNL 76
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G  T   P+      I+ + + NG L ++L      +      L +     
Sbjct: 77  SHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVC 130
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTL 489
             + YL        +HRD+ A N L+++    KV DFGL+++  + E  + + ++    +
Sbjct: 131 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFP--V 185
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            +  PE  +Y K +  SD+++FGV++ E+ S
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 142
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++
Sbjct: 5   EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNL 61
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G  T   P+      I+ + + NG L ++L      +      L +     
Sbjct: 62  SHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVC 115
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             + YL        +HRD+ A N L+++    KV DFGL+++  +     +      + +
Sbjct: 116 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRW 172
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             PE  +Y K +  SD+++FGV++ E+ S
Sbjct: 173 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 201

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 30/210 (14%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++       +F+ E++I+ ++    +V  R
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 381 GYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY--- 436
           G S       G Q + +V + L +G L D L            R R  L  +R L Y   
Sbjct: 79  GVSYGP----GRQSLRLVMEYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQ 123
Query: 437 ----LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LG 490
               + Y      +HRD+ A NIL++     K+ DFGLAK  P    +   R  G   + 
Sbjct: 124 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 183
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + APE       +  SDV+SFGVVL EL +
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 142
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 143 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 199
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 161
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 162 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 218
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 219 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 29  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 88
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 89  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 134
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 135 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 191
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 192 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 141
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 142 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 198
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 199 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++
Sbjct: 11  EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNL 67
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G  T   P+      I+ + + NG L ++L      +      L +     
Sbjct: 68  SHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVC 121
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             + YL        +HRD+ A N L+++    KV DFGL+++  +     +      + +
Sbjct: 122 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRW 178
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             PE  +Y K +  SD+++FGV++ E+ S
Sbjct: 179 SPPEVLMYSKFSSKSDIWAFGVLMWEIYS 207

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 34  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 94  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 139
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 140 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 196
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 197 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 32  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 92  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 137
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 138 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 195 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 33/217 (15%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDAN--FKHEVEIIASVK 372
              R  ++G G +G VYKG+ +P G  V +    +  N +    AN  F  E  I+AS+ 
Sbjct: 39  ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD 98
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           H +LV L G   + T+ L       V  L+ +G L +++       GS +  L+W +++ 
Sbjct: 99  HPHLVRLLGVCLSPTIQL-------VTQLMPHGCLLEYVHEHKDNIGSQLL-LNWCVQI- 149
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV 485
                A+G+ YL    +  ++HRD+ A N+L+      K+ DFGLA+   EG        
Sbjct: 150 -----AKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNAD 200
Query: 486 AGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            G +   ++A E   Y K T  SDV+S+GV + EL++
Sbjct: 201 GGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 120/263 (45%), Gaps = 52/263 (19%)
Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKGML--PNGTE----VAVKRFKNCSKAG-DANF 361
           K++EI  + + F  E  +G+  +G VYKG L  P   E    VA+K  K+ ++      F
Sbjct: 19  KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 76
Query: 362 KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF--------GS 413
           +HE  + A ++H N+V L G  T   PL      ++     +G L++ L         GS
Sbjct: 77  RHEAMLRARLQHPNVVCLLGVVTKDQPLS-----MIFSYCSHGDLHEFLVMRSPHSDVGS 131
Query: 414 G------MKKLSWPIRLRIALGTARGLAYL--HYGVQPAIIHRDIKASNILLDEAFEAKV 465
                     L  P  + +    A G+ YL  H+     ++H+D+   N+L+ +    K+
Sbjct: 132 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKI 186
Query: 466 GDFGLAKFNPEGITHLTTRVAGT----LGYVAPEYALYGKLTPGSDVYSFGVVLLELL-- 519
            D GL +   E       ++ G     + ++APE  +YGK +  SD++S+GVVL E+   
Sbjct: 187 SDLGLFR---EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSY 243
Query: 520 --------SGKKACEIIQGKSVL 534
                   S +   E+I+ + VL
Sbjct: 244 GLQPYCGYSNQDVVEMIRNRQVL 266

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 140
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 141 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 197
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++
Sbjct: 20  EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNL 76
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G  T   P+      I+ + + NG L ++L      +      L +     
Sbjct: 77  SHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVC 130
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTL 489
             + YL        +HRD+ A N L+++    KV DFGL+++  + E  + + ++    +
Sbjct: 131 EAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP--V 185
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            +  PE  +Y K +  SD+++FGV++ E+ S
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/213 (31%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 160
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGIT-HLTTRVAG 487
           A+G+ YL        +HRD+ A N +LDE F  KV DFGLA+  ++ E  + H  T    
Sbjct: 161 AKGMKYL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 217
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 218 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 285 VVKVTDNDE-PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKG--MLPN 341
            V V++ D+   ++ E  +  +   +  EI+   +   R   IG+G +G+V++G  M P 
Sbjct: 358 TVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPE 415
Query: 342 --GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC 398
                VA+K  KNC S +    F  E   +    H ++V L G  T   P+      I+ 
Sbjct: 416 NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PV-----WIIM 469
Query: 399 DLLHNGSLYDHLFGSGMKKLSWPIRLRI--ALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           +L   G L   L    ++K S  +   I  A   +  LAYL        +HRDI A N+L
Sbjct: 470 ELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 523
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLL 516
           +      K+GDFGL+++  +   +  ++    + ++APE   + + T  SDV+ FGV + 
Sbjct: 524 VSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 517 E-LLSGKKACEIIQGKSVL 534
           E L+ G K  + ++   V+
Sbjct: 584 EILMHGVKPFQGVKNNDVI 602

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 82  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 132
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ NILL      K+ DFG  A+  PE     T  + GT  ++APE 
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 187
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/239 (29%), Positives = 111/239 (46%), Gaps = 27/239 (11%)
Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKG-MLPNGTEVAVKRF--KNCSKAGDAN-FKHE 364
           KIE+ K         N++GKG +  VY+   +  G EVA+K    K   KAG     ++E
Sbjct: 9   KIEDFKVG-------NLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL 424
           V+I   +KH +++ L  Y       + +   +V ++ HNG +  +L  + +K  S     
Sbjct: 62  VKIHCQLKHPSILELYNYFE-----DSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEAR 115
Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTT 483
                   G+ YLH      I+HRD+  SN+LL      K+ DFGLA +       H T 
Sbjct: 116 HFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT- 171
Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS----VLLSDW 538
            + GT  Y++PE A        SDV+S G +   LL G+   +    K+    V+L+D+
Sbjct: 172 -LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 121/259 (46%), Gaps = 23/259 (8%)
Query: 285 VVKVTDNDE-PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKG--MLPN 341
            V V++ D+   ++ E  +  +   +  EI+   +   R   IG+G +G+V++G  M P 
Sbjct: 358 TVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGR--CIGEGQFGDVHQGIYMSPE 415
Query: 342 --GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC 398
                VA+K  KNC S +    F  E   +    H ++V L G  T   P+      I+ 
Sbjct: 416 NPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN-PV-----WIIM 469
Query: 399 DLLHNGSLYDHLFGSGMKKLSWPIRLRI--ALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
           +L   G L   L    ++K S  +   I  A   +  LAYL        +HRDI A N+L
Sbjct: 470 ELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVL 523
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLL 516
           +      K+GDFGL+++  +   +  ++    + ++APE   + + T  SDV+ FGV + 
Sbjct: 524 VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 517 E-LLSGKKACEIIQGKSVL 534
           E L+ G K  + ++   V+
Sbjct: 584 EILMHGVKPFQGVKNNDVI 602

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 27/234 (11%)
Query: 326 IGKGGYGNVYKG---MLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNLVALRG 381
           +G G +G+V +G   M     +VA+K  K  ++  D      E +I+  + +  +V L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR--LRIALGTARGLAYLHY 439
              A   +      +V ++   G L+  L G   K+   P+     +    + G+ YL  
Sbjct: 78  VCQAEALM------LVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLE- 127
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGYVAPEYA 497
             +   +HRD+ A N+LL     AK+ DFGL+K      ++ T R AG   L + APE  
Sbjct: 128 --EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185
Query: 498 LYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
            + K +  SDV+S+GV + E LS G+K  + ++G  V+        +++GK ++
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRME 233

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 82  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 132
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ NILL      K+ DFG  A+  PE      + + GT  ++APE 
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEV 187
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 58/266 (21%)
Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKGML--PNGTE----VAVKRFKNCSKAG-DANF 361
           K++EI  + + F  E  +G+  +G VYKG L  P   E    VA+K  K+ ++      F
Sbjct: 2   KLKEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF 59
Query: 362 KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF--------GS 413
           +HE  + A ++H N+V L G  T   PL      ++     +G L++ L         GS
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLS-----MIFSYCSHGDLHEFLVMRSPHSDVGS 114
Query: 414 G------MKKLSWPIRLRIALGTARGLAYL--HYGVQPAIIHRDIKASNILLDEAFEAKV 465
                     L  P  + +    A G+ YL  H+     ++H+D+   N+L+ +    K+
Sbjct: 115 TDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKI 169
Query: 466 GDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
            D GL +       +   G + L  R      ++APE  +YGK +  SD++S+GVVL E+
Sbjct: 170 SDLGLFREVYAADYYKLLGNSLLPIR------WMAPEAIMYGKFSIDSDIWSYGVVLWEV 223
Query: 519 L----------SGKKACEIIQGKSVL 534
                      S +   E+I+ + VL
Sbjct: 224 FSYGLQPYCGYSNQDVVEMIRNRQVL 249

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 16/216 (7%)
Query: 325 IIGKGGYGNVYKGMLPN----GTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVAL 379
           I+G+G +G VY+G+  N       VAVK  K +C+      F  E  I+ ++ H ++V L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
            G       +E     I+ +L   G L  H        L     +  +L   + +AYL  
Sbjct: 75  IGI------IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 126
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                 +HRDI   NIL+      K+GDFGL+++  +   +  +     + +++PE   +
Sbjct: 127 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 184
Query: 500 GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
            + T  SDV+ F V + E+LS GK+    ++ K V+
Sbjct: 185 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 220

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           I    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++ 
Sbjct: 1   IDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLS 57
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H  LV L G  T   P+      I+ + + NG L ++L      +      L +      
Sbjct: 58  HEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCE 111
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            + YL        +HRD+ A N L+++    KV DFGL+++  +     +      + + 
Sbjct: 112 AMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 168
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLS 520
            PE  +Y K +  SD+++FGV++ E+ S
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIYS 196

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 104/216 (48%), Gaps = 38/216 (17%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           IGKG +G V++G    G EVAVK F   S   + ++  E EI  +V  +H N++   G+ 
Sbjct: 11  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 63
Query: 384 TATVPLEGH--QRIIVCDLLHNGSLYDHLFG-----SGMKKLSWPIRLRIALGTARGLAY 436
            A     G   Q  +V D   +GSL+D+L        GM KL        AL TA GLA+
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--------ALSTASGLAH 115
Query: 437 LHYGV-----QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP---EGITHLTTRVAGT 488
           LH  +     +PAI HRD+K+ NIL+ +     + D GLA  +    + I        GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 489 LGYVAPEY------ALYGKLTPGSDVYSFGVVLLEL 518
             Y+APE         + +    +D+Y+ G+V  E+
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 38/216 (17%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           IGKG +G V++G    G EVAVK F   S   + ++  E EI  +V  +H N++   G+ 
Sbjct: 12  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 64
Query: 384 TATVPLEGH--QRIIVCDLLHNGSLYDHLFG-----SGMKKLSWPIRLRIALGTARGLAY 436
            A     G   Q  +V D   +GSL+D+L        GM KL        AL TA GLA+
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--------ALSTASGLAH 116
Query: 437 LHYGV-----QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT---TRVAGT 488
           LH  +     +PAI HRD+K+ NIL+ +     + D GLA  +      +        GT
Sbjct: 117 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 176
Query: 489 LGYVAPEY------ALYGKLTPGSDVYSFGVVLLEL 518
             Y+APE         + +    +D+Y+ G+V  E+
Sbjct: 177 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 82  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 132
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ NILL      K+ DFG  A+  PE      + + GT  ++APE 
Sbjct: 133 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEV 187
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKFSLDLASLI 114
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 115 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 326 IGKGGYGNV----YKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +GKG +G+V    Y  +  N G  VAVK+ ++       +F+ E++I+ ++    +V  R
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY---- 436
           G S    P     R+++ + L +G L D L            R R  L  +R L Y    
Sbjct: 75  GVSYG--PGRPELRLVM-EYLPSGCLRDFL-----------QRHRARLDASRLLLYSSQI 120
Query: 437 ---LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT--LGY 491
              + Y      +HRD+ A NIL++     K+ DFGLAK  P        R  G   + +
Sbjct: 121 CKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFW 180
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            APE       +  SDV+SFGVVL EL +
Sbjct: 181 YAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 83  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 133
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHRDIK+ NILL      K+ DFG  A+  PE      + + GT  ++APE 
Sbjct: 134 HSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEV 188
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 189 VTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 16/216 (7%)
Query: 325 IIGKGGYGNVYKGMLPN----GTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVAL 379
           I+G+G +G VY+G+  N       VAVK  K +C+      F  E  I+ ++ H ++V L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
            G       +E     I+ +L   G L  H        L     +  +L   + +AYL  
Sbjct: 91  IGI------IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 142
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                 +HRDI   NIL+      K+GDFGL+++  +   +  +     + +++PE   +
Sbjct: 143 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 200
Query: 500 GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
            + T  SDV+ F V + E+LS GK+    ++ K V+
Sbjct: 201 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 140
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPE-GITHLTTRVAG 487
           A+G+ +L        +HRD+ A N +LDE F  KV DFGLA+  ++ E    H  T    
Sbjct: 141 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 197
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 198 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 101/216 (46%), Gaps = 16/216 (7%)
Query: 325 IIGKGGYGNVYKGMLPN----GTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVAL 379
           I+G+G +G VY+G+  N       VAVK  K +C+      F  E  I+ ++ H ++V L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
            G       +E     I+ +L   G L  H        L     +  +L   + +AYL  
Sbjct: 79  IGI------IEEEPTWIIMELYPYGEL-GHYLERNKNSLKVLTLVLYSLQICKAMAYLE- 130
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                 +HRDI   NIL+      K+GDFGL+++  +   +  +     + +++PE   +
Sbjct: 131 --SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF 188
Query: 500 GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
            + T  SDV+ F V + E+LS GK+    ++ K V+
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI 224

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 38/216 (17%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           IGKG +G V++G    G EVAVK F   S   + ++  E EI  +V  +H N++   G+ 
Sbjct: 17  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 69
Query: 384 TATVPLEGH--QRIIVCDLLHNGSLYDHLFG-----SGMKKLSWPIRLRIALGTARGLAY 436
            A     G   Q  +V D   +GSL+D+L        GM KL        AL TA GLA+
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--------ALSTASGLAH 121
Query: 437 LHYGV-----QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT---TRVAGT 488
           LH  +     +PAI HRD+K+ NIL+ +     + D GLA  +      +        GT
Sbjct: 122 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 181
Query: 489 LGYVAPEY------ALYGKLTPGSDVYSFGVVLLEL 518
             Y+APE         + +    +D+Y+ G+V  E+
Sbjct: 182 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 143
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPE-GITHLTTRVAG 487
           A+G+ +L        +HRD+ A N +LDE F  KV DFGLA+  ++ E    H  T    
Sbjct: 144 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 200
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 142
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPE-GITHLTTRVAG 487
           A+G+ +L        +HRD+ A N +LDE F  KV DFGLA+  ++ E    H  T    
Sbjct: 143 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 147
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPE-GITHLTTRVAG 487
           A+G+ +L        +HRD+ A N +LDE F  KV DFGLA+  ++ E    H  T    
Sbjct: 148 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 204
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 205 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 38/216 (17%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           IGKG +G V++G    G EVAVK F   S   + ++  E EI  +V  +H N++   G+ 
Sbjct: 37  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 89
Query: 384 TATVPLEGH--QRIIVCDLLHNGSLYDHLFG-----SGMKKLSWPIRLRIALGTARGLAY 436
            A     G   Q  +V D   +GSL+D+L        GM KL        AL TA GLA+
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--------ALSTASGLAH 141
Query: 437 LHYGV-----QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT---TRVAGT 488
           LH  +     +PAI HRD+K+ NIL+ +     + D GLA  +      +        GT
Sbjct: 142 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 201
Query: 489 LGYVAPEY------ALYGKLTPGSDVYSFGVVLLEL 518
             Y+APE         + +    +D+Y+ G+V  E+
Sbjct: 202 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/216 (32%), Positives = 104/216 (48%), Gaps = 38/216 (17%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           IGKG +G V++G    G EVAVK F   S   + ++  E EI  +V  +H N++   G+ 
Sbjct: 50  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 102
Query: 384 TATVPLEGH--QRIIVCDLLHNGSLYDHLFG-----SGMKKLSWPIRLRIALGTARGLAY 436
            A     G   Q  +V D   +GSL+D+L        GM KL        AL TA GLA+
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--------ALSTASGLAH 154
Query: 437 LHYGV-----QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP---EGITHLTTRVAGT 488
           LH  +     +PAI HRD+K+ NIL+ +     + D GLA  +    + I        GT
Sbjct: 155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 214
Query: 489 LGYVAPEY------ALYGKLTPGSDVYSFGVVLLEL 518
             Y+APE         + +    +D+Y+ G+V  E+
Sbjct: 215 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 38/216 (17%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYS 383
           IGKG +G V++G    G EVAVK F   S   + ++  E EI  +V  +H N++   G+ 
Sbjct: 14  IGKGRFGEVWRGKW-RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENIL---GFI 66
Query: 384 TATVPLEGH--QRIIVCDLLHNGSLYDHLFG-----SGMKKLSWPIRLRIALGTARGLAY 436
            A     G   Q  +V D   +GSL+D+L        GM KL        AL TA GLA+
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL--------ALSTASGLAH 118
Query: 437 LHYGV-----QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT---TRVAGT 488
           LH  +     +PAI HRD+K+ NIL+ +     + D GLA  +      +        GT
Sbjct: 119 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 178
Query: 489 LGYVAPEY------ALYGKLTPGSDVYSFGVVLLEL 518
             Y+APE         + +    +D+Y+ G+V  E+
Sbjct: 179 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 108/216 (50%), Gaps = 21/216 (9%)
Query: 314 KAATMNFSRENIIGKGGYGNVY---KGMLPN-GTEVAVKRFKNCS-KAGD-ANFKHEVEI 367
           KA   +F    ++G+G +G V+   K   P+ G   A+K  K  + K  D    K E +I
Sbjct: 24  KADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI 83
Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           +A V H  +V L  Y+  T   EG +  ++ D L  G L+  L    M      ++  +A
Sbjct: 84  LADVNHPFVVKLH-YAFQT---EG-KLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA 137
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA- 486
              A GL +LH      II+RD+K  NILLDE    K+ DFGL+K   E I H     + 
Sbjct: 138 -ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSF 190
Query: 487 -GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT+ Y+APE       +  +D +S+GV++ E+L+G
Sbjct: 191 CGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 95/206 (46%), Gaps = 25/206 (12%)
Query: 324 NIIGKGGYGNVY--KGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
            ++G G +  V+  K  L  G   A+K  K      D++ ++E+ ++  +KH N+V L  
Sbjct: 15  EVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM---KKLSWPIRLRIALGTARGLAYLH 438
              +T         +V  L+  G L+D +   G+   K  S  I+  ++      + YLH
Sbjct: 74  IYESTT-----HYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS-----AVKYLH 123
Query: 439 YGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
              +  I+HRD+K  N+L    +E  +  + DFGL+K    GI    +   GT GYVAPE
Sbjct: 124 ---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGYVAPE 177
Query: 496 YALYGKLTPGSDVYSFGVVLLELLSG 521
                  +   D +S GV+   LL G
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 71/249 (28%), Positives = 110/249 (44%), Gaps = 40/249 (16%)
Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAV 347
           P+     ++S+++  K  E+    +   R   +G G +G VY+G +      P+  +VAV
Sbjct: 25  PNYCFAGKTSSISDLK--EVPRKNITLIRG--LGHGAFGEVYEGQVSGMPNDPSPLQVAV 80
Query: 348 KRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL 406
           K      S+  + +F  E  II+   H N+V   G S  ++P     R I+ +L+  G L
Sbjct: 81  KTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP-----RFILLELMAGGDL 135
Query: 407 YDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---D 458
              L       S    L+    L +A   A G  YL    +   IHRDI A N LL    
Sbjct: 136 KSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPG 192
Query: 459 EAFEAKVGDFGLAK-------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSF 511
               AK+GDFG+A+       +   G   L  +      ++ PE  + G  T  +D +SF
Sbjct: 193 PGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK------WMPPEAFMEGIFTSKTDTWSF 246
Query: 512 GVVLLELLS 520
           GV+L E+ S
Sbjct: 247 GVLLWEIFS 255

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 142
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPE-GITHLTTRVAG 487
           A+G+ +L        +HRD+ A N +LDE F  KV DFGLA+  ++ E    H  T    
Sbjct: 143 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 199
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 200 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G +Y  L     +KLS     R A    
Sbjct: 71  RHPNILRLYGYFHDATRV-----YLILEYAPRGEVYKEL-----QKLSKFDEQRTATYIT 120
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 174
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 175 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 108/231 (46%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKFSLDLASLI 114
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +      ++
Sbjct: 115 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASK 171
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 102/213 (47%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 201
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPE-GITHLTTRVAG 487
           A+G+ +L        +HRD+ A N +LDE F  KV DFGLA+  ++ E    H  T    
Sbjct: 202 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 259 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKYSLDLASLI 114
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 115 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 98/206 (47%), Gaps = 17/206 (8%)
Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N+V 
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 379 -LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L  Y      L G +  +V + L  GSL D +  + M +       R  L   + L +L
Sbjct: 83  YLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QALEFL 133
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY 496
           H      +IHR+IK+ NILL      K+ DFG  A+  PE     T  + GT  ++APE 
Sbjct: 134 HSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEV 188
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                  P  D++S G++ +E++ G+
Sbjct: 189 VTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 34/213 (15%)
Query: 325 IIGKGGYGNVYKGML--PNGTEV--AVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVAL 379
           +IG+G +G VY G L   +G ++  AVK     +  G+ + F  E  I+    H N+++L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 380 RG--YSTATVPL-------EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
            G    +   PL        G  R  + +  HN ++ D L G G++              
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKD-LIGFGLQ-------------V 143
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPE-GITHLTTRVAG 487
           A+G+ +L        +HRD+ A N +LDE F  KV DFGLA+   + E    H  T    
Sbjct: 144 AKGMKFL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL 200
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            + ++A E     K T  SDV+SFGV+L EL++
Sbjct: 201 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 8   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 65
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 66  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKYSLDLASLI 116
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 117 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 173
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 174 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 3   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 61  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKYSLDLASLI 111
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 112 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 168
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 169 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 6   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 63
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 64  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKYSLDLASLI 114
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 115 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 171
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 172 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 222

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 22/201 (10%)
Query: 326 IGKGGYGNVYKGMLPNGT-EVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG+G +  VYKG+    T EVA    ++   +K+    FK E E +  ++H N+V  R Y
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIV--RFY 91
Query: 383 STATVPLEGHQRII-VCDLLHNGSLYDHLFGSGMKKL----SWPIRLRIALGTARGLAYL 437
            +    ++G + I+ V +L  +G+L  +L    + K+    SW  ++       +GL +L
Sbjct: 92  DSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQI------LKGLQFL 145
Query: 438 HYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           H    P IIHRD+K  NI +       K+GD GLA             V GT  + APE 
Sbjct: 146 HTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFXAPE- 200
Query: 497 ALYGKLTPGSDVYSFGVVLLE 517
               K     DVY+FG   LE
Sbjct: 201 XYEEKYDESVDVYAFGXCXLE 221

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 9   EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 66
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 67  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKYSLDLASLI 117
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 118 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 174
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 175 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 225

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 27/249 (10%)
Query: 307 RFKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA--------- 356
           ++K  E +  T N F +  ++GKGG+G V    +      A  +   C K          
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRK 226
Query: 357 GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
           G+A   +E +I+  V    +V+L  Y+  T         +V  L++ G L  H++  G  
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSL-AYAYET----KDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
                  +  A     GL  LH   +  I++RD+K  NILLD+    ++ D GLA   PE
Sbjct: 282 GFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS 536
           G T +  RV GT+GY+APE     + T   D ++ G +L E+++G+   +  Q K  +  
Sbjct: 339 GQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ--QRKKKIKR 394
Query: 537 DWAWELVKE 545
           +    LVKE
Sbjct: 395 EEVERLVKE 403

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 34  EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 91
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 92  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKYSLDLASLI 142
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 143 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 199
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 200 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 250

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTELCGT 169
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 170 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY     N   +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY   +  +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFHDSTRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 116 ELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGT 169
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 170 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCS-KAGD-ANFKHEVEI 367
           KA    F    ++G+G +G V+     +G++     A+K  K  + K  D    K E +I
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           +  V H  +V L  Y+  T   EG +  ++ D L  G L+  L    M      ++  +A
Sbjct: 80  LVEVNHPFIVKLH-YAFQT---EG-KLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA 133
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA- 486
              A  L +LH      II+RD+K  NILLDE    K+ DFGL+K   E I H     + 
Sbjct: 134 -ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSF 186
Query: 487 -GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT+ Y+APE       T  +D +SFGV++ E+L+G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 25/209 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASVKHVNLVALRG 381
           +GKG +GNVY         +   +  FK    KAG +   + EVEI + ++H N++ L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL---GTARGLAYLH 438
           Y      +      ++ +    G++Y  L     +KLS     R A      A  L+Y H
Sbjct: 93  YFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH 142
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                 +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GTL Y+ PE  +
Sbjct: 143 ---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPE-MI 195
Query: 499 YGKLTPGS-DVYSFGVVLLELLSGKKACE 526
            G++     D++S GV+  E L GK   E
Sbjct: 196 EGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 92  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 141
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 142 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 195
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 196 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 115/249 (46%), Gaps = 27/249 (10%)
Query: 307 RFKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKA--------- 356
           ++K  E +  T N F +  ++GKGG+G V    +      A  +   C K          
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQV-----RATGKMYACKKLEKKRIKKRK 226
Query: 357 GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK 416
           G+A   +E +I+  V    +V+L  Y+  T         +V  L++ G L  H++  G  
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSL-AYAYET----KDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
                  +  A     GL  LH   +  I++RD+K  NILLD+    ++ D GLA   PE
Sbjct: 282 GFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS 536
           G T +  RV GT+GY+APE     + T   D ++ G +L E+++G+   +  Q K  +  
Sbjct: 339 GQT-IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ--QRKKKIKR 394
Query: 537 DWAWELVKE 545
           +    LVKE
Sbjct: 395 EEVERLVKE 403

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 109/231 (47%), Gaps = 22/231 (9%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKG--MLPN--GTEVAVKRFKNC-SKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G  M P      VA+K  KNC S +    F  E  
Sbjct: 11  EIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68
Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T   P+      I+ +L   G L   L    ++K S  +   I
Sbjct: 69  TMRQFDHPHIVKLIGVITEN-PV-----WIIMELCTLGELRSFL---QVRKYSLDLASLI 119
Query: 427 --ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
             A   +  LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++
Sbjct: 120 LYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASK 176
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE-LLSGKKACEIIQGKSVL 534
               + ++APE   + + T  SDV+ FGV + E L+ G K  + ++   V+
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 227

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 69  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 172
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 173 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 67  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 116
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T ++GT
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP---SSRRTTLSGT 170
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 171 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 67  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 116
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGT 170
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 171 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 71  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 120
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 174
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 175 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 111/236 (47%), Gaps = 25/236 (10%)
Query: 293 EPSLVLESRSSNLAR-FKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF 350
           EP    E  +  LAR FK  E++       +  ++G G +G V+KG+ +P G  + +   
Sbjct: 12  EPLDPSEKANKVLARIFKETELR-------KLKVLGSGVFGTVHKGVWIPEGESIKIPVC 64
Query: 351 KNC--SKAGDANFKHEVE---IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGS 405
                 K+G  +F+   +    I S+ H ++V L G         G    +V   L  GS
Sbjct: 65  IKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------GSSLQLVTQYLPLGS 118
Query: 406 LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV 465
           L DH+       L   + L   +  A+G+ YL    +  ++HR++ A N+LL    + +V
Sbjct: 119 LLDHVR-QHRGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQV 174
Query: 466 GDFGLAKFNPEGITHLTTRVAGT-LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            DFG+A   P     L    A T + ++A E   +GK T  SDV+S+GV + EL++
Sbjct: 175 ADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 169
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 170 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCS-KAGD-ANFKHEVEI 367
           KA    F    ++G+G +G V+     +G++     A+K  K  + K  D    K E +I
Sbjct: 20  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 79
Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           +  V H  +V L  Y+  T   EG +  ++ D L  G L+  L    M      ++  +A
Sbjct: 80  LVEVNHPFIVKLH-YAFQT---EG-KLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA 133
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA- 486
              A  L +LH      II+RD+K  NILLDE    K+ DFGL+K   E I H     + 
Sbjct: 134 -ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSF 186
Query: 487 -GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT+ Y+APE       T  +D +SFGV++ E+L+G
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGT 169
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 170 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 23/218 (10%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 71  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 120
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 174
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE 526
           L Y+ PE           D++S GV+  E L GK   E
Sbjct: 175 LDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 98/216 (45%), Gaps = 19/216 (8%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
                L Y     +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GTL Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDY 172
Query: 492 VAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           + PE  + G++     D++S GV+  E L GK   E
Sbjct: 173 LPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 71  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 120
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGT 174
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 175 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCS-KAGD-ANFKHEVEI 367
           KA    F    ++G+G +G V+     +G++     A+K  K  + K  D    K E +I
Sbjct: 21  KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDI 80
Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           +  V H  +V L  Y+  T   EG +  ++ D L  G L+  L    M      ++  +A
Sbjct: 81  LVEVNHPFIVKLH-YAFQT---EG-KLYLILDFLRGGDLFTRLSKEVMFT-EEDVKFYLA 134
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA- 486
              A  L +LH      II+RD+K  NILLDE    K+ DFGL+K   E I H     + 
Sbjct: 135 -ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSF 187
Query: 487 -GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT+ Y+APE       T  +D +SFGV++ E+L+G
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 102/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY       +  +  ++ +    G++Y  L     +KLS     R A    
Sbjct: 65  RHPNILRLYGYFH-----DATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 114
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 115 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 168
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 169 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 84/312 (26%), Positives = 141/312 (45%), Gaps = 59/312 (18%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 96  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 203
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 204 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 263 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 595 TDVPLSNIKIFL 606
             V L++ + +L
Sbjct: 308 RIVALTSNQEYL 319

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 69  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 172
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 173 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTXLCGT 169
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 170 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 106/230 (46%), Gaps = 35/230 (15%)
Query: 320 FSRENIIGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEI 367
           +++   IG+G YG V   Y  +    T VA+K+         + F+H         E++I
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHV--RKTRVAIKKI--------SPFEHQTYCQRTLREIQI 94
Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           +   +H N++ +R    A+  LE  + + +   L    LY  L     ++LS        
Sbjct: 95  LLRFRHENVIGIRDILRAST-LEAMRDVYIVQDLMETDLYKLL---KSQQLSNDHICYFL 150
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPE-GITHLTTRV 485
               RGL Y+H      ++HRD+K SN+L++   + K+ DFGLA+  +PE   T   T  
Sbjct: 151 YQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEX 207
Query: 486 AGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
             T  Y APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 254

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 99/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 11  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 70
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G +Y  L     +KLS     R A    
Sbjct: 71  RHPNILRLYGYFHDATRV-----YLILEYAPRGEVYKEL-----QKLSKFDEQRTATYIT 120
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 121 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLXGT 174
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 175 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 137/307 (44%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 96  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 203
Query: 482 TTRVAGTLG-----YVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                 T G     ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 204 DXXKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 263 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 595 TDVPLSN 601
             V L++
Sbjct: 308 RIVALTS 314

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 70  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 119
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 120 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 173
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 174 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 29/210 (13%)
Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC--SKAGDANFKHEVE---IIASVKHVNLV 377
            ++G G +G V+KG+ +P G  + +         K+G  +F+   +    I S+ H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLRIALGTA 431
            L G         G    +V   L  GSL DH+       G  +  L+W +++      A
Sbjct: 79  RLLGLCP------GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLL-LNWGVQI------A 125
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT-LG 490
           +G+ YL    +  ++HR++ A N+LL    + +V DFG+A   P     L    A T + 
Sbjct: 126 KGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIK 182
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           ++A E   +GK T  SDV+S+GV + EL++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 81  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 136 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 188
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 189 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 248 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 595 TDVPLSN 601
             V L++
Sbjct: 293 RIVALTS 299

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 93/218 (42%), Gaps = 30/218 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNV----------YKGMLPNGTEVAVKRFKNCSKAGDANFKH 363
           K +  +F     +G G +G V          Y  M     E+ V R K      D     
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV-RLKQVEHTNDERL-- 58
Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
              +++ V H  ++ + G        +  Q  ++ D +  G L+  L  S  ++   P+ 
Sbjct: 59  ---MLSIVTHPFIIRMWGTFQ-----DAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVA 108
Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
              A      L YLH      II+RD+K  NILLD+    K+ DFG AK+ P+    +T 
Sbjct: 109 KFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTY 161
Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            + GT  Y+APE           D +SFG+++ E+L+G
Sbjct: 162 XLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 63  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 112
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +   T + GT
Sbjct: 113 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGT 166
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 167 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 85  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 140 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 192
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 193 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 251
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 252 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 296
Query: 595 TDVPLSN 601
             V L++
Sbjct: 297 RIVALTS 303

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 89  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 144 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 196
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 197 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 255
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 256 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 300
Query: 595 TDVPLSN 601
             V L++
Sbjct: 301 RIVALTS 307

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 107/233 (45%), Gaps = 35/233 (15%)
Query: 325 IIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEI--IASVKHVNLVALRGY 382
           +IG+G YG VYKG L +   VAVK F   S A   NF +E  I  +  ++H N +A    
Sbjct: 20  LIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDN-IARFIV 74
Query: 383 STATVPLEGH-QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
               V  +G  + ++V +   NGSL  +L    +    W    R+A    RGLAYLH  +
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL---SLHTSDWVSSCRLAHSVTRGLAYLHTEL 131
Query: 442 ------QPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------FNPEGITHLTTRVAGT 488
                 +PAI HRD+ + N+L+       + DFGL+          P    +      GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 489 LGYVAPEYALYGKLT--------PGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
           + Y+APE  L G +            D+Y+ G++  E+    +  ++  G+SV
Sbjct: 192 IRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF--MRCTDLFPGESV 241

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 88  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 143 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 195
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 196 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 254
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 255 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 299
Query: 595 TDVPLSN 601
             V L++
Sbjct: 300 RIVALTS 306

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 96  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 203
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 204 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 263 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 595 TDVPLSN 601
             V L++
Sbjct: 308 RIVALTS 314

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 138/307 (44%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 96  IINLLGACTQDGPL-----YVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 151 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 203
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 204 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 262
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                 +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 263 ------KLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 595 TDVPLSN 601
             V L++
Sbjct: 308 RIVALTS 314

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVN 375
           ++  + +IG G    V      P   +VA+KR   + C  + D   K E++ ++   H N
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK-EIQAMSQCHHPN 74
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD---HLFGSGMKK---LSWPIRLRIALG 429
           +V+   Y T+ V  +  +  +V  LL  GS+ D   H+   G  K   L       I   
Sbjct: 75  IVS---YYTSFVVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG--ITHLTTR--V 485
              GL YLH   Q   IHRD+KA NILL E    ++ DFG++ F   G  IT    R   
Sbjct: 130 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 486 AGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSG 521
            GT  ++APE     +     +D++SFG+  +EL +G
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 83/307 (27%), Positives = 139/307 (45%), Gaps = 59/307 (19%)
Query: 326 IGKGGYGNVYKGML-------PNG-TEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V            PN  T+VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--------------SGMKKLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L                +  ++LS  
Sbjct: 137 IINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+     I H+
Sbjct: 192 DLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHI 244
Query: 482 -----TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
                TT     + ++APE AL+ ++ T  SDV+SFGV+L E+ + G      +  + + 
Sbjct: 245 DYYKKTTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL- 302
Query: 535 LSDWAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
                ++L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 303 -----FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 595 TDVPLSN 601
             V L++
Sbjct: 349 RIVALTS 355

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 68  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 117
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 118 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGT 171
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 172 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 325 IIGKGGYGNVYK-GMLPNGTEVAVKRFKNCS-KAGD-ANFKHEVEIIASVKHVNLVALRG 381
           ++GKG +G V K        E AVK     S K  D +    EVE++  + H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL-- 86
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                +  +     IV +L   G L+D +     K+ S     RI      G+ Y+H   
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH--- 138
Query: 442 QPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
           +  I+HRD+K  NILL   ++  + K+ DFGL+    +  T +  R+ GT  Y+APE  L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VL 195
Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
            G      DV+S GV+L  LLSG
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 101/217 (46%), Gaps = 23/217 (10%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVN 375
           ++  + +IG G    V      P   +VA+KR   + C  + D   K E++ ++   H N
Sbjct: 11  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLK-EIQAMSQCHHPN 69
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD---HLFGSGMKK---LSWPIRLRIALG 429
           +V+   Y T+ V  +  +  +V  LL  GS+ D   H+   G  K   L       I   
Sbjct: 70  IVS---YYTSFVVKD--ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 124
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG--ITHLTTR--V 485
              GL YLH   Q   IHRD+KA NILL E    ++ DFG++ F   G  IT    R   
Sbjct: 125 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 181
Query: 486 AGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSG 521
            GT  ++APE     +     +D++SFG+  +EL +G
Sbjct: 182 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 91
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 92  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 141
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 142 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDDLCGT 195
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 196 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 8   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 67
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 68  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 117
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ +FG +   P   +   T + GT
Sbjct: 118 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGT 171
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 172 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 7   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 66
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 67  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 116
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 117 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDTLCGT 170
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 171 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 69  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGT 172
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 173 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 326 IGKGGYGNVYKGMLPN-GTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           +G GG+G V + +  + G +VA+K+ +   S      +  E++I+  + H N+V+ R   
Sbjct: 22  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR--- 78
Query: 384 TATVPLEGHQRIIVCDL-------LHNGSLYDHL--FGSGMKKLSWPIRLRIALGTARGL 434
              VP +G Q++   DL          G L  +L  F +       PIR  ++   +  L
Sbjct: 79  --EVP-DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 134
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            YLH   +  IIHRD+K  NI+L    +    K+ D G AK   +G   L T   GTL Y
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQY 189
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE     K T   D +SFG +  E ++G
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 69  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ +FG +   P   +   T + GT
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGT 172
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 173 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 326 IGKGGYGNVYKGMLPN-GTEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           +G GG+G V + +  + G +VA+K+ +   S      +  E++I+  + H N+V+ R   
Sbjct: 23  LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR--- 79
Query: 384 TATVPLEGHQRIIVCDL-------LHNGSLYDHL--FGSGMKKLSWPIRLRIALGTARGL 434
              VP +G Q++   DL          G L  +L  F +       PIR  ++   +  L
Sbjct: 80  --EVP-DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 135
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            YLH   +  IIHRD+K  NI+L    +    K+ D G AK   +G   L T   GTL Y
Sbjct: 136 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQY 190
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE     K T   D +SFG +  E ++G
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 69  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGT 172
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 173 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGT 169
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 170 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 13/235 (5%)
Query: 295 SLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS 354
           S+  +S + +L    +  ++     F    ++G G YG VYKG      ++A  +  + +
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT 60
Query: 355 KAGDANFKHEVEIIASVKHVNLVALR--GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG 412
              +   K E+ ++    H   +A     +     P    Q  +V +    GS+ D +  
Sbjct: 61  GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN 120
Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
           +    L       I     RGL++LH   Q  +IHRDIK  N+LL E  E K+ DFG++ 
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG------SDVYSFGVVLLELLSG 521
                +    T + GT  ++APE  +     P       SD++S G+  +E+  G
Sbjct: 178 QLDRTVGRRNTFI-GTPYWMAPE-VIACDENPDATYDFKSDLWSLGITAIEMAEG 230

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANF----KHEVEIIASVKHVNLVAL 379
           I+G GG   V+    L +  +VAVK  +    A D +F    + E +  A++ H  +VA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                A  P  G    IV + +   +L D +   G       I +      A     L++
Sbjct: 78  YDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-----IADACQALNF 131
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA--GTLGYVAPEYA 497
             Q  IIHRD+K +NI++      KV DFG+A+   +    +T   A  GT  Y++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
               +   SDVYS G VL E+L+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY       +  +  ++ +    G++Y  L     +KLS     R A    
Sbjct: 66  RHPNILRLYGYFH-----DATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 115
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 116 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGT 169
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 170 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANF----KHEVEIIASVKHVNLVAL 379
           I+G GG   V+    L +  +VAVK  +    A D +F    + E +  A++ H  +VA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                A  P  G    IV + +   +L D +   G       I +      A     L++
Sbjct: 78  YDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-----IADACQALNF 131
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA--GTLGYVAPEYA 497
             Q  IIHRD+K +NI++      KV DFG+A+   +    +T   A  GT  Y++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
               +   SDVYS G VL E+L+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/229 (29%), Positives = 103/229 (44%), Gaps = 26/229 (11%)
Query: 301 RSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF-KNCSKAGD 358
            SS+  + + E+IK     F  +  +G G +  V        G   AVK   K   K  +
Sbjct: 8   ESSSSWKKQAEDIKKI---FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKE 64
Query: 359 ANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM--- 415
           ++ ++E+ ++  +KH N+VAL     +   L      +V  L+  G L+D +   G    
Sbjct: 65  SSIENEIAVLRKIKHENIVALEDIYESPNHL-----YLVMQLVSGGELFDRIVEKGFYTE 119
Query: 416 KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAK 472
           K  S  IR  +       + YLH   +  I+HRD+K  N+L    DE  +  + DFGL+K
Sbjct: 120 KDASTLIRQVL-----DAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK 171
Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
              EG   + +   GT GYVAPE       +   D +S GV+   LL G
Sbjct: 172 M--EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/219 (30%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASV 371
           A  +F     +GKG +GNVY         +   +  FK    KAG +   + EVEI + +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL--- 428
           +H N++ L GY      +      ++ +    G++Y  L     +KLS     R A    
Sbjct: 69  RHPNILRLYGYFHDATRV-----YLILEYAPLGTVYREL-----QKLSKFDEQRTATYIT 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P   +     + GT
Sbjct: 119 ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDDLCGT 172
Query: 489 LGYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGKKACE 526
           L Y+ PE  + G++     D++S GV+  E L GK   E
Sbjct: 173 LDYLPPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           F++   IGKG +G V+KG+     +V   +  +  +A D     + EI    +  +    
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           + Y +    L+G +  I+ + L  GS  D L      +      L+  L   +GL YLH 
Sbjct: 85  KYYGSY---LKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHS 138
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +   IHRDIKA+N+LL E  + K+ DFG+A    +      T V GT  ++APE    
Sbjct: 139 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQ 194
Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
                 +D++S G+  +EL  G+
Sbjct: 195 SAYDSKADIWSLGITAIELAKGE 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 85
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 86  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQI- 136
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 137 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 188
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 189 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 224

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 136/308 (44%), Gaps = 51/308 (16%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 103 IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITH 480
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+  N      
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 481 LTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDW 538
            TT     + ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +     
Sbjct: 215 KTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---- 269
Query: 539 AWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILETDVP 598
             +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+  + 
Sbjct: 270 --KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 599 LSNIKIFL 606
           L+  + +L
Sbjct: 319 LTTNEEYL 326

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANF----KHEVEIIASVKHVNLVAL 379
           I+G GG   V+    L +  +VAVK  +    A D +F    + E +  A++ H  +VA+
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                A  P  G    IV + +   +L D +   G       I +      A     L++
Sbjct: 78  YDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-----IADACQALNF 131
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL--TTRVAGTLGYVAPEYA 497
             Q  IIHRD+K +NIL+      KV DFG+A+   +    +  T  V GT  Y++PE A
Sbjct: 132 SHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQA 191
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
               +   SDVYS G VL E+L+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           IG G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 92
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 93  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 325 IIGKGGYGNVYK-GMLPNGTEVAVKRFKNCS-KAGD-ANFKHEVEIIASVKHVNLVALRG 381
           ++GKG +G V K        E AVK     S K  D +    EVE++  + H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL-- 86
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                +  +     IV +L   G L+D +     K+ S     RI      G+ Y+H   
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH--- 138
Query: 442 QPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
           +  I+HRD+K  NILL   ++  + K+ DFGL+    +  T +  R+ GT  Y+APE  L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VL 195
Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
            G      DV+S GV+L  LLSG
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 76  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 126
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 325 IIGKGGYGNVYK-GMLPNGTEVAVKRFKNCS-KAGD-ANFKHEVEIIASVKHVNLVALRG 381
           ++GKG +G V K        E AVK     S K  D +    EVE++  + H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL-- 86
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                +  +     IV +L   G L+D +     K+ S     RI      G+ Y+H   
Sbjct: 87  ---FEILEDSSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH--- 138
Query: 442 QPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
           +  I+HRD+K  NILL   ++  + K+ DFGL+    +  T +  R+ GT  Y+APE  L
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VL 195
Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
            G      DV+S GV+L  LLSG
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSG 218

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 69
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 70  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQI- 120
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 121 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 104/219 (47%), Gaps = 20/219 (9%)
Query: 324 NIIGKGGYGNVYKGM-LPNGTEV----AVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
            ++G G +G VYKG+ +P+G  V    A+K  + N S   +     E  ++A V    + 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 378 ALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
            L G   T+TV L       V  L+  G L DH+      +L     L   +  A+G++Y
Sbjct: 83  RLLGICLTSTVQL-------VTQLMPYGCLLDHVR-ENRGRLGSQDLLNWCMQIAKGMSY 134
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPE 495
           L       ++HRD+ A N+L+      K+ DFGLA+  + +   +        + ++A E
Sbjct: 135 LE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
             L  + T  SDV+S+GV + EL++ G K  + I  + +
Sbjct: 192 SILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 230

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 136/308 (44%), Gaps = 51/308 (16%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 103 IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITH 480
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+  N      
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXK 214
Query: 481 LTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDW 538
            TT     + ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +     
Sbjct: 215 KTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---- 269
Query: 539 AWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILETDVP 598
             +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+  + 
Sbjct: 270 --KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 599 LSNIKIFL 606
           L+  + +L
Sbjct: 319 LTTNEEYL 326

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 76  NPHVCRLLGICLTSTVQL-------ITQLMPFGXLLDYVREHKDNIGS-QYLLNWCVQI- 126
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 76  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 126
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 6   EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G  +     +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 64  ASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 118
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 119 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 171
Query: 477 GITHLTTRVAGTLG-----YVAPEYALYGKLTPGSDVYSFGVVLLEL 518
            I        G  G     +++PE    G  T  SDV+SFGVVL E+
Sbjct: 172 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 103/227 (45%), Gaps = 34/227 (14%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 15  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G  +     +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 73  ASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR---- 180
Query: 477 GITHLTTRVAGTLG-----YVAPEYALYGKLTPGSDVYSFGVVLLEL 518
            I        G  G     +++PE    G  T  SDV+SFGVVL E+
Sbjct: 181 DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 97/208 (46%), Gaps = 28/208 (13%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKA---GDANFKHEVEIIASVKHVNLVALRG 381
           +G G YG+V     + +G ++AVK+     ++       ++ E+ ++  +KH N++ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 117
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGLA 435
             T    LE    +          L  HL G+ +      +KL+      +     RGL 
Sbjct: 118 VFTPATSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 168
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +    T    T  Y APE
Sbjct: 169 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPE 221
Query: 496 YAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             L +       D++S G ++ ELL+G+
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 79  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 129
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 79  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 129
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 77  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 127
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 128 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 76  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 126
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 324 NIIGKGGYGNVYKGMLP-NGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           + +G G +G V  G     G +VAVK   R K  S       + E++ +   +H +++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
             Y   + P +     +V + +  G L+D++  +G  +L      R+      G+ Y H 
Sbjct: 82  --YQVISTPSDI---FMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHR 134
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
            +   ++HRD+K  N+LLD    AK+ DFGL+    +G         G+  Y APE  + 
Sbjct: 135 HM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRXSCGSPNYAAPE-VIS 188
Query: 500 GKL--TPGSDVYSFGVVLLELLSG 521
           G+L   P  D++S GV+L  LL G
Sbjct: 189 GRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 79  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 129
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 78  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 128
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 83  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 133
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 76
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 77  NPHVCRLLGICLTSTVQL-------IMQLMPFGXLLDYVREHKDNIGS-QYLLNWCVQI- 127
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 128 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 100
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 101 NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 151
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 152 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 203
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 204 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 239

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 78
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 79  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 129
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 217

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR------IALGTARGL 434
              T    LE    +          L  HL G+ +  +    +L       +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 22  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 81
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 82  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 132
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 133 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 184
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 185 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 220

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 140
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 238

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 78  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 128
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 80  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 130
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 131 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 182
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 103 IITLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 213
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 214 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 270 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 92
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 93  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+ + +H
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLAFRH 82
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 138
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 139 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 236

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR------IALGTARGL 434
              T    LE    +          L  HL G+ +  +    +L       +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 85
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 141
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 142 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 198
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 239

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 37  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 86
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 87  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 142
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 143 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 199
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 200 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 240

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 28  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 77
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 78  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 133
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 134 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 190
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 191 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 231

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 140
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 238

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYXQRTLREIKILLRFRH 84
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 140
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 238

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 103 IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 213
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 214 KNTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 270 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 136
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 234

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK---HEVEIIASVKHVN 375
           FS    IG G +G VY    + N   VA+K+     K  +  ++    EV  +  ++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
            +  RG       L  H   +V +    GS  D L     K L       +  G  +GLA
Sbjct: 77  TIQYRG-----CYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLA 129
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH      +IHRD+KA NILL E    K+GDFG A      I        GT  ++APE
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPE 181
Query: 496 YAL---YGKLTPGSDVYSFGVVLLELLSGK 522
             L    G+     DV+S G+  +EL   K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 136
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 234

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 78
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 134
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 135 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 232

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 94
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 95  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRA 197
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 92
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 93  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 86
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 87  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 137
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 138 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 189
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 92
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 93  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 143
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 144 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 195
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 29  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 78
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 79  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 134
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 135 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 191
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 192 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 232

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 72
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 73  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 123
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 124 -----AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 175
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 211

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 94
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 95  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 197
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 326 IGKGGYGNVYKGML--PNG--TEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLV 377
           +G G +G V +G    P+G    VAVK  K    +  +A D +F  EV  + S+ H NL+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNLI 78
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G    T P++     +V +L   GSL D L       L   +  R A+  A G+ YL
Sbjct: 79  RLYGV-VLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYL 131
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPE 495
                   IHRD+ A N+LL      K+GDFGL +  P+   H  +         + APE
Sbjct: 132 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +  SD + FGV L E+ + G++    + G  +L      ++ KEG+ L
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERL 238

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 94
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 95  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRA 197
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 98
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 99  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 150 KYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRA 201
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 136
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 234

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 136
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 234

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 43/261 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 12  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 69
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G     V  +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 70  ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 124
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 125 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 181
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 182 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 233
Query: 530 GKSVLLSDWAWELVKEGKTLD 550
           G   L ++     V EG  LD
Sbjct: 234 G---LSNEQVLRFVMEGGLLD 251

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KCQHLSNDHICYFLYQILRG 140
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 238

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 117/261 (44%), Gaps = 43/261 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 21  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G  +     +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 133
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 191 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 242
Query: 530 GKSVLLSDWAWELVKEGKTLD 550
           G   L ++     V EG  LD
Sbjct: 243 G---LSNEQVLRFVMEGGLLD 260

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK---HEVEIIASVKHVN 375
           FS    IG G +G VY    + N   VA+K+     K  +  ++    EV  +  ++H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
            +  RG       L  H   +V +    GS  D L     K L       +  G  +GLA
Sbjct: 116 TIQYRG-----CYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH      +IHRD+KA NILL E    K+GDFG A      I        GT  ++APE
Sbjct: 169 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPE 220
Query: 496 YAL---YGKLTPGSDVYSFGVVLLELLSGK 522
             L    G+     DV+S G+  +EL   K
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERK 250

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEV-AVKRFKNCSKAGDANFKHEVEIIAS 370
           +IK    +F    ++GKG +G V+        +  A+K  K            +V ++  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-----------DVVLMDD 60
Query: 371 VKHVNLVALRGYSTA-TVPLEGH---------QRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
                +V  R  S A   P   H             V + L+ G L  H+       LS 
Sbjct: 61  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS- 119
Query: 421 PIRLRIALGTAR---GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG 477
               R     A    GL +LH      I++RD+K  NILLD+    K+ DFG+ K N  G
Sbjct: 120 ----RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 172
Query: 478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
               T    GT  Y+APE  L  K     D +SFGV+L E+L G+
Sbjct: 173 DAK-TNEFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 94
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 95  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 146 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRA 197
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 89
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 90  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 192
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 103 IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 213
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 214 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 270 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 98/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+ + +H
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLAFRH 82
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 138
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 139 LKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 236

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 89
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 90  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRA 192
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 30/209 (14%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +    T    T  Y AP
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGXVATRWYRAP 191
Query: 495 EYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           E  L +       D++S G ++ ELL+G+
Sbjct: 192 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 117/261 (44%), Gaps = 43/261 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 14  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G  +     +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 72  ASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 184 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 235
Query: 530 GKSVLLSDWAWELVKEGKTLD 550
           G   L ++     V EG  LD
Sbjct: 236 G---LSNEQVLRFVMEGGLLD 253

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 103 IIHLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 213
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 214 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 270 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 92/210 (43%), Gaps = 25/210 (11%)
Query: 325 IIGKGGYGNVYKGMLPNGTEVAV-KRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           ++GKG +G   K       EV V K      +     F  EV+++  ++H N++   G  
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV- 75
Query: 384 TATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                L   +R+  + + +  G+L   +  S   +  W  R+  A   A G+AYLH    
Sbjct: 76  -----LYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLH---S 126
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKF------NPEGITHLTT-------RVAGTL 489
             IIHRD+ + N L+ E     V DFGLA+        PEG+  L          V G  
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELL 519
            ++APE           DV+SFG+VL E++
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 89
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 90  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 192
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 93
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 94  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 145 KYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRA 196
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 94/210 (44%), Gaps = 21/210 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDAN-----FKHEVEIIASVKHVNLVALR 380
           IGKG +G V      +  ++   ++ N  K  + N     FK E++I+  ++H  LV L 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK-ELQIMQGLEHPFLVNL- 80
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
            YS      +     +V DLL  G L  HL  +   K        + L     +  L Y 
Sbjct: 81  WYSFQ----DEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-----TVKLFICELVMALDYL 131
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
               IIHRD+K  NILLDE     + DF +A   P   T +TT +AGT  Y+APE     
Sbjct: 132 QNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT-MAGTKPYMAPEMFSSR 189
Query: 501 K---LTPGSDVYSFGVVLLELLSGKKACEI 527
           K    +   D +S GV   ELL G++   I
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHI 219

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 116/261 (44%), Gaps = 43/261 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 21  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 78
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G  +     +G   +++ +L+  G L  +L        + P+  
Sbjct: 79  ASVMKEFNCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 191 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 242
Query: 530 GKSVLLSDWAWELVKEGKTLD 550
           G   L ++     V EG  LD
Sbjct: 243 G---LSNEQVLRFVMEGGLLD 260

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 43/261 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 43  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 100
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G     V  +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 101 ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 155
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 156 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 212
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 213 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 264
Query: 530 GKSVLLSDWAWELVKEGKTLD 550
           G   L ++     V EG  LD
Sbjct: 265 G---LSNEQVLRFVMEGGLLD 282

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 93
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 94  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 144
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 145 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 196
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 14  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 71
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G     V  +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 72  ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 126
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 127 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 183
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+
Sbjct: 184 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 84
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 85  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 136 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 187
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 99
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 100 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 151 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 202
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 97
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 98  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 148
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 149 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 200
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 99
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 100 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 151 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 202
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 82
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 83  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 138
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 139 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 195
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 196 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 236

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 89
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 90  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 140
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 141 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 192
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 324 NIIGKGGYGNVYKGMLPNGTE-VAVKRF-KNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           +++G G +  V         + VA+K   K   +  + + ++E+ ++  +KH N+VAL  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
              +     GH  +I+  L+  G L+D +   G        RL   +  A  + YLH   
Sbjct: 84  IYESG----GHLYLIM-QLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLH--- 133
Query: 442 QPAIIHRDIKASNIL---LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              I+HRD+K  N+L   LDE  +  + DFGL+K    G   + +   GT GYVAPE   
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLA 191
Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 99
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 100 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 150
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 151 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 202
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 117/261 (44%), Gaps = 43/261 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGDA-NFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 15  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 72
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G     V  +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 73  ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 127
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 128 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 184
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 185 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 236
Query: 530 GKSVLLSDWAWELVKEGKTLD 550
           G   L ++     V EG  LD
Sbjct: 237 G---LSNEQVLRFVMEGGLLD 254

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 84
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 85  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 135
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 136 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 187
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 324 NIIGKGGYGNVYKGMLPNGTE-VAVKRF-KNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           +++G G +  V         + VA+K   K   +  + + ++E+ ++  +KH N+VAL  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
              +     GH  +I+  L+  G L+D +   G        RL   +  A  + YLH   
Sbjct: 84  IYESG----GHLYLIM-QLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLH--- 133
Query: 442 QPAIIHRDIKASNIL---LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              I+HRD+K  N+L   LDE  +  + DFGL+K    G   + +   GT GYVAPE   
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLA 191
Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)
Query: 324 NIIGKGGYGNVYKGMLPNGTE-VAVKRF-KNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           +++G G +  V         + VA+K   K   +  + + ++E+ ++  +KH N+VAL  
Sbjct: 24  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
              +     GH  +I+  L+  G L+D +   G        RL   +  A  + YLH   
Sbjct: 84  IYESG----GHLYLIM-QLVSGGELFDRIVEKGFYTERDASRLIFQVLDA--VKYLH--- 133
Query: 442 QPAIIHRDIKASNIL---LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              I+HRD+K  N+L   LDE  +  + DFGL+K    G   + +   GT GYVAPE   
Sbjct: 134 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGYVAPEVLA 191
Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 315 AATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK-HEVEIIASVK 372
           +++  F +   +G G Y  VYKG+    G  VA+K  K  S+ G  +    E+ ++  +K
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNG---SLYDHLFGSGMKKLSWPIRLRIALG 429
           H N+V L       V    ++  +V + + N     +     G+  + L   +       
Sbjct: 62  HENIVRL-----YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQ 116
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
             +GLA+ H   +  I+HRD+K  N+L+++  + K+GDFGLA+     +   ++ V  TL
Sbjct: 117 LLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TL 172
Query: 490 GYVAPEYALYGKLTPGS-DVYSFGVVLLELLSGK 522
            Y AP+  +  +    S D++S G +L E+++GK
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 98
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 99  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 149
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 150 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 201
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 83
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 84  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 186
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRF-KNCSKAGDANFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK   ++ S      F +E  ++
Sbjct: 15  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 74
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 75  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
              +++A   A G+AYL+       +HRD+ A N ++   F  K+GDFG+ +     I  
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXE 182
Query: 481 LTTRVAGTLG-----YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                 G  G     ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 38/229 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGDA-NFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 8   EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G     V  +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 66  ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 177
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+
Sbjct: 178 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 116/261 (44%), Gaps = 43/261 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 11  EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 68
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G     V  +G   +++ +L+  G L  +L        + P+  
Sbjct: 69  ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+ +   A +  Q
Sbjct: 181 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEIAT--LAEQPYQ 232
Query: 530 GKSVLLSDWAWELVKEGKTLD 550
           G   L ++     V EG  LD
Sbjct: 233 G---LSNEQVLRFVMEGGLLD 250

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKA---GDANFKHEVEIIASVKHVNLVALRG 381
           +G G YG+V        G  VAVK+     ++       ++ E+ ++  +KH N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGLA 435
             T    LE    +          L  HL G+ +      +KL+      +     RGL 
Sbjct: 95  VFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +    T    T  Y APE
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPE 198
Query: 496 YAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             L +       D++S G ++ ELL+G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 37/225 (16%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRF-KNCSKAGDANFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK   ++ S      F +E  ++
Sbjct: 12  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 71
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 72  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 126
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
              +++A   A G+AYL+       +HRD+ A N ++   F  K+GDFG+ +     I  
Sbjct: 127 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXE 179
Query: 481 LTTRVAGTLG-----YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                 G  G     ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 180 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 28/208 (13%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKA---GDANFKHEVEIIASVKHVNLVALRG 381
           +G G YG+V        G  VAVK+     ++       ++ E+ ++  +KH N++ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 94
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGLA 435
             T    LE    +          L  HL G+ +      +KL+      +     RGL 
Sbjct: 95  VFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 145
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +    T    T  Y APE
Sbjct: 146 YIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYRAPE 198
Query: 496 YAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             L +       D++S G ++ ELL+G+
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 83
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR------IALGTARGL 434
              T    LE    +          L  HL G+ +  +    +L       +     RGL
Sbjct: 84  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 186
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TLGY 491
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+       H    +AG   T  Y
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWY 188
Query: 492 VAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L +       D++S G ++ ELL+G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 326 IGKGGYGNVYKGML--PNG--TEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLV 377
           +G G +G V +G    P+G    VAVK  K    +  +A D +F  EV  + S+ H NL+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNLI 74
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G    T P++     +V +L   GSL D L       L   +  R A+  A G+ YL
Sbjct: 75  RLYGV-VLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYL 127
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPE 495
                   IHRD+ A N+LL      K+GDFGL +  P+   H  +         + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +  SD + FGV L E+ + G++    + G  +L      ++ KEG+ L
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERL 234

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 90  IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 144
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 145 DLVSCTYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLAR-DINNIDYY 200
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 201 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 256
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 257 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 301

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 83
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 84  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 186
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 102/225 (45%), Gaps = 37/225 (16%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGDA-NFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK     +   +   F +E  ++
Sbjct: 15  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 74
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 75  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
              +++A   A G+AYL+       +HRD+ A N ++   F  K+GDFG+ +     I  
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXE 182
Query: 481 LTTRVAGTLG-----YVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                 G  G     ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 183 TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 85
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 86  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 136
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 137 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 188
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TLGY 491
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+       H    +AG   T  Y
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWY 188
Query: 492 VAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L +       D++S G ++ ELL+G+
Sbjct: 189 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 326 IGKGGYGNVYKGML--PNG--TEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLV 377
           +G G +G V +G    P+G    VAVK  K    +  +A D +F  EV  + S+ H NL+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNLI 74
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G    T P++     +V +L   GSL D L       L   +  R A+  A G+ YL
Sbjct: 75  RLYGV-VLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYL 127
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPE 495
                   IHRD+ A N+LL      K+GDFGL +  P+   H  +         + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +  SD + FGV L E+ + G++    + G  +L      ++ KEG+ L
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERL 234

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 88
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 89  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 144
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 145 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 201
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 202 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 242

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 80
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 81  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 136
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 137 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 193
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 194 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 234

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+++         + F+H         E++I+   +H
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIRKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 140
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 238

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANF----KHEVEIIASVKHVNLVAL 379
           I+G GG   V+    L    +VAVK  +    A D +F    + E +  A++ H  +VA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                A  P  G    IV + +   +L D +   G       I +      A     L++
Sbjct: 78  YATGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-----IADACQALNF 131
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA--GTLGYVAPEYA 497
             Q  IIHRD+K +NI++      KV DFG+A+   +    +T   A  GT  Y++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
               +   SDVYS G VL E+L+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           ++GKG YG VY G  L N   +A+K               E+ +   +KH N+V   G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW-PIR---LRIALGTAR---GLAY 436
           +    ++     I  + +  GSL      S + +  W P++     I   T +   GL Y
Sbjct: 89  SENGFIK-----IFMEQVPGGSL------SALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137
Query: 437 LHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           LH      I+HRDIK  N+L++  +   K+ DFG +K    GI   T    GTL Y+APE
Sbjct: 138 LH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPE 193
Query: 496 YALYGKLTPG--SDVYSFGVVLLELLSGK 522
               G    G  +D++S G  ++E+ +GK
Sbjct: 194 IIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 326 IGKGGYGNVYKGML--PNG--TEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLV 377
           +G G +G V +G    P+G    VAVK  K    +  +A D +F  EV  + S+ H NL+
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNLI 74
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G    T P++     +V +L   GSL D L       L   +  R A+  A G+ YL
Sbjct: 75  RLYGV-VLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYL 127
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPE 495
                   IHRD+ A N+LL      K+GDFGL +  P+   H  +         + APE
Sbjct: 128 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +  SD + FGV L E+ + G++    + G  +L      ++ KEG+ L
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERL 234

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 110
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 111 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 162 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 213
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 107
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 108 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 159 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 210
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 326 IGKGGYGNVYKGML--PNG--TEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLV 377
           +G G +G V +G    P+G    VAVK  K    +  +A D +F  EV  + S+ H NL+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNLI 84
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G    T P++     +V +L   GSL D L       L   +  R A+  A G+ YL
Sbjct: 85  RLYGV-VLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYL 137
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPE 495
                   IHRD+ A N+LL      K+GDFGL +  P+   H  +         + APE
Sbjct: 138 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +  SD + FGV L E+ + G++    + G  +L      ++ KEG+ L
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERL 244

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 326 IGKGGYGNVYKGML--PNG--TEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLV 377
           +G G +G V +G    P+G    VAVK  K    +  +A D +F  EV  + S+ H NL+
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNLI 78
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G    T P++     +V +L   GSL D L       L   +  R A+  A G+ YL
Sbjct: 79  RLYGV-VLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYL 131
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPE 495
                   IHRD+ A N+LL      K+GDFGL +  P+   H  +         + APE
Sbjct: 132 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +  SD + FGV L E+ + G++    + G  +L      ++ KEG+ L
Sbjct: 189 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERL 238

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/235 (30%), Positives = 107/235 (45%), Gaps = 27/235 (11%)
Query: 326 IGKGGYGNVYKGML--PNG--TEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLV 377
           +G G +G V +G    P+G    VAVK  K    +  +A D +F  EV  + S+ H NL+
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREVNAMHSLDHRNLI 84
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G    T P++     +V +L   GSL D L       L   +  R A+  A G+ YL
Sbjct: 85  RLYGV-VLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVAEGMGYL 137
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPE 495
                   IHRD+ A N+LL      K+GDFGL +  P+   H  +         + APE
Sbjct: 138 E---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194
Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +  SD + FGV L E+ + G++    + G  +L      ++ KEG+ L
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH-----KIDKEGERL 244

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 97/224 (43%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 100
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 101 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 156
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y
Sbjct: 157 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 213
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 214 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 254

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 106
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 107 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 158 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 209
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYALYG-KLTPGSDVYSFGVVLLELLSGK 522
           PE  L         D++S G ++ ELL+G+
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 36/256 (14%)
Query: 279 KKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM 338
           K++  R+++  +  EP L     + N A  +I         F +  ++G G +G VYKG+
Sbjct: 15  KRTLRRLLQERELVEP-LTPSGEAPNQALLRI----LKETEFKKIKVLGSGAFGTVYKGL 69
Query: 339 -LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYS-TATVPLEG 391
            +P G +V    A+   +   S   +     E  ++ASV + ++  L G   T+TV L  
Sbjct: 70  WIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL-- 127
Query: 392 HQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAI 445
                +  L+  G L D++       GS    L+W +++      A+G+ YL       +
Sbjct: 128 -----ITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQI------AKGMNYLE---DRRL 172
Query: 446 IHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGKLTP 504
           +HRD+ A N+L+      K+ DFGLAK    E   +        + ++A E  L+   T 
Sbjct: 173 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTH 232
Query: 505 GSDVYSFGVVLLELLS 520
            SDV+S+GV + EL++
Sbjct: 233 QSDVWSYGVTVWELMT 248

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 83
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 84  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 134
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TLGY 491
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+       H    +AG   T  Y
Sbjct: 135 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMAGFVATRWY 184
Query: 492 VAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L +       D++S G ++ ELL+G+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 103 IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    ++ DFGLA+ +   I + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLAR-DINNIDYY 213
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 214 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 270 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 107
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 108 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 159 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 210
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 92  IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 146
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 147 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 202
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 203 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 258
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 259 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 303

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANF----KHEVEIIASVKHVNLVAL 379
           I+G GG   V+    L    +VAVK  +    A D +F    + E +  A++ H  +VA+
Sbjct: 19  ILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                A  P  G    IV + +   +L D +   G       I +      A     L++
Sbjct: 78  YDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-----IADACQALNF 131
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA--GTLGYVAPEYA 497
             Q  IIHRD+K +NI++      KV DFG+A+   +    +T   A  GT  Y++PE A
Sbjct: 132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
               +   SDVYS G VL E+L+G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 106
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 107 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 157
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +T ++ TR      Y A
Sbjct: 158 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRA 209
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 80/174 (45%), Gaps = 15/174 (8%)
Query: 351 KNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL 410
           K   +  + + ++E+ ++  +KH N+VAL     +     G    ++  L+  G L+D +
Sbjct: 53  KKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-----GGHLYLIMQLVSGGELFDRI 107
Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL---LDEAFEAKVGD 467
              G        RL   +  A  + YLH      I+HRD+K  N+L   LDE  +  + D
Sbjct: 108 VEKGFYTERDASRLIFQVLDA--VKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISD 162
Query: 468 FGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           FGL+K    G   + +   GT GYVAPE       +   D +S GV+   LL G
Sbjct: 163 FGLSKMEDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 26/209 (12%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           ++GKG YG VY G  L N   +A+K               E+ +   +KH N+V   G  
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW-PIR---LRIALGTAR---GLAY 436
           +    ++     I  + +  GSL      S + +  W P++     I   T +   GL Y
Sbjct: 75  SENGFIK-----IFMEQVPGGSL------SALLRSKWGPLKDNEQTIGFYTKQILEGLKY 123
Query: 437 LHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           LH      I+HRDIK  N+L++  +   K+ DFG +K    GI   T    GTL Y+APE
Sbjct: 124 LH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMAPE 179
Query: 496 YALYGKLTPG--SDVYSFGVVLLELLSGK 522
               G    G  +D++S G  ++E+ +GK
Sbjct: 180 IIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 131/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 95  IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 149
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 150 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 205
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 206 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 261
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 262 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 306

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ D+GLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 92/225 (40%), Gaps = 34/225 (15%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEV-AVKRFKNCSKAGDANFKHEVEIIAS 370
           +IK    +F    ++GKG +G V+        +  A+K  K            +V ++  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKK-----------DVVLMDD 59
Query: 371 VKHVNLVALRGYSTA-TVPLEGH---------QRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
                +V  R  S A   P   H             V + L+ G L  H+       LS 
Sbjct: 60  DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS- 118
Query: 421 PIRLRIALGTAR---GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG 477
               R     A    GL +LH      I++RD+K  NILLD+    K+ DFG+ K N  G
Sbjct: 119 ----RATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171
Query: 478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
               T    GT  Y+APE  L  K     D +SFGV+L E+L G+
Sbjct: 172 DAK-TNXFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 132/297 (44%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++ +    G+L ++L      GM+           ++++ 
Sbjct: 149 IINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 204 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 259
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 260 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---- 314
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
             ++L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 315 --FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 360

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 97/230 (42%), Gaps = 47/230 (20%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 51  IGEGAYGMVCSAYDNV--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 100
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR------IA 427
            N++ +     A             + + +  L  HL G+ + KL     L         
Sbjct: 101 ENIIGINDIIRAPT----------IEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFL 150
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRV 485
               RGL Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T  
Sbjct: 151 YQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 486 AGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
             T  Y APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 254

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 79
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 80  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQI- 130
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFG AK    E   +    
Sbjct: 131 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 182
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 218

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 31/222 (13%)
Query: 319 NFSRENI-----IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK 372
           +F+ E++     IG+G YG+V K +  P+G  +AVKR ++       + K + +++  + 
Sbjct: 18  DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST-----VDEKEQKQLLMDLD 72
Query: 373 HVNLVALRGYSTATV-----PLEGHQRIIVCDLLHNGSL---YDHLFGSGMKKLSWPIRL 424
               V +R      +      L       +C  L + S    Y +++      +   I  
Sbjct: 73  ----VVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILG 128
Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
           +I L T + L +L   ++  IIHRDIK SNILLD +   K+ DFG++    + I    TR
Sbjct: 129 KITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TR 184
Query: 485 VAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSGK 522
            AG   Y+APE         G    SDV+S G+ L EL +G+
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR------IALGTARGL 434
              T    LE    +          L  HL G+ +  +    +L       +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGL +   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++  G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 76  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGSQYL-LNWCVQI- 126
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 78  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 128
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFG AK    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 76  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 126
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFG AK    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 178
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++      G+L ++L      GM+           ++++ 
Sbjct: 103 IINLLGACTQDGPL-----YVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 213
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 214 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 270 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 130/297 (43%), Gaps = 53/297 (17%)
Query: 326 IGKGGYGNVY--------KGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASV-KHVN 375
           +G+G +G V         K        VAVK  K+ +   D ++   E+E++  + KH N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG---SGMK-----------KLSWP 421
           ++ L G  T   PL      ++      G+L ++L      GM+           ++++ 
Sbjct: 103 IINLLGACTQDGPL-----YVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 157
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
             +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+ +   I + 
Sbjct: 158 DLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR-DINNIDYY 213
Query: 482 TTRVAGTL--GYVAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD 537
                G L   ++APE AL+ ++ T  SDV+SFGV++ E+ + G      I  + +    
Sbjct: 214 KKTTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--- 269
Query: 538 WAWELVKEGKTLDVIXXXXXXXXXXXXXXQYVLTAAICAHPILQARPTMDQIVKILE 594
              +L+KEG  +D                +  +    C H +   RPT  Q+V+ L+
Sbjct: 270 ---KLLKEGHRMD---------KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 314

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 78  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 128
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFG AK    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 29/237 (12%)
Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN--GTE--VAVKR 349
           PS   +  S+NL R K+        +F+   ++GKG +G V   ML +  GTE   A+K 
Sbjct: 2   PSEDRKQPSNNLDRVKL-------TDFNFLMVLGKGSFGKV---MLADRKGTEELYAIKI 51
Query: 350 FKNCSKAGDANFK---HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL 406
            K      D + +    E  ++A +     +        TV     +   V + ++ G L
Sbjct: 52  LKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTV----DRLYFVMEYVNGGDL 107
Query: 407 YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
             H+   G  K   P  +  A   + GL +LH   +  II+RD+K  N++LD     K+ 
Sbjct: 108 MYHIQQVG--KFKEPQAVFYAAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIA 162
Query: 467 DFGLAKFN-PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           DFG+ K +  +G+T  T    GT  Y+APE   Y       D +++GV+L E+L+G+
Sbjct: 163 DFGMCKEHMMDGVT--TREFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++  G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 83  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 133
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 83  NPHVCRLLGICLTSTVQL-------ITQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 133
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFG AK    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 185
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 103/229 (44%), Gaps = 38/229 (16%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHE 364
           E+    +  SRE  +G+G +G VY+G+          T VA+K     +   +   F +E
Sbjct: 8   EVAREKITMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-- 422
             ++      ++V L G     V  +G   +++ +L+  G L  +L     +  + P+  
Sbjct: 66  ASVMKEFNCHHVVRLLG-----VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLA 120
Query: 423 ------RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---- 472
                  +++A   A G+AYL+       +HRD+ A N  + E F  K+GDFG+ +    
Sbjct: 121 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYE 177
Query: 473 ---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
              +   G   L  R      +++PE    G  T  SDV+SFGVVL E+
Sbjct: 178 TDYYRKGGKGLLPVR------WMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 95/205 (46%), Gaps = 14/205 (6%)
Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANF----KHEVEIIASVKHVNLVAL 379
           I+G GG   V+    L    +VAVK  +    A D +F    + E +  A++ H  +VA+
Sbjct: 36  ILGFGGMSEVHLARDLRLHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAALNHPAIVAV 94
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                A  P  G    IV + +   +L D +   G       I +      A     L++
Sbjct: 95  YDTGEAETP-AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEV-----IADACQALNF 148
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA--GTLGYVAPEYA 497
             Q  IIHRD+K +NI++      KV DFG+A+   +    +T   A  GT  Y++PE A
Sbjct: 149 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 208
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
               +   SDVYS G VL E+L+G+
Sbjct: 209 RGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++  G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 82
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 83  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 133
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFGLAK    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 221

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 41/227 (18%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRF-KNCSKAGDANFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK   ++ S      F +E  ++
Sbjct: 15  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 74
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 75  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------F 473
              +++A   A G+AYL+       +HRD+ A N ++   F  K+GDFG+ +       +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYY 186
Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              G   L  R      ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 187 RKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 35  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 84
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 140
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H         T  Y
Sbjct: 141 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 197
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 238

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 96/224 (42%), Gaps = 35/224 (15%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNCSKAGDANFKH---------EVEIIASVKH 373
           IG+G YG V   Y  +  N   VA+K+         + F+H         E++I+   +H
Sbjct: 36  IGEGAYGMVCSAYDNL--NKVRVAIKKI--------SPFEHQTYCQRTLREIKILLRFRH 85
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ +     A    +     IV DL+    LY  L     + LS            RG
Sbjct: 86  ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLL---KTQHLSNDHICYFLYQILRG 141
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGY 491
           L Y+H      ++HRD+K SN+LL+   + K+ DFGLA+       H         T  Y
Sbjct: 142 LKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWY 198
Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            APE  L  K  T   D++S G +L E+LS +    I  GK  L
Sbjct: 199 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP---IFPGKHYL 239

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           F++ + IGKG +G VYKG+  +  EV   +  +  +A D     + EI    +  +    
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           R + +    L+  +  I+ + L  GS  D L    +++      LR  L   +GL YLH 
Sbjct: 81  RYFGSY---LKSTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL---KGLDYLHS 134
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYAL 498
             +   IHRDIKA+N+LL E  + K+ DFG+A +     I        GT  ++APE   
Sbjct: 135 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAPEVIK 189
Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
                  +D++S G+  +EL  G+
Sbjct: 190 QSAYDFKADIWSLGITAIELAKGE 213

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 31/216 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEV----AVKRFKNC-SKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+ +P G +V    A+K  +   S   +     E  ++ASV 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 77
Query: 373 HVNLVALRGYS-TATVPLEGHQRIIVCDLLHNGSLYDHL------FGSGMKKLSWPIRLR 425
           + ++  L G   T+TV L       +  L+  G L D++       GS    L+W +++ 
Sbjct: 78  NPHVCRLLGICLTSTVQL-------IMQLMPFGCLLDYVREHKDNIGS-QYLLNWCVQI- 128
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTR 484
                A+G+ YL       ++HRD+ A N+L+      K+ DFG AK    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
               + ++A E  L+   T  SDV+S+GV + EL++
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 216

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 25/209 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASVKHVNLVALRG 381
           +GKG +GNVY         +   +  FK    KAG +   + EVEI + ++H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL---GTARGLAYLH 438
           Y      +      ++ +    G++Y  L     +KLS     R A      A  L+Y H
Sbjct: 80  YFHDATRV-----YLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALSYCH 129
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                 +IHRDIK  N+LL    E K+ DFG +   P   +   T + GTL Y+ PE  +
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPE-MI 182
Query: 499 YGKLTPGS-DVYSFGVVLLELLSGKKACE 526
            G++     D++S GV+  E L G    E
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 104/227 (45%), Gaps = 41/227 (18%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRF-KNCSKAGDANFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK   ++ S      F +E  ++
Sbjct: 15  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 74
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 75  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------F 473
              +++A   A G+AYL+       +HRD+ A N ++   F  K+GDFG+ +       +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 186
Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              G   L  R      ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 187 RKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 110
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 111 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 161
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+  + E   ++ TR      Y A
Sbjct: 162 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRA 213
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 79/163 (48%), Gaps = 12/163 (7%)
Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
           F+ EV   + + H N+V++       V  E     +V + +   +L +++   G      
Sbjct: 58  FEREVHNSSQLSHQNIVSM-----IDVDEEDDCYYLVMEYIEGPTLSEYIESHG------ 106
Query: 421 PIRLRIALG-TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
           P+ +  A+  T + L  + +     I+HRDIK  NIL+D     K+ DFG+AK   E   
Sbjct: 107 PLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166
Query: 480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
             T  V GT+ Y +PE A        +D+YS G+VL E+L G+
Sbjct: 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 103/227 (45%), Gaps = 41/227 (18%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGDA-NFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK     +   +   F +E  ++
Sbjct: 14  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 73
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 74  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 128
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------F 473
              +++A   A G+AYL+       +HRD+ A N ++   F  K+GDFG+ +       +
Sbjct: 129 QEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 185
Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              G   L  R      ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 186 RKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           F++   IGKG +G V+KG+     +V   +  +  +A D     + EI    +  +    
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           + Y +    L+  +  I+ + L  GS  D L    + +      LR  L   +GL YLH 
Sbjct: 89  KYYGSY---LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHS 142
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +   IHRDIKA+N+LL E  E K+ DFG+A    +      T V GT  ++APE    
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 198
Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
                 +D++S G+  +EL  G+
Sbjct: 199 SAYDSKADIWSLGITAIELARGE 221

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 10/203 (4%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           F++   IGKG +G V+KG+     +V   +  +  +A D     + EI    +  +    
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           + Y +    L+  +  I+ + L  GS  D L    + +      LR  L   +GL YLH 
Sbjct: 69  KYYGSY---LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHS 122
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             +   IHRDIKA+N+LL E  E K+ DFG+A    +      T V GT  ++APE    
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 178
Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
                 +D++S G+  +EL  G+
Sbjct: 179 SAYDSKADIWSLGITAIELARGE 201

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEV--AVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           ++ EN IG+G +G V K  +  GT +  A K+           FK E+EI+ S+ H N++
Sbjct: 28  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 378 ALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
            L  Y T     E +  I +V +L   G L++ +    + + S     RI       +AY
Sbjct: 87  RL--YET----FEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSAVAY 138
Query: 437 LHYGVQPAIIHRDIKASNIL-LDEAFEA--KVGDFGL-AKFNPEGITHLTTRVAGTLGYV 492
            H   +  + HRD+K  N L L ++ ++  K+ DFGL A+F P  +  + T+V GT  YV
Sbjct: 139 CH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYV 192
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +P+  L G   P  D +S GV++  LL G
Sbjct: 193 SPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 23/209 (11%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEV--AVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           ++ EN IG+G +G V K  +  GT +  A K+           FK E+EI+ S+ H N++
Sbjct: 11  YTLENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 378 ALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
            L  Y T     E +  I +V +L   G L++ +    + + S     RI       +AY
Sbjct: 70  RL--YET----FEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSAVAY 121
Query: 437 LHYGVQPAIIHRDIKASNIL-LDEAFEA--KVGDFGL-AKFNPEGITHLTTRVAGTLGYV 492
            H   +  + HRD+K  N L L ++ ++  K+ DFGL A+F P  +  + T+V GT  YV
Sbjct: 122 CH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM--MRTKV-GTPYYV 175
Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +P+  L G   P  D +S GV++  LL G
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 91/208 (43%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+  +  IGKG +  V     +  G EVAVK          +  K   EV I+  + H N
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           +V L         L      +V +    G ++D+L   G MK+     + R  +   +  
Sbjct: 76  IVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 128
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N   + +      G+  Y AP
Sbjct: 129 -YCH---QKYIVHRDLKAENLLLDGDMNIKIADFGFS--NEFTVGNKLDTFCGSPPYAAP 182
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 30/209 (14%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 107
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 108 DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 158
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   + +         T  Y AP
Sbjct: 159 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----XGXVATRWYRAP 211
Query: 495 EYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           E  L +       D++S G ++ ELL+G+
Sbjct: 212 EIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 20/241 (8%)
Query: 293 EPSLVLESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEV----AV 347
           +PS  ++ +S+ L       +   TM  + R   +GKGG+   Y+    +  EV     V
Sbjct: 16  KPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV 75
Query: 348 KRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSL 406
            +              E+ I  S+ + ++V   G+       E    + +V ++    SL
Sbjct: 76  PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF------FEDDDFVYVVLEICRRRSL 129
Query: 407 YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
            +       K ++ P        T +G+ YLH      +IHRD+K  N+ L++  + K+G
Sbjct: 130 LE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIG 184
Query: 467 DFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC 525
           DFGLA K   +G    T  + GT  Y+APE       +   D++S G +L  LL GK   
Sbjct: 185 DFGLATKIEFDGERKKT--LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPF 242
Query: 526 E 526
           E
Sbjct: 243 E 243

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNC---SKAGD-ANFKHEVEIIASV 371
           F    ++GKGGYG V++     G       A+K  K       A D A+ K E  I+  V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALG 429
           KH  +V L  Y+  T    G +  ++ + L  G L+  L   G  M+  +      I++ 
Sbjct: 79  KHPFIVDLI-YAFQT----GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
               L +LH   Q  II+RD+K  NI+L+     K+ DFGL K +    T +T    GT+
Sbjct: 134 ----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTI 185
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            Y+APE  +        D +S G ++ ++L+G
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNC---SKAGD-ANFKHEVEIIASV 371
           F    ++GKGGYG V++     G       A+K  K       A D A+ K E  I+  V
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALG 429
           KH  +V L  Y+  T    G +  ++ + L  G L+  L   G  M+  +      I++ 
Sbjct: 79  KHPFIVDLI-YAFQT----GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA 133
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
               L +LH   Q  II+RD+K  NI+L+     K+ DFGL K +    T +T    GT+
Sbjct: 134 ----LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTI 185
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            Y+APE  +        D +S G ++ ++L+G
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHV 374
           +  + ++GKG +G V   K  +  G E AVK   + +   K    +   EV+++  + H 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 375 NLVAL------RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
           N++ L      +GY             +V ++   G L+D +     K+ S     RI  
Sbjct: 87  NIMKLYEFFEDKGYF-----------YLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 133
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRV 485
               G+ Y+H   +  I+HRD+K  N+LL+   +    ++ DFGL+  + E    +  ++
Sbjct: 134 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKI 189
Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT  Y+APE  L+G      DV+S GV+L  LLSG
Sbjct: 190 -GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+  FGLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 107/236 (45%), Gaps = 22/236 (9%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP--NGT--EVAVKRFK-- 351
           L  R S   + K+E++           I+G+G +G+V +G L   +GT  +VAVK  K  
Sbjct: 14  LVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD 73
Query: 352 NCSKAGDANFKHEVEIIASVKHVNLVALRG----YSTATVPLEGHQRIIVCDLLHNGSLY 407
           N S+     F  E   +    H N++ L G     S+  +P    + +++   +  G L+
Sbjct: 74  NSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIP----KPMVILPFMKYGDLH 129
Query: 408 DHLFGS----GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA 463
            +L  S    G K +     L+  +  A G+ YL        +HRD+ A N +L +    
Sbjct: 130 TYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTV 186
Query: 464 KVGDFGLAKFNPEGITHLTTRVAGT-LGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
            V DFGL+K    G  +   R+A   + ++A E       T  SDV++FGV + E+
Sbjct: 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ D GLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 24/243 (9%)
Query: 293 EPSLVLESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEV----AV 347
           +PS  ++ +S+ L       +   TM  + R   +GKGG+   Y+    +  EV     V
Sbjct: 16  KPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV 75
Query: 348 KRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSL 406
            +              E+ I  S+ + ++V   G+       E    + +V ++    SL
Sbjct: 76  PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF------FEDDDFVYVVLEICRRRSL 129
Query: 407 YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
            +       K ++ P        T +G+ YLH      +IHRD+K  N+ L++  + K+G
Sbjct: 130 LE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIG 184
Query: 467 DFGLA---KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           DFGLA   +F+ E    L     GT  Y+APE       +   D++S G +L  LL GK 
Sbjct: 185 DFGLATKIEFDGERKKDL----CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP 240
Query: 524 ACE 526
             E
Sbjct: 241 PFE 243

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ D GLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           +G G YG+V   Y   L    +VAVK+    F++   A       E+ ++  +KH N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHA--RRTYRELRLLKHLKHENVIG 91
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L    T    +E    + +   L    L + +    +          +     RGL Y+H
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF---LVYQLLRGLKYIH 148
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYA 497
                 IIHRD+K SN+ ++E  E ++ DFGLA+   E +T ++ TR      Y APE  
Sbjct: 149 SA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIM 200
Query: 498 L-YGKLTPGSDVYSFGVVLLELLSGK 522
           L +       D++S G ++ ELL GK
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G V++ +      V V +F N     D    K+E+ I+  + H  L+ L     
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
                + ++ +++ + L  G L+D +     K +S    +        GL ++H   + +
Sbjct: 119 -----DKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMH---EHS 169
Query: 445 IIHRDIKASNILLD--EAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           I+H DIK  NI+ +  +A   K+ DFGLA K NP+ I  +TT    T  + APE      
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREP 226
Query: 502 LTPGSDVYSFGVVLLELLSG 521
           +   +D+++ GV+   LLSG
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT--YRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ DF LA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHV 374
           +  + ++GKG +G V   K  +  G E AVK   + +   K    +   EV+++  + H 
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 375 NLVAL------RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
           N++ L      +GY             +V ++   G L+D +     K+ S     RI  
Sbjct: 93  NIMKLYEFFEDKGYF-----------YLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 139
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRV 485
               G+ Y+H   +  I+HRD+K  N+LL+   +    ++ DFGL+  + E    +  ++
Sbjct: 140 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKI 195
Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT  Y+APE  L+G      DV+S GV+L  LLSG
Sbjct: 196 -GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 104/243 (42%), Gaps = 24/243 (9%)
Query: 293 EPSLVLESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEV----AV 347
           +PS  ++ +S+ L       +   TM  + R   +GKGG+   Y+    +  EV     V
Sbjct: 16  KPSAHVDPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVV 75
Query: 348 KRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSL 406
            +              E+ I  S+ + ++V   G+       E    + +V ++    SL
Sbjct: 76  PKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGF------FEDDDFVYVVLEICRRRSL 129
Query: 407 YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
            +       K ++ P        T +G+ YLH      +IHRD+K  N+ L++  + K+G
Sbjct: 130 LE--LHKRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIG 184
Query: 467 DFGLA---KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           DFGLA   +F+ E    L     GT  Y+APE       +   D++S G +L  LL GK 
Sbjct: 185 DFGLATKIEFDGERKKXL----CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKP 240
Query: 524 ACE 526
             E
Sbjct: 241 PFE 243

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 97/204 (47%), Gaps = 19/204 (9%)
Query: 324 NIIGKGGYGNVYKGMLP-NGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           + +G G +G V  G     G +VAVK   R K  S       K E++ +   +H +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
             Y   + P +     +V + +  G L+D++   G  +     RL   + +A    + H 
Sbjct: 77  --YQVISTPTD---FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH- 130
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                ++HRD+K  N+LLD    AK+ DFGL+    +G    T+   G+  Y APE  + 
Sbjct: 131 ----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VIS 183
Query: 500 GKL--TPGSDVYSFGVVLLELLSG 521
           G+L   P  D++S GV+L  LL G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           F++   IGKG +G V+KG+     +V   +  +  +A D     + EI    +  +    
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           + Y +    L+  +  I+ + L  GS  D L    + +      LR  L   +GL YLH 
Sbjct: 84  KYYGSY---LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHS 137
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYAL 498
             +   IHRDIKA+N+LL E  E K+ DFG+A +     I        GT  ++APE   
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAPEVIK 192
Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
                  +D++S G+  +EL  G+
Sbjct: 193 QSAYDSKADIWSLGITAIELARGE 216

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK---HEVEIIASVKHV 374
           N+     IGKG +  V     +  G EVAV R  + ++   ++ +    EV I+  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARG 433
           N+V L         L      +V +    G ++D+L   G MK+     + R  +   + 
Sbjct: 74  NIVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ- 127
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
             Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N     +      G+  Y A
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDEFCGSPPYAA 180
Query: 494 PEYALYGKLT-PGSDVYSFGVVLLELLSG 521
           PE     K   P  DV+S GV+L  L+SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           F++   IGKG +G V+KG+     +V   +  +  +A D     + EI    +  +    
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           + Y +    L+  +  I+ + L  GS  D L    + +      LR  L   +GL YLH 
Sbjct: 69  KYYGSY---LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDYLHS 122
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYAL 498
             +   IHRDIKA+N+LL E  E K+ DFG+A +     I        GT  ++APE   
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NXFVGTPFWMAPEVIK 177
Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
                  +D++S G+  +EL  G+
Sbjct: 178 QSAYDSKADIWSLGITAIELARGE 201

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 32/210 (15%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V        G  VAVK+    F++   A       E+ ++  +KH N++ L 
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHENVIGLL 87
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------KKLSWPIRLRIALGTARGL 434
              T    LE    +          L  HL G+ +      +KL+      +     RGL
Sbjct: 88  DVFTPARSLEEFNDVY---------LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 138
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVA 493
            Y+H      IIHRD+K SN+ ++E  E K+ D GLA+   + +T ++ TR      Y A
Sbjct: 139 KYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRA 190
Query: 494 PEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L +       D++S G ++ ELL+G+
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
            V + ++ G L  H+   G  +   P  +  A   A GL +L       II+RD+K  N+
Sbjct: 98  FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNV 152
Query: 456 LLDEAFEAKVGDFGLAKFN-PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVV 514
           +LD     K+ DFG+ K N  +G+T  T    GT  Y+APE   Y       D ++FGV+
Sbjct: 153 MLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 210
Query: 515 LLELLSGKKACE 526
           L E+L+G+   E
Sbjct: 211 LYEMLAGQAPFE 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALR 380
           +G G YG+V   Y   L    +VAVK+      S         E+ ++  +KH N++ L 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
              T    +E    + +   L    L + +     + LS      +     RGL Y+H  
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQFLVYQLLRGLKYIHSA 142
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYAL- 498
               IIHRD+K SN+ ++E  E ++ DFGLA+   E +T ++ TR      Y APE  L 
Sbjct: 143 ---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEIMLN 194
Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
           +       D++S G ++ ELL GK
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+     IGKG +  V     +  G EVAVK          +  K   EV I+  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           +V L         L      +V +    G ++D+L   G MK+     + R  +   +  
Sbjct: 75  IVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N     +      G+  Y AP
Sbjct: 128 -YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAAP 181
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+     IGKG +  V     +  G EVAVK          +  K   EV I+  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           +V L         L      +V +    G ++D+L   G MK+     + R  +   +  
Sbjct: 75  IVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N     +      G+  Y AP
Sbjct: 128 -YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAAP 181
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+     IGKG +  V     +  G EVAVK          +  K   EV I+  + H N
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 67
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           +V L         L      +V +    G ++D+L   G MK+     + R  +   +  
Sbjct: 68  IVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ-- 120
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N     +      G+  Y AP
Sbjct: 121 -YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAAP 174
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 175 ELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 66/132 (50%), Gaps = 8/132 (6%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
            V + ++ G L  H+   G  +   P  +  A   A GL +L       II+RD+K  N+
Sbjct: 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNV 473
Query: 456 LLDEAFEAKVGDFGLAKFN-PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVV 514
           +LD     K+ DFG+ K N  +G+T  T    GT  Y+APE   Y       D ++FGV+
Sbjct: 474 MLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPYGKSVDWWAFGVL 531
Query: 515 LLELLSGKKACE 526
           L E+L+G+   E
Sbjct: 532 LYEMLAGQAPFE 543

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 324 NIIGKGGYGNVYKGMLP-NGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           + +G G +G V  G     G +VAVK   R K  S       K E++ +   +H +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
             Y   + P +     +V + +  G L+D++   G  +     RL   + +A    + H 
Sbjct: 77  --YQVISTPTD---FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRH- 130
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                ++HRD+K  N+LLD    AK+ DFGL+    +G         G+  Y APE  + 
Sbjct: 131 ----MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRDSCGSPNYAAPE-VIS 183
Query: 500 GKL--TPGSDVYSFGVVLLELLSG 521
           G+L   P  D++S GV+L  LL G
Sbjct: 184 GRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR--FK-NCSKAG-DANFKHEVEIIASVKHVNLVALRG 381
           +GKG +GNVY         +   +  FK    KAG +   + EVEI + ++H N++ L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL---GTARGLAYLH 438
           Y      +      ++ +    G++Y  L     +KLS     R A      A  L+Y H
Sbjct: 80  YFHDATRV-----YLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALSYCH 129
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                 +IHRDIK  N+LL    E K+ DFG +   P   +     + GTL Y+ PE  +
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRDTLCGTLDYLPPE-MI 182
Query: 499 YGKLTPGS-DVYSFGVVLLELLSGKKACE 526
            G++     D++S GV+  E L G    E
Sbjct: 183 EGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 41/227 (18%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGDA-NFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK     +   +   F +E  ++
Sbjct: 15  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 74
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 75  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 129
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------F 473
              +++A   A G+AYL+       +HR++ A N ++   F  K+GDFG+ +       +
Sbjct: 130 QEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 186
Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              G   L  R      ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 187 RKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 103/227 (45%), Gaps = 41/227 (18%)
Query: 321 SRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGDA-NFKHEVEII 368
           SRE I     +G+G +G VY+G   +       T VAVK     +   +   F +E  ++
Sbjct: 16  SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVM 75
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR----- 423
                 ++V L G  +     +G   ++V +L+ +G L  +L     +  + P R     
Sbjct: 76  KGFTCHHVVRLLGVVS-----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTL 130
Query: 424 ---LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------F 473
              +++A   A G+AYL+       +HR++ A N ++   F  K+GDFG+ +       +
Sbjct: 131 QEMIQMAAEIADGMAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYY 187
Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              G   L  R      ++APE    G  T  SD++SFGVVL E+ S
Sbjct: 188 RKGGKGLLPVR------WMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHV 374
           +  + ++GKG +G V   K  +  G E AVK   + +   K    +   EV+++  + H 
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 375 NLVAL------RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
           N++ L      +GY             +V ++   G L+D +     K+ S     RI  
Sbjct: 110 NIMKLYEFFEDKGYF-----------YLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 156
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRV 485
               G+ Y+H   +  I+HRD+K  N+LL+   +    ++ DFGL+  + E    +  ++
Sbjct: 157 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKI 212
Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT  Y+APE  L+G      DV+S GV+L  LLSG
Sbjct: 213 -GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 97/227 (42%), Gaps = 34/227 (14%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +F    ++G+G +G V K     +    A+K+ ++  +   +    EV ++AS+ H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVV 65
Query: 378 AL-------RGYSTATVPLEGHQRIIV-CDLLHNGSLYDHLFGSGMKKLS---WPIRLRI 426
                    R +      ++    + +  +   NG+LYD +    + +     W    R+
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RL 121
Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF------------- 473
                  L+Y+H      IIHRD+K  NI +DE+   K+GDFGLAK              
Sbjct: 122 FRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 474 NPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELL 519
           N  G +   T   GT  YVA E     G      D+YS G++  E++
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRF--KNCSKAGDANFKHEVEI--IASVKHVNLVALRG 381
           +G+G +G V         +    +F  +   K  D + + E EI  +  ++H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
           Y   T P +    I++      G L+D++     K+++     R        + Y H   
Sbjct: 75  YDVITTPTD----IVMVIEYAGGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCH--- 125
Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           +  I+HRD+K  N+LLD+    K+ DFGL+    +G  +      G+  Y APE  + GK
Sbjct: 126 RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPE-VINGK 182
Query: 502 L--TPGSDVYSFGVVLLELLSGK 522
           L   P  DV+S G+VL  +L G+
Sbjct: 183 LYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK---HEVEIIASVKHV 374
           N+     IGKG +  V     +  G EVAV R  + ++   ++ +    EV I+  + H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAV-RIIDKTQLNSSSLQKLFREVRIMKVLNHP 73
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARG 433
           N+V L         L      +V +    G ++D+L   G MK+     + R  +   + 
Sbjct: 74  NIVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ- 127
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
             Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N     +      G+  Y A
Sbjct: 128 --YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDTFCGSPPYAA 180
Query: 494 PEYALYGKLT-PGSDVYSFGVVLLELLSG 521
           PE     K   P  DV+S GV+L  L+SG
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           +G G YG+V   Y   L    +VAVK+    F++   A       E+ ++  +KH N++ 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHA--RRTYRELRLLKHLKHENVIG 91
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L    T    +E    + +   L    L + +     + LS      +     RGL Y+H
Sbjct: 92  LLDVFTPATSIEDFSEVYLVTTLMGADLNNIV---KCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYA 497
                 IIHRD+K SN+ ++E  E ++ DFGLA+   E +T ++ TR      Y APE  
Sbjct: 149 SA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATR-----WYRAPEIM 200
Query: 498 L-YGKLTPGSDVYSFGVVLLELLSGK 522
           L +       D++S G ++ ELL GK
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 14/148 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           I +C    +G   D +     K++   I  ++++   RGLAYL    Q  I+HRD+K SN
Sbjct: 89  ISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSN 145
Query: 455 ILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVV 514
           IL++   E K+ DFG++    + I  +     GT  Y+APE       +  SD++S G+ 
Sbjct: 146 ILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLS 202
Query: 515 LLELLSGK--------KACEIIQGKSVL 534
           L+EL  G+        K  E I G+ V+
Sbjct: 203 LVELAVGRYPIPPPDAKELEAIFGRPVV 230

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 34/216 (15%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHV 374
           +  + ++GKG +G V   K  +  G E AVK   + +   K    +   EV+++  + H 
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 375 NLVAL------RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
           N++ L      +GY             +V ++   G L+D +     K+ S     RI  
Sbjct: 111 NIMKLYEFFEDKGYF-----------YLVGEVYTGGELFDEIISR--KRFSEVDAARIIR 157
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRV 485
               G+ Y+H   +  I+HRD+K  N+LL+   +    ++ DFGL+  + E    +  ++
Sbjct: 158 QVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKMKDKI 213
Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT  Y+APE  L+G      DV+S GV+L  LLSG
Sbjct: 214 -GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 117/249 (46%), Gaps = 34/249 (13%)
Query: 286 VKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEV 345
           VK+   D+P+ V++  +S+    +  EI      ++   +IG G +G V++  L    EV
Sbjct: 13  VKLNPLDDPNKVIKVLASDGKTGEQREIA-----YTNCKVIGNGSFGVVFQAKLVESDEV 67
Query: 346 AVKRFKNCSKAGDANFKH-EVEIIASVKHVNLVALRG--YSTATVPLEGHQRII---VCD 399
           A+K+        D  FK+ E++I+  VKH N+V L+   YS      E    ++   V +
Sbjct: 68  AIKKV-----LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122
Query: 400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE 459
            ++  S +       M  L   + +   L   R LAY+H      I HRDIK  N+LLD 
Sbjct: 123 TVYRASRHYAKLKQTMPMLLIKLYMYQLL---RSLAYIH---SIGICHRDIKPQNLLLDP 176
Query: 460 AFEA-KVGDFGLAKFNPEG---ITHLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGV 513
                K+ DFG AK    G   ++ + +R      Y APE  ++G    T   D++S G 
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPNVSXICSRY-----YRAPEL-IFGATNYTTNIDIWSTGC 230
Query: 514 VLLELLSGK 522
           V+ EL+ G+
Sbjct: 231 VMAELMQGQ 239

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+     IGKG +  V     +  G EVAVK          +  K   EV I+  + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           +V L         L      +V +    G ++D+L   G MK+     + R  +   +  
Sbjct: 75  IVKLFEVIETEKTL-----YLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ-- 127
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N     +      G   Y AP
Sbjct: 128 -YCH---QKFIVHRDLKAENLLLDADMNIKIADFGFS--NEFTFGNKLDAFCGAPPYAAP 181
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 46/233 (19%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +F    ++G+G +G V K     +    A+K+ ++  +   +    EV ++AS+ H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVV 65
Query: 378 -----------------ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
                            A++  ST  + +E  +   + DL+H+ +L      +  +   W
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENL------NQQRDEYW 119
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-------- 472
               R+       L+Y+H      IIHRD+K  NI +DE+   K+GDFGLAK        
Sbjct: 120 ----RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 473 -----FNPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELL 519
                 N  G +   T   GT  YVA E     G      D+YS G++  E++
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 320 FSRENI-----IGKGGYGNVYK------GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEI 367
           F R N+     +G G +G V +      G      +VAVK  K+ + A +      E++I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS----WPI 422
           ++ + +H N+V L G  T   P+     +++ +    G L + L       L      P+
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPV-----LVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 423 RLRIAL----GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI 478
            LR  L      A+G+A+L        IHRD+ A N+LL     AK+GDFGLA+      
Sbjct: 158 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 214
Query: 479 THLTTRVAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            ++    A   + ++APE       T  SDV+S+G++L E+ S
Sbjct: 215 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 106/219 (48%), Gaps = 26/219 (11%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFK--NCSKAGDANFK---HEV 365
           ++K+    + + + +G+G +  VYK    N  + VA+K+ K  + S+A D   +    E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 366 EIIASVKHVNLVALR---GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
           +++  + H N++ L    G+ +    +       +  ++ + SL   L  S +K      
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV--LTPSHIKA----- 116
Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHL 481
                L T +GL YLH   Q  I+HRD+K +N+LLDE    K+ DFGLAK F      + 
Sbjct: 117 ---YMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYX 170
Query: 482 TTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELL 519
              V  T  Y APE     ++   G D+++ G +L ELL
Sbjct: 171 HQVV--TRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 30/223 (13%)
Query: 320 FSRENI-----IGKGGYGNVYK------GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEI 367
           F R N+     +G G +G V +      G      +VAVK  K+ + A +      E++I
Sbjct: 35  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 94
Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS----WPI 422
           ++ + +H N+V L G  T   P+     +++ +    G L + L       L      P+
Sbjct: 95  MSHLGQHENIVNLLGACTHGGPV-----LVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 423 RLRIAL----GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI 478
            LR  L      A+G+A+L        IHRD+ A N+LL     AK+GDFGLA+      
Sbjct: 150 ELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 206
Query: 479 THLTTRVAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            ++    A   + ++APE       T  SDV+S+G++L E+ S
Sbjct: 207 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 91/198 (45%), Gaps = 13/198 (6%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           +G+G YG+VYK +    G  VA+K+    S   +     E+ I+      ++V   G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQE--IIKEISIMQQCDSPHVVKYYGSYF 94
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
               L      IV +    GS+ D +     K L+      I   T +GL YLH+  +  
Sbjct: 95  KNTDL-----WIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK-- 146
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTP 504
            IHRDIKA NILL+    AK+ DFG+A    + +      V GT  ++APE         
Sbjct: 147 -IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAK-RNXVIGTPFWMAPEVIQEIGYNC 204
Query: 505 GSDVYSFGVVLLELLSGK 522
            +D++S G+  +E+  GK
Sbjct: 205 VADIWSLGITAIEMAEGK 222

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L D +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 19/201 (9%)
Query: 326 IGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V      + G +VAVK+     +       +EV I+    H N+V +  YS+
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDM--YSS 110
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   R L+YLH      
Sbjct: 111 YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLH---NQG 161
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE  +  +L 
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMAPE--VISRLP 217
Query: 504 PGS--DVYSFGVVLLELLSGK 522
            G+  D++S G++++E++ G+
Sbjct: 218 YGTEVDIWSLGIMVIEMIDGE 238

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR---FKNCSKAGDANFKHEVEIIASVKHV 374
           NF  E  IG+G +  VY+   L +G  VA+K+   F        A+   E++++  + H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR--LRIALGTAR 432
           N++  + Y++    +E ++  IV +L   G L   +     +K   P R   +  +    
Sbjct: 93  NVI--KYYASF---IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            L ++H      ++HRDIK +N+ +      K+GD GL +F     T   + V GT  Y+
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 493 APEYALYGKLTPGSDVYSFGVVLLEL 518
           +PE          SD++S G +L E+
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFK-NCSKAG-DANFKHEVEIIASVKHVNLVAL---- 379
           +G+G YG VYK     G  VA+KR + +    G  +    E+ ++  + H N+V+L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                 T+  E  ++ +   L  N +        G++     I L   L   RG+A+ H 
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDENKT--------GLQDSQIKIYLYQLL---RGVAHCH- 136
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL- 498
             Q  I+HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y AP+  + 
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMG 193
Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
             K +   D++S G +  E+++GK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 22/204 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFK-NCSKAG-DANFKHEVEIIASVKHVNLVAL---- 379
           +G+G YG VYK     G  VA+KR + +    G  +    E+ ++  + H N+V+L    
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                 T+  E  ++ +   L  N +        G++     I L   L   RG+A+ H 
Sbjct: 89  HSERCLTLVFEFMEKDLKKVLDENKT--------GLQDSQIKIYLYQLL---RGVAHCH- 136
Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             Q  I+HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y AP+  + 
Sbjct: 137 --QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMG 193
Query: 500 GKLTPGS-DVYSFGVVLLELLSGK 522
            K    S D++S G +  E+++GK
Sbjct: 194 SKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 98/226 (43%), Gaps = 26/226 (11%)
Query: 320 FSRENIIGKGGYGN-VYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNL 376
           + R   IG+G +G  +      +G +  +K       S       + EV ++A++KH N+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDH-------LFGSGMKKLSWPIRLRIALG 429
           V  R         E     IV D    G L+         LF    + L W +++ +AL 
Sbjct: 86  VQYRESFE-----ENGSLYIVMDYCEGGDLFKRINAQKGVLFQED-QILDWFVQICLAL- 138
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
                 ++H      I+HRDIK+ NI L +    ++GDFG+A+        L     GT 
Sbjct: 139 -----KHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV-LNSTVELARACIGTP 189
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL 535
            Y++PE          SD+++ G VL EL + K A E    K+++L
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 95/205 (46%), Gaps = 16/205 (7%)
Query: 321 SRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           S+  I+G G +G V+K      G ++A K  K          K+E+ ++  + H NL+ L
Sbjct: 92  SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQL 151
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                +   +     ++V + +  G L+D +       L+    +        G+ ++H 
Sbjct: 152 YDAFESKNDI-----VLVMEYVDGGELFDRIIDESYN-LTELDTILFMKQICEGIRHMH- 204
Query: 440 GVQPAIIHRDIKASNILL--DEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEY 496
             Q  I+H D+K  NIL    +A + K+ DFGLA+ + P     +     GT  ++APE 
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEV 259
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSG 521
             Y  ++  +D++S GV+   LLSG
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 63  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 71  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 125 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 180
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 63  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 65  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 174
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 100/237 (42%), Gaps = 24/237 (10%)
Query: 299 ESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNC 353
           + +S+ L       +   TM  + R   +GKGG+   Y+    +  EV     V +    
Sbjct: 6   DPKSAPLKEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLL 65
Query: 354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFG 412
                     E+ I  S+ + ++V   G+       E    + +V ++    SL +    
Sbjct: 66  KPHQKEKMSTEIAIHKSLDNPHVVGFHGF------FEDDDFVYVVLEICRRRSLLE--LH 117
Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA- 471
              K ++ P        T +G+ YLH      +IHRD+K  N+ L++  + K+GDFGLA 
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLAT 174
Query: 472 --KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE 526
             +F+ E    L     GT  Y+APE       +   D++S G +L  LL GK   E
Sbjct: 175 KIEFDGERKKDL----CGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE 227

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 68  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 122 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 177
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 21/224 (9%)
Query: 304 NLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FKN-CSKAG-DA 359
           N A  ++ + K    +F     +GKG +GNVY         +   +  FK+   K G + 
Sbjct: 1   NTALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEH 60
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKL 418
             + E+EI + ++H N++ +  Y          +RI ++ +    G LY  L   G    
Sbjct: 61  QLRREIEIQSHLRHPNILRMYNY------FHDRKRIYLMLEFAPRGELYKELQKHGRFDE 114
Query: 419 SWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI 478
                    L  A     LHY  +  +IHRDIK  N+L+    E K+ DFG +   P   
Sbjct: 115 QRSATFMEELADA-----LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 167
Query: 479 THLTTR-VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             L  R + GTL Y+ PE           D++  GV+  E L G
Sbjct: 168 --LRRRXMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 70
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 71  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 124
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 125 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 180
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 102/227 (44%), Gaps = 34/227 (14%)
Query: 320 FSRENI-----IGKGGYGNVYK------GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEI 367
           F R N+     +G G +G V +      G      +VAVK  K+ + A +      E++I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL------------FGSG 414
           ++ + +H N+V L G  T   P+     +++ +    G L + L            F   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPV-----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157
Query: 415 MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN 474
              LS    L  +   A+G+A+L        IHRD+ A N+LL     AK+GDFGLA+  
Sbjct: 158 NSTLSTRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 475 PEGITHLTTRVAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                ++    A   + ++APE       T  SDV+S+G++L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+     IGKG +  V     +  G EVA+K          +  K   EV I+  + H N
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 72
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           +V L         L      ++ +    G ++D+L   G MK+     + R  +   +  
Sbjct: 73  IVKLFEVIETEKTL-----YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ-- 125
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N   +        G+  Y AP
Sbjct: 126 -YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS--NEFTVGGKLDTFCGSPPYAAP 179
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 180 ELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 317 TMN-FSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV 374
           TMN FS   IIG+GG+G VY     + G   A+K    C        K + E +A  + +
Sbjct: 186 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMK-QGETLALNERI 240
Query: 375 NLVALRGYSTATVPLEGHQRIIVC---------------DLLHNGSLYDHLFGSGMKKLS 419
            L  +   ST   P       IVC               DL++ G L+ HL   G+   S
Sbjct: 241 MLSLV---STGDCPF------IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FS 289
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                  A     GL ++H      +++RD+K +NILLDE    ++ D GLA    +   
Sbjct: 290 EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 346
Query: 480 HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSG 521
           H +    GT GY+APE    G      +D +S G +L +LL G
Sbjct: 347 HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 317 TMN-FSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV 374
           TMN FS   IIG+GG+G VY     + G   A+K    C        K + E +A  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMK-QGETLALNERI 241
Query: 375 NLVALRGYSTATVPLEGHQRIIVC---------------DLLHNGSLYDHLFGSGMKKLS 419
            L  +   ST   P       IVC               DL++ G L+ HL   G+   S
Sbjct: 242 MLSLV---STGDCPF------IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FS 290
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                  A     GL ++H      +++RD+K +NILLDE    ++ D GLA    +   
Sbjct: 291 EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 480 HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSG 521
           H +    GT GY+APE    G      +D +S G +L +LL G
Sbjct: 348 HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 86/202 (42%), Gaps = 21/202 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR--FKN-CSKAG-DANFKHEVEIIASVKHVNLVALRG 381
           +GKG +GNVY         +   +  FK+   K G +   + E+EI + ++H N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           Y          +RI ++ +    G LY  L   G             L  A     LHY 
Sbjct: 82  Y------FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADA-----LHYC 130
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGYVAPEYALY 499
            +  +IHRDIK  N+L+    E K+ DFG +   P     L  R + GTL Y+ PE    
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCGTLDYLPPEMIEG 186
Query: 500 GKLTPGSDVYSFGVVLLELLSG 521
                  D++  GV+  E L G
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVG 208

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 317 TMN-FSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV 374
           TMN FS   IIG+GG+G VY     + G   A+K    C        K + E +A  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMK-QGETLALNERI 241
Query: 375 NLVALRGYSTATVPLEGHQRIIVC---------------DLLHNGSLYDHLFGSGMKKLS 419
            L  +   ST   P       IVC               DL++ G L+ HL   G+   S
Sbjct: 242 MLSLV---STGDCPF------IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FS 290
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                  A     GL ++H      +++RD+K +NILLDE    ++ D GLA    +   
Sbjct: 291 EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 480 HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSG 521
           H +    GT GY+APE    G      +D +S G +L +LL G
Sbjct: 348 HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 97/223 (43%), Gaps = 40/223 (17%)
Query: 317 TMN-FSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV 374
           TMN FS   IIG+GG+G VY     + G   A+K    C        K + E +A  + +
Sbjct: 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMK-QGETLALNERI 241
Query: 375 NLVALRGYSTATVPLEGHQRIIVC---------------DLLHNGSLYDHLFGSGMKKLS 419
            L  +   ST   P       IVC               DL++ G L+ HL   G+   S
Sbjct: 242 MLSLV---STGDCPF------IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FS 290
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                  A     GL ++H      +++RD+K +NILLDE    ++ D GLA    +   
Sbjct: 291 EADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347
Query: 480 HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSG 521
           H +    GT GY+APE    G      +D +S G +L +LL G
Sbjct: 348 HASV---GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 88/208 (42%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+     IGKG +  V     +  G EVA+K          +  K   EV I+  + H N
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           +V L         L      ++ +    G ++D+L   G MK+     + R  +   +  
Sbjct: 76  IVKLFEVIETEKTL-----YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ-- 128
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   Q  I+HRD+KA N+LLD     K+ DFG +  N   +        G   Y AP
Sbjct: 129 -YCH---QKRIVHRDLKAENLLLDADMNIKIADFGFS--NEFTVGGKLDAFCGAPPYAAP 182
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNL 376
           +F  ++++G+G YG V      P G  VA+K+ +   K   A     E++I+   KH N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           + +          E    + +   L    L+  +  + M  LS          T R +  
Sbjct: 72  ITIFNIQRPDS-FENFNEVYIIQELMQTDLH-RVISTQM--LSDDHIQYFIYQTLRAVKV 127
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---------NPEGITHLTTRVAG 487
           LH      +IHRD+K SN+L++   + KV DFGLA+           P G     T    
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 488 TLGYVAPEYALY-GKLTPGSDVYSFGVVLLELL 519
           T  Y APE  L   K +   DV+S G +L EL 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 19/207 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRG 381
           +GKGG+   ++    +  EV   +    S             E+ I  S+ H ++V   G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           +       E +  + +V +L    SL +       K L+ P           G  YLH  
Sbjct: 89  F------FEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 140
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALY 499
               +IHRD+K  N+ L+E  E K+GDFGLA K   +G    T  + GT  Y+APE    
Sbjct: 141 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 195
Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACE 526
              +   DV+S G ++  LL GK   E
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 19/207 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRG 381
           +GKGG+   ++    +  EV   +    S             E+ I  S+ H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           +       E +  + +V +L    SL +       K L+ P           G  YLH  
Sbjct: 85  F------FEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALY 499
               +IHRD+K  N+ L+E  E K+GDFGLA K   +G    T  + GT  Y+APE    
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 191
Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACE 526
              +   DV+S G ++  LL GK   E
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
           N + E+EI+  + H  ++ ++ +       +     IV +L+  G L+D + G+  K+L 
Sbjct: 186 NVETEIEILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGN--KRLK 237
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPE 476
                         + YLH   +  IIHRD+K  N+LL    E    K+ DFG +K    
Sbjct: 238 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--L 292
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSG 521
           G T L   + GT  Y+APE  L    T G     D +S GV+L   LSG
Sbjct: 293 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 88/207 (42%), Gaps = 19/207 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRG 381
           +GKGG+   ++    +  EV   +    S             E+ I  S+ H ++V   G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           +       E +  + +V +L    SL +       K L+ P           G  YLH  
Sbjct: 85  F------FEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 136
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALY 499
               +IHRD+K  N+ L+E  E K+GDFGLA K   +G    T  + GT  Y+APE    
Sbjct: 137 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVLSK 191
Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACE 526
              +   DV+S G ++  LL GK   E
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 19/213 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNL 376
           +F  ++++G+G YG V      P G  VA+K+ +   K   A     E++I+   KH N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           + +          E    + +   L    L+  +  + M  LS          T R +  
Sbjct: 72  ITIFNIQRPDS-FENFNEVYIIQELMQTDLH-RVISTQM--LSDDHIQYFIYQTLRAVKV 127
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---------NPEGITHLTTRVAG 487
           LH      +IHRD+K SN+L++   + KV DFGLA+           P G     T    
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 488 TLGYVAPEYALY-GKLTPGSDVYSFGVVLLELL 519
           T  Y APE  L   K +   DV+S G +L EL 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
           N + E+EI+  + H  ++ ++ +       +     IV +L+  G L+D + G+  K+L 
Sbjct: 200 NVETEIEILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGN--KRLK 251
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPE 476
                         + YLH   +  IIHRD+K  N+LL    E    K+ DFG +K    
Sbjct: 252 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--L 306
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSG 521
           G T L   + GT  Y+APE  L    T G     D +S GV+L   LSG
Sbjct: 307 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 101/225 (44%), Gaps = 30/225 (13%)
Query: 320 FSRENI-----IGKGGYGNVYK------GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEI 367
           F R N+     +G G +G V +      G      +VAVK  K+ + A +      E++I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           ++ + +H N+V L G  T   P+     +++ +    G L + L     + L       I
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPV-----LVITEYCCYGDLLNFLRRKS-RVLETDPAFAI 156
Query: 427 ALGTARGLAYLHYGVQPA----------IIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
           A  TA     LH+  Q A           IHRD+ A N+LL     AK+GDFGLA+    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 477 GITHLTTRVAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              ++    A   + ++APE       T  SDV+S+G++L E+ S
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GL+
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLS 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
           N + E+EI+  + H  ++ ++ +       +     IV +L+  G L+D + G+  K+L 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGN--KRLK 112
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPE 476
                         + YLH   +  IIHRD+K  N+LL    E    K+ DFG +K    
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 167
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSG 521
           G T L   + GT  Y+APE  L    T G     D +S GV+L   LSG
Sbjct: 168 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
           N + E+EI+  + H  ++ ++ +       +     IV +L+  G L+D + G+  K+L 
Sbjct: 60  NVETEIEILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGN--KRLK 111
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPE 476
                         + YLH   +  IIHRD+K  N+LL    E    K+ DFG +K    
Sbjct: 112 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 166
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSG 521
           G T L   + GT  Y+APE  L    T G     D +S GV+L   LSG
Sbjct: 167 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 99/216 (45%), Gaps = 34/216 (15%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHV 374
           +  + ++GKG +G V   K  +  G E AVK   + +   K    +   EV+++  + H 
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 375 NLVAL------RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
           N+  L      +GY             +V ++   G L+D +     K+ S     RI  
Sbjct: 87  NIXKLYEFFEDKGYF-----------YLVGEVYTGGELFDEIIS--RKRFSEVDAARIIR 133
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRV 485
               G+ Y H   +  I+HRD+K  N+LL+   +    ++ DFGL+  + E       ++
Sbjct: 134 QVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST-HFEASKKXKDKI 189
Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT  Y+APE  L+G      DV+S GV+L  LLSG
Sbjct: 190 -GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
           N + E+EI+  + H  ++ ++ +       +     IV +L+  G L+D + G+  K+L 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGN--KRLK 112
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGLAKFNPE 476
                         + YLH   +  IIHRD+K  N+LL    E    K+ DFG +K    
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 167
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSG 521
           G T L   + GT  Y+APE  L    T G     D +S GV+L   LSG
Sbjct: 168 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
           N + E+EI+  + H  ++ ++ +       +     IV +L+  G L+D + G+  K+L 
Sbjct: 61  NVETEIEILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGN--KRLK 112
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGLAKFNPE 476
                         + YLH   +  IIHRD+K  N+LL    E    K+ DFG +K    
Sbjct: 113 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 167
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSG 521
           G T L   + GT  Y+APE  L    T G     D +S GV+L   LSG
Sbjct: 168 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 326 IGKGGYGNV-YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V    +  +G  VAVK+     +       +EV I+   +H N+V +  Y++
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM--YNS 94
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   + L+ LH      
Sbjct: 95  YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQ---G 145
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE        
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYG 203
Query: 504 PGSDVYSFGVVLLELLSGK 522
           P  D++S G++++E++ G+
Sbjct: 204 PEVDIWSLGIMVIEMVDGE 222

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 326 IGKGGYGNV-YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V    +  +G  VAVK+     +       +EV I+   +H N+V +  Y++
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM--YNS 96
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   + L+ LH      
Sbjct: 97  YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQ---G 147
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE        
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYG 205
Query: 504 PGSDVYSFGVVLLELLSGK 522
           P  D++S G++++E++ G+
Sbjct: 206 PEVDIWSLGIMVIEMVDGE 224

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 44  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 98
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 156
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 157 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 212
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 213 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 326 IGKGGYGNV-YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V    +  +G  VAVK+     +       +EV I+   +H N+V +  Y++
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM--YNS 85
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   + L+ LH      
Sbjct: 86  YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQ---G 136
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE        
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYG 194
Query: 504 PGSDVYSFGVVLLELLSGK 522
           P  D++S G++++E++ G+
Sbjct: 195 PEVDIWSLGIMVIEMVDGE 213

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 105/242 (43%), Gaps = 40/242 (16%)
Query: 326 IGKGGYGNVYKGM-LPNGTE-VAVKRFKNCSKAGDANFK----HEVEII---ASVKHVNL 376
           IG+G YG V+K   L NG   VA+KR +   + G+         EV ++    + +H N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP------IRLRIALGT 430
           V L  +   TV     +  +     H     D    + + K+  P      I+  +    
Sbjct: 77  VRL--FDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIK-DMMFQL 129
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            RGL +LH      ++HRD+K  NIL+  + + K+ DFGLA+          T V  TL 
Sbjct: 130 LRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLW 184
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           Y APE  L        D++S G +  E+   K    + +G S        ++ + GK LD
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSS--------DVDQLGKILD 233
Query: 551 VI 552
           VI
Sbjct: 234 VI 235

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 29  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 83
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 141
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 142 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 197
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 198 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           IG+G YG VYK     G   A+K  R +   +   +    E+ I+  +KH N+V L  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLA 435
                +   +R+++        +++HL    +KKL       +   TA+        G+A
Sbjct: 68  V----IHTKKRLVL--------VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y H      ++HRD+K  N+L++   E K+ DFGLA+     +   T  V  TL Y AP+
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPD 170
Query: 496 YALYG--KLTPGSDVYSFGVVLLELLSG 521
             L G  K +   D++S G +  E+++G
Sbjct: 171 -VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 70
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 129 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 184
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 185 SRY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
           N + E+EI+  + H  ++ ++ +       +     IV +L+  G L+D + G+  K+L 
Sbjct: 67  NVETEIEILKKLNHPCIIKIKNF------FDAEDYYIVLELMEGGELFDKVVGN--KRLK 118
Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPE 476
                         + YLH   +  IIHRD+K  N+LL    E    K+ DFG +K    
Sbjct: 119 EATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-- 173
Query: 477 GITHLTTRVAGTLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSG 521
           G T L   + GT  Y+APE  L    T G     D +S GV+L   LSG
Sbjct: 174 GETSLMRTLCGTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           IG+G YG VYK     G   A+K  R +   +   +    E+ I+  +KH N+V L  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLA 435
                +   +R+++        +++HL    +KKL       +   TA+        G+A
Sbjct: 68  V----IHTKKRLVL--------VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y H      ++HRD+K  N+L++   E K+ DFGLA+     +   T  V  TL Y AP+
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPD 170
Query: 496 YALYG--KLTPGSDVYSFGVVLLELLSG 521
             L G  K +   D++S G +  E+++G
Sbjct: 171 -VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 104
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 163 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 218
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 219 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 109/220 (49%), Gaps = 29/220 (13%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIAS 370
           E+KA  +    E  +G+G YG V K   +P+G  +AVKR +    + +   +  +++  S
Sbjct: 47  EVKADDLEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDIS 103
Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL---YDHLFGSGMKKLSWPIRLRIA 427
           ++ V+      +  A    EG   + +C  L + SL   Y  +   G + +   I  +IA
Sbjct: 104 MRTVDCPFTVTFYGALF-REGD--VWICMELMDTSLDKFYKQVIDKG-QTIPEDILGKIA 159
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           +   + L +LH  +  ++IHRD+K SN+L++   + K+ DFG++ +  + +    T  AG
Sbjct: 160 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK--TIDAG 215
Query: 488 TLGYVAPEYALYGKLTP---------GSDVYSFGVVLLEL 518
              Y+APE     ++ P          SD++S G+ ++EL
Sbjct: 216 CKPYMAPE-----RINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 326 IGKGGYGNV-YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V    +  +G  VAVK+     +       +EV I+   +H N+V +  Y++
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM--YNS 216
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   + L+ LH      
Sbjct: 217 YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQI---AAVCLAVLQALSVLHAQ---G 267
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE        
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYG 325
Query: 504 PGSDVYSFGVVLLELLSGK 522
           P  D++S G++++E++ G+
Sbjct: 326 PEVDIWSLGIMVIEMVDGE 344

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 21  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 75
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 133
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 134 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 189
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 190 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 63  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 172
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 54  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 108
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 166
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 167 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 222
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 223 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 113/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 52  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 106
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 164
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 165 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 220
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 221 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 50/93 (53%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 197
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE       +  SD+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+   R    ++   +    E+ ++  + H N
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 63
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 64  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 117
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 118 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 173
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+   R    ++   +    E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 63  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 63  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 172
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 65  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 65  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRG 381
           +GKGG+   ++    +  EV   +    S             E+ I  S+ H ++V   G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           +       E +  + +V +L    SL +       K L+ P           G  YLH  
Sbjct: 107 F------FEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 158
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALY 499
               +IHRD+K  N+ L+E  E K+GDFGLA K   +G       + GT  Y+APE    
Sbjct: 159 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 213
Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACE 526
              +   DV+S G ++  LL GK   E
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           IG+G YG VYK     G   A+K  R +   +   +    E+ I+  +KH N+V L  Y 
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKL--YD 67
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLA 435
                +   +R+++        +++HL    +KKL       +   TA+        G+A
Sbjct: 68  V----IHTKKRLVL--------VFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y H      ++HRD+K  N+L++   E K+ DFGLA+     +   T  +  TL Y AP+
Sbjct: 115 YCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPD 170
Query: 496 YALYG--KLTPGSDVYSFGVVLLELLSG 521
             L G  K +   D++S G +  E+++G
Sbjct: 171 -VLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 326 IGKGGYGNV-YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V    +  +G  VAVK+     +       +EV I+   +H N+V +  Y++
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM--YNS 89
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   + L+ LH      
Sbjct: 90  YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQ---G 140
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE        
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYG 198
Query: 504 PGSDVYSFGVVLLELLSGK 522
           P  D++S G++++E++ G+
Sbjct: 199 PEVDIWSLGIMVIEMVDGE 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 105/242 (43%), Gaps = 40/242 (16%)
Query: 326 IGKGGYGNVYKGM-LPNGTE-VAVKRFKNCSKAGDANFK----HEVEII---ASVKHVNL 376
           IG+G YG V+K   L NG   VA+KR +   + G+         EV ++    + +H N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP------IRLRIALGT 430
           V L  +   TV     +  +     H     D    + + K+  P      I+  +    
Sbjct: 77  VRL--FDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIK-DMMFQL 129
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            RGL +LH      ++HRD+K  NIL+  + + K+ DFGLA+          T V  TL 
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLW 184
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           Y APE  L        D++S G +  E+   K    + +G S        ++ + GK LD
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSS--------DVDQLGKILD 233
Query: 551 VI 552
           VI
Sbjct: 234 VI 235

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 67  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 66  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRG 381
           +GKGG+   ++    +  EV   +    S             E+ I  S+ H ++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           +       E +  + +V +L    SL +       K L+ P           G  YLH  
Sbjct: 83  F------FEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALY 499
               +IHRD+K  N+ L+E  E K+GDFGLA K   +G       + GT  Y+APE    
Sbjct: 135 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 189
Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACE 526
              +   DV+S G ++  LL GK   E
Sbjct: 190 KGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKHEVEIIASVK 372
           +   ++++   +IG G +G VY+  L +  E VA+K+       G A    E++I+  + 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKNRELQIMRKLD 71
Query: 373 HVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIALG 429
           H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ + 
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 430 TA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLTT 483
              R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ +
Sbjct: 130 QLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 484 RVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 186 RY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 66  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/242 (28%), Positives = 105/242 (43%), Gaps = 40/242 (16%)
Query: 326 IGKGGYGNVYKGM-LPNGTE-VAVKRFKNCSKAGDANFK----HEVEII---ASVKHVNL 376
           IG+G YG V+K   L NG   VA+KR +   + G+         EV ++    + +H N+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTIREVAVLRHLETFEHPNV 76
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP------IRLRIALGT 430
           V L  +   TV     +  +     H     D    + + K+  P      I+  +    
Sbjct: 77  VRL--FDVCTVSRTDRETKLTLVFEH----VDQDLTTYLDKVPEPGVPTETIK-DMMFQL 129
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            RGL +LH      ++HRD+K  NIL+  + + K+ DFGLA+          T V  TL 
Sbjct: 130 LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLW 184
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           Y APE  L        D++S G +  E+   K    + +G S        ++ + GK LD
Sbjct: 185 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP---LFRGSS--------DVDQLGKILD 233
Query: 551 VI 552
           VI
Sbjct: 234 VI 235

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF----------KNCSKAGDANFKHEVEI 367
           N+  + I+G+G    V + +  P   E AVK            +   +  +A  K EV+I
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK-EVDI 63
Query: 368 IASVK-HVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
           +  V  H N++ L+  Y T T         +V DL+  G L+D+L  +    LS     +
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTF------FFLVFDLMKKGELFDYL--TEKVTLSEKETRK 115
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTR 484
           I       +  LH   +  I+HRD+K  NILLD+    K+ DFG + + +P         
Sbjct: 116 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLRE 169
Query: 485 VAGTLGYVAPE---------YALYGKLTPGSDVYSFGVVLLELLSG 521
           V GT  Y+APE         +  YGK     D++S GV++  LL+G
Sbjct: 170 VCGTPSYLAPEIIECSMNDNHPGYGKEV---DMWSTGVIMYTLLAG 212

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 66  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 120 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKHEVEIIASVK 372
           +   ++++   +IG G +G VY+  L +  E VA+K+       G A    E++I+  + 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKNRELQIMRKLD 71
Query: 373 HVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIALG 429
           H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ + 
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 430 TA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLTT 483
              R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ +
Sbjct: 130 QLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 484 RVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 186 RY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 65  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 119 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 67
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 68  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 121
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 122 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 177
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 75/244 (30%), Positives = 122/244 (50%), Gaps = 35/244 (14%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 95  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 149
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 207
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++++ 
Sbjct: 208 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC 263
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW 540
           +R      Y APE  ++G    T   DV+S G VL ELL G+    I  G S +  D   
Sbjct: 264 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQP---IFPGDSGV--DQLV 312
Query: 541 ELVK 544
           E++K
Sbjct: 313 EIIK 316

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 92/217 (42%), Gaps = 26/217 (11%)
Query: 315 AATMNFSRENIIGKGGYGNVYKGMLPNGTEV--AVKRFKNCSKAGDANFKHEVE----II 368
           A   +F    +IGKG +G V         EV  AVK  +  +       KH +     ++
Sbjct: 35  AKPSDFHFLKVIGKGSFGKVLLARH-KAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 369 ASVKHVNLVALR-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI- 426
            +VKH  LV L   + TA       +   V D ++ G L+ HL     ++     R R  
Sbjct: 94  KNVKHPFLVGLHFSFQTAD------KLYFVLDYINGGELFYHL---QRERCFLEPRARFY 144
Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTR 484
           A   A  L YLH      I++RD+K  NILLD      + DFGL K   E I H   T+ 
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTST 198
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             GT  Y+APE           D +  G VL E+L G
Sbjct: 199 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 95/199 (47%), Gaps = 15/199 (7%)
Query: 326 IGKGGYGNV-YKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG+G  G V    +  +G  VAVK+     +       +EV I+   +H N+V +  Y++
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEM--YNS 139
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA 444
             V   G +  +V + L  G+L D +  + M +        + L   + L+ LH      
Sbjct: 140 YLV---GDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLQALSVLHAQ---G 190
Query: 445 IIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT 503
           +IHRDIK+ +ILL      K+ DFG  A+ + E        + GT  ++APE        
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMAPELISRLPYG 248
Query: 504 PGSDVYSFGVVLLELLSGK 522
           P  D++S G++++E++ G+
Sbjct: 249 PEVDIWSLGIMVIEMVDGE 267

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 113 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 172
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 173 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 41/246 (16%)
Query: 308 FKIEEIKAATMNFSRENII-----GKGGYGNVYKGML------PNGTEVAVKRFK-NCSK 355
           FKI  ++     F R+N++     G+G +G V K            T VAVK  K N S 
Sbjct: 10  FKI--LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP 67
Query: 356 AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL----- 410
           +   +   E  ++  V H +++ L G  +   PL     +++ +    GSL   L     
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRK 122
Query: 411 FGSG---------MKKLSWPIRLRIALGTARGLAY-----LHYGVQPAIIHRDIKASNIL 456
            G G            L  P    + +G     A+     + Y  +  ++HRD+ A NIL
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLTPGSDVYSFGVV 514
           + E  + K+ DFGL++   E  +++  R  G +   ++A E       T  SDV+SFGV+
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 515 LLELLS 520
           L E+++
Sbjct: 242 LWEIVT 247

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 114 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 173
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 174 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 67  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 115 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 174
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 175 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNL 376
           +F  ++++G+G YG V      P G  VA+K+ +   K   A     E++I+   KH N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           + +          E    + +   L    L+  +  + M  LS          T R +  
Sbjct: 72  ITIFNIQRPDS-FENFNEVYIIQELMQTDLH-RVISTQM--LSDDHIQYFIYQTLRAVKV 127
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---------NPEGITHLTTRVAG 487
           LH      +IHRD+K SN+L++   + KV DFGLA+           P G          
Sbjct: 128 LHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 488 TLGYVAPEYALY-GKLTPGSDVYSFGVVLLELL 519
           T  Y APE  L   K +   DV+S G +L EL 
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLV-----GIKHLHSA---GIIHRDLKPSNIVVKSDA 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S GV++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 70
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 129 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 185 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 116 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 175
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 176 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 50  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 104
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 163 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 218
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 219 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 19/207 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRG 381
           +GKGG+   ++    +  EV   +    S             E+ I  S+ H ++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           +       E +  + +V +L    SL +       K L+ P           G  YLH  
Sbjct: 109 F------FEDNDFVFVVLELCRRRSLLE--LHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYVAPEYALY 499
               +IHRD+K  N+ L+E  E K+GDFGLA K   +G       + GT  Y+APE    
Sbjct: 161 ---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSK 215
Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACE 526
              +   DV+S G ++  LL GK   E
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 67  IVKL-----LDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + +H   L   +  S +  +  P+         +GLA
Sbjct: 63  IVKL-----LDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V  TL Y APE
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 172
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF----------KNCSKAGDANFKHEVEI 367
           N+  + I+G+G    V + +  P   E AVK            +   +  +A  K EV+I
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK-EVDI 76
Query: 368 IASVK-HVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
           +  V  H N++ L+  Y T T         +V DL+  G L+D+L  +    LS     +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTF------FFLVFDLMKKGELFDYL--TEKVTLSEKETRK 128
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTR 484
           I       +  LH   +  I+HRD+K  NILLD+    K+ DFG + + +P         
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLRE 182
Query: 485 VAGTLGYVAPE---------YALYGKLTPGSDVYSFGVVLLELLSG 521
           V GT  Y+APE         +  YGK     D++S GV++  LL+G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEV---DMWSTGVIMYTLLAG 225

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 120 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 179
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 180 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 35  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 89
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 90  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 147
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 148 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 203
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 204 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 194
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 24  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 78
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 136
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 137 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 192
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 193 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 135 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 194
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 195 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 95/210 (45%), Gaps = 34/210 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N++ 
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTHAKRAY--RELVLMKVVNHKNIIG 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 88  LLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDH------ERMSYLLYQMLV---- 137
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 138 -GIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            APE  L        D++S GV++ E++ G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 70
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 129 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 184
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 185 SRY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVKRFKNCSKAGDAN---FKHEVEIIASVKHV 374
           + R   +G G YG V   K  L  G E A+K  K  S    +N      EV ++  + H 
Sbjct: 23  YQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N++ L  +       +     +V ++   G L+D +     +K S      I      G 
Sbjct: 82  NIMKLYEFFE-----DKRNYYLVMEVYRGGELFDEIILR--QKFSEVDAAVIMKQVLSGT 134
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGL-AKFNPEGITHLTTRVAGTLG 490
            YLH   +  I+HRD+K  N+LL+        K+ DFGL A F   G   +  R+ GT  
Sbjct: 135 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--KMKERL-GTAY 188
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           Y+APE  L  K     DV+S GV+L  LL G
Sbjct: 189 YIAPE-VLRKKYDEKCDVWSCGVILYILLCG 218

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L         +    ++ +     +  L D +  S +  +  P+         +GLA
Sbjct: 67  IVKLLDV------IHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 95/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 65
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + L +  L D +  S +  +  P+         +GLA
Sbjct: 66  IVKL-----LDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 120 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 175
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 143 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 202
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 203 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 108/246 (43%), Gaps = 41/246 (16%)
Query: 308 FKIEEIKAATMNFSRENII-----GKGGYGNVYKGML------PNGTEVAVKRFK-NCSK 355
           FKI  ++     F R+N++     G+G +G V K            T VAVK  K N S 
Sbjct: 10  FKI--LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP 67
Query: 356 AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL----- 410
           +   +   E  ++  V H +++ L G  +   PL     +++ +    GSL   L     
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRK 122
Query: 411 FGSG---------MKKLSWPIRLRIALGTARGLAY-----LHYGVQPAIIHRDIKASNIL 456
            G G            L  P    + +G     A+     + Y  + +++HRD+ A NIL
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNIL 182
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLTPGSDVYSFGVV 514
           + E  + K+ DFGL++   E  + +  R  G +   ++A E       T  SDV+SFGV+
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 515 LLELLS 520
           L E+++
Sbjct: 242 LWEIVT 247

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 17  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 71
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 72  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 129
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 130 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 185
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 186 SRY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 28  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 82
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 141 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 197 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 195
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 28  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 82
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 140
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 141 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 196
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 197 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 114/224 (50%), Gaps = 34/224 (15%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 70
Query: 372 KHVNLVALRGYSTATVPLEGHQR-IIVCDLLHN---GSLYDHLFGSGMKKLSWP-IRLRI 426
            H N+V LR +  ++    G ++ ++  +L+ +    ++Y         K + P I +++
Sbjct: 71  DHCNIVRLRYFFYSS----GEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126
Query: 427 ALGTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITH 480
            +    R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ 
Sbjct: 127 YMYQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSX 182
Query: 481 LTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           + +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 183 ICSRY-----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 198
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 86/208 (41%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           N+     IGKG +  V     +  G EVAVK          +  K   EV I   + H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL- 434
           +V L         L      +V +    G ++D+L   G  K       + A    R + 
Sbjct: 75  IVKLFEVIETEKTL-----YLVXEYASGGEVFDYLVAHGRXKE------KEARAKFRQIV 123
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           + + Y  Q  I+HRD+KA N+LLD     K+ DFG +  N     +      G   Y AP
Sbjct: 124 SAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFS--NEFTFGNKLDAFCGAPPYAAP 181
Query: 495 EYALYGKLT-PGSDVYSFGVVLLELLSG 521
           E     K   P  DV+S GV+L  L+SG
Sbjct: 182 ELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/226 (29%), Positives = 102/226 (45%), Gaps = 41/226 (18%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF----------KNCSKAGDANFKHEVEI 367
           N+  + I+G+G    V + +  P   E AVK            +   +  +A  K EV+I
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLK-EVDI 76
Query: 368 IASVK-HVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
           +  V  H N++ L+  Y T T         +V DL+  G L+D+L  +    LS     +
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTF------FFLVFDLMKKGELFDYL--TEKVTLSEKETRK 128
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTR 484
           I       +  LH   +  I+HRD+K  NILLD+    K+ DFG + + +P         
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKLRS 182
Query: 485 VAGTLGYVAPE---------YALYGKLTPGSDVYSFGVVLLELLSG 521
           V GT  Y+APE         +  YGK     D++S GV++  LL+G
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEV---DMWSTGVIMYTLLAG 225

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 139 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 198
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 199 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 106/236 (44%), Gaps = 43/236 (18%)
Query: 320 FSRENI-----IGKGGYGNVYK------GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEI 367
           F R N+     +G G +G V +      G      +VAVK  K+ + A +      E++I
Sbjct: 28  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 87
Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-------FGSGM---- 415
           ++ + +H N+V L G  T   P+     +++ +    G L + L        G  +    
Sbjct: 88  MSHLGQHENIVNLLGACTHGGPV-----LVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 416 ------KKLSWPIRLRIAL----GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV 465
                 K+   P+ LR  L      A+G+A+L        IHRD+ A N+LL     AK+
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKI 199
Query: 466 GDFGLAKFNPEGITHLTTRVAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           GDFGLA+       ++    A   + ++APE       T  SDV+S+G++L E+ S
Sbjct: 200 GDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 97/233 (41%), Gaps = 46/233 (19%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +F    ++G+G +G V K     +    A+K+ ++  +   +    EV ++AS+ H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVXLLASLNHQYVV 65
Query: 378 -----------------ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
                            A++  ST  +  E  +   + DL+H+ +L      +  +   W
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENL------NQQRDEYW 119
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF------- 473
               R+       L+Y+H      IIHR++K  NI +DE+   K+GDFGLAK        
Sbjct: 120 ----RLFRQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDI 172
Query: 474 ------NPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELL 519
                 N  G +   T   GT  YVA E     G      D YS G++  E +
Sbjct: 173 LKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 30/222 (13%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKH-EVEIIASV 371
           +   ++++   +IG G +G VY+  L +  E VA+K+        D  FK+ E++I+  +
Sbjct: 20  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKL 74
Query: 372 KHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIAL 428
            H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ +
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVL-DYVPE-TVYRVARHYSRAKQTLPVIYVKLYM 132
Query: 429 GTA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLT 482
               R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + 
Sbjct: 133 YQLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXIC 188
Query: 483 TRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           +R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 189 SRY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 138 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 197
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 198 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 25/213 (11%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   +  +L  G  VAVK+    F+N + A  A    E+ ++  V H N+++
Sbjct: 32  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY--RELVLLKCVNHKNIIS 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYL 437
           L    T    LE  Q + +   L + +L   +      +++S+ +   +      G+ +L
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLC-----GIKHL 142
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      IIHRD+K SNI++      K+ DFGLA+        + T    T  Y APE  
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVI 197
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG 530
           L        D++S G ++ EL+ G   C I QG
Sbjct: 198 LGMGYAANVDIWSVGCIMGELVKG---CVIFQG 227

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 18/203 (8%)
Query: 326 IGKGGYGNVY-KGMLPNGTEVAVKRF-KNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           +G G +G+V+      +G E  +K   K+ S+      + E+E++ S+ H N++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI---- 85
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM--KKLSWPIRLRIALGTARGLAYLHYGV 441
              V  + H   IV +    G L + +  +    K LS      +       LAY H   
Sbjct: 86  -FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH--- 141
Query: 442 QPAIIHRDIKASNILLDEA---FEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              ++H+D+K  NIL  +       K+ DFGLA+         +T  AGT  Y+APE   
Sbjct: 142 SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE-VF 198
Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
              +T   D++S GVV+  LL+G
Sbjct: 199 KRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFKNCSKAGDANFKHEVEIIASVK 372
           +   ++++   +IG G +G VY+  L +  E VA+K+       G A    E++I+  + 
Sbjct: 16  RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ----GKAFKNRELQIMRKLD 71
Query: 373 HVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIALG 429
           H N+V LR   YS+     E +  +++ D +   ++Y         K + P I +++ + 
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVL-DYV-PATVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 430 TA-RGLAYLH-YGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEG---ITHLTT 483
              R LAY+H +G    I HRDIK  N+LLD +    K+ DFG AK    G   ++ + +
Sbjct: 130 QLFRSLAYIHSFG----ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICS 185
Query: 484 RVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
           R      Y APE  ++G    T   DV+S G VL ELL G+
Sbjct: 186 RY-----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGT 195
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      + +A  +  +     +  ++  E++I+AS  H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD--- 101
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-RLRIALGTARGLAYLHYGVQP 443
                E +  I++ +    G++      + M +L  P+   +I +   + L  L+Y    
Sbjct: 102 -AFYYENNLWILI-EFCAGGAV-----DAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YGK 501
            IIHRD+KA NIL     + K+ DFG++  N   I    + + GT  ++APE  +    K
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSK 213
Query: 502 LTP---GSDVYSFGVVLLEL 518
             P    +DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 49/93 (52%), Gaps = 1/93 (1%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGT 488
           TA  ++ L Y     IIHRD+K  NILL+E    ++ DFG AK  +PE          GT
Sbjct: 141 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGT 200
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             YV+PE          SD+++ G ++ +L++G
Sbjct: 201 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 30/213 (14%)
Query: 326 IGKGGYGNVYKGMLPNG-TEVAVKRFKNCS----KAGDAN---------FKHEVEIIASV 371
           +G G YG V      NG +E A+K  K       +  D N           +E+ ++ S+
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H N++ L       V  +     +V +    G L++ +      K        I     
Sbjct: 104 DHPNIIKL-----FDVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQIL 156
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEA---FEAKVGDFGLAKFNPEGITHLTTRVAGT 488
            G+ YLH   +  I+HRDIK  NILL+        K+ DFGL+ F  +    L  R+ GT
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GT 211
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             Y+APE  L  K     DV+S GV++  LL G
Sbjct: 212 AYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 18/200 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      + +A  +  +     +  ++  E++I+AS  H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD--- 101
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-RLRIALGTARGLAYLHYGVQP 443
                E +  I++ +    G++      + M +L  P+   +I +   + L  L+Y    
Sbjct: 102 -AFYYENNLWILI-EFCAGGAV-----DAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YGK 501
            IIHRD+KA NIL     + K+ DFG++  N   I    + + GT  ++APE  +    K
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETSK 213
Query: 502 LTP---GSDVYSFGVVLLEL 518
             P    +DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVKRFKNCSKAGDAN---FKHEVEIIASVKHV 374
           + R   +G G YG V   K  L  G E A+K  K  S    +N      EV ++  + H 
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKL-TGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N++ L  +       +     +V ++   G L+D +     +K S      I      G 
Sbjct: 65  NIMKLYEFFE-----DKRNYYLVMEVYRGGELFDEIILR--QKFSEVDAAVIMKQVLSGT 117
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGL-AKFNPEGITHLTTRVAGTLG 490
            YLH   +  I+HRD+K  N+LL+        K+ DFGL A F   G   +  R+ GT  
Sbjct: 118 TYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--KMKERL-GTAY 171
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           Y+APE  L  K     DV+S GV+L  LL G
Sbjct: 172 YIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 100/225 (44%), Gaps = 41/225 (18%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVK-HVNLVAL 379
           +GKG YG V+K +    G  VAVK+    F+N + A    F+ E+ I+  +  H N+V L
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA-QRTFR-EIMILTELSGHENIVNL 74
Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR-IALGTARGLAYLH 438
                A    + +   +V D +        L       +  P+  + +     + + YLH
Sbjct: 75  LNVLRADNDRDVY---LVFDYMETD-----LHAVIRANILEPVHKQYVVYQLIKVIKYLH 126
Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK--FNPEGITH---------------- 480
            G    ++HRD+K SNILL+     KV DFGL++   N   +T+                
Sbjct: 127 SG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 481 --LTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             + T    T  Y APE  L   K T G D++S G +L E+L GK
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 108/220 (49%), Gaps = 29/220 (13%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIAS 370
           E+KA  +    E  +G+G YG V K   +P+G  +AVKR +    + +   +  +++  S
Sbjct: 3   EVKADDLEPIME--LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK-RLLMDLDIS 59
Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL---YDHLFGSGMKKLSWPIRLRIA 427
           ++ V+      +  A    EG   + +C  L + SL   Y  +   G + +   I  +IA
Sbjct: 60  MRTVDCPFTVTFYGALF-REGD--VWICMELMDTSLDKFYKQVIDKG-QTIPEDILGKIA 115
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           +   + L +LH  +  ++IHRD+K SN+L++   + K+ DFG++ +  + +       AG
Sbjct: 116 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AG 171
Query: 488 TLGYVAPEYALYGKLTP---------GSDVYSFGVVLLEL 518
              Y+APE     ++ P          SD++S G+ ++EL
Sbjct: 172 CKPYMAPE-----RINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 107/246 (43%), Gaps = 41/246 (16%)
Query: 308 FKIEEIKAATMNFSRENII-----GKGGYGNVYKGML------PNGTEVAVKRFK-NCSK 355
           FKI  ++     F R+N++     G+G +G V K            T VAVK  K N S 
Sbjct: 10  FKI--LEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASP 67
Query: 356 AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL----- 410
           +   +   E  ++  V H +++ L G  +   PL     +++ +    GSL   L     
Sbjct: 68  SELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRK 122
Query: 411 FGSG---------MKKLSWPIRLRIALGTARGLAY-----LHYGVQPAIIHRDIKASNIL 456
            G G            L  P    + +G     A+     + Y  +  ++HRD+ A NIL
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLTPGSDVYSFGVV 514
           + E  + K+ DFGL++   E  + +  R  G +   ++A E       T  SDV+SFGV+
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVL 241
Query: 515 LLELLS 520
           L E+++
Sbjct: 242 LWEIVT 247

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 36/229 (15%)
Query: 320 FSRENI-----IGKGGYGNVYK------GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEI 367
           F R N+     +G G +G V +      G      +VAVK  K+ + A +      E++I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102
Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--------------FG 412
           ++ + +H N+V L G  T   P+     +++ +    G L + L                
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPV-----LVITEYCCYGDLLNFLRRKRPPGLEYSYNPSH 157
Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
           +  ++LS    L  +   A+G+A+L        IHRD+ A N+LL     AK+GDFGLA+
Sbjct: 158 NPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 214
Query: 473 FNPEGITHLTTRVAG-TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
                  ++    A   + ++APE       T  SDV+S+G++L E+ S
Sbjct: 215 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 324 NIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVAL 379
            ++G+GG+G V+   M   G   A K+           ++    E +I+A V    +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 380 R-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW--PIRLRIALGTARGLAY 436
              + T T         +V  +++ G +  H++        +  P  +        GL +
Sbjct: 251 AYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH   Q  II+RD+K  N+LLD+    ++ D GLA     G T  T   AGT G++APE 
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPEL 360
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
            L  +     D ++ GV L E+++ +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 105/235 (44%), Gaps = 25/235 (10%)
Query: 303 SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNG----TEVAVKRFKN--CSKA 356
           S+  + K+E++      F+   ++GKG +G+V +  L        +VAVK  K    + +
Sbjct: 8   SDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASS 67
Query: 357 GDANFKHEVEIIASVKHVNL-----VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF 411
               F  E   +    H ++     V+LR  +   +P+     +++   + +G L+  L 
Sbjct: 68  DIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIP----MVILPFMKHGDLHAFLL 123
Query: 412 GS--GMKKLSWPIR--LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
            S  G    + P++  +R  +  A G+ YL        IHRD+ A N +L E     V D
Sbjct: 124 ASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVAD 180
Query: 468 FGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGL++    G  +     A  L   ++A E       T  SDV++FGV + E+++
Sbjct: 181 FGLSRKIYSG-DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 316 ATMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIAS 370
            TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 371 VKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-AL 428
            +H  L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R    
Sbjct: 62  TRHPFLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVA 486
                L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFC 166
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 66/135 (48%), Gaps = 19/135 (14%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V DL+  G L+D+L  +    LS      I       +++LH      I+HRD+K  NI
Sbjct: 177 LVFDLMRKGELFDYL--TEKVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENI 231
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE---------YALYGKLTPGS 506
           LLD+  + ++ DFG +     G       + GT GY+APE         +  YGK     
Sbjct: 232 LLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEV--- 286
Query: 507 DVYSFGVVLLELLSG 521
           D+++ GV+L  LL+G
Sbjct: 287 DLWACGVILFTLLAG 301

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 324 NIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVAL 379
            ++G+GG+G V+   M   G   A K+           ++    E +I+A V    +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 380 R-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW--PIRLRIALGTARGLAY 436
              + T T         +V  +++ G +  H++        +  P  +        GL +
Sbjct: 251 AYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH   Q  II+RD+K  N+LLD+    ++ D GLA     G T  T   AGT G++APE 
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPEL 360
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
            L  +     D ++ GV L E+++ +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 317 TMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN F    ++GKG +G V        G   A+K  K     +K   A+   E  ++ + 
Sbjct: 6   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALG 429
           +H  L AL+ YS  T     H R+  V +  + G L+ HL     +++    R R     
Sbjct: 66  RHPFLTALK-YSFQT-----HDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAE 116
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAG 487
               L YLH   +  +++RD+K  N++LD+    K+ DFGL K   EGI    T     G
Sbjct: 117 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCG 171
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y+APE           D +  GVV+ E++ G+
Sbjct: 172 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 324 NIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVAL 379
            ++G+GG+G V+   M   G   A K+           ++    E +I+A V    +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 380 R-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW--PIRLRIALGTARGLAY 436
              + T T         +V  +++ G +  H++        +  P  +        GL +
Sbjct: 251 AYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH   Q  II+RD+K  N+LLD+    ++ D GLA     G T  T   AGT G++APE 
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPEL 360
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
            L  +     D ++ GV L E+++ +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 324 NIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVAL 379
            ++G+GG+G V+   M   G   A K+           ++    E +I+A V    +V+L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 380 R-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW--PIRLRIALGTARGLAY 436
              + T T         +V  +++ G +  H++        +  P  +        GL +
Sbjct: 251 AYAFETKT------DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH   Q  II+RD+K  N+LLD+    ++ D GLA     G T  T   AGT G++APE 
Sbjct: 305 LH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPEL 360
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
            L  +     D ++ GV L E+++ +
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 317 TMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN F    ++GKG +G V        G   A+K  K     +K   A+   E  ++ + 
Sbjct: 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 205
Query: 372 KHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALG 429
           +H  L AL+ YS  T     H R+  V +  + G L+ HL     +++    R R     
Sbjct: 206 RHPFLTALK-YSFQT-----HDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAE 256
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAG 487
               L YLH   +  +++RD+K  N++LD+    K+ DFGL K   EGI    T     G
Sbjct: 257 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCG 311
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y+APE           D +  GVV+ E++ G+
Sbjct: 312 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 317 TMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN F    ++GKG +G V        G   A+K  K     +K   A+   E  ++ + 
Sbjct: 149 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 208
Query: 372 KHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALG 429
           +H  L AL+ YS  T     H R+  V +  + G L+ HL     +++    R R     
Sbjct: 209 RHPFLTALK-YSFQT-----HDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAE 259
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAG 487
               L YLH   +  +++RD+K  N++LD+    K+ DFGL K   EGI    T     G
Sbjct: 260 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCG 314
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y+APE           D +  GVV+ E++ G+
Sbjct: 315 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 316 ATMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIAS 370
            TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 371 VKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-AL 428
            +H  L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R    
Sbjct: 62  TRHPFLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVA 486
                L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFC 166
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 317 TMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN F    ++GKG +G V        G   A+K  K     +K   A+   E  ++ + 
Sbjct: 7   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 66
Query: 372 KHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALG 429
           +H  L AL+ YS  T     H R+  V +  + G L+ HL     +++    R R     
Sbjct: 67  RHPFLTALK-YSFQT-----HDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAE 117
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAG 487
               L YLH   +  +++RD+K  N++LD+    K+ DFGL K   EGI    T     G
Sbjct: 118 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCG 172
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y+APE           D +  GVV+ E++ G+
Sbjct: 173 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 316 ATMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIAS 370
            TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 371 VKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-AL 428
            +H  L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R    
Sbjct: 62  TRHPFLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVA 486
                L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFC 166
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 316 ATMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIAS 370
            TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 371 VKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-AL 428
            +H  L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R    
Sbjct: 62  TRHPFLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVA 486
                L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 166
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 18/200 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      + +A  +  +     +  ++  E++I+AS  H N+V L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLD--- 101
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI-RLRIALGTARGLAYLHYGVQP 443
                E +  I++ +    G++      + M +L  P+   +I +   + L  L+Y    
Sbjct: 102 -AFYYENNLWILI-EFCAGGAV-----DAVMLELERPLTESQIQVVCKQTLDALNYLHDN 154
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YGK 501
            IIHRD+KA NIL     + K+ DFG++  N   I      + GT  ++APE  +    K
Sbjct: 155 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMCETSK 213
Query: 502 LTP---GSDVYSFGVVLLEL 518
             P    +DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 97/215 (45%), Gaps = 23/215 (10%)
Query: 317 TMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN F    ++GKG +G V        G   A+K  K     +K   A+   E  ++ + 
Sbjct: 8   TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 67
Query: 372 KHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALG 429
           +H  L AL+ YS  T     H R+  V +  + G L+ HL     +++    R R     
Sbjct: 68  RHPFLTALK-YSFQT-----HDRLCFVMEYANGGELFFHL---SRERVFSEDRARFYGAE 118
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAG 487
               L YLH   +  +++RD+K  N++LD+    K+ DFGL K   EGI    T     G
Sbjct: 119 IVSALDYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCG 173
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y+APE           D +  GVV+ E++ G+
Sbjct: 174 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 316 ATMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIAS 370
            TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ +
Sbjct: 7   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 66
Query: 371 VKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-AL 428
            +H  L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R    
Sbjct: 67  TRHPFLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 117
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVA 486
                L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     
Sbjct: 118 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFC 171
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 172 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 97/215 (45%), Gaps = 24/215 (11%)
Query: 317 TMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ + 
Sbjct: 6   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 65
Query: 372 KHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-ALG 429
           +H  L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R     
Sbjct: 66  RHPFLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAE 116
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAG 487
               L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     G
Sbjct: 117 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCG 170
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T  Y+APE           D +  GVV+ E++ G+
Sbjct: 171 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 3   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 60
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 61  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 118
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 119 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 164
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 165 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/99 (39%), Positives = 51/99 (51%), Gaps = 14/99 (14%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
            L +LH      II+RD+K  N+LLD     K+ DFG+ K   EGI +   T    GT  
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPD 189
Query: 491 YVAPEY---ALYGKLTPGSDVYSFGVVLLELLSGKKACE 526
           Y+APE     LYG   P  D ++ GV+L E+L G    E
Sbjct: 190 YIAPEILQEMLYG---PAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 97/216 (44%), Gaps = 24/216 (11%)
Query: 316 ATMN-FSRENIIGKGGYGNV-YKGMLPNGTEVAVKRFKN---CSKAGDANFKHEVEIIAS 370
            TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ +
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 371 VKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI-AL 428
            +H  L AL+ Y+  T     H R+  V +  + G L+ HL     +++    R R    
Sbjct: 62  TRHPFLTALK-YAFQT-----HDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGA 112
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVA 486
                L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+   T     
Sbjct: 113 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 166
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 19  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 192 FGLARDIYKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 19  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 192 FGLARDIXKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLV-----GIKHLHSA---GIIHRDLKPSNIVVKSDA 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDA 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 21/231 (9%)
Query: 299 ESRSSNLARFKIEEIKAATM---NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCS 354
           E +   L  F  ++ K   +   +F + + +G G  G V+K    P+G  +A K      
Sbjct: 11  EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 70
Query: 355 KAGDAN-FKHEVEIIASVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLF 411
           K    N    E++++       +V   G  YS   +        I  + +  GSL   L 
Sbjct: 71  KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLK 123
Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
            +G  ++   I  ++++   +GL YL    +  I+HRD+K SNIL++   E K+ DFG++
Sbjct: 124 KAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
               + I  +     GT  Y++PE       +  SD++S G+ L+E+  G+
Sbjct: 180 G---QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 8/94 (8%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVA 486
            ARG+ +L        IHRD+ A NILL E    K+ DFGLA+    NP+ +    TR+ 
Sbjct: 208 VARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             L ++APE       +  SDV+S+GV+L E+ S
Sbjct: 265 --LKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 105/231 (45%), Gaps = 21/231 (9%)
Query: 299 ESRSSNLARFKIEEIKAATM---NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCS 354
           E +   L  F  ++ K   +   +F + + +G G  G V+K    P+G  +A K      
Sbjct: 46  EQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI 105
Query: 355 KAGDAN-FKHEVEIIASVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLF 411
           K    N    E++++       +V   G  YS   +        I  + +  GSL   L 
Sbjct: 106 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLK 158
Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
            +G  ++   I  ++++   +GL YL    +  I+HRD+K SNIL++   E K+ DFG++
Sbjct: 159 KAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 214
Query: 472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
               + I  +     GT  Y++PE       +  SD++S G+ L+E+  G+
Sbjct: 215 G---QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 262

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNL 376
           +F + + +G G  G V+K    P+G  +A K      K    N    E++++       +
Sbjct: 10  DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 69
Query: 377 VALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           V   G  YS   +        I  + +  GSL   L  +G  ++   I  ++++   +GL
Sbjct: 70  VGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 120
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +     GT  Y++P
Sbjct: 121 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDEMANEFVGTRSYMSP 175
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G+ L+E+  G+
Sbjct: 176 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 37/234 (15%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGTE--VAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 21  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALM 80
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 81  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 422 IR------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG 469
                         +  +   A+G+ +L        IHRD+ A NILL E    K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFG 193
Query: 470 LAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           LA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 194 LARDIXKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKXVNHKNIIS 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-FGSGMKKLSWPIRLRIALGTARGLAYL 437
           L    T    LE  Q + +   L + +L   +      +++S+     +      G+ +L
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLXGIKHL 142
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y APE  
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
           L        D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 69
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 183 FGLARDIXKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNHKNIIS 80
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-FGSGMKKLSWPIRLRIALGTARGLAYL 437
           L    T    LE  Q + +   L + +L   +      +++S+     +      G+ +L
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLXGIKHL 135
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y APE  
Sbjct: 136 HSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 190
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
           L        D++S G ++ E++  K
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 69
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 183 FGLARDIXKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 23/210 (10%)
Query: 320 FSRENIIGKGGYGNVY--KGMLPNGTEVAVKRFKNCSKAGDANFK--HEVEIIASVKHVN 375
           + R   +G G YG V   +  + +  E A+K  +  S +  +N K   EV ++  + H N
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTH-VERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPN 97
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGL 434
           ++ L  +       +     +V +    G L+D +       ++   + ++  L    G+
Sbjct: 98  IMKLYDFFE-----DKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GV 149
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            YLH   +  I+HRD+K  N+LL+   +    K+ DFGL+    E    +  R+ GT  Y
Sbjct: 150 TYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV-FENQKKMKERL-GTAYY 204
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE  L  K     DV+S GV+L  LL+G
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-FGSGMKKLSWPIRLRIALGTARGLAYL 437
           L    T    LE  Q + +   L + +L   +      +++S+     +      G+ +L
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSY-----LLYQMLXGIKHL 142
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y APE  
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
           L        D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 106/240 (44%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDA 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++ G
Sbjct: 164 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 105/232 (45%), Gaps = 35/232 (15%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGTE--VAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 19  ASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALM 78
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL---------FG 412
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L         + 
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 413 SGMKK-LSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
              K  L+    +  +   A+G+ +L        IHRD+ A NILL E    K+ DFGLA
Sbjct: 135 DLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLA 191
Query: 472 K---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           +    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 192 RDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 33/235 (14%)
Query: 288 VTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAV 347
           V D  +P L+L+S        KI E     +  +RE                 +G +VAV
Sbjct: 37  VVDQGDPRLLLDSY------VKIGEGSTGIVCLAREK---------------HSGRQVAV 75
Query: 348 KRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY 407
           K      +       +EV I+   +H N+V +  Y +  V   G +  ++ + L  G+L 
Sbjct: 76  KMMDLRKQQRRELLFNEVVIMRDYQHFNVVEM--YKSYLV---GEELWVLMEFLQGGALT 130
Query: 408 DHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           D +      +L+      +     + LAYLH      +IHRDIK+ +ILL      K+ D
Sbjct: 131 DIV---SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSD 184
Query: 468 FGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           FG      + +      + GT  ++APE           D++S G++++E++ G+
Sbjct: 185 FGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 104/235 (44%), Gaps = 38/235 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 20  ASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 79
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 80  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 135
Query: 422 IRLRI-------------ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF 468
               +             +   A+G+ +L        IHRD+ A NILL E    K+ DF
Sbjct: 136 TPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 469 GLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           GLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 193 GLARDIXKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 102/218 (46%), Gaps = 20/218 (9%)
Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVE 366
           K+ E+K    +F + + +G G  G V+K    P+G  +A K      K    N    E++
Sbjct: 18  KVGELKDD--DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQ 75
Query: 367 IIASVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL 424
           ++       +V   G  YS   +        I  + +  GSL   L  +G  ++   I  
Sbjct: 76  VLHECNSPYIVGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLKKAG--RIPEQILG 126
Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
           ++++   +GL YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +   
Sbjct: 127 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANS 181
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
             GT  Y++PE       +  SD++S G+ L+E+  G+
Sbjct: 182 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 219

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNL 376
           +F + + +G G  G V+K    P+G  +A K      K    N    E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           V   G  YS   +        I  + +  GSL   L  +G  ++   I  ++++   +GL
Sbjct: 67  VGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 117
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +     GT  Y++P
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSP 172
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNL 376
           +F + + +G G  G V+K    P+G  +A K      K    N    E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           V   G  YS   +        I  + +  GSL   L  +G  ++   I  ++++   +GL
Sbjct: 67  VGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 117
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +     GT  Y++P
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSP 172
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 19  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 78
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 191
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 192 FGLARDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 69
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 183 FGLARDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      G   A K  +  S+    ++  E+EI+A+  H  +V L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 385 ATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                +G   I++  C     G   D +     + L+ P    +       L +LH    
Sbjct: 87  H----DGKLWIMIEFC----PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---S 135
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YG 500
             IIHRD+KA N+L+    + ++ DFG++  N + +    + + GT  ++APE  +    
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 194
Query: 501 KLTP---GSDVYSFGVVLLEL 518
           K TP    +D++S G+ L+E+
Sbjct: 195 KDTPYDYKADIWSLGITLIEM 215

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNL 376
           +F + + +G G  G V+K    P+G  +A K      K    N    E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           V   G  YS   +        I  + +  GSL   L  +G  ++   I  ++++   +GL
Sbjct: 67  VGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 117
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +     GT  Y++P
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSP 172
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 104/232 (44%), Gaps = 35/232 (15%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGTE--VAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 19  ASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALM 78
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 79  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 422 IRLR----------IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
              +           +   A+G+ +L        IHRD+ A NILL E    K+ DFGLA
Sbjct: 135 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLA 191
Query: 472 K---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           +    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 192 RDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 20/201 (9%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           +G G +G VYK      G   A K  +  S+    ++  E+EI+A+  H  +V L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 385 ATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                +G   I++  C     G   D +     + L+ P    +       L +LH    
Sbjct: 79  H----DGKLWIMIEFC----PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---S 127
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL--YG 500
             IIHRD+KA N+L+    + ++ DFG++  N + +    + + GT  ++APE  +    
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 186
Query: 501 KLTP---GSDVYSFGVVLLEL 518
           K TP    +D++S G+ L+E+
Sbjct: 187 KDTPYDYKADIWSLGITLIEM 207

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 139 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 139 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 196 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 239

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 119 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 219

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +GKG +  V + M +P G E A K    K  S       + E  I   +KH N+V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 70
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
              ++  EG    +V DL+  G L++ +         +      +    + L  +++   
Sbjct: 71  ---SISEEGFH-YLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILESVNHCHL 121
Query: 443 PAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             I+HRD+K  N+LL    +    K+ DFGLA    +G        AGT GY++PE    
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 500 GKLTPGSDVYSFGVVLLELLSG 521
                  D+++ GV+L  LL G
Sbjct: 181 DPYGKPVDMWACGVILYILLVG 202

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 123 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 180 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 223

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 10  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 69
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 70  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVITEFCKFGNLSTYLRSKRNEFVPYK 125
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 126 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 182
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 183 FGLARDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNL 376
           +F + + +G G  G V+K    P+G  +A K      K    N    E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           V   G  YS   +        I  + +  GSL   L  +G  ++   I  ++++   +GL
Sbjct: 67  VGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 117
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +     GT  Y++P
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSP 172
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 22/205 (10%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY--RELVLMKXVNHKNIIS 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-FGSGMKKLSWPIRLRIALGTARGLAYL 437
           L    T    LE  Q + +   L + +L   +      +++S+ +   +      G+ +L
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLC-----GIKHL 142
Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y APE  
Sbjct: 143 HSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 197
Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
           L        D++S G ++ E++  K
Sbjct: 198 LGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 129 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 186 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 229

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 117 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 173
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 174 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 137 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 193
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 194 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 237

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 32  IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAY--RELVLMKXVNHKNIIS 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 137
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 138 -GIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +GKG +  V + M +P G E A K    K  S       + E  I   +KH N+V L   
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 70
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
              ++  EG    +V DL+  G L++ +         +      +    + L  +++   
Sbjct: 71  ---SISEEGFH-YLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILESVNHCHL 121
Query: 443 PAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             I+HRD+K  N+LL    +    K+ DFGLA    +G        AGT GY++PE    
Sbjct: 122 NGIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 500 GKLTPGSDVYSFGVVLLELLSG 521
                  D+++ GV+L  LL G
Sbjct: 181 DPYGKPVDMWACGVILYILLVG 202

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV---- 374
           +F    +IG+G Y  V    L     +   R     K    N   +++ + + KHV    
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMR---VVKKELVNDDEDIDWVQTEKHVFEQA 109
Query: 375 -NLVALRGYSTATVPLEGHQRII-VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            N   L G  +     +   R+  V + ++ G L  H+     +KL        +   + 
Sbjct: 110 SNHPFLVGLHSC---FQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISL 164
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLG 490
            L YLH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 218
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII 528
           Y+APE           D ++ GV++ E+++G+   +I+
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF-KNCSKAGDANFKHEVEI--IASVKHV 374
           N+     +G+G +G V        G +VA+K   K      D   + E EI  +  ++H 
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           +++ L  Y      ++    II+        L+D++      K+S     R        +
Sbjct: 65  HIIKL--YDV----IKSKDEIIMVIEYAGNELFDYIVQRD--KMSEQEARRFFQQIISAV 116
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   +  I+HRD+K  N+LLDE    K+ DFGL+    +G  +      G+  Y AP
Sbjct: 117 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAP 171
Query: 495 EYALYGKL--TPGSDVYSFGVVLLELL 519
           E  + GKL   P  DV+S GV+L  +L
Sbjct: 172 E-VISGKLYAGPEVDVWSCGVILYVML 197

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G      + EV I+  V H N++ L   Y   T        +++ +L+  G
Sbjct: 47  KRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRT------DVVLILELVSGG 100
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + LS             G+ YLH      I H D+K  NI LLD+    
Sbjct: 101 ELFD--FLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA    +G+      + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 156 PHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 521 G 521
           G
Sbjct: 214 G 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 18/208 (8%)
Query: 319 NFSRENIIGKGGYGNVYK-GMLPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNL 376
           +F + + +G G  G V+K    P+G  +A K      K    N    E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 377 VALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           V   G  YS   +        I  + +  GSL   L  +G  ++   I  ++++   +GL
Sbjct: 67  VGFYGAFYSDGEIS-------ICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGL 117
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YL    +  I+HRD+K SNIL++   E K+ DFG++    + I  +     GT  Y++P
Sbjct: 118 TYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSP 172
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E       +  SD++S G+ L+E+  G+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGR 200

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF-KNCSKAGDANFKHEVEI--IASVKHV 374
           N+     +G+G +G V        G +VA+K   K      D   + E EI  +  ++H 
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           +++ L  Y      ++    II+        L+D++      K+S     R        +
Sbjct: 75  HIIKL--YDV----IKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAV 126
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   +  I+HRD+K  N+LLDE    K+ DFGL+    +G  +      G+  Y AP
Sbjct: 127 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAP 181
Query: 495 EYALYGKL--TPGSDVYSFGVVLLELL 519
           E  + GKL   P  DV+S GV+L  +L
Sbjct: 182 E-VISGKLYAGPEVDVWSCGVILYVML 207

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 56  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 115
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 116 SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 171
Query: 422 IR--------------LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           +               +  +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 228
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 229 FGLARDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVK--RFKNCSKAGDANFKHEVEII---A 369
           AT  +     IG G YG VYK   P+ G  VA+K  R  N  +    +   EV ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 370 SVKHVNLVALRGY-STATVPLEGHQRIIVCDLLHNGSLY-DHLFGSGMKKLSWPIRLRIA 427
           + +H N+V L    +T+    E    ++   +  +   Y D     G+   +    +R  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           L   RGL +LH      I+HRD+K  NIL+      K+ DFGLA+     +      V  
Sbjct: 122 L---RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-- 173
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           TL Y APE  L        D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF-KNCSKAGDANFKHEVEI--IASVKHV 374
           N+     +G+G +G V        G +VA+K   K      D   + E EI  +  ++H 
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           +++ L  Y      ++    II+        L+D++      K+S     R        +
Sbjct: 74  HIIKL--YDV----IKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAV 125
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   +  I+HRD+K  N+LLDE    K+ DFGL+    +G  +      G+  Y AP
Sbjct: 126 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAP 180
Query: 495 EYALYGKL--TPGSDVYSFGVVLLELL 519
           E  + GKL   P  DV+S GV+L  +L
Sbjct: 181 E-VISGKLYAGPEVDVWSCGVILYVML 206

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 16/209 (7%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L         +    ++ +     +  L   +  S +  +  P+         +GLA
Sbjct: 67  IVKLLDV------IHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAP 494
           + H      ++HRD+K  N+L++     K+ DFGLA+ F     T+    V  TL Y AP
Sbjct: 121 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWYRAP 175
Query: 495 EYALYGK-LTPGSDVYSFGVVLLELLSGK 522
           E  L  K  +   D++S G +  E+++ +
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 64
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L       V    ++  +V + L +  L   +  S +  +  P+         +GLA
Sbjct: 65  IVKL-----LDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 119 FCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 174
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF-KNCSKAGDANFKHEVEI--IASVKHV 374
           N+     +G+G +G V        G +VA+K   K      D   + E EI  +  ++H 
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           +++ L  Y      ++    II+        L+D++      K+S     R        +
Sbjct: 69  HIIKL--YDV----IKSKDEIIMVIEYAGNELFDYIVQR--DKMSEQEARRFFQQIISAV 120
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            Y H   +  I+HRD+K  N+LLDE    K+ DFGL+    +G  +      G+  Y AP
Sbjct: 121 EYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAP 175
Query: 495 EYALYGKL--TPGSDVYSFGVVLLELL 519
           E  + GKL   P  DV+S GV+L  +L
Sbjct: 176 E-VISGKLYAGPEVDVWSCGVILYVML 201

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVK--RFKNCSKAGDANFKHEVEII---A 369
           AT  +     IG G YG VYK   P+ G  VA+K  R  N  +    +   EV ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 370 SVKHVNLVALRGY-STATVPLEGHQRIIVCDLLHNGSLY-DHLFGSGMKKLSWPIRLRIA 427
           + +H N+V L    +T+    E    ++   +  +   Y D     G+   +    +R  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           L   RGL +LH      I+HRD+K  NIL+      K+ DFGLA+     +      V  
Sbjct: 122 L---RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LAPVVV 173
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           TL Y APE  L        D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 84/201 (41%), Gaps = 13/201 (6%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR---FKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG G YG   K    +  ++ V +   + + ++A       EV ++  +KH N+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK---LSWPIRLRIALGTARGLAYLHY 439
               +        IV +    G L   +   G K+   L     LR+       L   H 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 440 GVQPA--IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
                  ++HRD+K +N+ LD     K+GDFGLA+      +   T V GT  Y++PE  
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQM 188
Query: 498 LYGKLTPGSDVYSFGVVLLEL 518
                   SD++S G +L EL
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL 209

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 105/240 (43%), Gaps = 38/240 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 4   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 61
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 62  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 119
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 120 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 165
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + +      T  Y APE  L        D++S G ++ E++ G
Sbjct: 166 TLKILDFGLAR--TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 320 FSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANF-KHEVEIIASVKHVNLVA 378
           F  E+ +G+G    VY+     GT+      K   K  D    + E+ ++  + H N++ 
Sbjct: 55  FEVESELGRGATSIVYRCK-QKGTQKPYA-LKVLKKTVDKKIVRTEIGVLLRLSHPNIIK 112
Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR----G 433
           L+  + T T      +  +V +L+  G L+D +   G          R A    +     
Sbjct: 113 LKEIFETPT------EISLVLELVTGGELFDRIVEKGY------YSERDAADAVKQILEA 160
Query: 434 LAYLHYGVQPAIIHRDIKASNILL-DEAFEA--KVGDFGLAKFNPEGITHLTTRVAGTLG 490
           +AYLH   +  I+HRD+K  N+L    A +A  K+ DFGL+K     +  L   V GT G
Sbjct: 161 VAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPG 215
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           Y APE        P  D++S G++   LL G
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 88
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 138
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 139 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVK--RFKNCSKAGDANFKHEVEII---A 369
           AT  +     IG G YG VYK   P+ G  VA+K  R  N  +    +   EV ++    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 370 SVKHVNLVALRGY-STATVPLEGHQRIIVCDLLHNGSLY-DHLFGSGMKKLSWPIRLRIA 427
           + +H N+V L    +T+    E    ++   +  +   Y D     G+   +    +R  
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 121
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           L   RGL +LH      I+HRD+K  NIL+      K+ DFGLA+     +      V  
Sbjct: 122 L---RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LDPVVV 173
Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           TL Y APE  L        D++S G +  E+   K
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 208

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 310 IEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCSKAGDANFKHEV 365
           ++E++    +F    +IG+G +G V    + N   +     + +++   +A  A F+ E 
Sbjct: 66  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 125
Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIV-----CDLLHNGSLYDHLFGSGMKKLSW 420
           +++ +     + AL  Y+      E H  +++      DLL   S ++      M +  +
Sbjct: 126 DVLVNGDCQWITALH-YAFQD---ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF-Y 180
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG-LAKFNPEGIT 479
              + +A+ +   L Y         +HRDIK  N+LLD     ++ DFG   K N +G  
Sbjct: 181 IGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 231
Query: 480 HLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGK 522
             +  V GT  Y++PE         GK  P  D +S GV + E+L G+
Sbjct: 232 QSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 137
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 138 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 92/212 (43%), Gaps = 39/212 (18%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFK----HEVEIIASVKHVNLVALR 380
           IG+G YG V+K      G  VA+K+F       D   K     E+ ++  +KH NLV L 
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKF--LESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68
Query: 381 GYSTATVPLEGHQRIIVCD--LLHNGSLY-----DHLFGSGMKKLSWPIRLRIALGTARG 433
                   L  H     CD  +LH    Y     +HL    +K ++W         T + 
Sbjct: 69  EVFRRKRRL--HLVFEYCDHTVLHELDRYQRGVPEHL----VKSITW--------QTLQA 114
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           + + H   +   IHRD+K  NIL+ +    K+ DFG A+       +    VA T  Y +
Sbjct: 115 VNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRS 170
Query: 494 PEYAL----YGKLTPGSDVYSFGVVLLELLSG 521
           PE  +    YG   P  DV++ G V  ELLSG
Sbjct: 171 PELLVGDTQYG---PPVDVWAIGCVFAELLSG 199

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 32  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 87
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 88  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 137
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 138 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 104/237 (43%), Gaps = 45/237 (18%)
Query: 320 FSREN-----IIGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FKHEVEI 367
           F REN     ++G G +G V      G+   G   +VAVK  K  + + +      E+++
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101
Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG-------------- 412
           +  +  H N+V L G  T + P+      ++ +    G L ++L                
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 413 -------SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV 465
                    +  L++   L  A   A+G+ +L +    + +HRD+ A N+L+      K+
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKI 213
Query: 466 GDFGLAKFNPEGITHLTTRVAGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            DFGLA+ +    ++   R    L   ++APE    G  T  SDV+S+G++L E+ S
Sbjct: 214 CDFGLAR-DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNHKNIIS 81
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 131
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 132 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 31  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 86
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 87  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 136
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 137 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 190
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 80
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 81  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 130
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 131 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRA--YRELVLMKCVNHKNIIS 125
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 175
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 176 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 33  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 88
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 89  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 138
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 139 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 21/219 (9%)
Query: 314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCSKAGDA----NFKHEV 365
           K    NF    ++G G YG V+     +G +     A+K  K  +    A    + + E 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
           +++  ++    +    Y+  T      +  ++ D ++ G L+ HL     ++      ++
Sbjct: 110 QVLEHIRQSPFLVTLHYAFQTET----KLHLILDYINGGELFTHL---SQRERFTEHEVQ 162
Query: 426 IALGT-ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
           I +G     L +LH   +  II+RDIK  NILLD      + DFGL+K      T     
Sbjct: 163 IYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219
Query: 485 VAGTLGYVAPEYALYGK--LTPGSDVYSFGVVLLELLSG 521
             GT+ Y+AP+    G        D +S GV++ ELL+G
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +G G YG+V   +   +G +VA+K+      S+        E+ ++  ++H N++ L   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
            T    L       +        L   +   G+K     I+  +     +GL Y+H    
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIM---GLKFSEEKIQY-LVYQMLKGLKYIHSA-- 145
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLGYVAPEYAL-YG 500
             ++HRD+K  N+ ++E  E K+ DFGLA+  + E   ++ TR      Y APE  L + 
Sbjct: 146 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 199
Query: 501 KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
                 D++S G ++ E+L+GK    + +GK  L
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGKT---LFKGKDYL 230

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 81
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 82  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 131
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 132 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 481 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 537
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 538 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 581

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 101/228 (44%), Gaps = 30/228 (13%)
Query: 310 IEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCSKAGDANFKHEV 365
           ++E++    +F    +IG+G +G V    + N   +     + +++   +A  A F+ E 
Sbjct: 82  VKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREER 141
Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIV-----CDLLHNGSLYDHLFGSGMKKLSW 420
           +++ +     + AL  Y+      E H  +++      DLL   S ++      M +  +
Sbjct: 142 DVLVNGDCQWITALH-YAFQD---ENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARF-Y 196
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG-LAKFNPEGIT 479
              + +A+ +   L Y         +HRDIK  N+LLD     ++ DFG   K N +G  
Sbjct: 197 IGEMVLAIDSIHQLHY---------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTV 247
Query: 480 HLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGK 522
             +  V GT  Y++PE         GK  P  D +S GV + E+L G+
Sbjct: 248 QSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G      + EV I+  V H N++ L   Y   T        +++ +L+  G
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT------DVVLILELVSGG 100
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + LS             G+ YLH      I H D+K  NI LLD+    
Sbjct: 101 ELFD--FLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA    +G+      + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 156 PHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 521 G 521
           G
Sbjct: 214 G 214

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV---- 374
           +F    +IG+G Y  V    L     +   +     K    N   +++ + + KHV    
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK---VVKKELVNDDEDIDWVQTEKHVFEQA 77
Query: 375 -NLVALRGYSTATVPLEGHQRII-VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            N   L G  +     +   R+  V + ++ G L  H+     +KL        +   + 
Sbjct: 78  SNHPFLVGLHSC---FQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISL 132
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLG 490
            L YLH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 133 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 186
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII 528
           Y+APE           D ++ GV++ E+++G+   +I+
Sbjct: 187 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 95/211 (45%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N+++
Sbjct: 70  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIS 125
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 175
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 176 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV---- 374
           +F    +IG+G Y  V    L     +   +     K    N   +++ + + KHV    
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK---VVKKELVNDDEDIDWVQTEKHVFEQA 62
Query: 375 -NLVALRGYSTATVPLEGHQRII-VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            N   L G  +     +   R+  V + ++ G L  H+     +KL        +   + 
Sbjct: 63  SNHPFLVGLHSC---FQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISL 117
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLG 490
            L YLH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 118 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 171
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII 528
           Y+APE           D ++ GV++ E+++G+   +I+
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 34/210 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   +  +L  G  VAVK+    F+N + A  A    E+ ++  V H N+++
Sbjct: 30  IGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTHAKRAY--RELVLLKCVNHKNIIS 85
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 86  LLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDH------ERMSYLLYQMLC---- 135
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+        + T    T  Y
Sbjct: 136 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYY 189
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            APE  L        D++S G ++ EL+ G
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G      + EV I+  V H N++ L   Y   T        +++ +L+  G
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT------DVVLILELVSGG 100
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + LS             G+ YLH      I H D+K  NI LLD+    
Sbjct: 101 ELFD--FLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA    +G+      + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 156 PHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 521 G 521
           G
Sbjct: 214 G 214

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/104 (35%), Positives = 53/104 (50%), Gaps = 6/104 (5%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLG 490
           G+ YL    +   +HRD+ A N+LL     AK+ DFGL+K     E      T     + 
Sbjct: 482 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 538
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSV 533
           + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  V
Sbjct: 539 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV 582

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G      + EV I+  V H N++ L   Y   T        +++ +L+  G
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT------DVVLILELVSGG 100
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + LS             G+ YLH      I H D+K  NI LLD+    
Sbjct: 101 ELFD--FLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA    +G+      + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 156 PHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 521 G 521
           G
Sbjct: 214 G 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G      + EV I+  V H N++ L   Y   T        +++ +L+  G
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT------DVVLILELVSGG 100
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + LS             G+ YLH      I H D+K  NI LLD+    
Sbjct: 101 ELFD--FLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA    +G+      + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 156 PHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 521 G 521
           G
Sbjct: 214 G 214

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/241 (27%), Positives = 106/241 (43%), Gaps = 38/241 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 7   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 64
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 65  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 122
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 123 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 168
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + + T    T  Y APE  L        D++S G ++ E++  
Sbjct: 169 TLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 226
Query: 522 K 522
           K
Sbjct: 227 K 227

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 94/207 (45%), Gaps = 26/207 (12%)
Query: 326 IGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +G G YG V   +    G +VA+K+      S+        E+ ++  ++H N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL---RIAL---GTARGLAY 436
            T    L         D   +  L     G+ + KL    +L   RI        +GL Y
Sbjct: 93  FTPDETL---------DDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           +H      IIHRD+K  N+ ++E  E K+ DFGLA+   +  + +   V  T  Y APE 
Sbjct: 144 IHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV-TRWYRAPEV 196
Query: 497 AL-YGKLTPGSDVYSFGVVLLELLSGK 522
            L + + T   D++S G ++ E+++GK
Sbjct: 197 ILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 94/218 (43%), Gaps = 22/218 (10%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV---- 374
           +F    +IG+G Y  V    L     +   +     K    N   +++ + + KHV    
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMK---VVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 375 -NLVALRGYSTATVPLEGHQRII-VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            N   L G  +     +   R+  V + ++ G L  H+     +KL        +   + 
Sbjct: 67  SNHPFLVGLHSC---FQTESRLFFVIEYVNGGDLMFHM--QRQRKLPEEHARFYSAEISL 121
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLG 490
            L YLH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 175
Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII 528
           Y+APE           D ++ GV++ E+++G+   +I+
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 34/211 (16%)
Query: 326 IGKGGYGNV---YKGMLPNGTEVAVKR----FKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           IG G  G V   Y  +L     VA+K+    F+N + A  A    E+ ++  V H N++ 
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHKNIIG 81
Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSL-------YDHLFGSGMKKLSWPIRLRIALGTA 431
           L    T    LE  Q + +   L + +L        DH      +++S+ +   +     
Sbjct: 82  LLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH------ERMSYLLYQMLC---- 131
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            G+ +LH      IIHRD+K SNI++      K+ DFGLA+    G + + T    T  Y
Sbjct: 132 -GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G ++ E++  K
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 20/214 (9%)
Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +G G YG+V   +   +G +VA+K+      S+        E+ ++  ++H N++ L   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
            T    L       +        L   +   GM+     I+  +     +GL Y+H    
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIM---GMEFSEEKIQY-LVYQMLKGLKYIHSA-- 163
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLGYVAPEYAL-YG 500
             ++HRD+K  N+ ++E  E K+ DFGLA+  + E   ++ TR      Y APE  L + 
Sbjct: 164 -GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVILSWM 217
Query: 501 KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
                 D++S G ++ E+L+GK    + +GK  L
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGKT---LFKGKDYL 248

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +GKG +  V + + +  G E A K    K  S       + E  I   +KH N+V L   
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 88
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
              ++  EGH  +I  DL+  G L++ +         +      +    + L  + +  Q
Sbjct: 89  ---SISEEGHHYLIF-DLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ 139
Query: 443 PAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             ++HRD+K  N+LL    +    K+ DFGLA    EG        AGT GY++PE    
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRK 198
Query: 500 GKLTPGSDVYSFGVVLLELLSG 521
                  D+++ GV+L  LL G
Sbjct: 199 DPYGKPVDLWACGVILYILLVG 220

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 105/236 (44%), Gaps = 39/236 (16%)
Query: 315 AATMNFSRENI-----IGKGGYGNVYK----GMLPNGT--EVAVKRFKNCSKAGDAN-FK 362
           A+   F R+ +     +G+G +G V +    G+    T   VAVK  K  +   +     
Sbjct: 21  ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALM 80
Query: 363 HEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW- 420
            E++I+  +  H+N+V L G  T      G   +++ +    G+L  +L     + + + 
Sbjct: 81  SELKILIHIGHHLNVVNLLGACTKP----GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 136
Query: 421 --PIRLR-----------IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
             P  L             +   A+G+ +L        IHRD+ A NILL E    K+ D
Sbjct: 137 EAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICD 193
Query: 468 FGLAK---FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           FGLA+    +P+ +     R+   L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 194 FGLARDIYKDPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   IG G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    KV DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 20/224 (8%)
Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEV----AVKRFKNCSKAGDANFKHE 364
           K+++++    +F    +IG+G +G V    L N  +V     + +++   +A  A F+ E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 365 VEIIASVKHVNLVALR-GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
            +++ +     +  L   +             +  DLL   S ++      M +  +   
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF-YLAE 183
Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           + IA+ +   L Y         +HRDIK  NIL+D     ++ DFG      E  T  ++
Sbjct: 184 MVIAIDSVHQLHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 234
Query: 484 RVAGTLGYVAPEY-----ALYGKLTPGSDVYSFGVVLLELLSGK 522
              GT  Y++PE         G+  P  D +S GV + E+L G+
Sbjct: 235 VAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   IG G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYMPGGDMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    KV DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 82/201 (40%), Gaps = 13/201 (6%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR---FKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG G YG   K    +  ++ V +   + + ++A       EV ++  +KH N+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK---LSWPIRLRIALGTARGLAYLHY 439
               +        IV +    G L   +   G K+   L     LR+       L   H 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 440 GVQPA--IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
                  ++HRD+K +N+ LD     K+GDFGLA+      T       GT  Y++PE  
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQM 188
Query: 498 LYGKLTPGSDVYSFGVVLLEL 518
                   SD++S G +L EL
Sbjct: 189 NRMSYNEKSDIWSLGCLLYEL 209

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 91/208 (43%), Gaps = 14/208 (6%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K  R    ++   +    E+ ++  + H N
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L         +    ++ +     +  L   +  S +  +  P+         +GLA
Sbjct: 67  IVKLLDV------IHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +      V  TL Y APE
Sbjct: 121 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPE 176
Query: 496 YALYGK-LTPGSDVYSFGVVLLELLSGK 522
             L  K  +   D++S G +  E+++ +
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 78/173 (45%), Gaps = 15/173 (8%)
Query: 354 SKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG 412
           SK  +AN + E+  +   + H N+V L       V  +     +V +LL+ G L++ +  
Sbjct: 45  SKRMEANTQKEITALKLCEGHPNIVKLH-----EVFHDQLHTFLVMELLNGGELFERI-- 97
Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFG 469
              K  S      I       ++++H      ++HRD+K  N+L    ++  E K+ DFG
Sbjct: 98  KKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFG 154
Query: 470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            A+  P     L T    TL Y APE           D++S GV+L  +LSG+
Sbjct: 155 FARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G      + EV I+  V H N++ L   Y   T        +++ +L+  G
Sbjct: 47  KRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRT------DVVLILELVSGG 100
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + LS             G+ YLH      I H D+K  NI LLD+    
Sbjct: 101 ELFD--FLAQKESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA    +G+      + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 156 PHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213
Query: 521 G 521
           G
Sbjct: 214 G 214

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 102/220 (46%), Gaps = 29/220 (13%)
Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIAS 370
           E+KA  +    E  +G+G YG V K   +P+G   AVKR +    + +   +   ++  S
Sbjct: 30  EVKADDLEPIXE--LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQK-RLLXDLDIS 86
Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL---YDHLFGSGMKKLSWPIRLRIA 427
            + V+      +  A    EG   + +C  L + SL   Y  +   G + +   I  +IA
Sbjct: 87  XRTVDCPFTVTFYGALF-REGD--VWICXELXDTSLDKFYKQVIDKG-QTIPEDILGKIA 142
Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           +   + L +LH  +  ++IHRD+K SN+L++   + K  DFG++ +  + +       AG
Sbjct: 143 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID--AG 198
Query: 488 TLGYVAPEYALYGKLTP---------GSDVYSFGVVLLEL 518
              Y APE     ++ P          SD++S G+  +EL
Sbjct: 199 CKPYXAPE-----RINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   IG G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    KV DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/121 (33%), Positives = 61/121 (50%), Gaps = 23/121 (19%)
Query: 416 KKLSWPIRLRI----ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
           K++  PI  RI     +   + L YL    +  +IHRD+K SNILLDE  + K+ DFG++
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
Query: 472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG----------SDVYSFGVVLLELLSG 521
               +       R AG   Y+APE     ++ P           +DV+S G+ L+EL +G
Sbjct: 173 GRLVD--DKAKDRSAGCAAYMAPE-----RIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 522 K 522
           +
Sbjct: 226 Q 226

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 29/242 (11%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR-FKNCSKA 356
           ++++     R  I E+ A    ++ +  I  G YG V  G+   G  VA+KR F   S  
Sbjct: 2   MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 357 GDANF----------KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNG-- 404
              N             E+ ++    H N++ LR           H+  +V +L+     
Sbjct: 62  RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 405 -SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA 463
             ++D       + + +     I LG       LH   +  ++HRD+   NILL +  + 
Sbjct: 122 QVIHDQRIVISPQHIQY-FMYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDI 173
Query: 464 KVGDFGLAKFNPEGI--THLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLS 520
            + DF LA+ +      TH  T       Y APE  +  K  T   D++S G V+ E+ +
Sbjct: 174 TICDFNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
Query: 521 GK 522
            K
Sbjct: 230 RK 231

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 83/204 (40%), Gaps = 19/204 (9%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR---FKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG G YG   K    +  ++ V +   + + ++A       EV ++  +KH N+V    Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVR---Y 70
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK---LSWPIRLRIALGTARGLAYLHY 439
               +        IV +    G L   +   G K+   L     LR+       L   H 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLAS-VITKGTKERQYLDEEFVLRVMTQLTLALKECHR 129
Query: 440 GVQPA--IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH---LTTRVAGTLGYVAP 494
                  ++HRD+K +N+ LD     K+GDFGLA+     + H         GT  Y++P
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI----LNHDEDFAKEFVGTPYYMSP 185
Query: 495 EYALYGKLTPGSDVYSFGVVLLEL 518
           E          SD++S G +L EL
Sbjct: 186 EQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 78/163 (47%), Gaps = 13/163 (7%)
Query: 363 HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
            E+ I+  + H N+V L        P E H   +V +L++ G + +      +K LS   
Sbjct: 85  QEIAILKKLDHPNVVKL--VEVLDDPNEDH-LYMVFELVNQGPVME---VPTLKPLSEDQ 138
Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
                    +G+ YLHY     IIHRDIK SN+L+ E    K+ DFG++    +G   L 
Sbjct: 139 ARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSN-EFKGSDALL 194
Query: 483 TRVAGTLGYVAPE-YALYGKLTPGS--DVYSFGVVLLELLSGK 522
           +   GT  ++APE  +   K+  G   DV++ GV L   + G+
Sbjct: 195 SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVA 486
            A+G+ +L        IHRD+ A NILL E    K+ DFGLA+    +P+ +     R+ 
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 259 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVA 486
            A+G+ +L        IHRD+ A NILL E    K+ DFGLA+    +P+ +     R+ 
Sbjct: 200 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 257 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 30/225 (13%)
Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNL 376
           +F     +G+GG+G V++     +    A+KR +  ++         EV+ +A ++H  +
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 377 VALRGYSTATVPLEGHQRI----------IVCDLLHNGSLYDHLFGS-GMKKLSWPIRLR 425
           V    Y  A +     +++          I   L    +L D + G   +++    + L 
Sbjct: 66  VR---YFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLT 482
           I L  A  + +LH      ++HRD+K SNI        KVGDFGL      + E  T LT
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 483 --------TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL 519
                   T   GT  Y++PE       +   D++S G++L ELL
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 95/213 (44%), Gaps = 43/213 (20%)
Query: 326 IGKGGYGNVYKGMLPNGTE--VAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           IG G +G V + M    T+  VAVK  +    A D N + E+    S++H N+V  +   
Sbjct: 28  IGSGNFG-VARLMRDKLTKELVAVKYIER-GAAIDENVQREIINHRSLRHPNIVRFK--- 82
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLA 435
              V L      I+ +    G LY+ +  +G          R +   AR        G++
Sbjct: 83  --EVILTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLSGVS 130
Query: 436 YLHYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGYV 492
           Y H  +Q  I HRD+K  N LLD   A   K+ DFG +K     + H   +   GT  Y+
Sbjct: 131 YCH-SMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYI 184
Query: 493 APEYALY----GKLTPGSDVYSFGVVLLELLSG 521
           APE  L     GK+   +DV+S GV L  +L G
Sbjct: 185 APEVLLRQEYDGKI---ADVWSCGVTLYVMLVG 214

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/242 (23%), Positives = 97/242 (40%), Gaps = 29/242 (11%)
Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKR-FKNCSKA 356
           ++++     R  I E+ A    ++ +  I  G YG V  G+   G  VA+KR F   S  
Sbjct: 2   MQAKGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDG 61
Query: 357 GDANF----------KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNG-- 404
              N             E+ ++    H N++ LR           H+  +V +L+     
Sbjct: 62  RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 405 -SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA 463
             ++D       + + +     I LG       LH   +  ++HRD+   NILL +  + 
Sbjct: 122 QVIHDQRIVISPQHIQY-FMYHILLG-------LHVLHEAGVVHRDLHPGNILLADNNDI 173
Query: 464 KVGDFGLAKFNPEGI--THLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLS 520
            + DF LA+ +      TH  T       Y APE  +  K  T   D++S G V+ E+ +
Sbjct: 174 TICDFNLAREDTADANKTHYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229
Query: 521 GK 522
            K
Sbjct: 230 RK 231

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVA 486
            A+G+ +L        IHRD+ A NILL E    K+ DFGLA+    +P+ +     R+ 
Sbjct: 207 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 264 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 8/94 (8%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRVA 486
            A+G+ +L        IHRD+ A NILL E    K+ DFGLA+    +P+ +     R+ 
Sbjct: 209 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
             L ++APE       T  SDV+SFGV+L E+ S
Sbjct: 266 --LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 33/252 (13%)
Query: 288 VTDNDEPSLVLESRSSN-LARFK-----IEEIKAATMNFSRENIIGKGGYGNV----YKG 337
           V D D P+L       N L+R+K     I +++    ++    +IG+G +G V    +K 
Sbjct: 33  VYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS 92
Query: 338 MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV 397
                    + +F+   ++  A F  E +I+A      +V L  Y+      +     +V
Sbjct: 93  TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-FYAFQ----DDRYLYMV 147
Query: 398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL 457
            + +  G L + +    + +  W         TA  +  L        IHRD+K  N+LL
Sbjct: 148 MEYMPGGDLVNLMSNYDVPE-KWA-----RFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201
Query: 458 DEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY-------ALYGKLTPGSDVY 509
           D++   K+ DFG   K N EG+    T V GT  Y++PE          YG+     D +
Sbjct: 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR---ECDWW 257
Query: 510 SFGVVLLELLSG 521
           S GV L E+L G
Sbjct: 258 SVGVFLYEMLVG 269

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 105/241 (43%), Gaps = 38/241 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + +      T  Y APE  L        D++S G ++ E++  
Sbjct: 164 TLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCH 221
Query: 522 K 522
           K
Sbjct: 222 K 222

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 33/252 (13%)
Query: 288 VTDNDEPSLVLESRSSN-LARFK-----IEEIKAATMNFSRENIIGKGGYGNV----YKG 337
           V D D P+L       N L+R+K     I +++    ++    +IG+G +G V    +K 
Sbjct: 38  VYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS 97
Query: 338 MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV 397
                    + +F+   ++  A F  E +I+A      +V L  Y+      +     +V
Sbjct: 98  TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-FYAFQ----DDRYLYMV 152
Query: 398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL 457
            + +  G L + +    + +  W         TA  +  L        IHRD+K  N+LL
Sbjct: 153 MEYMPGGDLVNLMSNYDVPE-KWA-----RFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 206
Query: 458 DEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY-------ALYGKLTPGSDVY 509
           D++   K+ DFG   K N EG+    T V GT  Y++PE          YG+     D +
Sbjct: 207 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR---ECDWW 262
Query: 510 SFGVVLLELLSG 521
           S GV L E+L G
Sbjct: 263 SVGVFLYEMLVG 274

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 69/249 (27%), Positives = 103/249 (41%), Gaps = 64/249 (25%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFK-------NCSKAGDANFKHEVEIIAS 370
           N+  +++IG+G YG VY     N  + VA+K+         +C +        E+ I+  
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKR-----ILREITILNR 83
Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD--HLFGSGMKKL-SWPIRLR-- 425
           +K   ++ L            H  II  DLL    LY    +  S +KKL   PI L   
Sbjct: 84  LKSDYIIRL------------HDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQ 131
Query: 426 ----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITH 480
               I      G  ++H   +  IIHRD+K +N LL++    K+ DFGLA+  N +   H
Sbjct: 132 HVKTILYNLLLGEKFIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIH 188
Query: 481 ------------------------LTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVL 515
                                   LT+ V  T  Y APE  L  +  T   D++S G + 
Sbjct: 189 IVNDLEEKEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTNSIDIWSTGCIF 247
Query: 516 LELLSGKKA 524
            ELL+  K+
Sbjct: 248 AELLNMMKS 256

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  +AGT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 107/252 (42%), Gaps = 33/252 (13%)
Query: 288 VTDNDEPSLVLESRSSN-LARFK-----IEEIKAATMNFSRENIIGKGGYGNV----YKG 337
           V D D P+L       N L+R+K     I +++    ++    +IG+G +G V    +K 
Sbjct: 38  VYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS 97
Query: 338 MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV 397
                    + +F+   ++  A F  E +I+A      +V L  Y+      +     +V
Sbjct: 98  TRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL-FYAFQ----DDRYLYMV 152
Query: 398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL 457
            + +  G L + +    + +  W         TA  +  L        IHRD+K  N+LL
Sbjct: 153 MEYMPGGDLVNLMSNYDVPE-KWA-----RFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 206
Query: 458 DEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY-------ALYGKLTPGSDVY 509
           D++   K+ DFG   K N EG+    T V GT  Y++PE          YG+     D +
Sbjct: 207 DKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGR---ECDWW 262
Query: 510 SFGVVLLELLSG 521
           S GV L E+L G
Sbjct: 263 SVGVFLYEMLVG 274

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 90/211 (42%), Gaps = 39/211 (18%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G           E+   ++    +  D N K E+    S++H N+V  +     
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFK----- 81
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLAYL 437
            V L      IV +    G L++ +  +G          R +   AR        G++Y 
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYA 131
Query: 438 HYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTRVA-GTLGYVAP 494
           H  +Q  + HRD+K  N LLD   A   K+ DFG +K     + H   + A GT  Y+AP
Sbjct: 132 H-AMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAP 185
Query: 495 EYALY----GKLTPGSDVYSFGVVLLELLSG 521
           E  L     GK+   +DV+S GV L  +L G
Sbjct: 186 EVLLKKEYDGKV---ADVWSCGVTLYVMLVG 213

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 90/203 (44%), Gaps = 19/203 (9%)
Query: 326 IGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVNLVALRGY 382
           +G+G +  V + +  + G E A K  K   +  D  A   HE+ ++   K       R  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP----RVI 92
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
           +   V     + I++ +    G ++        + +S    +R+      G+ YLH   Q
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---Q 149
Query: 443 PAIIHRDIKASNILLDEAF---EAKVGDFGLAKFNPEGITHLTT--RVAGTLGYVAPEYA 497
             I+H D+K  NILL   +   + K+ DFG+++     I H      + GT  Y+APE  
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGHACELREIMGTPEYLAPEIL 205
Query: 498 LYGKLTPGSDVYSFGVVLLELLS 520
            Y  +T  +D+++ G++   LL+
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLT 228

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 105/241 (43%), Gaps = 38/241 (15%)
Query: 300 SRSSNLARFKIEEIKAATMNFSR--ENI--IGKGGYGNV---YKGMLPNGTEVAVKR--- 349
           SRS     F   EI  +T    +  +N+  IG G  G V   Y  +L     VA+K+   
Sbjct: 2   SRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSR 59
Query: 350 -FKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSL-- 406
            F+N + A  A    E+ ++  V H N++ L    T    LE  Q + +   L + +L  
Sbjct: 60  PFQNQTHAKRAY--RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQ 117
Query: 407 -----YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF 461
                 DH      +++S+ +   +      G+ +LH      IIHRD+K SNI++    
Sbjct: 118 VIQMELDH------ERMSYLLYQMLC-----GIKHLHSA---GIIHRDLKPSNIVVKSDC 163
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFGLA+    G + +      T  Y APE  L        D++S G ++ E++  
Sbjct: 164 TLKILDFGLAR--TAGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCH 221
Query: 522 K 522
           K
Sbjct: 222 K 222

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLAHKIDFG--NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 19/204 (9%)
Query: 325 IIGKGGYGNVYKGMLPN-GTEVAVKRF--KNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           ++G+G YG V K    + G  VA+K+F   +  K        E++++  ++H NLV L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNL-- 89
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYD-HLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
                V  +  +  +V + + +  L D  LF +G   L + +  +       G+ + H  
Sbjct: 90  ---LEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCH-- 141
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
               IIHRDIK  NIL+ ++   K+ DFG A+            VA T  Y APE  L G
Sbjct: 142 -SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE-LLVG 198
Query: 501 KLTPGS--DVYSFGVVLLELLSGK 522
            +  G   DV++ G ++ E+  G+
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMGE 222

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 105 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 159
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+DE    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 160 LIDEQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 215
Query: 516 LELLSG 521
            E+ +G
Sbjct: 216 YEMAAG 221

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 90/205 (43%), Gaps = 23/205 (11%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IGKG +  V + + L  G E A K    K  S       + E  I   +KH N+V L   
Sbjct: 12  IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHD- 70
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
              ++  EG    +V DL+  G L++ +         +      +    + L  + +  Q
Sbjct: 71  ---SISEEGFH-YLVFDLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ 121
Query: 443 PAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY--- 496
             ++HRD+K  N+LL    +    K+ DFGLA    +G        AGT GY++PE    
Sbjct: 122 MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 497 ALYGKLTPGSDVYSFGVVLLELLSG 521
             YGK     D+++ GV+L  LL G
Sbjct: 181 EAYGKPV---DIWACGVILYILLVG 202

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 88/200 (44%), Gaps = 14/200 (7%)
Query: 326 IGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYS 383
           +G+G Y  VYKG        VA+K  +   + G       EV ++  +KH N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                L      +V + L +  L  +L   G       ++L +     RGLAY H   + 
Sbjct: 70  HTEKSL-----TLVFEYL-DKDLKQYLDDCGNIINMHNVKLFL-FQLLRGLAYCH---RQ 119
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-YGKL 502
            ++HRD+K  N+L++E  E K+ DFGLA+            V  TL Y  P+  L     
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDY 178
Query: 503 TPGSDVYSFGVVLLELLSGK 522
           +   D++  G +  E+ +G+
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVK--RFKNCSKAGDANFKHEVEIIA--- 369
           AT  +     IG G YG VYK   P+ G  VA+K  R  N    G       V  +A   
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 370 ---SVKHVNLVALRGY-STATVPLEGHQRIIVCDLLHNGSLY-DHLFGSGMKKLSWPIRL 424
              + +H N+V L    +T+    E    ++   +  +   Y D     G+   +    +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLM 126
Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
           R  L   RGL +LH      I+HRD+K  NIL+      K+ DFGLA+     +    T 
Sbjct: 127 RQFL---RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTP 178
Query: 485 VAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           V  TL Y APE  L        D++S G +  E+   K
Sbjct: 179 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V +    G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVLEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    KV DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 LIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 326 IGKGGYGNVYKGMLPNGTE-VAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG+G YG V+K       E VA+KR +  +  +   ++   E+ ++  +KH N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 L   +++ +     +  L  + F S    L   I         +GL + H    
Sbjct: 70  ------LHSDKKLTLVFEFCDQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL 502
             ++HRD+K  N+L++   E K+ DFGLA+     +   +  V  TL Y  P+     KL
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 503 TPGS-DVYSFGVVLLELLSGKK 523
              S D++S G +  EL +  +
Sbjct: 179 YSTSIDMWSAGCIFAELANAAR 200

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V +    G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           ++D+    KV DFGLAK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 MIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 24/210 (11%)
Query: 319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDANFKH---EVEIIASV 371
            F R   +G G +G V   ML      G   A+K             +H   E  I+ +V
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
               LV L  YS      +     +V + +  G ++ HL   G  + S P     A    
Sbjct: 99  NFPFLVKLE-YSFK----DNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIV 151
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
               YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEY 204
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE  L        D ++ GV++ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D L  +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFDFL--AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA  +     +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLA--HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/86 (38%), Positives = 45/86 (52%), Gaps = 12/86 (13%)
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVAPEY------ 496
            +IHRD+K  N+LLD+    K+ DFG   K +  G+ H  T V GT  Y++PE       
Sbjct: 194 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLKSQGG 252
Query: 497 -ALYGKLTPGSDVYSFGVVLLELLSG 521
              YG+     D +S GV L E+L G
Sbjct: 253 DGYYGR---ECDWWSVGVFLFEMLVG 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 98
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 99  ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 153
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA  +     +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 154 PRIKIIDFGLA--HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 521 G 521
           G
Sbjct: 212 G 212

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 24/210 (11%)
Query: 319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDANFKH---EVEIIASV 371
            F R   +G G +G V   ML      G   A+K             +H   E  I+ +V
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
               LV L  YS      +     +V + +  G ++ HL   G  + S P     A    
Sbjct: 99  NFPFLVKLE-YSFK----DNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIV 151
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
               YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEY 204
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE  L        D ++ GV++ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 98
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 99  ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 153
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 154 PRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211
Query: 521 G 521
           G
Sbjct: 212 G 212

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 86/210 (40%), Gaps = 24/210 (11%)
Query: 319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDANFKH---EVEIIASV 371
            F R   +G G +G V   ML      G   A+K             +H   E  I+ +V
Sbjct: 42  QFERIKTLGTGSFGRV---MLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAV 98
Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
               LV L  YS      +     +V + +  G ++ HL   G  + S P     A    
Sbjct: 99  NFPFLVKLE-YSFK----DNSNLYMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIV 151
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
               YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y
Sbjct: 152 LTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEY 204
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +APE  L        D ++ GV++ E+ +G
Sbjct: 205 LAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 99/223 (44%), Gaps = 30/223 (13%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNLVAL--- 379
           IG+G +G V+K      G +VA+K+   +N  +        E++I+  +KH N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 380 -RGYSTATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
            R  ++     +G   ++   C+    G L + L    + ++      R+      GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQMLLNGLYY 140
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TLGYVA 493
           +H      I+HRD+KA+N+L+      K+ DFGLA+           R      TL Y  
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 494 PEYAL----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS 532
           PE  L    YG   P  D++  G ++ E+ +      I+QG +
Sbjct: 198 PELLLGERDYG---PPIDLWGAGCIMAEMWT---RSPIMQGNT 234

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA  +     +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLA--HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA  +     +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLA--HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/212 (25%), Positives = 89/212 (41%), Gaps = 31/212 (14%)
Query: 324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
            +IGKG +G VY G       + +   +  ++     FK EV      +H N+V   G  
Sbjct: 39  ELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
            +   L      I+  L    +LY  +  + +  L      +IA    +G+ YLH     
Sbjct: 99  MSPPHL-----AIITSLCKGRTLYSVVRDAKI-VLDVNKTRQIAQEIVKGMGYLH---AK 149
Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA------GTLGYVAPEYA 497
            I+H+D+K+ N+  D   +  + DFGL  F+  G+     R        G L ++APE  
Sbjct: 150 GILHKDLKSKNVFYDNG-KVVITDFGL--FSISGVLQAGRREDKLRIQNGWLCHLAPE-- 204
Query: 498 LYGKLTPG-----------SDVYSFGVVLLEL 518
           +  +L+P            SDV++ G +  EL
Sbjct: 205 IIRQLSPDTEEDKLPFSKHSDVFALGTIWYEL 236

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 28  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 87
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 88  FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 140
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 141 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAP 193
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVA--VKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +GKG +  V + + +  G E A  +   K  S       + E  I   +KH N+V L   
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 77
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
              ++  EGH  +I  DL+  G L++ +         +      +    + L  + +  Q
Sbjct: 78  ---SISEEGHHYLIF-DLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQ 128
Query: 443 PAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             ++HR++K  N+LL    +    K+ DFGLA    EG        AGT GY++PE    
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRK 187
Query: 500 GKLTPGSDVYSFGVVLLELLSG 521
                  D+++ GV+L  LL G
Sbjct: 188 DPYGKPVDLWACGVILYILLVG 209

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 39/211 (18%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G           E+   ++    +  D N K E+    S++H N+V  +     
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFK----- 80
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLAYL 437
            V L      IV +    G L++ +  +G          R +   AR        G++Y 
Sbjct: 81  EVILTPTHLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYC 130
Query: 438 HYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGYVAP 494
           H  +Q  + HRD+K  N LLD   A   K+ DFG +K     + H   +   GT  Y+AP
Sbjct: 131 H-AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAP 184
Query: 495 EYALY----GKLTPGSDVYSFGVVLLELLSG 521
           E  L     GK+   +DV+S GV L  +L G
Sbjct: 185 EVLLKKEYDGKV---ADVWSCGVTLYVMLVG 212

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 100/217 (46%), Gaps = 30/217 (13%)
Query: 318 MNFSRENIIGKGGYGN-VYKGMLPNGTEVAVKR-FKNCSKAGDANFKHEVEII-ASVKHV 374
           ++F  ++++G G  G  VY+GM  N  +VAVKR    C    D     EV+++  S +H 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDN-RDVAVKRILPECFSFAD----REVQLLRESDEHP 78
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW-PIRLRIALGTARG 433
           N++  R + T       +  I +C      +L +++       L   PI L     T  G
Sbjct: 79  NVI--RYFCTEKDRQFQYIAIELC----AATLQEYVEQKDFAHLGLEPITL--LQQTTSG 130
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDE-----AFEAKVGDFGLAKFNPEGITHLTTR--VA 486
           LA+LH      I+HRD+K  NIL+         +A + DFGL K    G    + R  V 
Sbjct: 131 LAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP 187
Query: 487 GTLGYVAPEYALYG-KLTP--GSDVYSFGVVLLELLS 520
           GT G++APE      K  P    D++S G V   ++S
Sbjct: 188 GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 111 MVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 165
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 166 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 221
Query: 516 LELLSG 521
            E+ +G
Sbjct: 222 YEMAAG 227

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNLVAL--- 379
           IG+G +G V+K      G +VA+K+   +N  +        E++I+  +KH N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 380 -RGYSTATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
            R  ++     +G   ++   C+    G L + L    + ++      R+      GL Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQMLLNGLYY 139
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TLGYVA 493
           +H   +  I+HRD+KA+N+L+      K+ DFGLA+           R      TL Y  
Sbjct: 140 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 494 PEYAL----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS 532
           PE  L    YG   P  D++  G ++ E+ +      I+QG +
Sbjct: 197 PELLLGERDYG---PPIDLWGAGCIMAEMWT---RSPIMQGNT 233

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 103 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 156 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILIGELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D  F +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFD--FLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
              K+ DFGLA  +     +    + GT  +VAPE   Y  L   +D++S GV+   LLS
Sbjct: 155 PRIKIIDFGLA--HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 212
Query: 521 G 521
           G
Sbjct: 213 G 213

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 83/207 (40%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  + S P     A       
Sbjct: 103 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 155
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 156 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAP 208
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 81/184 (44%), Gaps = 26/184 (14%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNG 404
           KR    S+ G    + + EV I+  ++H N++ L   Y   T        I++ +L+  G
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKT------DVILILELVAGG 99
Query: 405 SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF-- 461
            L+D L  +  + L+             G+ YLH      I H D+K  NI LLD     
Sbjct: 100 ELFDFL--AEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154
Query: 462 -EAKVGDFGLA---KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE 517
              K+ DFGLA    F  E        + GT  +VAPE   Y  L   +D++S GV+   
Sbjct: 155 PRIKIIDFGLAHKIDFGNE-----FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYI 209
Query: 518 LLSG 521
           LLSG
Sbjct: 210 LLSG 213

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 88/225 (39%), Gaps = 45/225 (20%)
Query: 317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH--------EVEI 367
           +  +S  + +G G +G V+  +      EV VK  K      D   +         E+ I
Sbjct: 23  SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF---GSGMK-------- 416
           ++ V+H N++                   V D+  N   +  +    GSG+         
Sbjct: 83  LSRVEHANIIK------------------VLDIFENQGFFQLVMEKHGSGLDLFAFIDRH 124
Query: 417 -KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP 475
            +L  P+   I       + YL       IIHRDIK  NI++ E F  K+ DFG A +  
Sbjct: 125 PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181
Query: 476 EGITHLTTRVAGTLGYVAPEYALYGKLT-PGSDVYSFGVVLLELL 519
            G   L     GT+ Y APE  +      P  +++S GV L  L+
Sbjct: 182 RG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 94/213 (44%), Gaps = 43/213 (20%)
Query: 326 IGKGGYGNVYKGMLPNGTE--VAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           IG G +G V + M    +   VAVK  +   K   AN K E+    S++H N+V  +   
Sbjct: 27  IGSGNFG-VARLMRDKQSNELVAVKYIERGEKIA-ANVKREIINHRSLRHPNIVRFK--- 81
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLA 435
              V L      IV +    G L++ +  +G          R +   AR        G++
Sbjct: 82  --EVILTPTHLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVS 129
Query: 436 YLHYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGYV 492
           Y H  +Q  + HRD+K  N LLD   A   K+ DFG +K     + H   +   GT  Y+
Sbjct: 130 YCH-AMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYI 183
Query: 493 APEYALY----GKLTPGSDVYSFGVVLLELLSG 521
           APE  L     GK+   +DV+S GV L  +L G
Sbjct: 184 APEVLLKKEYDGKV---ADVWSCGVTLYVMLVG 213

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V +    G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           ++D+    KV DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 MIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V +    G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           ++D+    KV DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 MIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 82/207 (39%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V +    G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+++D+    KV DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 139 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 193
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 194 LIDQQGYIQVTDFGFAK----RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 516 LELLSG 521
            E+ +G
Sbjct: 250 YEMAAG 255

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V +    G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           ++D+    KV DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 MIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V +    G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           ++D+    +V DFGLAK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 MIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 30/223 (13%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNLVAL--- 379
           IG+G +G V+K      G +VA+K+   +N  +        E++I+  +KH N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 380 -RGYSTATVPLEGHQRIIV--CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
            R  ++     +G   ++   C+    G L + L    + ++      R+      GL Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQMLLNGLYY 140
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TLGYVA 493
           +H   +  I+HRD+KA+N+L+      K+ DFGLA+           R      TL Y  
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 494 PEYAL----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS 532
           PE  L    YG   P  D++  G ++ E+ +      I+QG +
Sbjct: 198 PELLLGERDYG---PPIDLWGAGCIMAEMWT---RSPIMQGNT 234

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/126 (29%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 139 MVMEYVPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 193
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 194 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 516 LELLSG 521
            E+ +G
Sbjct: 250 YEMAAG 255

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 88/202 (43%), Gaps = 17/202 (8%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSK--AGD-ANFKHEVEIIASVKHVNLVALRGY 382
           +GKG +  V + +    T+    +  N  K  A D    + E  I   +KH N+V L   
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD- 97
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
              ++  EG    +V DL+  G L++ +         +      +    + L  +++  Q
Sbjct: 98  ---SISEEGFH-YLVFDLVTGGELFEDIVAR-----EYYSEADASHCIHQILESVNHIHQ 148
Query: 443 PAIIHRDIKASNILLD---EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
             I+HRD+K  N+LL    +    K+ DFGLA    +G        AGT GY++PE    
Sbjct: 149 HDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPEVLRK 207
Query: 500 GKLTPGSDVYSFGVVLLELLSG 521
                  D+++ GV+L  LL G
Sbjct: 208 DPYGKPVDIWACGVILYILLVG 229

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 90/207 (43%), Gaps = 21/207 (10%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR--FKN-CSKAG-DANFKHEVEIIASVKHVNLVALRG 381
           +GKG +GNVY         +   +  FK+   K G +   + E+EI A + H N++ L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           Y          +RI ++ +    G LY  L  S          +   L  A  L Y H  
Sbjct: 91  Y------FYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADA--LMYCH-- 140
Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
               +IHRDIK  N+LL    E K+ DFG +   P   +     + GTL Y+ PE  + G
Sbjct: 141 -GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAP---SLRRKTMCGTLDYLPPE-MIEG 195
Query: 501 KL-TPGSDVYSFGVVLLELLSGKKACE 526
           ++     D++  GV+  ELL G    E
Sbjct: 196 RMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGS 405
           KR  + S+ G      + EV I+  ++H N++ L         +     +++ +L+  G 
Sbjct: 47  KRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV-----VLILELVSGGE 101
Query: 406 LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF--- 461
           L+D  F +  + L+     +       G+ YLH      I H D+K  NI LLD+     
Sbjct: 102 LFD--FLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNP 156
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFG+A     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLSG
Sbjct: 157 RIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 102/242 (42%), Gaps = 61/242 (25%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFK-------NCSKAGDANFKHEVEIIAS 370
           N+  +++IG+G YG VY     N  + VA+K+         +C +        E+ I+  
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-----ILREITILNR 81
Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYD--HLFGSGMKKL-SWPIRLR-- 425
           +K   ++ L            +  II  DLL    LY    +  S +KKL   PI L   
Sbjct: 82  LKSDYIIRL------------YDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE 129
Query: 426 ----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITH 480
               I      G  ++H   +  IIHRD+K +N LL++    KV DFGLA+  N E  T+
Sbjct: 130 HIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTN 186
Query: 481 ---------------------LTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLEL 518
                                LT+ V  T  Y APE  L  +  T   D++S G +  EL
Sbjct: 187 IVNDLEENEEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245
Query: 519 LS 520
           L+
Sbjct: 246 LN 247

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + + P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFAEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/180 (28%), Positives = 82/180 (45%), Gaps = 18/180 (10%)
Query: 348 KRFKNCSKAG--DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGS 405
           KR  + S+ G      + EV I+  ++H N++ L         +     +++ +L+  G 
Sbjct: 40  KRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV-----VLILELVSGGE 94
Query: 406 LYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF--- 461
           L+D  F +  + L+     +       G+ YLH      I H D+K  NI LLD+     
Sbjct: 95  LFD--FLAEKESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNP 149
Query: 462 EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             K+ DFG+A     G  +    + GT  +VAPE   Y  L   +D++S GV+   LLSG
Sbjct: 150 RIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            ++ +G
Sbjct: 229 YQMAAG 234

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/96 (41%), Positives = 50/96 (52%), Gaps = 15/96 (15%)
Query: 437 LHYGVQPAIIHRDIKASNILL--DEAFEAKVGDFGLA----KFNPEGITHLTTRVAGTLG 490
           LHY     I HRDIK  N L   +++FE K+ DFGL+    K N      +TT+ AGT  
Sbjct: 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTK-AGTPY 239
Query: 491 YVAPEY-----ALYGKLTPGSDVYSFGVVLLELLSG 521
           +VAPE        YG   P  D +S GV+L  LL G
Sbjct: 240 FVAPEVLNTTNESYG---PKCDAWSAGVLLHLLLMG 272

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/251 (24%), Positives = 101/251 (40%), Gaps = 32/251 (12%)
Query: 279 KKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNVYKG 337
           K SE+  VK         + +++   L +++      A ++ F R   +G G +G V   
Sbjct: 8   KGSEQESVK-------EFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV--- 57
Query: 338 ML----PNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALRGYSTATVPLE 390
           ML     +G   A+K             +H   E  I+ +V    LV L         L 
Sbjct: 58  MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL- 116
Query: 391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDI 450
                +V + +  G ++ HL   G  +   P     A        YLH      +I+RD+
Sbjct: 117 ----YMVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDL 167
Query: 451 KASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYS 510
           K  N+L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++
Sbjct: 168 KPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWA 223
Query: 511 FGVVLLELLSG 521
            GV++ E+ +G
Sbjct: 224 LGVLIYEMAAG 234

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 23/209 (11%)
Query: 326 IGKGGYGNVYKGMLP--------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +G+G +  ++KG+          + TEV +K      +    +F     +++ + H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY- 436
              G     V   G + I+V + +  GSL  +L     KK    I +   L  A+ LA+ 
Sbjct: 76  LNYG-----VCFCGDENILVQEFVKFGSLDTYL-----KKNKNCINILWKLEVAKQLAWA 125
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG--ITHLTTRV-AGTLGYVA 493
           +H+  +  +IH ++ A NILL    + K G+    K +  G  IT L   +    + +V 
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 494 PEYALYGK-LTPGSDVYSFGVVLLELLSG 521
           PE     K L   +D +SFG  L E+ SG
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 362 KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
           + EV I+  ++H N++ L         +     +++ +L+  G L+D L  +  + L+  
Sbjct: 77  EREVNILREIRHPNIITLHDIFENKTDV-----VLILELVSGGELFDFL--AEKESLTED 129
Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI-LLDEAF---EAKVGDFGLAKFNPEG 477
              +       G+ YLH      I H D+K  NI LLD+       K+ DFG+A     G
Sbjct: 130 EATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 186
Query: 478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             +    + GT  +VAPE   Y  L   +D++S GV+   LLSG
Sbjct: 187 --NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V +    G ++ HL   G  + S P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYAPGGEMFSHLRRIG--RFSEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+++D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  +   P     A        YLH      +I+RD+K  N+
Sbjct: 113 MVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 167
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 168 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 223
Query: 516 LELLSG 521
            E+ +G
Sbjct: 224 YEMAAG 229

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 88/197 (44%), Gaps = 15/197 (7%)
Query: 326 IGKGGYGNVYKGMLPNGTE-VAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG+G YG V+K       E VA+KR +  +  +   ++   E+ ++  +KH N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 L   +++ +     +  L  + F S    L   I         +GL + H    
Sbjct: 70  ------LHSDKKLTLVFEFCDQDLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCH---S 119
Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL 502
             ++HRD+K  N+L++   E K+ +FGLA+     +   +  V  TL Y  P+     KL
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKL 178
Query: 503 TPGS-DVYSFGVVLLEL 518
              S D++S G +  EL
Sbjct: 179 YSTSIDMWSAGCIFAEL 195

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  +   P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           ++D+    +V DFG AK     +   T  + GT  Y+APE  +        D ++ GV++
Sbjct: 173 IIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  +   P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  +   P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 43  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 102
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  +   P     A       
Sbjct: 103 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 155
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 156 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           IG+G +G V+K      G +VA+K+   +N  +        E++I+  +KH N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 383 -STATVPLEGHQRII-----VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
             T   P    +  I      C+    G L + L    + ++      R+      GL Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQMLLNGLYY 140
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG---TLGYVA 493
           +H   +  I+HRD+KA+N+L+      K+ DFGLA+           R      TL Y  
Sbjct: 141 IH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 494 PEYAL----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS 532
           PE  L    YG   P  D++  G ++ E+ +      I+QG +
Sbjct: 198 PELLLGERDYG---PPIDLWGAGCIMAEMWT---RSPIMQGNT 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  +   P     A        YLH      +I+RD+K  N+
Sbjct: 111 MVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 165
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 166 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 221
Query: 516 LELLSG 521
            E+ +G
Sbjct: 222 YEMAAG 227

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 82/207 (39%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V + +  G ++ HL   G  +   P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYVPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+L+D+    +V DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 21/216 (9%)
Query: 314 KAATMNFSRENIIGK---GGYGNVYKGMLPNGTEVAVK--RFKNCSKAGDANFKHEVEII 368
           K + ++F + N + K      G ++KG    G ++ VK  + ++ S     +F  E   +
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
               H N++ + G   +  P   H  +I    +  GSLY+ L       +     ++ AL
Sbjct: 62  RIFSHPNVLPVLGACQS--PPAPHPTLI-THWMPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             ARG+A+LH  ++P I    + + ++++DE   A++      KF+ +    +       
Sbjct: 119 DMARGMAFLH-TLEPLIPRHALNSRSVMIDEDMTARIS-MADVKFSFQSPGRMYAP---- 172
Query: 489 LGYVAPEYALYGKLTP----GSDVYSFGVVLLELLS 520
             +VAPE AL  K        +D++SF V+L EL++
Sbjct: 173 -AWVAPE-ALQKKPEDTNRRSADMWSFAVLLWELVT 206

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 364 EVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
           E+EI+    +H N++ L+      V  +G    +V +L+  G L D +     +K     
Sbjct: 70  EIEILLRYGQHPNIITLK-----DVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSER 121
Query: 423 RLRIALGT-ARGLAYLHYGVQPAIIHRDIKASNIL-LDEAFEA---KVGDFGLAKFNPEG 477
                L T  + + YLH      ++HRD+K SNIL +DE+      ++ DFG AK     
Sbjct: 122 EASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK-QLRA 177
Query: 478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
              L      T  +VAPE         G D++S G++L  +L+G
Sbjct: 178 ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG-TL 489
           A+G+A+L        IHRD+ A NILL      K+ DFGLA+       ++    A   +
Sbjct: 178 AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPV 234
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            ++APE       T  SDV+S+G+ L EL S
Sbjct: 235 KWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 81/207 (39%), Gaps = 18/207 (8%)
Query: 319 NFSRENIIGKGGYGNVY-KGMLPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHV 374
            F R   +G G +G V     +  G   A+K             +H   E  I+ +V   
Sbjct: 42  QFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            LV L         L      +V +    G ++ HL   G  +   P     A       
Sbjct: 102 FLVKLEFSFKDNSNL-----YMVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTF 154
Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YLH      +I+RD+K  N+++D+    KV DFG AK     +   T  + GT  Y+AP
Sbjct: 155 EYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E  L        D ++ GV++ E+ +G
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 36/107 (33%), Positives = 50/107 (46%), Gaps = 14/107 (13%)
Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITH 480
           L I +  A  + +LH      ++HRD+K SNI        KVGDFGL      + E  T 
Sbjct: 167 LHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
Query: 481 LTTRVA--------GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL 519
           LT   A        GT  Y++PE       +   D++S G++L ELL
Sbjct: 224 LTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V +    G ++ HL   G  +   P     A        YLH      +I+RD+K  N+
Sbjct: 119 MVMEYAPGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 173
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           ++D+    KV DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 174 MIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 229
Query: 516 LELLSG 521
            E+ +G
Sbjct: 230 YEMAAG 235

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  +   P     A        YLH      +I+RD+K  N+
Sbjct: 139 MVMEYVAGGEMFSHLRRIG--RFXEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 193
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+APE  L        D ++ GV++
Sbjct: 194 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLI 249
Query: 516 LELLSG 521
            E+ +G
Sbjct: 250 YEMAAG 255

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 364 EVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
           E+EI+    +H N++ L+      V  +G    +V +L+  G L D +     +K     
Sbjct: 70  EIEILLRYGQHPNIITLK-----DVYDDGKHVYLVTELMRGGELLDKIL---RQKFFSER 121
Query: 423 RLRIALGT-ARGLAYLHYGVQPAIIHRDIKASNIL-LDEAFEA---KVGDFGLAKFNPEG 477
                L T  + + YLH      ++HRD+K SNIL +DE+      ++ DFG AK     
Sbjct: 122 EASFVLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAK-QLRA 177
Query: 478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
              L      T  +VAPE         G D++S G++L  +L+G
Sbjct: 178 ENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG-T 488
            A+G+A+L        IHRD+ A NILL      K+ DFGLA+       ++    A   
Sbjct: 170 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + ++APE       T  SDV+S+G+ L EL S
Sbjct: 227 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT  Y+AP   L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/183 (25%), Positives = 83/183 (45%), Gaps = 25/183 (13%)
Query: 341 NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDL 400
           N  ++++K     SK  D  FK+E++II  +K+   +   G  T        +  I+ + 
Sbjct: 77  NNDKISIK-----SKYDD--FKNELQIITDIKNEYCLTCEGIITNY-----DEVYIIYEY 124
Query: 401 LHNGSL--YDHLFGSGMKKLSWPIRLR----IALGTARGLAYLHYGVQPAIIHRDIKASN 454
           + N S+  +D  F    K  +  I ++    I        +Y+H   +  I HRD+K SN
Sbjct: 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSN 182
Query: 455 ILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGS--DVYSFG 512
           IL+D+    K+ DFG +++    +        GT  ++ PE+        G+  D++S G
Sbjct: 183 ILMDKNGRVKLSDFGESEY---MVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLG 239
Query: 513 VVL 515
           + L
Sbjct: 240 ICL 242

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 107/253 (42%), Gaps = 29/253 (11%)
Query: 276 TRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVY 335
            R  +S E   K  DN+   ++L  +   +     EE+  AT        +G+G +G V+
Sbjct: 38  ARGSRSREPSPKTEDNE--GVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVH 91
Query: 336 KGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR 394
           +      G + AVK+ +      +     E+   A +    +V L G        EG   
Sbjct: 92  RMEDKQTGFQCAVKKVRL-----EVFRAEELMACAGLTSPRIVPLYGAVR-----EGPWV 141
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA-RGLAYLHYGVQPAIIHRDIKAS 453
            I  +LL  GSL   +   G        R    LG A  GL YLH      I+H D+KA 
Sbjct: 142 NIFMELLEGGSLGQLVKEQGCLPED---RALYYLGQALEGLEYLH---SRRILHGDVKAD 195
Query: 454 NILL-DEAFEAKVGDFGLAK-FNPEGITH--LTTR-VAGTLGYVAPEYALYGKLTPGSDV 508
           N+LL  +   A + DFG A    P+G+    LT   + GT  ++APE  L        DV
Sbjct: 196 NVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDV 255
Query: 509 YSFGVVLLELLSG 521
           +S   ++L +L+G
Sbjct: 256 WSSCCMMLHMLNG 268

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 47/92 (51%), Gaps = 4/92 (4%)
Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG-T 488
            A+G+A+L        IHRD+ A NILL      K+ DFGLA+       ++    A   
Sbjct: 172 VAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
           + ++APE       T  SDV+S+G+ L EL S
Sbjct: 229 VKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG-TL 489
           A+G+A+L        IHRD+ A NILL      K+ DFGLA+       ++    A   +
Sbjct: 155 AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            ++APE       T  SDV+S+G+ L EL S
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           N+  +  +GKG +  V + +    G E A K    K  S       + E  I   ++H N
Sbjct: 6   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 65
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L          E     +V DL+  G L++ +        S              +A
Sbjct: 66  IVRLHDSIQ-----EESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIA 118
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
           Y H      I+HR++K  N+LL    +    K+ DFGLA + N     H     AGT GY
Sbjct: 119 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 172
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           ++PE       +   D+++ GV+L  LL G
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 107/253 (42%), Gaps = 29/253 (11%)
Query: 276 TRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVY 335
            R  +S E   K  DN+   ++L  +   +     EE+  AT        +G+G +G V+
Sbjct: 57  ARGSRSREPSPKTEDNE--GVLLTEKLKPVDYEYREEVHWATHQLR----LGRGSFGEVH 110
Query: 336 KGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR 394
           +      G + AVK+ +      +     E+   A +    +V L G        EG   
Sbjct: 111 RMEDKQTGFQCAVKKVRL-----EVFRAEELMACAGLTSPRIVPLYGAVR-----EGPWV 160
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA-RGLAYLHYGVQPAIIHRDIKAS 453
            I  +LL  GSL   +   G        R    LG A  GL YLH      I+H D+KA 
Sbjct: 161 NIFMELLEGGSLGQLVKEQGCLPED---RALYYLGQALEGLEYLH---SRRILHGDVKAD 214
Query: 454 NILL-DEAFEAKVGDFGLAK-FNPEGITH--LTTR-VAGTLGYVAPEYALYGKLTPGSDV 508
           N+LL  +   A + DFG A    P+G+    LT   + GT  ++APE  L        DV
Sbjct: 215 NVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDV 274
Query: 509 YSFGVVLLELLSG 521
           +S   ++L +L+G
Sbjct: 275 WSSCCMMLHMLNG 287

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 47/91 (51%), Gaps = 4/91 (4%)
Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG-TL 489
           A+G+A+L        IHRD+ A NILL      K+ DFGLA+       ++    A   +
Sbjct: 178 AKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 234
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLS 520
            ++APE       T  SDV+S+G+ L EL S
Sbjct: 235 KWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           N+  +  +GKG +  V + +    G E A K    K  S       + E  I   ++H N
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L          E     +V DL+  G L++ +        S              +A
Sbjct: 67  IVRLHDSIQ-----EESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIA 119
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
           Y H      I+HR++K  N+LL    +    K+ DFGLA + N     H     AGT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 173
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           ++PE       +   D+++ GV+L  LL G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 23/209 (11%)
Query: 326 IGKGGYGNVYKGMLP--------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +G+G +  ++KG+          + TEV +K      +    +F     +++ + H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY- 436
              G         G + I+V + +  GSL  +L     KK    I +   L  A+ LA  
Sbjct: 76  LNYGVCVC-----GDENILVQEFVKFGSLDTYL-----KKNKNCINILWKLEVAKQLAAA 125
Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG--ITHLTTRV-AGTLGYVA 493
           +H+  +  +IH ++ A NILL    + K G+    K +  G  IT L   +    + +V 
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVP 185
Query: 494 PEYALYGK-LTPGSDVYSFGVVLLELLSG 521
           PE     K L   +D +SFG  L E+ SG
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           N+  +  +GKG +  V + +    G E A K    K  S       + E  I   ++H N
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 66
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L          E     +V DL+  G L++ +        S              +A
Sbjct: 67  IVRLHDSIQ-----EESFHYLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIA 119
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
           Y H      I+HR++K  N+LL    +    K+ DFGLA + N     H     AGT GY
Sbjct: 120 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 173
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           ++PE       +   D+++ GV+L  LL G
Sbjct: 174 LSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 39/211 (18%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G           E+   ++    +  D N K E+    S++H N+V  +     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFK----- 81
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLAYL 437
            V L      IV +    G L++ +  +G          R +   AR        G++Y 
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYC 131
Query: 438 HYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGYVAP 494
           H  +Q  + HRD+K  N LLD   A   K+  FG +K     + H   +   GT  Y+AP
Sbjct: 132 H-AMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAP 185
Query: 495 EYALY----GKLTPGSDVYSFGVVLLELLSG 521
           E  L     GK+   +DV+S GV L  +L G
Sbjct: 186 EVLLKKEYDGKV---ADVWSCGVTLYVMLVG 213

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 92/219 (42%), Gaps = 36/219 (16%)
Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRG 381
            ++G+G Y  V   + L NG E AVK  +  +    +    EVE +   + + N++ L  
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           +       E   R  +V + L  GS+  H+     K  +     R+    A  L +LH  
Sbjct: 79  F------FEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREASRVVRDVAAALDFLH-- 128
Query: 441 VQPAIIHRDIKASNILL---DEAFEAKVGDFGLA---KFN----PEGITHLTTRVAGTLG 490
               I HRD+K  NIL    ++    K+ DF L    K N    P     LTT   G+  
Sbjct: 129 -TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTT-PCGSAE 186
Query: 491 YVAPEY--------ALYGKLTPGSDVYSFGVVLLELLSG 521
           Y+APE           Y K     D++S GVVL  +LSG
Sbjct: 187 YMAPEVVEVFTDQATFYDKRC---DLWSLGVVLYIMLSG 222

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 39/211 (18%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA 385
           IG G +G           E+   ++    +  D N K E+    S++H N+V  +     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFK----- 81
Query: 386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLAYL 437
            V L      IV +    G L++ +  +G          R +   AR        G++Y 
Sbjct: 82  EVILTPTHLAIVMEYASGGELFERICNAG----------RFSEDEARFFFQQLISGVSYC 131
Query: 438 HYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTR-VAGTLGYVAP 494
           H  +Q  + HRD+K  N LLD   A   K+  FG +K     + H   +   GT  Y+AP
Sbjct: 132 H-AMQ--VCHRDLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAP 185
Query: 495 EYALY----GKLTPGSDVYSFGVVLLELLSG 521
           E  L     GK+   +DV+S GV L  +L G
Sbjct: 186 EVLLKKEYDGKV---ADVWSCGVTLYVMLVG 213

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 58/126 (46%), Gaps = 9/126 (7%)
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           +V + +  G ++ HL   G  + S P     A        YLH      +I+RD+K  N+
Sbjct: 118 MVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENL 172
Query: 456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVL 515
           L+D+    +V DFG AK     +   T  + GT   +APE  L        D ++ GV++
Sbjct: 173 LIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLI 228
Query: 516 LELLSG 521
            E+ +G
Sbjct: 229 YEMAAG 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 20/210 (9%)
Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           N+  +  +GKG +  V + +    G E A K    K  S       + E  I   ++H N
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPN 89
Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L      ++  E     +V DL+  G L++ +        S              +A
Sbjct: 90  IVRLHD----SIQEESFH-YLVFDLVTGGELFEDIVAREF--YSEADASHCIQQILESIA 142
Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
           Y H      I+HR++K  N+LL    +    K+ DFGLA + N     H     AGT GY
Sbjct: 143 YCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGY 196
Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           ++PE       +   D+++ GV+L  LL G
Sbjct: 197 LSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 77/171 (45%), Gaps = 10/171 (5%)
Query: 308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVE 366
           F  + ++   +      ++ +GG+  VY+   + +G E A+KR  +  +  +     EV 
Sbjct: 18  FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVC 77
Query: 367 IIASVK-HVNLVALRGYSTATVPLE----GHQRIIVCDLLHNGSLYDHLFGSGMK-KLSW 420
            +  +  H N+V     S A++  E    G    ++   L  G L + L     +  LS 
Sbjct: 78  FMKKLSGHPNIVQF--CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSC 135
Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
              L+I   T R + ++H   +P IIHRD+K  N+LL      K+ DFG A
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 112/256 (43%), Gaps = 51/256 (19%)
Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNV-YKGMLPNGTEVAVKRF--KNCSKA 356
           SR +N+  F+ + +K   ++   E I+G G  G V ++G    G  VAVKR     C  A
Sbjct: 1   SRIANIPNFE-QSLKNLVVS---EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA 55
Query: 357 GDANFKHEVEIIA-SVKHVNLVALRGYSTATVPLEGHQRIIVC-----DLLHNGSLYDHL 410
                  E++++  S  H N++  R Y + T     +  + +C     DL+ + ++ D  
Sbjct: 56  -----LMEIKLLTESDDHPNVI--RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDE- 107
Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD------------ 458
               ++K   PI L   +  A G+A+LH      IIHRD+K  NIL+             
Sbjct: 108 -NLKLQKEYNPISLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTG 161
Query: 459 -EAFEAKVGDFGLAKFNPEGITHLTTRV---AGTLGYVAPE-------YALYGKLTPGSD 507
            E     + DFGL K    G +   T +   +GT G+ APE            +LT   D
Sbjct: 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221
Query: 508 VYSFGVVLLELLSGKK 523
           ++S G V   +LS  K
Sbjct: 222 IFSMGCVFYYILSKGK 237

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 37/223 (16%)
Query: 324 NIIGKGGYGNVYKGM--LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           + +G+G +G V + +     G  VAVK  KN  +  +A  + E++++  +   +  +   
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-RSEIQVLEHLNTTDPNSTFR 78
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL----RIALGTARGLAYL 437
                   E H  I +   L   S YD +  +G      P RL    ++A    + + +L
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFL 134
Query: 438 HYGVQPAIIHRDIKASNILL-----DEAF--------------EAKVGDFGLAKFNPEGI 478
           H      + H D+K  NIL       EA+              + KV DFG A ++ E  
Sbjct: 135 HSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-- 189
Query: 479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            H +T V+ T  Y APE  L    +   DV+S G +L+E   G
Sbjct: 190 -HHSTLVS-TRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 26/214 (12%)
Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNLVALRGYST 384
           +G+G YG+VYK    +G +      K     G   +   E+ ++  +KH N+++L+    
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQ---- 84
Query: 385 ATVPLEGHQRIIVCDLLHNGSLYD--HL--FGSGMKKLSWPIRLRIALGTARGLAY---- 436
             V L    R +   LL + + +D  H+  F    K    P++L    G  + L Y    
Sbjct: 85  -KVFLSHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQL--PRGMVKSLLYQILD 139
Query: 437 -LHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLT--TRVAGTL 489
            +HY     ++HRD+K +NIL+     E    K+ D G A+     +  L     V  T 
Sbjct: 140 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 490 GYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
            Y APE  L  +  T   D+++ G +  ELL+ +
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/113 (31%), Positives = 57/113 (50%), Gaps = 11/113 (9%)
Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAG--T 488
           RGL Y+H      ++HRD+K +N+ ++ E    K+GDFGLA+      +H      G  T
Sbjct: 131 RGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 489 LGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKK----ACEIIQGKSVLLS 536
             Y +P   L     T   D+++ G +  E+L+GK     A E+ Q + +L S
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILES 240

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 23/212 (10%)
Query: 317 TMNFSRENIIGKGGYGNVYKGMLPNGT--EVAVKRFKNCSKAGDANFKHEVEIIASV-KH 373
           T  +  +  IG G Y +V K  +   T  E AVK      +    +   E+EI+    +H
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQH 75
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L+      V  +G    +V +L+  G L D +     K  S      +     + 
Sbjct: 76  PNIITLK-----DVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKT 128
Query: 434 LAYLHYGVQPAIIHRDIKASNIL-LDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTL 489
           + YLH      ++HRD+K SNIL +DE+      ++ DFG AK        L      T 
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK-QLRAENGLLMTPCYTA 184
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            +VAPE           D++S GV+L  +L+G
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 23/207 (11%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVALRGYS 383
           IG G +G +Y G  +    EVA+K  +N  K       +E +I   ++    +  +R + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIK-LENV-KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                +EG   ++V DLL  G   + LF    +KLS    L +A      + ++H     
Sbjct: 73  -----VEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVH---SK 122
Query: 444 AIIHRDIKASNILLD---EAFEAKVGDFGLAKFNPEGITHL------TTRVAGTLGYVAP 494
           + +HRDIK  N L+     A +  + DFGLAK   +  TH          + GT  Y + 
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASV 182
Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
              L  + +   D+ S G VL+  L G
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFLRG 209

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 56/131 (42%), Gaps = 10/131 (7%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 145
Query: 455 ILLDEAFE---AKVGDFGLAKFNPEGITHLT-TRVAGTLGYVAPEYALYGKLTPGSDVYS 510
           +L          K+ DFG AK   E  +H + T    T  YVAPE     K     D++S
Sbjct: 146 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 511 FGVVLLELLSG 521
            GV++  LL G
Sbjct: 203 LGVIMYILLCG 213

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 29/120 (24%)
Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG--- 490
           LA+LH      ++H D+K +NI L      K+GDFGL       +  L T  AG +    
Sbjct: 170 LAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGL-------LVELGTAGAGEVQEGD 219
Query: 491 --YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC--EIIQGKSVLLSDWAWELVKEG 546
             Y+APE  L G     +DV+S G+ +LE+     AC  E+  G         W+ +++G
Sbjct: 220 PRYMAPEL-LQGSYGTAADVFSLGLTILEV-----ACNMELPHGGE------GWQQLRQG 267

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 112/253 (44%), Gaps = 47/253 (18%)
Query: 299 ESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNV-YKGMLPNGTEVAVKRF--KNCSK 355
           +SR +N+  F+ + +K   ++   E I+G G  G V ++G    G  VAVKR     C  
Sbjct: 18  KSRIANIPNFE-QSLKNLVVS---EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDI 72
Query: 356 AGDANFKHEVEIIA-SVKHVNLVALRGYSTATVPLEGHQRIIVC-----DLLHNGSLYDH 409
           A       E++++  S  H N++  R Y + T     +  + +C     DL+ + ++ D 
Sbjct: 73  A-----LMEIKLLTESDDHPNVI--RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDE 125
Query: 410 LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD----------- 458
                ++K   PI L   +  A G+A+LH      IIHRD+K  NIL+            
Sbjct: 126 --NLKLQKEYNPISLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQT 178
Query: 459 --EAFEAKVGDFGLAKFNPEGITHLTTRV---AGTLGYVAPEY---ALYGKLTPGSDVYS 510
             E     + DFGL K    G       +   +GT G+ APE    +   +LT   D++S
Sbjct: 179 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFS 238
Query: 511 FGVVLLELLSGKK 523
            G V   +LS  K
Sbjct: 239 MGCVFYYILSKGK 251

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 34/216 (15%)
Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGDANFKHEVEIIASVKHVNLV 377
            +IGKG +  V + +    G + AVK     +F +       + K E  I   +KH ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 378 AL-RGYSTATVPLEGHQRIIVCDLLHN-------GSLYDHLFGSG-MKKLSWPIRLRIAL 428
            L   YS+  +     + +   DL          G +Y     S  M+++          
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI---------- 139
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRV 485
                L  L Y     IIHRD+K  N+LL   + +   K+GDFG+A    E       RV
Sbjct: 140 -----LEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV 194
Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            GT  ++APE           DV+  GV+L  LLSG
Sbjct: 195 -GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 152
Query: 455 ILLDEAFE---AKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 153 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 208
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 209 SLGVIMYILLCG 220

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 153
Query: 455 ILLDEAFE---AKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 154 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 209
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 210 SLGVIMYILLCG 221

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 324 NIIGKGGYGNVYKG-MLPNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALR 380
           +I+G+G   NV++G     G   A+K F N S  +  D   + E E++  + H N+V L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLF----GSGMKKLSWPIRLRIALGTARGLAY 436
                T       ++++ +    GSLY  L       G+ +  + I LR  +G   G+ +
Sbjct: 74  AIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG---GMNH 127
Query: 437 LHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAK 472
           L    +  I+HR+IK  NI+     D     K+ DFG A+
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 151
Query: 455 ILLDEAFE---AKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 152 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 207
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 208 SLGVIMYILLCG 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 147
Query: 455 ILLDEAFE---AKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 203
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 204 SLGVIMYILLCG 215

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 191
Query: 455 ILLDEAFEA---KVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 192 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 247
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 248 SLGVIMYILLCG 259

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 112/253 (44%), Gaps = 47/253 (18%)
Query: 299 ESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNV-YKGMLPNGTEVAVKRF--KNCSK 355
           +SR +N+  F+ + +K   ++   E I+G G  G V ++G    G  VAVKR     C  
Sbjct: 18  KSRIANIPNFE-QSLKNLVVS---EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDI 72
Query: 356 AGDANFKHEVEIIA-SVKHVNLVALRGYSTATVPLEGHQRIIVC-----DLLHNGSLYDH 409
           A       E++++  S  H N++  R Y + T     +  + +C     DL+ + ++ D 
Sbjct: 73  A-----LMEIKLLTESDDHPNVI--RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDE 125
Query: 410 LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD----------- 458
                ++K   PI L   +  A G+A+LH      IIHRD+K  NIL+            
Sbjct: 126 --NLKLQKEYNPISLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQT 178
Query: 459 --EAFEAKVGDFGLAKFNPEGITHLTTRV---AGTLGYVAPEY---ALYGKLTPGSDVYS 510
             E     + DFGL K    G       +   +GT G+ APE    +   +LT   D++S
Sbjct: 179 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFS 238
Query: 511 FGVVLLELLSGKK 523
            G V   +LS  K
Sbjct: 239 MGCVFYYILSKGK 251

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 146
Query: 455 ILLDEAFE---AKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 147 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 202
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 203 SLGVIMYILLCG 214

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 145
Query: 455 ILLDEAFE---AKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 146 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 201
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 202 SLGVIMYILLCG 213

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 147
Query: 455 ILLDEAFEA---KVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 148 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 203
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 204 SLGVIMYILLCG 215

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 161
Query: 455 ILLDEAFEA---KVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 162 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 217
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 218 SLGVIMYILLCG 229

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 57/132 (43%), Gaps = 12/132 (9%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPEN 197
Query: 455 ILLDEAFEA---KVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVY 509
           +L          K+ DFG AK   E  +H  LTT    T  YVAPE     K     D++
Sbjct: 198 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCY-TPYYVAPEVLGPEKYDKSCDMW 253
Query: 510 SFGVVLLELLSG 521
           S GV++  LL G
Sbjct: 254 SLGVIMYILLCG 265

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 74/160 (46%), Gaps = 21/160 (13%)
Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALR 380
           +I+G+G   NV++G     G   A+K F N S  +  D   + E E++  + H N+V L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKKLNHKNIVKLF 73
Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHL----FGSGMKKLSWPIRLRIALGTARGLAY 436
                T       ++++ +    GSLY  L       G+ +  + I LR  +G   G+ +
Sbjct: 74  AIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVG---GMNH 127
Query: 437 LHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAK 472
           L    +  I+HR+IK  NI+     D     K+ DFG A+
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 23/202 (11%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVALRGYS 383
           IG G +G++Y G  +  G EVA+K    C K        E +I   ++  V +  +R   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIR--- 71
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                 EG   ++V +LL  G   + LF    +K S    L +A      + Y+H     
Sbjct: 72  --WCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124
Query: 444 AIIHRDIKASNILLDEAFEAK---VGDFGLAKFNPEGITHL------TTRVAGTLGYVAP 494
             IHRD+K  N L+    +     + DFGLAK   +  TH          + GT  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 495 EYALYGKLTPGSDVYSFGVVLL 516
              L  + +   D+ S G VL+
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLM 206

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 84/202 (41%), Gaps = 23/202 (11%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVALRGYS 383
           IG G +G++Y G  +  G EVA+K    C K        E +I   ++  V +  +R   
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                 EG   ++V +LL  G   + LF    +K S    L +A      + Y+H     
Sbjct: 73  A-----EGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122
Query: 444 AIIHRDIKASNILLDEAFEAK---VGDFGLAKFNPEGITHL------TTRVAGTLGYVAP 494
             IHRD+K  N L+    +     + DFGLAK   +  TH          + GT  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182
Query: 495 EYALYGKLTPGSDVYSFGVVLL 516
              L  + +   D+ S G VL+
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLM 204

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 113/254 (44%), Gaps = 44/254 (17%)
Query: 283 ERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPN 341
           +R+   T+++E  L+ E        ++ EE+   T     +  +G+G +G V++      
Sbjct: 44  QRLGPETEDNEGVLLTEKLKPVDYEYR-EEVHWMT----HQPRVGRGSFGEVHRMKDKQT 98
Query: 342 GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA-TVPLEGHQRI----- 395
           G + AVK+ +                +   +   LVA  G S+   VPL G  R      
Sbjct: 99  GFQCAVKKVR----------------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVN 142
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSW--PIRLRIALGTA-RGLAYLHYGVQPAIIHRDIKA 452
           I  +LL  GSL     G  +K++      R    LG A  GL YLH      I+H D+KA
Sbjct: 143 IFMELLEGGSL-----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKA 194
Query: 453 SNILL-DEAFEAKVGDFGLAK-FNPEGI--THLTTR-VAGTLGYVAPEYALYGKLTPGSD 507
            N+LL  +   A + DFG A    P+G+  + LT   + GT  ++APE  +        D
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 254
Query: 508 VYSFGVVLLELLSG 521
           ++S   ++L +L+G
Sbjct: 255 IWSSCCMMLHMLNG 268

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 37/223 (16%)
Query: 324 NIIGKGGYGNVYKGM--LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           + +G+G +G V + +     G  VAVK  KN  +  +A  + E++++  +   +  +   
Sbjct: 20  DTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-RSEIQVLEHLNTTDPNSTFR 78
Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL----RIALGTARGLAYL 437
                   E H  I +   L   S YD +  +G      P RL    ++A    + + +L
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGF----LPFRLDHIRKMAYQICKSVNFL 134
Query: 438 HYGVQPAIIHRDIKASNILL-----DEAF--------------EAKVGDFGLAKFNPEGI 478
           H      + H D+K  NIL       EA+              + KV DFG A ++ E  
Sbjct: 135 HSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-- 189
Query: 479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            H +T V     Y APE  L    +   DV+S G +L+E   G
Sbjct: 190 -HHSTLVXXR-HYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 114/254 (44%), Gaps = 44/254 (17%)
Query: 283 ERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPN 341
           +R+   T+++E  L+ E        ++ EE+   T     +  +G+G +G V++      
Sbjct: 28  QRLGPETEDNEGVLLTEKLKPVDYEYR-EEVHWMT----HQPRVGRGSFGEVHRMKDKQT 82
Query: 342 GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA-TVPLEGHQRI----- 395
           G + AVK+ +             +E+    +   LVA  G S+   VPL G  R      
Sbjct: 83  GFQCAVKKVR-------------LEVF---RVEELVACAGLSSPRIVPLYGAVREGPWVN 126
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSW--PIRLRIALGTA-RGLAYLHYGVQPAIIHRDIKA 452
           I  +LL  GSL     G  +K++      R    LG A  GL YLH      I+H D+KA
Sbjct: 127 IFMELLEGGSL-----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKA 178
Query: 453 SNILL-DEAFEAKVGDFGLAK-FNPEGITH--LTTR-VAGTLGYVAPEYALYGKLTPGSD 507
            N+LL  +   A + DFG A    P+G+    LT   + GT  ++APE  +        D
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238
Query: 508 VYSFGVVLLELLSG 521
           ++S   ++L +L+G
Sbjct: 239 IWSSCCMMLHMLNG 252

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 101/234 (43%), Gaps = 23/234 (9%)
Query: 297 VLESRSSNLARFKIEEIKAATM--NFSRENIIGKGGYGNVYKGMLPNGTE-VAVKRFK-- 351
            LE+++       +    +AT    + R   +G+G YG VYK +     E VA+KR +  
Sbjct: 11  TLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLE 70
Query: 352 NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLF 411
           +  +        EV ++  ++H N++ L+     +V    H+  ++ +   N  L  ++ 
Sbjct: 71  HEEEGVPGTAIREVSLLKELQHRNIIELK-----SVIHHNHRLHLIFEYAEN-DLKKYM- 123
Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL--DEAFEA---KVG 466
                 +S  +          G+ + H       +HRD+K  N+LL   +A E    K+G
Sbjct: 124 -DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIG 179
Query: 467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGS-DVYSFGVVLLELL 519
           DFGLA+     I   T  +  TL Y  PE  L  +    S D++S   +  E+L
Sbjct: 180 DFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 70/254 (27%), Positives = 112/254 (44%), Gaps = 44/254 (17%)
Query: 283 ERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPN 341
           +R+   T+++E  L+ E        ++ EE+   T     +  +G+G +G V++      
Sbjct: 42  QRLGPETEDNEGVLLTEKLKPVDYEYR-EEVHWMT----HQPRLGRGSFGEVHRMKDKQT 96
Query: 342 GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTA-TVPLEGHQRI----- 395
           G + AVK+ +                +   +   LVA  G S+   VPL G  R      
Sbjct: 97  GFQCAVKKVR----------------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVN 140
Query: 396 IVCDLLHNGSLYDHLFGSGMKKLSW--PIRLRIALGTA-RGLAYLHYGVQPAIIHRDIKA 452
           I  +LL  GSL     G  +K++      R    LG A  GL YLH      I+H D+KA
Sbjct: 141 IFMELLEGGSL-----GQLIKQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKA 192
Query: 453 SNILL-DEAFEAKVGDFGLAK-FNPEGITH--LTTR-VAGTLGYVAPEYALYGKLTPGSD 507
            N+LL  +   A + DFG A    P+G+    LT   + GT  ++APE  +        D
Sbjct: 193 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 252
Query: 508 VYSFGVVLLELLSG 521
           ++S   ++L +L+G
Sbjct: 253 IWSSCCMMLHMLNG 266

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 317 TMNFSRENIIGKGGYGNVYKGMLPNGT--EVAVKRFKNCSKAGDANFKHEVEIIASV-KH 373
           T  +  +  IG G Y +V K  +   T  E AVK      +    +   E+EI+    +H
Sbjct: 21  TDGYEVKEDIGVGSY-SVCKRCIHKATNXEFAVKIIDKSKR----DPTEEIEILLRYGQH 75
Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N++ L+      V  +G    +V +L   G L D +     K  S      +     + 
Sbjct: 76  PNIITLK-----DVYDDGKYVYVVTELXKGGELLDKILR--QKFFSEREASAVLFTITKT 128
Query: 434 LAYLHYGVQPAIIHRDIKASNIL-LDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTL 489
           + YLH      ++HRD+K SNIL +DE+      ++ DFG AK        L      T 
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAK-QLRAENGLLXTPCYTA 184
Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            +VAPE           D++S GV+L   L+G
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 13/201 (6%)
Query: 325 IIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           +IGKG +G V K         VA+K  +N  K        E+ I+  ++  +        
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                      I +   L + +LY+ +  +  +  S P+  + A    + L  LH   + 
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KN 219
Query: 444 AIIHRDIKASNILLDEAFEA--KVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYG 500
            IIH D+K  NILL +   +  KV DFG + +  + + T + +R      Y APE  L  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----YRAPEVILGA 274
Query: 501 KLTPGSDVYSFGVVLLELLSG 521
           +     D++S G +L ELL+G
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 110/256 (42%), Gaps = 51/256 (19%)
Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNV-YKGMLPNGTEVAVKRF--KNCSKA 356
           SR +N+  F+ + +K   ++   E I+G G  G V ++G    G  VAVKR     C  A
Sbjct: 1   SRIANIPNFE-QSLKNLVVS---EKILGYGSSGTVVFQGSF-QGRPVAVKRMLIDFCDIA 55
Query: 357 GDANFKHEVEIIA-SVKHVNLVALRGYSTATVPLEGHQRIIVC-----DLLHNGSLYDHL 410
                  E++++  S  H N++  R Y + T     +  + +C     DL+ + ++ D  
Sbjct: 56  -----LMEIKLLTESDDHPNVI--RYYCSETTDRFLYIALELCNLNLQDLVESKNVSDE- 107
Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD------------ 458
               ++K   PI L   +  A G+A+LH      IIHRD+K  NIL+             
Sbjct: 108 -NLKLQKEYNPISLLRQI--ASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTG 161
Query: 459 -EAFEAKVGDFGLAKFNPEGITHLTTRV---AGTLGYVAPE-------YALYGKLTPGSD 507
            E     + DFGL K    G       +   +GT G+ APE            +LT   D
Sbjct: 162 AENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID 221
Query: 508 VYSFGVVLLELLSGKK 523
           ++S G V   +LS  K
Sbjct: 222 IFSMGCVFYYILSKGK 237

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 84/202 (41%), Gaps = 23/202 (11%)
Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY-S 383
           IG G +G++Y G  + +G EVA+K    C K      KH    I S  +  +    G  S
Sbjct: 17  IGSGSFGDIYLGANIASGEEVAIKL--ECVKT-----KHPQLHIESKFYKMMQGGVGIPS 69
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                 EG   ++V +LL  G   + LF    +K S    L +A      + Y+H     
Sbjct: 70  IKWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 124
Query: 444 AIIHRDIKASNILLDEAFEAK---VGDFGLAKFNPEGITHL------TTRVAGTLGYVAP 494
             IHRD+K  N L+    +     + DFGLAK   +  TH          + GT  Y + 
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 495 EYALYGKLTPGSDVYSFGVVLL 516
              L  + +   D+ S G VL+
Sbjct: 185 NTHLGIEQSRRDDLESLGYVLM 206

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 314 KAATMNFSRENIIGK---GGYGNVYKGMLPNGTEVAVK--RFKNCSKAGDANFKHEVEII 368
           K + ++F + N + K      G ++KG    G ++ VK  + ++ S     +F  E   +
Sbjct: 3   KHSGIDFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
               H N++ + G   +  P   H  +I       GSLY+ L       +     ++ AL
Sbjct: 62  RIFSHPNVLPVLGACQS--PPAPHPTLIT-HWXPYGSLYNVLHEGTNFVVDQSQAVKFAL 118
Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAG 487
             ARG A+LH  ++P I    + + ++ +DE   A++    +   F   G  +       
Sbjct: 119 DXARGXAFLHT-LEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAP----- 172
Query: 488 TLGYVAPEYALYGKLTP----GSDVYSFGVVLLELLS 520
              +VAPE AL  K        +D +SF V+L EL++
Sbjct: 173 --AWVAPE-ALQKKPEDTNRRSADXWSFAVLLWELVT 206

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 87/201 (43%), Gaps = 13/201 (6%)
Query: 325 IIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           +IGKG +G V K         VA+K  +N  K        E+ I+  ++  +        
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162
Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
                      I +   L + +LY+ +  +  +  S P+  + A    + L  LH   + 
Sbjct: 163 HMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KN 219
Query: 444 AIIHRDIKASNILLDEAFEA--KVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYG 500
            IIH D+K  NILL +   +  KV DFG + +  + + T + +R      Y APE  L  
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----YRAPEVILGA 274
Query: 501 KLTPGSDVYSFGVVLLELLSG 521
           +     D++S G +L ELL+G
Sbjct: 275 RYGMPIDMWSLGCILAELLTG 295

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 54/131 (41%), Gaps = 10/131 (7%)
Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN 454
           +IV + L  G L+  +   G +  +      I       + YLH      I HRD+K  N
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLH---SINIAHRDVKPEN 191
Query: 455 ILLDEAFEA---KVGDFGLAKFNPEGITHLT-TRVAGTLGYVAPEYALYGKLTPGSDVYS 510
           +L          K+ DFG AK   E  +H + T    T  YVAPE     K     D +S
Sbjct: 192 LLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 511 FGVVLLELLSG 521
            GV+   LL G
Sbjct: 249 LGVIXYILLCG 259

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 31/76 (40%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 447 HRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG 505
           HRD+K  NIL+     A + DFG+A     E +T L   V GTL Y APE       T  
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 506 SDVYSFGVVLLELLSG 521
           +D+Y+   VL E L+G
Sbjct: 216 ADIYALTCVLYECLTG 231

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 12/111 (10%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLD------EAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           GL Y+H   +  IIH DIK  N+L++         + K+ D G A +  E   H T  + 
Sbjct: 143 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQ 197
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD 537
            T  Y +PE  L      G+D++S   ++ EL++G    E  +G S    D
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/111 (30%), Positives = 52/111 (46%), Gaps = 12/111 (10%)
Query: 433 GLAYLHYGVQPAIIHRDIKASNILLD------EAFEAKVGDFGLAKFNPEGITHLTTRVA 486
           GL Y+H   +  IIH DIK  N+L++         + K+ D G A +  E   H T  + 
Sbjct: 143 GLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQ 197
Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD 537
            T  Y +PE  L      G+D++S   ++ EL++G    E  +G S    D
Sbjct: 198 -TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 68/245 (27%), Positives = 108/245 (44%), Gaps = 46/245 (18%)
Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN 360
           S N A    E  +     F  E + G+G +G V  G   + G  VA+K+        D  
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-----IQDPR 61
Query: 361 FKH-EVEI---IASVKHVNLVALRGYSTATVPLEGHQRII--------VCDLLHN--GSL 406
           F++ E++I   +A + H N+V L+ Y       E  +R I        V D LH    + 
Sbjct: 62  FRNRELQIMQDLAVLHHPNIVQLQSYFYTLG--ERDRRDIYLNVVMEYVPDTLHRCCRNY 119
Query: 407 YDHLFGSGMKKLSWPIRLRIAL-GTARGLAYLHYGVQPAI--IHRDIKASNILLDEAFEA 463
           Y             PI +++ L    R +  LH    P++   HRDIK  N+L++EA   
Sbjct: 120 YRRQVAPP------PILIKVFLFQLIRSIGCLHL---PSVNVCHRDIKPHNVLVNEADGT 170
Query: 464 -KVGDFGLA-KFNPE--GITHLTTRVAGTLGYVAPEYALYGK--LTPGSDVYSFGVVLLE 517
            K+ DFG A K +P    + ++ +R      Y APE  ++G    T   D++S G +  E
Sbjct: 171 LKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPEL-IFGNQHYTTAVDIWSVGCIFAE 224
Query: 518 LLSGK 522
           ++ G+
Sbjct: 225 MMLGE 229

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	614
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-140
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-127
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-122
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-80
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	4e-66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-63
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-62
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-61
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-56
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-55
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-53
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-39
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-39
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-39
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	5e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-38
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-38
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-38
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-38
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-37
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-37
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-36
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	5e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-35
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-35
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	8e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-34
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	5e-34
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-34
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-33
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-33
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-33
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	6e-33
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-32
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-31
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-31
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-31
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-31
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-31
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-31
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	7e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-31
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-30
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-30
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-30
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-30
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-30
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	5e-30
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-29
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-29
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-29
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	9e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-28
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-28
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-27
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-27
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-26
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-26
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-25
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-25
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	4e-25
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-25
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	8e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	9e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-23
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-23
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-23
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-23
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-23
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-23
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-23
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-23
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-23
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-22
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-22
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-22
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-22
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-22
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-22
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-21
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-21
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-21
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-21
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-21
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-20
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-20
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-20
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	6e-20
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-20
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-20
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-19
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-19
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-19
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-19
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-19
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-19
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-19
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-19
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-19
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	6e-19
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	8e-19
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	9e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-18
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-18
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-17
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-17
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-17
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-17
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-17
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-16
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	9e-15
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-14
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-14
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-14
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-14
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-14
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-13
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	4e-13
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-12
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-12
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-12
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-12
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-12
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-12
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-12
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-12
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-12
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	6e-12
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-11
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	7e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	4e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  410 bits (1055), Expect = e-140
 Identities = 132/304 (43%), Positives = 185/304 (60%), Gaps = 11/304 (3%)

Query: 299 ESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG- 357
           E     L RF + E++ A+ NFS +NI+G+GG+G VYKG L +GT VAVKR K     G 
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70

Query: 358 DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFG--SGM 415
           +  F+ EVE+I+   H NL+ LRG+          +R++V   + NGS+   L       
Sbjct: 71  ELQFQTEVEMISMAVHRNLLRLRGFCM-----TPTERLLVYPYMANGSVASCLRERPESQ 125

Query: 416 KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP 475
             L WP R RIALG+ARGLAYLH    P IIHRD+KA+NILLDE FEA VGDFGLAK   
Sbjct: 126 PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ---GKS 532
              TH+TT V GT+G++APEY   GK +  +DV+ +GV+LLEL++G++A ++ +      
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 533 VLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI 592
           V+L DW   L+KE K   +++ ++      E +EQ +  A +C       RP M ++V++
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305

Query: 593 LETD 596
           LE D
Sbjct: 306 LEGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  375 bits (965), Expect = e-127
 Identities = 119/309 (38%), Positives = 176/309 (56%), Gaps = 12/309 (3%)

Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA 359
                  R  + +++ AT NF  + +IG G +G VYKG+L +G +VA+KR    S  G  
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE 80

Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK-- 417
            F+ E+E ++  +H +LV+L G+       E ++ I++   + NG+L  HL+GS +    
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCD-----ERNEMILIYKYMENGNLKRHLYGSDLPTMS 135

Query: 418 LSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG 477
           +SW  RL I +G ARGL YLH     AIIHRD+K+ NILLDE F  K+ DFG++K   E 
Sbjct: 136 MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 478 -ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS-VLL 535
             THL+T V GTLGY+ PEY + G+LT  SDVYSFGVVL E+L  + A      +  V L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 536 SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           ++WA E    G+   +++ N+ +   PE + ++  TA  C     + RP+M  ++  LE 
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

Query: 596 DVPLSNIKI 604
            + L    I
Sbjct: 313 ALRLQESVI 321

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  363 bits (934), Expect = e-122
 Identities = 114/316 (36%), Positives = 168/316 (53%), Gaps = 31/316 (9%)

Query: 298 LESRSSNLARFKIEEIKAATMNFSRE------NIIGKGGYGNVYKGMLPNGTEVAVKRFK 351
           LE   +    F   E+K  T NF         N +G+GG+G VYKG + N T VAVK+  
Sbjct: 5   LEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLA 63

Query: 352 NC----SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY 407
                 ++     F  E++++A  +H NLV L G+S      +G    +V   + NGSL 
Sbjct: 64  AMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFS-----SDGDDLCLVYVYMPNGSLL 118

Query: 408 DHLFG-SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
           D L    G   LSW +R +IA G A G+ +LH   +   IHRDIK++NILLDEAF AK+ 
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKIS 175

Query: 467 DFGLAKFNPEG-ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC 525
           DFGLA+ + +   T +T+R+ GT  Y+APE  L G++TP SD+YSFGVVLLE+++G  A 
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAV 234

Query: 526 EIIQGKSVLLSDWAWELVKEGKTLDVIE----ENMPEMELPEMMEQYVLTAAICAHPILQ 581
           +  +   +LL D   E+  E KT++        +     +  M       A+ C H    
Sbjct: 235 DEHREPQLLL-DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYS----VASQCLHEKKN 289

Query: 582 ARPTMDQIVKILETDV 597
            RP + ++ ++L+   
Sbjct: 290 KRPDIKKVQQLLQEMT 305

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  255 bits (653), Expect = 3e-80
 Identities = 81/320 (25%), Positives = 121/320 (37%), Gaps = 32/320 (10%)

Query: 299 ESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGD 358
               S+      E +   +M      +  +G +G V+K        VAVK F    K   
Sbjct: 5   HHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW 63

Query: 359 ANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKL 418
              ++EV  +  +KH N++   G              ++      GSL D L       +
Sbjct: 64  Q-NEYEVYSLPGMKHENILQFIGAEK-RGTSVDVDLWLITAFHEKGSLSDFLKA---NVV 118

Query: 419 SWPIRLRIALGTARGLAYLH-------YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
           SW     IA   ARGLAYLH        G +PAI HRDIK+ N+LL     A + DFGLA
Sbjct: 119 SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA 178

Query: 472 KFNPEGITHL-TTRVAGTLGYVAPEYA-----LYGKLTPGSDVYSFGVVLLELLSGKKAC 525
                G +   T    GT  Y+APE                D+Y+ G+VL EL S   A 
Sbjct: 179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 526 EIIQGKSVL-LSDWAW---------ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAIC 575
           +    + +L   +            E+V   K   V+ +   +     M+ +   T   C
Sbjct: 239 DGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE---TIEEC 295

Query: 576 AHPILQARPTMDQIVKILET 595
                +AR +   + + +  
Sbjct: 296 WDHDAEARLSAGCVGERITQ 315

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  217 bits (556), Expect = 4e-66
 Identities = 87/319 (27%), Positives = 141/319 (44%), Gaps = 28/319 (8%)

Query: 280 KSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML 339
           K       ++D D P+         +    ++ I    +N   +  IG G +G V++   
Sbjct: 2   KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMD-IPWCDLNI--KEKIGAGSFGTVHRAEW 58

Query: 340 PNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV 397
            +G++VAVK     +        F  EV I+  ++H N+V   G  T    L      IV
Sbjct: 59  -HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL-----SIV 112

Query: 398 CDLLHNGSLYDHLFGSGMK-KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNIL 456
            + L  GSLY  L  SG + +L    RL +A   A+G+ YLH    P I+HR++K+ N+L
Sbjct: 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLL 171

Query: 457 LDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLL 516
           +D+ +  KV DFGL++          +  AGT  ++APE          SDVYSFGV+L 
Sbjct: 172 VDKKYTVKVCDFGLSRLKASTFLSSKS-AAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230

Query: 517 ELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICA 576
           EL + ++    +    V        +  + K L+ I  N+   ++  ++E        C 
Sbjct: 231 ELATLQQPWGNLNPAQV-----VAAVGFKCKRLE-IPRNLNP-QVAAIIEG-------CW 276

Query: 577 HPILQARPTMDQIVKILET 595
                 RP+   I+ +L  
Sbjct: 277 TNEPWKRPSFATIMDLLRP 295

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  211 bits (540), Expect = 4e-64
 Identities = 80/308 (25%), Positives = 135/308 (43%), Gaps = 44/308 (14%)

Query: 303 SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN- 360
           S   + ++  +    + +  E  IGKGG+G V+KG  + + + VA+K        G+   
Sbjct: 6   SEFPKSRLPTLADNEIEY--EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEM 63

Query: 361 ------FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG 414
                 F+ EV I++++ H N+V L G      P       +V + +  G LY  L    
Sbjct: 64  IEKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PP-----RMVMEFVPCGDLYHRLLDKA 116

Query: 415 MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE-----AKVGDFG 469
              + W ++LR+ L  A G+ Y+     P I+HRD+++ NI L    E     AKV DFG
Sbjct: 117 -HPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174

Query: 470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTP---GSDVYSFGVVLLELLSGKKACE 526
           L++ +     H  + + G   ++APE  +  +       +D YSF ++L  +L+G+   +
Sbjct: 175 LSQQS----VHSVSGLLGNFQWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

Query: 527 IIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTM 586
                S     +   + +EG     I E+ P   L  ++E        C     + RP  
Sbjct: 230 ---EYSYGKIKFINMIREEGLRPT-IPEDCPP-RLRNVIEL-------CWSGDPKKRPHF 277

Query: 587 DQIVKILE 594
             IVK L 
Sbjct: 278 SYIVKELS 285

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  212 bits (541), Expect = 9e-64
 Identities = 73/320 (22%), Positives = 112/320 (35%), Gaps = 39/320 (12%)

Query: 308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEI 367
               E      N     +IG+G YG VYKG L +   VAVK F   ++    NF +E  I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 368 --IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
             +  ++H N+                + ++V +   NGSL  +L         W    R
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCR 115

Query: 426 IALGTARGLAYLH------YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF------ 473
           +A    RGLAYLH         +PAI HRD+ + N+L+       + DFGL+        
Sbjct: 116 LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRL 175

Query: 474 -NPEGITHLTTRVAGTLGYVAPEYA-------LYGKLTPGSDVYSFGVVLLELLSGKKAC 525
             P    +      GT+ Y+APE                  D+Y+ G++  E+       
Sbjct: 176 VRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235

Query: 526 EIIQGKSVLLSDWAWELVKEGKTLD----VIEENM-PEM-----ELPEMMEQYVLTAAIC 575
              +        +  E+       D    V  E   P+      E    +     T   C
Sbjct: 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDC 295

Query: 576 AHPILQARPTMDQIVKILET 595
                +AR T     + +  
Sbjct: 296 WDQDAEARLTAQXAEERMAE 315

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  209 bits (534), Expect = 6e-63
 Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 29/275 (10%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E ++G+G +G V K       +VA+K+ +  S++    F  E+  ++ V H N+V L G 
Sbjct: 13  EEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKLYGA 69

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGV 441
                P+      +V +    GSLY+ L G+  +   +    +   L  ++G+AYLH   
Sbjct: 70  CLN--PV-----CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 442 QPAIIHRDIKASNILLDEAFE-AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
             A+IHRD+K  N+LL       K+ DFG A      I    T   G+  ++APE     
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGS 178

Query: 501 KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEME 560
             +   DV+S+G++L E+++ +K  + I G +  +       V  G    +I +N+P+  
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW----AVHNGTRPPLI-KNLPK-P 232

Query: 561 LPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           +  +M +       C       RP+M++IVKI+  
Sbjct: 233 IESLMTR-------CWSKDPSQRPSMEEIVKIMTH 260

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  205 bits (524), Expect = 5e-62
 Identities = 59/278 (21%), Positives = 110/278 (39%), Gaps = 32/278 (11%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALR 380
              + +   G ++KG    G ++ VK  K  + S     +F  E   +    H N++ + 
Sbjct: 15  LTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVL 73

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           G   +  P   H   ++   +  GSLY+ L       +     ++ AL  ARG+A+LH  
Sbjct: 74  GACQS--PPAPH-PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-T 129

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-- 498
           ++P I    + + ++++DE   A++    +                    +VAPE AL  
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS------PGRMYAPAWVAPE-ALQK 182

Query: 499 --YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM 556
                    +D++SF V+L EL++ +     +    +       ++  EG     I   +
Sbjct: 183 KPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI-----GMKVALEGLRPT-IPPGI 236

Query: 557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
               + ++M+        C +     RP  D IV ILE
Sbjct: 237 SP-HVSKLMKI-------CMNEDPAKRPKFDMIVPILE 266

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  203 bits (519), Expect = 3e-61
 Identities = 91/285 (31%), Positives = 130/285 (45%), Gaps = 38/285 (13%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFK----NCSKAGDANFKHEVEIIASVKHVNLVA 378
           E IIG GG+G VY+     G EVAVK  +            N + E ++ A +KH N++A
Sbjct: 12  EEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIA 70

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           LRG       L      +V +    G L   L G   K++   I +  A+  ARG+ YLH
Sbjct: 71  LRGVCLKEPNL-----CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH 122

Query: 439 YGVQPAIIHRDIKASNILLDEAFE--------AKVGDFGLAKFNPEGITHLTTRVAGTLG 490
                 IIHRD+K+SNIL+ +  E         K+ DFGLA+             AG   
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYA 179

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           ++APE       + GSDV+S+GV+L ELL+G+     I G +V     A+ +      L 
Sbjct: 180 WMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-----AYGVAMNKLALP 234

Query: 551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
            I    PE    ++ME        C +P   +RP+   I+  L T
Sbjct: 235 -IPSTCPE-PFAKLMED-------CWNPDPHSRPSFTNILDQLTT 270

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  195 bits (497), Expect = 2e-57
 Identities = 63/287 (21%), Positives = 114/287 (39%), Gaps = 41/287 (14%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALR 380
             +IGKG +G VY G   +G EVA++       ++     FK EV      +H N+V   
Sbjct: 38  GELIGKGRFGQVYHGRW-HG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
           G   +   L      I+  L    +LY  +  +    L      +IA    +G+ YLH  
Sbjct: 96  GACMSPPHL-----AIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLH-- 147

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF----NPEGITHLTTRVAGTLGYVAPE- 495
               I+H+D+K+ N+  D   +  + DFGL                    G L ++APE 
Sbjct: 148 -AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEI 205

Query: 496 --------YALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK 547
                          +  SDV++ G +  EL + +   +    ++++   W    +  G 
Sbjct: 206 IRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII---WQ---MGTGM 259

Query: 548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
             ++ +  M + E+ +++         C     + RPT  +++ +LE
Sbjct: 260 KPNLSQIGMGK-EISDILLF-------CWAFEQEERPTFTKLMDMLE 298

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  193 bits (493), Expect = 1e-56
 Identities = 79/328 (24%), Positives = 124/328 (37%), Gaps = 34/328 (10%)

Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA 359
           S S +     ++   A  +       IGKG YG V+ G    G +VAVK F    +A   
Sbjct: 21  SGSGSGLPLLVQRTIAKQIQM--VKQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEEA--- 74

Query: 360 NFKHEVEI--IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK 417
           ++  E EI     ++H N++               Q  ++ D   NGSLYD+L       
Sbjct: 75  SWFRETEIYQTVLMRHENILGFIAADI-KGTGSWTQLYLITDYHENGSLYDYL---KSTT 130

Query: 418 LSWPIRLRIALGTARGLAYLH-----YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
           L     L++A  +  GL +LH        +PAI HRD+K+ NIL+ +     + D GLA 
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190

Query: 473 FNPEGITHL---TTRVAGTLGYVAPEYALYGKLTPGS-------DVYSFGVVLLELLSGK 522
                   +        GT  Y+ PE  L   L           D+YSFG++L E+    
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRC 249

Query: 523 KACEIIQGKSVLLSDWAWELVKEGKTLD-VIEENM-----PEMELPEMMEQYVLTAAICA 576
            +  I++   +   D            + V  + +           E + Q       C 
Sbjct: 250 VSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECW 309

Query: 577 HPILQARPTMDQIVKILETDVPLSNIKI 604
                +R T  ++ K L       +IK+
Sbjct: 310 AHNPASRLTALRVKKTLAKMSESQDIKL 337

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  192 bits (489), Expect = 1e-56
 Identities = 75/302 (24%), Positives = 122/302 (40%), Gaps = 46/302 (15%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEI--IASVKHVNLVALR 380
              +GKG YG V++G    G  VAVK F   S   + ++  E E+     ++H N++   
Sbjct: 13  LECVGKGRYGEVWRGSW-QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH-- 438
                +      Q  ++      GSLYD+L    +  L     LRI L  A GLA+LH  
Sbjct: 69  ASDMTSRHSST-QLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIE 124

Query: 439 ---YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL---TTRVAGTLGYV 492
                 +PAI HRD+K+ NIL+ +  +  + D GLA  + +    L        GT  Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184

Query: 493 APEYALYGKLTPG-------SDVYSFGVVLLELLSGKKACEIIQ----------GKSVLL 535
           APE  L   +           D+++FG+VL E+     +  I++                
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 536 SDWAWELVKEGKTLDVIEENMPEMELPEM---MEQYVLTAAICAHPILQARPTMDQIVKI 592
            D    +  + +  ++      +  L  +   M++       C +    AR T  +I K 
Sbjct: 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE-------CWYQNPSARLTALRIKKT 296

Query: 593 LE 594
           L 
Sbjct: 297 LT 298

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  190 bits (486), Expect = 3e-56
 Identities = 86/277 (31%), Positives = 132/277 (47%), Gaps = 32/277 (11%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           IG G +G VYKG   +G +VAVK       +      FK+EV ++   +HVN++   GYS
Sbjct: 32  IGSGSFGTVYKGKW-HG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP 443
           T        Q  IV       SLY HL  S   K      + IA  TARG+ YLH     
Sbjct: 90  T------APQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLH---AK 139

Query: 444 AIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLGYVAPE---YALY 499
           +IIHRD+K++NI L E    K+GDFGLA   +    +H   +++G++ ++APE       
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK--TLDVIEENMP 557
              +  SDVY+FG+VL EL++G+     I  +  ++      + +      L  +  N P
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII----EMVGRGSLSPDLSKVRSNCP 255

Query: 558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           +  +  +M +       C       RP+  +I+  +E
Sbjct: 256 K-RMKRLMAE-------CLKKKRDERPSFPRILAEIE 284

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  185 bits (472), Expect = 5e-54
 Identities = 63/287 (21%), Positives = 105/287 (36%), Gaps = 36/287 (12%)

Query: 323 ENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
             ++GKG +G   K      G  + +K      +     F  EV+++  ++H N++   G
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIG 74

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
                  L       + + +  G+L   +      +  W  R+  A   A G+AYLH   
Sbjct: 75  VLYKDKRL-----NFITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLH--- 125

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR-------------VAGT 488
              IIHRD+ + N L+ E     V DFGLA+   +  T                  V G 
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGN 185

Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT 548
             ++APE           DV+SFG+VL E++    A      +++         V+    
Sbjct: 186 PYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG----LNVRGFLD 241

Query: 549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
                 N P      +  +       C     + RP+  ++   LET
Sbjct: 242 RY-CPPNCPP-SFFPITVR-------CCDLDPEKRPSFVKLEHWLET 279

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  185 bits (472), Expect = 1e-53
 Identities = 74/295 (25%), Positives = 118/295 (40%), Gaps = 32/295 (10%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEI--IASVKHVNLVALR 380
           +  IGKG +G V++G    G EVAVK F       + ++  E EI     ++H N++   
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFI 102

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH-- 438
                       Q  +V D   +GSL+D+L       ++    +++AL TA GLA+LH  
Sbjct: 103 AADN-KDNGTWTQLWLVSDYHEHGSLFDYL---NRYTVTVEGMIKLALSTASGLAHLHME 158

Query: 439 ---YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGTLGYV 492
                 +PAI HRD+K+ NIL+ +     + D GLA       + I        GT  Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218

Query: 493 APEYALYGKLTPG-------SDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE 545
           APE  L   +          +D+Y+ G+V  E+        I +   +   D        
Sbjct: 219 APE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 546 GKTLDVIEENMPEMELPEMMEQYVLTAAICA------HPILQARPTMDQIVKILE 594
            +   V+ E      +P   +       +        +    AR T  +I K L 
Sbjct: 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  152 bits (387), Expect = 3e-41
 Identities = 79/294 (26%), Positives = 119/294 (40%), Gaps = 53/294 (18%)

Query: 321 SRENI-----IGKGGYGNVYKGML-PNGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           + E++     IG+G +G V+ G L  + T VAVK  +        A F  E  I+    H
Sbjct: 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSH 171

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            N+V L G  T   P+      IV +L+  G     L   G  +L     L++    A G
Sbjct: 172 PNIVRLIGVCTQKQPI-----YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAG 225

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV- 492
           + YL        IHRD+ A N L+ E    K+ DFG+++   +G+        G    V 
Sbjct: 226 MEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGL-RQVP 278

Query: 493 ----APEYALYGKLTPGSDVYSFGVVLLELLS-------GKKACEIIQGKSVLLSDWAWE 541
               APE   YG+ +  SDV+SFG++L E  S            +              E
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR------------E 326

Query: 542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
            V++G  L    E  P+  +  +MEQ       C       RP+   I + L++
Sbjct: 327 FVEKGGRLP-CPELCPD-AVFRLMEQ-------CWAYEPGQRPSFSTIYQELQS 371

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  146 bits (371), Expect = 1e-39
 Identities = 72/306 (23%), Positives = 125/306 (40%), Gaps = 54/306 (17%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLP-----NGTEVAVKRFK-NCSKAGDANFKHEVEII 368
           F +  +     +G+G +G V            G +VAVK  K        A+ K E+EI+
Sbjct: 18  FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEIL 77

Query: 369 ASVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            ++ H N+V  +G         +      ++ + L +GSL ++L  +   K++   +L+ 
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGI-----KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKY 131

Query: 427 ALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           A+   +G+ YL    Y      +HRD+ A N+L++   + K+GDFGL K       + T 
Sbjct: 132 AVQICKGMDYLGSRQY------VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 185

Query: 484 RVAGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAW 540
           +        + APE  +  K    SDV+SFGV L ELL+        +     ++     
Sbjct: 186 KDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHG 245

Query: 541 --------ELVKEGKTLDVIEENMPEM---ELPEMMEQYVLTAAICAHPILQARPTMDQI 589
                     +KEGK L       P     E+ ++M +       C       R +   +
Sbjct: 246 QMTVTRLVNTLKEGKRLP-----CPPNCPDEVYQLMRK-------CWEFQPSNRTSFQNL 293

Query: 590 VKILET 595
           ++  E 
Sbjct: 294 IEGFEA 299

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  145 bits (368), Expect = 2e-39
 Identities = 71/300 (23%), Positives = 133/300 (44%), Gaps = 42/300 (14%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLP-----NGTEVAVKRFKNCSKAGDANFKHEVEIIA 369
           F   ++     +GKG +G+V            G  VAVK+ ++ ++    +F+ E+EI+ 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
           S++H N+V  +G   +     G + + ++ + L  GSL D+L     +++     L+   
Sbjct: 67  SLQHDNIVKYKGVCYSA----GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTS 121

Query: 429 GTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV 485
              +G+ YL    Y      IHRD+   NIL++     K+GDFGL K  P+       + 
Sbjct: 122 QICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175

Query: 486 AGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWEL 542
            G     + APE     K +  SDV+SFGVVL EL +  +K+         ++ +     
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235

Query: 543 VKEGKTLDVIEEN--MPE-----MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           +     +++++ N  +P       E+  +M +       C +  +  RP+   +   ++ 
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALRVDQ 288

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  145 bits (369), Expect = 3e-39
 Identities = 73/301 (24%), Positives = 133/301 (44%), Gaps = 44/301 (14%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLP-----NGTEVAVKRFKNCSKAGDANFKHEVEIIA 369
           F   ++     +GKG +G+V            G  VAVK+ ++ ++    +F+ E+EI+ 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97

Query: 370 SVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           S++H N+V  +G  YS     L      ++ + L  GSL D+L     +++     L+  
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNL-----KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYT 151

Query: 428 LGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
               +G+ YL    Y      IHRD+   NIL++     K+GDFGL K  P+   +   +
Sbjct: 152 SQICKGMEYLGTKRY------IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVK 205

Query: 485 VAGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWE 541
             G     + APE     K +  SDV+SFGVVL EL +  +K+         ++ +    
Sbjct: 206 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQG 265

Query: 542 LVKEGKTLDVIEEN--MPE-----MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            +     +++++ N  +P       E+  +M +       C +  +  RP+   +   ++
Sbjct: 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTE-------CWNNNVNQRPSFRDLALRVD 318

Query: 595 T 595
            
Sbjct: 319 Q 319

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  148 bits (375), Expect = 5e-39
 Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 32/277 (11%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E  +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 247

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL---HY 439
            +           IV + +  GSL D L G   K L  P  + +A   A G+AY+   +Y
Sbjct: 248 VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                 +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALY
Sbjct: 302 ------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 355

Query: 500 GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           G+ T  SDV+SFG++L EL + G+     +  + VL      + V+ G  +       PE
Sbjct: 356 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVERGYRMP-CPPECPE 408

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
             L ++M Q       C     + RPT + +   LE 
Sbjct: 409 -SLHDLMCQ-------CWRKEPEERPTFEYLQAFLED 437

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  143 bits (362), Expect = 9e-39
 Identities = 71/291 (24%), Positives = 119/291 (40%), Gaps = 40/291 (13%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           EI    + F +E  +G G +G V  G      +VA+K  K  S + D  F  E +++ ++
Sbjct: 20  EIDPKDLTFLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE-FIEEAKVMMNL 76

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G  T   P+      I+ + + NG L ++L      +      L +     
Sbjct: 77  SHEKLVQLYGVCTKQRPI-----FIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVC 130

Query: 432 RGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             + YL    +      +HRD+ A N L+++    KV DFGL+++  +      T   G+
Sbjct: 131 EAMEYLESKQF------LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGS 181

Query: 489 LGYV---APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVK 544
              V    PE  +Y K +  SD+++FGV++ E+ S GK   E              E + 
Sbjct: 182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIA 235

Query: 545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           +G  L        E ++  +M         C H     RPT   ++  +  
Sbjct: 236 QGLRLY-RPHLASE-KVYTIMYS-------CWHEKADERPTFKILLSNILD 277

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  142 bits (361), Expect = 1e-38
 Identities = 74/291 (25%), Positives = 120/291 (41%), Gaps = 40/291 (13%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
            I  + + F +E  IG G +G V+ G   N  +VA+K  +  + + +  F  E E++  +
Sbjct: 4   VIDPSELTFVQE--IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKL 60

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV L G      P+      +V + + +G L D+L        +    L + L   
Sbjct: 61  SHPKLVQLYGVCLEQAPI-----CLVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVC 114

Query: 432 RGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
            G+AYL           IHRD+ A N L+ E    KV DFG+ +F  +      T   GT
Sbjct: 115 EGMAYLEEACV------IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGT 165

Query: 489 LGYV---APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVK 544
              V   +PE   + + +  SDV+SFGV++ E+ S GK   E      V+      E + 
Sbjct: 166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDIS 219

Query: 545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
            G  L           + ++M         C     + RP   ++++ L  
Sbjct: 220 TGFRLYK-PRLAST-HVYQIMNH-------CWRERPEDRPAFSRLLRQLAE 261

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  148 bits (376), Expect = 1e-38
 Identities = 83/277 (29%), Positives = 129/277 (46%), Gaps = 32/277 (11%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E  +G+G +G V+ G     T VA+K  K  + + +A F  E +++  ++H  LV L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQLYAV 330

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL---HY 439
            +           IV + +  GSL D L G   K L  P  + +A   A G+AY+   +Y
Sbjct: 331 VS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                 +HRD++A+NIL+ E    KV DFGLA+   +            + + APE ALY
Sbjct: 385 ------VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY 438

Query: 500 GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           G+ T  SDV+SFG++L EL + G+     +  + VL      + V+ G  +       PE
Sbjct: 439 GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVERGYRMP-CPPECPE 491

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
             L ++M Q       C     + RPT + +   LE 
Sbjct: 492 -SLHDLMCQ-------CWRKEPEERPTFEYLQAFLED 520

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  146 bits (371), Expect = 2e-38
 Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 32/277 (11%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           E  +G G +G V+       T+VAVK  K  S + +A F  E  ++ +++H  LV L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHAV 251

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
            T   P+      I+ + +  GSL D L      K   P  +  +   A G+A++    Q
Sbjct: 252 VTKE-PI-----YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---Q 302

Query: 443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV---APEYALY 499
              IHRD++A+NIL+  +   K+ DFGLA+   +      T   G    +   APE   +
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINF 359

Query: 500 GKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           G  T  SDV+SFG++L+E+++ G+     +    V+        ++ G  +    EN PE
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI------RALERGYRMP-RPENCPE 412

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
            EL  +M +       C     + RPT + I  +L+ 
Sbjct: 413 -ELYNIMMR-------CWKNRPEERPTFEYIQSVLDD 441

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  141 bits (359), Expect = 2e-38
 Identities = 77/291 (26%), Positives = 123/291 (42%), Gaps = 40/291 (13%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV 371
           E+K   +   +E  +G G +G V  G      +VAVK  K  S + D  F  E + +  +
Sbjct: 4   ELKREEITLLKE--LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE-FFQEAQTMMKL 60

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H  LV   G  +   P+      IV + + NG L ++L   G K L     L +     
Sbjct: 61  SHPKLVKFYGVCSKEYPI-----YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVC 114

Query: 432 RGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
            G+A+L    +      IHRD+ A N L+D     KV DFG+ ++  +          GT
Sbjct: 115 EGMAFLESHQF------IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ---YVSSVGT 165

Query: 489 LGYV---APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVK 544
              V   APE   Y K +  SDV++FG+++ E+ S GK   ++     V+        V 
Sbjct: 166 KFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVS 219

Query: 545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           +G  L        +  + ++M         C H + + RPT  Q++  +E 
Sbjct: 220 QGHRLY-RPHLASD-TIYQIMYS-------CWHELPEKRPTFQQLLSSIEP 261

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  147 bits (373), Expect = 2e-38
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 26/275 (9%)

Query: 323 ENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           ++ +G G YG VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV L G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 283

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
             T   P       I+ + +  G+L D+L     +++S  + L +A   +  + YL    
Sbjct: 284 VCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--- 335

Query: 442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK 501
           +   IHR++ A N L+ E    KV DFGL++                + + APE   Y K
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 502 LTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEME 560
            +  SDV++FGV+L E+ + G      I    V       EL+++   ++   E  PE +
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKDYRME-RPEGCPE-K 447

Query: 561 LPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           + E+M         C       RP+  +I +  ET
Sbjct: 448 VYELMRA-------CWQWNPSDRPSFAEIHQAFET 475

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  143 bits (363), Expect = 2e-38
 Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 45/301 (14%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLP-----NGTEVAVKRFKNCSKAGDANFKHEVEIIA 369
           F   ++     +GKG +G+V            G  VAVK+ ++       +F+ E++I+ 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79

Query: 370 SVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           ++    +V  RG  Y      L      +V + L +G L D L      +L     L  +
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSL-----RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYS 133

Query: 428 LGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR 484
               +G+ YL           +HRD+ A NIL++     K+ DFGLAK  P    +   R
Sbjct: 134 SQICKGMEYLGSRRC------VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVR 187

Query: 485 VAGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWE 541
             G     + APE       +  SDV+SFGVVL EL +   K+C        ++      
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDV 247

Query: 542 LVKEGKTLDVIEEN--MPE-----MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
                + L+++EE   +P       E+ E+M+        C  P  Q RP+   +   L+
Sbjct: 248 PALS-RLLELLEEGQRLPAPPACPAEVHELMKL-------CWAPSPQDRPSFSALGPQLD 299

Query: 595 T 595
            
Sbjct: 300 M 300

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  140 bits (354), Expect = 3e-37
 Identities = 83/306 (27%), Positives = 126/306 (41%), Gaps = 56/306 (18%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPN-----GTEVAVKRFK-NCSKAGDANFKHEVEII 368
           F +  +     +G+G +G V            G  VAVK  K +      + +K E++I+
Sbjct: 28  FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDIL 87

Query: 369 ASVKHVNLVALRG--YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            ++ H +++  +G         L      +V + +  GSL D+L       +     L  
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASL-----QLVMEYVPLGSLRDYLPRH---SIGLAQLLLF 139

Query: 427 ALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           A     G+AYL   HY      IHRD+ A N+LLD     K+GDFGLAK  PEG  +   
Sbjct: 140 AQQICEGMAYLHAQHY------IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193

Query: 484 RVAGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAW 540
           R  G     + APE     K    SDV+SFGV L ELL+    +         L+     
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253

Query: 541 --------ELVKEGKTLDVIEENMPEM---ELPEMMEQYVLTAAICAHPILQARPTMDQI 589
                   EL++ G+ L       P+    E+  +M+        C       RPT + +
Sbjct: 254 QMTVLRLTELLERGERLP-----RPDKCPAEVYHLMKN-------CWETEASFRPTFENL 301

Query: 590 VKILET 595
           + IL+T
Sbjct: 302 IPILKT 307

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  143 bits (362), Expect = 3e-37
 Identities = 84/281 (29%), Positives = 125/281 (44%), Gaps = 44/281 (15%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
              IGKG +G+V  G    G +VAVK  KN + A    F  E  ++  ++H NLV L G 
Sbjct: 198 LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLG- 253

Query: 383 STATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL---H 438
               V +E    + IV + +  GSL D+L   G   L     L+ +L     + YL   +
Sbjct: 254 ----VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 309

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV---APE 495
           +      +HRD+ A N+L+ E   AKV DFGL K         ++        V   APE
Sbjct: 310 F------VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPE 356

Query: 496 YALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE 554
                K +  SDV+SFG++L E+ S G+     I  K V+        V++G  +D   +
Sbjct: 357 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMD-APD 409

Query: 555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
             P   + ++M+        C H     RPT  Q+ + LE 
Sbjct: 410 GCPP-AVYDVMKN-------CWHLDAATRPTFLQLREQLEH 442

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  138 bits (349), Expect = 6e-37
 Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 12/205 (5%)

Query: 322 RENIIGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNLVA 378
            +  IG+G +  VYKG+      EVA    +    +K+    FK E E++  ++H N+V 
Sbjct: 30  FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVR 89

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
                 +TV  +    ++V +L+ +G+L  +L     K +   +         +GL +LH
Sbjct: 90  FYDSWESTVKGKKCI-VLVTELMTSGTLKTYL--KRFKVMKIKVLRSWCRQILKGLQFLH 146

Query: 439 YGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
               P IIHRD+K  NI +       K+GD GLA             V GT  ++APE  
Sbjct: 147 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEM- 201

Query: 498 LYGKLTPGSDVYSFGVVLLELLSGK 522
              K     DVY+FG+ +LE+ + +
Sbjct: 202 YEEKYDESVDVYAFGMCMLEMATSE 226

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  138 bits (349), Expect = 6e-37
 Identities = 83/278 (29%), Positives = 129/278 (46%), Gaps = 36/278 (12%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
              +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVRLYAV 76

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL---HY 439
            T   P+      I+ + + NGSL D L      KL+    L +A   A G+A++   +Y
Sbjct: 77  VTQE-PI-----YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNY 130

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY--VAPEYA 497
                 IHRD++A+NIL+ +    K+ DFGLA+   +     T R          APE  
Sbjct: 131 ------IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAI 182

Query: 498 LYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM 556
            YG  T  SDV+SFG++L E+++ G+     +    V+      + ++ G  +    +N 
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------QNLERGYRMV-RPDNC 235

Query: 557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           PE EL ++M         C     + RPT D +  +LE
Sbjct: 236 PE-ELYQLMRL-------CWKERPEDRPTFDYLRSVLE 265

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  137 bits (347), Expect = 1e-36
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 44/286 (15%)

Query: 323 ENIIGKGGYGNVYKGMLPNG---TEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLVA 378
           +  +G G +G+V +G+        +VA+K  K    KA       E +I+  + +  +V 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL- 437
           L G             ++V ++   G L+  L G   +++       +    + G+ YL 
Sbjct: 75  LIGVCQ------AEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLE 127

Query: 438 --HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL--GYVA 493
             ++      +HRD+ A N+LL     AK+ DFGL+K      ++ T R AG     + A
Sbjct: 128 EKNF------VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           PE   + K +  SDV+S+GV + E LS G+K  + ++G  V+        +++GK ++  
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRME-- 233

Query: 553 EENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
               P     EL  +M         C     + RP    + + +  
Sbjct: 234 ---CPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQRMRA 269

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  137 bits (347), Expect = 1e-36
 Identities = 76/283 (26%), Positives = 121/283 (42%), Gaps = 42/283 (14%)

Query: 323 ENIIGKGGYGNVYKGMLPNG-TEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           ++ +G G YG VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV L G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE-FLKEAAVMKEIKHPNLVQLLG 76

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL---H 438
             T   P       I+ + +  G+L D+L     +++S  + L +A   +  + YL   +
Sbjct: 77  VCTREPPF-----YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 131

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY--VAPEY 496
           +      IHRD+ A N L+ E    KV DFGL++         T            APE 
Sbjct: 132 F------IHRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPES 183

Query: 497 ALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN 555
             Y K +  SDV++FGV+L E+ + G      I    V       EL+++   ++     
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ELLEKDYRME----- 232

Query: 556 MPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
            PE    ++ E+M         C       RP+  +I +  ET
Sbjct: 233 RPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIHQAFET 268

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  135 bits (342), Expect = 5e-36
 Identities = 84/278 (30%), Positives = 123/278 (44%), Gaps = 40/278 (14%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
              IGKG +G+V  G    G +VAVK  KN + A    F  E  ++  ++H NLV L G 
Sbjct: 26  LQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA--FLAEASVMTQLRHSNLVQLLGV 82

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL---HY 439
                        IV + +  GSL D+L   G   L     L+ +L     + YL   ++
Sbjct: 83  IVEEKG----GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNF 138

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY--VAPEYA 497
                 +HRD+ A N+L+ E   AKV DFGL K         +T+  G L     APE  
Sbjct: 139 ------VHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQDTGKLPVKWTAPEAL 186

Query: 498 LYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM 556
              K +  SDV+SFG++L E+ S G+     I  K V+        V++G  +D   +  
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKGYKMDA-PDGC 239

Query: 557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           P   + E+M+        C H     RP+  Q+ + LE
Sbjct: 240 PP-AVYEVMKN-------CWHLDAAMRPSFLQLREQLE 269

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (342), Expect = 1e-35
 Identities = 70/308 (22%), Positives = 113/308 (36%), Gaps = 67/308 (21%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG----TEVAVKRFK--NCSKAGDANFKHEVEII 368
             R  +     +G+G +G+V +G L        +VAVK  K  N S+     F  E   +
Sbjct: 31  IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACM 90

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL----FGSGMKKLSWPIRL 424
               H N++ L G           + +++   +  G L+ +L      +G K +     L
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 425 RIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
           +  +  A G+ YL   ++      +HRD+ A N +L +     V DFGL+K     I   
Sbjct: 151 KFMVDIALGMEYLSNRNF------LHRDLAARNCMLRDDMTVCVADFGLSKK----IYSG 200

Query: 482 TTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS-------GKKACEIIQ 529
                G +  +     A E       T  SDV++FGV + E+ +       G +  E+  
Sbjct: 201 DYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY- 259

Query: 530 GKSVLLSDWAWELVKEGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTM 586
                      + +  G  L       PE    EL E+M         C       RPT 
Sbjct: 260 -----------DYLLHGHRLK-----QPEDCLDELYEIMYS-------CWRTDPLDRPTF 296

Query: 587 DQIVKILE 594
             +   LE
Sbjct: 297 SVLRLQLE 304

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (342), Expect = 2e-35
 Identities = 79/298 (26%), Positives = 128/298 (42%), Gaps = 47/298 (15%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTE-----VAVKRFK-NCSKAGDANFKHEV 365
           EI  + +   +   IG G +G VYKGML   +      VA+K  K   ++    +F  E 
Sbjct: 40  EIHPSCVTRQKV--IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 97

Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
            I+    H N++ L G  +   P+     +I+ + + NG+L   L      + S    + 
Sbjct: 98  GIMGQFSHHNIIRLEGVISKYKPM-----MIITEYMENGALDKFLREKD-GEFSVLQLVG 151

Query: 426 IALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
           +  G A G+ YL   +Y      +HRD+ A NIL++     KV DFGL++   +      
Sbjct: 152 MLRGIAAGMKYLANMNY------VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205

Query: 483 TRVAGTLGY--VAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWA 539
           T   G +     APE   Y K T  SDV+SFG+V+ E+++ G++    +    V+     
Sbjct: 206 TTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM----- 260

Query: 540 WELVKEGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            + + +G  L       P      + ++M Q       C       RP    IV IL+
Sbjct: 261 -KAINDGFRLP-----TPMDCPSAIYQLMMQ-------CWQQERARRPKFADIVSILD 305

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  134 bits (339), Expect = 2e-35
 Identities = 68/306 (22%), Positives = 122/306 (39%), Gaps = 52/306 (16%)

Query: 310 IEEIKAATMNFSRENI------IGKGGYGNVYKGMLPNG---TEVAVKRFKNC--SKAGD 358
           +EEI+   +   R+ +      +G G +G V KG          VAVK  KN     A  
Sbjct: 3   LEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 62

Query: 359 ANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKL 418
                E  ++  + +  +V + G             ++V ++   G L  +L  +  + +
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICE------AESWMLVMEMAELGPLNKYLQQN--RHV 114

Query: 419 SWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP 475
                + +    + G+ YL   ++      +HRD+ A N+LL     AK+ DFGL+K   
Sbjct: 115 KDKNIIELVHQVSMGMKYLEESNF------VHRDLAARNVLLVTQHYAKISDFGLSKALR 168

Query: 476 EGITHLTTRVAGTL--GYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKS 532
               +   +  G     + APE   Y K +  SDV+SFGV++ E  S G+K    ++G  
Sbjct: 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

Query: 533 VLLSDWAWELVKEGKTLDVIEENMPEM---ELPEMMEQYVLTAAICAHPILQARPTMDQI 589
           V        ++++G+ +       P     E+ ++M         C    ++ RP    +
Sbjct: 229 VT------AMLEKGERMG-----CPAGCPREMYDLMNL-------CWTYDVENRPGFAAV 270

Query: 590 VKILET 595
              L  
Sbjct: 271 ELRLRN 276

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (341), Expect = 2e-35
 Identities = 78/287 (27%), Positives = 117/287 (40%), Gaps = 44/287 (15%)

Query: 323 ENIIGKGGYGNVYKGMLP----NGTEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
           E IIG G  G V  G L         VA+K  K   ++    +F  E  I+    H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T          +IV + + NGSL   L      + +    + +  G   G+ YL
Sbjct: 114 RLEGVVTRGRLA-----MIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYL 167

Query: 438 ---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY--V 492
               Y      +HRD+ A N+L+D     KV DFGL++   +      T   G +     
Sbjct: 168 SDLGY------VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT 221

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDV 551
           APE   +   +  SDV+SFGVV+ E+L+ G++    +  + V+        V+EG  L  
Sbjct: 222 APEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI------SSVEEGYRLP- 274

Query: 552 IEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
                P      L ++M         C H     RP   QIV +L+ 
Sbjct: 275 ----APMGCPHALHQLMLD-------CWHKDRAQRPRFSQIVSVLDA 310

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  139 bits (351), Expect = 4e-35
 Identities = 72/303 (23%), Positives = 129/303 (42%), Gaps = 50/303 (16%)

Query: 311 EEIKAATMNFSRENI------IGKGGYGNVYKGMLPNG---TEVAVKRFK-NCSKAGDAN 360
           EE+K   +   R+N+      +G G +G+V +G+        +VA+K  K    KA    
Sbjct: 323 EELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE 382

Query: 361 FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSW 420
              E +I+  + +  +V L G             ++V ++   G L+  L G   +++  
Sbjct: 383 MMREAQIMHQLDNPYIVRLIGVCQ------AEALMLVMEMAGGGPLHKFLVGKR-EEIPV 435

Query: 421 PIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG 477
                +    + G+ YL   ++      +HR++ A N+LL     AK+ DFGL+K     
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNF------VHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489

Query: 478 ITHLTTRVAGTLGY--VAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVL 534
            ++ T R AG       APE   + K +  SDV+S+GV + E LS G+K  + ++G  V+
Sbjct: 490 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM 549

Query: 535 LSDWAWELVKEGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
                   +++GK ++      P     EL  +M         C     + RP    + +
Sbjct: 550 ------AFIEQGKRME-----CPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQ 591

Query: 592 ILE 594
            + 
Sbjct: 592 RMR 594

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  134 bits (340), Expect = 6e-35
 Identities = 82/297 (27%), Positives = 127/297 (42%), Gaps = 46/297 (15%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNG----TEVAVKRFK-NCSKAGDANFKHEVE 366
           E+ A   N S + ++G G +G V  G L         VA+K  K   ++    +F  E  
Sbjct: 41  ELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEAS 98

Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           I+    H N++ L G  T + P+     +IV + + NGSL   L      + +    + +
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPV-----MIVTEYMENGSLDSFLRKHD-AQFTVIQLVGM 152

Query: 427 ALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
             G A G+ YL    Y      +HRD+ A NIL++     KV DFGL +   +      T
Sbjct: 153 LRGIASGMKYLSDMGY------VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYT 206

Query: 484 RVAGTLGY--VAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAW 540
              G +     +PE   Y K T  SDV+S+G+VL E++S G++    +  + V+      
Sbjct: 207 TRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI------ 260

Query: 541 ELVKEGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           + V EG  L       P      L ++M         C       RP  +QIV IL+
Sbjct: 261 KAVDEGYRLP-----PPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSILD 305

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (337), Expect = 8e-35
 Identities = 74/318 (23%), Positives = 120/318 (37%), Gaps = 81/318 (25%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFKNCSKAGDANFKHEVEII 368
             R +I     +G+G +G V+     N         VAVK  K  S++   +F+ E E++
Sbjct: 38  IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 97

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-------------FGSGM 415
             ++H ++V   G  T   PL     ++V + + +G L   L                  
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPL-----LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAP 152

Query: 416 KKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
             L     L +A   A G+ YL   H+      +HRD+   N L+ +    K+GDFG+++
Sbjct: 153 GPLGLGQLLAVASQVAAGMVYLAGLHF------VHRDLATRNCLVGQGLVVKIGDFGMSR 206

Query: 473 FNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS------- 520
                      RV G    +      PE  LY K T  SDV+SFGVVL E+ +       
Sbjct: 207 DIYSTD---YYRV-GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWY 262

Query: 521 GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE---MELPEMMEQYVLTAAICAH 577
                E I            + + +G+ L+      P     E+  +M         C  
Sbjct: 263 QLSNTEAI------------DCITQGRELE-----RPRACPPEVYAIMRG-------CWQ 298

Query: 578 PILQARPTMDQIVKILET 595
              Q R ++  +   L+ 
Sbjct: 299 REPQQRHSIKDVHARLQA 316

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  133 bits (337), Expect = 8e-35
 Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 45/290 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNG-----TEVAVKRFK-NCSKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+           VA+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           + ++  L G              ++  L+  G L D++       +     L   +  A+
Sbjct: 76  NPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 128

Query: 433 GLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT- 488
           G+ YL           +HRD+ A N+L+      K+ DFGLAK                 
Sbjct: 129 GMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGK 547
           + ++A E  L+   T  SDV+S+GV + EL++ G K  + I    +        ++++G+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGE 236

Query: 548 TLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            L       P    +++  +M +       C      +RP   +++    
Sbjct: 237 RLP-----QPPICTIDVYMIMRK-------CWMIDADSRPKFRELIIEFS 274

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  132 bits (334), Expect = 1e-34
 Identities = 66/307 (21%), Positives = 107/307 (34%), Gaps = 62/307 (20%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG----TEVAVKRFK--NCSKAGDANFKHEVEII 368
              +       +GKG +G+V +  L        +VAVK  K    + +    F  E   +
Sbjct: 20  IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACM 79

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHL----FGSGMKKLSWPIR 423
               H ++  L G S  +          ++   + +G L+  L     G     L     
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTL 139

Query: 424 LRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
           +R  +  A G+ YL   ++      IHRD+ A N +L E     V DFGL++     I  
Sbjct: 140 VRFMVDIACGMEYLSSRNF------IHRDLAARNCMLAEDMTVCVADFGLSR----KIYS 189

Query: 481 LTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS-------GKKACEII 528
                 G    +     A E       T  SDV++FGV + E+++       G +  EI 
Sbjct: 190 GDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249

Query: 529 QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQ 588
                         +  G  L        E E+ ++M Q       C     + RP+   
Sbjct: 250 ------------NYLIGGNRLK-QPPECME-EVYDLMYQ-------CWSADPKQRPSFTC 288

Query: 589 IVKILET 595
           +   LE 
Sbjct: 289 LRMELEN 295

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  131 bits (332), Expect = 2e-34
 Identities = 70/293 (23%), Positives = 115/293 (39%), Gaps = 56/293 (19%)

Query: 323 ENIIGKGGYGNVYKGMLPNG----TEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLV 377
           + +IGKG +G VY G   +      + A+K     ++      F  E  ++  + H N++
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
           AL G       L      ++   + +G L   +     +  +    +   L  ARG+ YL
Sbjct: 86  ALIGIMLPPEGLP----HVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYL 140

Query: 438 ---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV-- 492
               +      +HRD+ A N +LDE+F  KV DFGLA+   +   +   +       V  
Sbjct: 141 AEQKF------VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKW 194

Query: 493 -APEYALYGKLTPGSDVYSFGVVLLELLS-------GKKACEIIQGKSVLLSDWAWELVK 544
            A E     + T  SDV+SFGV+L ELL+            ++               + 
Sbjct: 195 TALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT------------HFLA 242

Query: 545 EGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           +G+ L       PE     L ++M+Q       C       RPT   +V  +E
Sbjct: 243 QGRRLP-----QPEYCPDSLYQVMQQ-------CWEADPAVRPTFRVLVGEVE 283

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (332), Expect = 2e-34
 Identities = 75/316 (23%), Positives = 123/316 (38%), Gaps = 76/316 (24%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFKNCSKAGDANFKHEVEII 368
             R +I     +G+G +G V+     N         VAVK  K+ + A   +F+ E E++
Sbjct: 12  IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELL 71

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--------------FGSG 414
            +++H ++V   G      PL     I+V + + +G L   L                  
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPL-----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 126

Query: 415 MKKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
             +L     L IA   A G+ YL   H+      +HRD+   N L+      K+GDFG++
Sbjct: 127 KGELGLSQMLHIASQIASGMVYLASQHF------VHRDLATRNCLVGANLLVKIGDFGMS 180

Query: 472 KFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS------ 520
           +     +        G    +      PE  +Y K T  SDV+SFGV+L E+ +      
Sbjct: 181 RD----VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW 236

Query: 521 -GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPI 579
                 E+I            E + +G+ L+      P+ E+ ++M         C    
Sbjct: 237 FQLSNTEVI------------ECITQGRVLE-RPRVCPK-EVYDVMLG-------CWQRE 275

Query: 580 LQARPTMDQIVKILET 595
            Q R  + +I KIL  
Sbjct: 276 PQQRLNIKEIYKILHA 291

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  131 bits (331), Expect = 5e-34
 Identities = 85/305 (27%), Positives = 123/305 (40%), Gaps = 59/305 (19%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFK-NCSKAGDANFKHEVEI 367
             R+NI     +G G +G VY+G +          +VAVK     CS+  + +F  E  I
Sbjct: 27  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 86

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-----FGSGMKKLSWPI 422
           I+   H N+V   G S  ++P       I+ +L+  G L   L       S    L+   
Sbjct: 87  ISKFNHQNIVRCIGVSLQSLPR-----FILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141

Query: 423 RLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGLAKFNPE 476
            L +A   A G  YL   H+      IHRDI A N LL        AK+GDFG+A+    
Sbjct: 142 LLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 191

Query: 477 GITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG 530
            I   +    G    +      PE  + G  T  +D +SFGV+L E+ S G         
Sbjct: 192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251

Query: 531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV 590
           + VL      E V  G  +D   +N P   +  +M Q       C     + RP    I+
Sbjct: 252 QEVL------EFVTSGGRMDPP-KNCPG-PVYRIMTQ-------CWQHQPEDRPNFAIIL 296

Query: 591 KILET 595
           + +E 
Sbjct: 297 ERIEY 301

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (330), Expect = 5e-34
 Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 18/218 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           ++     +G+GG+  V     L +G   A+KR     +      + E ++     H N++
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR--LRIALGTARGLA 435
            L  Y         H+  ++      G+L++ +     K         L + LG  RGL 
Sbjct: 90  RLVAYCLRERG-AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA--------G 487
            +H        HRD+K +NILL +  +  + D G        +      +          
Sbjct: 149 AIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205

Query: 488 TLGYVAPE---YALYGKLTPGSDVYSFGVVLLELLSGK 522
           T+ Y APE      +  +   +DV+S G VL  ++ G+
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  130 bits (329), Expect = 5e-34
 Identities = 72/294 (24%), Positives = 114/294 (38%), Gaps = 56/294 (19%)

Query: 323 ENIIGKGGYGNVYKGMLPNG----TEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
             +IG+G +G VY G L +        AVK           + F  E  I+    H N++
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
           +L G    +        ++V   + +G L + +        +    +   L  A+G+ YL
Sbjct: 90  SLLGICLRSEG----SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYL 144

Query: 438 ---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV-- 492
               +      +HRD+ A N +LDE F  KV DFGLA+   +   +      G    V  
Sbjct: 145 ASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198

Query: 493 -APEYALYGKLTPGSDVYSFGVVLLELLS-------GKKACEIIQGKSVLLSDWAWELVK 544
            A E     K T  SDV+SFGV+L EL++            +I               + 
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------------VYLL 246

Query: 545 EGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           +G+ L       PE     L E+M +       C HP  + RP+  ++V  +  
Sbjct: 247 QGRRLL-----QPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISA 288

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  131 bits (332), Expect = 8e-34
 Identities = 71/294 (24%), Positives = 113/294 (38%), Gaps = 56/294 (19%)

Query: 323 ENIIGKGGYGNVYKGMLPNG----TEVAVKRFK-NCSKAGDANFKHEVEIIASVKHVNLV 377
             +IG+G +G VY G L +        AVK           + F  E  I+    H N++
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
           +L G    +        ++V   + +G L + +        +    +   L  A+G+ +L
Sbjct: 154 SLLGICLRSEG----SPLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFL 208

Query: 438 ---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV-- 492
               +      +HRD+ A N +LDE F  KV DFGLA+   +          G    V  
Sbjct: 209 ASKKF------VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 262

Query: 493 -APEYALYGKLTPGSDVYSFGVVLLELLS-------GKKACEIIQGKSVLLSDWAWELVK 544
            A E     K T  SDV+SFGV+L EL++            +I               + 
Sbjct: 263 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT------------VYLL 310

Query: 545 EGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
           +G+ L       PE     L E+M +       C HP  + RP+  ++V  +  
Sbjct: 311 QGRRLL-----QPEYCPDPLYEVMLK-------CWHPKAEMRPSFSELVSRISA 352

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (325), Expect = 1e-33
 Identities = 71/296 (23%), Positives = 119/296 (40%), Gaps = 45/296 (15%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNG----TEVAVKRFK-NCSKAGDANFKHEVE 366
           EI+   +   R   IG+G +G+V++G+  +       VA+K  K   S +    F  E  
Sbjct: 11  EIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 68

Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
            +    H ++V L G  T       +   I+ +L   G L   L       L     +  
Sbjct: 69  TMRQFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVRK-YSLDLASLILY 121

Query: 427 ALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           A   +  LAYL    +      +HRDI A N+L+      K+GDFGL+++  +       
Sbjct: 122 AYQLSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---YY 172

Query: 484 RVAGTLGYV---APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWA 539
           + +     +   APE   + + T  SDV+ FGV + E+L  G K  + ++   V+     
Sbjct: 173 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI----- 227

Query: 540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
              ++ G+ L  +  N P   L  +M +       C       RP   ++   L T
Sbjct: 228 -GRIENGERLP-MPPNCPP-TLYSLMTK-------CWAYDPSRRPRFTELKAQLST 273

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (324), Expect = 1e-33
 Identities = 60/218 (27%), Positives = 95/218 (43%), Gaps = 21/218 (9%)

Query: 318 MNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL 376
           M+F    +IG GG+G V+K     +G    +KR     K  +   + EV+ +A + HVN+
Sbjct: 11  MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKR----VKYNNEKAEREVKALAKLDHVNI 66

Query: 377 VALRGY-----------STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
           V   G            S  +   +     I  +    G+L   +     +KL   + L 
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV 485
           +     +G+ Y+H      +I+RD+K SNI L +  + K+GDFGL            TR 
Sbjct: 127 LFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRTRS 181

Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
            GTL Y++PE           D+Y+ G++L ELL    
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (325), Expect = 2e-33
 Identities = 67/320 (20%), Positives = 114/320 (35%), Gaps = 83/320 (25%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFK-NCSKAGDANFKHEVEI 367
            S   +     +G+  +G VYKG L           VA+K  K          F+HE  +
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--------------FGS 413
            A ++H N+V L G  T   PL      ++     +G L++ L                +
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPL-----SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 414 GMKKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
               L  P  + +    A G+ YL   H       +H+D+   N+L+ +    K+ D GL
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHHV------VHKDLATRNVLVYDKLNVKISDLGL 174

Query: 471 AKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS----- 520
            +     +             +     APE  +YGK +  SD++S+GVVL E+ S     
Sbjct: 175 FRE----VYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

Query: 521 --GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE---MELPEMMEQYVLTAAIC 575
             G    +++            E+++  + L       P+     +  +M +       C
Sbjct: 231 YCGYSNQDVV------------EMIRNRQVLP-----CPDDCPAWVYALMIE-------C 266

Query: 576 AHPILQARPTMDQIVKILET 595
            +     RP    I   L  
Sbjct: 267 WNEFPSRRPRFKDIHSRLRA 286

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  128 bits (325), Expect = 2e-33
 Identities = 62/225 (27%), Positives = 90/225 (40%), Gaps = 28/225 (12%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGML--PNG--TEVAVKRFKNCSKAGDAN---FKHE 364
            I     +      +G G +G V +G    P+G    VAVK  K    +       F  E
Sbjct: 14  LIGEK--DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIRE 71

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL 424
           V  + S+ H NL+ L G              +V +L   GSL D L              
Sbjct: 72  VNAMHSLDHRNLIRLYGVVL------TPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLS 124

Query: 425 RIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
           R A+  A G+ YL    +      IHRD+ A N+LL      K+GDFGL +  P+   H 
Sbjct: 125 RYAVQVAEGMGYLESKRF------IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY 178

Query: 482 TTRVAGTLGY--VAPEYALYGKLTPGSDVYSFGVVLLELLS-GKK 523
             +    + +   APE       +  SD + FGV L E+ + G++
Sbjct: 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  134 bits (338), Expect = 3e-33
 Identities = 56/253 (22%), Positives = 92/253 (36%), Gaps = 42/253 (16%)

Query: 326 IGKGGYGNVYKG--MLPNGTEVAVKRFKNCSKAGDAN----FKHEVEIIASVKHVNLVAL 379
           I  GG G +Y       NG  V +K   +   +GDA        E + +A V H ++V +
Sbjct: 88  IAHGGLGWIYLALDRNVNGRPVVLKGLVH---SGDAEAQAMAMAERQFLAEVVHPSIVQI 144

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
             +   T         IV + +   SL          KL     +   L     L+YLH 
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH- 199

Query: 440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                +++ D+K  NI+L E  + K+ D G        I      + GT G+ APE    
Sbjct: 200 --SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS----RINS-FGYLYGTPGFQAPEIVR- 250

Query: 500 GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM 559
              T  +D+Y+ G  L  L                         + G+ +D + E+ P +
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL-------------------PTRNGRYVDGLPEDDPVL 291

Query: 560 ELPEMMEQYVLTA 572
           +  +   + +  A
Sbjct: 292 KTYDSYGRLLRRA 304

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  128 bits (324), Expect = 4e-33
 Identities = 79/307 (25%), Positives = 127/307 (41%), Gaps = 65/307 (21%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFK-NCSKAGDANFKHEVEI 367
            +RE I     +G+G +G VY+G+          T VA+K      S      F +E  +
Sbjct: 22  VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--------FGSGMKKLS 419
           +      ++V L G  +   P      +++ +L+  G L  +L            +   S
Sbjct: 82  MKEFNCHHVVRLLGVVSQGQPT-----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136

Query: 420 WPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
               +++A   A G+AYL    +      +HRD+ A N ++ E F  K+GDFG+ +    
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKF------VHRDLAARNCMVAEDFTVKIGDFGMTRD--- 187

Query: 477 GITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG 530
            I        G  G +     +PE    G  T  SDV+SFGVVL E+ +  ++     QG
Sbjct: 188 -IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP---YQG 243

Query: 531 KS---VLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMD 587
            S   VL        V EG  LD   +N P+  L E+M         C     + RP+  
Sbjct: 244 LSNEQVL------RFVMEGGLLD-KPDNCPD-MLFELMRM-------CWQYNPKMRPSFL 288

Query: 588 QIVKILE 594
           +I+  ++
Sbjct: 289 EIISSIK 295

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  129 bits (326), Expect = 4e-33
 Identities = 84/305 (27%), Positives = 123/305 (40%), Gaps = 59/305 (19%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFK-NCSKAGDANFKHEVEI 367
             R+NI     +G G +G VY+G +          +VAVK     CS+  + +F  E  I
Sbjct: 68  VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALI 127

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-----KLSWPI 422
           I+   H N+V   G S  ++P       I+ +L+  G L   L  +  +      L+   
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPR-----FILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182

Query: 423 RLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGLAKFNPE 476
            L +A   A G  YL   H+      IHRDI A N LL        AK+GDFG+A+    
Sbjct: 183 LLHVARDIACGCQYLEENHF------IHRDIAARNCLLTCPGPGRVAKIGDFGMAR---- 232

Query: 477 GITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG 530
            I        G    +      PE  + G  T  +D +SFGV+L E+ S G         
Sbjct: 233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 292

Query: 531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV 590
           + VL      E V  G  +D   +N P   +  +M Q       C     + RP    I+
Sbjct: 293 QEVL------EFVTSGGRMDPP-KNCPG-PVYRIMTQ-------CWQHQPEDRPNFAIIL 337

Query: 591 KILET 595
           + +E 
Sbjct: 338 ERIEY 342

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  128 bits (323), Expect = 6e-33
 Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 45/290 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFK-NCSKAGDANFKHEVEIIASVK 372
            F +  ++G G +G VYKG+           VA+K  +   S   +     E  ++ASV 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           + ++  L G              ++  L+  G L D++       +     L   +  A+
Sbjct: 76  NPHVCRLLGICL------TSTVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAK 128

Query: 433 GLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT- 488
           G+ YL           +HRD+ A N+L+      K+ DFGLAK                 
Sbjct: 129 GMNYLEDRRL------VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGK 547
           + ++A E  L+   T  SDV+S+GV + EL++ G K  + I    +        ++++G+
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS------SILEKGE 236

Query: 548 TLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            L       P    +++  +M +       C      +RP   +++    
Sbjct: 237 RLP-----QPPICTIDVYMIMVK-------CWMIDADSRPKFRELIIEFS 274

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  126 bits (320), Expect = 6e-33
 Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 45/295 (15%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNG----TEVAVKRFK-NCSKAGDANFKHEVE 366
            I    +  +R   +G+G +G VY+G+  N       VAVK  K +C+      F  E  
Sbjct: 8   GIAREDVVLNRI--LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAV 65

Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           I+ ++ H ++V L G              I+ +L   G L  +L  +    L     +  
Sbjct: 66  IMKNLDHPHIVKLIGIIE------EEPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLY 118

Query: 427 ALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT 483
           +L   + +AYL   +       +HRDI   NIL+      K+GDFGL+++  +       
Sbjct: 119 SLQICKAMAYLESINC------VHRDIAVRNILVASPECVKLGDFGLSRYIEDED---YY 169

Query: 484 RVAGTLGYV---APEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWA 539
           + + T   +   +PE   + + T  SDV+ F V + E+LS GK+    ++ K V+     
Sbjct: 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI----- 224

Query: 540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
             ++++G  L    +  P   L  +M +       C       RP   ++V  L 
Sbjct: 225 -GVLEKGDRLP-KPDLCPP-VLYTLMTR-------CWDYDPSDRPRFTELVCSLS 269

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (319), Expect = 1e-32
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 18/203 (8%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN----FKHEVEIIASVKHVNLVALR 380
           +G GG   VY         +VA+K                F+ EV   + + H N+V++ 
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFI-PPREKEETLKRFEREVHNSSQLSHQNIVSM- 76

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
                    E     +V + +   +L +++   G   LS    +        G+ + H  
Sbjct: 77  -IDVDE---EDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH-- 128

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALY 499
               I+HRDIK  NIL+D     K+ DFG+AK  +   +T  T  V GT+ Y +PE A  
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKG 186

Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
                 +D+YS G+VL E+L G+
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGE 209

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  126 bits (319), Expect = 2e-32
 Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 47/297 (15%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCSKAGD-ANFKHEV 365
             K       +  ++G G +G V+KG+           V +K  ++ S           +
Sbjct: 9   IFKET--ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM 66

Query: 366 EIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
             I S+ H ++V L G         G    +V   L  GSL DH+       L   + L 
Sbjct: 67  LAIGSLDHAHIVRLLGLCP------GSSLQLVTQYLPLGSLLDHVRQHR-GALGPQLLLN 119

Query: 426 IALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
             +  A+G+ YL           +HR++ A N+LL    + +V DFG+A   P     L 
Sbjct: 120 WGVQIAKGMYYLEEHGM------VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173

Query: 483 TRVAGT-LGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAW 540
              A T + ++A E   +GK T  SDV+S+GV + EL++ G +    ++   V       
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP------ 227

Query: 541 ELVKEGKTLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           +L+++G+ L       P+   +++  +M +       C       RPT  ++     
Sbjct: 228 DLLEKGERLA-----QPQICTIDVYMVMVK-------CWMIDENIRPTFKELANEFT 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  125 bits (315), Expect = 5e-32
 Identities = 48/223 (21%), Positives = 85/223 (38%), Gaps = 34/223 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNL 376
            +S    IG GG   V++ +       A+K    +        ++++E+  +  ++  + 
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 377 --VALRGYSTATVPLEGHQRIIV---CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
             + L  Y          Q I +   C    N  L   L     K +    R        
Sbjct: 89  KIIRLYDY------EITDQYIYMVMEC---GNIDLNSWL--KKKKSIDPWERKSYWKNML 137

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLG 490
             +  +H   Q  I+H D+K +N L+ +    K+ DFG+A    P+  + +     GT+ 
Sbjct: 138 EAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 193

Query: 491 YVAPE-----------YALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+ PE                K++P SDV+S G +L  +  GK
Sbjct: 194 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (312), Expect = 9e-32
 Identities = 59/312 (18%), Positives = 110/312 (35%), Gaps = 71/312 (22%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGML--------PNGTEVAVKRFKNCSKAGDANFKH 363
           +I+   + F+    +G+G +  ++KG+          + TEV +K      +    +F  
Sbjct: 4   KIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE 61

Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
              +++ + H +LV   G             I+V + +  GSL  +L  +    ++   +
Sbjct: 62  AASMMSKLSHKHLVLNYGVCVCGDEN-----ILVQEFVKFGSLDTYLKKNK-NCINILWK 115

Query: 424 LRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFE--------AKVGDFGLAK 472
           L +A   A  + +L           IH ++ A NILL    +         K+ D G++ 
Sbjct: 116 LEVAKQLAAAMHFLEENTL------IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169

Query: 473 FNPEGITHLTTRVAGTLGY------VAPEYALYGKL-TPGSDVYSFGVVLLELLS-GKKA 524
                       V            V PE     K     +D +SFG  L E+ S G K 
Sbjct: 170 T-----------VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

Query: 525 CEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE-MELPEMMEQYVLTAAICAHPILQAR 583
              +  +  L      +  ++   L       P+  EL  ++         C       R
Sbjct: 219 LSALDSQRKL------QFYEDRHQLP-----APKAAELANLINN-------CMDYEPDHR 260

Query: 584 PTMDQIVKILET 595
           P+   I++ L +
Sbjct: 261 PSFRAIIRDLNS 272

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  129 bits (325), Expect = 1e-31
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 12/211 (5%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNL 376
            +  +  +G GG+G V + +    G +VA+K+ +      +   +  E++I+  + H N+
Sbjct: 15  PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 377 VALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           V+ R               ++  +    G L  +L        L       +    +  L
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL 134

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEA---KVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            YLH   +  IIHRD+K  NI+L    +    K+ D G AK   +G    T  V GTL Y
Sbjct: 135 RYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQY 189

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           +APE     K T   D +SFG +  E ++G 
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  124 bits (314), Expect = 1e-31
 Identities = 48/223 (21%), Positives = 85/223 (38%), Gaps = 34/223 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNL 376
            +S    IG GG   V++ +       A+K    +        ++++E+  +  ++  + 
Sbjct: 10  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 377 --VALRGYSTATVPLEGHQRIIV---CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
             + L  Y          Q I +   C    N  L   L     K +    R        
Sbjct: 70  KIIRLYDY------EITDQYIYMVMEC---GNIDLNSWL--KKKKSIDPWERKSYWKNML 118

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLG 490
             +  +H   Q  I+H D+K +N L+ +    K+ DFG+A    P+  + +     GT+ 
Sbjct: 119 EAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVN 174

Query: 491 YVAPE-----------YALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+ PE                K++P SDV+S G +L  +  GK
Sbjct: 175 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (311), Expect = 2e-31
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 14/204 (6%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN----FKHEVEIIASVKHVNLVALR 380
           +G GG   V+    L +  +VAVK  +    A D +    F+ E +  A++ H  +VA+ 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRA-DLARDPSFYLRFRREAQNAAALNHPAIVAVY 78

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
               A  P  G    IV + +   +L D +   G   ++    + +     + L + H  
Sbjct: 79  DTGEAETP-AGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH-- 133

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT--RVAGTLGYVAPEYAL 498
            Q  IIHRD+K +NI++      KV DFG+A+   +    +T    V GT  Y++PE A 
Sbjct: 134 -QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192

Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
              +   SDVYS G VL E+L+G+
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGE 216

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  123 bits (310), Expect = 2e-31
 Identities = 58/233 (24%), Positives = 100/233 (42%), Gaps = 42/233 (18%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +F    ++G+G +G V K     +    A+K+ +  ++   +    EV ++AS+ H  +V
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVV 65

Query: 378 ALRG-------YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGM---KKLSWPIRLRI 426
                      +      ++    + I  +   NG+LYD +    +   +   W +  +I
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI 125

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF------------- 473
                  L+Y+H      IIHRD+K  NI +DE+   K+GDFGLAK              
Sbjct: 126 LEA----LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 474 -NPEGITHLTTRVAGTLGYVAPE----YALYGKLTPGSDVYSFGVVLLELLSG 521
             P    +LT+ + GT  YVA E       Y +     D+YS G++  E++  
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNE---KIDMYSLGIIFFEMIYP 227

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  123 bits (312), Expect = 2e-31
 Identities = 78/316 (24%), Positives = 128/316 (40%), Gaps = 74/316 (23%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLP--------NGTEVAVKRFK-NCSKAGDANFKHEV 365
           F R+ +     +G+G +G V                  VAVK  K + ++   ++   E+
Sbjct: 32  FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 91

Query: 366 EIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-------------- 410
           E++  + KH N++ L G  T   PL      ++ +    G+L ++L              
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDI 146

Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                +++++   +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGL
Sbjct: 147 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 203

Query: 471 AKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS----- 520
           A+     I ++      T G +     APE       T  SDV+SFGV++ E+ +     
Sbjct: 204 ARD----INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

Query: 521 --GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHP 578
             G    E+             +L+KEG  +D    N    EL  MM         C H 
Sbjct: 260 YPGIPVEELF------------KLLKEGHRMD-KPANCTN-ELYMMMRD-------CWHA 298

Query: 579 ILQARPTMDQIVKILE 594
           +   RPT  Q+V+ L+
Sbjct: 299 VPSQRPTFKQLVEDLD 314

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (311), Expect = 3e-31
 Identities = 81/315 (25%), Positives = 123/315 (39%), Gaps = 78/315 (24%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG---TEVAVKRFK-NCSKAGDANFKHEVEIIAS 370
               +I     IG+G +G V K  +       + A+KR K   SK    +F  E+E++  
Sbjct: 22  LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 81

Query: 371 V-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--------------FGSGM 415
           +  H N++ L G       L      +  +   +G+L D L                S  
Sbjct: 82  LGHHPNIINLLGACEHRGYL-----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 136

Query: 416 KKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
             LS    L  A   ARG+ YL    +      IHRD+ A NIL+ E + AK+ DFGL++
Sbjct: 137 STLSSQQLLHFAADVARGMDYLSQKQF------IHRDLAARNILVGENYVAKIADFGLSR 190

Query: 473 FNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS------- 520
                       V  T+G +     A E   Y   T  SDV+S+GV+L E++S       
Sbjct: 191 GQEV-------YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC 243

Query: 521 GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPIL 580
           G    E+             E + +G  L+    N  + E+ ++M Q       C     
Sbjct: 244 GMTCAELY------------EKLPQGYRLEK-PLNCDD-EVYDLMRQ-------CWREKP 282

Query: 581 QARPTMDQIVKILET 595
             RP+  QI+  L  
Sbjct: 283 YERPSFAQILVSLNR 297

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  128 bits (322), Expect = 4e-31
 Identities = 71/298 (23%), Positives = 123/298 (41%), Gaps = 42/298 (14%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG----TEVAVKRFK-NCSKAGDANFKHEVEIIA 369
             RE I     IG+G +G+V++G+  +       VA+K  K   S +    F  E   + 
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMR 446

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG 429
              H ++V L G  T       +   I+ +L   G L   L       L     +  A  
Sbjct: 447 QFDHPHIVKLIGVIT------ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQ 499

Query: 430 TARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
            +  LAYL    +      +HRDI A N+L+      K+GDFGL+++  +   +  ++  
Sbjct: 500 LSTALAYLESKRF------VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553

Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKE 545
             + ++APE   + + T  SDV+ FGV + E+L  G K  + ++   V+        ++ 
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------GRIEN 607

Query: 546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIK 603
           G+ L  +  N P   L  +M +       C       RP   ++   L T +    ++
Sbjct: 608 GERLP-MPPNCPP-TLYSLMTK-------CWAYDPSRRPRFTELKAQLSTILEEEKLQ 656

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (307), Expect = 5e-31
 Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 28/224 (12%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           +F     +G+GG+G V++     +    A+K  R  N   A +     EV+ +A ++H  
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE-KVMREVKALAKLEHPG 64

Query: 376 LVALRGYSTATVPLEGHQRI-------IVCDLLHNGSLYDHLFG-SGMKKLSWPIRLRIA 427
           +V            E  Q         I   L    +L D + G   +++    + L I 
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-----------FNPE 476
           L  A  + +LH      ++HRD+K SNI        KVGDFGL               P 
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 477 GITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELL 519
                 T   GT  Y++PE  ++G   +   D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELL 224

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  123 bits (310), Expect = 7e-31
 Identities = 79/324 (24%), Positives = 131/324 (40%), Gaps = 74/324 (22%)

Query: 320 FSRENI-----IGKGGYGNVYKGML--------PNGTEVAVKRFK-NCSKAGDANFKHEV 365
           F R+ +     +G+G +G V                  VAVK  K + ++   ++   E+
Sbjct: 78  FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 137

Query: 366 EIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-------------- 410
           E++  + KH N++ L G  T   PL      ++ +    G+L ++L              
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                +++++   +      ARG+ YL        IHRD+ A N+L+ E    K+ DFGL
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGL 249

Query: 471 AKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS----- 520
           A+     I ++      T G +     APE       T  SDV+SFGV++ E+ +     
Sbjct: 250 AR----DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

Query: 521 --GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHP 578
             G    E+             +L+KEG  +D    N    EL  MM         C H 
Sbjct: 306 YPGIPVEELF------------KLLKEGHRMD-KPANCTN-ELYMMMRD-------CWHA 344

Query: 579 ILQARPTMDQIVKILETDVPLSNI 602
           +   RPT  Q+V+ L+  + L+  
Sbjct: 345 VPSQRPTFKQLVEDLDRILTLTTN 368

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  122 bits (308), Expect = 8e-31
 Identities = 57/233 (24%), Positives = 92/233 (39%), Gaps = 25/233 (10%)

Query: 302 SSNLARFKIEEIKAATM-NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAG 357
            S+      E +   +M  + R   IG+G +G         +G +  +K       S   
Sbjct: 7   HSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKE 66

Query: 358 DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK 417
               + EV ++A++KH N+V  R         E     IV D    G L+  +       
Sbjct: 67  REESRREVAVLANMKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQKGVL 121

Query: 418 LSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG 477
                 L   +     L ++H      I+HRDIK+ NI L +    ++GDFG+A+     
Sbjct: 122 FQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178

Query: 478 ITHLTTRVAGTLGYVAPE------YALYGKLTPGSDVYSFGVVLLELLSGKKA 524
           +      + GT  Y++PE      Y         SD+++ G VL EL + K A
Sbjct: 179 VELARACI-GTPYYLSPEICENKPY------NNKSDIWALGCVLYELCTLKHA 224

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  123 bits (310), Expect = 9e-31
 Identities = 47/223 (21%), Positives = 84/223 (37%), Gaps = 34/223 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASVKHVNL 376
            +S    IG GG   V++ +       A+K    +        ++++E+  +  ++  + 
Sbjct: 57  IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 377 --VALRGYSTATVPLEGHQRIIV---CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
             + L  Y          Q I +   C    N  L   L     K +    R        
Sbjct: 117 KIIRLYDY------EITDQYIYMVMEC---GNIDLNSWL--KKKKSIDPWERKSYWKNML 165

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLG 490
             +  +H   Q  I+H D+K +N L+ +    K+ DFG+A    P+  + +     G + 
Sbjct: 166 EAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 491 YVAPE-----------YALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+ PE                K++P SDV+S G +L  +  GK
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (307), Expect = 1e-30
 Identities = 82/327 (25%), Positives = 123/327 (37%), Gaps = 91/327 (27%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFK-NCSKAGDANFKHEVEI 367
           + R NI     IG+G +G V++   P        T VAVK  K   S    A+F+ E  +
Sbjct: 44  YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL----------------- 410
           +A   + N+V L G      P+      ++ + +  G L + L                 
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPM-----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158

Query: 411 -----FGSGMKKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFE 462
                   G   LS   +L IA   A G+AYL    +      +HRD+   N L+ E   
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF------VHRDLATRNCLVGENMV 212

Query: 463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLE 517
            K+ DFGL++     I       A     +      PE   Y + T  SDV+++GVVL E
Sbjct: 213 VKIADFGLSR----NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 268

Query: 518 LLS-------GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE---MELPEMMEQ 567
           + S       G    E+I              V++G  L       PE   +EL  +M  
Sbjct: 269 IFSYGLQPYYGMAHEEVI------------YYVRDGNILA-----CPENCPLELYNLMRL 311

Query: 568 YVLTAAICAHPILQARPTMDQIVKILE 594
                  C   +   RP+   I +IL+
Sbjct: 312 -------CWSKLPADRPSFCSIHRILQ 331

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  120 bits (304), Expect = 1e-30
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH----EVEIIASVKH 373
            + R   +GKGG+   ++          A K     S     + +     E+ I  S+ H
Sbjct: 16  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAH 74

Query: 374 VNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            ++V   G+       E +  + +V +L    SL +       K L+ P           
Sbjct: 75  QHVVGFHGF------FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL 126

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
           G  YLH   +  +IHRD+K  N+ L+E  E K+GDFGLA K   +G         GT  Y
Sbjct: 127 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNY 181

Query: 492 VAPEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
           +APE  L  K  +   DV+S G ++  LL GK
Sbjct: 182 IAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 212

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  120 bits (304), Expect = 2e-30
 Identities = 75/324 (23%), Positives = 122/324 (37%), Gaps = 85/324 (26%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFK-NCSKAGDANFKHEVEI 367
           F R+N+     +G+G +G V K    +       T VAVK  K N S +   +   E  +
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79

Query: 368 IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL----------------- 410
           +  V H +++ L G  +   PL     +++ +    GSL   L                 
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPL-----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSR 134

Query: 411 -----FGSGMKKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFE 462
                     + L+    +  A   ++G+ YL           +HRD+ A NIL+ E  +
Sbjct: 135 NSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKL------VHRDLAARNILVAEGRK 188

Query: 463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLE 517
            K+ DFGL++     +    + V  + G +     A E       T  SDV+SFGV+L E
Sbjct: 189 MKISDFGLSR----DVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWE 244

Query: 518 LLS-------GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVL 570
           +++       G     +              L+K G  ++   +N  E E+  +M Q   
Sbjct: 245 IVTLGGNPYPGIPPERLF------------NLLKTGHRME-RPDNCSE-EMYRLMLQ--- 287

Query: 571 TAAICAHPILQARPTMDQIVKILE 594
               C       RP    I K LE
Sbjct: 288 ----CWKQEPDKRPVFADISKDLE 307

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  121 bits (306), Expect = 2e-30
 Identities = 60/212 (28%), Positives = 90/212 (42%), Gaps = 23/212 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH----EVEIIASVKH 373
            + R   +GKGG+   ++          A K     S     + +     E+ I  S+ H
Sbjct: 42  RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIV-PKSLLLKPHQREKMSMEISIHRSLAH 100

Query: 374 VNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            ++V   G+       E +  + +V +L    SL +       K L+ P           
Sbjct: 101 QHVVGFHGF------FEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQIVL 152

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGY 491
           G  YLH   +  +IHRD+K  N+ L+E  E K+GDFGLA K   +G         GT  Y
Sbjct: 153 GCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNY 207

Query: 492 VAPEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
           +APE  L  K  +   DV+S G ++  LL GK
Sbjct: 208 IAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  122 bits (306), Expect = 2e-30
 Identities = 29/268 (10%), Positives = 65/268 (24%), Gaps = 47/268 (17%)

Query: 293 EPSLVLESRSSNLARFKIE-----EIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVA 346
           EP+ ++E+ ++ +     E      +            +  G    V+    +    + A
Sbjct: 32  EPAAMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91

Query: 347 VKRF---KNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-----LEGHQRII-- 396
           +K F      S++            A +   +    R      +P     ++        
Sbjct: 92  LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151

Query: 397 -------------------VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
                                DL    S  D ++              +     R  A L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR-GDEGILALHILTAQLIRLAANL 210

Query: 438 H-YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
              G    ++H      N+ +       +GD                  +  + Y   E+
Sbjct: 211 QSKG----LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREF 262

Query: 497 AL--YGKLTPGSDVYSFGVVLLELLSGK 522
                   T   + +  G+ +  +    
Sbjct: 263 LNASTATFTHALNAWQLGLSIYRVWCLF 290

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  120 bits (302), Expect = 2e-30
 Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 19/209 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAG-DANFKHEVEIIASVKHV 374
           +F     +GKG +GNVY      +   +A+K        KAG +   + EVEI + ++H 
Sbjct: 10  DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 69

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
           N++ L GY           R+ ++ +    G++Y  L    + K             A  
Sbjct: 70  NILRLYGY------FHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANA 121

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L+Y H      +IHRDIK  N+LL  A E K+ DFG +   P           GTL Y+ 
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL--CGTLDYLP 175

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE           D++S GV+  E L GK
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  119 bits (301), Expect = 2e-30
 Identities = 52/213 (24%), Positives = 84/213 (39%), Gaps = 11/213 (5%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVN 375
           ++     IG G YG   K     +G  +  K   + + ++A       EV ++  +KH N
Sbjct: 7   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR--LRIALGTARG 433
           +V    Y    +        IV +    G L   +     ++        LR+       
Sbjct: 67  IVR---YYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 123

Query: 434 LAYLHY--GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           L   H        ++HRD+K +N+ LD     K+GDFGLA+      +   T V GT  Y
Sbjct: 124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYY 182

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGKKA 524
           ++PE          SD++S G +L EL +    
Sbjct: 183 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  120 bits (303), Expect = 2e-30
 Identities = 52/212 (24%), Positives = 93/212 (43%), Gaps = 15/212 (7%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR---FKNCSKAGDANFKHEVEIIASVKHV 374
           NF  E  IG+G +  VY+   L +G  VA+K+   F        A+   E++++  + H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGTAR 432
           N++           +E ++  IV +L   G L   +  F    + +      +  +    
Sbjct: 93  NVIKYYASF-----IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            L ++H      ++HRDIK +N+ +      K+GD GL +F     T   + V GT  Y+
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKKA 524
           +PE          SD++S G +L E+ + +  
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  118 bits (299), Expect = 4e-30
 Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVK-RFKNCSKAGDA--NFKHEVEIIASVKHV 374
           +F   N++GKG +  VY+   +  G EVA+K   K            ++EV+I   +KH 
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
           +++ L  Y       E    + +V ++ HNG +  +L     K  S             G
Sbjct: 72  SILELYNY------FEDSNYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITG 124

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA-KFNPEGITHLTTRVAGTLGYV 492
           + YLH      I+HRD+  SN+LL      K+ DFGLA +       H T    GT  Y+
Sbjct: 125 MLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYI 179

Query: 493 APEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
           +PE           SDV+S G +   LL G+
Sbjct: 180 SPE-IATRSAHGLESDVWSLGCMFYTLLIGR 209

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 4e-30
 Identities = 40/224 (17%), Positives = 85/224 (37%), Gaps = 40/224 (17%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVK-----------------RFKNCSKAGDANFKHEVEII 368
           + +G +  +      +    A+K                   K   K+   +FK+E++II
Sbjct: 39  LNQGKFNKIILC-EKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRL--- 424
             +K+   +   G       +  +  + I+ + + N S+        +   ++   +   
Sbjct: 98  TDIKNEYCLTCEGI------ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 425 ---RIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
               I        +Y+H   +  I HRD+K SNIL+D+    K+ DFG +++  +     
Sbjct: 152 VIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK- 208

Query: 482 TTRVAGTLGYVAPEYALYGKLT---PGSDVYSFGVVLLELLSGK 522
            +   GT  ++ PE     + +      D++S G+ L  +    
Sbjct: 209 GS--RGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  119 bits (300), Expect = 5e-30
 Identities = 51/224 (22%), Positives = 84/224 (37%), Gaps = 30/224 (13%)

Query: 305 LARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDAN--- 360
              +++  +            +G+GG G+VY+         VA+K     + + D     
Sbjct: 33  FGPYRLRRL------------VGRGGMGDVYEAEDTVRERIVALKLMSE-TLSSDPVFRT 79

Query: 361 -FKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLS 419
             + E      ++  ++V +  +          Q  +   L++   L   L   G   L+
Sbjct: 80  RMQREARTAGRLQEPHVVPIHDFGE-----IDGQLYVDMRLINGVDLAAMLRRQG--PLA 132

Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGI 478
            P  + I       L   H        HRD+K  NIL+     A + DFG+A     E +
Sbjct: 133 PPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL 189

Query: 479 THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T       GTL Y+APE       T  +D+Y+   VL E L+G 
Sbjct: 190 TQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  118 bits (299), Expect = 7e-30
 Identities = 73/315 (23%), Positives = 115/315 (36%), Gaps = 70/315 (22%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFK-NCSKAGDANFKHEVEI 367
           F R+ +     +G+G +G V +              VAVK  K   + +       E++I
Sbjct: 24  FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKI 83

Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--------------FG 412
           +  +  H+N+V L G  T      G   +++ +    G+L  +L                
Sbjct: 84  LIHIGHHLNVVNLLGACT----KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139

Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
                L+    +  +   A+G+ +L        IHRD+ A NILL E    K+ DFGLA+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR 196

Query: 473 FNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS------- 520
                I      V      +     APE       T  SDV+SFGV+L E+ S       
Sbjct: 197 ----DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252

Query: 521 GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPIL 580
           G K       +           +KEG  +    +     E+ + M         C H   
Sbjct: 253 GVKI-----DEEFC------RRLKEGTRMR-APDYTTP-EMYQTMLD-------CWHGEP 292

Query: 581 QARPTMDQIVKILET 595
             RPT  ++V+ L  
Sbjct: 293 SQRPTFSELVEHLGN 307

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  120 bits (302), Expect = 1e-29
 Identities = 83/316 (26%), Positives = 130/316 (41%), Gaps = 74/316 (23%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPN--------GTEVAVKRFK-NCSKAGDANFKHEV 365
             R+ +     +G+G +G V                T+VAVK  K + ++   ++   E+
Sbjct: 66  LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125

Query: 366 EIIASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL-------------- 410
           E++  + KH N++ L G  T   PL      ++ +    G+L ++L              
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPL-----YVIVEYASKGNLREYLQARRPPGLEYSYNP 180

Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
             +  ++LS    +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGL
Sbjct: 181 SHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGL 237

Query: 471 AKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS----- 520
           A+     I H+      T G +     APE       T  SDV+SFGV+L E+ +     
Sbjct: 238 AR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

Query: 521 --GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHP 578
             G    E+             +L+KEG  +D    N    EL  MM         C H 
Sbjct: 294 YPGVPVEELF------------KLLKEGHRMD-KPSNCTN-ELYMMMRD-------CWHA 332

Query: 579 ILQARPTMDQIVKILE 594
           +   RPT  Q+V+ L+
Sbjct: 333 VPSQRPTFKQLVEDLD 348

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  118 bits (297), Expect = 2e-29
 Identities = 74/315 (23%), Positives = 118/315 (37%), Gaps = 75/315 (23%)

Query: 320 FSRENI-----IGKGGYGNVYKGML------PNGTEVAVKRFK-NCSKAGDANFKHEVEI 367
           F R N+     +G G +G V +             +VAVK  K             E++I
Sbjct: 43  FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKI 102

Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL------------FGSG 414
           ++ + +H N+V L G  T   P+     +++ +    G L + L            F   
Sbjct: 103 MSHLGQHENIVNLLGACTHGGPV-----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIA 157

Query: 415 MKKLSWPIRLRIALGTARGLAYL---HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
               S    L  +   A+G+A+L   +       IHRD+ A N+LL     AK+GDFGLA
Sbjct: 158 NSTASTRDLLHFSSQVAQGMAFLASKNC------IHRDVAARNVLLTNGHVAKIGDFGLA 211

Query: 472 KFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS------ 520
           +     I + +  +      +     APE       T  SDV+S+G++L E+ S      
Sbjct: 212 RD----IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267

Query: 521 -GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPI 579
            G                   +LVK+G  +       P+  +  +M+        C    
Sbjct: 268 PGILVNS-----KFY------KLVKDGYQMA-QPAFAPK-NIYSIMQA-------CWALE 307

Query: 580 LQARPTMDQIVKILE 594
              RPT  QI   L+
Sbjct: 308 PTHRPTFQQICSFLQ 322

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  119 bits (300), Expect = 3e-29
 Identities = 57/240 (23%), Positives = 95/240 (39%), Gaps = 31/240 (12%)

Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC 353
           PSL  +      +   + +I      F  ++++G G  G +    + +  +VAVKR    
Sbjct: 5   PSLEQDDGDEETSVVIVGKIS-----FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI--- 56

Query: 354 SKAGDANFKHEVEI-IASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLF 411
                +    EV++   S +H N++            +  Q   I  +L    +L +++ 
Sbjct: 57  LPECFSFADREVQLLRESDEHPNVIRYFCTE------KDRQFQYIAIELC-AATLQEYVE 109

Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE-----AKVG 466
                       + +   T  GLA+LH      I+HRD+K  NIL+          A + 
Sbjct: 110 QKD-FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMIS 165

Query: 467 DFGLAKFNPEGITHLTTR--VAGTLGYVAPEY---ALYGKLTPGSDVYSFGVVLLELLSG 521
           DFGL K    G    + R  V GT G++APE          T   D++S G V   ++S 
Sbjct: 166 DFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  116 bits (293), Expect = 5e-29
 Identities = 58/212 (27%), Positives = 78/212 (36%), Gaps = 23/212 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASV-KHV 374
           +F R + +G G YG V+K     +G   AVKR           A    EV     V +H 
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 375 NLVALRGYSTATVPLEGHQRIIV---CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
             V L          EG    +    C      SL  H    G   L           T 
Sbjct: 118 CCVRLEQAW-----EEGGILYLQTELCG----PSLQQHCEAWG-ASLPEAQVWGYLRDTL 167

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             LA+LH      ++H D+K +NI L      K+GDFGL                G   Y
Sbjct: 168 LALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRY 222

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           +APE  L G     +DV+S G+ +LE+    +
Sbjct: 223 MAPE-LLQGSYGTAADVFSLGLTILEVACNME 253

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  115 bits (290), Expect = 8e-29
 Identities = 57/209 (27%), Positives = 87/209 (41%), Gaps = 19/209 (9%)

Query: 319 NFSRENIIGKGGYGNVYKG-MLPNGTEVAVKR-FKNCSKAGD--ANFKHEVEIIASVKHV 374
           +F     +GKG +GNVY      N   +A+K  FK+  +        + E+EI + ++H 
Sbjct: 15  DFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHP 74

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
           N++ +  Y          +RI ++ +    G LY  L   G  +             A  
Sbjct: 75  NILRMYNY------FHDRKRIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADA 126

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L Y H   +  +IHRDIK  N+L+    E K+ DFG +   P      T    GTL Y+ 
Sbjct: 127 LHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLP 180

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE           D++  GV+  E L G 
Sbjct: 181 PEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  116 bits (292), Expect = 8e-29
 Identities = 73/311 (23%), Positives = 118/311 (37%), Gaps = 63/311 (20%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFK-NCSKAGDANFKHEVEI 367
           F R  +     +G G +G V +              VAVK  K +           E+++
Sbjct: 20  FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKV 79

Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL---------------- 410
           ++ +  H+N+V L G  T   P      +++ +    G L + L                
Sbjct: 80  LSYLGNHMNIVNLLGACTIGGPT-----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134

Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                  L     L  +   A+G+A+L        IHRD+ A NILL      K+ DFGL
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGL 191

Query: 471 AKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLSGKKA- 524
           A+     I + +  V      +     APE       T  SDV+S+G+ L EL S   + 
Sbjct: 192 AR----DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

Query: 525 -CEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR 583
              +             +++KEG  +    E+ P  E+ ++M+        C       R
Sbjct: 248 YPGMPVDSKFY------KMIKEGFRML-SPEHAPA-EMYDIMKT-------CWDADPLKR 292

Query: 584 PTMDQIVKILE 594
           PT  QIV+++E
Sbjct: 293 PTFKQIVQLIE 303

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  116 bits (292), Expect = 8e-29
 Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 20/223 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNL 376
                 ++ +GG+  VY+   + +G E A+KR  +  +  +     EV  +  +  H N+
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88

Query: 377 VALRGYSTAT--VPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-KLSWPIRLRIALGTARG 433
           V     ++        G    ++   L  G L + L     +  LS    L+I   T R 
Sbjct: 89  VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA------- 486
           + ++H   +P IIHRD+K  N+LL      K+ DFG A        +  +          
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 487 ----GTLGYVAPE-YALYGKL--TPGSDVYSFGVVLLELLSGK 522
                T  Y  PE   LY         D+++ G +L  L   +
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  116 bits (291), Expect = 9e-29
 Identities = 51/220 (23%), Positives = 83/220 (37%), Gaps = 25/220 (11%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNL 376
            +   +I+G+G   NV++G     G   A+K F N S          E E++  + H N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 377 VALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           V L       T       ++++ +    GSLY  L        L     L +      G+
Sbjct: 70  VKLFAIEEETT----TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 435 AYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            +L    +  I+HR+IK  NI+     D     K+ DFG A+   +      +   GT  
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEE 180

Query: 491 YVAPE--------YALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+ P+             K     D++S GV      +G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  117 bits (294), Expect = 1e-28
 Identities = 35/241 (14%), Positives = 66/241 (27%), Gaps = 44/241 (18%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD---ANFKHEVEIIASVKHV- 374
             R  ++G+       +      G    V       +         K EV  +  ++ + 
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 375 ---------------NLVALRGYSTATVPLEGHQRIIV-----------CDLLHNG-SLY 407
                          +LV               + + V            +L   G  L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 408 DHLFGSGMKKLSWPIRLRIALGTARGLAYLH-YGVQPAIIHRDIKASNILLDEAFEAKVG 466
            H        L    RL++ L   R LA LH YG    ++H  ++  +I+LD+     + 
Sbjct: 200 SHSSTHK--SLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQRGGVFLT 253

Query: 467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSG 521
            F     +         R        A     +       +T   D ++ G+ +  +   
Sbjct: 254 GFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCA 313

Query: 522 K 522
            
Sbjct: 314 D 314

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (286), Expect = 6e-28
 Identities = 68/328 (20%), Positives = 121/328 (36%), Gaps = 68/328 (20%)

Query: 320 FSRENI-----IGKGGYGNVYKGMLPNG------TEVAVKRFK-NCSKAGDANFKHEVEI 367
           F REN+     +G G +G V               +VAVK  K     +       E+++
Sbjct: 42  FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKM 101

Query: 368 IASV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL---------------- 410
           +  +  H N+V L G  T + P+      ++ +    G L ++L                
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPI-----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156

Query: 411 -----FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV 465
                    +  L++   L  A   A+G+ +L      + +HRD+ A N+L+      K+
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKI 213

Query: 466 GDFGLAKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS 520
            DFGLA+     I   +  V      +     APE    G  T  SDV+S+G++L E+ S
Sbjct: 214 CDFGLAR----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

Query: 521 GKKA--CEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHP 578
                   I    +        +L++ G  +D       E E+  +M+        C   
Sbjct: 270 LGVNPYPGIPVDANFY------KLIQNGFKMD-QPFYATE-EIYIIMQS-------CWAF 314

Query: 579 ILQARPTMDQIVKILETDVPLSNIKIFL 606
             + RP+   +   L   +  +   ++ 
Sbjct: 315 DSRKRPSFPNLTSFLGCQLADAEEAMYQ 342

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  114 bits (288), Expect = 8e-28
 Identities = 51/220 (23%), Positives = 83/220 (37%), Gaps = 25/220 (11%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA-NFKHEVEIIASVKHVNL 376
            +   +I+G+G   NV++G     G   A+K F N S          E E++  + H N+
Sbjct: 10  LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69

Query: 377 VALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGL 434
           V L       T       ++++ +    GSLY  L        L     L +      G+
Sbjct: 70  VKLFAIEEETT----TRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 435 AYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            +L    +  I+HR+IK  NI+     D     K+ DFG A+   +      +   GT  
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEE 180

Query: 491 YVAPE--------YALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+ P+             K     D++S GV      +G 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  110 bits (276), Expect = 6e-27
 Identities = 62/211 (29%), Positives = 89/211 (42%), Gaps = 24/211 (11%)

Query: 322 RENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALR 380
              ++GKG YG VY G  L N   +A+K               E+ +   +KH N+V   
Sbjct: 26  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR---IALGTA---RGL 434
           G        E     I  + +  GSL   L     +    P++     I   T     GL
Sbjct: 86  GSF-----SENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQILEGL 135

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
            YLH      I+HRDIK  N+L++      K+ DFG +K    GI   T    GTL Y+A
Sbjct: 136 KYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSK-RLAGINPCTETFTGTLQYMA 191

Query: 494 PEYALYGKL--TPGSDVYSFGVVLLELLSGK 522
           PE    G       +D++S G  ++E+ +GK
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  110 bits (277), Expect = 9e-27
 Identities = 61/255 (23%), Positives = 99/255 (38%), Gaps = 31/255 (12%)

Query: 276 TRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVY 335
           + S K +    +  DN+   L  + +  +       E +      + +  +G+G +G V+
Sbjct: 22  SGSAKLQRLGPETEDNEGVLLTEKLKPVDY------EYREEVHWMTHQPRVGRGSFGEVH 75

Query: 336 KGM-LPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH 392
           +      G + AVK  R +            E+   A +    +V L G        EG 
Sbjct: 76  RMKDKQTGFQCAVKKVRLEVFRV-------EELVACAGLSSPRIVPLYGAV-----REGP 123

Query: 393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA 452
              I  +LL  GSL   +   G   L     L        GL YLH      I+H D+KA
Sbjct: 124 WVNIFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKA 178

Query: 453 SNILLDEA-FEAKVGDFGLAK-FNPEGITHLTTR---VAGTLGYVAPEYALYGKLTPGSD 507
            N+LL      A + DFG A    P+G+         + GT  ++APE  +        D
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238

Query: 508 VYSFGVVLLELLSGK 522
           ++S   ++L +L+G 
Sbjct: 239 IWSSCCMMLHMLNGC 253

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  109 bits (274), Expect = 3e-26
 Identities = 39/254 (15%), Positives = 79/254 (31%), Gaps = 53/254 (20%)

Query: 312 EIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDANFKHEVEI 367
           E+        R  ++G+       +      G    V      +          K EV  
Sbjct: 67  ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLR 126

Query: 368 IASVKHV-NLVALRGYSTATVPLE-----GHQRII---------------------VCDL 400
           +  ++ + N    + +     P +       +++I                       +L
Sbjct: 127 LRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNL 186

Query: 401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH-YGVQPAIIHRDIKASNILLDE 459
              G +      S  K L    RL++ L   R LA LH YG    ++H  ++  +I+LD+
Sbjct: 187 QTFGEVLLSH-SSTHKSLVHHARLQLTLQVIRLLASLHHYG----LVHTYLRPVDIVLDQ 241

Query: 460 AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-----------GKLTPGSDV 508
                +  F       +G   +++    + G+  PE                 +T   D 
Sbjct: 242 RGGVFLTGFEHLV--RDGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDA 296

Query: 509 YSFGVVLLELLSGK 522
           ++ G+V+  +    
Sbjct: 297 WALGLVIYWIWCAD 310

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  110 bits (277), Expect = 4e-26
 Identities = 64/252 (25%), Positives = 95/252 (37%), Gaps = 47/252 (18%)

Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDA 359
           SR +N+  F+ + +K        E I+G G  G V       G  VAVKR          
Sbjct: 1   SRIANIPNFE-QSLKN---LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCD 53

Query: 360 NFKHEVEI-IASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYD-----HLFG 412
               E+++   S  H N++      +T           I  +L  N +L D     ++  
Sbjct: 54  IALMEIKLLTESDDHPNVIRYYCSETTD------RFLYIALELC-NLNLQDLVESKNVSD 106

Query: 413 SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-------------E 459
             +K       + +    A G+A+LH      IIHRD+K  NIL+              E
Sbjct: 107 ENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163

Query: 460 AFEAKVGDFGLAKFNPEGITHLTTR---VAGTLGYVAPE-------YALYGKLTPGSDVY 509
                + DFGL K    G +   T     +GT G+ APE            +LT   D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223

Query: 510 SFGVVLLELLSG 521
           S G V   +LS 
Sbjct: 224 SMGCVFYYILSK 235

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 6e-26
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 13/236 (5%)

Query: 295 SLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC 353
           S+  +S + +L    +  ++     F    ++G G YG VYKG  +  G   A+K   + 
Sbjct: 1   SMASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DV 59

Query: 354 SKAGDANFKHEVEIIASV-KHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLF 411
           +   +   K E+ ++     H N+    G +     P    Q  +V +    GS+ D + 
Sbjct: 60  TGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK 119

Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
            +    L       I     RGL++LH   Q  +IHRDIK  N+LL E  E K+ DFG++
Sbjct: 120 NTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176

Query: 472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGS-----DVYSFGVVLLELLSGK 522
                 +    T   GT  ++APE     +    +     D++S G+  +E+  G 
Sbjct: 177 AQLDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (276), Expect = 1e-25
 Identities = 55/217 (25%), Positives = 88/217 (40%), Gaps = 41/217 (18%)

Query: 323 ENIIGKGGYGNVYKG-MLPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
              +G G YG V          E A+K  R  + S + ++    EV ++  + H N++ L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 380 RGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIAL 428
             +       E  +   +V +    G L+D +              +K++          
Sbjct: 102 YDF------FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQV---------- 145

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRV 485
               G+ YLH   +  I+HRD+K  N+LL   ++    K+ DFGL+              
Sbjct: 146 --LSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ--KKMKER 198

Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            GT  Y+APE  L  K     DV+S GV+L  LL+G 
Sbjct: 199 LGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGY 234

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  106 bits (267), Expect = 1e-25
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 25/207 (12%)

Query: 323 ENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
             ++G G +  V+       G   A+K  K      D++ ++E+ ++  +KH N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGM---KKLSWPIRLRIALGTARGLAYL 437
                   E      +V  L+  G L+D +   G+   K  S  I+          + YL
Sbjct: 74  I------YESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ-----VLSAVKYL 122

Query: 438 HYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           H   +  I+HRD+K  N+L    +E  +  + DFGL+K    GI  ++T   GT GYVAP
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MST-ACGTPGYVAP 176

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSG 521
           E       +   D +S GV+   LL G
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCG 203

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  108 bits (272), Expect = 2e-25
 Identities = 62/220 (28%), Positives = 96/220 (43%), Gaps = 41/220 (18%)

Query: 319 NFSRENIIGKGGYGNVYKG-MLPNGTEVAVKRF--KNCSKAGDANFKHEVEIIASVKHVN 375
            ++   ++GKG +G V K        E AVK     +      +    EVE++  + H N
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82

Query: 376 LVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRL 424
           ++ L         LE      IV +L   G L+D +              +K++      
Sbjct: 83  IMKLFEI------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV------ 130

Query: 425 RIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHL 481
                   G+ Y+H   +  I+HRD+K  NILL   ++  + K+ DFGL+    +  T +
Sbjct: 131 ------FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKM 180

Query: 482 TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
             R+ GT  Y+APE  L G      DV+S GV+L  LLSG
Sbjct: 181 KDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (269), Expect = 4e-25
 Identities = 61/270 (22%), Positives = 100/270 (37%), Gaps = 48/270 (17%)

Query: 282 EERVVK-----VTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENI---------IG 327
            E V K     + +N E +L L         F   ++     +   + +         +G
Sbjct: 89  TELVGKGKRRPLNNNSEIALSLSRNKV----FVFFDLTVDDQSVYPKALRDEYIMSKTLG 144

Query: 328 KGGYGNVYKGM-LPNGTEVAVKRFK--------NCSKAGDANFKHEVEIIASVKHVNLVA 378
            G  G V          +VA++                   N + E+EI+  + H  ++ 
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
           ++  +             IV +L+  G L+D + G+   +L               + YL
Sbjct: 205 IKNFFDAEDY-------YIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYL 255

Query: 438 HYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           H   +  IIHRD+K  N+LL   +E    K+ DFG +K   E  + + T   GT  Y+AP
Sbjct: 256 H---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYLAP 310

Query: 495 E---YALYGKLTPGSDVYSFGVVLLELLSG 521
           E              D +S GV+L   LSG
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  104 bits (262), Expect = 4e-25
 Identities = 62/214 (28%), Positives = 94/214 (43%), Gaps = 41/214 (19%)

Query: 325 IIGKGGYGNVYKG-MLPNGTEVAVKRF--KNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           ++GKG +G V K        E AVK     +      +    EVE++  + H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALGT 430
                  LE      IV +L   G L+D +              +K++            
Sbjct: 89  I------LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV------------ 130

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
             G+ Y+H   +  I+HRD+K  NILL   ++  + K+ DFGL+    +  T +  R+ G
Sbjct: 131 FSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-G 185

Query: 488 TLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           T  Y+APE  L G      DV+S GV+L  LLSG
Sbjct: 186 TAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  104 bits (262), Expect = 4e-25
 Identities = 48/238 (20%), Positives = 82/238 (34%), Gaps = 51/238 (21%)

Query: 317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKHEVEIIASV-K 372
           T  F     IG G +G+V+K +   +G   A+KR          + N   EV   A + +
Sbjct: 10  TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL--FGSGMKKLSWPIRLRIALGT 430
           H ++V            E    +I  +  + GSL D +      M          + L  
Sbjct: 70  HSHVVRYFSAW-----AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDE-------------------AFEAKVGDFGLA 471
            RGL Y+H     +++H DIK SNI +                         K+GD G  
Sbjct: 125 GRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV 181

Query: 472 KFNPEGITHLTTRVAGTLGYVAPE-------YALYGKLTPGSDVYSFGVVLLELLSGK 522
                 I+       G   ++A E       +       P +D+++  + ++     +
Sbjct: 182 T----RISSPQVEE-GDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAE 228

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 6e-25
 Identities = 47/220 (21%), Positives = 78/220 (35%), Gaps = 29/220 (13%)

Query: 320 FSRENIIGKG--GYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHV 374
           +    +IGKG      V      P G  V V+R     CS       + E+ +     H 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 375 NLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
           N+V  R  +      +  ++  +V   +  GS  D +    M  ++      I  G  + 
Sbjct: 87  NIVPYRATF------IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKA 140

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG-LAKFNPEG-----ITHLTTRVAG 487
           L Y+H       +HR +KAS+IL+    +  +            G     +         
Sbjct: 141 LDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 488 TLGYVAPE-----YALYGKLTPGSDVYSFGVVLLELLSGK 522
            L +++PE        Y      SD+YS G+   EL +G 
Sbjct: 198 VLPWLSPEVLQQNLQGYD---AKSDIYSVGITACELANGH 234

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  104 bits (261), Expect = 6e-25
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKHVNLV 377
           F++   IGKG +G V+KG+       VA+K         +  + + E+ +++      + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 378 ALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
              G Y      L+  +  I+ + L  GS  D L    + +      LR  L   +GL Y
Sbjct: 84  KYYGSY------LKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL---KGLDY 134

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH       IHRDIKA+N+LL E  E K+ DFG+A    +      T V GT  ++APE 
Sbjct: 135 LH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEV 190

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
                    +D++S G+  +EL  G+
Sbjct: 191 IKQSAYDSKADIWSLGITAIELARGE 216

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  105 bits (265), Expect = 2e-24
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 45/242 (18%)

Query: 298 LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKG-MLPNGTEVAVK---RFKNC 353
           L +      +            +  + ++GKG +G V        G E AVK   + +  
Sbjct: 9   LHATPGMFVQHSTAIFSD---RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVK 65

Query: 354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFG 412
            K    +   EV+++  + H N++ L  +       E      +V ++   G L+D +  
Sbjct: 66  QKTDKESLLREVQLLKQLDHPNIMKLYEF------FEDKGYFYLVGEVYTGGELFDEIIS 119

Query: 413 SG----------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DE 459
                       ++++              G+ Y+H   +  I+HRD+K  N+LL    +
Sbjct: 120 RKRFSEVDAARIIRQV------------LSGITYMH---KNKIVHRDLKPENLLLESKSK 164

Query: 460 AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELL 519
               ++ DFGL+               GT  Y+APE  L+G      DV+S GV+L  LL
Sbjct: 165 DANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILL 221

Query: 520 SG 521
           SG
Sbjct: 222 SG 223

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (260), Expect = 2e-24
 Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 36/216 (16%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           +IGKG +  V + +    G + AVK     +F +       + K E  I   +KH ++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRL--RIALGTAR--- 432
           L   YS+           +V + +    L   +    +K+          +A    R   
Sbjct: 91  LLETYSSD------GMLYMVFEFMDGADLCFEI----VKRADAGFVYSEAVASHYMRQIL 140

Query: 433 -GLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             L Y H      IIHRD+K   +LL   + +   K+G FG+A    E       RV GT
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GT 196

Query: 489 LGYVAPE---YALYGKLTPGSDVYSFGVVLLELLSG 521
             ++APE      YGK     DV+  GV+L  LLSG
Sbjct: 197 PHFMAPEVVKREPYGK---PVDVWGCGVILFILLSG 229

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  100 bits (252), Expect = 7e-24
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 28/208 (13%)

Query: 326 IGKGGYGNVYKG-MLPNGTEVAVKRF-KNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
           +G G +G+V+      +G E  +K   K+ S+      + E+E++ S+ H N++ +    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV- 88

Query: 384 TATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRL--RIALGTAR----GLAY 436
                 E +  + IV +    G L + +    +   +    L         +     LAY
Sbjct: 89  -----FEDYHNMYIVMETCEGGELLERI----VSAQARGKALSEGYVAELMKQMMNALAY 139

Query: 437 LHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
            H      ++H+D+K  NIL          K+ DFGLA+       H T    GT  Y+A
Sbjct: 140 FH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYMA 194

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSG 521
           PE      +T   D++S GVV+  LL+G
Sbjct: 195 PE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  102 bits (256), Expect = 8e-24
 Identities = 40/238 (16%), Positives = 77/238 (32%), Gaps = 35/238 (14%)

Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKGM------LPNGTEVAVKRFKNCSKAGDANFK 362
              E +  +      +++G+G +  VY+          N  +  +K  K  +        
Sbjct: 56  PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115

Query: 363 HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHL---FGSGMKKLS 419
             +E +        +           L  +  ++V +L   G+L + +     +  K + 
Sbjct: 116 QLMERLKPSMQHMFMKFYSAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMP 170

Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA-----------KVGDF 468
             + +  A+     +  +H      IIH DIK  N +L   F              + D 
Sbjct: 171 QGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDL 227

Query: 469 GLA---KFNPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
           G +   K  P+G    T +   T G+   E  L  K      D +     +  +L G 
Sbjct: 228 GQSIDMKLFPKGTI-FTAK-CETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (255), Expect = 9e-24
 Identities = 62/250 (24%), Positives = 85/250 (34%), Gaps = 63/250 (25%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           IG+G YG V   +        A+K     + +  +       K EV ++  + H N+  L
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93

Query: 380 RGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR------ 432
                     E  Q I +V +L H G L D L               +            
Sbjct: 94  YEV------YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 433 --------------------------------GLAYLHYGVQPAIIHRDIKASNILL--D 458
                                            L YLH      I HRDIK  N L   +
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTN 204

Query: 459 EAFEAKVGDFGLAKF----NPEGITHLTTRVAGTLGYVAPE--YALYGKLTPGSDVYSFG 512
           ++FE K+ DFGL+K     N      +TT+  GT  +VAPE          P  D +S G
Sbjct: 205 KSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAG 263

Query: 513 VVLLELLSGK 522
           V+L  LL G 
Sbjct: 264 VLLHLLLMGA 273

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  104 bits (260), Expect = 9e-24
 Identities = 57/227 (25%), Positives = 88/227 (38%), Gaps = 52/227 (22%)

Query: 323 ENIIGKGGYGNVYKG-MLPNGTEVAVK-------------RFKNCSKAGDANFKHEVEII 368
              +G G YG V         +E A+K                   +       +E+ ++
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKK 417
            S+ H N++ L          E  +   +V +    G L++ +              MK+
Sbjct: 101 KSLDHPNIIKLFDV------FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQ 154

Query: 418 LSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFN 474
           +              G+ YLH   +  I+HRDIK  NILL   +     K+ DFGL+ F 
Sbjct: 155 I------------LSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF 199

Query: 475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            +    L  R+ GT  Y+APE  L  K     DV+S GV++  LL G
Sbjct: 200 SKDYK-LRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  100 bits (252), Expect = 1e-23
 Identities = 49/210 (23%), Positives = 92/210 (43%), Gaps = 18/210 (8%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           +     +G G +G VYK      G   A K  +  S+    ++  E+EI+A+  H  +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
           L G Y          +  I+ +    G++   +     + L+ P    +       L +L
Sbjct: 81  LLGAY------YHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFL 133

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      IIHRD+KA N+L+    + ++ DFG++  N + +    + + GT  ++APE  
Sbjct: 134 H---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVV 189

Query: 498 LYGKLTPGS-----DVYSFGVVLLELLSGK 522
           +   +         D++S G+ L+E+   +
Sbjct: 190 MCETMKDTPYDYKADIWSLGITLIEMAQIE 219

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  100 bits (251), Expect = 1e-23
 Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 46/217 (21%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRF--KNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
            +GKG +  V + +    G E A K    K  S       + E  I   ++H N+V L  
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 72

Query: 382 -YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALGT 430
                          +V DL+  G L++ +              ++++            
Sbjct: 73  SIQEE------SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI------------ 114

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
              +AY H      I+HR++K  N+LL    +    K+ DFGLA    +         AG
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAG 169

Query: 488 TLGYVAPE---YALYGKLTPGSDVYSFGVVLLELLSG 521
           T GY++PE      Y K     D+++ GV+L  LL G
Sbjct: 170 TPGYLSPEVLKKDPYSK---PVDIWACGVILYILLVG 203

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  100 bits (252), Expect = 2e-23
 Identities = 59/229 (25%), Positives = 94/229 (41%), Gaps = 34/229 (14%)

Query: 308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGD-AN 360
           FK ++++     +     +G G +  V K      G E A K     + +   +      
Sbjct: 5   FKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE 61

Query: 361 FKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM---K 416
            + EV I+  V H N++ L   Y            +++ +L+  G L+D L        +
Sbjct: 62  IEREVSILRQVLHHNVITLHDVYENR------TDVVLILELVSGGELFDFLAQKESLSEE 115

Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAK 472
           + +  I+ +I      G+ YLH      I H D+K  NI+L          K+ DFGLA 
Sbjct: 116 EATSFIK-QIL----DGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
              +G         GT  +VAPE   Y  L   +D++S GV+   LLSG
Sbjct: 168 EIEDG-VEFKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (251), Expect = 2e-23
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 31/222 (13%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD--ANFKHEVEIIASVKHVN 375
           ++  + +IG G    V      P   +VA+KR  N  K          E++ ++   H N
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMSQCHHPN 74

Query: 376 LVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR---IAL--- 428
           +V+    +      +   +  +V  LL  GS+ D +     K       L    IA    
Sbjct: 75  IVSYYTSF------VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR---- 484
               GL YLH   +   IHRD+KA NILL E    ++ DFG++ F   G      +    
Sbjct: 129 EVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185

Query: 485 VAGTLGYVAPE----YALYGKLTPGSDVYSFGVVLLELLSGK 522
             GT  ++APE       Y      +D++SFG+  +EL +G 
Sbjct: 186 FVGTPCWMAPEVMEQVRGYD---FKADIWSFGITAIELATGA 224

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (251), Expect = 2e-23
 Identities = 54/212 (25%), Positives = 85/212 (40%), Gaps = 28/212 (13%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFK--------NCSKAGDANFKHEVEIIASVKHVN 375
            +G G  G V          +VA+K                   N + E+EI+  + H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           ++ ++ +       +     IV +L+  G L+D + G+   +L               + 
Sbjct: 77  IIKIKNF------FDAEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQ 128

Query: 436 YLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           YLH   +  IIHRD+K  N+LL   +E    K+ DFG +K   E  + + T   GT  Y+
Sbjct: 129 YLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYL 183

Query: 493 APE---YALYGKLTPGSDVYSFGVVLLELLSG 521
           APE              D +S GV+L   LSG
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  101 bits (253), Expect = 2e-23
 Identities = 57/265 (21%), Positives = 102/265 (38%), Gaps = 44/265 (16%)

Query: 278 SKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFS------RENIIGKGGY 331
              ++        +   S +     +  A F    + A     +      +  I+G G +
Sbjct: 43  WSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRF 102

Query: 332 GNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG-YSTATVPL 389
           G V+K      G ++A K  K          K+E+ ++  + H NL+ L   + +     
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK---- 158

Query: 390 EGHQRIIVCDLLHNGSLYDHLFGSG-----------MKKLSWPIRLRIALGTARGLAYLH 438
             +  ++V + +  G L+D +               MK++              G+ ++H
Sbjct: 159 --NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICE------------GIRHMH 204

Query: 439 YGVQPAIIHRDIKASNILLDEAFEA--KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
              Q  I+H D+K  NIL         K+ DFGLA+        L     GT  ++APE 
Sbjct: 205 ---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNF-GTPEFLAPEV 259

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSG 521
             Y  ++  +D++S GV+   LLSG
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSG 284

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (255), Expect = 3e-23
 Identities = 52/237 (21%), Positives = 87/237 (36%), Gaps = 48/237 (20%)

Query: 305 LARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF--KNCSKAGDANF 361
           +A             +     +GKG +  V + + +  G E A      K  S       
Sbjct: 1   MATITCTRFTE---EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL 57

Query: 362 KHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG------ 414
           + E  I   +KH N+V L    S            ++ DL+  G L++ +          
Sbjct: 58  EREARICRLLKHPNIVRLHDSISEE------GHHYLIFDLVTGGELFEDIVAREYYSEAD 111

Query: 415 ----MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGD 467
               ++++               + + H   Q  ++HR++K  N+LL    +    K+ D
Sbjct: 112 ASHCIQQI------------LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLAD 156

Query: 468 FGLAKFNPEGITHLTTRVAGTLGYVAPE---YALYGKLTPGSDVYSFGVVLLELLSG 521
           FGLA               GT GY++PE      YGK     D+++ GV+L  LL G
Sbjct: 157 FGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYGK---PVDLWACGVILYILLVG 209

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  100 bits (250), Expect = 3e-23
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 47/220 (21%)

Query: 321 SRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVA 378
            ++  +G+G +    K +   +    AVK     SK  +AN + E+  +   + H N+V 
Sbjct: 14  LKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPNIVK 70

Query: 379 LRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIA 427
           L                 +V +LL+ G L++ +              M+KL         
Sbjct: 71  LHEV------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL--------- 115

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTR 484
                 ++++H      ++HRD+K  N+L    ++  E K+ DFG A+  P     L T 
Sbjct: 116 ---VSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169

Query: 485 VAGTLGYVAPE---YALYGKLTPGSDVYSFGVVLLELLSG 521
              TL Y APE      Y +     D++S GV+L  +LSG
Sbjct: 170 C-FTLHYAAPELLNQNGYDE---SCDLWSLGVILYTMLSG 205

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  100 bits (252), Expect = 3e-23
 Identities = 59/252 (23%), Positives = 95/252 (37%), Gaps = 51/252 (20%)

Query: 294 PSLVLESRSSNLARFKIEEIKAATMNFSRE----NIIGKGGYGNVYKGM-LPNGTEVAVK 348
           P +   +    + R   E +  A+  FS        +GKG +  V + +    G E A K
Sbjct: 2   PHMASMTGGQQMGR-GSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60

Query: 349 RF--KNCSKAGDANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGS 405
               K  S       + E  I   ++H N+V L                 +V DL+  G 
Sbjct: 61  IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE------SFHYLVFDLVTGGE 114

Query: 406 LYDHLFGSG----------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
           L++ +              ++++               +AY H      I+HR++K  N+
Sbjct: 115 LFEDIVAREFYSEADASHCIQQI------------LESIAYCH---SNGIVHRNLKPENL 159

Query: 456 LL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE---YALYGKLTPGSDVY 509
           LL    +    K+ DFGLA    +         AGT GY++PE      Y K     D++
Sbjct: 160 LLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPEVLKKDPYSK---PVDIW 214

Query: 510 SFGVVLLELLSG 521
           + GV+L  LL G
Sbjct: 215 ACGVILYILLVG 226

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 63/232 (27%), Positives = 102/232 (43%), Gaps = 21/232 (9%)

Query: 299 ESRSSNLARFKIEEIKAATMN------FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK 351
             +  N  R +++++   ++       F     +G+G YG+VYK +    G  VA+K+  
Sbjct: 4   TVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP 63

Query: 352 NCSKAGDANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHL 410
             S   +     E+ I+      ++V   G Y       +     IV +    GS+ D +
Sbjct: 64  VESDLQE--IIKEISIMQQCDSPHVVKYYGSY------FKNTDLWIVMEYCGAGSVSD-I 114

Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                K L+      I   T +GL YLH       IHRDIKA NILL+    AK+ DFG+
Sbjct: 115 IRLRNKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGV 171

Query: 471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           A    + +    T + GT  ++APE          +D++S G+  +E+  GK
Sbjct: 172 AGQLTDTMAKRNTVI-GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 98.4 bits (246), Expect = 4e-23
 Identities = 57/212 (26%), Positives = 84/212 (39%), Gaps = 39/212 (18%)

Query: 325 IIGKGGYGNVYKG-MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
            IG+G +G V            A K+           FK E+EI+ S+ H N++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET- 74

Query: 384 TATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALGTAR 432
                 E +  I +V +L   G L++ +              MK +              
Sbjct: 75  -----FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV------------LS 117

Query: 433 GLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
            +AY H   +  + HRD+K  N L          K+ DFGLA     G   + T+V GT 
Sbjct: 118 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTP 172

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
            YV+P+  L G   P  D +S GV++  LL G
Sbjct: 173 YYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 99.7 bits (249), Expect = 4e-23
 Identities = 50/209 (23%), Positives = 83/209 (39%), Gaps = 20/209 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNL 376
             S++ ++G G  G V +      G + A+K   +  KA     + EV+         ++
Sbjct: 31  QLSKQ-VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-----RQEVDHHWQASGGPHI 84

Query: 377 VALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           V +   Y            +I+ + +  G L+  +   G +  +      I       + 
Sbjct: 85  VCILDVYENMHHGKRCL--LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142

Query: 436 YLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           +LH      I HRD+K  N+L    ++    K+ DFG AK   +    L T    T  YV
Sbjct: 143 FLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPC-YTPYYV 196

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSG 521
           APE     K     D++S GV++  LL G
Sbjct: 197 APEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 31/215 (14%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFK---------NCSKAGDANFKHEVEIIASVK-H 373
           I+G+G    V + +  P   E AVK               +        EV+I+  V  H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 374 VNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
            N++ L+         E +    +V DL+  G L+D+L       LS     +I      
Sbjct: 84  PNIIQLKDT------YETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLE 135

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            +  LH   +  I+HRD+K  NILLD+    K+ DFG +     G   L     GT  Y+
Sbjct: 136 VICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVC-GTPSYL 190

Query: 493 APE------YALYGKLTPGSDVYSFGVVLLELLSG 521
           APE         +       D++S GV++  LL+G
Sbjct: 191 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 99.4 bits (248), Expect = 5e-23
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 15/208 (7%)

Query: 317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN 375
            +       IG+G  G V       +G +VAVK      +       +EV I+   +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 376 LVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           +V +   Y      L G +  ++ + L  G+L D +    + +          L   + L
Sbjct: 104 VVEMYKSY------LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVL---QAL 154

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           AYLH      +IHRDIK+ +ILL      K+ DFG      + +    + V GT  ++AP
Sbjct: 155 AYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAP 210

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E           D++S G++++E++ G+
Sbjct: 211 EVISRSLYATEVDIWSLGIMVIEMVDGE 238

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =   99 bits (249), Expect = 6e-23
 Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 28/232 (12%)

Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGD 358
            R       K +  +    +F + + +G G  G V+K    P+G  +A K      +   
Sbjct: 15  KRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH--LEIKP 72

Query: 359 ANFKH---EVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG 414
           A       E++++       +V   G +          +  I  + +  GSL        
Sbjct: 73  AIRNQIIRELQVLHECNSPYIVGFYGAF------YSDGEISICMEHMDGGSLDQ--VLKK 124

Query: 415 MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN 474
             ++   I  ++++   +GL YL    +  I+HRD+K SNIL++   E K+ DFG++   
Sbjct: 125 AGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS--- 179

Query: 475 PEGITHLTTRVA----GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
                 L   +A    GT  Y++PE       +  SD++S G+ L+E+  G+
Sbjct: 180 ----GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 99.8 bits (249), Expect = 9e-23
 Identities = 50/253 (19%), Positives = 94/253 (37%), Gaps = 24/253 (9%)

Query: 277 RSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYK 336
              K   +      ND      +     + +    +  +    +     +G G +G V++
Sbjct: 10  HGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHR 69

Query: 337 GM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQR 394
            +    G     K             K+E+ I+  + H  L+ L   +         ++ 
Sbjct: 70  CVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK------YEM 123

Query: 395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR----GLAYLHYGVQPAIIHRDI 450
           +++ + L  G L+D +     K +S        +   R    GL ++H   + +I+H DI
Sbjct: 124 VLILEFLSGGELFDRIAAEDYK-MSE----AEVINYMRQACEGLKHMH---EHSIVHLDI 175

Query: 451 KASNILL--DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDV 508
           K  NI+    +A   K+ DFGLA         +      T  + APE      +   +D+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTT-ATAEFAAPEIVDREPVGFYTDM 233

Query: 509 YSFGVVLLELLSG 521
           ++ GV+   LLSG
Sbjct: 234 WAIGVLGYVLLSG 246

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 97.8 bits (244), Expect = 1e-22
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 15/208 (7%)

Query: 317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN 375
              ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 376 LVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           +V     Y      L G +  +V + L  GSL D +  + M +       R  L   + L
Sbjct: 79  IVNYLDSY------LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL---QAL 129

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            +LH      +IHRDIK+ NILL      K+ DFG         +  +T V GT  ++AP
Sbjct: 130 EFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAP 185

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E        P  D++S G++ +E++ G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 63/219 (28%), Positives = 96/219 (43%), Gaps = 30/219 (13%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---EVEII-ASVKH 373
           +      IG+G YG+V K +  P+G  +AVKR +  S   +   K    +++++  S   
Sbjct: 23  DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIR--STVDEKEQKQLLMDLDVVMRSSDC 80

Query: 374 VNLVALRGYSTATVPLEGHQRIIV---CDLLHNGSL---YDHLFGSGMKKLSWPIRLRIA 427
             +V   G              I           S    Y +++      +   I  +I 
Sbjct: 81  PYIVQFYGAL-----FREGDCWICMELMS----TSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
           L T + L +L   ++  IIHRDIK SNILLD +   K+ DFG++    + I    TR AG
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAG 187

Query: 488 TLGYVAPEYALYGKLTPG----SDVYSFGVVLLELLSGK 522
              Y+APE         G    SDV+S G+ L EL +G+
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 97.2 bits (243), Expect = 1e-22
 Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 31/211 (14%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGD-ANFKHEVEIIASVKHVNLVA 378
           +G G +  V K      G E A K     R  +  +       + EV I+  ++H N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM---KKLSWPIRLRIALGTARGL 434
           L   +            +++ +L+  G L+D L         + +  ++ +I      G+
Sbjct: 73  LHDIFENK------TDVVLILELVSGGELFDFLAEKESLTEDEATQFLK-QIL----DGV 121

Query: 435 AYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            YLH      I H D+K  NI+L          K+ DFG+A     G         GT  
Sbjct: 122 HYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIF-GTPE 176

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +VAPE   Y  L   +D++S GV+   LLSG
Sbjct: 177 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 50/218 (22%), Positives = 81/218 (37%), Gaps = 49/218 (22%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIA-SVKHVNLVALRG 381
             IG G Y    + +      E AVK      +        E+EI+    +H N++ L+ 
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP----TEEIEILLRYGQHPNIITLKD 83

Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALGT 430
                   +  + + +V +L+  G L D +              +  +            
Sbjct: 84  V------YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTI------------ 125

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
            + + YLH      ++HRD+K SNIL           ++ DFG AK        L T   
Sbjct: 126 TKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC- 181

Query: 487 GTLGYVAPE---YALYGKLTPGSDVYSFGVVLLELLSG 521
            T  +VAPE      Y       D++S GV+L  +L+G
Sbjct: 182 YTANFVAPEVLERQGYDA---ACDIWSLGVLLYTMLTG 216

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 31/211 (14%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGD-ANFKHEVEIIASVKHVNLVA 378
           +G G +  V K      G E A K     + +   +       + EV I+  V H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM---KKLSWPIRLRIALGTARGL 434
           L   Y            +++ +L+  G L+D L        ++ +  I+ +I      G+
Sbjct: 80  LHDVYENR------TDVVLILELVSGGELFDFLAQKESLSEEEATSFIK-QIL----DGV 128

Query: 435 AYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            YLH      I H D+K  NI+L          K+ DFGLA    +G         GT  
Sbjct: 129 NYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIF-GTPE 183

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +VAPE   Y  L   +D++S GV+   LLSG
Sbjct: 184 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 60/275 (21%), Positives = 102/275 (37%), Gaps = 54/275 (19%)

Query: 278 SKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRE----NIIGKGGYGN 333
              +     K  ++ +P         ++         AA   F ++    ++IG+G    
Sbjct: 50  QSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSV 109

Query: 334 VYKGM-LPNGTEVAVKRF--------KNCSKAGDANFKHEVEIIASVK-HVNLVALRGYS 383
           V + +    G E AVK              +      + E  I+  V  H +++ L    
Sbjct: 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS- 168

Query: 384 TATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALGTAR 432
                 E    + +V DL+  G L+D+L              M+ L              
Sbjct: 169 -----YESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL------------LE 211

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            +++LH      I+HRD+K  NILLD+  + ++ DFG +     G   L     GT GY+
Sbjct: 212 AVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC-GTPGYL 266

Query: 493 APE------YALYGKLTPGSDVYSFGVVLLELLSG 521
           APE         +       D+++ GV+L  LL+G
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 56/230 (24%), Positives = 91/230 (39%), Gaps = 56/230 (24%)

Query: 323 ENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALR 380
           E+++G+G +  V   + L    E AVK  +       +    EVE++   + H N++ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 381 GYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALG 429
            +       E   R  +V + +  GS+  H+              ++ +           
Sbjct: 78  EF------FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDV----------- 120

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKF-------NPEGIT 479
            A  L +LH      I HRD+K  NIL    ++    K+ DF L          +P    
Sbjct: 121 -ASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176

Query: 480 HLTTRVAGTLGYVAPE--------YALYGKLTPGSDVYSFGVVLLELLSG 521
            L T   G+  Y+APE         ++Y K     D++S GV+L  LLSG
Sbjct: 177 ELLTPC-GSAEYMAPEVVEAFSEEASIYDK---RCDLWSLGVILYILLSG 222

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 30/219 (13%)

Query: 317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKH-EVEIIASVKHV 374
            ++++   +IG G +G VY+  L  +G  VA+K+        D  FK+ E++I+  + H 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHC 107

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWP---IRLRI--AL 428
           N+V LR +  ++   +    + +V D +   ++Y         K + P   ++L +    
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
              R LAY+H      I HRDIK  N+LLD +    K+ DFG AK    G     + +  
Sbjct: 167 ---RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYIC- 218

Query: 488 TLGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGK 522
           +  Y APE       Y   T   DV+S G VL ELL G+
Sbjct: 219 SRYYRAPELIFGATDY---TSSIDVWSAGCVLAELLLGQ 254

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 96.3 bits (240), Expect = 7e-22
 Identities = 69/237 (29%), Positives = 98/237 (41%), Gaps = 31/237 (13%)

Query: 299 ESRSSNLARFKIEEIKAA---TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCS 354
             R+ +L    + E+         FS    IG G +G VY    + N   VA+K+     
Sbjct: 32  GGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG 91

Query: 355 KAGDANFK---HEVEIIASVKHVNLVALRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHL 410
           K  +  ++    EV  +  ++H N +  RG Y      L  H   +V +    GS  D L
Sbjct: 92  KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCY------LREHTAWLVMEYC-LGSASD-L 143

Query: 411 FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
                K L       +  G  +GLAYLH      +IHRD+KA NILL E    K+GDFG 
Sbjct: 144 LEVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGS 200

Query: 471 AKFNPEGITHLTTR--VAGTLGYVAPEYALYGKLT---PGSDVYSFGVVLLELLSGK 522
           A       + +       GT  ++APE  L           DV+S G+  +EL   K
Sbjct: 201 A-------SIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 53/212 (25%), Positives = 84/212 (39%), Gaps = 40/212 (18%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYS 383
            +G+G    VY+          A+K  K          + E+ ++  + H N++ L+   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEI- 116

Query: 384 TATVPLEGHQRI-IVCDLLHNGSLYDHLFGSG----------MKKLSWPIRLRIALGTAR 432
                 E    I +V +L+  G L+D +   G          +K++              
Sbjct: 117 -----FETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------------LE 159

Query: 433 GLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
            +AYLH   +  I+HRD+K  N+L          K+ DFGL+K        L   V GT 
Sbjct: 160 AVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTP 214

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           GY APE        P  D++S G++   LL G
Sbjct: 215 GYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 53/210 (25%), Positives = 92/210 (43%), Gaps = 27/210 (12%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFK-NCSKAGDANFKHEVEII-ASVKHVNLVALRGY 382
           +G+G YG V K   +P+G  +AVKR +   +         +++I   +V     V   G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 383 STATVPLEGHQRIIV---CDLLHNGSL---YDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
                        I     D     SL   Y  +   G + +   I  +IA+   + L +
Sbjct: 75  L-----FREGDVWICMELMD----TSLDKFYKQVIDKG-QTIPEDILGKIAVSIVKALEH 124

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           LH   + ++IHRD+K SN+L++   + K+ DFG++ +  + +       AG   Y+APE 
Sbjct: 125 LH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI--DAGCKPYMAPER 180

Query: 497 ALYGKLTPG----SDVYSFGVVLLELLSGK 522
                   G    SD++S G+ ++EL   +
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILR 210

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 96.1 bits (240), Expect = 8e-22
 Identities = 62/241 (25%), Positives = 99/241 (41%), Gaps = 52/241 (21%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH--------EVEIIA 369
            + +   IG+G +G V+K      G +VA+K+          N K         E++I+ 
Sbjct: 18  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM------ENEKEGFPITALREIKILQ 71

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY------DH----LFGSGMKKLS 419
            +KH N+V L              +         GS+Y      +H    L  + + K +
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCK---------GSIYLVFDFCEHDLAGLLSNVLVKFT 122

Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF----NP 475
                R+      GL Y+H   +  I+HRD+KA+N+L+      K+ DFGLA+       
Sbjct: 123 LSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 179

Query: 476 EGITHLTTRVAGTLGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK 531
                 T RV  TL Y  PE  L    YG   P  D++  G ++ E+ +      I+QG 
Sbjct: 180 SQPNRYTNRVV-TLWYRPPELLLGERDYG---PPIDLWGAGCIMAEMWTRSP---IMQGN 232

Query: 532 S 532
           +
Sbjct: 233 T 233

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.4 bits (238), Expect = 1e-21
 Identities = 47/208 (22%), Positives = 86/208 (41%), Gaps = 27/208 (12%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHV-NLVALRG 381
           +G+G +  V + +    G E A K  K     +   A   HE+ ++   K    ++ L  
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96

Query: 382 -YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR----GLAY 436
            Y          + I++ +    G ++        + +S        +   +    G+ Y
Sbjct: 97  VYENT------SEIILILEYAAGGEIFSLCLPELAEMVSE----NDVIRLIKQILEGVYY 146

Query: 437 LHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           LH   Q  I+H D+K  NILL       + K+ DFG+++        L   + GT  Y+A
Sbjct: 147 LH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIM-GTPEYLA 201

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSG 521
           PE   Y  +T  +D+++ G++   LL+ 
Sbjct: 202 PEILNYDPITTATDMWNIGIIAYMLLTH 229

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 95.7 bits (238), Expect = 1e-21
 Identities = 44/260 (16%), Positives = 80/260 (30%), Gaps = 24/260 (9%)

Query: 284 RVVKVTDNDEPSLV------LESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKG 337
            V +  +  +          L +R     +   E    A +      I+           
Sbjct: 21  VVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEH--PGIVRYFNAWLETPP 78

Query: 338 MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-I 396
                    +      +    ++          ++ ++  + +       P      + I
Sbjct: 79  EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYI 138

Query: 397 VCDLLHNGSLYDHL-FGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI 455
              L    +L D +     ++     + L I +  A  + +LH      ++HRD+K SNI
Sbjct: 139 QMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNI 195

Query: 456 LLDEAFEAKVGDFGLAK-----------FNPEGITHLTTRVAGTLGYVAPEYALYGKLTP 504
                   KVGDFGL               P       T   GT  Y++PE       + 
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSH 255

Query: 505 GSDVYSFGVVLLELLSGKKA 524
             D++S G++L ELL     
Sbjct: 256 KVDIFSLGLILFELLYSFST 275

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 63/216 (29%), Positives = 100/216 (46%), Gaps = 25/216 (11%)

Query: 317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKH-EVEIIASVKHVN 375
            + ++   +IG G +G V++  L    EVA+K+        D  FK+ E++I+  VKH N
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPN 93

Query: 376 LVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT---A 431
           +V L+ +  +    +    + +V + +   ++Y         K + P+ L I L      
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLL-IKLYMYQLL 151

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
           R LAY+H      I HRDIK  N+LLD      K+ DFG AK    G     + +  +  
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSYIC-SRY 206

Query: 491 YVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGK 522
           Y APE       Y   T   D++S G V+ EL+ G+
Sbjct: 207 YRAPELIFGATNY---TTNIDIWSTGCVMAELMQGQ 239

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 31/211 (14%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGD-ANFKHEVEIIASVKHVNLVA 378
           +G G +  V K      G + A K     R K+  +     + + EV I+  ++H N++ 
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78

Query: 379 LRG-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM---KKLSWPIRLRIALGTARGL 434
           L   Y            I++ +L+  G L+D L        ++ +  ++ +I      G+
Sbjct: 79  LHEVYENK------TDVILILELVAGGELFDFLAEKESLTEEEATEFLK-QIL----NGV 127

Query: 435 AYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLG 490
            YLH      I H D+K  NI+L          K+ DFGLA     G         GT  
Sbjct: 128 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF-GTPE 182

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           +VAPE   Y  L   +D++S GV+   LLSG
Sbjct: 183 FVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 40/204 (19%), Positives = 83/204 (40%), Gaps = 25/204 (12%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG-YS 383
           +G+G +G V++ +   +      K F           K E+ I+   +H N++ L   + 
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRNILHLHESFE 71

Query: 384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR----GLAYLHY 439
           +        + +++ + +    +++ +  S   +L+     R  +         L +LH 
Sbjct: 72  SM------EELVMIFEFISGLDIFERINTSAF-ELNE----REIVSYVHQVCEALQFLH- 119

Query: 440 GVQPAIIHRDIKASNILL--DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
                I H DI+  NI+     +   K+ +FG A+    G  +          Y APE  
Sbjct: 120 --SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DNFRLLF-TAPEYYAPEVH 175

Query: 498 LYGKLTPGSDVYSFGVVLLELLSG 521
            +  ++  +D++S G ++  LLSG
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSG 199

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 59/204 (28%), Positives = 90/204 (44%), Gaps = 22/204 (10%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALRG 381
           IGKG +  V     +  G EVA+K   + ++    + +    EV I+  + H N+V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIK-IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF- 80

Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
                V +E  + + ++ +    G ++D+L   G  ++               + Y H  
Sbjct: 81  ----EV-IETEKTLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH-- 131

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
            Q  I+HRD+KA N+LLD     K+ DFG +     G   L     G   Y APE    G
Sbjct: 132 -QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPE-LFQG 187

Query: 501 KL--TPGSDVYSFGVVLLELLSGK 522
           K    P  DV+S GV+L  L+SG 
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGS 211

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 97.2 bits (242), Expect = 2e-21
 Identities = 44/261 (16%), Positives = 94/261 (36%), Gaps = 41/261 (15%)

Query: 276 TRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVY 335
                  +  V    ++    + +         K + +     ++     +G G +G V+
Sbjct: 118 QGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLD---HYDIHEELGTGAFGVVH 174

Query: 336 KGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG-YSTATVPLEGHQ 393
           +      G   A K      ++     + E++ ++ ++H  LV L   +         ++
Sbjct: 175 RVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD------NE 228

Query: 394 RIIVCDLLHNGSLYDHLFGSG-----------MKKLSWPIRLRIALGTARGLAYLHYGVQ 442
            +++ + +  G L++ +               M+++              GL ++H   +
Sbjct: 229 MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK------------GLCHMH---E 273

Query: 443 PAIIHRDIKASNILLDEAFEA--KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG 500
              +H D+K  NI+         K+ DFGL          +     GT  + APE A   
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-QSVKVTT-GTAEFAAPEVAEGK 331

Query: 501 KLTPGSDVYSFGVVLLELLSG 521
            +   +D++S GV+   LLSG
Sbjct: 332 PVGYYTDMWSVGVLSYILLSG 352

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 94.0 bits (234), Expect = 8e-21
 Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 18/205 (8%)

Query: 323 ENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALR 380
             ++G G  G V +        + A+K  ++C KA     + EVE+     +  ++V + 
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-----RREVELHWRASQCPHIVRIV 121

Query: 381 G-YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
             Y       +    +IV + L  G L+  +   G +  +      I       + YLH 
Sbjct: 122 DVYENLYAGRKCL--LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH- 178

Query: 440 GVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
                I HRD+K  N+L          K+ DFG AK        LTT    T  YVAPE 
Sbjct: 179 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPC-YTPYYVAPEV 234

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSG 521
               K     D++S GV++  LL G
Sbjct: 235 LGPEKYDKSCDMWSLGVIMYILLCG 259

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 64/210 (30%), Positives = 90/210 (42%), Gaps = 34/210 (16%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLVALRGY 382
           +G+G YG V   +       VAVK   +  +A D   N K E+ I   + H N+V   G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GL 434
                  EG+ + +  +    G L+D +               +    A+        G+
Sbjct: 73  ----HRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGV 118

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAGTLGYVA 493
            YLH      I HRDIK  N+LLDE    K+ DFGL   F       L  ++ GTL YVA
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175

Query: 494 PEYALYGKLTPG--SDVYSFGVVLLELLSG 521
           PE  L  +       DV+S G+VL  +L+G
Sbjct: 176 PE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 91.3 bits (227), Expect = 2e-20
 Identities = 52/236 (22%), Positives = 90/236 (38%), Gaps = 29/236 (12%)

Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD 358
            + +       +  +A   +      +G G  G V+K      G  +AVK+ +       
Sbjct: 7   GKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMR--RSGNK 64

Query: 359 ANFKH---EVEII-ASVKHVNLVALRGYSTATVPLEGHQRIIV---CDLLHNGSLYDHLF 411
              K    +++++  S     +V   G       +      I              + L 
Sbjct: 65  EENKRILMDLDVVLKSHDCPYIVQCFGTF-----ITNTDVFIAMELMG----TCA-EKLK 114

Query: 412 GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA 471
                 +   I  ++ +   + L YL    +  +IHRD+K SNILLDE  + K+ DFG++
Sbjct: 115 KRMQGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172

Query: 472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPG-----SDVYSFGVVLLELLSGK 522
               +       R AG   Y+APE       T       +DV+S G+ L+EL +G+
Sbjct: 173 GRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 92.0 bits (229), Expect = 3e-20
 Identities = 52/215 (24%), Positives = 82/215 (38%), Gaps = 29/215 (13%)

Query: 325 IIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDAN--FKH---------EVEIIASVKH 373
            I  G YG V  G+   G  VA+KR  N    G                 E+ ++    H
Sbjct: 29  FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDL----LHNGSLYDHLFGSGMKKLSWPIRLR-IAL 428
            N++ LR           H+  +V +L    L        +       +S P  ++    
Sbjct: 89  PNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ------VIHDQRIVIS-PQHIQYFMY 141

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
               GL  LH      ++HRD+   NILL +  +  + DF LA+ +     + T  V   
Sbjct: 142 HILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVT-H 196

Query: 489 LGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             Y APE  + +   T   D++S G V+ E+ + K
Sbjct: 197 RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 64/211 (30%), Positives = 88/211 (41%), Gaps = 36/211 (17%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLVALRGY 382
           +G+G YG V   +       VAVK   +  +A D   N K E+ I   + H N+V   G 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG- 72

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GL 434
                  EG+ + +  +    G L+D +               +    A+        G+
Sbjct: 73  ----HRREGNIQYLFLEYCSGGELFDRIEPDI----------GMPEPDAQRFFHQLMAGV 118

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT--HLTTRVAGTLGYV 492
            YLH      I HRDIK  N+LLDE    K+ DFGLA           L     GTL YV
Sbjct: 119 VYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYV 174

Query: 493 APEYALYGKLTPG--SDVYSFGVVLLELLSG 521
           APE  L  +       DV+S G+VL  +L+G
Sbjct: 175 APE-LLKRREFHAEPVDVWSCGIVLTAMLAG 204

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 56/247 (22%), Positives = 92/247 (37%), Gaps = 54/247 (21%)

Query: 317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH-EVEIIASVKHV 374
           +  +S    +G G +G V +   + +G   A+K+        D  +K+ E++I+  + HV
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLDHV 60

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP------------- 421
           N++ L  Y   T   E        D    G   + +       +  P             
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 422 -------IRLRIALGTA--------------RGLAYLHYGVQPAIIHRDIKASNILLD-E 459
                  ++  I  G +              R + ++H      I HRDIK  N+L++ +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSK 177

Query: 460 AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL----YGKLTPGSDVYSFGVVL 515
               K+ DFG AK            +  +  Y APE  L    Y   TP  D++S G V 
Sbjct: 178 DNTLKLCDFGSAKKLIPS-EPSVAYIC-SRFYRAPELMLGATEY---TPSIDLWSIGCVF 232

Query: 516 LELLSGK 522
            EL+ GK
Sbjct: 233 GELILGK 239

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 90.7 bits (226), Expect = 5e-20
 Identities = 60/237 (25%), Positives = 94/237 (39%), Gaps = 49/237 (20%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH--------EVEIIA 369
            + + + +G+G +  VYK         VA+K+ K       +  K         E++++ 
Sbjct: 11  RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIKLLQ 67

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY------DH----LFGSGMKKLS 419
            + H N++ L                      H  ++       +     +       L+
Sbjct: 68  ELSHPNIIGLLD-------------AFG----HKSNISLVFDFMETDLEVIIKDNSLVLT 110

Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                   L T +GL YLH   Q  I+HRD+K +N+LLDE    K+ DFGLAK       
Sbjct: 111 PSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167

Query: 480 HLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
             T +V  T  Y APE  L+G      G D+++ G +L ELL        + G S L
Sbjct: 168 AYTHQVV-TRWYRAPE-LLFGARMYGVGVDMWAVGCILAELLLRV---PFLPGDSDL 219

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 90.4 bits (225), Expect = 5e-20
 Identities = 55/226 (24%), Positives = 84/226 (37%), Gaps = 51/226 (22%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIA-------- 369
            +    ++G+G YG V K      G  VA+K+F        ++    V+ IA        
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE------SDDDKMVKKIAMREIKLLK 79

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLH-NGSLY------DH----LFGSGMKKL 418
            ++H NLV L                   ++       Y      DH            L
Sbjct: 80  QLRHENLVNLL------------------EVCKKKKRWYLVFEFVDHTILDDLELFPNGL 121

Query: 419 SWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI 478
            + +  +       G+ + H      IIHRDIK  NIL+ ++   K+ DFG A+      
Sbjct: 122 DYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178

Query: 479 THLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
                 VA T  Y APE  L G  K     DV++ G ++ E+  G+
Sbjct: 179 EVYDDEVA-TRWYRAPE-LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.6 bits (225), Expect = 5e-20
 Identities = 55/209 (26%), Positives = 84/209 (40%), Gaps = 27/209 (12%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGDANFKH---EVEIIASVKHVNL 376
           +G G +G V+  +      EV VK     +        D        E+ I++ V+H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 377 VALRGYSTATVPLEGHQRI-IVCDLLHNGS-LYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           + +          E      +V +   +G  L+  +      +L  P+   I       +
Sbjct: 92  IKVLDI------FENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAV 143

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            YL       IIHRDIK  NI++ E F  K+ DFG A +   G     T   GT+ Y AP
Sbjct: 144 GYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYT-FCGTIEYCAP 198

Query: 495 EYALYGKLTPGS--DVYSFGVVLLELLSG 521
           E  L G    G   +++S GV L  L+  
Sbjct: 199 E-VLMGNPYRGPELEMWSLGVTLYTLVFE 226

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 92.2 bits (229), Expect = 6e-20
 Identities = 63/273 (23%), Positives = 104/273 (38%), Gaps = 40/273 (14%)

Query: 273 FLFTRSKKSEERVVKVTDNDEPSLVLE--------SRSSNLARFKIEEIKAATMN----F 320
           FL+  S+ + +  +      +  + +         S+S    +F   E+  +T      +
Sbjct: 5   FLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRY 64

Query: 321 SRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDANFKH---EVEIIASVKHVN 375
                IG G  G V           VA+K+          A  K    E+ ++  V H N
Sbjct: 65  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA--KRAYRELVLMKCVNHKN 122

Query: 376 LVALRGYSTATVPLEGHQRI-IVCDL----LHNGSLYDHLFGSGMKKLSWPIRLRIAL-G 429
           +++L    T    LE  Q + +V +L    L             ++      R+   L  
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV----------IQMELDHERMSYLLYQ 172

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
              G+ +LH      IIHRD+K SNI++      K+ DFGLA+        +T  V  T 
Sbjct: 173 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVV-TR 227

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            Y APE  L        D++S G ++ E++  K
Sbjct: 228 YYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 91.2 bits (227), Expect = 6e-20
 Identities = 68/220 (30%), Positives = 91/220 (41%), Gaps = 37/220 (16%)

Query: 319 NFSRENIIGKGGYGNVY----KGMLPNGTEVAVK--RFKNCSKAGD-ANFKHEVEIIASV 371
           +F     IGKG +G V               A+K    + C +  +  N   E++I+  +
Sbjct: 16  HFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72

Query: 372 KHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIA-L 428
           +H  LV L  YS         + + +V DLL  G L  HL            ++L I  L
Sbjct: 73  EHPFLVNLW-YSFQD-----EEDMFMVVDLLLGGDLRYHL--QQNVHFKEETVKLFICEL 124

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
             A  L YL       IIHRD+K  NILLDE     + DF +A   P      T  +AGT
Sbjct: 125 VMA--LDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGT 177

Query: 489 LGYVAPE------YALYGKLTPGSDVYSFGVVLLELLSGK 522
             Y+APE       A Y       D +S GV   ELL G+
Sbjct: 178 KPYMAPEMFSSRKGAGYSF---AVDWWSLGVTAYELLRGR 214

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 89.5 bits (223), Expect = 8e-20
 Identities = 57/228 (25%), Positives = 87/228 (38%), Gaps = 55/228 (24%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIA-------- 369
            + +   IG+G YG V+K      G  VA+K+F        +     ++ IA        
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLE------SEDDPVIKKIALREIRMLK 57

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLH-NGSLY------DH----LFGSGMKKL 418
            +KH NLV L                   ++      L+      DH          + +
Sbjct: 58  QLKHPNLVNLL------------------EVFRRKRRLHLVFEYCDHTVLHELDRYQRGV 99

Query: 419 SWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI 478
              +   I   T + + + H   +   IHRD+K  NIL+ +    K+ DFG A+      
Sbjct: 100 PEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156

Query: 479 THLTTRVAGTLGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGK 522
            +    VA T  Y +PE  +    YG   P  DV++ G V  ELLSG 
Sbjct: 157 DYYDDEVA-TRWYRSPELLVGDTQYG---PPVDVWAIGCVFAELLSGV 200

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 89.5 bits (223), Expect = 8e-20
 Identities = 54/225 (24%), Positives = 91/225 (40%), Gaps = 50/225 (22%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKH--------EVEIIAS 370
            + +   +G+G YG VYK     G  VA+KR +                    E+ ++  
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL------DAEDEGIPSTAIREISLLKE 75

Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLH-NGSLY------DHLFGSGMKKLSWPIR 423
           + H N+V+L                   D++H    L       +      + +    ++
Sbjct: 76  LHHPNIVSLI------------------DVIHSERCLTLVFEFMEKDLKKVLDENKTGLQ 117

Query: 424 LR----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                       RG+A+ H   Q  I+HRD+K  N+L++     K+ DFGLA+     + 
Sbjct: 118 DSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR 174

Query: 480 HLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
             T  V  TL Y AP+  L G  K +   D++S G +  E+++GK
Sbjct: 175 SYTHEVV-TLWYRAPD-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 47/211 (22%), Positives = 82/211 (38%), Gaps = 29/211 (13%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDANFKH---EVEIIASVKHV--NL 376
           +G GG+G+VY G+ + +   VA+K   + +        N      EV ++  V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 377 VALRGYSTATVPLEGHQRI-IVCDL-LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           + L  +       E      ++ +       L+D +   G   L   +           +
Sbjct: 111 IRLLDW------FERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAV 162

Query: 435 AYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
            + H      ++HRDIK  NIL+D    E K+ DFG      +     T    GT  Y  
Sbjct: 163 RHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD-GTRVYSP 216

Query: 494 PEYALYGKLTPGS--DVYSFGVVLLELLSGK 522
           PE+ +      G    V+S G++L +++ G 
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 91.0 bits (226), Expect = 1e-19
 Identities = 60/269 (22%), Positives = 99/269 (36%), Gaps = 58/269 (21%)

Query: 290 DNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM---LPNGTEVA 346
           D D    +   R      F+ E  K           +G+G YG+VYK       +  + A
Sbjct: 4   DYDFKVKLSSERERVEDLFEYEGCK-----------VGRGTYGHVYKAKRKDGKDDKDYA 52

Query: 347 VKRFKNCSKAGDANFKH----EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV----- 397
           +K+ +                E+ ++  +KH N+++L+      V L    R +      
Sbjct: 53  LKQIE------GTGISMSACREIALLRELKHPNVISLQK-----VFLSHADRKVWLLFDY 101

Query: 398 --CDLLHNGSLYDHLFGSGMKKLSWPIRLR----IALGTARGLAYLHYGVQPAIIHRDIK 451
              DL H   +      S   K    +       +      G+ YLH      ++HRD+K
Sbjct: 102 AEHDLWH---IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLK 155

Query: 452 ASNILLDEAFEA----KVGDFGLA-KFNP--EGITHLTTRVAGTLGYVAPEYALYGKL-T 503
            +NIL+          K+ D G A  FN   + +  L   V  T  Y APE  L  +  T
Sbjct: 156 PANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFWYRAPELLLGARHYT 214

Query: 504 PGSDVYSFGVVLLELLSGKKACEIIQGKS 532
              D+++ G +  ELL+ +    I   + 
Sbjct: 215 KAIDIWAIGCIFAELLTSE---PIFHCRQ 240

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 88.3 bits (220), Expect = 1e-19
 Identities = 51/238 (21%), Positives = 89/238 (37%), Gaps = 53/238 (22%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH--------EVEIIA 369
            + +   IG+G YG V+K         VA+KR +        +           E+ ++ 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL------DDDDEGVPSSALREICLLK 56

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLH-NGSLY------DHLFGSGMKKLSWPI 422
            +KH N+V L                   D+LH +  L       D          +  +
Sbjct: 57  ELKHKNIVRLH------------------DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL 98

Query: 423 RLR----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI 478
                        +GL + H      ++HRD+K  N+L++   E K+ +FGLA+     +
Sbjct: 99  DPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155

Query: 479 THLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
              +  V  TL Y  P+  L+G    +   D++S G +  EL +  +   +  G  V 
Sbjct: 156 RCYSAEVV-TLWYRPPD-VLFGAKLYSTSIDMWSAGCIFAELANAGRP--LFPGNDVD 209

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 56/231 (24%), Positives = 91/231 (39%), Gaps = 41/231 (17%)

Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNL 376
            + + + +G+G Y  VYKG        VA+K  +   + G       EV ++  +KH N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLH-NGSLY------DH----LFGSGMKKLSWPIRLR 425
           V L                   D++H   SL       D             ++      
Sbjct: 63  VTLH------------------DIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKL 104

Query: 426 IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRV 485
                 RGLAY H   +  ++HRD+K  N+L++E  E K+ DFGLA+            V
Sbjct: 105 FLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEV 161

Query: 486 AGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
             TL Y  P+  L G    +   D++  G +  E+ +G+    +  G +V 
Sbjct: 162 V-TLWYRPPD-ILLGSTDYSTQIDMWGVGCIFYEMATGR---PLFPGSTVE 207

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 61/212 (28%), Positives = 94/212 (44%), Gaps = 37/212 (17%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           +G G +G V  G     G +VAVK   R K  S       K E++ +   +H +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY- 77

Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR-------- 432
                V +       +V + +  G L+D++   G          R+    AR        
Sbjct: 78  ----QV-ISTPTDFFMVMEYVSGGELFDYICKHG----------RVEEMEARRLFQQILS 122

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
            + Y H   +  ++HRD+K  N+LLD    AK+ DFGL+    +G   L T   G+  Y 
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRT-SCGSPNYA 177

Query: 493 APEYALYGKLTPG--SDVYSFGVVLLELLSGK 522
           APE  + G+L  G   D++S GV+L  LL G 
Sbjct: 178 APE-VISGRLYAGPEVDIWSCGVILYALLCGT 208

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 28/236 (11%)

Query: 302 SSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKR-FKNCSKAGDA 359
           S N A    E  +     F  E + G+G +G V  G     G  VA+K+  ++       
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR--- 63

Query: 360 NFKHEVEII---ASVKHVNLVALRGYSTATVPLEGHQR--IIVCDLLHNGSLYDHLFGSG 414
               E++I+   A + H N+V L+ Y       +       +V + +   +L+       
Sbjct: 64  --NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYY 120

Query: 415 MKKLSWPIRLRIALGT---ARGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVGDFGL 470
            ++++ P  L I +      R +  LH      + HRDIK  N+L++EA    K+ DFG 
Sbjct: 121 RRQVAPPPIL-IKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGS 178

Query: 471 AKFNPEGITHLTTRVAGTLGYVAPEYAL----YGKLTPGSDVYSFGVVLLELLSGK 522
           AK            +  +  Y APE       Y   T   D++S G +  E++ G+
Sbjct: 179 AKKLSPS-EPNVAYIC-SRYYRAPELIFGNQHY---TTAVDIWSVGCIFAEMMLGE 229

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 49/212 (23%), Positives = 85/212 (40%), Gaps = 31/212 (14%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDANFKH---EVEIIASV----KHV 374
           +GKGG+G V+ G  L +  +VA+K   R +    +  ++      EV ++  V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 375 NLVALRG-YSTATVPLEGHQRIIVCDLLHNGS-LYDHLFGSGMKKLSWPIRLRIALGTAR 432
            ++ L   + T          ++V +       L+D++   G   L              
Sbjct: 99  GVIRLLDWFETQE------GFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVA 150

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
            + + H      ++HRDIK  NIL+D     AK+ DFG      +     T    GT  Y
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD-GTRVY 204

Query: 492 VAPEYALYGKLTPGS--DVYSFGVVLLELLSG 521
             PE+ +           V+S G++L +++ G
Sbjct: 205 SPPEW-ISRHQYHALPATVWSLGILLYDMVCG 235

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.0 bits (221), Expect = 3e-19
 Identities = 62/245 (25%), Positives = 93/245 (37%), Gaps = 42/245 (17%)

Query: 298 LESRSSNLARFKIEEIKAATMN----FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKN 352
           + SRS     F   EI  +T      +     IG G  G V           VA+K+   
Sbjct: 1   MGSRSKRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR 60

Query: 353 CSKAGDANFKH---------EVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDL-- 400
                   F++         E+ ++  V H N++ L    T    LE  Q + IV +L  
Sbjct: 61  P-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD 113

Query: 401 --LHNGSLYDHLFGSGMKKLSWPIRLRIAL-GTARGLAYLHYGVQPAIIHRDIKASNILL 457
             L             ++      R+   L     G+ +LH      IIHRD+K SNI++
Sbjct: 114 ANLCQV----------IQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVV 160

Query: 458 DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLE 517
                 K+ DFGLA+        +T  V  T  Y APE  L        D++S G ++ E
Sbjct: 161 KSDCTLKILDFGLARTAGTS-FMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGE 218

Query: 518 LLSGK 522
           ++ G 
Sbjct: 219 MIKGG 223

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 87.6 bits (218), Expect = 4e-19
 Identities = 59/232 (25%), Positives = 87/232 (37%), Gaps = 36/232 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK-NCSKAGDANFKH----EVEI---IA 369
            +     IG G YG VYK     +G  VA+K  +      G          EV +   + 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLE 69

Query: 370 SVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN--GSLYDHLFGSGM-----KKLSWPI 422
           + +H N+V L      +      +  +V + +     +  D     G+     K L    
Sbjct: 70  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQF 129

Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITH 480
                    RGL +LH      I+HRD+K  NIL+      K+ DFGLA+       +T 
Sbjct: 130 --------LRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

Query: 481 LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS 532
               V  TL Y APE  L        D++S G +  E+   K    +  G S
Sbjct: 179 ---VVV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK---PLFCGNS 223

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 88.2 bits (219), Expect = 5e-19
 Identities = 60/209 (28%), Positives = 88/209 (42%), Gaps = 35/209 (16%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYST 384
           IG G +G             VAVK +     A D N + E+    S++H N+V  +    
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK-YIERGAAIDENVQREIINHRSLRHPNIVRFK---- 82

Query: 385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLAY 436
             V L      I+ +    G LY+ +  +G          R +   AR        G++Y
Sbjct: 83  -EVILTPTHLAIIMEYASGGELYERICNAG----------RFSEDEARFFFQQLLSGVSY 131

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEA--KVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
            H      I HRD+K  N LLD +     K+ DFG +K +    +   + V GT  Y+AP
Sbjct: 132 CH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAP 186

Query: 495 EYALYGKLTPG--SDVYSFGVVLLELLSG 521
           E  L  +   G  +DV+S GV L  +L G
Sbjct: 187 E-VLLRQEYDGKIADVWSCGVTLYVMLVG 214

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 86.8 bits (216), Expect = 5e-19
 Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 50/225 (22%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKH--------EVEIIAS 370
            +     IG+G YG VYK     G   A+K+ +                    E+ I+  
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL------EKEDEGIPSTTIREISILKE 56

Query: 371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLH-NGSLY------DHLFGSGMKKLSWPIR 423
           +KH N+V L                   D++H    L       D      +      + 
Sbjct: 57  LKHSNIVKLY------------------DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLE 98

Query: 424 LR----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
                   L    G+AY H      ++HRD+K  N+L++   E K+ DFGLA+     + 
Sbjct: 99  SVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155

Query: 480 HLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGK 522
             T  +  TL Y AP+  L G  K +   D++S G +  E+++G 
Sbjct: 156 KYTHEIV-TLWYRAPD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 87.3 bits (217), Expect = 5e-19
 Identities = 60/236 (25%), Positives = 101/236 (42%), Gaps = 46/236 (19%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAG-DANFKHEVEIIASVKHVNL 376
            F +   +G G Y  VYKG+    G  VA+K  K  S+ G  +    E+ ++  +KH N+
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENI 65

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLH-NGSLY---------------DHLFGSGMKKLSW 420
           V L                   D++H    L                    G+  + L  
Sbjct: 66  VRLY------------------DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLEL 107

Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
            +         +GLA+ H   +  I+HRD+K  N+L+++  + K+GDFGLA+     +  
Sbjct: 108 NLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT 164

Query: 481 LTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
            ++ V  TL Y AP+  L G    +   D++S G +L E+++GK    +  G +  
Sbjct: 165 FSSEVV-TLWYRAPD-VLMGSRTYSTSIDIWSCGCILAEMITGK---PLFPGTNDE 215

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 86.9 bits (216), Expect = 5e-19
 Identities = 50/217 (23%), Positives = 85/217 (39%), Gaps = 39/217 (17%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK-----RFKNCSKAGDANFKHEVEIIASVKHVNLVAL 379
           +G+G YG V + +        AVK     + +     G+AN K E++++  ++H N++ L
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRR-IPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 380 RGYSTATVPLEGHQRI-IVCDLLHNGS--LYDHLFGSGMKKLSWPIRLRIALGTAR---- 432
                  +  E  Q++ +V +    G   + D +              R  +  A     
Sbjct: 72  V----DVLYNEEKQKMYMVMEYCVCGMQEMLDSV-----------PEKRFPVCQAHGYFC 116

Query: 433 ----GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL-AKFNPEGITHLTTRVAG 487
               GL YLH      I+H+DIK  N+LL      K+   G+    +P           G
Sbjct: 117 QLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG 173

Query: 488 TLGYVAPEYALYGKLTPG--SDVYSFGVVLLELLSGK 522
           +  +  PE A       G   D++S GV L  + +G 
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 89.5 bits (222), Expect = 6e-19
 Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 25/225 (11%)

Query: 308 FKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEV-AVKRFKN---CSKAGDANFK 362
           +K  E +  T N F +  ++GKGG+G V    +    ++ A K+ +      + G+A   
Sbjct: 173 WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMAL 232

Query: 363 HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
           +E +I+  V    +V+L  Y+  T         +V  L++ G L  H++  G        
Sbjct: 233 NEKQILEKVNSRFVVSLA-YAYETK----DALCLVLTLMNGGDLKFHIYHMGQAGFPEA- 286

Query: 423 RLR-----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG 477
           R       I  G    L  LH   +  I++RD+K  NILLD+    ++ D GLA   PEG
Sbjct: 287 RAVFYAAEICCG----LEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339

Query: 478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            T       GT+GY+APE     + T   D ++ G +L E+++G+
Sbjct: 340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 59/236 (25%), Positives = 87/236 (36%), Gaps = 58/236 (24%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK----------------------RFKNCSKAGDANF- 361
           IGKG YG V       + T  A+K                      R             
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 362 ---KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKL 418
                E+ I+  + H N+V L        P E H   +V +L++ G + +          
Sbjct: 81  EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHL-YMVFELVNQGPVME---------- 127

Query: 419 SWPIRLRIALGTAR--------GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL 470
             P    ++   AR        G+ YLHY     IIHRDIK SN+L+ E    K+ DFG+
Sbjct: 128 -VPTLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT----PGSDVYSFGVVLLELLSGK 522
           +         L+    GT  ++APE +L            DV++ GV L   + G+
Sbjct: 184 SNEFKGSDALLSN-TVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 89.1 bits (221), Expect = 9e-19
 Identities = 56/230 (24%), Positives = 100/230 (43%), Gaps = 26/230 (11%)

Query: 305 LARFKIEEIKAATMN-FSRENIIGKGGYGNVYKGMLPNGTEV-AVKRFKN---CSKAGDA 359
             ++K  E +    + F    ++G+GG+G V+   +    ++ A K+        + G  
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQ 230

Query: 360 NFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKL 418
               E +I+A V    +V+L  Y+  T        + +V  +++ G +  H++       
Sbjct: 231 GAMVEKKILAKVHSRFIVSLA-YAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNP 284

Query: 419 SWPI-RLR-----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
            +   R       I  G    L +LH   Q  II+RD+K  N+LLD+    ++ D GLA 
Sbjct: 285 GFQEPRAIFYTAQIVSG----LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

Query: 473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
               G T       GT G++APE  L  +     D ++ GV L E+++ +
Sbjct: 338 ELKAGQTKTKGYA-GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 87.5 bits (217), Expect = 2e-18
 Identities = 62/212 (29%), Positives = 98/212 (46%), Gaps = 37/212 (17%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           +G G +G V  G     G +VAVK   R K  S       + E++ +   +H +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL-- 81

Query: 382 YSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR-------- 432
           Y    V +     I +V + +  G L+D++  +G          R+    +R        
Sbjct: 82  Y---QV-ISTPSDIFMVMEYVSGGELFDYICKNG----------RLDEKESRRLFQQILS 127

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYV 492
           G+ Y H   +  ++HRD+K  N+LLD    AK+ DFGL+    +G   L T   G+  Y 
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYA 182

Query: 493 APEYALYGKL--TPGSDVYSFGVVLLELLSGK 522
           APE  + G+L   P  D++S GV+L  LL G 
Sbjct: 183 APE-VISGRLYAGPEVDIWSSGVILYALLCGT 213

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.8 bits (213), Expect = 3e-18
 Identities = 64/230 (27%), Positives = 98/230 (42%), Gaps = 29/230 (12%)

Query: 317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVK 372
              ++  + IG+G YG V       N   VA+K+            +    E++I+   +
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYC--QRTLREIKILLRFR 83

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDL----LHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
           H N++ +     A    +     IV DL    L+      HL    +    + I      
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI------ 137

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK---FNPEGITHLTTRV 485
              RGL Y+H      ++HRD+K SN+LL+   + K+ DFGLA+    + +    LT  V
Sbjct: 138 --LRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 486 AGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL 534
           A T  Y APE  L     T   D++S G +L E+LS +    I  GK  L
Sbjct: 193 A-TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR---PIFPGKHYL 238

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 85.0 bits (211), Expect = 4e-18
 Identities = 56/257 (21%), Positives = 97/257 (37%), Gaps = 55/257 (21%)

Query: 293 EPSLVLESRSSNLARFKIEEIKAATM--NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKR 349
                LE+++       +    +AT    + R   +G+G YG VYK +       VA+KR
Sbjct: 7   HHMGTLEAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKR 66

Query: 350 FKNCSKAGDANFKH--------EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLL 401
            +        + +         EV ++  ++H N++ L+              +I     
Sbjct: 67  IRL------EHEEEGVPGTAIREVSLLKELQHRNIIELK-------------SVIH---- 103

Query: 402 HNGSLY------DH-LFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA 452
           HN  L+      ++ L         +S  +          G+ + H       +HRD+K 
Sbjct: 104 HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKP 160

Query: 453 SNILLDEAFEA-----KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG--KLTPG 505
            N+LL  +  +     K+GDFGLA+     I   T  +  TL Y  PE  L G    +  
Sbjct: 161 QNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPE-ILLGSRHYSTS 218

Query: 506 SDVYSFGVVLLELLSGK 522
            D++S   +  E+L   
Sbjct: 219 VDIWSIACIWAEMLMKT 235

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 85.1 bits (211), Expect = 6e-18
 Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 29/217 (13%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV--------- 374
            +G G +  V+    + N T VA+K  +      +A  + E++++  V            
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA-AEDEIKLLQRVNDADNTKEDSMG 84

Query: 375 --NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
             +++ L  +     P   H  ++V ++L   +L   +     + +      +I+     
Sbjct: 85  ANHILKLLDHFNHKGPNGVHV-VMVFEVLGE-NLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDE------AFEAKVGDFGLAKFNPEGIT-HLTTRV 485
           GL Y+H      IIH DIK  N+L++         + K+ D G A +  E  T  + TR 
Sbjct: 143 GLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 200

Query: 486 AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
                Y +PE  L      G+D++S   ++ EL++G 
Sbjct: 201 -----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 84.3 bits (209), Expect = 8e-18
 Identities = 51/222 (22%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 317 TMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---------EVE 366
              +     +G G YG+V   +   +G +VA+K+           F+          E+ 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75

Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDL----LHNGSLYDHLFGSGMKKLSWP 421
           ++  ++H N++ L    T    L       +V       L    +        ++ L + 
Sbjct: 76  LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQK-IMGLKFSEEKIQYLVYQ 134

Query: 422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL 481
           +         +GL Y+H      ++HRD+K  N+ ++E  E K+ DFGLA+        +
Sbjct: 135 M--------LKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EM 180

Query: 482 TTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           T  V  T  Y APE  L +       D++S G ++ E+L+GK
Sbjct: 181 TGYVV-TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 28/206 (13%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYS 383
           +G+G Y  V++ + + N  +V VK  K   K      K E++I+ +++   N++ L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITL--AD 98

Query: 384 TATVPLEGHQRIIVCDL----LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
               P+     ++   +         LY  L    ++   + I         + L Y H 
Sbjct: 99  IVKDPVSRTPALVFEHVNNTDFKQ--LYQTLTDYDIRFYMYEI--------LKALDYCH- 147

Query: 440 GVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                I+HRD+K  N+++D E  + ++ D+GLA+F   G      RVA +  +  PE  +
Sbjct: 148 --SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVA-SRYFKGPELLV 203

Query: 499 YGKL-TPGSDVYSFGVVLLELLSGKK 523
             ++     D++S G +L  ++  K+
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKE 229

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.4 bits (207), Expect = 1e-17
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 47/228 (20%)

Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTEVAVKRFKNCSKAGDANFKHEV---------EI 367
            +     IG+G YG V+K   +   G  VA+KR +          +            E+
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR---------VQTGEEGMPLSTIREV 62

Query: 368 -----IASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHN--GSLYDHLFGSGM----- 415
                + + +H N+V L    T +      +  +V + +     +  D +   G+     
Sbjct: 63  AVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI 122

Query: 416 KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FN 474
           K + + +         RGL +LH      ++HRD+K  NIL+  + + K+ DFGLA+ ++
Sbjct: 123 KDMMFQL--------LRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

Query: 475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            +    LT+ V  TL Y APE  L        D++S G +  E+   K
Sbjct: 172 FQ--MALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 85.7 bits (212), Expect = 1e-17
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 31/217 (14%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEV-AVKRFKNC---SKAGDANFKHEVEIIASVKHV 374
           +FS   IIG+GG+G VY     +  ++ A+K         K G+    +E  +++ V   
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249

Query: 375 N---LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLR-----I 426
           +   +V +  Y+  T      +   + DL++ G L+ HL   G+   +    +R     I
Sbjct: 250 DCPFIVCMS-YAFHT----PDKLSFILDLMNGGDLHYHLSQHGVFSEA---DMRFYAAEI 301

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVA 486
            LG    L ++H      +++RD+K +NILLDE    ++ D GLA    +   H    V 
Sbjct: 302 ILG----LEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV- 351

Query: 487 GTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
           GT GY+APE    G      +D +S G +L +LL G 
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 83.0 bits (206), Expect = 1e-17
 Identities = 52/243 (21%), Positives = 88/243 (36%), Gaps = 45/243 (18%)

Query: 300 SRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVY----KGMLPNGTEVAVKRFKNCSK 355
           + S   A+   +  K    +F    I+G+G +  V             E A+K  +    
Sbjct: 12  AGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRHI 68

Query: 356 AGDANFKH---EVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLF 411
             +    +   E ++++ + H   V L  ++         +++        NG L  ++ 
Sbjct: 69  IKENKVPYVTRERDVMSRLDHPFFVKLY-FTFQD-----DEKLYFGLSYAKNGELLKYIR 122

Query: 412 GSGMKKLSWPIRLRIALGTAR--------GLAYLHYGVQPAIIHRDIKASNILLDEAFEA 463
             G                 R         L YLH      IIHRD+K  NILL+E    
Sbjct: 123 KIG----------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHI 169

Query: 464 KVGDFGLAKFNPEGITHLTTR-VAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELL 519
           ++ DFG AK               GT  YV+PE        K    SD+++ G ++ +L+
Sbjct: 170 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK---SSDLWALGCIIYQLV 226

Query: 520 SGK 522
           +G 
Sbjct: 227 AGL 229

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 83.5 bits (207), Expect = 1e-17
 Identities = 55/211 (26%), Positives = 90/211 (42%), Gaps = 36/211 (17%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVK---RFKNCSKAGDANFKHEVEIIASVKHVNLVALRG 381
           +G+G +G V          +VA+K   R            + E+  +  ++H +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------G 433
           Y    V +     I++      G L+D++              R+     R         
Sbjct: 75  Y---DV-ITTPTDIVMVIEYAGGELFDYIVEKK----------RMTEDEGRRFFQQIICA 120

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           + Y H   +  I+HRD+K  N+LLD+    K+ DFGL+    +G   L T   G+  Y A
Sbjct: 121 IEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKT-SCGSPNYAA 175

Query: 494 PEYALYGKL--TPGSDVYSFGVVLLELLSGK 522
           PE  + GKL   P  DV+S G+VL  +L G+
Sbjct: 176 PE-VINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 83.1 bits (206), Expect = 2e-17
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 28/208 (13%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDANFKH---EVEIIASVKHVNLVALR 380
           +G G YG V   +    G +VA+K+          A  K    E+ ++  ++H N++ L 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA--KRAYRELRLLKHMRHENVIGLL 90

Query: 381 GYSTATVPLEGHQRI-IVCDL----LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
              T    L+      +V       L     ++ L    ++ L + +         +GL 
Sbjct: 91  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM--------LKGLR 142

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y+H      IIHRD+K  N+ ++E  E K+ DFGLA+      + +T  V  T  Y APE
Sbjct: 143 YIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVV-TRWYRAPE 195

Query: 496 YAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             L + + T   D++S G ++ E+++GK
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.0 bits (203), Expect = 5e-17
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDANFKH---EVEIIASVKHV 374
           +   + +G G YG+V        G  VAVK+          A  K    E+ ++  +KH 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA--KRTYRELRLLKHMKHE 88

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDL----LHNGSLYDHLFGSGMKKLSWPIRLRIALG 429
           N++ L    T    LE    + +V  L    L+N      L    ++ L + I       
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI------- 141

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
             RGL Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+   +    +T  VA T 
Sbjct: 142 -LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVA-TR 193

Query: 490 GYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
            Y APE  L +       D++S G ++ ELL+G+
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 54/227 (23%), Positives = 90/227 (39%), Gaps = 51/227 (22%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKR--FKNCSKAGDANFKH---EVEIIASVKHVNLVA 378
            +G GG G V+  +       VA+K+    +         KH   E++II  + H N+V 
Sbjct: 18  PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSV-----KHALREIKIIRRLDHDNIVK 72

Query: 379 LRGYSTATVPLEGHQRI---------IVCDL----LHN----GSL-YDHLFGSGMKKLSW 420
           +      +                  IV +     L N    G L  +H      +   +
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH-----ARLFMY 127

Query: 421 PIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLA---KFNPE 476
            +         RGL Y+H      ++HRD+K +N+ ++ E    K+GDFGLA     +  
Sbjct: 128 QL--------LRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176

Query: 477 GITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
              HL+  +  T  Y +P   L     T   D+++ G +  E+L+GK
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 21/204 (10%), Positives = 46/204 (22%), Gaps = 50/204 (24%)

Query: 326 IGKGGYGNVYKG---MLPNGTEVAVKRFKNCSKAGD---ANFKHEVEIIASVKHVNLVAL 379
            G       ++     L    +VA+          D            ++ +    +  +
Sbjct: 39  HGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR-LRIALGTARGLAYLH 438
                          ++V + +  GSL +    S       P+  +R     A      H
Sbjct: 97  --LDVVH---TRAGGLVVAEWIRGGSLQEVADTSPS-----PVGAIRAMQSLAAAADAAH 146

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              +  +       S + +    +  +                          +      
Sbjct: 147 ---RAGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA--- 179

Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
                P  D+   G  L  LL  +
Sbjct: 180 ----NPQDDIRGIGASLYALLVNR 199

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 58/218 (26%), Positives = 92/218 (42%), Gaps = 35/218 (16%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---EVEIIASVKHVNLVALR 380
           ++G+G YG V      P G  VA+K+ +   K   A       E++I+   KH N++ + 
Sbjct: 18  LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFA--LRTLREIKILKHFKHENIITIF 75

Query: 381 GYSTATVPLEGHQRIIVCDL----LHNGSLYDHLFGSGMKKLSWPIRLR-IALGTARGLA 435
                      ++  I+ +L    LH       +  +  + LS    ++     T R + 
Sbjct: 76  NIQRPDSFENFNEVYIIQELMQTDLHR------VIST--QMLS-DDHIQYFIYQTLRAVK 126

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA----------KFNPEGITHLTTRV 485
            LH      +IHRD+K SN+L++   + KV DFGLA                 + +   V
Sbjct: 127 VLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 486 AGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
           A T  Y APE  L   K +   DV+S G +L EL   +
Sbjct: 184 A-TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.3 bits (190), Expect = 2e-15
 Identities = 49/194 (25%), Positives = 73/194 (37%), Gaps = 27/194 (13%)

Query: 407 YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG 466
            +         L+    +  +   A+G+ +L        IHRD+ A NILL E    K+ 
Sbjct: 179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKIC 235

Query: 467 DFGLAKFNPEGITHLTTRVAGTLGYV-----APEYALYGKLTPGSDVYSFGVVLLELLS- 520
           DFGLA+     I      V      +     APE       T  SDV+SFGV+L E+ S 
Sbjct: 236 DFGLARD----IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 291

Query: 521 GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPIL 580
           G      ++             +KEG  +    +     E+ + M         C H   
Sbjct: 292 GASPYPGVKIDEEFC-----RRLKEGTRMR-APDYTTP-EMYQTMLD-------CWHGEP 337

Query: 581 QARPTMDQIVKILE 594
             RPT  ++V+ L 
Sbjct: 338 SQRPTFSELVEHLG 351

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 60/238 (25%), Positives = 88/238 (36%), Gaps = 57/238 (23%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDANFKH---EVEIIASVKHVNLVAL 379
           +IG+G YG VY          VA+K+         D   K    E+ I+  +K   ++ L
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDC--KRILREITILNRLKSDYIIRL 90

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA-------- 431
                    L+  +  IV ++            S +KKL    +  I L           
Sbjct: 91  YDLIIPDDLLKFDELYIVLEIA----------DSDLKKL---FKTPIFLTEEHIKTILYN 137

Query: 432 --RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA------------------ 471
              G  ++H      IIHRD+K +N LL++    KV DFGLA                  
Sbjct: 138 LLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194

Query: 472 ----KFNPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGKKA 524
                 N      LT+ V  T  Y APE  L     T   D++S G +  ELL+  ++
Sbjct: 195 EEPGPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.2 bits (190), Expect = 3e-15
 Identities = 57/249 (22%), Positives = 87/249 (34%), Gaps = 62/249 (24%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDANFKH---EVEIIASVKH 373
            +   ++IG G YG+V +         VA+K+         D   K    E+ I+  + H
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDC--KRILREIAILNRLNH 111

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA-- 431
            ++V +          +  +  +V ++            S  KKL    R  + L     
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIA----------DSDFKKL---FRTPVYLTELHI 158

Query: 432 --------RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA------------ 471
                    G+ Y+H      I+HRD+K +N L+++    KV DFGLA            
Sbjct: 159 KTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215

Query: 472 ---------------KFNPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVL 515
                                   LT  V  T  Y APE  L     T   DV+S G + 
Sbjct: 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVV-TRWYRAPELILLQENYTEAIDVWSIGCIF 274

Query: 516 LELLSGKKA 524
            ELL+  K 
Sbjct: 275 AELLNMIKE 283

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.9 bits (187), Expect = 9e-15
 Identities = 70/264 (26%), Positives = 106/264 (40%), Gaps = 39/264 (14%)

Query: 276 TRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNV 334
           T +   +++     D    S    S +  +     +     TMN F    ++GKG +G V
Sbjct: 105 TVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV 164

Query: 335 YKGMLPNGTEV-AVKRFKNCSKAGDANFKHEVE-------IIASVKHVNLVALRGYSTAT 386
                       A+K  K   K      K EV        ++ + +H  L AL+ YS  T
Sbjct: 165 ILVKEKATGRYYAMKILK---KE-VIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQT 219

Query: 387 VPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLR-----IALGTARGLAYLHYG 440
                H R+  V +  + G L+ HL  S  +  S   R R     I       L YLH  
Sbjct: 220 -----HDRLCFVMEYANGGELFFHL--SRERVFSED-RARFYGAEIVSA----LDYLH-- 265

Query: 441 VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLGYVAPEYAL 498
            +  +++RD+K  N++LD+    K+ DFGL K   EGI          GT  Y+APE   
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLE 322

Query: 499 YGKLTPGSDVYSFGVVLLELLSGK 522
                   D +  GVV+ E++ G+
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 39/214 (18%)

Query: 326 IGKGGYGNVY---KGMLPNGTEV-AVKRFKNCSKA-----GDANFKHEVEIIASVKHVNL 376
           +G+G +G V+   K    +  ++ A+K  K   KA          K E +I+  V H  +
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLK---KATLKVRDRVRTKMERDILVEVNHPFI 88

Query: 377 VALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLR-----IALGT 430
           V L  Y+  T       ++ ++ D L  G L+  L    M        ++     +AL  
Sbjct: 89  VKLH-YAFQT-----EGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELALA- 138

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGT 488
              L +LH      II+RD+K  NILLDE    K+ DFGL+K   E I H        GT
Sbjct: 139 ---LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGT 189

Query: 489 LGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           + Y+APE       T  +D +SFGV++ E+L+G 
Sbjct: 190 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT 223

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 74.4 bits (183), Expect = 3e-14
 Identities = 59/263 (22%), Positives = 96/263 (36%), Gaps = 57/263 (21%)

Query: 292 DEPSLVLESRSSNLARF---------KIEEIKAATMNFSRENIIGKGGYGNVY----KGM 338
           DE +     R  N+  +         K+++++    +F    +IG+G +G V     K  
Sbjct: 39  DECNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKN- 97

Query: 339 LPNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI 395
                  A+K         +A  A F+ E +++ +     +  L  Y+           +
Sbjct: 98  --ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH-YAFQD-----DNNL 149

Query: 396 -IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLAYLHYGVQPAII 446
            +V D    G L   L      K       R+    AR         +  +H   Q   +
Sbjct: 150 YLVMDYYVGGDLLTLL-----SK----FEDRLPEEMARFYLAEMVIAIDSVH---QLHYV 197

Query: 447 HRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE--------YAL 498
           HRDIK  NIL+D     ++ DFG      E  T  ++   GT  Y++PE           
Sbjct: 198 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGR 257

Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
           YG      D +S GV + E+L G
Sbjct: 258 YGP---ECDWWSLGVCMYEMLYG 277

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 73.6 bits (181), Expect = 4e-14
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 25/208 (12%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV------NLV 377
           +IGKG +G V K         VA+K  +N  +        E+ I+  ++        N++
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQ-AAEEIRILEHLRKQDKDNTMNVI 162

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            +            H   +  +LL   +LY+ +  +  +  S P+  + A    + L  L
Sbjct: 163 HMLEN----FTFRNHI-CMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDAL 216

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEA--KVGDFGLAKFNPEGI-THLTTRVAGTLGYVAP 494
           H   +  IIH D+K  NILL +   +  KV DFG + +  + + T++ +R      Y AP
Sbjct: 217 H---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF-----YRAP 268

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGK 522
           E  L  +     D++S G +L ELL+G 
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGY 296

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 53/236 (22%), Positives = 88/236 (37%), Gaps = 49/236 (20%)

Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVY----KGMLPNGTEVAVKRFKNC---SKAGDANF 361
           KI +++    ++    +IG+G +G V     K         A+K         ++  A F
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 362 KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSW 420
             E +I+A      +V L  Y+         + + +V + +  G L + +          
Sbjct: 117 WEERDIMAFANSPWVVQLF-YAFQD-----DRYLYMVMEYMPGGDLVNLM---------- 160

Query: 421 PIRLRIALGTAR--------GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK 472
                +    AR         L  +H       IHRD+K  N+LLD++   K+ DFG   
Sbjct: 161 -SNYDVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216

Query: 473 FNPEGITHLTTRVAGTLGYVAPE-------YALYGKLTPGSDVYSFGVVLLELLSG 521
              +          GT  Y++PE          YG+     D +S GV L E+L G
Sbjct: 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVG 269

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.2 bits (178), Expect = 6e-14
 Identities = 59/216 (27%), Positives = 94/216 (43%), Gaps = 41/216 (18%)

Query: 326 IGKGGYGNVY---KGMLPNGTEV-AVKRFKNCSKAGDANFKHEVE-------IIASVKHV 374
           +GKGGYG V+   K    N  ++ A+K  K      +A    +         I+  VKH 
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAK---DTAHTKAERNILEEVKHP 81

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLR-----IAL 428
            +V L  Y+  T       ++ ++ + L  G L+  L   G+               I++
Sbjct: 82  FIVDLI-YAFQT-----GGKLYLILEYLSGGELFMQLEREGIFMED---TACFYLAEISM 132

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVA 486
                L +LH   Q  II+RD+K  NI+L+     K+ DFGL K   E I    +T    
Sbjct: 133 ----ALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTHTFC 182

Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT+ Y+APE  +        D +S G ++ ++L+G 
Sbjct: 183 GTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA 218

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 71.9 bits (177), Expect = 9e-14
 Identities = 65/269 (24%), Positives = 104/269 (38%), Gaps = 62/269 (23%)

Query: 276 TRSKKSEERVVKVTDNDEPSLVLESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNV 334
              K SE+  VK           +++   L +++      A ++ F R   +G G +G V
Sbjct: 5   AAKKGSEQESVKEFLA-------KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV 57

Query: 335 YKGML----PNGTEVAVKRFKNCSKAGDANFKH------EVEIIASVKHVNLVALRGYST 384
              ML     +G   A+K      K      K       E  I+ +V    LV L  +S 
Sbjct: 58  ---MLVKHKESGNHYAMKILD---KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSF 110

Query: 385 ATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR--------GLA 435
                  +  + +V + +  G ++ HL   G          R +   AR           
Sbjct: 111 KD-----NSNLYMVMEYVAGGEMFSHLRRIG----------RFSEPHARFYAAQIVLTFE 155

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH      +I+RD+K  N+L+D+    +V DFG AK         T  + GT   +APE
Sbjct: 156 YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPE 208

Query: 496 YAL---YGKLTPGSDVYSFGVVLLELLSG 521
             L   Y K     D ++ GV++ E+ +G
Sbjct: 209 IILSKGYNK---AVDWWALGVLIYEMAAG 234

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 72.1 bits (177), Expect = 1e-13
 Identities = 49/234 (20%), Positives = 86/234 (36%), Gaps = 40/234 (17%)

Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEV-AVKRFKNC---SKAGDANFKHE 364
           +++E++    +F    +IG+G +  V    +    +V A+K         +   + F+ E
Sbjct: 52  RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREE 111

Query: 365 VEIIASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
            +++ +     +  L  ++           + +V +    G L   L   G         
Sbjct: 112 RDVLVNGDRRWITQLH-FAFQD-----ENYLYLVMEYYVGGDLLTLLSKFGE-------- 157

Query: 424 LRIALGTAR--------GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FN 474
            RI    AR         +  +H   +   +HRDIK  NILLD     ++ DFG      
Sbjct: 158 -RIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR 213

Query: 475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVY-------SFGVVLLELLSG 521
            +G       V GT  Y++PE        PG+  Y       + GV   E+  G
Sbjct: 214 ADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 70.1 bits (172), Expect = 4e-13
 Identities = 61/266 (22%), Positives = 111/266 (41%), Gaps = 36/266 (13%)

Query: 268 FTAFWFLFTRSKKSEERVVK-VTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENII 326
               +F    S K E +V     D+D    ++++    + R++I+ +            I
Sbjct: 15  TENLYFQSMSSHKKERKVYNDGYDDDNYDYIVKNGEKWMDRYEIDSL------------I 62

Query: 327 GKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV------NLVAL 379
           GKG +G V K         VA+K  KN     +   + EV ++  +          +V L
Sbjct: 63  GKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-QIEVRLLELMNKHDTEMKYYIVHL 121

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
           + +         H   +V ++L   +LYD L  +  + +S  +  + A      L +L  
Sbjct: 122 KRHFM----FRNHL-CLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175

Query: 440 GVQPAIIHRDIKASNILL--DEAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEY 496
             + +IIH D+K  NILL   +    K+ DFG +    + I  ++ +R      Y +PE 
Sbjct: 176 P-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----YRSPEV 229

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK 522
            L        D++S G +L+E+ +G+
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGE 255

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 68.6 bits (168), Expect = 7e-13
 Identities = 60/210 (28%), Positives = 87/210 (41%), Gaps = 27/210 (12%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVALRGYS 383
           IG G +G++Y G  +  G EVA+K    C K        E +I   ++  V +  +R   
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKL--ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCG 74

Query: 384 TATVPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG   ++V +LL  G SL D LF    +K S    L +A      + Y+H    
Sbjct: 75  A-----EGDYNVMVMELL--GPSLED-LFNFCSRKFSLKTVLLLADQMISRIEYIH---S 123

Query: 443 PAIIHRDIKASNILL---DEAFEAKVGDFGLAKF--NPEGITHLTTR----VAGTLGYVA 493
              IHRD+K  N L+    +     + DFGLAK   +     H+  R    + GT  Y A
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY-A 182

Query: 494 PEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
                 G   +   D+ S G VL+    G 
Sbjct: 183 SINTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.0 bits (171), Expect = 8e-13
 Identities = 60/210 (28%), Positives = 87/210 (41%), Gaps = 27/210 (12%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA-LRGYS 383
           IG G +G +Y G  +    EVA+K      K       +E +I   ++    +  +R + 
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTGIPNVRWFG 72

Query: 384 TATVPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG   ++V DLL  G SL D LF    +KLS    L +A      + ++H    
Sbjct: 73  V-----EGDYNVLVMDLL--GPSLED-LFNFCSRKLSLKTVLMLADQMINRVEFVHSKS- 123

Query: 443 PAIIHRDIKASNILLDEAFEAK---VGDFGLAKF--NPEGITHLTTR----VAGTLGYVA 493
              +HRDIK  N L+     A    + DFGLAK   +     H+  R    + GT  Y A
Sbjct: 124 --FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY-A 180

Query: 494 PEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
                 G   +   D+ S G VL+  L G 
Sbjct: 181 SVNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 68.4 bits (168), Expect = 1e-12
 Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 45/216 (20%)

Query: 326 IGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDANFKHEVE-------IIASVKHV 374
           +GKG +G V   +L      G   A+K  +   K      K EV        ++ + +H 
Sbjct: 13  LGKGTFGKV---ILVREKATGRYYAMKILR---KE-VIIAKDEVAHTVTESRVLQNTRHP 65

Query: 375 NLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLR-----IAL 428
            L AL+ Y+  T     H R+  V +  + G L+ HL    +       R R     I  
Sbjct: 66  FLTALK-YAFQT-----HDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVS 116

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVA 486
                L YLH      +++RDIK  N++LD+    K+ DFGL K   EGI+         
Sbjct: 117 ----ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFC 166

Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           GT  Y+APE           D +  GVV+ E++ G+
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 39/224 (17%)

Query: 319 NFSRENIIGKGGYGNVY---KGMLPNGTEV-AVKRFKNCSKAGDANFKHEVE-------I 367
           NF    ++G G YG V+   K    +  ++ A+K  K   KA         E       +
Sbjct: 55  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLK---KATIVQKAKTTEHTRTERQV 111

Query: 368 IASVKHVN-LVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLR 425
           +  ++    LV L  Y+  T       ++ ++ D ++ G L+ HL             ++
Sbjct: 112 LEHIRQSPFLVTLH-YAFQT-----ETKLHLILDYINGGELFTHLSQRERFTEH---EVQ 162

Query: 426 -----IALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH 480
                I L     L +LH   +  II+RDIK  NILLD      + DFGL+K      T 
Sbjct: 163 IYVGEIVLA----LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 215

Query: 481 LTTRVAGTLGYVAPEYALYGKLTPGSDV--YSFGVVLLELLSGK 522
                 GT+ Y+AP+    G       V  +S GV++ ELL+G 
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.1 bits (167), Expect = 2e-12
 Identities = 35/92 (38%), Positives = 43/92 (46%), Gaps = 8/92 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
            L YLH      I++RD+K  NILLD      + DFGL K   E I H   T+   GT  
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPE 204

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+APE           D +  G VL E+L G 
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 67.6 bits (166), Expect = 2e-12
 Identities = 62/225 (27%), Positives = 93/225 (41%), Gaps = 54/225 (24%)

Query: 319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDANFKH------EVEII 368
           +F     +G G +G V    L     NG   A+K  K   K      K       E  ++
Sbjct: 7   DFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLK---KEIVVRLKQVEHTNDERLML 60

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
           + V H  ++ +   +         Q+I ++ D +  G L+  L  S           R  
Sbjct: 61  SIVTHPFIIRMW-GTFQD-----AQQIFMIMDYIEGGELFSLLRKSQ----------RFP 104

Query: 428 LGTAR--------GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
              A+         L YLH      II+RD+K  NILLD+    K+ DFG AK+ P+   
Sbjct: 105 NPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159

Query: 480 HLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSG 521
             T  + GT  Y+APE      Y K     D +SFG+++ E+L+G
Sbjct: 160 --TYTLCGTPDYIAPEVVSTKPYNK---SIDWWSFGILIYEMLAG 199

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 68.9 bits (168), Expect = 2e-12
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 8/92 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
           GL +L       II+RD+K  N++LD     K+ DFG+ K   E I     T    GT  
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPD 507

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+APE   Y       D ++FGV+L E+L+G+
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 34/92 (36%), Positives = 48/92 (52%), Gaps = 8/92 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
           GL +L       II+RD+K  N++LD     K+ DFG+ K   E I     T    GT  
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPD 186

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+APE   Y       D ++FGV+L E+L+G+
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.8 bits (166), Expect = 3e-12
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
            L YLH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 218

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+APE           D ++ GV++ E+++G+
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 35/92 (38%), Positives = 47/92 (51%), Gaps = 8/92 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
            L +LH      II+RD+K  N+LLD     K+ DFG+ K   EGI +   T    GT  
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPD 189

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+APE        P  D ++ GV+L E+L G 
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 8/92 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
            L YLH   +  II+RD+K  N+LLD     K+ D+G+ K   EG+     T+   GT  
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 175

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           Y+APE           D ++ GV++ E+++G+
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 66/237 (27%), Positives = 96/237 (40%), Gaps = 61/237 (25%)

Query: 324 NIIGKGGYGNVYKGM-LPNGTEVAVKRFKNC-SKAGDANFKH---EVEIIASVK-HVNLV 377
             +GKG YG V+K +    G  VAVK+  +    + DA  +    E+ I+  +  H N+V
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDA--QRTFREIMILTELSGHENIV 72

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA------ 431
            L               ++  D   +  L      + +  +   IR  I L         
Sbjct: 73  NLL-------------NVLRADNDRDVYLVFDYMETDLHAV---IRANI-LEPVHKQYVV 115

Query: 432 ----RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA---------------- 471
               + + YLH G    ++HRD+K SNILL+     KV DFGL+                
Sbjct: 116 YQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 472 -----KFNPEGITHLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSGK 522
                +   +    LT  VA T  Y APE  L   K T G D++S G +L E+L GK
Sbjct: 173 INENTENFDDDQPILTDYVA-TRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 50/212 (23%), Positives = 84/212 (39%), Gaps = 29/212 (13%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA-LRGYS 383
           IG+G +G +++G  L N  +VA+K      ++     + E      +     +  +  + 
Sbjct: 18  IGEGSFGVIFEGTNLLNNQQVAIKF--EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFG 75

Query: 384 TATVPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                 EG   ++V DLL  G SL D L     +K S       A      +  +H    
Sbjct: 76  Q-----EGLHNVLVIDLL--GPSLED-LLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 124

Query: 443 PAIIHRDIKASNILLDEAFEAK-----VGDFGLAKF--NPEGITHLTTR----VAGTLGY 491
            ++++RDIK  N L+            V DFG+ KF  +P    H+  R    ++GT  Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184

Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
                   G+  +   D+ + G V +  L G 
Sbjct: 185 -MSINTHLGREQSRRDDLEALGHVFMYFLRGS 215

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 37/91 (40%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTLG 490
           GL +LH      I++RD+K  NILLD+    K+ DFG+ K   E +     T    GT  
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFCGTPD 183

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSG 521
           Y+APE  L  K     D +SFGV+L E+L G
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 214

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 58/253 (22%), Positives = 95/253 (37%), Gaps = 35/253 (13%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVALRGYS 383
           IG G +G +  G  L     VA+K      K+       E      +     +  +  + 
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGIPQVYYFG 74

Query: 384 TATVPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ 442
                  G    +V +LL  G SL D LF    +  S    L IA+     + Y+H    
Sbjct: 75  P-----CGKYNAMVLELL--GPSLED-LFDLCDRTFSLKTVLMIAIQLISRMEYVHS--- 123

Query: 443 PAIIHRDIKASNILLDEAFEAKVG-----DFGLAKF--NPEGITHLTTR----VAGTLGY 491
             +I+RD+K  N L+              DF LAK   +PE   H+  R    + GT  Y
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY 183

Query: 492 VAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK--- 547
                   GK  +   D+ + G + +  L G    + ++  +       ++ + + K   
Sbjct: 184 -MSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT---LKERYQKIGDTKRAT 239

Query: 548 TLDVIEENMPEME 560
            ++V+ EN PEM 
Sbjct: 240 PIEVLCENFPEMA 252

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 45/203 (22%), Positives = 73/203 (35%), Gaps = 39/203 (19%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRG- 381
           ++G G  G V +        + A+K  ++C KA     + EVE+     +  ++V +   
Sbjct: 25  VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-----RREVELHWRASQCPHIVRIVDV 79

Query: 382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV 441
           Y       +    +IV + L  G L+  +   G +  +      I       + YLH   
Sbjct: 80  YENLYAGRKCL--LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 134

Query: 442 QPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              I HRD+K  N+L          K+ DFG A                       E   
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------------------KE-TT 171

Query: 499 YGKLTPGSDVYSFGVVLLELLSG 521
             K     D++S GV++  LL G
Sbjct: 172 GEKYDKSCDMWSLGVIMYILLCG 194

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.5 bits (156), Expect = 2e-11
 Identities = 32/199 (16%), Positives = 57/199 (28%), Gaps = 48/199 (24%)

Query: 316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVK--RFKNCSKAGDANFKHEVEIIASV-- 371
            T    R   IG+G +G V++ +  + T VA+K    +       ++ K   EI+  +  
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 372 -------------KHVNLVALRG-------------------------YSTATVPLEGHQ 393
                        +    + L                            +      +  Q
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS 453
             IV +    G   + +     K  S      I       LA     ++    HRD+   
Sbjct: 137 LFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWG 191

Query: 454 NILLDEAFEAKVGDFGLAK 472
           N+LL +    K+      K
Sbjct: 192 NVLLKKTSLKKLHYTLNGK 210

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 52/263 (19%), Positives = 87/263 (33%), Gaps = 70/263 (26%)

Query: 321 SRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN- 375
            R ++I K G+G+     L         VA+K  K+     +     E+ ++ SV++ + 
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDP 95

Query: 376 -------LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
                  +V L      +     H   +V ++L +  L   +  S  + L  P   +I  
Sbjct: 96  NDPNREMVVQLLDDFKISGVNGTHI-CMVFEVLGH-HLLKWIIKSNYQGLPLPCVKKIIQ 153

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILL------------------------------- 457
              +GL YLH   +  IIH DIK  NILL                               
Sbjct: 154 QVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 458 ------------------DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY 499
                              E  + K+ D G A +  +  T        T  Y + E  + 
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ----TRQYRSLEVLIG 267

Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
                 +D++S   +  EL +G 
Sbjct: 268 SGYNTPADIWSTACMAFELATGD 290

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 44/224 (19%), Positives = 81/224 (36%), Gaps = 35/224 (15%)

Query: 326 IGKGGYGNVYKGMLPNGTEVAVKR-----------------FKNCSKAGDANFKHEVEII 368
           IG+GG+G +Y   + +   V                      K   +A       +    
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 369 ASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIA 427
             +K++ +    G        + + R ++ D    G  L   ++ +  K+ S    L+++
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSY-RFMIMDRF--GSDLQK-IYEANAKRFSRKTVLQLS 158

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV--GDFGLAK--FNPEGITHLTT 483
           L     L Y+H   +   +H DIKASN+LL+     +V   D+GLA              
Sbjct: 159 LRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAA 215

Query: 484 R----VAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
                  GT+ +     A  G   +   D+   G  +++ L+G 
Sbjct: 216 DPKRCHDGTIEF-TSIDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 33/167 (19%), Positives = 56/167 (33%), Gaps = 27/167 (16%)

Query: 326 IGKGGYGNVYKGM---------LPNGTEVAVKR-FKNCSKAGDANFKHEVEIIASVKHVN 375
             +   G +Y+            P   + ++K   K+     + NF         V    
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVN--K 107

Query: 376 LVALRGYSTATVPL-------EGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIA 427
              L       +P        +   R +V   L  G SL   L  S    LS    L++A
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSERSVLQVA 165

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV--GDFGLAK 472
                 L +LH   +   +H ++ A NI +D   +++V    +G A 
Sbjct: 166 CRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 58/263 (22%), Positives = 95/263 (36%), Gaps = 55/263 (20%)

Query: 288 VTDNDEPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGM--LPNGTEV 345
           V D+ E  LV         R++I               +G+G +G V + +      ++V
Sbjct: 1   VEDDKEGHLVCRIGDWLQERYEIVGN------------LGEGTFGKVVECLDHARGKSQV 48

Query: 346 AVKRFKNCSKAGDANFKHEVEIIASVKH------VNLVALRGYSTATVPLEGHQRIIVCD 399
           A+K  +N  K  +A  + E+ ++  +K          V +  +        GH   I  +
Sbjct: 49  ALKIIRNVGKYREAA-RLEINVLKKIKEKDKENKFLCVLMSDW----FNFHGHM-CIAFE 102

Query: 400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE 459
           LL   + ++ L  +  +    P    +A      L +LH   +  + H D+K  NIL   
Sbjct: 103 LLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVN 158

Query: 460 AFEA-------------------KVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALY 499
           +                      +V DFG A F+ E   T + TR      Y  PE  L 
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH-----YRPPEVILE 213

Query: 500 GKLTPGSDVYSFGVVLLELLSGK 522
                  DV+S G +L E   G 
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGF 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 59.6 bits (145), Expect = 1e-09
 Identities = 56/231 (24%), Positives = 89/231 (38%), Gaps = 49/231 (21%)

Query: 325 IIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV-----NLVA 378
            +G G +G V     + N    AVK  +N  K   +  K E +I+  +++      N+V 
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-KIEADILKKIQNDDINNNNIVK 100

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIALGTARGLAYL 437
             G          H   ++ + L   SLY+ +  +         I+    +   + L YL
Sbjct: 101 YHGK----FMYYDHM-CLIFEPLGP-SLYEIITRNNYNGFHIEDIK-LYCIEILKALNYL 153

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEA-------------------------KVGDFGLAK 472
               + ++ H D+K  NILLD+ +                           K+ DFG A 
Sbjct: 154 R---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCAT 210

Query: 473 FNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           F  +   + + TR      Y APE  L       SD++SFG VL EL +G 
Sbjct: 211 FKSDYHGSIINTRQ-----YRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 47/223 (21%), Positives = 71/223 (31%), Gaps = 36/223 (16%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEI---------IASVKHVN 375
           IG GG+G +Y         + A    K      +     E++          I       
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVK-VEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 376 LVALRG-----YSTATVPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALG 429
            +   G      S  T       R +V + L  G  L      +G         L++ + 
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNG--TFKKSTVLQLGIR 159

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV--GDFGLAK--FNPEGITHLTTRV 485
               L Y+H   +   +H DIKA+N+LL      +V   D+GL+                
Sbjct: 160 MLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP 216

Query: 486 A----GTLGYVAPEYALYGKLTPG--SDVYSFGVVLLELLSGK 522
                GT+ +     A  G       SDV   G  +L  L GK
Sbjct: 217 RKGHNGTIEF-TSLDAHKGV-ALSRRSDVEILGYCMLRWLCGK 257

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 58.4 bits (142), Expect = 2e-09
 Identities = 57/227 (25%), Positives = 91/227 (40%), Gaps = 45/227 (19%)

Query: 325 IIGKGGYGNVYKG--MLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH------VNL 376
            +G+G +G V +       G  VAVK  KN  +  +A  + E++++  +           
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-RSEIQVLEHLNTTDPNSTFRC 79

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP-IRLRIALGTARGLA 435
           V +  +        GH   IV +LL   S YD +  +G        IR ++A    + + 
Sbjct: 80  VQMLEW----FEHHGHI-CIVFELLGL-STYDFIKENGFLPFRLDHIR-KMAYQICKSVN 132

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEA-------------------KVGDFGLAKFNPE 476
           +LH      + H D+K  NIL  ++                      KV DFG A ++ E
Sbjct: 133 FLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE 189

Query: 477 GI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
              T ++TR      Y APE  L    +   DV+S G +L+E   G 
Sbjct: 190 HHSTLVSTRH-----YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 53.3 bits (127), Expect = 2e-07
 Identities = 80/534 (14%), Positives = 151/534 (28%), Gaps = 143/534 (26%)

Query: 61  DAVRRLVNEGPK-------RPMLTDMNTQCQIVLQGIRLLRAEYLRTNGYFLPPVNSSC- 112
           +   RL N+          R        + +  L  +R   A+ +  +G  +     +  
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRL---QPYLKLRQALLELR--PAKNVLIDG--VLGSGKTWV 166

Query: 113 -YESCRNFVTEFVQGFDIR-TSCGYY--PELISEA----CMNI----TSRAQFESLIP-- 158
             + C ++  +    F I   +      PE + E        I    TSR+   S I   
Sbjct: 167 ALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLR 226

Query: 159 -------KSKLQEIKRHCSQSL------ENSYACD----SCTSKLSSLSEIL---RHGPG 198
                    +L + K +    L      +N+ A +    SC         IL   R    
Sbjct: 227 IHSIQAELRRLLKSKPYE-NCLLVLLNVQNAKAWNAFNLSCK--------ILLTTR---- 273

Query: 199 NGNGNVSDCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVL 258
                V+D          ++ +    +     + L   Y   R   L    E++      
Sbjct: 274 --FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL--PREVL-----T 324

Query: 259 GS--VIGILGAFTA-------FWFLFTRSKKSEERVVKVT-DNDEPSLVLESRSSNLARF 308
            +   + I+             W      K +   +++ + +  EP+   E R      F
Sbjct: 325 TNPRRLSIIAESIRDGLATWDNWKHVNCDKLT--TIIESSLNVLEPA---EYR----KMF 375

Query: 309 KIEEIKAATMNFSRENI-IGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFK----- 362
               +      F   +  I       ++  ++ +   V V +    S   +   K     
Sbjct: 376 DRLSV------F-PPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV-EKQPKESTIS 427

Query: 363 -HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWP 421
              + +   VK  N  AL            H+ I+    +      D L          P
Sbjct: 428 IPSIYLELKVKLENEYAL------------HRSIVDHYNIPKTFDSDDLI---------P 466

Query: 422 IRLRIALGTARGLAYLHYG-----VQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFNP 475
             L           Y H G     ++     R      + LD  F E K+     A    
Sbjct: 467 PYLD-------QYFYSHIGHHLKNIEHP--ERMTLFRMVFLDFRFLEQKIRHDSTAWNAS 517

Query: 476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
             I +   ++     Y+      Y +L   + +  F   + E L   K  ++++
Sbjct: 518 GSILNTLQQLKFYKPYICDNDPKYERLV--NAILDFLPKIEENLICSKYTDLLR 569

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.8 bits (123), Expect = 6e-07
 Identities = 54/378 (14%), Positives = 114/378 (30%), Gaps = 122/378 (32%)

Query: 257 VLGSVIGILGAFTAFWFLFTRSKKSEERVVKVTDND--------------EPSLVLESRS 302
           ++ S   + G    FW L ++ ++  ++ V+                   +PS++     
Sbjct: 54  IIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI 113

Query: 303 S---------------NLARFK-IEEIKAATMNFSRENII---GKGGYGNVYKGMLPNGT 343
                           N++R +   +++ A +       +   G  G G   K  +    
Sbjct: 114 EQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSG---KTWV---- 166

Query: 344 EVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI---IVCDL 400
                       A D    ++V+     K +  + L+  ++    LE  Q++   I  + 
Sbjct: 167 ------------ALDVCLSYKVQCKMDFK-IFWLNLKNCNSPETVLEMLQKLLYQIDPNW 213

Query: 401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGT---ARGLAYLHYGVQPAIIHRDIKASNILL 457
               S  DH     ++  S    LR  L +      L          ++  +++ +    
Sbjct: 214 T---SRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL----------LVLLNVQNAKAW- 259

Query: 458 DEAFEAKVGDFGLAKFNPEGITHLTTR--------VAGTLGYVAPEYALYGKLTPGSDVY 509
             AF     +    K        LTTR         A T  +++ ++     LTP     
Sbjct: 260 -NAF-----NLS-CK------ILLTTRFKQVTDFLSAATTTHISLDHHSMT-LTPDE--- 302

Query: 510 SFGVVLLELLS---GKK-------ACEI----IQGKSVLLSDWA-----WELVKEGKTLD 550
                +  LL      +               +   +  + D       W+ V   K   
Sbjct: 303 -----VKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTT 357

Query: 551 VIEENMPEMELPEMMEQY 568
           +IE ++  +E  E  + +
Sbjct: 358 IIESSLNVLEPAEYRKMF 375

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 43.3 bits (101), Expect = 2e-04
 Identities = 78/544 (14%), Positives = 145/544 (26%), Gaps = 208/544 (38%)

Query: 96  EYLRTNGYFL----------PPVNSSCYESCRNFVTEFVQGFDIRTSCGYYPELISEACM 145
           E LR N  FL          P + +  Y   R+ +    Q F                  
Sbjct: 85  EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA--------K-------Y 129

Query: 146 NITSRAQFESLIPKSKLQEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVS 205
           N++    +  L  +  L E++                         +L  G   G     
Sbjct: 130 NVSRLQPYLKL--RQALLELRPA---------------------KNVLIDGVL-G----- 160

Query: 206 DCSGYPYLYAAAVVNQFGPIDRATARCLFSLYFSARQSSLNKRHEIVIYGLVLGSVIGIL 265
             SG  ++ A  V   +        +C                                 
Sbjct: 161 --SGKTWV-ALDVCLSYKV------QCKMD------------------------------ 181

Query: 266 GAFTAFWFLFTRSKKSEERVVKV----TDNDEPSLVLESRSSNLARFKIEEIKAATMNFS 321
             F  FW         E  +  +       D         SSN+ + +I  I+A      
Sbjct: 182 --FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI-KLRIHSIQAELRRLL 238

Query: 322 RENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC---------SKAGDANFKHEVEIIASVK 372
           +                         K ++NC         +KA +A F    +I+ + +
Sbjct: 239 KS------------------------KPYENCLLVLLNVQNAKAWNA-FNLSCKILLTTR 273

Query: 373 HVNLV-ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS--GMKKLSWPIR------ 423
              +   L   +T  + L+ H       L  +      L       +    P        
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSM----TLTPDEVK--SLLLKYLDCRPQDLPREVLTTNP 327

Query: 424 LRIAL-------GTARGLAYLHYGVQPAIIHRDIKASNILLDEA-----FEAKVGDFGLA 471
            R+++       G A    + H       +   I++S  +L+ A     F+       L+
Sbjct: 328 RRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDR------LS 379

Query: 472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK 531
            F P    H+ T +   + +   +           DV    VV+ +L             
Sbjct: 380 VF-PPS-AHIPTILLSLIWFDVIKS----------DV---MVVVNKLHK----------Y 414

Query: 532 SVLLSDWAWELVKEGKT------LDVIEENMPEMEL-PEMMEQYVLTAAICAHPILQARP 584
           S++         KE         L++  +   E  L   +++ Y +     +  ++   P
Sbjct: 415 SLVEKQP-----KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP--P 467

Query: 585 TMDQ 588
            +DQ
Sbjct: 468 YLDQ 471

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	614
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.63
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.27
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.95
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.94
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.54
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	98.29
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.27
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	98.26
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.16
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.14
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.9
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.87
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.7
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.53
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.45
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.27
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.01
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.99
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.96
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.86
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.77
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.53
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.5
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.22
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.02
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.81
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	94.91
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	94.91
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.8
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	92.85
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	92.66
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.93
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.5

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-54  Score=456.48  Aligned_cols=261  Identities=26%  Similarity=0.413  Sum_probs=210.1

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|...+.||+|+||+||+|++.      +++.||||+++..+....++|.+|++++++++|||||+++|+|.     ++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~  115 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----EG  115 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----EC
Confidence            35777889999999999999853      47899999998877777889999999999999999999999997     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCC-------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSG-------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~-------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      +..++|||||++|+|.++|....             ...++|.++++|+.|+|+||+|||   +.+|+||||||+||||+
T Consensus       116 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          116 RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEEC
Confidence            77899999999999999997632             246999999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhh
Q 043267          459 EAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLS  536 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~  536 (614)
                      +++++||+|||+++...... ....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||......     
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~-----  267 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT-----  267 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH-----
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH-----
Confidence            99999999999998654432 233455789999999999999999999999999999999999 89999644321     


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCC
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSN  601 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  601 (614)
                       .+...+..|...+     .+    ......+.+++..||+.||++||||+||++.|+...+.|+
T Consensus       268 -~~~~~i~~g~~~~-----~p----~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~pp  322 (329)
T 4aoj_A          268 -EAIDCITQGRELE-----RP----RACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAPP  322 (329)
T ss_dssp             -HHHHHHHHTCCCC-----CC----TTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSCC
T ss_pred             -HHHHHHHcCCCCC-----Cc----ccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCCc
Confidence             1223344443221     12    2233467788999999999999999999999998765553

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-54  Score=451.32  Aligned_cols=256  Identities=26%  Similarity=0.406  Sum_probs=213.1

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|...+.||+|+||+||+|++.      +|..||||+++..+....++|.+|++++++++|||||+++|+|.     ++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~~   87 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   87 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eC
Confidence            46788899999999999999863      47889999998877777889999999999999999999999997     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcC-----------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGS-----------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA  460 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~-----------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~  460 (614)
                      +..++|||||++|+|.++|...           ....++|.++++|+.|+|+||+|||   +++|+||||||+||||+++
T Consensus        88 ~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           88 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCC
Confidence            7789999999999999999753           2357999999999999999999999   8899999999999999999


Q ss_pred             CcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHH
Q 043267          461 FEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       461 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~  538 (614)
                      +++||+|||+|+....... .......||+.|||||++.++.|+.++|||||||++|||+| |+.||......      .
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~  238 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------E  238 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------H
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------H
Confidence            9999999999986544322 23344579999999999999999999999999999999999 89999654321      1


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      +...+..|...+     .    +......+.+++..||+.||++|||++||+++|++.
T Consensus       239 ~~~~i~~~~~~~-----~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          239 VIECITQGRVLQ-----R----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHHHHHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            223344443321     1    122344677889999999999999999999999875

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.2e-54  Score=447.81  Aligned_cols=254  Identities=24%  Similarity=0.362  Sum_probs=208.6

Q ss_pred             ccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          320 FSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      +...+.||+|+||+||+|++.      +++.||||+++.. +....++|.+|++++++++|||||+++|+|.     ++.
T Consensus        28 ~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-----~~~  102 (308)
T 4gt4_A           28 VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT-----KDQ  102 (308)
T ss_dssp             EEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS
T ss_pred             CeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE-----ECC
Confidence            455678999999999999862      5688999999753 3344578999999999999999999999997     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ..++|||||++|||.++|....              ...++|.++++|+.|||+||+|||   +.+||||||||+||||+
T Consensus       103 ~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          103 PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEC
T ss_pred             EEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEEC
Confidence            7899999999999999996532              246999999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhh
Q 043267          459 EAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLS  536 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~  536 (614)
                      +++++||+|||+++...... ....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||......     
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~-----  254 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ-----  254 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH-----
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH-----
Confidence            99999999999998654322 233455689999999999999999999999999999999999 89999654321     


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       .+...+..+....     .    +.+....+.+++..||+.||++||||+||++.|+..
T Consensus       255 -~~~~~i~~~~~~~-----~----p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          255 -DVVEMIRNRQVLP-----C----PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHHHHHTTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHHHHHcCCCCC-----C----cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             1223344443321     1    223345677889999999999999999999999865

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=5.3e-53  Score=439.39  Aligned_cols=257  Identities=32%  Similarity=0.479  Sum_probs=203.5

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +++...+.||+|+||+||+|++++  .||||+++..  +....++|.+|++++++++|||||+++|++.      ++..+
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~------~~~~~  107 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT------KDNLA  107 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE------CCeEE
Confidence            467778899999999999999753  5999998743  3455678999999999999999999999985      24579


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      ||||||++|+|.++|.... ..++|.++++|+.|||+||+|||   +.+||||||||+||||++++++||+|||+|+...
T Consensus       108 iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999999997643 46999999999999999999999   8899999999999999999999999999998655


Q ss_pred             CCC-ccccccccCCCCcCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          476 EGI-THLTTRVAGTLGYVAPEYALY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       476 ~~~-~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ... ....+...||+.|||||++.+   ++|+.++|||||||++|||+||+.||.....     ...+...+..+...  
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~-----~~~~~~~~~~~~~~--  256 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN-----RDQIIFMVGRGYAS--  256 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----HHHHHHHHHTTCCC--
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhcCCCC--
Confidence            332 233456789999999999964   4699999999999999999999999965432     12223333333221  


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                        +.++ ....+....+.+++..||+.||++||||.||++.|+..
T Consensus       257 --p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          257 --PDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             --CCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             --CCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence              1111 11223345677889999999999999999999998764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.4e-52  Score=436.54  Aligned_cols=275  Identities=27%  Similarity=0.303  Sum_probs=203.5

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +++...+.||+|+||+||+|++ +|+.||||+++.... ....+..|+..+.+++|||||+++|+|..... .....+||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~-~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCC-CceEEEEE
Confidence            4577889999999999999998 689999999975322 22233455666678899999999999975321 22468999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc-----CCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG-----VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~-----~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ||||++|+|.++|...   .++|+.+.+|+.|+++||+|||+.     .+++|+||||||+|||||+++++||+|||+++
T Consensus        80 ~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999754   599999999999999999999943     23499999999999999999999999999998


Q ss_pred             eCCCCCcc---ccccccCCCCcCchhhhccC------CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh-------
Q 043267          473 FNPEGITH---LTTRVAGTLGYVAPEYALYG------KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS-------  536 (614)
Q Consensus       473 ~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~-------  536 (614)
                      ........   ......||+.|||||++.+.      .++.++|||||||++|||+||+.|+...........       
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            66543322   22346799999999998754      477899999999999999999887743332211111       


Q ss_pred             --HHHHHHHHcCCchhhhhccCCCCC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCCc
Q 043267          537 --DWAWELVKEGKTLDVIEENMPEME-LPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNI  602 (614)
Q Consensus       537 --~~~~~~~~~g~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~  602 (614)
                        ......+..+    ..++.++... ..+....+.+++..||+.||++||||.||+++|+...+..++
T Consensus       237 ~~~~~~~~~~~~----~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~~i  301 (303)
T 3hmm_A          237 SVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI  301 (303)
T ss_dssp             CHHHHHHHHTTS----CCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC---
T ss_pred             hHHHHHHHHhcc----cCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHcCC
Confidence              1111111111    1122333211 234566788999999999999999999999999876544443

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3e-51  Score=434.61  Aligned_cols=269  Identities=26%  Similarity=0.344  Sum_probs=218.0

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccc-cceeee
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKH-VNLVAL  379 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H-~niv~l  379 (614)
                      ++..+.+...++|+..+.||+|+||+||+|++.      .++.||||+++... ....++|.+|++++++++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            344445555678999999999999999999853      24689999997643 3445679999999999965 899999


Q ss_pred             eeeeecccCCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCce
Q 043267          380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAI  445 (614)
Q Consensus       380 ~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~i  445 (614)
                      +|+|..    ++...++|||||++|+|.++|+...              ...++|.+++.|+.|||+||+|||   +.+|
T Consensus       134 ~g~~~~----~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~i  206 (353)
T 4ase_A          134 LGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKC  206 (353)
T ss_dssp             EEEECC----TTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             EEEEEe----cCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCe
Confidence            999863    3456799999999999999997532              245899999999999999999999   8999


Q ss_pred             EEeccCCCCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCC
Q 043267          446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKK  523 (614)
Q Consensus       446 iHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~  523 (614)
                      |||||||+|||+++++++||+|||+|+....+... ......||+.|||||++.++.|+.++|||||||++|||+| |+.
T Consensus       207 iHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~  286 (353)
T 4ase_A          207 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS  286 (353)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred             ecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCC
Confidence            99999999999999999999999999876544332 3445679999999999999999999999999999999998 999


Q ss_pred             CcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          524 ACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       524 p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ||......     ..+...+.+|....     .++    .....+.+++..||+.||++|||+.||++.|+..+
T Consensus       287 Pf~~~~~~-----~~~~~~i~~g~~~~-----~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~ll  346 (353)
T 4ase_A          287 PYPGVKID-----EEFCRRLKEGTRMR-----APD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  346 (353)
T ss_dssp             SSTTCCCS-----HHHHHHHHHTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCHH-----HHHHHHHHcCCCCC-----CCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            99654322     22334445543321     122    22345778889999999999999999999998753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.3e-51  Score=430.75  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=203.0

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|...+.||+|+||+||+|+.. +|+.||||++...  +....+.+.+|++++++++|||||++++++.     +++..
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~-----~~~~~   98 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE-----ENGSL   98 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEE-----ECCEE
Confidence            57999999999999999999964 7999999999753  3445678999999999999999999999987     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.++|...+...+++.+.+.|+.||+.||+|||   +.+|+||||||+||||++++++||+|||+|+..
T Consensus        99 yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           99 YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceee
Confidence            99999999999999998776677899999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      .... ...+..+||+.|||||++.+..|+.++||||+||++|||++|+.||.....     .+.... +..+...     
T Consensus       176 ~~~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~-i~~~~~~-----  243 (350)
T 4b9d_A          176 NSTV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM-----KNLVLK-IISGSFP-----  243 (350)
T ss_dssp             CHHH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHH-HHHTCCC-----
T ss_pred             cCCc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH-----HHHHHH-HHcCCCC-----
Confidence            4321 223456799999999999999999999999999999999999999964321     122222 2222211     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .+    .......+.+++..||+.||++|||+.|+++
T Consensus       244 ~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          244 PV----SLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC----CccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11    1223446778899999999999999999985

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=8.4e-50  Score=412.20  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             cccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          321 SRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ...+.||+|+||+||+|+.. ++..||||++...  +....+.|.+|++++++++|||||++++++..... .+...++|
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~~~~~~lv  107 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLV  107 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEET-TEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccC-CCcEEEEE
Confidence            55678999999999999965 6899999999643  34456779999999999999999999998864221 34568999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEECC-CCcEEEeecCCceeC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLDE-AFEAKVGDFGLAKFN  474 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd~-~~~~kl~DFGla~~~  474 (614)
                      |||+++|+|.++|.+.  ..+++..+..|+.||++||+|||   +.+  |+||||||+||||++ ++++||+|||+|+..
T Consensus       108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            9999999999999764  46999999999999999999999   666  999999999999984 799999999999864


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ...   .....+||+.|||||++. ++|+.++|||||||++|||++|+.||.....     ...+...+..+......+.
T Consensus       183 ~~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~  253 (290)
T 3fpq_A          183 RAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRVTSGVKPASFDK  253 (290)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-----HHHHHHHHTTTCCCGGGGG
T ss_pred             CCC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-----HHHHHHHHHcCCCCCCCCc
Confidence            432   234568999999999876 5799999999999999999999999964332     1112333333332222221


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .        ....+.+++..||+.||++|||++|+++
T Consensus       254 ~--------~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          254 V--------AIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             C--------CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c--------CCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1        1235678889999999999999999875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.7e-50  Score=423.72  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=209.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ..|+..+.||+|+||+||+|+.. +|+.||||+++.......+.+.+|++++++++|||||++++++.     +++..+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            35888899999999999999965 79999999997655555667899999999999999999999987     5678999


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++...   .+++.+...|+.||+.||+|||   +.+|+||||||+||||+.++++||+|||+|+....
T Consensus       149 vmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          149 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            99999999999999653   5999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ..+..+||+.|||||++.+..|+.++||||+||++|||++|+.||......     + ....+..+..     +.+
T Consensus       223 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----~-~~~~i~~~~~-----~~~  290 (346)
T 4fih_A          223 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----K-AMKMIRDNLP-----PRL  290 (346)
T ss_dssp             SSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----H-HHHHHHHSSC-----CCC
T ss_pred             CCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----H-HHHHHHcCCC-----CCC
Confidence            332 244578999999999999999999999999999999999999999643221     1 1122222211     111


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                      .  ........+.+++..|++.||++|||+.|+++  .+.+.
T Consensus       291 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          291 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             S--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             C--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence            1  12334456788999999999999999999986  45443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-49  Score=417.70  Aligned_cols=252  Identities=22%  Similarity=0.224  Sum_probs=202.8

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .+.|...++||+|+||+||+|+.. +|+.||||+++....     ..+|++++++++|||||++++++.     +++..+
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~-----~~~~~~  126 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR-----EGPWVN  126 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEE
Confidence            346888899999999999999964 699999999975322     246999999999999999999987     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGla~~~  474 (614)
                      |||||+++|+|.++|.+.+  .+++.+...|+.||+.||+|||   +.+|+||||||+||||+.++ ++||+|||+|+..
T Consensus       127 ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~  201 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCL  201 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC
T ss_pred             EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEc
Confidence            9999999999999997643  6999999999999999999999   89999999999999999987 6999999999876


Q ss_pred             CCCCcc----ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          475 PEGITH----LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       475 ~~~~~~----~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ..+...    .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.........     .. +..+... 
T Consensus       202 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-----~~-i~~~~~~-  274 (336)
T 4g3f_A          202 QPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC-----LK-IASEPPP-  274 (336)
T ss_dssp             ------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH-----HH-HHHSCCG-
T ss_pred             cCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH-----HH-HHcCCCC-
Confidence            543211    223467999999999999999999999999999999999999999654432221     11 1112110 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                        ...++    +.....+.+++..|++.||++|||+.|+++.|...
T Consensus       275 --~~~~~----~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          275 --IREIP----PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             --GGGSC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --chhcC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence              01112    22344677888999999999999999999888654

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.4e-49  Score=424.79  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=210.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +.|+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++|||||++++++.     +++..+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~-----~~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL-----VGDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEE-----ECCEEEE
Confidence            46889999999999999999964 79999999998665556677899999999999999999999987     5678999


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      |||||++|+|.+++...   .+++.+...|+.||+.||+|||   +.+||||||||+||||+.++++||+|||+|+....
T Consensus       226 VmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          226 VMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            99999999999999653   5999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ..+..+||+.|||||++.+..|+.++||||+||++|||++|+.||......     + +...+..+..     ..+
T Consensus       300 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~-----~-~~~~i~~~~~-----~~~  367 (423)
T 4fie_A          300 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-----K-AMKMIRDNLP-----PRL  367 (423)
T ss_dssp             SCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----H-HHHHHHHSCC-----CCC
T ss_pred             CCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH-----H-HHHHHHcCCC-----CCC
Confidence            332 234568999999999999999999999999999999999999999643221     1 1122222211     111


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                      .  ........+.+++..||+.||++|||+.|+++  .|.+.
T Consensus       368 ~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          368 K--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             S--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             c--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence            1  11223456778899999999999999999986  45543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.1e-49  Score=412.03  Aligned_cols=247  Identities=20%  Similarity=0.257  Sum_probs=205.8

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+++. .+|+.||||++.+.   .....+.+.+|++++++++|||||++++++.     +++.
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            4699999999999999999996 47999999999743   2234567899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.++|.+.  ..+++.+...++.||+.||+|||   +.+|+||||||+||||++++++||+|||+|+.
T Consensus       107 ~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            99999999999999999764  36999999999999999999999   89999999999999999999999999999997


Q ss_pred             CCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..... .......+||+.|||||++.+..|+.++||||+||++|||++|+.||.....     .+ ....+..+..    
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~-~~~~i~~~~~----  251 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GL-IFAKIIKLEY----  251 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH-HHHHHHHTCC----
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HH-HHHHHHcCCC----
Confidence            65433 2344567899999999999999999999999999999999999999964321     11 1222222221    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                        .+++    .....+.+++..|++.||++|||++|++
T Consensus       252 --~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 --DFPE----KFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             --CCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             --CCCc----ccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence              2222    2234567889999999999999999863

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.9e-48  Score=398.96  Aligned_cols=250  Identities=22%  Similarity=0.337  Sum_probs=192.0

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+++.. +|+.||||+++...   ....+.+.+|++++++++|||||++++++.     +++.
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~   87 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIK-----SKDE   87 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----ECCE
Confidence            57999999999999999999964 79999999997532   233467899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+ +|+|.+++.+.  ..+++.+...++.|++.||+|||   +.+|+||||||+|||+++++++||+|||+|+.
T Consensus        88 ~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           88 IIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCee
Confidence            99999999 68999999764  36999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..+..  ......||+.|||||.+.+..| +.++||||+||++|||++|+.||.....     .. ..+.+..+..    
T Consensus       162 ~~~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~-~~~~i~~~~~----  229 (275)
T 3hyh_A          162 MTDGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PV-LFKNISNGVY----  229 (275)
T ss_dssp             ---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH-HHHHHHHTCC----
T ss_pred             cCCCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HH-HHHHHHcCCC----
Confidence            54432  2344689999999999998876 5799999999999999999999964321     11 1222333321    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                        .++.    .....+.+++..|++.||++|||++|+++  .++.+
T Consensus       230 --~~p~----~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          230 --TLPK----FLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             --CCCT----TSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             --CCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence              1222    22345678899999999999999999986  44433

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.1e-48  Score=406.16  Aligned_cols=247  Identities=25%  Similarity=0.301  Sum_probs=194.6

Q ss_pred             cCccccceecccCceEEEEeEc----CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|+..+.||+|+||+||+|+.    ..++.||||+++...  ......+.+|++++++++|||||++++++.     ++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQ-----TE   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEE-----ET
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEE-----EC
Confidence            4699999999999999999985    247899999997532  223446889999999999999999999987     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +..++||||+++|+|.++|.+.+  .+++.+...++.|++.||+|||   +.+|+||||||+|||+++++++||+|||+|
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla  173 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLS  173 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccc
Confidence            78999999999999999997643  6999999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +....... ......||+.|||||.+.+..|+.++||||+||++|||++|+.||.....     .+. ...+.++..   
T Consensus       174 ~~~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~-~~~i~~~~~---  243 (304)
T 3ubd_A          174 KESIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR-----KET-MTMILKAKL---  243 (304)
T ss_dssp             EC-----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH-HHHHHHCCC---
T ss_pred             eeccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCH-----HHH-HHHHHcCCC---
Confidence            86543322 23456899999999999999999999999999999999999999964322     111 122222211   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                         .++.    .....+.+++..|++.||++|||     ++|+++
T Consensus       244 ---~~p~----~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 ---GMPQ----FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             ---CCCT----TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             ---CCCC----cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence               1222    23345778899999999999998     467663

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.4e-48  Score=399.55  Aligned_cols=254  Identities=23%  Similarity=0.301  Sum_probs=189.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCC------
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL------  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~------  389 (614)
                      ++|+..+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|++++++++|||||++++++......      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999964 79999999997533 34456799999999999999999999987643211      


Q ss_pred             -CCceEEEEEeecCCCChhhhhhcCCC-cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEee
Q 043267          390 -EGHQRIIVCDLLHNGSLYDHLFGSGM-KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       390 -~~~~~~lV~E~~~~GsL~~~L~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                       .....++||||+++|+|.+++..... ...++...+.|+.|+++||+|||   +.+|+||||||+||||+.++++||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEcc
Confidence             22347899999999999999976432 34667778999999999999999   89999999999999999999999999


Q ss_pred             cCCceeCCCCCcc-----------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh
Q 043267          468 FGLAKFNPEGITH-----------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS  536 (614)
Q Consensus       468 FGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~  536 (614)
                      ||+|+....+...           ..+..+||+.|||||.+.+..|+.++|||||||++|||++   ||.....   .. 
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~---~~-  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME---RV-  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH---HH-
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH---HH-
Confidence            9999876543211           1234579999999999999999999999999999999996   6642111   00 


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ........+.....         ..+.......++..|++.||++|||+.|+++
T Consensus       235 -~~~~~~~~~~~p~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 -RTLTDVRNLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHHHHHTTCCCHH---------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHHHHhcCCCCCC---------CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             01112222222111         1222334567889999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.9e-47  Score=396.74  Aligned_cols=293  Identities=45%  Similarity=0.732  Sum_probs=251.4

Q ss_pred             CCCcccCHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCCh-hhhHHHHHHHHHHHHccccceeeeee
Q 043267          303 SNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK-AGDANFKHEVEIIASVKHVNLVALRG  381 (614)
Q Consensus       303 ~~~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-~~~~~f~~Ei~il~~l~H~niv~l~g  381 (614)
                      .....|++.++...+++|...+.||+|+||.||+|+.++|+.||||++..... .....+.+|++++++++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            34578999999999999999999999999999999988899999999975432 23346899999999999999999999


Q ss_pred             eeecccCCCCceEEEEEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC
Q 043267          382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE  459 (614)
Q Consensus       382 ~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~  459 (614)
                      ++.     .....++||||+++|+|.+++....  ...++|..+..|+.|++.||+|||..+..+|+||||||+|||++.
T Consensus        95 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~  169 (326)
T 3uim_A           95 FCM-----TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDE  169 (326)
T ss_dssp             EEC-----CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECT
T ss_pred             EEe-----cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECC
Confidence            987     5567799999999999999997643  345999999999999999999999433349999999999999999


Q ss_pred             CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccc---ccCccchhh
Q 043267          460 AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEI---IQGKSVLLS  536 (614)
Q Consensus       460 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~---~~~~~~~l~  536 (614)
                      ++.+||+|||+++..............||+.|+|||.+.++.++.++||||||+++|||++|+.||..   .......+.
T Consensus       170 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~  249 (326)
T 3uim_A          170 EFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL  249 (326)
T ss_dssp             TCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHH
T ss_pred             CCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHH
Confidence            99999999999997765555555666799999999999999999999999999999999999999953   223344567


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                      +|..............+..+......+....+.+++..|++.||++|||+.||+++|++.....
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             HHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            7777777777777777777777778888999999999999999999999999999999874443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.3e-46  Score=392.43  Aligned_cols=283  Identities=41%  Similarity=0.684  Sum_probs=243.5

Q ss_pred             ccCHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecc
Q 043267          307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTAT  386 (614)
Q Consensus       307 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~  386 (614)
                      .+.+.++...+++|...+.||+|+||.||+|+.++|+.||||++........+.+.+|+++++.++||||+++++++.  
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--  105 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD--  105 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC--
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc--
Confidence            455566677889999999999999999999998889999999998766667788999999999999999999999986  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                         +++..++||||+++|+|.+++....  ...++|.++++|+.|+++||+|||   +.+|+||||||+|||++.++.+|
T Consensus       106 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~k  179 (321)
T 2qkw_B          106 ---ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPK  179 (321)
T ss_dssp             ---CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEE
T ss_pred             ---CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEE
Confidence               5667899999999999999997643  235999999999999999999999   88999999999999999999999


Q ss_pred             EeecCCceeCCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccC-ccchhhHHHHHH
Q 043267          465 VGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG-KSVLLSDWAWEL  542 (614)
Q Consensus       465 l~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~-~~~~l~~~~~~~  542 (614)
                      |+|||+++...... ........||+.|+|||.+.++.++.++||||||+++|||++|+.||..... .......|....
T Consensus       180 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  259 (321)
T 2qkw_B          180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES  259 (321)
T ss_dssp             ECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH
T ss_pred             EeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc
Confidence            99999998654322 2233445689999999999999999999999999999999999999954332 234456677677


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ...+...+.+++.+......+....+.+++..|++.||++|||+.||++.|+...
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             HTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            7777777777777777677888899999999999999999999999999998764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=389.26  Aligned_cols=265  Identities=25%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~~~  393 (614)
                      ++|...+.||+|+||+||+|+.. +|+.||||+++..  .....+.+.+|+++|++++|||||++++++..... .+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            47999999999999999999964 7999999999753  23345678899999999999999999998764332 24467


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||++ |+|.+++...  ..+++.++..|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeee
Confidence            899999995 7899999653  47999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCC---ccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH------
Q 043267          474 NPEGI---THLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV------  543 (614)
Q Consensus       474 ~~~~~---~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~------  543 (614)
                      .....   ....+..+||+.|||||++.+. .++.++||||+||++|||++|+.||......+  ....+....      
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~--~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVH--QLQLIMMVLGTPSPA  285 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCGG
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCChH
Confidence            54322   2234557899999999998875 56999999999999999999999996433211  100010000      


Q ss_pred             -----HcCCchhhhhccCCCCCc-------HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          544 -----KEGKTLDVIEENMPEMEL-------PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       544 -----~~g~~~~~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ........+ ..++....       +.....+.+++..|++.||++|||+.|+++
T Consensus       286 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          286 VIQAVGAERVRAYI-QSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GTC-----CHHHHH-HSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             Hhhhhhhhhhhhhh-hcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                 000001111 11111000       112346778999999999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-44  Score=385.42  Aligned_cols=200  Identities=27%  Similarity=0.348  Sum_probs=170.2

Q ss_pred             HHhcCccccceecccCceEEEEeEcC----CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ...++|+..+.||+|+||+||+|+.+    .++.||||++....  ....+.+|+++++.+ +||||+++++++.     
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----   90 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFR-----   90 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEE-----
Confidence            35678999999999999999999842    46889999987543  345678999999998 6999999999887     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-CcEEEeec
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVGDF  468 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-~~~kl~DF  468 (614)
                      +.+..++||||+++|+|.+++.     .+++.+...++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+||
T Consensus        91 ~~~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           91 KNDHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             ETTEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             ECCEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            5678999999999999999982     4899999999999999999999   8999999999999999877 79999999


Q ss_pred             CCceeCCCCCc---------------------------cccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHh
Q 043267          469 GLAKFNPEGIT---------------------------HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLS  520 (614)
Q Consensus       469 Gla~~~~~~~~---------------------------~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~Ellt  520 (614)
                      |+|+...+...                           ...+..+||+.|||||++.+. .|+.++||||+||++|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99986543221                           112345799999999999876 58999999999999999999


Q ss_pred             CCCCccccc
Q 043267          521 GKKACEIIQ  529 (614)
Q Consensus       521 G~~p~~~~~  529 (614)
                      |+.||....
T Consensus       243 G~~Pf~~~~  251 (361)
T 4f9c_A          243 GRYPFYKAS  251 (361)
T ss_dssp             TCSSSSCCS
T ss_pred             CCCCCCCCC
Confidence            999995433

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.8e-43  Score=360.82  Aligned_cols=282  Identities=39%  Similarity=0.623  Sum_probs=230.8

Q ss_pred             CCCcccCHHHHHHHhcCcccc------ceecccCceEEEEeEcCCCcEEEEEEeecC----ChhhhHHHHHHHHHHHHcc
Q 043267          303 SNLARFKIEEIKAATMNFSRE------NIIGKGGYGNVYKGMLPNGTEVAVKRFKNC----SKAGDANFKHEVEIIASVK  372 (614)
Q Consensus       303 ~~~~~f~~~el~~~t~~f~~~------~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~----~~~~~~~f~~Ei~il~~l~  372 (614)
                      .....|+++++..++++|...      +.||+|+||.||+|+. +++.||||++...    .....+.+.+|++++++++
T Consensus        10 ~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           10 TRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             -CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            345789999999999999988      8999999999999997 6889999998642    2334567999999999999


Q ss_pred             ccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcC-CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS-GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       373 H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~-~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                      ||||+++++++.     ++...++||||+++|+|.+++... ....++|..++.|+.|+++||.|||   +.+|+|||||
T Consensus        89 h~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlk  160 (307)
T 2nru_A           89 HENLVELLGFSS-----DGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIK  160 (307)
T ss_dssp             CTTBCCEEEEEC-----SSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCC
T ss_pred             CCCeEEEEEEEe-----cCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCC
Confidence            999999999986     556789999999999999999753 3356999999999999999999999   8899999999


Q ss_pred             CCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccC
Q 043267          452 ASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG  530 (614)
Q Consensus       452 p~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  530 (614)
                      |+||++++++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.....
T Consensus       161 p~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          161 SANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            9999999999999999999987654322 23345679999999998764 689999999999999999999999965443


Q ss_pred             ccchhhHHHHHHHHcC-CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          531 KSVLLSDWAWELVKEG-KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .. .+..+........ ...+.++..+. .......+.+.+++..|++.||++|||+.+|++.|+..
T Consensus       240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          240 PQ-LLLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             SS-BTTHHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             hH-HHHHHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            22 2333333332222 23344444443 24566778899999999999999999999999999875

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.3e-44  Score=403.17  Aligned_cols=251  Identities=21%  Similarity=0.274  Sum_probs=209.0

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||.+........+.+.+|+++|+.++|||||++++++.     +....++
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~-----~~~~~~i  231 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM  231 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----CSSEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEE
Confidence            57999999999999999999964 79999999998766666778999999999999999999999987     6678999


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC--CcEEEeecCCceeC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA--FEAKVGDFGLAKFN  474 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~--~~~kl~DFGla~~~  474 (614)
                      |||||++|+|.++|.... ..+++.+...++.||++||+|||   +.+|+||||||+|||++.+  +.+||+|||+++..
T Consensus       232 v~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             EEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             EEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999999996533 46999999999999999999999   8999999999999999854  89999999999987


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ....  .....+||+.|||||++.+..|+.++||||+||++|||++|+.||.......      ....+..+..      
T Consensus       308 ~~~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~------~~~~i~~~~~------  373 (573)
T 3uto_A          308 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDW------  373 (573)
T ss_dssp             CTTS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTTCC------
T ss_pred             cCCC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHhCCC------
Confidence            6543  2344579999999999999999999999999999999999999996433211      1122222211      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .++..........+.+++..|++.||++|||+.|+++
T Consensus       374 ~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             CCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111112233456778899999999999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=3.9e-43  Score=364.13  Aligned_cols=257  Identities=23%  Similarity=0.362  Sum_probs=210.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||+||+++.. +|+.||+|++...+....+.+.+|++++++++||||+++++++.     ++...++
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~l   84 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY-----KDKRLNF   84 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe-----cCCeeEE
Confidence            46888999999999999999964 68999999998777777888999999999999999999999987     5677899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++... ...++|.+++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        85 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           85 ITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            99999999999999764 356999999999999999999999   88999999999999999999999999999986543


Q ss_pred             CCccc-------------cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH
Q 043267          477 GITHL-------------TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       477 ~~~~~-------------~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      .....             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..............    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~----  236 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV----  236 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH----
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh----
Confidence            32211             1245799999999999999999999999999999999999999854333221111001    


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           ....+...+..    ....+.+++..|++.||++|||+.++++.|+..
T Consensus       237 -----~~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          237 -----RGFLDRYCPPN----CPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             -----HHHHHHTCCTT----CCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----hccccccCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 11112222221    123567788899999999999999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=6.9e-43  Score=393.95  Aligned_cols=247  Identities=24%  Similarity=0.298  Sum_probs=196.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHH---HHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHE---VEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...++||+|+||+||+++.. +|+.||||++++..   ........+|   +++++.++|||||++++++.     +
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~-----~  263 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T  263 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE-----E
Confidence            46999999999999999999965 79999999996421   1222333344   56666779999999999987     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....++||||+++|+|.++|...+  .+++.....++.||+.||+|||   +.+||||||||+||||+.+|++||+|||+
T Consensus       264 ~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          264 PDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccce
Confidence            678999999999999999997643  6999999999999999999999   99999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      |+......   ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||........  .. .......+.  
T Consensus       339 A~~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~--~~-i~~~i~~~~--  410 (689)
T 3v5w_A          339 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HE-IDRMTLTMA--  410 (689)
T ss_dssp             CEECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCH--HH-HHHHHHHCC--
T ss_pred             eeecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HH-HHHhhcCCC--
Confidence            98765432   344689999999999975 4799999999999999999999999965433221  11 111111111  


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIV  590 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl  590 (614)
                          ..++    ......+.+++..|++.||++|++     ++||+
T Consensus       411 ----~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~  448 (689)
T 3v5w_A          411 ----VELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK  448 (689)
T ss_dssp             ----CCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHT
T ss_pred             ----CCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHh
Confidence                1122    223446778899999999999998     67775

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.2e-42  Score=355.39  Aligned_cols=250  Identities=22%  Similarity=0.318  Sum_probs=207.2

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||+||+|.. .+|+.||||++........+.+.+|+.++++++||||+++++++.     .++..+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE-----ECCEEE
Confidence            35789999999999999999995 578999999997655556677899999999999999999999987     456789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  167 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (297)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence            999999999999999654   5899999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     .+........+..       
T Consensus       168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~~~~~~~~-------  234 (297)
T 3fxz_A          168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTP-------  234 (297)
T ss_dssp             STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSC-------
T ss_pred             Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC-------
Confidence            4332 23446799999999999999999999999999999999999999954322     1111122222111       


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ...........+.+++..|++.||++|||+.|+++
T Consensus       235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             11112333456788899999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.4e-42  Score=370.57  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=210.2

Q ss_pred             hcCccccceecccCceEEEEeEc--------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML--------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTAT  386 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~  386 (614)
                      .++|...+.||+|+||.||+|+.        .++..||||+++.. .....+++.+|+++++++ +||||+++++++.  
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC--
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc--
Confidence            35788999999999999999984        24567999999754 334456799999999999 8999999999986  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                         +....++||||+++|+|.+++....              ...+++.++++++.|+++||+|||   +.+|+||||||
T Consensus       158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp  231 (370)
T 2psq_A          158 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  231 (370)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCG
T ss_pred             ---cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccch
Confidence               5567899999999999999997643              245899999999999999999999   88999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~  530 (614)
                      +|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~  311 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  311 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999986654322 23344567889999999999999999999999999999999 9999864332


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..      ....+..+...         ..+......+.+++..||+.||++|||+.|+++.|+..
T Consensus       312 ~~------~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          312 EE------LFKLLKEGHRM---------DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             GG------HHHHHHTTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH------HHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11      12233333221         11223344677889999999999999999999999875

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.3e-42  Score=352.09  Aligned_cols=258  Identities=26%  Similarity=0.389  Sum_probs=212.6

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|...+.||+|+||.||++..+++..||||+++... ...+++.+|++++++++||||+++++++.     ++...++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   80 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS-----KEYPIYI   80 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCceEE
Confidence            45788999999999999999999888899999997643 23567899999999999999999999986     5667899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++.... ..+++..++.|+.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             EEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             EEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999999999999997642 46999999999999999999999   88999999999999999999999999999987765


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......     + ....+..+...      
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~-----~-~~~~~~~~~~~------  224 (268)
T 3sxs_A          157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS-----E-VVLKVSQGHRL------  224 (268)
T ss_dssp             TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH-----H-HHHHHHTTCCC------
T ss_pred             hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH-----H-HHHHHHcCCCC------
Confidence            54444445567788999999999999999999999999999999 99998643321     1 11122222110      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCC
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL  599 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  599 (614)
                         ..+......+.+++..|++.||++|||+.|+++.|+...+.
T Consensus       225 ---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          225 ---YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence               01111234577889999999999999999999999987543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5.4e-43  Score=366.85  Aligned_cols=259  Identities=28%  Similarity=0.413  Sum_probs=208.3

Q ss_pred             cCccccceecccCceEEEEeEcC----CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||.||+|+..    .+..||||+++.. .....+.+.+|++++++++||||+++++++.     ++.
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  123 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT-----RGR  123 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----GGG
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            46888899999999999999974    3456999999754 4445678999999999999999999999986     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++.... ..+++.+++.|+.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  199 (325)
T 3kul_A          124 LAMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSR  199 (325)
T ss_dssp             CCEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             ccEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence            7899999999999999996543 46999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          473 FNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......      ....+..+.. 
T Consensus       200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~-  272 (325)
T 3kul_A          200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD------VISSVEEGYR-  272 (325)
T ss_dssp             ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCC-
T ss_pred             ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHHcCCC-
Confidence            76543322  2333456788999999999999999999999999999999 999996433211      1122222211 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                              ..........+.+++..|++.||++|||+.||+++|+.....+
T Consensus       273 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          273 --------LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             --------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             --------CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence                    1112233456788999999999999999999999999875433

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.2e-42  Score=355.70  Aligned_cols=266  Identities=27%  Similarity=0.373  Sum_probs=206.2

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHH--ccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIAS--VKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~--l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+. +|+.||||++...   ....+..|.+++..  ++||||+++++++..... .....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~-~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRH-SSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET-TEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC-CCcee
Confidence            46799999999999999999998 7899999998653   34556778888777  799999999998764321 34568


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcC-----CCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV-----QPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~-----~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      ++||||+++|+|.+++..   ..+++..+++|+.|+++||+|||...     +.+|+||||||+|||++.++.+||+|||
T Consensus        82 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  158 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG  158 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCC
Confidence            999999999999999943   46999999999999999999999432     6799999999999999999999999999


Q ss_pred             CceeCCCCCccc---cccccCCCCcCchhhhccC------CCCchhhHHHHHHHHHHHHhC----------CCCcccccC
Q 043267          470 LAKFNPEGITHL---TTRVAGTLGYVAPEYALYG------KLTPGSDVYSFGVVLLELLSG----------KKACEIIQG  530 (614)
Q Consensus       470 la~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~------~~t~ksDVwS~Gvll~ElltG----------~~p~~~~~~  530 (614)
                      +++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.||.....
T Consensus       159 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~  238 (301)
T 3q4u_A          159 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP  238 (301)
T ss_dssp             TCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred             CeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence            998654433221   2335799999999999877      455799999999999999999          777754333


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEM-ELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ...............+.     .+.++.. ........+.+++..||+.||++|||+.||+++|++
T Consensus       239 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          239 NDPSFEDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             SSCCHHHHHHHHTTSCC-----CCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcchhhhhHHHhccCC-----CCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            22222222111111111     1111111 123456788999999999999999999999999986

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=7.9e-43  Score=363.22  Aligned_cols=262  Identities=29%  Similarity=0.430  Sum_probs=203.0

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      +....++|+..+.||+|+||.||+|+. +|+.||||++....  ....+++.+|++++++++||||+++++++.     +
T Consensus        32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~  105 (309)
T 3p86_A           32 MDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT-----Q  105 (309)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             ccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----E
Confidence            334456899999999999999999987 68899999987543  344567899999999999999999999986     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEECCCCcEEEee
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                      ....++||||+++|+|.+++.... ...+++..++.|+.|+++||+|||   +.+  |+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~D  182 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCD  182 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECC
Confidence            567899999999999999997643 234999999999999999999999   788  99999999999999999999999


Q ss_pred             cCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          468 FGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       468 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      ||+++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +..........
T Consensus       183 fg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~-----~~~~~~~~~~~  256 (309)
T 3p86_A          183 FGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-----QVVAAVGFKCK  256 (309)
T ss_dssp             CC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHHHHSCC
T ss_pred             CCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCC
Confidence            99998544322 1234467999999999999999999999999999999999999999643321     11111111111


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      ..     .+    +......+.+++..|++.||++|||+.++++.|+....
T Consensus       257 ~~-----~~----~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          257 RL-----EI----PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CC-----CC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CC-----CC----CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            11     11    12233467788999999999999999999999988754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=8.9e-43  Score=386.38  Aligned_cols=265  Identities=27%  Similarity=0.379  Sum_probs=219.3

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ...+|...+.||+|+||.||+|++. ++..||||+++... ...++|.+|++++++++||||+++++++.     .+...
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~  291 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF  291 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSC
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcE
Confidence            3457888999999999999999976 48899999997643 34678999999999999999999999986     55678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++.......+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999998766678999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ............+|+.|+|||.+.++.++.++||||||+++|||++ |+.||.......      +.+.+..+..     
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~~~-----  437 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKDYR-----  437 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTTCC-----
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCC-----
Confidence            5443333344557789999999999999999999999999999999 999986443211      2223332211     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCCchh
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIKI  604 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p~  604 (614)
                          ...+......+.+++..||+.||++|||+.+|+++|+.......+.-
T Consensus       438 ----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~~~~~~  484 (495)
T 1opk_A          438 ----MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD  484 (495)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSSSCHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhccccch
Confidence                11122334567788899999999999999999999999876655443

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1e-42  Score=363.95  Aligned_cols=266  Identities=29%  Similarity=0.325  Sum_probs=206.8

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|...+.||+|+||.||+|+.. ++.||||++.... .....+..|+.++++++||||+++++++..... .....++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence            357899999999999999999974 7999999997533 334456678999999999999999999875322 2456799


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC----------ceEEeccCCCCeEECCCCcEEEe
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP----------AIIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~----------~iiHrDIKp~NILLd~~~~~kl~  466 (614)
                      ||||+++|+|.+++...   .++|..++.|+.|+++||+|||   +.          +|+||||||+|||++.++.+||+
T Consensus       100 v~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence            99999999999999653   4999999999999999999999   77          99999999999999999999999


Q ss_pred             ecCCceeCCCCCcc-ccccccCCCCcCchhhhccC-----CCCchhhHHHHHHHHHHHHhCCCCcccccCccc-hh----
Q 043267          467 DFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYG-----KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV-LL----  535 (614)
Q Consensus       467 DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~-----~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~l----  535 (614)
                      |||+++........ ......||+.|+|||.+.+.     .++.++||||||+++|||++|+.||........ ..    
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999866543322 23446799999999999863     566789999999999999999999964332211 11    


Q ss_pred             ------hHHHHHHHHcCCchhhhhccCCCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          536 ------SDWAWELVKEGKTLDVIEENMPEM-ELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       536 ------~~~~~~~~~~g~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                            .++. .....+..    .+.++.. ........+.+++..||+.||++|||+.||++.|+..
T Consensus       254 ~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          254 GQHPSLEDMQ-EVVVHKKK----RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             CSSCCHHHHH-HHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCchhhhh-hhhhcccC----CCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  1111 11111111    1111110 1124456789999999999999999999999999864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-43  Score=354.65  Aligned_cols=254  Identities=26%  Similarity=0.383  Sum_probs=210.0

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...+.||+|+||.||+++..+++.||||++.... ...+++.+|++++++++||||+++++++.     ++...++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   83 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV   83 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCceEEE
Confidence            4688889999999999999999889999999997643 33467999999999999999999999986     55678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.... ..+++..++.|+.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  159 (269)
T 4hcu_A           84 FEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  159 (269)
T ss_dssp             EECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence            99999999999996543 46999999999999999999999   889999999999999999999999999999866544


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......     + ....+..+.         
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~-----~-~~~~~~~~~---------  224 (269)
T 4hcu_A          160 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS-----E-VVEDISTGF---------  224 (269)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H-HHHHHHTTC---------
T ss_pred             ccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH-----H-HHHHHhcCc---------
Confidence            3333445567889999999999999999999999999999999 99998643321     1 112222221         


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ....+......+.+++..|++.||++|||+.|+++.|+..
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            1111122234677888999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-43  Score=385.38  Aligned_cols=259  Identities=26%  Similarity=0.421  Sum_probs=213.9

Q ss_pred             HHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      +...++|...+.||+|+||.||+|+.+++..||||+++... ...++|.+|++++++++||||+++++++.      ...
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~  256 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEP  256 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSS
T ss_pred             eechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCc
Confidence            34456789999999999999999999889999999998643 34678999999999999999999999984      345


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++.......+++..+++|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            799999999999999997655457899999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .............+|..|+|||.+..+.++.++||||||+++|||++ |+.||......     + +...+..+...   
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~-----~-~~~~i~~~~~~---  404 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP-----E-VIRALERGYRM---  404 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----H-HHHHHHHTCCC---
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH-----H-HHHHHHcCCCC---
Confidence            65432222334456889999999999999999999999999999999 99999643321     1 11222222111   


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                          +  .+......+.+++..||+.||++|||+++|+++|+...
T Consensus       405 ----~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          405 ----P--RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             ----C--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ----C--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                1  12223456778899999999999999999999999874

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.2e-42  Score=358.18  Aligned_cols=261  Identities=22%  Similarity=0.276  Sum_probs=214.5

Q ss_pred             cccCHHHHHHHhcC----------ccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHcccc
Q 043267          306 ARFKIEEIKAATMN----------FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV  374 (614)
Q Consensus       306 ~~f~~~el~~~t~~----------f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~  374 (614)
                      ..+++++++.+++.          |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|++++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            46888898888875          777789999999999999976 7999999999876666677899999999999999


Q ss_pred             ceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCC
Q 043267          375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN  454 (614)
Q Consensus       375 niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~N  454 (614)
                      ||+++++++.     .+...++||||+++|+|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+|
T Consensus       103 niv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~N  171 (321)
T 2c30_A          103 NVVEMYKSYL-----VGEELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDS  171 (321)
T ss_dssp             TBCCEEEEEE-----ETTEEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGG
T ss_pred             CcceEEEEEE-----ECCEEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHH
Confidence            9999999987     45678999999999999999854   36999999999999999999999   8899999999999


Q ss_pred             eEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch
Q 043267          455 ILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL  534 (614)
Q Consensus       455 ILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~  534 (614)
                      ||++.++.+||+|||+++....... ......||+.|+|||++.++.++.++||||||+++|||++|+.||.....    
T Consensus       172 Ill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----  246 (321)
T 2c30_A          172 ILLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----  246 (321)
T ss_dssp             EEECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----
T ss_pred             EEECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----
Confidence            9999999999999999987654322 23456799999999999999999999999999999999999999964321    


Q ss_pred             hhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          535 LSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       535 l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       .+ ....+..+..     +.+.  ........+.+++..|++.||++|||+.|+++
T Consensus       247 -~~-~~~~~~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          247 -VQ-AMKRLRDSPP-----PKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             -HH-HHHHHHHSSC-----CCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HH-HHHHHhcCCC-----CCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             11 1122222111     1111  11223446778889999999999999999986

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.6e-43  Score=362.58  Aligned_cols=263  Identities=25%  Similarity=0.372  Sum_probs=206.6

Q ss_pred             cCccccceecccCceEEEEeEc-----CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|+..+.||+|+||.||++++     .+|+.||||++........+.+.+|++++++++||||+++++++...   +..
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   86 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   86 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH---HHT
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC---CCC
Confidence            5788899999999999999983     36889999999877777778899999999999999999999988542   234


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++.... ..+++..++.|+.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            5799999999999999997643 46999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCc----------cchhhHHHH
Q 043267          473 FNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK----------SVLLSDWAW  540 (614)
Q Consensus       473 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~----------~~~l~~~~~  540 (614)
                      ........  ......+|..|+|||.+.+..++.++||||||+++|||++|..|+......          .........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            76543221  223345778899999999999999999999999999999999987432210          000111111


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      +....+.         ....+......+.+++..||+.||++|||+.|+++.|+..
T Consensus       243 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          243 ELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccC---------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            2222221         1112223345678899999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.7e-43  Score=374.80  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=197.3

Q ss_pred             cCccccceecccCceEEEEeEcC----CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||.||+|+..    ++..||||+++.. .....++|.+|++++++++||||+++++++.     ++.
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~  119 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----KSK  119 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCC
Confidence            47889999999999999999864    5778999999754 3445678999999999999999999999986     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++... ...+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       120 ~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  195 (373)
T 2qol_A          120 PVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGR  195 (373)
T ss_dssp             SCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             ceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence            789999999999999999754 346999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccc--cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          473 FNPEGITHL--TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      .........  .....+|+.|+|||++.++.++.++||||||+++|||++ |+.||......     + ....+..+.. 
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~-----~-~~~~i~~~~~-  268 (373)
T 2qol_A          196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ-----D-VIKAVDEGYR-  268 (373)
T ss_dssp             ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH-----H-HHHHHHTTEE-
T ss_pred             ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH-----H-HHHHHHcCCC-
Confidence            765432221  222345788999999999999999999999999999998 99999643321     1 1122222211 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                            .  .........+.+++..|++.||++||++.+|+++|+...
T Consensus       269 ------~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~  308 (373)
T 2qol_A          269 ------L--PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLI  308 (373)
T ss_dssp             ------C--CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------C--CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHH
Confidence                  1  112233456788999999999999999999999998763

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.2e-42  Score=367.39  Aligned_cols=269  Identities=25%  Similarity=0.331  Sum_probs=215.4

Q ss_pred             ccCHHHHHHHhcCccccceecccCceEEEEeEc------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceee
Q 043267          307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVA  378 (614)
Q Consensus       307 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~  378 (614)
                      .+...+.+...++|...+.||+|+||.||+|++      .+++.||||+++.. .....+.+.+|++++.++ +||||++
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~   90 (359)
T 3vhe_A           11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   90 (359)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence            345556666778999999999999999999973      35689999999764 334456799999999999 8999999


Q ss_pred             eeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCC-------------------------------------------
Q 043267          379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM-------------------------------------------  415 (614)
Q Consensus       379 l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~-------------------------------------------  415 (614)
                      +++++..    .+...++||||+++|+|.+++.....                                           
T Consensus        91 ~~~~~~~----~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (359)
T 3vhe_A           91 LLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSG  166 (359)
T ss_dssp             EEEEECS----TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------
T ss_pred             eeeeeec----CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccc
Confidence            9999863    34458999999999999999976432                                           


Q ss_pred             ---------------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          416 ---------------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       416 ---------------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                                           ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  243 (359)
T 3vhe_A          167 FVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDI  243 (359)
T ss_dssp             -----------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCT
T ss_pred             cccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeee
Confidence                                 12899999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          475 PEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       475 ~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......     +.....+..+....  
T Consensus       244 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-----~~~~~~~~~~~~~~--  316 (359)
T 3vhe_A          244 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-----EEFCRRLKEGTRMR--  316 (359)
T ss_dssp             TSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS-----HHHHHHHHHTCCCC--
T ss_pred             cccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh-----HHHHHHHHcCCCCC--
Confidence            43322 23345668999999999999999999999999999999998 99999644322     12223333332211  


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                         .    +......+.+++..|++.||++|||+.|+++.|+..
T Consensus       317 ---~----~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          317 ---A----PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             ---C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C----CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence               1    122234577888999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-42  Score=352.88  Aligned_cols=256  Identities=23%  Similarity=0.363  Sum_probs=207.9

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|...+.||+|+||.||++...++..||||+++.... ..+++.+|++++++++|+||+++++++.     ++...++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   96 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFI   96 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSEEE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEe-----cCCCeEE
Confidence            457889999999999999999998888999999986432 3467899999999999999999999986     5677899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++... ...+++.+++.|+.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus        97 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           97 ITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             EECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             EEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            99999999999999653 246999999999999999999999   88999999999999999999999999999986654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||......      .....+..+..       
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~~~-------  239 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQGLR-------  239 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTTCC-------
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhcccC-------
Confidence            33333344567889999999999999999999999999999998 99998643321      11122222211       


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                        ...+......+.+++..|++.+|++|||+.|+++.|+...
T Consensus       240 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~  279 (283)
T 3gen_A          240 --LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVM  279 (283)
T ss_dssp             --CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHh
Confidence              1111222346778899999999999999999999998653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-42  Score=379.96  Aligned_cols=257  Identities=30%  Similarity=0.449  Sum_probs=206.3

Q ss_pred             HhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ..++|...+.||+|+||.||+|+++++..||||+++... ...++|.+|++++++++||||+++++++.      .+..+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~------~~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc------CCceE
Confidence            446788899999999999999999888899999998643 34567999999999999999999999985      24579


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.+++.......+++.+++.|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            9999999999999997654456999999999999999999999   8899999999999999999999999999998765


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ...........+|..|+|||.+.++.++.++||||||+++|||++ |+.||......      -+...+..+...     
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~~-----  400 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYRM-----  400 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCC-----
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC-----
Confidence            433333334557889999999999999999999999999999999 99998643321      112233333211     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                          ..+....+.+.+++..||+.||++|||+++++++|+...
T Consensus       401 ----~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          401 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ----CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence                112233456778899999999999999999999999864

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-42  Score=353.29  Aligned_cols=255  Identities=28%  Similarity=0.428  Sum_probs=210.5

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|...+.||+|+||.||+|+..++..||||.++... ...+.+.+|++++++++||||+++++++.      .+..++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   84 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYI   84 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc------CCCcEE
Confidence            35788899999999999999998888899999997543 34567999999999999999999999874      345799


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++++|.+++.......+++..+++++.|+++||+|||   +.+|+||||||+||++++++.+||+|||+++....
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            999999999999997644447999999999999999999999   88999999999999999999999999999987665


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..........+|..|+|||.+.++.++.++||||||+++|||++ |+.||......     + ....+..+..       
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~-----~-~~~~~~~~~~-------  228 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----E-VIQNLERGYR-------  228 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H-HHHHHHTTCC-------
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH-----H-HHHHHhcccC-------
Confidence            44333445567889999999999999999999999999999999 89998643221     1 1122222211       


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                        ..........+.+++..|++.||++|||+.+++++|+..
T Consensus       229 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          229 --MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              111122335677889999999999999999999999875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.3e-42  Score=373.68  Aligned_cols=251  Identities=31%  Similarity=0.396  Sum_probs=207.5

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|...+.||+|+||.||+|.. .|+.||||+++...  ..+.|.+|++++++++||||+++++++..    .....++
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~~i  264 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI  264 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEEC----TTSCEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEc----CCCceEE
Confidence            45788889999999999999998 47899999997643  45689999999999999999999999863    3346899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++...+...+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++....
T Consensus       265 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999998766566899999999999999999999   88999999999999999999999999999985433


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .    .....+|..|+|||.+.++.++.++||||||+++|||++ |+.||......+      +...+..+....     
T Consensus       342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~~~~i~~~~~~~-----  406 (450)
T 1k9a_A          342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYKMD-----  406 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------HHHHHHTTCCCC-----
T ss_pred             c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCCC-----
Confidence            2    122357889999999999999999999999999999999 999996544322      112333332211     


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          .+......+.+++..||+.||++|||+.++++.|+..
T Consensus       407 ----~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          407 ----APDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                1122345677888999999999999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-42  Score=371.64  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=207.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||.++... ....++|.+|++++++++||||+++++++.     .+...
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~  187 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPI  187 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSSSC
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCCCc
Confidence            357888999999999999999976 78999999997542 333457889999999999999999999986     45678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++...+ ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       188 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            99999999999999997532 46999999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCcccc-ccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          475 PEGITHLT-TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       475 ~~~~~~~~-~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ........ ....++..|+|||.+.++.++.++||||||+++|||++ |+.||.....      ..+.+.+..+....  
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~------~~~~~~~~~~~~~~--  335 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN------QQTREFVEKGGRLP--  335 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH------HHHHHHHHTTCCCC--
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHHcCCCCC--
Confidence            44322111 12235778999999999999999999999999999998 9999864432      11223333332111  


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                         .    +......+.+++..||+.||++|||+.++++.|+..
T Consensus       336 ---~----~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          336 ---C----PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             ---C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence               1    112234677888999999999999999999999864

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.7e-42  Score=354.60  Aligned_cols=258  Identities=27%  Similarity=0.391  Sum_probs=215.2

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ..++|...+.||+|+||.||+|+.. ++..||||.+... ....+.+.+|++++++++||||+++++++.     ++...
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   84 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPF   84 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCE
Confidence            4567899999999999999999976 5889999999753 334577999999999999999999999986     56678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++.......+++..++.|+.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            99999999999999998877778999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ............+|+.|+|||.+.+..++.++||||+|+++|||++ |+.|+.......      ..+.+..+       
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~------~~~~~~~~-------  228 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELLEKD-------  228 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HHHHHHTT-------
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcc-------
Confidence            6544444445567889999999999999999999999999999999 999986433211      11222222       


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                        .....+......+.+++..|++.||++|||+.|++++|+...
T Consensus       229 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          229 --YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence              111112233456788899999999999999999999998764

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=2.4e-42  Score=361.19  Aligned_cols=272  Identities=25%  Similarity=0.336  Sum_probs=213.7

Q ss_pred             cCccccceecccCceEEEEeEc-----CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||.||++++     .+++.||||++........+.+.+|++++++++|+||+++++++...   +..
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~   99 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGP---GRQ   99 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS---SSC
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC---CCc
Confidence            4788899999999999999983     46889999999877766777899999999999999999999987632   456


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++.... ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          100 SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            7899999999999999997633 36999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          473 FNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       473 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ........  ......||..|+|||.+.+..++.++||||||+++|||++|+.|+............+...........+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE  255 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence            76544322  2344568889999999999999999999999999999999999985322110000000000000000111


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .+...............+.+++..|++.||++|||+.|+++.|+..
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            2222222222334455778899999999999999999999999876

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-42  Score=361.71  Aligned_cols=254  Identities=24%  Similarity=0.386  Sum_probs=199.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCc----EEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGT----EVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|+..+.||+|+||+||+|+.. +|+    +||+|.+... +....+++.+|++++++++||||+++++++..      
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~------   88 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   88 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEES------
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec------
Confidence            46888999999999999999954 444    3688888643 33456789999999999999999999999862      


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++|+||+++|+|.+++.... ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++++||+|||++
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a  164 (327)
T 3poz_A           89 STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred             CCeEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcce
Confidence            34789999999999999997643 56999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +....... .......+|+.|+|||.+.++.++.++||||||+++|||++ |+.||.......      ....+..+.. 
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~~~~~~~-  237 (327)
T 3poz_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGER-  237 (327)
T ss_dssp             HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC-
T ss_pred             eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH------HHHHHHcCCC-
Confidence            86544322 22334567889999999999999999999999999999999 999996443221      1122222221 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                              ..........+.+++..||+.||++|||+.|+++.|+..
T Consensus       238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          238 --------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             --------CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                    111223345678899999999999999999999999764

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.5e-42  Score=356.53  Aligned_cols=268  Identities=28%  Similarity=0.349  Sum_probs=209.0

Q ss_pred             ccccceecccCceEEEEeEc-----CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          320 FSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      |...+.||+|+||.||++..     .+|+.||||+++... ....+.+.+|++++++++||||+++++++...   ....
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~  109 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---GAAS  109 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---TTTE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---CCce
Confidence            48889999999999988763     268899999997643 34467799999999999999999999998742   3467


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...   .+++..++.|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            89999999999999999654   4999999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          474 NPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       474 ~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      .......  ......||..|+|||.+.+..++.++||||||+++|||++|+.|+............+...........+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            6654322  23445688899999999999999999999999999999999999854322111110010011111112222


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ++..............+.+++..|++.||++|||+.|++++|+..
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            222222222334456788899999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-41  Score=352.45  Aligned_cols=257  Identities=26%  Similarity=0.353  Sum_probs=210.8

Q ss_pred             hcCccccceecccCceEEEEeEc------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      .++|...+.||+|+||.||+++.      .+++.||||+++.. .....+.+.+|++++++++||||+++++++.     
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----   96 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS-----   96 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe-----
Confidence            45788999999999999999985      34588999999753 3445577899999999999999999999986     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCC----------------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEE
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGM----------------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIH  447 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~----------------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiH  447 (614)
                      +....++||||+++|+|.+++.....                      ..+++.++++|+.|+++||+|||   +.+|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcc
Confidence            55678999999999999999976432                      34899999999999999999999   889999


Q ss_pred             eccCCCCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCc
Q 043267          448 RDIKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKAC  525 (614)
Q Consensus       448 rDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~  525 (614)
                      |||||+|||+++++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999876543322 2334567889999999999999999999999999999999 99998


Q ss_pred             ccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          526 EIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       526 ~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .......      ....+..+...         .........+.+++..|++.||++|||+.|+++.|+..
T Consensus       254 ~~~~~~~------~~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          254 PGIPPER------LFNLLKTGHRM---------ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             TTCCGGG------HHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHH------HHHHhhcCCcC---------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            6443211      22333333211         11223345678899999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-42  Score=361.19  Aligned_cols=265  Identities=27%  Similarity=0.394  Sum_probs=212.9

Q ss_pred             HHHHHhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeee
Q 043267          312 EIKAATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYST  384 (614)
Q Consensus       312 el~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~  384 (614)
                      ++....++|...+.||+|+||.||+|+..      +++.||||+++.. .....+.+.+|++++++++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            33445678999999999999999999964      3488999999754 3344577999999999999999999999986


Q ss_pred             cccCCCCceEEEEEeecCCCChhhhhhcCC----------------------CcCCChHHHHHHHHHHHHHHHHHhhcCC
Q 043267          385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSG----------------------MKKLSWPIRLRIALGTARGLAYLHYGVQ  442 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~----------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~  442 (614)
                           ++...++||||+++|+|.+++....                      ...+++.+++.|+.|+++||.|||   +
T Consensus       121 -----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~  192 (343)
T 1luf_A          121 -----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---E  192 (343)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---H
T ss_pred             -----cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---h
Confidence                 5667899999999999999997632                      257999999999999999999999   8


Q ss_pred             CceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-
Q 043267          443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-  520 (614)
Q Consensus       443 ~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-  520 (614)
                      .+|+||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||++ 
T Consensus       193 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          193 RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred             CCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence            8999999999999999999999999999975433221 22334568899999999999999999999999999999999 


Q ss_pred             CCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCC
Q 043267          521 GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL  599 (614)
Q Consensus       521 G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  599 (614)
                      |+.||.....      ......+..+....     .+    ......+.+++..|++.||++|||+.++++.|+...+.
T Consensus       273 g~~p~~~~~~------~~~~~~~~~~~~~~-----~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          273 GLQPYYGMAH------EEVIYYVRDGNILA-----CP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             TCCTTTTSCH------HHHHHHHHTTCCCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             CCCcCCCCCh------HHHHHHHhCCCcCC-----CC----CCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence            9999864332      11223333332211     11    22334677889999999999999999999999987543

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.6e-42  Score=352.74  Aligned_cols=261  Identities=23%  Similarity=0.297  Sum_probs=205.5

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|++++++++||||+++++++.     +++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDE-----EDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE-----CSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeee-----eCC
Confidence            357899999999999999999964 7899999998642   2334567899999999999999999999986     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...+  .+++..++.++.|+++||+|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  159 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAK  159 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSST
T ss_pred             eEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcc
Confidence            8899999999999999997643  6999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..............||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     .+......... .... 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~-~~~~-  232 (294)
T 4eqm_A          160 ALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA-----VSIAIKHIQDS-VPNV-  232 (294)
T ss_dssp             TC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH-----HHHHHHHHSSC-CCCH-
T ss_pred             ccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhhcc-CCCc-
Confidence            6654433344556799999999999999999999999999999999999999964332     11122222221 1111 


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhccCC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARP-TMDQIVKILETDVP  598 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~~~~  598 (614)
                      .....    .+....+.+++..|++.||++|| +++++.+.|+....
T Consensus       233 ~~~~~----~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          233 TTDVR----KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             HHHSC----TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             chhcc----cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            11111    12234677888999999999998 99999999988654

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.4e-41  Score=357.20  Aligned_cols=247  Identities=27%  Similarity=0.338  Sum_probs=204.4

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...  +....+.+.+|+++++.++||||+++++++.     ....
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~   88 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIE-----TEKT   88 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCE
Confidence            45799999999999999999996 58999999999753  3445567889999999999999999999986     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...+  .+++..+..++.|+++||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           89 LYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            899999999999999997643  6999999999999999999999   88999999999999999999999999999976


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLT-PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ...+.  ......||+.|+|||.+.+..++ .++||||+|+++|||++|+.||.....     .+. ...+..+..    
T Consensus       164 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~-~~~i~~~~~----  231 (328)
T 3fe3_A          164 FTVGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KEL-RERVLRGKY----  231 (328)
T ss_dssp             GSSSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH-HHHHHHCCC----
T ss_pred             cCCCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHH-HHHHHhCCC----
Confidence            54432  23456799999999999988875 799999999999999999999964321     111 122222211    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        .++.    .....+.+++..|++.||.+|||++|+++
T Consensus       232 --~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          232 --RIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             --CCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             --CCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence              1121    22345678889999999999999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=363.52  Aligned_cols=257  Identities=28%  Similarity=0.381  Sum_probs=210.4

Q ss_pred             hcCccccceecccCceEEEEeEc--------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML--------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTAT  386 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~  386 (614)
                      .++|...+.||+|+||.||+|+.        .++..||||+++.. ......++.+|+++++++ +||||+++++++.  
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec--
Confidence            45788999999999999999984        23467999999754 344457899999999999 9999999999987  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                         .+...++||||+++|+|.+++....              ...+++.++++|+.|+++||+|||   +.+|+||||||
T Consensus       146 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  219 (382)
T 3tt0_A          146 ---QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAA  219 (382)
T ss_dssp             ---SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCG
T ss_pred             ---cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCc
Confidence               5567899999999999999997643              245999999999999999999999   88999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~  530 (614)
                      +|||+++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~  299 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  299 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999986554322 23344567899999999999999999999999999999999 9999864321


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                            ....+.+..+....         ........+.+++..||+.||++|||+.||++.|+..
T Consensus       300 ------~~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          300 ------EELFKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             ------HHHHHHHHTTCCCC---------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------HHHHHHHHcCCCCC---------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                  11223333332211         1122344677889999999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-41  Score=348.29  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=195.8

Q ss_pred             hcCccccceecccCceEEEEeEcCC----CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|...+.||+|+||.||+|+...    +..||||+++.. .....+.+.+|+.++++++||||+++++++.      +
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   87 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------E   87 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------S
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc------c
Confidence            3578899999999999999998642    457999998753 3444567999999999999999999999873      3


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +..++||||+++|+|.+++... ...+++..++.++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccc
Confidence            4578999999999999999754 346999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      +..............+|+.|+|||.+....++.++||||||+++|||++ |+.||.......      ....+..+... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~~~~i~~~~~~-  236 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERL-  236 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCC-
T ss_pred             cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------HHHHHHcCCCC-
Confidence            8765443333344567889999999999999999999999999999997 999986443221      11222222211 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          .+    .......+.+++..|++.||++|||+.|+++.|+..
T Consensus       237 ----~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          237 ----PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                11    122345677889999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9.4e-42  Score=344.95  Aligned_cols=254  Identities=26%  Similarity=0.386  Sum_probs=209.1

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...+.||+|+||.||+++..+++.||+|++..... ..+++.+|++++++++||||+++++++.     ++...++|
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   81 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV   81 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEEE
Confidence            57888999999999999999988899999999976432 3467999999999999999999999986     45678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.... ..+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  157 (267)
T 3t9t_A           82 TEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  157 (267)
T ss_dssp             ECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred             EeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence            99999999999997643 46899999999999999999999   889999999999999999999999999999865443


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........+|..|+|||.+.+..++.++||||+|+++|||++ |+.||.....     .+ ....+..+..        
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~-~~~~i~~~~~--------  223 (267)
T 3t9t_A          158 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SE-VVEDISTGFR--------  223 (267)
T ss_dssp             HHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH-HHHHHHTTCC--------
T ss_pred             cccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HH-HHHHHhcCCc--------
Confidence            2223344567889999999999999999999999999999999 8999864321     11 1122222211        


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       ...+......+.+++..|++.||++|||+.++++.|+..
T Consensus       224 -~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          224 -LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             111122234677889999999999999999999999874

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.7e-42  Score=354.55  Aligned_cols=263  Identities=26%  Similarity=0.363  Sum_probs=206.6

Q ss_pred             cCccccceecccCceEEEEeEc-----CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      +.|+..+.||+|+||.||++++     .+|+.||||++... .....+.+.+|++++++++||||+++++++...   ..
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            3588889999999999999983     46899999999743 333457789999999999999999999998742   23


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++|+|.+++.... ..+++..++.|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             ceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence            56899999999999999996543 46999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccC---------ccchhhHHHH
Q 043267          472 KFNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG---------KSVLLSDWAW  540 (614)
Q Consensus       472 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~---------~~~~l~~~~~  540 (614)
                      +.......  .......||..|+|||.+.+..++.++||||+|+++|||++|+.|+.....         ..........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87655432  233445688899999999999999999999999999999999998642210         0000011111


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..+..+.         ....+......+.+++..|++.||++|||+.|++++|+..
T Consensus       254 ~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          254 NTLKEGK---------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHHHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccC---------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            1122211         1112233345678899999999999999999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-41  Score=350.56  Aligned_cols=259  Identities=26%  Similarity=0.369  Sum_probs=210.9

Q ss_pred             hcCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVP  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~  388 (614)
                      .++|...+.||+|+||.||+|+.      .+++.||||+++... ....+.+.+|+++++++ +||||+++++++.    
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   97 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT----   97 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe----
Confidence            45788999999999999999984      357899999997543 34457799999999999 9999999999986    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCC----------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGM----------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~----------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                       .++..++||||+++|+|.+++.....                ..+++..+++++.|+++||.|||   +.+|+||||||
T Consensus        98 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp  173 (313)
T 1t46_A           98 -IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA  173 (313)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             -cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCcc
Confidence             55678999999999999999976542                25999999999999999999999   88999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~  530 (614)
                      +|||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  253 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence            9999999999999999999866544332 2334557889999999999999999999999999999999 9999864432


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ..     ........+..         ..........+.+++..|++.||++|||+.|+++.|++..
T Consensus       254 ~~-----~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          254 DS-----KFYKMIKEGFR---------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             SH-----HHHHHHHHTCC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hh-----HHHHHhccCCC---------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            11     12222222211         1111223456788899999999999999999999998764

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.2e-41  Score=357.69  Aligned_cols=270  Identities=17%  Similarity=0.176  Sum_probs=207.4

Q ss_pred             HhcCccccceecccCceEEEEeEcCC------CcEEEEEEeecCChhhh-----------HHHHHHHHHHHHccccceee
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-----------ANFKHEVEIIASVKHVNLVA  378 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~~~~~~-----------~~f~~Ei~il~~l~H~niv~  378 (614)
                      ..++|...+.||+|+||.||+|.+.+      ++.||||++........           ..+..|+..++.++|+||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            35589999999999999999998754      47899999876432211           12334555667778999999


Q ss_pred             eeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       379 l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      +++++..... .....++||||+ +|+|.+++... ...+++.+++.|+.|++.||+|||   +.+|+||||||+|||++
T Consensus       113 ~~~~~~~~~~-~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKN-GKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEET-TEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEE
T ss_pred             EEeeeeeccC-CcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEe
Confidence            9999875321 235689999999 99999999764 357999999999999999999999   88999999999999999


Q ss_pred             --CCCcEEEeecCCceeCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccC
Q 043267          459 --EAFEAKVGDFGLAKFNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG  530 (614)
Q Consensus       459 --~~~~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  530 (614)
                        .++.+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8999999999999865433221      11335599999999999999999999999999999999999999975433


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ... ...+..... .....+.++..+.....+   ..+.+++..|++.+|++||++.+++++|+..
T Consensus       267 ~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~~~---~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DPK-YVRDSKIRY-RENIASLMDKCFPAANAP---GEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CHH-HHHHHHHHH-HHCHHHHHHHHSCTTCCC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CHH-HHHHHHHHh-hhhHHHHHHHhcccccCH---HHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            221 111222211 123445555555433333   3566788889999999999999999999765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=346.03  Aligned_cols=271  Identities=21%  Similarity=0.256  Sum_probs=213.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++...   .....+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   85 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV   85 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceEE
Confidence            57889999999999999999975 58999999997533 33456788999999999999999999988642   344789


Q ss_pred             EEEeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE----CCCCcEEEeecCC
Q 043267          396 IVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGL  470 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL----d~~~~~kl~DFGl  470 (614)
                      +||||+++|+|.+++.... ...+++.+++.|+.|+++||+|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999997643 234999999999999999999999   8899999999999999    8888999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhc--------cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYAL--------YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~--------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      ++.......  .....||+.|+|||.+.        +..++.++||||||+++|||++|+.||........ ........
T Consensus       163 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-~~~~~~~~  239 (319)
T 4euu_A          163 ARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR-NKEVMYKI  239 (319)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG-CHHHHHHH
T ss_pred             ceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch-hHHHHHHH
Confidence            987654332  23456999999999986        57899999999999999999999999964433221 12222222


Q ss_pred             HHcCCchhhh-------------hccCC--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          543 VKEGKTLDVI-------------EENMP--EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       543 ~~~g~~~~~~-------------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      .... ..+.+             ...++  ..........+.+++..|++.||++|||++|+++-...+..
T Consensus       240 ~~~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~  309 (319)
T 4euu_A          240 ITGK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (319)
T ss_dssp             HHHC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC
T ss_pred             hcCC-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhh
Confidence            2211 10000             00111  12335667778899999999999999999999999887643

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-41  Score=355.87  Aligned_cols=261  Identities=23%  Similarity=0.338  Sum_probs=208.8

Q ss_pred             HhcCccccceecccCceEEEEeEc------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      ..++|...+.||+|+||.||+|+.      .++..||||++... .....+.+.+|+++++++ +||||+++++++.   
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            457899999999999999999995      24678999999753 334457899999999999 9999999999987   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCC---------------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceE
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGM---------------------KKLSWPIRLRIALGTARGLAYLHYGVQPAII  446 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~---------------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~ii  446 (614)
                        ..+..++||||+++|+|.+++.....                     ..+++..++.|+.|+++||+|||   +.+|+
T Consensus       120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  194 (344)
T 1rjb_A          120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCV  194 (344)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcc
Confidence              45678999999999999999976432                     34899999999999999999999   88999


Q ss_pred             EeccCCCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCC
Q 043267          447 HRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKA  524 (614)
Q Consensus       447 HrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p  524 (614)
                      ||||||+|||++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||++ |+.|
T Consensus       195 H~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          195 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             cCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCC
Confidence            999999999999999999999999986543322 22334567889999999999999999999999999999998 9999


Q ss_pred             cccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          525 CEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       525 ~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      |.......     ........+...         ..+......+..++..|++.||.+|||+.|+++.|+....
T Consensus       275 ~~~~~~~~-----~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          275 YPGIPVDA-----NFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             STTCCCSH-----HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cccCCcHH-----HHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            96543211     122333332111         1122234567788999999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-42  Score=364.69  Aligned_cols=256  Identities=28%  Similarity=0.372  Sum_probs=205.7

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...+.||+|+||.||+|++.      +++.||||+++.. ......++.+|+.++++++||||+++++++.     +
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~  145 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----Q  145 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe-----c
Confidence            57888999999999999999942      4678999999753 4455667999999999999999999999986     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCC-----CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC---c
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSG-----MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF---E  462 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~-----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~---~  462 (614)
                      ....++||||+++|+|.+++....     ...+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++   .
T Consensus       146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCC
T ss_pred             CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCce
Confidence            566799999999999999997632     245999999999999999999999   88999999999999999554   5


Q ss_pred             EEEeecCCceeCCCC-CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHH
Q 043267          463 AKVGDFGLAKFNPEG-ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       463 ~kl~DFGla~~~~~~-~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~  540 (614)
                      +||+|||+++..... .........||+.|+|||.+.++.++.++|||||||++|||++ |+.||......     + ..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~-----~-~~  296 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ-----E-VL  296 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----H-HH
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H-HH
Confidence            999999999743221 1122334567999999999999999999999999999999998 99998643321     1 12


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..+..+...         .........+.+++..||+.||++|||+.+|++.|+..
T Consensus       297 ~~i~~~~~~---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          297 EFVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCC---------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            222222211         11122334577889999999999999999999999765

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.4e-41  Score=353.04  Aligned_cols=253  Identities=29%  Similarity=0.343  Sum_probs=202.6

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.     ++...
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~   80 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCCeE
Confidence            357999999999999999999965 78999999996433 233466889999999999999999999987     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++...  ..+++.+++.|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeecccee
Confidence            9999999999999999543  46999999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCC-ccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          475 PEGI-THLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       475 ~~~~-~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||............     +......   
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~-----~~~~~~~---  227 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD-----WKEKKTY---  227 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHH-----HHTTCTT---
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-----Hhccccc---
Confidence            4322 223345679999999999988775 78999999999999999999999654432222111     1111110   


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                           ..........+.+++..|++.||++|||+.|+++.
T Consensus       228 -----~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -----CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                 11112334566788999999999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=6.5e-41  Score=351.00  Aligned_cols=259  Identities=20%  Similarity=0.227  Sum_probs=205.8

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+. .+|+.||||.+.....  .+.+.+|+++++++ +|+||+++++++.     .+...
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~-----~~~~~   80 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGP-----CGKYN   80 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEE-----ETTEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEe-----cCCcc
Confidence            35789999999999999999995 5789999999875432  34588999999999 9999999999987     46778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc-----EEEeecC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE-----AKVGDFG  469 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~-----~kl~DFG  469 (614)
                      ++||||+ +++|.+++... ...+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.     +||+|||
T Consensus        81 ~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             EEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            9999999 99999999764 357999999999999999999999   889999999999999999887     9999999


Q ss_pred             CceeCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH
Q 043267          470 LAKFNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       470 la~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      +++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........  .... ..+
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~--~~~~-~~i  232 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL--KERY-QKI  232 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH--HHHH-HHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH--HHHH-HHH
Confidence            99865443221      12456799999999999999999999999999999999999999975433221  1111 111


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..+......+ .+...    .. .+.+++..|++.||.+||++.+|++.|+..
T Consensus       233 ~~~~~~~~~~-~~~~~----~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          233 GDTKRATPIE-VLCEN----FP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHHHHHSCHH-HHTTT----CH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhhhccCCHH-HHhcc----Ch-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            1111110000 00110    12 678888999999999999999999999753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.9e-41  Score=342.67  Aligned_cols=253  Identities=21%  Similarity=0.312  Sum_probs=205.4

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+. +|+.||||+++..  +....+.+.+|++++++++||||+++++++...   ++...+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~~   85 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAPHPT   85 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSSSCE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCCCeE
Confidence            4688889999999999999998 4899999999753  344556799999999999999999999998642   236789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +||||+++|+|.+++.......+++.+++.|+.|+++||+|||   +.+  |+||||||+||+++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            9999999999999998766567999999999999999999999   777  99999999999999999999999998754


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCc---hhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTP---GSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~---ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ...      ....||+.|+|||.+.+..++.   ++||||||+++|||++|+.||.....     .+........+... 
T Consensus       163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~-  230 (271)
T 3kmu_A          163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN-----MEIGMKVALEGLRP-  230 (271)
T ss_dssp             TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH-----HHHHHHHHHSCCCC-
T ss_pred             ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh-----HHHHHHHHhcCCCC-
Confidence            222      2346899999999998765544   89999999999999999999964332     11122222222111 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                          .+    +......+.+++..|++.||++|||++|+++.|+...
T Consensus       231 ----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          231 ----TI----PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             ----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                11    2223446778889999999999999999999998754

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.3e-41  Score=351.92  Aligned_cols=244  Identities=25%  Similarity=0.284  Sum_probs=194.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++...  ......++..|+..+.++ +|+||+++++++.     ++..
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~-----~~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWE-----EGGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEE-----eCCE
Confidence            57999999999999999999976 7999999998643  233344556666666666 9999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+ +|+|.+++...+ ..++|..++.|+.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEE
T ss_pred             EEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeee
Confidence            99999999 779999887643 46999999999999999999999   78999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .....  ......||+.|+|||++.+ .++.++||||||+++|||++|+.++....         .+..+..+.......
T Consensus       207 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---------~~~~~~~~~~~~~~~  274 (311)
T 3p1a_A          207 LGTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---------GWQQLRQGYLPPEFT  274 (311)
T ss_dssp             CC--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---------HHHHHTTTCCCHHHH
T ss_pred             cccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---------HHHHHhccCCCcccc
Confidence            65432  2344569999999998775 79999999999999999999977653211         123333333222111


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .        .....+.+++..|++.||++|||+.|+++
T Consensus       275 ~--------~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          275 A--------GLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             T--------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             c--------CCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1        22356788899999999999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.8e-42  Score=357.11  Aligned_cols=266  Identities=24%  Similarity=0.336  Sum_probs=196.3

Q ss_pred             HHhcCccccceecccCceEEEEeEcCCC----cEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLPNG----TEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP  388 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~  388 (614)
                      ...++|...+.||+|+||.||+|+....    ..||||+++..  .....+.+.+|++++++++||||+++++++.....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   99 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA   99 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence            3456799999999999999999997543    27999999753  34456789999999999999999999999864321


Q ss_pred             CC-CceEEEEEeecCCCChhhhhhcCC----CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          389 LE-GHQRIIVCDLLHNGSLYDHLFGSG----MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       389 ~~-~~~~~lV~E~~~~GsL~~~L~~~~----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                      .. ....++||||+++|+|.+++....    ...+++.++++|+.|+++||+|||   +.+|+||||||+|||+++++.+
T Consensus       100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A          100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCE
T ss_pred             ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCE
Confidence            11 112389999999999999996532    225999999999999999999999   8899999999999999999999


Q ss_pred             EEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHH
Q 043267          464 KVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       464 kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~  541 (614)
                      ||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......      ...
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~  250 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------IYN  250 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHH
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------HHH
Confidence            9999999986544322 22334557889999999999999999999999999999999 899986443211      112


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      .+..+...         .........+.+++..|++.||++|||+.++++.|++.+.
T Consensus       251 ~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          251 YLIGGNRL---------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             HHHTTCCC---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHhcCCCC---------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            22222111         1122334567889999999999999999999999998743

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=7e-42  Score=382.76  Aligned_cols=258  Identities=30%  Similarity=0.448  Sum_probs=212.1

Q ss_pred             HhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ..++|...+.||+|+||.||+|++.++..||||+++... ...++|.+|++++++++|+||+++++++.      .+..+
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~------~~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEe------eccce
Confidence            345788899999999999999999888899999998643 34567999999999999999999999985      25679


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.++|.......+++.++++|+.||++||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            9999999999999997654456999999999999999999999   8899999999999999999999999999998655


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ...........++..|+|||.+.++.++.++||||||+++|||++ |+.||......      -+...+..+...     
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~~-----  483 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYRM-----  483 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHHHTTCCC-----
T ss_pred             CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC-----
Confidence            432222334457889999999999999999999999999999999 99998643321      122233333211     


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                          .........+.+++..||+.||++|||+.+|+++|+....
T Consensus       484 ----~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          484 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ----CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                1112234467788999999999999999999999998743

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1e-41  Score=356.61  Aligned_cols=255  Identities=25%  Similarity=0.400  Sum_probs=202.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcE----EEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTE----VAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~----VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|...+.||+|+||.||+|+.. +|+.    ||+|.+.... ......+.+|+.++++++||||+++++++.      +
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~------~   86 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP------G   86 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC------B
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc------C
Confidence            46888899999999999999964 4544    7888875432 333456788999999999999999999884      4


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++|+|.+++... ...+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++++||+|||++
T Consensus        87 ~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  162 (325)
T 3kex_A           87 SSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVA  162 (325)
T ss_dssp             SSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGG
T ss_pred             CccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcc
Confidence            5689999999999999999754 357999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +........ ......||..|+|||.+.++.++.++||||||+++|||++ |+.||.......      ....+..+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~~  236 (325)
T 3kex_A          163 DLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE------VPDLLEKGERL  236 (325)
T ss_dssp             GGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH------HHHHHHTTCBC
T ss_pred             cccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH------HHHHHHcCCCC
Confidence            876544322 3345668889999999999999999999999999999999 999996543211      12233333221


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ..         +......+.+++..||+.||++|||+.|+++.|+...
T Consensus       237 ~~---------~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          237 AQ---------PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             CC---------CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             CC---------CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11         1112224667888899999999999999999998764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.4e-40  Score=341.74  Aligned_cols=260  Identities=22%  Similarity=0.306  Sum_probs=206.9

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+. .+|+.||||++....  ..+.+.+|+++++.+ +|+|++++++++.     ++...
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~   81 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN   81 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCcee
Confidence            35789999999999999999995 579999999987533  234578999999999 8999999999986     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc-----EEEeecC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE-----AKVGDFG  469 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~-----~kl~DFG  469 (614)
                      ++||||+ +++|.+++...+ ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.     +||+|||
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg  156 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  156 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence            9999999 999999997643 46999999999999999999999   899999999999999987776     9999999


Q ss_pred             CceeCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH
Q 043267          470 LAKFNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       470 la~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      +++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ......+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~  233 (298)
T 1csn_A          157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN---KQKYERI  233 (298)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH---HHHHHHH
T ss_pred             cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc---HHHHHHH
Confidence            99876543221      23456799999999999999999999999999999999999999965432211   1111111


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..+........ +.    ......+.+++..|++.||++|||+++|++.|+..
T Consensus       234 ~~~~~~~~~~~-~~----~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          234 GEKKQSTPLRE-LC----AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHHHHHSCHHH-HT----TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhhccCccHHH-HH----hhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            11111000000 00    11234677888999999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.7e-41  Score=342.72  Aligned_cols=249  Identities=34%  Similarity=0.505  Sum_probs=192.7

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCCh----hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK----AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~----~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+. .|+.||||+++....    ...+.+.+|+++++.++||||+++++++.     +++.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   80 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL-----KEPN   80 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CC--
T ss_pred             hheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCc
Confidence            5788899999999999999997 489999999865322    23467899999999999999999999986     5567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc---eEEeccCCCCeEECC--------CCc
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA---IIHRDIKASNILLDE--------AFE  462 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~---iiHrDIKp~NILLd~--------~~~  462 (614)
                      .++||||+++++|.+++..   ..+++..++.++.|+++||+|||   +.+   |+||||||+|||++.        ++.
T Consensus        81 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~  154 (271)
T 3dtc_A           81 LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKI  154 (271)
T ss_dssp             CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCC
T ss_pred             eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcc
Confidence            8999999999999999843   46999999999999999999999   555   999999999999986        778


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      +||+|||+++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......     ......
T Consensus       155 ~kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~  226 (271)
T 3dtc_A          155 LKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL-----AVAYGV  226 (271)
T ss_dssp             EEECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHH-----HHHHHH
T ss_pred             eEEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHhh
Confidence            9999999998654332   22356899999999999999999999999999999999999999643321     111111


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ....         ............+.+++..|++.||++|||+.|+++.|+.
T Consensus       227 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          227 AMNK---------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HTSC---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hcCC---------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            1111         1111122234567889999999999999999999999975

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.9e-42  Score=372.41  Aligned_cols=264  Identities=20%  Similarity=0.245  Sum_probs=210.6

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHHHHHccccceeeeeeee
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEIIASVKHVNLVALRGYS  383 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~niv~l~g~~  383 (614)
                      +++.+++..+++|+..++||+|+||+||+|+.. +|+.||||+++....   .....+.+|.+++..++||||+++++++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  143 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF  143 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            456677778899999999999999999999976 578999999975221   2233488999999999999999999998


Q ss_pred             ecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       384 ~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                      .     ++...++||||+++|+|.+++... ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++++
T Consensus       144 ~-----~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~v  214 (437)
T 4aw2_A          144 Q-----DDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHI  214 (437)
T ss_dssp             E-----CSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             e-----eCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCE
Confidence            7     567899999999999999999763 346999999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                      ||+|||+++..............||+.|+|||++.     .+.++.++|||||||++|||++|+.||......     +.
T Consensus       215 kL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-----~~  289 (437)
T 4aw2_A          215 RLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-----ET  289 (437)
T ss_dssp             EECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HH
T ss_pred             EEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-----HH
Confidence            99999999876655444455578999999999987     567999999999999999999999999643221     11


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQA--RPTMDQIVK  591 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~  591 (614)
                      ........     ....++.. .......+.+++..|+..+|++  ||+++|+++
T Consensus       290 ~~~i~~~~-----~~~~~p~~-~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          290 YGKIMNHK-----ERFQFPTQ-VTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHHHHTHH-----HHCCCCSS-CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             HHhhhhcc-----ccccCCcc-cccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            11111100     01111111 1123345677888888888887  999999985

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.8e-41  Score=349.28  Aligned_cols=255  Identities=23%  Similarity=0.291  Sum_probs=200.1

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccC------
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVP------  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~------  388 (614)
                      .++|+..+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457899999999999999999976 79999999997533 3456789999999999999999999998754321      


Q ss_pred             ----------------------------------------------CCCceEEEEEeecCCCChhhhhhcCC-CcCCChH
Q 043267          389 ----------------------------------------------LEGHQRIIVCDLLHNGSLYDHLFGSG-MKKLSWP  421 (614)
Q Consensus       389 ----------------------------------------------~~~~~~~lV~E~~~~GsL~~~L~~~~-~~~l~~~  421 (614)
                                                                    ......++||||+++|+|.+++.... ....++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                          01224799999999999999997643 3456777


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc-----------cccccccCCCC
Q 043267          422 IRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-----------HLTTRVAGTLG  490 (614)
Q Consensus       422 ~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~-----------~~~~~~~gt~~  490 (614)
                      .+++|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999   88999999999999999999999999999987654321           12234579999


Q ss_pred             cCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHH
Q 043267          491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVL  570 (614)
Q Consensus       491 Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~  570 (614)
                      |+|||.+.+..++.++||||||+++|||++|..|+....        ........+....         ........+.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------~~~~~~~~~~~~~---------~~~~~~~~~~~  304 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------RIITDVRNLKFPL---------LFTQKYPQEHM  304 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------HHHHHHHTTCCCH---------HHHHHCHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------HHHHHhhccCCCc---------ccccCChhHHH
Confidence            999999999999999999999999999999887653111        0111122221111         11233456678


Q ss_pred             HHHHccccCCCCCCCHHHHHH
Q 043267          571 TAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       571 l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ++..|++.||++|||+.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=3.6e-41  Score=344.20  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             hcCccccceecccCceEEEEeEcCC----CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|...+.||+|+||.||+|+..+    +..||||.+... .....+.+.+|++++++++||||+++++++.      .
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~   84 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE------E   84 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC------S
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc------C
Confidence            4578899999999999999998532    346999999764 3445678999999999999999999999874      3


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +..++||||+++++|.+++.... ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        85 ~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  160 (281)
T 3cc6_A           85 EPTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLS  160 (281)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGG
T ss_pred             CCCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCC
Confidence            45689999999999999997643 46899999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      +..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......      ....+..+... 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~------~~~~~~~~~~~-  233 (281)
T 3cc6_A          161 RYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD------VIGVLEKGDRL-  233 (281)
T ss_dssp             GCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG------HHHHHHHTCCC-
T ss_pred             cccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH------HHHHHhcCCCC-
Confidence            8665443333444567889999999999999999999999999999998 999996433221      11222222111 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          .    ........+.+++..|++.||++|||+.|+++.|+..
T Consensus       234 ----~----~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          234 ----P----KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C----CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence                0    1112234677889999999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-40  Score=348.26  Aligned_cols=277  Identities=27%  Similarity=0.326  Sum_probs=206.2

Q ss_pred             CHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc--cccceeeeeeeeecc
Q 043267          309 KIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV--KHVNLVALRGYSTAT  386 (614)
Q Consensus       309 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l--~H~niv~l~g~~~~~  386 (614)
                      ....-....++|...+.||+|+||.||+|+.. |+.||||++...   ....+..|.+++...  +||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            33344455678999999999999999999984 899999998653   234455566666554  999999999998743


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC--------ceEEeccCCCCeEEC
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP--------AIIHRDIKASNILLD  458 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~--------~iiHrDIKp~NILLd  458 (614)
                      .. .....++||||+++|+|.+++...   .+++..++.|+.|++.||+|||   +.        +|+||||||+|||++
T Consensus       104 ~~-~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~  176 (337)
T 3mdy_A          104 TG-SWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVK  176 (337)
T ss_dssp             CG-GGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred             CC-CCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEEC
Confidence            21 126789999999999999999653   5999999999999999999999   66        999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCCccc---cccccCCCCcCchhhhccCCCCch------hhHHHHHHHHHHHHhC--------
Q 043267          459 EAFEAKVGDFGLAKFNPEGITHL---TTRVAGTLGYVAPEYALYGKLTPG------SDVYSFGVVLLELLSG--------  521 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~~~---~~~~~gt~~Y~APE~~~~~~~t~k------sDVwS~Gvll~ElltG--------  521 (614)
                      .++.+||+|||+++.........   .....||+.|+|||.+.+...+.+      +||||||+++|||++|        
T Consensus       177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~  256 (337)
T 3mdy_A          177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE  256 (337)
T ss_dssp             TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred             CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence            99999999999997655433221   234579999999999988776665      9999999999999999        


Q ss_pred             --CCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          522 --KKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEME-LPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       522 --~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                        +.|+............. ........    ..+..+... ..+....+.+++..||+.||++|||+.||++.|+...+
T Consensus       257 ~~~~p~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~  331 (337)
T 3mdy_A          257 EYQLPYHDLVPSDPSYEDM-REIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE  331 (337)
T ss_dssp             CCCCTTTTTSCSSCCHHHH-HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccHhhhcCCCCchhhh-HHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHh
Confidence              55553322222111111 11111111    111111111 12566789999999999999999999999999988654


Q ss_pred             CCC
Q 043267          599 LSN  601 (614)
Q Consensus       599 ~p~  601 (614)
                      ...
T Consensus       332 ~~~  334 (337)
T 3mdy_A          332 SQD  334 (337)
T ss_dssp             TTT
T ss_pred             hcc
Confidence            433

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-41  Score=351.60  Aligned_cols=250  Identities=23%  Similarity=0.265  Sum_probs=202.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh------hhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK------AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||.++....      ...+.+.+|++++++++||||+++++++.     .
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~   85 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   85 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            46899999999999999999965 689999999975332      13567999999999999999999999987     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC----cEEEe
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF----EAKVG  466 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~----~~kl~  466 (614)
                      ....++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  160 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII  160 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence            67889999999999999999643  47999999999999999999999   89999999999999999887    89999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +.. ..+...
T Consensus       161 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~-~~~~~~  232 (326)
T 2y0a_A          161 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETL-ANVSAV  232 (326)
T ss_dssp             CCTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHH-HHHHHT
T ss_pred             ECCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----HHH-HHHHhc
Confidence            999998765432  233457999999999999999999999999999999999999999543211     111 111111


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..      .............+.+++..|++.||++|||+.|+++
T Consensus       233 ~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          233 NY------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CC------CCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CC------CcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11      0110001122345778899999999999999999986

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=7.2e-41  Score=342.71  Aligned_cols=251  Identities=29%  Similarity=0.472  Sum_probs=201.1

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhh-------hHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAG-------DANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~-------~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      ++|...+.||+|+||.||+|+. .+++.||||++.......       .+.+.+|++++++++||||+++++++..    
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~----   94 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN----   94 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT----
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC----
Confidence            5788899999999999999996 478999999986433221       1678999999999999999999998852    


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEECCCCc-----
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLDEAFE-----  462 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd~~~~-----  462 (614)
                       .  .++||||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+  |+||||||+|||++.++.     
T Consensus        95 -~--~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~  167 (287)
T 4f0f_A           95 -P--PRMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVC  167 (287)
T ss_dssp             -T--TEEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCC
T ss_pred             -C--CeEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCcee
Confidence             2  269999999999999887643 57999999999999999999999   778  999999999999988776     


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCchhhh--ccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA--LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~--~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                      +||+|||+++....    ......||+.|+|||.+  ....++.++||||+|+++|||++|+.||.........   +..
T Consensus       168 ~kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~---~~~  240 (287)
T 4f0f_A          168 AKVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK---FIN  240 (287)
T ss_dssp             EEECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH---HHH
T ss_pred             EEeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH---HHH
Confidence            99999999975433    23446799999999998  3556889999999999999999999999654432211   111


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      .....+         ............+.+++..|++.||++|||+.|+++.|++
T Consensus       241 ~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          241 MIREEG---------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             HHHHSC---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             HHhccC---------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            111111         1111222334567889999999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=4.4e-41  Score=352.14  Aligned_cols=266  Identities=26%  Similarity=0.325  Sum_probs=199.6

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHH--HHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEI--IASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~i--l~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+. +++.||||++....   ...+..|.++  +..++|+||+++++++...........+
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            5788999999999999999987 78999999997532   3344445554  4458999999999876543333455678


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC---------ceEEeccCCCCeEECCCCcEEEe
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP---------AIIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~---------~iiHrDIKp~NILLd~~~~~kl~  466 (614)
                      +||||+++|+|.+++....   .++..+.+|+.|+++||+|||   +.         +|+||||||+|||++.++.+||+
T Consensus        89 lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            9999999999999996543   589999999999999999999   77         99999999999999999999999


Q ss_pred             ecCCceeCCCCC-------ccccccccCCCCcCchhhhcc-------CCCCchhhHHHHHHHHHHHHhCCCCcccccCcc
Q 043267          467 DFGLAKFNPEGI-------THLTTRVAGTLGYVAPEYALY-------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS  532 (614)
Q Consensus       467 DFGla~~~~~~~-------~~~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~  532 (614)
                      |||+++......       ........||+.|+|||.+.+       ..++.++||||||+++|||++|+.|+.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998654322       112234569999999999986       456789999999999999999988773322211


Q ss_pred             chhh------------HHHHHHHHcCCchhhhhccCCCC--CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          533 VLLS------------DWAWELVKEGKTLDVIEENMPEM--ELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       533 ~~l~------------~~~~~~~~~g~~~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ....            +...........    .+.++..  ........+.+++..||+.||++|||+.|+++.|+..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          243 EYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            1100            011111111111    1111111  12345667899999999999999999999999998863

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=5.5e-41  Score=357.44  Aligned_cols=251  Identities=24%  Similarity=0.282  Sum_probs=203.9

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh------hhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA------GDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||.++.....      ..+.+.+|++++++++||||+++++++.     
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----   85 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYE-----   85 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEE-----
Confidence            457899999999999999999965 6899999999754322      3467899999999999999999999986     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC----cEEE
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF----EAKV  465 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~----~~kl  465 (614)
                      +....++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++    .+||
T Consensus        86 ~~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl  160 (361)
T 2yab_A           86 NRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (361)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             eCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEE
Confidence            567899999999999999999653  47999999999999999999999   88999999999999998877    7999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      +|||+++......  ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......     + ....+..
T Consensus       161 ~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~-~~~~i~~  232 (361)
T 2yab_A          161 IDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----E-TLANITA  232 (361)
T ss_dssp             CCCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----H-HHHHHHT
T ss_pred             EecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHh
Confidence            9999998765432  234467999999999999999999999999999999999999999643221     1 1122222


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +...      .+..........+.+++..|++.||++|||+.|+++
T Consensus       233 ~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          233 VSYD------FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCC------CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2110      000001122345778899999999999999999874

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.5e-41  Score=345.04  Aligned_cols=250  Identities=24%  Similarity=0.281  Sum_probs=196.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--------------------------hhhHHHHHHHHHHHH
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--------------------------AGDANFKHEVEIIAS  370 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------------------------~~~~~f~~Ei~il~~  370 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||++.....                          ...+.+.+|++++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            57899999999999999999964 689999999965321                          113468899999999


Q ss_pred             ccccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEecc
Q 043267          371 VKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDI  450 (614)
Q Consensus       371 l~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDI  450 (614)
                      ++||||+++++++...   .+...++||||+++|+|.+++.   ...+++.++..++.|+++||+|||   +.+|+||||
T Consensus        93 l~h~~iv~~~~~~~~~---~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dl  163 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDP---NEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDI  163 (298)
T ss_dssp             CCCTTBCCEEEEEECS---SSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCC
T ss_pred             CCCCCCCeEEEEEEcC---CCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCC
Confidence            9999999999998642   3567899999999999998763   346999999999999999999999   889999999


Q ss_pred             CCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCC---CCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          451 KASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK---LTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       451 Kp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      ||+|||++.++++||+|||+++....... ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            99999999999999999999987654322 234467999999999988765   47899999999999999999999964


Q ss_pred             ccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          528 IQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       528 ~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...     ..+ ...+..+...      .+  ........+.+++..|++.||++|||+.|+++
T Consensus       243 ~~~-----~~~-~~~~~~~~~~------~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          243 ERI-----MCL-HSKIKSQALE------FP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SSH-----HHH-HHHHHHCCCC------CC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccH-----HHH-HHHHhcccCC------CC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            321     111 1222222110      11  11223346778899999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.1e-40  Score=342.65  Aligned_cols=259  Identities=33%  Similarity=0.487  Sum_probs=197.4

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+..+  .||||+++..  .....+.+.+|++++++++||||+++++++.      ....
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~------~~~~   94 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQL   94 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc------CCcc
Confidence            4578999999999999999998643  5999998643  3445577999999999999999999999763      4567


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++++|.+++... ...+++..+++|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  170 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEK  170 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             EEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccc
Confidence            9999999999999999654 356999999999999999999999   889999999999999999999999999999754


Q ss_pred             CCC-CccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          475 PEG-ITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       475 ~~~-~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ... .........||+.|+|||.+.   ...++.++||||||+++|||++|+.||......     +...+....+....
T Consensus       171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~~~~~~~~  245 (289)
T 3og7_A          171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQIIEMVGRGSLSP  245 (289)
T ss_dssp             -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCH-----HHHHHHHHHTSCCC
T ss_pred             ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchH-----HHHHHHhcccccCc
Confidence            432 122334567999999999987   667899999999999999999999999654331     12233333333221


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ...     .........+.+++..|++.||++|||+.+++++|+...
T Consensus       246 ~~~-----~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          246 DLS-----KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CTT-----SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             chh-----hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            111     111233456788999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.3e-41  Score=354.18  Aligned_cols=261  Identities=27%  Similarity=0.369  Sum_probs=208.9

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CC-----cEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeec
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NG-----TEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTA  385 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g-----~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~  385 (614)
                      +...++|...+.||+|+||.||+|... ++     ..||||.+.... ....+.+.+|+++++++ +||||+++++++. 
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-  120 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT-  120 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe-
Confidence            334578999999999999999999964 22     479999997643 34456789999999999 8999999999986 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCC------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCC
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSG------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS  453 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~  453 (614)
                          .+...++||||+++|+|.+++....            ...+++..++.++.|++.||+|||   +.+|+||||||+
T Consensus       121 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  193 (333)
T 2i1m_A          121 ----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAAR  193 (333)
T ss_dssp             ----SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGG
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccc
Confidence                5567899999999999999997532            346899999999999999999999   889999999999


Q ss_pred             CeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCc
Q 043267          454 NILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGK  531 (614)
Q Consensus       454 NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~  531 (614)
                      |||++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||......
T Consensus       194 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  273 (333)
T 2i1m_A          194 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN  273 (333)
T ss_dssp             GCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred             eEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence            999999999999999999865433222 2334557889999999999999999999999999999999 99998643321


Q ss_pred             cchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       532 ~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           .........+...         ..+......+.+++..|++.||.+|||+.|+++.|+..
T Consensus       274 -----~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          274 -----SKFYKLVKDGYQM---------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -----HHHHHHHHHTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence                 1122333322111         11112234677889999999999999999999999864

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=345.87  Aligned_cols=268  Identities=20%  Similarity=0.247  Sum_probs=210.1

Q ss_pred             HhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ..++|...+.||+|+||.||+++. .+|+.||||++........+.+.+|++++++++||||+++++++..... .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~  105 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERG-AKHEA  105 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEET-TEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccC-CCcee
Confidence            346899999999999999999996 5799999999987666677889999999999999999999999863321 34578


Q ss_pred             EEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          395 IIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ++||||+++|+|.+++...  ....+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            9999999999999999752  3467999999999999999999999   8899999999999999999999999999987


Q ss_pred             eCCCCCcc--------ccccccCCCCcCchhhhccCC---CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH
Q 043267          473 FNPEGITH--------LTTRVAGTLGYVAPEYALYGK---LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       473 ~~~~~~~~--------~~~~~~gt~~Y~APE~~~~~~---~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      ........        ......||+.|+|||.+....   ++.++||||||+++|||++|+.||.........+    ..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~  258 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV----AL  258 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH----HH
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh----hH
Confidence            64321111        112345799999999987554   7899999999999999999999985322111111    11


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                      ....         .............+.+++..|++.||.+|||+.++++.|+...+.+
T Consensus       259 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  308 (317)
T 2buj_A          259 AVQN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA  308 (317)
T ss_dssp             HHHC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred             Hhhc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence            1111         1111111223456788999999999999999999999999875443

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-41  Score=351.81  Aligned_cols=251  Identities=18%  Similarity=0.211  Sum_probs=204.5

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||.||+++.. +|+.||+|.+... ......+.+|+++++.++||||+++++++.     +....+
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~   77 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEe-----cCCEEE
Confidence            467999999999999999999965 6889999998753 344567889999999999999999999986     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC--CCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE--AFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~--~~~~kl~DFGla~~  473 (614)
                      +||||+++|+|.+++... ...+++..+..++.|+++||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.
T Consensus        78 lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~  153 (321)
T 1tki_A           78 MIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence            999999999999999653 246999999999999999999999   889999999999999997  78999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ...+..  .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     .+.. ..+..+...    
T Consensus       154 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~-~~i~~~~~~----  221 (321)
T 1tki_A          154 LKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-----QQII-ENIMNAEYT----  221 (321)
T ss_dssp             CCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH-HHHHHTCCC----
T ss_pred             CCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH-----HHHH-HHHHcCCCC----
Confidence            654332  3345689999999999998899999999999999999999999964332     1111 122222110    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        .+..........+.+++..|++.||++|||+.|+++
T Consensus       222 --~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              000001122446788999999999999999999986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.9e-41  Score=350.20  Aligned_cols=257  Identities=26%  Similarity=0.394  Sum_probs=207.8

Q ss_pred             hcCccccceecccCceEEEEeEc--------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML--------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTAT  386 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~--------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~  386 (614)
                      .++|...+.||+|+||.||+|+.        .++..||||+++.. .....+.+.+|+++++++ +||||+++++++.  
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~--  111 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--  111 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc--
Confidence            46789999999999999999985        35678999999754 334556789999999999 9999999999986  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                         +....++||||+++|+|.+++....              ...+++..+++++.|+++||.|||   +.+|+||||||
T Consensus       112 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp  185 (334)
T 2pvf_A          112 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAA  185 (334)
T ss_dssp             ---SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSG
T ss_pred             ---cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCcc
Confidence               5567899999999999999997643              235899999999999999999999   88999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~  530 (614)
                      +|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~  265 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV  265 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence            999999999999999999987654332 22344567889999999999999999999999999999999 9999864321


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           .+ ....+..+...     .    ........+.+++..|++.||.+|||+.|+++.|+..
T Consensus       266 -----~~-~~~~~~~~~~~-----~----~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          266 -----EE-LFKLLKEGHRM-----D----KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             -----HH-HHHHHHHTCCC-----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HH-HHHHHhcCCCC-----C----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 11 12222222211     1    1122334677889999999999999999999999876

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-40  Score=347.04  Aligned_cols=262  Identities=21%  Similarity=0.261  Sum_probs=200.3

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||+||+++..+|+.||||++....  ......+.+|++++++++||||+++++++.     ++...
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   94 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIH-----SERCL   94 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----CSSCE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEc-----cCCEE
Confidence            45799999999999999999999889999999997432  223467889999999999999999999986     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||++ |+|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        95 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  169 (311)
T 3niz_A           95 TLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAF  169 (311)
T ss_dssp             EEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEET
T ss_pred             EEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceec
Confidence            99999998 58888886543 46999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch----
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL----  549 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~----  549 (614)
                      ..... ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........ + .............    
T Consensus       170 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~-~~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          170 GIPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQ-L-PKIFSILGTPNPREWPQ  246 (311)
T ss_dssp             TSCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTH-H-HHHHHHHCCCCTTTSGG
T ss_pred             CCCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHH-H-HHHHHHHCCCChHHhhh
Confidence            53322 2344578999999999876 5689999999999999999999999965443221 1 1111111110000    


Q ss_pred             -----hhhhccC---CCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 -----DVIEENM---PEME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 -----~~~d~~l---~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ...+...   ....    .+.....+.+++..|++.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                 0000000   0000    0112346778999999999999999999986

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=346.10  Aligned_cols=252  Identities=27%  Similarity=0.422  Sum_probs=197.2

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|...+.||+|+||.||+++. .++.||||++...  ...+.+.+|++++++++||||+++++++.       +..++|
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-------~~~~lv   77 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-------NPVCLV   77 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-------TTTEEE
T ss_pred             hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-------CCcEEE
Confidence            4688889999999999999998 4789999999753  34567899999999999999999999875       236899


Q ss_pred             EeecCCCChhhhhhcCCC-cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc-EEEeecCCceeCC
Q 043267          398 CDLLHNGSLYDHLFGSGM-KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE-AKVGDFGLAKFNP  475 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~-~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~-~kl~DFGla~~~~  475 (614)
                      |||+++|+|.+++..... ..+++..+++++.|+++||+|||+....+|+||||||+|||++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999999976432 35889999999999999999999432289999999999999998886 7999999997543


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ...+. ...+...      
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~~~~~-~~~~~~~------  223 (307)
T 2eva_A          158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF---RIMWA-VHNGTRP------  223 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH---HHHHH-HHTTCCC------
T ss_pred             cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH---HHHHH-HhcCCCC------
Confidence            32    2334689999999999999999999999999999999999999964433211   11122 1122111      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                         .........+.+++..|++.||++|||+.+++++|+..
T Consensus       224 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          224 ---PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             ---CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               11122334677889999999999999999999999764

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.8e-41  Score=348.00  Aligned_cols=268  Identities=24%  Similarity=0.330  Sum_probs=201.3

Q ss_pred             HHHHHHhcCccccceecccCceEEEEeEcC----CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeee
Q 043267          311 EEIKAATMNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYST  384 (614)
Q Consensus       311 ~el~~~t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~  384 (614)
                      +++....++|...+.||+|+||.||+|+..    .+..||||+++..  .....+.+.+|++++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            344445678999999999999999999853    3458999998743  3444567999999999999999999999987


Q ss_pred             cccCCCCceEEEEEeecCCCChhhhhhc----CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC
Q 043267          385 ATVPLEGHQRIIVCDLLHNGSLYDHLFG----SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA  460 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~GsL~~~L~~----~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~  460 (614)
                      ..........++||||+++|+|.+++..    .....+++..+++|+.|+++||.|||   +.+|+||||||+|||++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCC
Confidence            5432222356999999999999999854    23457999999999999999999999   8999999999999999999


Q ss_pred             CcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHH
Q 043267          461 FEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       461 ~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~  538 (614)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......      
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------  257 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------  257 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------
Confidence            9999999999986543322 22334557889999999999999999999999999999999 888886433211      


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .......+...         .........+.+++..|++.||++|||+.++++.|+..
T Consensus       258 ~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          258 MYDYLLHGHRL---------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HHHHHHTTCCC---------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCC---------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11222222211         11223345678889999999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.7e-40  Score=339.06  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=202.7

Q ss_pred             HhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ..++|...+.||+|+||.||+|+. .+|+.||||++.....  ..++.+|+++++.++|++++..++++..    ++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~   80 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYN   80 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecC----CCCce
Confidence            456899999999999999999995 5789999998765332  2357889999999999998888877753    55678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE---CCCCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL---d~~~~~kl~DFGla  471 (614)
                      ++||||+ +|+|.+++.... ..+++..++.++.|+++||.|||   +.+|+||||||+|||+   ++++.+||+|||++
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           81 VMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            9999999 999999987533 46999999999999999999999   8899999999999999   78999999999999


Q ss_pred             eeCCCCCc------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc--hhhHHHHHHH
Q 043267          472 KFNPEGIT------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV--LLSDWAWELV  543 (614)
Q Consensus       472 ~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~l~~~~~~~~  543 (614)
                      +.......      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........  .+........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  235 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  235 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc
Confidence            87654322      122356799999999999999999999999999999999999999965433221  1111111110


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      . . ..+....        .....+.+++..|++.||++|||+++++++|+..
T Consensus       236 ~-~-~~~~~~~--------~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          236 S-T-PIEVLCK--------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-S-CHHHHTT--------TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             c-c-hhhhhhc--------cCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            0 0 0000001        1134677889999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.9e-40  Score=346.41  Aligned_cols=281  Identities=26%  Similarity=0.332  Sum_probs=214.5

Q ss_pred             ccCHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHH--ccccceeeeeeeee
Q 043267          307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIAS--VKHVNLVALRGYST  384 (614)
Q Consensus       307 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~--l~H~niv~l~g~~~  384 (614)
                      ...+..-....++|...+.||+|+||.||+|+. +|+.||||++...   ....+.+|.+++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            334444455667899999999999999999998 6899999999643   34567889999988  79999999999987


Q ss_pred             cccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcC-----CCceEEeccCCCCeEECC
Q 043267          385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV-----QPAIIHRDIKASNILLDE  459 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~-----~~~iiHrDIKp~NILLd~  459 (614)
                      .... .....++||||+++|+|.+++.+.   .+++.++++++.|+++||+|||...     +.+|+||||||+|||++.
T Consensus       107 ~~~~-~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          107 KDNG-TWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CCCS-SCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred             ccCC-ccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence            4321 123789999999999999999653   5999999999999999999999321     578999999999999999


Q ss_pred             CCcEEEeecCCceeCCCCCcc---ccccccCCCCcCchhhhccC------CCCchhhHHHHHHHHHHHHhC---------
Q 043267          460 AFEAKVGDFGLAKFNPEGITH---LTTRVAGTLGYVAPEYALYG------KLTPGSDVYSFGVVLLELLSG---------  521 (614)
Q Consensus       460 ~~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~t~ksDVwS~Gvll~ElltG---------  521 (614)
                      ++++||+|||+++........   ......||+.|+|||.+.+.      .++.++||||||+++|||++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999865443322   23445799999999998876      334789999999999999999         


Q ss_pred             -CCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCC-CcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCC
Q 043267          522 -KKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEM-ELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL  599 (614)
Q Consensus       522 -~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  599 (614)
                       +.||............+.. .+..+..    .+.++.. ...+....+.+++..||+.||++|||+.||++.|+...+.
T Consensus       263 ~~~p~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~  337 (342)
T 1b6c_B          263 YQLPYYDLVPSDPSVEEMRK-VVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  337 (342)
T ss_dssp             CCCTTTTTSCSSCCHHHHHH-HHTTSCC----CCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccCccccCcCcccHHHHHH-HHHHHHh----CCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHH
Confidence             6677543332222222222 1111111    1112211 1235667889999999999999999999999999886443


Q ss_pred             C
Q 043267          600 S  600 (614)
Q Consensus       600 p  600 (614)
                      .
T Consensus       338 ~  338 (342)
T 1b6c_B          338 E  338 (342)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.7e-40  Score=355.99  Aligned_cols=267  Identities=19%  Similarity=0.220  Sum_probs=203.7

Q ss_pred             hcCccccceeccc--CceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKG--GYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G--~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|+..+.||+|  +||.||+++.. +|+.||||++...  +....+.+.+|+++++.++||||+++++++.     ++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~   98 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFI-----AD   98 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ET
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEE-----EC
Confidence            3578999999999  99999999975 7999999999753  3444567889999999999999999999987     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +..++||||+++|+|.+++.......+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.+
T Consensus        99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           99 NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence            78899999999999999998776667999999999999999999999   889999999999999999999999999998


Q ss_pred             eeCCCCCc------cccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH-
Q 043267          472 KFNPEGIT------HLTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL-  542 (614)
Q Consensus       472 ~~~~~~~~------~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~-  542 (614)
                      ........      .......||+.|+|||.+.+  ..++.++|||||||++|||++|+.||............+.... 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            64422111      11233478999999999987  6899999999999999999999999965433221110000000 


Q ss_pred             --HH------------------cCCchhhhhc---------cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          543 --VK------------------EGKTLDVIEE---------NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       543 --~~------------------~g~~~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ..                  .....+....         .............+.+++..|++.||++|||+.|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~  333 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN  333 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence              00                  0000000000         0000011223456888999999999999999999984

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=5.7e-41  Score=347.61  Aligned_cols=270  Identities=26%  Similarity=0.344  Sum_probs=215.6

Q ss_pred             ccCHHHHHHHhcCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceee
Q 043267          307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVA  378 (614)
Q Consensus       307 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~  378 (614)
                      .+...+.....++|...+.||+|+||.||+|+.      .+++.||||+++... ....+.+.+|++++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            344555556678899999999999999999973      357899999997643 33456789999999999 7999999


Q ss_pred             eeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCC--------------cCCChHHHHHHHHHHHHHHHHHhhcCCCc
Q 043267          379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM--------------KKLSWPIRLRIALGTARGLAYLHYGVQPA  444 (614)
Q Consensus       379 l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~--------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~  444 (614)
                      +++++..    .+...++||||+++|+|.+++.....              ..+++..++.++.|+++||.|||   +.+
T Consensus        96 ~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~  168 (316)
T 2xir_A           96 LLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRK  168 (316)
T ss_dssp             EEEEECC----TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             EEEEEec----CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCC
Confidence            9999863    34568999999999999999976442              22899999999999999999999   889


Q ss_pred             eEEeccCCCCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CC
Q 043267          445 IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GK  522 (614)
Q Consensus       445 iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~  522 (614)
                      |+||||||+||+++.++.+||+|||+++....... .......||+.|+|||.+.+..++.++||||||+++|||++ |+
T Consensus       169 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~  248 (316)
T 2xir_A          169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA  248 (316)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999986544332 22334567899999999999999999999999999999998 99


Q ss_pred             CCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          523 KACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       523 ~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      .||......     +.....+..+...     ..+    ......+.+++..|++.||.+|||+.|+++.|+..+
T Consensus       249 ~p~~~~~~~-----~~~~~~~~~~~~~-----~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          249 SPYPGVKID-----EEFCRRLKEGTRM-----RAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             CSSTTCCCS-----HHHHHHHHHTCCC-----CCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCcccchh-----HHHHHHhccCccC-----CCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            998643321     1122333333211     111    122346778889999999999999999999998753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-40  Score=354.23  Aligned_cols=252  Identities=25%  Similarity=0.303  Sum_probs=205.5

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ..++|...+.||+|+||.||+++.. +|+.||||++...  +....+.+.+|++++++++||||+++++++.     ++.
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~  101 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EES  101 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCC
Confidence            3567999999999999999999965 6899999999753  3344567899999999999999999999987     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC---cEEEeecC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF---EAKVGDFG  469 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~---~~kl~DFG  469 (614)
                      ..++||||+++|+|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++   .+||+|||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG  176 (362)
T 2bdw_A          102 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFG  176 (362)
T ss_dssp             EEEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecC
Confidence            889999999999999998653  46999999999999999999999   88999999999999998654   59999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....      .-....+..+...
T Consensus       177 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~------~~~~~~i~~~~~~  248 (362)
T 2bdw_A          177 LAIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ------HRLYAQIKAGAYD  248 (362)
T ss_dssp             TCBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTCCC
T ss_pred             cceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHhCCCC
Confidence            998665432  23446799999999999999999999999999999999999999964321      1122233333211


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            .+..........+.+++..|++.||++|||+.|+++
T Consensus       249 ------~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          249 ------YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ------CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ------CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                  111112233456788999999999999999999885

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-40  Score=351.25  Aligned_cols=247  Identities=22%  Similarity=0.279  Sum_probs=202.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+++.. +|+.||||+++..   .......+.+|+++++.++||||+++++++.     ....
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~-----~~~~   79 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEE-----eCCE
Confidence            57899999999999999999965 6899999999753   2234567889999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus        80 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           80 LCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            89999999999999999654  36899999999999999999999   88999999999999999999999999999985


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     ... ...+..+..     
T Consensus       155 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~-~~~i~~~~~-----  222 (337)
T 1o6l_A          155 GISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERL-FELILMEEI-----  222 (337)
T ss_dssp             SCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHH-HHHHHHCCC-----
T ss_pred             cccCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHH-HHHHHcCCC-----
Confidence            43222 223456799999999999999999999999999999999999999964321     111 122221111     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                       .++.    .....+.+++..|++.||++||     +++|+++
T Consensus       223 -~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          223 -RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence             1221    2234667888899999999999     8999874

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.2e-41  Score=352.34  Aligned_cols=268  Identities=24%  Similarity=0.392  Sum_probs=213.9

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeee
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALR  380 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~  380 (614)
                      +..++++...++|...+.||+|+||.||+|+..      +++.||||.+.... ......+.+|++++++++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334455566778999999999999999999854      36889999997533 34456789999999999999999999


Q ss_pred             eeeecccCCCCceEEEEEeecCCCChhhhhhcCC--------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       381 g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~--------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                      +++.     ++...++||||+++|+|.+++....        ...+++..+++|+.|+++||+|||   +.+|+||||||
T Consensus        95 ~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp  166 (322)
T 1p4o_A           95 GVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAA  166 (322)
T ss_dssp             EEEC-----SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSG
T ss_pred             EEEc-----cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCcc
Confidence            9986     5567899999999999999996522        246799999999999999999999   88999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~  530 (614)
                      +|||++.++.+||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||++ |+.|+.....
T Consensus       167 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  246 (322)
T 1p4o_A          167 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN  246 (322)
T ss_dssp             GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred             ceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence            999999999999999999975433221 12233457889999999999999999999999999999999 8888854322


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      .      .....+..+....         ........+.+++..|++.||++|||+.|+++.|+....
T Consensus       247 ~------~~~~~~~~~~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 E------QVLRFVMEGGLLD---------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             H------HHHHHHHTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             H------HHHHHHHcCCcCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            1      1122222222211         112233467788999999999999999999999988644

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=356.63  Aligned_cols=252  Identities=20%  Similarity=0.234  Sum_probs=206.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||+|.+..........+.+|+++++.++||||+++++++.     ++...+
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~  124 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMV  124 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEEE
Confidence            357999999999999999999965 68999999998766666678999999999999999999999987     567899


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC--CCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE--AFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~--~~~~kl~DFGla~~  473 (614)
                      +||||+++|+|.+++... ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.  ++.+||+|||+++.
T Consensus       125 lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~  200 (387)
T 1kob_A          125 LILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATK  200 (387)
T ss_dssp             EEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEeccccee
Confidence            999999999999999653 246999999999999999999999   889999999999999974  57899999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ......  .....||+.|+|||++.+..++.++||||||+++|||++|+.||......     +.. ..+..+..     
T Consensus       201 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~-----~~~-~~i~~~~~-----  267 (387)
T 1kob_A          201 LNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ETL-QNVKRCDW-----  267 (387)
T ss_dssp             CCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHH-HHHHHCCC-----
T ss_pred             cCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH-----HHH-HHHHhCCC-----
Confidence            654322  23346999999999999999999999999999999999999999643221     111 11122111     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       .............+.+++..|++.||++|||+.|+++
T Consensus       268 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          268 -EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             -CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence             1111112233456788999999999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.9e-40  Score=336.27  Aligned_cols=259  Identities=22%  Similarity=0.291  Sum_probs=205.7

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||.||+|+. .+|+.||||++.....  .+++.+|+++++.++|++++..++++..    ++...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~   81 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNV   81 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccC----CCCceE
Confidence            46899999999999999999996 5799999999875432  3468899999999999988887777653    456789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE---CCCCcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL---d~~~~~kl~DFGla~  472 (614)
                      +||||+ +++|.+++.... ..+++..++.|+.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++
T Consensus        82 lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            999999 999999996433 46999999999999999999999   8899999999999999   588999999999998


Q ss_pred             eCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCcc--chhhHHHHHHHH
Q 043267          473 FNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS--VLLSDWAWELVK  544 (614)
Q Consensus       473 ~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~--~~l~~~~~~~~~  544 (614)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ..+.........
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence            76543321      1345679999999999999999999999999999999999999996543221  111111111110


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       .. .+..    ..    .....+.+++..|++.||++|||+.++++.|+..
T Consensus       237 -~~-~~~~----~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          237 -TP-IEVL----CK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -SC-HHHH----TT----TSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -Cc-hHHH----Hh----hCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence             00 0001    11    1234677889999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-40  Score=339.67  Aligned_cols=258  Identities=25%  Similarity=0.364  Sum_probs=208.1

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC------
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP------  388 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~------  388 (614)
                      ..++|+..+.||+|+||.||+|+.. +|+.||||+++...    +.+.+|++++++++||||+++++++.....      
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4457999999999999999999975 79999999997643    356789999999999999999998753110      


Q ss_pred             -----CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          389 -----LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       389 -----~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                           ......++||||+++|+|.+++.......+++..++.|+.|+++||.|||   +.+|+||||||+|||+++++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCE
Confidence                 12455799999999999999998765567999999999999999999999   8899999999999999999999


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      ||+|||+++.......  .....||+.|+|||.+.+..++.++||||||+++|||++|..|+....        -.+...
T Consensus       162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~~~  231 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFTDL  231 (284)
T ss_dssp             EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHHHH
T ss_pred             EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHHHh
Confidence            9999999987654322  234568999999999999999999999999999999999998874211        111222


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCCc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNI  602 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~  602 (614)
                      ..+.        ++..    ....+.+++..|++.||++|||+.|+++.|+.....+..
T Consensus       232 ~~~~--------~~~~----~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          232 RDGI--------ISDI----FDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HTTC--------CCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             hccc--------cccc----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            2221        2221    223467788899999999999999999999887655543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=356.29  Aligned_cols=249  Identities=23%  Similarity=0.302  Sum_probs=198.6

Q ss_pred             ccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          320 FSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       320 f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +...+.||+|+||.||+|+. .+|+.||||+++.......+++.+|++++++++||||+++++++.     +....++||
T Consensus        91 ~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~lv~  165 (373)
T 2x4f_A           91 VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIVLVM  165 (373)
T ss_dssp             EEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEEEEE
T ss_pred             eecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEEEEE
Confidence            34467899999999999996 478999999998766667788999999999999999999999987     567889999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE--CCCCcEEEeecCCceeCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL--DEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL--d~~~~~kl~DFGla~~~~~  476 (614)
                      ||+++|+|.+++... ...+++..++.++.|+++||+|||   +.+|+||||||+|||+  ++++.+||+|||+++....
T Consensus       166 E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~  241 (373)
T 2x4f_A          166 EYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP  241 (373)
T ss_dssp             ECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred             eCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence            999999999998753 346999999999999999999999   8899999999999999  6778999999999987654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ...  .....||+.|+|||++.++.++.++||||||+++|||++|+.||......     +....... +..      .+
T Consensus       242 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~-----~~~~~i~~-~~~------~~  307 (373)
T 2x4f_A          242 REK--LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA-----ETLNNILA-CRW------DL  307 (373)
T ss_dssp             TCB--CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHH-TCC------CS
T ss_pred             ccc--cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHh-ccC------CC
Confidence            322  23456999999999999999999999999999999999999999643321     11112211 111      01


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...........+.+++..|++.||++|||+.|+++
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11111223456788999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=351.38  Aligned_cols=250  Identities=20%  Similarity=0.241  Sum_probs=195.2

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccc--cceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKH--VNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H--~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||++...+++.||||++...  .....+.+.+|++++++++|  +||+++++++.     .+.
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~   82 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ   82 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eCC
Confidence            4578999999999999999999988999999998743  34445789999999999987  99999999987     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||| +.+|+|.+++...  ..+++.++..|+.|+++||.|||   +.+|+||||||+|||++ ++.+||+|||+++
T Consensus        83 ~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~  155 (343)
T 3dbq_A           83 YIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIAN  155 (343)
T ss_dssp             EEEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred             EEEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccc
Confidence            8899999 5688999999764  46999999999999999999999   88999999999999997 5789999999998


Q ss_pred             eCCCCCcc-ccccccCCCCcCchhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          473 FNPEGITH-LTTRVAGTLGYVAPEYALY-----------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       473 ~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                      ........ ......||+.|+|||++.+           +.++.++||||||+++|||++|+.||.......    ....
T Consensus       156 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~----~~~~  231 (343)
T 3dbq_A          156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLH  231 (343)
T ss_dssp             CC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHH
T ss_pred             ccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH----HHHH
Confidence            66543322 3345679999999999865           788999999999999999999999996432211    0111


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                               ..++.......+......+.+++..|++.||.+|||+.|+++
T Consensus       232 ---------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          232 ---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             ---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                     111111111112222345778889999999999999999985

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.1e-40  Score=350.80  Aligned_cols=209  Identities=26%  Similarity=0.333  Sum_probs=183.3

Q ss_pred             CcccCHHHHHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-----ccceee
Q 043267          305 LARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-----HVNLVA  378 (614)
Q Consensus       305 ~~~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-----H~niv~  378 (614)
                      ...+++++.....++|...+.||+|+||.||+++. .+|+.||||+++. .......+..|++++++++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            34556666666778999999999999999999997 4789999999975 3344566788999999996     999999


Q ss_pred             eeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       379 l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      +++++.     .....++||||+ +++|.+++.......+++..+..|+.|++.||+|||   +.+|+||||||+|||++
T Consensus       101 ~~~~~~-----~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~  171 (360)
T 3llt_A          101 YHGKFM-----YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLD  171 (360)
T ss_dssp             EEEEEE-----ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEES
T ss_pred             ccceee-----ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEc
Confidence            999987     456789999999 999999998876667999999999999999999999   89999999999999997


Q ss_pred             C-------------------------CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHH
Q 043267          459 E-------------------------AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGV  513 (614)
Q Consensus       459 ~-------------------------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gv  513 (614)
                      .                         ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  247 (360)
T 3llt_A          172 DPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC  247 (360)
T ss_dssp             CTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             cccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence            5                         889999999999865432    23457899999999999999999999999999


Q ss_pred             HHHHHHhCCCCccc
Q 043267          514 VLLELLSGKKACEI  527 (614)
Q Consensus       514 ll~ElltG~~p~~~  527 (614)
                      ++|||++|+.||..
T Consensus       248 il~ell~g~~pf~~  261 (360)
T 3llt_A          248 VLAELYTGSLLFRT  261 (360)
T ss_dssp             HHHHHHHSSCSCCC
T ss_pred             HHHHHHHCCCCCCC
Confidence            99999999999954

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-40  Score=351.07  Aligned_cols=253  Identities=22%  Similarity=0.220  Sum_probs=202.8

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-----hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-----KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-----~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||++....     ....+.+.+|+++++.++||||+++++++.     +
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~   97 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYS-----S   97 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----E
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            347999999999999999999964 78999999986321     224577999999999999999999999987     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc---EEE
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---AKV  465 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~---~kl  465 (614)
                      +...++||||+++|+|.+++...  ....+++..+..|+.|+++||+|||   +.+|+||||||+|||++.++.   +||
T Consensus        98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl  174 (351)
T 3c0i_A           98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKL  174 (351)
T ss_dssp             TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEE
T ss_pred             CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEE
Confidence            67889999999999999888653  3346899999999999999999999   889999999999999987655   999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      +|||+++....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....       -....+..
T Consensus       175 ~Dfg~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-------~~~~~i~~  246 (351)
T 3c0i_A          175 GGFGVAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-------RLFEGIIK  246 (351)
T ss_dssp             CCCTTCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-------HHHHHHHH
T ss_pred             ecCcceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-------HHHHHHHc
Confidence            99999987654322 23445799999999999999999999999999999999999999964221       11222222


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +....      ...........+.+++..|++.||++|||+.|+++
T Consensus       247 ~~~~~------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          247 GKYKM------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             TCCCC------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCCCC------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            22110      00000122346778899999999999999999985

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.8e-41  Score=364.62  Aligned_cols=260  Identities=20%  Similarity=0.213  Sum_probs=208.4

Q ss_pred             CHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeee
Q 043267          309 KIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYST  384 (614)
Q Consensus       309 ~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~  384 (614)
                      ++.+++...++|...+.||+|+||+||+++.. +|+.||+|+++...   ....+.+.+|+++++.++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            34566667789999999999999999999975 68899999997521   122345789999999999999999999987


Q ss_pred             cccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                           ++...++||||+++|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++|
T Consensus       140 -----~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ik  208 (410)
T 3v8s_A          140 -----DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLK  208 (410)
T ss_dssp             -----CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEE
T ss_pred             -----ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEE
Confidence                 567899999999999999999653   5899999999999999999999   88999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhccCC----CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGK----LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~----~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                      |+|||+++..............||+.|+|||++.+..    ++.++|||||||++|||++|+.||......     +.. 
T Consensus       209 L~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-----~~~-  282 (410)
T 3v8s_A          209 LADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-----GTY-  282 (410)
T ss_dssp             ECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHH-
T ss_pred             EeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-----hHH-
Confidence            9999999876655444445678999999999998765    889999999999999999999999643211     111 


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCC--CCCHHHHHH
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQA--RPTMDQIVK  591 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~  591 (614)
                      ..+..+.    .....+.  .......+.+++..|++.+|.+  ||+++|+++
T Consensus       283 ~~i~~~~----~~~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          283 SKIMNHK----NSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHTHH----HHCCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             HHHHhcc----ccccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            1111110    0011111  1122345677888899999988  999999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=339.72  Aligned_cols=254  Identities=25%  Similarity=0.385  Sum_probs=206.4

Q ss_pred             cCccccc-eecccCceEEEEeEcC---CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSREN-IIGKGGYGNVYKGMLP---NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+ .||+|+||.||+|+..   ++..||||+++.. .....+++.+|++++++++||||+++++++.      .+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~   82 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE   82 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec------CC
Confidence            3455555 8999999999999853   6788999999764 3445678999999999999999999999984      34


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++++|.+++... ...+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+++
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~  158 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSK  158 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECccccee
Confidence            589999999999999999653 356999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          473 FNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ........  ......||+.|+|||.+.+..++.++||||||+++|||++ |+.||.......      ....+..+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~~i~~~~~~  232 (287)
T 1u59_A          159 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRM  232 (287)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCC
T ss_pred             eeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------HHHHHhcCCcC
Confidence            76543332  2233456899999999999999999999999999999999 999996443211      12223333211


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                               ..+......+.+++..|++.||++||++.++++.|+..
T Consensus       233 ---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          233 ---------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ---------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                     11223345677889999999999999999999999875

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=360.90  Aligned_cols=253  Identities=22%  Similarity=0.256  Sum_probs=204.9

Q ss_pred             HhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ..++|...+.||+|+||.||+++. .+|+.||+|++....  ....+.+.+|+++++.++||||+++++++.     ++.
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-----~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS-----EEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE-----CSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE-----ECC
Confidence            456799999999999999999985 478999999997533  334567899999999999999999999987     667


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC---CCCcEEEeecC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD---EAFEAKVGDFG  469 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd---~~~~~kl~DFG  469 (614)
                      ..++||||+++|+|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||++   .++.+||+|||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            889999999999999999764  36999999999999999999999   88999999999999998   56889999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +++....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......      -....+..+...
T Consensus       159 ~a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~~  231 (444)
T 3soa_A          159 LAIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAYD  231 (444)
T ss_dssp             SCBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC
T ss_pred             eeEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCCC
Confidence            9986654322 234467999999999999999999999999999999999999999543221      112233333221


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            .+..........+.+++..|++.||++|||+.|+++
T Consensus       232 ------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          232 ------FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             ------CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ------CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                  111111233456778899999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.2e-41  Score=344.52  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=201.5

Q ss_pred             cCccccceecccCceEEEEeEcCC-C-------cEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN-G-------TEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~-g-------~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      ++|...+.||+|+||.||+|+... +       ..||+|++........+.+.+|++++++++||||+++++++.     
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   82 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV-----   82 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC-----
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----
Confidence            478889999999999999998643 3       579999998766667788999999999999999999999987     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc-------
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE-------  462 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~-------  462 (614)
                      .+...++||||+++|+|.+++.... ..+++..++.|+.|+++||.|||   +.+|+||||||+|||++.++.       
T Consensus        83 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           83 CGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             CTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             eCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence            4567799999999999999997643 45999999999999999999999   889999999999999998887       


Q ss_pred             -EEEeecCCceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          463 -AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       463 -~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                       +||+|||++.....     .....||+.|+|||.+.+ ..++.++||||||+++|||++|..|+.......    . ..
T Consensus       159 ~~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~----~-~~  228 (289)
T 4fvq_A          159 FIKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ----R-KL  228 (289)
T ss_dssp             EEEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH----H-HH
T ss_pred             eeeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH----H-HH
Confidence             99999999864432     123457899999999987 779999999999999999999655543221110    0 11


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCC
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL  599 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  599 (614)
                      ......       ..++..    ....+.+++..|++.||++|||+.|+++.|+.....
T Consensus       229 ~~~~~~-------~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          229 QFYEDR-------HQLPAP----KAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HHHHTT-------CCCCCC----SSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             HHhhcc-------CCCCCC----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            111111       111111    123467788889999999999999999999987653

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-40  Score=345.15  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=209.1

Q ss_pred             hcCccccceecccCceEEEEeEc-----CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-----PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-----~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|...+.||+|+||.||+++.     .+|+.||||++........+.+.+|++++++++||||+++++++...   +.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~  116 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GR  116 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC------
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---CC
Confidence            34688889999999999999983     46899999999876666677899999999999999999999987632   23


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++|+|.+++.... ..+++..+++++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       117 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          117 RNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             -CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence            46799999999999999997643 46999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCc---------c-chhhHHH
Q 043267          472 KFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGK---------S-VLLSDWA  539 (614)
Q Consensus       472 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~---------~-~~l~~~~  539 (614)
                      +........  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......         . .......
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            876544322  223345788899999999999999999999999999999999987532110         0 0000111


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .+.+..+.         ...........+.+++..|++.||++|||+.|+++.|+..
T Consensus       273 ~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          273 IELLKNNG---------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHTTC---------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhcCC---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11122111         1111223345678899999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-40  Score=350.20  Aligned_cols=259  Identities=23%  Similarity=0.214  Sum_probs=200.4

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-----ChhhhHHHHHHHHHHHHccccceeeeeeeeecc
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-----SKAGDANFKHEVEIIASVKHVNLVALRGYSTAT  386 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-----~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~  386 (614)
                      +....++|...+.||+|+||.||+|+.. ++..||||++...     +....+.+.+|++++++++||||+++++++.  
T Consensus        21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~--   98 (345)
T 3hko_A           21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE--   98 (345)
T ss_dssp             HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE--
T ss_pred             hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc--
Confidence            4556678999999999999999999964 6889999998642     2344578999999999999999999999986  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcC--------------------------------------CCcCCChHHHHHHHH
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGS--------------------------------------GMKKLSWPIRLRIAL  428 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~--------------------------------------~~~~l~~~~~~~I~~  428 (614)
                         ++...++||||+++|+|.+++...                                      ....+++..+..|+.
T Consensus        99 ---~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           99 ---DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             ---CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             ---cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence               567899999999999999998521                                      122346778889999


Q ss_pred             HHHHHHHHHhhcCCCceEEeccCCCCeEECCCC--cEEEeecCCceeCCCC---CccccccccCCCCcCchhhhcc--CC
Q 043267          429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAF--EAKVGDFGLAKFNPEG---ITHLTTRVAGTLGYVAPEYALY--GK  501 (614)
Q Consensus       429 ~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~--~~kl~DFGla~~~~~~---~~~~~~~~~gt~~Y~APE~~~~--~~  501 (614)
                      |+++||+|||   +.+|+||||||+|||++.++  .+||+|||+++.....   .........||+.|+|||.+.+  ..
T Consensus       176 qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          176 QIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            9999999999   88999999999999998776  8999999999865321   1122345679999999999975  68


Q ss_pred             CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCC
Q 043267          502 LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQ  581 (614)
Q Consensus       502 ~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~  581 (614)
                      ++.++||||||+++|||++|+.||.....     .+............       ...........+.+++..|++.||.
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~  320 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVND-----ADTISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVD  320 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTT
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChh
Confidence            89999999999999999999999964332     11222222222111       1111122345678899999999999


Q ss_pred             CCCCHHHHHH
Q 043267          582 ARPTMDQIVK  591 (614)
Q Consensus       582 ~RPt~~eVl~  591 (614)
                      +|||+.|+++
T Consensus       321 ~Rps~~~~l~  330 (345)
T 3hko_A          321 ERFDAMRALQ  330 (345)
T ss_dssp             TSCCHHHHHH
T ss_pred             HCCCHHHHhc
Confidence            9999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=351.04  Aligned_cols=251  Identities=23%  Similarity=0.288  Sum_probs=189.7

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ..++|...+.||+|+||.||+|+.. +++.||||+++...  ..+.+.+|++++++++||||+++++++.     +....
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~  123 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEI  123 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeE
Confidence            3467999999999999999999976 58899999997643  3456889999999999999999999987     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~~kl~DFGla  471 (614)
                      ++||||+++|+|.+++...  ..+++.++..++.|+++||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       124 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          124 SLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             EEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            9999999999999999654  46999999999999999999999   889999999999999975   899999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......     .....+..+...  
T Consensus       199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~i~~~~~~--  269 (349)
T 2w4o_A          199 KIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ-----FMFRRILNCEYY--  269 (349)
T ss_dssp             ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH-----HHHHHHHTTCCC--
T ss_pred             cccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH-----HHHHHHHhCCCc--
Confidence            8654321  2334679999999999999999999999999999999999999996433221     122222222111  


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          .......+....+.+++..|++.||++|||+.|+++
T Consensus       270 ----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          270 ----FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ----CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                111111233456788999999999999999999986

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-40  Score=349.66  Aligned_cols=256  Identities=28%  Similarity=0.439  Sum_probs=200.1

Q ss_pred             cCccccceecccCceEEEEeEcCC-----CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN-----GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|...+.||+|+||.||+|+...     +..||||+++.. .......+.+|++++++++||||+++++++.     +.
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  118 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY  118 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe-----cC
Confidence            456778999999999999998642     246999999754 3344567899999999999999999999986     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++|+|.+++... ...+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       119 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  194 (333)
T 1mqb_A          119 KPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLS  194 (333)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcc
Confidence            7789999999999999999764 357999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          472 KFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       472 ~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      +........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......      .....+..+..
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~~~~~  268 (333)
T 1mqb_A          195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFR  268 (333)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC
T ss_pred             hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHCCCc
Confidence            865543221  2233456889999999999999999999999999999999 99999543221      11222333211


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      .         .........+.+++..||+.||++||++.+++++|+...
T Consensus       269 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          269 L---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             C---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             C---------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1         111223456778899999999999999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3e-40  Score=340.00  Aligned_cols=256  Identities=26%  Similarity=0.386  Sum_probs=201.4

Q ss_pred             cCccccceecccCceEEEEeEcCC----CcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .+|...+.||+|+||.||+|+..+    +..||||.+.... ....+.+.+|++++++++||||+++++++..    .+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~  100 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG  100 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSS
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CCC
Confidence            468888999999999999999642    2358999987533 3445779999999999999999999998753    445


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++... ...+++..++.|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++
T Consensus       101 ~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          101 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence            779999999999999999653 356899999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCc---cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhC-CCCcccccCccchhhHHHHHHHHcCCc
Q 043267          473 FNPEGIT---HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSG-KKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       473 ~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG-~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      .......   .......||+.|+|||.+.+..++.++||||+|+++|||++| ..|+........      ......+..
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~------~~~~~~~~~  250 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQGRR  250 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH------HHHHHTTCC
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH------HHHHhcCCC
Confidence            6544322   123345678899999999999999999999999999999995 555543322111      111222211


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .         ..+......+.+++..|++.||++|||+.|+++.|+..
T Consensus       251 ~---------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          251 L---------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             C---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1         01112234677889999999999999999999999875

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=341.23  Aligned_cols=268  Identities=24%  Similarity=0.254  Sum_probs=201.7

Q ss_pred             HhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC-----hhhhHHHHHHHHHHHHcc---ccceeeeeeeeecc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS-----KAGDANFKHEVEIIASVK---HVNLVALRGYSTAT  386 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-----~~~~~~f~~Ei~il~~l~---H~niv~l~g~~~~~  386 (614)
                      .+++|+..+.||+|+||+||+|+. .+|+.||||++....     ......+.+|++++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            456899999999999999999996 478999999986322     122346778888887775   99999999998754


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEe
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~  466 (614)
                      ........++||||+. |+|.+++.......+++.++..|+.|+++||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEe
Confidence            3222336789999997 69999998776667999999999999999999999   8899999999999999999999999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......  ......+.....
T Consensus       163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~  238 (308)
T 3g33_A          163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLP  238 (308)
T ss_dssp             SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred             eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCC
Confidence            999998654322  2345678999999999999999999999999999999999999996433211  111111111000


Q ss_pred             Cchh------hhhccCCCCC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLD------VIEENMPEME-------LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~------~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....      ..........       .++..+.+.+++..|++.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0000      0000000000       0123456788999999999999999999875

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-41  Score=363.79  Aligned_cols=263  Identities=19%  Similarity=0.227  Sum_probs=208.3

Q ss_pred             cCHHHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeee
Q 043267          308 FKIEEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYS  383 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~  383 (614)
                      +.+++++...++|+..+.||+|+||+||+++.+ +|+.||||++++..   ....+.+.+|.+++..++||||+++++++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            455666777889999999999999999999975 79999999997532   22234588999999999999999999998


Q ss_pred             ecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcE
Q 043267          384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEA  463 (614)
Q Consensus       384 ~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~  463 (614)
                      .     +.+..++||||+++|+|.+++.+.+ ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++
T Consensus       131 ~-----~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~v  201 (412)
T 2vd5_A          131 Q-----DENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHI  201 (412)
T ss_dssp             E-----CSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCE
T ss_pred             e-----eCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCE
Confidence            7     5678999999999999999997643 46999999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhc-------cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-------YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS  536 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~  536 (614)
                      ||+|||+++..............||+.|+|||++.       .+.++.++|||||||++|||++|+.||......     
T Consensus       202 kL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----  276 (412)
T 2vd5_A          202 RLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-----  276 (412)
T ss_dssp             EECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----
T ss_pred             EEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-----
Confidence            99999999876654443444568999999999987       467899999999999999999999999643321     


Q ss_pred             HHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCC---CCHHHHHH
Q 043267          537 DWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR---PTMDQIVK  591 (614)
Q Consensus       537 ~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~eVl~  591 (614)
                      +....... ..  .  ...++. ........+.+++..|++ +|++|   |+++|+++
T Consensus       277 ~~~~~i~~-~~--~--~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          277 ETYGKIVH-YK--E--HLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHHHHHT-HH--H--HCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHHHHHh-cc--c--CcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            11111111 00  0  001110 011233467788889999 99998   68998874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.6e-41  Score=341.23  Aligned_cols=251  Identities=30%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      .++|...+.||+|+||.||+++. +|+.||||.++...  ..+.+.+|++++++++||||+++++++..    .....++
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~~l   92 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYI   92 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEE
T ss_pred             hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCceEE
Confidence            35788999999999999999987 58899999997543  45678999999999999999999998753    3446899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++.......+++..+++++.|+++||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            999999999999997655445899999999999999999999   88999999999999999999999999999975443


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......      ....+..+..       
T Consensus       170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~~~~~~~~~-------  232 (278)
T 1byg_A          170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VVPRVEKGYK-------  232 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HHHHHTTTCC-------
T ss_pred             c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHhcCCC-------
Confidence            2    123357889999999999999999999999999999998 999986433211      1122222211       


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                        ..........+.+++..|++.||++|||+.|+++.|+..
T Consensus       233 --~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          233 --MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence              111222345677888999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.1e-41  Score=350.25  Aligned_cols=258  Identities=24%  Similarity=0.376  Sum_probs=200.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcE----EEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTE----VAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~----VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ++|...+.||+|+||.||+|+.. +|+.    ||+|.+... .....+.+.+|++++++++||||+++++++..      
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------   88 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   88 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES------
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec------
Confidence            57899999999999999999954 4544    577777543 34456789999999999999999999999862      


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++|+||+++|+|.+++.... ..+++..++.|+.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a  164 (327)
T 3lzb_A           89 STVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA  164 (327)
T ss_dssp             SSEEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred             CCceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence            34789999999999999997643 46999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......      ....+..+.. 
T Consensus       165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~~~~~~~~~~-  237 (327)
T 3lzb_A          165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGER-  237 (327)
T ss_dssp             ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCC-
T ss_pred             eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCC-
Confidence            86543322 22334457889999999999999999999999999999999 999996543321      1122222221 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                              ..........+.+++..|++.||++|||+.|+++.|+.....|
T Consensus       238 --------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          238 --------LPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             --------CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             --------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                    1112223446778899999999999999999999998865433

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.6e-40  Score=354.44  Aligned_cols=248  Identities=22%  Similarity=0.307  Sum_probs=198.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...++||+|+||+||+++.. +++.||||++++..   ....+.+.+|..++.++ +||||+++++++.     +..
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~~  126 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TES  126 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE-----ECC
Confidence            47899999999999999999965 68899999997532   23344678899999887 8999999999987     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus       127 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          127 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            899999999999999999764  36999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCcc---chhhHHHHHHHHcCCch
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS---VLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~---~~l~~~~~~~~~~g~~~  549 (614)
                      ..... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......   ....+...+.+..+.. 
T Consensus       202 ~~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-  279 (396)
T 4dc2_A          202 EGLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-  279 (396)
T ss_dssp             CCCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC-
T ss_pred             ecccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc-
Confidence            53322 223445689999999999999999999999999999999999999995432211   1112223333332221 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                           .++    ......+.+++..|++.||++||++
T Consensus       280 -----~~p----~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          280 -----RIP----RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             -----CCC----TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             -----CCC----CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence                 122    2234467788999999999999995

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-40  Score=352.27  Aligned_cols=262  Identities=16%  Similarity=0.140  Sum_probs=204.8

Q ss_pred             hcCccccceecccCceEEEEeEcCC---------CcEEEEEEeecCChhhhHHHHHHHHHHHHccccceee---------
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPN---------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA---------  378 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~---------  378 (614)
                      .++|...+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++|||+++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3579999999999999999999753         789999999753     35789999999999999998         


Q ss_pred             ------eeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCC
Q 043267          379 ------LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKA  452 (614)
Q Consensus       379 ------l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp  452 (614)
                            +++++..    ++...++||||+ +|+|.+++.......+++..++.|+.|+++||.|||   +.+|+||||||
T Consensus       116 ~~~i~~~~~~~~~----~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp  187 (352)
T 2jii_A          116 LLAIPTCMGFGVH----QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTA  187 (352)
T ss_dssp             TCSCCCCCEEEEE----TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCG
T ss_pred             ccCccchhhcccc----CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCH
Confidence                  4445442    357889999999 999999998765568999999999999999999999   88999999999


Q ss_pred             CCeEECCCC--cEEEeecCCceeCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Q 043267          453 SNILLDEAF--EAKVGDFGLAKFNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKA  524 (614)
Q Consensus       453 ~NILLd~~~--~~kl~DFGla~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p  524 (614)
                      +|||++.++  .+||+|||+++........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  9999999999865432211      12345799999999999999999999999999999999999999


Q ss_pred             cccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          525 CEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       525 ~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      |.........+..........  .....+....   .......+.+++..|++.||++|||+++++++|+..
T Consensus       268 f~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          268 WTNCLPNTEDIMKQKQKFVDK--PGPFVGPCGH---WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TGGGTTCHHHHHHHHHHHHHS--CCCEECTTSC---EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccCCcCHHHHHHHHHhccCC--hhhhhhhccc---cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            975542222222222111111  1111111110   112235677888999999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-40  Score=338.18  Aligned_cols=256  Identities=25%  Similarity=0.317  Sum_probs=202.0

Q ss_pred             CccccceecccCceEEEEeEcC-C---CcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-N---GTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~---g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .|...+.||+|+||.||+|+.. +   +..||+|.+.... ....+.+.+|++++++++||||+++++++..    .+..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~   97 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP----PEGL   97 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SSSC
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec----CCCC
Confidence            4666789999999999999853 2   3379999997533 3455788999999999999999999999863    2344


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++|+||+.+|+|.+++... ...+++..++.|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        98 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  173 (298)
T 3pls_A           98 PHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARD  173 (298)
T ss_dssp             CEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred             cEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence            58999999999999999663 357899999999999999999999   88999999999999999999999999999985


Q ss_pred             CCCCCc---cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          474 NPEGIT---HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       474 ~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ......   .......+|+.|+|||.+.+..++.++||||||+++|||++|..|+....... .    .......+... 
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~-~----~~~~~~~~~~~-  247 (298)
T 3pls_A          174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF-D----LTHFLAQGRRL-  247 (298)
T ss_dssp             TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG-G----HHHHHHTTCCC-
T ss_pred             ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH-H----HHHHhhcCCCC-
Confidence            543221   12334567899999999999999999999999999999999666653222111 1    11222222211 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                              .........+.+++..|++.||++|||+.++++.|+..
T Consensus       248 --------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          248 --------PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             --------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------CCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                    11122234677889999999999999999999999875

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-40  Score=342.27  Aligned_cols=243  Identities=26%  Similarity=0.350  Sum_probs=201.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||+||+++.. +|+.||+|+++...   ....+.+.+|+.+++.++||||+++++++.     +...
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~-----~~~~   80 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   80 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEE-----eCCE
Confidence            57899999999999999999965 78999999997532   233566889999999999999999999986     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus        81 ~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           81 IFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCccee
Confidence            99999999999999999764  36899999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ....    .....||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     .+.. ..+..+..     
T Consensus       156 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~-~~i~~~~~-----  220 (318)
T 1fot_A          156 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MKTY-EKILNAEL-----  220 (318)
T ss_dssp             CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHH-HHHHHCCC-----
T ss_pred             cCCc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHH-HHHHhCCC-----
Confidence            5432    3346799999999999999999999999999999999999999964321     1111 11212211     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIV  590 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl  590 (614)
                       .++    ......+.+++..|++.||++||     +++|++
T Consensus       221 -~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~  257 (318)
T 1fot_A          221 -RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK  257 (318)
T ss_dssp             -CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHH
T ss_pred             -CCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHh
Confidence             112    22234677888899999999999     888887

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=6.4e-40  Score=334.84  Aligned_cols=251  Identities=25%  Similarity=0.311  Sum_probs=204.0

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||.||++... +|+.||+|++...  +....+.+.+|++++++++||||+++++++.     ++..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   79 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ-----EESF   79 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEE-----cCCE
Confidence            468999999999999999999965 6899999999643  3444567889999999999999999999986     5677


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc---EEEeecCC
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGL  470 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~---~kl~DFGl  470 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus        80 ~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~  154 (284)
T 3kk8_A           80 HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGL  154 (284)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeecee
Confidence            89999999999999988664  36999999999999999999999   889999999999999987665   99999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      +.......  ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......     . ....+..+... 
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~-~~~~~~~~~~~-  225 (284)
T 3kk8_A          155 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----R-LYAQIKAGAYD-  225 (284)
T ss_dssp             CEECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHTCCC-
T ss_pred             eEEcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----H-HHHHHHhcccc-
Confidence            98665432  223467999999999999999999999999999999999999999543221     1 11222222111 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           .+..........+.+++..|++.||++|||+.|+++
T Consensus       226 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          226 -----YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                 111111223346778899999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=377.82  Aligned_cols=253  Identities=25%  Similarity=0.397  Sum_probs=201.5

Q ss_pred             Cccccc-eecccCceEEEEeEcC---CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          319 NFSREN-IIGKGGYGNVYKGMLP---NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~-~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++...+ .||+|+||.||+|.+.   ++..||||+++... ....+++.+|++++++++||||+++++++.      .+.
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~------~~~  409 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AEA  409 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEE------SSS
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEec------cCC
Confidence            344444 7999999999999863   56789999997643 345678999999999999999999999985      245


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++... ...+++..++.|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            89999999999999999654 356999999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCccc--cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          474 NPEGITHL--TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       474 ~~~~~~~~--~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ........  .....+|+.|+|||++.++.++.++|||||||++|||++ |+.||......+      +...+..+....
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~------~~~~i~~~~~~~  559 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRME  559 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH------HHHHHHTTCCCC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCCC
Confidence            65433222  222345789999999999999999999999999999998 999996544321      223334443211


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                               .+......+.+++..||+.||++||++.+|++.|+..
T Consensus       560 ---------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          560 ---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             ---------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                     1222345677889999999999999999999999874

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.4e-40  Score=346.55  Aligned_cols=268  Identities=18%  Similarity=0.182  Sum_probs=201.7

Q ss_pred             hcCccccceecccCceEEEEeEcC----CCcEEEEEEeecCChh-----------hhHHHHHHHHHHHHccccceeeeee
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNCSKA-----------GDANFKHEVEIIASVKHVNLVALRG  381 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~~~~-----------~~~~f~~Ei~il~~l~H~niv~l~g  381 (614)
                      .++|...+.||+|+||.||+|+..    ++..||||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357899999999999999999975    5788999998754321           1234667888999999999999999


Q ss_pred             eeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC
Q 043267          382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF  461 (614)
Q Consensus       382 ~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~  461 (614)
                      ++..... .....++||||+ +++|.+++...+  .+++.+++.|+.|++.||+|||   +.+|+||||||+|||++.++
T Consensus       116 ~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFK-GRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESS-SCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSS
T ss_pred             ccccccC-CCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCC
Confidence            9874321 367889999999 999999996544  7999999999999999999999   88999999999999999887


Q ss_pred             --cEEEeecCCceeCCCCCc------cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc
Q 043267          462 --EAKVGDFGLAKFNPEGIT------HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV  533 (614)
Q Consensus       462 --~~kl~DFGla~~~~~~~~------~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~  533 (614)
                        .+||+|||+++.......      .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999986643221      112446799999999999999999999999999999999999999964332222


Q ss_pred             hhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          534 LLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       534 ~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ...... ..... ...+.+....+..   .....+.+++..|++.||++|||+.+|+++|+..
T Consensus       269 ~~~~~~-~~~~~-~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          269 AVQTAK-TNLLD-ELPQSVLKWAPSG---SSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHH-HHHHH-TTTHHHHHHSCTT---SCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHH-Hhhcc-cccHHHHhhcccc---ccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            211111 11111 1112222222111   2234677888899999999999999999999885

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5e-40  Score=337.84  Aligned_cols=262  Identities=19%  Similarity=0.228  Sum_probs=199.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++....  ......+.+|++++++++||||+++++++.     ++...
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEE-----eCCEE
Confidence            47889999999999999999975 68999999997432  333467889999999999999999999987     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++ +|.+.+... ...+++..+..|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        77 ~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            999999975 666665443 356999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC---chh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK---TLD  550 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~---~~~  550 (614)
                      .... .......||+.|+|||.+.+.. ++.++||||+|+++|||++|+.|+.........+. ...+......   ...
T Consensus       152 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~-~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          152 GIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH-HHHHHHCCCCTTTCTT
T ss_pred             CCcc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHH-HHHHHhCCCChhhhhh
Confidence            5332 2234457899999999998765 89999999999999999999988643222111111 1111111000   000


Q ss_pred             hh---hc---------cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VI---EE---------NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~---d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..   +.         .......+.....+.+++..|++.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00   00         0000111233456778999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.1e-40  Score=344.04  Aligned_cols=270  Identities=22%  Similarity=0.267  Sum_probs=198.8

Q ss_pred             cCccc-cceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSR-ENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~-~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +.|.. .+.||+|+||.||+++.. +|+.||||++........+.+.+|++++.++ +||||+++++++.     +++..
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~-----~~~~~   86 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFE-----EEDRF   86 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEe-----eCCEE
Confidence            45766 478999999999999954 7899999999876655677899999999995 7999999999987     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc---EEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~---~kl~DFGla  471 (614)
                      ++||||+++|+|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.   +||+|||++
T Consensus        87 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~  161 (316)
T 2ac3_A           87 YLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLG  161 (316)
T ss_dssp             EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCC
T ss_pred             EEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCc
Confidence            9999999999999999764  36899999999999999999999   889999999999999998776   999999998


Q ss_pred             eeCCCCC------ccccccccCCCCcCchhhhcc-----CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh-----
Q 043267          472 KFNPEGI------THLTTRVAGTLGYVAPEYALY-----GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL-----  535 (614)
Q Consensus       472 ~~~~~~~------~~~~~~~~gt~~Y~APE~~~~-----~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l-----  535 (614)
                      +......      ........||+.|+|||.+..     ..++.++||||||+++|||++|+.||..........     
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  241 (316)
T 2ac3_A          162 SGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA  241 (316)
T ss_dssp             C-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----C
T ss_pred             cccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccccc
Confidence            7543211      111233569999999999875     568899999999999999999999996443221100     


Q ss_pred             ----hHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCch
Q 043267          536 ----SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIK  603 (614)
Q Consensus       536 ----~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p  603 (614)
                          .....+.+..+...      .+..........+.+++..|++.||++|||+.|+++  .+.+..+....|
T Consensus       242 ~~~~~~~~~~~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~~~~~  309 (316)
T 2ac3_A          242 CPACQNMLFESIQEGKYE------FPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLP  309 (316)
T ss_dssp             CHHHHHHHHHHHHHCCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---------
T ss_pred             chhHHHHHHHHHhccCcc------cCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCcccCC
Confidence                01112222222110      010000122346788999999999999999999987  444443333333

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=353.11  Aligned_cols=247  Identities=25%  Similarity=0.296  Sum_probs=197.5

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|...+.||+|+||+||+++.. +|+.||||+++..   .....+.+.+|.++++.+ +||||+++++++.     +.
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~-----~~   96 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ-----TP   96 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE-----eC
Confidence            468999999999999999999965 6899999999753   223445678999999998 7999999999987     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||++
T Consensus        97 ~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           97 DRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccce
Confidence            7899999999999999999764  36999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......     + ....+..+..   
T Consensus       172 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~-----~-~~~~i~~~~~---  241 (353)
T 3txo_A          172 KEGICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED-----D-LFEAILNDEV---  241 (353)
T ss_dssp             BCSCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHCCC---
T ss_pred             eecccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH-----H-HHHHHHcCCC---
Confidence            8543222 2334567999999999999999999999999999999999999999643321     1 1122222211   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH------HHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTM------DQIV  590 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~eVl  590 (614)
                         ..+    ......+.+++..|++.||++||++      .|++
T Consensus       242 ---~~p----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il  279 (353)
T 3txo_A          242 ---VYP----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAIL  279 (353)
T ss_dssp             ---CCC----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHH
T ss_pred             ---CCC----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHh
Confidence               111    2233457788899999999999998      6665

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=8.9e-40  Score=352.71  Aligned_cols=267  Identities=21%  Similarity=0.272  Sum_probs=198.4

Q ss_pred             cCcccc-ceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHH-ccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRE-NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIAS-VKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~-l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|... ++||+|+||+||++... +|+.||||+++..     ..+.+|++++.+ .+||||+++++++..... ++...
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~-~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeeccc-CCcEE
Confidence            355555 68999999999999965 6899999999742     456788888754 589999999998753211 35678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~~kl~DFGla  471 (614)
                      ++||||+++|+|.+++.......+++..+..|+.|+++||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence            99999999999999998766667999999999999999999999   889999999999999997   789999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +......  ......||+.|+|||++.++.++.++|||||||++|||++|+.||.........  ......+..+..   
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~i~~~~~---  284 (400)
T 1nxk_A          212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMGQY---  284 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC--CSHHHHHHHTCC---
T ss_pred             cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc--HHHHHHHHcCcc---
Confidence            8654322  234567899999999999999999999999999999999999999644332211  111222222221   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCch
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIK  603 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p  603 (614)
                         ..+..........+.+++..|++.||++|||+.|+++  .+.+....+..|
T Consensus       285 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~  335 (400)
T 1nxk_A          285 ---EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  335 (400)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCCB
T ss_pred             ---cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCCc
Confidence               1111111233456788999999999999999999986  344433444444

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.3e-40  Score=353.96  Aligned_cols=249  Identities=20%  Similarity=0.234  Sum_probs=195.4

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHcc--ccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVK--HVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~--H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||++...+|+.||||++...  .....+.+.+|++++++++  |+||+++++++.     .+..
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~~  130 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQY  130 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCCE
Confidence            469999999999999999999888999999998643  3445678999999999996  599999999987     5567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||| +.+++|.+++....  .+++.++..|+.||++||.|||   +.+|+||||||+|||++ ++.+||+|||+++.
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~  203 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  203 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCC
T ss_pred             EEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccc
Confidence            899999 57889999997643  7899999999999999999999   89999999999999996 57899999999986


Q ss_pred             CCCCCcc-ccccccCCCCcCchhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH
Q 043267          474 NPEGITH-LTTRVAGTLGYVAPEYALY-----------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       474 ~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      ....... ......||+.|+|||++.+           +.++.++|||||||++|||++|+.||.......    .....
T Consensus       204 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~~~~  279 (390)
T 2zmd_A          204 MQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI----SKLHA  279 (390)
T ss_dssp             C---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHH
T ss_pred             ccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH----HHHHH
Confidence            6543322 2345679999999999875           478999999999999999999999996432211    11111


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                               .++.......+......+.+++..|++.||++|||+.|+++
T Consensus       280 ---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          280 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                     11111111111111345778889999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=355.25  Aligned_cols=256  Identities=26%  Similarity=0.389  Sum_probs=194.8

Q ss_pred             cCccccceecccCceEEEEeEcC--CC--cEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP--NG--TEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ..|...+.||+|+||.||+|+..  ++  ..||||.++.. .....+++.+|++++++++||||+++++++..    .+.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~----~~~  164 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEG  164 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC----CSS
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc----CCC
Confidence            35677789999999999999863  22  46899998753 33456789999999999999999999998753    345


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++... ...+++..++.++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++
T Consensus       165 ~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~  240 (373)
T 3c1x_A          165 SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR  240 (373)
T ss_dssp             CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred             CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeeccccc
Confidence            678999999999999999653 356899999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCc---cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          473 FNPEGIT---HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       473 ~~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      .......   .......+|+.|+|||.+.++.++.++||||||+++|||++ |..||........      ...+..+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~------~~~~~~~~~  314 (373)
T 3c1x_A          241 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI------TVYLLQGRR  314 (373)
T ss_dssp             -----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH------HHHHHTTCC
T ss_pred             cccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH------HHHHHcCCC
Confidence            6543221   12234567889999999999999999999999999999999 6677754433221      122222321


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .     ..    +......+.+++..||+.||++|||+.|+++.|+..
T Consensus       315 ~-----~~----p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          315 L-----LQ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             C-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1     01    112234677888999999999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=8.4e-40  Score=333.05  Aligned_cols=250  Identities=24%  Similarity=0.307  Sum_probs=203.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||.||+|+.. ++..||+|++........+.+.+|++++++++||||+++++++.     ++...+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE-----DNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCeEE
Confidence            457999999999999999999965 57899999998765566778999999999999999999999987     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE---CCCCcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL---d~~~~~kl~DFGla~  472 (614)
                      +||||+++++|.+++...  ..+++..+..|+.|++.||+|||   +.+|+||||||+|||+   +.++.+||+|||++.
T Consensus        83 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~  157 (277)
T 3f3z_A           83 LVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA  157 (277)
T ss_dssp             EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccce
Confidence            999999999999998764  35899999999999999999999   8899999999999999   888999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ......  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......      .....+..+...   
T Consensus       158 ~~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---  225 (277)
T 3f3z_A          158 RFKPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTFT---  225 (277)
T ss_dssp             ECCTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC---
T ss_pred             eccCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCCC---
Confidence            765432  2334569999999998765 5999999999999999999999999643321      112222222211   


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .+..........+.+++..|++.||++|||+.|+++
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          226 ---FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---CCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000000122346778899999999999999999984

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.1e-40  Score=337.38  Aligned_cols=261  Identities=23%  Similarity=0.280  Sum_probs=197.4

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+..+|+.||||++.....  ...+.+.+|++++++++||||+++++++.     .+...+
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV   76 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEc-----cCCeEE
Confidence            46888999999999999999998899999999965332  23467889999999999999999999987     556789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++ +|.+++.... ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        77 lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  151 (288)
T 1ob3_A           77 LVFEHLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (288)
T ss_dssp             EEEECCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             EEEEecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccC
Confidence            99999975 9998886533 46999999999999999999999   8899999999999999999999999999997654


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc---h--
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT---L--  549 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~---~--  549 (614)
                      .... ......||+.|+|||.+.+. .++.++||||+|+++|||++|+.||........ + ............   .  
T Consensus       152 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          152 IPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-L-MRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-H-HHHHHHHCCCCTTTSTTG
T ss_pred             cccc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-H-HHHHHHHCCCChhhchhh
Confidence            3221 22345689999999998764 689999999999999999999999964332111 1 111111110000   0  


Q ss_pred             ---hhhhccCCC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 ---DVIEENMPE-------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ---~~~d~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ...++....       .........+.+++..|++.||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               000111110       001123456778999999999999999999875

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9e-40  Score=345.79  Aligned_cols=248  Identities=22%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||.||+++.+ +|+.||||+++..   .....+.+.+|.+++.++ +||||+++++++.     ...
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~~~   83 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TES   83 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE-----eCC
Confidence            46889999999999999999975 6899999999753   233456688999999988 8999999999986     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...  ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccc
Confidence            899999999999999999754  36999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCcc---chhhHHHHHHHHcCCch
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS---VLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~---~~l~~~~~~~~~~g~~~  549 (614)
                      ...... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......   ....+...+.+..+.. 
T Consensus       159 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-  236 (345)
T 3a8x_A          159 EGLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-  236 (345)
T ss_dssp             CSCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-
T ss_pred             cccCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-
Confidence            543221 22445679999999999999999999999999999999999999995432111   1112222333322221 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTM  586 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  586 (614)
                           .++    ......+.+++..|++.||++||++
T Consensus       237 -----~~p----~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 -----RIP----RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             -----CCC----TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             -----CCC----CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence                 122    2233467788899999999999995

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.7e-40  Score=348.70  Aligned_cols=245  Identities=20%  Similarity=0.296  Sum_probs=199.4

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+. .+|+.||||++....   ......+.+|+++++.++||||+++++++.     ....
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~~~~   83 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----TPTD   83 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            5789999999999999999996 578999999997421   222457889999999999999999999987     5667


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+ +|+|.+++...+  .+++.++..++.|++.||.|||   +.+|+||||||+|||+++++++||+|||+++.
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             EEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEecccee
Confidence            89999999 789999987643  6999999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ...+.  ......||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||.........               +.+
T Consensus       158 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i  220 (336)
T 3h4j_B          158 MTDGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKV  220 (336)
T ss_dssp             TTTSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCC
T ss_pred             ccCCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHH
Confidence            55432  2344579999999999988776 78999999999999999999999643321110               000


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .... ...+......+.+++..|++.||.+|||++|+++
T Consensus       221 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          221 NSCV-YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             CSSC-CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             HcCC-CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            0000 0011223345778899999999999999999985

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-40  Score=338.45  Aligned_cols=260  Identities=22%  Similarity=0.280  Sum_probs=207.0

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||.||+++.. +|+.||+|++...  +....+.+.+|++++++++||||+++++++...   .+..
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~~   81 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTT   81 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GGTE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CCce
Confidence            357899999999999999999975 7899999999753  344566799999999999999999999987532   3567


Q ss_pred             EEEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCc-----eEEeccCCCCeEECCCCcEEEe
Q 043267          394 RIIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPA-----IIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~-----iiHrDIKp~NILLd~~~~~kl~  466 (614)
                      .++||||+++|+|.+++...  ....+++..+++|+.|++.||+|||   +.+     |+||||||+||+++.++.+||+
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           82 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             EEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            89999999999999999753  3345999999999999999999999   666     9999999999999999999999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |||+++....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......      -....+..+
T Consensus       159 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~  231 (279)
T 2w5a_A          159 DFGLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREG  231 (279)
T ss_dssp             CCCHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHT
T ss_pred             cCchheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHhhc
Confidence            9999986544322 223356899999999999999999999999999999999999998643321      112233333


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      ...     .++    ......+.+++..|++.||++|||+.|+++.+....+
T Consensus       232 ~~~-----~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          232 KFR-----RIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CCC-----CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             ccc-----cCC----cccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            221     111    1233467788899999999999999999988765543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2e-40  Score=344.48  Aligned_cols=260  Identities=25%  Similarity=0.301  Sum_probs=197.1

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||+++. .+|+.||||+++...   ......+.+|++++++++||||+++++++..... .+.
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~~   89 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP   89 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET-TEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC-CCc
Confidence            35789999999999999999995 578999999997532   2334578899999999999999999998864322 233


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...+  .+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            4599999999999999997543  6999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          473 FNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       473 ~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      .......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .+..+..........
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~-----~~~~~~~~~~~~~~~  239 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIPP  239 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCH
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHhcCCCCCc
Confidence            6544322  223345689999999999999999999999999999999999999964332     222233333322211


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH-HHhh
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV-KILE  594 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl-~~L~  594 (614)
                      ...       .......+.+++..|++.||++||+..+++ ..|.
T Consensus       240 ~~~-------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  277 (311)
T 3ork_A          240 SAR-------HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  277 (311)
T ss_dssp             HHH-------STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ccc-------cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHH
Confidence            100       011234677888999999999999766654 4443

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.4e-40  Score=344.87  Aligned_cols=259  Identities=22%  Similarity=0.281  Sum_probs=184.2

Q ss_pred             cceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEEEEEee
Q 043267          323 ENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      .+.||+|+||.||+++.. +|+.||||++...   ....+.+|+++++.++ ||||+++++++.     ++...++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~-----~~~~~~lv~e~   87 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFH-----DQLHTFLVMEL   87 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSEEEEEECC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEE-----cCCEEEEEEEc
Confidence            378999999999999975 6899999999653   3456789999999997 999999999987     56788999999


Q ss_pred             cCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC---cEEEeecCCceeCCCC
Q 043267          401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF---EAKVGDFGLAKFNPEG  477 (614)
Q Consensus       401 ~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~---~~kl~DFGla~~~~~~  477 (614)
                      +++|+|.+++...  ..+++.++..|+.|+++||+|||   +.+|+||||||+|||++.++   .+||+|||+++.....
T Consensus        88 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           88 LNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999999764  46999999999999999999999   88999999999999997665   8999999999866543


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc-hhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV-LLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~-~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .. ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||........ .........+..+...      .
T Consensus       163 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~  235 (325)
T 3kn6_A          163 NQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------F  235 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------C
T ss_pred             CC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------C
Confidence            22 23445689999999999999999999999999999999999999964332110 1111122222222211      1


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH--HHhhccCCCCC
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIV--KILETDVPLSN  601 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl--~~L~~~~~~p~  601 (614)
                      ...........+.+++..|++.||++|||++|++  ..+.+..+.+.
T Consensus       236 ~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~  282 (325)
T 3kn6_A          236 EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSS  282 (325)
T ss_dssp             CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCC
T ss_pred             CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCC
Confidence            1111122345678899999999999999999998  34555444433

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.3e-39  Score=337.77  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=187.9

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++.     .++..
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~   78 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIH-----TENKL   78 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEEC-----CTTEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEE-----ECCeE
Confidence            357888899999999999999965 68999999997543 233467889999999999999999999986     56788


Q ss_pred             EEEEeecCCCChhhhhhcC----CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          395 IIVCDLLHNGSLYDHLFGS----GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~----~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ++||||++ |+|.+++...    ....+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        79 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           79 TLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCcc
Confidence            99999998 6999988653    2245899999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC---
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG---  546 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g---  546 (614)
                      ++....... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......  ......+.....   
T Consensus       155 ~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~  231 (317)
T 2pmi_A          155 ARAFGIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNES  231 (317)
T ss_dssp             CEETTSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCTT
T ss_pred             ceecCCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChh
Confidence            987643322 2234578999999999876 468999999999999999999999996433211  111111111000   


Q ss_pred             C---------------------chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 K---------------------TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~---------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .                     ..+.+.+....    .....+.+++..|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKE----PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             TCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSS----CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HhhhhhhhhhcccccccccchhHHHhhcccccc----cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0                     00000111111    12346788999999999999999999975

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.8e-40  Score=342.45  Aligned_cols=251  Identities=24%  Similarity=0.284  Sum_probs=203.6

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh------hhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA------GDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~------~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||.++.....      ..+++.+|++++++++||||+++++++.     
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----   85 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE-----   85 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe-----
Confidence            356899999999999999999965 6899999999753321      3567999999999999999999999986     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC----cEEE
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF----EAKV  465 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~----~~kl  465 (614)
                      ++...++||||+++++|.+++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++    .+||
T Consensus        86 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl  160 (321)
T 2a2a_A           86 NRTDVVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKL  160 (321)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEE
T ss_pred             cCCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEE
Confidence            567889999999999999999653  46899999999999999999999   88999999999999999888    7999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      +|||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     +.. ..+..
T Consensus       161 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~-~~i~~  232 (321)
T 2a2a_A          161 IDFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETL-ANITS  232 (321)
T ss_dssp             CCCTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHH-HHHHT
T ss_pred             ccCccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----HHH-HHHHh
Confidence            9999998765432  223456999999999999999999999999999999999999999543211     111 11222


Q ss_pred             CCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +..      ..+..........+.+++..|++.||++|||+.|+++
T Consensus       233 ~~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          233 VSY------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             TCC------CCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ccc------ccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111      0000000122346778899999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4e-40  Score=341.22  Aligned_cols=259  Identities=21%  Similarity=0.330  Sum_probs=197.6

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|.. .+|+.||||++...   .....+++.+|++++++++||||+++++++.     +.+.
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~  106 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI-----EDNE  106 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----cCCc
Confidence            4789999999999999999996 47999999999742   3445567899999999999999999999987     5568


Q ss_pred             EEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          394 RIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .++||||+++|+|.+++..  .....+++..+++++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++
T Consensus       107 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          107 LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            8999999999999999864  23456999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......   ..... ..+..+.... 
T Consensus       184 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~-~~~~~~~~~~-  257 (310)
T 2wqm_A          184 RFFSSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN---LYSLC-KKIEQCDYPP-  257 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC---HHHHH-HHHHTTCSCC-
T ss_pred             eeecCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh---HHHHH-HHhhcccCCC-
Confidence            76543322 223456899999999999999999999999999999999999998543221   11111 2222222111 


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                          ..   .......+.+++..|++.||++|||+.+|+++|+...
T Consensus       258 ----~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          258 ----LP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             ----CC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ----Cc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                11   1223346778889999999999999999999998863

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.4e-40  Score=350.17  Aligned_cols=252  Identities=23%  Similarity=0.263  Sum_probs=192.8

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||++.... ...+.+.+|+.++++++||||+++++++.     .....+
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            457999999999999999999975 78999999997633 33467889999999999999999999987     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc--EEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE--AKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~--~kl~DFGla~~  473 (614)
                      +||||+++|+|.+++...+  .+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.  +||+|||+++.
T Consensus        93 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999999999999996543  6999999999999999999999   899999999999999987766  99999999974


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPG-SDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~k-sDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ....  .......||+.|+|||.+.+..++.+ +||||+|+++|||++|+.||........ .......... ..     
T Consensus       168 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-~~~~~~~~~~-~~-----  238 (361)
T 3uc3_A          168 SVLH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD-YRKTIQRILS-VK-----  238 (361)
T ss_dssp             ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC-HHHHHHHHHT-TC-----
T ss_pred             cccc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhc-CC-----
Confidence            3322  12234569999999999998888766 8999999999999999999965443221 1111111111 11     


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ..++.  .......+.+++..|++.||++|||+.|+++
T Consensus       239 -~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          239 -YSIPD--DIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             -CCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             -CCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence             01111  1122346778899999999999999999985

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.4e-40  Score=340.05  Aligned_cols=260  Identities=20%  Similarity=0.220  Sum_probs=198.8

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      -++|...+.||+|+||.||+++.. +++.||||++....   ....+.+.+|++++++++||||+++++++.     .+.
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~  107 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGE-----IDG  107 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETT
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe-----eCC
Confidence            467999999999999999999965 78999999997532   223467899999999999999999999987     456


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++++|.+++...  ..+++..++.|+.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~  182 (309)
T 2h34_A          108 QLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIAS  182 (309)
T ss_dssp             EEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC--
T ss_pred             eEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCc
Confidence            889999999999999999764  36999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc-hhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT-LDV  551 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~-~~~  551 (614)
                      ..............||+.|+|||.+.+..++.++||||||+++|||++|+.||.....      ......+..... ...
T Consensus       183 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~  256 (309)
T 2h34_A          183 ATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL------SVMGAHINQAIPRPST  256 (309)
T ss_dssp             --------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH------HHHHHHHHSCCCCGGG
T ss_pred             cccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH------HHHHHHhccCCCCccc
Confidence            6654433333456789999999999999999999999999999999999999964321      112222222111 111


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhccCCCC
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARP-TMDQIVKILETDVPLS  600 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~~~~~p  600 (614)
                      .        .......+.+++..|++.||++|| +++++++.|+......
T Consensus       257 ~--------~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          257 V--------RPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             T--------STTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             c--------CCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            1        112233577888999999999999 9999999999876544

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.5e-40  Score=349.27  Aligned_cols=246  Identities=29%  Similarity=0.387  Sum_probs=198.8

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      +.|...+.||+|+||.||+|+. .+|+.||||++....   ....+++.+|++++++++||||+++++++.     .+..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCe
Confidence            4588889999999999999995 578999999997532   233467899999999999999999999987     5578


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||++ |+|.+++.... ..+++..+..|+.|+++||.|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus       129 ~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCcee
Confidence            899999997 78888886433 57999999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ....     ....||+.|+|||.+.   .+.++.++||||||+++|||++|+.||.....     .+..........   
T Consensus       204 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~-----~~~~~~~~~~~~---  270 (348)
T 1u5q_A          204 MAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIAQNES---  270 (348)
T ss_dssp             SSSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC---
T ss_pred             cCCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHhcCC---
Confidence            5432     3357999999999985   57899999999999999999999999854321     112222222211   


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                         +...   .......+.+++..|++.||++|||+.++++.
T Consensus       271 ---~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          271 ---PALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ---CCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ---CCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence               1111   11223456788889999999999999999853

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.9e-40  Score=343.01  Aligned_cols=259  Identities=20%  Similarity=0.238  Sum_probs=190.3

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccC---CC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVP---LE  390 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~---~~  390 (614)
                      ...+|...+.||+|+||.||+++.. +|+.||||++........+.+.+|+.+++++. ||||+++++++.....   ..
T Consensus        26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~  105 (337)
T 3ll6_A           26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG  105 (337)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred             cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence            3457999999999999999999964 78999999997766667778999999999996 9999999998853211   24


Q ss_pred             CceEEEEEeecCCCChhhhhhc-CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEECCCCcEEEee
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFG-SGMKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                      ....++|+||+. |+|.+++.. .....+++.+++.|+.|++.||+|||   +.+  |+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~D  181 (337)
T 3ll6_A          106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCD  181 (337)
T ss_dssp             SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred             CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEec
Confidence            556899999995 799998865 23456999999999999999999999   777  99999999999999999999999


Q ss_pred             cCCceeCCCCCcc-----------ccccccCCCCcCchhhh---ccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc
Q 043267          468 FGLAKFNPEGITH-----------LTTRVAGTLGYVAPEYA---LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV  533 (614)
Q Consensus       468 FGla~~~~~~~~~-----------~~~~~~gt~~Y~APE~~---~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~  533 (614)
                      ||+++........           ......||+.|+|||.+   .+..++.++||||||+++|||++|+.||....... 
T Consensus       182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-  260 (337)
T 3ll6_A          182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR-  260 (337)
T ss_dssp             CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH-
Confidence            9999865443221           11134589999999998   56688999999999999999999999995432211 


Q ss_pred             hhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          534 LLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       534 ~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                                       .................+.+++..|++.||++|||+.|+++.|+..
T Consensus       261 -----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          261 -----------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                             0011111001111122466788889999999999999999999775

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-40  Score=340.15  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=203.5

Q ss_pred             hcCccccc-eecccCceEEEEeEc---CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          317 TMNFSREN-IIGKGGYGNVYKGML---PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       317 t~~f~~~~-~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      .++|...+ .||+|+||.||+|..   .+++.||||+++...  ....+++.+|+++++.++||||+++++++.      
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~------   88 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------   88 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC------
Confidence            34677777 999999999999953   357889999997532  233567999999999999999999999983      


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      .+..++||||+++++|.+++...  ..+++..++.++.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~  163 (291)
T 1xbb_A           89 AESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGL  163 (291)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             CCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCc
Confidence            35678999999999999999764  36999999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCC
Q 043267          471 AKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       471 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      ++........  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......      .....+..+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~  237 (291)
T 1xbb_A          164 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGE  237 (291)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTC
T ss_pred             ceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC
Confidence            9876544332  2233456789999999999999999999999999999999 99999643321      1223333332


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..         ..+......+.+++..|++.||++||++.++++.|+..
T Consensus       238 ~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          238 RM---------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             CC---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CC---------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            21         11223345678889999999999999999999999875

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.3e-40  Score=333.53  Aligned_cols=245  Identities=23%  Similarity=0.344  Sum_probs=198.9

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~  391 (614)
                      ..++|...+.||+|+||.||+++.. +|+.||||+++..  ......++.+|+..+..+ +||||+++++++.     +.
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~-----~~   83 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWA-----ED   83 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEE-----ET
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeee-----cC
Confidence            3467999999999999999999975 7999999999753  334566788999999999 9999999999986     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC----------
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE----------  459 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~----------  459 (614)
                      ...++||||+++|+|.+++....  ...+++..++.|+.|+++||+|||   +.+|+||||||+|||++.          
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           84 DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC-----------
T ss_pred             CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccc
Confidence            78899999999999999997642  256999999999999999999999   889999999999999984          


Q ss_pred             ---------CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCccccc
Q 043267          460 ---------AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQ  529 (614)
Q Consensus       460 ---------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~  529 (614)
                               ...+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|+.++....
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~  235 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD  235 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred             cccccccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence                     4479999999998765432     23589999999999876 66789999999999999999987653211


Q ss_pred             CccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          530 GKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       530 ~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                               .+..+..+...     .++    ......+.+++..|++.||++|||+.|+++
T Consensus       236 ---------~~~~~~~~~~~-----~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          236 ---------QWHEIRQGRLP-----RIP----QVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ---------HHHHHHTTCCC-----CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------HHHHHHcCCCC-----CCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                     12233333221     112    122346778889999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=351.37  Aligned_cols=271  Identities=22%  Similarity=0.268  Sum_probs=213.0

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||+++... ....+.+.+|++++++++||||+++++++...   .....+
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~~   85 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHKV   85 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCeeE
Confidence            57889999999999999999975 58999999997533 23456788999999999999999999988642   344779


Q ss_pred             EEEeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE----CCCCcEEEeecCC
Q 043267          396 IVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEAKVGDFGL  470 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL----d~~~~~kl~DFGl  470 (614)
                      +||||+++|+|.+++.... ...+++..++.|+.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999997643 234999999999999999999999   8899999999999999    8888899999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhcc--------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALY--------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~--------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      ++......  ......||+.|+|||.+..        ..++.++||||||+++|||++|+.||......... .+.....
T Consensus       163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~~  239 (396)
T 4eut_A          163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYKI  239 (396)
T ss_dssp             CEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHHH
T ss_pred             ceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHHH
Confidence            98765432  2334579999999999875        56788999999999999999999999644332211 2222222


Q ss_pred             HHcCCchhhh-------------hccCC--CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCC
Q 043267          543 VKEGKTLDVI-------------EENMP--EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVP  598 (614)
Q Consensus       543 ~~~g~~~~~~-------------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  598 (614)
                      .. +.....+             ...++  ..........+..++..|++.||++||++.|+++.++..+.
T Consensus       240 ~~-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          240 IT-GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HH-SCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             hc-CCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            22 2211110             00111  12235667778899999999999999999999999877643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-40  Score=377.08  Aligned_cols=247  Identities=24%  Similarity=0.352  Sum_probs=198.3

Q ss_pred             ceecccCceEEEEeEc---CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGML---PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~---~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||.||+|.+   ..++.||||+++...  ....+++.+|++++++++||||+++++++.      .+..++||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~------~~~~~lv~  448 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM  448 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cCCEEEEE
Confidence            5799999999999964   256889999997533  334578999999999999999999999985      24578999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..+++.+++.|+.||++||+|||   +.+|+||||||+|||+++++.+||+|||+++....+.
T Consensus       449 E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~  523 (635)
T 4fl3_A          449 EMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  523 (635)
T ss_dssp             ECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--
T ss_pred             EccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCc
Confidence            999999999999654  46999999999999999999999   8899999999999999999999999999998765433


Q ss_pred             c--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          479 T--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       479 ~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .  .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......      .+...+..+....     
T Consensus       524 ~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~~~~~~~-----  592 (635)
T 4fl3_A          524 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGERMG-----  592 (635)
T ss_dssp             -----------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCC-----
T ss_pred             cccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCC-----
Confidence            2  22334457889999999999999999999999999999998 99999644321      1223333333211     


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          .+......+.+++..||+.||++||++.+|++.|+..
T Consensus       593 ----~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  629 (635)
T 4fl3_A          593 ----CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  629 (635)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                1222345677888999999999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-39  Score=330.74  Aligned_cols=252  Identities=28%  Similarity=0.335  Sum_probs=204.1

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||.+.... ....+.+.+|+++++.++||||+++++++.     ++...
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEE-----cCCEE
Confidence            457899999999999999999975 78999999997432 334577899999999999999999999986     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++++|.+++...  ..+++..+..++.|+++||+|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  155 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVF  155 (276)
T ss_dssp             EEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence            9999999999999998543  46999999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCC-ccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          475 PEGI-THLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       475 ~~~~-~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .... ........||+.|+|||.+.+..+ +.++||||||+++|||++|+.||..........     ..+......   
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~~~---  227 (276)
T 2yex_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKTY---  227 (276)
T ss_dssp             EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHH-----HHHHTTCTT---
T ss_pred             CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHH-----HHhhhcccc---
Confidence            4322 222345678999999999987765 789999999999999999999996544322222     122221110   


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ..........+.+++..|++.||++|||+.|+++
T Consensus       228 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 -----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 0011223446778899999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=344.94  Aligned_cols=252  Identities=15%  Similarity=0.150  Sum_probs=203.0

Q ss_pred             HHhcCccccceecccCceEEEEeE------cCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc---ccceeeeeeeeec
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGM------LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK---HVNLVALRGYSTA  385 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~------~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~---H~niv~l~g~~~~  385 (614)
                      ...++|...+.||+|+||.||+|+      ..+++.||||+++...   ..++..|+++++.++   |+|++++++++. 
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~-  137 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHL-  137 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE-
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeee-
Confidence            345789999999999999999994      4468899999997543   456788888888886   999999999987 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcC---CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGS---GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---  459 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~---~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---  459 (614)
                          .++..++||||+++|+|.+++...   ....++|..++.|+.|+++||+|||   +.+|+||||||+|||++.   
T Consensus       138 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~  210 (365)
T 3e7e_A          138 ----FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFL  210 (365)
T ss_dssp             ----CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGT
T ss_pred             ----cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEeccccc
Confidence                567789999999999999999752   3457999999999999999999999   899999999999999998   


Q ss_pred             --------CCcEEEeecCCceeCCC-CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccC
Q 043267          460 --------AFEAKVGDFGLAKFNPE-GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQG  530 (614)
Q Consensus       460 --------~~~~kl~DFGla~~~~~-~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~  530 (614)
                              ++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       211 ~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~  290 (365)
T 3e7e_A          211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG  290 (365)
T ss_dssp             CC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred             CccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence                    89999999999975432 222334556799999999999999999999999999999999999999854332


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCC-CCHHHHHHHhhccC
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQAR-PTMDQIVKILETDV  597 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~eVl~~L~~~~  597 (614)
                      ....                 ++..+.....   .+.+.+++..|++.+|.+| |+++++.+.|+...
T Consensus       291 ~~~~-----------------~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l  338 (365)
T 3e7e_A          291 GECK-----------------PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF  338 (365)
T ss_dssp             TEEE-----------------ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred             Ccee-----------------echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence            1110                 1111221122   3345567777999999998 68888888888763

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=3.2e-40  Score=349.39  Aligned_cols=250  Identities=24%  Similarity=0.303  Sum_probs=201.8

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccC
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVP  388 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~  388 (614)
                      +...++|...+.||+|+||.||+++.+ +|+.||||+++...   ....+.+..|.+++..+ +||||+++++++.    
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~----   88 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ----   88 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE----
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE----
Confidence            344568999999999999999999975 68999999997532   23345678899999887 9999999999987    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                       +....++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+||
T Consensus        89 -~~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DF  162 (345)
T 1xjd_A           89 -TKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADF  162 (345)
T ss_dssp             -CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCC
T ss_pred             -eCCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEC
Confidence             567899999999999999999764  36999999999999999999999   889999999999999999999999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      |+++...... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......     + ....+..+. 
T Consensus       163 G~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~-----~-~~~~i~~~~-  234 (345)
T 1xjd_A          163 GMCKENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE-----E-LFHSIRMDN-  234 (345)
T ss_dssp             TTCBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHCC-
T ss_pred             hhhhhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH-----H-HHHHHHhCC-
Confidence            9998543322 2244567999999999999999999999999999999999999999643221     1 112222221 


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMD-QIV  590 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl  590 (614)
                           ...+    ......+.+++..|++.||++||++. +++
T Consensus       235 -----~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          235 -----PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             -----CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             -----CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence                 1122    12234677888999999999999997 554

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.3e-40  Score=342.58  Aligned_cols=247  Identities=25%  Similarity=0.313  Sum_probs=191.9

Q ss_pred             cCccccceecccCceEEEEeEc----CCCcEEEEEEeecCC----hhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      ++|...+.||+|+||.||+++.    .+|+.||||+++...    ......+.+|++++++++||||+++++++.     
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----   91 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ-----   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE-----
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE-----
Confidence            5789999999999999999986    478999999997532    233456789999999999999999999987     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      .++..++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  166 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFG  166 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCS
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCC
Confidence            567889999999999999999754  36899999999999999999999   8899999999999999999999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .... ..+..+.. 
T Consensus       167 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~-~~i~~~~~-  238 (327)
T 3a62_A          167 LCKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR-----KKTI-DKILKCKL-  238 (327)
T ss_dssp             CC-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHH-HHHHHTCC-
T ss_pred             cccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH-----HHHH-HHHHhCCC-
Confidence            997543322 123446799999999999999999999999999999999999999964322     1111 11111111 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                           .++    ......+.+++..|++.||++||     ++.|+++
T Consensus       239 -----~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          239 -----NLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             -----CCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             -----CCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                 111    22334677888999999999999     7778764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=6.5e-40  Score=343.40  Aligned_cols=259  Identities=19%  Similarity=0.261  Sum_probs=204.1

Q ss_pred             HHHHHHhcCcccc-ceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHc-cccceeeeeeeeec
Q 043267          311 EEIKAATMNFSRE-NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASV-KHVNLVALRGYSTA  385 (614)
Q Consensus       311 ~el~~~t~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~  385 (614)
                      ...+...+.|... +.||+|+||.||+++.. +|+.||||+++..  ......++.+|+.++..+ +||||+++++++. 
T Consensus        21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~-   99 (327)
T 3lm5_A           21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE-   99 (327)
T ss_dssp             BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE-
T ss_pred             HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE-
Confidence            3344555677776 88999999999999965 6899999999753  233457889999999999 5699999999986 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCc
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFE  462 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~  462 (614)
                          +....++||||+++|+|.+++.......+++.+++.|+.|++.||+|||   +.+|+||||||+|||++.   ++.
T Consensus       100 ----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A          100 ----NTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             ----CSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCC
T ss_pred             ----eCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCc
Confidence                5678899999999999999997766678999999999999999999999   889999999999999998   789


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      +||+|||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.......     .. ..
T Consensus       173 ~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-----~~-~~  244 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE-----TY-LN  244 (327)
T ss_dssp             EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HH-HH
T ss_pred             EEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HH-HH
Confidence            9999999998765432  2234579999999999999999999999999999999999999995433211     11 11


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +....      ..............+.+++..|++.||++|||++|+++
T Consensus       245 i~~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          245 ISQVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            11111      11111122233456778899999999999999999985

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.8e-40  Score=347.01  Aligned_cols=244  Identities=24%  Similarity=0.291  Sum_probs=202.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||++....   ....+.+.+|+++++.++||||+++++++.     +...
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~  115 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----cCCE
Confidence            47889999999999999999965 78999999997532   233567889999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...+  .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       116 ~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEccccccee
Confidence            999999999999999997643  5999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .+ ....+..+..     
T Consensus       191 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~-~~~~i~~~~~-----  255 (350)
T 1rdq_E          191 VKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQ-IYEKIVSGKV-----  255 (350)
T ss_dssp             CSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HH-HHHHHHHCCC-----
T ss_pred             ccCC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HH-HHHHHHcCCC-----
Confidence            5432    2345799999999999999999999999999999999999999964321     11 1222222221     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                       .++.    .....+.+++..|++.||++||+     ++|+++
T Consensus       256 -~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          256 -RFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence             1222    22346778889999999999998     888864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.9e-39  Score=345.45  Aligned_cols=203  Identities=29%  Similarity=0.386  Sum_probs=164.5

Q ss_pred             HHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLE  390 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~  390 (614)
                      ...++|...+.||+|+||.||+|.. .+|+.||||++...  .......+.+|+.+++++. ||||+++++++...   +
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~   82 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---N   82 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---T
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---C
Confidence            3456899999999999999999996 47899999998642  3445567889999999997 99999999998642   3


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....++||||++ |+|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~  155 (388)
T 3oz6_A           83 DRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGL  155 (388)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             CCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCcc
Confidence            457899999997 689998865   36999999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCC--------------------CccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCccc
Q 043267          471 AKFNPEG--------------------ITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEI  527 (614)
Q Consensus       471 a~~~~~~--------------------~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~  527 (614)
                      ++.....                    .....+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||..
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          156 SRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             CEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence            9865321                    1112344679999999999986 6799999999999999999999999964

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5.4e-40  Score=343.32  Aligned_cols=254  Identities=29%  Similarity=0.402  Sum_probs=201.3

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcE--EEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTE--VAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~--VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||.||+|+.. +|..  ||||+++.. .....+.+.+|+++++++ +||||+++++++.     +.+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~-----~~~   99 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   99 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeee-----eCC
Confidence            46888999999999999999965 5664  499998753 334456789999999999 9999999999986     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ..++||||+++|+|.+++....              ...+++.+++.|+.|+++||+|||   +.+|+||||||+|||++
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A          100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  176 (327)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEc
Confidence            8899999999999999997643              347999999999999999999999   89999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhH
Q 043267          459 EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSD  537 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~  537 (614)
                      .++.+||+|||+++.....  .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......     +
T Consensus       177 ~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~-----~  249 (327)
T 1fvr_A          177 ENYVAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA-----E  249 (327)
T ss_dssp             GGGCEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H
T ss_pred             CCCeEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH-----H
Confidence            9999999999999743321  12233457889999999999999999999999999999998 99998543211     1


Q ss_pred             HHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       538 ~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       ....+..+.         ...........+.+++..|++.||++|||+.|+++.|+..
T Consensus       250 -~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          250 -LYEKLPQGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             -HHHHGGGTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHhhcCC---------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             112222221         1111223345678899999999999999999999998775

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.1e-39  Score=332.74  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=198.4

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||+++.. ++..||||++....   ......+.+|++++++++||||+++++++.     +..
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   82 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   82 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----cCC
Confidence            457899999999999999999865 67899999986422   223467889999999999999999999987     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...  ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++.
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~  157 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV  157 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEES
T ss_pred             EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccc
Confidence            889999999999999999654  36999999999999999999999   8999999999999999999999999999986


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .....   ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.....     .+ ....+...      
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~-~~~~~~~~------  222 (279)
T 3fdn_A          158 HAPSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QE-TYKRISRV------  222 (279)
T ss_dssp             CC-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HH-HHHHHHHT------
T ss_pred             cCCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HH-HHHHHHhC------
Confidence            54332   22345789999999999999999999999999999999999999963321     11 11112111      


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....+    ......+.+++..|++.||++|||+.|+++
T Consensus       223 ~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          223 EFTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             CCCCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            11112    122345678889999999999999999984

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=349.72  Aligned_cols=249  Identities=26%  Similarity=0.296  Sum_probs=201.3

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +|+.||+|.+....   ....+.+.+|+++++.++||||+++++++.     +...
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~   89 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----DEED   89 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCCE
Confidence            46889999999999999999965 68899999996432   233467889999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           90 MFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeee
Confidence            89999999999999999653  46999999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      .....  ......||+.|+|||++..   ..++.++|||||||++|||++|+.||.......  .... ...+....   
T Consensus       165 ~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~-~~~~~~~~---  236 (384)
T 4fr4_A          165 LPRET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS--SKEI-VHTFETTV---  236 (384)
T ss_dssp             CCTTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC--HHHH-HHHHHHCC---
T ss_pred             ccCCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc--HHHH-HHHHhhcc---
Confidence            65432  2345679999999999874   458999999999999999999999996433221  1111 11111111   


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPT-MDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~  591 (614)
                         ..    .+......+..++..|++.||.+||+ ++++.+
T Consensus       237 ---~~----~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 ---VT----YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CC----CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---cC----CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               11    12223456788899999999999998 777663

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=9.5e-40  Score=333.39  Aligned_cols=250  Identities=24%  Similarity=0.292  Sum_probs=199.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh------hhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK------AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||.++....      ...+.+.+|++++++++||||+++++++.     +
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            56899999999999999999975 689999999875321      13577999999999999999999999987     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC----cEEEe
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF----EAKVG  466 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~----~~kl~  466 (614)
                      ....++||||+++++|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++    .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEE
Confidence            67889999999999999999653  36999999999999999999999   88999999999999999877    89999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |||++.......  ......||+.|+|||.+.++.++.++||||||+++|||++|+.||......     + ....+..+
T Consensus       155 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~-~~~~~~~~  226 (283)
T 3bhy_A          155 DFGIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ-----E-TLTNISAV  226 (283)
T ss_dssp             CCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH-----H-HHHHHHTT
T ss_pred             ecccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH-----H-HHHHhHhc
Confidence            999998665432  223456899999999999999999999999999999999999999643221     1 11112221


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..      .............+.+++..|++.||++|||+.|+++
T Consensus       227 ~~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          227 NY------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CC------CCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cc------CCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            11      0000001122346788999999999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.8e-39  Score=329.33  Aligned_cols=250  Identities=25%  Similarity=0.392  Sum_probs=200.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .|...+.||+|+||.||+|... ++..||+|.+...  +....+.+.+|++++++++||||+++++++..... .+...+
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~~~~~  105 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIV  105 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC-CCceEE
Confidence            4677788999999999999964 6889999998743  34456778999999999999999999998764322 356789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEEC-CCCcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLD-EAFEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd-~~~~~kl~DFGla~  472 (614)
                      +||||+++|+|.+++...  ..+++..++.|+.|++.||.|||   +.+  |+||||||+|||++ .++.+||+|||++.
T Consensus       106 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~  180 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence            999999999999999654  46899999999999999999999   777  99999999999998 88999999999997


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .....   ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||......     .........+......
T Consensus       181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~  251 (290)
T 1t4h_A          181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKPASF  251 (290)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCCGGG
T ss_pred             ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcH-----HHHHHHHhccCCcccc
Confidence            54433   223456999999999776 56999999999999999999999999643321     1112223333222211


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.        .....+.+++..|++.||++|||+.|+++
T Consensus       252 ~~--------~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          252 DK--------VAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             GG--------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC--------CCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            11        11245788899999999999999999985

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=332.57  Aligned_cols=251  Identities=25%  Similarity=0.321  Sum_probs=197.8

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +|....+||+|+||.||+|+. .+++.||||.+........+.+.+|+++++.++||||+++++++.     +....++|
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv   97 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS-----ENGFIKIF   97 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEE-----eCCcEEEE
Confidence            355556899999999999995 478899999998766666778999999999999999999999986     55678999


Q ss_pred             EeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEEeecCCceeCC
Q 043267          398 CDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKVGDFGLAKFNP  475 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl~DFGla~~~~  475 (614)
                      |||+++++|.+++.... ...+++..+..++.|+++||.|||   +.+|+||||||+||+++. ++.+||+|||+++...
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~  174 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA  174 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccC
Confidence            99999999999997643 345778999999999999999999   889999999999999987 8999999999998665


Q ss_pred             CCCccccccccCCCCcCchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGK--LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ... .......||+.|+|||.+.++.  ++.++||||||+++|||++|+.||.........    ........     ..
T Consensus       175 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~-----~~  244 (295)
T 2clq_A          175 GIN-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA----MFKVGMFK-----VH  244 (295)
T ss_dssp             C------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH----HHHHHHHC-----CC
T ss_pred             CCC-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH----HHhhcccc-----cc
Confidence            322 2233457899999999997654  899999999999999999999999643321111    11110000     11


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.++    ......+.+++..|++.||++|||+.|+++
T Consensus       245 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          245 PEIP----ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCCC----TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccc----ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1122    223446778889999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.7e-40  Score=342.66  Aligned_cols=257  Identities=28%  Similarity=0.372  Sum_probs=202.3

Q ss_pred             hcCccccceecccCceEEEEeEc------CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      .++|...+.||+|+||.||+|+.      .++..||||++... ......++.+|+.++++++||||+++++++.     
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----  103 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL-----  103 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc-----
Confidence            45799999999999999999984      25778999999743 4455668999999999999999999999986     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCC-----cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGM-----KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AF  461 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~-----~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~  461 (614)
                      +....++||||+++|+|.+++.....     ..+++..++.++.|+++||.|||   +.+|+||||||+|||++.   +.
T Consensus       104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~  180 (327)
T 2yfx_A          104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGR  180 (327)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTC
T ss_pred             CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcc
Confidence            45667999999999999999976432     45899999999999999999999   889999999999999994   45


Q ss_pred             cEEEeecCCceeCCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHH
Q 043267          462 EAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       462 ~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~  539 (614)
                      .+||+|||+++...... ........||+.|+|||.+.++.++.++||||||+++|||++ |+.||......      -.
T Consensus       181 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~  254 (327)
T 2yfx_A          181 VAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EV  254 (327)
T ss_dssp             CEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HH
T ss_pred             eEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HH
Confidence            69999999987443222 122334567899999999999999999999999999999998 99998543211      11


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ...+..+...         .........+.+++..|++.||.+|||+.++++.|+..
T Consensus       255 ~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          255 LEFVTSGGRM---------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCC---------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            2222222211         11122334677889999999999999999999999765

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=332.31  Aligned_cols=248  Identities=25%  Similarity=0.357  Sum_probs=180.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCCh---hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSK---AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+. .+|+.||||.+.....   ...+.+.+|++++++++||||+++++++.     +...
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   85 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE-----DSNY   85 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEE-----CSSE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEc-----cCCe
Confidence            5788999999999999999996 4799999999964321   22467899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++... ...+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~  161 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQ  161 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceee
Confidence            89999999999999999753 357999999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........         .....   .+
T Consensus       162 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------~~~~~---~~  228 (278)
T 3cok_A          162 LKMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------NKVVL---AD  228 (278)
T ss_dssp             CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------CCS---SC
T ss_pred             ccCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------HHHhh---cc
Confidence            543222 223456899999999999999999999999999999999999999643321110         00000   01


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...+    ......+.+++..|++.||++|||++++++
T Consensus       229 ~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEMP----SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCc----cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1111    122346778899999999999999999975

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-39  Score=365.10  Aligned_cols=253  Identities=26%  Similarity=0.353  Sum_probs=206.8

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||++....   ......+.+|++++++++||||+++++++.     +..
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~  257 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYE-----TKD  257 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEe-----eCC
Confidence            457889999999999999999975 79999999996532   233566889999999999999999999886     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...+...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus       258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccce
Confidence            8999999999999999998766667999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ....+..  .....||+.|+|||++.+..++.++|||||||++|||++|+.||........  ...+...+...      
T Consensus       335 ~~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~--~~~i~~~i~~~------  404 (576)
T 2acx_A          335 HVPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK--REEVERLVKEV------  404 (576)
T ss_dssp             ECCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCC--HHHHHHHHHHC------
T ss_pred             ecccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchh--HHHHHHHhhcc------
Confidence            7654432  2345799999999999999999999999999999999999999965432111  11111222211      


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                          +...+......+.+++..|++.||++||     ++.|+++
T Consensus       405 ----~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          405 ----PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             ----cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                1111223345677888999999999999     7888873

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=334.47  Aligned_cols=261  Identities=23%  Similarity=0.278  Sum_probs=196.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||++....  ....+.+.+|++++++++||||+++++++.     ++...
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFR-----RKRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheee-----cCCeE
Confidence            57899999999999999999975 58999999986533  233567889999999999999999999987     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++++|.+++...  ..+++..+..|+.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        78 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhc
Confidence            9999999999999887543  46999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh---------hHHHHHHHH
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL---------SDWAWELVK  544 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l---------~~~~~~~~~  544 (614)
                      ..... ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||..........         ....+..+.
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (311)
T 4agu_A          153 TGPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFS  231 (311)
T ss_dssp             C-------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cCccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccc
Confidence            53322 2334578999999999876 678999999999999999999999996433211100         000011111


Q ss_pred             cCCchhhhhccCCCC--C------cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTLDVIEENMPEM--E------LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~--~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .......  ..++..  .      .+.....+.+++..|++.||++|||++|+++
T Consensus       232 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          232 TNQYFSG--VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TCGGGTT--CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccc--CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1111000  011100  0      0123445788999999999999999999985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3e-39  Score=331.35  Aligned_cols=250  Identities=24%  Similarity=0.293  Sum_probs=195.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+++.. +|..||+|++.... ....+.+.+|++++++++||||+++++++.     +....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~~~~~   96 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFE-----DYHNMY   96 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhee-----cCCeEE
Confidence            46899999999999999999964 68999999997533 334578999999999999999999999986     567889


Q ss_pred             EEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE---CCCCcEEEeecCC
Q 043267          396 IVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGL  470 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL---d~~~~~kl~DFGl  470 (614)
                      +||||+++|+|.+++...  ....+++..+++|+.|+++||+|||   +.+|+||||||+|||+   +.++.+||+|||+
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~  173 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGL  173 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeec
Confidence            999999999999998653  3357999999999999999999999   8899999999999999   5568899999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++......  ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.....     .+.... ...+..  
T Consensus       174 a~~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~-----~~~~~~-~~~~~~--  242 (285)
T 3is5_A          174 AELFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL-----EEVQQK-ATYKEP--  242 (285)
T ss_dssp             CCC------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHH-HHHCCC--
T ss_pred             ceecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH-----HHHHhh-hccCCc--
Confidence            97654332  234456899999999875 6789999999999999999999999964321     111111 111110  


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          .... ........+.+++..|++.||++|||+.|+++
T Consensus       243 ----~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          243 ----NYAV-ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ----CCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ----cccc-ccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                1110 00112345678899999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.6e-40  Score=344.67  Aligned_cols=243  Identities=23%  Similarity=0.345  Sum_probs=200.5

Q ss_pred             HhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCCh--------hhhHHHHHHHHHHHHccccceeeeeeeeecc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSK--------AGDANFKHEVEIIASVKHVNLVALRGYSTAT  386 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~  386 (614)
                      ..++|...+.||+|+||.||+|+. .+|+.||||+++....        .....+.+|++++++++||||+++++++.  
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~--   99 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE--   99 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE--
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--
Confidence            456899999999999999999985 4789999999975421        12345778999999999999999999987  


Q ss_pred             cCCCCceEEEEEeecCCC-ChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEE
Q 043267          387 VPLEGHQRIIVCDLLHNG-SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKV  465 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~G-sL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl  465 (614)
                         +....++||||+.+| +|.+++...  ..+++..+..|+.|++.||.|||   +.+|+||||||+|||++.++.+||
T Consensus       100 ---~~~~~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL  171 (335)
T 3dls_A          100 ---NQGFFQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKL  171 (335)
T ss_dssp             ---CSSEEEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEE
T ss_pred             ---eCCEEEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEE
Confidence               567889999999877 999998654  36999999999999999999999   889999999999999999999999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      +|||+++.......  .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....              
T Consensus       172 ~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------------  235 (335)
T 3dls_A          172 IDFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE--------------  235 (335)
T ss_dssp             CCCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------
T ss_pred             eecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------
Confidence            99999987654332  334579999999999998877 8899999999999999999999954221              


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                            .......  .+......+.+++..|++.||++|||+.|+++-
T Consensus       236 ------~~~~~~~--~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 ------TVEAAIH--PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------GTTTCCC--CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------HHhhccC--CCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0011111  011123457788899999999999999999874

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.2e-40  Score=360.79  Aligned_cols=248  Identities=23%  Similarity=0.262  Sum_probs=193.1

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||+++..   .......+.+|+++++.++||||+++++++.     ..+
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-----~~~  221 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQ-----THD  221 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEE-----ETT
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEe-----eCC
Confidence            467999999999999999999964 7899999999752   2334456788999999999999999999987     556


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ..++||||+++|+|.+++...  ..+++..+..++.|+++||+|||   + .+|+||||||+|||++.++.+||+|||++
T Consensus       222 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          222 RLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             EEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             EEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCc
Confidence            789999999999999999664  36999999999999999999999   6 89999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.....     .... ..+..+..   
T Consensus       297 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~-~~i~~~~~---  366 (446)
T 4ejn_A          297 KEGIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLF-ELILMEEI---  366 (446)
T ss_dssp             CTTCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-HHHHHCCC---
T ss_pred             eeccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHH-HHHHhCCC---
Confidence            8543322 223456799999999999999999999999999999999999999954322     1111 11111111   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                         .++    ......+.+++..|++.||.+||     +++|+++
T Consensus       367 ---~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          367 ---RFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             ---CCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             ---CCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence               112    12234677889999999999999     9999974

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.5e-40  Score=336.18  Aligned_cols=258  Identities=28%  Similarity=0.389  Sum_probs=197.0

Q ss_pred             cCccccceecccCceEEEEeEcC--CCc--EEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP--NGT--EVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~--~g~--~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...+.||+|+||.||+|++.  +++  .||||+++..   .....+.+.+|++++++++||||+++++++..     
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   92 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   92 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc-----
Confidence            47889999999999999999853  333  6899998753   23445778999999999999999999999852     


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                       ...++|+||+++|+|.+++.... ..+++..+.+++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus        93 -~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~  167 (291)
T 1u46_A           93 -PPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL  167 (291)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             -CCceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccc
Confidence             33789999999999999997642 46999999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCC
Q 043267          471 AKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       471 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      ++........  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.....     .+........+.
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~  242 (291)
T 1u46_A          168 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGE  242 (291)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCC
T ss_pred             cccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH-----HHHHHHHHccCC
Confidence            9876543322  2334567889999999999999999999999999999999 9999864332     111222222111


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCC
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL  599 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  599 (614)
                      .       .  .........+.+++..|++.||++|||+.++++.|+...+.
T Consensus       243 ~-------~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          243 R-------L--PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             C-------C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             C-------C--CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            1       1  11123345678899999999999999999999999987543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7.3e-39  Score=342.08  Aligned_cols=265  Identities=22%  Similarity=0.241  Sum_probs=205.3

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc--------ccceeeeeeeeeccc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK--------HVNLVALRGYSTATV  387 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~--------H~niv~l~g~~~~~~  387 (614)
                      .++|...+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+++++.++        |+||+++++++....
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            46899999999999999999985 46889999999753 344567889999999996        788999999876332


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEECCCC-----
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLDEAF-----  461 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd~~~-----  461 (614)
                      . .+...++||||+ +++|.+++.......+++..++.|+.|+++||+|||   +. +|+||||||+|||++.++     
T Consensus       115 ~-~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 V-NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             T-TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             C-CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhh
Confidence            1 456789999999 678888877666567999999999999999999999   77 999999999999999775     


Q ss_pred             --------------------------------------------cEEEeecCCceeCCCCCccccccccCCCCcCchhhh
Q 043267          462 --------------------------------------------EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA  497 (614)
Q Consensus       462 --------------------------------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~  497 (614)
                                                                  .+||+|||+++.....    .....||+.|+|||.+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999875432    2345789999999999


Q ss_pred             ccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh-hHHHH---H--------HHHcCCch-hhhhc-----cC---
Q 043267          498 LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL-SDWAW---E--------LVKEGKTL-DVIEE-----NM---  556 (614)
Q Consensus       498 ~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l-~~~~~---~--------~~~~g~~~-~~~d~-----~l---  556 (614)
                      .+..++.++|||||||++|||++|+.||.......... .+...   +        .+..+... +....     .+   
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999996544322110 01111   1        01111110 00000     00   


Q ss_pred             -----------CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          557 -----------PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       557 -----------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                                 ......+....+.+++..|++.||++|||+.|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                       00123556678899999999999999999999985

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.7e-39  Score=333.91  Aligned_cols=247  Identities=25%  Similarity=0.339  Sum_probs=202.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      +.|...+.||+|+||.||+|+. .+|+.||||++.... ....+.+.+|++++++++||||+++++++.     +....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe-----cCCeEE
Confidence            4688899999999999999985 478999999997543 344578999999999999999999999987     456789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++++|.+++..   ..+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++....
T Consensus        97 lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  170 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT  170 (303)
T ss_dssp             EEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred             EEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence            99999999999999854   46999999999999999999999   8899999999999999999999999999998655


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......     .. ...+..+..     ..
T Consensus       171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~-~~~~~~~~~-----~~  238 (303)
T 3a7i_A          171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM-----KV-LFLIPKNNP-----PT  238 (303)
T ss_dssp             TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH-----HH-HHHHHHSCC-----CC
T ss_pred             cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH-----HH-HHHhhcCCC-----CC
Confidence            4322 234457899999999999999999999999999999999999998643221     11 111111111     11


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +.    ......+.+++..|++.||++|||+.|+++
T Consensus       239 ~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  270 (303)
T 3a7i_A          239 LE----GNYSKPLKEFVEACLNKEPSFRPTAKELLK  270 (303)
T ss_dssp             CC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             Cc----cccCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11    222345778899999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.5e-39  Score=336.24  Aligned_cols=257  Identities=23%  Similarity=0.356  Sum_probs=205.5

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||.++.......+.+.+|++++++++||||+++++++.     +....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            357899999999999999999965 78999999998655555667899999999999999999999986     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE---CCCCcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL---d~~~~~kl~DFGla~  472 (614)
                      +||||+++|+|.+++...+  .+++..+..++.|++.||.|||   +.+|+||||||+||++   ++++.+||+|||+++
T Consensus        83 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~  157 (304)
T 2jam_A           83 LVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK  157 (304)
T ss_dssp             EEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred             EEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence            9999999999999986543  6899999999999999999999   8899999999999999   788999999999997


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .....   ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......      -....+.++...   
T Consensus       158 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~~~---  225 (304)
T 2jam_A          158 MEQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGYYE---  225 (304)
T ss_dssp             CCCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCCCC---
T ss_pred             ecCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCC---
Confidence            54432   223356899999999999999999999999999999999999998543211      112222232211   


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVP  598 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~  598 (614)
                         ............+.+++..|++.||++|||+.|+++  .+++..+
T Consensus       226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          226 ---FESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             ---CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence               111112233456788999999999999999999985  5555433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-40  Score=343.19  Aligned_cols=267  Identities=23%  Similarity=0.336  Sum_probs=202.6

Q ss_pred             cccCHHHHHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeee
Q 043267          306 ARFKIEEIKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYS  383 (614)
Q Consensus       306 ~~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~  383 (614)
                      ..+++.++....++|...+.||+|+||.||+|+. .+|+.||||++.... ...+.+.+|+++++++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            3445555666778999999999999999999996 478999999997533 3456789999999999 899999999998


Q ss_pred             ecccCC-CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          384 TATVPL-EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       384 ~~~~~~-~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      ...... .....++||||+++|+|.+++.......+++..++.|+.|++.||.|||   +.+|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCC
Confidence            753211 1467899999999999999998766668999999999999999999999   889999999999999999999


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhH
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSD  537 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~  537 (614)
                      +||+|||++........ ......||+.|+|||.+.     ...++.++||||||+++|||++|+.||......     .
T Consensus       168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~  241 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----R  241 (326)
T ss_dssp             EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----H
T ss_pred             EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHH-----H
Confidence            99999999976543221 223456899999999987     567899999999999999999999998543321     1


Q ss_pred             HHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       538 ~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....... +..     +...   .......+.+++..|++.||++|||+.++++
T Consensus       242 ~~~~~~~-~~~-----~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          242 ALFLIPR-NPA-----PRLK---SKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHHH-SCC-----CCCS---CSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHhhc-Ccc-----ccCC---ccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            1111111 111     1111   1122346778889999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.8e-39  Score=331.33  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=203.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +++.||+|.+...   .....+.+.+|++++++++|+||+++++++.     +++.
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~   89 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DNDF   89 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----cCCE
Confidence            57888999999999999999975 5789999998653   2344567899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++...  ..+++.+++.|+.|+++||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        90 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  164 (294)
T 2rku_A           90 VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK  164 (294)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence            89999999999999988654  36999999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .+. ...+..+..     
T Consensus       165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~-~~~~~~~~~-----  232 (294)
T 2rku_A          165 VEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KET-YLRIKKNEY-----  232 (294)
T ss_dssp             CCSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH-HHHHHTTCC-----
T ss_pred             cccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHH-HHHHhhccC-----
Confidence            543222 23345789999999999999999999999999999999999999964321     111 112222111     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       .++.    .....+.+++..|++.||++|||+.|+++
T Consensus       233 -~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          233 -SIPK----HINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             -CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             -CCcc----ccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence             1121    22345678889999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=7.4e-40  Score=355.39  Aligned_cols=253  Identities=25%  Similarity=0.350  Sum_probs=192.9

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--------hhhhHHHHHHHHHHHHccccceeeeeeeeec
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--------KAGDANFKHEVEIIASVKHVNLVALRGYSTA  385 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--------~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~  385 (614)
                      ...++|...+.||+|+||.||+|... +++.||||++....        ......+.+|++++++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45678999999999999999999864 68999999987432        112235789999999999999999999974 


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC---Cc
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA---FE  462 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~---~~  462 (614)
                           .+..++||||+++|+|.+++...  ..+++..+..|+.|+++||+|||   +.+|+||||||+|||++.+   +.
T Consensus       211 -----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~  280 (419)
T 3i6u_A          211 -----AEDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCL  280 (419)
T ss_dssp             -----SSEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCC
T ss_pred             -----cCceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcce
Confidence                 34579999999999999998653  46999999999999999999999   8899999999999999754   45


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~  539 (614)
                      +||+|||+++.....  .......||+.|+|||++.   ...++.++||||||+++|||++|+.||.........     
T Consensus       281 ~kl~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-----  353 (419)
T 3i6u_A          281 IKITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----  353 (419)
T ss_dssp             EEECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-----
T ss_pred             EEEeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-----
Confidence            999999999865432  2234567999999999986   367889999999999999999999999644332211     


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...+..+......+      ........+.+++..|++.||++|||+.|+++
T Consensus       354 ~~~i~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          354 KDQITSGKYNFIPE------VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHHHTTCCCCCHH------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCCCCch------hhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            12223322110000      00122456788999999999999999999886

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=8.9e-39  Score=351.50  Aligned_cols=264  Identities=21%  Similarity=0.211  Sum_probs=195.4

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~  392 (614)
                      .++|...+.||+|+||+||++... +|+.||||++...  .....+.+.+|+++++.++||||+++++++...... +..
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            457999999999999999999854 6899999999753  344456788999999999999999999998654321 335


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++ +|.+.+.    ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus       141 ~~~lv~E~~~~-~l~~~~~----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred             eEEEEEeCCCC-CHHHHHh----hcCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence            68999999975 4666663    24899999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH--------------
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW--------------  538 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~--------------  538 (614)
                      .....  ...+...||+.|+|||++.+..|+.++||||+||++|||++|+.||......+. +...              
T Consensus       213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~-~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ-WNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCSCCHHHHTT
T ss_pred             ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHHHH
Confidence            65432  223456799999999999999999999999999999999999999964321100 0000              


Q ss_pred             ----HHHHHHcC------Cchhhhhcc-CCCCC--cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 ----AWELVKEG------KTLDVIEEN-MPEME--LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ----~~~~~~~g------~~~~~~d~~-l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          ........      ......... .+...  .......+.+++..|++.||++|||++|+++
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                00000000      000000000 00000  0112456889999999999999999999985

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4.7e-39  Score=340.76  Aligned_cols=276  Identities=22%  Similarity=0.249  Sum_probs=204.1

Q ss_pred             ccCHHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCCh-----------hhhHHHHHHHHHHHHccccc
Q 043267          307 RFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK-----------AGDANFKHEVEIIASVKHVN  375 (614)
Q Consensus       307 ~f~~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~-----------~~~~~f~~Ei~il~~l~H~n  375 (614)
                      +..+.++....++|...+.||+|+||.||+|...+|+.||||++.....           ...+.+.+|++++++++|||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            3456788999999999999999999999999988899999999864221           12367899999999999999


Q ss_pred             eeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCe
Q 043267          376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNI  455 (614)
Q Consensus       376 iv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NI  455 (614)
                      |+++++++...........++||||++ |+|.+++... ...+++..+..|+.|++.||.|||   +.+|+||||||+||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPGNI  165 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChHHE
Confidence            999999986543334567899999998 6888888653 357999999999999999999999   88999999999999


Q ss_pred             EECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch
Q 043267          456 LLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL  534 (614)
Q Consensus       456 LLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~  534 (614)
                      |++.++.+||+|||+++......  ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||.......  
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--  241 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN--  241 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred             EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence            99999999999999997543322  2344578999999999887 689999999999999999999999996432111  


Q ss_pred             hhHHHHHHHHcCCc-----------hhhhhccCC---CCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          535 LSDWAWELVKEGKT-----------LDVIEENMP---EME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       535 l~~~~~~~~~~g~~-----------~~~~d~~l~---~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ......+.......           .+.+.....   ...    .+.....+.+++..|++.||++|||+.|+++
T Consensus       242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            00111111100000           011111111   000    0122345788999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-40  Score=347.69  Aligned_cols=253  Identities=25%  Similarity=0.282  Sum_probs=201.8

Q ss_pred             cCccccceecccCceEEEEeEc----CCCcEEEEEEeecCC----hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCS----KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVP  388 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~~----~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~  388 (614)
                      ++|...+.||+|+||.||+++.    .+|+.||||+++...    ....+.+.+|+++++++ +||||+++++++.    
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~----  129 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----  129 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe----
Confidence            5789999999999999999986    478999999986422    22345677899999999 6999999999886    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                       .+...++||||+++|+|.+++....  .+++..+..++.|+++||.|||   +.+|+||||||+|||++.++++||+||
T Consensus       130 -~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Df  203 (355)
T 1vzo_A          130 -TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF  203 (355)
T ss_dssp             -ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             -eCceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeC
Confidence             4567899999999999999997643  6999999999999999999999   889999999999999999999999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |+++..............||+.|+|||++.++  .++.++||||||+++|||++|+.||....... ............ 
T Consensus       204 G~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~-  281 (355)
T 1vzo_A          204 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN-SQAEISRRILKS-  281 (355)
T ss_dssp             SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC-CHHHHHHHHHHC-
T ss_pred             CCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccc-hHHHHHHHHhcc-
Confidence            99987654444444556799999999999863  57899999999999999999999996433221 111111111111 


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVKI  592 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  592 (614)
                            ...    .+.+....+.+++..|++.||++||     ++.|+++.
T Consensus       282 ------~~~----~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          282 ------EPP----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ------CCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ------CCC----CCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                  111    1223344677889999999999999     99999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.7e-39  Score=354.54  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=205.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ......+.+|+++++.++||||+++++++.     ....
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~~~~   90 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----TPSD   90 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCE
Confidence            46888999999999999999975 79999999997532   123457889999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus        91 ~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           91 IFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhh
Confidence            89999999999999999653  46999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ...+.  ......||+.|+|||.+.+..+ +.++||||+|+++|||++|+.||.....     .. ....+..+..    
T Consensus       166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~-----~~-~~~~i~~~~~----  233 (476)
T 2y94_A          166 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV-----PT-LFKKICDGIF----  233 (476)
T ss_dssp             CCTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS-----HH-HHHHHHTTCC----
T ss_pred             ccccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH-----HH-HHHHHhcCCc----
Confidence            65432  2334579999999999998765 6899999999999999999999964332     11 1122222221    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDV  597 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~  597 (614)
                        ..+    ......+.+++..|++.||++|||+.|+++  .+....
T Consensus       234 --~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          234 --YTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             --CCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             --CCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence              111    112345778889999999999999999996  555543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-39  Score=345.49  Aligned_cols=248  Identities=25%  Similarity=0.295  Sum_probs=200.6

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~  390 (614)
                      ..++|...+.||+|+||+||+++.. +|+.||||+++...   ....+.+..|.+++..+ +||||+++++++.     .
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~-----~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE-----C
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE-----c
Confidence            3467999999999999999999976 57899999997532   23346678899999888 8999999999886     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ....++||||+++|+|.+++...+  .+++..++.++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~  167 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM  167 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCc
Confidence            678999999999999999997643  6999999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .+.. +.+..+..  
T Consensus       168 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~-~~i~~~~~--  238 (353)
T 2i0e_A          168 CKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELF-QSIMEHNV--  238 (353)
T ss_dssp             CBCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-HHHHHCCC--
T ss_pred             ccccccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHH-HHHHhCCC--
Confidence            98543222 223456799999999999999999999999999999999999999964321     1111 22222211  


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIV  590 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl  590 (614)
                          .++    ......+.+++..|++.||++||+     +++++
T Consensus       239 ----~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~  275 (353)
T 2i0e_A          239 ----AYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  275 (353)
T ss_dssp             ----CCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHH
T ss_pred             ----CCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence                111    223446778889999999999995     56665

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.7e-40  Score=352.24  Aligned_cols=246  Identities=15%  Similarity=0.102  Sum_probs=188.7

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeec---CChhhhHHHHHHH---HHHHHccccceeeeee-------e
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKN---CSKAGDANFKHEV---EIIASVKHVNLVALRG-------Y  382 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~---~~~~~~~~f~~Ei---~il~~l~H~niv~l~g-------~  382 (614)
                      .++|...+.||+|+||.||+|+. .+|+.||||++..   ......+.+.+|+   +++++++||||+++++       +
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999996 4799999999973   2334557889999   5555668999999984       3


Q ss_pred             eecccC-------CCCc-----eEEEEEeecCCCChhhhhhcCC-----CcCCChHHHHHHHHHHHHHHHHHhhcCCCce
Q 043267          383 STATVP-------LEGH-----QRIIVCDLLHNGSLYDHLFGSG-----MKKLSWPIRLRIALGTARGLAYLHYGVQPAI  445 (614)
Q Consensus       383 ~~~~~~-------~~~~-----~~~lV~E~~~~GsL~~~L~~~~-----~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~i  445 (614)
                      +.....       .+++     ..++||||+ +|+|.+++...+     ...++|..+++|+.|+++||+|||   +.+|
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCe
Confidence            331100       0000     378999999 689999997531     234557899999999999999999   8899


Q ss_pred             EEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccC-----------CCCchhhHHHHHHH
Q 043267          446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-----------KLTPGSDVYSFGVV  514 (614)
Q Consensus       446 iHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-----------~~t~ksDVwS~Gvl  514 (614)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++||||||++
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986433    2344567 999999999987           89999999999999


Q ss_pred             HHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          515 LLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       515 l~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      +|||++|+.||........               .+.+....     ......+.+++..|++.||++|||+.|+++
T Consensus       303 l~elltg~~Pf~~~~~~~~---------------~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGG---------------SEWIFRSC-----KNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHSSCCC------CC---------------SGGGGSSC-----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHCCCCCcccccccc---------------hhhhhhhc-----cCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999954332111               01111111     112345778889999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.3e-38  Score=332.42  Aligned_cols=258  Identities=17%  Similarity=0.222  Sum_probs=200.6

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+. .+|+.||||+++...   .+.+.+|++++++++ ||||+++++++...   .....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~---~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccC---CCCceE
Confidence            5789999999999999999985 578999999997533   467889999999997 99999999998742   356789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGla~~~  474 (614)
                      +||||+++++|.+++.     .+++..+..|+.|+++||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus       110 lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             EEEECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            9999999999999883     4899999999999999999999   88999999999999999776 8999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH--------HHHHHHc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW--------AWELVKE  545 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~--------~~~~~~~  545 (614)
                      .....  .....||..|+|||.+.+ ..++.++||||||+++|||++|+.||.........+...        .+..+..
T Consensus       182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  259 (330)
T 3nsz_A          182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  259 (330)
T ss_dssp             CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHH
Confidence            54332  234578999999999887 679999999999999999999999995333221111111        1111111


Q ss_pred             CCc--------------hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKT--------------LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~--------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...              ....+..............+.+++..|++.||++|||++|+++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          260 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            100              0000111111112224567889999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=6.4e-39  Score=351.41  Aligned_cols=199  Identities=24%  Similarity=0.305  Sum_probs=157.2

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  +....+.+.+|++++++++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            357999999999999999999865 7899999999653  3344567899999999999999999999986543334467


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+ +|+|.+++...  ..+++..+..|+.||++||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            89999998 57999988653  46999999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCc--------------------------cccccccCCCCcCchhhhc-cCCCCchhhHHHHHHHHHHHHhC
Q 043267          474 NPEGIT--------------------------HLTTRVAGTLGYVAPEYAL-YGKLTPGSDVYSFGVVLLELLSG  521 (614)
Q Consensus       474 ~~~~~~--------------------------~~~~~~~gt~~Y~APE~~~-~~~~t~ksDVwS~Gvll~ElltG  521 (614)
                      ......                          ...+...||+.|+|||++. ...++.++|||||||++|||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            542211                          1234467899999999864 56799999999999999999994

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.2e-39  Score=341.18  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=200.3

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+++.+ +|+.||||+++....    ...+|++++.++ +||||+++++++.     ++...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~   91 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYD-----DGKYV   91 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEE-----cCCEE
Confidence            457999999999999999999965 689999999976432    235688888888 7999999999986     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC----CcEEEeecCC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA----FEAKVGDFGL  470 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~----~~~kl~DFGl  470 (614)
                      ++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+.++    +.+||+|||+
T Consensus        92 ~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~  166 (342)
T 2qr7_A           92 YVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGF  166 (342)
T ss_dssp             EEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence            9999999999999999654  36999999999999999999999   8899999999999998543    3599999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++....... ......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......  . .......+..+... 
T Consensus       167 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~-~~~~~~~i~~~~~~-  241 (342)
T 2qr7_A          167 AKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--T-PEEILARIGSGKFS-  241 (342)
T ss_dssp             CEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--C-HHHHHHHHHHCCCC-
T ss_pred             cccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--C-HHHHHHHHccCCcc-
Confidence            987544322 234467899999999999888999999999999999999999999643221  1 11122333333221 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           +...........+.+++..|++.||++|||+.|+++
T Consensus       242 -----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 -----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 111122233456778899999999999999999884

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.4e-39  Score=338.23  Aligned_cols=253  Identities=24%  Similarity=0.345  Sum_probs=205.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||+++.. +++.||+|.+...   .....+.+.+|+++++.++|+||+++++++.     +.+
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~  114 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DND  114 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cCC
Confidence            357888999999999999999975 5789999998653   2345567899999999999999999999987     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++++|.+++...  ..+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       115 ~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          115 FVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             EEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCce
Confidence            889999999999999998654  36999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ....... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .+. +..+..+..    
T Consensus       190 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~-~~~~~~~~~----  258 (335)
T 2owb_A          190 KVEYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL-----KET-YLRIKKNEY----  258 (335)
T ss_dssp             ECCSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHH-HHHHHHTCC----
T ss_pred             ecccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH-----HHH-HHHHhcCCC----
Confidence            7643322 23445799999999999999999999999999999999999999964321     111 111222111    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                        .++.    .....+.+++..|++.||++|||+.|+++  .+...
T Consensus       259 --~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          259 --SIPK----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             --CCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             --CCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence              1222    22345677889999999999999999985  45443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-39  Score=332.78  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=185.7

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC-hhh-hHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS-KAG-DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~-~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|+..+.||+|+||.||+++. .+|+.||||+++... ... .+.+.++...++.++||||+++++++.     ++..
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~-----~~~~   80 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALF-----REGD   80 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee-----ccCC
Confidence            46789999999999999999996 478999999997532 222 233445555578889999999999987     5667


Q ss_pred             EEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          394 RIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      .++||||++ |+|.+++..  .....+++..++.|+.|++.||+|||   +. +|+||||||+||+++.++.+||+|||+
T Consensus        81 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           81 VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCC
Confidence            899999997 588888754  24467999999999999999999999   76 999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYA----LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      ++.......  .....||+.|+|||.+    ....++.++||||+|+++|||++|+.||........    .........
T Consensus       157 ~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~  230 (290)
T 3fme_A          157 SGYLVDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ----QLKQVVEEP  230 (290)
T ss_dssp             ---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH----HHHHHHHSC
T ss_pred             ccccccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH----HHHHHhccC
Confidence            986544322  2334689999999996    566889999999999999999999999964332111    111222211


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                               .+..........+.+++..|++.||++|||+.|+++
T Consensus       231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ---------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                     111111223446788899999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6e-39  Score=349.50  Aligned_cols=203  Identities=26%  Similarity=0.323  Sum_probs=168.6

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  .....+.+.+|++++++++|+||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            358999999999999999999964 6889999999753  3344567899999999999999999999987543223367


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||++ |+|.+++...  ..+++..+..++.||++||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            899999986 6999999653  46999999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCc---------------------cccccccCCCCcCchhhh-ccCCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          474 NPEGIT---------------------HLTTRVAGTLGYVAPEYA-LYGKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       474 ~~~~~~---------------------~~~~~~~gt~~Y~APE~~-~~~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      ......                     ...+...||+.|+|||.+ ....++.++||||+||++|||++|..|+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            643321                     123556799999999986 4567999999999999999999876555

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.9e-39  Score=328.88  Aligned_cols=245  Identities=22%  Similarity=0.337  Sum_probs=201.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +++.||||.+....   ....+.+.+|++++++++||||+++++++.     ++..
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   88 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----DRKR   88 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----cCCE
Confidence            46889999999999999999975 67899999996432   223467899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...+  .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           89 IYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             EEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            899999999999999997643  6899999999999999999999   89999999999999999999999999999976


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .....   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......     + ....+..+.      
T Consensus       164 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~-~~~~~~~~~------  228 (284)
T 2vgo_A          164 APSLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----E-THRRIVNVD------  228 (284)
T ss_dssp             CSSSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----H-HHHHHHTTC------
T ss_pred             Ccccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----H-HHHHHhccc------
Confidence            54322   23456899999999999999999999999999999999999999643211     1 111121111      


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..++    ......+.+++..|++.||++|||+.|+++
T Consensus       229 ~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          229 LKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            1112    222346778899999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.5e-40  Score=348.12  Aligned_cols=259  Identities=8%  Similarity=-0.045  Sum_probs=184.5

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh---hhhHHHHHHHHHHHHc--cccceeeee-------eee
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK---AGDANFKHEVEIIASV--KHVNLVALR-------GYS  383 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l--~H~niv~l~-------g~~  383 (614)
                      ..+|...+.||+|+||.||+|+.. +|+.||||++.....   ...+.+.+|+++++.+  +|||+++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            446888999999999999999964 789999999986432   3455678886666555  599988754       222


Q ss_pred             ecccC------------CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHH------HHHHHHHHHHHHHHhhcCCCce
Q 043267          384 TATVP------------LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR------LRIALGTARGLAYLHYGVQPAI  445 (614)
Q Consensus       384 ~~~~~------------~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~------~~I~~~ia~gL~yLH~~~~~~i  445 (614)
                      .....            ......++||||++ |+|.+++...+ ..+++..+      +.|+.|+++||+|||   +.+|
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~i  215 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGL  215 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCC
Confidence            21100            00145799999999 89999997642 34577777      889999999999999   8899


Q ss_pred             EEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCC
Q 043267          446 IHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKK  523 (614)
Q Consensus       446 iHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~  523 (614)
                      +||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||.+.+  ..++.++||||||+++|||++|+.
T Consensus       216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~  291 (371)
T 3q60_A          216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL  291 (371)
T ss_dssp             EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999865432    224457799999999987  689999999999999999999999


Q ss_pred             CcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          524 ACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       524 p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ||..........       +........................+.+++..|++.||++|||+.|+++
T Consensus       292 Pf~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          292 PFGLVTPGIKGS-------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             STTBCCTTCTTC-------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCcCcccccc-------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            996543211100       0000000001111111111233456788899999999999999999874

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6e-40  Score=337.56  Aligned_cols=262  Identities=23%  Similarity=0.318  Sum_probs=184.6

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ..++|...+.||+|+||.||++... +|+.||||++.... ....+++.+|++++++++||||+++++++.     ..+.
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFV-----VKDE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEE-----SSSC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEe-----ecCC
Confidence            3568999999999999999999964 78999999986432 334567889999999999999999999987     4567


Q ss_pred             EEEEEeecCCCChhhhhhc------CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEee
Q 043267          394 RIIVCDLLHNGSLYDHLFG------SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~------~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                      .++||||+++|+|.+++..      .....+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+|
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEe
Confidence            8999999999999999864      13456999999999999999999999   88999999999999999999999999


Q ss_pred             cCCceeCCCCCc----cccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH
Q 043267          468 FGLAKFNPEGIT----HLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       468 FGla~~~~~~~~----~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      ||++........    .......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........     ....
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~  239 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-----LMLT  239 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-----HHHH
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH-----HHHH
Confidence            999876543221    12234578999999999876 5789999999999999999999999965432211     1111


Q ss_pred             HHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       543 ~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .. +.....................+.+++..|++.||++|||+.|+++
T Consensus       240 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          240 LQ-NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HT-SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hc-cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11 1111100000000011122345778889999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=329.08  Aligned_cols=257  Identities=21%  Similarity=0.240  Sum_probs=202.9

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC----hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS----KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~----~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .++|...+.||+|+||.||++... +++.||||+++...    ....+.+.+|++++++++||||+++++++...   +.
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNE---EK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-----
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcC---CC
Confidence            468999999999999999999974 68999999997532    23456799999999999999999999987532   45


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||++++ |.+++.......+++..+..|+.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            6789999999876 888887766678999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCC-ccccccccCCCCcCchhhhccCC--CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          472 KFNPEGI-THLTTRVAGTLGYVAPEYALYGK--LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       472 ~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~--~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      ....... ........||+.|+|||.+.+..  ++.++||||||+++|||++|+.||.....     .. ....+..+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~-~~~~i~~~~~  230 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YK-LFENIGKGSY  230 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH-HHHHHHHCCC
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HH-HHHHHhcCCC
Confidence            8764322 22234456899999999988654  37899999999999999999999964321     11 1222222221


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                            .++.    .....+.+++..|++.||++|||+.|+++  .+.+.
T Consensus       231 ------~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          231 ------AIPG----DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             ------CCCS----SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             ------CCCC----ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence                  1111    22345678889999999999999999995  45443

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.1e-39  Score=339.78  Aligned_cols=258  Identities=17%  Similarity=0.242  Sum_probs=204.7

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhh-----------------hHHHHHHHHHHHHccccceeee
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAG-----------------DANFKHEVEIIASVKHVNLVAL  379 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~-----------------~~~f~~Ei~il~~l~H~niv~l  379 (614)
                      .++|...+.||+|+||.||+++. +|+.||||++.......                 .+.+.+|++++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            35799999999999999999999 99999999997432211                 1789999999999999999999


Q ss_pred             eeeeecccCCCCceEEEEEeecCCCChhhh------hhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCC
Q 043267          380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDH------LFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKA  452 (614)
Q Consensus       380 ~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~------L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp  452 (614)
                      ++++.     +.+..++||||+++|+|.++      +.......+++..++.|+.|+++||.|||   + .+|+||||||
T Consensus       109 ~~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p  180 (348)
T 2pml_X          109 EGIIT-----NYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKP  180 (348)
T ss_dssp             SEEEE-----SSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCG
T ss_pred             EEEEe-----eCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCCh
Confidence            99987     56788999999999999999      65544678999999999999999999999   6 8999999999


Q ss_pred             CCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccC-CCCc-hhhHHHHHHHHHHHHhCCCCcccccC
Q 043267          453 SNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTP-GSDVYSFGVVLLELLSGKKACEIIQG  530 (614)
Q Consensus       453 ~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~-ksDVwS~Gvll~ElltG~~p~~~~~~  530 (614)
                      +||+++.++.+||+|||++......   ......||+.|+|||.+.+. .++. ++||||||+++|||++|+.||.....
T Consensus       181 ~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  257 (348)
T 2pml_X          181 SNILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS  257 (348)
T ss_dssp             GGEEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             HhEEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence            9999999999999999999875443   23456789999999999887 6766 99999999999999999999964432


Q ss_pred             ccchhhHHHHHHHHcCCchhhhhc-----cCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          531 KSVLLSDWAWELVKEGKTLDVIEE-----NMP----EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       531 ~~~~l~~~~~~~~~~g~~~~~~d~-----~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..     -....+..+......+.     ...    ..........+.+++..|++.||++|||+.|+++
T Consensus       258 ~~-----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          258 LV-----ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             SH-----HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HH-----HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11     11222333321100000     000    0001223456788999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.8e-38  Score=329.62  Aligned_cols=259  Identities=22%  Similarity=0.289  Sum_probs=202.9

Q ss_pred             hcCccccceecccCceEEEEeEc--CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc------eeeeeeeeecccC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML--PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN------LVALRGYSTATVP  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n------iv~l~g~~~~~~~  388 (614)
                      .++|...+.||+|+||.||++..  .+|+.||||+++.. ....+.+.+|+++++.++|+|      ++++++++.    
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~----   87 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE----   87 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc----
Confidence            35789999999999999999985  36899999999753 344567889999999998776      899999886    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---------
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---------  459 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---------  459 (614)
                       ..+..++||||+ +++|.+++.......+++..+..|+.|+++||+|||   +.+|+||||||+|||++.         
T Consensus        88 -~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~  162 (339)
T 1z57_A           88 -HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNP  162 (339)
T ss_dssp             -ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred             -cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCC
Confidence             456889999999 899999998776668999999999999999999999   889999999999999987         


Q ss_pred             ----------CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccccc
Q 043267          460 ----------AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ  529 (614)
Q Consensus       460 ----------~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  529 (614)
                                ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          163 KIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             ---CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             ccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                      678999999999865432    234578999999999999999999999999999999999999996433


Q ss_pred             CccchhhHHHHH--------HHHcCCchhhh-----------------hccC-----CCCCcHHHHHHHHHHHHHccccC
Q 043267          530 GKSVLLSDWAWE--------LVKEGKTLDVI-----------------EENM-----PEMELPEMMEQYVLTAAICAHPI  579 (614)
Q Consensus       530 ~~~~~l~~~~~~--------~~~~g~~~~~~-----------------d~~l-----~~~~~~~~~~~l~~l~~~Cl~~d  579 (614)
                      .... + .....        .+.........                 ....     ...........+.+++..|++.|
T Consensus       239 ~~~~-~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          239 SKEH-L-AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             HHHH-H-HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             hHHH-H-HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            2110 0 00000        00000000000                 0000     00112345667889999999999


Q ss_pred             CCCCCCHHHHHH
Q 043267          580 LQARPTMDQIVK  591 (614)
Q Consensus       580 P~~RPt~~eVl~  591 (614)
                      |++|||+.|+++
T Consensus       317 P~~Rpt~~ell~  328 (339)
T 1z57_A          317 PAKRITLREALK  328 (339)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             cccccCHHHHhc
Confidence            999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.2e-39  Score=341.17  Aligned_cols=257  Identities=24%  Similarity=0.317  Sum_probs=204.6

Q ss_pred             HHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh--------hhhHHHHHHHHHHHHc-cccceeeee
Q 043267          311 EEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK--------AGDANFKHEVEIIASV-KHVNLVALR  380 (614)
Q Consensus       311 ~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~--------~~~~~f~~Ei~il~~l-~H~niv~l~  380 (614)
                      .......++|...+.||+|+||.||+|+.. +|+.||||++.....        ...+.+.+|+++++++ +||||++++
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~  166 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI  166 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence            344556678999999999999999999975 799999999875321        1135678999999999 899999999


Q ss_pred             eeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC
Q 043267          381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA  460 (614)
Q Consensus       381 g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~  460 (614)
                      +++.     .....++||||+++|+|.+++...  ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.+
T Consensus       167 ~~~~-----~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          167 DSYE-----SSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDN  236 (365)
T ss_dssp             EEEE-----BSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTT
T ss_pred             EEEe-----eCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCC
Confidence            9986     567889999999999999999754  36999999999999999999999   8899999999999999999


Q ss_pred             CcEEEeecCCceeCCCCCccccccccCCCCcCchhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccch
Q 043267          461 FEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL  534 (614)
Q Consensus       461 ~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~  534 (614)
                      +.+||+|||++.......  ......||+.|+|||++.+      ..++.++||||||+++|||++|+.||......   
T Consensus       237 ~~ikl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~---  311 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI---  311 (365)
T ss_dssp             CCEEECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---
T ss_pred             CCEEEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH---
Confidence            999999999998765432  2344679999999999863      36889999999999999999999999543211   


Q ss_pred             hhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          535 LSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       535 l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .....+..+...... +.     .......+.+++..|++.||++|||+.|+++
T Consensus       312 ---~~~~~i~~~~~~~~~-~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          312 ---LMLRMIMEGQYQFSS-PE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             ---HHHHHHHHTCCCCCH-HH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ---HHHHHHHhCCCCCCC-cc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               111222222111000 00     0112345778899999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3e-39  Score=342.25  Aligned_cols=262  Identities=22%  Similarity=0.306  Sum_probs=200.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||++... +|+.||+|++... .....+.+.+|++++++++||||+++++++.     .+...
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE-----ETTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE-----ECCEE
Confidence            357899999999999999999975 7899999999754 3444577899999999999999999999987     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      ++||||+++|+|.+++....  .+++..+..|+.+++.||.|||   +. +|+||||||+|||++.++++||+|||+++.
T Consensus       107 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            99999999999999997643  6899999999999999999999   64 899999999999999999999999999864


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh----------hHHHHH--
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL----------SDWAWE--  541 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l----------~~~~~~--  541 (614)
                      ....   ......||+.|+|||.+.+..++.++||||||+++|||++|+.||..........          ....+.  
T Consensus       182 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3eqc_A          182 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  258 (360)
T ss_dssp             HHHH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC---------------
T ss_pred             cccc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcc
Confidence            3221   2234578999999999999999999999999999999999999995433211100          000000  


Q ss_pred             ------------HHHcCCchhhhh----ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          542 ------------LVKEGKTLDVIE----ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       542 ------------~~~~g~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                                  ........+.++    ...+..........+.+++..|++.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          259 TPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             ---------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                        000000001111    11111111123446788999999999999999999984

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-38  Score=336.48  Aligned_cols=265  Identities=24%  Similarity=0.320  Sum_probs=202.3

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+++.. +++.||||++.... ....+.+.+|++++++++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            457999999999999999999964 78899999997533 3344678999999999999999999999875433344678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|+||++ |+|.+++...   .+++.++..|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            99999997 5999998653   5999999999999999999999   889999999999999999999999999999876


Q ss_pred             CCCCcc--ccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC----
Q 043267          475 PEGITH--LTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK----  547 (614)
Q Consensus       475 ~~~~~~--~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~----  547 (614)
                      ......  ......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||........ + ...........    
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~-~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ-L-NHILGILGSPSQEDL  256 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH-H-HHHHHHHCSCCHHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH-H-HHHHHHhCCCCHHHH
Confidence            543222  2345679999999998765 4589999999999999999999999964332211 1 11100000000    


Q ss_pred             -------chhhhhccCCC--CC-----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 -------TLDVIEENMPE--ME-----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 -------~~~~~d~~l~~--~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                             ..... ..++.  ..     .+.....+.+++..|++.||++|||+.|+++
T Consensus       257 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          257 NCIINLKARNYL-LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HTCCCHHHHHHH-HTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhhhhhHHHHH-HhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                   00000 00000  00     0122346788999999999999999999985

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.3e-38  Score=327.42  Aligned_cols=252  Identities=25%  Similarity=0.290  Sum_probs=203.5

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---------hhhhHHHHHHHHHHHHcc-ccceeeeeeeee
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---------KAGDANFKHEVEIIASVK-HVNLVALRGYST  384 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---------~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~  384 (614)
                      ..++|...+.||+|+||.||+++.. +|+.||||+++...         ....+.+.+|++++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3468999999999999999999975 68999999997532         122456889999999995 999999999986


Q ss_pred             cccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEE
Q 043267          385 ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAK  464 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~k  464 (614)
                           .+...++||||+++++|.+++...  ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+|
T Consensus        95 -----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~k  164 (298)
T 1phk_A           95 -----TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIK  164 (298)
T ss_dssp             -----CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEE
T ss_pred             -----cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEE
Confidence                 567899999999999999999754  46999999999999999999999   88999999999999999999999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhc------cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL------YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~------~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                      |+|||++.......  ......||+.|+|||.+.      ...++.++||||||+++|||++|+.||......     . 
T Consensus       165 l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~-  236 (298)
T 1phk_A          165 LTDFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM-----L-  236 (298)
T ss_dssp             ECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-
T ss_pred             EecccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH-----H-
Confidence            99999998765432  233456899999999885      457899999999999999999999998543211     1 


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....+..+..      .............+.+++..|++.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          237 MLRMIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHHHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1122222211      1111112334557888999999999999999999875

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-38  Score=337.12  Aligned_cols=263  Identities=24%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~  392 (614)
                      .++|...+.||+|+||.||+|+. .+|+.||||++...  +....+.+.+|+++++.++||||+++++++...... ...
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            45799999999999999999996 47999999999642  333456788999999999999999999998643221 224


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+ +++|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~  176 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  176 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence            569999999 8899999865   35899999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH-cCCchh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK-EGKTLD  550 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~-~g~~~~  550 (614)
                      .....    .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......     ......+ .|....
T Consensus       177 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~l~~i~~~~g~~~~  247 (367)
T 1cm8_A          177 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-----QLKEIMKVTGTPPA  247 (367)
T ss_dssp             ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHHCCCCH
T ss_pred             ccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH-----HHHHHHHhcCCCCH
Confidence            75432    334578999999999887 689999999999999999999999996432211     1111110 011100


Q ss_pred             hhh------------ccCCC-------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhc
Q 043267          551 VIE------------ENMPE-------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILET  595 (614)
Q Consensus       551 ~~d------------~~l~~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~  595 (614)
                      ...            ..++.       .........+.+++..|++.||++|||+.|+++  .++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~  313 (367)
T 1cm8_A          248 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  313 (367)
T ss_dssp             HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHh
Confidence            000            00000       001122456788999999999999999999987  4444

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-38  Score=336.62  Aligned_cols=263  Identities=24%  Similarity=0.251  Sum_probs=195.2

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh-----hhHHHHHHHHHHHHccccceeeeeeeeeccc
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA-----GDANFKHEVEIIASVKHVNLVALRGYSTATV  387 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~  387 (614)
                      ....++|...+.||+|+||.||+|+.. +|+.||||++......     ....+.+|++++++++||||+++++++.   
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~---   82 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG---   82 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEe---
Confidence            334568999999999999999999975 6899999999743211     1246789999999999999999999986   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEee
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                        .....++||||+++ +|.+++... ...+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        83 --~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~D  155 (346)
T 1ua2_A           83 --HKSNISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLAD  155 (346)
T ss_dssp             --CTTCCEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             --eCCceEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEe
Confidence              55678999999985 888888653 356999999999999999999999   88999999999999999999999999


Q ss_pred             cCCceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH-c
Q 043267          468 FGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK-E  545 (614)
Q Consensus       468 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~-~  545 (614)
                      ||+++...... .......||+.|+|||.+.+. .++.++||||||+++|||++|+.|+.......     ....... .
T Consensus       156 fg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~-----~~~~i~~~~  229 (346)
T 1ua2_A          156 FGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-----QLTRIFETL  229 (346)
T ss_dssp             CGGGSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHHH
T ss_pred             cccceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-----HHHHHHHHc
Confidence            99998654332 223446789999999998764 58999999999999999999999985433211     1111111 1


Q ss_pred             CCchh-hh-------hc----cCCCCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          546 GKTLD-VI-------EE----NMPEME----LPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       546 g~~~~-~~-------d~----~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                      +.... ..       +.    ..+...    .......+.+++..|++.||++|||+.|+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             CCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            11000 00       00    000000    01223568889999999999999999999864

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.7e-39  Score=332.15  Aligned_cols=252  Identities=21%  Similarity=0.302  Sum_probs=197.2

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|+..+.||+|+||.||+|+.. +|+.||+|.+...+....+.+.+|++++++++||||+++++++.     .....+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY-----HDGKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CC-CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee-----eCCeEE
Confidence            357889999999999999999975 58999999998766666788999999999999999999999987     456789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++++|.+++.... ..+++..+..++.|+++||.|||   +.+++||||||+||+++.++.+||+|||++....
T Consensus        93 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999999986533 46999999999999999999999   8899999999999999999999999999875321


Q ss_pred             CCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          476 EGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      .. ........||+.|+|||.+.     ...++.++||||||+++|||++|+.|+.....     .+.......... ..
T Consensus       169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~-~~  241 (302)
T 2j7t_A          169 KT-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP-----MRVLLKIAKSDP-PT  241 (302)
T ss_dssp             HH-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHSCC-CC
T ss_pred             cc-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH-----HHHHHHHhccCC-cc
Confidence            11 11123356899999999984     67889999999999999999999999864332     111112211111 00


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                             ..........+.+++..|++.||++|||+.|+++
T Consensus       242 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          242 -------LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             -------CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             -------cCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                   0112233456788899999999999999999875

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-38  Score=348.81  Aligned_cols=261  Identities=24%  Similarity=0.304  Sum_probs=202.2

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||.||+|+. .+|+.||||++.....  ..++.+|+++++.++|++.+..+.++..    ++...+
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~   79 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV   79 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence            46799999999999999999995 5799999998875433  3357899999999988655544444432    567789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE---CCCCcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL---d~~~~~kl~DFGla~  472 (614)
                      +||||+ +++|.+++.... ..+++.+++.|+.||+.||+|||   +.+|+||||||+|||+   +.++.+||+|||+++
T Consensus        80 lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           80 LVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             EEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            999999 999999996533 46999999999999999999999   8899999999999999   688999999999998


Q ss_pred             eCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          473 FNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       473 ~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      ........      ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........  .. ...+...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~--~~-~~~i~~~  231 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKK--QK-YEKISEK  231 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHH--HH-HHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHH--HH-HHHHhhc
Confidence            76543321      123567999999999999999999999999999999999999999654432211  11 1111111


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .....++...     ......+.+++..|++.+|++||++.+|+++|+..
T Consensus       232 ~~~~~~~~l~-----~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          232 KVATSIEALC-----RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HHHSCHHHHH-----TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccccHHHHh-----cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            1111111000     11134678889999999999999999999999775

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-38  Score=355.58  Aligned_cols=252  Identities=23%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||++....   ......+.+|++++++++||||+++++++.     ....
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~-----~~~~  259 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFE-----TKTD  259 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEe-----eCCE
Confidence            47888899999999999999975 69999999997532   233467889999999999999999999886     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCC--CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          394 RIIVCDLLHNGSLYDHLFGSG--MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~--~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      .++||||+++|+|.+++....  ...+++..++.++.||+.||+|||   +.+|+||||||+|||++.++++||+|||++
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence            899999999999999997643  457999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...... +.+..+..   
T Consensus       337 ~~~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~-~~~~~~-~~i~~~~~---  410 (543)
T 3c4z_A          337 VELKAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV-ENKELK-QRVLEQAV---  410 (543)
T ss_dssp             EECCTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCC-CHHHHH-HHHHHCCC---
T ss_pred             eeccCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccch-hHHHHH-HHHhhccc---
Confidence            87654332 2344579999999999999999999999999999999999999996443211 111111 11111111   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTM-----DQIV  590 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl  590 (614)
                         ..    +......+.+++..|++.||++||++     .+++
T Consensus       411 ---~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~  447 (543)
T 3c4z_A          411 ---TY----PDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLR  447 (543)
T ss_dssp             ---CC----CTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHH
T ss_pred             ---CC----CcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHH
Confidence               11    12334567788899999999999975     5665

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.2e-38  Score=334.85  Aligned_cols=268  Identities=22%  Similarity=0.286  Sum_probs=204.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-----------ccceeeeeeeeec
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-----------HVNLVALRGYSTA  385 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-----------H~niv~l~g~~~~  385 (614)
                      ++|...+.||+|+||.||+|+. .+|+.||||++.. +....+.+.+|++++++++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            5789999999999999999996 4789999999975 3344567889999999886           8999999999864


Q ss_pred             ccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEEC------
Q 043267          386 TVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLD------  458 (614)
Q Consensus       386 ~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd------  458 (614)
                      ... .+...++||||+ +++|.+++.......+++..+..|+.|++.||+|||   +. +|+||||||+|||++      
T Consensus        98 ~~~-~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           98 KGP-NGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EET-TEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTT
T ss_pred             cCC-CCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCc
Confidence            321 334789999999 899999998766667999999999999999999999   76 999999999999994      


Q ss_pred             CCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch-hhH
Q 043267          459 EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL-LSD  537 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-l~~  537 (614)
                      ..+.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||......... -.+
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            4558999999999876532    23457899999999999999999999999999999999999999644322110 000


Q ss_pred             HHHHH-----------HHcCCch----------------------hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC
Q 043267          538 WAWEL-----------VKEGKTL----------------------DVIEENMPEMELPEMMEQYVLTAAICAHPILQARP  584 (614)
Q Consensus       538 ~~~~~-----------~~~g~~~----------------------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  584 (614)
                      .....           +..+...                      +.....  ..........+.+++..|++.||++||
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEK--YKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHT--TCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhc--ccCCcchHHHHHHHHHHHhccCccccC
Confidence            01111           1111110                      000111  112356677889999999999999999


Q ss_pred             CHHHHHH--HhhccC
Q 043267          585 TMDQIVK--ILETDV  597 (614)
Q Consensus       585 t~~eVl~--~L~~~~  597 (614)
                      |+.|+++  .+.+..
T Consensus       327 t~~ell~hp~f~~~~  341 (373)
T 1q8y_A          327 DAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CHHHHHTCGGGTTCT
T ss_pred             CHHHHhhChhhhccc
Confidence            9999986  455443

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.2e-38  Score=336.34  Aligned_cols=265  Identities=21%  Similarity=0.226  Sum_probs=198.6

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccC---CCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVP---LEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~---~~~  391 (614)
                      ++|...+.||+|+||.||+|+. .+|+.||||++....  ......+.+|+++++.++||||+++++++.....   ..+
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            5789999999999999999997 478999999986432  2334578899999999999999999999875321   114


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +..++||||+++ +|.+.+.... ..+++.++..|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCC-CHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            578999999974 7877775533 46999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCc---cccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          472 KFNPEGIT---HLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       472 ~~~~~~~~---~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +.......   .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||.......  .........  +.
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~i~~~~--~~  247 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLC--GS  247 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH--CC
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHh--CC
Confidence            86653221   22344678999999999876 468999999999999999999999996433211  111111111  11


Q ss_pred             chhhhhc---------cC----C-CCCcHHH------HHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIEE---------NM----P-EMELPEM------MEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~---------~l----~-~~~~~~~------~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ......+         .+    . .....+.      ...+.+++..|++.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            1000000         00    0 0001111      234778999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-38  Score=326.62  Aligned_cols=256  Identities=23%  Similarity=0.311  Sum_probs=195.2

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-------
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-------  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-------  388 (614)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++.. .....+.+.+|++++++++||||+++++++.....       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            457999999999999999999964 789999999965 33445778999999999999999999998754211       


Q ss_pred             -CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEee
Q 043267          389 -LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       389 -~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                       ......++||||+++|+|.+++.... ..+++..++.++.|+++||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEee
Confidence             12467899999999999999997643 56888999999999999999999   88999999999999999999999999


Q ss_pred             cCCceeCCCCC-------------ccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccc
Q 043267          468 FGLAKFNPEGI-------------THLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV  533 (614)
Q Consensus       468 FGla~~~~~~~-------------~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~  533 (614)
                      ||+++......             ........||+.|+|||.+.+. .++.++||||||+++|||++   |+.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~---  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME---  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH---
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh---
Confidence            99997654321             1122345689999999999864 79999999999999999998   4321111   


Q ss_pred             hhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          534 LLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       534 ~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ..+ ....+...      ...++..........+.+++..|++.||++|||+.++++
T Consensus       234 -~~~-~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 -RVN-ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             -HHH-HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -HHH-HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence             011 11222221      112222233344456788999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1e-38  Score=334.48  Aligned_cols=263  Identities=24%  Similarity=0.330  Sum_probs=197.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||++....  ....+.+.+|++++++++||||+++++++.     ++...
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~   99 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCK-----KKKRW   99 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEee-----cCCEE
Confidence            46889999999999999999975 58999999986533  333556889999999999999999999987     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++++|.+++...  ..+++..+..|+.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       100 ~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A          100 YLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            9999999999998886543  36999999999999999999999   889999999999999999999999999999765


Q ss_pred             CCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchh---------hHHHHHHHH
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL---------SDWAWELVK  544 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l---------~~~~~~~~~  544 (614)
                      ..... ......||+.|+|||.+.+. .++.++||||+|+++|||++|+.||..........         ....+..+.
T Consensus       175 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (331)
T 4aaa_A          175 AAPGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN  253 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cCCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence            43222 23345689999999999875 78999999999999999999999996433211100         000111111


Q ss_pred             cCCch-hhhhccCCCCCc-----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTL-DVIEENMPEMEL-----PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~-~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..... ....+.+.....     +.....+.+++..|++.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11100 000011111111     123456888999999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.8e-38  Score=330.51  Aligned_cols=268  Identities=22%  Similarity=0.239  Sum_probs=203.2

Q ss_pred             HhcCccccceecccCceEEEEeEc--CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHc---cccceeeeeeeeecccC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML--PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASV---KHVNLVALRGYSTATVP  388 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~--~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l---~H~niv~l~g~~~~~~~  388 (614)
                      +.++|...+.||+|+||.||+++.  .+|+.||||+++...  ......+.+|+++++.+   +||||+++++++.....
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            456899999999999999999996  468899999986422  22234567788887776   89999999999864332


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                      ......++||||++ |+|.+++.......+++..++.++.|+++||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Df  164 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADF  164 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecC
Confidence            24567899999998 69999998766667999999999999999999999   889999999999999999999999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      |+++.....  .......||+.|+|||.+.++.++.++||||||+++|||++|+.||.......  ..............
T Consensus       165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~  240 (326)
T 1blx_A          165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE  240 (326)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCG
T ss_pred             cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCCCc
Confidence            999865432  22344678999999999999999999999999999999999999996433211  11111111100000


Q ss_pred             hh----------hhhccC---CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          549 LD----------VIEENM---PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       549 ~~----------~~d~~l---~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..          ......   ...........+.+++..|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00          000000   00011223456778899999999999999999984

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-38  Score=338.70  Aligned_cols=265  Identities=20%  Similarity=0.229  Sum_probs=195.4

Q ss_pred             HHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC----
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP----  388 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~----  388 (614)
                      +...++|...+.||+|+||.||+|+. .+|+.||||++.....    ...+|+++++.++||||+++++++.....    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567899999999999999999986 5799999999975432    23479999999999999999998854321    


Q ss_pred             -----------------------------CCCceEEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHH
Q 043267          389 -----------------------------LEGHQRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYL  437 (614)
Q Consensus       389 -----------------------------~~~~~~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yL  437 (614)
                                                   .++...++||||++ |+|.+.+..  .....+++..+..|+.|+++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                         13445889999998 588887764  3446799999999999999999999


Q ss_pred             hhcCCCceEEeccCCCCeEEC-CCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHH
Q 043267          438 HYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVL  515 (614)
Q Consensus       438 H~~~~~~iiHrDIKp~NILLd-~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll  515 (614)
                      |   +.+|+||||||+|||++ .++.+||+|||+++.......  .....||+.|+|||.+.+. .++.++||||+|+++
T Consensus       158 H---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 H---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             H---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             H---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            9   89999999999999998 689999999999987654322  2345689999999998875 599999999999999


Q ss_pred             HHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh-------h---ccCCCC-----CcHHHHHHHHHHHHHccccCC
Q 043267          516 LELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI-------E---ENMPEM-----ELPEMMEQYVLTAAICAHPIL  580 (614)
Q Consensus       516 ~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~-------d---~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP  580 (614)
                      |||++|+.||......+ .+...+ +........+..       +   +.....     ........+.+++..|++.||
T Consensus       233 ~ell~g~~pf~~~~~~~-~~~~i~-~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          233 GELILGKPLFSGETSID-QLVRII-QIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHSSCSSCCSSHHH-HHHHHH-HHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHhCCCCCCCCChHH-HHHHHH-HHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999999996433211 111110 000000000000       0   000000     011123457889999999999


Q ss_pred             CCCCCHHHHH
Q 043267          581 QARPTMDQIV  590 (614)
Q Consensus       581 ~~RPt~~eVl  590 (614)
                      ++|||+.|++
T Consensus       311 ~~R~t~~e~l  320 (383)
T 3eb0_A          311 DLRINPYEAM  320 (383)
T ss_dssp             GGSCCHHHHH
T ss_pred             hhCCCHHHHh
Confidence            9999999998

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.2e-39  Score=366.99  Aligned_cols=257  Identities=26%  Similarity=0.382  Sum_probs=204.1

Q ss_pred             HHhcCccccceecccCceEEEEeEcC----CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL  389 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~----~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~  389 (614)
                      ...++|...+.||+|+||.||+|+..    .+..||||+++.. .....+.+.+|+.++++++||||+++++++.     
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----  461 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----  461 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence            34567888999999999999999864    2567999998753 3344577999999999999999999999984     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                       ++..++||||+++|+|.+++.... ..+++..++.++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||
T Consensus       462 -~~~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          462 -ENPVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             -cCceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecC
Confidence             345799999999999999997543 46999999999999999999999   8899999999999999999999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      +++..............+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......     + ....+..+..
T Consensus       537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~-----~-~~~~i~~~~~  610 (656)
T 2j0j_A          537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN-----D-VIGRIENGER  610 (656)
T ss_dssp             CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H-HHHHHHHTCC
T ss_pred             CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH-----H-HHHHHHcCCC
Confidence            998765544333444567889999999999999999999999999999997 99998643321     1 1122222221


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .     .+    +......+.+++..||+.||++|||+.|+++.|+..
T Consensus       611 ~-----~~----~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 L-----PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             C-----CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C-----CC----CccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1     11    122345677889999999999999999999999875

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.3e-38  Score=323.71  Aligned_cols=252  Identities=23%  Similarity=0.359  Sum_probs=196.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||.+....   ....+.+.+|+++++.++||||+++++++.     ....
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   85 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TPTD   85 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCCe
Confidence            47889999999999999999975 79999999997532   223457889999999999999999999986     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++....  .+++..+..++.|+++||.|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~  160 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM  160 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGC
T ss_pred             EEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccc
Confidence            899999999999999997643  6899999999999999999999   88999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      .....  ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||.....     . ...+.+..+..    
T Consensus       161 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~-~~~~~~~~~~~----  228 (276)
T 2h6d_A          161 MSDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----P-TLFKKIRGGVF----  228 (276)
T ss_dssp             CCC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----H-HHHHHHHHCCC----
T ss_pred             cCCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----H-HHHHHhhcCcc----
Confidence            55432  2234568999999999988765 6899999999999999999999864321     1 11222222211    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccC
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDV  597 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~  597 (614)
                        .++.    .....+.+++..|++.||++|||+.|+++  .+.+..
T Consensus       229 --~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          229 --YIPE----YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             --CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             --cCch----hcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence              1111    22345778889999999999999999986  344443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-39  Score=345.76  Aligned_cols=244  Identities=26%  Similarity=0.301  Sum_probs=189.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHH-HHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEI-IASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~i-l~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||+||+++.+ +++.||||+++...   ......+.+|..+ ++.++||||+++++++.     +..
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~-----~~~  112 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TAD  112 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEE-----CSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEE-----eCC
Confidence            57899999999999999999975 68899999997532   2234456667776 56789999999999987     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++
T Consensus       113 ~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          113 KLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             EEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            899999999999999999764  36899999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||.....     .+ ..+.+..+..    
T Consensus       188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~-~~~~i~~~~~----  256 (373)
T 2r5t_A          188 ENIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AE-MYDNILNKPL----  256 (373)
T ss_dssp             GGBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HH-HHHHHHHSCC----
T ss_pred             ccccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HH-HHHHHHhccc----
Confidence            533221 234456799999999999999999999999999999999999999964321     11 1122222111    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQ  588 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  588 (614)
                        .++    ......+.+++..|++.||++||++.+
T Consensus       257 --~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 --QLK----PNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --CCC----SSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --CCC----CCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence              111    223345778889999999999999853

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.2e-38  Score=327.23  Aligned_cols=251  Identities=26%  Similarity=0.312  Sum_probs=198.8

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ..++|...+.||+|+||.||+|+.. +|+.||||.+....  ..+++.+|++++++++||||+++++++.     .....
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   99 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF-----KNTDL   99 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEE-----eCCEE
Confidence            4567999999999999999999975 58999999997643  3567899999999999999999999987     45678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++... ...+++..+..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++...
T Consensus       100 ~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          100 WIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            9999999999999998643 346999999999999999999999   889999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......     ...... ..+..     .
T Consensus       176 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-----~~~~~~-~~~~~-----~  243 (314)
T 3com_A          176 TDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPM-----RAIFMI-PTNPP-----P  243 (314)
T ss_dssp             BTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHH-----HHHHHH-HHSCC-----C
T ss_pred             hhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHH-hcCCC-----c
Confidence            54322 233457899999999999999999999999999999999999999643221     111111 11110     0


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..  .........+.+++..|++.||++|||+.++++
T Consensus       244 ~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          244 TF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            01  112223456788999999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=6.1e-39  Score=334.65  Aligned_cols=252  Identities=25%  Similarity=0.352  Sum_probs=196.5

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--------hhhhHHHHHHHHHHHHccccceeeeeeeeecc
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--------KAGDANFKHEVEIIASVKHVNLVALRGYSTAT  386 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--------~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~  386 (614)
                      ..++|...+.||+|+||.||+|+.. +|+.||||.+....        ......+.+|++++++++||||+++++++.. 
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-   86 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-   86 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC-
Confidence            3457999999999999999999964 68999999986432        1123458899999999999999999999852 


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc---E
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---A  463 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~---~  463 (614)
                           ...++||||+++|+|.+++...  ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.   +
T Consensus        87 -----~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~  156 (322)
T 2ycf_A           87 -----EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLI  156 (322)
T ss_dssp             -----SSEEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCE
T ss_pred             -----CceEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeE
Confidence                 3479999999999999998643  47999999999999999999999   889999999999999987665   9


Q ss_pred             EEeecCCceeCCCCCccccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          464 KVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       464 kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                      ||+|||+++......  ......||+.|+|||.+.   ...++.++||||||+++|||++|+.||........ +    .
T Consensus       157 kl~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~  229 (322)
T 2ycf_A          157 KITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS-L----K  229 (322)
T ss_dssp             EECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC-H----H
T ss_pred             EEccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH-H----H
Confidence            999999998765432  223456899999999974   56789999999999999999999999964433221 1    1


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+..+..... . .    ........+.+++..|++.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~-~-~----~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          230 DQITSGKYNFI-P-E----VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHHHHTCCCCC-H-H----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhCccccC-c-h----hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            22222221100 0 0    00122456788999999999999999999874

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.1e-38  Score=353.14  Aligned_cols=250  Identities=25%  Similarity=0.332  Sum_probs=197.8

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||+||+++.. ++..||||++....  ......+.+|+++++.++||||+++++++.     +...
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFE-----DKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----eCCE
Confidence            346999999999999999999975 78999999997532  334577899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC---CcEEEeecCC
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA---FEAKVGDFGL  470 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~---~~~kl~DFGl  470 (614)
                      .++||||+++|+|.+++...  ..+++..+..|+.|+++||.|||   +.+|+||||||+|||++.+   +.+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            89999999999999988654  36999999999999999999999   8899999999999999764   5599999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++......  ......||+.|+|||++. +.++.++||||+||++|||++|+.||......     + ....+..+... 
T Consensus       186 a~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~-~~~~i~~~~~~-  255 (494)
T 3lij_A          186 SAVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ-----E-ILRKVEKGKYT-  255 (494)
T ss_dssp             CEECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHTCCC-
T ss_pred             CeECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHhCCCC-
Confidence            98765432  234467999999999876 57999999999999999999999999643321     1 12222322211 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ............+.+++..|++.||++|||+.|+++
T Consensus       256 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 -----FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -----CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                 111111223446778899999999999999999884

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-38  Score=335.01  Aligned_cols=270  Identities=19%  Similarity=0.249  Sum_probs=182.9

Q ss_pred             hcCcccc-ceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRE-NIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~-~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|... ++||+|+||.||+++.. +|+.||||++....    ....+....++.++|||++++++++..... .+...
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~  101 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHH-GKRCL  101 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccC-CCceE
Confidence            4578884 57999999999999975 78999999997532    112222334667799999999999864221 24568


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~~kl~DFGla  471 (614)
                      ++||||+++|+|.+++.......+++.+++.|+.|+++||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~  178 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA  178 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence            99999999999999998776678999999999999999999999   889999999999999986   455999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +.....   ......||+.|+|||.+....++.++||||||+++|||++|+.||.........  .........+     
T Consensus       179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~-----  248 (336)
T 3fhr_A          179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS--PGMKRRIRLG-----  248 (336)
T ss_dssp             EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh--hhHHHhhhcc-----
Confidence            865432   223456899999999999899999999999999999999999999544332110  0000111110     


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCchhh
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIKIF  605 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p~~  605 (614)
                       ....+..........+.+++..|++.||++|||+.|+++  .+.+....|..|.+
T Consensus       249 -~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~  303 (336)
T 3fhr_A          249 -QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLH  303 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBCS
T ss_pred             -ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCccc
Confidence             111111112233456788899999999999999999997  66665555555443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.9e-38  Score=328.56  Aligned_cols=268  Identities=21%  Similarity=0.242  Sum_probs=198.1

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-------
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-------  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-------  388 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...+....+++.+|++++++++||||+++++++.....       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            357889999999999999999976 589999999987666677889999999999999999999998743211       


Q ss_pred             --CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-CCCcEEE
Q 043267          389 --LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKV  465 (614)
Q Consensus       389 --~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-~~~~~kl  465 (614)
                        .+....++||||++ |+|.+++..   ..+++..++.++.|+++||+|||   +.+|+||||||+|||++ +++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEE
Confidence              24467899999997 699999853   46899999999999999999999   88999999999999997 6779999


Q ss_pred             eecCCceeCCCCCc--cccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH
Q 043267          466 GDFGLAKFNPEGIT--HLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL  542 (614)
Q Consensus       466 ~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~  542 (614)
                      +|||+++.......  .......+|..|+|||.+.. ..++.++||||||+++|||++|+.||.......     .....
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~  237 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-----QMQLI  237 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-----HHHHH
Confidence            99999986543221  12234567999999998876 689999999999999999999999996433211     01111


Q ss_pred             HHcC-------------CchhhhhccCCCC--C----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          543 VKEG-------------KTLDVIEENMPEM--E----LPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       543 ~~~g-------------~~~~~~d~~l~~~--~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                      ....             .....+.......  .    .......+.+++..|++.||++|||+.|+++  .+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  312 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY  312 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence            1100             0000111111100  0    0123456788999999999999999999985  45543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.8e-38  Score=341.60  Aligned_cols=198  Identities=27%  Similarity=0.341  Sum_probs=173.4

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHc------cccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASV------KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l------~H~niv~l~g~~~~~~~~  389 (614)
                      ..+|...+.||+|+||.||+|+.. +++.||||+++.. .....++.+|+++++.+      +|+||+++++++.     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~-----  169 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT-----  169 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc-----
Confidence            457999999999999999999864 6899999999763 34456788899999888      5669999999987     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc--EEEee
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE--AKVGD  467 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~--~kl~D  467 (614)
                      .....++||||+. ++|.+++.......+++..++.|+.|+++||+|||   +.+|+||||||+|||++.++.  +||+|
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~D  245 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVID  245 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEee
Confidence            4578899999996 69999998877677999999999999999999999   889999999999999999887  99999


Q ss_pred             cCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccc
Q 043267          468 FGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII  528 (614)
Q Consensus       468 FGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~  528 (614)
                      ||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       246 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~  302 (429)
T 3kvw_A          246 FGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGE  302 (429)
T ss_dssp             CTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCC
Confidence            9999865432    23457899999999999999999999999999999999999999643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.6e-38  Score=329.90  Aligned_cols=255  Identities=20%  Similarity=0.241  Sum_probs=196.1

Q ss_pred             HHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHcc--ccceeeeeeeeeccc
Q 043267          312 EIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVK--HVNLVALRGYSTATV  387 (614)
Q Consensus       312 el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~--H~niv~l~g~~~~~~  387 (614)
                      .+....++|...+.||+|+||.||+++..+|+.||||++...  .....+.+.+|++++++++  |+||+++++++.   
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~---   98 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI---   98 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE---
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee---
Confidence            334455679999999999999999999988999999999643  3445678999999999997  499999999987   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEee
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD  467 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~D  467 (614)
                        ++...++||| +.+++|.+++...  ..+++..++.|+.|+++||.|||   +.+|+||||||+|||+++ +.+||+|
T Consensus        99 --~~~~~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~D  169 (313)
T 3cek_A           99 --TDQYIYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLID  169 (313)
T ss_dssp             --CSSEEEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECC
T ss_pred             --cCCEEEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEee
Confidence              5667899999 6688999999764  37899999999999999999999   889999999999999975 8999999


Q ss_pred             cCCceeCCCCCcc-ccccccCCCCcCchhhhcc-----------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchh
Q 043267          468 FGLAKFNPEGITH-LTTRVAGTLGYVAPEYALY-----------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL  535 (614)
Q Consensus       468 FGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~-----------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l  535 (614)
                      ||+++........ ......||+.|+|||.+.+           ..++.++||||||+++|||++|+.||.......   
T Consensus       170 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~---  246 (313)
T 3cek_A          170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---  246 (313)
T ss_dssp             CSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---
T ss_pred             ccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH---
Confidence            9999865443222 2334568999999999875           578999999999999999999999996433211   


Q ss_pred             hHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          536 SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       536 ~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       .......         +..............+.+++..|++.||++|||+.|+++
T Consensus       247 -~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          247 -SKLHAII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             -HHHHHHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHH---------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence             1111111         111111111112346778889999999999999999985

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-39  Score=335.35  Aligned_cols=261  Identities=21%  Similarity=0.296  Sum_probs=192.5

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChh-hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA-GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||++...... ....+.+|++++++++||||+++++++.     .+...+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe-----eCCEEE
Confidence            47889999999999999999975 7899999999753321 1224567999999999999999999987     567789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||++ |+|.+++.... ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        77 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            9999997 69999887643 46999999999999999999999   8899999999999999999999999999998654


Q ss_pred             CCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC---chhh
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK---TLDV  551 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~---~~~~  551 (614)
                      ... .......||+.|+|||.+.+ ..++.++||||+|+++|||++|+.||.......  .............   ....
T Consensus       152 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~  228 (324)
T 3mtl_A          152 IPT-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE--QLHFIFRILGTPTEETWPGI  228 (324)
T ss_dssp             ------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTG
T ss_pred             CCc-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHhchhh
Confidence            322 22334568999999999876 578999999999999999999999996433211  1111111111000   0000


Q ss_pred             ------hhccCCC---CC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          552 ------IEENMPE---ME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       552 ------~d~~l~~---~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            .....+.   ..    .+.....+.+++..|++.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                  0000000   00    0122346778999999999999999999986

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=4.8e-39  Score=337.06  Aligned_cols=260  Identities=21%  Similarity=0.274  Sum_probs=190.6

Q ss_pred             HHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCCh--hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSK--AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~--~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ...++|...+.||+|+||+||+++. .+|+.||||+++....  ...+.+.+|++++++++||||+++++++.     ++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIH-----HN  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEE-----ET
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEe-----cC
Confidence            3456899999999999999999985 4789999999975332  23456789999999999999999999987     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE-----CCCCcEEEe
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL-----DEAFEAKVG  466 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL-----d~~~~~kl~  466 (614)
                      ...++||||++ |+|.+++....  .+++..+..|+.|+++||+|||   +.+|+||||||+|||+     ++++.+||+
T Consensus       106 ~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          106 HRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEEC
Confidence            78899999997 59999997644  5999999999999999999999   8899999999999999     455669999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE  545 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~  545 (614)
                      |||+++....... ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||.......     ........
T Consensus       180 Dfg~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-----~~~~~~~~  253 (329)
T 3gbz_A          180 DFGLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID-----QLFKIFEV  253 (329)
T ss_dssp             CTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-----HHHHHHHH
T ss_pred             cCCCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH-----HHHHHHHH
Confidence            9999976543322 23345689999999999875 58999999999999999999999996433211     11111110


Q ss_pred             -CCchhh----------hhccCC---CCCcH-----HHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 -GKTLDV----------IEENMP---EMELP-----EMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 -g~~~~~----------~d~~l~---~~~~~-----~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       +.....          .....+   .....     .....+.+++..|++.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          254 LGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             000000          000000   00000     12356788999999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6.8e-39  Score=353.63  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=203.4

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.     +..
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~   99 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFE-----DKG   99 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSS
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----eCC
Confidence            347899999999999999999975 78999999996432   344677999999999999999999999987     567


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE---CCCCcEEEeecC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFG  469 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL---d~~~~~kl~DFG  469 (614)
                      ..++||||+++|+|.+++...  ..+++..+..|+.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||
T Consensus       100 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  174 (484)
T 3nyv_A          100 YFYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFG  174 (484)
T ss_dssp             EEEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTT
T ss_pred             EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeee
Confidence            889999999999999999654  46999999999999999999999   8899999999999999   567899999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +++......  ......||+.|+|||.+.+ .++.++||||+|+++|||++|+.||......     + ....+..+...
T Consensus       175 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~-~~~~i~~~~~~  245 (484)
T 3nyv_A          175 LSTHFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-----D-ILKKVEKGKYT  245 (484)
T ss_dssp             HHHHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHCCCC
T ss_pred             eeEEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-----H-HHHHHHcCCCC
Confidence            998665432  2334569999999998865 7999999999999999999999999643321     1 12223333211


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            ............+.+++..|++.||++|||+.|+++
T Consensus       246 ------~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 ------FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ------CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                  011111233456788999999999999999999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-37  Score=331.66  Aligned_cols=203  Identities=26%  Similarity=0.299  Sum_probs=173.6

Q ss_pred             HHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-cc-----ceeeeeeeeecc
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HV-----NLVALRGYSTAT  386 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~-----niv~l~g~~~~~  386 (614)
                      ....++|...+.||+|+||+||+|+.. +|+.||||+++.. .....++..|+++++.++ |+     +++++.+++.  
T Consensus        50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~--  126 (382)
T 2vx3_A           50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--  126 (382)
T ss_dssp             CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE--
T ss_pred             CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec--
Confidence            344678999999999999999999965 6889999999753 344567788999998885 44     4899999886  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC--CCCcEE
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD--EAFEAK  464 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd--~~~~~k  464 (614)
                         .....++||||++ |+|.+++.......+++..+..|+.|++.||.|||.. +.+|+||||||+|||++  .++.+|
T Consensus       127 ---~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~k  201 (382)
T 2vx3_A          127 ---FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIK  201 (382)
T ss_dssp             ---ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEE
T ss_pred             ---cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEE
Confidence               4578899999996 5999999877666799999999999999999999932 47899999999999994  578899


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccc
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII  528 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~  528 (614)
                      |+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999876542    23457899999999999999999999999999999999999999643

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-38  Score=352.20  Aligned_cols=251  Identities=24%  Similarity=0.334  Sum_probs=200.1

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-------------hhhHHHHHHHHHHHHccccceeeeee
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-------------AGDANFKHEVEIIASVKHVNLVALRG  381 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-------------~~~~~f~~Ei~il~~l~H~niv~l~g  381 (614)
                      ..++|...+.||+|+||+||+++.. +++.||||++.....             ...+.+.+|++++++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4568999999999999999999965 688999999975321             23467899999999999999999999


Q ss_pred             eeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC
Q 043267          382 YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF  461 (614)
Q Consensus       382 ~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~  461 (614)
                      ++.     ++...++||||+++|+|.+++...  ..+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++
T Consensus       114 ~~~-----~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~  183 (504)
T 3q5i_A          114 VFE-----DKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKN  183 (504)
T ss_dssp             EEE-----CSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTT
T ss_pred             EEE-----cCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCC
Confidence            987     567889999999999999999664  36999999999999999999999   88999999999999998775


Q ss_pred             ---cEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          462 ---EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       462 ---~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                         .+||+|||+++......  ......||+.|+|||.+. +.++.++||||+|+++|||++|+.||......     + 
T Consensus       184 ~~~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~-  254 (504)
T 3q5i_A          184 SLLNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ-----D-  254 (504)
T ss_dssp             CCSSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-
T ss_pred             CCccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----H-
Confidence               69999999998765432  234457999999999876 57999999999999999999999999643321     1 


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....+..+.......      ........+.+++..|++.||.+|||+.|+++
T Consensus       255 ~~~~i~~~~~~~~~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          255 IIKKVEKGKYYFDFN------DWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHHHHCCCCCCHH------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHcCCCCCCcc------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            122233332210000      00122346788899999999999999999984

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.7e-38  Score=350.95  Aligned_cols=250  Identities=26%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||+||+++.. +|+.||||++...  .......+.+|++++++++||||+++++++.     +...
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~   95 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEE-----cCCE
Confidence            347999999999999999999965 7899999998642  2234567899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC---CCCcEEEeecCC
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD---EAFEAKVGDFGL  470 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd---~~~~~kl~DFGl  470 (614)
                      .++||||+++|+|.+++...  ..+++..+..|+.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~  170 (486)
T 3mwu_A           96 FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (486)
T ss_dssp             EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSC
T ss_pred             EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCc
Confidence            89999999999999998664  36999999999999999999999   88999999999999995   566799999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++......  ......||+.|+|||++.+ .++.++||||+||++|||++|+.||......     + ....+..+... 
T Consensus       171 a~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~-~~~~i~~~~~~-  240 (486)
T 3mwu_A          171 STCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----D-ILKRVETGKYA-  240 (486)
T ss_dssp             TTTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHTCCC-
T ss_pred             CeECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHhCCCC-
Confidence            98654432  2334579999999998865 6999999999999999999999999643321     1 11222222211 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                           ............+.+++..|++.||++|||+.|+++
T Consensus       241 -----~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          241 -----FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -----SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 011111233456788999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.7e-37  Score=326.17  Aligned_cols=259  Identities=20%  Similarity=0.283  Sum_probs=200.3

Q ss_pred             hcCccccceecccCceEEEEeEcC-CC-cEEEEEEeecCChhhhHHHHHHHHHHHHccccc------eeeeeeeeecccC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NG-TEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN------LVALRGYSTATVP  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g-~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n------iv~l~g~~~~~~~  388 (614)
                      .++|...+.||+|+||.||+++.. ++ +.||||+++.. ....+.+.+|++++++++|++      ++.+.+++.    
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~----   92 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN----   92 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee----
Confidence            357999999999999999999964 34 78999999753 344567889999999998877      888888776    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE-----------
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL-----------  457 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL-----------  457 (614)
                       .....++||||+ +++|.+++.......+++.+++.|+.|+++||+|||   +.+|+||||||+|||+           
T Consensus        93 -~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           93 -FHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             -ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred             -eCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccc
Confidence             456889999999 778888887766667999999999999999999999   8999999999999999           


Q ss_pred             --------CCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCccccc
Q 043267          458 --------DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ  529 (614)
Q Consensus       458 --------d~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~  529 (614)
                              +.++.+||+|||+++.....    .....||+.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                    67889999999999865432    234579999999999999999999999999999999999999996433


Q ss_pred             CccchhhHHHHHH--------HHcCCchhh-----------------hhccCC-----CCCcHHHHHHHHHHHHHccccC
Q 043267          530 GKSVLLSDWAWEL--------VKEGKTLDV-----------------IEENMP-----EMELPEMMEQYVLTAAICAHPI  579 (614)
Q Consensus       530 ~~~~~l~~~~~~~--------~~~g~~~~~-----------------~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~d  579 (614)
                      .... + ......        +........                 ......     ......+...+.+++..|++.|
T Consensus       244 ~~~~-~-~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  321 (355)
T 2eu9_A          244 NREH-L-VMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFD  321 (355)
T ss_dssp             HHHH-H-HHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             HHHH-H-HHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCC
Confidence            2111 0 000000        000000000                 000000     0112234557889999999999


Q ss_pred             CCCCCCHHHHHH
Q 043267          580 LQARPTMDQIVK  591 (614)
Q Consensus       580 P~~RPt~~eVl~  591 (614)
                      |++|||+.|+++
T Consensus       322 P~~Rpt~~e~l~  333 (355)
T 2eu9_A          322 PAQRITLAEALL  333 (355)
T ss_dssp             TTTSCCHHHHTT
T ss_pred             hhhCcCHHHHhc
Confidence            999999999973

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.8e-38  Score=330.69  Aligned_cols=265  Identities=22%  Similarity=0.278  Sum_probs=200.1

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||++.... ......+.+|++++++++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457999999999999999999965 68999999997533 3445678899999999999999999998865433334678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+. |+|.+++..   ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            99999997 699998865   35999999999999999999999   889999999999999999999999999999866


Q ss_pred             CCCCcc---------ccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          475 PEGITH---------LTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       475 ~~~~~~---------~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      ......         ......||+.|+|||.+.. ..++.++||||||+++|||++|+.||........  .........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~  240 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIFGIIG  240 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhC
Confidence            532211         1223578999999998765 7899999999999999999999999964332110  000001000


Q ss_pred             cCC------------chhhhhccCC---CCC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGK------------TLDVIEENMP---EME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~------------~~~~~d~~l~---~~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...            ..+.+. .++   ...    .+.....+.+++..|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIK-SLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHH-TSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhccccccccchhhHHhh-cccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            000            000000 000   000    0123346778999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.1e-38  Score=363.61  Aligned_cols=248  Identities=25%  Similarity=0.292  Sum_probs=202.4

Q ss_pred             HhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC---ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCC
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~  390 (614)
                      ..++|...+.||+|+||.||+++.. +|+.||||+++..   .....+.+..|.+++..+ +|+||+++++++.     +
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~-----~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----T  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB-----C
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE-----e
Confidence            4467999999999999999999965 6889999999753   223456678899999988 7999999999886     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      .+..++||||+++|+|.+++...+  .+++..++.|+.||+.||+|||   +.+|+||||||+||||+.++++||+|||+
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGl  488 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGM  488 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecce
Confidence            678899999999999999997643  6999999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......     + ..+.+..+..  
T Consensus       489 a~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~-----~-~~~~i~~~~~--  559 (674)
T 3pfq_A          489 CKENIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-----E-LFQSIMEHNV--  559 (674)
T ss_dssp             CEECCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHSSCC--
T ss_pred             eeccccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH-----H-HHHHHHhCCC--
Confidence            98643322 2344568999999999999999999999999999999999999999643321     1 1122222211  


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCH-----HHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTM-----DQIV  590 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl  590 (614)
                          .+    +......+.+++..|++.||++||++     +||+
T Consensus       560 ----~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~  596 (674)
T 3pfq_A          560 ----AY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIK  596 (674)
T ss_dssp             ----CC----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHH
T ss_pred             ----CC----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHh
Confidence                11    22334567888899999999999997     6665

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=334.46  Aligned_cols=259  Identities=23%  Similarity=0.292  Sum_probs=198.8

Q ss_pred             HHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ...++|...+.||+|+||.||+|+..+  .||+|.++...  ....+.+.+|++++++++|+||+++++++.     +..
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~  102 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACM-----SPP  102 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEE-----CSS
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cCC
Confidence            345678999999999999999999743  59999986432  233456788999999999999999999987     456


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++++|.+++... ...+++..++.|+.|+++||+|||   +.+|+||||||+|||++ ++.+||+|||+++
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~  177 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFS  177 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred             ceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence            789999999999999999653 346999999999999999999999   88999999999999998 6799999999987


Q ss_pred             eCCCCC----ccccccccCCCCcCchhhhcc---------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH
Q 043267          473 FNPEGI----THLTTRVAGTLGYVAPEYALY---------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA  539 (614)
Q Consensus       473 ~~~~~~----~~~~~~~~gt~~Y~APE~~~~---------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~  539 (614)
                      ......    ........||+.|+|||.+..         ..++.++||||||+++|||++|+.||.....     ....
T Consensus       178 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~  252 (319)
T 2y4i_B          178 ISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA-----EAII  252 (319)
T ss_dssp             ----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH-----HHHH
T ss_pred             ccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHH
Confidence            543211    112234568999999999874         4589999999999999999999999964332     1111


Q ss_pred             HHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCC
Q 043267          540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPL  599 (614)
Q Consensus       540 ~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  599 (614)
                       ..+..+....     ...   ......+.+++..|++.||++|||+.+++++|+.....
T Consensus       253 -~~~~~~~~~~-----~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          253 -WQMGTGMKPN-----LSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             -HHHHTTCCCC-----CCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             -HHhccCCCCC-----CCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence             2222222211     111   11223567888899999999999999999999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.8e-38  Score=334.62  Aligned_cols=265  Identities=22%  Similarity=0.221  Sum_probs=192.1

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~  392 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  .....+.+.+|+++++.++||||+++++++...... +..
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            357899999999999999999864 6899999999753  334456788999999999999999999998643221 234


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||++ |+|.+.+.    ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHh----hccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999997 57888884    35899999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch-----------------h
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL-----------------L  535 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-----------------l  535 (614)
                      .....  .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||.........                 +
T Consensus       176 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          176 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             ccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            65432  1233457899999999999999999999999999999999999999643221000                 0


Q ss_pred             hHHHHHHHHcCC------chhhhhc-cCCCCC--cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          536 SDWAWELVKEGK------TLDVIEE-NMPEME--LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       536 ~~~~~~~~~~g~------~~~~~d~-~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ............      ..+.... ..+...  .......+.+++..|++.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            000000000000      0000000 001000  1123567889999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.8e-38  Score=336.13  Aligned_cols=261  Identities=26%  Similarity=0.306  Sum_probs=182.9

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~  392 (614)
                      .++|...+.||+|+||.||+|.. .+|+.||||++...  +....+.+.+|+++++.++||||+++++++...... +..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            35799999999999999999985 47899999999653  334456788999999999999999999998643211 235


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++|+|++ +++|.+++..   ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~  180 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR  180 (367)
T ss_dssp             CCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred             eEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence            679999999 7899998854   46999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc------
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE------  545 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~------  545 (614)
                      .....    .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.......  ......+....      
T Consensus       181 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          181 HTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELL  254 (367)
T ss_dssp             --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred             ccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence            65432    334578999999999887 689999999999999999999999996433211  00111111000      


Q ss_pred             --C---CchhhhhccCC---CCCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 --G---KTLDVIEENMP---EMEL----PEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 --g---~~~~~~d~~l~---~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        -   .....+ ..++   ....    ......+.+++..|++.||++|||+.|+++
T Consensus       255 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          255 KKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             TTCCCHHHHHHH-HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhHHHHHHH-hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence              0   000000 0111   0000    112345788999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.5e-38  Score=342.32  Aligned_cols=263  Identities=25%  Similarity=0.273  Sum_probs=194.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~~~~~  395 (614)
                      .+|...+.||+|+||.||+|+.. +|+.||||++.....    ...+|++++++++|+||+++++++..... .+....+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            36888999999999999999975 689999999975322    23479999999999999999998754322 1233467


Q ss_pred             EEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC-CcEEEeecCCce
Q 043267          396 IVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA-FEAKVGDFGLAK  472 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~-~~~kl~DFGla~  472 (614)
                      +||||+++ +|.+.+..  .....+++..++.++.|+++||+|||   +.+|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999985 66666543  33467999999999999999999999   8999999999999999955 678999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH-------HHH
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE-------LVK  544 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~-------~~~  544 (614)
                      ....+..  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+......       .+.
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~-~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCSCCHHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            7654322  2345789999999998765 79999999999999999999999996433211 11111110       000


Q ss_pred             c--CCchhhhhccCCCC-----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 E--GKTLDVIEENMPEM-----ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~--g~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .  ....+...+.+...     ........+.+++..|++.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0  00000000001000     01122356788999999999999999999984

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=341.81  Aligned_cols=201  Identities=23%  Similarity=0.358  Sum_probs=155.1

Q ss_pred             Cccc-cceecccCceEEEEeEcC---CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSR-ENIIGKGGYGNVYKGMLP---NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~-~~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|.. .++||+|+||.||+|+..   +++.||||++....  ....+.+|++++++++||||+++++++...   .+...
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~   95 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSH---ADRKV   95 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeE
Confidence            4554 458999999999999965   57899999997532  234688999999999999999999998532   45678


Q ss_pred             EEEEeecCCCChhhhhhcC-------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE----CCCCcE
Q 043267          395 IIVCDLLHNGSLYDHLFGS-------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL----DEAFEA  463 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~-------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL----d~~~~~  463 (614)
                      ++||||++ |+|.+++...       ....+++..++.|+.|++.||.|||   +.+|+||||||+|||+    +.++.+
T Consensus        96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~  171 (405)
T 3rgf_A           96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRV  171 (405)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCE
T ss_pred             EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcE
Confidence            99999996 5888887532       2235999999999999999999999   8899999999999999    778999


Q ss_pred             EEeecCCceeCCCCCc--cccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccc
Q 043267          464 KVGDFGLAKFNPEGIT--HLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEII  528 (614)
Q Consensus       464 kl~DFGla~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~  528 (614)
                      ||+|||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       172 kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~  239 (405)
T 3rgf_A          172 KIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  239 (405)
T ss_dssp             EECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCC
T ss_pred             EEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCc
Confidence            9999999986654322  223456799999999999874 5999999999999999999999999543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.4e-37  Score=331.71  Aligned_cols=258  Identities=22%  Similarity=0.299  Sum_probs=194.2

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~  392 (614)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  +......+.+|+++++.++||||+++++++...... ...
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            457889999999999999999964 7899999999753  333456788999999999999999999998743221 112


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+. |+|.+++.    ..+++..+..|+.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             eEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            3499999997 68888772    34999999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH-cCCch-
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK-EGKTL-  549 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~-~g~~~-  549 (614)
                      .....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+     ......+ .+... 
T Consensus       193 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-----~~~~i~~~~~~~~~  263 (371)
T 4exu_A          193 HADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-----QLTQILKVTGVPGT  263 (371)
T ss_dssp             -----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCH
T ss_pred             ccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCcH
Confidence            55432    334578999999999987 789999999999999999999999996433111     1111110 00000 


Q ss_pred             -----------hhhhccCCCC---C----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 -----------DVIEENMPEM---E----LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 -----------~~~d~~l~~~---~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                                 ......++..   .    .+.....+.+++..|++.||++|||+.|+++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          264 EFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence                       0000011100   0    0122456788999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3e-38  Score=339.90  Aligned_cols=263  Identities=23%  Similarity=0.289  Sum_probs=194.6

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~~~~~l  396 (614)
                      .+|...+.||+|+||.||+|+..++..||+|++......    ..+|+++++.++||||+++++++..... ......++
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l  115 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL  115 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence            468899999999999999999887778999998653322    2369999999999999999999865432 23344789


Q ss_pred             EEeecCCCChhhhhh-cCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-CCCcEEEeecCCceeC
Q 043267          397 VCDLLHNGSLYDHLF-GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFN  474 (614)
Q Consensus       397 V~E~~~~GsL~~~L~-~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-~~~~~kl~DFGla~~~  474 (614)
                      ||||++++.+..... ......+++..+..++.|+++||+|||   +.+|+||||||+|||++ .++.+||+|||+++..
T Consensus       116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            999998654433322 123457999999999999999999999   88999999999999999 8999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc-----
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT-----  548 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~-----  548 (614)
                      ..+..  .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||........ +.... +.......     
T Consensus       193 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-l~~i~-~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ-LVEII-KVLGTPSREQIKT  268 (394)
T ss_dssp             CTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHH-HHHCCCCHHHHHH
T ss_pred             cCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHH-HHhCCCCHHHHHh
Confidence            44332  2345689999999998765 599999999999999999999999964332111 11110 00000000     


Q ss_pred             --hhhhhccCCCCC--------cHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          549 --LDVIEENMPEME--------LPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       549 --~~~~d~~l~~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ....+..++...        .......+.+++..|++.||++|||+.|+++
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence              001111111100        1113346788999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.4e-38  Score=329.50  Aligned_cols=253  Identities=26%  Similarity=0.326  Sum_probs=176.8

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHH-HHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVE-IIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~-il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|...+.||+|+||.||+++.. +|+.||||+++... .....++..|+. +++.++||||+++++++.     ..+..
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~-----~~~~~   96 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF-----REGDC   96 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE-----CSSEE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE-----eCCce
Confidence            57888899999999999999974 78999999997542 334455666666 677789999999999987     56788


Q ss_pred             EEEEeecCCCChhhhhhc---CCCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          395 IIVCDLLHNGSLYDHLFG---SGMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~---~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ++||||+++ +|.+++..   .....+++..+.+++.|+++||.|||   +. +|+||||||+|||++.++.+||+|||+
T Consensus        97 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           97 WICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             EEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCC
Confidence            999999985 88877753   23467999999999999999999999   77 999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhh----ccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYA----LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~----~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      ++......  ......||+.|+|||.+    .+..++.++||||||+++|||++|+.||........        ...  
T Consensus       173 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--------~~~--  240 (327)
T 3aln_A          173 SGQLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--------QLT--  240 (327)
T ss_dssp             SCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------C--
T ss_pred             ceeccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--------HHH--
Confidence            98654332  22334689999999998    466799999999999999999999999964322100        000  


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .......+.+...........+.+++..|++.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          241 QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            000000111121111233456788999999999999999999864

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.6e-37  Score=326.56  Aligned_cols=274  Identities=18%  Similarity=0.177  Sum_probs=192.2

Q ss_pred             HHHHHHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-
Q 043267          311 EEIKAATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-  388 (614)
Q Consensus       311 ~el~~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-  388 (614)
                      ++.....++|...+.||+|+||.||+|+.. +|+.||||++.... .....+.+|++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            455677789999999999999999999974 68999999986533 233456778888999999999999999864322 


Q ss_pred             -CCCceEEEEEeecCCCChhhhhhc--CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEE
Q 043267          389 -LEGHQRIIVCDLLHNGSLYDHLFG--SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAK  464 (614)
Q Consensus       389 -~~~~~~~lV~E~~~~GsL~~~L~~--~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~k  464 (614)
                       ......++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+|
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEE
Confidence             122347899999986 55554433  3445789999999999999999999943 679999999999999996 89999


Q ss_pred             EeecCCceeCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHH----
Q 043267          465 VGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA----  539 (614)
Q Consensus       465 l~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~----  539 (614)
                      |+|||+++......  ......||+.|+|||.+.+. .++.++||||||+++|||++|+.||....... .+....    
T Consensus       173 l~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG-QLHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHC
T ss_pred             EeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHH-HHHHHHHHcC
Confidence            99999998665432  23345689999999998765 48999999999999999999999996433211 111111    


Q ss_pred             ------HHHHHcC-Cchhhhh-------ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          540 ------WELVKEG-KTLDVIE-------ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       540 ------~~~~~~g-~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            +..+... ...+..+       ..+. .........+.+++..|++.||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFS-DHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTT-TCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccc-hhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                  0101000 0000000       0000 011123567889999999999999999999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-37  Score=338.97  Aligned_cols=250  Identities=24%  Similarity=0.264  Sum_probs=186.5

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceEEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .|...+.||+|+||+||.+...+|+.||||++...   ..+.+.+|+++++++ +||||+++++++.     ++...++|
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~~~~lv   87 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET-----TDRFLYIA   87 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE-----CSSEEEEE
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCeEEEE
Confidence            45566889999999998766668999999998653   234678999999987 8999999999886     56788999


Q ss_pred             EeecCCCChhhhhhcCCCc-----CCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC------------
Q 043267          398 CDLLHNGSLYDHLFGSGMK-----KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA------------  460 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~-----~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~------------  460 (614)
                      |||+. |+|.+++......     ..++..+++|+.|++.||+|||   +.+|+||||||+|||++.+            
T Consensus        88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~  163 (434)
T 2rio_A           88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAE  163 (434)
T ss_dssp             ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCC
T ss_pred             EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCC
Confidence            99995 7999999764321     1244456889999999999999   8899999999999999654            


Q ss_pred             -CcEEEeecCCceeCCCCCcc---ccccccCCCCcCchhhhcc-------CCCCchhhHHHHHHHHHHHHh-CCCCcccc
Q 043267          461 -FEAKVGDFGLAKFNPEGITH---LTTRVAGTLGYVAPEYALY-------GKLTPGSDVYSFGVVLLELLS-GKKACEII  528 (614)
Q Consensus       461 -~~~kl~DFGla~~~~~~~~~---~~~~~~gt~~Y~APE~~~~-------~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~  528 (614)
                       +.+||+|||+++........   ......||+.|+|||++.+       +.++.++|||||||++|||++ |+.||...
T Consensus       164 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             SCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             ceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence             58999999999876654322   2234679999999999976       678999999999999999999 99998543


Q ss_pred             cCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          529 QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       529 ~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ....       ..... +...   .+.............+.+++..|++.||++|||+.|+++
T Consensus       244 ~~~~-------~~i~~-~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          244 YSRE-------SNIIR-GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TTHH-------HHHHH-TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhH-------HHHhc-CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            2211       11111 1110   011112223456678889999999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.7e-38  Score=319.97  Aligned_cols=252  Identities=26%  Similarity=0.335  Sum_probs=201.1

Q ss_pred             HHhcCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          315 AATMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       315 ~~t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ...++|...+.||+|+||.||+++.. +++.||||++...  .....+.+.+|++++++++||||+++++++.     +.
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   93 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DS   93 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CC
Confidence            34568999999999999999999975 7899999998643  2334677899999999999999999999986     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCC---CcEEEeec
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEA---FEAKVGDF  468 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~---~~~kl~DF  468 (614)
                      ...++|+||+++++|.+++....  .+++..++.++.|+++||.|||   +.+++||||||+||+++.+   +.+||+||
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Df  168 (287)
T 2wei_A           94 SSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDF  168 (287)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred             CeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEecc
Confidence            78899999999999999986543  6899999999999999999999   8899999999999999754   47999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      |++........  .....||+.|+|||.+.+ .++.++||||||+++|||++|+.||......     + ....+..+..
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~-~~~~~~~~~~  239 (287)
T 2wei_A          169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-----D-ILKRVETGKY  239 (287)
T ss_dssp             TGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHHCCC
T ss_pred             CcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHcCCC
Confidence            99976543321  223457899999998765 5999999999999999999999999643221     1 1222333322


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...    .+  ........+.+++..|++.||++|||+.|+++
T Consensus       240 ~~~----~~--~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          240 AFD----LP--QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             CCC----SG--GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCC----ch--hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            100    00  01122346778899999999999999999986

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=325.37  Aligned_cols=256  Identities=23%  Similarity=0.299  Sum_probs=194.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~~  393 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||++...  +....+.+.+|+.++++++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            57888999999999999999964 7899999999653  333456788999999999999999999998643211 1124


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||++ |+|.+++.    ..+++..+..++.|+++||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             EEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            599999997 68888773    34999999999999999999999   88999999999999999999999999999975


Q ss_pred             CCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH-cCCch--
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK-EGKTL--  549 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~-~g~~~--  549 (614)
                      ....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.||......     +......+ .|...  
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~  246 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-----DQLTQILKVTGVPGTE  246 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-----HHHHHHHHHHCBCCHH
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHH
Confidence            4332    234578999999999887 68899999999999999999999999643321     11111110 00000  


Q ss_pred             -----------hhhh-------ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          550 -----------DVIE-------ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       550 -----------~~~d-------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                                 ..+.       ..+. .........+.+++..|++.||++|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          247 FVQKLNDKAAKSYIQSLPQTPRKDFT-QLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHTTCSCHHHHHHHHTSCBCSSCCTT-TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHhhHHHHHHHHhCcCCCCccHH-HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                       0000       0000 111233457788999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.7e-38  Score=324.78  Aligned_cols=244  Identities=23%  Similarity=0.348  Sum_probs=191.0

Q ss_pred             HHHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChh------hhHHHHHHHHHHHHc----cccceeeeee
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKA------GDANFKHEVEIIASV----KHVNLVALRG  381 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~il~~l----~H~niv~l~g  381 (614)
                      .....++|...+.||+|+||.||+|+. .+|+.||||++......      ....+.+|++++.++    +|+||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            345567899999999999999999986 47899999999754321      223456799999999    8999999999


Q ss_pred             eeecccCCCCceEEEEEee-cCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-C
Q 043267          382 YSTATVPLEGHQRIIVCDL-LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-E  459 (614)
Q Consensus       382 ~~~~~~~~~~~~~~lV~E~-~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-~  459 (614)
                      ++.     ..+..++|+|| +++++|.+++....  .+++..++.++.|+++||+|||   +.+|+||||||+||+++ +
T Consensus       106 ~~~-----~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          106 WFE-----TQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLR  175 (312)
T ss_dssp             EC----------CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETT
T ss_pred             EEe-----cCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCC
Confidence            986     45677999999 78999999997643  6999999999999999999999   88999999999999999 8


Q ss_pred             CCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccccCccchhhHH
Q 043267          460 AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLT-PGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDW  538 (614)
Q Consensus       460 ~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t-~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~  538 (614)
                      ++.+||+|||+++......   .....||..|+|||.+.+..+. .++||||||+++|||++|+.||.....        
T Consensus       176 ~~~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------  244 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------  244 (312)
T ss_dssp             TTEEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred             CCeEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence            9999999999998765432   2345689999999999877765 599999999999999999999853210        


Q ss_pred             HHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          539 AWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       539 ~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         ... ..      ..++    ......+.+++..|++.||++|||+.|+++
T Consensus       245 ---~~~-~~------~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 ---ILE-AE------LHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ---HHH-TC------CCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ---Hhh-hc------cCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               000 10      0111    223346778899999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.1e-38  Score=327.40  Aligned_cols=243  Identities=21%  Similarity=0.372  Sum_probs=197.4

Q ss_pred             HHHhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChh------hhHHHHHHHHHHHHcc--ccceeeeeeeee
Q 043267          314 KAATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKA------GDANFKHEVEIIASVK--HVNLVALRGYST  384 (614)
Q Consensus       314 ~~~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~------~~~~f~~Ei~il~~l~--H~niv~l~g~~~  384 (614)
                      ....++|...+.||+|+||.||+|+. .+|+.||||+++.....      ..+.+.+|++++++++  |+|++++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            44556899999999999999999985 47899999999753221      2245678999999996  599999999987


Q ss_pred             cccCCCCceEEEEEeecCC-CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-CCCc
Q 043267          385 ATVPLEGHQRIIVCDLLHN-GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-EAFE  462 (614)
Q Consensus       385 ~~~~~~~~~~~lV~E~~~~-GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-~~~~  462 (614)
                           .....++|+|++.+ ++|.+++...  ..+++..++.|+.|+++||+|||   +.+|+||||||+|||++ +++.
T Consensus       119 -----~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~  188 (320)
T 3a99_A          119 -----RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGE  188 (320)
T ss_dssp             -----CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTE
T ss_pred             -----cCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCC
Confidence                 56788999999976 8999999764  36899999999999999999999   88999999999999999 7899


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHH
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE  541 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~  541 (614)
                      +||+|||+++......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.||....           .
T Consensus       189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----------~  254 (320)
T 3a99_A          189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------E  254 (320)
T ss_dssp             EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------H
T ss_pred             EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----------h
Confidence            9999999998765432   234569999999999987766 688999999999999999999985321           0


Q ss_pred             HHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          542 LVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       542 ~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .. .+..      ..+    ......+.+++..|++.||++|||+.|+++
T Consensus       255 ~~-~~~~------~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 II-RGQV------FFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HH-HCCC------CCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hh-cccc------ccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11 1110      011    122346778889999999999999999986

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.4e-37  Score=318.63  Aligned_cols=251  Identities=22%  Similarity=0.300  Sum_probs=176.9

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCCh-hh-hHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-AG-DANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-~~-~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||.||+++.. +|+.||||++..... .. .+.+.++..+++.++||||+++++++.     ++..
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~-----~~~~   98 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFI-----TNTD   98 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSSE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEe-----cCCc
Confidence            357888999999999999999975 789999999975432 22 233445555788889999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCC-ceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQP-AIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~-~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      .++||||+ ++.+ +.+.......+++..+..++.|+++||.|||   +. +|+||||||+||+++.++.+||+|||+++
T Consensus        99 ~~lv~e~~-~~~~-~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A           99 VFIAMELM-GTCA-EKLKKRMQGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEEEECCC-SEEH-HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EEEEEecc-CCcH-HHHHHHhccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            89999999 3444 4444433457999999999999999999999   64 99999999999999999999999999997


Q ss_pred             eCCCCCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      ......  ......||+.|+|||.+.     ...++.++||||||+++|||++|+.||.......    +....... +.
T Consensus       174 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~~~~~~~~-~~  246 (318)
T 2dyl_A          174 RLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF----EVLTKVLQ-EE  246 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH----HHHHHHHH-SC
T ss_pred             hccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH----HHHHHHhc-cC
Confidence            654332  223456899999999984     5678999999999999999999999996433211    11111111 11


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .     +.++.  .......+.+++..|++.||.+|||+.|+++
T Consensus       247 ~-----~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 P-----PLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             C-----CCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             C-----CCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1     11111  1122346778889999999999999999875

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.3e-37  Score=333.29  Aligned_cols=249  Identities=23%  Similarity=0.260  Sum_probs=185.8

Q ss_pred             HhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceE
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ...+|...+.||+|+||+||.....+|+.||||++.....   ..+.+|+++++++ +||||+++++++.     +....
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~   93 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQ   93 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEE
Confidence            3457888999999999996655555899999999965332   2356899999999 8999999999886     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC-----CCCcEEEeecC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD-----EAFEAKVGDFG  469 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd-----~~~~~kl~DFG  469 (614)
                      ++||||++ |+|.+++.... ..+.+..++.|+.|+++||+|||   +.+|+||||||+|||++     ....+||+|||
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG  168 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFG  168 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTT
T ss_pred             EEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEeccc
Confidence            99999996 69999997644 34566677899999999999999   88999999999999994     33468899999


Q ss_pred             CceeCCCCCc--cccccccCCCCcCchhhhc---cCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHH
Q 043267          470 LAKFNPEGIT--HLTTRVAGTLGYVAPEYAL---YGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       470 la~~~~~~~~--~~~~~~~gt~~Y~APE~~~---~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      +++.......  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||......      .... .
T Consensus       169 ~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~------~~~~-~  241 (432)
T 3p23_A          169 LCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR------QANI-L  241 (432)
T ss_dssp             EEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTH------HHHH-H
T ss_pred             ceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHH------HHHH-H
Confidence            9987654322  2234567999999999997   4678889999999999999999 89998532211      1111 1


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      .......    ...  ........+.+++..|++.||++|||+.||+
T Consensus       242 ~~~~~~~----~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl  282 (432)
T 3p23_A          242 LGACSLD----CLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVL  282 (432)
T ss_dssp             TTCCCCT----TSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             hccCCcc----ccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHH
Confidence            1111100    001  1123344577899999999999999999998

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-36  Score=346.77  Aligned_cols=243  Identities=22%  Similarity=0.247  Sum_probs=192.6

Q ss_pred             hcCccccceecccCceEEEEeEcC--CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP--NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~--~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|...+.||+|+||.||+++..  +|+.||||++... .......+.+|++++++++||||+++++++..........
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            368999999999999999999965  6899999998643 3344567899999999999999999999987543322233


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++..    .++|.+++.|+.|+++||.|||   +.+|+||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            6999999999999987743    6999999999999999999999   8899999999999999986 899999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ....     ....||+.|+|||++.++. +.++||||||+++|||++|..|+.........                   
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------------------  285 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------------------  285 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------------------
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccccc-------------------
Confidence            6543     3457999999999987654 89999999999999999998887532211000                   


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-HHHHHHHhhc
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPT-MDQIVKILET  595 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~~L~~  595 (614)
                         ...........+.+++..|++.||++||+ ++++.+.|.+
T Consensus       286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence               00011122346778999999999999995 5556555543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-35  Score=306.31  Aligned_cols=244  Identities=20%  Similarity=0.279  Sum_probs=184.9

Q ss_pred             cCcccc-ceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHH-HHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRE-NIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEII-ASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il-~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|... +.||+|+||.||++.. .+|+.||||+++.     ...+.+|++++ +..+||||+++++++..... .+...
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~-~~~~~   90 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL   90 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC-CCceE
Confidence            356665 7899999999999996 4789999999975     24567888887 56699999999998763211 35678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~~kl~DFGla  471 (614)
                      ++||||+++|+|.+++.......+++..++.|+.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            99999999999999998876678999999999999999999999   889999999999999998   789999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +...                       +..++.++||||+|+++|||++|+.||.........          .+.....
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~----------~~~~~~~  214 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS----------PGMKTRI  214 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCSS
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh----------HHHHHHH
Confidence            7533                       235678999999999999999999999543321100          0000000


Q ss_pred             hhc--cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCch
Q 043267          552 IEE--NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIK  603 (614)
Q Consensus       552 ~d~--~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p  603 (614)
                      ...  ..+..........+.+++..|++.||++|||+.|+++  .+.+....|..|
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~  270 (299)
T 3m2w_A          215 RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  270 (299)
T ss_dssp             CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCB
T ss_pred             hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCC
Confidence            000  0010000123456788999999999999999999996  455554444444

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.9e-36  Score=326.49  Aligned_cols=246  Identities=14%  Similarity=0.077  Sum_probs=181.3

Q ss_pred             HhcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCCh---hhhHHHHHHHHHHHHccc-cceeeeeee--------
Q 043267          316 ATMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSK---AGDANFKHEVEIIASVKH-VNLVALRGY--------  382 (614)
Q Consensus       316 ~t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---~~~~~f~~Ei~il~~l~H-~niv~l~g~--------  382 (614)
                      .+.+|...++||+|+||.||+|+. .+|+.||||+++....   ...+.+.+|+.+++.++| +|......+        
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345678889999999999999994 5799999999874322   335789999999999977 322111111        


Q ss_pred             -eec------------ccCCCCceEEEEEeecCCCChhhhhh-----cCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc
Q 043267          383 -STA------------TVPLEGHQRIIVCDLLHNGSLYDHLF-----GSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA  444 (614)
Q Consensus       383 -~~~------------~~~~~~~~~~lV~E~~~~GsL~~~L~-----~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~  444 (614)
                       ...            .........+++|+++ +++|.+++.     ......++|..++.|+.|+++||+|||   +.+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYG  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTT
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCC
Confidence             100            0000122356666655 689999885     334567899999999999999999999   899


Q ss_pred             eEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhh----------ccCCCCchhhHHHHHHH
Q 043267          445 IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA----------LYGKLTPGSDVYSFGVV  514 (614)
Q Consensus       445 iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~----------~~~~~t~ksDVwS~Gvl  514 (614)
                      |+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999999865432    344567 999999999          55568899999999999


Q ss_pred             HHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          515 LLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       515 l~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                      +|||++|+.||.........              ...+. ...     ...+.+.+++..|++.||++|||+.|++
T Consensus       307 l~elltg~~Pf~~~~~~~~~--------------~~~~~-~~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGS--------------EWIFR-SCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCS--------------GGGGS-SCC-----CCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhhhH--------------HHHHh-hcc-----cCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            99999999999643321110              01111 011     1124677888899999999999976664

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.7e-36  Score=343.76  Aligned_cols=262  Identities=24%  Similarity=0.284  Sum_probs=198.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~~~~  394 (614)
                      ++|...+.||+|+||.||+|... +|+.||||++... +....+.+.+|++++++++||||+++++++..... ..+...
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            57999999999999999999974 6899999998753 44556779999999999999999999998754221 135677


Q ss_pred             EEEEeecCCCChhhhhhcCC-CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc---EEEeecCC
Q 043267          395 IIVCDLLHNGSLYDHLFGSG-MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---AKVGDFGL  470 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~-~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~---~kl~DFGl  470 (614)
                      ++||||+++|+|.+++.... ...+++..++.|+.+++.||+|||   +.+|+||||||+||+++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999997633 346999999999999999999999   889999999999999997665   99999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc--
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT--  548 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~--  548 (614)
                      ++......  ......||+.|+|||.+.++.++.++||||||+++|||++|+.||.....    ...|.......+..  
T Consensus       171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~----~~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ----PVQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH----HHHSSTTCC------C
T ss_pred             cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc----hhhhhhhhhcccchhh
Confidence            98765432  23446799999999999999999999999999999999999999953211    11111000000000  


Q ss_pred             --hhhh------hcc--CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHH
Q 043267          549 --LDVI------EEN--MPEMELPEMMEQYVLTAAICAHPILQARPTMDQ  588 (614)
Q Consensus       549 --~~~~------d~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  588 (614)
                        .+..      ...  .+..........+.+++..|++.||++|||+.|
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence              0000      001  112233456678899999999999999999976

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.5e-35  Score=301.56  Aligned_cols=229  Identities=12%  Similarity=0.041  Sum_probs=178.9

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|++++++++||||+++++++.     +++.
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~-----~~~~  105 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVH-----TRAG  105 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----ETTE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEE-----ECCc
Confidence            57899999999999999999975 58999999997542   233467899999999999999999999987     4567


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++++|.+++...    ....+..+|+.|+++||+|||   +.+|+||||||+|||++.++.+||+++     
T Consensus       106 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~-----  173 (286)
T 3uqc_A          106 GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYP-----  173 (286)
T ss_dssp             EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSC-----
T ss_pred             EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEec-----
Confidence            89999999999999999432    355678899999999999999   889999999999999999999999743     


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                                      +|++       .++.++||||||+++|||++|+.||...........  ..... .+.... . 
T Consensus       174 ----------------~~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~-~~~~~~-~-  225 (286)
T 3uqc_A          174 ----------------ATMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDT-AGQPIE-P-  225 (286)
T ss_dssp             ----------------CCCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCT-TSCBCC-H-
T ss_pred             ----------------cccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHh-ccCCCC-h-
Confidence                            3444       378999999999999999999999965433211000  00000 000000 0 


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ...    .......+.+++..|++.||++| |+.|+++.|+..
T Consensus       226 ~~~----~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          226 ADI----DRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             HHH----CTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             hhc----ccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            000    11223457788999999999999 999999999875

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.5e-35  Score=309.37  Aligned_cols=248  Identities=15%  Similarity=0.128  Sum_probs=182.9

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecCC--------hhhhHHHHHHHHHHHHcc---------ccceeee
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS--------KAGDANFKHEVEIIASVK---------HVNLVAL  379 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--------~~~~~~f~~Ei~il~~l~---------H~niv~l  379 (614)
                      .++|...+.||+|+||+||+|+. +|+.||||++....        ....+.+.+|++++++++         |+|++++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            34688899999999999999998 78999999997542        222377899999999996         6666655


Q ss_pred             eee-----------------eeccc--------CCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHH
Q 043267          380 RGY-----------------STATV--------PLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL  434 (614)
Q Consensus       380 ~g~-----------------~~~~~--------~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL  434 (614)
                      .+.                 +....        ..++...++||||+++|++.+.+.+   ..+++..++.|+.|++.||
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence            554                 32100        0125789999999999988777743   4689999999999999999


Q ss_pred             HHHhhcCCCceEEeccCCCCeEECCCC--------------------cEEEeecCCceeCCCCCccccccccCCCCcCch
Q 043267          435 AYLHYGVQPAIIHRDIKASNILLDEAF--------------------EAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP  494 (614)
Q Consensus       435 ~yLH~~~~~~iiHrDIKp~NILLd~~~--------------------~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~AP  494 (614)
                      +|||+  +.+|+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+||
T Consensus       175 ~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          175 AVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            99993  36899999999999999887                    8999999999865432      34799999999


Q ss_pred             hhhccCCCCchhhHHHHHHH-HHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHH
Q 043267          495 EYALYGKLTPGSDVYSFGVV-LLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAA  573 (614)
Q Consensus       495 E~~~~~~~t~ksDVwS~Gvl-l~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~  573 (614)
                      |.+.+.. +.++||||+|++ .+++++|..||....    ...............    ...............+.+++.
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQMTF----KTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTCCC----SSCCCSHHHHHHHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhhcc----CcccchhhhhhcCHHHHHHHH
Confidence            9988666 899999998777 777888999874210    000000011111000    001111112356678899999


Q ss_pred             HccccCCCCCCCHHHHH
Q 043267          574 ICAHPILQARPTMDQIV  590 (614)
Q Consensus       574 ~Cl~~dP~~RPt~~eVl  590 (614)
                      .|++.|     |++|++
T Consensus       318 ~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          318 TMLNFS-----SATDLL  329 (336)
T ss_dssp             HGGGSS-----SHHHHH
T ss_pred             HHhccC-----CHHHHH
Confidence            999966     898887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=7.6e-29  Score=278.86  Aligned_cols=185  Identities=17%  Similarity=0.117  Sum_probs=129.7

Q ss_pred             ecccCceEEEEeEc-CCCcEEEEEEeecC----------ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCce
Q 043267          326 IGKGGYGNVYKGML-PNGTEVAVKRFKNC----------SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       326 LG~G~fG~Vykg~~-~~g~~VAVK~l~~~----------~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .+.|+.|.+..++. --|+.+|||.+...          +....++|.+|+++|+++ .|+||+++++++.     ++..
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e-----d~~~  316 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE-----NAQS  316 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE-----CSSE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE-----ECCE
Confidence            55666666665542 25888999999643          123346799999999999 7999999999987     6788


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .||||||++||+|.+.|.+.+  .++..   +|+.||+.||+|+|   +.+||||||||+||||++++++||+|||+|+.
T Consensus       317 ~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          317 GWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCee
Confidence            999999999999999997643  45543   58999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      ....... .+...||++|||||.+.+ ++..++|+||+|++++++.++..++
T Consensus       389 ~~~~~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          389 TPQDCSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             CC---CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCCCCcc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            6544332 344679999999998764 5778899999999998887765544

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=9.5e-27  Score=260.27  Aligned_cols=184  Identities=19%  Similarity=0.200  Sum_probs=144.7

Q ss_pred             cccceecccCceEEEEeEcCCCcEEEEEEeecCCh--------hhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          321 SRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK--------AGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~--------~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ...++||+|+||.||++.. .++.+++|+......        ...+.+.+|++++++++||||+++..++.     ..+
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~~~  412 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDV-----DLD  412 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEE-----ETT
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEE-----eCC
Confidence            4467899999999999965 678899998643211        11345899999999999999996666655     334


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++..          +++|+.|+++||+|||   +.+|+||||||+|||+++  ++||+|||+++
T Consensus       413 ~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~  477 (540)
T 3en9_A          413 NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGK  477 (540)
T ss_dssp             TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCE
T ss_pred             ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCE
Confidence            56999999999999999954          5689999999999999   889999999999999999  99999999999


Q ss_pred             eCCCCCccc------cccccCCCCcCchhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCc
Q 043267          473 FNPEGITHL------TTRVAGTLGYVAPEYALY--GKLTPGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       473 ~~~~~~~~~------~~~~~gt~~Y~APE~~~~--~~~t~ksDVwS~Gvll~ElltG~~p~  525 (614)
                      .........      .....||+.|||||++..  ..|+..+|+||..+-.++-+.++.+|
T Consensus       478 ~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          478 ISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             ECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             ECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            876532221      235679999999999986  67888999999999999988887765

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=1.3e-23  Score=215.71  Aligned_cols=153  Identities=14%  Similarity=0.075  Sum_probs=123.9

Q ss_pred             HHHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCCh------------------hhhHHHHHHHHHHHHc
Q 043267          310 IEEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK------------------AGDANFKHEVEIIASV  371 (614)
Q Consensus       310 ~~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~------------------~~~~~f~~Ei~il~~l  371 (614)
                      +..+......|+..+.||+|+||.||+|...+|+.||||.++....                  .....+.+|+++++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l  161 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL  161 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence            3445555667778899999999999999997899999999964221                  1345689999999999


Q ss_pred             cccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       372 ~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                      +  | +++.+++.      .+..++||||+++|+|.+ +..        .....++.|+++||.|||   +.+|+|||||
T Consensus       162 ~--~-~~v~~~~~------~~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH---~~giiHrDlk  220 (282)
T 1zar_A          162 Q--G-LAVPKVYA------WEGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFY---HRGIVHGDLS  220 (282)
T ss_dssp             T--T-SSSCCEEE------EETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHH---HTTEECSCCS
T ss_pred             c--C-CCcCeEEe------ccceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHH---HCCCEeCCCC
Confidence            9  5 66766553      245699999999999988 421        234579999999999999   8999999999


Q ss_pred             CCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhc
Q 043267          452 ASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL  498 (614)
Q Consensus       452 p~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~  498 (614)
                      |+|||++ ++.+||+|||+++.              +..|+|||++.
T Consensus       221 p~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          221 QYNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TTSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             HHHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9999999 99999999999974              33478999875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=1.1e-18  Score=176.40  Aligned_cols=140  Identities=16%  Similarity=0.120  Sum_probs=108.0

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcE--EEEEEeecCCh------------------------hhhHHHHHHHHHHH
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTE--VAVKRFKNCSK------------------------AGDANFKHEVEIIA  369 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~--VAVK~l~~~~~------------------------~~~~~f~~Ei~il~  369 (614)
                      ..-|+..+.||+|+||.||+|.. .+|+.  ||||+++....                        .....+.+|++++.
T Consensus        46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~  125 (258)
T 1zth_A           46 GYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLE  125 (258)
T ss_dssp             TSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHH
T ss_pred             CCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHH
Confidence            33466788999999999999998 68999  99998753211                        11236789999999


Q ss_pred             Hcccccee--eeeeeeecccCCCCceEEEEEeecCC-C----ChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC
Q 043267          370 SVKHVNLV--ALRGYSTATVPLEGHQRIIVCDLLHN-G----SLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ  442 (614)
Q Consensus       370 ~l~H~niv--~l~g~~~~~~~~~~~~~~lV~E~~~~-G----sL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~  442 (614)
                      +++|+++.  ..+.+         ...++||||+.+ |    +|.++...     .++.....++.|++.||.|||.  +
T Consensus       126 ~l~~~~i~~p~~~~~---------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~--~  189 (258)
T 1zth_A          126 RAKEAGVSVPQPYTY---------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ--E  189 (258)
T ss_dssp             HHHHTTCCCCCEEEE---------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH--T
T ss_pred             HHHhCCCCCCeEEEc---------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH--H
Confidence            99988642  22221         245899999952 4    56555422     3456788999999999999994  4


Q ss_pred             CceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          443 PAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       443 ~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      .+|+||||||+|||++.  .++|+|||++...
T Consensus       190 ~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          190 AELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            68999999999999998  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.63  E-value=4.7e-16  Score=165.45  Aligned_cols=150  Identities=16%  Similarity=0.098  Sum_probs=103.3

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCC--------------hhhhHHHHHHHHHHHHccccceee
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS--------------KAGDANFKHEVEIIASVKHVNLVA  378 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--------------~~~~~~f~~Ei~il~~l~H~niv~  378 (614)
                      +..-..-|+..+.||+|+||.||+|..++|+.||||+++...              .........++.+.....|+|+.+
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r  169 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA  169 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence            333333488999999999999999999999999999875311              011122333444444445555555


Q ss_pred             eeeeee-cccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEE
Q 043267          379 LRGYST-ATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILL  457 (614)
Q Consensus       379 l~g~~~-~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILL  457 (614)
                      +..... ...+......+|||||+++++|.+...        .+...+++.|++.+|.|||   +.+||||||||.|||+
T Consensus       170 L~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl  238 (397)
T 4gyi_A          170 LYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILI  238 (397)
T ss_dssp             HHHTTCSCCCEEEEETTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEE
T ss_pred             HHhcCCCCCeeeeccCceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEE
Confidence            533211 000111223479999999988876542        1234578899999999999   8899999999999999


Q ss_pred             CCCC----------cEEEeecCCcee
Q 043267          458 DEAF----------EAKVGDFGLAKF  473 (614)
Q Consensus       458 d~~~----------~~kl~DFGla~~  473 (614)
                      ++++          .+.|+||+-+-.
T Consensus       239 ~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          239 REEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             eCCCCcccccccccceEEEEeCCccc
Confidence            8776          389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.27  E-value=1.5e-11  Score=123.44  Aligned_cols=147  Identities=12%  Similarity=0.047  Sum_probs=113.3

Q ss_pred             HHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCC
Q 043267          313 IKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       313 l~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~  391 (614)
                      +...-.+|.....++.|+.+.||+.... |+.+++|+...........+.+|+++++.+. |..+.+++++..     ..
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~-----~~   82 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----HD   82 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----ET
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEe-----cC
Confidence            3444557888888898999999999864 6889999987532223346889999999994 667778888775     45


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc-------------------------------
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG-------------------------------  440 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~-------------------------------  440 (614)
                      +..++||||++|.+|.+.+.       +......++.+++++|..||.-                               
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             CceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            67899999999999887641       2233457889999999999961                               


Q ss_pred             -------------------------CCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          441 -------------------------VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       441 -------------------------~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                                               ....++|+|++|.|||++++..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                     01569999999999999876666799999775

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=5.1e-11  Score=118.59  Aligned_cols=137  Identities=13%  Similarity=0.041  Sum_probs=99.1

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccce--eeeeeeeecccCCCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL--VALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni--v~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++....+.+.|..+.||+....+|..+++|.....   ....+.+|+++++.+.+.++  .+++++..     .++..++
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~   92 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWL   92 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEE
Confidence            44443333456669999998878889999987653   23457889999999965554  44777654     3456899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV-----------------------------------  441 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~-----------------------------------  441 (614)
                      ||||+++.+|.  ...     .   ....++.++++.|..||...                                   
T Consensus        93 v~e~i~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           93 LLGEVPGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEECCSSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEecCCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            99999998884  211     1   12367788888888888421                                   


Q ss_pred             --------------------CCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          442 --------------------QPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       442 --------------------~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                                          ...++|+|++|.||+++++..++|.|||.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                12399999999999998876677999998763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.95  E-value=1.2e-09  Score=112.29  Aligned_cols=186  Identities=19%  Similarity=0.183  Sum_probs=123.2

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccc--eeeeeeeeecccCCCCceEEEEEe
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVN--LVALRGYSTATVPLEGHQRIIVCD  399 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~n--iv~l~g~~~~~~~~~~~~~~lV~E  399 (614)
                      .+.++.|....||+..    ..+++|+...  ......+.+|.++++.+. +..  +.+.+.......  .....++|||
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~--~~~~~~~vm~   96 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE--TYQMSFAGFT   96 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS--SCSCSCEEEE
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC--CCCcceEEEc
Confidence            3568999999999864    5688887643  234567889999999884 333  233333322110  1123478999


Q ss_pred             ecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc---------------------------------------
Q 043267          400 LLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG---------------------------------------  440 (614)
Q Consensus       400 ~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~---------------------------------------  440 (614)
                      +++|.+|.+...    ..++..++..++.++++.|..||..                                       
T Consensus        97 ~i~G~~l~~~~~----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           97 KIKGVPLTPLLL----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCCCEECCHHHH----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             ccCCeECCcccc----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            999988876432    2467778888888888888888841                                       


Q ss_pred             ----------------CCCceEEeccCCCCeEECC--CCcEEEeecCCceeCCCCCccccccccCCCCc---Cchhhhc-
Q 043267          441 ----------------VQPAIIHRDIKASNILLDE--AFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY---VAPEYAL-  498 (614)
Q Consensus       441 ----------------~~~~iiHrDIKp~NILLd~--~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y---~APE~~~-  498 (614)
                                      ....++|+|++|.||++++  +..+.|.||+.+.........     .....+   ..|+... 
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-----~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-----ISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-----HTTCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-----HHHHhhccccCHHHHHH
Confidence                            1246899999999999998  556789999998754321100     001111   2233211 


Q ss_pred             ----cCCCC---------chhhHHHHHHHHHHHHhCCCCc
Q 043267          499 ----YGKLT---------PGSDVYSFGVVLLELLSGKKAC  525 (614)
Q Consensus       499 ----~~~~t---------~ksDVwS~Gvll~ElltG~~p~  525 (614)
                          ++..+         ...+.|++|.++|++.+|+.++
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                12111         2368999999999999999776

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.94  E-value=2.2e-09  Score=113.00  Aligned_cols=145  Identities=14%  Similarity=0.182  Sum_probs=107.0

Q ss_pred             ccceecccCceEEEEeEcCCCcEEEEEEee--cCC-hhhhHHHHHHHHHHHHcc--ccceeeeeeeeecccCCCCceEEE
Q 043267          322 RENIIGKGGYGNVYKGMLPNGTEVAVKRFK--NCS-KAGDANFKHEVEIIASVK--HVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~--~~~-~~~~~~f~~Ei~il~~l~--H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+++++.+.  +..+.++++++....  ..+..++
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~--~~g~~~~  118 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDES--VIGRAFY  118 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTT--TTSSCEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCC--ccCCeEE
Confidence            34679999999999998754 678888775  322 123456888999999997  455777888775321  1245789


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGV-----------------------------------  441 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~-----------------------------------  441 (614)
                      ||||+++..+.+..    ...++..++..++.++++.|..||...                                   
T Consensus       119 vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          119 IMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             EEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            99999998875422    234788889999999999999999520                                   


Q ss_pred             --------------------CCceEEeccCCCCeEECCCCc--EEEeecCCcee
Q 043267          442 --------------------QPAIIHRDIKASNILLDEAFE--AKVGDFGLAKF  473 (614)
Q Consensus       442 --------------------~~~iiHrDIKp~NILLd~~~~--~kl~DFGla~~  473 (614)
                                          ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                267999999999999997753  68999999875

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=98.29  E-value=7.2e-08  Score=83.85  Aligned_cols=51  Identities=18%  Similarity=0.185  Sum_probs=48.2

Q ss_pred             hHhhhcccCCCCCccchhHHHHHHHHhhhhhcCCCCCCCcccCCCCCccccc
Q 043267          163 QEIKRHCSQSLENSYACDSCTSKLSSLSEILRHGPGNGNGNVSDCSGYPYLY  214 (614)
Q Consensus       163 ~~l~~qC~~dL~~~~~C~~CL~~~~~~~~~~l~g~~Gg~~~~~~C~~r~~~y  214 (614)
                      .+.++||++|| ++.+|+.||..++..++++|.++.||++...+|++||+.|
T Consensus        56 vygl~qC~~Dl-s~~~C~~Cl~~a~~~~~~~C~~~~g~~i~~~~C~lRY~~~  106 (108)
T 3a2e_A           56 AYGRATCKQSI-SQSDCTACLSNLVNRIFSICNNAIGARVQLVDCFIQYEQR  106 (108)
T ss_dssp             EEEEEEECTTS-CHHHHHHHHHHHHTTHHHHTTSBSSEEEEETTEEEEEESS
T ss_pred             EEEEEEEcCCC-CHHHHHHHHHHHHHHHHHHCCCCceEEEECCCEEEEEeCC
Confidence            47899999999 8999999999999999999999999999999999999876

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.27  E-value=6.7e-06  Score=84.50  Aligned_cols=137  Identities=17%  Similarity=0.158  Sum_probs=93.5

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcccc---ceeeeeeeeecccCCCCceEEEEEee
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV---NLVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~---niv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      +.++.|....||+.    |..+++|+-.  .......+.+|.++++.+.+.   .+.+.+.++..    ..+..++||||
T Consensus        25 ~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~----~~g~~~~v~e~   94 (306)
T 3tdw_A           25 ESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR----SDGNPFVGYRK   94 (306)
T ss_dssp             EEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC----TTSCEEEEEEC
T ss_pred             eecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc----CCCceEEEEec
Confidence            56888888999987    5678888753  233456788999999999753   24445555431    23456899999


Q ss_pred             cCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 043267          401 LHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG----------------------------------------  440 (614)
Q Consensus       401 ~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~----------------------------------------  440 (614)
                      ++|.++.+...    ..++..++..++.++++.|..||..                                        
T Consensus        95 i~G~~l~~~~~----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           95 VQGQILGEDGM----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             CCSEECHHHHH----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             cCCeECchhhh----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            99988876321    1234444555555555555555521                                        


Q ss_pred             -----------------CCCceEEeccCCCCeEECC---CCc-EEEeecCCceeC
Q 043267          441 -----------------VQPAIIHRDIKASNILLDE---AFE-AKVGDFGLAKFN  474 (614)
Q Consensus       441 -----------------~~~~iiHrDIKp~NILLd~---~~~-~kl~DFGla~~~  474 (614)
                                       ....++|+|+++.||+++.   ++. ..|.||+.+...
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                             2446799999999999997   455 489999988753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.22  E-value=7.3e-06  Score=81.95  Aligned_cols=135  Identities=16%  Similarity=0.128  Sum_probs=94.0

Q ss_pred             eecccCce-EEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEEEEEeec
Q 043267          325 IIGKGGYG-NVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       325 ~LG~G~fG-~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      .+..|..| .||+.... ++..+++|+-...   ...++.+|...++.+. +--+-++++++.     +++..++|||++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~-----~~~~~~lvme~l  102 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIR-----TPDDAWLLTTAI  102 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEE-----ETTEEEEEEECC
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEE-----ECCeEEEEEEee
Confidence            35556555 68988764 5678899986542   3456888999999884 333556677765     446789999999


Q ss_pred             CCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc-----------------------------------------
Q 043267          402 HNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG-----------------------------------------  440 (614)
Q Consensus       402 ~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~-----------------------------------------  440 (614)
                      ++.++.+....      ....+..+..++++.|.-||..                                         
T Consensus       103 ~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (272)
T 4gkh_A          103 PGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV  176 (272)
T ss_dssp             CSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred             CCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence            99887765422      1223345566666666666621                                         


Q ss_pred             --------------CCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          441 --------------VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       441 --------------~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                                    ....++|+|+++.|||+++++.+-|.||+.+..
T Consensus       177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                          123489999999999999887777999998863

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.16  E-value=4.3e-06  Score=87.40  Aligned_cols=84  Identities=13%  Similarity=0.030  Sum_probs=55.9

Q ss_pred             ccee-cccCceEEEEeEcC-------CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccc---cceeeeeeeeecccC
Q 043267          323 ENII-GKGGYGNVYKGMLP-------NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKH---VNLVALRGYSTATVP  388 (614)
Q Consensus       323 ~~~L-G~G~fG~Vykg~~~-------~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H---~niv~l~g~~~~~~~  388 (614)
                      .+.| +.|....+|+....       +|+.+++|+.....   ......+.+|+.+++.+..   ..+.++++++.... 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~-  103 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD-  103 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST-
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC-
Confidence            3567 88889999998764       26788898765422   1112457789999998853   24566777664221 


Q ss_pred             CCCceEEEEEeecCCCChhh
Q 043267          389 LEGHQRIIVCDLLHNGSLYD  408 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~  408 (614)
                       .....++||||+++..+.+
T Consensus       104 -~~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          104 -VLGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             -TTSSCEEEEECCCCBCCCB
T ss_pred             -ccCCceEEEEecCCCChhh
Confidence             1134689999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.90  E-value=4.5e-05  Score=80.99  Aligned_cols=75  Identities=12%  Similarity=0.041  Sum_probs=48.7

Q ss_pred             cceecccCceEEEEeEcC-CCcEEEEEEeecCCh-------hhhHHHHHHHHHHHHccc--cc-eeeeeeeeecccCCCC
Q 043267          323 ENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSK-------AGDANFKHEVEIIASVKH--VN-LVALRGYSTATVPLEG  391 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~-------~~~~~f~~Ei~il~~l~H--~n-iv~l~g~~~~~~~~~~  391 (614)
                      .+.||.|..+.||++... +++.++||.......       ...+.+..|.++++.+..  +. +.+++.+.       .
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d-------~  107 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------T  107 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------T
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc-------C
Confidence            457999999999999864 568899998653211       123456789999988743  33 33454432       2


Q ss_pred             ceEEEEEeecCCC
Q 043267          392 HQRIIVCDLLHNG  404 (614)
Q Consensus       392 ~~~~lV~E~~~~G  404 (614)
                      ...++||||+++.
T Consensus       108 ~~~~lvmE~l~g~  120 (397)
T 2olc_A          108 EMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTEEEECCCTTS
T ss_pred             CccEEEEEeCCCc
Confidence            2358999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.87  E-value=6.7e-05  Score=77.23  Aligned_cols=145  Identities=18%  Similarity=0.204  Sum_probs=82.3

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeeccc-CCCCceEEEEEee
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTATV-PLEGHQRIIVCDL  400 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~-~~~~~~~~lV~E~  400 (614)
                      +.|+.|..+.||+...++| .+++|+....    ..++..|.++++.+...+  +.+++....... ...++..+++|||
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566677899999987555 4899988752    234455667666664222  333332110000 0024567899999


Q ss_pred             cCCCChh--------------hhhhc--CCC----------cCCChHHHH------------------------------
Q 043267          401 LHNGSLY--------------DHLFG--SGM----------KKLSWPIRL------------------------------  424 (614)
Q Consensus       401 ~~~GsL~--------------~~L~~--~~~----------~~l~~~~~~------------------------------  424 (614)
                      +++.++.              ..++.  ...          ..-.|....                              
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9987653              01111  100          012332211                              


Q ss_pred             -HHHHHHHHHHHHHhh----------cCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          425 -RIALGTARGLAYLHY----------GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       425 -~I~~~ia~gL~yLH~----------~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                       .+...+.+++.+|+.          .....++|+|+++.|||++.++.+.|.||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence             011123345666653          1267899999999999998888999999998753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.70  E-value=8.7e-05  Score=75.16  Aligned_cols=80  Identities=16%  Similarity=0.201  Sum_probs=58.3

Q ss_pred             CccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcccc---ceeeeeeeeecccCCCCceEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHV---NLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~---niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .....+.+|.|..+.||+.++.||+.|.||+...........|..|.+.|+.+.-.   -+.+.+++.         ..+
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~---------~~~   86 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD---------DRT   86 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE---------TTE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc---------Cce
Confidence            45556779999999999999999999999987654444445688999999988422   233344432         237


Q ss_pred             EEEeecCCCChh
Q 043267          396 IVCDLLHNGSLY  407 (614)
Q Consensus       396 lV~E~~~~GsL~  407 (614)
                      +||||++.+...
T Consensus        87 lv~e~l~~~~~~   98 (288)
T 3f7w_A           87 LAMEWVDERPPT   98 (288)
T ss_dssp             EEEECCCCCCCC
T ss_pred             EEEEeecccCCC
Confidence            899999877643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.53  E-value=0.00013  Score=78.27  Aligned_cols=80  Identities=14%  Similarity=0.120  Sum_probs=50.9

Q ss_pred             CCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccC---CCCchhhHHHHHHHHHHH
Q 043267          442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYG---KLTPGSDVYSFGVVLLEL  518 (614)
Q Consensus       442 ~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~---~~t~ksDVwS~Gvll~El  518 (614)
                      ...++|+|+++.|||++.++ ++|.||+.+...+....-...-..-...|.+|+.....   .-....++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            68899999999999999876 99999999875432111000000001345666655421   112345667888888888


Q ss_pred             HhCC
Q 043267          519 LSGK  522 (614)
Q Consensus       519 ltG~  522 (614)
                      +.++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.45  E-value=0.00081  Score=69.25  Aligned_cols=138  Identities=15%  Similarity=0.154  Sum_probs=90.8

Q ss_pred             ccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccc---cceeeeeeeeecccCCCCceEEEEE
Q 043267          322 RENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH---VNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H---~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      ..+.|+.|....+|+... ++..+++|+....   ....+..|.+.++.+..   ..+.+.++++.     ..+..++||
T Consensus        40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvm  110 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLL  110 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEE
T ss_pred             eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEE
Confidence            346789999999999887 5678889987642   35568899999988842   45677777765     345789999


Q ss_pred             eecCCCChhh-----------hhhcCCC-c-------------------CCChHHHH---HHHH----------------
Q 043267          399 DLLHNGSLYD-----------HLFGSGM-K-------------------KLSWPIRL---RIAL----------------  428 (614)
Q Consensus       399 E~~~~GsL~~-----------~L~~~~~-~-------------------~l~~~~~~---~I~~----------------  428 (614)
                      ||+++..+..           .|+.... .                   .-+|....   ++..                
T Consensus       111 e~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~  190 (312)
T 3jr1_A          111 EALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNID  190 (312)
T ss_dssp             ECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHH
T ss_pred             EeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence            9999887532           1222111 1                   12454321   1111                


Q ss_pred             HHHHH-HHHHh-hcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          429 GTARG-LAYLH-YGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       429 ~ia~g-L~yLH-~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      .+.+- ...|. ....+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       191 ~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          191 LIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            11111 12342 13367899999999999999887 8899974

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.27  E-value=0.0017  Score=66.26  Aligned_cols=162  Identities=11%  Similarity=0.106  Sum_probs=90.2

Q ss_pred             cCHHHHHHHhcCccc-----cceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccce--eeee
Q 043267          308 FKIEEIKAATMNFSR-----ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL--VALR  380 (614)
Q Consensus       308 f~~~el~~~t~~f~~-----~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni--v~l~  380 (614)
                      ++.+++...-..|..     .+.|+.|....+|+....+| .+++|.....  ...+++..|++++..+...++  .+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            445566655555654     24466788899999987666 6888988652  123356678888888854333  2333


Q ss_pred             eeeeccc-CCCCceEEEEEeecCCCChhh--------------hhhcC--C--Cc------CCChHHHHHH---------
Q 043267          381 GYSTATV-PLEGHQRIIVCDLLHNGSLYD--------------HLFGS--G--MK------KLSWPIRLRI---------  426 (614)
Q Consensus       381 g~~~~~~-~~~~~~~~lV~E~~~~GsL~~--------------~L~~~--~--~~------~l~~~~~~~I---------  426 (614)
                      ....... ....+..+++++|+++..+..              .++..  .  ..      ...|.....-         
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            2110000 001245689999999865421              01110  0  00      0123331110         


Q ss_pred             ---HHHHHHHHHHHhhc----CCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          427 ---ALGTARGLAYLHYG----VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       427 ---~~~ia~gL~yLH~~----~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                         ...+.+.++.++..    ....++|+|+++.|||++++..+.|.||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               11244455555532    24579999999999999987666899999775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.01  E-value=0.0071  Score=61.79  Aligned_cols=145  Identities=12%  Similarity=0.034  Sum_probs=83.9

Q ss_pred             ceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeeccc-CCCCceEEEEEee
Q 043267          324 NIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTATV-PLEGHQRIIVCDL  400 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~-~~~~~~~~lV~E~  400 (614)
                      ..++ |....||+....+|+.+++|...... .....+..|..++..+....  +.+++.. .... ...++..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEe
Confidence            4566 88889999888778889999986321 23456777888888885333  3344433 1100 0013456889999


Q ss_pred             cCCCChhh----h----------hhc--C-----CCcCCChHHH----HHH---------------HHHHHHHHHHHhh-
Q 043267          401 LHNGSLYD----H----------LFG--S-----GMKKLSWPIR----LRI---------------ALGTARGLAYLHY-  439 (614)
Q Consensus       401 ~~~GsL~~----~----------L~~--~-----~~~~l~~~~~----~~I---------------~~~ia~gL~yLH~-  439 (614)
                      +++..+..    .          ++.  .     .....++...    ..+               ...+.+.+..+.. 
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98755421    0          111  0     0112222211    001               0111122222221 


Q ss_pred             ---cCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          440 ---GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       440 ---~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                         .....++|+|+++.|||++ + .+.|.||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               1256789999999999999 4 899999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.99  E-value=0.00091  Score=68.00  Aligned_cols=138  Identities=14%  Similarity=0.102  Sum_probs=76.3

Q ss_pred             cceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCceEEEEEeec
Q 043267          323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      .+.|+.|....+|+.     ..+++|+....... .....+|+.+++.+...++. +++++.       ....++++||+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~-------~~~~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD-------PATGVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC-------TTTCCEEEECC
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE-------CCCCEEEEeec
Confidence            577999999999998     56888887643221 12235688888877543333 444432       22347899999


Q ss_pred             -CCCChhhh------------------hhcCCC---cCCC-hHHHHHHHH--------------HHHHHHH----HHh-h
Q 043267          402 -HNGSLYDH------------------LFGSGM---KKLS-WPIRLRIAL--------------GTARGLA----YLH-Y  439 (614)
Q Consensus       402 -~~GsL~~~------------------L~~~~~---~~l~-~~~~~~I~~--------------~ia~gL~----yLH-~  439 (614)
                       ++.++...                  ++....   ...+ +....++..              .+.+.+.    .|. .
T Consensus        90 ~~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~  169 (301)
T 3dxq_A           90 AGAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAH  169 (301)
T ss_dssp             TTCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhc
Confidence             55444321                  111110   0011 111111100              0111111    111 1


Q ss_pred             cCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          440 GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       440 ~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      .....++|+|+.+.||+ ..++.+.++||..+...
T Consensus       170 ~~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          170 PLPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             CCCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             CCCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            23456899999999999 56667899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.96  E-value=0.0017  Score=69.77  Aligned_cols=72  Identities=17%  Similarity=0.180  Sum_probs=49.1

Q ss_pred             ceecccCceEEEEeEcCC--------CcEEEEEEeecCChhhhHHHHHHHHHHHHccccce-eeeeeeeecccCCCCceE
Q 043267          324 NIIGKGGYGNVYKGMLPN--------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL-VALRGYSTATVPLEGHQR  394 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~~~~~  394 (614)
                      +.|+.|....+|+...++        +..+++|+.....  ..+.+..|..+++.+...++ .++++.+.      +   
T Consensus        79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~------~---  147 (429)
T 1nw1_A           79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFS------G---  147 (429)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEET------T---
T ss_pred             EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeC------C---
Confidence            568888889999998753        5789999884321  11456689999998854444 45565442      1   


Q ss_pred             EEEEeecCCCCh
Q 043267          395 IIVCDLLHNGSL  406 (614)
Q Consensus       395 ~lV~E~~~~GsL  406 (614)
                      .+|+||+++.+|
T Consensus       148 g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 GRLEEYIPSRPL  159 (429)
T ss_dssp             EEEECCCCEEEC
T ss_pred             CEEEEEeCCccc
Confidence            289999986444

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.86  E-value=0.0064  Score=62.47  Aligned_cols=142  Identities=12%  Similarity=0.114  Sum_probs=73.9

Q ss_pred             ceecccCceE-EEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeecccCCCCceEEEEEee
Q 043267          324 NIIGKGGYGN-VYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTATVPLEGHQRIIVCDL  400 (614)
Q Consensus       324 ~~LG~G~fG~-Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~~~~~~lV~E~  400 (614)
                      +.|+.|+... +|+....+|..+++|.......   +++..|+.+++.+....  +.+++.+..     +.+  +++||+
T Consensus        24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~-----~~g--~ll~e~   93 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEH-----ARG--LLLIED   93 (333)
T ss_dssp             CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEET-----TTT--EEEECC
T ss_pred             eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecC-----CCC--EEEEee
Confidence            4465565544 6677665577787776543211   23456777777774323  444555432     222  789999


Q ss_pred             cCCCChhhhhhcCC------------------------CcCCChHHHH-------HH-------------HHHHHHHHHH
Q 043267          401 LHNGSLYDHLFGSG------------------------MKKLSWPIRL-------RI-------------ALGTARGLAY  436 (614)
Q Consensus       401 ~~~GsL~~~L~~~~------------------------~~~l~~~~~~-------~I-------------~~~ia~gL~y  436 (614)
                      +.+..+.+++....                        ...++.....       .+             ...+.+.+..
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            97766654432110                        0111111000       00             0011112222


Q ss_pred             Hh---hcCCCceEEeccCCCCeEECCC----CcEEEeecCCceeCC
Q 043267          437 LH---YGVQPAIIHRDIKASNILLDEA----FEAKVGDFGLAKFNP  475 (614)
Q Consensus       437 LH---~~~~~~iiHrDIKp~NILLd~~----~~~kl~DFGla~~~~  475 (614)
                      +.   ......++|+|+.+.|||++.+    ..+.|.||+.+...+
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            21   1125689999999999999875    689999999987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.77  E-value=0.0042  Score=65.71  Aligned_cols=140  Identities=18%  Similarity=0.177  Sum_probs=82.9

Q ss_pred             ceecccCceEEEEeEcC--------CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccce-eeeeeeeecccCCCCceE
Q 043267          324 NIIGKGGYGNVYKGMLP--------NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL-VALRGYSTATVPLEGHQR  394 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~~~~~  394 (614)
                      +.|..|-...+|+...+        +++.+++|+.... ........+|..+++.+...++ .++++++.      +   
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~------~---  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFP------E---  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEET------T---
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcC------C---
Confidence            45777888889998875        3578999986432 2234566789999988853333 44555542      2   


Q ss_pred             EEEEeecCCCChhhh-----------------hhcCC---CcCCC--hHHHHHHHHHHH-------------------HH
Q 043267          395 IIVCDLLHNGSLYDH-----------------LFGSG---MKKLS--WPIRLRIALGTA-------------------RG  433 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~-----------------L~~~~---~~~l~--~~~~~~I~~~ia-------------------~g  433 (614)
                      -+||||+++..|..-                 |+...   .+...  |.+..++..++.                   +.
T Consensus       126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~  205 (379)
T 3feg_A          126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE  205 (379)
T ss_dssp             EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred             ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence            289999998665421                 11110   11222  444444443332                   12


Q ss_pred             HHHHh-----hcCCCceEEeccCCCCeEECCC----CcEEEeecCCcee
Q 043267          434 LAYLH-----YGVQPAIIHRDIKASNILLDEA----FEAKVGDFGLAKF  473 (614)
Q Consensus       434 L~yLH-----~~~~~~iiHrDIKp~NILLd~~----~~~kl~DFGla~~  473 (614)
                      +..|.     ......++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33332     1234579999999999999876    7899999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.53  E-value=0.0051  Score=64.34  Aligned_cols=73  Identities=15%  Similarity=0.094  Sum_probs=43.8

Q ss_pred             ceecccCceEEEEeEcCC---------CcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCce
Q 043267          324 NIIGKGGYGNVYKGMLPN---------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQ  393 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~---------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~  393 (614)
                      +.|+.|....+|+....+         +..+++|+...... ...+...|.++++.+...+++ ++++..      .   
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~------~---  108 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF------N---  108 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE------T---
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec------C---
Confidence            457788889999988654         26788887654322 112346788888888544443 455432      1   


Q ss_pred             EEEEEeecCCCCh
Q 043267          394 RIIVCDLLHNGSL  406 (614)
Q Consensus       394 ~~lV~E~~~~GsL  406 (614)
                      ..+||||+++..+
T Consensus       109 ~~~v~e~i~G~~l  121 (369)
T 3c5i_A          109 GGRIEEWLYGDPL  121 (369)
T ss_dssp             TEEEEECCCSEEC
T ss_pred             CcEEEEEecCCcC
Confidence            2689999987544

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.50  E-value=0.0092  Score=64.67  Aligned_cols=73  Identities=14%  Similarity=0.072  Sum_probs=46.8

Q ss_pred             ceecccCceEEEEeEcCC-CcEEEEEEeecCChhhhHHHHHHHHHHHHccccce-eeeeeeeecccCCCCceEEEEEeec
Q 043267          324 NIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL-VALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      +.|+.|-...+|+...++ +..+++|+....... ..+..+|..+++.+...++ .++++++.      +   .+||||+
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~------~---G~v~e~I  183 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT------N---GRIEEFM  183 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET------T---EEEEECC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC------C---eEEEEee
Confidence            568888889999998765 578888877432211 1112578999999965555 45565542      1   2499999


Q ss_pred             CCCCh
Q 043267          402 HNGSL  406 (614)
Q Consensus       402 ~~GsL  406 (614)
                      ++.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87555

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.22  E-value=0.016  Score=56.20  Aligned_cols=172  Identities=15%  Similarity=0.041  Sum_probs=89.4

Q ss_pred             CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCCccccc
Q 043267          404 GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTT  483 (614)
Q Consensus       404 GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~~~~~~  483 (614)
                      -||.+.|... +.++++++.+.++.|.+++|.-+-....+  ..+=+.|..|+|..+|++...+ +.+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence            3788888653 36899999999999999998876211011  1233446889999999887763 1110           


Q ss_pred             cccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHH
Q 043267          484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPE  563 (614)
Q Consensus       484 ~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~  563 (614)
                        .....+.|||... ...+.+.=|||+|+++|.-+-=..|-+....=...|....-.+-.........|+.+......+
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~  174 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEERELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGL  174 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEECCCHHHHHHHHHHTTCCC----------------
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccchhhCHHHHHHHHHHHhccccccccccccccccccc
Confidence              0122456787653 3567899999999999998863322211111011122222111111011112222222000000


Q ss_pred             HHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCC
Q 043267          564 MMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSN  601 (614)
Q Consensus       564 ~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  601 (614)
                      ..+.        -...+..|++.++|+++=+..++.|+
T Consensus       175 ~d~~--------~~~~~~~~~sl~~Vi~~C~~hl~~ps  204 (229)
T 2yle_A          175 GDED--------EKRKISAIRSYRDVMKLCAAHLPTES  204 (229)
T ss_dssp             ------------CCSCCCCCCSHHHHHHHHHTTSSSGG
T ss_pred             cccc--------ccccccCcCCHHHHHHHHHhhccCcc
Confidence            0000        02467899999999999999888765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.02  E-value=0.02  Score=59.30  Aligned_cols=33  Identities=21%  Similarity=0.305  Sum_probs=29.0

Q ss_pred             CCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       442 ~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ...++|+|+.+.||++++++.+.|.||+.+...
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            467999999999999998888999999887643

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=94.91  E-value=0.012  Score=41.64  Aligned_cols=30  Identities=13%  Similarity=0.145  Sum_probs=14.7

Q ss_pred             EEehHHHHHHHHHHHHHHHHHHhhhccccc
Q 043267          253 IYGLVLGSVIGILGAFTAFWFLFTRSKKSE  282 (614)
Q Consensus       253 ii~i~~~~v~~vl~~~~~~~~~~~r~kk~~  282 (614)
                      |++.+++++++++++++++|+++|||++++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHIVR   42 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTCCS
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHhhc
Confidence            344444444444434455556666555543

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=94.91  E-value=0.0089  Score=42.31  Aligned_cols=31  Identities=16%  Similarity=0.135  Sum_probs=15.6

Q ss_pred             EEehHHHHHHHHHHHHHHHHHHhhhcccccc
Q 043267          253 IYGLVLGSVIGILGAFTAFWFLFTRSKKSEE  283 (614)
Q Consensus       253 ii~i~~~~v~~vl~~~~~~~~~~~r~kk~~~  283 (614)
                      |++.+++++++++++..++|+++|||+++++
T Consensus        12 IA~gVVgGv~~v~ii~~~~~~~~RRRr~~~k   42 (44)
T 2l2t_A           12 IAAGVIGGLFILVIVGLTFAVYVRRKSIKKK   42 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCSSCC
T ss_pred             EEEeehHHHHHHHHHHHHHHHHhhhhhhhhc
Confidence            4444455444444344555666666555443

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.80  E-value=0.13  Score=54.95  Aligned_cols=140  Identities=11%  Similarity=0.110  Sum_probs=84.3

Q ss_pred             cceecccCceEEEEeEcCC--------CcEEEEEEeecCChhhhHHHHHHHHHHHHccccce-eeeeeeeecccCCCCce
Q 043267          323 ENIIGKGGYGNVYKGMLPN--------GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNL-VALRGYSTATVPLEGHQ  393 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~--------g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~ni-v~l~g~~~~~~~~~~~~  393 (614)
                      .+.+..|-...+|+...++        +..+++|+....... ..+..+|..+++.+...++ .++++.+.         
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~---------  144 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP---------  144 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET---------
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC---------
Confidence            3457778889999998753        578999986543221 1234578888888854333 34444321         


Q ss_pred             EEEEEeecCCCChhhh-----------------hhc--C---------CCcCCChHHHHHHHHHH---------------
Q 043267          394 RIIVCDLLHNGSLYDH-----------------LFG--S---------GMKKLSWPIRLRIALGT---------------  430 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~-----------------L~~--~---------~~~~l~~~~~~~I~~~i---------------  430 (614)
                      ..+|+||+++..|..-                 |+.  .         ...+.-|.+..++..++               
T Consensus       145 ~~~I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~  224 (424)
T 3mes_A          145 EGRIEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKEL  224 (424)
T ss_dssp             TEEEEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHH
T ss_pred             CCEEEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhcccc
Confidence            2789999998664310                 111  0         11111244443333222               


Q ss_pred             ----HHHHHHHh---------------------hcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          431 ----ARGLAYLH---------------------YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       431 ----a~gL~yLH---------------------~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                          ...+..|.                     ......++|+|+.+.||+ +.++.+.++||..+..
T Consensus       225 ~~~l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          225 YSKILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence                22233332                     122457899999999999 8888999999998864

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=92.85  E-value=0.056  Score=38.17  Aligned_cols=27  Identities=15%  Similarity=0.166  Sum_probs=11.7

Q ss_pred             EEehHHHHHHHHHHHHHHHHHHhhhcc
Q 043267          253 IYGLVLGSVIGILGAFTAFWFLFTRSK  279 (614)
Q Consensus       253 ii~i~~~~v~~vl~~~~~~~~~~~r~k  279 (614)
                      |++.++|+++++++.+++++|++||+.
T Consensus        14 Ia~~vVGvll~vi~~l~~~~~~RRR~~   40 (44)
T 2jwa_A           14 IISAVVGILLVVVLGVVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             hHHHHHHHHHHHHHHHHHHhheehhhh
Confidence            455566644333333333344444433

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=92.66  E-value=0.032  Score=38.29  Aligned_cols=29  Identities=17%  Similarity=0.212  Sum_probs=18.2

Q ss_pred             eEEEEehHHHHHHHHHHHHHHHHHHhhhc
Q 043267          250 EIVIYGLVLGSVIGILGAFTAFWFLFTRS  278 (614)
Q Consensus       250 ~~~ii~i~~~~v~~vl~~~~~~~~~~~r~  278 (614)
                      ...|.++++++++.++++.+++||++|||
T Consensus        10 ~GaIAGiVvG~v~gv~li~~l~~~~~rrr   38 (38)
T 2k1k_A           10 GGEIVAVIFGLLLGAALLLGILVFRSRRA   38 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred             CCceeeeehHHHHHHHHHHHHHHHHeecC
Confidence            34567788887776665555566655543

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.93  E-value=0.51  Score=49.73  Aligned_cols=30  Identities=30%  Similarity=0.465  Sum_probs=25.6

Q ss_pred             ceEEeccCCCCeEE------CCCCcEEEeecCCcee
Q 043267          444 AIIHRDIKASNILL------DEAFEAKVGDFGLAKF  473 (614)
Q Consensus       444 ~iiHrDIKp~NILL------d~~~~~kl~DFGla~~  473 (614)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46799999999999      4567799999998864

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.50  E-value=2.7  Score=40.31  Aligned_cols=116  Identities=11%  Similarity=0.113  Sum_probs=76.9

Q ss_pred             cccceeeeeeeeecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccC
Q 043267          372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIK  451 (614)
Q Consensus       372 ~H~niv~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIK  451 (614)
                      .||+++.. .+-.     +++...+.|+.-+.+-=+..+     +.++...+++++..++.-..+++     .-+|--++
T Consensus        43 ~~~~Fl~~-~I~e-----~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~  106 (215)
T 4ann_A           43 HSPYFIDA-ELTE-----LRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLA  106 (215)
T ss_dssp             CCTTBCCE-EEEE-----CSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCS
T ss_pred             cCCcccce-EEEE-----cccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEe
Confidence            57777755 2222     345555555554332222223     45788999999999998876555     23688899


Q ss_pred             CCCeEECCCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcc
Q 043267          452 ASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACE  526 (614)
Q Consensus       452 p~NILLd~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~  526 (614)
                      |+|+++|.++.+++.-.|+-..                  ++|.     ..++..=.-.+=+++..+++++..|+
T Consensus       107 P~NL~f~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          107 PDELFFTRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGGEEECTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cceEEEcCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999999987765432                  1221     22233334468889999999999885

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	614
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-59
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-57
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-56
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-56
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-56
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-56
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-55
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-54
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-53
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-52
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-51
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-51
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-50
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-50
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-50
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-50
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-50
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-49
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-48
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-48
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-46
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-46
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-42
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	6e-41
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-39
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-39
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-39
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-38
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-38
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-38
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-38
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-37
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	9e-37
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-34
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-34
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	6e-34
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-33
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-33
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-29
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	7e-21

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 6e-66
 Identities = 81/280 (28%), Positives = 124/280 (44%), Gaps = 24/280 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
             +    IG G +G VYKG       V +      +      FK+EV ++   +HVN++ 
Sbjct: 9   QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL 68

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
             GYST        Q  IV       SLY HL      K      + IA  TA+G+ YLH
Sbjct: 69  FMGYST------APQLAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH 121

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG-ITHLTTRVAGTLGYVAPEYA 497
                +IIHRD+K++NI L E    K+GDFGLA        +H   +++G++ ++APE  
Sbjct: 122 A---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

Query: 498 LY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE 554
                   +  SDVY+FG+VL EL++G+         ++   D    +V  G     + +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-----NINNRDQIIFMVGRGYLSPDLSK 233

Query: 555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
                  P+ M++ +     C       RP   QI+  +E
Sbjct: 234 --VRSNCPKAMKRLMAE---CLKKKRDERPLFPQILASIE 268

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 7e-63
 Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 24/276 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
                  +G G +G V+ G     T+VAVK  K  S + DA F  E  ++  ++H  LV 
Sbjct: 14  TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA-FLAEANLMKQLQHQRLVR 72

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L    T           I+ + + NGSL D L      KL+    L +A   A G+A++ 
Sbjct: 73  LYAVVT------QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              +   IHRD++A+NIL+ +    K+ DFGLA+   +            + + APE   
Sbjct: 127 ---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 183

Query: 499 YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           YG  T  SDV+SFG++L E+++  +          + +    + ++ G  + V  +N PE
Sbjct: 184 YGTFTIKSDVWSFGILLTEIVTHGRIPY-----PGMTNPEVIQNLERGYRM-VRPDNCPE 237

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            EL ++M         C     + RPT D +  +LE
Sbjct: 238 -ELYQLMRL-------CWKERPEDRPTFDYLRSVLE 265

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (517), Expect = 2e-61
 Identities = 77/276 (27%), Positives = 117/276 (42%), Gaps = 24/276 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           +   E  +G+G +G V+ G     T VA+K  K         F  E +++  ++H  LV 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L    +           IV + +  GSL D L G   K L  P  + +A   A G+AY+ 
Sbjct: 77  LYAVVS------EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                  +HRD++A+NIL+ E    KV DFGLA+   +            + + APE AL
Sbjct: 131 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 187

Query: 499 YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           YG+ T  SDV+SFG++L EL +  +                +  +   + LD +E     
Sbjct: 188 YGRFTIKSDVWSFGILLTELTTKGRVP--------------YPGMVNREVLDQVERGYRM 233

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
              PE  E        C     + RPT + +   LE
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-59
 Identities = 76/302 (25%), Positives = 127/302 (42%), Gaps = 26/302 (8%)

Query: 323 ENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY 382
           +  IGKG +G V++G    G EVAVK F +  +      + E+     ++H N++     
Sbjct: 8   QESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH---- 438
                     Q  +V D   +GSL+D+L       ++    +++AL TA GLA+LH    
Sbjct: 66  DN-KDNGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIV 121

Query: 439 -YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG---ITHLTTRVAGTLGYVAP 494
               +PAI HRD+K+ NIL+ +     + D GLA  +      I        GT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 495 EYAL------YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKS-----VLLSDWAWELV 543
           E         + +    +D+Y+ G+V  E+        I +        ++ SD + E +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 544 KEGKTLDVIEENMPE-MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNI 602
           ++      +  N+P   +  E +         C +    AR T  +I K L        I
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGI 301

Query: 603 KI 604
           K+
Sbjct: 302 KM 303

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 2e-57
 Identities = 65/276 (23%), Positives = 115/276 (41%), Gaps = 24/276 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
             +    IG G +G V+ G   N  +VA+K  +      + +F  E E++  + H  LV 
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L G        E     +V + + +G L D+   +     +    L + L    G+AYL 
Sbjct: 65  LYGVCL-----EQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGMAYLE 118

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              +  +IHRD+ A N L+ E    KV DFG+ +F  +     +T     + + +PE   
Sbjct: 119 ---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFS 175

Query: 499 YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           + + +  SDV+SFGV++ E+ S  K     +  S ++     E +  G  L         
Sbjct: 176 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV-----EDISTGFRL-YKPRLAST 229

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
             + ++M         C     + RP   ++++ L 
Sbjct: 230 -HVYQIMNH-------CWKERPEDRPAFSRLLRQLA 257

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 2e-57
 Identities = 78/276 (28%), Positives = 115/276 (41%), Gaps = 28/276 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
                  IGKG +G+V  G    G +VAVK  KN   A    F  E  ++  ++H NLV 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 64

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L G        E     IV + +  GSL D+L   G   L     L+ +L     + YL 
Sbjct: 65  LLGVIVE----EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                  +HRD+ A N+L+ E   AKV DFGL K      +         + + APE   
Sbjct: 121 ---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE----ASSTQDTGKLPVKWTAPEALR 173

Query: 499 YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
             K +  SDV+SFG++L E+ S  +          +        V++G  +D  +   P 
Sbjct: 174 EKKFSTKSDVWSFGILLWEIYSFGRVPY-----PRIPLKDVVPRVEKGYKMDAPDGCPPA 228

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           +   E+M+        C H     RP+  Q+ + LE
Sbjct: 229 VY--EVMKN-------CWHLDAAMRPSFLQLREQLE 255

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-56
 Identities = 58/276 (21%), Positives = 108/276 (39%), Gaps = 24/276 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           + +    +G G +G V  G      +VA+K  K      +  F  E +++ ++ H  LV 
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
           L G  T     +     I+ + + NG L ++L      +      L +       + YL 
Sbjct: 64  LYGVCT-----KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLE 117

Query: 439 YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
                  +HRD+ A N L+++    KV DFGL+++  +     +      + +  PE  +
Sbjct: 118 S---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLM 174

Query: 499 YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
           Y K +  SD+++FGV++ E+ S  K                +E     +T + I + +  
Sbjct: 175 YSKFSSKSDIWAFGVLMWEIYSLGK--------------MPYERFTNSETAEHIAQGLRL 220

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
                  E+       C H     RPT   ++  + 
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (483), Expect = 2e-56
 Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 24/286 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           + + ++ +G G YG VY+G+       VAVK  K  +   +  F  E  ++  +KH NLV
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLV 76

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L G  T           I+ + +  G+L D+L     +++S  + L +A   +  + YL
Sbjct: 77  QLLGVCT-----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
               +   IHRD+ A N L+ E    KV DFGL++                + + APE  
Sbjct: 132 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESL 188

Query: 498 LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP 557
            Y K +  SDV++FGV+L E+ +   +     G  +      +EL+++   ++  E    
Sbjct: 189 AYNKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDL---SQVYELLEKDYRMERPEGCPE 243

Query: 558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNIK 603
           ++   E+M         C       RP+  +I +  ET    S+I 
Sbjct: 244 KVY--ELMRA-------CWQWNPSDRPSFAEIHQAFETMFQESSIS 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 6e-56
 Identities = 60/291 (20%), Positives = 114/291 (39%), Gaps = 25/291 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNL 376
           +F + + +G G  G V+K    P+G  +A K      K    N    E++++       +
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           V   G           +  I  + +  GSL   L  +G  ++   I  ++++   +GL Y
Sbjct: 67  VGFYGAFY-----SDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTY 119

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
           L    +  I+HRD+K SNIL++   E K+ DFG++    +    +     GT  Y++PE 
Sbjct: 120 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMSPER 174

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK-----------KACEIIQGKSVLLSDWAWELVKE 545
                 +  SD++S G+ L+E+  G+           +     Q +              
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234

Query: 546 GKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD 596
                   ++ P M + E+++  V          + +    D + K L  +
Sbjct: 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKN 285

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  189 bits (480), Expect = 6e-56
 Identities = 74/305 (24%), Positives = 121/305 (39%), Gaps = 41/305 (13%)

Query: 308 FKIEEIKAATMNFSRE---------NIIGKGGYGNVYKGMLP----NGTEVAVKRFK-NC 353
           F  E+   A   F++E          +IG G +G V  G L         VA+K  K   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 354 SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
           ++    +F  E  I+    H N++ L G  T     +    +I+ + + NGSL D     
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KSTPVMIITEFMENGSL-DSFLRQ 120

Query: 414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
              + +    + +  G A G+ YL        +HRD+ A NIL++     KV DFGL++F
Sbjct: 121 NDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177

Query: 474 NPEGITHLTTRVA----GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQ 529
             +  +  T   A      + + APE   Y K T  SDV+S+G+V+ E++S  +      
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER----- 232

Query: 530 GKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQI 589
                     +  +     ++ IE++       +           C       RP   QI
Sbjct: 233 ---------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283

Query: 590 VKILE 594
           V  L+
Sbjct: 284 VNTLD 288

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 9e-55
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 33/284 (11%)

Query: 319 NFSRENI-IGKGGYGNVYKGML---PNGTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKH 373
           N    +I +G G +G+V +G+        +VA+K  K  ++  D      E +I+  + +
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
             +V L G        +    ++V ++   G L+  L G   +++       +    + G
Sbjct: 69  PYIVRLIGV------CQAEALMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMG 121

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR--VAGTLGY 491
           + YL        +HRD+ A N+LL     AK+ DFGL+K      ++ T R      L +
Sbjct: 122 MKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
            APE   + K +  SDV+S+GV + E LS G+K  + ++G  V+        +++GK ++
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQGKRME 232

Query: 551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
                 P  EL  +M         C     + RP    + + + 
Sbjct: 233 -CPPECPP-ELYALMSD-------CWIYKWEDRPDFLTVEQRMR 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-54
 Identities = 66/273 (24%), Positives = 115/273 (42%), Gaps = 25/273 (9%)

Query: 323 ENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNLVAL 379
           +  IG+G +  VYKG+      EVA    ++   +K+    FK E E++  ++H N+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 380 RGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHY 439
                +TV  +    ++V +L+ +G+L  +L       +   +         +GL +LH 
Sbjct: 74  YDSWESTVKGKKC-IVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHT 130

Query: 440 GVQPAIIHRDIKASNILL-DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYAL 498
              P IIHRD+K  NI +       K+GD GLA             V GT  ++APE   
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEM-Y 185

Query: 499 YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPE 558
             K     DVY+FG+ +LE+ + +      Q  + +     +  V  G      ++    
Sbjct: 186 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRRVTSGVKPASFDKVAIP 240

Query: 559 MELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
            E+ E++E        C       R ++  ++ 
Sbjct: 241 -EVKEIIEG-------CIRQNKDERYSIKDLLN 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (466), Expect = 7e-54
 Identities = 77/316 (24%), Positives = 123/316 (38%), Gaps = 57/316 (18%)

Query: 314 KAATMNFSRENI-----IGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANF 361
           K  ++ + R NI     IG+G +G V++   P        T VAVK  K  + A   A+F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 362 KHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------ 415
           + E  ++A   + N+V L G         G    ++ + +  G L + L           
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCA-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL 118

Query: 416 ----------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE 459
                             LS   +L IA   A G+AYL    +   +HRD+   N L+ E
Sbjct: 119 SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGE 175

Query: 460 AFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLEL 518
               K+ DFGL++              A  + ++ PE   Y + T  SDV+++GVVL E+
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235

Query: 519 LSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHP 578
            S         G +    +     V++G  L   E    E+    +M         C   
Sbjct: 236 FSYGLQPY--YGMAH---EEVIYYVRDGNILACPENCPLELY--NLMRL-------CWSK 281

Query: 579 ILQARPTMDQIVKILE 594
           +   RP+   I +IL+
Sbjct: 282 LPADRPSFCSIHRILQ 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-53
 Identities = 60/279 (21%), Positives = 108/279 (38%), Gaps = 32/279 (11%)

Query: 323 ENIIGKGGYGNVYKGMLPN---GTEVAVKRFKNCSKAGDA--NFKHEVEIIASVKHVNLV 377
           +  +G G +G V KG          VAVK  KN +           E  ++  + +  +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            + G        E    ++V ++   G L  +L  +    +     + +    + G+ YL
Sbjct: 72  RMIGIC------EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYL 123

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTR--VAGTLGYVAPE 495
                   +HRD+ A N+LL     AK+ DFGL+K       +   +      + + APE
Sbjct: 124 EE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN 555
              Y K +  SDV+SFGV++ E  S  +     +G           ++++G+ +      
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQK--PYRGMK---GSEVTAMLEKGERMG-CPAG 234

Query: 556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            P  E+ ++M         C    ++ RP    +   L 
Sbjct: 235 CPR-EMYDLMNL-------CWTYDVENRPGFAAVELRLR 265

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 7e-53
 Identities = 77/310 (24%), Positives = 129/310 (41%), Gaps = 38/310 (12%)

Query: 293 EPSLVLESRSSNLARFKIEEIKAATMNFSRENIIGKGGYGNVYKGMLPN----GTEVAVK 348
            P LV   +   +    +       ++F+   +IG+G +G VY G L +        AVK
Sbjct: 10  NPELVQAVQHVVIGPSSL------IVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVK 61

Query: 349 RFKNCSKAGD-ANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLY 407
                +  G+ + F  E  I+    H N+++L G    +        ++V   + +G L 
Sbjct: 62  SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSPLVVLPYMKHGDLR 117

Query: 408 DHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGD 467
           + +        +    +   L  A+G+ +L        +HRD+ A N +LDE F  KV D
Sbjct: 118 NFIRNET-HNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVAD 173

Query: 468 FGLAKFNPEG---ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKA 524
           FGLA+   +      H  T     + ++A E     K T  SDV+SFGV+L EL++    
Sbjct: 174 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

Query: 525 CEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARP 584
                   V   D    L++  + L    E  P+  L E+M +       C HP  + RP
Sbjct: 234 PY----PDVNTFDITVYLLQGRRLLQ--PEYCPD-PLYEVMLK-------CWHPKAEMRP 279

Query: 585 TMDQIVKILE 594
           +  ++V  + 
Sbjct: 280 SFSELVSRIS 289

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-52
 Identities = 72/284 (25%), Positives = 121/284 (42%), Gaps = 31/284 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTE-----VAVKRFKNCSKAGD-ANFKHEVEIIASVK 372
             +R+ +IG G +G VYKGML   +      VA+K  K         +F  E  I+    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 373 HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           H N++ L G  +     +    +I+ + + NG+L          + S    + +  G A 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALDKF-LREKDGEFSVLQLVGMLRGIAA 121

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI--THLTTRVAGTLG 490
           G+ YL        +HRD+ A NIL++     KV DFGL++   +    T+ T+     + 
Sbjct: 122 GMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 491 YVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD 550
           + APE   Y K T  SDV+SFG+V+ E+++  +          ++     + + +G  L 
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM-----KAINDGFRLP 233

Query: 551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
              +    +   ++M Q       C       RP    IV IL+
Sbjct: 234 TPMDCPSAIY--QLMMQ-------CWQQERARRPKFADIVSILD 268

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 7e-52
 Identities = 61/280 (21%), Positives = 105/280 (37%), Gaps = 26/280 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVN 375
           ++     IG G YG   K     +G  +  K     + ++A       EV ++  +KH N
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKK--LSWPIRLRIALGTARG 433
           +V                  IV +    G L   +     ++  L     LR+       
Sbjct: 65  IVRYYDRIIDR---TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121

Query: 434 LAYLHYGVQPA--IIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           L   H        ++HRD+K +N+ LD     K+GDFGLA+      +       GT  Y
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYY 180

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV 551
           ++PE          SD++S G +L EL +          K +         ++EGK    
Sbjct: 181 MSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------GKIREGK-FRR 233

Query: 552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
           I     + EL E++ +         +     RP++++I++
Sbjct: 234 IPYRYSD-ELNEIITR-------MLNLKDYHRPSVEEILE 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-51
 Identities = 77/277 (27%), Positives = 113/277 (40%), Gaps = 27/277 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRF-KNCSKAGDANFKHEVEIIASVKHVNL 376
           ++     +G+G YG V   +       VAVK      +     N K E+ I   + H N+
Sbjct: 6   DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           V   G+       EG+ + +  +    G L+D +       +  P   R       G+ Y
Sbjct: 66  VKFYGHRR-----EGNIQYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVY 118

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLTTRVAGTLGYVAPE 495
           LH      I HRDIK  N+LLDE    K+ DFGLA  F       L  ++ GTL YVAPE
Sbjct: 119 LH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 496 YALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE 554
                +      DV+S G+VL  +L+G+   +         SDW     KE KT     +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-----KEKKTYLNPWK 230

Query: 555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
            +        +   +L   +  +P   AR T+  I K
Sbjct: 231 KID----SAPLA--LLHKILVENP--SARITIPDIKK 259

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  177 bits (449), Expect = 3e-51
 Identities = 71/279 (25%), Positives = 107/279 (38%), Gaps = 36/279 (12%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD---ANFKHEVEIIASVKHVN 375
           FS    IG G +G VY    + N   VA+K+     K  +    +   EV  +  ++H N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
            +  RG          H   +V +     +          K L       +  G  +GLA
Sbjct: 77  TIQYRGCYL-----REHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLA 129

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           YLH      +IHRD+KA NILL E    K+GDFG A               GT  ++APE
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPE 181

Query: 496 YAL---YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
             L    G+     DV+S G+  +EL   K     +   S L        + + ++  + 
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNESPALQ 235

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
             +  E      ++        C   I Q RPT + ++K
Sbjct: 236 SGHWSE-YFRNFVDS-------CLQKIPQDRPTSEVLLK 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-50
 Identities = 64/279 (22%), Positives = 108/279 (38%), Gaps = 37/279 (13%)

Query: 319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHV 374
           +F     +GKG +GNVY      +   +A+K            +   + EVEI + ++H 
Sbjct: 7   DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
           N++ L GY       +  +  ++ +    G++Y  L    + K             A  L
Sbjct: 67  NILRLYGYFH-----DATRVYLILEYAPLGTVYRELQK--LSKFDEQRTATYITELANAL 119

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           +Y H      +IHRDIK  N+LL  A E K+ DFG +   P         + GTL Y+ P
Sbjct: 120 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPP 173

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE 554
           E           D++S GV+  E L GK                 +E     +T   I  
Sbjct: 174 EMIEGRMHDEKVDLWSLGVLCYEFLVGKP---------------PFEANTYQETYKRISR 218

Query: 555 NMPEM--ELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
                   + E     +++  +  +P    RP + ++++
Sbjct: 219 VEFTFPDFVTEGARD-LISRLLKHNP--SQRPMLREVLE 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-50
 Identities = 68/283 (24%), Positives = 116/283 (40%), Gaps = 31/283 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNCSKAGD-ANFKHEVEIIASVKH 373
                  IG+G +G+V++G+  +       VA+K  KNC+       F  E   +    H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            ++V L G  T       +   I+ +L   G L           L     +  A   +  
Sbjct: 68  PHIVKLIGVIT------ENPVWIIMELCTLGELRSF-LQVRKYSLDLASLILYAYQLSTA 120

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           LAYL        +HRDI A N+L+      K+GDFGL+++  +   +  ++    + ++A
Sbjct: 121 LAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA 177

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELL-SGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           PE   + + T  SDV+ FGV + E+L  G K  + ++   V+        ++ G+ L  +
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI------GRIENGERLP-M 230

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET 595
             N P   L  +M +       C       RP   ++   L T
Sbjct: 231 PPNCPP-TLYSLMTK-------CWAYDPSRRPRFTELKAQLST 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 3e-50
 Identities = 61/279 (21%), Positives = 107/279 (38%), Gaps = 29/279 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
            +     +G G +G VYK          A K     S+    ++  E++I+AS  H N+V
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L            +   I+ +    G++   +     + L+      +   T   L YL
Sbjct: 73  KLLDAFY-----YENNLWILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYL 126

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      IIHRD+KA NIL     + K+ DFG++  N   I    + + GT  ++APE  
Sbjct: 127 H---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVV 182

Query: 498 LY-----GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           +            +DV+S G+ L+E+   +     +    VLL     ++ K        
Sbjct: 183 MCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL-----KIAKSEPPTLAQ 237

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
                     + +++       C    + AR T  Q+++
Sbjct: 238 PSRWSS-NFKDFLKK-------CLEKNVDARWTTSQLLQ 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 3e-50
 Identities = 77/295 (26%), Positives = 125/295 (42%), Gaps = 43/295 (14%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNG---TEVAVKRFK-NCSKAGDANFKHEVEIIASV-KH 373
           +   +++IG+G +G V K  +       + A+KR K   SK    +F  E+E++  +  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM--------------KKLS 419
            N++ L G              +  +   +G+L D L  S +                LS
Sbjct: 71  PNIINLLGACE-----HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 420 WPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGIT 479
               L  A   ARG+ YL    Q   IHRD+ A NIL+ E + AK+ DFGL++     + 
Sbjct: 126 SQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182

Query: 480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA 539
              T     + ++A E   Y   T  SDV+S+GV+L E++S         G +       
Sbjct: 183 --KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT--PYCGMTC---AEL 235

Query: 540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           +E + +G  L+    N  + E+ ++M Q       C       RP+  QI+  L 
Sbjct: 236 YEKLPQGYRLE-KPLNCDD-EVYDLMRQ-------CWREKPYERPSFAQILVSLN 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 5e-50
 Identities = 70/304 (23%), Positives = 118/304 (38%), Gaps = 46/304 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASV 371
             S    +G G +G V +              VAVK  K  +   +      E+++++ +
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 372 K-HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-------------- 416
             H+N+V L G  T      G   +++ +    G L + L                    
Sbjct: 84  GNHMNIVNLLGACT-----IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD 138

Query: 417 --KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN 474
              L     L  +   A+G+A+L        IHRD+ A NILL      K+ DFGLA+  
Sbjct: 139 ELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 475 PEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
                + +       + ++APE       T  SDV+S+G+ L EL S   +        +
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY----PGM 251

Query: 534 LLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
            +    ++++KEG  +   E    EM   ++M+        C       RPT  QIV+++
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMY--DIMKT-------CWDADPLKRPTFKQIVQLI 302

Query: 594 ETDV 597
           E  +
Sbjct: 303 EKQI 306

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-49
 Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 51/306 (16%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHEVEIIASV 371
           N     ++G G +G V               +VAVK  K  + + +      E++++  +
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 372 -KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-------------- 416
             H N+V L G  T           ++ +    G L ++L     K              
Sbjct: 98  GSHENIVNLLGACT-----LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 417 -------KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG 469
                   L++   L  A   A+G+ +L      + +HRD+ A N+L+      K+ DFG
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFG 209

Query: 470 LAKFNPEGITHLT-TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEII 528
           LA+       ++        + ++APE    G  T  SDV+S+G++L E+ S        
Sbjct: 210 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV--NPY 267

Query: 529 QGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQ 588
            G    +    ++L++ G  +D       E E+  +M+        C     + RP+   
Sbjct: 268 PGIP--VDANFYKLIQNGFKMD-QPFYATE-EIYIIMQS-------CWAFDSRKRPSFPN 316

Query: 589 IVKILE 594
           +   L 
Sbjct: 317 LTSFLG 322

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 3e-49
 Identities = 60/282 (21%), Positives = 112/282 (39%), Gaps = 31/282 (10%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTE----VAVKRFK-NCSKAGDANFKHEVEIIASVKH 373
           F +  ++G G +G VYKG+ +P G +    VA+K  +   S   +     E  ++ASV +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
            ++  L G              ++  L+  G L D++             L   +  A+G
Sbjct: 71  PHVCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKG 123

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLGYV 492
           + YL       ++HRD+ A N+L+      K+ DFGLAK    E   +        + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180

Query: 493 APEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI 552
           A E  L+   T  SDV+S+GV + EL++                   ++ +   +   ++
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGS--------------KPYDGIPASEISSIL 226

Query: 553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           E+     + P       +    C      +RP   +++    
Sbjct: 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (429), Expect = 1e-48
 Identities = 59/274 (21%), Positives = 111/274 (40%), Gaps = 26/274 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
            ++R   IG+G  G VY  M +  G EVA+++     +       +E+ ++   K+ N+V
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIV 80

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
                        G +  +V + L  GSL D +  + M          +     + L +L
Sbjct: 81  NYLDSYL-----VGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFL 132

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H      +IHRDIK+ NILL      K+ DFG         +  +T V GT  ++APE  
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVV 188

Query: 498 LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP 557
                 P  D++S G++ +E++ G+        ++ L     + +   G       E + 
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPP---YLNENPL--RALYLIATNGTPELQNPEKLS 243

Query: 558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
                + + +       C    ++ R +  ++++
Sbjct: 244 A-IFRDFLNR-------CLDMDVEKRGSAKELLQ 269

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 4e-48
 Identities = 73/285 (25%), Positives = 108/285 (37%), Gaps = 32/285 (11%)

Query: 319 NFSRENIIGKGGYGNVYKGMLP----NGTEVAVKRFKNC---SKAGDANFKHEVEIIASV 371
           +      +G G +G V +G           VAVK  K           +F  EV  + S+
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
            H NL+ L G              +V +L   GSL D                R A+  A
Sbjct: 69  DHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDR-LRKHQGHFLLGTLSRYAVQVA 121

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITH--LTTRVAGTL 489
            G+ YL        IHRD+ A N+LL      K+GDFGL +  P+   H  +        
Sbjct: 122 EGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL 549
            + APE       +  SD + FGV L E+ +  +  E   G +   S    ++ KEG+ L
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ--EPWIGLNG--SQILHKIDKEGERL 234

Query: 550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
               E+ P+ ++  +M Q       C     + RPT   +   L 
Sbjct: 235 P-RPEDCPQ-DIYNVMVQ-------CWAHKPEDRPTFVALRDFLL 270

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  163 bits (414), Expect = 2e-46
 Identities = 71/299 (23%), Positives = 117/299 (39%), Gaps = 43/299 (14%)

Query: 319 NFSRENIIGKGGYGNVYKGM------LPNGTEVAVKRFKNCSKAGDA-NFKHEVEIIASV 371
                  +G+G +G V +              VAVK  K  +   +      E++I+  +
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 372 KH-VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMK-------------- 416
            H +N+V L G  T      G   +++ +    G+L  +L     +              
Sbjct: 74  GHHLNVVNLLGACTK----PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 417 KLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE 476
            L+    +  +   A+G+ +L        IHRD+ A NILL E    K+ DFGLA+   +
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 477 GITHL-TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLL 535
              ++        L ++APE       T  SDV+SFGV+L E+ S   +        V +
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY----PGVKI 242

Query: 536 SDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
            +     +KEG  +   +   PEM   + M         C H     RPT  ++V+ L 
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMY--QTMLD-------CWHGEPSQRPTFSELVEHLG 292

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 7e-46
 Identities = 78/307 (25%), Positives = 128/307 (41%), Gaps = 47/307 (15%)

Query: 319 NFSRENIIGKGGYGNVYKGMLP--------NGTEVAVKRFKNCSKAGD-ANFKHEVEIIA 369
                  +G+G +G V                T+VAVK  K+ +   D ++   E+E++ 
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73

Query: 370 SV-KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGM------------- 415
            + KH N++ L G  T     +     ++ +    G+L ++L                  
Sbjct: 74  MIGKHKNIINLLGACT-----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNP 128

Query: 416 -KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN 474
            ++LS    +  A   ARG+ YL        IHRD+ A N+L+ E    K+ DFGLA+  
Sbjct: 129 EEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 475 PEGITHLTTRV-AGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV 533
                +  T      + ++APE       T  SDV+SFGV+L E+ +   +     G  V
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS--PYPGVPV 243

Query: 534 LLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKIL 593
              +  ++L+KEG  +D       E+    MM         C H +   RPT  Q+V+ L
Sbjct: 244 ---EELFKLLKEGHRMDKPSNCTNELY--MMMRD-------CWHAVPSQRPTFKQLVEDL 291

Query: 594 ETDVPLS 600
           +  V L+
Sbjct: 292 DRIVALT 298

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 9e-46
 Identities = 70/295 (23%), Positives = 127/295 (43%), Gaps = 38/295 (12%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNCSKAGD-ANFKHEVEIIASV 371
             +    +G+G +G VY+G+          T VA+K     +   +   F +E  ++   
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSG--------MKKLSWPIR 423
              ++V L G  +     +G   +++ +L+  G L  +L            +   S    
Sbjct: 81  NCHHVVRLLGVVS-----QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 135

Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK-FNPEGITHLT 482
           +++A   A G+AYL+       +HRD+ A N ++ E F  K+GDFG+ +           
Sbjct: 136 IQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 483 TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL 542
            +    + +++PE    G  T  SDV+SFGVVL E+ +  +     QG S   ++     
Sbjct: 193 GKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--PYQGLS---NEQVLRF 247

Query: 543 VKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV 597
           V EG  LD   +N P+  L E+M         C     + RP+  +I+  ++ ++
Sbjct: 248 VMEGGLLD-KPDNCPD-MLFELMRM-------CWQYNPKMRPSFLEIISSIKEEM 293

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 1e-44
 Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 15/209 (7%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASVKHV 374
           +F    I+G+G +  V     L    E A+K  +      +        E ++++ + H 
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
             V L          +  +         NG L  ++    +                  L
Sbjct: 69  FFVKLYFTFQ-----DDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSAL 121

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF-NPEGITHLTTRVAGTLGYVA 493
            YLH      IIHRD+K  NILL+E    ++ DFG AK  +PE          GT  YV+
Sbjct: 122 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 178

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE          SD+++ G ++ +L++G 
Sbjct: 179 PELLTEKSACKSSDLWALGCIIYQLVAGL 207

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  159 bits (402), Expect = 4e-44
 Identities = 45/207 (21%), Positives = 89/207 (42%), Gaps = 14/207 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           ++     +G G +G V++      G   A K      ++     + E++ ++ ++H  LV
Sbjct: 27  HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L          + ++ +++ + +  G L++ +      K+S    +       +GL ++
Sbjct: 87  NLHDAFE-----DDNEMVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHM 140

Query: 438 HYGVQPAIIHRDIKASNILL--DEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           H   +   +H D+K  NI+     + E K+ DFGL        +   T   GT  + APE
Sbjct: 141 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPE 195

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
            A    +   +D++S GV+   LLSG 
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGL 222

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (394), Expect = 1e-43
 Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 29/285 (10%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVA 378
           +     IG G +G++Y G  +  G EVA+K      K        E +I   ++    + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVGIP 66

Query: 379 LRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLH 438
              +  A    EG   ++V +LL         F S   K S    L +A      + Y+H
Sbjct: 67  TIRWCGA----EGDYNVMVMELLGPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIH 120

Query: 439 YGVQPAIIHRDIKASNIL---LDEAFEAKVGDFGLAKFNPEGITH------LTTRVAGTL 489
                  IHRD+K  N L     +     + DFGLAK   +  TH          + GT 
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 490 GYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL 549
            Y +    L  + +   D+ S G VL+    G    + ++  +           K    +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237

Query: 550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           +V+ +  P  E    +         C       +P    + ++  
Sbjct: 238 EVLCKGYPS-EFATYLNF-------CRSLRFDDKPDYSYLRQLFR 274

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 46/207 (22%), Positives = 85/207 (41%), Gaps = 14/207 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
            +     +G G +G V++ +    G     K             K+E+ I+  + H  L+
Sbjct: 30  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L          + ++ +++ + L  G L+D +      K+S    +        GL ++
Sbjct: 90  NLHDAFE-----DKYEMVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHM 143

Query: 438 HYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           H   + +I+H DIK  NI+ +  +A   K+ DFGLA         +      T  + APE
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPE 198

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
                 +   +D+++ GV+   LLSG 
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGL 225

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  150 bits (379), Expect = 1e-41
 Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 31/288 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           ++     IG+G +G +++G  L N  +VA+K      ++     + E      +     +
Sbjct: 6   HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTGI 63

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
               Y       EG   ++V DLL  G   + L     +K S       A      +  +
Sbjct: 64  PNVYYFGQ----EGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSI 117

Query: 438 HYGVQPAIIHRDIKASNILLDEAFE-----AKVGDFGLAKFNPEGIT------HLTTRVA 486
           H   + ++++RDIK  N L+            V DFG+ KF  + +T           ++
Sbjct: 118 H---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 487 GTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG 546
           GT  Y++    L  + +   D+ + G V +  L G       QG     +   +E + E 
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW---QGLKAATNKQKYERIGEK 231

Query: 547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILE 594
           K    + E       PE   +Y+       +    A P  D +  +  
Sbjct: 232 KQSTPLRELCA--GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFS 274

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  147 bits (373), Expect = 6e-41
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 12/209 (5%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD---ANFKHEVEIIASVKHVN 375
           +    I+G GG   V+    L    +VAVK  +            F+ E +  A++ H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +VA+     A  P  G    IV + +   +L D +       ++    + +     + L 
Sbjct: 69  IVAVYDTGEAETP-AGPLPYIVMEYVDGVTLRDIVHT--EGPMTPKRAIEVIADACQALN 125

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHL--TTRVAGTLGYVA 493
           + H   Q  IIHRD+K +NI++      KV DFG+A+   +    +  T  V GT  Y++
Sbjct: 126 FSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE A    +   SDVYS G VL E+L+G+
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGE 211

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (372), Expect = 7e-40
 Identities = 61/215 (28%), Positives = 93/215 (43%), Gaps = 22/215 (10%)

Query: 317 TMN-FSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN FS   IIG+GG+G VY       G   A+K         K G+    +E  +++ V
Sbjct: 2   TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61

Query: 372 K---HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIAL 428
                  +V +             +   + DL++ G L+ HL   G+           A 
Sbjct: 62  STGDCPFIVCMSYAFH-----TPDKLSFILDLMNGGDLHYHLSQHGVFS--EADMRFYAA 114

Query: 429 GTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGT 488
               GL ++H      +++RD+K +NILLDE    ++ D GLA    +   H +    GT
Sbjct: 115 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GT 168

Query: 489 LGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGK 522
            GY+APE    G      +D +S G +L +LL G 
Sbjct: 169 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 1e-39
 Identities = 52/305 (17%), Positives = 111/305 (36%), Gaps = 28/305 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVN 375
           NF +   IG+G YG VYK      G  VA+K+ +    ++   +    E+ ++  + H N
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L            ++  +V + LH   L   +  S +  +  P+         +GLA
Sbjct: 63  IVKLLDVIH-----TENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLA 116

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++     K+ DFGLA+     +   T  V          
Sbjct: 117 FCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEI 173

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGKK------ACEIIQGKSVLLSDWAWELVKEGKTL 549
                  +   D++S G +  E+++ +         + +      L      +     ++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233

Query: 550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQ-------ARPTMDQIVK---ILETDVPL 599
              + + P+    +  +            + Q        R +    +      +   P+
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293

Query: 600 SNIKI 604
            ++++
Sbjct: 294 PHLRL 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 1e-39
 Identities = 39/207 (18%), Positives = 80/207 (38%), Gaps = 15/207 (7%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
            +     +G+G +G V++ +   +      K  K          K E+ I+   +H N++
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNIL 64

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L             + +++ + +    +++ +  S   +L+    +         L +L
Sbjct: 65  HLHESFE-----SMEELVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFL 118

Query: 438 HYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           H      I H DI+  NI+     +   K+ +FG A+    G             Y APE
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPE 173

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
              +  ++  +D++S G ++  LLSG 
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGI 200

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-39
 Identities = 58/209 (27%), Positives = 87/209 (41%), Gaps = 16/209 (7%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKH---EVEIIA-SVKH 373
           +F    ++GKG +G V+           A+K  K      D + +    E  +++ + +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
             L  +                 V + L+ G L  H+      K         A     G
Sbjct: 63  PFLTHMFCTFQ-----TKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILG 115

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVA 493
           L +LH      I++RD+K  NILLD+    K+ DFG+ K N  G     T   GT  Y+A
Sbjct: 116 LQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIA 171

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L  K     D +SFGV+L E+L G+
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 7e-39
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 20/219 (9%)

Query: 309 KIEEIKAATMNFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD-ANFKHEVE 366
           + E+I+     +   +++G G +  V           VA+K     +  G   + ++E+ 
Sbjct: 3   QAEDIRD---IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIA 59

Query: 367 IIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRI 426
           ++  +KH N+VAL           G    ++  L+  G L+D +   G    +     R+
Sbjct: 60  VLHKIKHPNIVALDDIYE-----SGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRL 112

Query: 427 ALGTARGLAYLHYGVQPAIIHRDIKASNILL---DEAFEAKVGDFGLAKFNPEGITHLTT 483
                  + YLH      I+HRD+K  N+L    DE  +  + DFGL+K    G   + +
Sbjct: 113 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLS 167

Query: 484 RVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
              GT GYVAPE       +   D +S GV+   LL G 
Sbjct: 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 206

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 1e-38
 Identities = 55/274 (20%), Positives = 96/274 (35%), Gaps = 24/274 (8%)

Query: 323 ENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALR 380
             ++G G  G V +        + A+K  ++C K      + EVE+     +  ++V + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 381 GYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG 440
                         +IV + L  G L+  +   G +  +      I       + YLH  
Sbjct: 72  DVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH-- 128

Query: 441 VQPAIIHRDIKASNILLDEAFE---AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
               I HRD+K  N+L          K+ DFG AK      +  T     T  YVAPE  
Sbjct: 129 -SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 498 LYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP 557
              K     D++S GV++  LL G        G ++         + + +  +     + 
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245

Query: 558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
           E E+  ++                 R T+ + + 
Sbjct: 246 E-EVKMLIRN-------LLKTEPTQRMTITEFMN 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 2e-38
 Identities = 53/211 (25%), Positives = 88/211 (41%), Gaps = 13/211 (6%)

Query: 319 NFSRENIIGKGGYGNVYKG--MLPNGTEVAVKRFK--NCSKAGDANFKHEVEI---IASV 371
            +     IG+G YG V+K   +   G  VA+KR +     +    +   EV +   + + 
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 67

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +H N+V L    T +      +  +V + +       +L       +       +     
Sbjct: 68  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLL 126

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
           RGL +LH      ++HRD+K  NIL+  + + K+ DFGLA+     +    T V  TL Y
Sbjct: 127 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWY 181

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
            APE  L        D++S G +  E+   K
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  140 bits (354), Expect = 2e-38
 Identities = 67/295 (22%), Positives = 111/295 (37%), Gaps = 51/295 (17%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDA---------NFKHEVEII 368
           N+  + I+G+G    V + +  P   E AVK          +             EV+I+
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 369 ASVK-HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIA 427
             V  H N++ L+               +V DL+  G L+D+L       LS     +I 
Sbjct: 64  RKVSGHPNIIQLKDTYE-----TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIM 116

Query: 428 LGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAG 487
                 +  LH   +  I+HRD+K  NILLD+    K+ DFG +     G       V G
Sbjct: 117 RALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCG 171

Query: 488 TLGYVAPEYAL------YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWE 541
           T  Y+APE         +       D++S GV++  LL+G                  + 
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP---------------PFW 216

Query: 542 LVKEGKTLDVIEENMPEMELPEMME-----QYVLTAAICAHPILQARPTMDQIVK 591
             K+   L +I     +   PE  +     + +++  +   P  Q R T ++ + 
Sbjct: 217 HRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQP--QKRYTAEEALA 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  140 bits (354), Expect = 6e-38
 Identities = 52/209 (24%), Positives = 85/209 (40%), Gaps = 18/209 (8%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASVKHV 374
           +F     +G G +G V+      NG   A+K  K           +   E  +++ V H 
Sbjct: 5   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64

Query: 375 NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGL 434
            ++ + G        +  Q  ++ D +  G L+  L  S              +      
Sbjct: 65  FIIRMWGTFQ-----DAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV-----C 114

Query: 435 AYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
             L Y     II+RD+K  NILLD+    K+ DFG AK+    +  +T  + GT  Y+AP
Sbjct: 115 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYTLCGTPDYIAP 170

Query: 495 EYALYGKLTPGSDVYSFGVVLLELLSGKK 523
           E           D +SFG+++ E+L+G  
Sbjct: 171 EVVSTKPYNKSIDWWSFGILIYEMLAGYT 199

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 3e-37
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 12/208 (5%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN-FKHEVEIIASVKHVNLV 377
           ++  + IG+G YG V       N   VA+K+               E++I+   +H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            +         +E  + + +   L    LY  L     + LS            RGL Y+
Sbjct: 70  GINDIIR-APTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYI 125

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT--TRVAGTLGYVAPE 495
           H      ++HRD+K SN+LL+   + K+ DFGLA+       H    T    T  Y APE
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 496 YALYGKL-TPGSDVYSFGVVLLELLSGK 522
             L  K  T   D++S G +L E+LS +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 9e-37
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 14/209 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV 377
           +++   +IG G +G VY+  L  +G  VA+K+     +        E++I+  + H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIV 76

Query: 378 ALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKK-LSWPIRLRIALGTARGLA 435
            LR +  ++   +    + +V D +           S  K+ L             R LA
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 436 YLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAP 494
           Y+H      I HRDIK  N+LLD +    K+ DFG AK    G  +++   +    Y AP
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR--YYRAP 191

Query: 495 EYALYG-KLTPGSDVYSFGVVLLELLSGK 522
           E        T   DV+S G VL ELL G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  133 bits (336), Expect = 8e-36
 Identities = 61/290 (21%), Positives = 103/290 (35%), Gaps = 29/290 (10%)

Query: 319 NFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVNL 376
            +     IG+G YG VYK     G   A+K+ +     +   +    E+ I+  +KH N+
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           V L             + ++V + L            G   L         L    G+AY
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAY 115

Query: 437 LHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEY 496
            H      ++HRD+K  N+L++   E K+ DFGLA+     +   T  +           
Sbjct: 116 CH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 497 ALYGKLTPGSDVYSFGVVLLELLSGK-------------KACEIIQGKSVLLSDWAWELV 543
               K +   D++S G +  E+++G              +   I+   +        EL 
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 544 KEGKTLDVIEENMPEMELPEMMEQYV--LTAAICAHPILQARPTMDQIVK 591
           K      V E    E  L  + E  +  L+  +   P    R T  Q ++
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP--NQRITAKQALE 280

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 64/292 (21%), Positives = 106/292 (36%), Gaps = 44/292 (15%)

Query: 320 FSRENI---------IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGD------ANFKH 363
           F +EN+         +G G +  V K      G + A K  K              + + 
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62

Query: 364 EVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIR 423
           EV I+  ++H N++ L               I++ +L+  G L+D L       L+    
Sbjct: 63  EVSILKEIQHPNVITLHEVYE-----NKTDVILILELVAGGELFDFLAEKE--SLTEEEA 115

Query: 424 LRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE----AFEAKVGDFGLAKFNPEGIT 479
                    G+ YLH      I H D+K  NI+L +        K+ DFGLA     G  
Sbjct: 116 TEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-- 170

Query: 480 HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWA 539
           +    + GT  +VAPE   Y  L   +D++S GV+   LLSG               D  
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL---------GDTK 221

Query: 540 WELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK 591
            E +     ++   E+        + +   +   +   P  + R T+   ++
Sbjct: 222 QETLANVSAVNYEFEDEYFSNTSALAKD-FIRRLLVKDP--KKRMTIQDSLQ 270

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 1e-34
 Identities = 57/206 (27%), Positives = 88/206 (42%), Gaps = 18/206 (8%)

Query: 324 NIIGKGGYGNVYKGMLPN-GTEVAVKRFKNCSKAGD-----ANFKHEVEIIASVKHVNLV 377
           + +G+G +  VYK    N    VA+K+ K   ++            E++++  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 378 ALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYL 437
            L                +V D +           S    L+        L T +GL YL
Sbjct: 64  GLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSL--VLTPSHIKAYMLMTLQGLEYL 116

Query: 438 HYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYA 497
           H   Q  I+HRD+K +N+LLDE    K+ DFGLAK         T +V  T  Y APE  
Sbjct: 117 H---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELL 172

Query: 498 LYGKL-TPGSDVYSFGVVLLELLSGK 522
              ++   G D+++ G +L ELL   
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRV 198

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-34
 Identities = 55/211 (26%), Positives = 87/211 (41%), Gaps = 16/211 (7%)

Query: 317 TMN-FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKN---CSKAGDANFKHEVEIIASV 371
           TMN F    ++GKG +G V        G   A+K  +     +K   A+   E  ++ + 
Sbjct: 3   TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62

Query: 372 KHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTA 431
           +H  L AL+            +   V +  + G L+ HL  S  +  +            
Sbjct: 63  RHPFLTALK-----YAFQTHDRLCFVMEYANGGELFFHL--SRERVFTEERARFYGAEIV 115

Query: 432 RGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGY 491
             L YLH      +++RDIK  N++LD+    K+ DFGL K        + T   GT  Y
Sbjct: 116 SALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEY 171

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           +APE           D +  GVV+ E++ G+
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  130 bits (327), Expect = 6e-34
 Identities = 53/229 (23%), Positives = 90/229 (39%), Gaps = 19/229 (8%)

Query: 299 ESRSSNLARFKIEEIKAATMN-FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKA 356
           +++   L +++      A ++ F R   +G G +G V       +G   A+K        
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80

Query: 357 GD---ANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGS 413
                 +  +E  I+ +V    LV L          +     +V + +  G ++ HL   
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSNLYMVMEYVAGGEMFSHLRRI 135

Query: 414 GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF 473
           G  + S P     A        YLH      +I+RD+K  N+L+D+    +V DFG AK 
Sbjct: 136 G--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR 190

Query: 474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
                  L     GT   +APE  L        D ++ GV++ E+ +G 
Sbjct: 191 VKGRTWTLC----GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGY 235

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 2e-33
 Identities = 52/214 (24%), Positives = 87/214 (40%), Gaps = 15/214 (7%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVN 375
            + +   IG+G +G V+K      G +VA+K+    N  +        E++I+  +KH N
Sbjct: 11  KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHEN 70

Query: 376 LVALRGYSTATVPLEGHQR---IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTAR 432
           +V L              +    +V D   +              LS   R+   L    
Sbjct: 71  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML---- 126

Query: 433 GLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF---NPEGITHLTTRVAGTL 489
            L  L+Y  +  I+HRD+KA+N+L+      K+ DFGLA+          +  T    TL
Sbjct: 127 -LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 490 GYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGK 522
            Y  PE  L  +   P  D++  G ++ E+ +  
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 3e-33
 Identities = 41/208 (19%), Positives = 79/208 (37%), Gaps = 13/208 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFK--NCSKAGDANFKHEVEIIASVKHVN 375
            + +   IG+G YG V+K         VA+KR +  +  +   ++   E+ ++  +KH N
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           +V L             +  +V +             +G       I         +GL 
Sbjct: 63  IVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSCNGDLD--PEIVKSFLFQLLKGLG 115

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           + H      ++HRD+K  N+L++   E K+ +FGLA+     +   +  V          
Sbjct: 116 FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGKK 523
                  +   D++S G +  EL +  +
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGR 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 3e-33
 Identities = 48/243 (19%), Positives = 91/243 (37%), Gaps = 30/243 (12%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDAN------FKHEVEIIASVK 372
           +    ++G GG+G+VY G+ + +   VA+K  +    +             EV ++  V 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 373 --HVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGT 430
                ++ L  +            +++ +                  L   +        
Sbjct: 66  SGFSGVIRLLDWFE-----RPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQV 119

Query: 431 ARGLAYLHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
              + + H      ++HRDIK  NIL+D    E K+ DFG      +    + T   GT 
Sbjct: 120 LEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTR 173

Query: 490 GYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGK----KACEIIQGKSVL---LSDWAWE 541
            Y  PE+  Y +     + V+S G++L +++ G        EII+G+      +S     
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQH 233

Query: 542 LVK 544
           L++
Sbjct: 234 LIR 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 49/207 (23%), Positives = 86/207 (41%), Gaps = 14/207 (6%)

Query: 320 FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKN--CSKAGDANFKHEVEIIASVKHVNL 376
           +     +G G YG V   +    G +VA+K+      S+        E+ ++  ++H N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 377 VALRGYSTATVPLEGHQRI-IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           + L    T    L+      +V   +  G+    L      KL       +     +GL 
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLR 135

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y+H      IIHRD+K  N+ ++E  E K+ DFGLA+        +T  V          
Sbjct: 136 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEV 189

Query: 496 YALYGKLTPGSDVYSFGVVLLELLSGK 522
              + + T   D++S G ++ E+++GK
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 1e-29
 Identities = 50/220 (22%), Positives = 87/220 (39%), Gaps = 13/220 (5%)

Query: 307 RFKIEEIKAATMN-FSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKN--CSKAGDANFK 362
             ++ +     +  +     IG G  G V           VA+K+      ++       
Sbjct: 5   SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY 64

Query: 363 HEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPI 422
            E+ ++  V H N+++L    T    LE  Q + +   L + +L   +      +L    
Sbjct: 65  RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI----QMELDHER 120

Query: 423 RLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLT 482
              +      G+ +LH      IIHRD+K SNI++      K+ DFGLA+      + + 
Sbjct: 121 MSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMM 175

Query: 483 TRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           T    T  Y APE  L        D++S G ++ E++  K
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-29
 Identities = 58/208 (27%), Positives = 90/208 (43%), Gaps = 14/208 (6%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKN--CSKAGDANFKHEVEIIASVKHVN 375
            +   + +G G YG+V        G  VAVK+      S         E+ ++  +KH N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78

Query: 376 LVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
           ++ L    T    LE    + +   L    L + +     +KL+      +     RGL 
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLK 135

Query: 436 YLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
           Y+H      IIHRD+K SN+ ++E  E K+ DFGLA+          T    T  Y APE
Sbjct: 136 YIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH----TDDEMTGYVATRWYRAPE 188

Query: 496 YAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             L +       D++S G ++ ELL+G+
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 1e-28
 Identities = 54/215 (25%), Positives = 88/215 (40%), Gaps = 21/215 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNCSKAGDA----NFKHEVEIIAS 370
           NF    ++G G YG V+          G   A+K  K  +    A    + + E +++  
Sbjct: 25  NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84

Query: 371 VKHV-NLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALG 429
           ++    LV L             +  ++ D ++ G L+ HL  S  ++ +          
Sbjct: 85  IRQSPFLVTLHYAFQ-----TETKLHLILDYINGGELFTHL--SQRERFTEHEVQIYV-- 135

Query: 430 TARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGITHLTTRVAGTL 489
               +  L +  +  II+RDIK  NILLD      + DFGL+K      T       GT+
Sbjct: 136 -GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 490 GYVAPEYALYGK--LTPGSDVYSFGVVLLELLSGK 522
            Y+AP+    G        D +S GV++ ELL+G 
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  114 bits (286), Expect = 1e-28
 Identities = 43/208 (20%), Positives = 86/208 (41%), Gaps = 20/208 (9%)

Query: 319 NFSRENIIGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNL 376
           ++     +G+G Y  V++ + + N  +V VK  K   K      K E++I+ +++   N+
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNI 92

Query: 377 VALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAY 436
           + L                +V + ++N            + L+            + L Y
Sbjct: 93  ITLADIVKDP---VSRTPALVFEHVNNTDFKQL-----YQTLTDYDIRFYMYEILKALDY 144

Query: 437 LHYGVQPAIIHRDIKASNILLD-EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPE 495
            H      I+HRD+K  N+++D E  + ++ D+GLA+F   G  +       +  +  PE
Sbjct: 145 CH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199

Query: 496 YAL-YGKLTPGSDVYSFGVVLLELLSGK 522
             + Y       D++S G +L  ++  K
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRK 227

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (270), Expect = 3e-26
 Identities = 39/209 (18%), Positives = 76/209 (36%), Gaps = 15/209 (7%)

Query: 326 IGKGGYGNVYKGM-LPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRG--- 381
           +G G +  V+    + N T VA+K  +   K      + E++++  V   +         
Sbjct: 21  LGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 79

Query: 382 ------YSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLA 435
                              +++   +   +L   +     + +      +I+     GL 
Sbjct: 80  NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139

Query: 436 YLHYGVQPAIIHRDIKASNILLDEA-FEAKVGDFGLAKF-NPEGITHLTTRVAGTLGYVA 493
           Y+H   +  IIH DIK  N+L++       +    +A   N        T    T  Y +
Sbjct: 140 YMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS 197

Query: 494 PEYALYGKLTPGSDVYSFGVVLLELLSGK 522
           PE  L      G+D++S   ++ EL++G 
Sbjct: 198 PEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 88.3 bits (218), Expect = 7e-21
 Identities = 31/206 (15%), Positives = 60/206 (29%), Gaps = 32/206 (15%)

Query: 324 NIIGKGGYGNVYKGMLPNGTEVAVKRFK----------NCSKAGDANFKHEVEIIASVKH 373
            ++G+G    V+        E  VK  K               GD +F       A  + 
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 374 VNLVALRGYSTATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARG 433
             L  L+G +            ++ +L+             + ++       +       
Sbjct: 66  RALQKLQGLAVPK-VYAWEGNAVLMELIDAKE---------LYRVRVENPDEVLDMILEE 115

Query: 434 LAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF--NPEGITHLTTRVAGTLGY 491
           +A  +      I+H D+   N+L+ E     + DF  +           L   V   + Y
Sbjct: 116 VAKFY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITY 171

Query: 492 VAPEYALYGKLTPGSDVYSFGVVLLE 517
            +  Y          D+ S    +L+
Sbjct: 172 FSRTY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	614
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.43
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.81
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.31
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.95
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.11
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.03

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=425.36  Aligned_cols=254  Identities=28%  Similarity=0.412  Sum_probs=211.6

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|+..+.||+|+||+||+|++++++.||||+++... ...++|.+|++++++++|||||+++|++.      .+..++|
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~------~~~~~iv   85 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT------QEPIYII   85 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec------cCCeEEE
Confidence            4688889999999999999999888999999997643 34567999999999999999999999884      3456899


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.......++|.++++|+.||++||+|||   +.+|+||||||+||||++++.+||+|||+++.....
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCC
Confidence            99999999999887665567999999999999999999999   889999999999999999999999999999987765


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      .........||+.|||||++.++.++.++|||||||++|||+||..|+......     .-+...+..+...     ..+
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-----~~~~~~i~~~~~~-----~~p  232 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-----PEVIQNLERGYRM-----VRP  232 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCCC-----CCC
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHhcCCC-----CCc
Confidence            555556678999999999999999999999999999999999976665322211     1122333333221     111


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                          ....+.+.+++..||+.||++||||+||+++|+.
T Consensus       233 ----~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         233 ----DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----ccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence                2233467788999999999999999999999985

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=420.54  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=198.7

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|+..+.||+|+||+||+|++.+++.||||+++.. ....++|.+|++++++++|||||+++|+|.     +++..++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-----~~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceec-----cCCceEEE
Confidence            468888999999999999999988999999999763 344578999999999999999999999997     55678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++... ...++|..+++|+.|+++||+|||   +.+|+||||||+|||+|+++++||+|||+++.....
T Consensus        79 ~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             EECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             EEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCC
Confidence            9999999999998654 357999999999999999999999   899999999999999999999999999999876654


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-cccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKA-CEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p-~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........||+.|+|||++.++.++.++|||||||++|||+|+..| +.....     .+ ..+.+..+...     ..
T Consensus       155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~-~~~~i~~~~~~-----~~  223 (263)
T d1sm2a_         155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SE-VVEDISTGFRL-----YK  223 (263)
T ss_dssp             ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HH-HHHHHHHTCCC-----CC
T ss_pred             CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HH-HHHHHHhcCCC-----CC
Confidence            44444556799999999999999999999999999999999996544 432211     11 12223333211     11


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          +....+++.+++..||+.||++||||+||++.|++.
T Consensus       224 ----p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         224 ----PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                122234677899999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-52  Score=427.72  Aligned_cols=263  Identities=27%  Similarity=0.363  Sum_probs=219.2

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|+..+.||+|+||+||+|++. +|+.||||+++... ...++|.+|++++++++|||||+++|++.     +++..+
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~   89 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY   89 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCeeE
Confidence            457888999999999999999975 68899999997543 34567999999999999999999999987     567789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.+++.......++|..+++|+.|+++||+|||   +.+|+||||||+||||++++++||+|||+++...
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~  166 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT  166 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecC
Confidence            9999999999999998877788999999999999999999999   8899999999999999999999999999999776


Q ss_pred             CCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ...........||+.|+|||++.++.|+.++|||||||++|||++|..|+.....     ..-+.+.+..+...      
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-----~~~~~~~i~~~~~~------  235 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKDYRM------  235 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-----HHHHHHHHHTTCCC------
T ss_pred             CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-----HHHHHHHHhcCCCC------
Confidence            6555555556789999999999999999999999999999999998777643222     11122333333221      


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCCCc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLSNI  602 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~  602 (614)
                         ..+......+.+++..||+.||++|||++||++.|+......++
T Consensus       236 ---~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~~  279 (287)
T d1opja_         236 ---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSI  279 (287)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSCH
T ss_pred             ---CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhCCC
Confidence               12223345678899999999999999999999999887654443

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.2e-52  Score=427.81  Aligned_cols=258  Identities=27%  Similarity=0.425  Sum_probs=198.0

Q ss_pred             CccccceecccCceEEEEeEcC-CC---cEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NG---TEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g---~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      +|+..++||+|+||+||+|+++ +|   ..||||++... +....++|.+|++++++++|||||+++|++.     +++.
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~-----~~~~  101 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT-----KSTP  101 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----SSSS
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----eCCE
Confidence            3455689999999999999975 33   35899998653 4455678999999999999999999999996     5667


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++.... ..++|.++++|+.|+++||+|||   +.+|+||||||+||||++++++||+|||+++.
T Consensus       102 ~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  177 (299)
T d1jpaa_         102 VMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRF  177 (299)
T ss_dssp             CEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceE
Confidence            899999999999999886543 46999999999999999999999   88999999999999999999999999999987


Q ss_pred             CCCCCccc----cccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCc
Q 043267          474 NPEGITHL----TTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKT  548 (614)
Q Consensus       474 ~~~~~~~~----~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~  548 (614)
                      ........    .....||+.|||||.+.++.++.++|||||||++|||+| |+.||......     + +...+..+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~-----~-~~~~i~~~~~  251 (299)
T d1jpaa_         178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ-----D-VINAIEQDYR  251 (299)
T ss_dssp             ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----H-HHHHHHTTCC
T ss_pred             ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH-----H-HHHHHHcCCC
Confidence            65433221    223457999999999999999999999999999999998 89998644321     1 1122333321


Q ss_pred             hhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          549 LDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       549 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                      .         ..+.+....+.+++..||+.||++|||+.||++.|+..+..|
T Consensus       252 ~---------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p  294 (299)
T d1jpaa_         252 L---------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP  294 (299)
T ss_dssp             C---------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             C---------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcCh
Confidence            1         112233456778999999999999999999999998865443

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=413.50  Aligned_cols=258  Identities=33%  Similarity=0.480  Sum_probs=203.9

Q ss_pred             hcCccccceecccCceEEEEeEcCCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||+||+|+++  ..||||+++..  +....+.|.+|++++++++|||||+++|++.      +...
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~------~~~~   78 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST------APQL   78 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSC
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe------ccEE
Confidence            356888899999999999999974  35999998643  4455678999999999999999999999974      3457


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|.+++...+ ..++|.++++|+.|+++||+|||   +.+|+||||||+||||+.++++||+|||+++..
T Consensus        79 ~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          79 AIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             EEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            99999999999999997543 46999999999999999999999   889999999999999999999999999999866


Q ss_pred             CCCC-ccccccccCCCCcCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          475 PEGI-THLTTRVAGTLGYVAPEYALY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       475 ~~~~-~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      .... ....+...||+.|||||++.+   +.|+.++|||||||++|||+||+.||......     ......+..+....
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~-----~~~~~~~~~~~~~p  229 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR-----DQIIFMVGRGYLSP  229 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHHTSCCC
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChH-----HHHHHHHhcCCCCC
Confidence            5432 233456789999999999864   46899999999999999999999999654321     22233344333221


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ... ..+    .+....+.+++..||+.||++|||++||++.|+..
T Consensus       230 ~~~-~~~----~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         230 DLS-KVR----SNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             CGG-GSC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cch-hcc----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            111 111    12234677888999999999999999999999875

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=406.60  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=212.9

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|+..+.||+|+||+||+|+++++++||||+++... ...++|.+|++++++++||||++++|++.     +.+..++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEE
Confidence            5788899999999999999999889999999998643 34578999999999999999999999997     56778999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.... ..+++..+.+|+.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++.....
T Consensus        78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            99999999999976543 57899999999999999999999   889999999999999999999999999999876655


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      .........||+.|+|||.+..+.++.++||||||+++|||+| |+.||......+      +...+.++...     ..
T Consensus       154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~------~~~~i~~~~~~-----~~  222 (258)
T d1k2pa_         154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE------TAEHIAQGLRL-----YR  222 (258)
T ss_dssp             SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH------HHHHHHTTCCC-----CC
T ss_pred             CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH------HHHHHHhCCCC-----CC
Confidence            4444555779999999999999999999999999999999998 898986543211      22333333221     11


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      +    ....+.+.+++..||+.||++|||++|+++.|..
T Consensus       223 p----~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         223 P----HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             C----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             c----ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            1    2223467889999999999999999999998853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-50  Score=412.71  Aligned_cols=260  Identities=27%  Similarity=0.406  Sum_probs=203.0

Q ss_pred             cCccccceecccCceEEEEeEcCCC-----cEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNG-----TEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g-----~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      ..|+..++||+|+||+||+|+++++     ..||||+++.. +.....+|.+|++++++++|||||+++|++.     +.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence            4578889999999999999997532     47999999753 3444567999999999999999999999997     56


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||+.+|++.+++.... ..++|.++++|+.|+++||+|||   +.+|+||||||+||||++++++||+|||++
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla  157 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLS  157 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred             CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchh
Confidence            77899999999999999876543 57999999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +.......  .......||+.|||||++.++.++.++|||||||++|||++|..|+......     .-+.+.+..+...
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~~~~  232 (283)
T d1mqba_         158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGFRL  232 (283)
T ss_dssp             ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTCCC
T ss_pred             hcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-----HHHHHHHhccCCC
Confidence            87654332  2234456899999999999999999999999999999999976665322211     1122333333221


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                               ..+.+....+.+++..||+.||++||||.||+++|+.....|
T Consensus       233 ---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         233 ---------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             ---------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ---------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence                     122233456788999999999999999999999998865444

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-50  Score=414.00  Aligned_cols=256  Identities=30%  Similarity=0.429  Sum_probs=205.2

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|+..+.||+|+||+||+|+++++++||||+++.. ....+.|.+|++++++++|||||+++|++.      ++..++|
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~------~~~~~lv   89 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS------EEPIYIV   89 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC------SSSCEEE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe------cCCeEEE
Confidence            468999999999999999999988889999999754 344578999999999999999999999984      2457899


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++.......++|.++++|+.||++||+|||   +.+|+||||||+|||||+++++||+|||+++.....
T Consensus        90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~  166 (285)
T d1fmka3          90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  166 (285)
T ss_dssp             ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence            99999999999997765567999999999999999999999   889999999999999999999999999999876655


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccCC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMP  557 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~  557 (614)
                      .........||+.|+|||++..+.++.++||||||+++|||++|..|+......    .+ ....+..+...        
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~----~~-~~~~i~~~~~~--------  233 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN----RE-VLDQVERGYRM--------  233 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH----HH-HHHHHHTTCCC--------
T ss_pred             CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH----HH-HHHHHHhcCCC--------
Confidence            444445567999999999999999999999999999999999977766432221    11 12223333211        


Q ss_pred             CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          558 EMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       558 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                       ..+....+.+.+++..||+.||++|||+++|+++|+...
T Consensus       234 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         234 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             -CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence             112233456788999999999999999999999998864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-50  Score=409.90  Aligned_cols=253  Identities=26%  Similarity=0.421  Sum_probs=207.7

Q ss_pred             cCccccce-ecccCceEEEEeEcC---CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENI-IGKGGYGNVYKGMLP---NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~-LG~G~fG~Vykg~~~---~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+. ||+|+||+||+|+++   ++..||||+++.. +....++|.+|++++++++|||||+++|++.      .+
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~------~~   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ------AE   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE------SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeec------cC
Confidence            45666664 999999999999853   4567999999754 3445678999999999999999999999985      23


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++... ...+++.++++|+.|+++||+|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~  157 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSK  157 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhh
Confidence            579999999999999998543 357999999999999999999999   8899999999999999999999999999999


Q ss_pred             eCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          473 FNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       473 ~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ........  ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+      +...+.+|...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~------~~~~i~~~~~~  231 (285)
T d1u59a_         158 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------VMAFIEQGKRM  231 (285)
T ss_dssp             ECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------HHHHHHTTCCC
T ss_pred             cccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH------HHHHHHcCCCC
Confidence            76544332  2334568999999999999999999999999999999998 999996543211      22344455432


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      +     .+    ......+.+++..||+.||++|||+.+|++.|+.
T Consensus       232 ~-----~p----~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         232 E-----CP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             C-----CC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             C-----CC----CcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2     11    2233467788999999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=404.22  Aligned_cols=259  Identities=22%  Similarity=0.334  Sum_probs=212.0

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.......+.+.+|++++++++|||||++++++.     +++..++
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEE-----ECCEEEE
Confidence            3689999999999999999996 479999999998655555678999999999999999999999987     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++.+.   .+++.++..|+.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++....
T Consensus        95 vmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            99999999999988653   5999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          477 GITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                      ... ......||+.|+|||.+.++.++.++||||+||++|||++|+.||.....     .+........+...      +
T Consensus       169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~~~~~~~~~~~~~------~  236 (293)
T d1yhwa1         169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-----LRALYLIATNGTPE------L  236 (293)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHHCSCC------C
T ss_pred             ccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCCCC------C
Confidence            332 33456799999999999999999999999999999999999999964322     11222222222110      1


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCC
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSN  601 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~  601 (614)
                        ..+......+.+++..|++.||++|||+.|+++  .++...+.++
T Consensus       237 --~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~~~~~  281 (293)
T d1yhwa1         237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSS  281 (293)
T ss_dssp             --SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred             --CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCCCCCc
Confidence              112333456788999999999999999999975  4544444443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=405.69  Aligned_cols=251  Identities=28%  Similarity=0.332  Sum_probs=202.4

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++|||||++++++.     +++..+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~-----~~~~~~   79 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR-----EGNIQY   79 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEE-----ETTEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeec-----cCceeE
Confidence            57899999999999999999964 79999999997533 233457899999999999999999999987     567889


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||+++|+|.++|..  ...+++.++..|+.|+++||+|||   +.+|+||||||+|||+++++++||+|||+|+...
T Consensus        80 ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~  154 (271)
T d1nvra_          80 LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFR  154 (271)
T ss_dssp             EEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECE
T ss_pred             EEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeec
Confidence            99999999999999954  347999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCC-ccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          476 EGI-THLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       476 ~~~-~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ... ....+...||+.|||||++.+..+ +.++||||+||++|||++|+.||..........     .........    
T Consensus       155 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-----~~~~~~~~~----  225 (271)
T d1nvra_         155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKTY----  225 (271)
T ss_dssp             ETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-----HHHHTTCTT----
T ss_pred             cCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcCCCC----
Confidence            332 233456789999999999988876 578999999999999999999996543322111     111111111    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          ..........+.+++..|++.||++|||++|+++
T Consensus       226 ----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         226 ----LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ----STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                1112233456678889999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-49  Score=406.52  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=199.5

Q ss_pred             ceecccCceEEEEeEcC---CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEEE
Q 043267          324 NIIGKGGYGNVYKGMLP---NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIVC  398 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~---~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV~  398 (614)
                      +.||+|+||+||+|.+.   .++.||||+++..  +....++|.+|++++++++|||||+++|+|.      .+..++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~------~~~~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE------AESWMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE------SSSEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec------cCCEEEEE
Confidence            57999999999999864   3568999999643  2334567999999999999999999999985      23568999


Q ss_pred             eecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC
Q 043267          399 DLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI  478 (614)
Q Consensus       399 E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~  478 (614)
                      ||+++|+|.+++...  ..++|.++++|+.||++||+|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus        87 E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          87 EMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             ECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             EcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            999999999999754  36999999999999999999999   8899999999999999999999999999998765443


Q ss_pred             cc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhcc
Q 043267          479 TH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEEN  555 (614)
Q Consensus       479 ~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~  555 (614)
                      ..  ......||+.|||||.+.++.++.++|||||||++|||++ |+.||......      -+...+..|...+     
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~~~~~i~~~~~~~-----  230 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGERMG-----  230 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCCC-----
T ss_pred             cccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------HHHHHHHcCCCCC-----
Confidence            32  2344679999999999999999999999999999999998 89999654321      1223444443221     


Q ss_pred             CCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          556 MPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       556 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      .+    ......+.+++..||+.||++|||+++|+++|+.
T Consensus       231 ~p----~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         231 CP----AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CC----cccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            11    2223467788999999999999999999999875

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=405.06  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=193.7

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||.+...  +....+.+.+|++++++++|||||++++++...   .....
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~---~~~~~   80 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TNTTL   80 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------CE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeC---CCCEE
Confidence            4789999999999999999996 47899999999753  344456789999999999999999999988632   34567


Q ss_pred             EEEEeecCCCChhhhhhcC--CCcCCChHHHHHHHHHHHHHHHHHhhcC--CCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          395 IIVCDLLHNGSLYDHLFGS--GMKKLSWPIRLRIALGTARGLAYLHYGV--QPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~--~~~~l~~~~~~~I~~~ia~gL~yLH~~~--~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      ++||||+++|+|.+++.+.  ....+++..++.|+.|+++||+|||+..  ..+|+||||||+|||+++++++||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            9999999999999998652  3457999999999999999999999432  24599999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      ++....+.. ......||+.|||||.+.+..|+.++|||||||++|||++|+.||......      .....+.++... 
T Consensus       161 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~~~~-  232 (269)
T d2java1         161 ARILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREGKFR-  232 (269)
T ss_dssp             HHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCCC-
T ss_pred             eeecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCC-
Confidence            987654332 234568999999999999999999999999999999999999999643321      122333333321 


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                          .++.    ...+.+.+++..|++.||++|||+.|+++
T Consensus       233 ----~~~~----~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ----RIPY----RYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCc----ccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                1121    22345778889999999999999999874

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-49  Score=411.98  Aligned_cols=256  Identities=23%  Similarity=0.342  Sum_probs=206.0

Q ss_pred             cCccccceecccCceEEEEeEcCC------CcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN------GTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ++|+..+.||+|+||+||+|+...      ...||||++... .......+.+|+.++.++ +|||||++++++.     
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----  111 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT-----  111 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe-----
Confidence            578899999999999999998642      236999998643 344556799999999998 8999999999997     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCC---------------------cCCChHHHHHHHHHHHHHHHHHhhcCCCceEEe
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGM---------------------KKLSWPIRLRIALGTARGLAYLHYGVQPAIIHR  448 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~---------------------~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHr  448 (614)
                      +.+..++||||+++|+|.++|.....                     ..++|..++.|+.|+++||+|||   +.+|+||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHR  188 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  188 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeec
Confidence            55678999999999999999976432                     35899999999999999999999   8899999


Q ss_pred             ccCCCCeEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcc
Q 043267          449 DIKASNILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACE  526 (614)
Q Consensus       449 DIKp~NILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~  526 (614)
                      ||||+|||++.++++||+|||+|+........ ......||+.|||||.+.++.++.++|||||||++|||+| |+.||.
T Consensus       189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~  268 (325)
T d1rjba_         189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  268 (325)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence            99999999999999999999999865443322 2345668999999999999999999999999999999998 899996


Q ss_pred             cccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhc
Q 043267          527 IIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILET  595 (614)
Q Consensus       527 ~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  595 (614)
                      ......     -..+.++.+...         ..+....+.+.+++..||+.||++|||++||+++|..
T Consensus       269 ~~~~~~-----~~~~~~~~~~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         269 GIPVDA-----NFYKLIQNGFKM---------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             TCCCSH-----HHHHHHHTTCCC---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHH-----HHHHHHhcCCCC---------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            543321     123334433221         1122234567889999999999999999999999964

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-49  Score=397.33  Aligned_cols=245  Identities=26%  Similarity=0.372  Sum_probs=204.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+|+.+ +|+.||||++....   ....+.+.+|++++++++|||||++++++.     +++.
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~   80 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DATR   80 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECCE
Confidence            36889999999999999999975 68999999986422   233567899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..|+.||++||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus        81 ~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          81 VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeee
Confidence            99999999999999999754  36999999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      .....   .....||+.|||||++.+..++.++|||||||++|||++|+.||.....      ......+..+..     
T Consensus       156 ~~~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~------~~~~~~i~~~~~-----  221 (263)
T d2j4za1         156 APSSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY------QETYKRISRVEF-----  221 (263)
T ss_dssp             CCCCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH------HHHHHHHHTTCC-----
T ss_pred             cCCCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH------HHHHHHHHcCCC-----
Confidence            55432   3346799999999999999999999999999999999999999964321      112222222221     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       .+++    ...+.+.+++..|++.||++|||++|+++
T Consensus       222 -~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 -TFPD----FVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             1222    22345678889999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-48  Score=393.04  Aligned_cols=248  Identities=25%  Similarity=0.394  Sum_probs=198.8

Q ss_pred             cccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          321 SRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +..+.||+|+||+||+|+.. +++.||+|++...  .....+.+.+|++++++++|||||++++++..... .+...++|
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~~~~~iv   90 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK-GKKCIVLV   90 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS-SCEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc-cCCEEEEE
Confidence            45568999999999999965 6889999998753  34456679999999999999999999999864321 35678999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCc--eEEeccCCCCeEEC-CCCcEEEeecCCceeC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPA--IIHRDIKASNILLD-EAFEAKVGDFGLAKFN  474 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~--iiHrDIKp~NILLd-~~~~~kl~DFGla~~~  474 (614)
                      |||+++|+|.+++.+.  ..+++..++.|+.||++||+|||   +.+  |+||||||+|||++ +++.+||+|||+++..
T Consensus        91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            9999999999999764  36999999999999999999999   666  99999999999997 5789999999999864


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ...   ......||+.|||||.+.+ +++.++|||||||++|||++|+.||......     ....+.+..+......+.
T Consensus       166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~-----~~~~~~i~~~~~~~~~~~  236 (270)
T d1t4ha_         166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA-----AQIYRRVTSGVKPASFDK  236 (270)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH-----HHHHHHHTTTCCCGGGGG
T ss_pred             cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccH-----HHHHHHHHcCCCCcccCc
Confidence            432   2345689999999998764 6999999999999999999999999643321     112233333332222221


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                              .....+.+++..|++.||++|||++|+++
T Consensus       237 --------~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         237 --------VAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             --------CCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------cCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                    12235678889999999999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=401.64  Aligned_cols=251  Identities=23%  Similarity=0.307  Sum_probs=205.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      +.|+..+.||+|+||+||+|+.. +|+.||||+++..+....+.+.+|++++++++|||||++++++.     +.+..++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY-----YENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----eCCeEEE
Confidence            35888899999999999999964 78999999998766667778999999999999999999999987     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPE  476 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~  476 (614)
                      ||||+++|+|.+++.+.. ..+++.++..|+.|+++||+|||   +.+|+||||||+|||++.++++||+|||+++....
T Consensus        87 vmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            999999999999986543 46999999999999999999999   88999999999999999999999999999976433


Q ss_pred             CCccccccccCCCCcCchhhhc-----cCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          477 GITHLTTRVAGTLGYVAPEYAL-----YGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       477 ~~~~~~~~~~gt~~Y~APE~~~-----~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      .. .......||+.|+|||++.     ...|+.++|||||||++|||++|+.||......+.     ... +..+...  
T Consensus       163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-----~~~-i~~~~~~--  233 (288)
T d2jfla1         163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-----LLK-IAKSEPP--  233 (288)
T ss_dssp             HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-----HHH-HHHSCCC--
T ss_pred             Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH-----HHH-HHcCCCC--
Confidence            21 1234567999999999984     45689999999999999999999999965432211     112 1122111  


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                         .+  ..+......+.+++..||+.||++|||++|+++
T Consensus       234 ---~~--~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         234 ---TL--AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             ---CC--SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---CC--CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               11  112334456788999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.9e-49  Score=405.59  Aligned_cols=264  Identities=27%  Similarity=0.385  Sum_probs=212.1

Q ss_pred             HHHHHHhcCccccceecccCceEEEEeEcC------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeee
Q 043267          311 EEIKAATMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYS  383 (614)
Q Consensus       311 ~el~~~t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~  383 (614)
                      .+++...++|+..+.||+|+||+||+|+.+      +++.||||+++... ....++|.+|++++++++|||++++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   85 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC   85 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence            344445678999999999999999999853      46789999997543 33456799999999999999999999999


Q ss_pred             ecccCCCCceEEEEEeecCCCChhhhhhcCC----------------------CcCCChHHHHHHHHHHHHHHHHHhhcC
Q 043267          384 TATVPLEGHQRIIVCDLLHNGSLYDHLFGSG----------------------MKKLSWPIRLRIALGTARGLAYLHYGV  441 (614)
Q Consensus       384 ~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~----------------------~~~l~~~~~~~I~~~ia~gL~yLH~~~  441 (614)
                      .     .....+++|||+++|+|.+++....                      ...++|..+++|+.|++.||+|||   
T Consensus        86 ~-----~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---  157 (301)
T d1lufa_          86 A-----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---  157 (301)
T ss_dssp             C-----SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---
T ss_pred             c-----cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---
Confidence            7     5677899999999999999996422                      235899999999999999999999   


Q ss_pred             CCceEEeccCCCCeEECCCCcEEEeecCCceeCCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh
Q 043267          442 QPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS  520 (614)
Q Consensus       442 ~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt  520 (614)
                      +.+|+||||||+|||+|.++++||+|||+++...... ....+...||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       158 ~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         158 ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             cCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence            8999999999999999999999999999998654332 223445678999999999999999999999999999999999


Q ss_pred             CC-CCcccccCccchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          521 GK-KACEIIQGKSVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       521 G~-~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      |. .|+......     +. ...+.++...+     .+    ......+.+++..||+.+|++||||.||+++|++..
T Consensus       238 ~~~~p~~~~~~~-----e~-~~~v~~~~~~~-----~p----~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         238 YGLQPYYGMAHE-----EV-IYYVRDGNILA-----CP----ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTCCTTTTSCHH-----HH-HHHHHTTCCCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCCCCCCCCCHH-----HH-HHHHHcCCCCC-----CC----ccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            86 566543221     11 13344443321     11    223346788999999999999999999999998753

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=396.05  Aligned_cols=250  Identities=31%  Similarity=0.398  Sum_probs=198.8

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      ++|+..+.||+|+||.||+|++ .|++||||++++..  ..++|.+|++++++++||||++++|+|..    +.+..++|
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv   79 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGLYIV   79 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CCEEE
T ss_pred             HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEe----cCCcEEEE
Confidence            4677889999999999999998 57899999997533  45679999999999999999999999853    23457999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.++|.......++|..+++|+.||++||.|||   +.+|+||||||+|||++.++++||+|||+++.....
T Consensus        80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999998765567999999999999999999999   889999999999999999999999999999864432


Q ss_pred             CccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhhhhccC
Q 043267          478 ITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEENM  556 (614)
Q Consensus       478 ~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~~l  556 (614)
                          .....+|..|+|||++.++.++.++||||||+++|||+| |+.|+......+  +    ...+.++...+     +
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~--~----~~~i~~~~~~~-----~  221 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V----VPRVEKGYKMD-----A  221 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--H----HHHHTTTCCCC-----C
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH--H----HHHHHcCCCCC-----C
Confidence                233467899999999999999999999999999999998 677775433221  1    12233332221     1


Q ss_pred             CCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          557 PEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       557 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          +......+.+++..||+.||++|||+.+++++|+..
T Consensus       222 ----~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i  257 (262)
T d1byga_         222 ----PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  257 (262)
T ss_dssp             ----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence                222234677889999999999999999999999763

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-48  Score=406.65  Aligned_cols=262  Identities=22%  Similarity=0.313  Sum_probs=202.6

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++.. +....+.+.+|++++++++|||||++++++.     +....
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            56899999999999999999996 47899999999753 3344567899999999999999999999997     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCC-CceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQ-PAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~-~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      ++||||+++|+|.+++.+.+  .+++..+..++.|+++||.|||   + .+|+||||||+|||+++++++||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            99999999999999997643  6999999999999999999999   5 4899999999999999999999999999985


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh----------HHHHHHH
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS----------DWAWELV  543 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~----------~~~~~~~  543 (614)
                      ..+.   ..+...||+.|+|||++.+.+|+.++||||+||++|||++|+.||...........          .......
T Consensus       155 ~~~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (322)
T d1s9ja_         155 LIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR  231 (322)
T ss_dssp             HHHH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC----------------
T ss_pred             cCCC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccc
Confidence            4322   23346899999999999999999999999999999999999999954332211000          0000000


Q ss_pred             Hc--------------CCchhhhh----ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          544 KE--------------GKTLDVIE----ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       544 ~~--------------g~~~~~~d----~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..              ....+..+    ...+..........+.+++..|++.||++|||++|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             --------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            00              00000000    00000011112346778899999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=393.28  Aligned_cols=254  Identities=26%  Similarity=0.385  Sum_probs=197.1

Q ss_pred             cCccccceecccCceEEEEeEcCC----CcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPN----GTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|+..+.||+|+||.||+|++..    +..||||.++.. .....+.|.+|++++++++|||||+++|++.      .+
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~------~~   80 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT------EN   80 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC------SS
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe------cC
Confidence            578889999999999999998642    457899998753 3444567999999999999999999999984      34


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++... ...+++..++.++.|+++||.|||   +.+|+||||||+||++++++++||+|||+++
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhe
Confidence            679999999999999987654 357999999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ..........+...||+.|+|||.+.++.++.++|||||||++|||++ |+.|+......+      +...+..+.... 
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~------~~~~i~~~~~~~-  229 (273)
T d1mp8a_         157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------VIGRIENGERLP-  229 (273)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------HHHHHHTTCCCC-
T ss_pred             eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCC-
Confidence            766554445566778999999999999999999999999999999998 888886544322      123334443221 


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                          .    +......+.+++..||+.||++|||+.||++.|+..
T Consensus       230 ----~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i  266 (273)
T d1mp8a_         230 ----M----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  266 (273)
T ss_dssp             ----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----C----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                1    222345678889999999999999999999998764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-48  Score=400.20  Aligned_cols=254  Identities=24%  Similarity=0.399  Sum_probs=202.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCc----EEEEEEeec-CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGT----EVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~VAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~  391 (614)
                      .+|+..++||+|+||+||+|++. +|+    +||||+++. .+....++|.+|++++++++|||||+++|+|..      
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~------   82 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT------   82 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES------
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            35899999999999999999864 444    689998864 344556789999999999999999999999862      


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      +..++++||+.+|+|.+++... ...++|..+++|+.||++||+|||   +.+|+||||||+|||+++++++||+|||++
T Consensus        83 ~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla  158 (317)
T d1xkka_          83 STVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLA  158 (317)
T ss_dssp             SSEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHH
T ss_pred             CCeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccc
Confidence            3568889999999999988764 457999999999999999999999   889999999999999999999999999999


Q ss_pred             eeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          472 KFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       472 ~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      +........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||.......      +...+..|...
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~------~~~~i~~~~~~  232 (317)
T d1xkka_         159 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE------ISSILEKGERL  232 (317)
T ss_dssp             HHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG------HHHHHHHTCCC
T ss_pred             eecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHcCCCC
Confidence            876544332 3344578999999999999999999999999999999999 788886443221      22333333221


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      .         .+......+.+++..||+.||++|||+.|+++.|+..
T Consensus       233 ~---------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 P---------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             C---------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             C---------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            1         1223345678899999999999999999999887653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.7e-48  Score=399.25  Aligned_cols=249  Identities=27%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .|+..+.||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|++++++++|||||++++++.     +++..
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL-----REHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEE-----ECCEE
Confidence            588999999999999999995 478999999997543   233457899999999999999999999987     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+++|+|..++...  ..+++.+++.|+.||++||.|||   +.+|+||||||+|||++.++++||+|||+++..
T Consensus        91 ~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeeccccccc
Confidence            9999999999998766543  47999999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCccccccccCCCCcCchhhhcc---CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY---GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~---~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      ..     .....||+.|||||++.+   ++|+.++|||||||++|||++|+.||.....     .+...... .+...  
T Consensus       166 ~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~-----~~~~~~i~-~~~~~--  232 (309)
T d1u5ra_         166 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----MSALYHIA-QNESP--  232 (309)
T ss_dssp             SS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHH-HSCCC--
T ss_pred             CC-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH-----HHHHHHHH-hCCCC--
Confidence            43     234579999999999863   5689999999999999999999999964322     11111211 12111  


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                         .+.   .....+.+.+++..||+.||++|||++|+++  .+.+.
T Consensus       233 ---~~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         233 ---ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             ---CCS---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             ---CCC---CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence               111   1222346778889999999999999999986  44443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-48  Score=395.49  Aligned_cols=247  Identities=20%  Similarity=0.260  Sum_probs=201.3

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|++++++++||||+++++++.     +++.
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~-----~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ-----DDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEE-----CSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEE-----ECCE
Confidence            4689999999999999999996 479999999997422   233467899999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        83 ~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEeccccccee
Confidence            89999999999999998654  36999999999999999999999   89999999999999999999999999999997


Q ss_pred             CCCCC-ccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          474 NPEGI-THLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       474 ~~~~~-~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ..... ........||+.|||||++.+..++.++||||+||++|||++|+.||......      .....+..+..    
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~----  227 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIKLEY----  227 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTCC----
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHcCCC----
Confidence            65432 22344567999999999999999999999999999999999999999643211      11222222221    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIV  590 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  590 (614)
                        .++.    .....+.+++..|++.||++|||++|++
T Consensus       228 --~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~  259 (288)
T d1uu3a_         228 --DFPE----KFFPKARDLVEKLLVLDATKRLGCEEME  259 (288)
T ss_dssp             --CCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGT
T ss_pred             --CCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHc
Confidence              1222    2334677889999999999999999864

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.4e-47  Score=402.12  Aligned_cols=251  Identities=21%  Similarity=0.276  Sum_probs=208.2

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|...+.||+|+||.||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.     +++..++
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i  100 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE-----DDNEMVM  100 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE-----ETTEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            4799999999999999999996 479999999998766666778999999999999999999999987     5678999


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC--CCCcEEEeecCCceeC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFN  474 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd--~~~~~kl~DFGla~~~  474 (614)
                      ||||+++|+|.+++.+.. ..+++..+..|+.||+.||+|||   +.+|+||||||+|||++  .++.+||+|||+++..
T Consensus       101 vmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         101 IYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             EECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             EEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999999999999996543 46999999999999999999999   89999999999999996  4678999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ....  ......||+.|||||++.+..++.++||||+||++|||++|+.||.....     .+.. ..+..+..      
T Consensus       177 ~~~~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~-~~i~~~~~------  242 (350)
T d1koaa2         177 DPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-----DETL-RNVKSCDW------  242 (350)
T ss_dssp             CTTS--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHH-HHHHHTCC------
T ss_pred             cccc--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-----HHHH-HHHHhCCC------
Confidence            5433  23446799999999999999999999999999999999999999964322     1111 22222211      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+........+.+.+++..|++.||++|||++|+++
T Consensus       243 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111112233456788999999999999999999987

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-48  Score=398.28  Aligned_cols=270  Identities=27%  Similarity=0.310  Sum_probs=202.3

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      +.|...+.||+|+||.||+|++ +|+.||||+++.... ....+..|+..+..++|||||+++|+|..... .....++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~-~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~-~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccch-hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCC-cceEEEEE
Confidence            4577788999999999999997 689999999965322 22223345555567899999999999975432 33468999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc-----CCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG-----VQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~-----~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      |||+++|+|.++|.+.   .++|.++++++.|+|.||+|||..     .+++|+||||||+||||+.++++||+|||+++
T Consensus        80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999999754   599999999999999999999942     24799999999999999999999999999998


Q ss_pred             eCCCCCcc---ccccccCCCCcCchhhhccC------CCCchhhHHHHHHHHHHHHhCCCCcccccCccch---------
Q 043267          473 FNPEGITH---LTTRVAGTLGYVAPEYALYG------KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL---------  534 (614)
Q Consensus       473 ~~~~~~~~---~~~~~~gt~~Y~APE~~~~~------~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~---------  534 (614)
                      ........   ......||+.|+|||++...      .++.++|||||||++|||+||..|+.........         
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            66443322   23456799999999998754      3678999999999999999999887433222111         


Q ss_pred             hhHHHHHHHHcCCchhhhhccCCCCC-cHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          535 LSDWAWELVKEGKTLDVIEENMPEME-LPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       535 l~~~~~~~~~~g~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                      ...........+.    .++.++... ..+.+..+.+++..||+.||++|||+.||+++|+...
T Consensus       237 ~~~~~~~~~~~~~----~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~  296 (303)
T d1vjya_         237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHhccc----cCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            1111222221111    122222211 2345667889999999999999999999999998653

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=394.42  Aligned_cols=260  Identities=26%  Similarity=0.334  Sum_probs=201.2

Q ss_pred             hcCccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVP  388 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~  388 (614)
                      .++|...+.||+|+||.||+|+..      +++.||||+++.. .....+++.+|.+.+.++ +|+||+.+++++..   
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~---   88 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK---   88 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS---
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc---
Confidence            357899999999999999999842      3568999999753 344456788888888887 68999999998763   


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCC
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASN  454 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~N  454 (614)
                       ++...++||||+++|+|.++|....              ...++|.+++.++.|+++||+|||   +.+|+||||||+|
T Consensus        89 -~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~N  164 (299)
T d1ywna1          89 -PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARN  164 (299)
T ss_dssp             -TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             -CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccc
Confidence             3456899999999999999997532              235899999999999999999999   8999999999999


Q ss_pred             eEECCCCcEEEeecCCceeCCCCCcc-ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCC-CCcccccCcc
Q 043267          455 ILLDEAFEAKVGDFGLAKFNPEGITH-LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK-KACEIIQGKS  532 (614)
Q Consensus       455 ILLd~~~~~kl~DFGla~~~~~~~~~-~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~-~p~~~~~~~~  532 (614)
                      |||++++++||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||++|. .||.....  
T Consensus       165 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~--  242 (299)
T d1ywna1         165 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--  242 (299)
T ss_dssp             EEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC--
T ss_pred             eeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH--
Confidence            99999999999999999865543332 344567999999999999999999999999999999999975 56653332  


Q ss_pred             chhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccC
Q 043267          533 VLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDV  597 (614)
Q Consensus       533 ~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  597 (614)
                         .......+..+...+     .+    ......+.+++..||+.||++|||++|+++.|++.+
T Consensus       243 ---~~~~~~~~~~~~~~~-----~~----~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~il  295 (299)
T d1ywna1         243 ---DEEFCRRLKEGTRMR-----AP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  295 (299)
T ss_dssp             ---SHHHHHHHHHTCCCC-----CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHHHHHHhcCCCCC-----CC----ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               122334444443321     11    222346778999999999999999999999998753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-47  Score=396.96  Aligned_cols=256  Identities=22%  Similarity=0.327  Sum_probs=192.6

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .+.|+..+.||+|+||+||+|+.. +|+.||||++.... ......+.+|++++++++|||||++++++.     +++..
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   82 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYE-----SGGHL   82 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            356899999999999999999965 68999999997533 233456889999999999999999999987     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC---CCCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD---EAFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd---~~~~~kl~DFGla  471 (614)
                      ++||||+++|+|.++|...  ..+++.++..++.|++.||+|||   +.+|+||||||+|||++   +++.+||+|||++
T Consensus        83 ~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a  157 (307)
T d1a06a_          83 YLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLS  157 (307)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred             EEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEecccee
Confidence            9999999999999999653  47999999999999999999999   89999999999999994   5789999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +......  ......||+.|||||.+.++.|+.++||||+||++|||++|+.||......      -....+..+..   
T Consensus       158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~~---  226 (307)
T d1a06a_         158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILKAEY---  226 (307)
T ss_dssp             -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHTTCC---
T ss_pred             EEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhccCC---
Confidence            8654432  234467999999999999999999999999999999999999999643221      11222222221   


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                         ..+.....+....+.+++..|++.||++|||++|+++  .+.+.
T Consensus       227 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         227 ---EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ---CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence               1111112233456788999999999999999999987  45544

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-47  Score=393.93  Aligned_cols=252  Identities=26%  Similarity=0.371  Sum_probs=202.6

Q ss_pred             cceecccCceEEEEeEcCCC----cEEEEEEeec-CChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEEE
Q 043267          323 ENIIGKGGYGNVYKGMLPNG----TEVAVKRFKN-CSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRIIV  397 (614)
Q Consensus       323 ~~~LG~G~fG~Vykg~~~~g----~~VAVK~l~~-~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~lV  397 (614)
                      .++||+|+||+||+|++.++    ..||||+++. .+....++|.+|++++++++||||++++|++..    .+...++|
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~----~~~~~~lv  107 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SEGSPLVV  107 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE----TTTEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEe----cCCceEEE
Confidence            46899999999999997532    2589999975 345556789999999999999999999999863    34578999


Q ss_pred             EeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCCCC
Q 043267          398 CDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNPEG  477 (614)
Q Consensus       398 ~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~~~  477 (614)
                      |||+++|+|.+++... ...+++..+++++.|+++||.|||   +.+|+||||||+||||++++.+||+|||+++.....
T Consensus       108 ~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~  183 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  183 (311)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred             EEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence            9999999999988654 356889999999999999999999   899999999999999999999999999999876543


Q ss_pred             Ccc---ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          478 ITH---LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       478 ~~~---~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ...   ......||+.|+|||.+..+.++.++||||||+++|||++|+.|+.......    ++ ...+..|....    
T Consensus       184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~----~~-~~~i~~g~~~~----  254 (311)
T d1r0pa_         184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF----DI-TVYLLQGRRLL----  254 (311)
T ss_dssp             TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC----------C-HHHHHTTCCCC----
T ss_pred             ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH----HH-HHHHHcCCCCC----
Confidence            322   2334678999999999999999999999999999999999888874322211    11 12233343221    


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       .+    ......+.+++..||+.||++||+|.||++.|++.
T Consensus       255 -~p----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         255 -QP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -CC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -Cc----ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             11    12234677889999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=391.49  Aligned_cols=255  Identities=28%  Similarity=0.389  Sum_probs=197.2

Q ss_pred             cCccccceecccCceEEEEeEcC--CC--cEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP--NG--TEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~--~g--~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|+..+.||+|+||.||+|++.  ++  .+||||+++..   +....++|.+|++++++++||||++++|++.      
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~------   81 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL------   81 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEEC------
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe------
Confidence            46888999999999999999853  23  47899998643   2344568999999999999999999999985      


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      .+..++||||+++|+|.+++.... ..+++..+++++.|+++||.|||   +.+|+||||||+|||++.++++||+|||+
T Consensus        82 ~~~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl  157 (273)
T d1u46a_          82 TPPMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGL  157 (273)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             ecchheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchh
Confidence            235689999999999999887643 46999999999999999999999   88999999999999999999999999999


Q ss_pred             ceeCCCCCcc--ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCccchhhHHHHHHHHcCC
Q 043267          471 AKFNPEGITH--LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       471 a~~~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      ++........  ......||..|+|||.+.+..++.++||||||+++|||+| |+.||.....     .+......+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~-----~~~~~~i~~~~~  232 (273)
T d1u46a_         158 MRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG-----SQILHKIDKEGE  232 (273)
T ss_dssp             CEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTSCC
T ss_pred             hhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH-----HHHHHHHHhCCC
Confidence            9976554332  2344568889999999999999999999999999999998 8999864332     122223333332


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..+         ........+.+++..||+.||++|||+.||+++|++.
T Consensus       233 ~~~---------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         233 RLP---------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC---------CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            211         1122234677899999999999999999999999763

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-47  Score=399.93  Aligned_cols=256  Identities=21%  Similarity=0.250  Sum_probs=210.9

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++.........+.+|++++++++|||||++++++.     ++...++
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~i  103 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEMVL  103 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEEEE
Confidence            4699999999999999999996 479999999998766666778899999999999999999999987     5678899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC--CCCcEEEeecCCceeC
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD--EAFEAKVGDFGLAKFN  474 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd--~~~~~kl~DFGla~~~  474 (614)
                      ||||+++|+|.+++... ...+++.+.+.|+.||+.||+|||   +.+|+||||||+||||+  .++.+||+|||+++..
T Consensus       104 vmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         104 ILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             EEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             EEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence            99999999999987543 346999999999999999999999   89999999999999998  6789999999999877


Q ss_pred             CCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhhc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIEE  554 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d~  554 (614)
                      ..+.  ......||+.|+|||++.+..++.++||||+||++|||++|+.||......     +. ...+..+..      
T Consensus       180 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-----~~-~~~i~~~~~------  245 (352)
T d1koba_         180 NPDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL-----ET-LQNVKRCDW------  245 (352)
T ss_dssp             CTTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HH-HHHHHHCCC------
T ss_pred             CCCC--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----HH-HHHHHhCCC------
Confidence            6532  234467999999999999999999999999999999999999999643321     11 122222211      


Q ss_pred             cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc
Q 043267          555 NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD  596 (614)
Q Consensus       555 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  596 (614)
                      ..+..........+.+++..|++.||.+|||+.|+++  .+.+.
T Consensus       246 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            1122222334456788999999999999999999987  35443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-47  Score=389.24  Aligned_cols=250  Identities=23%  Similarity=0.263  Sum_probs=204.3

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC------hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS------KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~------~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...+.||+|+||+||+|+. .+|+.||||+++...      ....+.+.+|++++++++|||||++++++.     +
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~   84 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE-----N   84 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            5799999999999999999996 479999999996432      123577999999999999999999999987     6


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC----cEEEe
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF----EAKVG  466 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~----~~kl~  466 (614)
                      ....++||||+++|+|.+++...+  .+++..++.++.|+++||+|||   +.+|+||||||+|||++.++    .+||+
T Consensus        85 ~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~  159 (293)
T d1jksa_          85 KTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKII  159 (293)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEec
Confidence            678999999999999999997643  6999999999999999999999   89999999999999998776    49999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |||+++....+.  ......||+.|+|||++.++.++.++||||+||++|||++|+.||......     + ....+..+
T Consensus       160 DfG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~-----~-~~~~i~~~  231 (293)
T d1jksa_         160 DFGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----E-TLANVSAV  231 (293)
T ss_dssp             CCTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----H-HHHHHHTT
T ss_pred             chhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH-----H-HHHHHHhc
Confidence            999998765432  234467899999999999999999999999999999999999999643321     1 11222222


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...      .+..........+.+++..|++.||++|||++|+++
T Consensus       232 ~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         232 NYE------FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCC------CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCC------CCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            211      010001122346778999999999999999999985

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-47  Score=390.16  Aligned_cols=256  Identities=28%  Similarity=0.376  Sum_probs=206.0

Q ss_pred             cCccccceecccCceEEEEeEcC--------CCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeeccc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP--------NGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATV  387 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~  387 (614)
                      ++|...+.||+|+||.||+|+..        ++..||||+++... .....++.+|...+.++ +|||||+++++|.   
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~---   89 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT---   89 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc---
Confidence            46888899999999999999852        23579999997543 44567889999999988 8999999999997   


Q ss_pred             CCCCceEEEEEeecCCCChhhhhhcCC--------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCC
Q 043267          388 PLEGHQRIIVCDLLHNGSLYDHLFGSG--------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS  453 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~GsL~~~L~~~~--------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~  453 (614)
                        ++...++||||+++|+|.++|....              ...+++.++++++.|++.||+|||   +.+|+||||||+
T Consensus        90 --~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~  164 (299)
T d1fgka_          90 --QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAAR  164 (299)
T ss_dssp             --SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             --cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeeccc
Confidence              5667899999999999999997543              346999999999999999999999   899999999999


Q ss_pred             CeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHh-CCCCcccccCc
Q 043267          454 NILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLS-GKKACEIIQGK  531 (614)
Q Consensus       454 NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~Ellt-G~~p~~~~~~~  531 (614)
                      |||++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++||||||+++|||++ |+.||..... 
T Consensus       165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~-  243 (299)
T d1fgka_         165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV-  243 (299)
T ss_dssp             GEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-
T ss_pred             ceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH-
Confidence            99999999999999999986654332 23455678999999999999999999999999999999998 6778753332 


Q ss_pred             cchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       532 ~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           +.++..+..+...+.         +......+.+++.+||+.||++|||+.||+++|++.
T Consensus       244 -----~~~~~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         244 -----EELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             -----HHHHHHHHTTCCCCC---------CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHHHcCCCCCC---------CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                 223445555433221         122334678899999999999999999999999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-46  Score=390.12  Aligned_cols=257  Identities=26%  Similarity=0.359  Sum_probs=209.7

Q ss_pred             cCccccceecccCceEEEEeEc------CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML------PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~  389 (614)
                      ++|+..+.||+|+||.||+|++      .+++.||||+++... .....+|.+|+++++++ +|||||+++|+|.     
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~-----   97 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT-----   97 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe-----
Confidence            5788889999999999999984      356789999997543 34456799999999999 7999999999997     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCC----------------CcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSG----------------MKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKAS  453 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~----------------~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~  453 (614)
                      ++...++||||+++|+|.+++....                ...+++..+++|+.||++||+|||   +.+++||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccc
Confidence            5567899999999999999997532                236999999999999999999999   889999999999


Q ss_pred             CeEECCCCcEEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCC-cccccCc
Q 043267          454 NILLDEAFEAKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKA-CEIIQGK  531 (614)
Q Consensus       454 NILLd~~~~~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p-~~~~~~~  531 (614)
                      |||++.++.+|++|||+++....... ...+...||+.|+|||.+.++.++.++||||||+++|||+|+..| +......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987665433 234557789999999999999999999999999999999995544 4433221


Q ss_pred             cchhhHHHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          532 SVLLSDWAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       532 ~~~l~~~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                           +-.++.++.+...         ..+......+.+++..||+.||++|||++||+++|++.
T Consensus       255 -----~~~~~~i~~~~~~---------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         255 -----SKFYKMIKEGFRM---------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             -----HHHHHHHHHTCCC---------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHHhcCCCC---------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                 1123333333221         11222345678899999999999999999999999875

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-47  Score=391.38  Aligned_cols=260  Identities=25%  Similarity=0.377  Sum_probs=211.2

Q ss_pred             cCccccceecccCceEEEEeEcC------CCcEEEEEEeecC-ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP------NGTEVAVKRFKNC-SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~VAVK~l~~~-~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|...+.||+|+||+||+|++.      +++.||||+++.. .......|.+|++++++++||||++++|++.     .
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----~   94 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----Q   94 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----S
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----c
Confidence            57888899999999999999863      3678999999753 3444567899999999999999999999996     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcC--------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGS--------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~--------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      +...++||||+++|+|.+++...        ....++|..+.+|+.|+++||.|||   +.+|+||||||+|||+|++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCce
Confidence            66789999999999999998642        2345799999999999999999999   889999999999999999999


Q ss_pred             EEEeecCCceeCCCCCc-cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCC-CCcccccCccchhhHHHH
Q 043267          463 AKVGDFGLAKFNPEGIT-HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGK-KACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~-~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~-~p~~~~~~~~~~l~~~~~  540 (614)
                      +||+|||+++....... .......||+.|+|||.+.++.++.++||||||+++|||+||+ .|+.....     .++ .
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~-----~~~-~  245 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQV-L  245 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH-----HHH-H
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH-----HHH-H
Confidence            99999999986544332 2334456899999999999999999999999999999999985 56643322     122 2


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhccCCCC
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETDVPLS  600 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  600 (614)
                      ..+.++...+.         +......+.+++..||+.+|++||||+||+++|++.++..
T Consensus       246 ~~i~~~~~~~~---------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~  296 (308)
T d1p4oa_         246 RFVMEGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  296 (308)
T ss_dssp             HHHHTTCCCCC---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             HHHHhCCCCCC---------cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            33334432211         1222346888999999999999999999999999986543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=390.55  Aligned_cols=254  Identities=29%  Similarity=0.407  Sum_probs=201.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCc--EEEEEEeecC-ChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGT--EVAVKRFKNC-SKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~VAVK~l~~~-~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|+..+.||+|+||+||+|+++ +|.  .||||+++.. +....++|.+|+++++++ +|||||+++|++.     +++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~-----~~~   84 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACE-----HRG   84 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEE-----ETT
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEe-----cCC
Confidence            46888899999999999999975 344  5788988643 344556799999999999 7999999999997     567


Q ss_pred             eEEEEEeecCCCChhhhhhcC--------------CCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC
Q 043267          393 QRIIVCDLLHNGSLYDHLFGS--------------GMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD  458 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~--------------~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd  458 (614)
                      ..++||||+++|+|.++|+..              ....++|.++++++.||++||.|||   +.+|+||||||+|||++
T Consensus        85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~  161 (309)
T d1fvra_          85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVG  161 (309)
T ss_dssp             EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC
T ss_pred             eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEc
Confidence            899999999999999999753              2457999999999999999999999   88999999999999999


Q ss_pred             CCCcEEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCC-CcccccCccchhhH
Q 043267          459 EAFEAKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKK-ACEIIQGKSVLLSD  537 (614)
Q Consensus       459 ~~~~~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~-p~~~~~~~~~~l~~  537 (614)
                      .++.+||+|||+++......  ......||..|+|||.+.++.++.++|||||||++|||++|.. |+.....     .+
T Consensus       162 ~~~~~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~-----~~  234 (309)
T d1fvra_         162 ENYVAKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AE  234 (309)
T ss_dssp             GGGCEEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HH
T ss_pred             CCCceEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH-----HH
Confidence            99999999999998654322  2234568999999999999999999999999999999999765 5543221     11


Q ss_pred             HHHHHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          538 WAWELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       538 ~~~~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                       +...+.++...         ..+....+.+.+++..||+.||++||||+||++.|+..
T Consensus       235 -~~~~i~~~~~~---------~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         235 -LYEKLPQGYRL---------EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             -HHHHGGGTCCC---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHHHhcCCC---------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             11222233211         11223345677889999999999999999999998775

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-45  Score=376.74  Aligned_cols=261  Identities=25%  Similarity=0.301  Sum_probs=203.3

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      .++|...+.||+|+||+||+|+. .+|+.||||+++...   ....+.+.+|++++++++||||+++++++..... ...
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~-~~~   84 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP-AGP   84 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECS-SSE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccC-CCc
Confidence            35799999999999999999995 579999999997532   3345678999999999999999999999875432 344


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++...+  .+++.+++.|+.|+++||+|||   +.+|+||||||+|||++.++..+++|||.++
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             eEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhh
Confidence            6899999999999999886643  6999999999999999999999   8999999999999999999999999999997


Q ss_pred             eCCCCCc--cccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchh
Q 043267          473 FNPEGIT--HLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLD  550 (614)
Q Consensus       473 ~~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~  550 (614)
                      .......  .......||+.|+|||.+.++.++.++||||+||++|||++|+.||.....     .+..+...+.+....
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~-----~~~~~~~~~~~~~~~  234 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP-----VSVAYQHVREDPIPP  234 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCCCCG
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH-----HHHHHHHHhcCCCCC
Confidence            6543322  234456799999999999999999999999999999999999999964322     222334444332211


Q ss_pred             hhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-CHHHHHHHhhc
Q 043267          551 VIEENMPEMELPEMMEQYVLTAAICAHPILQARP-TMDQIVKILET  595 (614)
Q Consensus       551 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~  595 (614)
                      .       ....+..+.+.+++..|++.||++|| |++++++.|..
T Consensus       235 ~-------~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         235 S-------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             G-------GTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             c-------hhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            0       11122334677888999999999999 89999887764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-46  Score=388.32  Aligned_cols=247  Identities=22%  Similarity=0.273  Sum_probs=204.5

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+++. .+|+.||||++++.   .....+.+.+|++++++++||||+++++++.     +.+.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~~~~   79 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQ-----THDR   79 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEE-----CSSE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeec-----cccc
Confidence            5799999999999999999996 47999999999753   2234567889999999999999999999987     6678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++...+  .+++...+.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+.
T Consensus        80 ~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          80 LCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             cccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccc
Confidence            999999999999999997643  6899999999999999999999   89999999999999999999999999999986


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......      -..+.+..+..     
T Consensus       155 ~~~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~~~-----  222 (337)
T d1o6la_         155 GISDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILMEEI-----  222 (337)
T ss_dssp             SCCTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC-----
T ss_pred             cccCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcCCC-----
Confidence            54322 2334568999999999999999999999999999999999999999643321      11222222221     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                       .++.    .....+.+++..|++.||++||+     ++|+++
T Consensus       223 -~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 -RFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -CCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -CCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence             1222    23345678889999999999995     788775

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.9e-45  Score=375.35  Aligned_cols=250  Identities=25%  Similarity=0.305  Sum_probs=205.3

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCCh---------hhhHHHHHHHHHHHHcc-ccceeeeeeeeecc
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSK---------AGDANFKHEVEIIASVK-HVNLVALRGYSTAT  386 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~---------~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~  386 (614)
                      ++|+..+.||+|+||+||+++. .+|+.||||+++....         ...+.+.+|++++++++ ||||+++++++.  
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~--   80 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE--   80 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE--
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc--
Confidence            5789999999999999999996 4799999999975321         12346889999999997 999999999997  


Q ss_pred             cCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEe
Q 043267          387 VPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVG  466 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~  466 (614)
                         +++..++||||+++|+|.++|..++  .+++.+++.++.||++||+|||   +.+|+||||||+|||++.++.+||+
T Consensus        81 ---~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~  152 (277)
T d1phka_          81 ---TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT  152 (277)
T ss_dssp             ---CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             ---cCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEc
Confidence               6778999999999999999997643  6999999999999999999999   8999999999999999999999999


Q ss_pred             ecCCceeCCCCCccccccccCCCCcCchhhhcc------CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH
Q 043267          467 DFGLAKFNPEGITHLTTRVAGTLGYVAPEYALY------GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW  540 (614)
Q Consensus       467 DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~------~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~  540 (614)
                      |||+++....+.  ..+...||+.|+|||++.+      ..++.++||||+||++|||++|+.||.....      ....
T Consensus       153 DFG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~------~~~~  224 (277)
T d1phka_         153 DFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ------MLML  224 (277)
T ss_dssp             CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHH
T ss_pred             cchheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH------HHHH
Confidence            999999766533  2344679999999999863      3578899999999999999999999964331      1122


Q ss_pred             HHHHcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          541 ELVKEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       541 ~~~~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ..+..+...      .+........+.+.+++..|++.||++|||+.||++
T Consensus       225 ~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         225 RMIMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHhCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            333333221      122223344567888999999999999999999864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.5e-45  Score=383.16  Aligned_cols=244  Identities=26%  Similarity=0.362  Sum_probs=202.6

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC---ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC---SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~---~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..   .....+.+.+|++++++++||||+++++++.     +...
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ-----DAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEE-----CSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEe-----eCCe
Confidence            4689999999999999999996 47999999999742   2233567899999999999999999999987     6678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+++|+|.+++....  .+++.....++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus        79 ~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceE
Confidence            999999999999999886544  6889999999999999999999   99999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ..+.    .....||+.|||||++.+..|+.++||||+||++|||++|+.||.....     .+ ....+..+..     
T Consensus       154 ~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~-----~~-~~~~i~~~~~-----  218 (316)
T d1fota_         154 VPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT-----MK-TYEKILNAEL-----  218 (316)
T ss_dssp             CSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HH-HHHHHHHCCC-----
T ss_pred             eccc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH-----HH-HHHHHHcCCC-----
Confidence            6543    3346899999999999999999999999999999999999999964322     11 1122222211     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                       .++    +.....+.+++..|++.||.+||     |++++++
T Consensus       219 -~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         219 -RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             -CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence             111    22234577888999999999996     8999874

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-45  Score=385.84  Aligned_cols=267  Identities=21%  Similarity=0.254  Sum_probs=206.9

Q ss_pred             cCcccc-ceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHc-cccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRE-NIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASV-KHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~-~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l-~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|... ++||+|+||+||+|+. .+|+.||||+++.     ...+.+|++++.++ +|||||++++++..... .+...
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~-~~~~~   84 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYA-GRKCL   84 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET-TEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc-CCCEE
Confidence            468765 4699999999999996 5789999999975     24577899987655 89999999998753211 34678


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC---CCcEEEeecCCc
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE---AFEAKVGDFGLA  471 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~---~~~~kl~DFGla  471 (614)
                      ++||||+++|+|.++|.+.+...+++.++..|+.|++.||+|||   +.+|+||||||+|||+++   ++.+||+|||++
T Consensus        85 ~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHH---HcCCcccccccccccccccccccccccccccee
Confidence            99999999999999998766678999999999999999999999   899999999999999985   567999999999


Q ss_pred             eeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh
Q 043267          472 KFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV  551 (614)
Q Consensus       472 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~  551 (614)
                      +......  ......||+.|||||++.+..|+.++||||+||++|||++|+.||.........  +........+     
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~--~~~~~~i~~~-----  232 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS--PGMKTRIRMG-----  232 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC-----
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH--HHHHHHHhcC-----
Confidence            8765433  234567999999999999999999999999999999999999999654322110  0000000000     


Q ss_pred             hhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH--HhhccCCCCCch
Q 043267          552 IEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETDVPLSNIK  603 (614)
Q Consensus       552 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p  603 (614)
                       ...++..........+.+++..|++.||++|||+.|+++  .+.+....|..|
T Consensus       233 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~  285 (335)
T d2ozaa1         233 -QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP  285 (335)
T ss_dssp             -SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCE
T ss_pred             -CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCC
Confidence             111222222344567889999999999999999999987  354444555544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=375.31  Aligned_cols=271  Identities=23%  Similarity=0.217  Sum_probs=199.0

Q ss_pred             ccceecccCceEEEEeEcC-CCcEEEEEEeecCChh-----hhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          322 RENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKA-----GDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       322 ~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~-----~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ..++||+|+||+||+|+.. +|+.||||+++.....     ..+.+.+|++++++++|||||++++++.     .++..+
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG-----HKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC-----CTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec-----cCCcee
Confidence            3578999999999999964 6899999998643221     1346889999999999999999999987     566789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +||||++++++...+.  ....+++.++..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++...
T Consensus        77 ivmE~~~~~~~~~~~~--~~~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhhh--cccCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccC
Confidence            9999999887776653  3457999999999999999999999   8999999999999999999999999999998655


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhh---
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDV---  551 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~---  551 (614)
                      ..... .....||+.|+|||.+..+ .|+.++||||+||++|||++|+.||......+  ......+..........   
T Consensus       152 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~  228 (299)
T d1ua2a_         152 SPNRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDM  228 (299)
T ss_dssp             SCCCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSST
T ss_pred             CCccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccch
Confidence            43322 3345799999999998755 67999999999999999999999985433211  11111111100000000   


Q ss_pred             h---h----ccCCCCCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc-CCCCCchhh
Q 043267          552 I---E----ENMPEMEL----PEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD-VPLSNIKIF  605 (614)
Q Consensus       552 ~---d----~~l~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~-~~~p~~p~~  605 (614)
                      .   .    ...+....    ....+.+.+++..|++.||++|||++|+++  .|.+. .|.|..++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p  296 (299)
T d1ua2a_         229 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP  296 (299)
T ss_dssp             TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred             hccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence            0   0    00000000    122356788999999999999999999997  56554 344443333

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.1e-44  Score=383.88  Aligned_cols=248  Identities=24%  Similarity=0.289  Sum_probs=196.1

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHH---HHHHHHccccceeeeeeeeecccCCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHE---VEIIASVKHVNLVALRGYSTATVPLE  390 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~E---i~il~~l~H~niv~l~g~~~~~~~~~  390 (614)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ......+.+|   +++++.++|||||++++++.     +
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~-----~   78 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH-----T   78 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE-----C
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE-----E
Confidence            57999999999999999999965 79999999986421   1223334444   56666778999999999987     5


Q ss_pred             CceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCC
Q 043267          391 GHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGL  470 (614)
Q Consensus       391 ~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGl  470 (614)
                      .+..++||||+++|+|.++|...  ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          79 PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             CCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeece
Confidence            67899999999999999999764  36889999999999999999999   89999999999999999999999999999


Q ss_pred             ceeCCCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCch
Q 043267          471 AKFNPEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTL  549 (614)
Q Consensus       471 a~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~  549 (614)
                      ++......   .....||+.|+|||++.. ..|+.++||||+||++|||++|+.||.........      ...+.... 
T Consensus       154 a~~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~~~~~~~-  223 (364)
T d1omwa3         154 ACDFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH------EIDRMTLT-  223 (364)
T ss_dssp             CEECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH------HHHHHSSS-
T ss_pred             eeecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhccc-
Confidence            98765432   344679999999999975 46899999999999999999999999654332211      11111000 


Q ss_pred             hhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043267          550 DVIEENMPEMELPEMMEQYVLTAAICAHPILQARPT-----MDQIVK  591 (614)
Q Consensus       550 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  591 (614)
                        .....    +......+.+++..|++.||++|||     ++|+++
T Consensus       224 --~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         224 --MAVEL----PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --CCCCC----CSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CCCCC----CCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              00111    1223446778899999999999999     688863

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.2e-45  Score=383.68  Aligned_cols=244  Identities=24%  Similarity=0.290  Sum_probs=202.6

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   ....+.+.+|+++++.++|||||++++++.     ....
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~  115 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK-----DNSN  115 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccc-----cccc
Confidence            36899999999999999999964 79999999996422   233467889999999999999999999987     5678


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+.+|+|.+++...+  .+++..+..|+.||+.||.|||   +.+|+||||||+|||++.++++||+|||+++.
T Consensus       116 ~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         116 LYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             cccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            899999999999999997654  6999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ....    .....||+.|||||++.+..++.++|||||||++|||++|+.||.....     . .....+..+..     
T Consensus       191 ~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-----~-~~~~~i~~~~~-----  255 (350)
T d1rdqe_         191 VKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----I-QIYEKIVSGKV-----  255 (350)
T ss_dssp             CSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----H-HHHHHHHHCCC-----
T ss_pred             cccc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH-----H-HHHHHHhcCCC-----
Confidence            6532    2346799999999999999999999999999999999999999964321     1 11222222221     


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCC-----CCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQAR-----PTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-----Pt~~eVl~  591 (614)
                       ..+    ......+.+++..|++.||.+|     ||++|+++
T Consensus       256 -~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 -RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -CCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence             111    2233467788899999999999     48999975

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-45  Score=379.84  Aligned_cols=251  Identities=18%  Similarity=0.216  Sum_probs=203.7

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      .++|...+.||+|+||+||+|+.. +|+.||||.++... .....+.+|+++++.++|||||++++++.     +++..+
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~-----~~~~~~   77 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE-----SMEELV   77 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE-----ETTEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence            357899999999999999999965 68899999997643 34456889999999999999999999987     567899


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC--CCcEEEeecCCcee
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE--AFEAKVGDFGLAKF  473 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~--~~~~kl~DFGla~~  473 (614)
                      +||||+++|+|.++|...+ ..+++.+...|+.||++||+|||   +.+|+||||||+|||++.  ...+||+|||+++.
T Consensus        78 lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          78 MIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence            9999999999999996543 46999999999999999999999   899999999999999984  45899999999987


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhhh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVIE  553 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~d  553 (614)
                      ......  .....||+.|+|||...+..++.++||||+||++|||++|+.||......     + ....+..+...    
T Consensus       154 ~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~-~~~~i~~~~~~----  221 (321)
T d1tkia_         154 LKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----Q-IIENIMNAEYT----  221 (321)
T ss_dssp             CCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----H-HHHHHHHTCCC----
T ss_pred             cccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----H-HHHHHHhCCCC----
Confidence            654322  33456899999999999999999999999999999999999999643321     1 11222222110    


Q ss_pred             ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          554 ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       554 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                        ++..........+.+++..|++.||++|||+.|+++
T Consensus       222 --~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         222 --FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --CChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              110001122345778999999999999999999987

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-45  Score=377.64  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecCC---hhhhHHHHHHHHHHH-HccccceeeeeeeeecccCCCCc
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCS---KAGDANFKHEVEIIA-SVKHVNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~---~~~~~~f~~Ei~il~-~l~H~niv~l~g~~~~~~~~~~~  392 (614)
                      ++|...+.||+|+||+||+|+.. +|+.||||+++...   ....+.+..|..++. .++|||||++++++.     +++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~-----~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ-----TKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE-----CSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEc-----cCC
Confidence            47899999999999999999975 78999999997432   233456677777765 689999999999987     667


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+++|+|.+++....  .+++.++..++.||+.||+|||   +.+|+||||||+|||+++++++||+|||+++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             ceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhh
Confidence            8999999999999999997643  6899999999999999999999   8899999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCchhhh
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKTLDVI  552 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~~~~~  552 (614)
                      ...... ...+...||+.|+|||++.++.++.++||||+||++|||++|+.||.....      ..++..+..+..    
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~----  220 (320)
T d1xjda_         152 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE------EELFHSIRMDNP----  220 (320)
T ss_dssp             CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHCCC----
T ss_pred             hccccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH------HHHHHHHHcCCC----
Confidence            654432 234456799999999999999999999999999999999999999964332      122333333321    


Q ss_pred             hccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 043267          553 EENMPEMELPEMMEQYVLTAAICAHPILQARPTMD-QIV  590 (614)
Q Consensus       553 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl  590 (614)
                        ..+.    .....+.+++..|++.||++|||+. |++
T Consensus       221 --~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         221 --FYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             --CCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             --CCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence              1221    2234577889999999999999995 674

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=373.30  Aligned_cols=269  Identities=23%  Similarity=0.347  Sum_probs=204.0

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...  ....+.+.+|++++++++|||||++++++.     ++...
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~-----~~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEE-----ETTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccc-----cccce
Confidence            5799999999999999999996 579999999996432  233578999999999999999999999997     56789


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++||||+.+ ++.+++.......+++..+..++.|++.||+|||   +.+|+||||||+|||++.++++||+|||+++..
T Consensus        77 ~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceec
Confidence            999999964 5666665555677999999999999999999999   899999999999999999999999999999866


Q ss_pred             CCCCccccccccCCCCcCchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH-cCCchhhh
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK-EGKTLDVI  552 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~-~g~~~~~~  552 (614)
                      ..... ......||+.|+|||...... ++.++||||+||++|||++|+.||.......     ......+ .+...+..
T Consensus       153 ~~~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-----~~~~i~~~~~~~~~~~  226 (298)
T d1gz8a_         153 GVPVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-----QLFRIFRTLGTPDEVV  226 (298)
T ss_dssp             CCCSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-----HHHHHHHHHCCCCTTT
T ss_pred             cCCcc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH-----HHHHHHHhcCCCchhh
Confidence            54332 234457999999999887665 5789999999999999999999996432211     1111111 01100000


Q ss_pred             h----------ccCCC---CC----cHHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhcc-CCCCC
Q 043267          553 E----------ENMPE---ME----LPEMMEQYVLTAAICAHPILQARPTMDQIVK--ILETD-VPLSN  601 (614)
Q Consensus       553 d----------~~l~~---~~----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~-~~~p~  601 (614)
                      .          ...+.   ..    .......+.+++..|++.||++|||++|+++  .+++. .|+|.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p~  295 (298)
T d1gz8a_         227 WPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH  295 (298)
T ss_dssp             STTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCCC
T ss_pred             ccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCCC
Confidence            0          00000   00    0122346788899999999999999999987  36543 34444

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=366.35  Aligned_cols=267  Identities=22%  Similarity=0.236  Sum_probs=198.3

Q ss_pred             hcCccccceecccCceEEEEeEc-CC-CcEEEEEEeecC--ChhhhHHHHHHHHHHHHc---cccceeeeeeeeecccCC
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PN-GTEVAVKRFKNC--SKAGDANFKHEVEIIASV---KHVNLVALRGYSTATVPL  389 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~-g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l---~H~niv~l~g~~~~~~~~  389 (614)
                      .++|+..+.||+|+||+||+|+. ++ ++.||||+++..  .......+.+|+++++.+   +||||+++++++......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999996 34 667999998642  222234566788877766   799999999998654333


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecC
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFG  469 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFG  469 (614)
                      .....++++||+++|++.... ......+++.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchh
Confidence            456789999999887665443 344567999999999999999999999   8999999999999999999999999999


Q ss_pred             CceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHc-C--
Q 043267          470 LAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKE-G--  546 (614)
Q Consensus       470 la~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~-g--  546 (614)
                      +++.....  .......||+.|+|||++.+.+|+.++||||+||++|||++|+.||....... .+.. ....... +  
T Consensus       162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~-i~~~~~~~~~~  237 (305)
T d1blxa_         162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGK-ILDVIGLPGEE  237 (305)
T ss_dssp             SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHH-HHHHHCCCCGG
T ss_pred             hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH-HHHH-HHHhhCCCchh
Confidence            99864432  23455679999999999999999999999999999999999999996433211 1110 0010000 0  


Q ss_pred             ------CchhhhhccCC----CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 ------KTLDVIEENMP----EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ------~~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                            ...........    ........+.+.+++..|++.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                  00000000000    0011122345678899999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=366.23  Aligned_cols=240  Identities=22%  Similarity=0.364  Sum_probs=194.3

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCCh------hhhHHHHHHHHHHHHcc--ccceeeeeeeeeccc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSK------AGDANFKHEVEIIASVK--HVNLVALRGYSTATV  387 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~------~~~~~f~~Ei~il~~l~--H~niv~l~g~~~~~~  387 (614)
                      .++|...+.||+|+||+||+|+. .+|+.||||+++....      .....+.+|++++++++  |||||++++++.   
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~---   79 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE---   79 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE---
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEe---
Confidence            35799999999999999999996 4799999999874221      11234678999999996  899999999987   


Q ss_pred             CCCCceEEEEEeecCC-CChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-CCcEEE
Q 043267          388 PLEGHQRIIVCDLLHN-GSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-AFEAKV  465 (614)
Q Consensus       388 ~~~~~~~~lV~E~~~~-GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-~~~~kl  465 (614)
                        +.+..++||||+.+ +++.+++...  ..+++.++..++.|+++||+|||   +.+|+||||||+|||++. ++.+||
T Consensus        80 --~~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          80 --RPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             --CSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEE
T ss_pred             --eCCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEE
Confidence              56788999999976 5777777653  36999999999999999999999   899999999999999985 579999


Q ss_pred             eecCCceeCCCCCccccccccCCCCcCchhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHH
Q 043267          466 GDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKL-TPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVK  544 (614)
Q Consensus       466 ~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~  544 (614)
                      +|||+++.....   ..+...||+.|+|||++.+.++ +.++||||+||++|||++|+.||....           + +.
T Consensus       153 ~DFG~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----------~-i~  217 (273)
T d1xwsa_         153 IDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----------E-II  217 (273)
T ss_dssp             CCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------H-HH
T ss_pred             Cccccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----------H-Hh
Confidence            999999875443   2345679999999999988776 567899999999999999999995321           1 11


Q ss_pred             cCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .+..      .++.    .....+.+++..|++.||++|||++|+++
T Consensus       218 ~~~~------~~~~----~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         218 RGQV------FFRQ----RVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HCCC------CCSS----CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hccc------CCCC----CCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            1111      1111    12345778889999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.3e-44  Score=367.22  Aligned_cols=261  Identities=23%  Similarity=0.278  Sum_probs=197.0

Q ss_pred             cCccccceecccCceEEEEeEcCCCcEEEEEEeecCC--hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCS--KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~--~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|...+.||+|+||+||+|+.++|+.||||+++...  ....+.+.+|++++++++||||+++++++.     ..+..+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~~   76 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIH-----TKKRLV   76 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEE-----CSSCEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecc-----cCCcee
Confidence            5789999999999999999999999999999996533  333578999999999999999999999987     567789


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeCC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFNP  475 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~~  475 (614)
                      +++||+.++.+..+...  ...+++..+..|+.|+++||+|||   +.+|+||||||+|||++.++.+|++|||++....
T Consensus        77 i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~  151 (286)
T d1ob3a_          77 LVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFG  151 (286)
T ss_dssp             EEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHC
T ss_pred             EEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecc
Confidence            99999987776666533  357999999999999999999999   8899999999999999999999999999998654


Q ss_pred             CCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC------c
Q 043267          476 EGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK------T  548 (614)
Q Consensus       476 ~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~------~  548 (614)
                      .... ......|++.|+|||.+... .++.++||||+||++|||++|+.||......+. +.. .........      .
T Consensus       152 ~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~-~~~-i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         152 IPVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ-LMR-IFRILGTPNSKNWPNV  228 (286)
T ss_dssp             C----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHH-HHHHHCCCCTTTSTTG
T ss_pred             cCcc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH-HHH-HHHhhCCCChhhccch
Confidence            3322 23334689999999998754 579999999999999999999999964332111 100 011000000      0


Q ss_pred             hhh--hhccCC-------CCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          549 LDV--IEENMP-------EMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       549 ~~~--~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .+.  .+....       ..........+.+++..|++.||++|||++|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000  000000       0011123346788999999999999999999973

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-43  Score=358.50  Aligned_cols=260  Identities=22%  Similarity=0.278  Sum_probs=197.0

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceEEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQRII  396 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~~l  396 (614)
                      ++|+..+.||+|+||.||+|+. .+|+.||||++.....  ..++..|+++++.++|+|++..++.+..    ++...++
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~----~~~~~~i   80 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVM   80 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE----ETTEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe----cCCEEEE
Confidence            4699999999999999999996 4789999999875432  3457889999999998887777666543    5677899


Q ss_pred             EEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEEC---CCCcEEEeecCCcee
Q 043267          397 VCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLD---EAFEAKVGDFGLAKF  473 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd---~~~~~kl~DFGla~~  473 (614)
                      ||||+ +|+|.+.+... ...+++..++.++.|++.||+|||   +.+|+||||||+|||++   .+..+||+|||+++.
T Consensus        81 vme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          81 VMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            99999 56676665443 357999999999999999999999   89999999999999986   456799999999987


Q ss_pred             CCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          474 NPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       474 ~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      ..+....      ......||+.|||||.+.+..++.++|||||||++|||++|+.||..............+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            6543321      2345679999999999999999999999999999999999999996544322211100000000000


Q ss_pred             chhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          548 TLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       548 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ..+.    +..    .....+.+++..|++.+|++||+++++.++|+..
T Consensus       236 ~~~~----~~~----~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         236 PIEV----LCK----GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             CHHH----HTT----TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             ChhH----hcc----CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            0011    111    1224567788889999999999999998888753

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.3e-42  Score=351.00  Aligned_cols=260  Identities=22%  Similarity=0.305  Sum_probs=201.8

Q ss_pred             hcCccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccc-cceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKH-VNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H-~niv~l~g~~~~~~~~~~~~~  394 (614)
                      .++|...+.||+|+||+||+|+.. +|+.||||.+.....  ...+.+|++.++.++| +|++.++++..     ++...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~   76 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHN   76 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCcc
Confidence            357999999999999999999964 789999998865332  3457789999999965 89999998876     56778


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECC-----CCcEEEeecC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDE-----AFEAKVGDFG  469 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~-----~~~~kl~DFG  469 (614)
                      ++||||+ +|+|.+++...+ ..+++.++..|+.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||
T Consensus        77 ~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          77 VLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             EEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccc
Confidence            9999998 689999886543 57999999999999999999999   999999999999999974     5789999999


Q ss_pred             CceeCCCCCcc------ccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHH
Q 043267          470 LAKFNPEGITH------LTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELV  543 (614)
Q Consensus       470 la~~~~~~~~~------~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~  543 (614)
                      +++...+....      ......||+.|||||.+.+..++.++|||||||++|||++|+.||.........  . ....+
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~--~-~~~~i  228 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNK--Q-KYERI  228 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHH--H-HHHHH
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHH--H-HHHHH
Confidence            99876543221      234467999999999999999999999999999999999999999644332211  1 11111


Q ss_pred             HcCCchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHHHhhcc
Q 043267          544 KEGKTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVKILETD  596 (614)
Q Consensus       544 ~~g~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  596 (614)
                      ...+....... +...    ..+.+.+++..|++.+|++||+++.+.+.|++.
T Consensus       229 ~~~~~~~~~~~-l~~~----~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         229 GEKKQSTPLRE-LCAG----FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             HHHHHHSCHHH-HTTT----SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             HhccCCCChHH-hcCC----CCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11111000111 1111    123566777889999999999999998888764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-42  Score=358.65  Aligned_cols=267  Identities=23%  Similarity=0.294  Sum_probs=196.8

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecCC-hhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCS-KAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~-~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      +.+|...+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++|||++++++++..... .....
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~-~~~~~   85 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI-EQMKD   85 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST-TTCCC
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccc-cccce
Confidence            35789999999999999999985 589999999997543 3445678999999999999999999999865432 22334


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      +++++|+.+|+|.+++...   .+++..+..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++..
T Consensus        86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            5555677799999999653   5999999999999999999999   899999999999999999999999999999865


Q ss_pred             CCCCc--cccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCCc---
Q 043267          475 PEGIT--HLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGKT---  548 (614)
Q Consensus       475 ~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~~---  548 (614)
                      .....  .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||........  .............   
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILGSPSQEDL  237 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH--HHHHhhhccCCChhhh
Confidence            44322  22355679999999999854 5678999999999999999999999954332110  0000000000000   


Q ss_pred             -----hh--hhhccCCCCC-------cHHHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043267          549 -----LD--VIEENMPEME-------LPEMMEQYVLTAAICAHPILQARPTMDQIVKI  592 (614)
Q Consensus       549 -----~~--~~d~~l~~~~-------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  592 (614)
                           ..  ......+...       .+....++.+++..|++.||++|||+.|+++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 00  0000011000       01122467889999999999999999999963

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-42  Score=361.94  Aligned_cols=262  Identities=26%  Similarity=0.275  Sum_probs=193.1

Q ss_pred             CccccceecccCceEEEEeEcC-CCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeeeeecccC-CCCceEEE
Q 043267          319 NFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP-LEGHQRII  396 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~-~~~~~~~l  396 (614)
                      +|...++||+|+||+||+|+.. +|+.||||+++....    ...+|++++++++|+||+++++++..... .+....++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5788899999999999999975 699999999976432    23479999999999999999999864322 13445789


Q ss_pred             EEeecCCCChhhhhhc-CCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCCceeC
Q 043267          397 VCDLLHNGSLYDHLFG-SGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFN  474 (614)
Q Consensus       397 V~E~~~~GsL~~~L~~-~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGla~~~  474 (614)
                      ||||+++|.+...... .....+++.++..|+.|+++||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999986644433321 34457999999999999999999999   89999999999999999765 8999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH-------HHHHcC
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALY-GKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW-------ELVKEG  546 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~-~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~-------~~~~~g  546 (614)
                      .....  .....||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +.....       +.+...
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~-l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ-LVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH-HHHHHHHHCCCCHHHHHHH
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH-HHHHHHHhCCChHHhhhhh
Confidence            54332  234579999999998875 4789999999999999999999999954332111 111000       000000


Q ss_pred             CchhhhhccCCC--------CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          547 KTLDVIEENMPE--------MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      . ....+..++.        .........+.+++..|++.||++|||+.|+++
T Consensus       251 ~-~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         251 N-PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C-C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c-cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 0000001110        011223446788899999999999999999985

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-41  Score=351.75  Aligned_cols=265  Identities=21%  Similarity=0.211  Sum_probs=194.2

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccC---CCC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVP---LEG  391 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~---~~~  391 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||++...  .......+.+|++++++++|||++++++++.....   ..+
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            5789999999999999999996 57999999998542  33345678999999999999999999998764321   123


Q ss_pred             ceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCc
Q 043267          392 HQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLA  471 (614)
Q Consensus       392 ~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla  471 (614)
                      ...++||||++++.+....  .....++......|+.|+++||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~--~~~~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT--CTTCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhh--hcccccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeeccee
Confidence            5679999999887766544  33457899999999999999999999   899999999999999999999999999999


Q ss_pred             eeCCCCCcc---ccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC
Q 043267          472 KFNPEGITH---LTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK  547 (614)
Q Consensus       472 ~~~~~~~~~---~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~  547 (614)
                      +........   ......||+.|+|||.+.+. .++.++||||+||++|||++|+.||.......  ......+..  +.
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~--~~~~i~~~~--~~  240 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH--QLALISQLC--GS  240 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHH--CC
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH--HHHHHHHhc--CC
Confidence            866543221   22335799999999998865 68999999999999999999999996432211  111111111  11


Q ss_pred             chhhhhccC-------------C-CCCcHH------HHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          548 TLDVIEENM-------------P-EMELPE------MMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       548 ~~~~~d~~l-------------~-~~~~~~------~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .........             . .....+      ....+.+++..|++.||++|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            110000000             0 000111      1234567899999999999999999985

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-42  Score=357.96  Aligned_cols=252  Identities=24%  Similarity=0.266  Sum_probs=200.3

Q ss_pred             cCccccceecccCceEEEEeEc----CCCcEEEEEEeecC----ChhhhHHHHHHHHHHHHccc-cceeeeeeeeecccC
Q 043267          318 MNFSRENIIGKGGYGNVYKGML----PNGTEVAVKRFKNC----SKAGDANFKHEVEIIASVKH-VNLVALRGYSTATVP  388 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~VAVK~l~~~----~~~~~~~f~~Ei~il~~l~H-~niv~l~g~~~~~~~  388 (614)
                      ++|+..+.||+|+||+||+|+.    .+|+.||||.++..    +....+.+.+|++++++++| |||+++++++.    
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~----   99 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ----   99 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE----
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec----
Confidence            4699999999999999999984    25889999998642    22334568899999999977 79999999887    


Q ss_pred             CCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeec
Q 043267          389 LEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDF  468 (614)
Q Consensus       389 ~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DF  468 (614)
                       +....+++|||+.+|+|.+++...+  .++......++.|++.||+|||   +.+|+||||||+|||++.++.+||+||
T Consensus       100 -~~~~~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DF  173 (322)
T d1vzoa_         100 -TETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDF  173 (322)
T ss_dssp             -ETTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCS
T ss_pred             -cCCceeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeec
Confidence             5568899999999999999997654  5678889999999999999999   899999999999999999999999999


Q ss_pred             CCceeCCCCCccccccccCCCCcCchhhhccC--CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcC
Q 043267          469 GLAKFNPEGITHLTTRVAGTLGYVAPEYALYG--KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEG  546 (614)
Q Consensus       469 Gla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~--~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g  546 (614)
                      |+++..............|++.|+|||.+.+.  .++.++||||+||++|||++|+.||.........  .........+
T Consensus       174 G~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~~~~~~  251 (322)
T d1vzoa_         174 GLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS  251 (322)
T ss_dssp             SEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC
T ss_pred             cchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcccC
Confidence            99987665544445556799999999999765  4788999999999999999999999654432221  1111111111


Q ss_pred             CchhhhhccCCCCCcHHHHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043267          547 KTLDVIEENMPEMELPEMMEQYVLTAAICAHPILQARP-----TMDQIVK  591 (614)
Q Consensus       547 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  591 (614)
                      .      ..+    +......+.+++..|++.||++||     |++|+++
T Consensus       252 ~------~~~----~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 E------PPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             C------CCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             C------CCC----cccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1      111    223445677888999999999999     5888875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-41  Score=347.87  Aligned_cols=262  Identities=19%  Similarity=0.209  Sum_probs=201.4

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCceE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQR  394 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~~  394 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++..  .......+.+|+++++.++||||+++++++.     +....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-----~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH-----SDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccc-----cccce
Confidence            4789999999999999999996 47899999999643  2344578899999999999999999999997     56788


Q ss_pred             EEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCceeC
Q 043267          395 IIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKFN  474 (614)
Q Consensus       395 ~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~~  474 (614)
                      ++|+|++.+++|..++...  ..+++..+..++.|+++||+|||   +.+|+||||||+|||++.++++||+|||.++..
T Consensus        77 ~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcc
Confidence            9999999999988877543  47899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHHHHcCC---c--
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYGK-LTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWELVKEGK---T--  548 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~~-~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~~~~g~---~--  548 (614)
                      ..... ......++..|+|||.+.... ++.++||||+||++|||++|+.|+....+....+. -+........   .  
T Consensus       152 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         152 GIPVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH-HHHHHHCCCCTTTCTT
T ss_pred             cCCCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHH-HHHhhcCCCChhhhhh
Confidence            54332 233345788999999988665 68999999999999999999999743332111111 1111111000   0  


Q ss_pred             -hhhhhc---------cCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          549 -LDVIEE---------NMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       549 -~~~~d~---------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                       ....+.         .-...........+.+++..|++.||.+|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             000000         0001111233456778899999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-41  Score=353.47  Aligned_cols=263  Identities=23%  Similarity=0.276  Sum_probs=192.5

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCc
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGH  392 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~  392 (614)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++..  +....+.+.+|+++++.++|||+|++++++...... ...
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            35799999999999999999996 47999999999743  334456788999999999999999999998754322 234


Q ss_pred             eEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          393 QRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       393 ~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ..++||||+ +.+|.+.+..   ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            579999999 5567766643   35999999999999999999999   8999999999999999999999999999998


Q ss_pred             eCCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHH-------HHHH
Q 043267          473 FNPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAW-------ELVK  544 (614)
Q Consensus       473 ~~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~-------~~~~  544 (614)
                      .....    .+...||+.|+|||.+.+. .++.++||||+||++|||++|+.||....... .+.....       +.+.
T Consensus       170 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         170 QADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             ECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             ccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHH-HHHHHHhccCCCcHHHHh
Confidence            76543    3446799999999998764 57899999999999999999999995432211 1100000       0000


Q ss_pred             cCCch--hhhhccCC---CC----CcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          545 EGKTL--DVIEENMP---EM----ELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       545 ~g~~~--~~~d~~l~---~~----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      .....  ......++   ..    ........+.+++..|++.||++|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000  00000010   00    01122345678899999999999999999986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.2e-41  Score=351.62  Aligned_cols=258  Identities=17%  Similarity=0.216  Sum_probs=198.0

Q ss_pred             cCccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCCCCceEE
Q 043267          318 MNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPLEGHQRI  395 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~~~~~~~  395 (614)
                      ++|+..+.||+|+||+||+|+. .+|+.||||+++...   .+++.+|++++++++ ||||+++++++...   .....+
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~---~~~~~~  108 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDP---VSRTPA  108 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECT---TTCSEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEec---CCCcee
Confidence            4799999999999999999996 478999999997533   456889999999995 99999999988642   345689


Q ss_pred             EEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCC-cEEEeecCCceeC
Q 043267          396 IVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAF-EAKVGDFGLAKFN  474 (614)
Q Consensus       396 lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~-~~kl~DFGla~~~  474 (614)
                      +||||+++|+|.+..     +.+++..+..++.||++||+|||   +.+|+||||||+|||++.++ .+||+|||+++..
T Consensus       109 ~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceec
Confidence            999999999997764     36999999999999999999999   89999999999999998654 6999999999876


Q ss_pred             CCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhh--------HHHHHHHHc
Q 043267          475 PEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLS--------DWAWELVKE  545 (614)
Q Consensus       475 ~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~--------~~~~~~~~~  545 (614)
                      ....  ......||+.|+|||.+.+. .++.++||||+|++++||++|+.||...........        ...+.....
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            5433  23445789999999998865 579999999999999999999999954432111000        011111111


Q ss_pred             CCc--hhhhh------------ccCCCCCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          546 GKT--LDVIE------------ENMPEMELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       546 g~~--~~~~d------------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...  .....            ..............+.+++..|++.||++|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            100  00000            01111112233456788999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=348.95  Aligned_cols=267  Identities=25%  Similarity=0.295  Sum_probs=198.8

Q ss_pred             hcCccccceecccCceEEEEeEc-CCCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCCCCce
Q 043267          317 TMNFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPLEGHQ  393 (614)
Q Consensus       317 t~~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~~~~~  393 (614)
                      .++|+..+.||+|+||+||+|+. .+|+.||||+++..  +....+.+.+|++++++++|||+|++++++......+...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            45799999999999999999995 57999999999753  3344567889999999999999999999987554445556


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .+++++|+.+|+|.+++..   +.+++..+..|+.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcc
Confidence            6777888899999999854   35999999999999999999999   89999999999999999999999999999975


Q ss_pred             CCCCCccccccccCCCCcCchhhhccC-CCCchhhHHHHHHHHHHHHhCCCCcccccCccchhhHHHHHH--------HH
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYG-KLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVLLSDWAWEL--------VK  544 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~-~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~l~~~~~~~--------~~  544 (614)
                      ...    ......||+.|+|||...+. .++.++||||+||++|||++|+.||.......  ........        ..
T Consensus       171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~--~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCHHHHT
T ss_pred             cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCChHHhh
Confidence            432    23446789999999987765 46899999999999999999999995432111  00000000        00


Q ss_pred             cCCch--hhhhccC---CCCCc----HHHHHHHHHHHHHccccCCCCCCCHHHHHH--Hhhc
Q 043267          545 EGKTL--DVIEENM---PEMEL----PEMMEQYVLTAAICAHPILQARPTMDQIVK--ILET  595 (614)
Q Consensus       545 ~g~~~--~~~d~~l---~~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~  595 (614)
                      .....  ......+   +....    ......+.+++..|++.||++|||++|+++  .+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence            00000  0000000   00000    112345778999999999999999999986  4544

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-40  Score=347.57  Aligned_cols=264  Identities=21%  Similarity=0.201  Sum_probs=190.7

Q ss_pred             cCccccceecccCceEEEEeEcC-CCcEEEEEEeecC--ChhhhHHHHHHHHHHHHccccceeeeeeeeecccCC-CCce
Q 043267          318 MNFSRENIIGKGGYGNVYKGMLP-NGTEVAVKRFKNC--SKAGDANFKHEVEIIASVKHVNLVALRGYSTATVPL-EGHQ  393 (614)
Q Consensus       318 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~VAVK~l~~~--~~~~~~~f~~Ei~il~~l~H~niv~l~g~~~~~~~~-~~~~  393 (614)
                      ++|+..++||+|+||+||+|+.. +|+.||||++...  +......+.+|++++++++||||+++++++...... ....
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57899999999999999999965 7999999999753  334455788999999999999999999998654332 3468


Q ss_pred             EEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          394 RIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       394 ~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      .++||||+.++ +.+.+.    ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhhc
Confidence            89999999765 444442    35899999999999999999999   89999999999999999999999999999886


Q ss_pred             CCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccch-----------------hh
Q 043267          474 NPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSVL-----------------LS  536 (614)
Q Consensus       474 ~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~~-----------------l~  536 (614)
                      ....  ...+...||+.|+|||.+.+..+++++||||+||+++||++|+.||.........                 ..
T Consensus       169 ~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             cccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            5443  2334567899999999999999999999999999999999999999533211000                 00


Q ss_pred             HHHHHHHHcCC------chhhhhccCCC---CCcHHHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043267          537 DWAWELVKEGK------TLDVIEENMPE---MELPEMMEQYVLTAAICAHPILQARPTMDQIVK  591 (614)
Q Consensus       537 ~~~~~~~~~g~------~~~~~d~~l~~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  591 (614)
                      ...........      ...........   .........+.+++..|++.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00011111100      00011111110   012234567889999999999999999999984

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.2e-36  Score=320.23  Aligned_cols=263  Identities=20%  Similarity=0.199  Sum_probs=191.3

Q ss_pred             CccccceecccCceEEEEeEc-CCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-----------ccceeeeeeeeecc
Q 043267          319 NFSRENIIGKGGYGNVYKGML-PNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-----------HVNLVALRGYSTAT  386 (614)
Q Consensus       319 ~f~~~~~LG~G~fG~Vykg~~-~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-----------H~niv~l~g~~~~~  386 (614)
                      +|...++||+|+||+||+|+. .+|+.||||+++... ...+.+.+|++++++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            488999999999999999996 579999999997633 33457788999998885           57789898887543


Q ss_pred             cCCCCceEEEEEeecCCCCh-hhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc---
Q 043267          387 VPLEGHQRIIVCDLLHNGSL-YDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE---  462 (614)
Q Consensus       387 ~~~~~~~~~lV~E~~~~GsL-~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~---  462 (614)
                         .....+++++++..+.. ...........+++..+..++.|+++||+|||+  ..+|+||||||+|||++.++.   
T Consensus        93 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          93 ---GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             ---ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTT
T ss_pred             ---cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccc
Confidence               23455666666655443 333444556778999999999999999999993  389999999999999986653   


Q ss_pred             ---EEEeecCCceeCCCCCccccccccCCCCcCchhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccccCccc--h---
Q 043267          463 ---AKVGDFGLAKFNPEGITHLTTRVAGTLGYVAPEYALYGKLTPGSDVYSFGVVLLELLSGKKACEIIQGKSV--L---  534 (614)
Q Consensus       463 ---~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~t~ksDVwS~Gvll~ElltG~~p~~~~~~~~~--~---  534 (614)
                         +|++|||.+......    .....||+.|+|||.+....++.++||||+||+++||++|+.||........  .   
T Consensus       168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               999999999865432    2446799999999999999999999999999999999999999954332111  0   


Q ss_pred             hhHHHH-------HHHHcCCc-hhhhhc-----cC--------------CCCCcHHHHHHHHHHHHHccccCCCCCCCHH
Q 043267          535 LSDWAW-------ELVKEGKT-LDVIEE-----NM--------------PEMELPEMMEQYVLTAAICAHPILQARPTMD  587 (614)
Q Consensus       535 l~~~~~-------~~~~~g~~-~~~~d~-----~l--------------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  587 (614)
                      +....+       ..+..+.. ....+.     .+              ...........+.+++..|++.||++|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            111110       01111110 000000     00              1112345677889999999999999999999


Q ss_pred             HHHH
Q 043267          588 QIVK  591 (614)
Q Consensus       588 eVl~  591 (614)
                      |+++
T Consensus       324 e~L~  327 (362)
T d1q8ya_         324 GLVN  327 (362)
T ss_dssp             HHHT
T ss_pred             HHhc
Confidence            9986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=2.6e-23  Score=198.60  Aligned_cols=164  Identities=15%  Similarity=0.147  Sum_probs=121.7

Q ss_pred             cccceecccCceEEEEeEcCCCcEEEEEEeecCCh------------------hhhHHHHHHHHHHHHccccceeeeeee
Q 043267          321 SRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSK------------------AGDANFKHEVEIIASVKHVNLVALRGY  382 (614)
Q Consensus       321 ~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~------------------~~~~~f~~Ei~il~~l~H~niv~l~g~  382 (614)
                      ...+.||+|+||+||+|+..+|++||||.++....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999988999999998652100                  112334568888999999999887765


Q ss_pred             eecccCCCCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhcCCCceEEeccCCCCeEECCCCc
Q 043267          383 STATVPLEGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYGVQPAIIHRDIKASNILLDEAFE  462 (614)
Q Consensus       383 ~~~~~~~~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~~~~~iiHrDIKp~NILLd~~~~  462 (614)
                      ..         .+++|||++++.+.         .++.....+++.|++++|.|||   +.+|+||||||+|||++++ .
T Consensus        83 ~~---------~~lvme~~~~~~~~---------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~  140 (191)
T d1zara2          83 EG---------NAVLMELIDAKELY---------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-G  140 (191)
T ss_dssp             ET---------TEEEEECCCCEEGG---------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-E
T ss_pred             cC---------CEEEEEeecccccc---------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-C
Confidence            32         37999999876543         2455666789999999999999   8999999999999999965 5


Q ss_pred             EEEeecCCceeCCCCCccccccccCCCCcCc------hhhhccCCCCchhhHHHHHHHHH
Q 043267          463 AKVGDFGLAKFNPEGITHLTTRVAGTLGYVA------PEYALYGKLTPGSDVYSFGVVLL  516 (614)
Q Consensus       463 ~kl~DFGla~~~~~~~~~~~~~~~gt~~Y~A------PE~~~~~~~t~ksDVwS~Gvll~  516 (614)
                      ++|+|||+|..........         |..      .|. ..++|..++|+||..--++
T Consensus       141 ~~liDFG~a~~~~~~~~~~---------~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         141 IWIIDFPQSVEVGEEGWRE---------ILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             EEECCCTTCEETTSTTHHH---------HHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             EEEEECCCcccCCCCCcHH---------HHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            8999999998654322110         111      111 2357788999999765443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.43  E-value=6.3e-07  Score=86.93  Aligned_cols=150  Identities=12%  Similarity=0.048  Sum_probs=98.8

Q ss_pred             HHHHHHhcCccccceecccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcc-ccceeeeeeeeecccCC
Q 043267          311 EEIKAATMNFSRENIIGKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVK-HVNLVALRGYSTATVPL  389 (614)
Q Consensus       311 ~el~~~t~~f~~~~~LG~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~-H~niv~l~g~~~~~~~~  389 (614)
                      +++++.-.+|...+..+.++-+.||+... +++.++||+...........+.+|...+..+. +--+.+++.+..     
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~-----   80 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER-----   80 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE-----
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe-----
Confidence            35666666777665544444578999875 56667889887554444556778888888774 333455565554     


Q ss_pred             CCceEEEEEeecCCCChhhhhhcCCCcCCChHHHHHHHHHHHHHHHHHhhc-----------------------------
Q 043267          390 EGHQRIIVCDLLHNGSLYDHLFGSGMKKLSWPIRLRIALGTARGLAYLHYG-----------------------------  440 (614)
Q Consensus       390 ~~~~~~lV~E~~~~GsL~~~L~~~~~~~l~~~~~~~I~~~ia~gL~yLH~~-----------------------------  440 (614)
                      .++..++||+++++.++.+....       .....+++.++++.+..||..                             
T Consensus        81 ~~~~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (263)
T d1j7la_          81 HDGWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV  153 (263)
T ss_dssp             ETTEEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred             cCCceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence            34677999999999887654321       111233445555555555521                             


Q ss_pred             ---------------------------CCCceEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          441 ---------------------------VQPAIIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       441 ---------------------------~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                                                 ....++|+|+.|.|||++++...-|.||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                       123489999999999999877677999998763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.81  E-value=4.2e-05  Score=73.21  Aligned_cols=140  Identities=16%  Similarity=0.092  Sum_probs=82.4

Q ss_pred             eecccCc-eEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccc--eeeeeeeeecccCCCCceEEEEEeec
Q 043267          325 IIGKGGY-GNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVN--LVALRGYSTATVPLEGHQRIIVCDLL  401 (614)
Q Consensus       325 ~LG~G~f-G~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~n--iv~l~g~~~~~~~~~~~~~~lV~E~~  401 (614)
                      .+..|.. +.||+...++|..+++|......   ...+..|.+.++.+....  +.+++++..     +++..++||+++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i   88 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEV   88 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECC
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEee
Confidence            3455554 67999998888889999765432   234677888888774433  444565554     445679999999


Q ss_pred             CCCChhhhh-----------------hcC--CCcCCCh--HHHHHHH--------------------HHHHHHHHHHhh-
Q 043267          402 HNGSLYDHL-----------------FGS--GMKKLSW--PIRLRIA--------------------LGTARGLAYLHY-  439 (614)
Q Consensus       402 ~~GsL~~~L-----------------~~~--~~~~l~~--~~~~~I~--------------------~~ia~gL~yLH~-  439 (614)
                      ++.++.+.-                 +..  ....+.+  .....-.                    ......+..+.. 
T Consensus        89 ~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  168 (255)
T d1nd4a_          89 PGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKAR  168 (255)
T ss_dssp             SSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHT
T ss_pred             eccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHh
Confidence            886654311                 000  0000100  0000000                    001111222221 


Q ss_pred             ---cCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          440 ---GVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       440 ---~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                         .....++|+|+.|.|||++++..+-|.||+.+.
T Consensus       169 ~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         169 MPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             CCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence               113458999999999999988767899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.31  E-value=0.00049  Score=70.58  Aligned_cols=76  Identities=13%  Similarity=0.059  Sum_probs=47.7

Q ss_pred             ceecccCceEEEEeEcCC-CcEEEEEEeecC------C-hhhhHHHHHHHHHHHHcc-c--cceeeeeeeeecccCCCCc
Q 043267          324 NIIGKGGYGNVYKGMLPN-GTEVAVKRFKNC------S-KAGDANFKHEVEIIASVK-H--VNLVALRGYSTATVPLEGH  392 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~-g~~VAVK~l~~~------~-~~~~~~f~~Ei~il~~l~-H--~niv~l~g~~~~~~~~~~~  392 (614)
                      +.||.|....||+....+ |+.|+||.-...      + ....+....|.+.++.+. +  ..+.+++.+.       ..
T Consensus        32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d-------~~  104 (392)
T d2pula1          32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD-------TE  104 (392)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE-------TT
T ss_pred             EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc-------CC
Confidence            468999999999998764 678999975321      0 112234456888887663 2  3455555543       23


Q ss_pred             eEEEEEeecCCCCh
Q 043267          393 QRIIVCDLLHNGSL  406 (614)
Q Consensus       393 ~~~lV~E~~~~GsL  406 (614)
                      ..++|||++++..+
T Consensus       105 ~~~lvmE~L~~~~~  118 (392)
T d2pula1         105 MAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTEEEECCCTTSEE
T ss_pred             CCEEEEeccCCccc
Confidence            45899999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.95  E-value=0.0022  Score=63.63  Aligned_cols=140  Identities=13%  Similarity=0.069  Sum_probs=80.3

Q ss_pred             ceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHcccccee--eeeeeeecccCCCCceEEEEEeecCCCChhh
Q 043267          331 YGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV--ALRGYSTATVPLEGHQRIIVCDLLHNGSLYD  408 (614)
Q Consensus       331 fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv--~l~g~~~~~~~~~~~~~~lV~E~~~~GsL~~  408 (614)
                      --.||+.+.++|+.+++|..... ....+++..|...+..|...++.  ..+..........+...+.++++++|..+..
T Consensus        35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~  113 (325)
T d1zyla1          35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA  113 (325)
T ss_dssp             SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred             cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence            35899999999999999987642 33456788899999888544332  1221111111113456788999987644321


Q ss_pred             ----h----------hhc-------CCCcCCChH-------------------HHHHHHHHHHHHHHHHh----hcCCCc
Q 043267          409 ----H----------LFG-------SGMKKLSWP-------------------IRLRIALGTARGLAYLH----YGVQPA  444 (614)
Q Consensus       409 ----~----------L~~-------~~~~~l~~~-------------------~~~~I~~~ia~gL~yLH----~~~~~~  444 (614)
                          .          ++.       ..+..+++.                   .+..+...+.+.++.+.    .....+
T Consensus       114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~  193 (325)
T d1zyla1         114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL  193 (325)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred             CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence                0          110       011112211                   11112222222333332    223467


Q ss_pred             eEEeccCCCCeEECCCCcEEEeecCCcee
Q 043267          445 IIHRDIKASNILLDEAFEAKVGDFGLAKF  473 (614)
Q Consensus       445 iiHrDIKp~NILLd~~~~~kl~DFGla~~  473 (614)
                      +||+|+.+.|||++++  ..+.||+-+..
T Consensus       194 liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         194 RLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eecCCCCcccEEEeCC--ceEEechhccc
Confidence            9999999999999854  45889998864

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.11  E-value=0.0066  Score=61.73  Aligned_cols=73  Identities=15%  Similarity=0.140  Sum_probs=48.3

Q ss_pred             ceecccCceEEEEeEcCCC--------cEEEEEEeecCChhhhHHHHHHHHHHHHcccccee-eeeeeeecccCCCCceE
Q 043267          324 NIIGKGGYGNVYKGMLPNG--------TEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLV-ALRGYSTATVPLEGHQR  394 (614)
Q Consensus       324 ~~LG~G~fG~Vykg~~~~g--------~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv-~l~g~~~~~~~~~~~~~  394 (614)
                      +.|+.|-.-.+|+...+++        ..|.+++.-. .. ......+|..+++.+.-.++. ++++++.         -
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~---------~  116 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PE-TESHLVAESVIFTLLSERHLGPKLYGIFS---------G  116 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CC-CHHHHHHHHHHHHHHHHTTSSSCEEEEET---------T
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cc-hhhHHHHHHHHHHHHHhCCCCCeEEEEcC---------C
Confidence            5688888899999986543        4566665542 22 234566899999988544444 6677653         1


Q ss_pred             EEEEeecCCCChh
Q 043267          395 IIVCDLLHNGSLY  407 (614)
Q Consensus       395 ~lV~E~~~~GsL~  407 (614)
                      .+|+||+++.+|.
T Consensus       117 g~I~efi~g~~l~  129 (395)
T d1nw1a_         117 GRLEEYIPSRPLS  129 (395)
T ss_dssp             EEEECCCCEEECC
T ss_pred             ceEEEEeccccCC
Confidence            6889999875543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.03  E-value=0.027  Score=54.81  Aligned_cols=162  Identities=9%  Similarity=-0.003  Sum_probs=86.0

Q ss_pred             cCHHHHHHHhcCcccccee-----cccCceEEEEeEcCCCcEEEEEEeecCChhhhHHHHHHHHHHHHccccceeeeeee
Q 043267          308 FKIEEIKAATMNFSRENII-----GKGGYGNVYKGMLPNGTEVAVKRFKNCSKAGDANFKHEVEIIASVKHVNLVALRGY  382 (614)
Q Consensus       308 f~~~el~~~t~~f~~~~~L-----G~G~fG~Vykg~~~~g~~VAVK~l~~~~~~~~~~f~~Ei~il~~l~H~niv~l~g~  382 (614)
                      .+.+|++....+|...++.     ..|---+.|+.+.++|+ +++|+.....  ..+++..|++++..+.+.++.--.-.
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            4557788888888775543     35555778999886654 8899886432  23455667788888754433211100


Q ss_pred             eeccc---CCCCceEEEEEeecCCCChhhh--------------hhc---C---C--Cc-----------------CCCh
Q 043267          383 STATV---PLEGHQRIIVCDLLHNGSLYDH--------------LFG---S---G--MK-----------------KLSW  420 (614)
Q Consensus       383 ~~~~~---~~~~~~~~lV~E~~~~GsL~~~--------------L~~---~---~--~~-----------------~l~~  420 (614)
                      -....   .........++.+..+......              ++.   .   .  ..                 ....
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            00000   0012345566666665433210              000   0   0  00                 0011


Q ss_pred             HHHHHHHHHHHHHHHHHh-hcCCCceEEeccCCCCeEECCCCcEEEeecCCce
Q 043267          421 PIRLRIALGTARGLAYLH-YGVQPAIIHRDIKASNILLDEAFEAKVGDFGLAK  472 (614)
Q Consensus       421 ~~~~~I~~~ia~gL~yLH-~~~~~~iiHrDIKp~NILLd~~~~~kl~DFGla~  472 (614)
                      ......+......+.-.+ .....++||+|+.++||+++++...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            111222222223333332 2235789999999999999998777899999875